@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix obo: <http://www.geneontology.org/formats/oboInOwl#> .
@prefix ns1: <http://purl.obolibrary.org/obo/> .
@prefix ns2: <http://data.bioontology.org/metadata/> .
@prefix ns3: <http://data.bioontology.org/metadata/obo/> .
@prefix ns4: <http://purl.obolibrary.org/obo/pw#> .

<http://data.bioontology.org/metadata/treeView> a owl:AnnotationProperty .
<http://data.bioontology.org/metadata/obo/part_of> a owl:AnnotationProperty .
<http://purl.obolibrary.org/obo/IAO_0000115>
  a owl:AnnotationProperty ;
  rdfs:label "definition"^^xsd:string .

<http://purl.obolibrary.org/obo/IAO_0000231> a owl:AnnotationProperty .
<http://purl.obolibrary.org/obo/IAO_0100001> a owl:AnnotationProperty .
<http://www.geneontology.org/formats/oboInOwl#auto-generated-by> a owl:AnnotationProperty .
<http://www.geneontology.org/formats/oboInOwl#created_by> a owl:AnnotationProperty .
<http://www.geneontology.org/formats/oboInOwl#creation_date> a owl:AnnotationProperty .
<http://www.geneontology.org/formats/oboInOwl#date> a owl:AnnotationProperty .
<http://www.geneontology.org/formats/oboInOwl#default-namespace> a owl:AnnotationProperty .
<http://www.geneontology.org/formats/oboInOwl#hasAlternativeId>
  a owl:AnnotationProperty ;
  rdfs:label "has_alternative_id"^^xsd:string .

<http://www.geneontology.org/formats/oboInOwl#hasDbXref>
  a owl:AnnotationProperty ;
  rdfs:label "database_cross_reference"^^xsd:string .

<http://www.geneontology.org/formats/oboInOwl#hasExactSynonym>
  a owl:AnnotationProperty ;
  rdfs:label "has_exact_synonym"^^xsd:string .

<http://www.geneontology.org/formats/oboInOwl#hasOBOFormatVersion>
  a owl:AnnotationProperty ;
  rdfs:label "has_obo_format_version"^^xsd:string .

<http://www.geneontology.org/formats/oboInOwl#hasOBONamespace>
  a owl:AnnotationProperty ;
  rdfs:label "has_obo_namespace"^^xsd:string .

<http://www.geneontology.org/formats/oboInOwl#hasRelatedSynonym>
  a owl:AnnotationProperty ;
  rdfs:label "has_related_synonym"^^xsd:string .

<http://www.geneontology.org/formats/oboInOwl#id> a owl:AnnotationProperty .
<http://www.geneontology.org/formats/oboInOwl#saved-by> a owl:AnnotationProperty .
rdfs:comment a owl:AnnotationProperty .
rdfs:label a owl:AnnotationProperty .
owl:deprecated a owl:AnnotationProperty .
skos:notation a owl:AnnotationProperty .
<http://purl.obolibrary.org/obo/pw#part_of>
  a owl:ObjectProperty ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "part_of"^^xsd:string ;
  rdfs:label "part_of"^^xsd:string .

<http://purl.obolibrary.org/obo/OMIM_236130>
  a owl:Class ;
  ns1:IAO_0000231 ns1:IAO_0000227 ;
  ns1:IAO_0100001 ns1:PW_0001979 ;
  owl:deprecated true ;
  skos:notation "OMIM:236130"^^xsd:string .

ns1:PW_0000000
  a owl:Class ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000000"^^xsd:string ;
  rdfs:label "term zero"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0000000"^^xsd:string .

ns1:PW_0000001
  a owl:Class ;
  rdfs:subClassOf owl:Thing ;
  ns2:treeView owl:Thing ;
  ns1:IAO_0000115 "A pathway is a set of inter-connected  reactions and interactions whose delineation and scope are used as a model for exploring and studying, describing and understanding the working of and relationships between biomolecules within a context."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000001"^^xsd:string ;
  rdfs:label "pathway"^^xsd:string ;
  skos:notation "PW:0000001"^^xsd:string .

ns1:PW_0000002
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000001 ;
  ns2:treeView ns1:PW_0000001 ;
  ns1:IAO_0000115 "The various, enzyme controlled, series of reactions allowing for the conversion of materials, energy availability and biodegradation of xenobiotics."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000002"^^xsd:string ;
  rdfs:comment "The definition was compiled based on a number of available defintions in various dictionaries."^^xsd:string ;
  rdfs:label "classic metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000002"^^xsd:string .

ns1:PW_0000003
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000001 ;
  ns2:treeView ns1:PW_0000001 ;
  ns1:IAO_0000115 "The pathways where a signal - hormone, neurotransmitter, growth factor, peptide, any molecule - triggers one or multiple cascades of events. This involves a number of molecules, including receptors, proteins, ligands, messengers, any participating molecule. A signaling pathway may be upstream or downstream of other signaling pathways. Signaling pathways control a very broad spectrum of processes as well as pathways."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000003"^^xsd:string ;
  rdfs:comment "The definition was compiled based on a number of definitions available in various dictionaries."^^xsd:string ;
  rdfs:label "signaling pathway"^^xsd:string ;
  skos:notation "PW:0000003"^^xsd:string .

ns1:PW_0000004
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000001 ;
  ns2:treeView ns1:PW_0000001 ;
  ns1:IAO_0000115 "The pathways that control the processes by which a cell or organism develops, adjusts, behaves, responds to conditions or changes in these conditions, or in any manner helps promote and maintain its efficient functioning."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000004"^^xsd:string ;
  rdfs:comment "The definition was complied based on a number of definitions available in several dictionaries"^^xsd:string ;
  rdfs:label "regulatory pathway"^^xsd:string ;
  skos:notation "PW:0000004"^^xsd:string .

ns1:PW_0000005
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000002 ;
  ns2:treeView ns1:PW_0000002 ;
  ns1:IAO_0000115 "Those metabolic reactions and pathways involved in the oxidation, breakdown and synthesis of carbohydrates in the tissue. The breakdown can be utilized by the body for energy production. The converse synthesis is used for energy storage."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000005"^^xsd:string ;
  rdfs:comment "The definition  was compiled using the Online Medical dictionary and the Stedman's medical dictionary available at OneLook"^^xsd:string ;
  rdfs:label "carbohydrate metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000005"^^xsd:string .

ns1:PW_0000006
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000125 ;
  ns2:treeView ns1:PW_0000125 ;
  ns1:IAO_0000115 "The Ras superfamily consists of a diverse group of small, monomeric G proteins that function as molecular switches alternating between the GDP-inactive and the GTP-active bound state. The GTP-bound form can interact with many downstream effectors. Ras superfamily controls a broad spectrum of processes; deregulation of Ras cascades has been linked to several forms of cancer. The superfamily is structurally classified in five families."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "monomeric G protein mediated signaling pathway"^^xsd:string ;
  obo:id "PW:0000006"^^xsd:string ;
  rdfs:comment "Numerous articles contributed to this definition, too many to cite independently."^^xsd:string ;
  rdfs:label "Ras superfamily mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000006"^^xsd:string .

ns1:PW_0000007
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000003, ns1:PW_0001194 ;
  ns2:treeView ns1:PW_0000003, ns1:PW_0001194 ;
  ns1:IAO_0000115 "The mitogen -activated protein kinase pathway groups several serine/threonine protein kinases mediated cascades in response to a number of extracellular stimuli.  A characteristic feature of these cascades is the presence of at least three kinases in series leading to the activation of a multifunctional MAP kinase."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04010"^^xsd:string, "MAPK signaling pathway"^^xsd:string ;
  obo:id "PW:0000007"^^xsd:string ;
  rdfs:label "mitogen activated protein kinase signaling pathway"^^xsd:string ;
  skos:notation "PW:0000007"^^xsd:string .

ns1:PW_0000008
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000650, ns1:PW_0000656 ;
  ns2:treeView ns1:PW_0000650, ns1:PW_0000656 ;
  ns1:IAO_0000115 "The secreted glycoproteins of the Wnt family regulate a wide spectrum of developmental processes and they are also playing important roles in the adult organism. Deregulation of Wnt cascades has oncogenic effects and is responsible for tumorigenesis in adults."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04310"^^xsd:string ;
  obo:id "PW:0000008"^^xsd:string ;
  rdfs:label "Wnt signaling pathway"^^xsd:string ;
  skos:notation "PW:0000008"^^xsd:string .

ns1:PW_0000009
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001557 ;
  ns2:treeView ns1:PW_0001557 ;
  ns1:IAO_0000115 "Apoptosis is a programmed cell death pathway that is characterized by particular morphological features such as membrane blebbing and DNA fragmentation. It can be intrinsic or extrinsic and involves the activation of caspases."^^xsd:string ;
  obo:hasExactSynonym "Reactome:R-HSA-109581"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04210"^^xsd:string, "programmed cell death pathway"^^xsd:string ;
  obo:id "PW:0000009"^^xsd:string ;
  rdfs:label "apoptotic cell death pathway"^^xsd:string ;
  skos:notation "PW:0000009"^^xsd:string .

ns1:PW_0000010
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000002 ;
  ns2:treeView ns1:PW_0000002 ;
  ns1:IAO_0000115 "The metabolic reactions involved in the oxidation, utilization and/or synthesis of lipids in the tissues."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000010"^^xsd:string ;
  rdfs:label "lipid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000010"^^xsd:string .

ns1:PW_0000011
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000002 ;
  ns2:treeView ns1:PW_0000002 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of the primary or standard 20 amino acids found in proteins. Amino acids are described as non-essential or essential depending on whether humans can or can not synthesize them, respectively. Chemically, they are classified based on the polarity of their side chain or R group, as non-polar and hydrophobic and hydrophilic and charged or polar uncharged. Amino acid metabolic pathways are also listed with their KEGG entries."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000011"^^xsd:string ;
  rdfs:label "amino acid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000011"^^xsd:string .

ns1:PW_0000012
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000002 ;
  ns2:treeView ns1:PW_0000002 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of nucleotides. Nucleotides, which are the units of DNA and RNA, can also play important roles in cellular energy, enzyme regulation as well as serve as signaling molecules."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000012"^^xsd:string ;
  rdfs:label "nucleotide metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000012"^^xsd:string .

ns1:PW_0000013
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000001 ;
  ns2:treeView ns1:PW_0000001 ;
  ns1:IAO_0000115 "Complex human diseases encompass a spectrum of genetic and environmental attributes that together affect the normal functioning of several molecular and cellular pathways. Their combined and accumulated effect is manifested in the anomalous phenotype of the complex condition."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "complex human diseases"^^xsd:string ;
  obo:id "PW:0000013"^^xsd:string ;
  rdfs:label "disease pathway"^^xsd:string ;
  skos:notation "PW:0000013"^^xsd:string .

ns1:PW_0000014
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001412 ;
  ns2:treeView ns1:PW_0001412 ;
  ns1:IAO_0000115 "Neurodegenerative diseases group together a number of conditions of various and many times poorly understood origins that are characterized by the progressive loss of particular neurons, the formation of particular structures such as plaques and fibrils, and protein aggregates. Proteosomal degradation, programmed cell death and oxidative stress are among a number of pathways thought to be disrupted."^^xsd:string ;
  obo:hasExactSynonym "neurodegenerative disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000014"^^xsd:string ;
  rdfs:label "neurodegenerative pathway"^^xsd:string ;
  skos:notation "PW:0000014"^^xsd:string .

ns1:PW_0000015
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000014 ;
  ns2:treeView ns1:PW_0000014 ;
  ns1:IAO_0000115 "A mostly sporadic, late-onset condition affecting the central nervous system, that is the most prevalent neurodegenerative disease and the most common form of dementia. It is characterized by the presence of amyloid plaques and fibril tangles. Possible pathways affected range from protein mis-folding and aggregation, to oxidative stress and impaired metal homeostasis."^^xsd:string ;
  obo:hasExactSynonym "Alzheimer disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05010"^^xsd:string ;
  obo:id "PW:0000015"^^xsd:string ;
  rdfs:label "Alzheimer's disease pathway"^^xsd:string ;
  skos:notation "PW:0000015"^^xsd:string .

ns1:PW_0000016
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000014 ;
  ns2:treeView ns1:PW_0000014 ;
  ns1:IAO_0000115 "A late onset, mostly sporadic neurodegenerative disease characterized by the loss of motor neurons in the brain stem and spinal cord. Various pathways are thought to be deregulated and contribute to the condition; among them calcium and/or zinc homeostasis, apoptosis, Cdk5 and calcineurin dependent processes, and in the case of the more rare, genetically inherited form of the disease, mutations in the cytosolic Cu, Zn superoxide dismutase (SOD1) and the subsequent changes in the processes that involve SOD1."^^xsd:string ;
  obo:hasExactSynonym "ALS pathway"^^xsd:string, "amyotrophic lateral sclerosis disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05014"^^xsd:string ;
  obo:id "PW:0000016"^^xsd:string ;
  rdfs:label "amyotrophic lateral sclerosis pathway"^^xsd:string ;
  skos:notation "PW:0000016"^^xsd:string .

ns1:PW_0000017
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000171 ;
  ns2:treeView ns1:PW_0000171 ;
  ns1:IAO_0000115 "An autosomal dominant neurodegenerative disease manifesting in movement, cognitive and psychiatric disorders caused by the abnormal expansion of a polyglutamine (polyQ) stretch in the Huntingtin (HTT) protein. It mostly affects the caudate-putamen striatal neurons. Other areas are also affected and undergo a size reduction. HTT is thought to be involved in several cellular pathways. Its functions are overcome by the mutant protein mHTT."^^xsd:string ;
  obo:hasExactSynonym "HD pathway"^^xsd:string, "Huntington disease pathway"^^xsd:string, "Huntington's chorea pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05016"^^xsd:string ;
  obo:id "PW:0000017"^^xsd:string ;
  rdfs:label "Huntington's disease pathway"^^xsd:string ;
  skos:notation "PW:0000017"^^xsd:string .

ns1:PW_0000018
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000014 ;
  ns2:treeView ns1:PW_0000014 ;
  ns1:IAO_0000115 "One of the most common neurodegenerative diseases that is characterized by the loss of dopaminergic neurons in the substantia nigra and the presence of cytoplasmic inclusions called Lewy bodies in surrounding neurons. Several pathways are thought to be deregulated; for instance, imbalance of iron homeostasis is believed to contribute to the pathogenesis of the condition."^^xsd:string ;
  obo:hasExactSynonym "Parkinson disease pathway"^^xsd:string, "paralysis agitans pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05012"^^xsd:string ;
  obo:id "PW:0000018"^^xsd:string ;
  rdfs:label "Parkinson's disease pathway"^^xsd:string ;
  skos:notation "PW:0000018"^^xsd:string .

ns1:PW_0000019
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000014 ;
  ns2:treeView ns1:PW_0000014 ;
  ns1:IAO_0000115 "Prion disease - any of a group of fatal, transmissible neurodegenerative diseases caused by abnormalities of prion protein metabolism, which may result from mutations in the prion protein gene or from infection with pathogenic isoforms of the protein.  Characteristics include neuronal loss, gliosis, and extensive vacuolization of the cerebral cortex. Prion diseases may be sporadic, inherited as an autosomal dominant trait, or acquired. Human diseases include Creutzfeldt-Jakob disease, Gerstmann-Strussler syndrome, fatal familial insomnia, and kuru"^^xsd:string ;
  obo:hasExactSynonym "prion protein disease pathway"^^xsd:string, "spongiform encephalopathy pathway"^^xsd:string, "transmissible spongiform encephalopathy pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05020"^^xsd:string ;
  obo:id "PW:0000019"^^xsd:string ;
  rdfs:label "prion disease pathway"^^xsd:string ;
  skos:notation "PW:0000019"^^xsd:string .

ns1:PW_0000020
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000013 ;
  ns2:treeView ns1:PW_0000013 ;
  ns1:IAO_0000115 "Cardiovascular diseases represent a very broad spectrum of conditions that can also combine with diabetes and renal failure."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000020"^^xsd:string ;
  rdfs:label "cardiovascular system disease pathway"^^xsd:string ;
  skos:notation "PW:0000020"^^xsd:string .

ns1:PW_0000021
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000020 ;
  ns2:treeView ns1:PW_0000020 ;
  ns1:IAO_0000115 "Hypertension, high arterial blood pressure: various criteria for its threshold have been suggested, ranging from 140 mm Hg systolic and 90 mm Hg diastolic to as high as 200 mm Hg systolic and 110 mm Hg diastolic. Hypertension may have no known cause (essential or idiopathic h.) or be associated with other primary diseases (secondary h.)."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000021"^^xsd:string ;
  rdfs:label "hypertension pathway"^^xsd:string ;
  skos:notation "PW:0000021"^^xsd:string .

ns1:PW_0000022
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000020 ;
  ns2:treeView ns1:PW_0000020 ;
  ns1:IAO_0000115 "Cardiomyopathy - a general diagnostic term designating primary noninflammatory disease of the heart muscle, often of obscure or unknown etiology and not the result of ischemic, hypertensive, congenital, valvular, or pericardial disease. It is usually subdivided into dilated, hypertrophic, and restrictive cardiomyopathy (1). Cardiomyopathy is the deterioration of the cardiac muscle of the heart wall."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000022"^^xsd:string ;
  rdfs:label "cardiomyopathy pathway"^^xsd:string ;
  skos:notation "PW:0000022"^^xsd:string .

ns1:PW_0000023
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000004 ;
  ns2:treeView ns1:PW_0000004 ;
  ns1:IAO_0000115 "The Immune response pathways mediate the defense of host cells against infection and injury. The first line of defense is provided by the phylogenetically older innate immune response. The later, more versatile response is provided by the pathways of adaptive immunity: the B cell mediated humoral and the T cell mediated cellular or cell-mediated responses."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000023"^^xsd:string ;
  rdfs:label "immune response pathway"^^xsd:string ;
  skos:notation "PW:0000023"^^xsd:string .

ns1:PW_0000024
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000234
  ] ;
  ns2:treeView ns1:PW_0000234 ;
  ns3:part_of ns1:PW_0000234 ;
  ns1:IAO_0000115 "Inflammation is the cellular response of the innate immune system to infection or injury. Sensing of infection by pattern recognition receptors triggers signaling cascades leading to the expression of mediator genes such as the pro-inflammatory cytokines."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "CLR signaling pathway"^^xsd:string ;
  obo:id "PW:0000024"^^xsd:string ;
  rdfs:label "inflammatory response pathway"^^xsd:string ;
  skos:notation "PW:0000024"^^xsd:string .

ns1:PW_0000025
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005 ;
  ns2:treeView ns1:PW_0000005 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the energy-yielding conversion of glucose to pyruvate or in the formation of glucose from non-carbohydrate precursors such as pyruvate, lactate, citric acid cycle intermediates, the carbon skeleton of many amino acids. While many enzymes are shared by the two pathways, a few steps are carried out by pathway-specific enzymes. The two pathways are independently regulated."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00010"^^xsd:string ;
  obo:id "PW:0000025"^^xsd:string ;
  rdfs:label "glycolysis/gluconeogenesis pathway"^^xsd:string ;
  skos:notation "PW:0000025"^^xsd:string .

ns1:PW_0000026
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000033, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000357
  ] ;
  ns2:treeView ns1:PW_0000033, ns1:PW_0000357 ;
  ns3:part_of ns1:PW_0000357 ;
  ns1:IAO_0000115 "The series of chemical reactions that are central to all aerobic cells and constitute the citric acid cycle. Also known as the tricarboxylic acid cycle (TCA) or Krebs cycle, it is the center of convergence for all molecular fuels."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00020"^^xsd:string, "Krebs cycle pathway"^^xsd:string, "SMP:00057"^^xsd:string, "TCA cycle pathway"^^xsd:string, "tricarboxylic cycle pathway"^^xsd:string ;
  obo:id "PW:0000026"^^xsd:string ;
  rdfs:label "citric acid cycle pathway"^^xsd:string ;
  skos:notation "PW:0000026"^^xsd:string .

ns1:PW_0000027
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000445, ns1:PW_0001075 ;
  ns2:treeView ns1:PW_0000445, ns1:PW_0001075 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation glutamic acid/glutamate. Glutamate is the major excitatory neurotransmitter."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00072"^^xsd:string ;
  obo:id "PW:0000027"^^xsd:string ;
  rdfs:comment "Definition compiled based on the information available for glutamate at OneLook"^^xsd:string ;
  rdfs:label "glutamic acid/glutamate metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000027"^^xsd:string .

ns1:PW_0000028
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001077 ;
  ns2:treeView ns1:PW_0001077 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of alanine, aspartate and glutamate."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00250"^^xsd:string ;
  obo:id "PW:0000028"^^xsd:string ;
  rdfs:comment "The definition was compiled based on the information on alanine and aspartate available at OneLook."^^xsd:string ;
  rdfs:label "alanine, aspartate and glutamate metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000028"^^xsd:string .

ns1:PW_0000029
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000058 ;
  ns2:treeView ns1:PW_0000058 ;
  ns1:IAO_0000115 "Acetyl-CoA, the starting material for fatty acid biosynthesis, can be derived from amino acid and lipid degradation or the oxidative decarboxylation of pyruvate. Fatty acid biosynthesis involves the condensation of C2 units; it requires seven enzymatic reactions which are carried out by the multifunctional enzyme fatty acid synthase."^^xsd:string ;
  obo:hasAlternativeId "PW:0000030"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00061"^^xsd:string, "SMP:00456"^^xsd:string ;
  obo:id "PW:0000029"^^xsd:string ;
  rdfs:label "fatty acid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000029"^^xsd:string .

ns1:PW_0000030
  a owl:Class ;
  ns1:IAO_0000231 ns1:IAO_0000227 ;
  ns1:IAO_0100001 ns1:PW_0000029 ;
  owl:deprecated true ;
  skos:notation "PW:0000030"^^xsd:string .

ns1:PW_0000031
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000012 ;
  ns2:treeView ns1:PW_0000012 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of purines. Purines consist of a pyrimidine ring fused to an imidazole ring. The nucleobases adenine and guanine in DNA are purines."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00230"^^xsd:string, "SMP:00050"^^xsd:string ;
  obo:id "PW:0000031"^^xsd:string ;
  rdfs:label "purine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000031"^^xsd:string .

ns1:PW_0000032
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000012 ;
  ns2:treeView ns1:PW_0000012 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of pyrimidines. Cytosine, thymine and uracil - the nucleobases found in nucleic acids, are pyrimidine derivatives."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00240"^^xsd:string, "SMP:00046"^^xsd:string ;
  obo:id "PW:0000032"^^xsd:string ;
  rdfs:label "pyrimidine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000032"^^xsd:string .

ns1:PW_0000033
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000002 ;
  ns2:treeView ns1:PW_0000002 ;
  ns1:IAO_0000115 "Those metabolic reactions and pathways whose role is to release or provide energy."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000033"^^xsd:string ;
  rdfs:label "energy metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000033"^^xsd:string .

ns1:PW_0000034
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001059
  ] ;
  ns2:treeView ns1:PW_0001059 ;
  ns3:part_of ns1:PW_0001059 ;
  ns1:IAO_0000115 "Those metabolic reactions thereby the electrons derived from the oxidation of glucose and lipids or the degradation of amino acids, are passed to oxygen via a series of series of spatially separated complexes. The energy derived generates an electrochemical gradient that drives the synthesis of ATP. The coupling between the electron transport chain, also known as the respiratory chain and the ATP biosynthetic pathway is known as oxidative phosphorylation. Under certain circumstances the two may be uncoupled."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "ETC pathway"^^xsd:string, "SMP:00355"^^xsd:string, "respiratory chain pathway"^^xsd:string ;
  obo:id "PW:0000034"^^xsd:string ;
  rdfs:label "electron transport chain pathway"^^xsd:string ;
  skos:notation "PW:0000034"^^xsd:string .

ns1:PW_0000035
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001059
  ] ;
  ns2:treeView ns1:PW_0001059 ;
  ns3:part_of ns1:PW_0001059 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of adenosine triphosphate (ATP). ATP synthesis is coupled to the electron transfer or respiratory chain pathway which generates an electrochemical gradient that drives the phosphorylation of ADP. The coupling of the two pathways is called oxidative phosphorylation. Under certain circumstances however, the two may be uncoupled."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000035"^^xsd:string ;
  rdfs:label "ATP biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000035"^^xsd:string .

ns1:PW_0000036
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000033 ;
  ns2:treeView ns1:PW_0000033 ;
  ns1:IAO_0000115 "Those metabolic reactions in the nitrogen cycle carried out by various microorganisms."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000036"^^xsd:string ;
  rdfs:label "nitrogen metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000036"^^xsd:string .

ns1:PW_0000037
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000033 ;
  ns2:treeView ns1:PW_0000033 ;
  ns1:IAO_0000115 "Those metabolic reactions involving sulfur - a component of methionine and cysteine amino acids and of co-enzymes and vitamins. It also serves as electron donor in anaerobic respiration. Microorganisms and plants can incorporate inorganic sulfate into bioinorganic compounds; higher organisms derive them from diet."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00920"^^xsd:string ;
  obo:id "PW:0000037"^^xsd:string ;
  rdfs:label "sulfur metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000037"^^xsd:string .

ns1:PW_0000038
  a owl:Class ;
  ns1:IAO_0000115 "OBSOLETE. Originally found at KEGG, the term has since been deleted."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000038"^^xsd:string ;
  rdfs:label "Sterol, vitamin K, vitamine E and cartenoids  biosynthesis"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0000038"^^xsd:string .

ns1:PW_0000039
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001304 ;
  ns2:treeView ns1:PW_0001304 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the biosynthesis of bile acid - any of the steroid carboxylic acids derived from cholesterol. Cholic and chenodeoxycholic acids are the primary bile acids and are formed in the liver. Secondary bile acids - deoxycholic and lithocholic - are formed from the primary bile acids through the action of intestinal bacteria. Bile acid also acts as a signal molecule via several nuclear receptors."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00120"^^xsd:string, "SMP:00035"^^xsd:string ;
  obo:id "PW:0000039"^^xsd:string ;
  rdfs:label "bile acid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000039"^^xsd:string .

ns1:PW_0000040
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001152, ns1:PW_0001305 ;
  ns2:treeView ns1:PW_0001152, ns1:PW_0001305 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of steroid hormones. All steroid hormones are derived from cholesterol. Steroid hormone metabolism is extremely complex and its molecular details are incompletely understood. De novo steroid biosynthesis is confined to very few tissues, primarily the adrenals, the gonads and the placenta."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00140"^^xsd:string, "SMP:00130"^^xsd:string ;
  obo:id "PW:0000040"^^xsd:string ;
  rdfs:label "steroid hormone biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000040"^^xsd:string .

ns1:PW_0000041
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005 ;
  ns2:treeView ns1:PW_0000005 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of fructose and mannose, as depicted in the KEGG diagram."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00051"^^xsd:string, "SMP:00064"^^xsd:string ;
  obo:id "PW:0000041"^^xsd:string ;
  rdfs:label "fructose and mannose metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000041"^^xsd:string .

ns1:PW_0000042
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005 ;
  ns2:treeView ns1:PW_0000005 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of galactose - an aldohexose epimeric with glucose at the 4 carbon. Galactose is a component of lactose and other oligosaccharides, cerebrosides and gangliosides, and of various glycolipids and glycoproteins."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00052"^^xsd:string, "SMP:00043"^^xsd:string ;
  obo:id "PW:0000042"^^xsd:string ;
  rdfs:label "galactose metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000042"^^xsd:string .

ns1:PW_0000043
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005, ns1:PW_0000556 ;
  ns2:treeView ns1:PW_0000005, ns1:PW_0000556 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of pyruvate - a salt, ester, or anionic form of pyruvic acid. Pyruvate, which is the end-product of glycolysis can be converted to lactate under anaerobic conditions, can be further oxidized via the Krebs or citrate cycle or can be converted back to glucose via gluconeogenesis."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00620"^^xsd:string, "SMP:00060"^^xsd:string ;
  obo:id "PW:0000043"^^xsd:string ;
  rdfs:label "pyruvate metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000043"^^xsd:string .

ns1:PW_0000044
  a owl:Class ;
  ns1:IAO_0000115 "OBSOLETE. Duplicated term. Use PW:0000027."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000044"^^xsd:string ;
  rdfs:label "Duplicated Glutamate Metabolism term"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0000044"^^xsd:string .

ns1:PW_0000045
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005 ;
  ns2:treeView ns1:PW_0000005 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the generation of reducing equivalents and five carbon (pentose) sugars. The oxidative phase is irreversible; the non-oxidative is reversible."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00030"^^xsd:string, "SMP:00031"^^xsd:string, "hexose monophosphate pathway (shunt)"^^xsd:string, "pentose phosphate shunt"^^xsd:string, "phosphogluconate pathway"^^xsd:string ;
  obo:id "PW:0000045"^^xsd:string ;
  rdfs:label "pentose phosphate pathway"^^xsd:string ;
  skos:notation "PW:0000045"^^xsd:string .

ns1:PW_0000046
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005 ;
  ns2:treeView ns1:PW_0000005 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of inositol, a cyclic sugar alcohol occurring in a number of stereoisomers of which the myo-inositol is the most prominent form. myo-inositol provides a structural basis for compounds such as inositol phosphates and phosphatidylinositols  which are secondary messengers in several signaling pathways."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00011"^^xsd:string ;
  obo:id "PW:0000046"^^xsd:string ;
  rdfs:label "inositol metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000046"^^xsd:string .

ns1:PW_0000047
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001077 ;
  ns2:treeView ns1:PW_0001077 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of glycine, serine and threonine and which are intimately connected with serine being synthesized from glycine and threonine."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00260"^^xsd:string ;
  obo:id "PW:0000047"^^xsd:string ;
  rdfs:comment "Definition compiled based on the information available at oneLook"^^xsd:string ;
  rdfs:label "glycine, serine and threonine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000047"^^xsd:string .

ns1:PW_0000048
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001074, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001693
  ] ;
  ns2:treeView ns1:PW_0001074, ns1:PW_0001693 ;
  ns3:part_of ns1:PW_0001693 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis (remethylation), utilization and/or degradation of methionine, an essential amino acid for humans. The cycle produces S-adenosylmethionine (AdoMet),  the major methyl donor for proteins, nucleic acids, lipids and other small molecules. The cycle also produces homocysteine (Hcy) which either regenerates methionine via the  remethylation pathway or leads to the synthesis of cysteine and derivatives via the transsulfuration pathway. Homocysteine and folate metabolic pathways are intimately related to the methionine cycle."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00033"^^xsd:string ;
  obo:id "PW:0000048"^^xsd:string ;
  rdfs:label "methionine cycle/metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000048"^^xsd:string .

ns1:PW_0000049
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001075 ;
  ns2:treeView ns1:PW_0001075 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of cysteine, a non-essential amino acid that could be essential in certain cases. Its side chain contains a sulfhydryl group that is readily oxidized to form the cystine dimer covalently linked by a disulfide bond."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00013"^^xsd:string ;
  obo:id "PW:0000049"^^xsd:string ;
  rdfs:comment "Reference compiled based on the information available at OneLook for cysteine."^^xsd:string ;
  rdfs:label "cysteine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000049"^^xsd:string .

ns1:PW_0000050
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001077 ;
  ns2:treeView ns1:PW_0001077 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of arginine - an essential amino acid - and proline - an amino acid that can play important roles in protein secondary structure."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00330"^^xsd:string, "SMP:00020"^^xsd:string ;
  obo:id "PW:0000050"^^xsd:string ;
  rdfs:comment "Definition compiled based on the information on arginine and proline available at OneLook"^^xsd:string ;
  rdfs:label "arginine and proline metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000050"^^xsd:string .

ns1:PW_0000051
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001075, ns1:PW_0001077 ;
  ns2:treeView ns1:PW_0001075, ns1:PW_0001077 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of histidine, an essential amino acid which can act as either a proton donor or a proton acceptor. While the synthesis and degradation pathways of histidine are present in microorganisms, histidine can be acted upon by eukaryotic enzymes. Histidine is the precursor of histamine, involved in immune responses and also acting as a neurotransmitter."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00340"^^xsd:string, "SMP:00044"^^xsd:string ;
  obo:id "PW:0000051"^^xsd:string ;
  rdfs:label "histidine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000051"^^xsd:string .

ns1:PW_0000052
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001074, ns1:PW_0001077 ;
  ns2:treeView ns1:PW_0001074, ns1:PW_0001077 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of tyrosine - a non-essential amino acid produced from phenylalanine and precursor of thyroid hormones, catecholamines and melanin. Along with phenylalanine and tryptophan is one of the three aromatic amino acids."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00350"^^xsd:string, "SMP:00006"^^xsd:string ;
  obo:id "PW:0000052"^^xsd:string ;
  rdfs:label "tyrosine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000052"^^xsd:string .

ns1:PW_0000053
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001074, ns1:PW_0001077 ;
  ns2:treeView ns1:PW_0001074, ns1:PW_0001077 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of phenylalanine, an essential amino acid. Along with tyrosine and tryptophan is one of the three aromatic amino acids."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00360"^^xsd:string ;
  obo:id "PW:0000053"^^xsd:string ;
  rdfs:label "phenylalanine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000053"^^xsd:string .

ns1:PW_0000054
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001074, ns1:PW_0001077 ;
  ns2:treeView ns1:PW_0001074, ns1:PW_0001077 ;
  ns1:IAO_0000115 "Those metabolic reactions that are involved in the synthesis, utilization and/or degradation of tryptophan - a dietary essential amino acid and precursor for several important compounds. Along with phenylalanine and tyrosine is one of the three aromatic amino acids."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00380"^^xsd:string, "SMP:00063"^^xsd:string ;
  obo:id "PW:0000054"^^xsd:string ;
  rdfs:label "tryptophan metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000054"^^xsd:string .

ns1:PW_0000055
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005 ;
  ns2:treeView ns1:PW_0000005 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of nucleotide sugars. Nucleotide sugars are glycosyl donors usually classified depending on the type of the nucleoside forming them. Several are used in animals and many others can be found in plants and bacteria."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00520"^^xsd:string, "SMP:00010"^^xsd:string ;
  obo:id "PW:0000055"^^xsd:string ;
  rdfs:label "nucleotide sugar metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000055"^^xsd:string .

ns1:PW_0000056
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000033 ;
  ns2:treeView ns1:PW_0000033 ;
  ns1:IAO_0000115 "A chemical combination caused by the action of light; specifically the formation of carbohydrates (with release of molecular oxygen) from carbon dioxide and water in the chlorophyll tissue of plants and blue-green algae under the influence of light. In bacteria, photosynthesis employs hydrogen sulfide, molecular hydrogen, and other reduced compounds in place of water, so that molecular oxygen is not released."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000056"^^xsd:string ;
  rdfs:label "photosynthesis pathway"^^xsd:string ;
  skos:notation "PW:0000056"^^xsd:string .

ns1:PW_0000057
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000033 ;
  ns2:treeView ns1:PW_0000033 ;
  ns1:IAO_0000115 "The pathway thereby photosynthetic organisms such as plants and cyanobacteria convert inorganic carbon (usually carbon dioxide) into organic compounds (usually carbohydrates)."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000057"^^xsd:string ;
  rdfs:label "carbon fixation pathway"^^xsd:string ;
  skos:notation "PW:0000057"^^xsd:string .

ns1:PW_0000058
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000010 ;
  ns2:treeView ns1:PW_0000010 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of fatty acids - any long-chain monobasic organic acid."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00071"^^xsd:string, "SMP:00051"^^xsd:string ;
  obo:id "PW:0000058"^^xsd:string ;
  rdfs:label "fatty acid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000058"^^xsd:string .

ns1:PW_0000059
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000003 ;
  ns2:treeView ns1:PW_0000003 ;
  ns1:IAO_0000115 "Those signaling pathways that are involved in or mediate the various aspects of nervous system and/or brain function."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000059"^^xsd:string ;
  rdfs:label "signaling pathway pertinent to the brain and nervous system"^^xsd:string ;
  skos:notation "PW:0000059"^^xsd:string .

ns1:PW_0000060
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000455
  ] ;
  ns2:treeView ns1:PW_0000455 ;
  ns3:part_of ns1:PW_0000455 ;
  ns1:IAO_0000115 "Long-term potentiation (LTP) is a strengthening of the synapse that can last from hours to days and months.  It is thought to underlie information storage and constitute the cellular basis of learning and memory.  LTP engages numerous cascades of events on either side of the synapse and is accompanied by changes in gene expression."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04720"^^xsd:string, "LTP"^^xsd:string ;
  obo:id "PW:0000060"^^xsd:string ;
  rdfs:label "long term potentiation"^^xsd:string ;
  skos:notation "PW:0000060"^^xsd:string .

ns1:PW_0000061
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000455
  ] ;
  ns2:treeView ns1:PW_0000455 ;
  ns3:part_of ns1:PW_0000455 ;
  ns1:IAO_0000115 "Long term depression is a weakening of a synapse that lasts hours to days. It results from either strong synaptic stimulation (as in the cerebellum) or to weak synaptic stimulation (as in the hippocampus), and engages several cascades."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04730"^^xsd:string, "LTD"^^xsd:string ;
  obo:id "PW:0000061"^^xsd:string ;
  rdfs:comment "Adapted from Wikipedia at OneLook"^^xsd:string ;
  rdfs:label "long term depression"^^xsd:string ;
  skos:notation "PW:0000061"^^xsd:string .

ns1:PW_0000062
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005 ;
  ns2:treeView ns1:PW_0000005 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of ascorbate and aldarate, as depicted in the KEGG diagram."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00053"^^xsd:string ;
  obo:id "PW:0000062"^^xsd:string ;
  rdfs:label "ascorbate and aldarate metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000062"^^xsd:string .

ns1:PW_0000063
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005 ;
  ns2:treeView ns1:PW_0000005 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of glyoxylate and dicarboxylate, as depicted in the KEGG diagram."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00630"^^xsd:string ;
  obo:id "PW:0000063"^^xsd:string ;
  rdfs:label "glyoxylate and dicarboxylate metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000063"^^xsd:string .

ns1:PW_0000064
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005 ;
  ns2:treeView ns1:PW_0000005 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of propanoate - any salt or ester of propanoic or propionic acid. Several propanoates are used in the food industry."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00640"^^xsd:string, "SMP:00016"^^xsd:string ;
  obo:id "PW:0000064"^^xsd:string ;
  rdfs:label "propanoate metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000064"^^xsd:string .

ns1:PW_0000065
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005 ;
  ns2:treeView ns1:PW_0000005 ;
  ns1:IAO_0000115 "Those reactions involved in the synthesis, utilization and/or degradation of butanoate - an ester or salt of  n-Butyric acid. Various butanoates are used as ingredients in flavoring and perfumery."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00650"^^xsd:string, "SMP:00073"^^xsd:string, "butyrate metabolic pathway"^^xsd:string ;
  obo:id "PW:0000065"^^xsd:string ;
  rdfs:label "butanoate metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000065"^^xsd:string .

ns1:PW_0000066
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005 ;
  ns2:treeView ns1:PW_0000005 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000066"^^xsd:string ;
  rdfs:label "C5-branched dibasic acid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000066"^^xsd:string .

ns1:PW_0000067
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000033 ;
  ns2:treeView ns1:PW_0000033 ;
  ns1:IAO_0000115 "Those reactions involved in carbon dioxide fixation - the reductive carboxylate cycle (CO2 fixation) - the conversion of atmospheric carbon dioxide to organic carbon compounds, as in photosynthesis."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000067"^^xsd:string ;
  rdfs:label "reductive carboxylate cycle - CO2 fixation pathway"^^xsd:string ;
  skos:notation "PW:0000067"^^xsd:string .

ns1:PW_0000068
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000033 ;
  ns2:treeView ns1:PW_0000033 ;
  ns1:IAO_0000115 "Those pathways used by methanotrophs and the methanogens that metabolize methane as the sole carbon source or as byproduct."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000068"^^xsd:string ;
  rdfs:label "methane metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000068"^^xsd:string .

ns1:PW_0000069
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000058 ;
  ns2:treeView ns1:PW_0000058 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization or degradation of ketone bodies. The chemicals acetoacetate, acetone and beta-hydroxybutyrate are collectively known as ketone bodies, although only the first two are ketones. They provide fuel for heart and skeletal muscle and for the brain during starvation. Excessive accumulation of these acidic chemicals leads to dangerous diabetic conditions known as ketoacidosis."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00072"^^xsd:string, "SMP:00071"^^xsd:string ;
  obo:id "PW:0000069"^^xsd:string ;
  rdfs:comment "The definition was compiled using the information from a number of biological/medical dictionaries available at OneLook"^^xsd:string ;
  rdfs:label "ketone bodies metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000069"^^xsd:string .

ns1:PW_0000070
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000040 ;
  ns2:treeView ns1:PW_0000040 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of C21-steroid hormones. Pregnenolone, the first C21 steroid derived from cholesterol, and progesterone, to which pregnenolone can be converted, provide the starting material for the biosynthesis of C21, C19 and C18 steroid hormones. The C21 class includes glucocorticoids such as cortisol and mineralocorticoids such as aldosterone. Glucocorticoids and mineralocorticoids are collectively referred to as corticosteroids."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "corticosteroid biosynthetic pathway"^^xsd:string ;
  obo:id "PW:0000070"^^xsd:string ;
  rdfs:label "C21-steroid hormone biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000070"^^xsd:string .

ns1:PW_0000071
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001077 ;
  ns2:treeView ns1:PW_0001077 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the degradation of valine, leucine and isoleucine - the three, dietary essential, branched amino acids."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00280"^^xsd:string, "SMP:00032"^^xsd:string ;
  obo:id "PW:0000071"^^xsd:string ;
  rdfs:label "valine, leucine and isoleucine degradation pathway"^^xsd:string ;
  skos:notation "PW:0000071"^^xsd:string .

ns1:PW_0000072
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001077 ;
  ns2:treeView ns1:PW_0001077 ;
  ns1:IAO_0000115 "Those metabolic pathways involved in the synthesis of valine, leucine and isoleucine - the three, dietary essential, branched amino acids."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00290"^^xsd:string ;
  obo:id "PW:0000072"^^xsd:string ;
  rdfs:label "valine, leucine and isoleucine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000072"^^xsd:string .

ns1:PW_0000073
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001077 ;
  ns2:treeView ns1:PW_0001077 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the degradation of lysine. In mammals, lysine is metabolized to acetyl-CoA. A derivative of lysine, allysine, is used in the production of elastin and collagen."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00310"^^xsd:string, "SMP:00037"^^xsd:string ;
  obo:id "PW:0000073"^^xsd:string ;
  rdfs:label "lysine degradation pathway"^^xsd:string ;
  skos:notation "PW:0000073"^^xsd:string .

ns1:PW_0000074
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001077 ;
  ns2:treeView ns1:PW_0001077 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the biosynthesis of lysine - an essential amino acid. In plants and bacteria it is synthesized from aspartate."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00300"^^xsd:string ;
  obo:id "PW:0000074"^^xsd:string ;
  rdfs:label "lysine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000074"^^xsd:string .

ns1:PW_0000075
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001077 ;
  ns2:treeView ns1:PW_0001077 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of phenylalanine, tyrosine and tryptophan and which are intimately related. Although the body can not manufacture phenylalanine on its own, phenylalanine is the precursor of tyrosine. Phenylalanine together with tryptophan governs the release of an intestinal hormone - cholecystokinin."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00400"^^xsd:string ;
  obo:id "PW:0000075"^^xsd:string ;
  rdfs:label "phenylalanine, tyrosine and tryptophan biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000075"^^xsd:string .

ns1:PW_0000076
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000011 ;
  ns2:treeView ns1:PW_0000011 ;
  ns1:IAO_0000115 "The series of metabolic reactions, occurring in the liver, by which the ammonia derived from the breakdown of amino acids combines with carbon dioxide to form urea."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00059"^^xsd:string ;
  obo:id "PW:0000076"^^xsd:string ;
  rdfs:label "urea cycle pathway"^^xsd:string ;
  skos:notation "PW:0000076"^^xsd:string .

ns1:PW_0000077
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000132 ;
  ns2:treeView ns1:PW_0000132 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of beta-alanine. Beta-alanine is an amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Beta-alanine is not used in the synthesis of proteins but is a component of natural peptides, vitamins such as vitamin B5 and of coenzyme. A rare genetic disorder, hyper-beta-alaninemia, has been reported."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00410"^^xsd:string, "SMP:00007"^^xsd:string ;
  obo:id "PW:0000077"^^xsd:string ;
  rdfs:label "beta-alanine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000077"^^xsd:string .

ns1:PW_0000078
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000132 ;
  ns2:treeView ns1:PW_0000132 ;
  ns1:IAO_0000115 "Those metabolic reactions involving cyanoamino acid, amino acid derivatives that contain a cyanide group."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00460"^^xsd:string ;
  obo:id "PW:0000078"^^xsd:string ;
  rdfs:label "cyanoamino acid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000078"^^xsd:string .

ns1:PW_0000079
  a owl:Class ;
  ns1:IAO_0000115 "OBSOLETE. Duplicated term. Use PW:0000133"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000079"^^xsd:string ;
  rdfs:label "Duplicated Selenoamino acid metabolism term"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0000079"^^xsd:string .

ns1:PW_0000080
  a owl:Class ;
  ns1:IAO_0000115 "OBSOLETE. Duplicated term. Use PW:0000133"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000080"^^xsd:string ;
  rdfs:label "Duplicated term - Selenoamino acid metabolism"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0000080"^^xsd:string .

ns1:PW_0000081
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000132 ;
  ns2:treeView ns1:PW_0000132 ;
  ns1:IAO_0000115 "Those metabolic reactions involving D-glutamine and D-glutamate as depicted in the KEGG diagram. D-glutamic acid is naturally found primarily in the cell wall of certain bacteria."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00471"^^xsd:string ;
  obo:id "PW:0000081"^^xsd:string ;
  rdfs:label "D-glutamine and D-glutamate metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000081"^^xsd:string .

ns1:PW_0000082
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000132 ;
  ns2:treeView ns1:PW_0000132 ;
  ns1:IAO_0000115 "Those metabolic reactions involving D-arginine and D-ornithine as depicted in the KEGG diagram."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00472"^^xsd:string ;
  obo:id "PW:0000082"^^xsd:string ;
  rdfs:label "D-arginine and D-ornithine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000082"^^xsd:string .

ns1:PW_0000083
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000132 ;
  ns2:treeView ns1:PW_0000132 ;
  ns1:IAO_0000115 "Those metabolic reactions involving D-alanine, the D-enantiomer of alanine. D-alanine can be found in bacterial cell wall and in some peptide antibiotics."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000083"^^xsd:string ;
  rdfs:label "D-alanine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000083"^^xsd:string .

ns1:PW_0000084
  a owl:Class ;
  ns1:IAO_0000115 "OBSOLETE. Duplicated term. Use PW:0000134"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000084"^^xsd:string ;
  rdfs:label "Duplicated glutathione metabolism term"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0000084"^^xsd:string .

ns1:PW_0000085
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000004 ;
  ns2:treeView ns1:PW_0000004 ;
  ns1:IAO_0000115 "Those pathways involved in and/or controlling DNA replication, cell cycle, DNA repair and maintenance of genomic integrity, RNA and protein biosynthesis."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000085"^^xsd:string ;
  rdfs:label "pathway pertinent to DNA replication and repair, cell cycle, maintenance of genomic integrity, RNA and protein biosynthesis"^^xsd:string ;
  skos:notation "PW:0000085"^^xsd:string .

ns1:PW_0000086
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001317 ;
  ns2:treeView ns1:PW_0001317 ;
  ns1:IAO_0000115 "The series of events, collectively known as the cell cycle, that underlie the replication of the genome and the segregation of chromosomes into daughter cells. The cycle begins with a diploid cell and produces two identical diploid cells."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04110"^^xsd:string ;
  obo:id "PW:0000086"^^xsd:string ;
  rdfs:comment "Adapted from  O'Connell and Walwarth, Genome KnowledgeBase"^^xsd:string ;
  rdfs:label "cell cycle pathway, mitotic"^^xsd:string ;
  skos:notation "PW:0000086"^^xsd:string .

ns1:PW_0000087
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000086
  ] ;
  ns2:treeView ns1:PW_0000086 ;
  ns3:part_of ns1:PW_0000086 ;
  ns1:IAO_0000115 "The series of events underlying the progression of early cell cycle into the G phase and under the control of D-type cyclins together with Cdk4 and Cdk6. The formation of the pre-initiation replication complex takes place during this phase."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000087"^^xsd:string ;
  rdfs:label "G1 phase pathway"^^xsd:string ;
  skos:notation "PW:0000087"^^xsd:string .

ns1:PW_0000088
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000086
  ] ;
  ns2:treeView ns1:PW_0000086 ;
  ns3:part_of ns1:PW_0000086 ;
  ns1:IAO_0000115 "The series of events underlying the transition from G1 into S phase and under the control of Cyclin E/A - Cdk2 and cyclin D-Cdk4/Cdk6 complexes and their regulators. Genetic alterations of this important transition point are frequent in human cancers."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000088"^^xsd:string ;
  rdfs:label "G1/S transition pathway"^^xsd:string ;
  skos:notation "PW:0000088"^^xsd:string .

ns1:PW_0000089
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000086
  ] ;
  ns2:treeView ns1:PW_0000086 ;
  ns3:part_of ns1:PW_0000086 ;
  ns1:IAO_0000115 "The series of events underlying duplication of the hereditary material of the cell, formation of two copies of the chromosome."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000089"^^xsd:string ;
  rdfs:label "S phase pathway"^^xsd:string ;
  skos:notation "PW:0000089"^^xsd:string .

ns1:PW_0000090
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000086
  ] ;
  ns2:treeView ns1:PW_0000086 ;
  ns3:part_of ns1:PW_0000086 ;
  ns1:IAO_0000115 "The series of events underlying the second 'gap' phase of the mitotic cell cycle - an interval between the completion of DNA synthesis and the beginning of mitosis and during which protein synthesis occurs."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000090"^^xsd:string ;
  rdfs:label "G2 phase pathway"^^xsd:string ;
  skos:notation "PW:0000090"^^xsd:string .

ns1:PW_0000091
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000086
  ] ;
  ns2:treeView ns1:PW_0000086 ;
  ns3:part_of ns1:PW_0000086 ;
  ns1:IAO_0000115 "The series of events underlying the transition from the G2 phase into mitosis."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000091"^^xsd:string ;
  rdfs:label "G2/M transition pathway"^^xsd:string ;
  skos:notation "PW:0000091"^^xsd:string .

ns1:PW_0000092
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000086
  ] ;
  ns2:treeView ns1:PW_0000086 ;
  ns3:part_of ns1:PW_0000086 ;
  ns1:IAO_0000115 "The series of events underlying mitosis (M-phase), in turn comprised of several phases, involving nuclear division and cytokinesis and resulting in the formation of two daughter cells."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000092"^^xsd:string ;
  rdfs:label "M phase pathway"^^xsd:string ;
  skos:notation "PW:0000092"^^xsd:string .

ns1:PW_0000093
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000086
  ] ;
  ns2:treeView ns1:PW_0000086 ;
  ns3:part_of ns1:PW_0000086 ;
  ns1:IAO_0000115 "The series of events underlying progression out of mitosis and division into two daughter cells. It requires the inactivation of cyclinB-cdc2 by the ubiquitin-dependent proteolysis."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000093"^^xsd:string ;
  rdfs:label "M/G1 transition pathway"^^xsd:string ;
  skos:notation "PW:0000093"^^xsd:string .

ns1:PW_0000094
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001317
  ] ;
  ns2:treeView ns1:PW_0001317 ;
  ns3:part_of ns1:PW_0001317 ;
  ns1:IAO_0000115 "Those pathways involved in the control of cell cycle progression as well as its precision and fidelity."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000094"^^xsd:string ;
  rdfs:label "cell cycle checkpoint pathway"^^xsd:string ;
  skos:notation "PW:0000094"^^xsd:string .

ns1:PW_0000095
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000094 ;
  ns2:treeView ns1:PW_0000094 ;
  ns1:IAO_0000115 "Those pathways of DNA damage response that occur during the G1 phase."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000095"^^xsd:string ;
  rdfs:label "G1/S DNA damage checkpoint pathway"^^xsd:string ;
  skos:notation "PW:0000095"^^xsd:string .

ns1:PW_0000096
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000094 ;
  ns2:treeView ns1:PW_0000094 ;
  ns1:IAO_0000115 "Those pathways that assure the genome is replicated only once per cell cycle. The checkpoints control for damaged and un-replicated DNA."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000096"^^xsd:string ;
  rdfs:label "G2/M checkpoint pathway"^^xsd:string ;
  skos:notation "PW:0000096"^^xsd:string .

ns1:PW_0000097
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000094 ;
  ns2:treeView ns1:PW_0000094 ;
  ns1:IAO_0000115 "The pathway prevents cells with mis-aligned chromosomes from dividing. Defects of kinetochore function activate checkpoint proteins to initiate a cascade of events that eventually prevent separation of sister chromatid."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000097"^^xsd:string ;
  rdfs:label "mitotic spindle checkpoint pathway"^^xsd:string ;
  skos:notation "PW:0000097"^^xsd:string .

ns1:PW_0000098
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000085 ;
  ns2:treeView ns1:PW_0000085 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:03030"^^xsd:string ;
  obo:id "PW:0000098"^^xsd:string ;
  rdfs:label "DNA replication pathway"^^xsd:string ;
  skos:notation "PW:0000098"^^xsd:string .

ns1:PW_0000099
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000085, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001360
  ] ;
  ns2:treeView ns1:PW_0000085, ns1:PW_0001360 ;
  ns3:part_of ns1:PW_0001360 ;
  ns1:IAO_0000115 "The pathways involved in the repair of damaged DNA. The damage can involve mismatched or damaged bases, distortion of the helix or breaks in the DNA double strand. Repair of DNA lesions along with the upstream lesion  detection and signaling its presence are collectively known as the DNA damage response."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000099"^^xsd:string ;
  rdfs:label "DNA repair pathway"^^xsd:string ;
  skos:notation "PW:0000099"^^xsd:string .

ns1:PW_0000100
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000085 ;
  ns2:treeView ns1:PW_0000085 ;
  ns1:IAO_0000115 "The pathways governing and/or regulating DNA transcription and gene expression. DNA transcription into coding and non-coding RNA is accomplished by one prokaryotic and several eukaryotic RNA polymerases. Transcription-coupled repair handles DNA lesions that interfere with the progression of RNA polymerases. Splicing of nascent RNA is thought to be predominantly co-transcriptional. Signaling pathways mediated by various transcription factors are involved in the regulation of gene expression."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000100"^^xsd:string ;
  rdfs:label "transcription pathway"^^xsd:string ;
  skos:notation "PW:0000100"^^xsd:string .

ns1:PW_0000101
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000085 ;
  ns2:treeView ns1:PW_0000085 ;
  ns1:IAO_0000115 "The series of events governing the processes thereby mRNA is translated into a polypeptide chain. Post-translational modifications often accompany the formation of the final, mature protein. Translation involves initiation, elongation and termination steps and is dependent upon the availability of aminoacyl-tRNA and mature ribosomes."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "protein biosynthesis pathway"^^xsd:string ;
  obo:id "PW:0000101"^^xsd:string ;
  rdfs:label "translation pathway"^^xsd:string ;
  skos:notation "PW:0000101"^^xsd:string .

ns1:PW_0000102
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000007 ;
  ns2:treeView ns1:PW_0000007 ;
  ns1:IAO_0000115 "The Raf/Mek/Erk signaling pathway - a Ras activated protein kinase cascade - regulates diverse processes such as cell growth, proliferation and differentiation, in response to cytokines, hormones, growth factors."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000102"^^xsd:string ;
  rdfs:label "the extracellular signal-regulated Raf/Mek/Erk signaling pathway"^^xsd:string ;
  skos:notation "PW:0000102"^^xsd:string .

ns1:PW_0000103
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000004 ;
  ns2:treeView ns1:PW_0000004 ;
  ns1:IAO_0000115 "A pathway that mediates or facilitates the movement of biochemical material, organic and inorganic substances and/or drugs."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000103"^^xsd:string ;
  rdfs:label "transport pathway"^^xsd:string ;
  skos:notation "PW:0000103"^^xsd:string .

ns1:PW_0000104
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000009 ;
  ns2:treeView ns1:PW_0000009 ;
  ns1:IAO_0000115 "The apoptotic pathway involving organelles, primarily the mitochondrion and endoplasmic reticulum (ER), and involving the pro and anti-apoptotic members of the Bcl family of proteins, cytochrome c, formation of the apoptosome and activation of caspases."^^xsd:string ;
  obo:hasExactSynonym "Reactome:R-HSA-109606"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000104"^^xsd:string ;
  rdfs:comment "The reference was compiled based on the information available in the cited article."^^xsd:string ;
  rdfs:label "intrinsic apoptotic pathway"^^xsd:string ;
  skos:notation "PW:0000104"^^xsd:string .

ns1:PW_0000105
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000006 ;
  ns2:treeView ns1:PW_0000006 ;
  ns1:IAO_0000115 "Members of the Ras related Rho family of proteins control diverse processes such as actin cytoskeletal rearrangements, morphogenesis of dendritic spines, gene expression. Of note is the fact that cytoskeletal rearrangements, primarily actin remodeling have a role to play in vesicular trafficking, a process regulated by Rab proteins."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000105"^^xsd:string ;
  rdfs:label "Rho/Rac/Cdc42 mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000105"^^xsd:string .

ns1:PW_0000106
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000009 ;
  ns2:treeView ns1:PW_0000009 ;
  ns1:IAO_0000115 "The apoptotic pathway involving the death receptors mediated route of caspase activation. Members of tumor necrosis superfamily such as the better known Tnf-alpha (Tnf), Fas ligand or Trail elicit apoptosis via receptor associated adapters."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "death receptor mediated apoptotic pathway"^^xsd:string ;
  obo:id "PW:0000106"^^xsd:string ;
  rdfs:label "extrinsic apoptotic pathway"^^xsd:string ;
  skos:notation "PW:0000106"^^xsd:string .

ns1:PW_0000107
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001229 ;
  ns2:treeView ns1:PW_0001229 ;
  ns1:IAO_0000115 "Those reactions involved in the breaking down of toxic chemical compounds such as oil spills, solvents, pesticides and other pollutants. These chemicals are generally resistant to degradation, but microorganisms possess enzymes that are capable of breaking them down."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000107"^^xsd:string ;
  rdfs:label "xenobiotics biodegradation pathway"^^xsd:string ;
  skos:notation "PW:0000107"^^xsd:string .

ns1:PW_0000108
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000107 ;
  ns2:treeView ns1:PW_0000107 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the degradation of caprolactam - a cyclic amide of caproic acid used to produce a type of nylon."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000108"^^xsd:string ;
  rdfs:label "caprolactam degradation pathway"^^xsd:string ;
  skos:notation "PW:0000108"^^xsd:string .

ns1:PW_0000109
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000107 ;
  ns2:treeView ns1:PW_0000107 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the degradation of bisphenol A, known as BPA, an important compound in the production of plastics. However, it is believed to be hazardous to humans and reports have linked several health effects to levels of BPA exposure."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000109"^^xsd:string ;
  rdfs:label "bisphenol A degradation pathway"^^xsd:string ;
  skos:notation "PW:0000109"^^xsd:string .

ns1:PW_0000110
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000107 ;
  ns2:treeView ns1:PW_0000107 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the degradation of toluene and xylene. Toluene is used as organic solvent in rubber, paint, cement. Xylene represents any of three benzene derivatives used as solvent in printing, rubber, also as a cleaning agent."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000110"^^xsd:string ;
  rdfs:label "toluene and xylene degradation pathway"^^xsd:string ;
  skos:notation "PW:0000110"^^xsd:string .

ns1:PW_0000111
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000107 ;
  ns2:treeView ns1:PW_0000107 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the degradation of gamma-hexachlorocyclohexane,  also known as lindane, used as an insecticide and suspected to be carcinogenic."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000111"^^xsd:string ;
  rdfs:label "gamma-hexachlorocyclohexane degradation pathway"^^xsd:string ;
  skos:notation "PW:0000111"^^xsd:string .

ns1:PW_0000112
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000107 ;
  ns2:treeView ns1:PW_0000107 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the degradation of 3-chloroacrylic acid."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000112"^^xsd:string ;
  rdfs:label "3-chloroacrylic acid degradation pathway"^^xsd:string ;
  skos:notation "PW:0000112"^^xsd:string .

ns1:PW_0000113
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000107 ;
  ns2:treeView ns1:PW_0000107 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the degradation of atrazine - a herbicide used to kill weeds."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000113"^^xsd:string ;
  rdfs:label "atrazine degradation pathway"^^xsd:string ;
  skos:notation "PW:0000113"^^xsd:string .

ns1:PW_0000114
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000282 ;
  ns2:treeView ns1:PW_0000282 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the aerobic pathway of benzoate degradation."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000114"^^xsd:string ;
  rdfs:label "benzoate degradation pathway via hydroxylation"^^xsd:string ;
  skos:notation "PW:0000114"^^xsd:string .

ns1:PW_0000115
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000282 ;
  ns2:treeView ns1:PW_0000282 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the anaerobic pathway of benzoate degradation."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000115"^^xsd:string ;
  rdfs:label "benzoate degradation pathway via CoA ligation"^^xsd:string ;
  skos:notation "PW:0000115"^^xsd:string .

ns1:PW_0000116
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000107 ;
  ns2:treeView ns1:PW_0000107 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the degradation of carbazole - a crystalline, slightly basic cyclic compound found in anthracene. It reacts with carbohydrates and is used for assay and analysis of carbohydrates and in making dyes."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000116"^^xsd:string ;
  rdfs:label "carbazole degradation pathway"^^xsd:string ;
  skos:notation "PW:0000116"^^xsd:string .

ns1:PW_0000117
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000107 ;
  ns2:treeView ns1:PW_0000107 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the degradation of fluorene - a colorless, crystalline hydrocarbon. It is obtained from coal tar and used in making dyes."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000117"^^xsd:string ;
  rdfs:label "fluorene degradation pathway"^^xsd:string ;
  skos:notation "PW:0000117"^^xsd:string .

ns1:PW_0000118
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000107 ;
  ns2:treeView ns1:PW_0000107 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the degradation of ethylbenzene - a liquid hydrocarbon used in the manufacture of styrene and as a solvent and diluent for dyes and paints."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000118"^^xsd:string ;
  rdfs:label "ethylbenzene degradation pathway"^^xsd:string ;
  skos:notation "PW:0000118"^^xsd:string .

ns1:PW_0000119
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000107 ;
  ns2:treeView ns1:PW_0000107 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the degradation of nitrobenzene - an organic compound that occurs either as yellow crystals or yellow liquid used in the manufacture of aniline. It is a poisonous derivative of benzene."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000119"^^xsd:string ;
  rdfs:label "nitrobenzene degradation pathway"^^xsd:string ;
  skos:notation "PW:0000119"^^xsd:string .

ns1:PW_0000120
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000107 ;
  ns2:treeView ns1:PW_0000107 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the degradation of styrene - an aromatic hydrocarbon that is colorless and oily. It is used in the manufacture of rubber, resins, plastics. It is a toxic, possibly carcinogenic substance."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000120"^^xsd:string ;
  rdfs:label "styrene degradation pathway"^^xsd:string ;
  skos:notation "PW:0000120"^^xsd:string .

ns1:PW_0000121
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000107 ;
  ns2:treeView ns1:PW_0000107 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the degradation of tetrachloroethene - (acetylene tetrachloride) used as solvent for fats, waxes, resins and intermediate in the synthesis of chlorinated hydrocarbons."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000121"^^xsd:string ;
  rdfs:label "tetrachloroethene degradation pathway"^^xsd:string ;
  skos:notation "PW:0000121"^^xsd:string .

ns1:PW_0000122
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000650, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000660
  ] ;
  ns2:treeView ns1:PW_0000650, ns1:PW_0000660 ;
  ns3:part_of ns1:PW_0000660 ;
  ns1:IAO_0000115 "The Hedgehog signaling pathway (Hh) plays important roles in vertebrate embryogenesis, particularly in the differentiation of the neural tube, in vasculogenesis and angiogenesis. Post-embryonically it is believed to play a homeostatic role in the maintenance of stem cells. Alteration of the pathway has been implicated in a number of human cancers."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04340"^^xsd:string, "PID:200168"^^xsd:string, "PID:200172"^^xsd:string ;
  obo:id "PW:0000122"^^xsd:string ;
  rdfs:label "Hedgehog signaling pathway"^^xsd:string ;
  skos:notation "PW:0000122"^^xsd:string .

ns1:PW_0000123
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002423 ;
  ns2:treeView ns1:PW_0002423 ;
  ns1:IAO_0000115 "The pathway of synaptic vesicle endocytosis and neurotransmitter refill following exocytosis."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000123"^^xsd:string ;
  rdfs:label "synaptic vesicle endocytosis and recycling pathway"^^xsd:string ;
  skos:notation "PW:0000123"^^xsd:string .

ns1:PW_0000124
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000004 ;
  ns2:treeView ns1:PW_0000004 ;
  ns1:IAO_0000115 "A pathway triggered by exogenous or endogenous elements, compounds or molecules that can be harmful to the system. The phase I (oxidative) and phase II (conjugative) metabolizing enzyme and the phase III transport systems and other pathways are involved in the response mechanisms resulting in processing and subsequent elimination of such elements. Others induce downstream effects such as antioxidant, cell death or inflammatory response pathways."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000124"^^xsd:string ;
  rdfs:label "cellular detoxification pathway"^^xsd:string ;
  skos:notation "PW:0000124"^^xsd:string .

ns1:PW_0000125
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000003 ;
  ns2:treeView ns1:PW_0000003 ;
  ns1:IAO_0000115 "G-proteins act as signal transducers between activated receptors or other incoming signals and downstream effectors.  They comprise the heterotrimeric G proteins downstream of G protein coupled receptors (GPCRs) and the Ras superfamily of small, monomeric G proteins. They function as molecular switches alternating between the GDP-inactive and GTP-active bound state."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "heterotrimeric G protein mediated signaling pathway"^^xsd:string ;
  obo:id "PW:0000125"^^xsd:string ;
  rdfs:label "G protein mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000125"^^xsd:string .

ns1:PW_0000126
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001275 ;
  ns2:treeView ns1:PW_0001275 ;
  ns1:IAO_0000115 "The series of events governing the synthesis of the large ribosomal RNA (rRNA) precursor in the nucleolus."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000126"^^xsd:string ;
  rdfs:label "RNA polymerase I transcription pathway"^^xsd:string ;
  skos:notation "PW:0000126"^^xsd:string .

ns1:PW_0000127
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001275 ;
  ns2:treeView ns1:PW_0001275 ;
  ns1:IAO_0000115 "The series of events governing the synthesis of protein-coding messenger RNA (mRNA) precursor and of many classes of non-coding genes."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000127"^^xsd:string ;
  rdfs:label "RNA polymerase II transcription pathway"^^xsd:string ;
  skos:notation "PW:0000127"^^xsd:string .

ns1:PW_0000128
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001275 ;
  ns2:treeView ns1:PW_0001275 ;
  ns1:IAO_0000115 "The series of events governing the synthesis of transport/transfer RNA (tRNA) precursor, the small ribosomal rRNA and other small RNAs."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000128"^^xsd:string ;
  rdfs:label "RNA polymerase III transcription pathway"^^xsd:string ;
  skos:notation "PW:0000128"^^xsd:string .

ns1:PW_0000129
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000661 ;
  ns2:treeView ns1:PW_0000661 ;
  ns1:IAO_0000115 "Base excision repair pathway involves the identification and removal of the damaged base followed by its replacement with the correct nucleotide and ligation of the break in the strand."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "BER pathway"^^xsd:string, "KEGG:03410"^^xsd:string ;
  obo:id "PW:0000129"^^xsd:string ;
  rdfs:label "base excision repair pathway"^^xsd:string ;
  skos:notation "PW:0000129"^^xsd:string .

ns1:PW_0000130
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000661 ;
  ns2:treeView ns1:PW_0000661 ;
  ns1:IAO_0000115 "Nucleotide excision repair pathway is an important mechanism for the detection of helix distorting base alterations. Unlike the base excision repair pathway that only removes the damaged bases, the NER pathway removes an entire lesion containing segment. The single-strand gap thus introduced is filled in by DNA polymerase using the undamaged strand as a template. The pathway can be subdivided into two sub-pathways: the transcription-coupled and the global genome repair. They only differ in the lesion recognition step while the core repair component is common."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:03420"^^xsd:string, "NER pathway"^^xsd:string, "SMP:00478"^^xsd:string ;
  obo:id "PW:0000130"^^xsd:string ;
  rdfs:label "nucleotide excision repair pathway"^^xsd:string ;
  skos:notation "PW:0000130"^^xsd:string .

ns1:PW_0000131
  a owl:Class ;
  ns1:IAO_0000231 ns1:IAO_0000227 ;
  ns1:IAO_0100001 ns1:PW_0000663 ;
  owl:deprecated true ;
  skos:notation "PW:0000131"^^xsd:string .

ns1:PW_0000132
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000002 ;
  ns2:treeView ns1:PW_0000002 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of amino acids other than the common 20 amino acids found in protein. Some of these amino acids like carnitine or homocysteine derive from primary amino acids."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000132"^^xsd:string ;
  rdfs:label "metabolic pathway of other amino acids"^^xsd:string ;
  skos:notation "PW:0000132"^^xsd:string .

ns1:PW_0000133
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000132 ;
  ns2:treeView ns1:PW_0000132 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of selenoamino acid - an amino acid in which a selenium atom replaces a sulfur atom. Examples include selenocysteine, selenohomocysteine and selenomethionine."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00450"^^xsd:string, "SMP:00029"^^xsd:string, "selenocompound metabolic pathway"^^xsd:string ;
  obo:id "PW:0000133"^^xsd:string ;
  rdfs:label "selenoamino acid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000133"^^xsd:string .

ns1:PW_0000134
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000132, ns1:PW_0000135 ;
  ns2:treeView ns1:PW_0000132, ns1:PW_0000135 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of glutathione - a tripeptide that acts as an antioxidant and provides protection against reactive oxygen species. It is also used in the conjugation of xenobiotics and drugs by the phase II biotransformation enzymes."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00480"^^xsd:string, "SMP:00015"^^xsd:string ;
  obo:id "PW:0000134"^^xsd:string ;
  rdfs:label "glutathione metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000134"^^xsd:string .

ns1:PW_0000135
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000002 ;
  ns2:treeView ns1:PW_0000002 ;
  ns1:IAO_0000115 "Those reactions involved in the synthesis, utilization and/or degradation of cofactors, vitamins and other nutrients. Cofactors are necessary for the proper function of certain proteins and enzymes; they can be inorganic such as the metals ions or the iron-sulfur cluster or organic. Organic compounds that are tightly bound to proteins are also referred to as prosthetic groups. Often, they are or are made from vitamins, compounds that are vital but in small amounts and which are insufficiently synthesized by the organism. Some of these molecules can also perform signaling functions."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000135"^^xsd:string ;
  rdfs:label "metabolic pathway of cofactors, vitamins, nutrients"^^xsd:string ;
  skos:notation "PW:0000135"^^xsd:string .

ns1:PW_0000136
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000135 ;
  ns2:treeView ns1:PW_0000135 ;
  ns1:IAO_0000115 "Those metabolic reactions involving thiamine, a water-soluble vitamin of the B complex. It is synthesized in bacteria, fungi and plants while animals obtain thiamine from food. Thiamine insufficiency results in a condition called beriberi."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00730"^^xsd:string, "SMP:00076"^^xsd:string, "vitamin B1 metabolic pathway"^^xsd:string ;
  obo:id "PW:0000136"^^xsd:string ;
  rdfs:label "thiamine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000136"^^xsd:string .

ns1:PW_0000137
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000135 ;
  ns2:treeView ns1:PW_0000135 ;
  ns1:IAO_0000115 "Those metabolic reactions involving riboflavin, also known as vitamin B2 - a water-soluble vitamin. B2 occurs in several products and is a precursor for flavin coenzymes."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00740"^^xsd:string, "SMP:00070"^^xsd:string, "vitamin B2 metabolic pathway"^^xsd:string ;
  obo:id "PW:0000137"^^xsd:string ;
  rdfs:label "riboflavin metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000137"^^xsd:string .

ns1:PW_0000138
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000135 ;
  ns2:treeView ns1:PW_0000135 ;
  ns1:IAO_0000115 "Those metabolic reactions involving vitamin B6 - a water-soluble vitamin that exists in several forms. Vitamin B6 is required for many enzymatic reactions as the active pyridoxal 5'-phosphate (PLP) form. A number of organisms can carry out de novo synthesis of vitamin B6; humans derive it from diet."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00750"^^xsd:string, "SMP:00017"^^xsd:string, "pyridoxine metabolic pathway"^^xsd:string ;
  obo:id "PW:0000138"^^xsd:string ;
  rdfs:label "vitamin B6 metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000138"^^xsd:string .

ns1:PW_0000139
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000135 ;
  ns2:treeView ns1:PW_0000135 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of biotin, also known as vitamin B7 or H, a water-soluble vitamin. Biotin assists in various metabolic reactions and processes."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00780"^^xsd:string, "SMP:00066"^^xsd:string, "vitamin B7 metabolic pathway"^^xsd:string ;
  obo:id "PW:0000139"^^xsd:string ;
  rdfs:label "biotin metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000139"^^xsd:string .

ns1:PW_0000140
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000135, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001693
  ] ;
  ns2:treeView ns1:PW_0000135, ns1:PW_0001693 ;
  ns3:part_of ns1:PW_0001693 ;
  ns1:IAO_0000115 "Folate metabolism represents the various aspects of folate cycle and the folate mediate transfer reactions essential for several biosynthetic pathways. The folate cycle and the folate mediated one-carbon pathways are part of folate metabolism. Folate compounds are water-soluble forms of vitamin B9."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00790"^^xsd:string, "SMP:00053"^^xsd:string, "vitamin B9 metabolic pathway"^^xsd:string ;
  obo:id "PW:0000140"^^xsd:string ;
  rdfs:label "folate metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000140"^^xsd:string .

ns1:PW_0000141
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001003 ;
  ns2:treeView ns1:PW_0001003 ;
  ns1:IAO_0000115 "Those reactions involving retinol, a fat-soluble vitamin that is the dietary form of vitamin A and is important for bone growth and in vision. Precursors of retinol such as carotenoid or retinyl esters are derived from diet and are converted to retinal and retinol, respectively."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00830"^^xsd:string, "SMP:00074"^^xsd:string ;
  obo:id "PW:0000141"^^xsd:string ;
  rdfs:label "retinol metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000141"^^xsd:string .

ns1:PW_0000142
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000135 ;
  ns2:treeView ns1:PW_0000135 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the biosynthesis of ubiquinone, also known as coenzyme Q. Ubiquinone is a member of the mitochondrial respiratory chain and plays important roles in cellular metabolism."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00130"^^xsd:string, "SMP:00065"^^xsd:string ;
  obo:id "PW:0000142"^^xsd:string ;
  rdfs:label "ubiquinone biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000142"^^xsd:string .

ns1:PW_0000143
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000357
  ], [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000553
  ] ;
  ns2:treeView ns1:PW_0000357, ns1:PW_0000467, ns1:PW_0000553 ;
  ns3:part_of ns1:PW_0000357, ns1:PW_0000553 ;
  ns1:IAO_0000115 "Insulin, the peptide hormone, secreted by the pancreatic beta cells, plays essential roles in glucose and energy homeostasis. Insulin signaling activates two main intracellular pathways to regulate carbohydrate and fat metabolism and to prompt glucose absorption in insulin sensitive tissues such as skeletal muscle and adipocytes. Deregulation of the pathway has been associated with a number of conditions, primarily diabetes."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04910"^^xsd:string, "PID:200014"^^xsd:string, "SMP:00391"^^xsd:string ;
  obo:id "PW:0000143"^^xsd:string ;
  rdfs:label "insulin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000143"^^xsd:string .

ns1:PW_0000144
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000417 ;
  ns2:treeView ns1:PW_0000417 ;
  ns1:IAO_0000115 "The pathway for the ATP-dependent non-lysosomal proteolysis catalyzed by the 26S proteasome and for which ubiquitylation, the post-translational covalent conjugation of ubiquitin to target proteins is a key signal."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:03050"^^xsd:string, "KEGG:04120"^^xsd:string ;
  obo:id "PW:0000144"^^xsd:string ;
  rdfs:label "ubiquitin/proteasome degradation pathway"^^xsd:string ;
  skos:notation "PW:0000144"^^xsd:string .

ns1:PW_0000145
  a owl:Class ;
  ns1:IAO_0000115 "OBSOLETE. Originally found at KEGG, the term has since been deleted"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000145"^^xsd:string ;
  rdfs:label "Metabolism of complex carbohydrates"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0000145"^^xsd:string .

ns1:PW_0000146
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005 ;
  ns2:treeView ns1:PW_0000005 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of glycans. Glycans are a class of compounds that include oligo- and polysaccharides, simple sugars or polymeric structures of mono- or di-saccharides, respectively. The term also refers to the carbohydrate moiety of glycoproteins, proteoglycans and glycolipids."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000146"^^xsd:string ;
  rdfs:label "glycan metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000146"^^xsd:string .

ns1:PW_0000147
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000002 ;
  ns2:treeView ns1:PW_0000002 ;
  ns1:IAO_0000115 "Those reactions involved in the synthesis, utilization and/or degradation of secondary metabolites - products of cellular metabolism that are not essential for, or not directly involved in the normal growth, development or reproduction of an organism. Many of the chemicals that plants or microorganisms produce are secondary metabolites."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000147"^^xsd:string ;
  rdfs:label "metabolic pathway of secondary metabolites"^^xsd:string ;
  skos:notation "PW:0000147"^^xsd:string .

ns1:PW_0000148
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000147 ;
  ns2:treeView ns1:PW_0000147 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000148"^^xsd:string ;
  rdfs:label "alkaloid biosynthetic pathway I"^^xsd:string ;
  skos:notation "PW:0000148"^^xsd:string .

ns1:PW_0000149
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000147 ;
  ns2:treeView ns1:PW_0000147 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000149"^^xsd:string ;
  rdfs:label "alkaloid biosynthetic pathway II"^^xsd:string ;
  skos:notation "PW:0000149"^^xsd:string .

ns1:PW_0000150
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000147 ;
  ns2:treeView ns1:PW_0000147 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000150"^^xsd:string ;
  rdfs:label "stilbene, coumarine and lignin biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000150"^^xsd:string .

ns1:PW_0000151
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005 ;
  ns2:treeView ns1:PW_0000005 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of starch and sucrose, as depicted in the KEGG diagram. Starch is a polysaccharide produced by all green plants and is an important carbohydrate in the human diet. Sucrose, or the table sugar is a disaccharide of glucose and fructose that is produced by plants and cyanobacteria."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00500"^^xsd:string, "SMP:00058"^^xsd:string ;
  obo:id "PW:0000151"^^xsd:string ;
  rdfs:label "starch and sucrose metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000151"^^xsd:string .

ns1:PW_0000152
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005 ;
  ns2:treeView ns1:PW_0000005 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of amino sugars. An amino sugar has an amino group substituent in place of a hydroxyl group. Amino sugars are important constituents of a variety of polysaccharides and glycoproteins."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00520"^^xsd:string, "SMP:00045"^^xsd:string ;
  obo:id "PW:0000152"^^xsd:string ;
  rdfs:comment "Based on Dorland's Medical dictionary"^^xsd:string ;
  rdfs:label "amino sugar metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000152"^^xsd:string .

ns1:PW_0000153
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001156 ;
  ns2:treeView ns1:PW_0001156 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of triacylglycerols - esters of glycerols with three fatty acid molecules. Triglycerides are the common form of transport and storage of fatty acids. Esters with one or two fatty acid molecules are metabolic intermediates present in small amounts."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "triglyceride metabolic pathway"^^xsd:string ;
  obo:id "PW:0000153"^^xsd:string ;
  rdfs:label "triacylglycerol metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000153"^^xsd:string .

ns1:PW_0000154
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005 ;
  ns2:treeView ns1:PW_0000005 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of inositol phosphate which represents all of the possible phosphorylated states of inositol. Inositol phosphates have many important cellular functions."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00562"^^xsd:string, "SMP:00462"^^xsd:string ;
  obo:id "PW:0000154"^^xsd:string ;
  rdfs:label "inositol phosphate metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000154"^^xsd:string .

ns1:PW_0000155
  a owl:Class ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of phospholipids - lipids containing phosphorus, including those with a glycerol backbone or a backbone of sphingosine or related substances. Phospholipids are the major form of lipid in the cell membrane."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000155"^^xsd:string ;
  rdfs:label "phospholipid metabolic pathway"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0000155"^^xsd:string .

ns1:PW_0000156
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000461, ns1:PW_0001240 ;
  ns2:treeView ns1:PW_0000461, ns1:PW_0001240 ;
  ns1:IAO_0000115 "Those metabolic reactions involving prostaglandins - a family of prostanoid eicosanoids with many regulatory functions."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000156"^^xsd:string ;
  rdfs:label "prostaglandin metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000156"^^xsd:string .

ns1:PW_0000157
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000146 ;
  ns2:treeView ns1:PW_0000146 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or  degradation of glycosaminoglycans - any of several high molecular weight linear polysaccharides of repeating disaccharide units. In many cases, the unit consists of an amino sugar and a uronic acid.  When aggregating with proteins, they form proteoglycans."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000157"^^xsd:string ;
  rdfs:label "glycosaminoglycan metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000157"^^xsd:string .

ns1:PW_0000158
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000006 ;
  ns2:treeView ns1:PW_0000006 ;
  ns1:IAO_0000115 "The Ras family mediated signaling pathways are primarily involved in the regulation of gene expression."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000158"^^xsd:string ;
  rdfs:label "Ras family mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000158"^^xsd:string .

ns1:PW_0000159
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000006 ;
  ns2:treeView ns1:PW_0000006 ;
  ns1:IAO_0000115 "Rab family mediated signaling pathways are involved in the regulation of intracellular vesicle trafficking. More than 60 Rab members bind to specific effectors to regulate all aspects of vesicular trafficking - from formation and transport of vesicles, to tethering and fusion with target membranes. Of note is that cytoskeletal rearrangements such as actin remodeling, a process regulated by Rho family, have a role to play in vesicular trafficking."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000159"^^xsd:string ;
  rdfs:label "Rab family mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000159"^^xsd:string .

ns1:PW_0000160
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000006 ;
  ns2:treeView ns1:PW_0000006 ;
  ns1:IAO_0000115 "Ran family mediated signaling pathways are involved in nucleocytoplasmic trafficking."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000160"^^xsd:string ;
  rdfs:label "Ran family mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000160"^^xsd:string .

ns1:PW_0000161
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000146 ;
  ns2:treeView ns1:PW_0000146 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of glycosylphosphatidylinositol (GPI) anchor. The GPI anchor allows for the attachment of cell surface proteins to the cell membrane."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "GPI anchor biosynthesis"^^xsd:string, "KEGG:00563"^^xsd:string ;
  obo:id "PW:0000161"^^xsd:string ;
  rdfs:label "glycosylphosphatidylinositol anchor biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000161"^^xsd:string .

ns1:PW_0000162
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000197 ;
  ns2:treeView ns1:PW_0000197 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000162"^^xsd:string ;
  rdfs:label "sphingolipid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000162"^^xsd:string .

ns1:PW_0000163
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000197 ;
  ns2:treeView ns1:PW_0000197 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000163"^^xsd:string ;
  rdfs:label "sphingolipid degradation pathway"^^xsd:string ;
  skos:notation "PW:0000163"^^xsd:string .

ns1:PW_0000164
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000733 ;
  ns2:treeView ns1:PW_0000733 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of ganglioside - any of a group of glycosphingolipids in which the polar head group on ceramide is a sialic acid. Their names include letters and numbers where the letters M, D and T indicate the number of sialic acid residues in the molecule - one, two or three, respectively."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00604"^^xsd:string ;
  obo:id "PW:0000164"^^xsd:string ;
  rdfs:label "ganglioside metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000164"^^xsd:string .

ns1:PW_0000165
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000132 ;
  ns2:treeView ns1:PW_0000132 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of taurine and hypotaurine."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00430"^^xsd:string, "SMP:00021"^^xsd:string ;
  obo:id "PW:0000165"^^xsd:string ;
  rdfs:label "taurine and hypotaurine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000165"^^xsd:string .

ns1:PW_0000166
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000184 ;
  ns2:treeView ns1:PW_0000184 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of monoterpenoid. Terpenoids are a large class of naturally-occurring organic chemicals. They are derived from five-carbon units and are modifed in manifold ways."^^xsd:string ;
  obo:hasAlternativeId "PW:0000252"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00760"^^xsd:string ;
  obo:id "PW:0000166"^^xsd:string ;
  rdfs:label "monoterpenoid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000166"^^xsd:string .

ns1:PW_0000167
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000135 ;
  ns2:treeView ns1:PW_0000135 ;
  ns1:IAO_0000115 "Those metabolic reactions involving pantothenic acid or panthotenate, also known as vitamin B5 - a water-soluble vitamin. Vitamin B5 is the precursor to coenzyme A (CoA) which in turn, plays an essential role in fatty acids and pyruvate metabolism."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00770"^^xsd:string, "SMP:00027"^^xsd:string, "vitamin B5 metabolic pathway"^^xsd:string ;
  obo:id "PW:0000167"^^xsd:string ;
  rdfs:label "pantothenic acid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000167"^^xsd:string .

ns1:PW_0000168
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000003 ;
  ns2:treeView ns1:PW_0000003 ;
  ns1:IAO_0000115 "Those pathways that are triggered through the binding of a growth factor to its particular receptor. Growth factors carry out mitogenic signaling via their largely tyrosine kinase receptors."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000168"^^xsd:string ;
  rdfs:label "growth factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0000168"^^xsd:string .

ns1:PW_0000169
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000571 ;
  ns2:treeView ns1:PW_0000571 ;
  ns1:IAO_0000115 "Nerve growth factor (NGF) signaling pathways control a variety of processes such as neuronal cell differentiation, axon growth. Members of the NGF family are best known for their anti-apoptotic role as mediators of neuronal cell survival."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "NGF signaling pathway"^^xsd:string ;
  obo:id "PW:0000169"^^xsd:string ;
  rdfs:label "nerve growth factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0000169"^^xsd:string .

ns1:PW_0000170
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000168 ;
  ns2:treeView ns1:PW_0000168 ;
  ns1:IAO_0000115 "Members of the EGF/neuregulin superfamily are important regulators of tissue development and repair. A characteristic feature is the presence of the EGF module, a 36-40 amino acid sequence with a disulfide-bonded three loop structure necessary for receptor binding."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "EGF/neuregulin signaling pathway"^^xsd:string, "KEGG:04012"^^xsd:string, "PID:200101"^^xsd:string, "PID:200159"^^xsd:string ;
  obo:id "PW:0000170"^^xsd:string ;
  rdfs:label "epidermal growth factor/neuregulin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000170"^^xsd:string .

ns1:PW_0000171
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000014 ;
  ns2:treeView ns1:PW_0000014 ;
  ns1:IAO_0000115 "Inherited neurodegenerative diseases that are caused by the expansion of a polyglutamine (polyQ) tract in several, unrelated proteins. The diseases are manifested as distinct neuropathies and multiple pathways are perturbed."^^xsd:string ;
  obo:hasExactSynonym "polyglutamine repeat disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "polyQ repeat disease pathway"^^xsd:string ;
  obo:id "PW:0000171"^^xsd:string ;
  rdfs:comment "Definition adapted from an article in Trends in Genetics"^^xsd:string ;
  rdfs:label "polyglutamine repeat pathway"^^xsd:string ;
  skos:notation "PW:0000171"^^xsd:string .

ns1:PW_0000172
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000171 ;
  ns2:treeView ns1:PW_0000171 ;
  ns1:IAO_0000115 "An inherited neurodegenerative disease caused by an expanded polyglutamine (polyQ) tract. Various pathways are disrupted and contribute to the manifestation of the condition."^^xsd:string ;
  obo:hasExactSynonym "Kennedy disease pathway"^^xsd:string, "X-Linked Bulbo-Spinal Atrophy pathway"^^xsd:string, "X-linked Spinal and Bulbar Muscular Atrophy pathway"^^xsd:string, "spinal bulbar muscular atrophy pathway"^^xsd:string, "spinobulbar muscular atrophy disease pathway"^^xsd:string, "spinobulbar muscular atrophy pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SBMA disease pathway"^^xsd:string ;
  obo:id "PW:0000172"^^xsd:string ;
  rdfs:label "Kennedy's disease pathway"^^xsd:string ;
  skos:notation "PW:0000172"^^xsd:string .

ns1:PW_0000173
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000171 ;
  ns2:treeView ns1:PW_0000171 ;
  ns1:IAO_0000115 "An inherited form of neurodegenerative disease caused by an expanded polyglutamine (polyQ) tract. Several types are grouped under SCA, types 1-3, 6, 7 and 17. Various pathways are disrupted and contribute to the manifestation of the condition."^^xsd:string ;
  obo:hasExactSynonym "spinocerebellar ataxia disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SCA disease pathway"^^xsd:string ;
  obo:id "PW:0000173"^^xsd:string ;
  rdfs:label "spinocerebellar ataxia pathway"^^xsd:string ;
  skos:notation "PW:0000173"^^xsd:string .

ns1:PW_0000174
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000020, ns1:PW_0001472 ;
  ns2:treeView ns1:PW_0000020, ns1:PW_0001472 ;
  ns1:IAO_0000115 "The metabolic syndrome is a multiphenotypic condition with concurrent features of several diseases and metabolic abnormalities. Insulin resistance, obesity and hypertension are considered risk factors. Alterations in lipid, glucose and cholesterol metabolic pathways, among others, can contribute to the multifactorial metabolic syndrome and the conditions associated with it."^^xsd:string ;
  obo:hasExactSynonym "abdominal obesity-metabolic syndrome 1 pathway"^^xsd:string, "dysmetabolic syndrome X pathway"^^xsd:string, "metabolic syndrome pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000174"^^xsd:string ;
  rdfs:label "metabolic syndrome X pathway"^^xsd:string ;
  skos:notation "PW:0000174"^^xsd:string .

ns1:PW_0000175
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000174
  ] ;
  ns2:treeView ns1:PW_0000174 ;
  ns3:part_of ns1:PW_0000174 ;
  ns1:IAO_0000115 "A possible subset of the metabolic syndrome, characterized  by features such as hypertriglyceridemia, age-dependent changes in plasma total cholesterol, overproduction of triglyceride-rich lipoproteins. Several metabolic and possibly other pathways deviate from their normal functioning."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "FCHL"^^xsd:string ;
  obo:id "PW:0000175"^^xsd:string ;
  rdfs:label "familial combined hyperlipidemia pathway"^^xsd:string ;
  skos:notation "PW:0000175"^^xsd:string .

ns1:PW_0000176
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001547, ns1:PW_0001602 ;
  ns2:treeView ns1:PW_0001547, ns1:PW_0001602 ;
  ns1:IAO_0000115 "A range of conditions with various manifestations associated with disruptions of several pathways, primarily those revolving around glucose homeostasis and insulin signaling. Organs and tissues affected include the kidney, eye, cardiovascular system and nerve tissue."^^xsd:string ;
  obo:hasExactSynonym "diabetes pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000176"^^xsd:string ;
  rdfs:label "diabetes mellitus pathway"^^xsd:string ;
  skos:notation "PW:0000176"^^xsd:string .

ns1:PW_0000177
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000300, ns1:PW_0001548 ;
  ns2:treeView ns1:PW_0000300, ns1:PW_0001548 ;
  ns1:IAO_0000115 "A common complication of diabetes and a leading cause of end stage renal diseases affecting a number of pathways, particularly the thiol and anti-oxidant pathways."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000177"^^xsd:string ;
  rdfs:label "diabetic nephropathy pathway"^^xsd:string ;
  skos:notation "PW:0000177"^^xsd:string .

ns1:PW_0000178
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001412 ;
  ns2:treeView ns1:PW_0001412 ;
  ns1:IAO_0000115 "Neurological disorders are a group of disorders that involve the central nervous system (brain, brainstem and cerebellum), the peripheral nervous system (including cranial nerves), and the autonomic nervous system (parts of which are located in both the central and peripheral nervous systems). Major branches are headache, stupor and coma, dementia, seizure, sleep disorders, trauma, infections, neoplasms, neuro-ophthalmologic diseases, movement disorders, demyelinating diseases, spinal cord disorders, and disorders of peripheral nerves, muscle and neuromuscular junctions. Many mental illnesses are believed to be neurological disorders of the central nervous system, but they are classified separately. They are not traditionally listed as neurological diseases because their causes are not definitely determined as biological, although there are good reasons to suspect that bipolar disorder and schizophrenia have neuro-chemical causes."^^xsd:string ;
  obo:hasExactSynonym "neurological disorder disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000178"^^xsd:string ;
  rdfs:label "neurological disorder pathway"^^xsd:string ;
  skos:notation "PW:0000178"^^xsd:string .

ns1:PW_0000179
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000178 ;
  ns2:treeView ns1:PW_0000178 ;
  ns1:IAO_0000115 "An autosomal dominant condition that often leads to seizure and other neurological symptoms and that may be linked to deregulations in the mTOR signaling pathway."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "TSC"^^xsd:string ;
  obo:id "PW:0000179"^^xsd:string ;
  rdfs:label "tuberous sclerosis complex disease pathway"^^xsd:string ;
  skos:notation "PW:0000179"^^xsd:string .

ns1:PW_0000180
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000085, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000357
  ] ;
  ns2:treeView ns1:PW_0000085, ns1:PW_0000357 ;
  ns3:part_of ns1:PW_0000357 ;
  ns1:IAO_0000115 "mTOR signaling pathway regulates cellular processes such as translation, ribosome biogenesis, cell growth and autophagy and is regulated or responds to growth factors, energy metabolites and/or levels of nutrients."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04150"^^xsd:string, "PID:200096"^^xsd:string ;
  obo:id "PW:0000180"^^xsd:string ;
  rdfs:label "mTOR signaling pathway"^^xsd:string ;
  skos:notation "PW:0000180"^^xsd:string .

ns1:PW_0000181
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000004 ;
  ns2:treeView ns1:PW_0000004 ;
  ns1:IAO_0000115 "Those pathways that are involved in or mediate how protein fold or are maintained in a particular folding state, are sorted for translocation or degradation, are modified to regulate their function or to target them for degradation and finally, are degraded."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000181"^^xsd:string ;
  rdfs:label "pathway pertinent to protein folding, sorting, modification, translocation and degradation"^^xsd:string ;
  skos:notation "PW:0000181"^^xsd:string .

ns1:PW_0000182
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000325 ;
  ns2:treeView ns1:PW_0000325 ;
  ns1:IAO_0000115 "A protein degradation pathway that involves proteases residing in lysosomes and exhibiting optimal activity at an acidic pH (e.g., cathepsins)."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000182"^^xsd:string ;
  rdfs:label "lysosomes based pathway of protein degradation"^^xsd:string ;
  skos:notation "PW:0000182"^^xsd:string .

ns1:PW_0000183
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000325 ;
  ns2:treeView ns1:PW_0000325 ;
  ns1:IAO_0000115 "A protein degradation pathway that involves calcium-dependent proteases  (e.g., calpains) ,"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000183"^^xsd:string ;
  rdfs:label "the proteolytic pathway involving calcium-dependent proteases"^^xsd:string ;
  skos:notation "PW:0000183"^^xsd:string .

ns1:PW_0000184
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001394 ;
  ns2:treeView ns1:PW_0001394 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of terpenoids. The terpenoids, sometimes referred to as isoprenoids, are a class of naturally occurring chemicals. Terpenoids are derived from five-carbon isoprene units and are assembled and modified in manifold ways. They are classified according to the number of isoprene units. The mevalonate pathway and the non-mevalonate MEP/DOXP pathway are the two biosynthetic routes. The first can branch into non-sterol and sterol-producing compounds. The second is only found in plants."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00900"^^xsd:string ;
  obo:id "PW:0000184"^^xsd:string ;
  rdfs:label "terpenoid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000184"^^xsd:string .

ns1:PW_0000185
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001399 ;
  ns2:treeView ns1:PW_0001399 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the degradation of limonene -  an essential oil, a monocyclic terpene, found in the peel of oranges and lemons, and pinene - a terpene found in turpentine and many essential oils, used as a solvent and in the manufacture of camphor, insecticides, and synthetic pine oil."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000185"^^xsd:string ;
  rdfs:label "limonene and pinene degradation pathway"^^xsd:string ;
  skos:notation "PW:0000185"^^xsd:string .

ns1:PW_0000186
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000147 ;
  ns2:treeView ns1:PW_0000147 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of streptomycin - the first of the aminoglycoside antibiotics to be isolated, derived from Streptomyces griseus; it is effective against a wide variety of aerobic gram-negative bacilli and some gram-positive bacteria, including mycobacteria. Its use is now limited because of the emergence of resistant strains."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000186"^^xsd:string ;
  rdfs:label "streptomycin biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000186"^^xsd:string .

ns1:PW_0000187
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000147 ;
  ns2:treeView ns1:PW_0000147 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of erythromycin -   an intermediate spectrum macrolide (a chemical compound characterized by a large lactone ring containing multiple keto and hydroxyl groups) antibiotic, produced by Streptomyces erythreus, effective against most gram-positive and certain gram-negative bacteria, such as Neisseria species and Haemophilus influenzae, and against spirochetes, some rickettsias, and Entamoeba; it is also highly effective against Mycoplasma pneumoniae. It is used especially in patients allergic to penicillin and in those with penicillin-resistant infections and legionnaires' disease; administered orally or topically."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000187"^^xsd:string ;
  rdfs:label "erythromycin biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000187"^^xsd:string .

ns1:PW_0000188
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005 ;
  ns2:treeView ns1:PW_0000005 ;
  ns1:IAO_0000115 "The series or metabolic reactions involved in the interconversions of the monosaccharide pentose and glucuronate, the salts or esters of glucuronic acid, as depicted in the KEGG diagram."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00040"^^xsd:string ;
  obo:id "PW:0000188"^^xsd:string ;
  rdfs:label "pentose and glucuronate interconversion pathway"^^xsd:string ;
  skos:notation "PW:0000188"^^xsd:string .

ns1:PW_0000189
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000140
  ] ;
  ns2:treeView ns1:PW_0000140 ;
  ns3:part_of ns1:PW_0000140 ;
  ns1:IAO_0000115 "Folate mediated one-carbon metabolism represents the one-carbon transfer reactions important for de novo purine and thymidylate biosynthesis and for the remethylation of methionine in the methionine cycle and homocysteine metabolism. The methionine cycle also produces the major methyl donor for proteins, nucleic acids, lipids and other small molecules. The folate mediated one-carbon transfer and the folate cycle pathways are part of folate metabolism."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00670"^^xsd:string ;
  obo:id "PW:0000189"^^xsd:string ;
  rdfs:label "folate mediated one-carbon metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000189"^^xsd:string .

ns1:PW_0000190
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000135 ;
  ns2:treeView ns1:PW_0000135 ;
  ns1:IAO_0000115 "Those reactions involved in the synthesis, utilization and/or degradation of porphyrin - any of a group of compounds containing the porphyrin structure, four pyrrole rings connected by methine bridges in a cyclic configuration, to which a variety of side chains may be attached - and chlorophyll - any of a group of green magnesium-containing porphyrin derivatives occurring in all photosynthetic organisms."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00860"^^xsd:string ;
  obo:id "PW:0000190"^^xsd:string ;
  rdfs:label "porphyrin and chlorophyll metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000190"^^xsd:string .

ns1:PW_0000191
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000157 ;
  ns2:treeView ns1:PW_0000157 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the biosynthesis of keratan sulfate - a glycosaminoglycan found in the cornea, in cartilage, and in the nucleus pulposus and also as the accumulation product in Morquio's syndrome. It consists of repeating disaccharide units in specific linkage, each composed of a sulfated N-acetylglucosamine residue linked to one of galactose, which is usually sulfated. There are two forms, keratan sulfate I and keratan sulfate II, which differ in carbohydrate content and localization; the former occurs in the cornea and the latter in skeletal tissues."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00533"^^xsd:string ;
  obo:id "PW:0000191"^^xsd:string ;
  rdfs:label "keratan sulfate biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000191"^^xsd:string .

ns1:PW_0000192
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000146 ;
  ns2:treeView ns1:PW_0000146 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of N-linked glycans. A 14 residue sugar is first built on a dolichol carrier and then attached to the amide group of an asparagine of a nascent polypeptide chain. The asparagine is in a specific amino acid sequence. Subsequent processing involves removal as well as addition of various sugars and produces a wide range of N-glycan structures."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00510"^^xsd:string ;
  obo:id "PW:0000192"^^xsd:string ;
  rdfs:label "N-linked glycan biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000192"^^xsd:string .

ns1:PW_0000193
  a owl:Class ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the degradation of N-Glycans. N-Glycans are found attached to the R-group nitrogen of asparagine."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000193"^^xsd:string ;
  rdfs:label "N-Glycan degradation pathway"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0000193"^^xsd:string .

ns1:PW_0000194
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000146 ;
  ns2:treeView ns1:PW_0000146 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of O-linked glycans. Sugars are serially added to a fully synthesized polypeptide chain. The initial step involves the transfer of N-acetylgalactosamine to the carboxy group of a serine or threonine. The location of the residue appears to be dictated by structure rather than amino acid signature."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00512"^^xsd:string, "KEGG:00514"^^xsd:string ;
  obo:id "PW:0000194"^^xsd:string ;
  rdfs:label "O-linked glycan biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000194"^^xsd:string .

ns1:PW_0000195
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000157 ;
  ns2:treeView ns1:PW_0000157 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the biosynthesis of chondroitin. Chondroitin is a mucopolysaccharide occurring in sulfated form in various animal tissues (as cartilage)."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00532"^^xsd:string ;
  obo:id "PW:0000195"^^xsd:string ;
  rdfs:label "chondroitin sulfate biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000195"^^xsd:string .

ns1:PW_0000196
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000733 ;
  ns2:treeView ns1:PW_0000733 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of globoside - a glycosphingolipid containing acetylated amino sugars and simple hexoses."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00603"^^xsd:string ;
  obo:id "PW:0000196"^^xsd:string ;
  rdfs:label "globoside metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000196"^^xsd:string .

ns1:PW_0000197
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000010 ;
  ns2:treeView ns1:PW_0000010 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of sphingolipids - important components of animal and plant membranes. They contain a long chain amino alcohol and a ceramide core. Ceramides are also the precursors of glycolipids, also referred to as glycosphingolipids, which have attached sugar(s)."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00600"^^xsd:string, "SMP:00034"^^xsd:string ;
  obo:id "PW:0000197"^^xsd:string ;
  rdfs:label "sphingolipid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000197"^^xsd:string .

ns1:PW_0000198
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000312 ;
  ns2:treeView ns1:PW_0000312 ;
  ns1:IAO_0000115 "A SAPK MAPK pathway that plays an important role in inflammation and may be involved in several forms of cancer."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200018"^^xsd:string ;
  obo:id "PW:0000198"^^xsd:string ;
  rdfs:label "p38 MAPK signaling pathway"^^xsd:string ;
  skos:notation "PW:0000198"^^xsd:string .

ns1:PW_0000199
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000597 ;
  ns2:treeView ns1:PW_0000597 ;
  ns1:IAO_0000115 "A Wnt mediated pathway that is involved in the regulation of cell-cell adhesion and motility."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "the Wnt/Ca(II) pathway"^^xsd:string ;
  obo:id "PW:0000199"^^xsd:string ;
  rdfs:label "the Wnt/calcium signaling pathway"^^xsd:string ;
  skos:notation "PW:0000199"^^xsd:string .

ns1:PW_0000200
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000597 ;
  ns2:treeView ns1:PW_0000597 ;
  ns1:IAO_0000115 "The planar cell polarity (PCP) Wnt signaling pathway plays an essential role in morphogenesis through the regulation of tissues patterning."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PCP Wnt signaling pathway"^^xsd:string ;
  obo:id "PW:0000200"^^xsd:string ;
  rdfs:label "Wnt signaling, the planar cell polarity pathway"^^xsd:string ;
  skos:notation "PW:0000200"^^xsd:string .

ns1:PW_0000201
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000008 ;
  ns2:treeView ns1:PW_0000008 ;
  ns1:IAO_0000115 "Wnt signaling pathway is involved in many developmental processes. In the conventional or canonical Wnt pathway,  beta-catenin is a central component required for the  transcriptional control of Wnt signaling target genes."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200077"^^xsd:string, "beta-catenin dependent Wnt signaling pathway"^^xsd:string ;
  obo:id "PW:0000201"^^xsd:string ;
  rdfs:label "Wnt signaling, canonical pathway"^^xsd:string ;
  skos:notation "PW:0000201"^^xsd:string .

ns1:PW_0000202
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000663 ;
  ns2:treeView ns1:PW_0000663 ;
  ns1:IAO_0000115 "A specific pathway for repair of double-strand breaks. It is involved in repair of breaks induced by damaging agents or  generated during meiotic recombination."^^xsd:string ;
  obo:hasExactSynonym "HR pathway of double-strand break repair"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:03440"^^xsd:string, "homology-directed repair pathway"^^xsd:string ;
  obo:id "PW:0000202"^^xsd:string ;
  rdfs:label "homologous recombination pathway of double-strand break repair"^^xsd:string ;
  skos:notation "PW:0000202"^^xsd:string .

ns1:PW_0000203
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000663 ;
  ns2:treeView ns1:PW_0000663 ;
  ns1:IAO_0000115 "A specific pathway for repair of double-strand breaks. Possibly constitutive, it is the most important pathway in mammalian cells and plays an important role in mitotically replicating cells."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "NHEJ pathway of double-strand break repair"^^xsd:string ;
  obo:id "PW:0000203"^^xsd:string ;
  rdfs:label "non-homologous end joining pathway of double-strand break repair"^^xsd:string ;
  skos:notation "PW:0000203"^^xsd:string .

ns1:PW_0000204
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000332, ns1:PW_0000650, ns1:PW_0000656 ;
  ns2:treeView ns1:PW_0000332, ns1:PW_0000650, ns1:PW_0000656 ;
  ns1:IAO_0000115 "Notch signaling pathway regulates processes involved in early embryonic development. It plays an important role in cell fate determination. Target genes of Notch have been implicated in angiogenesis, somitogenesis, gliogenesis. Deregulation of the Notch signaling pathway underlies a broad spectrum of diseases and clinical conditions."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04330"^^xsd:string, "PID:200015"^^xsd:string ;
  obo:id "PW:0000204"^^xsd:string ;
  rdfs:label "Notch signaling pathway"^^xsd:string ;
  skos:notation "PW:0000204"^^xsd:string .

ns1:PW_0000205
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000171 ;
  ns2:treeView ns1:PW_0000171 ;
  ns1:IAO_0000115 "Dentatorubral-pallidoluysian atrophy (DRPLA) is caused by an expanded trinucleotide repeat in the atrophin-1 (ATN1) gene. A rather rare condition, it can be juvenile-, early adult- or late adult-onset."^^xsd:string ;
  obo:hasExactSynonym "dentatorubral-pallidoluysian atrophy disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "DRPLA disease pathway"^^xsd:string ;
  obo:id "PW:0000205"^^xsd:string ;
  rdfs:label "dentatorubral-pallidoluysian atrophy pathway"^^xsd:string ;
  skos:notation "PW:0000205"^^xsd:string .

ns1:PW_0000206
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000329 ;
  ns2:treeView ns1:PW_0000329 ;
  ns1:IAO_0000115 "Transforming growth factor-beta (TGF-beta) signaling pathway regulates numerous cellular processes such as proliferation, differentiation, migration and cell death. The SMAD dependent pathway represents the core signaling cascade mediated by the TGF-beta superfamily. Mutations in TGF - beta family are responsible for a number of human diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "TGF- beta signaling pathway - SMAD dependent"^^xsd:string ;
  obo:id "PW:0000206"^^xsd:string ;
  rdfs:label "transforming growth factor-beta signaling pathway"^^xsd:string ;
  skos:notation "PW:0000206"^^xsd:string .

ns1:PW_0000207
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000174
  ] ;
  ns2:treeView ns1:PW_0000174 ;
  ns3:part_of ns1:PW_0000174 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000207"^^xsd:string ;
  rdfs:label "central obesity with hypertension pathway"^^xsd:string ;
  skos:notation "PW:0000207"^^xsd:string .

ns1:PW_0000208
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000176, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000174
  ] ;
  ns2:treeView ns1:PW_0000174, ns1:PW_0000176 ;
  ns3:part_of ns1:PW_0000174 ;
  ns1:IAO_0000115 "Diabetes mellitus is characterized by abnormally high levels of glucose in the blood. Hereditary and environmental factors are likely contributors but the exact mechanisms are not well understood. Type 2 diabetes mellitus, characterized by insulin resistance, involves alterations in insulin secretion and signaling and impaired glucose homeostasis pathways."^^xsd:string ;
  obo:hasExactSynonym "NIDDM pathway"^^xsd:string, "T2D pathway"^^xsd:string, "non-insulin-dependent diabetes mellitus pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04930"^^xsd:string, "type II diabetes mellitus pathway"^^xsd:string ;
  obo:id "PW:0000208"^^xsd:string ;
  rdfs:label "type 2 diabetes mellitus pathway"^^xsd:string ;
  skos:notation "PW:0000208"^^xsd:string .

ns1:PW_0000209
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000818, ns1:PW_0001195 ;
  ns2:treeView ns1:PW_0000818, ns1:PW_0001195 ;
  ns1:IAO_0000115 "The Jak-Stat pathway is a main intracellular cascade initiated primarily in response to cytokine and also other ligand signaling. Four Janus kinases (Jak) and seven signal transducers and activators of transcription (Stat) families of proteins mediate the action of almost 40 cytokine receptors, including the receptor for leptin. Combinations between four Jak(s) and seven Stat(s) shape the outcome of ligand triggered signaling through the various receptors."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04630"^^xsd:string ;
  obo:id "PW:0000209"^^xsd:string ;
  rdfs:label "Jak-Stat signaling pathway"^^xsd:string ;
  skos:notation "PW:0000209"^^xsd:string .

ns1:PW_0000210
  a owl:Class ;
  ns1:IAO_0000115 "The core intracellular  signaling cascade mediated  by the TGF-beta superfamily. SMAD proteins function by carrying signals from the cell surface to the nucleus. There are eight vertebrate SMAD proteins and they are activated  by two types of  TGF-beta receptors in response to TGF cytokines binding.There are two known SMAD-dependent TGF-beta signaling pathways. SMAP pathways can also be activated via NGF signalign pathways"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000210"^^xsd:string ;
  rdfs:label "SMAD dependent signaling pathways"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0000210"^^xsd:string .

ns1:PW_0000211
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000002 ;
  ns2:treeView ns1:PW_0000002 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of biogenic amines and polyamines. Important biogenic amines are histamine, serotonin and the catecholamines.  Spermidine and spermine are examples of important polyamines."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000211"^^xsd:string ;
  rdfs:label "biogenic amines and polyamines metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000211"^^xsd:string .

ns1:PW_0000212
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000211 ;
  ns2:treeView ns1:PW_0000211 ;
  ns1:IAO_0000115 "Choline metabolism is important for the synthesis of phosphatidylcholine in mammalian cells. Its oxidation results in the production of betaine, an important methyl donor. In the brain, it is converted to the powerful neurotransmitter acetylcholine."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00123"^^xsd:string ;
  obo:id "PW:0000212"^^xsd:string ;
  rdfs:label "choline metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000212"^^xsd:string .

ns1:PW_0000213
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001275 ;
  ns2:treeView ns1:PW_0001275 ;
  ns1:IAO_0000115 "RNA polymerase IV transcription pathway is found in plants and is involved in the synthesis of small interfering RNA (siRNA)."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000213"^^xsd:string ;
  rdfs:label "RNA polymerase IV transcription pathway"^^xsd:string ;
  skos:notation "PW:0000213"^^xsd:string .

ns1:PW_0000214
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000211, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001693
  ] ;
  ns2:treeView ns1:PW_0000211, ns1:PW_0001693 ;
  ns3:part_of ns1:PW_0001693 ;
  ns1:IAO_0000115 "Polyamines play important roles in cell growth, proliferation and survival. They can be derived from diet as well as via cellular and intestinal flora mediated biosynthesis."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000214"^^xsd:string ;
  rdfs:label "polyamine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000214"^^xsd:string .

ns1:PW_0000215
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001275 ;
  ns2:treeView ns1:PW_0001275 ;
  ns1:IAO_0000115 "RNA polymerase V transcription pathway operates in plants and plays a role in heterochromatin formation."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000215"^^xsd:string ;
  rdfs:label "RNA polymerase V transcription pathway"^^xsd:string ;
  skos:notation "PW:0000215"^^xsd:string .

ns1:PW_0000216
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000214 ;
  ns2:treeView ns1:PW_0000214 ;
  ns1:IAO_0000115 "Polyamine metabolism plays important roles in a number of cellular processes. Spermidine and spermine are formed in two consecutive reactions carried out by distinct enzymes that employ the decarboxylated form of AdoMet as an aminopropyl donor."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00445"^^xsd:string ;
  obo:id "PW:0000216"^^xsd:string ;
  rdfs:label "spermine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000216"^^xsd:string .

ns1:PW_0000217
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000135 ;
  ns2:treeView ns1:PW_0000135 ;
  ns1:IAO_0000115 "Tetrahydrobiopterin is a cofactor for amino acid hydroxylases involved in the synthesis of several neurotransmitters. It can be synthesized de novo from guanosine triphosphate (GTP) or recycled via a regeneration pathway."^^xsd:string ;
  obo:hasExactSynonym "BH4 metabolic pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000217"^^xsd:string ;
  rdfs:label "tetrahydrobiopterin metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000217"^^xsd:string .

ns1:PW_0000218
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000221, ns1:PW_0002633 ;
  ns2:treeView ns1:PW_0000221, ns1:PW_0002633 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the biosynthesis of heme - an iron-containing compound where the iron is complexed within a porphyrin heterocyclic ring. There are several kinds of heme depending on the composition of their side chain. Heme serves as a prosthetic group for several classes of proteins that include hemoglobin and myoglobin, cytochromes, peroxidases, catalases and others."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000218"^^xsd:string ;
  rdfs:label "heme biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000218"^^xsd:string .

ns1:PW_0000219
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002580 ;
  ns2:treeView ns1:PW_0002580 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of nicotinamide adenine dinucleotide (NAD). NAD can be synthesized de novo downstream of kynurenine metabolism of tryptophan degradation, or from precursors such as nicotinamide, nicotinic acid or nicotinamide riboside, collectively known as vitamin B3 or niacin."^^xsd:string ;
  obo:hasExactSynonym "NAD biosynthetic pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000219"^^xsd:string ;
  rdfs:label "nicotinamide adenine dinucleotide biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000219"^^xsd:string .

ns1:PW_0000220
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000135 ;
  ns2:treeView ns1:PW_0000135 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000220"^^xsd:string ;
  rdfs:label "pyridine nucleotide biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000220"^^xsd:string .

ns1:PW_0000221
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002285 ;
  ns2:treeView ns1:PW_0002285 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of heme - an iron-containing compound where the iron is complexed within a porphyrin heterocyclic ring."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000221"^^xsd:string ;
  rdfs:label "heme metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000221"^^xsd:string .

ns1:PW_0000222
  a owl:Class ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000222"^^xsd:string ;
  rdfs:label "UDP-N-acetylgalactosamine biosynthetic pathway"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0000222"^^xsd:string .

ns1:PW_0000223
  a owl:Class ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000223"^^xsd:string ;
  rdfs:label "UDP-N-acetylglucosamine biosynthetic pathway"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0000223"^^xsd:string .

ns1:PW_0000224
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000152 ;
  ns2:treeView ns1:PW_0000152 ;
  ns1:IAO_0000115 "Those metabolic reactions leading to the decomposition of N-acetylglucosamine - an acetylated amino sugar that is an important moiety of glycoproteins, N-acetylmannosamine - the acetylated derivative of mannosamine, and N-acetylneuraminic acid - the most common form of sialic acid in mammals."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000224"^^xsd:string ;
  rdfs:label "N-acetylglucosamine, N-acetylmannosamine and N-acetylneuraminic acid dissimilation pathway"^^xsd:string ;
  skos:notation "PW:0000224"^^xsd:string .

ns1:PW_0000225
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000132 ;
  ns2:treeView ns1:PW_0000132 ;
  ns1:IAO_0000115 "Those metabolic reactions involving citrulline. Citrulline, not a DNA coded amino acid, is a product in the urea cycle."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000225"^^xsd:string ;
  rdfs:label "citrulline degradation pathway"^^xsd:string ;
  skos:notation "PW:0000225"^^xsd:string .

ns1:PW_0000226
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000214 ;
  ns2:treeView ns1:PW_0000214 ;
  ns1:IAO_0000115 "Putrescine, spermidine and spermine are the only polyamines synthesized in mammalian cells. Putrescine, derived from L-ornithine, an important component of the urea cycle, is the substrate for the formation of spermidine, in turn the substrate for spermine."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000226"^^xsd:string ;
  rdfs:label "putrescine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000226"^^xsd:string .

ns1:PW_0000227
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001539 ;
  ns2:treeView ns1:PW_0001539 ;
  ns1:IAO_0000115 "Based on sequence similarity, the Galpha genes have been grouped into four classes. Exchange of GDP to GTP promoted through binding to receptors dissociates the heterotrimeric Galpa/beta/gamma complex. GTP-bound Galpha can then interact with downstream effectors. Lipid modification of Galpha regulates membrane localization and interactions with specific effectors."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000227"^^xsd:string ;
  rdfs:label "G protein mediated signaling pathway via Galphas family"^^xsd:string ;
  skos:notation "PW:0000227"^^xsd:string .

ns1:PW_0000228
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001539 ;
  ns2:treeView ns1:PW_0001539 ;
  ns1:IAO_0000115 "Based on sequence similarity, the Galpha genes have been grouped into four classes. Exchange of GDP to GTP promoted through binding to receptors dissociates the heterotrimeric Galpha/beta/gamma complex. GTP-bound Galpha can then interact with downstream effectors. Lipid modification of Galpha regulates membrane localization and interactions with specific effectors."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000228"^^xsd:string ;
  rdfs:label "G protein mediated signaling pathway via Galphai family"^^xsd:string ;
  skos:notation "PW:0000228"^^xsd:string .

ns1:PW_0000229
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001539 ;
  ns2:treeView ns1:PW_0001539 ;
  ns1:IAO_0000115 "Based on sequence similarity, the Galpha genes have been grouped into four classes. Exchange of GDP to GTP promoted through binding to receptors dissociates the heterotrimeric Galpha/beta/gamma complex. GTP-bound Galpha can then interact with downstream effectors. Lipid modification of Galpha regulates membrane localization and interactions with specific effectors."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000229"^^xsd:string ;
  rdfs:label "G protein mediated signaling pathway via Galphaq family"^^xsd:string ;
  skos:notation "PW:0000229"^^xsd:string .

ns1:PW_0000230
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001539 ;
  ns2:treeView ns1:PW_0001539 ;
  ns1:IAO_0000115 "Based on sequence similarity, the Galpha genes have been grouped into four classes. Exchange of GDP to GTP promoted through binding to receptors dissociates the heterotrimeric Galpa/beta/gamma complex. GTP-bound Galpha can then interact with downstream effectors. Lipid modification of Galpha regulates membrane localization and interactions with specific effectors."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000230"^^xsd:string ;
  rdfs:label "G protein mediated signaling pathway via Galpha12/Galpha13 family"^^xsd:string ;
  skos:notation "PW:0000230"^^xsd:string .

ns1:PW_0000231
  a owl:Class ;
  ns1:IAO_0000115 "A very close relative of Ras, Rap1 mediated pathway  appears to control diverse processes such as modulation of growth and differentiation, secretion, integrin linked cell adhesion, morphogenesis."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000231"^^xsd:string ;
  rdfs:label "Rap1 pathways"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0000231"^^xsd:string .

ns1:PW_0000232
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000963, ns1:PW_0001194 ;
  ns2:treeView ns1:PW_0000963, ns1:PW_0001194 ;
  ns1:IAO_0000115 "Phosphatidylinositol 3-kinase-Akt signaling pathway involving PI3K class I enzymes, particularly class IA, controls various processes such as cell growth, proliferation and survival. Class IA enzymes couples to receptor tyrosine kinases or their adaptors; class IB couples to G-protein coupled receptor mainly via Galphai. The Akt family of protein kinases are activated downstream of class I PI3Ks and collectively (Akt1, 2, and 3) phosphorylate more than 70 cytoplasmic and nuclear substrates. Deregulation of the pathway has been linked to various forms of cancer."^^xsd:string ;
  obo:hasExactSynonym "Reactome:R-HSA-109704"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04151"^^xsd:string, "PI3K-Akt signaling pathway"^^xsd:string, "PID:200197"^^xsd:string, "phosphoinositide 3-kinase-Akt signaling pathway"^^xsd:string ;
  obo:id "PW:0000232"^^xsd:string ;
  rdfs:label "phosphatidylinositol 3-kinase-Akt signaling pathway"^^xsd:string ;
  skos:notation "PW:0000232"^^xsd:string .

ns1:PW_0000233
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000106, ns1:PW_0000236, ns1:PW_0000926 ;
  ns2:treeView ns1:PW_0000106, ns1:PW_0000236, ns1:PW_0000926 ;
  ns1:IAO_0000115 "Tumor necrosis factor (Tnf) signaling plays pivotal roles in immunity, cell proliferation, differentiation and apoptosis by activating several pathways. NF-kB is a major pathway activated by Tnf; others include JNK and P38 MAPK. Through receptor associated adapters Tnf elicits apoptosis via the extrinsic pathway. Deregulation of Tnf signaling has been implicated in a great number of human diseases - cerebral malaria, cancer, multiple sclerosis, are a few examples."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200102"^^xsd:string, "TNF signaling pathway"^^xsd:string, "TNFalpha signaling pathway"^^xsd:string ;
  obo:id "PW:0000233"^^xsd:string ;
  rdfs:label "tumor necrosis factor mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000233"^^xsd:string .

ns1:PW_0000234
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000023 ;
  ns2:treeView ns1:PW_0000023 ;
  ns1:IAO_0000115 "The innate immune response - a universal and ancient form of host defense against infection - is a first line of response to various pathogens and also to damaged cells. It plays a role in stimulating adaptive immunity; molecules generated during innate responses act as second signals that can impact on both the magnitude and the nature of the adaptive response."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000234"^^xsd:string ;
  rdfs:label "innate immune response pathway"^^xsd:string ;
  skos:notation "PW:0000234"^^xsd:string .

ns1:PW_0000235
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000023 ;
  ns2:treeView ns1:PW_0000023 ;
  ns1:IAO_0000115 "The adaptive immune response is an evolutionarily newer mechanism that provides great specificity and diversity of antigen recognition, immunological memory and specialized responses. The two types of adaptive immune response pathways are humoral and cellular or cell-mediated."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000235"^^xsd:string ;
  rdfs:label "adaptive immune response pathway"^^xsd:string ;
  skos:notation "PW:0000235"^^xsd:string .

ns1:PW_0000236
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000828 ;
  ns2:treeView ns1:PW_0000828 ;
  ns1:IAO_0000115 "Members of TNF superfamily mediate autoimmunity and inflammation, cell proliferation, survival and/or apoptosis through a number of signaling mechanisms that involve activation of nuclear factor-kappaB, of caspases and/or of mitogen-activated protein kinases (MAPK). TNF superfamily has been implicated in a wide range of human diseases including tumorigenesis, septic shock, rheumatoid arthritis and other conditions."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "TNF superfamily mediated signaling pathway"^^xsd:string ;
  obo:id "PW:0000236"^^xsd:string ;
  rdfs:label "tumor necrosis factor superfamily mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000236"^^xsd:string .

ns1:PW_0000237
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000004 ;
  ns2:treeView ns1:PW_0000004 ;
  ns1:IAO_0000115 "The pathway(s) elicited as a physiological response to various types of insults, injuries, shocks and other situations the organism perceives as threatening."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000237"^^xsd:string ;
  rdfs:label "stress response pathway"^^xsd:string ;
  skos:notation "PW:0000237"^^xsd:string .

ns1:PW_0000238
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000168, ns1:PW_0000467 ;
  ns2:treeView ns1:PW_0000168, ns1:PW_0000467 ;
  ns1:IAO_0000115 "Insulin-like growth factor signaling plays important roles in cell growth and proliferation. Produced primarily by the liver in response to stimulation by growth hormone (GH) , the proteins activate cognate receptors to prompt intracellular signaling pathways and cell growth in a variety of tissues. Deregulation of the pathway has been associated with various conditions, including cancer."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200100"^^xsd:string ;
  obo:id "PW:0000238"^^xsd:string ;
  rdfs:label "insulin-like growth factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0000238"^^xsd:string .

ns1:PW_0000239
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000176, ns1:PW_0001018 ;
  ns2:treeView ns1:PW_0000176, ns1:PW_0001018 ;
  ns1:IAO_0000115 "Diabetes mellitus is characterized by abnormally high levels of glucose in the blood. Hereditary and environmental factors are likely contributors but the exact mechanisms are not well understood. The type 1 diabetes mellitus pathway involves alterations in immune response pathways resulting in destruction of the insulin-producing beta cells."^^xsd:string ;
  obo:hasExactSynonym "IDDM pathway"^^xsd:string, "insulin-dependent diabetes mellitus pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04940"^^xsd:string, "type I diabetes mellitus pathway"^^xsd:string ;
  obo:id "PW:0000239"^^xsd:string ;
  rdfs:label "type 1 diabetes mellitus pathway"^^xsd:string ;
  skos:notation "PW:0000239"^^xsd:string .

ns1:PW_0000240
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000013 ;
  ns2:treeView ns1:PW_0000013 ;
  ns1:IAO_0000115 "Neuropsychiatric diseases are mental disorders due to various defects in the working of the nervous system."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "mental disorder pathway"^^xsd:string ;
  obo:id "PW:0000240"^^xsd:string ;
  rdfs:label "neuropsychiatric disease pathway"^^xsd:string ;
  skos:notation "PW:0000240"^^xsd:string .

ns1:PW_0000241
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000240 ;
  ns2:treeView ns1:PW_0000240 ;
  ns1:IAO_0000115 "Schizophrenia is a psychiatric diagnosis denoting a persistent, often chronic, mental illness variously affecting behavior, thinking, and emotion. The term schizophrenia comes from the Greek words schizo, (split or divide) and phrenos, (mind) and is best translated as 'shattered mind'."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000241"^^xsd:string ;
  rdfs:label "schizophrenia pathway"^^xsd:string ;
  skos:notation "PW:0000241"^^xsd:string .

ns1:PW_0000242
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000240 ;
  ns2:treeView ns1:PW_0000240 ;
  ns1:IAO_0000115 "As categorized by the DSM-IV, bipolar disorder is a form of mood disorder characterized by a variation of mood between a phase of manic or hypomanic elation, hyperactivity and hyper imagination, and a depressive phase of inhibition, slowness to conceive ideas and move, and anxiety or sadness. Together these form what is commonly known as manic depression. Manic depression, with its two principal sub-types, bipolar disorder and major depression, was first clinically described near the end of the 19th century by psychiatrist Emil Kraepelin, who published his account of the disease in his Textbook of Psychiatry. DSM-IV is the Diagnostic and Statistical Manual of Mental Disorders, published by the American Psychiatric Association, is the handbook used most often in diagnosing mental disorders in the United States and other countries."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000242"^^xsd:string ;
  rdfs:label "bipolar disorder pathway"^^xsd:string ;
  skos:notation "PW:0000242"^^xsd:string .

ns1:PW_0000243
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000168, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000476
  ] ;
  ns2:treeView ns1:PW_0000168, ns1:PW_0000476 ;
  ns3:part_of ns1:PW_0000476 ;
  ns1:IAO_0000115 "The VEGF family plays key roles in angiogenesis and lymphangiogenesis. Through their receptors, VEGFs can initiate a diverse and complex network of signaling cascades. Deregulation of VEGFs mediated pathways, mostly through upregulation of VEGFs expression, has been implicated in a number of conditions, primarily cancer."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04370"^^xsd:string, "PID:200109"^^xsd:string, "PID:200188"^^xsd:string, "VEGF signaling pathways"^^xsd:string ;
  obo:id "PW:0000243"^^xsd:string ;
  rdfs:label "vascular endothelial growth factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0000243"^^xsd:string .

ns1:PW_0000244
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000245 ;
  ns2:treeView ns1:PW_0000245 ;
  ns1:IAO_0000115 "Angiotensin II signaling pathways play a critical role in the control of cardiovascular and renal homeostasis. Angiotensin II pathway can also contribute to cardiovascular diseases such as hypertension, atherosclerosis and heart failure."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000244"^^xsd:string ;
  rdfs:label "angiotensin II signaling pathway"^^xsd:string ;
  skos:notation "PW:0000244"^^xsd:string .

ns1:PW_0000245
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000492
  ] ;
  ns2:treeView ns1:PW_0000467, ns1:PW_0000492 ;
  ns3:part_of ns1:PW_0000492 ;
  ns1:IAO_0000115 "Angiotensin peptides Ang II, Ang III, Ang IV and Ang (1-7) generated from a single precursor protein - angiotensinogen - regulate an array of physiological and pathophysiological processes."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000245"^^xsd:string ;
  rdfs:label "angiotensin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000245"^^xsd:string .

ns1:PW_0000246
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000158 ;
  ns2:treeView ns1:PW_0000158 ;
  ns1:IAO_0000115 "The Rheb family of proteins plays an essential role in the regulation of cell growth and cell cycle. Rheb could be a mediator of the mTOR signaling pathway. The results have been shown for Drosophila but remained to be established for mammals."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000246"^^xsd:string ;
  rdfs:label "Rheb mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000246"^^xsd:string .

ns1:PW_0000247
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000206 ;
  ns2:treeView ns1:PW_0000206 ;
  ns1:IAO_0000115 "TGF-beta can activate signaling cascades other than the Smad-mediated ones, including MAPK pathways such as Erk, p38 and JNK. The mechanisms of MAPK pathway activation by TGF-beta are not well understood."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "TGF-beta Smad independent signaling pathway"^^xsd:string ;
  obo:id "PW:0000247"^^xsd:string ;
  rdfs:label "transforming growth factor-beta Smad independent signaling pathway"^^xsd:string ;
  skos:notation "PW:0000247"^^xsd:string .

ns1:PW_0000248
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000010 ;
  ns2:treeView ns1:PW_0000010 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of isoprenoids or terpenoids - a large class of organic biomolecules. Isoprenoids are precursors of sterols such as cholesterol and its derivative and also of non-sterols molecules many of which are used in the post-translational modification of proteins. Plant isoprenoids are among the most commonly found and have a broad range of uses and applications in plants and beyond."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "terpenoid metabolic pathway"^^xsd:string ;
  obo:id "PW:0000248"^^xsd:string ;
  rdfs:label "isoprenoid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000248"^^xsd:string .

ns1:PW_0000249
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000876 ;
  ns2:treeView ns1:PW_0000876 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the biosynthesis of lipopolysaccharides, also known as lipoglycans, found in the outer membrane of Gram-negative bacteria. They are large molecules consisting of a lipid and a polysaccharide joined by a covalent bond. In host cells they act as endotoxins which are recognized by members of the Toll-like receptors to elicit strong immune responses."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "LPS biosynthetic pathway"^^xsd:string, "lipoglycan biosynthetic pathway"^^xsd:string ;
  obo:id "PW:0000249"^^xsd:string ;
  rdfs:label "lipopolysaccharide biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000249"^^xsd:string .

ns1:PW_0000250
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000876 ;
  ns2:treeView ns1:PW_0000876 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the biosynthesis of peptidoglycan - a high molecular weight polymer that forms the tough, rigid structure of bacterial cell walls. It is made up of three parts: (1) a backbone, composed of alternating N-acetylglucosamine and N-acetylmuramic acid; (2) a set of identical tetrapeptide side-chains attached to N-acetylmuramic acid; and (3) a set of identical peptide cross-bridges. The backbone is the same in all bacterial species; however, the tetrapeptide side-chains and the peptide cross-bridges vary from species to species."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "murein biosynthetic pathway"^^xsd:string ;
  obo:id "PW:0000250"^^xsd:string ;
  rdfs:label "peptidoglycan biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000250"^^xsd:string .

ns1:PW_0000251
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000184 ;
  ns2:treeView ns1:PW_0000184 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of diterpenoid. Terpenoids are a large class of naturally-occurring organic chemicals. They are derived from five-carbon units and are modifed in manifold ways."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00904"^^xsd:string ;
  obo:id "PW:0000251"^^xsd:string ;
  rdfs:label "diterpenoid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000251"^^xsd:string .

ns1:PW_0000252
  a owl:Class ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of monoterpenoid. Terpenoids are a large class of naturally-occurring organic chemicals. They are derived from five-carbon units and are modifed in manifold ways."^^xsd:string ;
  ns1:IAO_0000231 ns1:IAO_0000227 ;
  ns1:IAO_0100001 ns1:PW_0000166 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000252"^^xsd:string ;
  rdfs:label "monoterpenoid biosynthetic pathway"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0000252"^^xsd:string .

ns1:PW_0000253
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000147 ;
  ns2:treeView ns1:PW_0000147 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of indole and ipecac. Indole is a heterocyclic compound, obtained from coal tar, and produced by the decomposition of tryptophan in the intestine, being partly responsible for the peculiar odor of the feces. It is also found in cultures of Vibrio cholerae and other bacteria; a color test for its production is used in classifying enteric bacteria. Ipecac is derived from the dried rhizome and roots of Cephaelis ipecacuanha or of C. acuminata. It is a mixture of alkaloids, primarily emetine and cephaelin."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000253"^^xsd:string ;
  rdfs:label "indole and ipecac alkaloid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000253"^^xsd:string .

ns1:PW_0000254
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000147 ;
  ns2:treeView ns1:PW_0000147 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the biosynthesis of penicillin and cephalosporins. The former is the best known antibiotic which blocks the cross linking reaction in peptidoglycan synthesis, thus destroying the bacterial cell wall. The latter represents a broad class of antibiotics similar to penicillin, both chemically and in mode of action."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000254"^^xsd:string ;
  rdfs:label "penicillins and cephalosporins biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000254"^^xsd:string .

ns1:PW_0000255
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000147 ;
  ns2:treeView ns1:PW_0000147 ;
  ns1:IAO_0000115 "Those pathways that confer to an organism resistance to the action of beta-lactams - a class of broad spectrum antibiotics that are structurally and pharmacologically related to penicillins and cephalosporins."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000255"^^xsd:string ;
  rdfs:label "beta-Lactam resistance pathway"^^xsd:string ;
  skos:notation "PW:0000255"^^xsd:string .

ns1:PW_0000256
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000147 ;
  ns2:treeView ns1:PW_0000147 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the biosynthesis of polyketides. Polyketides are a group of secondary metabolites made by microorganisms that possess a broad range of pharmacologically important activities such as antimicrobial, antifungal, antiparasitic and antitumor."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000256"^^xsd:string ;
  rdfs:label "polyketides biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000256"^^xsd:string .

ns1:PW_0000257
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000147 ;
  ns2:treeView ns1:PW_0000147 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000257"^^xsd:string ;
  rdfs:label "polyketide sugar biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000257"^^xsd:string .

ns1:PW_0000258
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000147 ;
  ns2:treeView ns1:PW_0000147 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of tetracycline - any of a group of biosynthetic antibiotics. Some are isolated from certain species of Streptomyces and others are produced semisynthetically."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000258"^^xsd:string ;
  rdfs:label "tetracycline biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000258"^^xsd:string .

ns1:PW_0000259
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000147 ;
  ns2:treeView ns1:PW_0000147 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the biosynthesis of clavulanic acid. Clavulanic acid is a beta-lactam antibiotic produced by a bacterium of the genus Streptomyces (S. clavuligerus) that is a beta-lactamase inhibitor and is usually used in the form of its clavulanate salt of potassium especially in combination with amoxicillin"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000259"^^xsd:string ;
  rdfs:label "clavulanic acid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000259"^^xsd:string .

ns1:PW_0000260
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000147 ;
  ns2:treeView ns1:PW_0000147 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the biosynthesis of puromycin - an antibiotic produced by Streptomyces alboniger, which has been used experimentally as an antineoplastic because of its ability to inhibit protein synthesis; it also has trypanosomicidal and amebicidal activity and was formerly used in the treatment of African trypanosomiasis and amebic dysentery."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000260"^^xsd:string ;
  rdfs:label "puromycin biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000260"^^xsd:string .

ns1:PW_0000261
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001251 ;
  ns2:treeView ns1:PW_0001251 ;
  ns1:IAO_0000115 "The unique morphology of the neuron defies the classical organization of secretory pathways. The neuronal secretory pathway represents the intracellular trafficking route for proteins involved in synaptic transmission and plasticity and for lipids necessary for growth and remodeling of neurites. Neurons possess both somatic and dendritic Golgi compartments."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000261"^^xsd:string ;
  rdfs:label "neuronal secretory pathway"^^xsd:string ;
  skos:notation "PW:0000261"^^xsd:string .

ns1:PW_0000262
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000002 ;
  ns2:treeView ns1:PW_0000002 ;
  ns1:IAO_0000115 "Those metabolic pathways that deviate from what their normal course should be. Aberrant metabolic pathways, alone or in combination with other pathways, underlie many conditions, disorders and/or diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000262"^^xsd:string ;
  rdfs:label "altered metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000262"^^xsd:string .

ns1:PW_0000263
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000004 ;
  ns2:treeView ns1:PW_0000004 ;
  ns1:IAO_0000115 "Those regulatory pathways that deviate from what their normal course should be. Aberrant regulatory pathways, alone or in combination with other pathways underlie many conditions, disorders and/or diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000263"^^xsd:string ;
  rdfs:label "altered regulatory pathway"^^xsd:string ;
  skos:notation "PW:0000263"^^xsd:string .

ns1:PW_0000264
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000003 ;
  ns2:treeView ns1:PW_0000003 ;
  ns1:IAO_0000115 "Those signaling pathways that deviate from what their normal course should be. Aberrant signaling pathways, alone or in combination with other pathways underlie many conditions, disorders and/or diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000264"^^xsd:string ;
  rdfs:label "altered signaling pathway"^^xsd:string ;
  skos:notation "PW:0000264"^^xsd:string .

ns1:PW_0000265
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000019 ;
  ns2:treeView ns1:PW_0000019 ;
  ns1:IAO_0000115 "Creutzfeldt-Jakob disease -  a rare prion disease, associated with a number of different mutations of the prion protein gene, existing in sporadic, familial (as an autosomal dominant), and infectious forms, with onset usually in middle life, and having a wide variety of clinical and pathological features. The most commonly seen are varying degrees of spongiform degeneration of neurons, neuronal loss, gliosis, and amyloid plaque formation, accompanied by rapidly progressive dementia, myoclonus, motor disturbances."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "CJD"^^xsd:string ;
  obo:id "PW:0000265"^^xsd:string ;
  rdfs:label "Creutzfeldt-Jakob disease pathway"^^xsd:string ;
  skos:notation "PW:0000265"^^xsd:string .

ns1:PW_0000266
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000019 ;
  ns2:treeView ns1:PW_0000019 ;
  ns1:IAO_0000115 "Gerstmann-Strussler syndrome,   Gerstmann-Strussler-Scheinker syndrome - a group of rare prion diseases, of autosomal dominant inheritance but linked to different mutations of the prion protein gene. Common characteristics include cognitive and motor disturbances, the presence of multicentric amyloid plaques in the brain. Its manifestations include cerebellar ataxia and dementia, rigidity, tremor, memory loss and others, depending on the form of the condition."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000266"^^xsd:string ;
  rdfs:label "Gerstmann-Strussler syndrome, Gerstmann-Strussler-Scheinker syndrome pathway"^^xsd:string ;
  skos:notation "PW:0000266"^^xsd:string .

ns1:PW_0000267
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000019 ;
  ns2:treeView ns1:PW_0000019 ;
  ns1:IAO_0000115 "Fatal familial insomnia - an inherited prion disease, transmitted as an autosomal dominant trait, affecting primarily the ventral and dorsomedial nuclei of the thalamus and characterized by progressive insomnia, hallucinations, stupor, and coma ending in death within 6 months to 3 years of onset; autonomic and motor disturbances are also present."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000267"^^xsd:string ;
  rdfs:label "fatal familial insomnia pathway"^^xsd:string ;
  skos:notation "PW:0000267"^^xsd:string .

ns1:PW_0000268
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000019 ;
  ns2:treeView ns1:PW_0000019 ;
  ns1:IAO_0000115 "Kuru - an infectious form of prion disease with a long incubation period, found only among the Fore and neighboring peoples of New Guinea. It is thought to be associated with ritual cannibalism. Its manifestations include truncal and limb ataxia, tremor, others; ends invariably in death. Amyloid plaques are present in about two thirds of affected individuals."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000268"^^xsd:string ;
  rdfs:label "kuru"^^xsd:string ;
  skos:notation "PW:0000268"^^xsd:string .

ns1:PW_0000269
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000181, ns1:PW_0001756, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000280
  ] ;
  ns2:treeView ns1:PW_0000181, ns1:PW_0000280, ns1:PW_0001756 ;
  ns3:part_of ns1:PW_0000280 ;
  ns1:IAO_0000115 "Those reactions and molecular interactions underlying the folding of a protein into its functional three-dimensional structure. Folding takes place in the cytoplasm and, in the case of secreted proteins, in the endoplasmic reticulum. Proteins are checked (quality control) for proper folding and misfolded proteins are targeted for degradation."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000269"^^xsd:string ;
  rdfs:label "protein folding pathway"^^xsd:string ;
  skos:notation "PW:0000269"^^xsd:string .

ns1:PW_0000270
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002422 ;
  ns2:treeView ns1:PW_0002422 ;
  ns1:IAO_0000115 "The major events in presynaptic terminal differentiation are the formation of the active zone and the clustering of synaptic vesicles. Cytoskeletal and membrane specializations within the presynapse are necessary to for the regulated exo- and endocytosis of synaptic vesicles."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000270"^^xsd:string ;
  rdfs:label "presynaptic differentiation pathway"^^xsd:string ;
  skos:notation "PW:0000270"^^xsd:string .

ns1:PW_0000271
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002422 ;
  ns2:treeView ns1:PW_0002422 ;
  ns1:IAO_0000115 "The factors and components involved in, and the elements that regulate them and together shape and modulate the formation of the postsynaptic differentiation."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000271"^^xsd:string ;
  rdfs:label "postsynaptic differentiation pathway"^^xsd:string ;
  skos:notation "PW:0000271"^^xsd:string .

ns1:PW_0000272
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000059 ;
  ns2:treeView ns1:PW_0000059 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000272"^^xsd:string ;
  rdfs:label "neuron-to-neuron signaling pathways"^^xsd:string ;
  skos:notation "PW:0000272"^^xsd:string .

ns1:PW_0000273
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000272 ;
  ns2:treeView ns1:PW_0000272 ;
  ns1:IAO_0000115 "A simpler pathway of neuron-to-neuron signaling involving the direct flow of ionic currents. It is a reciprocal pathway involving membrane-to-membrane apposition known as gap junction."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000273"^^xsd:string ;
  rdfs:label "neuron-to-neuron signaling pathway via the electrical synapse"^^xsd:string ;
  skos:notation "PW:0000273"^^xsd:string .

ns1:PW_0000274
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000272 ;
  ns2:treeView ns1:PW_0000272 ;
  ns1:IAO_0000115 "A neurotransmitter-releasing pathway of neuron-to-neuron communication. It involves fusion of neurotransmitter-filled synaptic vesicles with the plasma membrane, activation of postsynaptic receptors. It also involves recycling and re-release of synaptic vesicles."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Neurotransmission pathway"^^xsd:string ;
  obo:id "PW:0000274"^^xsd:string ;
  rdfs:label "neuron-to-neuron signaling pathway via the chemical synapse"^^xsd:string ;
  skos:notation "PW:0000274"^^xsd:string .

ns1:PW_0000275
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000004 ;
  ns2:treeView ns1:PW_0000004 ;
  ns1:IAO_0000115 "A cell death pathway represents the particular series of events leading to the demise of a whole cell or parts of its contents. It plays an essential role in cellular and tissues homeostasis. Biochemical and morphological characteristics are used in the classification of various form of cell death. Deregulation of cell death can contribute to the development of cancer and neurodegeneration."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000275"^^xsd:string ;
  rdfs:label "cell death pathway"^^xsd:string ;
  skos:notation "PW:0000275"^^xsd:string .

ns1:PW_0000276
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001557 ;
  ns2:treeView ns1:PW_0001557 ;
  ns1:IAO_0000115 "Non-apoptotic cell death pathway refers collectively to those types of cell death whose functional and/or morphological features are different from the apoptotic cell death. Cellular autophagy is an example."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000276"^^xsd:string ;
  rdfs:label "non-apoptotic cell death pathway"^^xsd:string ;
  skos:notation "PW:0000276"^^xsd:string .

ns1:PW_0000277
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000276, ns1:PW_0000651 ;
  ns2:treeView ns1:PW_0000276, ns1:PW_0000651 ;
  ns1:IAO_0000115 "Cellular senescence, also known as replicative senescence, results from cells ceasing to divide. Generally, it is a state of steady cell cycle arrest induced by stresses such as DNA damage, toxins and/or oncogene activation."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000277"^^xsd:string ;
  rdfs:label "cellular senescence pathway"^^xsd:string ;
  skos:notation "PW:0000277"^^xsd:string .

ns1:PW_0000278
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002402 ;
  ns2:treeView ns1:PW_0002402 ;
  ns1:IAO_0000115 "Autophagic pathway involves the sequestration of misfolded or long-lived proteins and of defective organelles within double membrane vesicles, delivery of the cargo to lysosomes for degradation and recycling. It is also known as the macroautophagy, or bulk autophagy."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04140"^^xsd:string ;
  obo:id "PW:0000278"^^xsd:string ;
  rdfs:label "autophagy pathway"^^xsd:string ;
  skos:notation "PW:0000278"^^xsd:string .

ns1:PW_0000279
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001558 ;
  ns2:treeView ns1:PW_0001558 ;
  ns1:IAO_0000115 "Necrosis represents the sum of the morphological changes indicative of cell death and caused by the progressive degradative action of enzymes; it may affect groups of cells or part of a structure or an organ. There are many causes of necrosis including injury, infection, cancer, infarction, inflammation, others. There are several distinctive morphologic patterns of necrosis."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000279"^^xsd:string ;
  rdfs:label "necrosis pathway"^^xsd:string ;
  skos:notation "PW:0000279"^^xsd:string .

ns1:PW_0000280
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000181 ;
  ns2:treeView ns1:PW_0000181 ;
  ns1:IAO_0000115 "The secretory pathway is the route by which secreted proteins travel from sites of biosynthesis and folding, modification and sorting, to their final destinations. It involves ER insertion where folding and quality control of folding take place, move to Golgi and trans-Golgi Network (TGN) where sorting and final modifications take place, exit from Golgi and vesicular transport and delivery to plasma membrane and extracellular space or the endosomal system via constitutive or regulated exocytosis."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000280"^^xsd:string ;
  rdfs:label "protein secretory pathway"^^xsd:string ;
  skos:notation "PW:0000280"^^xsd:string .

ns1:PW_0000281
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002395 ;
  ns2:treeView ns1:PW_0002395 ;
  ns1:IAO_0000115 "The endocytic pathway allows for recycling of cargo delivered via the exocytic or secretory routes, uptake of nutrients, internalization of receptors and also, the engulfing of dying cells or of material foreign to the cell. Endocytosis can be subdivided into four pathways: clathrin-mediated  and caveolae-mediated endocytosis, micropinocytosis and phagocytosis. Endosomes and lysosomes are central endocytic components responsible for sorting,  recycling, or degradation of cargo, as necessary."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04144"^^xsd:string ;
  obo:id "PW:0000281"^^xsd:string ;
  rdfs:label "endocytosis pathway"^^xsd:string ;
  skos:notation "PW:0000281"^^xsd:string .

ns1:PW_0000282
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000107 ;
  ns2:treeView ns1:PW_0000107 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the degradation of benzoate - a salt of benzoic acid or benzene carboxylic acid, a fungistatic compound widely used as a food preservative."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000282"^^xsd:string ;
  rdfs:label "benzoate degradation pathway"^^xsd:string ;
  skos:notation "PW:0000282"^^xsd:string .

ns1:PW_0000283
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000146, ns1:PW_0000262 ;
  ns2:treeView ns1:PW_0000146, ns1:PW_0000262 ;
  ns1:IAO_0000115 "Those metabolic pathways involving glycan that deviate from what their normal course should be. Aberrant glycan metabolic pathways, alone or in combination with other pathways, underlie various diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000283"^^xsd:string ;
  rdfs:label "altered glycan metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000283"^^xsd:string .

ns1:PW_0000284
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000157, ns1:PW_0000283 ;
  ns2:treeView ns1:PW_0000157, ns1:PW_0000283 ;
  ns1:IAO_0000115 "Those metabolic pathways involving glycosaminoglycans that deviate from what their normal course should be. Aberrant glycosaminoglycan pathways, alone or in combination with other pathways underlie various diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000284"^^xsd:string ;
  rdfs:label "altered glycosaminoglycan pathway"^^xsd:string ;
  skos:notation "PW:0000284"^^xsd:string .

ns1:PW_0000285
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000284, ns1:PW_0000524 ;
  ns2:treeView ns1:PW_0000284, ns1:PW_0000524 ;
  ns1:IAO_0000115 "Those metabolic pathways involving heparan sulfate (HS) that deviate from what their normal course should be. Aberrant HS pathways, alone or in combination with other pathways may be involved in diseases. An example is the potential role of HS in Alzheimer's disease."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000285"^^xsd:string ;
  rdfs:label "altered heparan sulfate pathway"^^xsd:string ;
  skos:notation "PW:0000285"^^xsd:string .

ns1:PW_0000286
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000648, ns1:PW_0001502 ;
  ns2:treeView ns1:PW_0000648, ns1:PW_0001502 ;
  ns1:IAO_0000115 "Integrins signal bi-directionally across the plasma membrane and provide an example of mechanotransduction. Inside-out signaling modulates their interaction with ligands to regulate cell adhesion and ECM organization. Ligand binding initiates and shapes many signaling events and links to the cytoskeleton. Via protein clustering and ECM organization integrins synergize with and/or modulate various growth factor pathways. Integrin signaling regulates multiple processes including gene expression, cell proliferation, differentiation and survival."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000286"^^xsd:string ;
  rdfs:label "integrin mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000286"^^xsd:string .

ns1:PW_0000287
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000009, ns1:PW_0001559 ;
  ns2:treeView ns1:PW_0000009, ns1:PW_0001559 ;
  ns1:IAO_0000115 "Those apoptotic pathways that deviate from what their normal course should be. Aberrant pathways of programmed cell death, alone or in combination with other pathways underlie various diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000287"^^xsd:string ;
  rdfs:label "altered apoptotic cell death pathway"^^xsd:string ;
  skos:notation "PW:0000287"^^xsd:string .

ns1:PW_0000288
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000104, ns1:PW_0000287 ;
  ns2:treeView ns1:PW_0000104, ns1:PW_0000287 ;
  ns1:IAO_0000115 "An intrinsic apoptotic pathway that deviates from what its normal course should be. Aberrant intrinsic apoptotic pathway, alone or in combination with other pathways underlies various diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000288"^^xsd:string ;
  rdfs:label "altered intrinsic apoptotic pathway"^^xsd:string ;
  skos:notation "PW:0000288"^^xsd:string .

ns1:PW_0000289
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000263, ns1:PW_0000275 ;
  ns2:treeView ns1:PW_0000263, ns1:PW_0000275 ;
  ns1:IAO_0000115 "Those pathways of cell death that deviate from what their normal course should be. Aberrant pathways of cell death, alone or in combination with other pathways underlie various diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000289"^^xsd:string ;
  rdfs:label "altered cell death pathway"^^xsd:string ;
  skos:notation "PW:0000289"^^xsd:string .

ns1:PW_0000290
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000085, ns1:PW_0000263 ;
  ns2:treeView ns1:PW_0000085, ns1:PW_0000263 ;
  ns1:IAO_0000115 "Those pathways involved in and/or controlling DNA replication, cell cycle, DNA repair and preservation of genomic integrity, RNA and protein biosynthesis that deviate from what their normal course should be. Such aberrant pathways, alone or in combination with other pathways underlie various diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000290"^^xsd:string ;
  rdfs:label "altered pathway pertinent to DNA replication and repair, cell cycle, maintenance of genomic integrity, RNA and protein biosynthesis"^^xsd:string ;
  skos:notation "PW:0000290"^^xsd:string .

ns1:PW_0000291
  a owl:Class ;
  ns1:IAO_0000231 ns1:IAO_0000227 ;
  ns1:IAO_0100001 ns1:PW_0000663 ;
  owl:deprecated true ;
  skos:notation "PW:0000291"^^xsd:string .

ns1:PW_0000292
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000099, ns1:PW_0000290 ;
  ns2:treeView ns1:PW_0000099, ns1:PW_0000290 ;
  ns1:IAO_0000115 "Those pathways of DNA repair that deviate from what their normal course should be. Aberrant pathways of DNA repair, alone or in combination with other pathways underlie various diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000292"^^xsd:string ;
  rdfs:label "altered DNA repair pathway"^^xsd:string ;
  skos:notation "PW:0000292"^^xsd:string .

ns1:PW_0000293
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000181, ns1:PW_0000263 ;
  ns2:treeView ns1:PW_0000181, ns1:PW_0000263 ;
  ns1:IAO_0000115 "Those pathways of protein folding, sorting, modification, translocation and degradation that deviate from what their normal course should be. Aberrant protein pathways, alone or in combination with other pathways underlie various diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000293"^^xsd:string ;
  rdfs:label "altered pathway pertinent to protein folding, sorting, modification, translocation and degradation"^^xsd:string ;
  skos:notation "PW:0000293"^^xsd:string .

ns1:PW_0000294
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000144, ns1:PW_0000418 ;
  ns2:treeView ns1:PW_0000144, ns1:PW_0000418 ;
  ns1:IAO_0000115 "An ubiquitin/proteasome degradation pathway that deviates from what its normal course should be. Aberrations in the pathway have been implicated in a number of diseases. Examples include certain malignancies, disorders of the immune and inflammatory responses and neurodegeneration."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000294"^^xsd:string ;
  rdfs:label "altered ubiquitin/proteasome degradation pathway"^^xsd:string ;
  skos:notation "PW:0000294"^^xsd:string .

ns1:PW_0000295
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000286, ns1:PW_0000671 ;
  ns2:treeView ns1:PW_0000286, ns1:PW_0000671 ;
  ns1:IAO_0000115 "An integrin signaling pathway that deviates from what its normal course should be. Aberrant integrin signaling pathway, alone or in combination with other pathways underlies various diseases. An example is hypertrophic cardiomyopathy that involves integrins and the synergy between integrins and growth factors. Aberrant integrin signaling has also been correlated with tumor progression in several cancers."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000295"^^xsd:string ;
  rdfs:label "altered integrin mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000295"^^xsd:string .

ns1:PW_0000296
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000022 ;
  ns2:treeView ns1:PW_0000022 ;
  ns1:IAO_0000115 "Hypertrophic cardiomyopathy, or HCM, is a disease of the myocardium (the muscle of the heart) in which a portion of the myocardium is thickened. Many physiological and pathological conditions as well as many pathways underlie the hypertrophic response."^^xsd:string ;
  obo:hasExactSynonym "HCM pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05410"^^xsd:string ;
  obo:id "PW:0000296"^^xsd:string ;
  rdfs:label "hypertrophic cardiomyopathy pathway"^^xsd:string ;
  skos:notation "PW:0000296"^^xsd:string .

ns1:PW_0000297
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000168, ns1:PW_0000650 ;
  ns2:treeView ns1:PW_0000168, ns1:PW_0000650 ;
  ns1:IAO_0000115 "PDGF signaling pathway plays an important role in the regulation of cell growth and survival."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PDGF signaling pathway"^^xsd:string, "PID:200149"^^xsd:string, "PID:200162"^^xsd:string, "PID:200201"^^xsd:string ;
  obo:id "PW:0000297"^^xsd:string ;
  rdfs:label "platelet-derived growth factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0000297"^^xsd:string .

ns1:PW_0000298
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000168, ns1:PW_0000264 ;
  ns2:treeView ns1:PW_0000168, ns1:PW_0000264 ;
  ns1:IAO_0000115 "Those growth factor mediated signaling pathways that deviate from what their normal course should be. Aberrant growth factor mediated pathways, alone or in combination with other pathways underlie various diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000298"^^xsd:string ;
  rdfs:label "altered growth factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0000298"^^xsd:string .

ns1:PW_0000299
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000020 ;
  ns2:treeView ns1:PW_0000020 ;
  ns1:IAO_0000115 "Myocardial infarction, commonly known as heart attack, is a serious, sudden heart condition characterized by varying degrees of chest pain, weakness, sweating, nausea and vomiting, sometimes causing loss of consciousness. It occurs when parts of the heart muscle die because they are not supplied with enough blood."^^xsd:string ;
  obo:hasExactSynonym "heart attack pathway"^^xsd:string, "myocardial infarct pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000299"^^xsd:string ;
  rdfs:label "myocardial infarction pathway"^^xsd:string ;
  skos:notation "PW:0000299"^^xsd:string .

ns1:PW_0000300
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001700 ;
  ns2:treeView ns1:PW_0001700 ;
  ns1:IAO_0000115 "The congenital and acquired diseases affecting the kidney."^^xsd:string ;
  obo:hasExactSynonym "nephropathy pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000300"^^xsd:string ;
  rdfs:label "kidney disease pathway"^^xsd:string ;
  skos:notation "PW:0000300"^^xsd:string .

ns1:PW_0000301
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000300 ;
  ns2:treeView ns1:PW_0000300 ;
  ns1:IAO_0000115 "Renal failure implies the loss of kidney function. It can be acute and rapidly progressing, or chronic with slow progression. Chronic renal failure may involve a number of kidney diseases and end-stage renal failure is the ultimate consequence."^^xsd:string ;
  obo:hasExactSynonym "renal failure pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000301"^^xsd:string ;
  rdfs:label "kidney failure pathway"^^xsd:string ;
  skos:notation "PW:0000301"^^xsd:string .

ns1:PW_0000302
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000300 ;
  ns2:treeView ns1:PW_0000300 ;
  ns1:IAO_0000115 "Glomerulonephritis is accompanied by inflammation of the capillary loops in the glomeruli of the kidney. It occurs in acute, subacute, and chronic forms and may be secondary to hemolytic streptococcal infection. Evidence also supports possible immune or autoimmune mechanisms."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000302"^^xsd:string ;
  rdfs:label "glomerulonephritis pathway"^^xsd:string ;
  skos:notation "PW:0000302"^^xsd:string .

ns1:PW_0000303
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000095 ;
  ns2:treeView ns1:PW_0000095 ;
  ns1:IAO_0000115 "The p53-dependent pathway of G1 arrest in response to damaged DNA."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "ATM pathway"^^xsd:string ;
  obo:id "PW:0000303"^^xsd:string ;
  rdfs:label "p53-dependent G1/S DNA damage checkpoint pathway"^^xsd:string ;
  skos:notation "PW:0000303"^^xsd:string .

ns1:PW_0000304
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000095 ;
  ns2:treeView ns1:PW_0000095 ;
  ns1:IAO_0000115 "The p53-independent pathway of G1/S arrest in response to damaged DNA."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000304"^^xsd:string ;
  rdfs:label "p53-independent G1/S DNA damage checkpoint pathway"^^xsd:string ;
  skos:notation "PW:0000304"^^xsd:string .

ns1:PW_0000305
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005, ns1:PW_0000262 ;
  ns2:treeView ns1:PW_0000005, ns1:PW_0000262 ;
  ns1:IAO_0000115 "Those pathways of carbohydrate metabolism that deviate from what their normal course should be. Aberrant carbohydrate metabolic pathways, alone or in combination with other pathways, underlie various diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000305"^^xsd:string ;
  rdfs:label "altered carbohydrate metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000305"^^xsd:string .

ns1:PW_0000306
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000042, ns1:PW_0000305 ;
  ns2:treeView ns1:PW_0000042, ns1:PW_0000305 ;
  ns1:IAO_0000115 "Those pathways of galactose metabolism that deviate from what their normal course should be. An aberrant galactose metabolic pathways, alone or in combination with other pathways underlies various diseases. One example is the involvement of aberrant galactose catabolism in cancer."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000306"^^xsd:string ;
  rdfs:label "altered galactose metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000306"^^xsd:string .

ns1:PW_0000307
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000279 ;
  ns2:treeView ns1:PW_0000279 ;
  ns1:IAO_0000115 "Coagulative necrosis is typically seen in hypoxic environments. Cell outlines remain after cell death and can be observed by light microscopy (e.g. myocardial infarction, infarct of the spleen)."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000307"^^xsd:string ;
  rdfs:label "coagulative necrosis pathway"^^xsd:string ;
  skos:notation "PW:0000307"^^xsd:string .

ns1:PW_0000308
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000279 ;
  ns2:treeView ns1:PW_0000279 ;
  ns1:IAO_0000115 "Liquefactive necrosis is associated with cellular destruction and pus formation (e.g. pneumonia)."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000308"^^xsd:string ;
  rdfs:label "liquefactive necrosis pathway"^^xsd:string ;
  skos:notation "PW:0000308"^^xsd:string .

ns1:PW_0000309
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000279 ;
  ns2:treeView ns1:PW_0000279 ;
  ns1:IAO_0000115 "Caseous necrosis is a mix of coagulative necrosis and liquefactive necrosis (e.g. tuberculosis)."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000309"^^xsd:string ;
  rdfs:label "caseous necrosis pathway"^^xsd:string ;
  skos:notation "PW:0000309"^^xsd:string .

ns1:PW_0000310
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000279 ;
  ns2:treeView ns1:PW_0000279 ;
  ns1:IAO_0000115 "Fatty necrosis results from the action of lipases on fatty tissues (e.g. acute pancreatitis)."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000310"^^xsd:string ;
  rdfs:label "fatty necrosis pathway"^^xsd:string ;
  skos:notation "PW:0000310"^^xsd:string .

ns1:PW_0000311
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000279 ;
  ns2:treeView ns1:PW_0000279 ;
  ns1:IAO_0000115 "Fibrinoid necrosis involves the deposition of fibrin and other plasma proteins in the walls of afferent renal arterioles in malignant hypertension, often accompanied by an inflammatory infiltrate within the walls and thrombosis of the vessel lumen. "^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000311"^^xsd:string ;
  rdfs:label "fibrinoid necrosis pathway"^^xsd:string ;
  skos:notation "PW:0000311"^^xsd:string .

ns1:PW_0000312
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000007 ;
  ns2:treeView ns1:PW_0000007 ;
  ns1:IAO_0000115 "MAPK signaling pathways that are responding to stress or injury as well as inflammatory cytokines"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SAPK signaling pathway"^^xsd:string ;
  obo:id "PW:0000312"^^xsd:string ;
  rdfs:label "stress-regulated MAPK signaling pathway"^^xsd:string ;
  skos:notation "PW:0000312"^^xsd:string .

ns1:PW_0000313
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000312 ;
  ns2:treeView ns1:PW_0000312 ;
  ns1:IAO_0000115 "A stress induced MAPK pathway that regulates an array of processes such as gene expression, cell migration, cytoskeletal organization, apoptosis."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "JNK signaling pathway"^^xsd:string ;
  obo:id "PW:0000313"^^xsd:string ;
  rdfs:label "c-Jun N-terminal kinases MAPK signaling pathway"^^xsd:string ;
  skos:notation "PW:0000313"^^xsd:string .

ns1:PW_0000314
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001140 ;
  ns2:treeView ns1:PW_0001140 ;
  ns1:IAO_0000115 "Those signaling pathways that are mediated through the binding of calmodulin - a multifunctional calcium transducer - to its target effectors."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Ca/CaM dependent signaling pathways"^^xsd:string ;
  obo:id "PW:0000314"^^xsd:string ;
  rdfs:label "calcium/calmodulin dependent signaling pathway"^^xsd:string ;
  skos:notation "PW:0000314"^^xsd:string .

ns1:PW_0000315
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000314, ns1:PW_0000653 ;
  ns2:treeView ns1:PW_0000314, ns1:PW_0000653 ;
  ns1:IAO_0000115 "Calcineurin - a calcium/calmodulin dependent serine/threonine phosphatase - plays important regulatory roles in cardiac muscle growth and differentiation, memory processes and apoptosis."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000315"^^xsd:string ;
  rdfs:label "calcineurin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000315"^^xsd:string .

ns1:PW_0000316
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000314, ns1:PW_0001194 ;
  ns2:treeView ns1:PW_0000314, ns1:PW_0001194 ;
  ns1:IAO_0000115 "The multifunctional calcium/calmodulin dependent serine/threonine kinases (CAMKs) play important regulatory roles in the cardiac, muscle, nervous and immune tissues. They are represented by CAMK2 whose Ca2+/CaM binding leads to autophosphorylation and activation and the CAMK cascades that depend on an upstream CAMK kinase (CAMKK) for phosphorylation of an 'activation loop' and subsequent activation. CAMK1 and CAMK4 are the two CAMK signaling cascades."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "CaMK signaling pathway"^^xsd:string ;
  obo:id "PW:0000316"^^xsd:string ;
  rdfs:label "calcium/calmodulin dependent kinase signaling pathway"^^xsd:string ;
  skos:notation "PW:0000316"^^xsd:string .

ns1:PW_0000317
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000716, ns1:PW_0001313 ;
  ns2:treeView ns1:PW_0000716, ns1:PW_0001313 ;
  ns1:IAO_0000115 "Members of the NFAT family of transcription factors, once de-phosphorylated by calcineurin translocate from the cytoplasm to the nucleus where they induce the transcription of genes involved in the immune response, cell-cell interactions. NFAT signaling is believed to play important roles in the development and function of the cardiovascular system."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "NFAT signaling pathway"^^xsd:string ;
  obo:id "PW:0000317"^^xsd:string ;
  rdfs:label "nuclear factor of activated T-cells signaling pathway"^^xsd:string ;
  skos:notation "PW:0000317"^^xsd:string .

ns1:PW_0000318
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000314, ns1:PW_0001169 ;
  ns2:treeView ns1:PW_0000314, ns1:PW_0001169 ;
  ns1:IAO_0000115 "Those calcium/CaM dependent pathways that deviate from what their normal course should be. Aberrant calcium/CaM dependent pathways, alone or in combination with other pathways underlie many diseases. One example is the potential role disruptions within these pathways play in cardiac hypertrophy."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered Ca/CaM dependent pathway"^^xsd:string ;
  obo:id "PW:0000318"^^xsd:string ;
  rdfs:label "altered calcium/calmodulin dependent signaling pathway"^^xsd:string ;
  skos:notation "PW:0000318"^^xsd:string .

ns1:PW_0000319
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000315, ns1:PW_0000318, ns1:PW_0001197 ;
  ns2:treeView ns1:PW_0000315, ns1:PW_0000318, ns1:PW_0001197 ;
  ns1:IAO_0000115 "A calcineurin signaling pathway that deviates from what its normal course should be. Aberrant calcineurin pathway, alone or in combination with other pathways underlie various diseases. One example is the role a constitutively active calcineurin plays in cardiac hypertrophy, via the NFAT pathway."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000319"^^xsd:string ;
  rdfs:label "altered calcineurin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000319"^^xsd:string .

ns1:PW_0000320
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000147 ;
  ns2:treeView ns1:PW_0000147 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of novobiocin, an aminocoumarin antibiotic. It is also known as albamycin or cathomycin and is produced by an actinomycete of the order Actinobacteria."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000320"^^xsd:string ;
  rdfs:label "novobiocin biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000320"^^xsd:string .

ns1:PW_0000321
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000122, ns1:PW_0000673 ;
  ns2:treeView ns1:PW_0000122, ns1:PW_0000673 ;
  ns1:IAO_0000115 "A Hedgehog signaling pathway that deviates from what its normal course should be. Aberrant Hedgehog signaling pathway has been involved in a number of human cancers."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000321"^^xsd:string ;
  rdfs:label "altered Hedgehog signaling pathway"^^xsd:string ;
  skos:notation "PW:0000321"^^xsd:string .

ns1:PW_0000322
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000332 ;
  ns2:treeView ns1:PW_0000332 ;
  ns1:IAO_0000115 "Ephrins and their receptors constitute a bidirectional signaling pathway transducing forward signals through the receptors and reverse signals through the ephrins that influence the behavior of both interacting cells. The Eph/ephrin axis plays important roles in cell morphology, adhesion and migration. Its disruption has been implicated in several human cancers."^^xsd:string ;
  obo:hasExactSynonym "eph/ephrin receptor bidirectional signaling axis"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200052"^^xsd:string, "PID:200059"^^xsd:string, "PID:200142"^^xsd:string, "PID:200204"^^xsd:string, "PID:200216"^^xsd:string ;
  obo:id "PW:0000322"^^xsd:string ;
  rdfs:label "ephrin - ephrin receptor bidirectional signaling axis"^^xsd:string ;
  skos:notation "PW:0000322"^^xsd:string .

ns1:PW_0000323
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000322, ns1:PW_0000336 ;
  ns2:treeView ns1:PW_0000322, ns1:PW_0000336 ;
  ns1:IAO_0000115 "An Eph/ephrin bidirectional axis that deviates from what its normal course should be. Aberrant Eph/ephrins axis has been implicated in a number of human cancers."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000323"^^xsd:string ;
  rdfs:label "altered ephrin - ephrin receptor bidirectional signaling pathway"^^xsd:string ;
  skos:notation "PW:0000323"^^xsd:string .

ns1:PW_0000324
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000204, ns1:PW_0000336, ns1:PW_0000669, ns1:PW_0000673 ;
  ns2:treeView ns1:PW_0000204, ns1:PW_0000336, ns1:PW_0000669, ns1:PW_0000673 ;
  ns1:IAO_0000115 "A Notch signaling pathway that deviates from what its normal course should be. Aberrant Notch signaling pathway has been implicated in a number of human cancers."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000324"^^xsd:string ;
  rdfs:label "altered Notch signaling pathway"^^xsd:string ;
  skos:notation "PW:0000324"^^xsd:string .

ns1:PW_0000325
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000181 ;
  ns2:treeView ns1:PW_0000181 ;
  ns1:IAO_0000115 "Those pathways involved in the degradation of proteins."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000325"^^xsd:string ;
  rdfs:label "protein degradation pathway"^^xsd:string ;
  skos:notation "PW:0000325"^^xsd:string .

ns1:PW_0000326
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000293, ns1:PW_0000325 ;
  ns2:treeView ns1:PW_0000293, ns1:PW_0000325 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000326"^^xsd:string ;
  rdfs:label "altered protein degradation pathway"^^xsd:string ;
  skos:notation "PW:0000326"^^xsd:string .

ns1:PW_0000327
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000269 ;
  ns2:treeView ns1:PW_0000269 ;
  ns1:IAO_0000115 "The pathways involved in the formation, reduction and isomerization of disulphide bonds in proteins. Disulphide bonds are essential for the stability of proteins that are secreted or are localized to organelles of the secretory pathway."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000327"^^xsd:string ;
  rdfs:label "protein disulphide bond formation pathway"^^xsd:string ;
  skos:notation "PW:0000327"^^xsd:string .

ns1:PW_0000328
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000168 ;
  ns2:treeView ns1:PW_0000168 ;
  ns1:IAO_0000115 "The family of fibroblast growth factors (FGF) comprises 22 ligands classified into seven phylogenetic subfamilies and three groups by mode of action: the intracellular intracrine and the extracellular paracrine or canonical and endocrine or hormone-like groups. The paracrine subfamilies signal via the fibroblast growth factor receptors (FGFR), receptor tyrosine kinases (RTK). The endocrine subfamily is FGFR-dependent but the affinity towards the receptors is low and it relies on the Klotho family of transmembrane proteins. The intracrine subfamily is FGFR-independent. Overall, the pathway plays important roles during embryonic and postnatal development, neuromodulation, mineral metabolism and homeostasis. Deregulation of the pathway has been associated with neoplastic and metabolic diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "FGF signaling pathway"^^xsd:string, "PID:200220"^^xsd:string ;
  obo:id "PW:0000328"^^xsd:string ;
  rdfs:label "fibroblast growth factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0000328"^^xsd:string .

ns1:PW_0000329
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000168 ;
  ns2:treeView ns1:PW_0000168 ;
  ns1:IAO_0000115 "The TGF-beta superfamily of growth factors regulates a broad spectrum of processes such as angiogenesis, embryonic development, cell differentiation, proliferation, wound healing. Binding to two types of serine/threonine receptors and activation of Smad proteins is a common theme. However, ligand-receptor interaction and the identity of the activated Smad protein(s) appear to be member specific."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04350"^^xsd:string, "TGF-beta superfamily mediated signaling pathway"^^xsd:string ;
  obo:id "PW:0000329"^^xsd:string ;
  rdfs:label "transforming growth factor-beta superfamily mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000329"^^xsd:string .

ns1:PW_0000330
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000329, ns1:PW_0000650 ;
  ns2:treeView ns1:PW_0000329, ns1:PW_0000650 ;
  ns1:IAO_0000115 "The bone morphogenetic proteins (BMP) are related to TGF-beta and activins and are members of the TGF-beta superfamily. The BMP signaling pathway plays important roles in induction and patterning of the mesoderm. BMP pathway cross-talks to other pathways such as TGF-beta, Wnt, MAPK, Notch, JAK-STAT and others."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "BMP signaling pathway"^^xsd:string, "PID:200144"^^xsd:string ;
  obo:id "PW:0000330"^^xsd:string ;
  rdfs:label "Bone morphogenetic proteins signaling pathway"^^xsd:string ;
  skos:notation "PW:0000330"^^xsd:string .

ns1:PW_0000331
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000329, ns1:PW_0000650 ;
  ns2:treeView ns1:PW_0000329, ns1:PW_0000650 ;
  ns1:IAO_0000115 "Activins are members of the TGF-beta superfamily of growth factors. The pathway plays important roles in embryonic development, inflammation, reproductive biology. Deregulation of activin signaling contributes to a number of pathological conditions."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200029"^^xsd:string ;
  obo:id "PW:0000331"^^xsd:string ;
  rdfs:label "activin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000331"^^xsd:string .

ns1:PW_0000332
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000648 ;
  ns2:treeView ns1:PW_0000648 ;
  ns1:IAO_0000115 "Cell-cell signaling pathway conveys information between cells using cell adhesion molecules."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000332"^^xsd:string ;
  rdfs:label "cell-cell signaling pathway"^^xsd:string ;
  skos:notation "PW:0000332"^^xsd:string .

ns1:PW_0000333
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000332 ;
  ns2:treeView ns1:PW_0000332 ;
  ns1:IAO_0000115 "Cadherins represent a large protein superfamily with many and important roles in cell adhesion and signaling. Cadherins are characterized by the presence of the extracellular cadherin, calcium-binding repeat. The number and structural similarities of repeats across families vary."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000333"^^xsd:string ;
  rdfs:label "cadherin mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000333"^^xsd:string .

ns1:PW_0000334
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000332 ;
  ns2:treeView ns1:PW_0000332 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000334"^^xsd:string ;
  rdfs:label "connexin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000334"^^xsd:string .

ns1:PW_0000335
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000298, ns1:PW_0000329 ;
  ns2:treeView ns1:PW_0000298, ns1:PW_0000329 ;
  ns1:IAO_0000115 "Those TGF-beta superfamily mediated signaling pathways that deviate from what their normal course should be. Alone or in combination with other pathways they underlie many conditions such as pulmonary hypertension and various types of cancer."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered TGF-beta superfamily mediated signaling pathway"^^xsd:string ;
  obo:id "PW:0000335"^^xsd:string ;
  rdfs:label "altered transforming growth factor-beta superfamily mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000335"^^xsd:string .

ns1:PW_0000336
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000332, ns1:PW_0000671 ;
  ns2:treeView ns1:PW_0000332, ns1:PW_0000671 ;
  ns1:IAO_0000115 "Those cell-cell signaling pathways that deviate from what their normal course should be."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000336"^^xsd:string ;
  rdfs:label "altered cell-cell signaling pathway"^^xsd:string ;
  skos:notation "PW:0000336"^^xsd:string .

ns1:PW_0000337
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000332 ;
  ns2:treeView ns1:PW_0000332 ;
  ns1:IAO_0000115 "Selectins represent a small family of lectin-like adhesion receptors that mediate cell-cell interactions via calcium-dependent recognition of sialylated glycans. The exact role of this signaling pathway is not well known."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000337"^^xsd:string ;
  rdfs:label "selectin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000337"^^xsd:string .

ns1:PW_0000338
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000333 ;
  ns2:treeView ns1:PW_0000333 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000338"^^xsd:string ;
  rdfs:label "altered cadherins mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000338"^^xsd:string .

ns1:PW_0000339
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000334 ;
  ns2:treeView ns1:PW_0000334 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000339"^^xsd:string ;
  rdfs:label "altered connexins mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000339"^^xsd:string .

ns1:PW_0000340
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000324 ;
  ns2:treeView ns1:PW_0000324 ;
  ns1:IAO_0000115 "An altered Notch signaling pathway due to mutation(s) in the main players. They include receptor(s), ligand(s), and members of the CSL complex."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000340"^^xsd:string ;
  rdfs:label "altered Notch signaling pathway involving the main players"^^xsd:string ;
  skos:notation "PW:0000340"^^xsd:string .

ns1:PW_0000341
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000324 ;
  ns2:treeView ns1:PW_0000324 ;
  ns1:IAO_0000115 "An altered Notch signaling pathway due to mutation(s) in the enzymes, macromolecules that act upon the main players. They include proteases, elements of the proteo- and glucosaminoglycan metabolic pathways, ubiquitin ligases, other proteins that modulate availability, sensitivity, endocytosis of ligands/receptors."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000341"^^xsd:string ;
  rdfs:label "altered Notch signaling pathway involving the macromolecules modifying the main players"^^xsd:string ;
  skos:notation "PW:0000341"^^xsd:string .

ns1:PW_0000342
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000324 ;
  ns2:treeView ns1:PW_0000324 ;
  ns1:IAO_0000115 "An altered Notch signaling pathway due to mutation(s) in the target gene(s). They may include members of the HES and HERP families of basic helix-loop-helix (bHLH) transcriptional repressors."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000342"^^xsd:string ;
  rdfs:label "altered Notch signaling pathway involving target gene(s)"^^xsd:string ;
  skos:notation "PW:0000342"^^xsd:string .

ns1:PW_0000343
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000324 ;
  ns2:treeView ns1:PW_0000324 ;
  ns1:IAO_0000115 "An altered Notch signaling pathway due to mutation(s) in the promoters of target gene(s)."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000343"^^xsd:string ;
  rdfs:label "altered Notch signaling pathway involving promoters"^^xsd:string ;
  skos:notation "PW:0000343"^^xsd:string .

ns1:PW_0000344
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000020, ns1:PW_0001412 ;
  ns2:treeView ns1:PW_0000020, ns1:PW_0001412 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000344"^^xsd:string ;
  rdfs:label "cerebrovascular disease pathway"^^xsd:string ;
  skos:notation "PW:0000344"^^xsd:string .

ns1:PW_0000345
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000344 ;
  ns2:treeView ns1:PW_0000344 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000345"^^xsd:string ;
  rdfs:label "cerebral arterial diseases pathway"^^xsd:string ;
  skos:notation "PW:0000345"^^xsd:string .

ns1:PW_0000346
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000345 ;
  ns2:treeView ns1:PW_0000345 ;
  ns1:IAO_0000115 "CADASIL - cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy - a disease of the small cerebral arteries characterized by subcortical stroke and vascular dementia. It is associated with mutations in the Notch3 gene. More than fifty mutations are clustered within the first EGF repeats and involve the gain or loss of a cysteine."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000346"^^xsd:string ;
  rdfs:label "CADASIL pathway"^^xsd:string ;
  skos:notation "PW:0000346"^^xsd:string .

ns1:PW_0000347
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000020 ;
  ns2:treeView ns1:PW_0000020 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000347"^^xsd:string ;
  rdfs:label "cardiovascular abnormalities pathway"^^xsd:string ;
  skos:notation "PW:0000347"^^xsd:string .

ns1:PW_0000348
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000347 ;
  ns2:treeView ns1:PW_0000347 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000348"^^xsd:string ;
  rdfs:label "congenital heart defects pathway"^^xsd:string ;
  skos:notation "PW:0000348"^^xsd:string .

ns1:PW_0000349
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000348 ;
  ns2:treeView ns1:PW_0000348 ;
  ns1:IAO_0000115 "Alagille syndrome is a developmental disease characterized by defects in heart, as well as liver, skeleton and eye. Abnormalities of the central nervous system are also found. The disease is associated with mutations across the entire Jag1 gene."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000349"^^xsd:string ;
  rdfs:label "Alagille syndrome pathway"^^xsd:string ;
  skos:notation "PW:0000349"^^xsd:string .

ns1:PW_0000350
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000243, ns1:PW_0000298, ns1:PW_0001538 ;
  ns2:treeView ns1:PW_0000243, ns1:PW_0000298, ns1:PW_0001538 ;
  ns1:IAO_0000115 "A VEGF mediated pathway that deviates from what its normal course should be. Aberrant VEGF mediated pathways have been implicated in a number of human cancers. Upregulation of VEGF expression is associated with cancer and tumor growth."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered VEGF signaling pathways"^^xsd:string ;
  obo:id "PW:0000350"^^xsd:string ;
  rdfs:label "altered vascular endothelial growth factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0000350"^^xsd:string .

ns1:PW_0000351
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000350 ;
  ns2:treeView ns1:PW_0000350 ;
  ns1:IAO_0000115 "An altered VEGF signaling pathway due to mutation(s) in the main players. They include the various VEGF molecules and VEGF receptors."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered VEGF signaling pathway involving the main players"^^xsd:string ;
  obo:id "PW:0000351"^^xsd:string ;
  rdfs:label "altered vascular endothelial growth factor signaling pathway involving the main players"^^xsd:string ;
  skos:notation "PW:0000351"^^xsd:string .

ns1:PW_0000352
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000350 ;
  ns2:treeView ns1:PW_0000350 ;
  ns1:IAO_0000115 "An altered VEGF signaling pathway due to mutation(s) in the enzymes that process VEGF, such as the plasmin and furin-like proteases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered VEGF signaling pathway involving the macromolecules modifying the main players"^^xsd:string ;
  obo:id "PW:0000352"^^xsd:string ;
  rdfs:label "altered vascular endothelial growth factor signaling pathway involving the macromolecules modifying the main players"^^xsd:string ;
  skos:notation "PW:0000352"^^xsd:string .

ns1:PW_0000353
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000350 ;
  ns2:treeView ns1:PW_0000350 ;
  ns1:IAO_0000115 "An altered VEGF signaling pathway due to mutation(s), any activity change in the proteins that regulate VEGF expression. They include transcription factors such as the hypoxia-inducible factor and the many proteins impacting on the stability and/or activity of these factors."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered VEGF signaling pathway involving proteins affecting its expression"^^xsd:string ;
  obo:id "PW:0000353"^^xsd:string ;
  rdfs:label "altered vascular endothelial growth factor signaling pathway involving proteins affecting its expression"^^xsd:string ;
  skos:notation "PW:0000353"^^xsd:string .

ns1:PW_0000354
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000010 ;
  ns2:treeView ns1:PW_0000010 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of glycerophospholipids, also known as phospholipids. They are key components of membranes and some are also involved in signaling."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00564"^^xsd:string, "SMP:00025"^^xsd:string, "phospholipid metabolic pathway"^^xsd:string ;
  obo:id "PW:0000354"^^xsd:string ;
  rdfs:label "glycerophospholipid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000354"^^xsd:string .

ns1:PW_0000355
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000004 ;
  ns2:treeView ns1:PW_0000004 ;
  ns1:IAO_0000115 "Those pathways involved in the maintenance of the internal environment of an organism, the adequate levels of substances and nutrients, the stability of normal body states and the feedback regulatory mechanisms that control them."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000355"^^xsd:string ;
  rdfs:label "homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0000355"^^xsd:string .

ns1:PW_0000356
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001692 ;
  ns2:treeView ns1:PW_0001692 ;
  ns1:IAO_0000115 "The pathways involved in responding to changes in and maintenance of adequate oxygen levels."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000356"^^xsd:string ;
  rdfs:label "oxygen homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0000356"^^xsd:string .

ns1:PW_0000357
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000355 ;
  ns2:treeView ns1:PW_0000355 ;
  ns1:IAO_0000115 "Those pathways involved in the balance between energy uptake and energy expenditure. Disturbance of this equilibrium has been linked to various conditions including obesity."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000357"^^xsd:string ;
  rdfs:label "energy homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0000357"^^xsd:string .

ns1:PW_0000358
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000263, ns1:PW_0000355 ;
  ns2:treeView ns1:PW_0000263, ns1:PW_0000355 ;
  ns1:IAO_0000115 "Those homeostatic pathways that deviate from what their normal course should be. Aberrant homeostatic pathways, alone or in combination with other pathways, underlie many conditions, disorders and/or diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000358"^^xsd:string ;
  rdfs:label "altered homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0000358"^^xsd:string .

ns1:PW_0000359
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000357, ns1:PW_0000358 ;
  ns2:treeView ns1:PW_0000357, ns1:PW_0000358 ;
  ns1:IAO_0000115 "Those pathways of energy homeostasis that deviate from what their normal course should be. Obesity in particular has been associated with disturbances in the control of energy balance."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000359"^^xsd:string ;
  rdfs:label "altered energy homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0000359"^^xsd:string .

ns1:PW_0000360
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000716, ns1:PW_0001313, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000356
  ] ;
  ns2:treeView ns1:PW_0000356, ns1:PW_0000716, ns1:PW_0001313 ;
  ns3:part_of ns1:PW_0000356 ;
  ns1:IAO_0000115 "The hypoxia inducible transcription factor is activated in response to hypoxic conditions to promote the expression of many genes that play important roles in glucose and energy metabolism, angiogenesis and erythropoiesis."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "HIF pathway"^^xsd:string, "PID:200036"^^xsd:string, "PID:200202"^^xsd:string ;
  obo:id "PW:0000360"^^xsd:string ;
  rdfs:label "hypoxia inducible factor pathway"^^xsd:string ;
  skos:notation "PW:0000360"^^xsd:string .

ns1:PW_0000361
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000356, ns1:PW_0001833 ;
  ns2:treeView ns1:PW_0000356, ns1:PW_0001833 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000361"^^xsd:string ;
  rdfs:label "altered oxygen homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0000361"^^xsd:string .

ns1:PW_0000362
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000356
  ] ;
  ns2:treeView ns1:PW_0000356 ;
  ns3:part_of ns1:PW_0000356 ;
  ns1:IAO_0000115 "The acute hypoxic response is mediated through the activity of excitable cells via oxygen-sensing ion channels."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000362"^^xsd:string ;
  rdfs:label "the ion channels pathway"^^xsd:string ;
  skos:notation "PW:0000362"^^xsd:string .

ns1:PW_0000363
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000357
  ] ;
  ns2:treeView ns1:PW_0000357, ns1:PW_0000467 ;
  ns3:part_of ns1:PW_0000357 ;
  ns1:IAO_0000115 "Leptin acts on two populations of hypothalamic neurons that express orexigenic (feeding inducing) and anorexigenic genes, respectively. Leptin reduces the expression of genes from the former and enhances the expression of genes from the latter neurons. Leptin mediated response acts primarily via Jak-dependent activation of STAT."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000363"^^xsd:string ;
  rdfs:label "leptin system pathway"^^xsd:string ;
  skos:notation "PW:0000363"^^xsd:string .

ns1:PW_0000364
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000359, ns1:PW_0000363, ns1:PW_0000511 ;
  ns2:treeView ns1:PW_0000359, ns1:PW_0000363, ns1:PW_0000511 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000364"^^xsd:string ;
  rdfs:label "altered leptin system pathway"^^xsd:string ;
  skos:notation "PW:0000364"^^xsd:string .

ns1:PW_0000365
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000357
  ] ;
  ns2:treeView ns1:PW_0000357, ns1:PW_0000467 ;
  ns3:part_of ns1:PW_0000357 ;
  ns1:IAO_0000115 "The melanocortin dependent system is involved in a diverse number of pathways such as pigmentation, steroidogenesis, sexual function, energy homeostasis. Its implication in energy homeostasis is of particular interest as alterations of this system have been associated with obesity."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00310"^^xsd:string ;
  obo:id "PW:0000365"^^xsd:string ;
  rdfs:label "melanocortin system pathway"^^xsd:string ;
  skos:notation "PW:0000365"^^xsd:string .

ns1:PW_0000366
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000359, ns1:PW_0000365, ns1:PW_0000511 ;
  ns2:treeView ns1:PW_0000359, ns1:PW_0000365, ns1:PW_0000511 ;
  ns1:IAO_0000115 "A melanocortin dependent system pathway that deviates from what its normal course should be. Mutations in the prohormone gene PMOC and the modifying enzyme PC1 are linked to obesity. Mutations in MC2R receptor and its accessory protein MRAP have been associated with type 1 and 2 familial glucocorticoid deficiency, respectively."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000366"^^xsd:string ;
  rdfs:label "altered melanocortin system pathway"^^xsd:string ;
  skos:notation "PW:0000366"^^xsd:string .

ns1:PW_0000367
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000209, ns1:PW_0001537, ns1:PW_0001543 ;
  ns2:treeView ns1:PW_0000209, ns1:PW_0001537, ns1:PW_0001543 ;
  ns1:IAO_0000115 "Jak-Stat signaling pathways that deviate from what their normal course should be."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000367"^^xsd:string ;
  rdfs:label "altered Jak-Stat signaling pathway"^^xsd:string ;
  skos:notation "PW:0000367"^^xsd:string .

ns1:PW_0000368
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001195 ;
  ns2:treeView ns1:PW_0001195 ;
  ns1:IAO_0000115 "Those pathways dependent on activation by JAK kinases but independent of Stat proteins."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000368"^^xsd:string ;
  rdfs:label "Non-Stat, Jak dependent pathway"^^xsd:string ;
  skos:notation "PW:0000368"^^xsd:string .

ns1:PW_0000369
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000124, ns1:PW_0000378, ns1:PW_0000716, ns1:PW_0001229, ns1:PW_0001313 ;
  ns2:treeView ns1:PW_0000124, ns1:PW_0000378, ns1:PW_0000716, ns1:PW_0001229, ns1:PW_0001313 ;
  ns1:IAO_0000115 "Nuclear factor, 2 like 2 (Nfe2l2, also known as Nrf2) signaling pathway is one of the most important regulator of antioxidant and/or electrophilic stress responses. Upon activation, Nfe2l2 induces the expression of antioxidant, xenobiotic metabolism, and cytoprotective genes, among others. Deregulation of the pathway has been associated with various conditions, including neurodegeneration and cancer."^^xsd:string ;
  obo:hasExactSynonym "Nrf2 signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Nfe2l2 signaling pathway"^^xsd:string ;
  obo:id "PW:0000369"^^xsd:string ;
  rdfs:label "nuclear factor, erythroid 2 like 2 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000369"^^xsd:string .

ns1:PW_0000370
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000124, ns1:PW_0001229, ns1:PW_0001371 ;
  ns2:treeView ns1:PW_0000124, ns1:PW_0001229, ns1:PW_0001371 ;
  ns1:IAO_0000115 "The aryl hydrocarbon receptor (AhR) is a transcription factor whose ligands include a variety of aromatic hydrocarbons and which regulates the expression of phase I and phase II drug- and xenobiotic-metabolizing enzymes. Phase I enzymes convert otherwise inactive hydrocarbons into active metabolites with potential carcinogenic effects, thus rendering AhR a player in tumor initiation."^^xsd:string ;
  obo:hasExactSynonym "AhR signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000370"^^xsd:string ;
  rdfs:label "aryl hydrocarbon receptor signaling pathway"^^xsd:string ;
  skos:notation "PW:0000370"^^xsd:string .

ns1:PW_0000371
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000589 ;
  ns2:treeView ns1:PW_0000589 ;
  ns1:IAO_0000115 "The maintenance of adequate intracellular calcium levels are crucial in order to assure the availability of this important ion and, at the same time prevent against the damage its high concentration can cause. Pumps and exchangers move the calcium ions into organelles or outside the cell, channels of many types allow for its transient flow inside the cell. Calcium transport, which maintains and controls the calcium gradient, and calcium signaling, which the gradient promotes, are inextricably connected in the fabric of calcium homeostasis."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000371"^^xsd:string ;
  rdfs:label "calcium homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0000371"^^xsd:string .

ns1:PW_0000372
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000358, ns1:PW_0000371, ns1:PW_0001832 ;
  ns2:treeView ns1:PW_0000358, ns1:PW_0000371, ns1:PW_0001832 ;
  ns1:IAO_0000115 "Dysfunction of calcium homeostasis has been implicated in several human neural, neurodegenerative and cardiac conditions."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000372"^^xsd:string ;
  rdfs:label "altered calcium homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0000372"^^xsd:string .

ns1:PW_0000373
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000378, ns1:PW_0000858 ;
  ns2:treeView ns1:PW_0000378, ns1:PW_0000858 ;
  ns1:IAO_0000115 "The glutathione conjugation of endogenous and exogenous electrophilic compounds represents a major pathway phase II biotransformation. The glutathione conjugates may either be excreted or undergo further processing."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "phase II biotransformation"^^xsd:string ;
  obo:id "PW:0000373"^^xsd:string ;
  rdfs:label "glutathione conjugation pathway"^^xsd:string ;
  skos:notation "PW:0000373"^^xsd:string .

ns1:PW_0000374
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000373 ;
  ns2:treeView ns1:PW_0000373 ;
  ns1:IAO_0000115 "Pathways of glutathione conjugates processing other than the mercapturic acid pathway."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000374"^^xsd:string ;
  rdfs:label "alternate pathways of glutathione conjugates processing"^^xsd:string ;
  skos:notation "PW:0000374"^^xsd:string .

ns1:PW_0000375
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000857 ;
  ns2:treeView ns1:PW_0000857 ;
  ns1:IAO_0000115 "The major phase I biotransformation pathway for the activation of endogenous and exogenous substances carried out by members of the cytochrome P450 superfamily."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00980"^^xsd:string, "KEGG:00982"^^xsd:string ;
  obo:id "PW:0000375"^^xsd:string ;
  rdfs:label "phase I biotransformation pathway via cytochrome P450"^^xsd:string ;
  skos:notation "PW:0000375"^^xsd:string .

ns1:PW_0000376
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000857 ;
  ns2:treeView ns1:PW_0000857 ;
  ns1:IAO_0000115 "A minor phase I biotransformation pathway for the activation of endogenous and exogenous substances carried by flavin-containing monooxygenases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000376"^^xsd:string ;
  rdfs:label "cytochrome P450-independent phase I biotransformation pathway"^^xsd:string ;
  skos:notation "PW:0000376"^^xsd:string .

ns1:PW_0000377
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000373 ;
  ns2:treeView ns1:PW_0000373 ;
  ns1:IAO_0000115 "The mercapturic acid pathway of glutathione conjugates processing involves the sequential cleavage of glutamyl and glycine residues of glutathione followed by cysteine N-acetylation."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000377"^^xsd:string ;
  rdfs:label "glutathione conjugates processing - the mercapturic acid pathway"^^xsd:string ;
  skos:notation "PW:0000377"^^xsd:string .

ns1:PW_0000378
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000237 ;
  ns2:treeView ns1:PW_0000237 ;
  ns1:IAO_0000115 "Oxidative stress occurs when the redox balance between pro- and anti-oxidants is upset due to an increase in endogenous or exogenous pro-oxidant stimuli. The response triggers the upregulation of antioxidant and detoxification systems. Oxidants can also act as second messengers to trigger a variety of cellular signaling pathways."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000378"^^xsd:string ;
  rdfs:label "oxidative stress response pathway"^^xsd:string ;
  skos:notation "PW:0000378"^^xsd:string .

ns1:PW_0000379
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000237 ;
  ns2:treeView ns1:PW_0000237 ;
  ns1:IAO_0000115 "Inhibition of protein folding or its disruption by mutant proteins in the endoplasmic reticulum triggers a signal transduction response known as the unfolded protein response (UPR). UPR increases the biosynthetic capacity while decreasing the biosynthetic burden of the secretory pathway through up- and downregulation of gene expression."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "ER stress - UPR pathway"^^xsd:string ;
  obo:id "PW:0000379"^^xsd:string ;
  rdfs:label "endoplasmic reticulum stress  - the unfolded protein response pathway"^^xsd:string ;
  skos:notation "PW:0000379"^^xsd:string .

ns1:PW_0000380
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000103, ns1:PW_0000124, ns1:PW_0000378, ns1:PW_0001229 ;
  ns2:treeView ns1:PW_0000103, ns1:PW_0000124, ns1:PW_0000378, ns1:PW_0001229 ;
  ns1:IAO_0000115 "Drugs, endogenous and/or exogenous compounds processed through the phase I and II of  bioactivation, biotransformation pathways are eliminated via phase III transport pathway carried out by several transporter families."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000380"^^xsd:string ;
  rdfs:label "transport pathway for the elimination of drugs, endogenous or exogenous compounds and metabolites"^^xsd:string ;
  skos:notation "PW:0000380"^^xsd:string .

ns1:PW_0000381
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000380 ;
  ns2:treeView ns1:PW_0000380 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "MRP mediated pathway"^^xsd:string ;
  obo:id "PW:0000381"^^xsd:string ;
  rdfs:label "multidrug resistance-associated protein mediated transport pathway"^^xsd:string ;
  skos:notation "PW:0000381"^^xsd:string .

ns1:PW_0000382
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000380 ;
  ns2:treeView ns1:PW_0000380 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "MDR mediated pathway"^^xsd:string ;
  obo:id "PW:0000382"^^xsd:string ;
  rdfs:label "multidrug resistance protein mediated transport pathway"^^xsd:string ;
  skos:notation "PW:0000382"^^xsd:string .

ns1:PW_0000383
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000380 ;
  ns2:treeView ns1:PW_0000380 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "OAT mediated pathway"^^xsd:string ;
  obo:id "PW:0000383"^^xsd:string ;
  rdfs:label "multispecific organic anion transporter mediated transport pathway"^^xsd:string ;
  skos:notation "PW:0000383"^^xsd:string .

ns1:PW_0000384
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000096 ;
  ns2:treeView ns1:PW_0000096 ;
  ns1:IAO_0000115 "The G2M checkpoint pathways assure the genome is replicated only once per cell cycle. The checkpoints control for damaged and un-replicated DNA. Various DNA damage checkpoints lead to inhibition of the cyclin- dependent kinases that regulate the next cell cycle point."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000384"^^xsd:string ;
  rdfs:label "G2/M DNA damage checkpoint pathway"^^xsd:string ;
  skos:notation "PW:0000384"^^xsd:string .

ns1:PW_0000385
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000096 ;
  ns2:treeView ns1:PW_0000096 ;
  ns1:IAO_0000115 "Those pathways that assure the genome is replicated only once per cell cycle. The checkpoints control for damaged and un-replicated DNA. Un-replicated DNA signals to block the cell cycle from proceeding. The mechanism by which the cell detects un-replicated DNA is not known."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000385"^^xsd:string ;
  rdfs:label "G2/M DNA replication checkpoint pathway"^^xsd:string ;
  skos:notation "PW:0000385"^^xsd:string .

ns1:PW_0000386
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000158 ;
  ns2:treeView ns1:PW_0000158 ;
  ns1:IAO_0000115 "A very close relative of Ras, Rap1 mediated pathway  appears to control diverse processes such as modulation of growth and differentiation, secretion, integrin linked cell adhesion, morphogenesis."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000386"^^xsd:string ;
  rdfs:label "Rap1 mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000386"^^xsd:string .

ns1:PW_0000387
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000006 ;
  ns2:treeView ns1:PW_0000006 ;
  ns1:IAO_0000115 "Arf family mediated signaling pathways are involved in the regulation of intracellular vesicle trafficking. In particular they appear to control early events such as vesicle budding."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200195"^^xsd:string ;
  obo:id "PW:0000387"^^xsd:string ;
  rdfs:label "Arf family mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000387"^^xsd:string .

ns1:PW_0000388
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000059, ns1:PW_0000656 ;
  ns2:treeView ns1:PW_0000059, ns1:PW_0000656 ;
  ns1:IAO_0000115 "The reelin signaling pathway regulates neuronal positioning and may also play a role in synaptic plasticity. The reelin gene appears to be downregulated in schizophrenic brains but the link between the reelin pathway and the disease remains to be established."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200062"^^xsd:string ;
  obo:id "PW:0000388"^^xsd:string ;
  rdfs:label "Reelin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000388"^^xsd:string .

ns1:PW_0000389
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000059, ns1:PW_0000264 ;
  ns2:treeView ns1:PW_0000059, ns1:PW_0000264 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000389"^^xsd:string ;
  rdfs:label "altered signaling pathway pertinent to the brain and nervous system"^^xsd:string ;
  skos:notation "PW:0000389"^^xsd:string .

ns1:PW_0000390
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000388, ns1:PW_0000389, ns1:PW_0000669 ;
  ns2:treeView ns1:PW_0000388, ns1:PW_0000389, ns1:PW_0000669 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000390"^^xsd:string ;
  rdfs:label "altered Reelin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000390"^^xsd:string .

ns1:PW_0000391
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000006, ns1:PW_0001541 ;
  ns2:treeView ns1:PW_0000006, ns1:PW_0001541 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered monomeric G protein mediated signaling pathway"^^xsd:string ;
  obo:id "PW:0000391"^^xsd:string ;
  rdfs:label "altered Ras superfamily mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000391"^^xsd:string .

ns1:PW_0000392
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000525, ns1:PW_0001540 ;
  ns2:treeView ns1:PW_0000525, ns1:PW_0001540 ;
  ns1:IAO_0000115 "A Ras mediated signaling pathway that deviates from what its normal course should be. Aberrant Ras mediated signaling pathways have been implicated in a number of human cancers and deregulation of Ras has been reported even in the absence of mutations."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000392"^^xsd:string ;
  rdfs:label "altered Ras mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000392"^^xsd:string .

ns1:PW_0000393
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000180, ns1:PW_0000290, ns1:PW_0000359 ;
  ns2:treeView ns1:PW_0000180, ns1:PW_0000290, ns1:PW_0000359 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000393"^^xsd:string ;
  rdfs:label "altered mTOR signaling pathway"^^xsd:string ;
  skos:notation "PW:0000393"^^xsd:string .

ns1:PW_0000394
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000274, ns1:PW_0000798, ns1:PW_0001162 ;
  ns2:treeView ns1:PW_0000274, ns1:PW_0000798, ns1:PW_0001162 ;
  ns1:IAO_0000115 "Dopamine signaling plays important roles in processes such as motivation, learning and movement. It also plays several roles in the periphery as a modulator of renal, cardiovascular and the endocrine systems. Dopamine signals to a family of at least 5 receptors that are classified into two subfamilies that couple to distinct G proteins to elicit diverse downstream events. Deregulation of the pathway has been implicated in several neuropsychiatric and neurological disorders."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04728"^^xsd:string, "dopaminergic pathway"^^xsd:string ;
  obo:id "PW:0000394"^^xsd:string ;
  rdfs:label "dopamine signaling pathway"^^xsd:string ;
  skos:notation "PW:0000394"^^xsd:string .

ns1:PW_0000395
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000389, ns1:PW_0000394 ;
  ns2:treeView ns1:PW_0000389, ns1:PW_0000394 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered dopaminergic pathway"^^xsd:string ;
  obo:id "PW:0000395"^^xsd:string ;
  rdfs:label "altered dopamine signaling pathway"^^xsd:string ;
  skos:notation "PW:0000395"^^xsd:string .

ns1:PW_0000396
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000214 ;
  ns2:treeView ns1:PW_0000214 ;
  ns1:IAO_0000115 "Polyamine metabolism plays important roles in a number of cellular processes. Spermidine and spermine are formed in two consecutive reactions carried out by distinct enzymes that employ the decarboxylated form of AdoMet as an aminopropyl donor."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00445"^^xsd:string ;
  obo:id "PW:0000396"^^xsd:string ;
  rdfs:label "spermidine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000396"^^xsd:string .

ns1:PW_0000397
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000135 ;
  ns2:treeView ns1:PW_0000135 ;
  ns1:IAO_0000115 "Those metabolic reactions involving cobalamin, known as vitamin B12 - a water-soluble vitamin. Cobalamin which important roles in a number of metabolic pathways. There are several related compounds whose synthesis occurs in bacteria but whose conversion can be carried out in higher organisms."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Vitamin B12 metabolic pathway"^^xsd:string ;
  obo:id "PW:0000397"^^xsd:string ;
  rdfs:label "cobalamin metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000397"^^xsd:string .

ns1:PW_0000398
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000132, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001693
  ] ;
  ns2:treeView ns1:PW_0000132, ns1:PW_0001693 ;
  ns3:part_of ns1:PW_0001693 ;
  ns1:IAO_0000115 "Homocysteine (Hcy) metabolism is at the intersection of two pathways: the remethylation pathway that regenerates methionine and thus the methionine cycle and the transsulfuration pathway that gives rise to cysteine and derivatives. The Hcy pathway also engages choline, folate, vitamin(s) metabolism and links to the metabolism of other amino acids and compounds."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Hcy metabolism"^^xsd:string ;
  obo:id "PW:0000398"^^xsd:string ;
  rdfs:label "homocysteine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000398"^^xsd:string .

ns1:PW_0000399
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000398
  ] ;
  ns2:treeView ns1:PW_0000398 ;
  ns3:part_of ns1:PW_0000398 ;
  ns1:IAO_0000115 "The predominant route of homocysteine remethylation to methionine that requires the 5-methyl tetrahydrofolate 1 carbon donor and as such, engages folate metabolism."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000399"^^xsd:string ;
  rdfs:label "remethylation pathway of homocysteine metabolism - cobalamin dependent"^^xsd:string ;
  skos:notation "PW:0000399"^^xsd:string .

ns1:PW_0000400
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000398
  ] ;
  ns2:treeView ns1:PW_0000398 ;
  ns3:part_of ns1:PW_0000398 ;
  ns1:IAO_0000115 "The transulfuration pathway is one of the two routes of homocysteine metabolism. It allows for the transfer of sulfur from methionine to cysteine. 70% of cysteine is then converted to glutathione and the remainder ends up as either taurine or pyruvate and sulfate."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00455"^^xsd:string ;
  obo:id "PW:0000400"^^xsd:string ;
  rdfs:label "transsulfuration pathway of homocysteine metabolism"^^xsd:string ;
  skos:notation "PW:0000400"^^xsd:string .

ns1:PW_0000401
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000398
  ] ;
  ns2:treeView ns1:PW_0000398 ;
  ns3:part_of ns1:PW_0000398 ;
  ns1:IAO_0000115 "The route of homocysteine remethyation to methionine that mainly occurs in the liver and requires betaine as the methyl donor."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00123"^^xsd:string ;
  obo:id "PW:0000401"^^xsd:string ;
  rdfs:label "remethylation pathway of homocysteine metabolism - cobalamin independent, betaine dependent"^^xsd:string ;
  skos:notation "PW:0000401"^^xsd:string .

ns1:PW_0000402
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000132, ns1:PW_0000262 ;
  ns2:treeView ns1:PW_0000132, ns1:PW_0000262 ;
  ns1:IAO_0000115 "Those metabolic pathways of amino acids other than the common amino acids that deviate from what their normal course should be. Aberrant metabolic pathways of other amino acids, alone or in combination with other pathways, underlie various diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000402"^^xsd:string ;
  rdfs:label "altered metabolic pathway of other amino acids"^^xsd:string ;
  skos:notation "PW:0000402"^^xsd:string .

ns1:PW_0000403
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000011, ns1:PW_0000262 ;
  ns2:treeView ns1:PW_0000011, ns1:PW_0000262 ;
  ns1:IAO_0000115 "Those pathways of amino acid metabolism that deviate from what their normal course should be. Aberrant amino acid metabolic pathways, alone or in combination with other pathways, underlie various diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000403"^^xsd:string ;
  rdfs:label "altered amino acid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000403"^^xsd:string .

ns1:PW_0000404
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000033, ns1:PW_0000132 ;
  ns2:treeView ns1:PW_0000033, ns1:PW_0000132 ;
  ns1:IAO_0000115 "Those metabolic reactions involving creatine. Officially methyl guanidino-acetic acid formed from arginine and glycine and the methyl group of methionine, creatine supplies energy to muscle cells."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000404"^^xsd:string ;
  rdfs:label "creatine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000404"^^xsd:string .

ns1:PW_0000405
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002423 ;
  ns2:treeView ns1:PW_0002423 ;
  ns1:IAO_0000115 "Release of neurotransmitters is mediated through the exocytosis of neurotransmitter-filled synaptic vesicles. Synaptic vesicle trafficking cycle is composed of a number of steps that culminate in calcium-triggered fusion and release."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000405"^^xsd:string ;
  rdfs:label "synaptic vesicle exocytosis - neurotransmitter release pathway"^^xsd:string ;
  skos:notation "PW:0000405"^^xsd:string .

ns1:PW_0000406
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000002 ;
  ns2:treeView ns1:PW_0000002 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000406"^^xsd:string ;
  rdfs:label "metabolic pathway pertinent to the brain"^^xsd:string ;
  skos:notation "PW:0000406"^^xsd:string .

ns1:PW_0000407
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000406 ;
  ns2:treeView ns1:PW_0000406 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000407"^^xsd:string ;
  rdfs:label "neurotransmitter metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000407"^^xsd:string .

ns1:PW_0000408
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000212, ns1:PW_0000436 ;
  ns2:treeView ns1:PW_0000212, ns1:PW_0000436 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of acetylcholine - an ester of choline and acetic acid that acts as a neurotransmitter in both the peripheral nervous system and the central nervous system."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000408"^^xsd:string ;
  rdfs:label "acetylcholine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000408"^^xsd:string .

ns1:PW_0000409
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000443 ;
  ns2:treeView ns1:PW_0000443 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of dopamine that acts as a neurotransmitter and a neurohormone. Dopamine has multiple functions in the brain."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000409"^^xsd:string ;
  rdfs:label "dopamine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000409"^^xsd:string .

ns1:PW_0000410
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000444 ;
  ns2:treeView ns1:PW_0000444 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of serotonin - an amine neurotransmitter that is believed to play important roles in a number of conditions such as depression, bipolar disorder, anxiety."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000410"^^xsd:string ;
  rdfs:label "serotonin metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000410"^^xsd:string .

ns1:PW_0000411
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000444 ;
  ns2:treeView ns1:PW_0000444 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of histamine - a biogenic amine that acts as a neurotransmitter and is also involved in the local immune responses."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000411"^^xsd:string ;
  rdfs:label "histamine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000411"^^xsd:string .

ns1:PW_0000412
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000446 ;
  ns2:treeView ns1:PW_0000446 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of gamma-aminobutyric acid (GABA)."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "GABA metabolism"^^xsd:string ;
  obo:id "PW:0000412"^^xsd:string ;
  rdfs:label "gamma-aminobutyric acid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000412"^^xsd:string .

ns1:PW_0000413
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000221 ;
  ns2:treeView ns1:PW_0000221 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the degradation of heme - an iron-containing compound where the iron is complexed within a porphyrin heterocyclic ring, There are several kinds of hemes depending on the composition of their side chain. Heme serves as a prosthetic group for a number of proteins."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000413"^^xsd:string ;
  rdfs:label "heme degradation pathway"^^xsd:string ;
  skos:notation "PW:0000413"^^xsd:string .

ns1:PW_0000414
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000325 ;
  ns2:treeView ns1:PW_0000325 ;
  ns1:IAO_0000115 "The 'core' 20S proteasome degrades oxidized and/or unfolded proteins in an ATP and ubiquitin independent manner. The association with the 19S regulatory cap yields the 26S proteasome which has substrate selectivity and ATP and ubiquitin-dependent activity."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000414"^^xsd:string ;
  rdfs:label "protein degradation pathway via the 'core' 20S proteasome pathway"^^xsd:string ;
  skos:notation "PW:0000414"^^xsd:string .

ns1:PW_0000415
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000144 ;
  ns2:treeView ns1:PW_0000144 ;
  ns1:IAO_0000115 "A proteasome degradation pathway mediated by cullins. Cullins are components of E3 ligase complexes and substrates for Nedd8 - a ubiquitin-like molecule. Neddylation is thought to modulate the activity of cullins."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000415"^^xsd:string ;
  rdfs:label "proteasome degradation pathway involving cullin-dependent ubiquitin ligases"^^xsd:string ;
  skos:notation "PW:0000415"^^xsd:string .

ns1:PW_0000416
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000433 ;
  ns2:treeView ns1:PW_0000433 ;
  ns1:IAO_0000115 "A pathway of protein modification via conjugation with SUMO (small ubiquitin-related modifier).  SUMOylation does not target proteins to the proteasome, rather it targets proteins to particular cellular compartments."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SUMO modification pathway"^^xsd:string ;
  obo:id "PW:0000416"^^xsd:string ;
  rdfs:label "sumoylation pathway"^^xsd:string ;
  skos:notation "PW:0000416"^^xsd:string .

ns1:PW_0000417
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000325 ;
  ns2:treeView ns1:PW_0000325 ;
  ns1:IAO_0000115 "The pathway for the ATP-dependent non-lysosomal proteolysis catalyzed by the 26S proteasome and for which ubiquitination, the post-translational covalent conjugation of ubiquitin, or ubiquitin-like, to target proteins is a key signal."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000417"^^xsd:string ;
  rdfs:label "ubiquitin, ubiquitin-like/proteasome degradation pathway"^^xsd:string ;
  skos:notation "PW:0000417"^^xsd:string .

ns1:PW_0000418
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000326, ns1:PW_0000417 ;
  ns2:treeView ns1:PW_0000326, ns1:PW_0000417 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000418"^^xsd:string ;
  rdfs:label "altered ubiquitin, ubiquitin-like degradation pathway"^^xsd:string ;
  skos:notation "PW:0000418"^^xsd:string .

ns1:PW_0000419
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000103 ;
  ns2:treeView ns1:PW_0000103 ;
  ns1:IAO_0000115 "The pathways by which water flows into and out of the cell and into and out of sub-cellular compartments for multi-cellular organisms and mediated by members of the aquaporin family of water channels (WCP). The 13 members identified in mammals are grouped into three subfamilies: aquaporins, selective for water; aquaglyceroporins,  permeable to both water and small molecules; superaquaporins, the sub-cellular aquaporins. WCPs belong to the superfamily of major intrinsic proteins (MIPs)."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000419"^^xsd:string ;
  rdfs:label "water transport pathway"^^xsd:string ;
  skos:notation "PW:0000419"^^xsd:string .

ns1:PW_0000420
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000313, ns1:PW_0000422 ;
  ns2:treeView ns1:PW_0000313, ns1:PW_0000422 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered JNK signaling pathway"^^xsd:string ;
  obo:id "PW:0000420"^^xsd:string ;
  rdfs:label "altered c-Jun N-terminal kinase MAPK signaling pathway"^^xsd:string ;
  skos:notation "PW:0000420"^^xsd:string .

ns1:PW_0000421
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000007, ns1:PW_0000264, ns1:PW_0001199 ;
  ns2:treeView ns1:PW_0000007, ns1:PW_0000264, ns1:PW_0001199 ;
  ns1:IAO_0000115 "A mitogen activated protein kinase pathway that deviates from what its normal course should be. Altered MAPK pathways have been linked to a spectrum of conditions."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered MAPK signaling pathway"^^xsd:string ;
  obo:id "PW:0000421"^^xsd:string ;
  rdfs:label "altered mitogen activated protein kinase pathway"^^xsd:string ;
  skos:notation "PW:0000421"^^xsd:string .

ns1:PW_0000422
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000312, ns1:PW_0000421 ;
  ns2:treeView ns1:PW_0000312, ns1:PW_0000421 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered SAPK pathways"^^xsd:string ;
  obo:id "PW:0000422"^^xsd:string ;
  rdfs:label "altered stress-regulated MAPK signaling pathway"^^xsd:string ;
  skos:notation "PW:0000422"^^xsd:string .

ns1:PW_0000423
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000355 ;
  ns2:treeView ns1:PW_0000355 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000423"^^xsd:string ;
  rdfs:label "surfactant homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0000423"^^xsd:string .

ns1:PW_0000424
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000358, ns1:PW_0000423 ;
  ns2:treeView ns1:PW_0000358, ns1:PW_0000423 ;
  ns1:IAO_0000115 "A surfactant homeostatic pathway that deviates from what its normal course should be. Mutations in surfactant proteins and in ABCA3 - a member of the ABC transporters have been implicated in the altered pathway and associated with conditions such as Respiratory Distress Syndrome (RDS) in newborns and lung diseases in infants."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000424"^^xsd:string ;
  rdfs:label "altered surfactant homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0000424"^^xsd:string .

ns1:PW_0000425
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001496, ns1:PW_0001549 ;
  ns2:treeView ns1:PW_0001496, ns1:PW_0001549 ;
  ns1:IAO_0000115 "High glucose-mediated oxidative stress effects on the expression of vascular endothelial growth factor and insulin-like growth factor, triggering of polyol metabolic pathway and activation of protein kinase c (PKC) signaling are thought to play a role in the pathophysiology of diabetic retinopathy."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000425"^^xsd:string ;
  rdfs:label "diabetic retinopathy pathway"^^xsd:string ;
  skos:notation "PW:0000425"^^xsd:string .

ns1:PW_0000426
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000181, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000280
  ] ;
  ns2:treeView ns1:PW_0000181, ns1:PW_0000280 ;
  ns3:part_of ns1:PW_0000280 ;
  ns1:IAO_0000115 "In the secretory pathway, protein sorting, mainly in trans-Golgi Network (TGN), but also in other compartments, underlies cargo recognition by various carriers to assure the specificity of final localization."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000426"^^xsd:string ;
  rdfs:label "protein sorting pathway"^^xsd:string ;
  skos:notation "PW:0000426"^^xsd:string .

ns1:PW_0000427
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000135 ;
  ns2:treeView ns1:PW_0000135 ;
  ns1:IAO_0000115 "Molybdenum cofactor is a complex between molybdopterin and an oxide of molybdenum and is required for the activity of several enzymes."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000427"^^xsd:string ;
  rdfs:label "molybdenum cofactor biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000427"^^xsd:string .

ns1:PW_0000428
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000427, ns1:PW_0000429 ;
  ns2:treeView ns1:PW_0000427, ns1:PW_0000429 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000428"^^xsd:string ;
  rdfs:label "altered molybdenum cofactor biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000428"^^xsd:string .

ns1:PW_0000429
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000135, ns1:PW_0000262 ;
  ns2:treeView ns1:PW_0000135, ns1:PW_0000262 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000429"^^xsd:string ;
  rdfs:label "altered metabolic pathway of cofactors, vitamins, nutrients"^^xsd:string ;
  skos:notation "PW:0000429"^^xsd:string .

ns1:PW_0000430
  a owl:Class ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000430"^^xsd:string ;
  rdfs:label "killed term"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0000430"^^xsd:string .

ns1:PW_0000431
  a owl:Class ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000431"^^xsd:string ;
  rdfs:label "another killed term"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0000431"^^xsd:string .

ns1:PW_0000432
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000181 ;
  ns2:treeView ns1:PW_0000181 ;
  ns1:IAO_0000115 "Protein modification pathway exerts a central role in the regulation of protein function and the pathways these function impinge upon. It is also used to target protein for degradation. In the more special aspect of protein modification in the secretory pathway, it involves the final modification of glycoproteins and glycosaminoglycans as well as processing of proteins to their mature forms."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000432"^^xsd:string ;
  rdfs:label "protein modification pathway"^^xsd:string ;
  skos:notation "PW:0000432"^^xsd:string .

ns1:PW_0000433
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000432 ;
  ns2:treeView ns1:PW_0000432 ;
  ns1:IAO_0000115 "Conjugation of proteins with ubiquitin and ubiquitin-like molecules proceeds via a cascade-like, enzyme-driven mechanism with diverse functionality."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000433"^^xsd:string ;
  rdfs:label "protein modification pathway via conjugation with ubiquitin and ubiqutin-like molecules"^^xsd:string ;
  skos:notation "PW:0000433"^^xsd:string .

ns1:PW_0000434
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000433 ;
  ns2:treeView ns1:PW_0000433 ;
  ns1:IAO_0000115 "A pathway of protein modification via conjugation with ubiquitin. Ubiquitination is well known for targeting proteins for degradation.  However, ubiquitination is also used as a tag that modulates the signaling outcomes of modified substrates."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000434"^^xsd:string ;
  rdfs:label "ubiquitination pathway"^^xsd:string ;
  skos:notation "PW:0000434"^^xsd:string .

ns1:PW_0000435
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000433 ;
  ns2:treeView ns1:PW_0000433 ;
  ns1:IAO_0000115 "A pathway of protein modification via conjugation with Nedd8  - a ubiquitin-like protein. All Nedd8 targets appear to be members of the cullin family. Cullins participate in the assembly of various E3 ligase complexes. Neddylation pathway is important for embryogenesis and cell cycle control in metazoa, embryonic development in animals."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000435"^^xsd:string ;
  rdfs:label "neddylation pathway"^^xsd:string ;
  skos:notation "PW:0000435"^^xsd:string .

ns1:PW_0000436
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000407 ;
  ns2:treeView ns1:PW_0000407 ;
  ns1:IAO_0000115 "The prominent examples of biogenic amines are histamine, serotonin, the catecholamine and the choline derived acetylcholine, all acting as neurotransmitters involved in a wide range of processes."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000436"^^xsd:string ;
  rdfs:label "amine neurotransmitter metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000436"^^xsd:string .

ns1:PW_0000437
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000407 ;
  ns2:treeView ns1:PW_0000407 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000437"^^xsd:string ;
  rdfs:label "amino acid neurotransmitter metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000437"^^xsd:string .

ns1:PW_0000438
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001074 ;
  ns2:treeView ns1:PW_0001074 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of alanine. Alanine is a non-essential amino acid with roles in glucose and protein metabolism."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00055"^^xsd:string ;
  obo:id "PW:0000438"^^xsd:string ;
  rdfs:label "alanine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000438"^^xsd:string .

ns1:PW_0000439
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000445, ns1:PW_0001075 ;
  ns2:treeView ns1:PW_0000445, ns1:PW_0001075 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of aspartic acid/aspartate. Aspartic acid is a non-essential amino acid with roles in glucose, protein and nucleotide metabolism. In the brain, it can act as a neurotransmitter."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "<new synonym>SMP:00067"^^xsd:string ;
  obo:id "PW:0000439"^^xsd:string ;
  rdfs:label "aspartic acid/aspartate metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000439"^^xsd:string .

ns1:PW_0000440
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000446, ns1:PW_0001074 ;
  ns2:treeView ns1:PW_0000446, ns1:PW_0001074 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of glycine, a non-essential amino acid. Glycine has the simplest structure with a hydrogen atom as its side chain. The amino acid is the major inhibitory neurotransmitter."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000440"^^xsd:string ;
  rdfs:label "glycine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000440"^^xsd:string .

ns1:PW_0000441
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000443 ;
  ns2:treeView ns1:PW_0000443 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of epinephrine - a catecholamine derived from the amino acids phenylalanine and tyrosine. It acts as a hormone and a neurotransmitter."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "adrenaline metabolism"^^xsd:string ;
  obo:id "PW:0000441"^^xsd:string ;
  rdfs:label "epinephrine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000441"^^xsd:string .

ns1:PW_0000442
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000443 ;
  ns2:treeView ns1:PW_0000443 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of norepinephrine - a catecholamine derived from the amino acid tyrosine. It acts as a hormone and a neurotransmitter."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "noradrenaline metabolism"^^xsd:string ;
  obo:id "PW:0000442"^^xsd:string ;
  rdfs:label "norepinephrine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000442"^^xsd:string .

ns1:PW_0000443
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000211, ns1:PW_0000436 ;
  ns2:treeView ns1:PW_0000211, ns1:PW_0000436 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of catecholamines - chemical compounds derived from tyrosine. Epinephrine, norepinephrine and dopamine are among the most abundant and are produced primarily from the adrenal medulla and the postganglionic fibers of the sympathetic nervous system."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000443"^^xsd:string ;
  rdfs:label "catecholamine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000443"^^xsd:string .

ns1:PW_0000444
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000211, ns1:PW_0000436 ;
  ns2:treeView ns1:PW_0000211, ns1:PW_0000436 ;
  ns1:IAO_0000115 "Any of a number of indole derivatives containing an amine group."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000444"^^xsd:string ;
  rdfs:label "indoleamine and related compounds metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000444"^^xsd:string .

ns1:PW_0000445
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000437 ;
  ns2:treeView ns1:PW_0000437 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000445"^^xsd:string ;
  rdfs:label "excitatory neurotransmitter metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000445"^^xsd:string .

ns1:PW_0000446
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000437 ;
  ns2:treeView ns1:PW_0000437 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000446"^^xsd:string ;
  rdfs:label "inhibitory neurotransmitter metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000446"^^xsd:string .

ns1:PW_0000447
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000407 ;
  ns2:treeView ns1:PW_0000407 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000447"^^xsd:string ;
  rdfs:label "peptide neurotransmitter metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000447"^^xsd:string .

ns1:PW_0000448
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000447 ;
  ns2:treeView ns1:PW_0000447 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of neuropeptide Y."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000448"^^xsd:string ;
  rdfs:label "neuropeptide Y metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000448"^^xsd:string .

ns1:PW_0000449
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000447 ;
  ns2:treeView ns1:PW_0000447 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of enkephalin, a pentapeptide involved in the regulation of nociception."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000449"^^xsd:string ;
  rdfs:label "enkephalin metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000449"^^xsd:string .

ns1:PW_0000450
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000447 ;
  ns2:treeView ns1:PW_0000447 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of neurotensin."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000450"^^xsd:string ;
  rdfs:label "neurotensin metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000450"^^xsd:string .

ns1:PW_0000451
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000447 ;
  ns2:treeView ns1:PW_0000447 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of beta-endorphine - a peptide neurotransmitter that may play a role in depression."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000451"^^xsd:string ;
  rdfs:label "beta-endorphin metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000451"^^xsd:string .

ns1:PW_0000452
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000447 ;
  ns2:treeView ns1:PW_0000447 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of substance P - a  short-chain polypeptide that acts as a neurotransmitter and a neuromodulator."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000452"^^xsd:string ;
  rdfs:label "substance P metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000452"^^xsd:string .

ns1:PW_0000453
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000248 ;
  ns2:treeView ns1:PW_0000248 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of an isoprenoid. Isoprenoids are precursors of both sterols and non-sterol derivatives."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "steroid alcohol"^^xsd:string ;
  obo:id "PW:0000453"^^xsd:string ;
  rdfs:label "isoprenoid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000453"^^xsd:string .

ns1:PW_0000454
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001152, ns1:PW_0001304 ;
  ns2:treeView ns1:PW_0001152, ns1:PW_0001304 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of cholesterol, an essential sterol component of mammalian cell membrane. Cholesterol is the precursor of all steroid hormones."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00023"^^xsd:string ;
  obo:id "PW:0000454"^^xsd:string ;
  rdfs:label "cholesterol biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000454"^^xsd:string .

ns1:PW_0000455
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000274 ;
  ns2:treeView ns1:PW_0000274 ;
  ns1:IAO_0000115 "Synaptic transmission, or neurotransmission is the pathway of neuron-to-neuron signaling via the chemical synapse and mediated by neurotransmitters. Their effect can be excitatory or inhibitory and many neurotransmitters can exert either effect. The major excitatory neurotransmitter is the amino acid glutamate."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "excitatory neurotransmission pathway"^^xsd:string ;
  obo:id "PW:0000455"^^xsd:string ;
  rdfs:label "excitatory synaptic transmission pathway"^^xsd:string ;
  skos:notation "PW:0000455"^^xsd:string .

ns1:PW_0000456
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000274 ;
  ns2:treeView ns1:PW_0000274 ;
  ns1:IAO_0000115 "Synaptic transmission, or neurotransmission is the pathway of neuron-to-neuron signaling via the chemical synapse and mediated by neurotransmitters. Their effect can be excitatory or inhibitory and many neurotransmitters can exert either effect. The major inhibitory neurotransmitter is gamma-aminobutyric acid (GABA)."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Inhibitory neurotransmission pathway"^^xsd:string ;
  obo:id "PW:0000456"^^xsd:string ;
  rdfs:label "Inhibitory synaptic transmission pathway"^^xsd:string ;
  skos:notation "PW:0000456"^^xsd:string .

ns1:PW_0000457
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000245 ;
  ns2:treeView ns1:PW_0000245 ;
  ns1:IAO_0000115 "Angiotensin III is derived from angiotensin II through the action of aminopeptidase A and in turn is cleaved by aminopeptidase N to generate angiotensin IV. Angiotensin III appears to function in a manner similar to angiotensin II. It plays a role in vasoconstriction and the control of arterial blood pressure. Angiotensin III may be the effective angiotensin peptide in the central nervous system."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000457"^^xsd:string ;
  rdfs:label "angiotensin III signaling pathway"^^xsd:string ;
  skos:notation "PW:0000457"^^xsd:string .

ns1:PW_0000458
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000245 ;
  ns2:treeView ns1:PW_0000245 ;
  ns1:IAO_0000115 "Angiotensin IV is derived from angiotensin III through the action of aminopeptidase N. The receptor for angiotensin IV has been shown to be the insulin-regulated membrane aminopeptidase. Studies suggest that angiotensin IV signaling activates a number of intracellular second messenger systems and plays a role in vascular remodeling and memory."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000458"^^xsd:string ;
  rdfs:label "angiotensin IV signaling pathway"^^xsd:string ;
  skos:notation "PW:0000458"^^xsd:string .

ns1:PW_0000459
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467 ;
  ns2:treeView ns1:PW_0000467 ;
  ns1:IAO_0000115 "Apelin signaling pathway plays a role in the vascular, cardiac, bone and digestive systems as well as the brain."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000459"^^xsd:string ;
  rdfs:label "apelin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000459"^^xsd:string .

ns1:PW_0000460
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000058 ;
  ns2:treeView ns1:PW_0000058 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or conversion of arachidonic acid - a polyunsaturated, omega-6 fatty acid. It is a precursor in the production of eicosanoids and can also be converted to other metabolites, collectively known as the arachidonic acid cascade."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00590"^^xsd:string, "SMP:00075"^^xsd:string, "arachidonic acid cascade"^^xsd:string ;
  obo:id "PW:0000460"^^xsd:string ;
  rdfs:label "arachidonic acid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000460"^^xsd:string .

ns1:PW_0000461
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000460 ;
  ns2:treeView ns1:PW_0000460 ;
  ns1:IAO_0000115 "The cyclooxygenase pathway is one of the three major routes of arachidonic acid oxygenation."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000461"^^xsd:string ;
  rdfs:label "cyclooxygenase mediated pathway of arachidonic acid metabolism"^^xsd:string ;
  skos:notation "PW:0000461"^^xsd:string .

ns1:PW_0000462
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000460 ;
  ns2:treeView ns1:PW_0000460 ;
  ns1:IAO_0000115 "Lipoxygenase pathway is one of three major routes of arachidonic acid oxygenation"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000462"^^xsd:string ;
  rdfs:label "lipoxygenase mediated pathway of arachidonic acid metabolism"^^xsd:string ;
  skos:notation "PW:0000462"^^xsd:string .

ns1:PW_0000463
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000460 ;
  ns2:treeView ns1:PW_0000460 ;
  ns1:IAO_0000115 "Cytochrome P450 monooxygenase pathway is one the three major routes of arachidonic acid oxygenation."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000463"^^xsd:string ;
  rdfs:label "cytochrome P450 monooxygenase mediated pathway of arachidonic acid metabolism"^^xsd:string ;
  skos:notation "PW:0000463"^^xsd:string .

ns1:PW_0000464
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000462, ns1:PW_0000485 ;
  ns2:treeView ns1:PW_0000462, ns1:PW_0000485 ;
  ns1:IAO_0000115 "Those metabolic reactions involving leukotrienes - a class of eicosanoids whose effects include vasoconstriction and bronchoconstriction."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000464"^^xsd:string ;
  rdfs:label "leukotriene metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000464"^^xsd:string .

ns1:PW_0000465
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000003 ;
  ns2:treeView ns1:PW_0000003 ;
  ns1:IAO_0000115 "Hormones are a class of molecules that are used as messengers between cells and serve as signals to the target cell. Vertebrate hormones belong to three classes: amine and amino acid derived, peptide and protein hormones, and lipid and phospholipid derived hormones."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000465"^^xsd:string ;
  rdfs:label "hormone signaling pathway"^^xsd:string ;
  skos:notation "PW:0000465"^^xsd:string .

ns1:PW_0000466
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000465 ;
  ns2:treeView ns1:PW_0000465 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000466"^^xsd:string ;
  rdfs:label "amine and amino acid-derived hormone signaling pathway"^^xsd:string ;
  skos:notation "PW:0000466"^^xsd:string .

ns1:PW_0000467
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000465 ;
  ns2:treeView ns1:PW_0000465 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000467"^^xsd:string ;
  rdfs:label "peptide and protein hormone signaling pathway"^^xsd:string ;
  skos:notation "PW:0000467"^^xsd:string .

ns1:PW_0000468
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000469 ;
  ns2:treeView ns1:PW_0000469 ;
  ns1:IAO_0000115 "steroid hormones - steroids that act as hormones - can be grouped into several categories depending on the receptor to which they bind."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000468"^^xsd:string ;
  rdfs:label "steroid hormone signaling pathway"^^xsd:string ;
  skos:notation "PW:0000468"^^xsd:string .

ns1:PW_0000469
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000465 ;
  ns2:treeView ns1:PW_0000465 ;
  ns1:IAO_0000115 "The main categories of lipid hormones are the eicosanoids derived from arachidonic acid metabolism and the cholesterol derived steroid hormones. The signaling they initiate plays important roles in metabolism, inflammation and immunity, in the cardiovascular, nervous, renal and reproductive systems."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000469"^^xsd:string ;
  rdfs:label "lipid hormone signaling pathway"^^xsd:string ;
  skos:notation "PW:0000469"^^xsd:string .

ns1:PW_0000470
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000476
  ] ;
  ns2:treeView ns1:PW_0000467, ns1:PW_0000476 ;
  ns3:part_of ns1:PW_0000476 ;
  ns1:IAO_0000115 "The natriuretic peptide family consists of three peptide hormones of diverse roles in cardiovascular as well as neuroendocrine and renal functions."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000470"^^xsd:string ;
  rdfs:label "natriuretic peptide signaling pathway"^^xsd:string ;
  skos:notation "PW:0000470"^^xsd:string .

ns1:PW_0000471
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000470 ;
  ns2:treeView ns1:PW_0000470 ;
  ns1:IAO_0000115 "Atrial natriuretic peptide hormone pathway plays important roles in the regulation of body fluid volume and blood pressure."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "ANP signaling pathway"^^xsd:string ;
  obo:id "PW:0000471"^^xsd:string ;
  rdfs:label "atrial natriuretic peptide signaling pathway"^^xsd:string ;
  skos:notation "PW:0000471"^^xsd:string .

ns1:PW_0000472
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000470 ;
  ns2:treeView ns1:PW_0000470 ;
  ns1:IAO_0000115 "brain natriuretic peptide signaling pathway appears to elicit cardiovascular, renal and endocrine functions similar to those elicited by the atrial natriuretic peptide."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "BNP signaling pathway"^^xsd:string ;
  obo:id "PW:0000472"^^xsd:string ;
  rdfs:label "brain natriuretic peptide signaling pathway"^^xsd:string ;
  skos:notation "PW:0000472"^^xsd:string .

ns1:PW_0000473
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000470 ;
  ns2:treeView ns1:PW_0000470 ;
  ns1:IAO_0000115 "The role of the C-type signaling pathway is not well established. The receptor for the C-type natriuretic peptide, unlike the receptors for the other two types of peptides, is non-guanylyl cyclase receptor that appears to couple to adenylyl cyclase inhibition/phospholipase C activation via Gi family of G-protein."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "C-type brain natriuretic peptide signaling pathway"^^xsd:string, "CNP signaling pathway"^^xsd:string ;
  obo:id "PW:0000473"^^xsd:string ;
  rdfs:label "C-type natriuretic peptide signaling pathway"^^xsd:string ;
  skos:notation "PW:0000473"^^xsd:string .

ns1:PW_0000474
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000475
  ] ;
  ns2:treeView ns1:PW_0000475 ;
  ns3:part_of ns1:PW_0000475 ;
  ns1:IAO_0000115 "The coagulation cascade is the series of events proceeding via the tissue factor (extrinsic) or the contact activation (intrinsic) pathway and converging in the formation of fibrin clots. Several anticoagulation systems are in place to modulate the pathway. The coagulation cascade and the complement pathway of  immune responses are connected in a cross talk."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04610"^^xsd:string, "secondary hemostasis"^^xsd:string ;
  obo:id "PW:0000474"^^xsd:string ;
  rdfs:label "coagulation cascade pathway"^^xsd:string ;
  skos:notation "PW:0000474"^^xsd:string .

ns1:PW_0000475
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000476
  ] ;
  ns2:treeView ns1:PW_0000476 ;
  ns3:part_of ns1:PW_0000476 ;
  ns1:IAO_0000115 "Hemostasis is the response to blood vessel injury to prevent blood loss via platelet mediated primary homeostasis and the secondary homeostasis of coagulation. The latter is a complex cascade which is triggered by the innate immune response and inflammation."^^xsd:string ;
  obo:hasExactSynonym "Reactome:R-HSA-109582"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "haemostasis pathway"^^xsd:string ;
  obo:id "PW:0000475"^^xsd:string ;
  rdfs:label "hemostasis pathway"^^xsd:string ;
  skos:notation "PW:0000475"^^xsd:string .

ns1:PW_0000476
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000355 ;
  ns2:treeView ns1:PW_0000355 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000476"^^xsd:string ;
  rdfs:label "cardiovascular system homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0000476"^^xsd:string .

ns1:PW_0000477
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000476
  ] ;
  ns2:treeView ns1:PW_0000476 ;
  ns3:part_of ns1:PW_0000476 ;
  ns1:IAO_0000115 "The endogenous routes of inhibiting the coagulation cascade, collectively known as the natural anticoagulant pathways."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000477"^^xsd:string ;
  rdfs:label "natural anticoagulant pathway"^^xsd:string ;
  skos:notation "PW:0000477"^^xsd:string .

ns1:PW_0000478
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000477 ;
  ns2:treeView ns1:PW_0000477 ;
  ns1:IAO_0000115 "Tissue factor pathway inhibitor isoforms alpha and beta are the main anticoagulants targeting the extrinsic coagulation cascade factors F7a and F7a-dependent F10a."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "TFPI"^^xsd:string ;
  obo:id "PW:0000478"^^xsd:string ;
  rdfs:label "tissue factor pathway inhibitor"^^xsd:string ;
  skos:notation "PW:0000478"^^xsd:string .

ns1:PW_0000479
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000477 ;
  ns2:treeView ns1:PW_0000477 ;
  ns1:IAO_0000115 "Antithrombin (AT) affects the activity of many coagulation factors in the intrinsic and common coagulation cascade. Heparin, though not essential, is an important AT cofactor. increasing the activity of AT by ~1,000-fold."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000479"^^xsd:string ;
  rdfs:label "heparin-antithrombin pathway"^^xsd:string ;
  skos:notation "PW:0000479"^^xsd:string .

ns1:PW_0000480
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000477 ;
  ns2:treeView ns1:PW_0000477 ;
  ns1:IAO_0000115 "Activated protein C, with the aid of protein S, inhibits F8a and F5a - the important cofactors of the intrinsic tenase and thrombinase complexes, respectively, of coagulation cascade."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000480"^^xsd:string ;
  rdfs:label "protein C anticoagulant pathway"^^xsd:string ;
  skos:notation "PW:0000480"^^xsd:string .

ns1:PW_0000481
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000476
  ] ;
  ns2:treeView ns1:PW_0000476 ;
  ns3:part_of ns1:PW_0000476 ;
  ns1:IAO_0000115 "The steps leading to the activation of plasminogen and the subsequent breaking down of a fibrin clot - the product of coagulation cascade."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000481"^^xsd:string ;
  rdfs:label "fibrinolysis pathway"^^xsd:string ;
  skos:notation "PW:0000481"^^xsd:string .

ns1:PW_0000482
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000010 ;
  ns2:treeView ns1:PW_0000010 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of lipoproteins - any of the protein-lipid complexes. In the blood lipoproteins carry fats essential for the cell. Genetic variability and environmental (nongenetic) factors contribute to alterations in the homeostasis of lipid metabolic pathways and constitute cardiovascular disease risk."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000482"^^xsd:string ;
  rdfs:label "lipoprotein metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000482"^^xsd:string .

ns1:PW_0000483
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000010, ns1:PW_0000262 ;
  ns2:treeView ns1:PW_0000010, ns1:PW_0000262 ;
  ns1:IAO_0000115 "Those lipid metabolic pathways that deviate from what their normal course should be. Aberrant lipid metabolic pathways, alone or in combination with other pathways underlie a number of diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000483"^^xsd:string ;
  rdfs:label "altered lipid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000483"^^xsd:string .

ns1:PW_0000484
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000482, ns1:PW_0000483 ;
  ns2:treeView ns1:PW_0000482, ns1:PW_0000483 ;
  ns1:IAO_0000115 "Those lipoprotein metabolic pathways that deviate from what their normal course should be. Aberrant lipoprotein metabolic pathways, alone or in combination with other pathways underlie several diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000484"^^xsd:string ;
  rdfs:label "altered lipoprotein metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000484"^^xsd:string .

ns1:PW_0000485
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000010 ;
  ns2:treeView ns1:PW_0000010 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of eicosanoids. Eicosanoids are derived from omega-6 or omega-3 fatty acids and derivatives. Examples include the leukotriene and the prostanoid classes, the latter represented by several families. Eicosanoids play important roles in the immune and vascular systems."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000485"^^xsd:string ;
  rdfs:label "eicosanoid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000485"^^xsd:string .

ns1:PW_0000486
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000825 ;
  ns2:treeView ns1:PW_0000825 ;
  ns1:IAO_0000115 "Peptides generated from proteolytic degradation of cytosolic proteins are translocated to the ER where they associate with class I MHC molecules. Peptide-class I MHC complexes move through the Golgi and are transported to the cell surface to be recognized by CD8+ T cells."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "MHC class I antigen presentation pathway"^^xsd:string, "class I MHC pathway"^^xsd:string ;
  obo:id "PW:0000486"^^xsd:string ;
  rdfs:label "class I major histocompatibility complex pathway"^^xsd:string ;
  skos:notation "PW:0000486"^^xsd:string .

ns1:PW_0000487
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000825 ;
  ns2:treeView ns1:PW_0000825 ;
  ns1:IAO_0000115 "Peptides generated from enzymatic degradation of proteins internalized in late endosomes or lysosomes bind to class II MHC molecules. Peptide-class II MHC complexes are delivered to the cell surface to be recognized by CD4+ T cells."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "class II MHC pathway"^^xsd:string ;
  obo:id "PW:0000487"^^xsd:string ;
  rdfs:label "class II major histocompatibility complex pathway"^^xsd:string ;
  skos:notation "PW:0000487"^^xsd:string .

ns1:PW_0000488
  a owl:Class ;
  ns1:IAO_0000115 "Antigen processing pathway engages the proteosomal machinery in the cytosol, ER specific proteases as well as chaperones for loading the HMC class I molecules with the 8-10 amino acid peptides"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000488"^^xsd:string ;
  rdfs:label "antigen processing pathway"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0000488"^^xsd:string .

ns1:PW_0000489
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000168 ;
  ns2:treeView ns1:PW_0000168 ;
  ns1:IAO_0000115 "Angiopoietin signaling pathway is involved in the regulation of angiogenic remodeling. Recent studies suggest that the pathway may also be involved in lymphangiogenesis and possibly in the development of hematopoietic system."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000489"^^xsd:string ;
  rdfs:label "angiopoietin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000489"^^xsd:string .

ns1:PW_0000490
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000206, ns1:PW_0000650 ;
  ns2:treeView ns1:PW_0000206, ns1:PW_0000650 ;
  ns1:IAO_0000115 "Transforming growth factor-beta (TGF-beta) signaling is one of the best characterized module of the Tgf-b superfamily pathways. Binding to the type II receptor leads to activation of the type I receptor and subsequent activation of Smad pathway. Nuclear translocation of Smad(s) and interaction with transcription factors leads to activation or repression of many genes."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200227"^^xsd:string, "TGF-beta Smad dependent signaling pathway"^^xsd:string ;
  obo:id "PW:0000490"^^xsd:string ;
  rdfs:label "transforming growth factor-beta Smad dependent signaling pathway"^^xsd:string ;
  skos:notation "PW:0000490"^^xsd:string .

ns1:PW_0000491
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000476
  ] ;
  ns2:treeView ns1:PW_0000467, ns1:PW_0000476 ;
  ns3:part_of ns1:PW_0000476 ;
  ns1:IAO_0000115 "The hormone vasopressin plays central roles in cardiovascular and water homeostasis by signaling via two receptor types, G-protein coupled receptors coupling to particular G alpha subunits of heterotrimeric G proteins."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Avp signaling pathway"^^xsd:string, "arginine-vasopressin signaling pathway"^^xsd:string ;
  obo:id "PW:0000491"^^xsd:string ;
  rdfs:label "vasopressin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000491"^^xsd:string .

ns1:PW_0000492
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001757, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000476
  ] ;
  ns2:treeView ns1:PW_0000476, ns1:PW_0001757 ;
  ns3:part_of ns1:PW_0000476 ;
  ns1:IAO_0000115 "The renin-angiotensin cascade (RAS) generates a number of bioactive peptides with diverse physiological and pathophysiological functions. RAS exerts vasoconstriction, vasodilation or vascular remodeling, cell proliferation or anti-proliferation effects, depending on which angiotensin peptide generates the signaling. Some of these features are also shared by the kallikrein-kinin system (KKS); the two systems can interact and cross-talk."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04614"^^xsd:string, "RAS system signaling pathway"^^xsd:string ;
  obo:id "PW:0000492"^^xsd:string ;
  rdfs:label "renin-angiotensin cascade pathway"^^xsd:string ;
  skos:notation "PW:0000492"^^xsd:string .

ns1:PW_0000493
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467 ;
  ns2:treeView ns1:PW_0000467 ;
  ns1:IAO_0000115 "Corticotropin-releasing hormone is secreted by the hypothalamus in response to stress or fear and signaling through its receptors stimulates secretion of corticotropic (adrenocorticotropic, ACTH) hormone by the anterior pituitary. ACTH is one of the cleavage products of pro-opiomelanocortin (POMC)."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "CRH"^^xsd:string ;
  obo:id "PW:0000493"^^xsd:string ;
  rdfs:label "corticotropin-releasing hormone signaling pathway"^^xsd:string ;
  skos:notation "PW:0000493"^^xsd:string .

ns1:PW_0000494
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467 ;
  ns2:treeView ns1:PW_0000467 ;
  ns1:IAO_0000115 "The peptide hormone oxytocin plays a central role in parturition, lactation and sexual behavior."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000494"^^xsd:string ;
  rdfs:label "oxytocin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000494"^^xsd:string .

ns1:PW_0000495
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000168 ;
  ns2:treeView ns1:PW_0000168 ;
  ns1:IAO_0000115 "Gas6, a vitamin K-dependent growth factor signals through the Axl subfamily of tyrosine kinase receptors. The Gas6-Axl axis appears to be involved in growth and survival of various cell types as well as in tissue remodeling and regeneration. Deregulation of the axis is involved in a number of conditions, particularly renal."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Gas6-Axl signaling system"^^xsd:string ;
  obo:id "PW:0000495"^^xsd:string ;
  rdfs:label "Gas6 - Axl signaling axis"^^xsd:string ;
  skos:notation "PW:0000495"^^xsd:string .

ns1:PW_0000496
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000482
  ] ;
  ns2:treeView ns1:PW_0000482 ;
  ns3:part_of ns1:PW_0000482 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000496"^^xsd:string ;
  rdfs:label "exogenous pathway"^^xsd:string ;
  skos:notation "PW:0000496"^^xsd:string .

ns1:PW_0000497
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000482
  ] ;
  ns2:treeView ns1:PW_0000482 ;
  ns3:part_of ns1:PW_0000482 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000497"^^xsd:string ;
  rdfs:label "endogenous pathway"^^xsd:string ;
  skos:notation "PW:0000497"^^xsd:string .

ns1:PW_0000498
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001346, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000482
  ] ;
  ns2:treeView ns1:PW_0000482, ns1:PW_0001346 ;
  ns3:part_of ns1:PW_0000482 ;
  ns1:IAO_0000115 "Reverse cholesterol transport (RCT) is the pathway by which cholesterol from extrahepatic cells/tissue is transported to the liver for excretion. The pathway may prevent the development of atherosclerosis by reducing the accumulation of cholesterol in the wall of arteries."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "RCT pathway"^^xsd:string, "selective cholesterol uptake pathway"^^xsd:string ;
  obo:id "PW:0000498"^^xsd:string ;
  rdfs:label "reverse cholesterol transport pathway"^^xsd:string ;
  skos:notation "PW:0000498"^^xsd:string .

ns1:PW_0000499
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000716, ns1:PW_0000818, ns1:PW_0001313 ;
  ns2:treeView ns1:PW_0000716, ns1:PW_0000818, ns1:PW_0001313 ;
  ns1:IAO_0000115 "NF-kB signaling plays an essential role in the mammalian immune system. The classical/canonical pathway, downstream but not exclusively of tumor necrosis factor/receptor 1 signaling, is regarded as a paradigm of NF-kB signaling. The classical and the non-classical pathway downstream of a subset of Tnf receptor superfamily, share similar sets of core components, albeit in distinct ways. Collectively they regulate the expression of a vast array of genes."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04064"^^xsd:string, "NF-kB signaling pathway"^^xsd:string, "NF-kappaB signaling pathway"^^xsd:string, "PID:200021"^^xsd:string, "PID:200031"^^xsd:string, "PID:200048"^^xsd:string ;
  obo:id "PW:0000499"^^xsd:string ;
  rdfs:label "nuclear factor kappa B signaling pathway"^^xsd:string ;
  skos:notation "PW:0000499"^^xsd:string .

ns1:PW_0000500
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000466 ;
  ns2:treeView ns1:PW_0000466 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000500"^^xsd:string ;
  rdfs:label "tyrosine-based hormone signaling pathway"^^xsd:string ;
  skos:notation "PW:0000500"^^xsd:string .

ns1:PW_0000501
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000059, ns1:PW_0000500 ;
  ns2:treeView ns1:PW_0000059, ns1:PW_0000500 ;
  ns1:IAO_0000115 "Thyroid hormone (TH) signaling pathway plays important roles in glucose and lipid metabolism. The TH receptors are nuclear receptors that once activated act as transcription factors. Low levels of TH stimulate the release of thyrotropin-releasing hormone (TRH) from the hypothalamus, in turn stimulating the secretion of thyroid-stimulating hormone (TSH) from the pituitary whose signaling then triggers TH production. TRH, TSH and TH signaling pathways are part of the hypothalamic-pituitary-thyroid (HPT) axis for which TH itself provides a negative regulatory loop."^^xsd:string ;
  obo:hasExactSynonym "TH signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000501"^^xsd:string ;
  rdfs:label "thyroid hormone signaling pathway"^^xsd:string ;
  skos:notation "PW:0000501"^^xsd:string .

ns1:PW_0000502
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000234
  ], [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000823
  ] ;
  ns2:treeView ns1:PW_0000234, ns1:PW_0000823 ;
  ns3:part_of ns1:PW_0000234, ns1:PW_0000823 ;
  ns1:IAO_0000115 "The complement system is an important effector of innate and also of humoral adaptive immunity. It consists of three biochemical cascades that are differently initiated but share similar late steps and effector functions. The complement pathway and the coagulation cascade are connected in a cross talk."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04610"^^xsd:string ;
  obo:id "PW:0000502"^^xsd:string ;
  rdfs:label "complement system pathway"^^xsd:string ;
  skos:notation "PW:0000502"^^xsd:string .

ns1:PW_0000503
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000502 ;
  ns2:treeView ns1:PW_0000502 ;
  ns1:IAO_0000115 "The classical complement pathway is one of the three biochemical pathways of the complement system. It is activated by antigen-bound antibodies."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "classical pathway"^^xsd:string ;
  obo:id "PW:0000503"^^xsd:string ;
  rdfs:label "classical complement pathway"^^xsd:string ;
  skos:notation "PW:0000503"^^xsd:string .

ns1:PW_0000504
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000502 ;
  ns2:treeView ns1:PW_0000502 ;
  ns1:IAO_0000115 "The lectin pathway is one of the three biochemical pathways of the complement system. It is activated by microbial polysaccharides binding to circulating lectins."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "lectin pathway"^^xsd:string, "mannose-binding lectin pathway"^^xsd:string ;
  obo:id "PW:0000504"^^xsd:string ;
  rdfs:label "lectin complement pathway"^^xsd:string ;
  skos:notation "PW:0000504"^^xsd:string .

ns1:PW_0000505
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000502 ;
  ns2:treeView ns1:PW_0000502 ;
  ns1:IAO_0000115 "The alternative pathway is one of the three biochemical pathways of the complement system. Stable activation of the alternative pathway occurs on microbial cell surfaces."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "alternative pathway"^^xsd:string ;
  obo:id "PW:0000505"^^xsd:string ;
  rdfs:label "alternative complement pathway"^^xsd:string ;
  skos:notation "PW:0000505"^^xsd:string .

ns1:PW_0000506
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467 ;
  ns2:treeView ns1:PW_0000467 ;
  ns1:IAO_0000115 "Endothelins represent a family of three vasoconstrictor peptides that play a role in several intracellular signaling pathways and have been associated with hypertension, heart failure and myocardial infarction."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200005"^^xsd:string ;
  obo:id "PW:0000506"^^xsd:string ;
  rdfs:label "endothelin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000506"^^xsd:string .

ns1:PW_0000507
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000567, ns1:PW_0000716, ns1:PW_0001313 ;
  ns2:treeView ns1:PW_0000567, ns1:PW_0000716, ns1:PW_0001313 ;
  ns1:IAO_0000115 "Estrogens are C18 steroid hormones that constitutes the females sex hormones. Estrogen signals via the estrogen receptor which ones activated drive the expression of target genes."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000507"^^xsd:string ;
  rdfs:label "estrogen signaling pathway"^^xsd:string ;
  skos:notation "PW:0000507"^^xsd:string .

ns1:PW_0000508
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000475
  ] ;
  ns2:treeView ns1:PW_0000475 ;
  ns3:part_of ns1:PW_0000475 ;
  ns1:IAO_0000115 "The pathway involving the attachment of platelets to one another and leading to the formation of a thrombus. Platelets attachment can be induced by a variety of agents."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "primary hemostasis"^^xsd:string ;
  obo:id "PW:0000508"^^xsd:string ;
  rdfs:label "platelet aggregation pathway"^^xsd:string ;
  skos:notation "PW:0000508"^^xsd:string .

ns1:PW_0000509
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000264, ns1:PW_0000465 ;
  ns2:treeView ns1:PW_0000264, ns1:PW_0000465 ;
  ns1:IAO_0000115 "A hormone signaling pathway that deviates from what its normal course should be."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000509"^^xsd:string ;
  rdfs:label "altered hormone signaling pathway"^^xsd:string ;
  skos:notation "PW:0000509"^^xsd:string .

ns1:PW_0000510
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000238, ns1:PW_0000511 ;
  ns2:treeView ns1:PW_0000238, ns1:PW_0000511 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000510"^^xsd:string ;
  rdfs:label "altered insulin-like growth factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0000510"^^xsd:string .

ns1:PW_0000511
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467, ns1:PW_0000509 ;
  ns2:treeView ns1:PW_0000467, ns1:PW_0000509 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000511"^^xsd:string ;
  rdfs:label "altered peptide and protein hormone signaling pathway"^^xsd:string ;
  skos:notation "PW:0000511"^^xsd:string .

ns1:PW_0000512
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000828 ;
  ns2:treeView ns1:PW_0000828 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000512"^^xsd:string ;
  rdfs:label "Interleukin mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000512"^^xsd:string .

ns1:PW_0000513
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000512 ;
  ns2:treeView ns1:PW_0000512 ;
  ns1:IAO_0000115 "The interleukin-10 family comprises several interleukins, including members of the interferon type III also known as interferon lambda or interferon-like type, that carry out various immunomodulatory functions."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Il-10 family mediated signaling pathway"^^xsd:string ;
  obo:id "PW:0000513"^^xsd:string ;
  rdfs:label "interleukin-10 family mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000513"^^xsd:string .

ns1:PW_0000514
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000512 ;
  ns2:treeView ns1:PW_0000512 ;
  ns1:IAO_0000115 "Interleukin-6 family includes several members involved in a wide range of biological processes such as immune regulation, inflammation, hematopoiesis and oncogenesis. All members share a common signal transducer, gp130 which activates Jak-Stat and Raf/Mek/Erk signaling pathways."^^xsd:string ;
  obo:hasExactSynonym "Reactome:R-HSA-6783589"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Il-6 family mediated signaling pathway"^^xsd:string ;
  obo:id "PW:0000514"^^xsd:string ;
  rdfs:label "interleukin-6 family mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000514"^^xsd:string .

ns1:PW_0000515
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000513 ;
  ns2:treeView ns1:PW_0000513 ;
  ns1:IAO_0000115 "Interleukin-10 signaling is involved in various immunomodulatory functions. It promotes the release of immune mediators and antigen presentation exerting important anti-inflammatory effects that may primarily characterize this family member. Signaling by Il-10 and the other members of the family activate the intracellular Jak-Stat cascade."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Il-10 signaling pathway"^^xsd:string ;
  obo:id "PW:0000515"^^xsd:string ;
  rdfs:label "Interleukin-10 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000515"^^xsd:string .

ns1:PW_0000516
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000514, ns1:PW_0000926 ;
  ns2:treeView ns1:PW_0000514, ns1:PW_0000926 ;
  ns1:IAO_0000115 "Interleukin-6 signaling is involved in a wide range of biological processes such as immune regulation, inflammation, hematopoiesis and oncogenesis. A signal transducer common to all family members, gp130 activates Jak-Stat and Raf/Mek/Erk signaling pathways."^^xsd:string ;
  obo:hasExactSynonym "Reactome:R-HSA-1059683"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Il-6 signaling pathway"^^xsd:string, "PID:200146"^^xsd:string ;
  obo:id "PW:0000516"^^xsd:string ;
  rdfs:label "interleukin-6 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000516"^^xsd:string .

ns1:PW_0000517
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000020 ;
  ns2:treeView ns1:PW_0000020 ;
  ns1:IAO_0000115 "A pathway leading to a general or specific artery occlusion."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000517"^^xsd:string ;
  rdfs:label "arterial occlusive disease pathway"^^xsd:string ;
  skos:notation "PW:0000517"^^xsd:string .

ns1:PW_0000518
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000517 ;
  ns2:treeView ns1:PW_0000517 ;
  ns1:IAO_0000115 "A pathway leading to the thickening of medium and large arteries. While lipoprotein related pathways are of interest, monogenic conditions such as those linked to mutations in the laminin gene may also provide clues regarding atherosclerosis pathways."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000518"^^xsd:string ;
  rdfs:label "atherosclerosis pathway"^^xsd:string ;
  skos:notation "PW:0000518"^^xsd:string .

ns1:PW_0000519
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000107 ;
  ns2:treeView ns1:PW_0000107 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the degradation of DDT - a chlorinated organic insecticide and environmental pollutant. Although it is banned in the United States, it is still widely used in developing countries."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "DDT degradation pathway"^^xsd:string ;
  obo:id "PW:0000519"^^xsd:string ;
  rdfs:label "1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane degradation pathway"^^xsd:string ;
  skos:notation "PW:0000519"^^xsd:string .

ns1:PW_0000520
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000107 ;
  ns2:treeView ns1:PW_0000107 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the degradation of 2,4-dichlorobenzoate - a key intermediate in the aerobic degradation of over 200 polychlorinated biphenyls."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000520"^^xsd:string ;
  rdfs:label "2,4-dichlorobenzoate degradation pathway"^^xsd:string ;
  skos:notation "PW:0000520"^^xsd:string .

ns1:PW_0000521
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000107 ;
  ns2:treeView ns1:PW_0000107 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the degradation of 1,2-dichloroethane - a moderately reactive alkylating compound."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000521"^^xsd:string ;
  rdfs:label "1,2-dichloroethane degradation pathway"^^xsd:string ;
  skos:notation "PW:0000521"^^xsd:string .

ns1:PW_0000522
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000147 ;
  ns2:treeView ns1:PW_0000147 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the biosynthesis of flavonoids - a class of plant secondary metabolites generally known for their antioxidant activity."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000522"^^xsd:string ;
  rdfs:label "flavonoid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000522"^^xsd:string .

ns1:PW_0000523
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000058 ;
  ns2:treeView ns1:PW_0000058 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the synthesis, utilization or degradation of linoleic acid - an unsaturated omega-6 fatty acid. Linoleic acid is an essential fatty acid that humans and other animals cannot synthesize and must obtain from diet."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00591"^^xsd:string, "SMP:00018"^^xsd:string ;
  obo:id "PW:0000523"^^xsd:string ;
  rdfs:label "linoleic acid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000523"^^xsd:string .

ns1:PW_0000524
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000157 ;
  ns2:treeView ns1:PW_0000157 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the biosynthesis of heparan sulfate. Heparan sulfate is a glycosaminoglycan occurring in the cell membrane of most cells. It consists of repeating disaccharide units in specific linkage, each composed of a glucosamine residue linked to an uronic acid, either glucuronic acid or L-iduronic acid, which may be sulfated."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00534"^^xsd:string ;
  obo:id "PW:0000524"^^xsd:string ;
  rdfs:label "heparan sulfate biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000524"^^xsd:string .

ns1:PW_0000525
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000158 ;
  ns2:treeView ns1:PW_0000158 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000525"^^xsd:string ;
  rdfs:label "Ras mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000525"^^xsd:string .

ns1:PW_0000526
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000818, ns1:PW_0001536, ns1:PW_0001756, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000476
  ] ;
  ns2:treeView ns1:PW_0000476, ns1:PW_0000818, ns1:PW_0001536, ns1:PW_0001756 ;
  ns3:part_of ns1:PW_0000476 ;
  ns1:IAO_0000115 "The kallikrein-kinin system (KKS) cascade generates several bioactive kinins with roles in vasodilation, release of inflammatory mediators and stimulation of sensory neurons. Kinins also play a role in the renal handling of sodium and water metabolism. In the latter case, the system parallels renin-angiotensin (RAS); the two systems can cross-talk."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KKS system signaling pathway"^^xsd:string ;
  obo:id "PW:0000526"^^xsd:string ;
  rdfs:label "kallikrein-kinin cascade pathway"^^xsd:string ;
  skos:notation "PW:0000526"^^xsd:string .

ns1:PW_0000527
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000244 ;
  ns2:treeView ns1:PW_0000244 ;
  ns1:IAO_0000115 "Angiotensin II signaling through the angiotensin type 1 receptor (AT1) activates downstream signaling pathways and elicits a broad range of physiological responses. It is involved in the regulation of blood pressure and volume, water and electrolyte balance and exerts a potent vasoconstrictive effect."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000527"^^xsd:string ;
  rdfs:label "angiotensin II signaling pathway via AT1 receptor"^^xsd:string ;
  skos:notation "PW:0000527"^^xsd:string .

ns1:PW_0000528
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000244 ;
  ns2:treeView ns1:PW_0000244 ;
  ns1:IAO_0000115 "Angiotensin II signaling through the angiotensin type 2 receptor (AT2) is less well understood and rather controversial. It appears to counteract AT1 receptor function and promote apoptosis. Alternatively, it may complement the effects of AT1 receptor with deleterious consequences in cardiac pathologies. AT2 receptor appears to function in a G-protein dependent as well as independent manner."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000528"^^xsd:string ;
  rdfs:label "angiotensin II signaling pathway via AT2 receptor"^^xsd:string ;
  skos:notation "PW:0000528"^^xsd:string .

ns1:PW_0000529
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000245 ;
  ns2:treeView ns1:PW_0000245 ;
  ns1:IAO_0000115 "Angiotensin (1-7) is derived from angiotensin II through the action of angiotensin converting enzyme 2 (ACE2) or from angiotensin I through the action of neutral endopeptidase (NEP). Angiotensin (1-7) signaling appears to have a vasodilatory effect but the exact action of this peptide in humans remains to be established."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000529"^^xsd:string ;
  rdfs:label "angiotensin (1-7) signaling pathway"^^xsd:string ;
  skos:notation "PW:0000529"^^xsd:string .

ns1:PW_0000530
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000457 ;
  ns2:treeView ns1:PW_0000457 ;
  ns1:IAO_0000115 "Angiotensin III, like angiotensin II, binds to the type 1 and 2 receptors and triggers downstream signaling pathways. In rats, angiotensin III signaling through the receptor type 1 (AT1) can modulate noradrenergic transmission via phospholipase C activation."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000530"^^xsd:string ;
  rdfs:label "angiotensin III signaling pathway via AT1 receptor"^^xsd:string ;
  skos:notation "PW:0000530"^^xsd:string .

ns1:PW_0000531
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000457 ;
  ns2:treeView ns1:PW_0000457 ;
  ns1:IAO_0000115 "The role of angiotensin type 2 receptor is less well understood. In rats, angiotensin III can mediate natriuresis through the activation of receptor type 2."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000531"^^xsd:string ;
  rdfs:label "angiotensin III signaling pathway via AT2 receptor"^^xsd:string ;
  skos:notation "PW:0000531"^^xsd:string .

ns1:PW_0000532
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000533, ns1:PW_0000557 ;
  ns2:treeView ns1:PW_0000533, ns1:PW_0000557 ;
  ns1:IAO_0000115 "Those metabolic reactions leading to the biosynthesis of glycogen, a highly branched polysaccharide. Glycogen is the storage form of glucose in the cell; it represents an energy reserve that can be mobilized when and where there is a need for glucose."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "glycogenesis"^^xsd:string ;
  obo:id "PW:0000532"^^xsd:string ;
  rdfs:label "glycogen biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000532"^^xsd:string .

ns1:PW_0000533
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005 ;
  ns2:treeView ns1:PW_0000005 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of glycogen, a highly branched polysaccharide that constitutes the major form of glucose storage in the cell."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000533"^^xsd:string ;
  rdfs:label "glycogen metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000533"^^xsd:string .

ns1:PW_0000534
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000533, ns1:PW_0000685 ;
  ns2:treeView ns1:PW_0000533, ns1:PW_0000685 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the breakdown of glycogen to glucose-6-phosphate. Glucose-6-phosphate can then be dephosphorylated to glucose or it can be utilized via glycolysis for energy production; an alternative pathways of G6P utilization is the oxidative phase of the pentose phosphate shunt. A small percentage of glucose-6-phosphate can be converted to hexosamines."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "glycogenolysis"^^xsd:string ;
  obo:id "PW:0000534"^^xsd:string ;
  rdfs:label "glycogen degradation pathway"^^xsd:string ;
  skos:notation "PW:0000534"^^xsd:string .

ns1:PW_0000535
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000103 ;
  ns2:treeView ns1:PW_0000103 ;
  ns1:IAO_0000115 "The pathway that mediates the transport of proteins to their proper destination and the trafficking of proteins between organelles. Notable examples are the nucleocytoplasmic shuttling and the mitochondrial protein import pathways."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000535"^^xsd:string ;
  rdfs:label "protein transport pathway"^^xsd:string ;
  skos:notation "PW:0000535"^^xsd:string .

ns1:PW_0000536
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000636 ;
  ns2:treeView ns1:PW_0000636 ;
  ns1:IAO_0000115 "In the constitutive secretory pathway, common to all cell types, newly synthesized proteins are sorted into transport vesicles and targeted to their destination in the absence of a signal."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000536"^^xsd:string ;
  rdfs:label "constitutive protein secretory pathway"^^xsd:string ;
  skos:notation "PW:0000536"^^xsd:string .

ns1:PW_0000537
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000636 ;
  ns2:treeView ns1:PW_0000636 ;
  ns1:IAO_0000115 "In the regulated secretory pathway, secreted proteins are sorted into secretory vesicles which are stored intracellularly and move to the final destination upon receiving a signal. It is a salient feature of endocrine and neuroendocrine cells."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000537"^^xsd:string ;
  rdfs:label "regulated protein secretory pathway"^^xsd:string ;
  skos:notation "PW:0000537"^^xsd:string .

ns1:PW_0000538
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000535 ;
  ns2:treeView ns1:PW_0000535 ;
  ns1:IAO_0000115 "The import-export cycle that underlies the shuttling of proteins between the cytoplasm and the nucleus."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000538"^^xsd:string ;
  rdfs:label "nuclear protein transport pathway"^^xsd:string ;
  skos:notation "PW:0000538"^^xsd:string .

ns1:PW_0000539
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000357
  ] ;
  ns2:treeView ns1:PW_0000357, ns1:PW_0000467 ;
  ns3:part_of ns1:PW_0000357 ;
  ns1:IAO_0000115 "Ghrelin is an appetite-stimulating hormone secreted primarily from the stomach in response to fasting that can downregulate energy expenditure and lead to weight increase."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000539"^^xsd:string ;
  rdfs:label "ghrelin system pathway"^^xsd:string ;
  skos:notation "PW:0000539"^^xsd:string .

ns1:PW_0000540
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001601 ;
  ns2:treeView ns1:PW_0001601 ;
  ns1:IAO_0000115 "Obesity, usually defined as 20% or more excess body weight, constitutes a major public health problem and an independent risk factor for a number of conditions such as hypertension and diabetes. Deregulation of energy homeostasis, of various metabolic and signaling pathways, genetic and environmental aspects, all can contribute to the development of an obese state."^^xsd:string ;
  obo:hasExactSynonym "obesity disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000540"^^xsd:string ;
  rdfs:label "obesity pathway"^^xsd:string ;
  skos:notation "PW:0000540"^^xsd:string .

ns1:PW_0000541
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000003 ;
  ns2:treeView ns1:PW_0000003 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000541"^^xsd:string ;
  rdfs:label "signaling pathway involving second messengers"^^xsd:string ;
  skos:notation "PW:0000541"^^xsd:string .

ns1:PW_0000542
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000541, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000357
  ] ;
  ns2:treeView ns1:PW_0000357, ns1:PW_0000541 ;
  ns3:part_of ns1:PW_0000357 ;
  ns1:IAO_0000115 "AMPK senses changes in cellular energy as ATP/AMP ratio. AMP binding allosterically activates AMPK; subsequent phosphorylation events lead to repression of energy consuming pathways. One target of AMPK is mTOR signaling pathway. AMPK activates the inhibitory Tsc2 while inhibiting mTorc1 complex."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "5'AMP-activated protein kinase"^^xsd:string, "AMPK signaling pathway"^^xsd:string ;
  obo:id "PW:0000542"^^xsd:string ;
  rdfs:label "adenosine monophosphate-activated protein kinase (AMPK) signaling pathway"^^xsd:string ;
  skos:notation "PW:0000542"^^xsd:string .

ns1:PW_0000543
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000541, ns1:PW_0001194 ;
  ns2:treeView ns1:PW_0000541, ns1:PW_0001194 ;
  ns1:IAO_0000115 "Protein kinase A (PKA) signaling is a widely used intracellular pathway and the major route for channeling the cAMP signal. cAMP is regulated by adenylyl cyclases that produce it and phosphodiesterases that hydrolyze it. Compartmentalization of PKA signaling is mediated by the AKAP family of scaffold proteins that bring together the kinase, cAMP modulators and sometimes the targets."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "cAMP-dependent protein kinase A signaling pathway"^^xsd:string, "cAMP/PKA signaling pathway"^^xsd:string ;
  obo:id "PW:0000543"^^xsd:string ;
  rdfs:label "protein kinase A (PKA) signaling pathway"^^xsd:string ;
  skos:notation "PW:0000543"^^xsd:string .

ns1:PW_0000544
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000484, ns1:PW_0000498, ns1:PW_0001347 ;
  ns2:treeView ns1:PW_0000484, ns1:PW_0000498, ns1:PW_0001347 ;
  ns1:IAO_0000115 "An impaired pathway of reverse cholesterol transport and efflux can pose a risk for the development of cardiovascular disease. This varies in severity and manifestation depending on which gene in the pathway is affected."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered RCT pathway"^^xsd:string ;
  obo:id "PW:0000544"^^xsd:string ;
  rdfs:label "altered reverse cholesterol transport pathway"^^xsd:string ;
  skos:notation "PW:0000544"^^xsd:string .

ns1:PW_0000545
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000103, ns1:PW_0000263 ;
  ns2:treeView ns1:PW_0000103, ns1:PW_0000263 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000545"^^xsd:string ;
  rdfs:label "altered transport pathway"^^xsd:string ;
  skos:notation "PW:0000545"^^xsd:string .

ns1:PW_0000546
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001161 ;
  ns2:treeView ns1:PW_0001161 ;
  ns1:IAO_0000115 "The pathways of mRNA quality control thereby erroneous mRNA is degraded in the nucleus or cytoplasm, or normal mRNA accumulated in the nucleus is degraded."^^xsd:string ;
  obo:hasExactSynonym "mRNA quality control pathway"^^xsd:string, "mRNA surveillance pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:03015"^^xsd:string ;
  obo:id "PW:0000546"^^xsd:string ;
  rdfs:label "mRNA decay pathway"^^xsd:string ;
  skos:notation "PW:0000546"^^xsd:string .

ns1:PW_0000547
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000546, ns1:PW_0001641 ;
  ns2:treeView ns1:PW_0000546, ns1:PW_0001641 ;
  ns1:IAO_0000115 "The nuclear exosome pathway degrades erroneous mRNA as well as normal mRNA that has accumulated in the nucleus. The nucleolar exosome is  involved in the processing of rRNA."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "exosome mediated mRNA degradation pathway"^^xsd:string ;
  obo:id "PW:0000547"^^xsd:string ;
  rdfs:label "exosome mediated RNA decay pathway"^^xsd:string ;
  skos:notation "PW:0000547"^^xsd:string .

ns1:PW_0000548
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000546 ;
  ns2:treeView ns1:PW_0000546 ;
  ns1:IAO_0000115 "The nonsense-mediated decay pathway (NMD) degrades mRNA that contains a premature translation termination codon (PTC) and is one of the best characterized systems in eukaryotes."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "NMD pathway"^^xsd:string ;
  obo:id "PW:0000548"^^xsd:string ;
  rdfs:label "nonsense-mediated mRNA decay pathway"^^xsd:string ;
  skos:notation "PW:0000548"^^xsd:string .

ns1:PW_0000549
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000546 ;
  ns2:treeView ns1:PW_0000546 ;
  ns1:IAO_0000115 "The nonstop mRNA decay pathway degrades mRNA that lacks a translation termination codon."^^xsd:string ;
  obo:hasExactSynonym "NSD pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000549"^^xsd:string ;
  rdfs:label "nonstop mRNA decay pathway"^^xsd:string ;
  skos:notation "PW:0000549"^^xsd:string .

ns1:PW_0000550
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000546 ;
  ns2:treeView ns1:PW_0000546 ;
  ns1:IAO_0000115 "Staufen-mediated mRNA decay pathway (SMD) is a rather novel pathway identified in mammals. Staufen (Stau1) is thought to be involved in mRNA localization and it has recently been shown to be involved in mRNA decay. It shares some of the features of the nonsense-mediated mRNA decay pathway (NMD) but does not require components essential for NMD."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMD pathway"^^xsd:string ;
  obo:id "PW:0000550"^^xsd:string ;
  rdfs:label "Staufen-mediated mRNA decay pathway"^^xsd:string ;
  skos:notation "PW:0000550"^^xsd:string .

ns1:PW_0000551
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000290, ns1:PW_0000546 ;
  ns2:treeView ns1:PW_0000290, ns1:PW_0000546 ;
  ns1:IAO_0000115 "An mRNA decay pathway that deviates from what its normal course should be. An aberrant mRNA decay pathway would lead to the translation of erroneous mRNA with potentially serious consequences."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000551"^^xsd:string ;
  rdfs:label "altered mRNA decay pathway"^^xsd:string ;
  skos:notation "PW:0000551"^^xsd:string .

ns1:PW_0000552
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000147 ;
  ns2:treeView ns1:PW_0000147 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the biosynthesis of brassinosteroids or brassins, a group of plant hormones released in response to low oxygen and sugar, or to root stresses."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000552"^^xsd:string ;
  rdfs:label "brassinosteroid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000552"^^xsd:string .

ns1:PW_0000553
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000355 ;
  ns2:treeView ns1:PW_0000355 ;
  ns1:IAO_0000115 "Those pathways involved in the balanced maintenance of  glucose levels, transport and processing as demanded by the needs of the cells, tissues and organs. Glucose is an important and the most efficient fuel source.  Disruption of glucose homeostasis underlies many complex disorders."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000553"^^xsd:string ;
  rdfs:label "glucose homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0000553"^^xsd:string .

ns1:PW_0000554
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000575, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000553
  ] ;
  ns2:treeView ns1:PW_0000553, ns1:PW_0000575 ;
  ns3:part_of ns1:PW_0000553 ;
  ns1:IAO_0000115 "Glucose diffusion into cells requires specific transporter proteins. Two families of hexose transporters facilitate glucose transport down its concentration gradient."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000554"^^xsd:string ;
  rdfs:label "glucose transport pathway"^^xsd:string ;
  skos:notation "PW:0000554"^^xsd:string .

ns1:PW_0000555
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000553
  ] ;
  ns2:treeView ns1:PW_0000553 ;
  ns3:part_of ns1:PW_0000553 ;
  ns1:IAO_0000115 "The various pathways thereby glucose is oxidized to produce energy, is converted to other molecules or is stored for further use."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000555"^^xsd:string ;
  rdfs:label "glucose utilization pathway"^^xsd:string ;
  skos:notation "PW:0000555"^^xsd:string .

ns1:PW_0000556
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000555 ;
  ns2:treeView ns1:PW_0000555 ;
  ns1:IAO_0000115 "The various pathways thereby glucose is converted to other compounds to yield primarily ATP. The final oxidation of glucose to carbon dioxide and water produces a net of 38 molecules of ATP per molecule of glucose."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000556"^^xsd:string ;
  rdfs:label "glucose oxidation pathway"^^xsd:string ;
  skos:notation "PW:0000556"^^xsd:string .

ns1:PW_0000557
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000555 ;
  ns2:treeView ns1:PW_0000555 ;
  ns1:IAO_0000115 "Glycogen is the major form of glucose storage. Excess glucose is converted into glycogen - a highly branched polysaccharide. When glucose is rapidly needed, glycogen can be broken down via glycogenolysis."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000557"^^xsd:string ;
  rdfs:label "glucose storage pathway"^^xsd:string ;
  skos:notation "PW:0000557"^^xsd:string .

ns1:PW_0000558
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000555 ;
  ns2:treeView ns1:PW_0000555 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000558"^^xsd:string ;
  rdfs:label "glucose conversion pathway"^^xsd:string ;
  skos:notation "PW:0000558"^^xsd:string .

ns1:PW_0000559
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000558, ns1:PW_0000570 ;
  ns2:treeView ns1:PW_0000558, ns1:PW_0000570 ;
  ns1:IAO_0000115 "The formation of nucleotide hexosamines, primarily UDP-N-acetylglucosamine, constitutes the final step in the hexosamine biosynthetic pathway which provides substrates for the O-linked glycosylation of proteins. Glycoproteins that are either secreted from the cell or inserted into the plasma membrane undergo N-linked glycosylation. The O-linked glycosylation of nuclear and/or cytosolic proteins confers a signaling dimension to the hexosamine biosynthetic pathway."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000559"^^xsd:string ;
  rdfs:label "hexosamine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000559"^^xsd:string .

ns1:PW_0000560
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000554 ;
  ns2:treeView ns1:PW_0000554 ;
  ns1:IAO_0000115 "The GLUT family contains 14 members in mammals which can be grouped into 3 classes based on sequence similarities. The members of group I (best characterized) and of group III transporters facilitate glucose transport."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "GLUT mediated glucose transport pathway"^^xsd:string ;
  obo:id "PW:0000560"^^xsd:string ;
  rdfs:label "facilitative sugar transporter mediated glucose transport pathway"^^xsd:string ;
  skos:notation "PW:0000560"^^xsd:string .

ns1:PW_0000561
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000554 ;
  ns2:treeView ns1:PW_0000554 ;
  ns1:IAO_0000115 "The sodium-glucose or the sodium-dependent glucose cotransporters are characterized by the presence of 14 transmembrane alpha-helices. The N- and C-termini are responsible for permeating sodium and sugar, respectively."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SGLT mediated glucose transport pathway"^^xsd:string ;
  obo:id "PW:0000561"^^xsd:string ;
  rdfs:label "sodium-glucose cotransporter mediated glucose transport pathway"^^xsd:string ;
  skos:notation "PW:0000561"^^xsd:string .

ns1:PW_0000562
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467 ;
  ns2:treeView ns1:PW_0000467 ;
  ns1:IAO_0000115 "The growth hormone signaling pathway is an important regulator of postnatal development. However, despite many years of research, the molecular mechanism underlying its many actions are incompletely understood. It is believed that its actions involve direct and indirect routes. An example of the latter is the role the pathway plays in stimulating the production of insulin-like growth factor."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000562"^^xsd:string ;
  rdfs:label "growth hormone signaling pathway"^^xsd:string ;
  skos:notation "PW:0000562"^^xsd:string .

ns1:PW_0000563
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467 ;
  ns2:treeView ns1:PW_0000467 ;
  ns1:IAO_0000115 "Adiponectin signaling, a hormone secreted by the adipose tissue, impacts on metabolic pathways such as glucose and lipid metabolism, possibly via activation of AMPK pathway. Its deregulation has been linked to obesity, cardiovascular diseases, diabetes and metabolic syndrome."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000563"^^xsd:string ;
  rdfs:label "adiponectin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000563"^^xsd:string .

ns1:PW_0000564
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000567, ns1:PW_0000716, ns1:PW_0001313 ;
  ns2:treeView ns1:PW_0000567, ns1:PW_0000716, ns1:PW_0001313 ;
  ns1:IAO_0000115 "Androgens are C19 steroids that constitutes the male sex hormones. They are also the precursors of female sex hormones, the estrogens. Testosterone and its more potent metabolite, dihydrotestosterone bind to androgen receptors to then translocate to the nucleus and activate the transcription of target genes. Many regulators, both activators and repressors, have been identified. Upregulation of receptor activity has been implicated in prostate cancer."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200105"^^xsd:string ;
  obo:id "PW:0000564"^^xsd:string ;
  rdfs:label "androgen signaling pathway"^^xsd:string ;
  skos:notation "PW:0000564"^^xsd:string .

ns1:PW_0000565
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000469, ns1:PW_0000959 ;
  ns2:treeView ns1:PW_0000469, ns1:PW_0000959 ;
  ns1:IAO_0000115 "Eicosanoids, derived from omega-3 or omega-6 fatty acids, are represented by the leukotriene and prostanoid classes of which the latter is represented by several families. Some can act as endogenous ligands for members of the peroxisomal proliferator-activated nuclear receptors (PPARs). Once activated, PPARs heterodimerize with the retinoid X receptor (RXR) and modulate the expression of target genes."^^xsd:string ;
  obo:hasAlternativeId "PW:0001294"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200082"^^xsd:string ;
  obo:id "PW:0000565"^^xsd:string ;
  rdfs:label "eicosanoid signaling pathway"^^xsd:string ;
  skos:notation "PW:0000565"^^xsd:string .

ns1:PW_0000566
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000468 ;
  ns2:treeView ns1:PW_0000468 ;
  ns1:IAO_0000115 "Corticosteroids group together glucocorticoids and mineralocorticoids, C21-steroid hormones derived from cholesterol. They control a wide range of physiological and cellular responses. Synthetic drugs mimicking their effects are used in the treatment of many conditions. Side effects, long-term use and/or natural deficiencies have been associated with various disorders."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000566"^^xsd:string ;
  rdfs:label "corticosteroid signaling pathway"^^xsd:string ;
  skos:notation "PW:0000566"^^xsd:string .

ns1:PW_0000567
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000468 ;
  ns2:treeView ns1:PW_0000468 ;
  ns1:IAO_0000115 "Sex steroid mediated signaling pathways have important roles in the development and/or maintenance of sex-specific characteristics or attributes."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000567"^^xsd:string ;
  rdfs:label "sex steroids signaling pathway"^^xsd:string ;
  skos:notation "PW:0000567"^^xsd:string .

ns1:PW_0000568
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000716, ns1:PW_0000783, ns1:PW_0001313 ;
  ns2:treeView ns1:PW_0000716, ns1:PW_0000783, ns1:PW_0001313 ;
  ns1:IAO_0000115 "Aldosterone signaling through the mineralocorticoid receptor plays an important role in the balance of fluids and electrolytes in the body. Its biosynthesis is primarily regulated by the renin-angiotensin system and potassium ions concentration."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04960"^^xsd:string ;
  obo:id "PW:0000568"^^xsd:string ;
  rdfs:label "aldosterone signaling pathway"^^xsd:string ;
  skos:notation "PW:0000568"^^xsd:string .

ns1:PW_0000569
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000716, ns1:PW_0000782, ns1:PW_0001313 ;
  ns2:treeView ns1:PW_0000716, ns1:PW_0000782, ns1:PW_0001313 ;
  ns1:IAO_0000115 "Cortisol, also known as hydrocortison, is the most important glucocorticoid. Cortisol signaling, via binding to the glucocorticoid receptor present in almost every animal cell, is essential for many cellular and physiological functions."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200030"^^xsd:string ;
  obo:id "PW:0000569"^^xsd:string ;
  rdfs:label "cortisol signaling pathway"^^xsd:string ;
  skos:notation "PW:0000569"^^xsd:string .

ns1:PW_0000570
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000152 ;
  ns2:treeView ns1:PW_0000152 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of hexosamines, amino sugars created by adding an amino group to a hexose. Hexosamines, particularly N-acetylglucosamine, are used to modify proteins."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000570"^^xsd:string ;
  rdfs:label "hexosamine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000570"^^xsd:string .

ns1:PW_0000571
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000059, ns1:PW_0000168 ;
  ns2:treeView ns1:PW_0000059, ns1:PW_0000168 ;
  ns1:IAO_0000115 "Signaling pathways activated by members of the neurotrophic family of growth factors are involved in differentiation of progenitor cells, survival and differentiation of neural cells. They exert their effects by engaging specific tropomyosin-related kinase (Trk) receptors."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04722"^^xsd:string ;
  obo:id "PW:0000571"^^xsd:string ;
  rdfs:label "neurotrophic factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0000571"^^xsd:string .

ns1:PW_0000572
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000571 ;
  ns2:treeView ns1:PW_0000571 ;
  ns1:IAO_0000115 "Brain-derived neurotrophic factor (BDNF) signaling pathway plays important roles in the growth, differentiation and survival of neurons, particularly the striatal neurons. BDNF signals via the tropomyosin-related kinase receptor type B (TrkB) to activate PKC, PI3K-AKT and MAPK/ERK intracellular pathways. Impaired BDNF signaling contributes to the pathogenesis of conditions such as Huntington Disease (HD) and psychiatric disorders. Upregulation on the other hand, is associated with several malignancies."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "BDNF signaling pathway"^^xsd:string ;
  obo:id "PW:0000572"^^xsd:string ;
  rdfs:label "brain-derived neurotrophic factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0000572"^^xsd:string .

ns1:PW_0000573
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000556, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000045
  ] ;
  ns2:treeView ns1:PW_0000045, ns1:PW_0000556 ;
  ns3:part_of ns1:PW_0000045 ;
  ns1:IAO_0000115 "The oxidative (linear) phase of the pentose phosphate pathway involves the oxidation and decarboxylation of glucose-6-phosphate to produce the 5 carbon sugar ribulose-5-phosphate and the generation of NADPH."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000573"^^xsd:string ;
  rdfs:label "pentose phosphate pathway - oxidative phase"^^xsd:string ;
  skos:notation "PW:0000573"^^xsd:string .

ns1:PW_0000574
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000045
  ] ;
  ns2:treeView ns1:PW_0000045 ;
  ns3:part_of ns1:PW_0000045 ;
  ns1:IAO_0000115 "The non-oxidative (circular) phase of the pentose phosphate pathway involves conversion of  ribulose-5-phosphate to ribose-5-phosphate, important in the synthesis of nucleotides and nucleic acid, or to 3 or 6 carbon sugars."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000574"^^xsd:string ;
  rdfs:label "pentose phosphate pathway - non-oxidative phase"^^xsd:string ;
  skos:notation "PW:0000574"^^xsd:string .

ns1:PW_0000575
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000103 ;
  ns2:treeView ns1:PW_0000103 ;
  ns1:IAO_0000115 "Those pathways that mediate the transport of sugars across the cell membrane. Transport of glucose, one of the major energy sources in the cell, is an important aspect of sugar transport pathway."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "carbohydrate transport pathway"^^xsd:string ;
  obo:id "PW:0000575"^^xsd:string ;
  rdfs:label "sugar transport pathway"^^xsd:string ;
  skos:notation "PW:0000575"^^xsd:string .

ns1:PW_0000576
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000575 ;
  ns2:treeView ns1:PW_0000575 ;
  ns1:IAO_0000115 "The GLUT family contains 14 members in mammals which can be grouped into 3 classes based on sequence similarities. These transporters are characterized by the presence of 12 transmembrane alpha helices. Of the 14 members of the GLUT family, 11 have been shown to be involved in sugar transport pathway."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "GLUT mediated sugar transport pathway"^^xsd:string ;
  obo:id "PW:0000576"^^xsd:string ;
  rdfs:label "facilitative sugar transporter mediated sugar transport pathway"^^xsd:string ;
  skos:notation "PW:0000576"^^xsd:string .

ns1:PW_0000577
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000003 ;
  ns2:treeView ns1:PW_0000003 ;
  ns1:IAO_0000115 "Cytokines are small proteins released by the cell and acting as intercellular mediators. Chemokines are a subset of cytokine that can attract and activate leukocytes. They are characterized by a small size and the presence of four cysteines whose location is important for their structural folding. Cytokines or chemokines binding to cognate receptors triggers numerous downstream signaling cascades."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000577"^^xsd:string ;
  rdfs:label "cytokine and chemokine mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000577"^^xsd:string .

ns1:PW_0000578
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000168 ;
  ns2:treeView ns1:PW_0000168 ;
  ns1:IAO_0000115 "Scatter factor/hepatocyte signaling impacts on various biological processes such as proliferation and survival, morphogenesis and motility. SF/HGF and its receptor c-Met have also been implicated in tumor growth and angiogenesis."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SF/HGF signaling pathway"^^xsd:string ;
  obo:id "PW:0000578"^^xsd:string ;
  rdfs:label "scatter factor/hepatocyte growth factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0000578"^^xsd:string .

ns1:PW_0000579
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467 ;
  ns2:treeView ns1:PW_0000467 ;
  ns1:IAO_0000115 "Somatostatin signaling through its receptors regulates processes such as proliferation, secretion and motility via inhibition of growth hormone and factor. The potential anti-tumor activity of somatostatin has led to the development and clinical use of its analogs."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SRIF"^^xsd:string, "somatotropin release inhibitory factor"^^xsd:string ;
  obo:id "PW:0000579"^^xsd:string ;
  rdfs:label "somatostatin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000579"^^xsd:string .

ns1:PW_0000580
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000101
  ] ;
  ns2:treeView ns1:PW_0000101 ;
  ns3:part_of ns1:PW_0000101 ;
  ns1:IAO_0000115 "Translation initiation is the first, the rate-limiting and the most regulated step of translation. It involves the formation of a scanning competent small subunit. Upon finding the initiation codon, scanning is stopped, the large 60S subunit joins and an elongation competent 80S ribosome is formed."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000580"^^xsd:string ;
  rdfs:label "translation initiation pathway"^^xsd:string ;
  skos:notation "PW:0000580"^^xsd:string .

ns1:PW_0000581
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000101
  ] ;
  ns2:treeView ns1:PW_0000101 ;
  ns3:part_of ns1:PW_0000101 ;
  ns1:IAO_0000115 "Translation elongation involves sampling of aminoacyl-tRNAs until a cognate tRNA is found followed by peptidyl transfer and translocation reactions. The iterative step continues until a stop codon is read or other events stall the ribosome."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000581"^^xsd:string ;
  rdfs:label "translation elongation pathway"^^xsd:string ;
  skos:notation "PW:0000581"^^xsd:string .

ns1:PW_0000582
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000101
  ] ;
  ns2:treeView ns1:PW_0000101 ;
  ns3:part_of ns1:PW_0000101 ;
  ns1:IAO_0000115 "Translation termination occurs when a stop codon is read, followed by splitting of the ribosomal subunits and their recycling. Ribosome recycling also happens in the case of aberrantly stalled ribosomes due to features of mRNA, absence of a stop codon or its premature presence. In this case mRNA surveillance mechanisms trigger appropriate mRNA decay pathways."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000582"^^xsd:string ;
  rdfs:label "translation termination pathway"^^xsd:string ;
  skos:notation "PW:0000582"^^xsd:string .

ns1:PW_0000583
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467 ;
  ns2:treeView ns1:PW_0000467 ;
  ns1:IAO_0000115 "The orexin/hypocretin signaling appears to play a role in the stimulation of food intake. Alterations of the system are associated with the narcolepsy sleep disorder."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000583"^^xsd:string ;
  rdfs:label "orexin/hypocretin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000583"^^xsd:string .

ns1:PW_0000584
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000511, ns1:PW_0000583 ;
  ns2:treeView ns1:PW_0000511, ns1:PW_0000583 ;
  ns1:IAO_0000115 "An orexin/hypocretin signaling pathway that deviates from what its normal course should be. Alterations in orexin/hypocretin signaling pathway have been linked to narcolepsy. It may also play a role in obesity."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000584"^^xsd:string ;
  rdfs:label "altered orexin/hypocretin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000584"^^xsd:string .

ns1:PW_0000585
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000583 ;
  ns2:treeView ns1:PW_0000583 ;
  ns1:IAO_0000115 "Orexin/hypocretin signaling through receptor 1 couples to Galphaq class of G proteins. Orexin/hypocretin receptor 1 primarily binds orexin A. Orexin A and B are derived from prepro-orexin precursor."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000585"^^xsd:string ;
  rdfs:label "orexin/hypocretin signaling pathway via orexin/hypocretin receptor 1"^^xsd:string ;
  skos:notation "PW:0000585"^^xsd:string .

ns1:PW_0000586
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000583 ;
  ns2:treeView ns1:PW_0000583 ;
  ns1:IAO_0000115 "Orexin/hypocretin signaling through receptor 2 couples to Galphaq and the inhibitory Galphai classes of G proteins. Orexin/hypocretin receptor 2 binds both orexin A and B derived from the prepro-orexin precursor."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000586"^^xsd:string ;
  rdfs:label "orexin/hypocretin signaling pathway via orexin/hypocretin receptor 2"^^xsd:string ;
  skos:notation "PW:0000586"^^xsd:string .

ns1:PW_0000587
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000178 ;
  ns2:treeView ns1:PW_0000178 ;
  ns1:IAO_0000115 "Narcolepsy is a neurological condition characterized by excessive day sleep, an inability to maintain awake states. Dysfunction of the orexin/hypocretin signaling pathway has been linked to this condition."^^xsd:string ;
  obo:hasExactSynonym "narcolepsy disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000587"^^xsd:string ;
  rdfs:label "narcolepsy pathway"^^xsd:string ;
  skos:notation "PW:0000587"^^xsd:string .

ns1:PW_0000588
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000511, ns1:PW_0000563 ;
  ns2:treeView ns1:PW_0000511, ns1:PW_0000563 ;
  ns1:IAO_0000115 "An adiponectin signaling pathway that deviates from what its normal course should be. Deregulation of adiponectin signaling have been linked to obesity, cardiovascular diseases, diabetes and metabolic syndrome."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000588"^^xsd:string ;
  rdfs:label "altered adiponectin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000588"^^xsd:string .

ns1:PW_0000589
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001692 ;
  ns2:treeView ns1:PW_0001692 ;
  ns1:IAO_0000115 "Those pathways involved in the proper balance of metal ion levels, uptake and transport, utilization and storage as demanded by the needs of cells, tissues and organs. Disruption of metal ion homeostasis can have toxic and harmful consequences."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000589"^^xsd:string ;
  rdfs:label "metal homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0000589"^^xsd:string .

ns1:PW_0000590
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000589 ;
  ns2:treeView ns1:PW_0000589 ;
  ns1:IAO_0000115 "Those pathways involved in the proper balance of iron levels, uptake and transport, utilization and storage as needed by cells, tissues and organs. Iron is essential for many life processes but its reactivity makes it potentially dangerous."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000590"^^xsd:string ;
  rdfs:label "iron homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0000590"^^xsd:string .

ns1:PW_0000591
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000593, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000590
  ] ;
  ns2:treeView ns1:PW_0000590, ns1:PW_0000593 ;
  ns3:part_of ns1:PW_0000590 ;
  ns1:IAO_0000115 "The uptake and efflux routes of iron transport. Several systems mediate uptake of recycled and dietary iron. One system is involved in the efflux."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000591"^^xsd:string ;
  rdfs:label "iron transport pathway"^^xsd:string ;
  skos:notation "PW:0000591"^^xsd:string .

ns1:PW_0000592
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000590
  ] ;
  ns2:treeView ns1:PW_0000590 ;
  ns3:part_of ns1:PW_0000590 ;
  ns1:IAO_0000115 "The main storage system for iron is represented by ferritin. The iron entering the cell is in its ferrous Fe(II) form. It is oxidized to the stored ferric Fe(III) by the oxidase activity of ferritin heavy chain. Neuromelanin pigment, abundant in the dopaminergic neurons of the substantia nigra, is known as a metal chelator and is the storage form of iron in these cells."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000592"^^xsd:string ;
  rdfs:label "iron storage pathway"^^xsd:string ;
  skos:notation "PW:0000592"^^xsd:string .

ns1:PW_0000593
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001348 ;
  ns2:treeView ns1:PW_0001348 ;
  ns1:IAO_0000115 "Those pathways that mediate the uptake and transport of metal ions. Metal ion transport pathways are important aspects of metal ion homeostasis."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000593"^^xsd:string ;
  rdfs:label "metal ion transport pathway"^^xsd:string ;
  skos:notation "PW:0000593"^^xsd:string .

ns1:PW_0000594
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000358, ns1:PW_0000553 ;
  ns2:treeView ns1:PW_0000358, ns1:PW_0000553 ;
  ns1:IAO_0000115 "The pathways involved in the balanced maintenance of glucose levels, transport and processing as demanded by the needs of the cells, tissues and organs assure the maintenance of glucose homeostasis. Disruption in these pathways alter glucose homeostasis and underlie many complex disorders - type 2 diabetes and its associated complications is one example."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000594"^^xsd:string ;
  rdfs:label "altered glucose homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0000594"^^xsd:string .

ns1:PW_0000595
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000541 ;
  ns2:treeView ns1:PW_0000541 ;
  ns1:IAO_0000115 "Phosphatidylinositol kinases represent a family of lipid kinases that phosphorylate the 3' position of the inositol ring in target substrates. They are grouped into three classes: class I further subdivided into subclass A and B, class II and class III. By far the best known and characterized is class I, particularly IA that signals downstream of receptor tyrosine kinases and engages the Akt family of kinases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04070"^^xsd:string, "PI3K signaling pathway"^^xsd:string, "phosphoinositide 3-kinase signaling pathway"^^xsd:string ;
  obo:id "PW:0000595"^^xsd:string ;
  rdfs:label "phosphatidylinositol 3-kinase signaling pathway"^^xsd:string ;
  skos:notation "PW:0000595"^^xsd:string .

ns1:PW_0000596
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000143, ns1:PW_0000359, ns1:PW_0000511, ns1:PW_0000594 ;
  ns2:treeView ns1:PW_0000143, ns1:PW_0000359, ns1:PW_0000511, ns1:PW_0000594 ;
  ns1:IAO_0000115 "An insulin signaling pathway that deviates from what its normal course should be. Deregulation of insulin signaling can have profound health consequences due to its potential to alter glucose and energy homeostasis."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000596"^^xsd:string ;
  rdfs:label "altered insulin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000596"^^xsd:string .

ns1:PW_0000597
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000008 ;
  ns2:treeView ns1:PW_0000008 ;
  ns1:IAO_0000115 "The non-canonical Wnt signaling pathway groups the various Wnt signaling routes that are beta-catenin independent."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200020"^^xsd:string, "beta-catenin independent Wnt signaling pathway"^^xsd:string ;
  obo:id "PW:0000597"^^xsd:string ;
  rdfs:label "Wnt signaling, non-canonical pathway"^^xsd:string ;
  skos:notation "PW:0000597"^^xsd:string .

ns1:PW_0000598
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000008, ns1:PW_0000669, ns1:PW_0000673 ;
  ns2:treeView ns1:PW_0000008, ns1:PW_0000669, ns1:PW_0000673 ;
  ns1:IAO_0000115 "A Wnt signaling pathway that deviates from what its normal course should be. Deregulation of Wnt signaling has been implicated in several cancers as well as diseases other than cancer."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000598"^^xsd:string ;
  rdfs:label "altered Wnt signaling pathway"^^xsd:string ;
  skos:notation "PW:0000598"^^xsd:string .

ns1:PW_0000599
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000201, ns1:PW_0000598 ;
  ns2:treeView ns1:PW_0000201, ns1:PW_0000598 ;
  ns1:IAO_0000115 "A canonical Wnt signaling pathway that deviates from what its normal course should be. Mutations in core components of the canonical pathway have been implicated in several types of cancer as well as diseases other than cancer."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000599"^^xsd:string ;
  rdfs:label "altered Wnt signaling, canonical pathway"^^xsd:string ;
  skos:notation "PW:0000599"^^xsd:string .

ns1:PW_0000600
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000597, ns1:PW_0000598 ;
  ns2:treeView ns1:PW_0000597, ns1:PW_0000598 ;
  ns1:IAO_0000115 "A non-canonical Wnt signaling pathway that deviates from what its normal course should be. Deregulation of the beta-catenin independent pathway appears to play a role in the biology of tumors."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000600"^^xsd:string ;
  rdfs:label "altered Wnt signaling, non-canonical pathway"^^xsd:string ;
  skos:notation "PW:0000600"^^xsd:string .

ns1:PW_0000601
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000198, ns1:PW_0000422 ;
  ns2:treeView ns1:PW_0000198, ns1:PW_0000422 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000601"^^xsd:string ;
  rdfs:label "altered p38 MAPK signaling pathway"^^xsd:string ;
  skos:notation "PW:0000601"^^xsd:string .

ns1:PW_0000602
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000102, ns1:PW_0000421 ;
  ns2:treeView ns1:PW_0000102, ns1:PW_0000421 ;
  ns1:IAO_0000115 "A Raf/Mek/Erk signaling pathway that deviates from what its normal course should be. Aberrant Raf/Mek/Erk signaling has been implicated in many types of cancer."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000602"^^xsd:string ;
  rdfs:label "altered extracellular signal-regulated Raf/Mek/Erk signaling pathway"^^xsd:string ;
  skos:notation "PW:0000602"^^xsd:string .

ns1:PW_0000603
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000007 ;
  ns2:treeView ns1:PW_0000007 ;
  ns1:IAO_0000115 "Erk5 pathway, also known as the big MAP kinase, is activated by various stresses but not by inflammatory cytokines. In HeLa and PC12 cells, the pathway can be activated by growth factors."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Bmk1 MAPK signaling pathway"^^xsd:string ;
  obo:id "PW:0000603"^^xsd:string ;
  rdfs:label "Erk5 MAPK signaling pathway"^^xsd:string ;
  skos:notation "PW:0000603"^^xsd:string .

ns1:PW_0000604
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000421, ns1:PW_0000603 ;
  ns2:treeView ns1:PW_0000421, ns1:PW_0000603 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000604"^^xsd:string ;
  rdfs:label "altered Erk5 MAPK signaling pathway"^^xsd:string ;
  skos:notation "PW:0000604"^^xsd:string .

ns1:PW_0000605
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000013 ;
  ns2:treeView ns1:PW_0000013 ;
  ns1:IAO_0000115 "Cancer, or malignant neoplasm, represents a category of diseases characterized by uncontrolled cell growth and avoidance of apoptosis, invasion and metastasis.  Deregulation of many pathways - signaling, regulatory, metabolic and combination of them, have been implicated in susceptibility to or development of these conditions. Generally, cancer is classified according to the tissue or organ affected."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "neoplasm pathway"^^xsd:string ;
  obo:id "PW:0000605"^^xsd:string ;
  rdfs:label "cancer pathway"^^xsd:string ;
  skos:notation "PW:0000605"^^xsd:string .

ns1:PW_0000606
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000605 ;
  ns2:treeView ns1:PW_0000605 ;
  ns1:IAO_0000115 "Urogenital cancer groups those malignancies that affect the urinary system and reproductive organs. Deregulation of several pathways along with genetic damage accumulated over time can lead to the development of these conditions."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "genitourinary cancer pathway"^^xsd:string, "urinogenital cancer pathway"^^xsd:string ;
  obo:id "PW:0000606"^^xsd:string ;
  rdfs:label "urogenital cancer pathway"^^xsd:string ;
  skos:notation "PW:0000606"^^xsd:string .

ns1:PW_0000607
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000606 ;
  ns2:treeView ns1:PW_0000606 ;
  ns1:IAO_0000115 "Ovarian cancer is a leading cause of cancer deaths in women. Several susceptibility genes have been identified and they have a role to play in pathways involved in or regulating proliferation, DNA repair and apoptosis."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "ovarian neoplasm pathway"^^xsd:string ;
  obo:id "PW:0000607"^^xsd:string ;
  rdfs:label "ovarian cancer pathway"^^xsd:string ;
  skos:notation "PW:0000607"^^xsd:string .

ns1:PW_0000608
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000606 ;
  ns2:treeView ns1:PW_0000606 ;
  ns1:IAO_0000115 "Cervical cancer affects the cervical area and human papilloma virus (HPV) infection plays a major role in the pathogenesis of the condition. A number of HPV proteins interact with and affect the function of several host proteins that play a role in apoptoptic pathway and/or those involved in cell proliferation."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "cervical neoplasm pathway"^^xsd:string ;
  obo:id "PW:0000608"^^xsd:string ;
  rdfs:label "cervical cancer pathway"^^xsd:string ;
  skos:notation "PW:0000608"^^xsd:string .

ns1:PW_0000609
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000606 ;
  ns2:treeView ns1:PW_0000606 ;
  ns1:IAO_0000115 "Prostate cancer is a frequent form of cancer in men over the age of fifty. It is usually asymptomatic but when in an advanced stage, it may spread to other parts of the body, causing symptoms others than those sometimes observed. Several susceptibility as well as defective genes have been identified."^^xsd:string ;
  obo:hasExactSynonym "familial prostate cancer pathway"^^xsd:string, "hereditary prostate cancer pathway"^^xsd:string, "malignant tumor of the prostate pathway"^^xsd:string, "prostatic cancer pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05215"^^xsd:string, "prostate neoplasm pathway"^^xsd:string ;
  obo:id "PW:0000609"^^xsd:string ;
  rdfs:label "prostate cancer pathway"^^xsd:string ;
  skos:notation "PW:0000609"^^xsd:string .

ns1:PW_0000610
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000606 ;
  ns2:treeView ns1:PW_0000606 ;
  ns1:IAO_0000115 "Bladder cancer groups several types of malignant tumors of the urinary bladder. It is more prevalent in men than in women and combines both risk factors such as tobacco and exposure to certain carcinogens and genetic factors. Mutations in genes involved in a number of signaling pathways have been implicated in the development of these conditions."^^xsd:string ;
  obo:hasExactSynonym "bladder cancer pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05219"^^xsd:string, "bladder neoplasm pathway"^^xsd:string ;
  obo:id "PW:0000610"^^xsd:string ;
  rdfs:label "urinary bladder cancer pathway"^^xsd:string ;
  skos:notation "PW:0000610"^^xsd:string .

ns1:PW_0000611
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000606 ;
  ns2:treeView ns1:PW_0000606 ;
  ns1:IAO_0000115 "Endometrial cancer affects the lining of the uterus, or endometrium. Hormonal and genetic alterations play a role in the development of this carcinoma type. Mutations in genes acting in several pathways have been associated with the condition and its types."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05213"^^xsd:string, "endometrial neoplasm pathway"^^xsd:string ;
  obo:id "PW:0000611"^^xsd:string ;
  rdfs:label "endometrial cancer pathway"^^xsd:string ;
  skos:notation "PW:0000611"^^xsd:string .

ns1:PW_0000612
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000627 ;
  ns2:treeView ns1:PW_0000627 ;
  ns1:IAO_0000115 "Colorectal cancer are malignant tumors of the colon and rectum. Both risk factors usually relating to life style such as physical exercise or use of tobacco and genetics contribute to the development of the condition. Mutations in the components of canonical Wnt and Smad-dependent TGF-beta signaling and of DNA mismatch repair pathways  have been associated with the pathogenesis of colorectal cancer pathway."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05210"^^xsd:string, "colorectal neoplasm pathway"^^xsd:string ;
  obo:id "PW:0000612"^^xsd:string ;
  rdfs:label "colorectal cancer pathway"^^xsd:string ;
  skos:notation "PW:0000612"^^xsd:string .

ns1:PW_0000613
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000206, ns1:PW_0000335 ;
  ns2:treeView ns1:PW_0000206, ns1:PW_0000335 ;
  ns1:IAO_0000115 "A trasforming growth factor-beta (TGF-beta) signaling pathway that deviates from what its normal course should be. Altered Tgf-b signaling, primarily the well characterized SMAD dependent pathway, has been implicated in numerous conditions."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered TGF-beta signaling pathway"^^xsd:string ;
  obo:id "PW:0000613"^^xsd:string ;
  rdfs:label "altered transforming growth factor-beta signaling pathway"^^xsd:string ;
  skos:notation "PW:0000613"^^xsd:string .

ns1:PW_0000614
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000490, ns1:PW_0000613, ns1:PW_0000673 ;
  ns2:treeView ns1:PW_0000490, ns1:PW_0000613, ns1:PW_0000673 ;
  ns1:IAO_0000115 "A transfoming growth factor-beta Smad dependent signaling pathway that deviates from what its normal course should be. Altered TGF-beta Smad dependent signaling has been implicated in vascular conditions and tumorigenesis."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered TGF-beta Smad dependent signaling pathway"^^xsd:string ;
  obo:id "PW:0000614"^^xsd:string ;
  rdfs:label "altered transforming growth factor-beta Smad dependent signaling pathway"^^xsd:string ;
  skos:notation "PW:0000614"^^xsd:string .

ns1:PW_0000615
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000330, ns1:PW_0000335, ns1:PW_0000673 ;
  ns2:treeView ns1:PW_0000330, ns1:PW_0000335, ns1:PW_0000673 ;
  ns1:IAO_0000115 "A bone morphogenetic protein (BMP) signaling pathway that deviates from what its normal course should be. Altered BMP signaling has been implicated in cardiovascular condition, pulmonary hypertension, the juvenile polyposis syndrome (JPS)."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered BMP signaling pathway"^^xsd:string ;
  obo:id "PW:0000615"^^xsd:string ;
  rdfs:label "altered bone morphogenetic protein signaling pathway"^^xsd:string ;
  skos:notation "PW:0000615"^^xsd:string .

ns1:PW_0000616
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000236, ns1:PW_0000617 ;
  ns2:treeView ns1:PW_0000236, ns1:PW_0000617 ;
  ns1:IAO_0000115 "Those tumor necrosis factor superfamily mediated pathways that deviate from what their normal course should be. Altered tumor necrosis factor superfamily pathways have been implicated in a spectrum of conditions ranging from septic shock and tumorigenesis to diabetes, rheumatoid arthritis and various inflammatory diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered TNF superfamily signaling pathay"^^xsd:string ;
  obo:id "PW:0000616"^^xsd:string ;
  rdfs:label "altered tumor necrosis factor superfamily mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000616"^^xsd:string .

ns1:PW_0000617
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000264, ns1:PW_0000828 ;
  ns2:treeView ns1:PW_0000264, ns1:PW_0000828 ;
  ns1:IAO_0000115 "A cytokine mediated signaling pathway that deviates from what its normal course should be. Aberrant cytokine signaling pathway, alone or in combination with other pathways underlie various diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000617"^^xsd:string ;
  rdfs:label "altered cytokine mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000617"^^xsd:string .

ns1:PW_0000618
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000233, ns1:PW_0000616, ns1:PW_0000680 ;
  ns2:treeView ns1:PW_0000233, ns1:PW_0000616, ns1:PW_0000680 ;
  ns1:IAO_0000115 "A tumor necrosis factor (Tnf) signaling pathway that deviates from what its normal course should be. Altered Tnf signaling has been implicated in many human diseases - cerebral malaria, cancer, multiple sclerosis - are a few examples."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered TNF signaling pathway"^^xsd:string, "altered TNF-alpha signaling pathway"^^xsd:string ;
  obo:id "PW:0000618"^^xsd:string ;
  rdfs:label "altered tumor necrosis factor mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000618"^^xsd:string .

ns1:PW_0000619
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000499, ns1:PW_0000719, ns1:PW_0001314, ns1:PW_0001543 ;
  ns2:treeView ns1:PW_0000499, ns1:PW_0000719, ns1:PW_0001314, ns1:PW_0001543 ;
  ns1:IAO_0000115 "A nuclear factor kappa B (NF-kB) signaling pathway that deviates from what its normal course should be. Altered NF-kB signaling has been implicated in a number of conditions including immunodeficiency, inflammation and several forms of cancer."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered NF-kB signaling pathway"^^xsd:string, "altered NF-kappaB signaling pathway"^^xsd:string ;
  obo:id "PW:0000619"^^xsd:string ;
  rdfs:label "altered nuclear factor kappa B signaling pathway"^^xsd:string ;
  skos:notation "PW:0000619"^^xsd:string .

ns1:PW_0000620
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000264, ns1:PW_0000541 ;
  ns2:treeView ns1:PW_0000264, ns1:PW_0000541 ;
  ns1:IAO_0000115 "Those signaling pathways involving second messengers that deviate from what their normal course should be. Deregulation of these pathways can have far reaching consequences."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000620"^^xsd:string ;
  rdfs:label "altered signaling pathway involving second messengers"^^xsd:string ;
  skos:notation "PW:0000620"^^xsd:string .

ns1:PW_0000621
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000595, ns1:PW_0000620 ;
  ns2:treeView ns1:PW_0000595, ns1:PW_0000620 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000621"^^xsd:string ;
  rdfs:label "altered phosphatidylinositol 3-kinase signaling pathway"^^xsd:string ;
  skos:notation "PW:0000621"^^xsd:string .

ns1:PW_0000622
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000232, ns1:PW_0000964, ns1:PW_0001199 ;
  ns2:treeView ns1:PW_0000232, ns1:PW_0000964, ns1:PW_0001199 ;
  ns1:IAO_0000115 "A phosphatidylinositol 3-kinase-Akt signaling pathway that deviates from what its normal course should be. Altered phosphatidylinositol 3-kinase-Akt signaling pathway has been implicated in several forms of cancer. The components of the pathway are attractive targets for the development of therapeutics."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000622"^^xsd:string ;
  rdfs:label "altered phosphatidylinositol 3-kinase-Akt signaling pathway"^^xsd:string ;
  skos:notation "PW:0000622"^^xsd:string .

ns1:PW_0000623
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000298, ns1:PW_0000578 ;
  ns2:treeView ns1:PW_0000298, ns1:PW_0000578 ;
  ns1:IAO_0000115 "A scatter factor/hepatocyte growth factor signaling pathway that deviates from what its normal course should be. Aberrant Hgf signaling via Met receptor has been implicated in numerous forms of cancer."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered HGF/SF signaling pathway"^^xsd:string ;
  obo:id "PW:0000623"^^xsd:string ;
  rdfs:label "altered scatter factor/hepatocyte growth factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0000623"^^xsd:string .

ns1:PW_0000624
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000605 ;
  ns2:treeView ns1:PW_0000605 ;
  ns1:IAO_0000115 "Breast cancer or neoplasm is the most common cancer among women and the second worldwide after lung cancer. Deregulated pathways such estrogen or PI3K-Akt signaling have been implicated in breast cancer. In many cases, the disease is estrogen-dependent and it is possible that dysregulation of miRNA may correlate with the expression of estrogen receptor. Mutations in a number of other genes such as Brca1, 2 and 3 or p53 have also been associated with breast cancer."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "breast neoplasm"^^xsd:string ;
  obo:id "PW:0000624"^^xsd:string ;
  rdfs:label "breast cancer pathway"^^xsd:string ;
  skos:notation "PW:0000624"^^xsd:string .

ns1:PW_0000625
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000605 ;
  ns2:treeView ns1:PW_0000605 ;
  ns1:IAO_0000115 "A general term grouping neoplastic pathways of the biliary tract, liver, pancreas and the gastrointestinal system."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "digestive system neoplasm pathway"^^xsd:string, "gastrointestinal neoplasm pathway"^^xsd:string ;
  obo:id "PW:0000625"^^xsd:string ;
  rdfs:label "digestive system cancer pathway"^^xsd:string ;
  skos:notation "PW:0000625"^^xsd:string .

ns1:PW_0000626
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000625, ns1:PW_0000700 ;
  ns2:treeView ns1:PW_0000625, ns1:PW_0000700 ;
  ns1:IAO_0000115 "Pancreatic cancer, a malignant tumor of the pancreas, has both genetic and predisposing factors. Deregulated pathways, such as TGF-B, PI3K-Akt or RAF/MEK/ERK, have been implicated in the development of pancreatic cancer."^^xsd:string ;
  obo:hasExactSynonym "malignant neoplasm of pancreas pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05212"^^xsd:string, "pancreatic neoplasm pathway"^^xsd:string ;
  obo:id "PW:0000626"^^xsd:string ;
  rdfs:label "pancreatic cancer pathway"^^xsd:string ;
  skos:notation "PW:0000626"^^xsd:string .

ns1:PW_0000627
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000625 ;
  ns2:treeView ns1:PW_0000625 ;
  ns1:IAO_0000115 "A general term grouping neoplastic pathways of the esophagus, gastric or stomach and intestinal system."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "gastrointestinal neoplasm pathway"^^xsd:string ;
  obo:id "PW:0000627"^^xsd:string ;
  rdfs:label "gastrointestinal cancer pathway"^^xsd:string ;
  skos:notation "PW:0000627"^^xsd:string .

ns1:PW_0000628
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000627 ;
  ns2:treeView ns1:PW_0000627 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "intestinal neoplasm pathway"^^xsd:string ;
  obo:id "PW:0000628"^^xsd:string ;
  rdfs:label "intestinal cancer pathway"^^xsd:string ;
  skos:notation "PW:0000628"^^xsd:string .

ns1:PW_0000629
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000627 ;
  ns2:treeView ns1:PW_0000627 ;
  ns1:IAO_0000115 "Gastric cancer is the fourth most common form of cancer worldwide and has a high death rate. Deregulated pathways, such as Wnt, PI3K-Akt or RAF/MEK/ERK, have been implicated in the development of gastric cancer."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "gastric neoplasm pathway"^^xsd:string, "stomach cancer pathway"^^xsd:string, "stomach neoplasm pathway"^^xsd:string ;
  obo:id "PW:0000629"^^xsd:string ;
  rdfs:label "gastric cancer pathway"^^xsd:string ;
  skos:notation "PW:0000629"^^xsd:string .

ns1:PW_0000630
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000625 ;
  ns2:treeView ns1:PW_0000625 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "hepatic cancer pathway"^^xsd:string, "hepatic neoplasm pathway"^^xsd:string, "liver neoplasm pathway"^^xsd:string ;
  obo:id "PW:0000630"^^xsd:string ;
  rdfs:label "liver cancer pathway"^^xsd:string ;
  skos:notation "PW:0000630"^^xsd:string .

ns1:PW_0000631
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000605 ;
  ns2:treeView ns1:PW_0000605 ;
  ns1:IAO_0000115 "A general term grouping neoplastic pathways of the upper aerodigestive system. Deregulated pathways, such as TGF-B, PI3K-Akt or epidermal growth factor (EGF) signaling, have been implicated in the of head and neck cancer."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "head and neck neoplasm pathway"^^xsd:string ;
  obo:id "PW:0000631"^^xsd:string ;
  rdfs:label "head and neck cancer pathway"^^xsd:string ;
  skos:notation "PW:0000631"^^xsd:string .

ns1:PW_0000632
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000605 ;
  ns2:treeView ns1:PW_0000605 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "bone neoplasm pathway"^^xsd:string ;
  obo:id "PW:0000632"^^xsd:string ;
  rdfs:label "bone cancer pathway"^^xsd:string ;
  skos:notation "PW:0000632"^^xsd:string .

ns1:PW_0000633
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000605 ;
  ns2:treeView ns1:PW_0000605 ;
  ns1:IAO_0000115 "A general term grouping together neoplastic pathways of the sweat and sebaceous gland or of neuroectodermal and neuroendocrine origins."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "skin neoplasm pathway"^^xsd:string ;
  obo:id "PW:0000633"^^xsd:string ;
  rdfs:label "skin cancer pathway"^^xsd:string ;
  skos:notation "PW:0000633"^^xsd:string .

ns1:PW_0000634
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000200, ns1:PW_0000600 ;
  ns2:treeView ns1:PW_0000200, ns1:PW_0000600 ;
  ns1:IAO_0000115 "A planar cell polarity Wnt signaling pathway that deviates from what its normal course should be. Altered planar cell polarity Wnt signaling has been implicated in a number of conditions including gastric and pancreatic cancer."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered PCP signaling pathway"^^xsd:string ;
  obo:id "PW:0000634"^^xsd:string ;
  rdfs:label "altered Wnt signaling, the planar cell polarity pathway"^^xsd:string ;
  skos:notation "PW:0000634"^^xsd:string .

ns1:PW_0000635
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000199, ns1:PW_0000600 ;
  ns2:treeView ns1:PW_0000199, ns1:PW_0000600 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered Wnt/Ca(II) signaling pathway"^^xsd:string ;
  obo:id "PW:0000635"^^xsd:string ;
  rdfs:label "altered Wnt/calcium signaling pathway"^^xsd:string ;
  skos:notation "PW:0000635"^^xsd:string .

ns1:PW_0000636
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000280
  ] ;
  ns2:treeView ns1:PW_0000280 ;
  ns3:part_of ns1:PW_0000280 ;
  ns1:IAO_0000115 "The protein exocytosis pathway involves trafficking of protein-containing vesicles to their final destination. It consists of several steps: budding, transport mediated by microtubule and actin associated molecular motors, tethering/docking and fusion with target membrane. Members of the Arf and Rab family of Ras superfamily are involved in the control of exit from Golgi and exocytic route, respectively. These are two main types of protein exocytosis which also represented in the more general exocytosis thereby material is delivered outside the cell."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000636"^^xsd:string ;
  rdfs:label "protein exocytosis pathway"^^xsd:string ;
  skos:notation "PW:0000636"^^xsd:string .

ns1:PW_0000637
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000432, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000280
  ] ;
  ns2:treeView ns1:PW_0000280, ns1:PW_0000432 ;
  ns3:part_of ns1:PW_0000280 ;
  ns1:IAO_0000115 "In the secretory pathway, the protein modification pathway involves the appropriate modification of glycoproteins and proteoglycans. It also provides for processing of the pro-forms of proteins into their mature form."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000637"^^xsd:string ;
  rdfs:label "protein modification pathway in the secretory pathway"^^xsd:string ;
  skos:notation "PW:0000637"^^xsd:string .

ns1:PW_0000638
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000325, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000280
  ] ;
  ns2:treeView ns1:PW_0000280, ns1:PW_0000325 ;
  ns3:part_of ns1:PW_0000280 ;
  ns1:IAO_0000115 "In the endoplasmic reticulum correctly folded proteins are targeted for further export whereas misfolded proteins are retained and targeted for degradation."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "ERAD pathway"^^xsd:string, "KEGG:04141"^^xsd:string ;
  obo:id "PW:0000638"^^xsd:string ;
  rdfs:label "Endoplasmic Reticulum-associated degradation pathway"^^xsd:string ;
  skos:notation "PW:0000638"^^xsd:string .

ns1:PW_0000639
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000560 ;
  ns2:treeView ns1:PW_0000560 ;
  ns1:IAO_0000115 "The GLUT family contains 14 members in mammals which can be grouped into 3 classes based on sequence similarities. The members of group I (best characterized) and of group III transporters facilitate glucose transport. Of the three members of group I, Slc2a4 (Glut4), is involved in insulin-mediated uptake of glucose in the heart, skeletal muscle and adipose tissue. The response - central to glucose homeostasis - brings together several signaling and trafficking events."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200196"^^xsd:string ;
  obo:id "PW:0000639"^^xsd:string ;
  rdfs:label "insulin responsive facilitative sugar transporter mediated glucose transport pathway"^^xsd:string ;
  skos:notation "PW:0000639"^^xsd:string .

ns1:PW_0000640
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000025, ns1:PW_0000556 ;
  ns2:treeView ns1:PW_0000025, ns1:PW_0000556 ;
  ns1:IAO_0000115 "The glycolytic pathway converts the six-carbon glucose to two three-carbon pyruvate molecules. The ten reactions of glycolysis can be subdivided into an energy consuming 'stage I' and an energy generating 'stage II'. The net energy yield is two molecules of ATP. Pyruvate can further be oxidized via the citrate cycle, converted to lactose under anaerobic conditions or back to glucose via gluconeogenesis."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Embden-Meyerhof-Parnas pathway"^^xsd:string, "KEGG:00010"^^xsd:string, "SMP:00040"^^xsd:string ;
  obo:id "PW:0000640"^^xsd:string ;
  rdfs:label "glycolysis pathway"^^xsd:string ;
  skos:notation "PW:0000640"^^xsd:string .

ns1:PW_0000641
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000025, ns1:PW_0000685 ;
  ns2:treeView ns1:PW_0000025, ns1:PW_0000685 ;
  ns1:IAO_0000115 "The gluconeogenic pathway involves the synthesis of glucose from noncarbohydrate precursors. They include the glycolysis products pyruvate and lactate, citric acid cycle intermediates and the carbon skeletons of many amino acids."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00010"^^xsd:string, "SMP:00128"^^xsd:string ;
  obo:id "PW:0000641"^^xsd:string ;
  rdfs:label "gluconeogenesis pathway"^^xsd:string ;
  skos:notation "PW:0000641"^^xsd:string .

ns1:PW_0000642
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000058 ;
  ns2:treeView ns1:PW_0000058 ;
  ns1:IAO_0000115 "Fatty acid degradation occurs primarily via beta oxidation in the mitochondrion. It also occurs via the alpha degradation in peroxisomes and the omega degradation which is an alternative pathway. Other pathways include the degradation of branched-chain, unsaturated and odd-chain fatty acids."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000642"^^xsd:string ;
  rdfs:label "fatty acid degradation pathway"^^xsd:string ;
  skos:notation "PW:0000642"^^xsd:string .

ns1:PW_0000643
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000305, ns1:PW_0000533 ;
  ns2:treeView ns1:PW_0000305, ns1:PW_0000533 ;
  ns1:IAO_0000115 "A glycogen metabolic pathway that deviates from what its normal course should be. Aberrant glycogen metabolism has been associated with several glycogen storage diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000643"^^xsd:string ;
  rdfs:label "altered glycogen metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000643"^^xsd:string .

ns1:PW_0000644
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000532, ns1:PW_0000643 ;
  ns2:treeView ns1:PW_0000532, ns1:PW_0000643 ;
  ns1:IAO_0000115 "A glycogen biosynthetic pathway that deviates from what its normal course should be. Aberrant glycogen metabolism has been associated with several glycogen storage diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000644"^^xsd:string ;
  rdfs:label "altered glycogen biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000644"^^xsd:string .

ns1:PW_0000645
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000534, ns1:PW_0000643 ;
  ns2:treeView ns1:PW_0000534, ns1:PW_0000643 ;
  ns1:IAO_0000115 "A glycogen degradation pathway that deviates from what its normal course should be. Aberrant glycogen metabolism has been associated with several glycogen storage diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000645"^^xsd:string ;
  rdfs:label "altered glycogen degradation pathway"^^xsd:string ;
  skos:notation "PW:0000645"^^xsd:string .

ns1:PW_0000646
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000648 ;
  ns2:treeView ns1:PW_0000648 ;
  ns1:IAO_0000115 "Cell-extracellular matrix signaling pathway conveys information between cells and components of the extracellular matrix using cell adhesion molecules."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04512"^^xsd:string, "cell-ECM signaling pathway"^^xsd:string ;
  obo:id "PW:0000646"^^xsd:string ;
  rdfs:label "cell-extracellular matrix signaling pathway"^^xsd:string ;
  skos:notation "PW:0000646"^^xsd:string .

ns1:PW_0000647
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000716, ns1:PW_0001313 ;
  ns2:treeView ns1:PW_0000716, ns1:PW_0001313 ;
  ns1:IAO_0000115 "Forkhead proteins represent a large family of transcription factors that regulate the expression of genes involved in cell growth, proliferation and survival as well as organ development and speech acquisition."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "FOX signaling pathway"^^xsd:string, "forkead box signaling pathway"^^xsd:string ;
  obo:id "PW:0000647"^^xsd:string ;
  rdfs:label "forkhead signaling pathway"^^xsd:string ;
  skos:notation "PW:0000647"^^xsd:string .

ns1:PW_0000648
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000003 ;
  ns2:treeView ns1:PW_0000003 ;
  ns1:IAO_0000115 "Cell adhesion signaling pathway conveys information between cells or between cells and the extracellular matrix (ECM) using cell adhesion molecules (CAMs). While many CAMs appear to be specialized for either cell-cell or cell-ECM communication, integrin family of receptors mediates both types of signaling."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000648"^^xsd:string ;
  rdfs:label "cell adhesion signaling pathway"^^xsd:string ;
  skos:notation "PW:0000648"^^xsd:string .

ns1:PW_0000649
  a owl:Class ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000649"^^xsd:string ;
  rdfs:label "<new term>"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0000649"^^xsd:string .

ns1:PW_0000650
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000003 ;
  ns2:treeView ns1:PW_0000003 ;
  ns1:IAO_0000115 "Those signaling pathways that are involved in or mediate the various aspects of development."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000650"^^xsd:string ;
  rdfs:label "signaling pathway pertinent to development"^^xsd:string ;
  skos:notation "PW:0000650"^^xsd:string .

ns1:PW_0000651
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000004 ;
  ns2:treeView ns1:PW_0000004 ;
  ns1:IAO_0000115 "Aging or the overall deteriorating change of function can be at the cellular level as well as the whole organism level. Cellular aging or senescence underlies organismal aging."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000651"^^xsd:string ;
  rdfs:label "aging pathway"^^xsd:string ;
  skos:notation "PW:0000651"^^xsd:string .

ns1:PW_0000652
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000003 ;
  ns2:treeView ns1:PW_0000003 ;
  ns1:IAO_0000115 "Phosphatases are essential components of biological pathways. Phosphorylaton by protein kinases and dephosphorylation by protein phosphatases exert major regulatory roles. In addition, they can also initiate signaling cascades."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000652"^^xsd:string ;
  rdfs:label "phosphatase mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000652"^^xsd:string .

ns1:PW_0000653
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000652 ;
  ns2:treeView ns1:PW_0000652 ;
  ns1:IAO_0000115 "Serine/threonine-specific phosphatase mediated signaling presents an interesting case. If the number of tyrosine kinases and of tyrosine phosphatases is similar (~100 in mammals), serine/threonine kinases have diversified to some 400 members in the course of evolution while the serine/threonine phosphatases count to about 25. The functional versatility is conferred through the diversity of regulatory subunits with which they interact. The holoenzyme dictates the role the protein complex plays in signaling pathways."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000653"^^xsd:string ;
  rdfs:label "serine/threonine-specific phosphatase mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000653"^^xsd:string .

ns1:PW_0000654
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000652 ;
  ns2:treeView ns1:PW_0000652 ;
  ns1:IAO_0000115 "The protein tyrosine phosphatase superfamily exerts essential roles in signaling pathways. The coordinated interplay of tyrosine kinase mediated phosphorylation and tyrosine phosphatase mediated dephosphorylation of substrates shapes the functional topology of signaling networks. The PTP superfamily is composed of four families."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000654"^^xsd:string ;
  rdfs:label "tyrosine-specific phosphatase mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000654"^^xsd:string .

ns1:PW_0000655
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000003 ;
  ns2:treeView ns1:PW_0000003 ;
  ns1:IAO_0000115 "Those signaling pathways mediated or initiated by oligosaccharide or polysaccharide linked proteins."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000655"^^xsd:string ;
  rdfs:label "glycoconjugated protein signaling pathway"^^xsd:string ;
  skos:notation "PW:0000655"^^xsd:string .

ns1:PW_0000656
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000655 ;
  ns2:treeView ns1:PW_0000655 ;
  ns1:IAO_0000115 "Those pathways initiated or mediated by glycoproteins. Glycoproteins have oligosaccharides attached to their amino acid side chains via N- or O-glycosylation. Glycoproteins represent a large category of proteins encompassing a wide range of functionalities."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000656"^^xsd:string ;
  rdfs:label "glycoprotein signaling pathway"^^xsd:string ;
  skos:notation "PW:0000656"^^xsd:string .

ns1:PW_0000657
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000655 ;
  ns2:treeView ns1:PW_0000655 ;
  ns1:IAO_0000115 "Those pathways initiated or mediated by proteoglycans - heavily glycosylated proteins that have glycosaminoglycan (GAG) chain(s) linked to their protein cores. GAGs are long unbranched polysaccharides of repeating disaccharide units. Proteoglycans are categorized by the nature of the GAG chain or by their size."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000657"^^xsd:string ;
  rdfs:label "proteoglycan signaling pathway"^^xsd:string ;
  skos:notation "PW:0000657"^^xsd:string .

ns1:PW_0000658
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000657 ;
  ns2:treeView ns1:PW_0000657 ;
  ns1:IAO_0000115 "Glypicans are heparan sulfate proteoglycans represented by six families in mammals. They impact on a number of signaling pathways; the effect on signaling can be either inhibitory or stimulatory, depending on the context. They also appear to integrate directional cues important for neuronal migration, axon guidance and synapse formation."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200026"^^xsd:string, "PID:200126"^^xsd:string, "PID:200225"^^xsd:string ;
  obo:id "PW:0000658"^^xsd:string ;
  rdfs:label "glypican signaling pathway"^^xsd:string ;
  skos:notation "PW:0000658"^^xsd:string .

ns1:PW_0000659
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000646, ns1:PW_0000657 ;
  ns2:treeView ns1:PW_0000646, ns1:PW_0000657 ;
  ns1:IAO_0000115 "Syndecan family of proteoglycans appears to be involved in cell-adhesion, particularly cell-extracellular matrix (ECM) signaling and to integrate with the integrin pathway. They also appear to integrate directional cues important for neuronal migration, axon guidance and synapse formation."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200134"^^xsd:string, "PID:200156"^^xsd:string, "PID:200192"^^xsd:string, "PID:200198"^^xsd:string ;
  obo:id "PW:0000659"^^xsd:string ;
  rdfs:label "syndecan signaling pathway"^^xsd:string ;
  skos:notation "PW:0000659"^^xsd:string .

ns1:PW_0000660
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000476
  ] ;
  ns2:treeView ns1:PW_0000476 ;
  ns3:part_of ns1:PW_0000476 ;
  ns1:IAO_0000115 "Hematopoiesis refers to the formation of blood cellular components. All components are derived from the hematopoietic stem cells residing in the marrow. A great amount of new blood cells needs to be produced daily to maintain steady state levels of circulation."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000660"^^xsd:string ;
  rdfs:label "hematopoiesis pathway"^^xsd:string ;
  skos:notation "PW:0000660"^^xsd:string .

ns1:PW_0000661
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000099 ;
  ns2:treeView ns1:PW_0000099 ;
  ns1:IAO_0000115 "A DNA repair pathway responsible for removing one or several damaged nucleotides or of  nucleotide mismatched during DNA replication in one of the DNA strands. Several excision pathways are available for correcting single-strand damage."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000661"^^xsd:string ;
  rdfs:label "single-strand DNA repair pathway"^^xsd:string ;
  skos:notation "PW:0000661"^^xsd:string .

ns1:PW_0000662
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000661 ;
  ns2:treeView ns1:PW_0000661 ;
  ns1:IAO_0000115 "Mismatch repair pathway assures the maintenance of normal Watson-Crick base pairing. Bases incorrectly matched during DNA replication are removed and replaced with the correct ones."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:03430"^^xsd:string, "MMR pathway"^^xsd:string ;
  obo:id "PW:0000662"^^xsd:string ;
  rdfs:label "mismatch repair pathway"^^xsd:string ;
  skos:notation "PW:0000662"^^xsd:string .

ns1:PW_0000663
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000099 ;
  ns2:treeView ns1:PW_0000099 ;
  ns1:IAO_0000115 "A pathway dealing with repair of double-strand breaks of the DNA or of strand damage such interstrand cross links."^^xsd:string ;
  obo:hasAlternativeId "PW:0000131"^^xsd:string, "PW:0000291"^^xsd:string, "PW:0000664"^^xsd:string, "PW:0000665"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000663"^^xsd:string ;
  rdfs:label "double-strand DNA repair pathway"^^xsd:string ;
  skos:notation "PW:0000663"^^xsd:string .

ns1:PW_0000664
  a owl:Class ;
  ns1:IAO_0000231 ns1:IAO_0000227 ;
  ns1:IAO_0100001 ns1:PW_0000663 ;
  owl:deprecated true ;
  skos:notation "PW:0000664"^^xsd:string .

ns1:PW_0000665
  a owl:Class ;
  ns1:IAO_0000231 ns1:IAO_0000227 ;
  ns1:IAO_0100001 ns1:PW_0000663 ;
  owl:deprecated true ;
  skos:notation "PW:0000665"^^xsd:string .

ns1:PW_0000666
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000292, ns1:PW_0000661 ;
  ns2:treeView ns1:PW_0000292, ns1:PW_0000661 ;
  ns1:IAO_0000115 "A single-strand DNA repair pathway that deviates from what its normal course should be. Aberrant single-strand repair pathways have been linked to several diseases."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000666"^^xsd:string ;
  rdfs:label "altered single-strand DNA repair pathway"^^xsd:string ;
  skos:notation "PW:0000666"^^xsd:string .

ns1:PW_0000667
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000292, ns1:PW_0000663 ;
  ns2:treeView ns1:PW_0000292, ns1:PW_0000663 ;
  ns1:IAO_0000115 "Defective repair pathway(s) of double-strand breaks can lead to chromosomal rearrangements, genomic instability and oncogenic activation."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000667"^^xsd:string ;
  rdfs:label "altered double-strand DNA repair pathway"^^xsd:string ;
  skos:notation "PW:0000667"^^xsd:string .

ns1:PW_0000668
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000662, ns1:PW_0000666 ;
  ns2:treeView ns1:PW_0000662, ns1:PW_0000666 ;
  ns1:IAO_0000115 "A mismatch repair pathway that deviates from what its normal course should be. Mutations in several genes in the pathway have been implicated in cases of colorectal cancer, primarily the inherited forms. To a lesser extent they are found in other types of cancer, such as for instance type 1 endometrial."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered MMR pathway"^^xsd:string ;
  obo:id "PW:0000668"^^xsd:string ;
  rdfs:label "altered mismatch repair pathway"^^xsd:string ;
  skos:notation "PW:0000668"^^xsd:string .

ns1:PW_0000669
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000656, ns1:PW_0000670 ;
  ns2:treeView ns1:PW_0000656, ns1:PW_0000670 ;
  ns1:IAO_0000115 "A glycoprotein signaling pathway that deviates from what its normal course should be."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000669"^^xsd:string ;
  rdfs:label "altered glycoprotein signaling pathway"^^xsd:string ;
  skos:notation "PW:0000669"^^xsd:string .

ns1:PW_0000670
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000264, ns1:PW_0000655 ;
  ns2:treeView ns1:PW_0000264, ns1:PW_0000655 ;
  ns1:IAO_0000115 "A glycoconjugated protein signaling pathway that deviates from what its normal course should be."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000670"^^xsd:string ;
  rdfs:label "altered glycoconjugated protein signaling pathway"^^xsd:string ;
  skos:notation "PW:0000670"^^xsd:string .

ns1:PW_0000671
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000264, ns1:PW_0000648 ;
  ns2:treeView ns1:PW_0000264, ns1:PW_0000648 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000671"^^xsd:string ;
  rdfs:label "altered cell adhesion signaling pathway"^^xsd:string ;
  skos:notation "PW:0000671"^^xsd:string .

ns1:PW_0000672
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000671 ;
  ns2:treeView ns1:PW_0000671 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000672"^^xsd:string ;
  rdfs:label "altered cell-extracellular matrix signaling pathway"^^xsd:string ;
  skos:notation "PW:0000672"^^xsd:string .

ns1:PW_0000673
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000264, ns1:PW_0000650 ;
  ns2:treeView ns1:PW_0000264, ns1:PW_0000650 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000673"^^xsd:string ;
  rdfs:label "altered signaling pathway pertinent to development"^^xsd:string ;
  skos:notation "PW:0000673"^^xsd:string .

ns1:PW_0000674
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000553
  ] ;
  ns2:treeView ns1:PW_0000553 ;
  ns3:part_of ns1:PW_0000553 ;
  ns1:IAO_0000115 "Insulin secretion by pancreatic beta-cells is an important aspect of glucose homeostasis. A major component of glucose stimulated insulin secretion is represented by the route dependent on the ATP sensitive potassium channels. However, other contributions are also likely to promote insulin secretion."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000674"^^xsd:string ;
  rdfs:label "insulin secretion pathway"^^xsd:string ;
  skos:notation "PW:0000674"^^xsd:string .

ns1:PW_0000675
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000553
  ] ;
  ns2:treeView ns1:PW_0000553 ;
  ns3:part_of ns1:PW_0000553 ;
  ns1:IAO_0000115 "Glucagon is secreted by pancreatic alpha cell; the mechanisms of its release in response to low glucose levels are poorly understood."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000675"^^xsd:string ;
  rdfs:label "glucagon secretion pathway"^^xsd:string ;
  skos:notation "PW:0000675"^^xsd:string .

ns1:PW_0000676
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000553
  ] ;
  ns2:treeView ns1:PW_0000467, ns1:PW_0000553 ;
  ns3:part_of ns1:PW_0000553 ;
  ns1:IAO_0000115 "Glucagon signaling responds to low levels of circulating glucose to stimulate its release. The action of glucagon signaling is counter-regulatory to the action of insulin and it plays an essential role in glucose homeostasis."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000676"^^xsd:string ;
  rdfs:label "glucagon signaling pathway"^^xsd:string ;
  skos:notation "PW:0000676"^^xsd:string .

ns1:PW_0000677
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000594, ns1:PW_0000674 ;
  ns2:treeView ns1:PW_0000594, ns1:PW_0000674 ;
  ns1:IAO_0000115 "An insulin secretion pathway that deviates from what its normal course should be. Altered insulin secretion has been associated with type 2 diabetes mellitus. Multiple defects are thought to underle malfunctions of insulin secretion; the exact molecular mechanisms are only partially understood."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000677"^^xsd:string ;
  rdfs:label "altered insulin secretion pathway"^^xsd:string ;
  skos:notation "PW:0000677"^^xsd:string .

ns1:PW_0000678
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000594, ns1:PW_0000675 ;
  ns2:treeView ns1:PW_0000594, ns1:PW_0000675 ;
  ns1:IAO_0000115 "A glucagon secretion pathway that deviates from what its normal course should be. Elevated serum glucagon has been observed in patients with type 2 diabetes. The pathway of glucagon secretion is not well understood and this complicates the understanding of how the pathway may falter."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000678"^^xsd:string ;
  rdfs:label "altered glucagon secretion pathway"^^xsd:string ;
  skos:notation "PW:0000678"^^xsd:string .

ns1:PW_0000679
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000511, ns1:PW_0000594, ns1:PW_0000676 ;
  ns2:treeView ns1:PW_0000511, ns1:PW_0000594, ns1:PW_0000676 ;
  ns1:IAO_0000115 "A glucagon signaling pathway that deviates from what its normal course should be. Glucagon signaling counteracts the signaling of insulin and the potential exists that an alteration of glucagon signaling has a role to play in diabetes type 2. Serum glucagon is elevated in patients with the disease; the mechanisms leading to and the consequences of elevated glucagon remain to be established."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000679"^^xsd:string ;
  rdfs:label "altered glucagon signaling pathway"^^xsd:string ;
  skos:notation "PW:0000679"^^xsd:string .

ns1:PW_0000680
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000106, ns1:PW_0000287 ;
  ns2:treeView ns1:PW_0000106, ns1:PW_0000287 ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000680"^^xsd:string ;
  rdfs:label "altered extrinsic apoptotic pathway"^^xsd:string ;
  skos:notation "PW:0000680"^^xsd:string .

ns1:PW_0000681
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000106, ns1:PW_0000236 ;
  ns2:treeView ns1:PW_0000106, ns1:PW_0000236 ;
  ns1:IAO_0000115 "Fas ligand binding to its receptor triggers a conformational change that allows the receptor to assemble a signaling complex known as DISC, followed by recruitment of pro-caspase-8 and activation of caspase-3 and -7. It is believed that Fas mediated signaling to elicit apoptosis follows two routes."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200080"^^xsd:string ;
  obo:id "PW:0000681"^^xsd:string ;
  rdfs:label "FasL mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000681"^^xsd:string .

ns1:PW_0000682
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000106, ns1:PW_0000236 ;
  ns2:treeView ns1:PW_0000106, ns1:PW_0000236 ;
  ns1:IAO_0000115 "Trail mediated signaling leads to apoptosis via assembly of the DISC complex (Death-Inducing Signaling Complex) downstream of its receptors."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200068"^^xsd:string ;
  obo:id "PW:0000682"^^xsd:string ;
  rdfs:label "Trail mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000682"^^xsd:string .

ns1:PW_0000683
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000286, ns1:PW_0000332 ;
  ns2:treeView ns1:PW_0000286, ns1:PW_0000332 ;
  ns1:IAO_0000115 "A cell-cell signaling pathway mediated by integrins, a family of receptors that convey both 'outside-in' and 'inside-out' signals."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2009-08-03T02:43:27Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000683"^^xsd:string ;
  rdfs:label "integrin mediated cell-cell signaling pathway"^^xsd:string ;
  skos:notation "PW:0000683"^^xsd:string .

ns1:PW_0000684
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000286, ns1:PW_0000646 ;
  ns2:treeView ns1:PW_0000286, ns1:PW_0000646 ;
  ns1:IAO_0000115 "A cell-extracellular matrix signaling pathway mediated by integrins, a family of receptors that convey both 'outside-in' and 'inside-out' signals."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2009-08-03T02:45:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "integrin mediated cell-ECM signaling pathway"^^xsd:string ;
  obo:id "PW:0000684"^^xsd:string ;
  rdfs:label "integrin mediated cell-extracellular matrix signaling pathway"^^xsd:string ;
  skos:notation "PW:0000684"^^xsd:string .

ns1:PW_0000685
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000553
  ] ;
  ns2:treeView ns1:PW_0000553 ;
  ns3:part_of ns1:PW_0000553 ;
  ns1:IAO_0000115 "The metabolic pathways for generating glucose to meet the body's glucose needs. Gluconeogenesis in the liver and to some extent in kidney is the major pathway of glucose production; glycogenolysis is another route for generating glucose in these tissues."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2009-08-05T08:54:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000685"^^xsd:string ;
  rdfs:label "glucose biosynthesis pathway"^^xsd:string ;
  skos:notation "PW:0000685"^^xsd:string .

ns1:PW_0000686
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000491, ns1:PW_0000511, ns1:PW_0001538 ;
  ns2:treeView ns1:PW_0000491, ns1:PW_0000511, ns1:PW_0001538 ;
  ns1:IAO_0000115 "A vasopressin signaling pathway that deviates from what its normal course should be. Altered vasopressin signaling manifests clinically as problems associated with water and sodium balance."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2009-08-27T09:07:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000686"^^xsd:string ;
  rdfs:label "altered vasopressin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000686"^^xsd:string .

ns1:PW_0000687
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000545, ns1:PW_0000575 ;
  ns2:treeView ns1:PW_0000545, ns1:PW_0000575 ;
  ns1:IAO_0000115 "A sugar transport pathway that deviates from what its normal course should be. Alterations in sugar transport, particularly glucose, can potentially have very harmful consequences."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2009-10-07T11:59:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000687"^^xsd:string ;
  rdfs:label "altered sugar transport pathway"^^xsd:string ;
  skos:notation "PW:0000687"^^xsd:string .

ns1:PW_0000688
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000576, ns1:PW_0000687 ;
  ns2:treeView ns1:PW_0000576, ns1:PW_0000687 ;
  ns1:IAO_0000115 "A facilitative sugar transporter mediated sugar transport pathway that deviates from what its normal course should be. Alterations in sugar transport, particularly glucose, can potentially have very harmful consequences."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2009-10-07T12:05:27Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000688"^^xsd:string ;
  rdfs:label "altered facilitative sugar transporter mediated sugar transport pathway"^^xsd:string ;
  skos:notation "PW:0000688"^^xsd:string .

ns1:PW_0000689
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000554, ns1:PW_0000594, ns1:PW_0000687 ;
  ns2:treeView ns1:PW_0000554, ns1:PW_0000594, ns1:PW_0000687 ;
  ns1:IAO_0000115 "A glucose transport pathway that deviates from what its normal course should be. Alterations in glucose transport can potentially have very harmful consequences."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2009-10-07T12:08:39Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000689"^^xsd:string ;
  rdfs:label "altered glucose transport pathway"^^xsd:string ;
  skos:notation "PW:0000689"^^xsd:string .

ns1:PW_0000690
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000560, ns1:PW_0000689 ;
  ns2:treeView ns1:PW_0000560, ns1:PW_0000689 ;
  ns1:IAO_0000115 "A facilitative sugar transporter mediated glucose transport pathway that deviates from what its normal course should be. Alterations in glucose transport can potentially have very harmful consequences."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2009-10-07T12:12:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000690"^^xsd:string ;
  rdfs:label "altered facilitative sugar transporter mediated glucose transport pathway"^^xsd:string ;
  skos:notation "PW:0000690"^^xsd:string .

ns1:PW_0000691
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000561, ns1:PW_0000689 ;
  ns2:treeView ns1:PW_0000561, ns1:PW_0000689 ;
  ns1:IAO_0000115 "A sodium-glucose cotransporter mediated glucose transport pathway that deviates from what its normal course should be. Alterations in glucose transport can potentially have very harmful consequences."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2009-10-07T12:21:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000691"^^xsd:string ;
  rdfs:label "altered sodium-glucose cotransporter mediated glucose transport pathway"^^xsd:string ;
  skos:notation "PW:0000691"^^xsd:string .

ns1:PW_0000692
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000639, ns1:PW_0000690 ;
  ns2:treeView ns1:PW_0000639, ns1:PW_0000690 ;
  ns1:IAO_0000115 "An insulin responsive facilitative sugar transporter mediated glucose transport pathway that deviates from what its normal course should be. Alterations in the pathway can manifest in insulin resistance, a hallmark of type 2 diabetes."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2009-10-07T12:24:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000692"^^xsd:string ;
  rdfs:label "altered insulin responsive facilitative sugar transporter mediated glucose transport pathway"^^xsd:string ;
  skos:notation "PW:0000692"^^xsd:string .

ns1:PW_0000693
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000107 ;
  ns2:treeView ns1:PW_0000107 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the degradation of biphenyl, an aromatic hydrocarbon used as a starting material for the production of polychlorinated biphenyls or as an intermediate for the production of a variety of organic compounds."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2009-10-20T08:59:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000693"^^xsd:string ;
  rdfs:label "biphenyl degradation pathway"^^xsd:string ;
  skos:notation "PW:0000693"^^xsd:string .

ns1:PW_0000694
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000107 ;
  ns2:treeView ns1:PW_0000107 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the degradation of geraniol, a monoterpenoid and an alcohol, used in perfumes and in flavors."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2009-10-20T09:30:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000694"^^xsd:string ;
  rdfs:label "geraniol degradation pathway"^^xsd:string ;
  skos:notation "PW:0000694"^^xsd:string .

ns1:PW_0000695
  a owl:Class ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2009-10-20T10:20:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000695"^^xsd:string ;
  rdfs:label "<new term>"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0000695"^^xsd:string .

ns1:PW_0000696
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000147 ;
  ns2:treeView ns1:PW_0000147 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of zeatin - a plant hormone derived from adenine. It induces plant growth and has been reported to have anti-aging effects on human skin fibroblasts."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2009-10-20T10:23:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000696"^^xsd:string ;
  rdfs:label "zeatin biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000696"^^xsd:string .

ns1:PW_0000697
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000147 ;
  ns2:treeView ns1:PW_0000147 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of carotenoids, organic pigments found in plants and other photosynthetic organisms. Some can act as antioxidants."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2009-10-20T10:29:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000697"^^xsd:string ;
  rdfs:label "carotenoid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000697"^^xsd:string .

ns1:PW_0000698
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000631, ns1:PW_0000700 ;
  ns2:treeView ns1:PW_0000631, ns1:PW_0000700 ;
  ns1:IAO_0000115 "Thyroid cancer refers to one of several types of malignant tumors of the thyroid gland of which papillary thyroid cancer is the most frequent, accounting for almost 80% of all cases. The other types include follicular, medullary and anaplastic."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2009-10-28T01:33:42Z"^^xsd:string ;
  obo:hasExactSynonym "malignant neoplasm of thyroid gland pathway"^^xsd:string, "malignant tumor of thyroid gland pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05216"^^xsd:string, "thyroid neoplasm pathway"^^xsd:string ;
  obo:id "PW:0000698"^^xsd:string ;
  rdfs:label "thyroid cancer pathway"^^xsd:string ;
  skos:notation "PW:0000698"^^xsd:string .

ns1:PW_0000699
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000631 ;
  ns2:treeView ns1:PW_0000631 ;
  ns1:IAO_0000115 "Parathyroid cancer is a rare type of cancer whose causes are unknown. There are four parathyroid glands, each of the two lobes of the thyroid gland houses two."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2009-10-28T01:39:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000699"^^xsd:string ;
  rdfs:label "parathyroid cancer pathway"^^xsd:string ;
  skos:notation "PW:0000699"^^xsd:string .

ns1:PW_0000700
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000605 ;
  ns2:treeView ns1:PW_0000605 ;
  ns1:IAO_0000115 "A general term grouping neoplastic pathways of the adrenal gland, ovaries and pancreas, pituitary and thyroid."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2009-10-28T01:48:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "endocrine gland neoplasm pathway"^^xsd:string ;
  obo:id "PW:0000700"^^xsd:string ;
  rdfs:label "endocrine gland cancer pathway"^^xsd:string ;
  skos:notation "PW:0000700"^^xsd:string .

ns1:PW_0000701
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000605 ;
  ns2:treeView ns1:PW_0000605 ;
  ns1:IAO_0000115 "A general term grouping neoplastic pathways of the heart, respiratory tract and thymus."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2009-10-28T01:55:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "thoracic neoplasm pathway"^^xsd:string ;
  obo:id "PW:0000701"^^xsd:string ;
  rdfs:label "thoracic cancer pathway"^^xsd:string ;
  skos:notation "PW:0000701"^^xsd:string .

ns1:PW_0000702
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000701 ;
  ns2:treeView ns1:PW_0000701 ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2009-10-28T01:57:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "respiratory tract neoplasm pathway"^^xsd:string ;
  obo:id "PW:0000702"^^xsd:string ;
  rdfs:label "respiratory tract cancer pathway"^^xsd:string ;
  skos:notation "PW:0000702"^^xsd:string .

ns1:PW_0000703
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000702 ;
  ns2:treeView ns1:PW_0000702 ;
  ns1:IAO_0000115 "Lung cancer is one of the most common causes of cancer-related death in men but is also very common in women. The main types are represented by small cell and non-small cell lung carcinomas. The former tends to respond better to chemotherapy; the latter is at times treated surgically."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2009-10-28T02:00:27Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "lung neoplasm pathway"^^xsd:string ;
  obo:id "PW:0000703"^^xsd:string ;
  rdfs:label "lung cancer pathway"^^xsd:string ;
  skos:notation "PW:0000703"^^xsd:string .

ns1:PW_0000704
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000703 ;
  ns2:treeView ns1:PW_0000703 ;
  ns1:IAO_0000115 "Small cell lung cancer is an aggressive type of lung cancer. Several pathways appear to be deregulated and they include the intrinsic apoptotic pathway, PI3K-Akt signaling and changes in oncogene transcription factors such as Myc and p53."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2009-10-28T02:00:59Z"^^xsd:string ;
  obo:hasExactSynonym "oat cell carcinoma of lung pathway"^^xsd:string, "small cell carcinoma of lung pathway"^^xsd:string, "small cell lung cancer pathway"^^xsd:string, "small cell neuroendocrine carcinoma of lung pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05222"^^xsd:string, "SCLC pathway"^^xsd:string, "small cell lung neoplasm pathway"^^xsd:string ;
  obo:id "PW:0000704"^^xsd:string ;
  rdfs:label "small cell lung carcinoma pathway"^^xsd:string ;
  skos:notation "PW:0000704"^^xsd:string .

ns1:PW_0000705
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000703 ;
  ns2:treeView ns1:PW_0000703 ;
  ns1:IAO_0000115 "Non-small cell lung carcinoma groups together several non-small cell lung carcinomas. The main types are represented by squamous cell, adeno- and large-cell carcinoma. Alterations in Ras and epidermal growth factor signaling, among others, have been implicated in the condition."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2009-10-28T02:45:27Z"^^xsd:string ;
  obo:hasExactSynonym "non-small cell lung cancer pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05223"^^xsd:string, "NSCLC pathway"^^xsd:string, "non-small cell lung neoplasm pathway"^^xsd:string ;
  obo:id "PW:0000705"^^xsd:string ;
  rdfs:label "non-small cell lung carcinoma pathway"^^xsd:string ;
  skos:notation "PW:0000705"^^xsd:string .

ns1:PW_0000706
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000605 ;
  ns2:treeView ns1:PW_0000605 ;
  ns1:IAO_0000115 "Leukemia is a cancer of the blood or bone marrow. The term covers a broad spectrum of conditions subdivided by proliferation type - acute and chronic, and by cell type - myeloid and lymphocytic leukemia."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2009-10-28T03:34:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000706"^^xsd:string ;
  rdfs:label "leukemia pathway"^^xsd:string ;
  skos:notation "PW:0000706"^^xsd:string .

ns1:PW_0000707
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000706 ;
  ns2:treeView ns1:PW_0000706 ;
  ns1:IAO_0000115 "Myeloid leukemia affects cells of the myeloid lineage and their precursors and in turn is subdivided by proliferation type."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2009-10-28T03:55:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000707"^^xsd:string ;
  rdfs:label "myeloid leukemia pathway"^^xsd:string ;
  skos:notation "PW:0000707"^^xsd:string .

ns1:PW_0000708
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000706 ;
  ns2:treeView ns1:PW_0000706 ;
  ns1:IAO_0000115 "Lymphoid leukemia affects lymphoid tissues and there are increase numbers of circulating lymphoblasts and lymphocytes."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2009-10-28T04:33:38Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "lymphocytic leukemia pathway"^^xsd:string ;
  obo:id "PW:0000708"^^xsd:string ;
  rdfs:label "lymphoid leukemia pathway"^^xsd:string ;
  skos:notation "PW:0000708"^^xsd:string .

ns1:PW_0000709
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000707 ;
  ns2:treeView ns1:PW_0000707 ;
  ns1:IAO_0000115 "Acute myeloid leukemia is a common type of leukemia among adults. Abnormal cells are present inside the bone marrow that grow very vast and replace healthy blood cells. Several signaling pathways are disrupted and/or constitutively activated."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2009-10-28T04:39:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05221"^^xsd:string ;
  obo:id "PW:0000709"^^xsd:string ;
  rdfs:label "acute myeloid leukemia pathway"^^xsd:string ;
  skos:notation "PW:0000709"^^xsd:string .

ns1:PW_0000710
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000707 ;
  ns2:treeView ns1:PW_0000707 ;
  ns1:IAO_0000115 "Chronic myeloid leukemia, a slowly progressing condition, is a type of leukemia where too many white blood cells are made in the bone marrow."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2009-10-28T04:39:38Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05220"^^xsd:string ;
  obo:id "PW:0000710"^^xsd:string ;
  rdfs:label "chronic myeloid leukemia pathway"^^xsd:string ;
  skos:notation "PW:0000710"^^xsd:string .

ns1:PW_0000711
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001550 ;
  ns2:treeView ns1:PW_0001550 ;
  ns1:IAO_0000115 "Gliomas are tumors of the brain categorized by the type of cell they are associated with, their location and grade. Several pathways appear to be deregulated via amplifications, overexpression, mutations or loss."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2009-10-29T04:24:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05214"^^xsd:string ;
  obo:id "PW:0000711"^^xsd:string ;
  rdfs:label "glioma pathway"^^xsd:string ;
  skos:notation "PW:0000711"^^xsd:string .

ns1:PW_0000712
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000491 ;
  ns2:treeView ns1:PW_0000491 ;
  ns1:IAO_0000115 "Vasopressin signaling via receptor type 1 couples to Gq alpha subunit leading to stimulation of phospholipase C beta, subsequent generation of second messengers and increase in intracellular calcium resulting in vasoconstriction."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2009-11-03T08:25:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000712"^^xsd:string ;
  rdfs:label "vasopressin signaling pathway via receptor type 1"^^xsd:string ;
  skos:notation "PW:0000712"^^xsd:string .

ns1:PW_0000713
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000491 ;
  ns2:treeView ns1:PW_0000491 ;
  ns1:IAO_0000115 "Vasopressin signaling via receptor type 2 plays a central role in water homeostasis by regulating the translocation of Aqp2 channel. The receptor couples to Gs alpha subunit leading to activation of adenylyl cyclase, production of cyclic AMP and triggering of protein kinase A (PKA) signaling pathway. PKA regulates both the translocation and the expression of the channel."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2009-11-03T08:39:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04962"^^xsd:string, "SMP:00322"^^xsd:string ;
  obo:id "PW:0000713"^^xsd:string ;
  rdfs:label "vasopressin signaling pathway via receptor type 2"^^xsd:string ;
  skos:notation "PW:0000713"^^xsd:string .

ns1:PW_0000714
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000686, ns1:PW_0000712 ;
  ns2:treeView ns1:PW_0000686, ns1:PW_0000712 ;
  ns1:IAO_0000115 "A vasopressin, receptor type 1 mediated signaling pathway, that deviates from what its normal course should be. Alterations in this pathway might relate to septic shock."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2009-11-03T08:51:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000714"^^xsd:string ;
  rdfs:label "altered vasopressin signaling pathway via receptor type 1"^^xsd:string ;
  skos:notation "PW:0000714"^^xsd:string .

ns1:PW_0000715
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000686, ns1:PW_0000713 ;
  ns2:treeView ns1:PW_0000686, ns1:PW_0000713 ;
  ns1:IAO_0000115 "A vasopressin, receptor type 2 mediated signaling pathway, that deviates from what its normal course should be. Alterations in the pathway have been associated with Nephrogenic Diabetes Insipidus (NDI) caused by mutations in the receptor or, more rarely, in aquaporin channel 2."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2009-11-03T09:09:09Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000715"^^xsd:string ;
  rdfs:label "altered vasopressin signaling pathway via receptor type 2"^^xsd:string ;
  skos:notation "PW:0000715"^^xsd:string .

ns1:PW_0000716
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000003 ;
  ns2:treeView ns1:PW_0000003 ;
  ns1:IAO_0000115 "Transcription factors mediated signaling are components of transcription that, by controlling the expression of target genes, impact upon a wide range of processes."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2009-11-30T01:34:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000716"^^xsd:string ;
  rdfs:label "transcription factor mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000716"^^xsd:string .

ns1:PW_0000717
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000647 ;
  ns2:treeView ns1:PW_0000647 ;
  ns1:IAO_0000115 "The signaling pathway mediated by the FoxO subgroup of forkhead family of transcription factors regulates cell cycle and survival via the expression of its target genes. FoxO pathway is negatively regulated by PI3K-Akt pathway downstream of insulin signaling. It is positively regulated by the Jnk pathway of stress activated MAPK cascade."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2009-11-30T01:42:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "FoxO signaling pathway"^^xsd:string ;
  obo:id "PW:0000717"^^xsd:string ;
  rdfs:label "forkhead class O signaling pathway"^^xsd:string ;
  skos:notation "PW:0000717"^^xsd:string .

ns1:PW_0000718
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000237, ns1:PW_0000303, ns1:PW_0000716, ns1:PW_0001313 ;
  ns2:treeView ns1:PW_0000237, ns1:PW_0000303, ns1:PW_0000716, ns1:PW_0001313 ;
  ns1:IAO_0000115 "p53 transcription factor is a tumor suppressor frequently mutated in cancer. p53 is at the hub of many signaling and regulatory pathways. In response to various stresses, it promotes apoptosis, cell cycle arrest and other defense pathways via transcription dependent as well as independent routes. A key regulator of p53 is Mdm2. Mdm2 is a transcriptional target of p53 thus providing a negative feedback loop."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2009-11-30T03:01:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04115"^^xsd:string, "PID:200206"^^xsd:string ;
  obo:id "PW:0000718"^^xsd:string ;
  rdfs:label "p53 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000718"^^xsd:string .

ns1:PW_0000719
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000264, ns1:PW_0000716 ;
  ns2:treeView ns1:PW_0000264, ns1:PW_0000716 ;
  ns1:IAO_0000115 "A transcription factor mediated signaling pathway that deviates from what its normal course should be. Deregulation of such pathways has been linked to cancer and various other diseases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2009-11-30T03:40:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000719"^^xsd:string ;
  rdfs:label "altered transcription factor mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000719"^^xsd:string .

ns1:PW_0000720
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000718, ns1:PW_0000719, ns1:PW_0001314, ns1:PW_0001545 ;
  ns2:treeView ns1:PW_0000718, ns1:PW_0000719, ns1:PW_0001314, ns1:PW_0001545 ;
  ns1:IAO_0000115 "A p53 signaling pathway that deviates from what its normal course should be. Due to its central role at the intersection of many cellular pathways, disturbance of p53 network can have far-reaching negative consequences. The tumor suppressor Tp53 gene is frequently mutated in cancer."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2009-11-30T03:43:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000720"^^xsd:string ;
  rdfs:label "altered p53 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000720"^^xsd:string .

ns1:PW_0000721
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000923 ;
  ns2:treeView ns1:PW_0000923 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of nicotine, an alkaloid found in tobacco and other plants. It is an agonist of nicotinic acetylcholine receptors and exerts stimulatory roles. It is also responsible for tobacco dependence.  Prolonged exposure and high levels of nicotine can have toxic effects. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-01-18T03:34:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000721"^^xsd:string ;
  rdfs:label "nicotine drug pathway"^^xsd:string ;
  skos:notation "PW:0000721"^^xsd:string .

ns1:PW_0000722
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002325 ;
  ns2:treeView ns1:PW_0002325 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of warfarin. Warfarin is used as anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-01-18T03:34:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000722"^^xsd:string ;
  rdfs:label "warfarin drug pathway"^^xsd:string ;
  skos:notation "PW:0000722"^^xsd:string .

ns1:PW_0000723
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000921 ;
  ns2:treeView ns1:PW_0000921 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of anti-diabetic drugs such as repaglinide, nateglinide and sulfonylurea - inhibitors of ATP-dependent potassium channel. By blocking the channel they stimulate insulin secretion to lower blood glucose level. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-01-18T03:43:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000723"^^xsd:string ;
  rdfs:label "anti-diabetic drug pathway"^^xsd:string ;
  skos:notation "PW:0000723"^^xsd:string .

ns1:PW_0000724
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000920 ;
  ns2:treeView ns1:PW_0000920 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of statin. Statins are a class of drugs used to lower cholesterol. They act as inhibitors of HMG-CoA reductase, the enzyme that catalyzes an early rate-limiting step in cholesterol biosynthesis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-01-19T10:48:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000724"^^xsd:string ;
  rdfs:label "statin drug pathway"^^xsd:string ;
  skos:notation "PW:0000724"^^xsd:string .

ns1:PW_0000725
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000723 ;
  ns2:treeView ns1:PW_0000723 ;
  ns1:IAO_0000115 "The pathway of anti-diabetic drugs-target interaction and of the biochemical or physiological responses to them. Repaglinide, nateglinide and sulfonylurea are used as inhibitors of ATP-dependent potassium channel. By blocking the channel they stimulate insulin secretion to lower blood glucose level. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-01-20T12:12:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00453"^^xsd:string, "SMP:00454"^^xsd:string ;
  obo:id "PW:0000725"^^xsd:string ;
  rdfs:label "potassium channel inhibitors pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0000725"^^xsd:string .

ns1:PW_0000726
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000723 ;
  ns2:treeView ns1:PW_0000723 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of repaglinide. The drug is used as an inhibitor of ATP-dependent potassium channel. By blocking the channel it stimulates insulin secretion to lower blood glucose level. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-01-20T12:14:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000726"^^xsd:string ;
  rdfs:label "repaglinide pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0000726"^^xsd:string .

ns1:PW_0000727
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000723 ;
  ns2:treeView ns1:PW_0000723 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of nateglinide. The drug is used as an inhibitor of ATP-dependent potassium channel. By blocking the channel it stimulates insulin secretion to lower blood glucose level. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-01-20T12:15:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000727"^^xsd:string ;
  rdfs:label "nateglinide pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0000727"^^xsd:string .

ns1:PW_0000728
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000724 ;
  ns2:treeView ns1:PW_0000724 ;
  ns1:IAO_0000115 "The pathway of statins-target interaction and of the biochemical or physiological responses to drug. Statins are a class of drugs used to lower cholesterol. They act as inhibitors of HMG-CoA reductase, the enzyme that catalyzes an early rate-limiting step in cholesterol biosynthesis. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-01-20T12:21:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00082"^^xsd:string, "SMP:00089"^^xsd:string, "SMP:00092"^^xsd:string, "SMP:00099"^^xsd:string, "SMP:00111"^^xsd:string, "SMP:00119"^^xsd:string, "SMP:00131"^^xsd:string ;
  obo:id "PW:0000728"^^xsd:string ;
  rdfs:label "statin pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0000728"^^xsd:string .

ns1:PW_0000729
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000724 ;
  ns2:treeView ns1:PW_0000724 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of statin. Statins are a class of drugs used to lower cholesterol. They act as inhibitors of HMG-CoA reductase, the enzyme that catalyzes an early rate-limiting step in cholesterol biosynthesis. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-01-20T12:22:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000729"^^xsd:string ;
  rdfs:label "statin pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0000729"^^xsd:string .

ns1:PW_0000730
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000722 ;
  ns2:treeView ns1:PW_0000722 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of warfarin. Warfarin is used as anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-01-20T12:42:35Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000730"^^xsd:string ;
  rdfs:label "warfarin pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0000730"^^xsd:string .

ns1:PW_0000731
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000722 ;
  ns2:treeView ns1:PW_0000722 ;
  ns1:IAO_0000115 "The pathway of warfarin-target interaction and of the biochemical or physiological responses to drug. Warfarin is used as anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-01-20T12:42:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00268"^^xsd:string ;
  obo:id "PW:0000731"^^xsd:string ;
  rdfs:label "warfarin pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0000731"^^xsd:string .

ns1:PW_0000732
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001240 ;
  ns2:treeView ns1:PW_0001240 ;
  ns1:IAO_0000115 "Those metabolic reactions involving thromboxanes - a family of prostanoid eicosanoids whose effects include vasoconstriction and platelet aggregation."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-02-17T11:26:21Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000732"^^xsd:string ;
  rdfs:label "thromboxane metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000732"^^xsd:string .

ns1:PW_0000733
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000197 ;
  ns2:treeView ns1:PW_0000197 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of glycosphingolipids - glycolipids with sugar(s) attached to the ceramide core. Based on the sequences of the core carbohydrate residues, they are classified into a number of series such as lacto- and neolacto-, globo-, ganglio- or muco-series."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-02-17T02:03:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "GSL metabolic pathway"^^xsd:string, "glycolipid metabolic pathway"^^xsd:string ;
  obo:id "PW:0000733"^^xsd:string ;
  rdfs:label "glycosphingolipid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000733"^^xsd:string .

ns1:PW_0000734
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000733 ;
  ns2:treeView ns1:PW_0000733 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of cerebroside, sphingolipids in which the sugar is a monosaccharide."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-02-17T02:05:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000734"^^xsd:string ;
  rdfs:label "cerebroside metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000734"^^xsd:string .

ns1:PW_0000735
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000197, ns1:PW_0000483 ;
  ns2:treeView ns1:PW_0000197, ns1:PW_0000483 ;
  ns1:IAO_0000115 "A sphingolipid metabolic pathway that deviates from what its normal course should be. Altered sphingolipid metabolism has been associated with several lysosomal storage diseases and most appear to be fatal."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-02-17T02:08:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000735"^^xsd:string ;
  rdfs:label "altered sphingolipid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000735"^^xsd:string .

ns1:PW_0000736
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000153 ;
  ns2:treeView ns1:PW_0000153 ;
  ns1:IAO_0000115 "The de novo synthesis of triacylglycerol, the common form of fatty acid transport and storage. Most triacylglycerols are synthesized in the liver and stored in the adipose tissue."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-02-17T02:15:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "lipogenesis pathway"^^xsd:string ;
  obo:id "PW:0000736"^^xsd:string ;
  rdfs:label "triacylglycerol biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000736"^^xsd:string .

ns1:PW_0000737
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000153 ;
  ns2:treeView ns1:PW_0000153 ;
  ns1:IAO_0000115 "The degradation pathway of triacylglycerols when the energy reserves are low such as in the fasting state, during exercise or in response to stress. Triacylglycerols are the common form of fatty acid transport and storage."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-02-17T02:19:06Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "lipolysis pathway"^^xsd:string ;
  obo:id "PW:0000737"^^xsd:string ;
  rdfs:label "triacylglycerol degradation pathway"^^xsd:string ;
  skos:notation "PW:0000737"^^xsd:string .

ns1:PW_0000738
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000642 ;
  ns2:treeView ns1:PW_0000642 ;
  ns1:IAO_0000115 "Fatty acid degradation via beta oxidation, the most common fatty acid degradation pathway, occurs in four reactions resulting in the formation of acetyl-CoA and a fatty acyl-CoA two carbon shorter than the one that began the cycle. Acetyl-CoA can undergo further oxidation via the Krebs cycle or can be converted to ketone bodies."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-02-17T02:50:24Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00052"^^xsd:string, "SMP:00480"^^xsd:string, "SMP:00481"^^xsd:string, "SMP:00482"^^xsd:string, "fatty acid beta oxidation pathway"^^xsd:string ;
  obo:id "PW:0000738"^^xsd:string ;
  rdfs:label "fatty acid beta degradation pathway"^^xsd:string ;
  skos:notation "PW:0000738"^^xsd:string .

ns1:PW_0000739
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000642 ;
  ns2:treeView ns1:PW_0000642 ;
  ns1:IAO_0000115 "The degradation of branched-chain fatty acids is carried out by the alpha oxidation pathway. In humans, this pathway occurs in peroxisomes."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-02-17T03:02:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "fatty acid alpha oxidation pathway"^^xsd:string ;
  obo:id "PW:0000739"^^xsd:string ;
  rdfs:label "fatty acid alpha degradation pathway"^^xsd:string ;
  skos:notation "PW:0000739"^^xsd:string .

ns1:PW_0000740
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000642 ;
  ns2:treeView ns1:PW_0000642 ;
  ns1:IAO_0000115 "The pathway of unsaturated fatty acids requires additional enzymes."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-02-17T03:06:21Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000740"^^xsd:string ;
  rdfs:label "unsaturated fatty acid degradation pathway"^^xsd:string ;
  skos:notation "PW:0000740"^^xsd:string .

ns1:PW_0000741
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000164, ns1:PW_0000742 ;
  ns2:treeView ns1:PW_0000164, ns1:PW_0000742 ;
  ns1:IAO_0000115 "A ganglioside metabolic pathway that deviates from what its normal course should be. For instance, Tay-Sachs disease is caused by a deficiency in the enzyme that degrades ganglioside GM2. This and other conditions involving impaired sphingolipid metabolism are collectively known as sphingolipid storage disease."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2010-02-18T12:39:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000741"^^xsd:string ;
  rdfs:label "altered ganglioside metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000741"^^xsd:string .

ns1:PW_0000742
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000733, ns1:PW_0000735 ;
  ns2:treeView ns1:PW_0000733, ns1:PW_0000735 ;
  ns1:IAO_0000115 "A glycoshingolipid metabolic pathway that deviates from what its normal course should be. Altered glycosphingolipid metabolism has been associated with several lysosomal storage diseases and most appear to be fatal."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2010-02-18T01:03:56Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000742"^^xsd:string ;
  rdfs:label "altered glycosphingolipid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000742"^^xsd:string .

ns1:PW_0000743
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000734 ;
  ns2:treeView ns1:PW_0000734 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of galactocerebroside, a cerebroside in which the monosaccharide is galactose."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2010-02-18T01:15:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000743"^^xsd:string ;
  rdfs:label "galactocerebroside metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000743"^^xsd:string .

ns1:PW_0000744
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000734 ;
  ns2:treeView ns1:PW_0000734 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of glucocerebroside, a cerebroside in which the monosaccharide is glucose."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2010-02-18T01:15:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000744"^^xsd:string ;
  rdfs:label "glucocerebroside metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000744"^^xsd:string .

ns1:PW_0000745
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000197 ;
  ns2:treeView ns1:PW_0000197 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of sphingomyelin - a sphingolipid found abundantly in the myelin sheath of nerve cells."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2010-02-18T01:28:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000745"^^xsd:string ;
  rdfs:label "sphingomyelin metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000745"^^xsd:string .

ns1:PW_0000746
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000735, ns1:PW_0000745 ;
  ns2:treeView ns1:PW_0000735, ns1:PW_0000745 ;
  ns1:IAO_0000115 "A sphingomyelin metabolic pathway that deviates from what its normal course should be. For instance, Niemann-Pick disease is caused by a deficiency in the enzyme that degrades sphingomyelin. This and other conditions involving impaired sphingolipid metabolism are collectively known as sphingolipid storage disease."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2010-02-18T01:34:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000746"^^xsd:string ;
  rdfs:label "altered sphingomyelin metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000746"^^xsd:string .

ns1:PW_0000747
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000743, ns1:PW_0000748 ;
  ns2:treeView ns1:PW_0000743, ns1:PW_0000748 ;
  ns1:IAO_0000115 "A galactocerebroside metabolic pathway that deviates from what its normal course should be. For instance, Krabbe's disease is caused by a deficiency in the enzyme that degrades galactocerebroside. This and other conditions involving impaired sphingolipid metabolism are collectively known as sphingolipid storage disease."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2010-02-18T01:41:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000747"^^xsd:string ;
  rdfs:label "altered galactocerebroside metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000747"^^xsd:string .

ns1:PW_0000748
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000734, ns1:PW_0000742 ;
  ns2:treeView ns1:PW_0000734, ns1:PW_0000742 ;
  ns1:IAO_0000115 "A cerebroside metabolic pathway that deviates from what its normal course should be. Altered cerebroside metabolism has been associated with several lysosomal storage diseases and most appear to be fatal."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2010-02-18T01:45:45Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000748"^^xsd:string ;
  rdfs:label "altered cerebroside metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000748"^^xsd:string .

ns1:PW_0000749
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000744, ns1:PW_0000748 ;
  ns2:treeView ns1:PW_0000744, ns1:PW_0000748 ;
  ns1:IAO_0000115 "A glucocerebroside metabolic pathway that deviates from what its normal course should be. For instance, Gaucher's disease is caused by a deficiency in the enzyme that degrades glucocerebroside. This and other conditions involving impaired sphingolipid metabolism are collectively known as sphingolipid storage disease."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2010-02-18T02:02:09Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000749"^^xsd:string ;
  rdfs:label "altered glucocerebroside metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000749"^^xsd:string .

ns1:PW_0000750
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000248, ns1:PW_0000483 ;
  ns2:treeView ns1:PW_0000248, ns1:PW_0000483 ;
  ns1:IAO_0000115 "An isoprenoid metabolic pathway that deviates from what its normal course should be. Aberrant isoprenoid metabolism, as evidenced in alterations in cholesterol metabolism, has been associated with a variety of conditions."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-02-23T03:06:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000750"^^xsd:string ;
  rdfs:label "altered isoprenoid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000750"^^xsd:string .

ns1:PW_0000751
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000453, ns1:PW_0000750 ;
  ns2:treeView ns1:PW_0000453, ns1:PW_0000750 ;
  ns1:IAO_0000115 "An isoprenoid biosynthetic pathway that deviates from what its normal course should be. Aberrant isoprenoid biosynthetic pathway, as evidenced in altered cholesterol biosynthesis has been associated with several conditions."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-02-23T03:12:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000751"^^xsd:string ;
  rdfs:label "altered isoprenoid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000751"^^xsd:string .

ns1:PW_0000752
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000454, ns1:PW_0001306 ;
  ns2:treeView ns1:PW_0000454, ns1:PW_0001306 ;
  ns1:IAO_0000115 "A cholesterol biosynthetic pathway that deviates from what its normal course should be. Aberrant cholesterol biosynthesis involves defects in enzymes of both early and later steps leading to several disorders."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-02-23T03:18:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000752"^^xsd:string ;
  rdfs:label "altered cholesterol biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000752"^^xsd:string .

ns1:PW_0000753
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001313, ns1:PW_0001371 ;
  ns2:treeView ns1:PW_0001313, ns1:PW_0001371 ;
  ns1:IAO_0000115 "The sterol regulatory element-binding protein (SREBP) pathway has important roles in the control of lipid and cholesterol metabolism. SREBPs are sterol regulated transcription factors that belong to the bHLH family."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-02-24T10:47:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SREBP signaling pathway"^^xsd:string ;
  obo:id "PW:0000753"^^xsd:string ;
  rdfs:label "sterol regulatory element-binding protein signaling pathway"^^xsd:string ;
  skos:notation "PW:0000753"^^xsd:string .

ns1:PW_0000754
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000001 ;
  ns2:treeView ns1:PW_0000001 ;
  ns1:IAO_0000115 "The pharmacokinetics and the pharmacodynamics pathway elicited by the administration of specific drugs. The systems involved in drug processing and responses are also those handling exogenous, xenobiotic compounds in the cellular detoxification pathway. The distinction between a random encounter with a foreign compound and the processing of a substance administered for treatment along with the importance of genetic variation for the individual responses to particular drugs warrant their separate consideration."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-03-15T11:01:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000754"^^xsd:string ;
  rdfs:label "drug pathway"^^xsd:string ;
  skos:notation "PW:0000754"^^xsd:string .

ns1:PW_0000755
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002295 ;
  ns2:treeView ns1:PW_0002295 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of benzodiazepines, a class of drugs acting upon the central nervous system. The drugs are administered as sedatives and also as antiepileptics. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-03-15T11:26:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000755"^^xsd:string ;
  rdfs:label "benzodiazepine drug pathway"^^xsd:string ;
  skos:notation "PW:0000755"^^xsd:string .

ns1:PW_0000756
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000755 ;
  ns2:treeView ns1:PW_0000755 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of benzodiazepines. Benzodiazepine represent a class of drugs used as sedatives. They act as ligands for the GABA-A receptor to stimulate its inhibitory activity. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-03-15T11:30:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000756"^^xsd:string ;
  rdfs:label "benzodiazepine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0000756"^^xsd:string .

ns1:PW_0000757
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000755 ;
  ns2:treeView ns1:PW_0000755 ;
  ns1:IAO_0000115 "The pathway of benzodiazepine-target interaction and of the biochemical or physiological responses to drug. Benzodiazepines are a class of drugs used as sedatives. They act as ligands for the GABA-A receptor to stimulate its inhibitory activity. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-03-15T11:31:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000757"^^xsd:string ;
  rdfs:label "benzodiazepine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0000757"^^xsd:string .

ns1:PW_0000758
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of gemcitabine, a cytidine analogue that is administered as a prodrug for the treatment of certain types of cancer. The diphosphate form is an inhibitor of ribonucleotide reductases, essential enzymes of deoxyribonucleotide synthesis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-03-17T08:04:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000758"^^xsd:string ;
  rdfs:label "gemcitabine pathway"^^xsd:string ;
  skos:notation "PW:0000758"^^xsd:string .

ns1:PW_0000759
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000758 ;
  ns2:treeView ns1:PW_0000758 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination of gemcitabine. Gemcitabine is a cytidine analogue administered as a prodrug for the treatment of certain cancers. The diphosphate form is an inhibitor of ribonucleotide reductases, essential enzymes of deoxyribonucleotide synthesis. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-03-17T08:18:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00603"^^xsd:string ;
  obo:id "PW:0000759"^^xsd:string ;
  rdfs:label "gemcitabine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0000759"^^xsd:string .

ns1:PW_0000760
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000758 ;
  ns2:treeView ns1:PW_0000758 ;
  ns1:IAO_0000115 "The pathway of gemcitabine-target interaction and of the biochemical or physiological responses to drug. Gemcitabine is a cytidine analogue that is administered as a prodrug for the treatment of certain types of cancer. The diphosphate form is an inhibitor of ribonucleotide reductases, essential enzymes of deoxyribonucleotide synthesis. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-03-17T08:27:03Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00446"^^xsd:string ;
  obo:id "PW:0000760"^^xsd:string ;
  rdfs:label "gemcitabine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0000760"^^xsd:string .

ns1:PW_0000761
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001170 ;
  ns2:treeView ns1:PW_0001170 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of celecoxib, a selective cyclooxygenase 2 inhibitor used for the treatment of osteoarthritis and rheumatoid arthritis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-03-17T08:51:56Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "celebrex pathway"^^xsd:string ;
  obo:id "PW:0000761"^^xsd:string ;
  rdfs:label "celecoxib drug pathway"^^xsd:string ;
  skos:notation "PW:0000761"^^xsd:string .

ns1:PW_0000762
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000761 ;
  ns2:treeView ns1:PW_0000761 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination of celecoxib - a selective inhibitor of cyclooxygenase 2 used for the treatment of osteoarthritis and rheumatoid arthritis. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-03-17T09:03:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00644"^^xsd:string, "celebrex pharmacokinetics pathway"^^xsd:string ;
  obo:id "PW:0000762"^^xsd:string ;
  rdfs:label "celecoxib pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0000762"^^xsd:string .

ns1:PW_0000763
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000761 ;
  ns2:treeView ns1:PW_0000761 ;
  ns1:IAO_0000115 "The pathway of celecoxib-target interaction and of the biochemical or physiological responses to drug. Celecoxib is a selective inhibitor of cyclooxygenase 2 used for the treatment of osteoarthritis and rheumatoid arthritis. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-03-17T09:14:56Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00096"^^xsd:string, "celebrex pharmacodynamics pathway"^^xsd:string ;
  obo:id "PW:0000763"^^xsd:string ;
  rdfs:label "celecoxib pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0000763"^^xsd:string .

ns1:PW_0000764
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of ifosfamide, am antitumor agent used in the treatment of certain cancers. It is administered as a prodrug that has to be converted to the active form. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-03-22T01:04:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000764"^^xsd:string ;
  rdfs:label "ifosfamide drug pathway"^^xsd:string ;
  skos:notation "PW:0000764"^^xsd:string .

ns1:PW_0000765
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000764 ;
  ns2:treeView ns1:PW_0000764 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination of ifosfamide, a prodrug used against solid tumors. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-03-22T01:13:38Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00605"^^xsd:string ;
  obo:id "PW:0000765"^^xsd:string ;
  rdfs:label "ifosfamide pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0000765"^^xsd:string .

ns1:PW_0000766
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000764 ;
  ns2:treeView ns1:PW_0000764 ;
  ns1:IAO_0000115 "The pathway of ifosfamide-target interaction and of the biochemical or physiological responses to drug. Ifosfamide is administered as a prodrug and is widely used as an alkylating agent for the treatment of certain cancers. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-03-22T01:21:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00448"^^xsd:string ;
  obo:id "PW:0000766"^^xsd:string ;
  rdfs:label "ifosfamide pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0000766"^^xsd:string .

ns1:PW_0000767
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000918 ;
  ns2:treeView ns1:PW_0000918 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of omeprazole, a proton pump inhibitor. Omeprazole is the representative compound of a class of such inhibitors that are administered for the treatment of acid-related disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-03-22T01:39:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000767"^^xsd:string ;
  rdfs:label "omeprazole drug pathway"^^xsd:string ;
  skos:notation "PW:0000767"^^xsd:string .

ns1:PW_0000768
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000767 ;
  ns2:treeView ns1:PW_0000767 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination of omeprazole, a representative compound of a class of proton pump inhibitors. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-03-22T01:44:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00613"^^xsd:string ;
  obo:id "PW:0000768"^^xsd:string ;
  rdfs:label "omeprazole pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0000768"^^xsd:string .

ns1:PW_0000769
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000767 ;
  ns2:treeView ns1:PW_0000767 ;
  ns1:IAO_0000115 "The pathway of omeprazole-target interaction and of the biochemical or physiological responses to drug. Omeprazole is a representative compound of a class of proton pump inhibitors used in the treatment of acid-related disorders. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-03-22T01:50:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00226"^^xsd:string ;
  obo:id "PW:0000769"^^xsd:string ;
  rdfs:label "omeprazole pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0000769"^^xsd:string .

ns1:PW_0000770
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000040 ;
  ns2:treeView ns1:PW_0000040 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of C19-steroid hormones. Pregnenolone, a C21 steroid derived from cholesterol, and progesterone, to which pregnenolone can be converted, provide the starting material for the C21, C19 and C18 steroid hormones. The C19 class is represented by androgens such as testosterone."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-04-20T03:43:21Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "androgen biosynthetic pathway"^^xsd:string ;
  obo:id "PW:0000770"^^xsd:string ;
  rdfs:label "C19-steroid hormone biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000770"^^xsd:string .

ns1:PW_0000771
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000070 ;
  ns2:treeView ns1:PW_0000070 ;
  ns1:IAO_0000115 "Mineralocorticoids are a group of C21 steroid hormones synthesized by the adrenal cortex and so named because of their effects on the concentration of sodium as well as potassium and chloride. The group is best exemplified by aldosterone."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-04-20T04:01:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000771"^^xsd:string ;
  rdfs:label "mineralocorticoid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000771"^^xsd:string .

ns1:PW_0000772
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000070 ;
  ns2:treeView ns1:PW_0000070 ;
  ns1:IAO_0000115 "Glucocorticoids are a group of C21 steroid hormones synthesized by the adrenal cortex and so named because of their effects on glucose metabolism. They also play a role in developmental processes and the immune system. The group is best exemplified by cortisol."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-04-20T04:31:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000772"^^xsd:string ;
  rdfs:label "glucocorticoid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000772"^^xsd:string .

ns1:PW_0000773
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000771 ;
  ns2:treeView ns1:PW_0000771 ;
  ns1:IAO_0000115 "Aldosterone is a C21 mineralocorticoid produced in the outer zone, the zona glomerulosa, of the adrenal cortex from the cholesterol precursor. It plays important roles in the regulation of water and salt balance."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-04-20T04:49:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000773"^^xsd:string ;
  rdfs:label "aldosterone biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000773"^^xsd:string .

ns1:PW_0000774
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000772 ;
  ns2:treeView ns1:PW_0000772 ;
  ns1:IAO_0000115 "Cortisol is a C21 glucocorticoid produced in the middle zone, the zona fasciculata, of the adrenal cortex from the cholesterol precursor. It plays important roles in carbohydrate and other nutrients metabolism."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-04-20T04:49:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000774"^^xsd:string ;
  rdfs:label "cortisol biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000774"^^xsd:string .

ns1:PW_0000775
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000170, ns1:PW_0000298 ;
  ns2:treeView ns1:PW_0000170, ns1:PW_0000298 ;
  ns1:IAO_0000115 "An epidermal growth factor/neuregulin signaling pathway that deviates from what its normal course should be. Deregulation of the pathway, mostly as upregulation due to the increased expression or amplification of ligands and/or receptors, or mutations leading to such increases, has been linked to numerous forms of cancer, such as pancreatic, lung, endometrial and breast."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-04-26T10:53:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000775"^^xsd:string ;
  rdfs:label "altered epidermal growth factor/neuregulin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000775"^^xsd:string .

ns1:PW_0000776
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000069 ;
  ns2:treeView ns1:PW_0000069 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of acetoacetate and beta-hydroxybutyrate also known as ketone bodies although only acetoacetate is a ketone. Generally, the acetyl-CoA derived from fatty acids oxidation enters the citrate cycle. In the liver, a substantial fraction of acetyl-CoA is converted to ketone bodies which are then released into the blood stream for supply to peripheral tissues."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-05-20T01:06:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000776"^^xsd:string ;
  rdfs:label "ketone bodies biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000776"^^xsd:string .

ns1:PW_0000777
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000069 ;
  ns2:treeView ns1:PW_0000069 ;
  ns1:IAO_0000115 "Those metabolic reactions that convert acetoacetate and beta-hydroxybutyrate back to acetyl-CoA which then can enter the citrate cycle for energy production. The ketone bodies are synthesized in the liver and released into to blood stream to supply fuel to peripheral tissues, heart and skeletal muscle in particular and during starvation, the brain."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-05-20T01:23:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000777"^^xsd:string ;
  rdfs:label "ketone bodies degradation pathway"^^xsd:string ;
  skos:notation "PW:0000777"^^xsd:string .

ns1:PW_0000778
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000770 ;
  ns2:treeView ns1:PW_0000770 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of testosterone, a C19-steroid hormone secreted primarily in the testes and ovaries and to a lesser extend by the adrenal glands."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-05-20T02:21:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000778"^^xsd:string ;
  rdfs:label "testosterone biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000778"^^xsd:string .

ns1:PW_0000779
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000770 ;
  ns2:treeView ns1:PW_0000770 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of dehydroepiandrosterone, a C19 steroid hormone produced in the adrenal cortex and a primary precursor of estrogens."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-05-20T02:25:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "DHEA biosynthetic pathway"^^xsd:string ;
  obo:id "PW:0000779"^^xsd:string ;
  rdfs:label "dehydroepiandrosterone biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000779"^^xsd:string .

ns1:PW_0000780
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000040 ;
  ns2:treeView ns1:PW_0000040 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of C18-steroid hormones. Pregnenolone, a C21 steroid derived from cholesterol, and progesterone, to which pregnenolone can be converted, provide the starting material for the C21, C19 and C18 steroid hormones. The C18 class is represented by estrogens. The major natural estrogens are beta-estradiol - the primary estrogen, the estrone of menopause and the estriol of pregnancy."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-05-20T02:42:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "estrogen biosynthetic pathway"^^xsd:string ;
  obo:id "PW:0000780"^^xsd:string ;
  rdfs:label "C18-steroid hormone biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000780"^^xsd:string .

ns1:PW_0000781
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000780 ;
  ns2:treeView ns1:PW_0000780 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of estradiol, the major C18 steroid hormone. The term generally refers to the 17 beta isomer, the most potent form of estrogen."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-05-20T03:08:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "17beta-estradiol biosynthetic pathway"^^xsd:string ;
  obo:id "PW:0000781"^^xsd:string ;
  rdfs:label "estradiol biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000781"^^xsd:string .

ns1:PW_0000782
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000566 ;
  ns2:treeView ns1:PW_0000566 ;
  ns1:IAO_0000115 "Glucocorticoids, C21-steroid hormones, initiate signaling by binding to their specific nuclear receptor to regulate metabolism, development and immune response. The major glucocorticoid is cortisol."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-05-21T01:43:39Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000782"^^xsd:string ;
  rdfs:label "glucocorticoid signaling pathway"^^xsd:string ;
  skos:notation "PW:0000782"^^xsd:string .

ns1:PW_0000783
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000566 ;
  ns2:treeView ns1:PW_0000566 ;
  ns1:IAO_0000115 "Mineralocorticoids, C21 steroid hormones, initiate signaling by binding to their cognate receptor to regulate water and mineral levels. The main endogenous mineralocorticoid is aldosterone."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-05-21T02:05:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000783"^^xsd:string ;
  rdfs:label "mineralocorticoid signaling pathway"^^xsd:string ;
  skos:notation "PW:0000783"^^xsd:string .

ns1:PW_0000784
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000564, ns1:PW_0000719, ns1:PW_0000787, ns1:PW_0001314 ;
  ns2:treeView ns1:PW_0000564, ns1:PW_0000719, ns1:PW_0000787, ns1:PW_0001314 ;
  ns1:IAO_0000115 "An androgen signaling pathway that deviates from what its normal course should be. Altered androgen signaling, due to upregulation of the androgen receptor, has been implicated in prostate cancer."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-06-01T09:36:38Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000784"^^xsd:string ;
  rdfs:label "altered androgen signaling pathway"^^xsd:string ;
  skos:notation "PW:0000784"^^xsd:string .

ns1:PW_0000785
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000469, ns1:PW_0000509 ;
  ns2:treeView ns1:PW_0000469, ns1:PW_0000509 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-06-02T09:54:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000785"^^xsd:string ;
  rdfs:label "altered lipid hormone signaling pathway"^^xsd:string ;
  skos:notation "PW:0000785"^^xsd:string .

ns1:PW_0000786
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000468, ns1:PW_0000785 ;
  ns2:treeView ns1:PW_0000468, ns1:PW_0000785 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-06-02T09:54:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000786"^^xsd:string ;
  rdfs:label "altered steroid hormone signaling pathway"^^xsd:string ;
  skos:notation "PW:0000786"^^xsd:string .

ns1:PW_0000787
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000567, ns1:PW_0000786 ;
  ns2:treeView ns1:PW_0000567, ns1:PW_0000786 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-06-02T09:55:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000787"^^xsd:string ;
  rdfs:label "altered sex steroids signaling pathway"^^xsd:string ;
  skos:notation "PW:0000787"^^xsd:string .

ns1:PW_0000788
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467 ;
  ns2:treeView ns1:PW_0000467 ;
  ns1:IAO_0000115 "Glucose-dependent insulinotropic peptide signaling plays an important role in promoting insulin secretion. Gip is secreted from the K intestinal cells in response to nutrient ingestion. It signals via a G-protein coupled receptor to increase calcium and cAMP and activate downstream signaling pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-06-18T02:32:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "GIP signaling pathway"^^xsd:string ;
  obo:id "PW:0000788"^^xsd:string ;
  rdfs:label "glucose-dependent insulinotropic peptide signaling pathway"^^xsd:string ;
  skos:notation "PW:0000788"^^xsd:string .

ns1:PW_0000789
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467 ;
  ns2:treeView ns1:PW_0000467 ;
  ns1:IAO_0000115 "Glucagon-like peptide-1 signaling pathway plays an important role in promoting insulin secretion. GLp-1 is secreted from the L intestinal cells in response to nutrient ingestion. It signals via a G-protein coupled receptor to increase calcium and cAMP and activate numerous downstream signaling pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-06-18T02:44:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000789"^^xsd:string ;
  rdfs:label "glucagon-like peptide-1 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000789"^^xsd:string .

ns1:PW_0000790
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000274, ns1:PW_0000798, ns1:PW_0001162, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000476
  ] ;
  ns2:treeView ns1:PW_0000274, ns1:PW_0000476, ns1:PW_0000798, ns1:PW_0001162 ;
  ns3:part_of ns1:PW_0000476 ;
  ns1:IAO_0000115 "Epinephrine acts as a hormone and a neurotransmitter. It promotes various actions by signaling via various adrenergic receptors, G-protein coupled receptor type. The alpha receptor 1 and 2 couple to the Galphaq and Galphai subunits of heterotrimeric G proteins, respectively. The three beta receptors couple to the Galphas subunit."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-06-18T03:39:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000790"^^xsd:string ;
  rdfs:label "epinephrine signaling pathway"^^xsd:string ;
  skos:notation "PW:0000790"^^xsd:string .

ns1:PW_0000791
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000274, ns1:PW_0000798, ns1:PW_0001162 ;
  ns2:treeView ns1:PW_0000274, ns1:PW_0000798, ns1:PW_0001162 ;
  ns1:IAO_0000115 "Norepinephrine acts as a hormone and a neurotransmitter. It promotes various actions by signaling via various adrenergic receptors, G-protein coupled receptor type. The alpha receptor 1 and 2 couple to the Galphaq and Galphai subunits of heterotrimeric G proteins, respectively. The three beta receptors couple to the Galphas subunit."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-06-18T03:50:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000791"^^xsd:string ;
  rdfs:label "norepinephrine signaling pathway"^^xsd:string ;
  skos:notation "PW:0000791"^^xsd:string .

ns1:PW_0000792
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000790 ;
  ns2:treeView ns1:PW_0000790 ;
  ns1:IAO_0000115 "Epinephrine acts as a hormone and a neurotransmitter. It promotes various actions by signaling via various adrenergic receptors, G-protein coupled receptor type. The alpha 1 receptors couple to the Galphaq subunit."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-06-18T03:54:56Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000792"^^xsd:string ;
  rdfs:label "epinephrine signaling pathway via adrenergic receptor alpha 1"^^xsd:string ;
  skos:notation "PW:0000792"^^xsd:string .

ns1:PW_0000793
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000790 ;
  ns2:treeView ns1:PW_0000790 ;
  ns1:IAO_0000115 "Epinephrine acts as a hormone and a neurotransmitter. It promotes various actions by signaling via various adrenergic receptors, G-protein coupled receptor type. The alpha 2 receptors couple to the Galphai subunit."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-06-18T03:55:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000793"^^xsd:string ;
  rdfs:label "epinephrine signaling pathway via adrenergic receptor alpha 2"^^xsd:string ;
  skos:notation "PW:0000793"^^xsd:string .

ns1:PW_0000794
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000790 ;
  ns2:treeView ns1:PW_0000790 ;
  ns1:IAO_0000115 "Epinephrine acts as a hormone and a neurotransmitter. It promotes various actions by signaling via various adrenergic receptors, G-protein coupled receptor type. The beta receptors couple to the Galphas subunit. Beta 2 receptor may also couple to Galphai."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-06-18T03:56:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000794"^^xsd:string ;
  rdfs:label "epinephrine signaling pathway via adrenergic receptor beta"^^xsd:string ;
  skos:notation "PW:0000794"^^xsd:string .

ns1:PW_0000795
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000791 ;
  ns2:treeView ns1:PW_0000791 ;
  ns1:IAO_0000115 "Norepinephrine acts as a hormone and a neurotransmitter. It promotes various actions by signaling via various adrenergic receptors, G-protein coupled receptor type. The alpha 1 receptors couple to the Galphaq subunit."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-06-18T03:58:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000795"^^xsd:string ;
  rdfs:label "norepinephrine signaling pathway via adrenergic receptor alpha 1"^^xsd:string ;
  skos:notation "PW:0000795"^^xsd:string .

ns1:PW_0000796
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000791 ;
  ns2:treeView ns1:PW_0000791 ;
  ns1:IAO_0000115 "Norepinephrine acts as a hormone and a neurotransmitter. It promotes various actions by signaling via various adrenergic receptors, G-protein coupled receptor type. The alpha 2 receptors couple to the Galphai subunit."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-06-18T03:59:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000796"^^xsd:string ;
  rdfs:label "norepinephrine signaling pathway via adrenergic receptor alpha 2"^^xsd:string ;
  skos:notation "PW:0000796"^^xsd:string .

ns1:PW_0000797
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000791 ;
  ns2:treeView ns1:PW_0000791 ;
  ns1:IAO_0000115 "Norepinephrine acts as a hormone and a neurotransmitter. It promotes various actions by signaling via various adrenergic receptors, G-protein coupled receptor type. The beta receptors couple to the Galphas subunit. Beta 2 receptor may also couple to Galphai."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-06-18T03:59:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000797"^^xsd:string ;
  rdfs:label "norepinephrine signaling pathway via adrenergic receptor beta"^^xsd:string ;
  skos:notation "PW:0000797"^^xsd:string .

ns1:PW_0000798
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000466 ;
  ns2:treeView ns1:PW_0000466 ;
  ns1:IAO_0000115 "Catecholamines act as hormones and neurotransmitters. The major catecholamines are dopamine, epinephrine and norepinephrine. They are derived from tyrosine and are not to be confused with tyrosine-based hormones."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-06-18T04:09:20Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000798"^^xsd:string ;
  rdfs:label "catecholamine signaling pathway"^^xsd:string ;
  skos:notation "PW:0000798"^^xsd:string .

ns1:PW_0000799
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000920, ns1:PW_0000924 ;
  ns2:treeView ns1:PW_0000920, ns1:PW_0000924 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of adrenergic beta receptors drugs - beta-agonists and blockers. Adrenergic beta receptors, in response to epinephrine or norepinephrine couple to the Gs alpha subunit of heterotrimeric G protein to elicit several responses. Beta-agonists are used to stimulate while beta-blocker antagonists are used to inhibit these responses, as necessary. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-06-30T10:47:27Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000799"^^xsd:string ;
  rdfs:label "adrenergic beta receptor drug pathway - beta-agonist and beta-blocker"^^xsd:string ;
  skos:notation "PW:0000799"^^xsd:string .

ns1:PW_0000800
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000799 ;
  ns2:treeView ns1:PW_0000799 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of beta adrenergic receptor drugs. The beta-agonists are used to stimulate while the beta-blockers are used to inhibit the action of adrenergic beta receptors, as necessary. Adrenergic beta receptors are G-protein coupled receptors that in response to epinephrine or norepinephrine elicit various sympathetic responses important for proper cardiac function and in the case of beta2 receptor, smooth muscle relaxation and bronchodilation. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-07-01T08:56:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000800"^^xsd:string ;
  rdfs:label "adrenergic beta receptor agonist and beta-blocker pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0000800"^^xsd:string .

ns1:PW_0000801
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000799 ;
  ns2:treeView ns1:PW_0000799 ;
  ns1:IAO_0000115 "The pathway of beta adrenergic drug-target interactions and of the biochemical or physiological responses to drug. The beta-agonists are used to stimulate while the beta-blockers are used to inhibit the action of adrenergic beta receptors, as necessary. Adrenergic beta receptors are G-protein coupled receptors that in response to epinephrine or norepinephrine elicit various sympathetic responses important for proper cardiac function and in the case of beta2 receptor, smooth muscle relaxation and bronchodilation. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-07-01T09:12:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00296"^^xsd:string, "SMP:00297"^^xsd:string ;
  obo:id "PW:0000801"^^xsd:string ;
  rdfs:label "adrenergic beta receptor agonist and beta-blocker pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0000801"^^xsd:string .

ns1:PW_0000802
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000409, ns1:PW_0001235 ;
  ns2:treeView ns1:PW_0000409, ns1:PW_0001235 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of dopamine."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-08-13T02:17:38Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000802"^^xsd:string ;
  rdfs:label "dopamine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000802"^^xsd:string .

ns1:PW_0000803
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000441, ns1:PW_0001235 ;
  ns2:treeView ns1:PW_0000441, ns1:PW_0001235 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the biosynthesis of epinephrine. Epinephrine is primarily synthesized in adrenal chromaffin cells in response to specific stresses that activate the sympatho-adreno-medullary system."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-08-13T02:18:06Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000803"^^xsd:string ;
  rdfs:label "epinephrine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000803"^^xsd:string .

ns1:PW_0000804
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000442, ns1:PW_0001235 ;
  ns2:treeView ns1:PW_0000442, ns1:PW_0001235 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the biosynthesis of norepinephrine. Norepinephrine is primarily synthesized in sympathetic neurons in response to stresses such as cold or pain."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-08-13T02:18:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000804"^^xsd:string ;
  rdfs:label "norepinephrine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000804"^^xsd:string .

ns1:PW_0000805
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000680, ns1:PW_0000682 ;
  ns2:treeView ns1:PW_0000680, ns1:PW_0000682 ;
  ns1:IAO_0000115 "A Trail mediated signaling pathway that deviates from what its normal course should be. Mutations with the death domain of the receptors or deletions within the region containing the receptor genes have been reported for certain types of lymphomas."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-09-10T04:41:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000805"^^xsd:string ;
  rdfs:label "altered Trail mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000805"^^xsd:string .

ns1:PW_0000806
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000680, ns1:PW_0000681 ;
  ns2:treeView ns1:PW_0000680, ns1:PW_0000681 ;
  ns1:IAO_0000115 "A FasL mediated signaling pathway that deviates from what its normal course should be."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-09-10T05:12:24Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000806"^^xsd:string ;
  rdfs:label "altered FasL mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000806"^^xsd:string .

ns1:PW_0000807
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000100, ns1:PW_0000290 ;
  ns2:treeView ns1:PW_0000100, ns1:PW_0000290 ;
  ns1:IAO_0000115 "A transcription pathway that deviates from what its normal course should be. Aberrant transcription can have devastating consequences. Altered signaling mediated by various transcription factors has been implicated in a spectrum of human diseases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-10-08T11:40:35Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000807"^^xsd:string ;
  rdfs:label "altered transcription pathway"^^xsd:string ;
  skos:notation "PW:0000807"^^xsd:string .

ns1:PW_0000808
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000809 ;
  ns2:treeView ns1:PW_0000809 ;
  ns1:IAO_0000115 "MicroRNAs (miRNAs) are a large family of small RNAs involved in the post transcriptional regulation of gene expression. The biogenesis and function of miRNA is subject to complex control. Deregulation of miRNA expression has been linked to many diseases including cancer."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-10-08T12:35:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "miRNA pathway"^^xsd:string ;
  obo:id "PW:0000808"^^xsd:string ;
  rdfs:label "microRNA pathway"^^xsd:string ;
  skos:notation "PW:0000808"^^xsd:string .

ns1:PW_0000809
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001334 ;
  ns2:treeView ns1:PW_0001334 ;
  ns1:IAO_0000115 "The small non-coding RNA pathways have emerged as potent regulators of gene expression. Three major classes have been identified of which the microRNA (miRNA) system is the better understood one."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-10-15T02:16:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000809"^^xsd:string ;
  rdfs:label "small non-coding RNA pathway"^^xsd:string ;
  skos:notation "PW:0000809"^^xsd:string .

ns1:PW_0000810
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000809 ;
  ns2:treeView ns1:PW_0000809 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-10-15T03:37:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "endo-siRNA"^^xsd:string ;
  obo:id "PW:0000810"^^xsd:string ;
  rdfs:label "endogenous small interfering RNA pathway"^^xsd:string ;
  skos:notation "PW:0000810"^^xsd:string .

ns1:PW_0000811
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000809 ;
  ns2:treeView ns1:PW_0000809 ;
  ns1:IAO_0000115 "Piwi-RNA (piRNAs) are believed to play a role in gene silencing, particularly the silencing of transposons as many"^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-10-15T03:48:40Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "piRNA pathway"^^xsd:string ;
  obo:id "PW:0000811"^^xsd:string ;
  rdfs:label "Piwi-interacting RNA pathway"^^xsd:string ;
  skos:notation "PW:0000811"^^xsd:string .

ns1:PW_0000812
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000290, ns1:PW_0000809 ;
  ns2:treeView ns1:PW_0000290, ns1:PW_0000809 ;
  ns1:IAO_0000115 "A small non-coding RNA pathway that deviates from what its normal course should. For instance, alterations in miRNA pathway have been associated with many diseases including various types of cancer."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-10-15T03:53:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000812"^^xsd:string ;
  rdfs:label "altered small non-coding RNA pathway"^^xsd:string ;
  skos:notation "PW:0000812"^^xsd:string .

ns1:PW_0000813
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000808, ns1:PW_0000812 ;
  ns2:treeView ns1:PW_0000808, ns1:PW_0000812 ;
  ns1:IAO_0000115 "A microRNA pathway that deviates from what its normal course should be. An altered miRNA pathway has been implicated in many diseases including various forms of cancer."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-10-15T04:05:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered miRNA pathway"^^xsd:string ;
  obo:id "PW:0000813"^^xsd:string ;
  rdfs:label "altered microRNA pathway"^^xsd:string ;
  skos:notation "PW:0000813"^^xsd:string .

ns1:PW_0000814
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000925 ;
  ns2:treeView ns1:PW_0000925 ;
  ns1:IAO_0000115 "Toll-like receptors represent a large and the better understood family of pattern recognition receptors that sense an array of exogenous structures and recent evidence shows they can also recognize defective endogenous molecules. The intracellular signaling cascades they set in motion lead to the expression of inflammatory mediators."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-10-27T11:29:27Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04620"^^xsd:string, "TLR signaling pathway"^^xsd:string ;
  obo:id "PW:0000814"^^xsd:string ;
  rdfs:label "Toll-like receptor signaling pathway"^^xsd:string ;
  skos:notation "PW:0000814"^^xsd:string .

ns1:PW_0000815
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000925 ;
  ns2:treeView ns1:PW_0000925 ;
  ns1:IAO_0000115 "C-type lectin receptors represent one of four classes of pattern recognition receptors. The intracellular signaling cascades they set in motion lead to the expression of inflammatory mediators."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-10-27T11:38:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000815"^^xsd:string ;
  rdfs:label "C-type lectin receptor signaling pathway"^^xsd:string ;
  skos:notation "PW:0000815"^^xsd:string .

ns1:PW_0000816
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000925 ;
  ns2:treeView ns1:PW_0000925 ;
  ns1:IAO_0000115 "This family of pattern recognition receptors are cytoplasmic proteins that recognize exogenous cytoplasmic DNA. The signaling cascades they set in motion lead to the expression of inflammatory mediators."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-10-27T11:43:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04622"^^xsd:string, "RLR signaling pathway"^^xsd:string ;
  obo:id "PW:0000816"^^xsd:string ;
  rdfs:label "Retinoic acid-inducible gene (RIG) I-like receptor signaling pathway"^^xsd:string ;
  skos:notation "PW:0000816"^^xsd:string .

ns1:PW_0000817
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000925 ;
  ns2:treeView ns1:PW_0000925 ;
  ns1:IAO_0000115 "NOD-like receptors are cytosolic proteins that recognize components of bacterial peptidoglycans. The signaling cascades they set in motion lead to the expression of inflammatory mediators."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-10-27T11:45:03Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04621"^^xsd:string, "NLR signaling pathway"^^xsd:string ;
  obo:id "PW:0000817"^^xsd:string ;
  rdfs:label "NOD-like receptor signaling pathway"^^xsd:string ;
  skos:notation "PW:0000817"^^xsd:string .

ns1:PW_0000818
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000003 ;
  ns2:treeView ns1:PW_0000003 ;
  ns1:IAO_0000115 "Those signaling pathways that are involved in or mediate the various aspects of immune responses."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-10-27T03:08:21Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000818"^^xsd:string ;
  rdfs:label "signaling pathway pertinent to immunity"^^xsd:string ;
  skos:notation "PW:0000818"^^xsd:string .

ns1:PW_0000819
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000818 ;
  ns2:treeView ns1:PW_0000818 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-10-27T03:09:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000819"^^xsd:string ;
  rdfs:label "signaling pathway in the innate immune response"^^xsd:string ;
  skos:notation "PW:0000819"^^xsd:string .

ns1:PW_0000820
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000818 ;
  ns2:treeView ns1:PW_0000818 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-10-27T03:09:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000820"^^xsd:string ;
  rdfs:label "signaling pathway in the adaptive immune response"^^xsd:string ;
  skos:notation "PW:0000820"^^xsd:string .

ns1:PW_0000821
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000820, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000824
  ] ;
  ns2:treeView ns1:PW_0000820, ns1:PW_0000824 ;
  ns3:part_of ns1:PW_0000824 ;
  ns1:IAO_0000115 "T cell receptor (TCR) signaling in developing thymocytes is important for the establishment of CD4 and CD8 lineages. Mature T cells express either CD4 or CD8 co-receptors which are essential for the interaction with peptide-bound class II or class I MHC complexes to elicit CD4 T helper (Th) or CD8 cytotoxic T lymphocyte responses, respectively. In either case, T cells initiated signaling activates the expression of genes whose products mediate these responses."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-10-27T03:28:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04660"^^xsd:string, "TCR signaling pathway"^^xsd:string ;
  obo:id "PW:0000821"^^xsd:string ;
  rdfs:label "T cell receptor signaling pathway"^^xsd:string ;
  skos:notation "PW:0000821"^^xsd:string .

ns1:PW_0000822
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000820, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000823
  ] ;
  ns2:treeView ns1:PW_0000820, ns1:PW_0000823 ;
  ns3:part_of ns1:PW_0000823 ;
  ns1:IAO_0000115 "Antigen recognition by B cell receptors initiates signaling cascades that activate the expression of genes whose products are important for B cell functional responses."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-10-27T04:44:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "BCR signaling pathway"^^xsd:string, "KEGG:04662"^^xsd:string ;
  obo:id "PW:0000822"^^xsd:string ;
  rdfs:label "B cell receptor signaling pathway"^^xsd:string ;
  skos:notation "PW:0000822"^^xsd:string .

ns1:PW_0000823
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000235 ;
  ns2:treeView ns1:PW_0000235 ;
  ns1:IAO_0000115 "Humoral immunity is mediated by antibodies secreted by the B cell lymphocytes. Antibodies recognize antigens of extracellular microbes and act to neutralize and eliminate them. Activation of B cells can occur in a T cell dependent or independent manner."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-11-01T01:49:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000823"^^xsd:string ;
  rdfs:label "humoral immunity pathway"^^xsd:string ;
  skos:notation "PW:0000823"^^xsd:string .

ns1:PW_0000824
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000235 ;
  ns2:treeView ns1:PW_0000235 ;
  ns1:IAO_0000115 "Cell-mediated immune response pathways are carried out by T cell lymphocytes. T cells receptors recognize peptides bound to a major histocompatibility complex (MHC) on the antigen presenting cell. Depending on whether the co-receptor is CD4 or CD8, the receptors will interact with MHC class II or class I to elicit distinct responses against intracellular pathogens."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-11-01T01:49:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000824"^^xsd:string ;
  rdfs:label "cell-mediated immunity pathway"^^xsd:string ;
  skos:notation "PW:0000824"^^xsd:string .

ns1:PW_0000825
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000824
  ] ;
  ns2:treeView ns1:PW_0000824 ;
  ns3:part_of ns1:PW_0000824 ;
  ns1:IAO_0000115 "The pathways of antigen processing and presentation assure the generation of peptides that have the structural attributes necessary for the association with and their placement near major histocompatibility complex (MHC) molecules. Protein antigen present in vesicular compartments generate class II peptides, those in cytosol class I."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-11-01T05:17:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04612"^^xsd:string ;
  obo:id "PW:0000825"^^xsd:string ;
  rdfs:label "antigen processing and presentation pathway"^^xsd:string ;
  skos:notation "PW:0000825"^^xsd:string .

ns1:PW_0000826
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000821 ;
  ns2:treeView ns1:PW_0000821 ;
  ns1:IAO_0000115 "T cells that express the CD4 co-receptor, also called T helper cells, recognize class II MHC presented antigens derived from internalized microbes to initiate a signaling cascade that results in enhanced microbicidal capacity of phagocytes. T helper cells can be further subdivided into subsets of CD4+ T cells based on the distinct cytokines they produce and effector functions they perform."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-11-03T10:24:41Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000826"^^xsd:string ;
  rdfs:label "T cell receptor signaling pathway in CD4+ T cells"^^xsd:string ;
  skos:notation "PW:0000826"^^xsd:string .

ns1:PW_0000827
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000821 ;
  ns2:treeView ns1:PW_0000821 ;
  ns1:IAO_0000115 "T cells that express the CD8 co-receptor, also called cytotoxic or cytolytic T cells, recognize class I MHC presented antigens derived from cytosolic proteins to initiate a signaling cascade that results in killing of the target cell."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-11-03T10:44:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000827"^^xsd:string ;
  rdfs:label "T cell receptor signaling pathway in CD8+ T cells"^^xsd:string ;
  skos:notation "PW:0000827"^^xsd:string .

ns1:PW_0000828
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000577, ns1:PW_0000818 ;
  ns2:treeView ns1:PW_0000577, ns1:PW_0000818 ;
  ns1:IAO_0000115 "Cytokine initiated signaling pathways play important roles in innate and adaptive immunity, as well as cell proliferation and apoptosis."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-11-03T03:48:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04060"^^xsd:string ;
  obo:id "PW:0000828"^^xsd:string ;
  rdfs:label "cytokine mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000828"^^xsd:string .

ns1:PW_0000829
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000577, ns1:PW_0000818 ;
  ns2:treeView ns1:PW_0000577, ns1:PW_0000818 ;
  ns1:IAO_0000115 "Chemokine initiated pathways play important roles in the innate and adaptive immunity. They are also involved in development and tissue maintenance. The presence and localization of four cysteines is important for structural folding and is also the basis for chemokine classification. The spacing between the first two cysteine residues divides the family members into four groups. Most mammalian chemokines belong to the CC and CXC families. Chemokines signal via G-protein coupled receptors to engage distinct G protein signaling and downstream cascades."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-11-03T04:27:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04062"^^xsd:string ;
  obo:id "PW:0000829"^^xsd:string ;
  rdfs:label "chemokine mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000829"^^xsd:string .

ns1:PW_0000830
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000829 ;
  ns2:treeView ns1:PW_0000829 ;
  ns1:IAO_0000115 "The CXC family members are characterized by the presence of two cysteine resides separated by one amino acid. CXC and CC are the two most prominent families. This family of chemokines is also subdivided into two subgroups: the one with the ELR motif - ELR (+) and the one without - ELR(-), respectively. Generally, ELR(+) and ELR(-) members bind to distinct chemokine, G-coupled protein, receptors. The effects of their signaling is for the most part angiogenic or angiostatic, respectively."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-11-04T11:30:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000830"^^xsd:string ;
  rdfs:label "CXC chemokine mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000830"^^xsd:string .

ns1:PW_0000831
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000829 ;
  ns2:treeView ns1:PW_0000829 ;
  ns1:IAO_0000115 "The CC family members are characterized by the presence of two adjacent cysteine residues. The CC and the CXC family are the two most prominent families. Chemokines signal via G-protein coupled receptors to engage distinct G protein signaling and downstream cascades."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-11-04T11:30:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000831"^^xsd:string ;
  rdfs:label "CC chemokine mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000831"^^xsd:string .

ns1:PW_0000832
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000829 ;
  ns2:treeView ns1:PW_0000829 ;
  ns1:IAO_0000115 "The C family of chemokine is small and its members have two rather than four cysteines residues. Chemokines signal via G-protein coupled receptors to engage distinct G protein signaling and downstream cascades."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-11-04T11:32:38Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000832"^^xsd:string ;
  rdfs:label "C chemokine mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000832"^^xsd:string .

ns1:PW_0000833
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000829 ;
  ns2:treeView ns1:PW_0000829 ;
  ns1:IAO_0000115 "The CX3X family of chemokine is small and characterized by the presence of three residues separating the first two cysteines. Currently, only one member is known in mammals. Chemokines signal via G-protein coupled receptors to engage distinct G protein signaling and downstream cascades."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-11-12T05:03:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000833"^^xsd:string ;
  rdfs:label "CX3C chemokine mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000833"^^xsd:string .

ns1:PW_0000834
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000103 ;
  ns2:treeView ns1:PW_0000103 ;
  ns1:IAO_0000115 "Bile acid absorption by the intestinal epithelium and hepatic recycling collectively group the transport pathway of the important molecules of cholesterol catabolism."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2010-12-22T02:05:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04976"^^xsd:string ;
  obo:id "PW:0000834"^^xsd:string ;
  rdfs:label "bile acid transport pathway"^^xsd:string ;
  skos:notation "PW:0000834"^^xsd:string .

ns1:PW_0000835
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "Breast cancer is a major cause of death among Western women and many breast tumors are estrogen-dependent. Pharmacologically two major therapies have been developed: one targets the estrogen receptors via antagonists and selective modulators (SERM) and the second targets estrogen synthesis via aromatase inhibitors."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-01-06T02:11:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000835"^^xsd:string ;
  rdfs:label "anti-estrogen drug pathway"^^xsd:string ;
  skos:notation "PW:0000835"^^xsd:string .

ns1:PW_0000836
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000835 ;
  ns2:treeView ns1:PW_0000835 ;
  ns1:IAO_0000115 "Aromatase inhibitors block the last step of estrogen biosynthesis. They can be classified into first-, second- and third-generation drugs. Depending on whether they inactivate the aromatase complex irreversibly or reversibly, they can be further subdivided into type I and II, respectively. Currently, third generation drugs are being used."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-01-07T05:07:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000836"^^xsd:string ;
  rdfs:label "aromatase inhibitor pathway"^^xsd:string ;
  skos:notation "PW:0000836"^^xsd:string .

ns1:PW_0000837
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000835 ;
  ns2:treeView ns1:PW_0000835 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of tamoxifen - one of the most widely used anti-estrogen drug that targets the estrogen receptor. The drug is a modulator than acts as an antagonist in breast cancer cells but can be an agonist in bone and the cardiovascular system. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-01-17T01:05:40Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000837"^^xsd:string ;
  rdfs:label "tamoxifen drug pathway"^^xsd:string ;
  skos:notation "PW:0000837"^^xsd:string .

ns1:PW_0000838
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000837 ;
  ns2:treeView ns1:PW_0000837 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of tamoxifen - a SERM anti-estrogen drug. Genetic variations can result in changes in the availability of the drug. For instance, variation in CYP2D6, an important enzyme for the production of a primary drug metabolite, impacts on the available concentration of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-01-17T01:06:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00606"^^xsd:string ;
  obo:id "PW:0000838"^^xsd:string ;
  rdfs:label "tamoxifen pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0000838"^^xsd:string .

ns1:PW_0000839
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000837 ;
  ns2:treeView ns1:PW_0000837 ;
  ns1:IAO_0000115 "The pathway of tamoxifen-target interaction and of the biochemical or physiological responses to drug. In breast cancer cells, tamoxifen binding antagonizes estrogen binding and the subsequent conformational changes necessary for co-activators recruitment. It may also prompt the recruitment of co-repressor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-01-17T01:06:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00471"^^xsd:string ;
  obo:id "PW:0000839"^^xsd:string ;
  rdfs:label "tamoxifen pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0000839"^^xsd:string .

ns1:PW_0000840
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000541, ns1:PW_0001194 ;
  ns2:treeView ns1:PW_0000541, ns1:PW_0001194 ;
  ns1:IAO_0000115 "Protein kinase C constitutes a family of serine/threonine kinases activated by diacylglycerol (DAG) and calcium whose signal transduction plays important roles in many cellular processes. Ligand activated G protein-coupled receptors, via Galphaq pathway, stimulate phospholipase C which cleaves PIP2 into DAG and IP3. IP3 promotes calcium release."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-03-09T10:02:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000840"^^xsd:string ;
  rdfs:label "protein kinase C (PKC) signaling pathway"^^xsd:string ;
  skos:notation "PW:0000840"^^xsd:string .

ns1:PW_0000841
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000274, ns1:PW_0001162 ;
  ns2:treeView ns1:PW_0000274, ns1:PW_0001162 ;
  ns1:IAO_0000115 "Acetylcholine signaling plays important roles in the central and peripheral nervous system and exerts both excitatory and inhibitory effects. It is synthesized from acetyl-CoA and choline by choline O-acetyltransferase."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-03-09T11:08:00Z"^^xsd:string ;
  obo:hasExactSynonym "ACh signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04725"^^xsd:string ;
  obo:id "PW:0000841"^^xsd:string ;
  rdfs:label "acetylcholine signaling pathway"^^xsd:string ;
  skos:notation "PW:0000841"^^xsd:string .

ns1:PW_0000842
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000841 ;
  ns2:treeView ns1:PW_0000841 ;
  ns1:IAO_0000115 "Activation of the pentameric ionotropic nicotinic acetylcholine receptor leads to membrane depolarization and subsequent excitatory transmission. A salient feature of presynaptic signaling is promoting the release of various neurotransmitters depending on the neuron expressing the receptors."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-03-09T11:18:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000842"^^xsd:string ;
  rdfs:label "acetylcholine signaling pathway via nicotinic acetylcholine receptor"^^xsd:string ;
  skos:notation "PW:0000842"^^xsd:string .

ns1:PW_0000843
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000841 ;
  ns2:treeView ns1:PW_0000841 ;
  ns1:IAO_0000115 "Acetylcholine signaling via the metabotropic muscarinic receptors exerts important roles in the central and peripheral nervous system, the autonomic nervous system and also in non-neuronal cells. The five G protein-coupled receptors can be classified according to the G proteins they engage. Receptors M1, M3 and M5 predominantly couple to Galphaq whereas receptors M2 and M4 predominantly couple to Galphai mediated pathways. The signaling effects can be either excitatory or inhibitory."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-03-09T11:29:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000843"^^xsd:string ;
  rdfs:label "acetylcholine signaling pathway via muscarinic acetylcholine receptor"^^xsd:string ;
  skos:notation "PW:0000843"^^xsd:string .

ns1:PW_0000844
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000455 ;
  ns2:treeView ns1:PW_0000455 ;
  ns1:IAO_0000115 "Glutamate signaling via the ionotropic AMPA or NMDA and several metabotropic receptors plays important roles in the modulation of synaptic plasticity, long term depression or potentiation, and in learning and memory."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-03-09T11:57:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04724"^^xsd:string ;
  obo:id "PW:0000844"^^xsd:string ;
  rdfs:label "glutamate signaling pathway"^^xsd:string ;
  skos:notation "PW:0000844"^^xsd:string .

ns1:PW_0000845
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000844 ;
  ns2:treeView ns1:PW_0000844 ;
  ns1:IAO_0000115 "Glutamate signaling via the ionotropic NMDA glutamate receptor plays important roles in synaptic plasticity and in learning and memory. The receptor is ligand-gated and voltage-dependent and requires glycine as a co-agonist."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-03-09T12:10:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000845"^^xsd:string ;
  rdfs:label "glutamate signaling pathway via NMDA receptor"^^xsd:string ;
  skos:notation "PW:0000845"^^xsd:string .

ns1:PW_0000846
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000844 ;
  ns2:treeView ns1:PW_0000844 ;
  ns1:IAO_0000115 "Glutamate signaling via the ionotropic AMPA receptor plays important roles in long-term potentiation (LTP). The AMPA receptors are both receptors and cation channels."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-03-09T12:24:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000846"^^xsd:string ;
  rdfs:label "glutamate signaling pathway via AMPA receptor"^^xsd:string ;
  skos:notation "PW:0000846"^^xsd:string .

ns1:PW_0000847
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000844 ;
  ns2:treeView ns1:PW_0000844 ;
  ns1:IAO_0000115 "Glutamate signaling via the various metabotropic, G protein-coupled receptors plays important roles in both the central and peripheral nervous systems. Based on their structure and physiological function, the receptors have been classified into three groups. Group I receptors couple to Galphaq, group II and III couple to Galphai"^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-03-09T01:06:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000847"^^xsd:string ;
  rdfs:label "glutamate signaling pathway via metabotropic glutamate receptor"^^xsd:string ;
  skos:notation "PW:0000847"^^xsd:string .

ns1:PW_0000848
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000456 ;
  ns2:treeView ns1:PW_0000456 ;
  ns1:IAO_0000115 "Gamma-aminobutyric acid signals at inhibitory synapses via the type A receptor, which is part of a ligand-gated ion channel and the type B receptors which are metabotropic, G protein-coupled receptors."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-03-09T02:10:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04727"^^xsd:string ;
  obo:id "PW:0000848"^^xsd:string ;
  rdfs:label "gamma-aminobutyric acid signaling pathway"^^xsd:string ;
  skos:notation "PW:0000848"^^xsd:string .

ns1:PW_0000849
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000847 ;
  ns2:treeView ns1:PW_0000847 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-03-09T03:02:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000849"^^xsd:string ;
  rdfs:label "glutamate signaling pathway via group I metabotropic glutamate receptor"^^xsd:string ;
  skos:notation "PW:0000849"^^xsd:string .

ns1:PW_0000850
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000847 ;
  ns2:treeView ns1:PW_0000847 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-03-09T03:03:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000850"^^xsd:string ;
  rdfs:label "glutamate signaling pathway via group II or III glutamate receptor"^^xsd:string ;
  skos:notation "PW:0000850"^^xsd:string .

ns1:PW_0000851
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000394 ;
  ns2:treeView ns1:PW_0000394 ;
  ns1:IAO_0000115 "Dopamine signaling via D1-like receptors engages the Galphas family of G proteins leading to activation of adenylyl cyclases and increase in intracellular cAMP. Dopamine receptors 1 and 5 belong to this family."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-03-09T03:15:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00308"^^xsd:string ;
  obo:id "PW:0000851"^^xsd:string ;
  rdfs:label "dopamine signaling pathway via D1 family of receptors"^^xsd:string ;
  skos:notation "PW:0000851"^^xsd:string .

ns1:PW_0000852
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000394 ;
  ns2:treeView ns1:PW_0000394 ;
  ns1:IAO_0000115 "Dopamine signaling via D2-like family of receptors engages the Galphai family of G proteins leading to inhibition of adenylyl cyclases and reduction of intracellular cAMP. Dopamine receptors 2, 3 and 4 belong to this family."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-03-09T03:22:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000852"^^xsd:string ;
  rdfs:label "dopamine signaling pathway via D2 family of receptors"^^xsd:string ;
  skos:notation "PW:0000852"^^xsd:string .

ns1:PW_0000853
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000274, ns1:PW_0002120 ;
  ns2:treeView ns1:PW_0000274, ns1:PW_0002120 ;
  ns1:IAO_0000115 "Histamine signaling is important for the central and to some extent the peripheral nervous systems and is also involved in the immune responses. Histamine signaling engages four G-protein coupled receptors (GPCR). In the brain, it involves receptors H1 and H3 that couple to Galphaq and Galphai, respectively."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-03-09T03:53:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000853"^^xsd:string ;
  rdfs:label "histamine signaling pathway, neuronal"^^xsd:string ;
  skos:notation "PW:0000853"^^xsd:string .

ns1:PW_0000854
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000274, ns1:PW_0000466, ns1:PW_0001162 ;
  ns2:treeView ns1:PW_0000274, ns1:PW_0000466, ns1:PW_0001162 ;
  ns1:IAO_0000115 "Serotonin signaling exerts many roles, from regulation of appetite, mood and sleep to involvement in learning and memory and in muscle contraction. Serotonin signals via several receptors known as 5-hydroxytryptamine or 5-HT receptors. With one exception, 5-HT receptors are G protein-coupled receptors engaging distinct G protein signaling to elicit distinct, both inhibitory and excitatory responses."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-03-09T04:11:20Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04726"^^xsd:string ;
  obo:id "PW:0000854"^^xsd:string ;
  rdfs:label "serotonin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000854"^^xsd:string .

ns1:PW_0000855
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000843 ;
  ns2:treeView ns1:PW_0000843 ;
  ns1:IAO_0000115 "Acetylcholine signaling via receptor type M1, M3 and M5 primarily engages G alphaq protein family resulting in activation of phospholipase C and mobilization of intracellular calcium. The receptors are expressed in various areas of the brain and the cell membrane of effector tissues."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-04-01T10:31:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000855"^^xsd:string ;
  rdfs:label "acetylcholine signaling pathway via muscarinic acetylcholine receptors engaging G alphaq protein family"^^xsd:string ;
  skos:notation "PW:0000855"^^xsd:string .

ns1:PW_0000856
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000843 ;
  ns2:treeView ns1:PW_0000843 ;
  ns1:IAO_0000115 "Acetylcholine signaling via receptor type M2 and M4 primarily engages G alphai protein family resulting in inhibition of adenylate cyclases and reduction of intracellular cAMP. The receptors are expressed in various areas of the brain and the cell membrane of effector tissues. A special feature is their role as autoreceptors at the presynapse of cholinergic neurons."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-04-01T11:01:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000856"^^xsd:string ;
  rdfs:label "acetylcholine signaling pathway via muscarinic acetylcholine receptors engaging G alphai protein family"^^xsd:string ;
  skos:notation "PW:0000856"^^xsd:string .

ns1:PW_0000857
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000124, ns1:PW_0001229 ;
  ns2:treeView ns1:PW_0000124, ns1:PW_0001229 ;
  ns1:IAO_0000115 "Phase I biotransformation pathway involves the conversion of exogenous substances to more polar metabolites. Members of the cytochrome P450 superfamily and to a lesser extent, flavin containing monooxygenases mediate the reactions."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-04-04T04:25:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000857"^^xsd:string ;
  rdfs:label "phase I biotransformation pathway"^^xsd:string ;
  skos:notation "PW:0000857"^^xsd:string .

ns1:PW_0000858
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000124, ns1:PW_0001229 ;
  ns2:treeView ns1:PW_0000124, ns1:PW_0001229 ;
  ns1:IAO_0000115 "Phase II biotransformation pathway involves the conjugation of phase I products to various hydrophilic moieties that renders them more suitable for excretion. Various enzyme superfamilies are involved in carrying out the specific conjugation of metabolites."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-04-04T04:37:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000858"^^xsd:string ;
  rdfs:label "phase II biotransformation pathway"^^xsd:string ;
  skos:notation "PW:0000858"^^xsd:string .

ns1:PW_0000859
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000858 ;
  ns2:treeView ns1:PW_0000858 ;
  ns1:IAO_0000115 "Glucuronidation of phase I products by members of the UDP-glucuronosyltranferase superfamily represents the major phase II conjugation pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-04-04T05:03:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000859"^^xsd:string ;
  rdfs:label "glucuronidation conjugation pathway"^^xsd:string ;
  skos:notation "PW:0000859"^^xsd:string .

ns1:PW_0000860
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000858 ;
  ns2:treeView ns1:PW_0000858 ;
  ns1:IAO_0000115 "The sulfonation of phase I products by members of the sulfotransferase family represents a major route of phase II biotransformation, second to the glucuronidation pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-04-04T05:12:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000860"^^xsd:string ;
  rdfs:label "sulfonation conjugation pathway"^^xsd:string ;
  skos:notation "PW:0000860"^^xsd:string .

ns1:PW_0000861
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000032 ;
  ns2:treeView ns1:PW_0000032 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the synthesis of pyrimidine nucleotides. A major route for pyrimidine synthesis is the novo pathway. However, an alternate pathway, the salvage pathway, converts nucleosides generated by DNA or RNA breakdown back to nucleotide monophosphates which can then re-enter the biosynthetic pathway."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2011-06-03T03:33:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000861"^^xsd:string ;
  rdfs:label "pyrimidine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000861"^^xsd:string .

ns1:PW_0000862
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000861 ;
  ns2:treeView ns1:PW_0000861 ;
  ns1:IAO_0000115 "In the de novo biosynthetic pathway, pyrimidines are synthesized from simple precursors. Six reactions carried out by three genes in higher eukaryotes result in the formation of UMP, the precursor of all other pyrimidine nucleotides."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2011-06-03T03:58:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000862"^^xsd:string ;
  rdfs:label "de novo pyrimidine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000862"^^xsd:string .

ns1:PW_0000863
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000861 ;
  ns2:treeView ns1:PW_0000861 ;
  ns1:IAO_0000115 "The salvage pathway of pyrimidine biosynthesis, mostly used in resting and differentiated cells, allows for the synthesis of pyrimidines from intermediates derived from DNA and RNA degradation pathways."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2011-06-03T04:12:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000863"^^xsd:string ;
  rdfs:label "pyrimidine salvage pathway"^^xsd:string ;
  skos:notation "PW:0000863"^^xsd:string .

ns1:PW_0000864
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000032 ;
  ns2:treeView ns1:PW_0000032 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the degradation of pyrimidines."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2011-06-03T04:46:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000864"^^xsd:string ;
  rdfs:label "pyrimidine degradation pathway"^^xsd:string ;
  skos:notation "PW:0000864"^^xsd:string .

ns1:PW_0000865
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000031 ;
  ns2:treeView ns1:PW_0000031 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the synthesis of purine nucleotides. A major route for purine synthesis is the novo pathway. However, an alternate pathway, the salvage pathway, can also be used."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-06-06T04:49:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000865"^^xsd:string ;
  rdfs:label "purine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000865"^^xsd:string .

ns1:PW_0000866
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000031 ;
  ns2:treeView ns1:PW_0000031 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the degradation pathway of purines. Several enzymes are involved in the breakdown of adenine and guanine to uric acid. Primates, birds and other animal excrete uric acid. In other species uric acid is further metabolized to allantoin."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-06-06T04:49:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000866"^^xsd:string ;
  rdfs:label "purine degradation pathway"^^xsd:string ;
  skos:notation "PW:0000866"^^xsd:string .

ns1:PW_0000867
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000865 ;
  ns2:treeView ns1:PW_0000865 ;
  ns1:IAO_0000115 "De novo purine biosynthesis requires ten enzymatic reactions to produce inosine monophosphate (IMP). Both adenine and guanine are then derived from IMP via several reactions. Purines are synthesized as nucleosides, i.e., as bases attached to ribose. Purines can also be created synthetically."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-06-06T04:50:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000867"^^xsd:string ;
  rdfs:label "de novo purine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000867"^^xsd:string .

ns1:PW_0000868
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000865 ;
  ns2:treeView ns1:PW_0000865 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-06-06T04:50:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000868"^^xsd:string ;
  rdfs:label "purine salvage pathway"^^xsd:string ;
  skos:notation "PW:0000868"^^xsd:string .

ns1:PW_0000869
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of gefitinib. Gefitinib is the first selective inhibitor of EGFR whose mutations within the tyrosine kinase domain have been associated with hyperactive epidermal growth factor signaling in non-small cell lung cancers. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-06-09T05:30:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000869"^^xsd:string ;
  rdfs:label "gefitinib drug pathway"^^xsd:string ;
  skos:notation "PW:0000869"^^xsd:string .

ns1:PW_0000870
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000869 ;
  ns2:treeView ns1:PW_0000869 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of gefitinib. Gefitinib is the first selective inhibitor of EGFR whose mutations within the tyrosine kinase domain have been associated with hyperactive epidermal growth factor signaling in non-small cell lung cancers. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-06-09T05:30:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000870"^^xsd:string ;
  rdfs:label "gefitinib pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0000870"^^xsd:string .

ns1:PW_0000871
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000869 ;
  ns2:treeView ns1:PW_0000869 ;
  ns1:IAO_0000115 "The pathway of gefitinib-target interactions and of the biochemical or physiological responses to drug. Gefitinib is the first selective inhibitor of EGFR whose mutations within the tyrosine kinase domain have been associated with hyperactive epidermal growth factor signaling in non-small cell lung cancers. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-06-09T05:31:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00473"^^xsd:string ;
  obo:id "PW:0000871"^^xsd:string ;
  rdfs:label "gefitinib pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0000871"^^xsd:string .

ns1:PW_0000872
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of erlotinib. Erlotinib is the second (after gefitinib) selective inhibitor of EGFR whose mutations within the tyrosine kinase domain have been associated with hyperactive epidermal growth factor signaling in non-small cell lung cancers. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-06-14T03:33:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000872"^^xsd:string ;
  rdfs:label "erlotinib drug pathway"^^xsd:string ;
  skos:notation "PW:0000872"^^xsd:string .

ns1:PW_0000873
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000872 ;
  ns2:treeView ns1:PW_0000872 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of erlotinib. Erlotinib is the second (after gefitinib) selective inhibitor of EGFR whose mutations within the tyrosine kinase domain have been associated with hyperactive epidermal growth factor signaling in non-small cell lung cancers. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-06-14T03:33:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000873"^^xsd:string ;
  rdfs:label "erlotinib pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0000873"^^xsd:string .

ns1:PW_0000874
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000872 ;
  ns2:treeView ns1:PW_0000872 ;
  ns1:IAO_0000115 "The pathway of erlotinib-target interaction and of the biochemical or physiological responses to drug. Erlotinib is the second (after gefitinib) selective inhibitor of EGFR whose mutations within the tyrosine kinase domain have been associated with hyperactive epidermal growth factor signaling in non-small cell lung cancers. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-06-14T03:34:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00472"^^xsd:string ;
  obo:id "PW:0000874"^^xsd:string ;
  rdfs:label "erlotinib pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0000874"^^xsd:string .

ns1:PW_0000875
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000012 ;
  ns2:treeView ns1:PW_0000012 ;
  ns1:IAO_0000115 "Deoxyribonucleotide synthesis occurs via the de novo pathway mediated by ribonucleotide reductase or via the salvage pathway. The de novo pathway is responsible for the bulk of dNTP during the S phase of cell cycle whereas the salvage pathway mostly operates in the quiescent state of the cell. Several cytosolic and mitochondrial enzymes are responsible for the initial steps of the salvage pathway in the two compartments and for the reverse reactions that control the size of the dNTP pool."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-07-01T10:58:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000875"^^xsd:string ;
  rdfs:label "deoxyribonucleotide metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000875"^^xsd:string .

ns1:PW_0000876
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000146 ;
  ns2:treeView ns1:PW_0000146 ;
  ns1:IAO_0000115 "Those metabolic reaction involved in the synthesis, utilization and/or degradation of polysaccharides that are components of bacterial cell wall. They may also act as virulence factors."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-07-11T09:36:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000876"^^xsd:string ;
  rdfs:label "bacterial polysaccharide metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000876"^^xsd:string .

ns1:PW_0000877
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000055 ;
  ns2:treeView ns1:PW_0000055 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of cytosine monophosphate, the only nucleotide sugar in the monophosphate form."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-07-11T10:29:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000877"^^xsd:string ;
  rdfs:label "cytosine monophosphate metabolic pathway"^^xsd:string ;
  skos:notation "PW:0000877"^^xsd:string .

ns1:PW_0000878
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001307 ;
  ns2:treeView ns1:PW_0001307 ;
  ns1:IAO_0000115 "Phosphatidylcholine is the predominant phospholipid of eukaryotic membranes. Of the three known biosynthetic pathways, two are found in eukaryotes and one, the CDP-choline, is the best characterized."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-07-11T10:44:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000878"^^xsd:string ;
  rdfs:label "phosphatidylcholine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0000878"^^xsd:string .

ns1:PW_0000879
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000569, ns1:PW_0000719, ns1:PW_0000881, ns1:PW_0001314 ;
  ns2:treeView ns1:PW_0000569, ns1:PW_0000719, ns1:PW_0000881, ns1:PW_0001314 ;
  ns1:IAO_0000115 "A cortisol signaling pathway that deviates from what its normal course should be. Mutations in the glucocorticoid receptor have been associated with rare, sporadic or familial, glucocorticoid resistance."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-08-23T09:15:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000879"^^xsd:string ;
  rdfs:label "altered cortisol signaling pathway"^^xsd:string ;
  skos:notation "PW:0000879"^^xsd:string .

ns1:PW_0000880
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000566 ;
  ns2:treeView ns1:PW_0000566 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-08-23T09:19:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000880"^^xsd:string ;
  rdfs:label "altered corticosteroid signaling pathway"^^xsd:string ;
  skos:notation "PW:0000880"^^xsd:string .

ns1:PW_0000881
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000782, ns1:PW_0000880 ;
  ns2:treeView ns1:PW_0000782, ns1:PW_0000880 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-08-23T09:20:35Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000881"^^xsd:string ;
  rdfs:label "altered glucocorticoid signaling pathway"^^xsd:string ;
  skos:notation "PW:0000881"^^xsd:string .

ns1:PW_0000882
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000512 ;
  ns2:treeView ns1:PW_0000512 ;
  ns1:IAO_0000115 "The interleukin-1 family mediated signaling plays important roles in innate and adaptive immune responses. The best characterized member of the family is interleukin-1 followed by interleukin-18 and the more recently identified interleukin-33. Other family members are less well characterized."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-08-29T11:08:06Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Il-1 family mediated signaling pathway"^^xsd:string ;
  obo:id "PW:0000882"^^xsd:string ;
  rdfs:label "interleukin-1 family mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000882"^^xsd:string .

ns1:PW_0000883
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000882, ns1:PW_0000926 ;
  ns2:treeView ns1:PW_0000882, ns1:PW_0000926 ;
  ns1:IAO_0000115 "Interleukin-1 signaling, primarily via interleukin-1beta, plays important roles in innate and adaptive immune responses. Binding of the processed cytokine to its receptor, allows for the recruitment of several accessory and adaptor proteins leading to the activation of NF-kappaB and MAPK signaling cascades. A natural receptor antagonist and a decoy receptor act as regulators of interleukin 1alpha and beta."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-08-29T11:15:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Il-1 signaling pathway"^^xsd:string, "PID:200089"^^xsd:string ;
  obo:id "PW:0000883"^^xsd:string ;
  rdfs:label "interleukin-1 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000883"^^xsd:string .

ns1:PW_0000884
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000882 ;
  ns2:treeView ns1:PW_0000882 ;
  ns1:IAO_0000115 "Interleukin-18 signaling plays important roles in innate and adaptive immunity. In the central nervous system (CNS), Il-18 and its receptors have been shown to play a role in neuroinflammatory and neurodegenerative processes as well as behavior and homeostasis. In addition, Il-18 may be a mediator of inflammation in rheumatoid arthritis."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-08-29T11:16:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Il-18 signaling pathway"^^xsd:string ;
  obo:id "PW:0000884"^^xsd:string ;
  rdfs:label "interleukin-18 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000884"^^xsd:string .

ns1:PW_0000885
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000882 ;
  ns2:treeView ns1:PW_0000882 ;
  ns1:IAO_0000115 "Interleukin-33 is the most recently discovered member of the interleukin-1 family. Like with the other members of the family, signaling by interleukin-33 plays important roles in inflammation and immunity and may be critical for the development of inflammatory and immune diseases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-08-29T11:16:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Il-33 signaling pathway"^^xsd:string ;
  obo:id "PW:0000885"^^xsd:string ;
  rdfs:label "interleukin-33 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000885"^^xsd:string .

ns1:PW_0000886
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000513 ;
  ns2:treeView ns1:PW_0000513 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-12-06T09:28:03Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000886"^^xsd:string ;
  rdfs:label "interleukin-19 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000886"^^xsd:string .

ns1:PW_0000887
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000513 ;
  ns2:treeView ns1:PW_0000513 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-12-06T09:37:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000887"^^xsd:string ;
  rdfs:label "interleukin-20 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000887"^^xsd:string .

ns1:PW_0000888
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000513 ;
  ns2:treeView ns1:PW_0000513 ;
  ns1:IAO_0000115 "Interleukin-22 signaling triggers the Jak-Stat intracellular cascade resulting in the activation of various T helper (Th) cells."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-12-06T09:38:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Il-22 signaling pathway"^^xsd:string ;
  obo:id "PW:0000888"^^xsd:string ;
  rdfs:label "interleukin-22 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000888"^^xsd:string .

ns1:PW_0000889
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000513 ;
  ns2:treeView ns1:PW_0000513 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-12-06T09:39:50Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000889"^^xsd:string ;
  rdfs:label "interleukin-24 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000889"^^xsd:string .

ns1:PW_0000890
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000513 ;
  ns2:treeView ns1:PW_0000513 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-12-06T09:40:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000890"^^xsd:string ;
  rdfs:label "interleukin-26 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000890"^^xsd:string .

ns1:PW_0000891
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000513 ;
  ns2:treeView ns1:PW_0000513 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-12-06T10:26:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "interferon lambda2 signaling pathway"^^xsd:string ;
  obo:id "PW:0000891"^^xsd:string ;
  rdfs:label "interleukin-28A signaling pathway"^^xsd:string ;
  skos:notation "PW:0000891"^^xsd:string .

ns1:PW_0000892
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000513 ;
  ns2:treeView ns1:PW_0000513 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-12-06T10:29:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "interferon lambda3 signaling pathway"^^xsd:string ;
  obo:id "PW:0000892"^^xsd:string ;
  rdfs:label "interleukin-28B signaling pathway"^^xsd:string ;
  skos:notation "PW:0000892"^^xsd:string .

ns1:PW_0000893
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000513 ;
  ns2:treeView ns1:PW_0000513 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-12-06T10:30:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "interferon lambda1 signaling pathway"^^xsd:string ;
  obo:id "PW:0000893"^^xsd:string ;
  rdfs:label "interleukin-29 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000893"^^xsd:string .

ns1:PW_0000894
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000828 ;
  ns2:treeView ns1:PW_0000828 ;
  ns1:IAO_0000115 "The interferons represent a subset of cytokines whose signaling is involved in various aspects of innate and adaptive immunity. Based on the type of receptors they employ, interferons have been classified into type I and II. A third type, the lambda interferons, are members of the interleukin 10 family."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-12-06T10:46:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000894"^^xsd:string ;
  rdfs:label "interferon mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000894"^^xsd:string .

ns1:PW_0000895
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000894 ;
  ns2:treeView ns1:PW_0000894 ;
  ns1:IAO_0000115 "Type I interferon, which includes all but one of the seven known human genes, binds to distinct receptors that activate the Jak-Stat signaling pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-12-06T10:58:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000895"^^xsd:string ;
  rdfs:label "type I interferon signaling pathway"^^xsd:string ;
  skos:notation "PW:0000895"^^xsd:string .

ns1:PW_0000896
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000894 ;
  ns2:treeView ns1:PW_0000894 ;
  ns1:IAO_0000115 "Type II interferon, of which there is only one in humans, binds to distinct receptors that activate Jak-Stat signaling pathway. It is known as the interferon gamma signaling."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-12-06T11:07:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200129"^^xsd:string, "interferon gamma signaling"^^xsd:string ;
  obo:id "PW:0000896"^^xsd:string ;
  rdfs:label "type II interferon signaling pathway"^^xsd:string ;
  skos:notation "PW:0000896"^^xsd:string .

ns1:PW_0000897
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000512 ;
  ns2:treeView ns1:PW_0000512 ;
  ns1:IAO_0000115 "The interleukin-17 family mediated signaling plays important roles in inflammation and the development of autoimmunity as well as in the host defense against fungal and bacterial infections."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-12-06T11:23:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Il-17 family mediated signaling pathway"^^xsd:string ;
  obo:id "PW:0000897"^^xsd:string ;
  rdfs:label "interleukin-17 family mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000897"^^xsd:string .

ns1:PW_0000898
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000897 ;
  ns2:treeView ns1:PW_0000897 ;
  ns1:IAO_0000115 "Interleukin-17E signaling, also known as interleukin-25, induces the production of Th2 cell cytokine leading to enhancement of Th2 cell responses."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-12-06T02:31:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Il-17E signaling pathway"^^xsd:string, "Il-25 signaling pathway"^^xsd:string ;
  obo:id "PW:0000898"^^xsd:string ;
  rdfs:label "interleukin-17E signaling pathway"^^xsd:string ;
  skos:notation "PW:0000898"^^xsd:string .

ns1:PW_0000899
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000897 ;
  ns2:treeView ns1:PW_0000897 ;
  ns1:IAO_0000115 "Of the six family members of interleukin-17 family, interleukin-17A is the founding member and the better characterized system. While interleukin-17A binds the same receptor as interleukin-17F and can also heterodimerize with it, its signaling elicits distinct and broader responses."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-12-06T02:31:40Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Il-17A signaling pathway"^^xsd:string ;
  obo:id "PW:0000899"^^xsd:string ;
  rdfs:label "interleukin-17A signaling pathway"^^xsd:string ;
  skos:notation "PW:0000899"^^xsd:string .

ns1:PW_0000900
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000897 ;
  ns2:treeView ns1:PW_0000897 ;
  ns1:IAO_0000115 "Interleukin-17F binds the same receptor as interleukin-17A and can also heterodimerize with it. However, its signaling while sharing features of interleukin-17A pathway also elicits distinct responses."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-12-06T02:41:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000900"^^xsd:string ;
  rdfs:label "interleukin-17F signaling pathway"^^xsd:string ;
  skos:notation "PW:0000900"^^xsd:string .

ns1:PW_0000901
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000512, ns1:PW_0000617 ;
  ns2:treeView ns1:PW_0000512, ns1:PW_0000617 ;
  ns1:IAO_0000115 "An interleukin mediated signaling pathway that deviates from what its normal course should be. Aberrant interleukin signaling pathway, alone or in combination with other pathways underlie various diseases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2011-12-06T03:18:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000901"^^xsd:string ;
  rdfs:label "altered interleukin mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000901"^^xsd:string .

ns1:PW_0000902
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000514 ;
  ns2:treeView ns1:PW_0000514 ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2012-01-23T04:17:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000902"^^xsd:string ;
  rdfs:label "interleukin-11 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000902"^^xsd:string .

ns1:PW_0000903
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000514 ;
  ns2:treeView ns1:PW_0000514 ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2012-01-23T04:19:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "LIF signaling pathway"^^xsd:string ;
  obo:id "PW:0000903"^^xsd:string ;
  rdfs:label "leukemia inhibitory factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0000903"^^xsd:string .

ns1:PW_0000904
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000514 ;
  ns2:treeView ns1:PW_0000514 ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2012-01-23T04:21:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "C"^^xsd:string, "CNTF signaling pathway"^^xsd:string ;
  obo:id "PW:0000904"^^xsd:string ;
  rdfs:label "ciliary neurotrophic factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0000904"^^xsd:string .

ns1:PW_0000905
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000514 ;
  ns2:treeView ns1:PW_0000514 ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2012-01-23T04:22:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "OSM signaling pathway"^^xsd:string ;
  obo:id "PW:0000905"^^xsd:string ;
  rdfs:label "oncostatin M signaling pathway"^^xsd:string ;
  skos:notation "PW:0000905"^^xsd:string .

ns1:PW_0000906
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000512 ;
  ns2:treeView ns1:PW_0000512 ;
  ns1:IAO_0000115 "Interleukin-2 family of cytokines, also known as gamma(c) family because of the shared gamma(c) receptor, plays crucial roles in the regulation of T cells."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-03-23T12:26:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Il-2 family mediated signaling pathway"^^xsd:string ;
  obo:id "PW:0000906"^^xsd:string ;
  rdfs:label "interleukin-2 family mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000906"^^xsd:string .

ns1:PW_0000907
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000906 ;
  ns2:treeView ns1:PW_0000906 ;
  ns1:IAO_0000115 "Interleukin-2 is the prototypical member of the interleukin-2 family of cytokines. The signaling pathway initiated by Il-2 and the other family members activates the Jak-Stat intracellular cascade to regulate T cell, innate and adaptive immune responses."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-03-23T12:33:40Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Il-2 signaling pathway"^^xsd:string, "PID:200098"^^xsd:string ;
  obo:id "PW:0000907"^^xsd:string ;
  rdfs:label "interleukin-2 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000907"^^xsd:string .

ns1:PW_0000908
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000906 ;
  ns2:treeView ns1:PW_0000906 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-03-23T12:38:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000908"^^xsd:string ;
  rdfs:label "interleukin-7 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000908"^^xsd:string .

ns1:PW_0000909
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000906 ;
  ns2:treeView ns1:PW_0000906 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-03-23T12:39:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000909"^^xsd:string ;
  rdfs:label "interleukin-9 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000909"^^xsd:string .

ns1:PW_0000910
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000906 ;
  ns2:treeView ns1:PW_0000906 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-03-23T12:39:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000910"^^xsd:string ;
  rdfs:label "interleukin-15 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000910"^^xsd:string .

ns1:PW_0000911
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000906 ;
  ns2:treeView ns1:PW_0000906 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-03-23T12:39:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000911"^^xsd:string ;
  rdfs:label "interleukin-21 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000911"^^xsd:string .

ns1:PW_0000912
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000906 ;
  ns2:treeView ns1:PW_0000906 ;
  ns1:IAO_0000115 "Interleukin-4 is a member of interleukin 2 family of cytokine whose signaling is important for the differentiation of naive T helper cells."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-03-23T12:48:51Z"^^xsd:string ;
  obo:hasExactSynonym "Il-4 signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200022"^^xsd:string ;
  obo:id "PW:0000912"^^xsd:string ;
  rdfs:label "interleukin-4 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000912"^^xsd:string .

ns1:PW_0000913
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000512 ;
  ns2:treeView ns1:PW_0000512 ;
  ns1:IAO_0000115 "Interleukin-12 family members of heterodimeric cytokines are produced by antigen presenting cells. The signaling they initiate triggers the Jak-Stat intracellular cascade and plays important roles in the regulation of T helper (Th) cell differentiation."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-03-23T03:39:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Il-12 family mediated signaling pathway"^^xsd:string ;
  obo:id "PW:0000913"^^xsd:string ;
  rdfs:label "interleukin-12 family mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000913"^^xsd:string .

ns1:PW_0000914
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000913 ;
  ns2:treeView ns1:PW_0000913 ;
  ns1:IAO_0000115 "Interleukin-12 signaling activates the Jak-Stat intracellular cascade and promotes the differentiation and proliferation of Th1 cells and the production of interferon-gamma."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-03-23T03:43:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Il-12 signaling pathway"^^xsd:string, "PID:200045"^^xsd:string ;
  obo:id "PW:0000914"^^xsd:string ;
  rdfs:label "interleukin-12 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000914"^^xsd:string .

ns1:PW_0000915
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000913 ;
  ns2:treeView ns1:PW_0000913 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-03-23T03:49:27Z"^^xsd:string ;
  obo:hasExactSynonym "Il-23 signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200154"^^xsd:string ;
  obo:id "PW:0000915"^^xsd:string ;
  rdfs:label "interleukin-23 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000915"^^xsd:string .

ns1:PW_0000916
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000913 ;
  ns2:treeView ns1:PW_0000913 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-03-23T03:49:45Z"^^xsd:string ;
  obo:hasExactSynonym "Il-27 signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200028"^^xsd:string ;
  obo:id "PW:0000916"^^xsd:string ;
  rdfs:label "interleukin-27 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000916"^^xsd:string .

ns1:PW_0000917
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000913 ;
  ns2:treeView ns1:PW_0000913 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-03-23T03:50:45Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000917"^^xsd:string ;
  rdfs:label "interleukin-35 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000917"^^xsd:string .

ns1:PW_0000918
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000921 ;
  ns2:treeView ns1:PW_0000921 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of proton pump inhibitor (PPI), a class of compounds that block the acid secretion from parietal cells in the stomach. A representative PPI compound is omeprazole. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-03-28T02:13:39Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000918"^^xsd:string ;
  rdfs:label "proton pump inhibitor drug pathway"^^xsd:string ;
  skos:notation "PW:0000918"^^xsd:string .

ns1:PW_0000919
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000754 ;
  ns2:treeView ns1:PW_0000754 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of compounds used as antineoplastic or as immunomodulatory agents. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-03-28T02:35:45Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000919"^^xsd:string ;
  rdfs:label "antineoplastic and immunomodulatory drug pathway"^^xsd:string ;
  skos:notation "PW:0000919"^^xsd:string .

ns1:PW_0000920
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000754 ;
  ns2:treeView ns1:PW_0000754 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of compounds used for the treatment of various cardiovascular conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-03-28T02:45:12Z"^^xsd:string ;
  obo:hasAlternativeId "PW:0002488"^^xsd:string ;
  obo:hasExactSynonym "dermatological drug pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000920"^^xsd:string ;
  rdfs:label "cardiovascular system drug pathway"^^xsd:string ;
  skos:notation "PW:0000920"^^xsd:string .

ns1:PW_0000921
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000754 ;
  ns2:treeView ns1:PW_0000754 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of compounds used for the treatment of alimentary tract and metabolism-related conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-03-28T02:49:20Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000921"^^xsd:string ;
  rdfs:label "alimentary tract and metabolism drug pathway"^^xsd:string ;
  skos:notation "PW:0000921"^^xsd:string .

ns1:PW_0000922
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000754 ;
  ns2:treeView ns1:PW_0000754 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of compounds used for the treatment of conditions associated with blood and blood forming organs. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-03-28T02:55:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000922"^^xsd:string ;
  rdfs:label "blood and blood forming organs drug pathway"^^xsd:string ;
  skos:notation "PW:0000922"^^xsd:string .

ns1:PW_0000923
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000754 ;
  ns2:treeView ns1:PW_0000754 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of compounds used for the treatment of conditions associated with the nervous system. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-03-28T02:58:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000923"^^xsd:string ;
  rdfs:label "nervous system drug pathway"^^xsd:string ;
  skos:notation "PW:0000923"^^xsd:string .

ns1:PW_0000924
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000754 ;
  ns2:treeView ns1:PW_0000754 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of compounds used for the treatment of conditions associated with the respiratory system. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-04-05T03:45:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000924"^^xsd:string ;
  rdfs:label "respiratory system drug pathway"^^xsd:string ;
  skos:notation "PW:0000924"^^xsd:string .

ns1:PW_0000925
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000024, ns1:PW_0000819 ;
  ns2:treeView ns1:PW_0000024, ns1:PW_0000819 ;
  ns1:IAO_0000115 "Pattern recognition receptors (PRR) respond to a diverse array of exogenous molecules and also several endogenous ones. PRR's 'sensing' of pathogen-associated molecular patterns (PAMP) or damage-associated (DAMP) prompts signaling cascades leading to the expression of pro-inflammatory genes."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-04-24T11:34:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000925"^^xsd:string ;
  rdfs:label "pattern recognition receptor mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000925"^^xsd:string .

ns1:PW_0000926
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000024 ;
  ns2:treeView ns1:PW_0000024 ;
  ns1:IAO_0000115 "An early response of the innate immunity is the secretion of cytokines critical for the acute inflammatory response. The major pro-inflammatory cytokines are tumor necrosis factor alpha and the interleukins 1 and 6."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-04-24T11:43:45Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000926"^^xsd:string ;
  rdfs:label "pro-inflammatory cytokine mediated pathway"^^xsd:string ;
  skos:notation "PW:0000926"^^xsd:string .

ns1:PW_0000927
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002369 ;
  ns2:treeView ns1:PW_0002369 ;
  ns1:IAO_0000115 "Tumor necrosis factor (TNF) inhibitors are used in the treatment of rheumatoid arthritis. The inhibitors are recombinant proteins that bind the soluble and membrane-associated TNF and inhibit the effects of this pro-inflammatory cytokine."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-04-26T02:36:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "anti-TNF drug pathway"^^xsd:string ;
  obo:id "PW:0000927"^^xsd:string ;
  rdfs:label "anti-tumor necrosis factor drug pathway"^^xsd:string ;
  skos:notation "PW:0000927"^^xsd:string .

ns1:PW_0000928
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002369 ;
  ns2:treeView ns1:PW_0002369 ;
  ns1:IAO_0000115 "Tocilizumab is a humanized anti-interleukin 6 (Il-6) receptor antibody used in the treatment of patients with rheumatoid arthritis, Castleman's disease or juvenile idiopathic arthritis. Tocilizumab binds to the soluble and membrane associated interleukin-6 receptor and competitively blocks binding of interleukin-6 to its receptor(s) and inhibits the effects of this potent cytokine."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-04-26T03:00:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Actemra drug pathway"^^xsd:string ;
  obo:id "PW:0000928"^^xsd:string ;
  rdfs:label "tocilizumab drug pathway"^^xsd:string ;
  skos:notation "PW:0000928"^^xsd:string .

ns1:PW_0000929
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002369 ;
  ns2:treeView ns1:PW_0002369 ;
  ns1:IAO_0000115 "Anakinra is a recombinant, non-glycosylated version of the human interleukin-1 (Il-1) receptor antagonist used for the treatment of inflammation associated with rheumatoid arthritis. Like the natural antagonist, anakinra competitively inhibits binding of interleukin-1 to its receptor and the subsequent effects of this potent pro-inflammatory cytokine."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-04-26T03:26:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "kineret drug pathway"^^xsd:string ;
  obo:id "PW:0000929"^^xsd:string ;
  rdfs:label "anakinra drug pathway"^^xsd:string ;
  skos:notation "PW:0000929"^^xsd:string .

ns1:PW_0000930
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367, ns1:PW_0002369 ;
  ns2:treeView ns1:PW_0002367, ns1:PW_0002369 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of methotrexate (MTX), a polyglutamatable antifolate used in the treatment of cancers and autoimmune diseases. The impact of MTX on cancer and rheumatoid arthritis is thought to arise through distinct mechanisms and pharmacodynamics pathways. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-04-27T01:27:25Z"^^xsd:string ;
  obo:hasExactSynonym "MTX drug pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000930"^^xsd:string ;
  rdfs:label "methotrexate drug pathway"^^xsd:string ;
  skos:notation "PW:0000930"^^xsd:string .

ns1:PW_0000931
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000930 ;
  ns2:treeView ns1:PW_0000930 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of methotrexate (MTX), a folate analogue used in the treatment of cancers and autoimmune diseases. Genetic variations can result in changes in the availability of the drug and It is believed that variability in MTX pharmacokinetics is linked to genetic variations in transporter proteins."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-04-27T01:46:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "MTX pharmacokinetics pathway"^^xsd:string ;
  obo:id "PW:0000931"^^xsd:string ;
  rdfs:label "methotrexate pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0000931"^^xsd:string .

ns1:PW_0000932
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000930 ;
  ns2:treeView ns1:PW_0000930 ;
  ns1:IAO_0000115 "The pathway of methotrexate-target interaction and of the biochemical or physiological responses to drug. The impact of MTX on cancer and rheumatoid arthritis is thought to arise through distinct mechanisms and pharmacodynamics pathways. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-04-27T02:16:39Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "MTX pharmacodynamics pathway"^^xsd:string, "SMP:00432"^^xsd:string ;
  obo:id "PW:0000932"^^xsd:string ;
  rdfs:label "methotrexate pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0000932"^^xsd:string .

ns1:PW_0000933
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000236 ;
  ns2:treeView ns1:PW_0000236 ;
  ns1:IAO_0000115 "Tumor necrosis factor member 14, also known as Light, binds the lymphotoxin beta receptor and the tumor necrosis receptor member 14 known as Hvem of the tumor necrosis receptor superfamily to elicit important responses for the dendritic (DC) and T cells of the immune system."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-01T10:26:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Tnfsf14 (Light) signaling pathway"^^xsd:string, "Tnfsf14 signaling pathway"^^xsd:string ;
  obo:id "PW:0000933"^^xsd:string ;
  rdfs:label "tumor necrosis factor member 14 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000933"^^xsd:string .

ns1:PW_0000934
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000236 ;
  ns2:treeView ns1:PW_0000236 ;
  ns1:IAO_0000115 "Tumor necrosis factor member 13 also known as April, binds the tumor necrosis factor receptor member 13B known as Taci and receptor member 17 known as Bcma of the tumor necrosis factor receptor superfamily to elicit important responses for the B cells of the immune system."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-01T11:00:20Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Tnfsf13 (April) signaling pathway"^^xsd:string, "Tnfsf13 signaling pathway"^^xsd:string ;
  obo:id "PW:0000934"^^xsd:string ;
  rdfs:label "tumor necrosis factor member 13 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000934"^^xsd:string .

ns1:PW_0000935
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000236 ;
  ns2:treeView ns1:PW_0000236 ;
  ns1:IAO_0000115 "The tumor necrosis factor member 13b known as Baff binds to three receptors of the tumor necrosis factor receptor superfamily - the receptor member 13B known as Taci and member 17 known as Bcma to which member 13 of the ligand superfamily also binds, and additionally to member 13C of the receptor superfamily to elicit important responses for the B cells of the immune system."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-01T11:11:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Tnfsf13b (Baff) signaling pathway"^^xsd:string, "Tnfsf13b signaling pathway"^^xsd:string ;
  obo:id "PW:0000935"^^xsd:string ;
  rdfs:label "tumor necrosis factor member 13b signaling pathway"^^xsd:string ;
  skos:notation "PW:0000935"^^xsd:string .

ns1:PW_0000936
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000831 ;
  ns2:treeView ns1:PW_0000831 ;
  ns1:IAO_0000115 "Chemokine ligand 1 signaling engages the chemokine (C-C motif) receptor 8 (Ccr8) and together with other CC chemokines is classified as a member of the allergenic subgroup."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2012-05-01T02:12:50Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Ccl1 signaling pathway"^^xsd:string ;
  obo:id "PW:0000936"^^xsd:string ;
  rdfs:label "chemokine (C-C motif) ligand 1 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000936"^^xsd:string .

ns1:PW_0000937
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000831 ;
  ns2:treeView ns1:PW_0000831 ;
  ns1:IAO_0000115 "Chemokine ligand 1 signaling engages the chemokine (C-C motif) receptor 2 (Ccr2) and together with other CC chemokines is classified as a member of the allergenic subgroup."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2012-05-01T02:20:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Ccl2 signaling pathway"^^xsd:string ;
  obo:id "PW:0000937"^^xsd:string ;
  rdfs:label "chemokine (C-C motif) ligand 2 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000937"^^xsd:string .

ns1:PW_0000938
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000831 ;
  ns2:treeView ns1:PW_0000831 ;
  ns1:IAO_0000115 "Chemokine ligand 3 signaling pathway engages chemokine (C-C motif) receptors 2 and 5 (Ccr2 and Ccr5) and together with other chemokines is classified as a member of the pro-inflammatory subgroup."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2012-05-01T02:30:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Ccl3 signaling pathway"^^xsd:string ;
  obo:id "PW:0000938"^^xsd:string ;
  rdfs:label "chemokine (C-C motif) ligand 3 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000938"^^xsd:string .

ns1:PW_0000939
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000831 ;
  ns2:treeView ns1:PW_0000831 ;
  ns1:IAO_0000115 "Chemokine ligand 4 signaling engages the chemokine (C-C motif) receptor 5 (Ccr5) and together with other chemokines is classified as a member of the pro-inflammatory subgroup."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2012-05-01T02:34:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Ccl4 signaling pathway"^^xsd:string ;
  obo:id "PW:0000939"^^xsd:string ;
  rdfs:label "chemokine (C-C motif) ligand 4 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000939"^^xsd:string .

ns1:PW_0000940
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000831 ;
  ns2:treeView ns1:PW_0000831 ;
  ns1:IAO_0000115 "Chemokine ligand 5 signaling engages chemokine (C-C motif) receptors 1, 3 and 5 (Ccr1, Ccr3 and Ccr5) and together with other chemokines is classified as a member of the pro-inflammatory subgroup."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2012-05-01T02:39:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Ccl5 signaling pathway"^^xsd:string ;
  obo:id "PW:0000940"^^xsd:string ;
  rdfs:label "chemokine (C-C motif) ligand 5 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000940"^^xsd:string .

ns1:PW_0000941
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000831 ;
  ns2:treeView ns1:PW_0000831 ;
  ns1:IAO_0000115 "Chemokine ligand 6 signaling is known to act in rodents and does not appear to have a human equivalent. Ccl6, together with other chemokines is classified as a member of the pro-inflammatory subgroup."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2012-05-01T02:43:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Ccl6 signaling pathway"^^xsd:string ;
  obo:id "PW:0000941"^^xsd:string ;
  rdfs:label "chemokine (C-C motif) ligand 6 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000941"^^xsd:string .

ns1:PW_0000942
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000831 ;
  ns2:treeView ns1:PW_0000831 ;
  ns1:IAO_0000115 "Chemokine ligand 7 signaling engages chemokine (C-C) motif receptors 1, 2, and 3 (Ccr1, Ccr2, Ccr3) and together with other chemokines is classified as a member of the allergenic subgroup."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2012-05-01T02:51:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Ccl7 signaling pathway"^^xsd:string ;
  obo:id "PW:0000942"^^xsd:string ;
  rdfs:label "chemokine (C-C motif) ligand 7 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000942"^^xsd:string .

ns1:PW_0000943
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000831 ;
  ns2:treeView ns1:PW_0000831 ;
  ns1:IAO_0000115 "Chemokine ligand 8 signaling engages chemokine (C-C motif) receptors 3 and 5 (Ccr3 and Ccr5) and together with other chemokines is classified as a member of the allergenic subgroup."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2012-05-01T02:54:39Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Ccl8 signaling pathway"^^xsd:string ;
  obo:id "PW:0000943"^^xsd:string ;
  rdfs:label "chemokine (C-C motif) ligand 8 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000943"^^xsd:string .

ns1:PW_0000944
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000831 ;
  ns2:treeView ns1:PW_0000831 ;
  ns1:IAO_0000115 "Chemokine ligand 11 signaling engages the chemokine (C-C motif) receptor 3 (Ccr3) and together with other chemokines is classified as a member of the allergenic subgroup."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2012-05-01T03:09:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Ccl11 signaling pathway"^^xsd:string, "eotaxin signaling pathway"^^xsd:string ;
  obo:id "PW:0000944"^^xsd:string ;
  rdfs:label "chemokine (C-C motif) ligand 11 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000944"^^xsd:string .

ns1:PW_0000945
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000831 ;
  ns2:treeView ns1:PW_0000831 ;
  ns1:IAO_0000115 "Chemokine ligand 12 signaling is known to act in rodents and does not appear to have a human equivalent. Ccl12, together with other chemokines is classified as a member of the allergenic subgroup."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2012-05-01T03:16:03Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Ccl12 signaling pathway"^^xsd:string ;
  obo:id "PW:0000945"^^xsd:string ;
  rdfs:label "chemokine (C-C motif) ligand 12 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000945"^^xsd:string .

ns1:PW_0000946
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000831 ;
  ns2:treeView ns1:PW_0000831 ;
  ns1:IAO_0000115 "Chemokine ligand 13 signaling engages chemokine (C-C motif) receptors 2 and 3 (Ccr2 and Ccr3) and together with other chemokines is classified as a member of the allergenic subgroup."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2012-05-01T03:17:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Ccl13 signaling pathway"^^xsd:string ;
  obo:id "PW:0000946"^^xsd:string ;
  rdfs:label "chemokine (C-C motif) ligand 13 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000946"^^xsd:string .

ns1:PW_0000947
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000831 ;
  ns2:treeView ns1:PW_0000831 ;
  ns1:IAO_0000115 "Chemokine ligand 17 signaling engages the chemokine (C-C motif) receptor 4 (Ccr4) and together with other chemokines is classified as a member of the developmental subgroup."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2012-05-01T03:23:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Ccl17 signaling pathway"^^xsd:string ;
  obo:id "PW:0000947"^^xsd:string ;
  rdfs:label "chemokine (C-C motif) ligand 17 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000947"^^xsd:string .

ns1:PW_0000948
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000831 ;
  ns2:treeView ns1:PW_0000831 ;
  ns1:IAO_0000115 "Chemokine ligand 22 signaling engages the chemokine (C-C motif) receptor 4 (Ccr4) and together with other chemokines is classified as member of the developmental subgroup."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2012-05-01T03:26:56Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Ccl22 signaling pathway"^^xsd:string ;
  obo:id "PW:0000948"^^xsd:string ;
  rdfs:label "chemokine (C-C motif) ligand 22 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000948"^^xsd:string .

ns1:PW_0000949
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000831 ;
  ns2:treeView ns1:PW_0000831 ;
  ns1:IAO_0000115 "Chemokine ligand 25 signaling engages the chemokine (C-C motif) receptor 9 (Ccr9) and together with other chemokines is classified as a member of the developmental subgroup."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2012-05-01T03:31:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Ccl25 signaling pathway"^^xsd:string ;
  obo:id "PW:0000949"^^xsd:string ;
  rdfs:label "chemokine (C-C motif) ligand 25 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000949"^^xsd:string .

ns1:PW_0000950
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000831 ;
  ns2:treeView ns1:PW_0000831 ;
  ns1:IAO_0000115 "Chemokine ligand 24 signaling engages the chemokine (C-C motif) receptor 3 (Ccr3) and together with other chemokines is classified as member of the allergenic subgroup."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2012-05-01T03:37:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Ccl24 signaling pathway"^^xsd:string, "eotaxin-2 signaling pathway"^^xsd:string ;
  obo:id "PW:0000950"^^xsd:string ;
  rdfs:label "chemokine (C-C motif) ligand 24 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000950"^^xsd:string .

ns1:PW_0000951
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000831 ;
  ns2:treeView ns1:PW_0000831 ;
  ns1:IAO_0000115 "Chemokine ligand 26 signaling engages the chemokine (C-C motif) receptor 3 (Ccr3) and together with other chemokines is classified as member of the allergenic subgroup."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2012-05-01T03:39:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Ccl26 signaling pathway"^^xsd:string, "eotaxin-3 signaling pathway"^^xsd:string ;
  obo:id "PW:0000951"^^xsd:string ;
  rdfs:label "chemokine (C-C motif) ligand 26 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000951"^^xsd:string .

ns1:PW_0000952
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000831 ;
  ns2:treeView ns1:PW_0000831 ;
  ns1:IAO_0000115 "Chemokine ligand 14 signaling engages chemokine (C-C motif) receptors 1 and 5 (Ccr1 and Ccr5) and together with other chemokines is classified as a member of the HCC (hemofiltrate CC chemokine) subgroup."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2012-05-02T03:16:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Ccl14 signaling pathway"^^xsd:string ;
  obo:id "PW:0000952"^^xsd:string ;
  rdfs:label "chemokine (C-C motif) ligand 14 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000952"^^xsd:string .

ns1:PW_0000953
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000831 ;
  ns2:treeView ns1:PW_0000831 ;
  ns1:IAO_0000115 "Chemokine ligand 15 signaling engages chemokine (C-C motif) receptors 1 and 3 (Ccr1 and Ccr3) and together with other chemokines is classified as a member of the HCC (hemofiltrate CC chemokine) subgroup."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2012-05-02T03:32:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Ccl15 signaling pathway"^^xsd:string ;
  obo:id "PW:0000953"^^xsd:string ;
  rdfs:label "chemokine (C-C motif) ligand 15 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000953"^^xsd:string .

ns1:PW_0000954
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000831 ;
  ns2:treeView ns1:PW_0000831 ;
  ns1:IAO_0000115 "Chemokine ligand 16 signaling engages chemokine (C-C motif) receptors 1 and 2 (Ccr1 and Ccr2) and together with other chemokines is classified as a member of the HCC (hemofiltrate CC chemokine) subgroup."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2012-05-02T03:34:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Ccl16 signaling pathway"^^xsd:string ;
  obo:id "PW:0000954"^^xsd:string ;
  rdfs:label "chemokine (C-C motif) ligand 16 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000954"^^xsd:string .

ns1:PW_0000955
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000831 ;
  ns2:treeView ns1:PW_0000831 ;
  ns1:IAO_0000115 "Chemokine ligand 23 signaling engages the chemokine (C-C motif) receptor 1 (Ccr1) and together with other chemokines is classified as a member of the HCC (hemofiltrate CC chemokine) subgroup."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2012-05-02T03:37:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Ccl23 signaling pathway"^^xsd:string ;
  obo:id "PW:0000955"^^xsd:string ;
  rdfs:label "chemokine (C-C motif) ligand 23 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000955"^^xsd:string .

ns1:PW_0000956
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000831 ;
  ns2:treeView ns1:PW_0000831 ;
  ns1:IAO_0000115 "Chemokine ligand 27 signaling engages chemokine (C-C motif) receptor 10 (Ccr10) and does not appear to be a member of any of the chemokines subgroups."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-15T01:08:34Z"^^xsd:string ;
  obo:hasExactSynonym "Ccl27 signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000956"^^xsd:string ;
  rdfs:label "chemokine (C-C motif) ligand 27 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000956"^^xsd:string .

ns1:PW_0000957
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000971 ;
  ns2:treeView ns1:PW_0000971 ;
  ns1:IAO_0000115 "Chemokine (C-X-C) ligand 1belongs to the growth-related oncogene (GRO) subgroup whose signaling engages receptor 2 and promotes chemotaxis of neutrophils."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-15T01:23:49Z"^^xsd:string ;
  obo:hasExactSynonym "Cxcl1 signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Gro alpha signaling pathway"^^xsd:string ;
  obo:id "PW:0000957"^^xsd:string ;
  rdfs:label "chemokine (C-X-C motif) ligand 1 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000957"^^xsd:string .

ns1:PW_0000958
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000647 ;
  ns2:treeView ns1:PW_0000647 ;
  ns1:IAO_0000115 "The signaling pathway mediated by the FoxA subgroup of forkhead family of transcription factors plays important roles in development and in modulating steroid hormone signaling. Three FoxA genes carry out overlapping yet distinct functions. FOXA1 appears to modulate steroid receptor activity in breast and prostate cancer."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-17T11:10:35Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "FoxA signaling pathway"^^xsd:string, "PID:200087"^^xsd:string, "PID:200226"^^xsd:string ;
  obo:id "PW:0000958"^^xsd:string ;
  rdfs:label "forkhead class A signaling pathway"^^xsd:string ;
  skos:notation "PW:0000958"^^xsd:string .

ns1:PW_0000959
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000003 ;
  ns2:treeView ns1:PW_0000003 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-17T01:09:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000959"^^xsd:string ;
  rdfs:label "lipid signaling pathway"^^xsd:string ;
  skos:notation "PW:0000959"^^xsd:string .

ns1:PW_0000960
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000541, ns1:PW_0000959 ;
  ns2:treeView ns1:PW_0000541, ns1:PW_0000959 ;
  ns1:IAO_0000115 "Sphingosine 1-phosphate (S1P), a sphingolipid metabolite, can signal intracellularly as a second messenger or extracellularly as a ligand for five G protein coupled receptors. S1P pathway plays important roles in processes such as cell migration, proliferation and survival. The five receptors engage similar G proteins but their expression varies."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-17T01:10:40Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200046"^^xsd:string, "PID:200054"^^xsd:string, "PID:200076"^^xsd:string, "PID:200085"^^xsd:string, "PID:200123"^^xsd:string, "PID:200211"^^xsd:string, "S1P signaling pathway"^^xsd:string ;
  obo:id "PW:0000960"^^xsd:string ;
  rdfs:label "sphingosine 1-phosphate signaling pathway"^^xsd:string ;
  skos:notation "PW:0000960"^^xsd:string .

ns1:PW_0000961
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000541, ns1:PW_0000959 ;
  ns2:treeView ns1:PW_0000541, ns1:PW_0000959 ;
  ns1:IAO_0000115 "Ceramide signaling can act as a lipid second messenger or as a mediator of various cellular signaling pathways by promoting receptor clustering. The pathway plays important roles in apoptosis."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-17T01:43:41Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05212"^^xsd:string, "PID:200119"^^xsd:string ;
  obo:id "PW:0000961"^^xsd:string ;
  rdfs:label "ceramide signaling pathway"^^xsd:string ;
  skos:notation "PW:0000961"^^xsd:string .

ns1:PW_0000962
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001008, ns1:PW_0001116, ns1:PW_0001536, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001007
  ] ;
  ns2:treeView ns1:PW_0001007, ns1:PW_0001008, ns1:PW_0001116, ns1:PW_0001536 ;
  ns3:part_of ns1:PW_0001007 ;
  ns1:IAO_0000115 "The signaling pathway initiated by light induced isomerization of 11-cis retinal and subsequent activation of its photoreceptors in rods and cones."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-17T05:16:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04744"^^xsd:string ;
  obo:id "PW:0000962"^^xsd:string ;
  rdfs:label "visual phototransduction pathway"^^xsd:string ;
  skos:notation "PW:0000962"^^xsd:string .

ns1:PW_0000963
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000595 ;
  ns2:treeView ns1:PW_0000595 ;
  ns1:IAO_0000115 "Phosphatidylinositol kinases represent a family of lipid kinases that phosphorylate the 3' position of the inositol ring in target substrates. They are grouped into three classes: class I further subdivided into subclass A and B, class II and class III. By far the best known and characterized is class I, particularly IA that signals downstream of receptor tyrosine kinases and engages the Akt family of kinases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-18T10:40:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200116"^^xsd:string ;
  obo:id "PW:0000963"^^xsd:string ;
  rdfs:label "phosphatidylinositol 3-kinase class I signaling pathway"^^xsd:string ;
  skos:notation "PW:0000963"^^xsd:string .

ns1:PW_0000964
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000621 ;
  ns2:treeView ns1:PW_0000621 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-18T10:41:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000964"^^xsd:string ;
  rdfs:label "altered phosphatidylinositol 3-kinase class I signaling pathway"^^xsd:string ;
  skos:notation "PW:0000964"^^xsd:string .

ns1:PW_0000965
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000595 ;
  ns2:treeView ns1:PW_0000595 ;
  ns1:IAO_0000115 "Phosphatidylinositol kinases represent a family of lipid kinases that phosphorylate the 3' position of the inositol ring in target substrates. They are grouped into three classes: class I further subdivided into subclass A and B, class II and class III. By far the best known and characterized is class I, particularly IA that signals downstream of receptor tyrosine kinases and engages the Akt family of kinases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-18T10:50:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000965"^^xsd:string ;
  rdfs:label "phosphatidylinositol 3-kinase class II signaling pathway"^^xsd:string ;
  skos:notation "PW:0000965"^^xsd:string .

ns1:PW_0000966
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000595 ;
  ns2:treeView ns1:PW_0000595 ;
  ns1:IAO_0000115 "Phosphatidylinositol kinases represent a family of lipid kinases that phosphorylate the 3' position of the inositol ring in target substrates. They are grouped into three classes: class I further subdivided into subclass A and B, class II and class III. By far the best known and characterized is class I, particularly IA that signals downstream of receptor tyrosine kinases and engages the Akt family of kinases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-18T10:53:38Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000966"^^xsd:string ;
  rdfs:label "phosphatidylinositol 3-kinase class III signaling pathway"^^xsd:string ;
  skos:notation "PW:0000966"^^xsd:string .

ns1:PW_0000967
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000512 ;
  ns2:treeView ns1:PW_0000512 ;
  ns1:IAO_0000115 "Interleukin-3, interleukin 5 and granulocyte-macrophage colony-stimulating factors family of hemopoietic cytokine mediate overlapping and distinct signals. Collectively they regulate the production and activation of hemopoietic cells."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-22T11:30:25Z"^^xsd:string ;
  obo:hasExactSynonym "Il-3/Il-5/GM-CSF family mediated signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "hemopoietic cytokine family mediated signaling pathway"^^xsd:string ;
  obo:id "PW:0000967"^^xsd:string ;
  rdfs:label "interleukin-3/interleukin-5/GM-CSF mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000967"^^xsd:string .

ns1:PW_0000968
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000967 ;
  ns2:treeView ns1:PW_0000967 ;
  ns1:IAO_0000115 "Interleukin-3 signaling plays important roles in the function of hematopoietic cells."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-22T11:43:49Z"^^xsd:string ;
  obo:hasExactSynonym "Il-3 signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200145"^^xsd:string ;
  obo:id "PW:0000968"^^xsd:string ;
  rdfs:label "interleukin-3 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000968"^^xsd:string .

ns1:PW_0000969
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000967 ;
  ns2:treeView ns1:PW_0000967 ;
  ns1:IAO_0000115 "Interleukin-5 signaling plays important roles in the function of hematopoietic cells."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-22T11:44:14Z"^^xsd:string ;
  obo:hasExactSynonym "Il-5 signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200107"^^xsd:string ;
  obo:id "PW:0000969"^^xsd:string ;
  rdfs:label "interleukin-5 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000969"^^xsd:string .

ns1:PW_0000970
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000967 ;
  ns2:treeView ns1:PW_0000967 ;
  ns1:IAO_0000115 "GM-CSF signaling, like the other hemopoietic cytokines, is involved in the production and activation of hemopoietic cells. The GM-CSF pathway acts on monocytes, macrophages and granulocytes and is also involved in the regulation of T and dendritic cells functions."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-22T11:44:40Z"^^xsd:string ;
  obo:hasExactSynonym "GM-CSF signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200019"^^xsd:string ;
  obo:id "PW:0000970"^^xsd:string ;
  rdfs:label "granulocyte-macrophage colony-stimulating factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0000970"^^xsd:string .

ns1:PW_0000971
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000830 ;
  ns2:treeView ns1:PW_0000830 ;
  ns1:IAO_0000115 "The CXC chemokine ELR(+) subgroup mediated signaling primarily engages receptor 2 to promote angiogenic effects."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-22T02:49:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000971"^^xsd:string ;
  rdfs:label "CXC chemokine ELR(+) subgroup mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000971"^^xsd:string .

ns1:PW_0000972
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000830 ;
  ns2:treeView ns1:PW_0000830 ;
  ns1:IAO_0000115 "CXC chemokine (ELR-) subgroup mediated signaling primarily engages receptor 3 to promote angiostatic effects."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-22T02:49:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000972"^^xsd:string ;
  rdfs:label "CXC chemokine ELR(-) subgroup mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000972"^^xsd:string .

ns1:PW_0000973
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000971 ;
  ns2:treeView ns1:PW_0000971 ;
  ns1:IAO_0000115 "Chemokine (C-X-C) ligand 2 belongs to the growth-related oncogene (GRO) subgroup whose signaling engages receptor 2 to promote chemotaxis of neutrophils."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-22T03:26:21Z"^^xsd:string ;
  obo:hasExactSynonym "Cxcl2 signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Gro beta signaling pathway"^^xsd:string ;
  obo:id "PW:0000973"^^xsd:string ;
  rdfs:label "chemokine (C-X-C motif) ligand 2 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000973"^^xsd:string .

ns1:PW_0000974
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000971 ;
  ns2:treeView ns1:PW_0000971 ;
  ns1:IAO_0000115 "Chemokine (C-X-C) ligand 3 belongs to the growth-related oncogene (GRO) subgroup whose signaling engages receptor 2 to promote chemotaxis of neutrophils."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-22T03:29:34Z"^^xsd:string ;
  obo:hasExactSynonym "Cxcl3 signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Gro gamma signaling pathway"^^xsd:string ;
  obo:id "PW:0000974"^^xsd:string ;
  rdfs:label "chemokine (C-X-C motif) ligand 3 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000974"^^xsd:string .

ns1:PW_0000975
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000971 ;
  ns2:treeView ns1:PW_0000971 ;
  ns1:IAO_0000115 "Chemokine (C-X-C) ligand 5 signaling engages receptor 2 to exert potent chemotactic functions in neutrophil activation."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-22T03:37:57Z"^^xsd:string ;
  obo:hasExactSynonym "Cxcl5 signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Ena-78 signaling pathway"^^xsd:string ;
  obo:id "PW:0000975"^^xsd:string ;
  rdfs:label "chemokine (C-X-C motif) ligand 5 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000975"^^xsd:string .

ns1:PW_0000976
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000971 ;
  ns2:treeView ns1:PW_0000971 ;
  ns1:IAO_0000115 "Chemokine (C-X-C0) ligand 6 engages receptors 1 and 2 to promote chemoattraction of neutrophils and angiogenic effects, respectively."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-22T03:42:45Z"^^xsd:string ;
  obo:hasExactSynonym "Cxcl6 signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000976"^^xsd:string ;
  rdfs:label "chemokine (C-X-C motif) ligand 6 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000976"^^xsd:string .

ns1:PW_0000977
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000971 ;
  ns2:treeView ns1:PW_0000971 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-22T03:48:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000977"^^xsd:string ;
  rdfs:label "chemokine (C-X-C motif) ligand 7 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000977"^^xsd:string .

ns1:PW_0000978
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000971 ;
  ns2:treeView ns1:PW_0000971 ;
  ns1:IAO_0000115 "Chemokine (C-X-C) ligand 8, also known as interleukin-8 (Il-8), although a chemokine, engages receptor 1 and 2 to promote angiogenic effects."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-22T03:49:12Z"^^xsd:string ;
  obo:hasExactSynonym "Cxcl8 signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Il-8 signaling pathway"^^xsd:string, "PID:200136"^^xsd:string ;
  obo:id "PW:0000978"^^xsd:string ;
  rdfs:label "chemokine (C-X-C motif) ligand 8 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000978"^^xsd:string .

ns1:PW_0000979
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000972 ;
  ns2:treeView ns1:PW_0000972 ;
  ns1:IAO_0000115 "Chemokine (C-X-C) ligand 4 signaling engages receptor 3 to promote angiostatic effects."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-22T03:55:01Z"^^xsd:string ;
  obo:hasExactSynonym "Cxcl4 signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000979"^^xsd:string ;
  rdfs:label "chemokine (C-X-C motif) ligand 4 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000979"^^xsd:string .

ns1:PW_0000980
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000972 ;
  ns2:treeView ns1:PW_0000972 ;
  ns1:IAO_0000115 "Chemokine (C-X-C) ligand 9 engages receptor 3 to promote angiostatic effects."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-22T03:57:41Z"^^xsd:string ;
  obo:hasExactSynonym "Cxcl9 signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Mig signaling pathway"^^xsd:string ;
  obo:id "PW:0000980"^^xsd:string ;
  rdfs:label "chemokine (C-X-C motif) ligand 9 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000980"^^xsd:string .

ns1:PW_0000981
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000972 ;
  ns2:treeView ns1:PW_0000972 ;
  ns1:IAO_0000115 "Chemokine (C-X-C) ligand 10 signaling engages receptor 3 to promote angiostatic effects."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-22T04:00:20Z"^^xsd:string ;
  obo:hasExactSynonym "Cxcl10 signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000981"^^xsd:string ;
  rdfs:label "chemokine (C-X-C motif) ligand 10 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000981"^^xsd:string .

ns1:PW_0000982
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000972 ;
  ns2:treeView ns1:PW_0000972 ;
  ns1:IAO_0000115 "Chemokine (C-X-C) ligand 11 signaling engages receptor 3 to promote angiostatic effects."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-22T04:10:07Z"^^xsd:string ;
  obo:hasExactSynonym "Cxcl11 signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000982"^^xsd:string ;
  rdfs:label "chemokine (C-X-C motif) ligand 11 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000982"^^xsd:string .

ns1:PW_0000983
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000972 ;
  ns2:treeView ns1:PW_0000972 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-22T05:01:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000983"^^xsd:string ;
  rdfs:label "chemokine (C-X-C motif) ligand 12 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000983"^^xsd:string .

ns1:PW_0000984
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000972 ;
  ns2:treeView ns1:PW_0000972 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-22T05:02:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000984"^^xsd:string ;
  rdfs:label "chemokine (C-X-C motif) ligand 13 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000984"^^xsd:string .

ns1:PW_0000985
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000972 ;
  ns2:treeView ns1:PW_0000972 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-22T05:03:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000985"^^xsd:string ;
  rdfs:label "chemokine (C-X-C motif) ligand 14 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000985"^^xsd:string .

ns1:PW_0000986
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000972 ;
  ns2:treeView ns1:PW_0000972 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-22T05:04:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000986"^^xsd:string ;
  rdfs:label "chemokine (C-X-C motif) ligand 16 signaling pathway"^^xsd:string ;
  skos:notation "PW:0000986"^^xsd:string .

ns1:PW_0000987
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467, ns1:PW_0000828 ;
  ns2:treeView ns1:PW_0000467, ns1:PW_0000828 ;
  ns1:IAO_0000115 "Erythropoietin (EPO) signaling is crucial for the production of blood cell or erythropoiesis and also plays important roles in wound healing and responses to neural injury. EPO is a glycoprotein hormone and also a cytokine whose receptor belongs to type I cytokine receptor. The pathway engages the Jak-Stat intracellular cascade."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-24T02:57:05Z"^^xsd:string ;
  obo:hasExactSynonym "EPO signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PID:200183"^^xsd:string ;
  obo:id "PW:0000987"^^xsd:string ;
  rdfs:label "erythropoietin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000987"^^xsd:string .

ns1:PW_0000988
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000333 ;
  ns2:treeView ns1:PW_0000333 ;
  ns1:IAO_0000115 "Classical cadherins, such as E- or N-cadherin are single-span transmembrane proteins with five extracellular cadherin repeats and a conserved cytoplasmic tail. Their interaction with many cytoskeletal and signaling molecules underlies the calcium-dependent cell-cell adhesion and signaling. While E- and N-cadherin share some of the interacting partners, they have different localization and impact on distinct cellular events."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-25T10:07:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000988"^^xsd:string ;
  rdfs:label "classical cadherin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000988"^^xsd:string .

ns1:PW_0000989
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000333 ;
  ns2:treeView ns1:PW_0000333 ;
  ns1:IAO_0000115 "Desmosomal cadherins, which can be further subdivided into two subgroups, possess the five cadherin repeats but have distinct cytoplasmic tails."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-25T10:37:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000989"^^xsd:string ;
  rdfs:label "desmosomal cadherin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000989"^^xsd:string .

ns1:PW_0000990
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000333 ;
  ns2:treeView ns1:PW_0000333 ;
  ns1:IAO_0000115 "Protocadherin represent a very large family which can be further subdivided into two groups. The protocadherin are predominantly expressed in the nervous system. They have up to seven cadherin repeats but distinct and even divergent cytoplasmic regions."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-25T10:37:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000990"^^xsd:string ;
  rdfs:label "protocadherin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000990"^^xsd:string .

ns1:PW_0000991
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000333 ;
  ns2:treeView ns1:PW_0000333 ;
  ns1:IAO_0000115 "The atypical, or unconventional group includes the seven transmembrane (7TM), GPCR-like cadherins with up to nine cadherin repeats along with EGF-like and laminin motifs, the large FAT and the t-Cadherin proteins."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-25T10:38:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000991"^^xsd:string ;
  rdfs:label "atypical cadherin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000991"^^xsd:string .

ns1:PW_0000992
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000988 ;
  ns2:treeView ns1:PW_0000988 ;
  ns1:IAO_0000115 "E-cadherin or the epithelial cadherin encoded by the Cdh1 gene, is a member of the classical cadherin family and among the best studied cadherin pathway. Deregulation of the pathway has been associated with several forms of cancer."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-25T10:51:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Cdh1 signaling pathway"^^xsd:string, "PID:200124"^^xsd:string, "PID:200147"^^xsd:string, "PID:200182"^^xsd:string ;
  obo:id "PW:0000992"^^xsd:string ;
  rdfs:label "E-cadherin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000992"^^xsd:string .

ns1:PW_0000993
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000988 ;
  ns2:treeView ns1:PW_0000988 ;
  ns1:IAO_0000115 "N-cadherin, or neuronal cadherin, is predominantly expressed in the brain. The pathway plays important roles in learning and memory."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-25T10:52:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Cdh2 signaling pathway"^^xsd:string, "PID:200209"^^xsd:string ;
  obo:id "PW:0000993"^^xsd:string ;
  rdfs:label "N-cadherin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000993"^^xsd:string .

ns1:PW_0000994
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000338, ns1:PW_0000988 ;
  ns2:treeView ns1:PW_0000338, ns1:PW_0000988 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-25T11:18:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000994"^^xsd:string ;
  rdfs:label "altered classical cadherin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000994"^^xsd:string .

ns1:PW_0000995
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000992, ns1:PW_0000994 ;
  ns2:treeView ns1:PW_0000992, ns1:PW_0000994 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-25T11:18:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000995"^^xsd:string ;
  rdfs:label "altered E-cadherin signaling pathway"^^xsd:string ;
  skos:notation "PW:0000995"^^xsd:string .

ns1:PW_0000996
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000754 ;
  ns2:treeView ns1:PW_0000754 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of compounds used as anti-infective agents. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-25T11:37:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000996"^^xsd:string ;
  rdfs:label "anti-infective drug pathway"^^xsd:string ;
  skos:notation "PW:0000996"^^xsd:string .

ns1:PW_0000997
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000003 ;
  ns2:treeView ns1:PW_0000003 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-25T11:48:24Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000997"^^xsd:string ;
  rdfs:label "nucleoside and nucleotide mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0000997"^^xsd:string .

ns1:PW_0000998
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000997 ;
  ns2:treeView ns1:PW_0000997 ;
  ns1:IAO_0000115 "Adenosine signaling is involved in the regulation of several physiological processes. It uses four receptors of the GPCR family that activate the Gaphas or Galphai types of G proteins to increase or decrease the levels of cAMP. The adenosine receptors are a class of purinergic or purinoreceptors."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-25T11:53:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00320"^^xsd:string, "SMP:00321"^^xsd:string ;
  obo:id "PW:0000998"^^xsd:string ;
  rdfs:label "adenosine signaling pathway"^^xsd:string ;
  skos:notation "PW:0000998"^^xsd:string .

ns1:PW_0000999
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000997 ;
  ns2:treeView ns1:PW_0000997 ;
  ns1:IAO_0000115 "Adenosine triphosphate (ATP) extracellular signaling activates the P2X ligand-gated ion channels that are permeable to sodium, potassium and calcium ions. There are several P2X subtypes that are involved in a range of physiological processes. ATP along with other nucleotide also engages a class of metabotropic purinergic receptors known as P2Y that couple to either the Galphaq or to G alphai subunit of heterotrimeric G proteins. ATP is the sole ligand of P2Y 11 receptor."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-25T12:03:02Z"^^xsd:string ;
  obo:hasExactSynonym "ATP signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0000999"^^xsd:string ;
  rdfs:label "adenosine triphosphate signaling pathway"^^xsd:string ;
  skos:notation "PW:0000999"^^xsd:string .

ns1:PW_0001000
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000997 ;
  ns2:treeView ns1:PW_0000997 ;
  ns1:IAO_0000115 "The P2Y receptors are a class of purinergic or purinoreceptors, Gprotein-coupled receptors that respond to ADP, ATP, UDP, UTP and UDP-glucose to activate either the Galphaq or the Galphai mediated signal transduction pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-25T12:11:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001000"^^xsd:string ;
  rdfs:label "nucleotide signaling via the purinergic P2Y receptors."^^xsd:string ;
  skos:notation "PW:0001000"^^xsd:string .

ns1:PW_0001001
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000999 ;
  ns2:treeView ns1:PW_0000999 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-30T02:32:59Z"^^xsd:string ;
  obo:hasExactSynonym "ATP signaling via the P2X ligand-gated ion channel"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001001"^^xsd:string ;
  rdfs:label "adenosine triphosphate signaling via the P2X ligand-gated ion channel"^^xsd:string ;
  skos:notation "PW:0001001"^^xsd:string .

ns1:PW_0001002
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000589 ;
  ns2:treeView ns1:PW_0000589 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-05-31T04:20:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001002"^^xsd:string ;
  rdfs:label "copper homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0001002"^^xsd:string .

ns1:PW_0001003
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000135, ns1:PW_0000406, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001007
  ] ;
  ns2:treeView ns1:PW_0000135, ns1:PW_0000406, ns1:PW_0001007 ;
  ns3:part_of ns1:PW_0001007 ;
  ns1:IAO_0000115 "Those metabolic reactions involving the fat-soluble vitamin A and its metabolites. Vitamin A, retinol and vitamin A activities of metabolites such as retinal and retinoic acids are essential for visual transduction as well as for neuro and immune system functions and epithelial differentiation. Plants and microorganisms can synthesize vitamin A de novo while higher organisms derive it from diet as precursors carotenoids or retinyl esters."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-06-04T10:52:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "vitamin A metabolic pathway"^^xsd:string ;
  obo:id "PW:0001003"^^xsd:string ;
  rdfs:label "retinoid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001003"^^xsd:string .

ns1:PW_0001004
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001003 ;
  ns2:treeView ns1:PW_0001003 ;
  ns1:IAO_0000115 "The reactions involved in deriving retinoic acid (RA) from retinal and its further processing to more polar derivatives. Retinoic acid engages several retinoic acid receptors; its actions are important for the neuro and immune system functions and energy balance. Deregulation of proper RA activity has been associated with obesity and cancer."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-06-04T11:05:02Z"^^xsd:string ;
  obo:hasExactSynonym "RA metabolic pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001004"^^xsd:string ;
  rdfs:label "retinoic acid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001004"^^xsd:string .

ns1:PW_0001005
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001003 ;
  ns2:treeView ns1:PW_0001003 ;
  ns1:IAO_0000115 "The series of reactions involved in the regeneration of the visual chromophore 11-cis retinal from the all-trans retinal released from the light -activated rhodopsin."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-06-04T11:19:05Z"^^xsd:string ;
  obo:hasExactSynonym "visual cycle metabolic pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001005"^^xsd:string ;
  rdfs:label "retinoid cycle metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001005"^^xsd:string .

ns1:PW_0001006
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001691 ;
  ns2:treeView ns1:PW_0001691 ;
  ns1:IAO_0000115 "Those pathways involved in the proper balance of vitamin levels, uptake and transport, utilization and storage, as demanded by the needs of cells tissues and organs. Disruption of vitamin homeostasis can have harmful consequences. Collectively they represent a class of organic chemicals that the organism cannot synthesize or does not in adequate quantities."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-06-04T01:28:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001006"^^xsd:string ;
  rdfs:label "vitamin homeostasis"^^xsd:string ;
  skos:notation "PW:0001006"^^xsd:string .

ns1:PW_0001007
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001006 ;
  ns2:treeView ns1:PW_0001006 ;
  ns1:IAO_0000115 "The pathways involved in the balanced maintenance of vitamin A and vitamin A metabolites uptake and transport, utilization and storage, as demanded by the needs of cells, tissues and organs. 11-cis retinal is the visual chromophore while retinoic acid signaling through its nuclear receptors transcription factors exerts the rest and manifold functions of vitamin A."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-06-04T01:30:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001007"^^xsd:string ;
  rdfs:label "vitamin A homeostasis"^^xsd:string ;
  skos:notation "PW:0001007"^^xsd:string .

ns1:PW_0001008
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000003 ;
  ns2:treeView ns1:PW_0000003 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-06-05T10:44:24Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001008"^^xsd:string ;
  rdfs:label "photosignal transduction pathway"^^xsd:string ;
  skos:notation "PW:0001008"^^xsd:string .

ns1:PW_0001009
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000135 ;
  ns2:treeView ns1:PW_0000135 ;
  ns1:IAO_0000115 "Those metabolic reactions involving ascorbic acid, known as vitamin C, a water-soluble vitamin. Vitamin C is an essential antioxidant that is derived from glucose. Unlike many animals, humans do not have the ability to produce it. Vitamin C acts as an antioxidant."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-06-05T11:40:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "vitamin C metabolic pathway"^^xsd:string ;
  obo:id "PW:0001009"^^xsd:string ;
  rdfs:label "ascorbic acid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001009"^^xsd:string .

ns1:PW_0001010
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000135 ;
  ns2:treeView ns1:PW_0000135 ;
  ns1:IAO_0000115 "Those metabolic reactions involving niacin, also known as vitamin B3 or vitamin PP - a water-soluble vitamin. Niacin represents an essential nutrient and is also a precursor of NAD through a salvage pathway. Niacin is among the few vitamins humans can synthesize."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-06-05T11:44:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00760"^^xsd:string, "SMP:00048"^^xsd:string, "vitamin B3 metabolic pathway"^^xsd:string ;
  obo:id "PW:0001010"^^xsd:string ;
  rdfs:label "niacin metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001010"^^xsd:string .

ns1:PW_0001011
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000135 ;
  ns2:treeView ns1:PW_0000135 ;
  ns1:IAO_0000115 "Those metabolic reactions involving vitamin D - a fat-soluble vitamin. Vitamin D represents a group of fat-soluble compounds that can be synthesized from cholesterol and exposure to sunlight. In view of the latter source, it is not considered a true vitamin. One of its metabolites, calcitriol acts in a hormone-like manner as a signaling molecule."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-06-05T12:01:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001011"^^xsd:string ;
  rdfs:label "vitamin D metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001011"^^xsd:string .

ns1:PW_0001012
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000003 ;
  ns2:treeView ns1:PW_0000003 ;
  ns1:IAO_0000115 "Vitamin and metabolites of vitamin in addition to representing important nutrients and aid in cellular metabolism can also, in a hormone-like manner, acts as signaling molecules."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-06-05T12:07:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001012"^^xsd:string ;
  rdfs:label "vitamin and vitamin metabolites signaling pathway"^^xsd:string ;
  skos:notation "PW:0001012"^^xsd:string .

ns1:PW_0001013
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000716, ns1:PW_0001012, ns1:PW_0001313 ;
  ns2:treeView ns1:PW_0000716, ns1:PW_0001012, ns1:PW_0001313 ;
  ns1:IAO_0000115 "The active vitamin D metabolite plays important roles in cell growth and differentiation and in immunity. Its receptor is a transcription factor nuclear receptor."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-06-05T12:13:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001013"^^xsd:string ;
  rdfs:label "vitamin D signaling pathway"^^xsd:string ;
  skos:notation "PW:0001013"^^xsd:string .

ns1:PW_0001014
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000716, ns1:PW_0001116, ns1:PW_0001313, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001007
  ] ;
  ns2:treeView ns1:PW_0000716, ns1:PW_0001007, ns1:PW_0001116, ns1:PW_0001313 ;
  ns3:part_of ns1:PW_0001007 ;
  ns1:IAO_0000115 "Retinoic acid, a vitamin A-derived metabolite plays important roles in development and cell differentiation. all-trans retinoic acid (RA) binds to nuclear RA (RARs) and X (RXRs) receptor subtypes that once activated act as transcription factors."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-06-05T12:22:48Z"^^xsd:string ;
  obo:hasExactSynonym "RA signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001014"^^xsd:string ;
  rdfs:label "retinoic acid signaling pathway"^^xsd:string ;
  skos:notation "PW:0001014"^^xsd:string .

ns1:PW_0001015
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000135 ;
  ns2:treeView ns1:PW_0000135 ;
  ns1:IAO_0000115 "Those metabolic reactions involving vitamin E - a fat-soluble vitamin which represents a class of chemical compounds known as tocopherols. The alpha- and gamma-tocopherols appear to be the main dietary forms. Vitamin E is best known for its antioxidant properties."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-06-11T01:34:39Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "tocopherol metabolic pathway"^^xsd:string ;
  obo:id "PW:0001015"^^xsd:string ;
  rdfs:label "vitamin E metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001015"^^xsd:string .

ns1:PW_0001016
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000135 ;
  ns2:treeView ns1:PW_0000135 ;
  ns1:IAO_0000115 "Those metabolic reactions involving vitamin K - a fat-soluble vitamin which represents a group of related compounds.  K1 form is found in plants, other forms are synthesized by bacteria, including species present in the microflora of the human gut. Vitamin K is an essential cofactor in the modification reaction of vitamin K-dependent proteins."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-06-11T01:46:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00464"^^xsd:string ;
  obo:id "PW:0001016"^^xsd:string ;
  rdfs:label "vitamin K metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001016"^^xsd:string .

ns1:PW_0001017
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000606 ;
  ns2:treeView ns1:PW_0000606 ;
  ns1:IAO_0000115 "Renal cell cancer, although representing a small percentage of human neoplasms, has one of the highest rates of mortality amongst genitourinary cancers. Several mutated genes and associated altered pathways have been implicated in the condition but many more remain to be elucidated."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-03T01:03:23Z"^^xsd:string ;
  obo:hasExactSynonym "RCC pathway"^^xsd:string, "adenocarcinoma of kidney pathway"^^xsd:string, "hypernephroma pathway"^^xsd:string, "renal cell cancer pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05211"^^xsd:string ;
  obo:id "PW:0001017"^^xsd:string ;
  rdfs:label "renal cell carcinoma pathway"^^xsd:string ;
  skos:notation "PW:0001017"^^xsd:string .

ns1:PW_0001018
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000013 ;
  ns2:treeView ns1:PW_0000013 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-03T01:17:41Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001018"^^xsd:string ;
  rdfs:label "immune system disease pathway"^^xsd:string ;
  skos:notation "PW:0001018"^^xsd:string .

ns1:PW_0001019
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001440 ;
  ns2:treeView ns1:PW_0001440 ;
  ns1:IAO_0000115 "Rheumatoid arthritis is an autoimmune condition characterized by persistent inflammation. Several pro-inflammatory cytokines and chemokines are over-activated."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-03T01:18:10Z"^^xsd:string ;
  obo:hasExactSynonym "atrophic arthritis pathway"^^xsd:string, "rheumatic arthritis pathway"^^xsd:string, "rheumatic polyarthritis pathway"^^xsd:string, "rheumatoid arthritis disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05323"^^xsd:string ;
  obo:id "PW:0001019"^^xsd:string ;
  rdfs:label "rheumatoid arthritis pathway"^^xsd:string ;
  skos:notation "PW:0001019"^^xsd:string .

ns1:PW_0001020
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000633 ;
  ns2:treeView ns1:PW_0000633 ;
  ns1:IAO_0000115 "Basal cell carcinoma is the most common form of skin cancer that is mostly sporadic. Hedgehog signaling pathway via sonic hedgehog appears to be constitutively active. Mutations in Tp53 are also frequent."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-10T12:40:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05217"^^xsd:string ;
  obo:id "PW:0001020"^^xsd:string ;
  rdfs:label "basal cell carcinoma pathway"^^xsd:string ;
  skos:notation "PW:0001020"^^xsd:string .

ns1:PW_0001021
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000633 ;
  ns2:treeView ns1:PW_0000633 ;
  ns1:IAO_0000115 "Melanoma is a form of skin cancer which, despite being less common than other forms of skin malignancies, can be dangerous if not detected earlier, and accounts for the highest percentage of skin cancer related deaths. Oncogenic Nras and other mutations in downstream pathways appear to be associated with it."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-10T12:47:47Z"^^xsd:string ;
  obo:hasExactSynonym "malignant melanoma pathway"^^xsd:string, "nevocarcinoma pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05218"^^xsd:string ;
  obo:id "PW:0001021"^^xsd:string ;
  rdfs:label "melanoma pathway"^^xsd:string ;
  skos:notation "PW:0001021"^^xsd:string .

ns1:PW_0001022
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001018, ns1:PW_0001308 ;
  ns2:treeView ns1:PW_0001018, ns1:PW_0001308 ;
  ns1:IAO_0000115 "Asthma, a complex condition with many phenotypic manifestations, is primarily characterized by inflammation of the airways. Environmental and genetic factors contribute to it through complex and incompletely understood interactions."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-10T01:39:57Z"^^xsd:string ;
  obo:hasExactSynonym "asthma disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05310"^^xsd:string ;
  obo:id "PW:0001022"^^xsd:string ;
  rdfs:label "asthma pathway"^^xsd:string ;
  skos:notation "PW:0001022"^^xsd:string .

ns1:PW_0001023
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001018 ;
  ns2:treeView ns1:PW_0001018 ;
  ns1:IAO_0000115 "Systemic lupus erythematosus (SLE) is an autoimmune condition that can affect many parts of the body and which, although treatable, does not have a cure. Activation of complement and deregulations of immune regulatory and signaling pathways contribute in ways that are incompletely understood."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-10T01:48:28Z"^^xsd:string ;
  obo:hasExactSynonym "SLE pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05322"^^xsd:string ;
  obo:id "PW:0001023"^^xsd:string ;
  rdfs:label "systemic lupus erythematosus pathway"^^xsd:string ;
  skos:notation "PW:0001023"^^xsd:string .

ns1:PW_0001024
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001018 ;
  ns2:treeView ns1:PW_0001018 ;
  ns1:IAO_0000115 "Autoimmune thyroid disease (AITD) groups several conditions that are generally relatively mild but that can progress to serious symptoms."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-10T01:56:40Z"^^xsd:string ;
  obo:hasExactSynonym "AITD pathway"^^xsd:string, "autoimmune thyroid disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05320"^^xsd:string ;
  obo:id "PW:0001024"^^xsd:string ;
  rdfs:label "autoimmune thyroiditis pathway"^^xsd:string ;
  skos:notation "PW:0001024"^^xsd:string .

ns1:PW_0001025
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001018 ;
  ns2:treeView ns1:PW_0001018 ;
  ns1:IAO_0000115 "Allograft or transplant rejection results from the recipient's autoimmune response to non-self antigens."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-11T10:38:17Z"^^xsd:string ;
  obo:hasExactSynonym "chronic allograft dysfunction pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05330"^^xsd:string ;
  obo:id "PW:0001025"^^xsd:string ;
  rdfs:label "allograft rejection pathway"^^xsd:string ;
  skos:notation "PW:0001025"^^xsd:string .

ns1:PW_0001026
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001018 ;
  ns2:treeView ns1:PW_0001018 ;
  ns1:IAO_0000115 "Graft-versus-host disease (GVHD) is a complication following transplantation of cells, tissues or organs from a genetically non-identical donor in which the donor T cells attack the host cells. Several pro-inflammatory pathways are activated as a result of damage in the host tissue induced by the procedure. GVHD is commonly associated with stem cell or bone marrow transplant."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-11T10:43:26Z"^^xsd:string ;
  obo:hasExactSynonym "GVHD pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05332"^^xsd:string ;
  obo:id "PW:0001026"^^xsd:string ;
  rdfs:label "graft-versus-host disease pathway"^^xsd:string ;
  skos:notation "PW:0001026"^^xsd:string .

ns1:PW_0001027
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001018 ;
  ns2:treeView ns1:PW_0001018 ;
  ns1:IAO_0000115 "Primary immunodeficiency groups disorders that result from the immune system malfunctioning that affect both cell-mediated and humoral immunity pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-11T10:56:46Z"^^xsd:string ;
  obo:hasExactSynonym "primary immunodeficiency disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05340"^^xsd:string ;
  obo:id "PW:0001027"^^xsd:string ;
  rdfs:label "primary immunodeficiency pathway"^^xsd:string ;
  skos:notation "PW:0001027"^^xsd:string .

ns1:PW_0001028
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000013 ;
  ns2:treeView ns1:PW_0000013 ;
  ns1:IAO_0000115 "Infectious diseases are caused by pathogens that have gained access to the host organism and have managed to avoid the host defense mechanisms while taking over some of the host pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-11T11:07:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "communicable disease pathway"^^xsd:string, "transmissible disease pathway"^^xsd:string ;
  obo:id "PW:0001028"^^xsd:string ;
  rdfs:label "infectious disease pathway"^^xsd:string ;
  skos:notation "PW:0001028"^^xsd:string .

ns1:PW_0001029
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000013 ;
  ns2:treeView ns1:PW_0000013 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-11T11:08:32Z"^^xsd:string ;
  obo:hasExactSynonym "substance dependence disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001029"^^xsd:string ;
  rdfs:label "substance dependence pathway"^^xsd:string ;
  skos:notation "PW:0001029"^^xsd:string .

ns1:PW_0001030
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001029 ;
  ns2:treeView ns1:PW_0001029 ;
  ns1:IAO_0000115 "Prolonged use of cocaine results in cardiovascular and brain damage. Cocaine is thought to bind to the dopamine reuptake transporter thus blocking the reuptake of dopamine into nerve terminals. The resulting higher concentration of dopamine in synapses leads to overactivation of dopamine receptors such as D1 and of signaling pathways downstream of it overall believed to be critical in mediating the behavioral responses to cocaine."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-11T11:18:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05030"^^xsd:string ;
  obo:id "PW:0001030"^^xsd:string ;
  rdfs:label "cocaine addiction pathway"^^xsd:string ;
  skos:notation "PW:0001030"^^xsd:string .

ns1:PW_0001031
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001029 ;
  ns2:treeView ns1:PW_0001029 ;
  ns1:IAO_0000115 "Amphetamine is believed to promote an elevation in extracellular dopamine. Higher and high levels of the drug lead to overactivation of transcription factors and cofactors."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-11T11:31:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05031"^^xsd:string ;
  obo:id "PW:0001031"^^xsd:string ;
  rdfs:label "amphetamine addiction pathway"^^xsd:string ;
  skos:notation "PW:0001031"^^xsd:string .

ns1:PW_0001032
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001029 ;
  ns2:treeView ns1:PW_0001029 ;
  ns1:IAO_0000115 "Morphine, an effective pain killer drug, can also be extremely addictive. Activation of dopamine neurons and reduction of inhibitory synaptic transmission might be associated with the effects or morphine. Changes in neuronal responses and communication may underlie the addictive behavior."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-11T11:41:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05032"^^xsd:string ;
  obo:id "PW:0001032"^^xsd:string ;
  rdfs:label "morphine addiction pathway"^^xsd:string ;
  skos:notation "PW:0001032"^^xsd:string .

ns1:PW_0001033
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001029 ;
  ns2:treeView ns1:PW_0001029 ;
  ns1:IAO_0000115 "Nicotine, like the other addictive substances, impacts on the dopaminergic and mesolimbic reward circuitries. Nicotine is also a ligand for the nicotinic acetylcholine receptors which are ligand-gated ion channels."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-11T11:46:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05033"^^xsd:string ;
  obo:id "PW:0001033"^^xsd:string ;
  rdfs:label "nicotine addiction pathway"^^xsd:string ;
  skos:notation "PW:0001033"^^xsd:string .

ns1:PW_0001034
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001029 ;
  ns2:treeView ns1:PW_0001029 ;
  ns1:IAO_0000115 "The mechanisms of alcohol dependence, or alcoholism, are not well understood. Like in the case of other substances of abuse, alcohol may lead to stimulation of dopamine release and overactivation of dopamine-related circuitries."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-11T11:57:05Z"^^xsd:string ;
  obo:hasExactSynonym "alcohol dependence pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05034"^^xsd:string ;
  obo:id "PW:0001034"^^xsd:string ;
  rdfs:label "alcoholism pathway"^^xsd:string ;
  skos:notation "PW:0001034"^^xsd:string .

ns1:PW_0001035
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000022 ;
  ns2:treeView ns1:PW_0000022 ;
  ns1:IAO_0000115 "Arrhythmogenic right ventricular cardiomyopathy (ARVC) represents an inherited heart muscle condition leading to arrhythmia and heart failure that could results in death. Mutations in several genes and disruption of associated pathways have been implicated in the condition."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-11T12:12:10Z"^^xsd:string ;
  obo:hasExactSynonym "ARVC pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05412"^^xsd:string ;
  obo:id "PW:0001035"^^xsd:string ;
  rdfs:label "arrhythmogenic right ventricular cardiomyopathy pathway"^^xsd:string ;
  skos:notation "PW:0001035"^^xsd:string .

ns1:PW_0001036
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000022 ;
  ns2:treeView ns1:PW_0000022 ;
  ns1:IAO_0000115 "Dilated cardiomyopathy (DCM) is a condition in which the heart is weakened and enlarged resulting in inefficient blood pumping. Although mostly occurring in adults, it can also affect children."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-11T12:20:46Z"^^xsd:string ;
  obo:hasExactSynonym "DCM pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05414"^^xsd:string ;
  obo:id "PW:0001036"^^xsd:string ;
  rdfs:label "dilated cardiomyopathy pathway"^^xsd:string ;
  skos:notation "PW:0001036"^^xsd:string .

ns1:PW_0001037
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000022 ;
  ns2:treeView ns1:PW_0000022 ;
  ns1:IAO_0000115 "Myocarditis is a condition associated with inflammation of the heart muscle that can have both infectious and non-infectious etiologies, with the former being the primary cause. Viral proteins, once inside the host cells, interfere with the function of host gene and they can either avoid or appropriate host pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-11T12:29:11Z"^^xsd:string ;
  obo:hasExactSynonym "myocardial inflammation pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05416"^^xsd:string ;
  obo:id "PW:0001037"^^xsd:string ;
  rdfs:label "myocarditis pathway"^^xsd:string ;
  skos:notation "PW:0001037"^^xsd:string .

ns1:PW_0001038
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000176 ;
  ns2:treeView ns1:PW_0000176 ;
  ns1:IAO_0000115 "Maturity onset diabetes of the young (MODY) represents any of a number of hereditary, monogenic forms of diabetes caused by mutations in several genes."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-11T12:37:25Z"^^xsd:string ;
  obo:hasExactSynonym "MODY pathway"^^xsd:string, "Mason-type diabetes pathway"^^xsd:string, "maturity onset diabetes of the young pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04950"^^xsd:string ;
  obo:id "PW:0001038"^^xsd:string ;
  rdfs:label "maturity-onset diabetes of the young pathway"^^xsd:string ;
  skos:notation "PW:0001038"^^xsd:string .

ns1:PW_0001039
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001028 ;
  ns2:treeView ns1:PW_0001028 ;
  ns1:IAO_0000115 "Vibrio cholerae disease is an infection of the small intestine resulting in dehydration and electrolyte imbalance which in some cases can cause death. Cholera toxin, is one the main virulence factors of the Gram-negative Vibrio cholerae bacterium which, together with other virulence factors can invade the host."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-11T12:46:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05110"^^xsd:string ;
  obo:id "PW:0001039"^^xsd:string ;
  rdfs:label "Vibrio cholerae infection pathway"^^xsd:string ;
  skos:notation "PW:0001039"^^xsd:string .

ns1:PW_0001040
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001028 ;
  ns2:treeView ns1:PW_0001028 ;
  ns1:IAO_0000115 "Salmonella, a Gram-negative bacterium of which  many species exist, in humans can cause gastroenteritis or the more severe typhoid fever. Salmonella enters the host via the digestive tract; bacteria that escape the host defense machinery can survive and replicate in Salmonella-containing vacuole (SCV) whose maturation they control."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-11T12:59:20Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05132"^^xsd:string ;
  obo:id "PW:0001040"^^xsd:string ;
  rdfs:label "Salmonella infection pathway"^^xsd:string ;
  skos:notation "PW:0001040"^^xsd:string .

ns1:PW_0001041
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001028 ;
  ns2:treeView ns1:PW_0001028 ;
  ns1:IAO_0000115 "The pathogenic Escherichia coli strains EPEC and EHEC (enteropathogenic and enterohemorrhagic E. coli, respectively) can cause sever food poisoning in humans. The non-pathogenic strains are part of the gut normal flora with beneficial contributions for the host."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-11T01:23:38Z"^^xsd:string ;
  obo:hasExactSynonym "pathogenic E. coli infection pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05130"^^xsd:string ;
  obo:id "PW:0001041"^^xsd:string ;
  rdfs:label "pathogenic Escherichia coli infection pathway"^^xsd:string ;
  skos:notation "PW:0001041"^^xsd:string .

ns1:PW_0001042
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001028 ;
  ns2:treeView ns1:PW_0001028 ;
  ns1:IAO_0000115 "Shigella, a Gram-negative bacterium that is related to Salmonella and to Escherichia coli, is a disease causing agent in humans and primates. Shigellosis, also known as bacillary dysentery or Marlow syndrome is due to colonization of the intestinal epithelium and the subsequent evasion of the host defense machinery and use of host intracellular pathways by the bacteria."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-11T01:44:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05131"^^xsd:string, "Marlow syndrome pathway"^^xsd:string, "Shigellosis pathway"^^xsd:string, "bacillary dysentery pathway"^^xsd:string ;
  obo:id "PW:0001042"^^xsd:string ;
  rdfs:label "Shigella infection pathway"^^xsd:string ;
  skos:notation "PW:0001042"^^xsd:string .

ns1:PW_0001043
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001028 ;
  ns2:treeView ns1:PW_0001028 ;
  ns1:IAO_0000115 "The Gram-negative Bordetella pertusis Gram-negative is the causative agent of pertussis or whooping cough. One of its main virulence factors, pertussis toxin blocks the interaction of Galphai subunit of heterotrimeric G protein with its partner receptors. This results in unrestrained adenylyl cyclase activity and subsequent increased concentration of cAMP which affects normal intracellular signaling."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-11T03:37:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05133"^^xsd:string, "pertussis pathway"^^xsd:string ;
  obo:id "PW:0001043"^^xsd:string ;
  rdfs:label "Bordetella pertussis infection pathway"^^xsd:string ;
  skos:notation "PW:0001043"^^xsd:string .

ns1:PW_0001044
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001028 ;
  ns2:treeView ns1:PW_0001028 ;
  ns1:IAO_0000115 "Legionella, a pathogenic Gram-negative bacterium that includes species such as legionella pneumophila, causes several respiratory infections of which Legionnaires' disease is potentially fatal. L. pneumophila can grow within lung macrophages and is known to subvert several host pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-11T04:04:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05134"^^xsd:string ;
  obo:id "PW:0001044"^^xsd:string ;
  rdfs:label "Legionella infection pathway"^^xsd:string ;
  skos:notation "PW:0001044"^^xsd:string .

ns1:PW_0001045
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001028 ;
  ns2:treeView ns1:PW_0001028 ;
  ns1:IAO_0000115 "Staphylococcus aureus, a Gram-positive bacteria of which there are many species, usually colonizes the skin and mucous membranes of humans and other organisms and are mostly harmless. However, they can also cause a range of infections of which some can be extremely severe."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-11T04:18:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05150"^^xsd:string ;
  obo:id "PW:0001045"^^xsd:string ;
  rdfs:label "Staphylococcus aureus infection pathway"^^xsd:string ;
  skos:notation "PW:0001045"^^xsd:string .

ns1:PW_0001046
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001028 ;
  ns2:treeView ns1:PW_0001028 ;
  ns1:IAO_0000115 "Mycobacterium tuberculosis is the causative agent of most forms of tuberculosis. Once in the lung, the bacteria interfere with a number of intracellular pathways and processes."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-11T04:31:42Z"^^xsd:string ;
  obo:hasExactSynonym "Mycobacterium tuberculosis infection pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05152"^^xsd:string ;
  obo:id "PW:0001046"^^xsd:string ;
  rdfs:label "tuberculosis pathway"^^xsd:string ;
  skos:notation "PW:0001046"^^xsd:string .

ns1:PW_0001047
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001028 ;
  ns2:treeView ns1:PW_0001028 ;
  ns1:IAO_0000115 "Leishmania is a protozoan parasite and a number of its species can infect mammals, including humans. While cutaneous leishmaniasis is the most common form, others such as visceral or mucosal have also been reported. The infection results in alterations in a number of host signaling pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-13T11:53:50Z"^^xsd:string ;
  obo:hasExactSynonym "Leishmania infection pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05140"^^xsd:string ;
  obo:id "PW:0001047"^^xsd:string ;
  rdfs:label "Leishmaniasis pathway"^^xsd:string ;
  skos:notation "PW:0001047"^^xsd:string .

ns1:PW_0001048
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001028 ;
  ns2:treeView ns1:PW_0001028 ;
  ns1:IAO_0000115 "Trypanosoma is a protozoan parasite of which T brucei and cruzi are responsible for causing the sleeping sickness and Chagas disease, respectively. Several host signaling and regulatory pathways are altered in the infection."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-13T12:03:02Z"^^xsd:string ;
  obo:hasExactSynonym "Trypanosoma infection pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05142"^^xsd:string ;
  obo:id "PW:0001048"^^xsd:string ;
  rdfs:label "trypanosomiasis pathway"^^xsd:string ;
  skos:notation "PW:0001048"^^xsd:string .

ns1:PW_0001049
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001048 ;
  ns2:treeView ns1:PW_0001048 ;
  ns1:IAO_0000115 "Trypanosoma brucei, a protozoan parasite, is the causative agent of sleeping sickness, also known as the African trypanosomiasis, as its vector is the tsetse fly common to sub-Saharan Africa. Several pro-inflammatory cytokines are overactivated. The neurological damage the infection causes is irreversible and the disease is fatal."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-13T12:14:00Z"^^xsd:string ;
  obo:hasExactSynonym "African sleeping sickness pathway"^^xsd:string, "African trypanosomiasis pathway"^^xsd:string, "Trypanosoma brucei infection pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05143"^^xsd:string ;
  obo:id "PW:0001049"^^xsd:string ;
  rdfs:label "sleeping sickness pathway"^^xsd:string ;
  skos:notation "PW:0001049"^^xsd:string .

ns1:PW_0001050
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001048 ;
  ns2:treeView ns1:PW_0001048 ;
  ns1:IAO_0000115 "Trypanosoma cruzi is the causative agent of the Chagas disease, also known as the American trypanosomiasis, as it occurs primarily in poor areas of the Americas, mostly Central and South America. Infection interferes with a number of intracellular pathways and it appears to activate calcium signaling."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-13T12:26:45Z"^^xsd:string ;
  obo:hasExactSynonym "American trypanosomiasis pathway"^^xsd:string, "Chagas' disease pathway"^^xsd:string, "Chagas-Mazza disease pathway"^^xsd:string, "South American trypanosomiasis pathway"^^xsd:string, "Trypanosoma cruzi infection pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05142"^^xsd:string ;
  obo:id "PW:0001050"^^xsd:string ;
  rdfs:label "Chagas disease pathway"^^xsd:string ;
  skos:notation "PW:0001050"^^xsd:string .

ns1:PW_0001051
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001028 ;
  ns2:treeView ns1:PW_0001028 ;
  ns1:IAO_0000115 "Several species of the protozoan parasite Plasmodium can infect humans and cause malaria. Severe malaria, which is primarily caused by Plasmodium falciparum, can lead to death and the fatalities are mostly children. Deregulated induction of cytokines appears to play a role in the infection."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-13T12:36:12Z"^^xsd:string ;
  obo:hasExactSynonym "Plasmodium infection pathway"^^xsd:string, "malaria infection pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05144"^^xsd:string ;
  obo:id "PW:0001051"^^xsd:string ;
  rdfs:label "malaria pathway"^^xsd:string ;
  skos:notation "PW:0001051"^^xsd:string .

ns1:PW_0001052
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001028 ;
  ns2:treeView ns1:PW_0001028 ;
  ns1:IAO_0000115 "Toxoplasma gondii, whose hosts include various warm-blooded species including humans, is the causative agent of toxoplasmosis. The infection interferes with a number of host pathways; in its most severe manifestations it can be fatal."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-13T01:00:51Z"^^xsd:string ;
  obo:hasExactSynonym "Toxoplasma gondii infection pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05145"^^xsd:string ;
  obo:id "PW:0001052"^^xsd:string ;
  rdfs:label "toxoplasmosis pathway"^^xsd:string ;
  skos:notation "PW:0001052"^^xsd:string .

ns1:PW_0001053
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001028 ;
  ns2:treeView ns1:PW_0001028 ;
  ns1:IAO_0000115 "Entamoeba histolyca is a protozoan parasite that is the causative agent of amoebiasis which affects the intestinal tissue leading to severe dysentery and ulcerations. It can also infect other tissues such as the liver and to a lesser extent the brain, lungs and spleen."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-13T01:13:24Z"^^xsd:string ;
  obo:hasExactSynonym "Entamoeba histolyca infection pathway"^^xsd:string, "amoebiasis infection pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05146"^^xsd:string ;
  obo:id "PW:0001053"^^xsd:string ;
  rdfs:label "Entamoebiasis pathway"^^xsd:string ;
  skos:notation "PW:0001053"^^xsd:string .

ns1:PW_0001054
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001028 ;
  ns2:treeView ns1:PW_0001028 ;
  ns1:IAO_0000115 "The influenza A virus is the causative agent of seasonal epidemics and occasional pandemics of influenza which affects the respiratory system."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-13T01:21:37Z"^^xsd:string ;
  obo:hasExactSynonym "influenza A virus infection pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05164"^^xsd:string ;
  obo:id "PW:0001054"^^xsd:string ;
  rdfs:label "influenza A pathway"^^xsd:string ;
  skos:notation "PW:0001054"^^xsd:string .

ns1:PW_0001055
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001028 ;
  ns2:treeView ns1:PW_0001028 ;
  ns1:IAO_0000115 "The hepatitis C virus is the causative agent of hepatitis C, a chronic liver disease in humans. The virus interferes with several signaling and regulatory pathways in the host cells."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-13T01:22:51Z"^^xsd:string ;
  obo:hasExactSynonym "NANBH pathway"^^xsd:string, "Viral hepatitis C pathway"^^xsd:string, "chronic hepatitis C pathway"^^xsd:string, "hepatitis C infection pathway"^^xsd:string, "hepatitis C virus infection pathway"^^xsd:string, "hepatitis nonA nonB pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05160"^^xsd:string ;
  obo:id "PW:0001055"^^xsd:string ;
  rdfs:label "hepatitis C pathway"^^xsd:string ;
  skos:notation "PW:0001055"^^xsd:string .

ns1:PW_0001056
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001028 ;
  ns2:treeView ns1:PW_0001028 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-16T01:24:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05168"^^xsd:string ;
  obo:id "PW:0001056"^^xsd:string ;
  rdfs:label "Herpes simplex virus infection pathway"^^xsd:string ;
  skos:notation "PW:0001056"^^xsd:string .

ns1:PW_0001057
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001028 ;
  ns2:treeView ns1:PW_0001028 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-16T01:26:38Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05169"^^xsd:string ;
  obo:id "PW:0001057"^^xsd:string ;
  rdfs:label "Epstein-Barr virus infection pathway"^^xsd:string ;
  skos:notation "PW:0001057"^^xsd:string .

ns1:PW_0001058
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001028 ;
  ns2:treeView ns1:PW_0001028 ;
  ns1:IAO_0000115 "The measles virus (MV) of the genus Morbillivirus is the causative agent of the condition that bears its name. The condition causes immunosuppression and several MV proteins are thought to interfere with the normal host immune responses."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-16T01:37:38Z"^^xsd:string ;
  obo:hasExactSynonym "Rubeola pathway"^^xsd:string, "measles infection pathway"^^xsd:string, "morbilli pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05162"^^xsd:string ;
  obo:id "PW:0001058"^^xsd:string ;
  rdfs:label "measles pathway"^^xsd:string ;
  skos:notation "PW:0001058"^^xsd:string .

ns1:PW_0001059
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000033, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000357
  ] ;
  ns2:treeView ns1:PW_0000033, ns1:PW_0000357 ;
  ns3:part_of ns1:PW_0000357 ;
  ns1:IAO_0000115 "Oxidative phosphorylation is the coupling of the electron transport chain and the ATP biosynthetic pathways. The electron transfer chain generates an electrochemical gradient that drives the phosphorylation of ADP. Under certain circumstances the two may be uncoupled."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-18T09:38:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00190"^^xsd:string ;
  obo:id "PW:0001059"^^xsd:string ;
  rdfs:label "oxidative phosphorylation pathway"^^xsd:string ;
  skos:notation "PW:0001059"^^xsd:string .

ns1:PW_0001060
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000039 ;
  ns2:treeView ns1:PW_0000039 ;
  ns1:IAO_0000115 "Primary bile acids, cholic and  chenodeoxycholic acids, are derived from cholesterol in the liver. Upon conjugation with glycine or taurine they can be secreted into the intestine."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-18T10:47:50Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00120"^^xsd:string ;
  obo:id "PW:0001060"^^xsd:string ;
  rdfs:label "primary bile acid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001060"^^xsd:string .

ns1:PW_0001061
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000039 ;
  ns2:treeView ns1:PW_0000039 ;
  ns1:IAO_0000115 "Secondary bile acids, deoxycholic and lithocholic acids, are synthesized from the primary ones by intestinal bacteria. like the primary bile acids, they need to be conjugated to glycine or taurine prior to secretion."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-18T10:54:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001061"^^xsd:string ;
  rdfs:label "secondary bile acid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001061"^^xsd:string .

ns1:PW_0001062
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000733 ;
  ns2:treeView ns1:PW_0000733 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of lacto-series type of glycosphingolipids."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-19T01:18:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00601"^^xsd:string ;
  obo:id "PW:0001062"^^xsd:string ;
  rdfs:label "lacto-series glycosphingolipid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001062"^^xsd:string .

ns1:PW_0001063
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000135 ;
  ns2:treeView ns1:PW_0000135 ;
  ns1:IAO_0000115 "The metabolic reactions involving lipoic acid, a compound derived from octanoic acid that contains two sulfur centers. Lipoic acid is a co-factor for the pyruvate dehydrogenase complex responsible for the irreversible decarboxylation of pyruvate to acetyl-CoA."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-19T01:37:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00785"^^xsd:string ;
  obo:id "PW:0001063"^^xsd:string ;
  rdfs:label "lipoic acid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001063"^^xsd:string .

ns1:PW_0001064
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000132 ;
  ns2:treeView ns1:PW_0000132 ;
  ns1:IAO_0000115 "Those metabolic reactions involving phosphonate and phosphinate, organic compounds that contain carbon-phosphorus bonds and which can be synthesized by bacteria and protists."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-23T03:43:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001064"^^xsd:string ;
  rdfs:label "phosphonate and phosphinate metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001064"^^xsd:string .

ns1:PW_0001065
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000663 ;
  ns2:treeView ns1:PW_0000663 ;
  ns1:IAO_0000115 "Interstrand cross links (ICL) of DNA can be induced by both endogenous and exogenous ligands. ICL if not repaired will lead to cell death. ICL repair pathway, also known as Fanconi anemia pathway is the cellular response to this type of DNA damage."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-24T09:31:12Z"^^xsd:string ;
  obo:hasExactSynonym "Fanconi anemia pathway"^^xsd:string, "ICL repair pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:03460"^^xsd:string ;
  obo:id "PW:0001065"^^xsd:string ;
  rdfs:label "interstrand cross link repair pathway"^^xsd:string ;
  skos:notation "PW:0001065"^^xsd:string .

ns1:PW_0001066
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000101
  ] ;
  ns2:treeView ns1:PW_0000101 ;
  ns3:part_of ns1:PW_0000101 ;
  ns1:IAO_0000115 "The pathway of ribosome biogenesis starts with the transcription of rRNA precursors, involves the co-transciptional events of pre-rRNA processing and the assembly of pre-ribosomal particles. The maturation of pre-40S and pre-60S particles follows independent routes.  Once in the cytoplasm, additional steps yield the mature, translation competent, ribosome. Alterations in the pathway result in specific phenotypes collectively known as ribosomopathies."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-25T03:15:38Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:03008"^^xsd:string ;
  obo:id "PW:0001066"^^xsd:string ;
  rdfs:label "ribosome biogenesis pathway"^^xsd:string ;
  skos:notation "PW:0001066"^^xsd:string .

ns1:PW_0001067
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001066, ns1:PW_0001068 ;
  ns2:treeView ns1:PW_0001066, ns1:PW_0001068 ;
  ns1:IAO_0000115 "Alterations in the pathway result in specific phenotypes collectively known as ribosomopathies."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-25T04:19:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001067"^^xsd:string ;
  rdfs:label "altered ribosome biogenesis pathway"^^xsd:string ;
  skos:notation "PW:0001067"^^xsd:string .

ns1:PW_0001068
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000101, ns1:PW_0000290 ;
  ns2:treeView ns1:PW_0000101, ns1:PW_0000290 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-25T04:21:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001068"^^xsd:string ;
  rdfs:label "altered translation pathway"^^xsd:string ;
  skos:notation "PW:0001068"^^xsd:string .

ns1:PW_0001069
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467 ;
  ns2:treeView ns1:PW_0000467 ;
  ns1:IAO_0000115 "Gonadotropin-releasing hormone signaling pathway induces the synthesis and secretion of luteinizing and follicle-stimulating hormones from the pituitary."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-30T11:02:37Z"^^xsd:string ;
  obo:hasExactSynonym "GnRH signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04912"^^xsd:string, "luteinizing hormone-releasing hormone signaling pathway"^^xsd:string ;
  obo:id "PW:0001069"^^xsd:string ;
  rdfs:label "gonadotropin-releasing hormone signaling pathway"^^xsd:string ;
  skos:notation "PW:0001069"^^xsd:string .

ns1:PW_0001070
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467 ;
  ns2:treeView ns1:PW_0000467 ;
  ns1:IAO_0000115 "Lutenizing hormone signaling is important for the normal development and function of the ovaries and testes. It acts synergistically with the follicle-stimulating hormone."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-30T11:12:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00338"^^xsd:string ;
  obo:id "PW:0001070"^^xsd:string ;
  rdfs:label "luteinizing hormone signaling pathway"^^xsd:string ;
  skos:notation "PW:0001070"^^xsd:string .

ns1:PW_0001071
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467 ;
  ns2:treeView ns1:PW_0000467 ;
  ns1:IAO_0000115 "Follicle-stimulating hormone signaling is important for the normal development and function of the ovaries and testes. It acts synergistically with the lutenizing hormone."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-30T11:13:34Z"^^xsd:string ;
  obo:hasExactSynonym "FSH signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00333"^^xsd:string ;
  obo:id "PW:0001071"^^xsd:string ;
  rdfs:label "follicle-stimulating hormone signaling pathway"^^xsd:string ;
  skos:notation "PW:0001071"^^xsd:string .

ns1:PW_0001072
  a owl:Class ;
  ns1:IAO_0000115 "The cycle of synaptic vesicle exocytosis and neurotransmitter release and the subsequent endocytosis and recycling of synaptic vesicles at nerve terminals."^^xsd:string ;
  ns1:IAO_0000231 ns1:IAO_0000227 ;
  ns1:IAO_0100001 ns1:PW_0002423 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-30T03:31:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04721"^^xsd:string ;
  obo:id "PW:0001072"^^xsd:string ;
  rdfs:label "synaptic vesicle cycle pathway"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0001072"^^xsd:string .

ns1:PW_0001073
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001569, ns1:PW_0001580 ;
  ns2:treeView ns1:PW_0001569, ns1:PW_0001580 ;
  ns1:IAO_0000115 "The spliceosome is a multimegadalton ribonucleoprotein complex that removes the exons to produce the mature mRNA, including several mature mRNAs from a single RNA transcript via alternative splicing. A complex assembly/disassembly  pathway mediates the two chemical steps of a splicing event.  lncRNAs are also frequently spliced."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-31T09:43:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:03040"^^xsd:string ;
  obo:id "PW:0001073"^^xsd:string ;
  rdfs:label "spliceosome pathway"^^xsd:string ;
  skos:notation "PW:0001073"^^xsd:string .

ns1:PW_0001074
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000011 ;
  ns2:treeView ns1:PW_0000011 ;
  ns1:IAO_0000115 "Those metabolic reactions involving hydrophobic, uncharged amino acids. Hydrophobic amino acids include alanine, valine, isoleucine, leucine and methionine with hydrocarbon side chains and the phenylalanine, tyrosine and tryptophan with bulky, aromatic side chains."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-31T10:30:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001074"^^xsd:string ;
  rdfs:label "hydrophobic amino acid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001074"^^xsd:string .

ns1:PW_0001075
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000011 ;
  ns2:treeView ns1:PW_0000011 ;
  ns1:IAO_0000115 "Those metabolic reactions involving hydrophilic, polar amino acids. The hydrophilic amino acids include the negatively charged (acidic) aspartic acid and glutamic acid whose salts are glutamate and aspartate, respectively, the positively charged (basic) lysine and arginine and the uncharged polar asparagine, cysteine, glutamine, serine and threonine. Histidine, whose side chain contains an imidazole can shift from positively charged to neutral."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-31T10:39:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001075"^^xsd:string ;
  rdfs:label "hydrophilic amino acid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001075"^^xsd:string .

ns1:PW_0001076
  a owl:Class ;
  ns1:IAO_0000115 "Those metabolic reactions involving special amino acids. The special amino acids include cysteine whose side chain contains a sulfhydryl group, glycine whose side chain is a hydrogen atom and proline whose side chain bends to form a ring and hose rigidity limits the folding abilities of proteins around proline residues."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-31T10:47:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001076"^^xsd:string ;
  rdfs:label "special amino acid metabolic pathway"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0001076"^^xsd:string .

ns1:PW_0001077
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000011 ;
  ns2:treeView ns1:PW_0000011 ;
  ns1:IAO_0000115 "Those metabolic reactions involving amino acids as listed in the Kyoto Encyclopedia of Genes and Genomes (KEGG)."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-31T10:56:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001077"^^xsd:string ;
  rdfs:label "amino acid metabolic pathway (KEGG)"^^xsd:string ;
  skos:notation "PW:0001077"^^xsd:string .

ns1:PW_0001078
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001077 ;
  ns2:treeView ns1:PW_0001077 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-31T11:04:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00270"^^xsd:string ;
  obo:id "PW:0001078"^^xsd:string ;
  rdfs:label "cysteine and methionine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001078"^^xsd:string .

ns1:PW_0001079
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001074 ;
  ns2:treeView ns1:PW_0001074 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of proline, a non-essential amino acid that could be essential in certain cases. Its side chain bends to form a ring and its rigidity limits the folding abilities of proteins around proline residues."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-31T11:05:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001079"^^xsd:string ;
  rdfs:label "proline metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001079"^^xsd:string .

ns1:PW_0001080
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001074 ;
  ns2:treeView ns1:PW_0001074 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of valine, an essential amino acid. Valine, along with leucine and isoleucine is a branched-chain amino acid."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-31T11:06:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001080"^^xsd:string ;
  rdfs:label "valine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001080"^^xsd:string .

ns1:PW_0001081
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001075 ;
  ns2:treeView ns1:PW_0001075 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of lysine, an essential amino acid."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-31T11:07:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001081"^^xsd:string ;
  rdfs:label "lysine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001081"^^xsd:string .

ns1:PW_0001082
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001075 ;
  ns2:treeView ns1:PW_0001075 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of arginine, a non-essential amino acid that could be essential in certain cases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-31T11:08:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001082"^^xsd:string ;
  rdfs:label "arginine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001082"^^xsd:string .

ns1:PW_0001083
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001075 ;
  ns2:treeView ns1:PW_0001075 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of asparagine, a non-essential amino acid."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-31T11:08:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001083"^^xsd:string ;
  rdfs:label "asparagine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001083"^^xsd:string .

ns1:PW_0001084
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001075 ;
  ns2:treeView ns1:PW_0001075 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of serine, a non-essential amino acid that could be essential in certain cases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-31T11:10:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001084"^^xsd:string ;
  rdfs:label "serine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001084"^^xsd:string .

ns1:PW_0001085
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001075 ;
  ns2:treeView ns1:PW_0001075 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of threonine, an essential amino acid."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-31T11:11:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001085"^^xsd:string ;
  rdfs:label "threonine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001085"^^xsd:string .

ns1:PW_0001086
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001075 ;
  ns2:treeView ns1:PW_0001075 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of glutamine, a non-essential amino acid that could be essential in certain cases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-31T11:12:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001086"^^xsd:string ;
  rdfs:label "glutamine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001086"^^xsd:string .

ns1:PW_0001087
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001074 ;
  ns2:treeView ns1:PW_0001074 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of isoleucine, an essential amino acid."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-31T11:18:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001087"^^xsd:string ;
  rdfs:label "isoleucine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001087"^^xsd:string .

ns1:PW_0001088
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001074 ;
  ns2:treeView ns1:PW_0001074 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of leucine, an essential amino acid."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-07-31T11:18:56Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001088"^^xsd:string ;
  rdfs:label "leucine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001088"^^xsd:string .

ns1:PW_0001089
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000854 ;
  ns2:treeView ns1:PW_0000854 ;
  ns1:IAO_0000115 "Serotonin signaling via receptor family 1 and 5 primarily engages G alphai protein family resulting in inhibition of adenylate cyclases and reduction of intracellular cAMP. There are five receptors subtypes in family 1 and one in the human family 5."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-08-01T03:14:20Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001089"^^xsd:string ;
  rdfs:label "serotonin signaling pathway via receptors engaging G alphai protein family"^^xsd:string ;
  skos:notation "PW:0001089"^^xsd:string .

ns1:PW_0001090
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000854 ;
  ns2:treeView ns1:PW_0000854 ;
  ns1:IAO_0000115 "Serotonin signaling via receptor family 2 engages G alphaq protein family resulting in activation of phospholipase C, mobilization of calcium ions and production of inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG). There are three receptors subtypes in family 2."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-08-01T03:20:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001090"^^xsd:string ;
  rdfs:label "serotonin signaling pathway via receptors engaging G alphaq protein family"^^xsd:string ;
  skos:notation "PW:0001090"^^xsd:string .

ns1:PW_0001091
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000854 ;
  ns2:treeView ns1:PW_0000854 ;
  ns1:IAO_0000115 "Serotonin signaling via receptor family 4, 6, and 7 engages G alphas protein family resulting in activation of adenylyl cyclases and increased concentration of cAMP. There are seven receptor subtypes in family 4 and only one in families 6 and 7."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-08-01T03:28:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00309"^^xsd:string, "SMP:00311"^^xsd:string, "SMP:00312"^^xsd:string ;
  obo:id "PW:0001091"^^xsd:string ;
  rdfs:label "serotonin signaling pathway via receptors engaging G alphas protein family"^^xsd:string ;
  skos:notation "PW:0001091"^^xsd:string .

ns1:PW_0001092
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000854 ;
  ns2:treeView ns1:PW_0000854 ;
  ns1:IAO_0000115 "Serotonin family 3 receptor is a ligand-gated Na+/K+ channel with two receptor subtypes and their heterodimerization is believed to be necessary for their function. Serotonin signaling results in depolarization of plasma membrane."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-08-01T03:33:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001092"^^xsd:string ;
  rdfs:label "serotonin signaling via receptor family 3"^^xsd:string ;
  skos:notation "PW:0001092"^^xsd:string .

ns1:PW_0001093
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000716, ns1:PW_0000959, ns1:PW_0001313 ;
  ns2:treeView ns1:PW_0000716, ns1:PW_0000959, ns1:PW_0001313 ;
  ns1:IAO_0000115 "Bile acid binds to and activates several nuclear receptors such as the farnesoid X and liver X receptors as well as a cell surface G-protein coupled receptor."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-08-03T10:23:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001093"^^xsd:string ;
  rdfs:label "bile acid signaling pathway"^^xsd:string ;
  skos:notation "PW:0001093"^^xsd:string .

ns1:PW_0001094
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000507, ns1:PW_0000719, ns1:PW_0000787, ns1:PW_0001314 ;
  ns2:treeView ns1:PW_0000507, ns1:PW_0000719, ns1:PW_0000787, ns1:PW_0001314 ;
  ns1:IAO_0000115 "Disregulated estrogen signaling is associated with the growth and development of breast cancers; estrogen mediated transcription is constitutively active in more than 50% of cases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-08-03T10:51:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001094"^^xsd:string ;
  rdfs:label "altered estrogen signaling pathway"^^xsd:string ;
  skos:notation "PW:0001094"^^xsd:string .

ns1:PW_0001095
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000996 ;
  ns2:treeView ns1:PW_0000996 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of zidovudine, an anti-viral drug used for the treatment of HIV infection. It belongs to the family of nucleoside analog reverse transcriptase inhibitors. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-08-03T11:18:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "ZDV drug pathway"^^xsd:string ;
  obo:id "PW:0001095"^^xsd:string ;
  rdfs:label "zidovudine drug pathway"^^xsd:string ;
  skos:notation "PW:0001095"^^xsd:string .

ns1:PW_0001096
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001095 ;
  ns2:treeView ns1:PW_0001095 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of zidovudine, a drug used for the treatment of HIV. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-08-03T11:23:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001096"^^xsd:string ;
  rdfs:label "zidovudine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001096"^^xsd:string .

ns1:PW_0001097
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001095 ;
  ns2:treeView ns1:PW_0001095 ;
  ns1:IAO_0000115 "The pathway of zidovudine-target interaction and of the biochemical or physiological responses to drug. Zidovudine is a drug used for the treatment of HIV infection. Zidovudine, in its active triphosphate form, inhibits HIV-1 reverse transcriptase activity. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-08-03T11:25:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001097"^^xsd:string ;
  rdfs:label "zidovudine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001097"^^xsd:string .

ns1:PW_0001098
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002443 ;
  ns2:treeView ns1:PW_0002443 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of tramadol, an analgesic used for the treatment of moderate to moderately severe pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-08-03T11:37:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001098"^^xsd:string ;
  rdfs:label "tramadol drug pathway"^^xsd:string ;
  skos:notation "PW:0001098"^^xsd:string .

ns1:PW_0001099
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001098 ;
  ns2:treeView ns1:PW_0001098 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of tramadol, an analgesic used in the treatment of pain. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-08-03T11:41:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00637"^^xsd:string ;
  obo:id "PW:0001099"^^xsd:string ;
  rdfs:label "tramadol pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001099"^^xsd:string .

ns1:PW_0001100
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001098 ;
  ns2:treeView ns1:PW_0001098 ;
  ns1:IAO_0000115 "The pathway of tramadol-target interaction and of the biochemical or physiological responses to drug. Tramadol is an analgesic used for the treatment of pain. The drug and its o-desmethyl metabolite are weak, but selective opiate receptor 3 (OP3) agonists. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-08-03T11:41:20Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00671"^^xsd:string ;
  obo:id "PW:0001100"^^xsd:string ;
  rdfs:label "tramadol pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001100"^^xsd:string .

ns1:PW_0001101
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000605 ;
  ns2:treeView ns1:PW_0000605 ;
  ns1:IAO_0000115 "A number of human viruses have been shown to be associated/contribute to approximately 10 to 15% of cancers. The viral particles encode oncogenes whose escape from the host defense system impacts on many cellular pathways and promotes tumor development."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-09-06T16:03:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05203"^^xsd:string ;
  obo:id "PW:0001101"^^xsd:string ;
  rdfs:label "viral carcinogenesis pathway"^^xsd:string ;
  skos:notation "PW:0001101"^^xsd:string .

ns1:PW_0001102
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000360, ns1:PW_0000361, ns1:PW_0000719, ns1:PW_0001314 ;
  ns2:treeView ns1:PW_0000360, ns1:PW_0000361, ns1:PW_0000719, ns1:PW_0001314 ;
  ns1:IAO_0000115 "A hypoxia inducible pathway that deviates from what its normal course should be. Mutations in the von Hippel-Lindau (Vhl), the E3 ubiquitin ligase which targets Hif alpha for degradation under normoxic conditions, lead to a constitutively active pathway regardless the levels of oxygen. Mutations in Vhl and a number of other genes have been implicated in renal cancers."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-04T11:04:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001102"^^xsd:string ;
  rdfs:label "altered hypoxia inducible factor pathway"^^xsd:string ;
  skos:notation "PW:0001102"^^xsd:string .

ns1:PW_0001103
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000355 ;
  ns2:treeView ns1:PW_0000355 ;
  ns1:IAO_0000115 "The pathways that respond to and control the levels of protons, bicarbonate and carbon dioxide and of ammonia the cells. Several sensing pathways, i.e., prompting intracellular signaling cascade, and transport have been identified as critical players. The kidneys play a major role along with the respiratory system."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-04T12:58:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001103"^^xsd:string ;
  rdfs:label "acid-base homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0001103"^^xsd:string .

ns1:PW_0001104
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001105, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001103
  ] ;
  ns2:treeView ns1:PW_0001103, ns1:PW_0001105 ;
  ns3:part_of ns1:PW_0001103 ;
  ns1:IAO_0000115 "The pathway that respond to increases or decreases in protons, or pH levels and whose signaling aim at restoring systemic acid-base balance. Several G-protein coupled receptor  (GPCRs) and ion channel mediated signaling have been reported in the literature."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-04T13:14:56Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "proton-activated signaling pathway"^^xsd:string ;
  obo:id "PW:0001104"^^xsd:string ;
  rdfs:label "pH sensing signaling pathway"^^xsd:string ;
  skos:notation "PW:0001104"^^xsd:string .

ns1:PW_0001105
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000003 ;
  ns2:treeView ns1:PW_0000003 ;
  ns1:IAO_0000115 "The signaling pathway elicited by changes in pH and bicarbonate levels."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-04T13:39:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001105"^^xsd:string ;
  rdfs:label "acid and base sensing signaling pathway"^^xsd:string ;
  skos:notation "PW:0001105"^^xsd:string .

ns1:PW_0001106
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001105, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001103
  ] ;
  ns2:treeView ns1:PW_0001103, ns1:PW_0001105 ;
  ns3:part_of ns1:PW_0001103 ;
  ns1:IAO_0000115 "The signaling pathway elicited by increased levels of bicarbonate. Bicarbonate results from the instantaneous dissociation of carbonic acid, the end product of carbonic anhydrase hydration of exogenous or metabolically produced carbon dioxide."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-04T13:43:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001106"^^xsd:string ;
  rdfs:label "bicarbonate sensing signaling pathway"^^xsd:string ;
  skos:notation "PW:0001106"^^xsd:string .

ns1:PW_0001107
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of sorafenib, a multikinase inhibitor used in the treatment of cancer, in particular for advanced renal cell carcinoma.  The drug binds to the intracytoplasmic domain of tyrosine kinase receptors blocking the downstream signaling cascade. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-04T15:24:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001107"^^xsd:string ;
  rdfs:label "sorafenib drug pathway"^^xsd:string ;
  skos:notation "PW:0001107"^^xsd:string .

ns1:PW_0001108
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001107 ;
  ns2:treeView ns1:PW_0001107 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of sorafenib. The drug was the first oral multikinase inhibitor approved for the treatment of renal cell carcinoma. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-04T15:30:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00648"^^xsd:string ;
  obo:id "PW:0001108"^^xsd:string ;
  rdfs:label "sorafenib pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001108"^^xsd:string .

ns1:PW_0001109
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001107 ;
  ns2:treeView ns1:PW_0001107 ;
  ns1:IAO_0000115 "The pathway of sorafenib-target interaction and of the biochemical or physiological responses to drug. Sorafenib is the first multikinase inhibitor approved for the treatment of renal cell carcinoma.  The drug binds to the intracytoplasmic domain of tyrosine kinase receptors blocking the downstream signaling cascade. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-04T15:31:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001109"^^xsd:string ;
  rdfs:label "sorafenib pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001109"^^xsd:string .

ns1:PW_0001110
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of sunitinib, a multikinase inhibitor used in the treatment of cancer, in particular for advanced renal cell carcinoma. The drug binds to the intracytoplasmic domain of tyrosine kinase receptors blocking the downstream signaling cascade. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-04T15:54:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001110"^^xsd:string ;
  rdfs:label "sunitinib drug pathway"^^xsd:string ;
  skos:notation "PW:0001110"^^xsd:string .

ns1:PW_0001111
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000928 ;
  ns2:treeView ns1:PW_0000928 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-04T15:57:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001111"^^xsd:string ;
  rdfs:label "tocilizumab pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001111"^^xsd:string .

ns1:PW_0001112
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000928 ;
  ns2:treeView ns1:PW_0000928 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-04T15:57:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001112"^^xsd:string ;
  rdfs:label "tocilizumab pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001112"^^xsd:string .

ns1:PW_0001113
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001110 ;
  ns2:treeView ns1:PW_0001110 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of sunitinib. The drug is a multikinase inhibitor approved for the treatment of renal cell carcinoma. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-04T15:58:20Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001113"^^xsd:string ;
  rdfs:label "sunitinib pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001113"^^xsd:string .

ns1:PW_0001114
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001110 ;
  ns2:treeView ns1:PW_0001110 ;
  ns1:IAO_0000115 "The pathway of sunitinib-target interaction and of the biochemical or physiological responses to drug. Sunitinib is a multikinase inhibitor approved for the treatment of renal cell carcinoma. The drug binds to the intracytoplasmic domain of tyrosine kinase receptors blocking the downstream signaling cascade. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-04T15:58:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001114"^^xsd:string ;
  rdfs:label "sunitinib pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001114"^^xsd:string .

ns1:PW_0001115
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001008 ;
  ns2:treeView ns1:PW_0001008 ;
  ns1:IAO_0000115 "A signaling cascade triggered by light in the visible and red spectrum whose sensor appears to be cytochrome c oxidase, the terminal enzyme of the electron transfer chain, and which relies on a retrograde mitochondrion-to-nucleus pathway that translates in the upregulation of various genes. Unlike the visual phototransduction, this pathway does not require vitamin A metabolites."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-11T09:27:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001115"^^xsd:string ;
  rdfs:label "non-visual phototransduction pathway"^^xsd:string ;
  skos:notation "PW:0001115"^^xsd:string .

ns1:PW_0001116
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001012 ;
  ns2:treeView ns1:PW_0001012 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-11T10:05:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001116"^^xsd:string ;
  rdfs:label "vitamin A and metabolites signaling pathway"^^xsd:string ;
  skos:notation "PW:0001116"^^xsd:string .

ns1:PW_0001117
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001116 ;
  ns2:treeView ns1:PW_0001116 ;
  ns1:IAO_0000115 "A signaling pathway mediated by a signaling complex for which retinol or vitamin A appears to be an essential docking molecule and redox sensor. The pathway may play an important role in regulating the tricarboxylic acid cycle through the pyruvate dehydrogenase complex by mechanisms that are still to be elucidated."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-11T10:06:06Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001117"^^xsd:string ;
  rdfs:label "retinol mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0001117"^^xsd:string .

ns1:PW_0001118
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000033, ns1:PW_0000262 ;
  ns2:treeView ns1:PW_0000033, ns1:PW_0000262 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-12T16:31:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001118"^^xsd:string ;
  rdfs:label "altered energy metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001118"^^xsd:string .

ns1:PW_0001119
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000026, ns1:PW_0000359, ns1:PW_0001118 ;
  ns2:treeView ns1:PW_0000026, ns1:PW_0000359, ns1:PW_0001118 ;
  ns1:IAO_0000115 "Defects in components of the citrate cycle have been shown to relate to several types of cancer. For instance, mutations in fumarate hydratase are associated with renal cancer, in succinate dehydrogenase in renal as well as paragangliomas and pheochromocytomas. Mutations in isocitrate dehydrogenase have also been implicated in several types of cancer. Defects in this central metabolic network result in unwanted activation of hypoxia inducible factor whose target genes are involved in angiogenesis, erythropoiesis, glycolysis, among others."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-12T16:32:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001119"^^xsd:string ;
  rdfs:label "altered citric acid cycle pathway"^^xsd:string ;
  skos:notation "PW:0001119"^^xsd:string .

ns1:PW_0001120
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002370 ;
  ns2:treeView ns1:PW_0002370 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of bevacizumab, a humanized monoclonal antibody that inhibits VEGF activity. It is used for the treatment of several types of advanced cancers. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-15T08:49:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001120"^^xsd:string ;
  rdfs:label "bevacizumab drug pathway"^^xsd:string ;
  skos:notation "PW:0001120"^^xsd:string .

ns1:PW_0001121
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001120 ;
  ns2:treeView ns1:PW_0001120 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of bevacizumab, a VEGF inhibitor used in the treatment of several types of  tumors. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-15T08:56:41Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001121"^^xsd:string ;
  rdfs:label "bevacizumab pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001121"^^xsd:string .

ns1:PW_0001122
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001120 ;
  ns2:treeView ns1:PW_0001120 ;
  ns1:IAO_0000115 "The pathway of bevacizumab-target interaction and of the biochemical or physiological responses to drug. The drug is an inhibitor of VEGF and is used in the treatment of several types of cancers such as for instance renal cell carcinoma. VEGF is a target of hypoxia inducible factor pathway, which is constitutively active in the condition.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-15T08:57:45Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00420"^^xsd:string ;
  obo:id "PW:0001122"^^xsd:string ;
  rdfs:label "bevacizumab pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001122"^^xsd:string .

ns1:PW_0001123
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of axitinib, a receptor tyrosine kinase inhibitor used in the treatment of renal cell carcinoma as well as other tumors. Angiogenic factors such as vascular endothelial or platelet derived growth factors are direct and indirect targets of hypoxia inducible factor pathway, constitutively active in renal cell carcinoma. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-19T11:46:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001123"^^xsd:string ;
  rdfs:label "axitinib drug pathway"^^xsd:string ;
  skos:notation "PW:0001123"^^xsd:string .

ns1:PW_0001124
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001123 ;
  ns2:treeView ns1:PW_0001123 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of axitinib, a receptor tyrosine kinase inhibitor used in the treatment of renal cell carcinoma and other tumors. Axitinib is a selective second generation inhibitor of vascular endothelial growth factor receptors 1, 2 and 3. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-19T11:49:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001124"^^xsd:string ;
  rdfs:label "axitinib pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001124"^^xsd:string .

ns1:PW_0001125
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001123 ;
  ns2:treeView ns1:PW_0001123 ;
  ns1:IAO_0000115 "The pathway of axitinib-target interaction and of the biochemical or physiological responses to drug. Axitinib is a receptor tyrosine kinase inhibitor used in the treatment of renal cell carcinoma as well as other tumors. Axitinib is a selective second generation inhibitor of vascular endothelial growth factor receptors 1, 2 and 3. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-19T11:50:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001125"^^xsd:string ;
  rdfs:label "axitinib pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001125"^^xsd:string .

ns1:PW_0001126
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367, ns1:PW_0002369 ;
  ns2:treeView ns1:PW_0002367, ns1:PW_0002369 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of everolimus, an inhibitor of mTOR pathway used in the treatment of several types of tumors, including renal cell carcinoma. Hypoxia inducible factor (HIF) pathway is constitutively active in the disease; mTOR regulates the translation of HIF-alpha gene. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-19T13:54:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001126"^^xsd:string ;
  rdfs:label "everolimus drug pathway"^^xsd:string ;
  skos:notation "PW:0001126"^^xsd:string .

ns1:PW_0001127
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001126 ;
  ns2:treeView ns1:PW_0001126 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of everolimus, an inhibitor of mTOR pathway used in the treatment of renal cell carcinoma and other tumors. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-19T15:41:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001127"^^xsd:string ;
  rdfs:label "everolimus pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001127"^^xsd:string .

ns1:PW_0001128
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001126 ;
  ns2:treeView ns1:PW_0001126 ;
  ns1:IAO_0000115 "The pathway of everolimus-target interactions and of the biochemical or physiological responses to drug. The drug is an inhibitor of mTOR pathway and is used in the treatment of renal cell carcinoma and other types of tumors. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-19T15:45:06Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001128"^^xsd:string ;
  rdfs:label "everolimus pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001128"^^xsd:string .

ns1:PW_0001129
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of temsirolimus, an inhibitor of mTOR pathway used in the treatment of renal cell carcinoma and other types of tumors. Hypoxia inducible factor (HIF) pathway is constitutively active in renal cell carcinoma; HIF-alpha translation is under the control of mTOR pathway. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-19T16:04:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001129"^^xsd:string ;
  rdfs:label "temsirolimus drug pathway"^^xsd:string ;
  skos:notation "PW:0001129"^^xsd:string .

ns1:PW_0001130
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001129 ;
  ns2:treeView ns1:PW_0001129 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of temsirolimus, an inhibitor of mTOR pathway used in the treatment of renal cell carcinoma and other tumors. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-19T16:12:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001130"^^xsd:string ;
  rdfs:label "temsirolimus pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001130"^^xsd:string .

ns1:PW_0001131
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001129 ;
  ns2:treeView ns1:PW_0001129 ;
  ns1:IAO_0000115 "The pathway of temsirolimus-target interaction and of the biochemical or physiological responses to drug. The drug is an inhibitor of mTOR pathway and is used in the treatment of renal cell carcinoma and other types of tumors. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-19T16:12:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001131"^^xsd:string ;
  rdfs:label "temsirolimus pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001131"^^xsd:string .

ns1:PW_0001132
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of pazopanib, a receptor tyrosine kinase inhibitor used in the treatment of renal cell carcinoma as well as other tumors. Angiogenic factors such as vascular endothelial or platelet derived growth factors are direct and indirect targets of hypoxia inducible factor pathway, constitutively active in renal cell carcinoma. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-19T16:13:35Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001132"^^xsd:string ;
  rdfs:label "pazopanib drug pathway"^^xsd:string ;
  skos:notation "PW:0001132"^^xsd:string .

ns1:PW_0001133
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001132 ;
  ns2:treeView ns1:PW_0001132 ;
  ns1:IAO_0000115 "he pathway of processing - absorption, distribution, metabolism or elimination - of pazopanib. The drug is a multikinase inhibitor approved for the treatment of renal cell carcinoma. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-19T16:13:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001133"^^xsd:string ;
  rdfs:label "pazopanib pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001133"^^xsd:string .

ns1:PW_0001134
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001132 ;
  ns2:treeView ns1:PW_0001132 ;
  ns1:IAO_0000115 "The pathway of pazopanib-target interaction and of the biochemical or physiological responses to drug. Pazopanib is a selective multikinase inhibitor approved for the treatment or renal cell carcinoma. The drug binds to the intracytoplasmic domain of tyrosine kinase receptors blocking the downstream signaling cascade. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-10-19T16:14:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001134"^^xsd:string ;
  rdfs:label "pazopanib pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001134"^^xsd:string .

ns1:PW_0001135
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001180, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000371
  ], [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001182
  ] ;
  ns2:treeView ns1:PW_0000371, ns1:PW_0001180, ns1:PW_0001182 ;
  ns3:part_of ns1:PW_0000371, ns1:PW_0001182 ;
  ns1:IAO_0000115 "Parathyroid hormone (PTH) signaling is important for calcium and phosphate homeostasis in bone and kidney. It acts to increase the concentration of calcium in the blood, has both anabolic and catabolic effects in the bone and regulates calcium and phosphate reabsorption in the kidney. It also plays important roles in vitamin D metabolism."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-01T09:32:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PTH signaling pathway"^^xsd:string ;
  obo:id "PW:0001135"^^xsd:string ;
  rdfs:label "parathyroid hormone signaling pathway"^^xsd:string ;
  skos:notation "PW:0001135"^^xsd:string .

ns1:PW_0001136
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000029 ;
  ns2:treeView ns1:PW_0000029 ;
  ns1:IAO_0000115 "The C16 palmitate product of fatty acid biosynthetic pathway can be esterifed to triacylglycerol or converted to longer chain saturated and unsaturated fatty acid molecules by elongases and desaturases, depending on the needs of the cell. The elongation pathway takes place in the endoplasmic reticulum or in the mitochondrion. Longer chain fatty acids are present in certain specialized tissues; for instance, myelin contains large amounts of C22 and C24 molecules."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-02T15:26:41Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00062"^^xsd:string, "SMP:00054"^^xsd:string ;
  obo:id "PW:0001136"^^xsd:string ;
  rdfs:label "fatty acid elongation pathway"^^xsd:string ;
  skos:notation "PW:0001136"^^xsd:string .

ns1:PW_0001137
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000029 ;
  ns2:treeView ns1:PW_0000029 ;
  ns1:IAO_0000115 "The C16 palmitate product of fatty acid biosynthetic pathway can be esterifed to triacylglycerol or converted to longer chain saturated and unsaturated fatty acid molecules by elongases and desaturases, depending on the needs of the cell. Unsaturated fatty acids are essential membrane components."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-02T15:40:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:01040"^^xsd:string ;
  obo:id "PW:0001137"^^xsd:string ;
  rdfs:label "unsaturated fatty acid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001137"^^xsd:string .

ns1:PW_0001138
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000010 ;
  ns2:treeView ns1:PW_0000010 ;
  ns1:IAO_0000115 "Those metabolic reactions involving ether lipids, lipid molecules in which one or several of the carbons on glycerol has an ether linkage to an alkyl chain. Ether lipids are constituents of cell membrane; some metabolites could act as signaling second messengers or carry out antioxidant functions."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-02T16:17:56Z"^^xsd:string ;
  obo:hasAlternativeId "PW:0001157"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00565"^^xsd:string ;
  obo:id "PW:0001138"^^xsd:string ;
  rdfs:label "ether lipid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001138"^^xsd:string .

ns1:PW_0001139
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000593, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000371
  ] ;
  ns2:treeView ns1:PW_0000371, ns1:PW_0000593 ;
  ns3:part_of ns1:PW_0000371 ;
  ns1:IAO_0000115 "Calcium is pumped into organelles or outside the cell by pumps and exchangers to maintain the low calcium concentration necessary for cell viability. Many type of channels, some calcium-selective, others of lower selectivity or calcium-permeant, allow for the flow of calcium from external sources or internal stores into the cell to initiate many signaling events. The movement of calcium ions, which controls and maintains the calcium gradient, and calcium signaling, which the gradient promotes, are inextricably connected in the fabric of calcium homeostasis."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-05T09:59:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001139"^^xsd:string ;
  rdfs:label "calcium transport pathway"^^xsd:string ;
  skos:notation "PW:0001139"^^xsd:string .

ns1:PW_0001140
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000003, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000371
  ] ;
  ns2:treeView ns1:PW_0000003, ns1:PW_0000371 ;
  ns3:part_of ns1:PW_0000371 ;
  ns1:IAO_0000115 "Calcium signaling impacts on a large and diverse spectrum of cellular processes such as gene expression and cell death, proliferation, muscle contraction and energy metabolism, learning, memory and synaptic plasticity. Calcium acts in signal transduction as a first as well as a second messenger. Calcium transport, which controls and maintains the calcium gradient, and calcium signaling, which the gradient promotes, are inextricably connected in the fabric of calcium homeostasis."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-05T10:53:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04020"^^xsd:string ;
  obo:id "PW:0001140"^^xsd:string ;
  rdfs:label "calcium/calcium-mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0001140"^^xsd:string .

ns1:PW_0001141
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001140 ;
  ns2:treeView ns1:PW_0001140 ;
  ns1:IAO_0000115 "Calcium signaling through the calcium-sensing receptor inhibits the secretion of parathyroid hormone in the parathyroid glands and controls calcium absorption and water balance in the kidneys. Calcium is considered the main physiological agonist but other cations and various agonists can activate the receptor. The G protein coupled receptor (GPCR) is believed to engage several types of Galpha proteins and to have many other interacting partners. The pathway leads to activation of MAPK cascades, particularly the one mediated by Erk1/2. Casr signaling is cell specific; many of its molecular details are not fully understood. Many mutations, both inactivating and activating the receptor, have been identified."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-07T13:22:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001141"^^xsd:string ;
  rdfs:label "calcium signaling pathway via the calcium-sensing receptor"^^xsd:string ;
  skos:notation "PW:0001141"^^xsd:string .

ns1:PW_0001142
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000281 ;
  ns2:treeView ns1:PW_0000281 ;
  ns1:IAO_0000115 "The clathrin-mediated endocytosis pathway involves clathrin-coated vesicles used for the engulfment of material."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-08T15:18:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001142"^^xsd:string ;
  rdfs:label "clathrin-mediated endocytosis pathway"^^xsd:string ;
  skos:notation "PW:0001142"^^xsd:string .

ns1:PW_0001143
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000281 ;
  ns2:treeView ns1:PW_0000281 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-08T15:40:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001143"^^xsd:string ;
  rdfs:label "caveolae-mediated endocytosis pathway"^^xsd:string ;
  skos:notation "PW:0001143"^^xsd:string .

ns1:PW_0001144
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000281 ;
  ns2:treeView ns1:PW_0000281 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-08T15:41:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001144"^^xsd:string ;
  rdfs:label "micropinocytosis pathway"^^xsd:string ;
  skos:notation "PW:0001144"^^xsd:string .

ns1:PW_0001145
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000281 ;
  ns2:treeView ns1:PW_0000281 ;
  ns1:IAO_0000115 "Phagocytosis pathway is used for the removal of unwanted material such as dying cells and also of foreign material. As such is also part of the immune response. Various receptors on the surface of a phagocytic cell will recognize/bind material and induce signaling cascades."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-08T15:41:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04145"^^xsd:string ;
  obo:id "PW:0001145"^^xsd:string ;
  rdfs:label "phagocytosis pathway"^^xsd:string ;
  skos:notation "PW:0001145"^^xsd:string .

ns1:PW_0001146
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001145, ns1:PW_0001150 ;
  ns2:treeView ns1:PW_0001145, ns1:PW_0001150 ;
  ns1:IAO_0000115 "The signaling cascade initiated by an activated Fc gamma receptor. Fc receptors are classified by the type of antibody they recognize; thus, Fc gamma receptors bind IgG, the most common type of antibody. Fc gamma receptors belong to the immunoglobulin superfamily."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-08T16:04:35Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04666"^^xsd:string ;
  obo:id "PW:0001146"^^xsd:string ;
  rdfs:label "Fc gamma receptor mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0001146"^^xsd:string .

ns1:PW_0001147
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000565 ;
  ns2:treeView ns1:PW_0000565 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-08T16:29:11Z"^^xsd:string ;
  obo:hasExactSynonym "eicosanoid signaling pathway via PPARG"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:03320"^^xsd:string ;
  obo:id "PW:0001147"^^xsd:string ;
  rdfs:label "eicosanoid signaling pathway via peroxisome proliferator-activated receptor gamma"^^xsd:string ;
  skos:notation "PW:0001147"^^xsd:string .

ns1:PW_0001148
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001028 ;
  ns2:treeView ns1:PW_0001028 ;
  ns1:IAO_0000115 "Hepatitis B virus (HBV) is the causative agent of hepatitis B, an inflammatory condition of the liver affecting people in parts of Asia and Africa. The virus interferes with a number of regulatory and signaling pathways in the host."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-09T08:47:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05161"^^xsd:string ;
  obo:id "PW:0001148"^^xsd:string ;
  rdfs:label "hepatitis B virus infection pathway"^^xsd:string ;
  skos:notation "PW:0001148"^^xsd:string .

ns1:PW_0001149
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001028 ;
  ns2:treeView ns1:PW_0001028 ;
  ns1:IAO_0000115 "The human T-lymphotropic virus type 1 (HTLV-1) is a pathogenic retrovirus causing a type of cancer known as adult T-cell leukemia and lymphoma and a demyelinating condition referred to as HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). A viral regulatory protein known as Tax, which is a transcriptional co-factor, interferes with a number of signaling pathways in the host."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-09T09:00:17Z"^^xsd:string ;
  obo:hasExactSynonym "HTLV-1 infection pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05166"^^xsd:string ;
  obo:id "PW:0001149"^^xsd:string ;
  rdfs:label "human T-lymphotropic virus type 1 infection pathway"^^xsd:string ;
  skos:notation "PW:0001149"^^xsd:string .

ns1:PW_0001150
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000235, ns1:PW_0000820 ;
  ns2:treeView ns1:PW_0000235, ns1:PW_0000820 ;
  ns1:IAO_0000115 "Fc receptors mediated signaling exerts important regulatory and modulatory roles in immunity. Fc receptors are classified by the type of antibody they recognize. They are widely expressed on immune system cells and a number of other cell types. With one exception, they mediate activating signaling cascades."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-09T10:50:09Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001150"^^xsd:string ;
  rdfs:label "Fc receptor mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0001150"^^xsd:string .

ns1:PW_0001151
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001150 ;
  ns2:treeView ns1:PW_0001150 ;
  ns1:IAO_0000115 "The signaling cascade initiated by an activated Fc epsilon receptor. Fc receptors are classified by the type of antibody they recognize; thus, Fc epsilon receptors bind IgE antibody."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-09T11:02:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04664"^^xsd:string, "SMP:00358"^^xsd:string ;
  obo:id "PW:0001151"^^xsd:string ;
  rdfs:label "Fc epsilon receptor mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0001151"^^xsd:string .

ns1:PW_0001152
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000453, ns1:PW_0001303 ;
  ns2:treeView ns1:PW_0000453, ns1:PW_0001303 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of steroids. Notable examples include cholesterol and steroid hormones."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-09T15:05:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00100"^^xsd:string ;
  obo:id "PW:0001152"^^xsd:string ;
  rdfs:label "steroid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001152"^^xsd:string .

ns1:PW_0001153
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000147 ;
  ns2:treeView ns1:PW_0000147 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of caffeine, a xanthine alkaloid found in the seeds, leaves, and fruit of certain plants that humans use as a stimulant."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-09T15:14:24Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00232"^^xsd:string ;
  obo:id "PW:0001153"^^xsd:string ;
  rdfs:label "caffeine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001153"^^xsd:string .

ns1:PW_0001154
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000157 ;
  ns2:treeView ns1:PW_0000157 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the degradation of glycosaminoglycans."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-09T15:21:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00531"^^xsd:string ;
  obo:id "PW:0001154"^^xsd:string ;
  rdfs:label "glycosaminoglycan degradation pathway"^^xsd:string ;
  skos:notation "PW:0001154"^^xsd:string .

ns1:PW_0001155
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000147 ;
  ns2:treeView ns1:PW_0000147 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of butirosin and neomycin -aminoglycoside antibiotics produced by Bacillus circulans and Streptomyces fradiae, respectively."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-09T15:34:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00524"^^xsd:string ;
  obo:id "PW:0001155"^^xsd:string ;
  rdfs:label "butirosin and neomycin biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001155"^^xsd:string .

ns1:PW_0001156
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000010 ;
  ns2:treeView ns1:PW_0000010 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of glycerolipids which are composed of mono-, di-, and tri-substituted glycerols. Triacylglycerol, or triglyceride, is the best known example."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-09T15:42:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00561"^^xsd:string, "SMP:00039"^^xsd:string ;
  obo:id "PW:0001156"^^xsd:string ;
  rdfs:label "glycerolipid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001156"^^xsd:string .

ns1:PW_0001157
  a owl:Class ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of ether lipids. On these molecules one or more of the carbon atoms of glycerol is bonded to an alkyl group via an ether linkage."^^xsd:string ;
  ns1:IAO_0000231 ns1:IAO_0000227 ;
  ns1:IAO_0100001 ns1:PW_0001138 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-09T15:51:41Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001157"^^xsd:string ;
  rdfs:label "ether lipid metabolic pathway"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0001157"^^xsd:string .

ns1:PW_0001158
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000058 ;
  ns2:treeView ns1:PW_0000058 ;
  ns1:IAO_0000115 "Those enzymatic reactions involved in the synthesis, utilization or degradation of alpha-linoleic acid - an unsaturated omega-3 fatty acid. Alpha-linoleic acid is an essential fatty acid that humans and other animals cannot synthesize and must obtain from diet."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-09T16:06:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00592"^^xsd:string, "SMP:00018"^^xsd:string ;
  obo:id "PW:0001158"^^xsd:string ;
  rdfs:label "alpha-linoleic acid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001158"^^xsd:string .

ns1:PW_0001159
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000101
  ] ;
  ns2:treeView ns1:PW_0000101 ;
  ns3:part_of ns1:PW_0000101 ;
  ns1:IAO_0000115 "Aminoacyl-tRNA, or transfer RNA (tRNA) carries amino acids to ribosomes and is part of the translation pathway. tRNAs are specific for the amino acids with which they are associated. Their synthesis involves adenylation of the amino acid followed by its transfer; both steps require ATP."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-09T16:13:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:00970"^^xsd:string ;
  obo:id "PW:0001159"^^xsd:string ;
  rdfs:label "aminoacyl-tRNA biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001159"^^xsd:string .

ns1:PW_0001160
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000085, ns1:PW_0000103 ;
  ns2:treeView ns1:PW_0000085, ns1:PW_0000103 ;
  ns1:IAO_0000115 "The pathway whereby various RNA molecules synthesized in the nucleus are exported to the cytoplasm to be further processed such as protein-coding mRNA or to fulfill particular functions."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-12T15:25:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:03013"^^xsd:string ;
  obo:id "PW:0001160"^^xsd:string ;
  rdfs:label "RNA transport pathway"^^xsd:string ;
  skos:notation "PW:0001160"^^xsd:string .

ns1:PW_0001161
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001567 ;
  ns2:treeView ns1:PW_0001567 ;
  ns1:IAO_0000115 "The turnover of RNA molecules produced by the three eukaryotic polymerases and those resulting from their processing and/or assembly. It includes the degradation of defective molecules, of excess molecules, or of defective components by the RNA surveillance or decay pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-12T15:38:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:03018"^^xsd:string ;
  obo:id "PW:0001161"^^xsd:string ;
  rdfs:label "RNA degradation pathway"^^xsd:string ;
  skos:notation "PW:0001161"^^xsd:string .

ns1:PW_0001162
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000003 ;
  ns2:treeView ns1:PW_0000003 ;
  ns1:IAO_0000115 "The signaling pathway initiated by a chemical entity. It could be an organic or inorganic molecule."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-13T09:02:24Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001162"^^xsd:string ;
  rdfs:label "chemical compound signaling pathway"^^xsd:string ;
  skos:notation "PW:0001162"^^xsd:string .

ns1:PW_0001163
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001162 ;
  ns2:treeView ns1:PW_0001162 ;
  ns1:IAO_0000115 "Cannabinoids are a class of rather diverse chemical compounds of which some, like endocannabinoids are naturally produced by the body in humans and other animals, while others are found in plants or are synthesized. Signaling is mediated by the cannabinoid receptors that are G protein coupled (GPCR) receptors. The endogenous cannabinoids are lipids and the signaling route is referred to as retrograde as it  travels 'backwards' from the postsynaptic to the presynaptic cell."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-13T09:02:41Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001163"^^xsd:string ;
  rdfs:label "cannabinoid signaling pathway"^^xsd:string ;
  skos:notation "PW:0001163"^^xsd:string .

ns1:PW_0001164
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000959, ns1:PW_0001163 ;
  ns2:treeView ns1:PW_0000959, ns1:PW_0001163 ;
  ns1:IAO_0000115 "The signaling pathway initiated by the endogenous cannabinoids that activate the G protein coupled (GPCR) cannabinoid receptors and utilize a retrograde route from the postsynaptic to the presynaptic neuron."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-13T09:19:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04723"^^xsd:string, "retrograde endocannabinoid signaling pathway"^^xsd:string ;
  obo:id "PW:0001164"^^xsd:string ;
  rdfs:label "endocannabinoid signaling pathway"^^xsd:string ;
  skos:notation "PW:0001164"^^xsd:string .

ns1:PW_0001165
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000407 ;
  ns2:treeView ns1:PW_0000407 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-13T09:46:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001165"^^xsd:string ;
  rdfs:label "lipid neurotransmitter metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001165"^^xsd:string .

ns1:PW_0001166
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001165 ;
  ns2:treeView ns1:PW_0001165 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2012-11-13T09:47:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001166"^^xsd:string ;
  rdfs:label "endocannabinoid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001166"^^xsd:string .

ns1:PW_0001167
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001180 ;
  ns2:treeView ns1:PW_0001180 ;
  ns1:IAO_0000115 "Parathyroid hormone related peptide (PTHLH) signaling exerts pleiotropic roles, unlike the related parathyroid hormone whose specific role is in calcium and phosphate homeostasis. Initially identified as a  molecule produced by certain cancers, it is now known that it is important for normal physiological functions, mostly related to development and organogenesis."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-01-04T11:32:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PTHrP signaling pathway"^^xsd:string, "parathyroid hormone related peptide signaling pathway"^^xsd:string ;
  obo:id "PW:0001167"^^xsd:string ;
  rdfs:label "parathyroid hormone-like hormone signaling pathway"^^xsd:string ;
  skos:notation "PW:0001167"^^xsd:string .

ns1:PW_0001168
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001141, ns1:PW_0001169 ;
  ns2:treeView ns1:PW_0001141, ns1:PW_0001169 ;
  ns1:IAO_0000115 "Altered calcium signaling due to mutations in the calcium-sensing receptor has been associated with a number of conditions. To date, more than 250 mutations have been identified of which more than half reside in the extracellular part of the receptor."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-01-04T15:17:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001168"^^xsd:string ;
  rdfs:label "altered calcium signaling pathway via the calcium-sensing receptor"^^xsd:string ;
  skos:notation "PW:0001168"^^xsd:string .

ns1:PW_0001169
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000264, ns1:PW_0001140 ;
  ns2:treeView ns1:PW_0000264, ns1:PW_0001140 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-01-04T15:22:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001169"^^xsd:string ;
  rdfs:label "altered calcium/calcium-mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0001169"^^xsd:string .

ns1:PW_0001170
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000754 ;
  ns2:treeView ns1:PW_0000754 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of compounds used for the treatment of conditions associated with the musculo-skeletal system. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-01-21T15:17:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001170"^^xsd:string ;
  rdfs:label "musculo-skeletal system drug pathway"^^xsd:string ;
  skos:notation "PW:0001170"^^xsd:string .

ns1:PW_0001171
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001180 ;
  ns2:treeView ns1:PW_0001180 ;
  ns1:IAO_0000115 "Tuberoinfundibular peptide of 39 residues (Tip39) is encoded by the parathyroid hormone 2 gene, weakly homologous to parathyroid hormone (PTH) and parathyroid hormone-like hormone (PTHrP). Tip39 is an endogenous ligand for the parathyroid hormone receptor 2, a G protein coupled receptor (GPCR), initially considered an orphan receptor. Signaling, mostly in the brain but also in the pancreas, testis and renal tissues, appears to involve elevation in cAMP."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-01-28T14:00:14Z"^^xsd:string ;
  obo:hasExactSynonym "Tip39 signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "PTH2 signaling pathway"^^xsd:string ;
  obo:id "PW:0001171"^^xsd:string ;
  rdfs:label "tuberoinfundibular 39 residues peptide signaling pathway"^^xsd:string ;
  skos:notation "PW:0001171"^^xsd:string .

ns1:PW_0001172
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000298, ns1:PW_0000328 ;
  ns2:treeView ns1:PW_0000298, ns1:PW_0000328 ;
  ns1:IAO_0000115 "Fibroblast growth factor (FGF) signaling involves more than 20 proteins involved in embryonic and postnatal development and for some members, also acting as hormones in the adult. Deregulation of the pathway has been implicated in a number of neoplastic and metabolic conditions."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-01-29T09:20:46Z"^^xsd:string ;
  obo:hasExactSynonym "altered FGF signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001172"^^xsd:string ;
  rdfs:label "altered fibroblast growth factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0001172"^^xsd:string .

ns1:PW_0001173
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000328 ;
  ns2:treeView ns1:PW_0000328 ;
  ns1:IAO_0000115 "The fibroblast growth factors (FGF)  also known as FGF homologous factors belong to the phylogenetic subfamily FGF11/12/13/14. They signal intracellularly and independent of fibroblast growth factor receptors (FGFR). The pathway plays important neuromodulatory roles. Deregulation of the pathway has been associated with several neurodegenerative disorders."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-01-29T11:11:31Z"^^xsd:string ;
  obo:hasExactSynonym "intracrine FGF signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "intracellular FGF signaling pathway"^^xsd:string, "intracellular fibroblast growth factor signaling pathway"^^xsd:string ;
  obo:id "PW:0001173"^^xsd:string ;
  rdfs:label "intracrine fibroblast growth factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0001173"^^xsd:string .

ns1:PW_0001174
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000328, ns1:PW_0000650 ;
  ns2:treeView ns1:PW_0000328, ns1:PW_0000650 ;
  ns1:IAO_0000115 "Paracrine fibroblast growth factors (FGF) are represented by five phylogenetic subfamilies whose signaling, also referred to as canonical, is involved in the well known role of FGF in embryonic and postnatal development. Deregulation of the pathway has been associated with several conditions."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-01-29T11:20:28Z"^^xsd:string ;
  obo:hasExactSynonym "paracrine FGF signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "canonical fibroblast growth factor signaling pathway"^^xsd:string ;
  obo:id "PW:0001174"^^xsd:string ;
  rdfs:label "paracrine fibroblast growth factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0001174"^^xsd:string .

ns1:PW_0001175
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000328 ;
  ns2:treeView ns1:PW_0000328 ;
  ns1:IAO_0000115 "The endocrine fibroblast growth factors (FGF) also known as hormone-like belong to the 15/19/21/23 phylogenetic subfamily, also referred to as FGF19 subfamily. They have low affinity for the fibroblast growth factor receptors (FGFR) and rely on the Klotho family members to bind the receptors under physiological conditions. In particular, FGF23 signaling via Klotho, also known as the FGF23/Klotho axis plays a central role in vitamin D metabolism and renal phosphate homeostasis. Deregulation of the pathway has been associated with several conditions."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-01-29T11:20:53Z"^^xsd:string ;
  obo:hasExactSynonym "endocrine FGF signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "fibroblast growth factor subfamily 19 signaling pathway"^^xsd:string ;
  obo:id "PW:0001175"^^xsd:string ;
  rdfs:label "endocrine fibroblast growth factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0001175"^^xsd:string .

ns1:PW_0001176
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001172, ns1:PW_0001175 ;
  ns2:treeView ns1:PW_0001172, ns1:PW_0001175 ;
  ns1:IAO_0000115 "Deregulation of endocrine fibroblast growth factor signaling pathway has been associated with several paraneoplastic and metabolic diseases that include renal failure, Cushing's syndrome, type 2 diabetes and obesity, among others."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-01-29T13:42:12Z"^^xsd:string ;
  obo:hasExactSynonym "altered endocrine FGF signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001176"^^xsd:string ;
  rdfs:label "altered endocrine fibroblast growth factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0001176"^^xsd:string .

ns1:PW_0001177
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001172, ns1:PW_0001173 ;
  ns2:treeView ns1:PW_0001172, ns1:PW_0001173 ;
  ns1:IAO_0000115 "Deregulation of the intracrine fibroblast growth factor signaling pathway has been associated with several neurodegenerative disorders and also with mental retardation."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-01-29T13:47:31Z"^^xsd:string ;
  obo:hasExactSynonym "altered intracrine FGF signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001177"^^xsd:string ;
  rdfs:label "altered intracrine fibroblast growth factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0001177"^^xsd:string .

ns1:PW_0001178
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000673, ns1:PW_0001172, ns1:PW_0001174 ;
  ns2:treeView ns1:PW_0000673, ns1:PW_0001172, ns1:PW_0001174 ;
  ns1:IAO_0000115 "Deregulation of the paracrine fibroblast growth factor signaling pathway has been associated with several congenital disorders."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-01-29T13:58:04Z"^^xsd:string ;
  obo:hasExactSynonym "altered paracrine FGF signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered canonical fibroblast growth factor signaling pathway"^^xsd:string ;
  obo:id "PW:0001178"^^xsd:string ;
  rdfs:label "altered paracrine fibroblast growth factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0001178"^^xsd:string .

ns1:PW_0001179
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001175, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001182
  ] ;
  ns2:treeView ns1:PW_0001175, ns1:PW_0001182 ;
  ns3:part_of ns1:PW_0001182 ;
  ns1:IAO_0000115 "Fibroblast growth factor 23 signaling, a member of the endocrine subfamily of fibroblast growth factor family plays important roles in phosphate homeostasis. It is also important in vitamin D metabolism. The pathway is also referred to as the FGF23-Klotho axis, Klotho representing the obligatory co-receptor family for this subfamily with low affinity for the FGF receptors."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-02-04T09:00:06Z"^^xsd:string ;
  obo:hasExactSynonym "FGF23 signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "FGF23/Klotho axis"^^xsd:string ;
  obo:id "PW:0001179"^^xsd:string ;
  rdfs:label "fibroblast growth factor 23 signaling pathway"^^xsd:string ;
  skos:notation "PW:0001179"^^xsd:string .

ns1:PW_0001180
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467 ;
  ns2:treeView ns1:PW_0000467 ;
  ns1:IAO_0000115 "The parathyroid hormone family consists of parathyroid hormone and parathyroid hormone-like hormone that employ the same parathyroid hormone receptor type 1, a G-protein coupled receptor (GPCR) of family B of GPCRs. Despite signaling through the same receptor, the two hormones elicit distinct functions. Receptor type 2 has been considered an orphan receptor, but a specific ligand has been identified, a 39 residues peptide with weaker amino acid sequence similarity to the two hormones."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-02-04T09:25:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001180"^^xsd:string ;
  rdfs:label "parathyroid hormone family signaling pathway"^^xsd:string ;
  skos:notation "PW:0001180"^^xsd:string .

ns1:PW_0001181
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001176, ns1:PW_0001179 ;
  ns2:treeView ns1:PW_0001176, ns1:PW_0001179 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-02-04T09:48:12Z"^^xsd:string ;
  obo:hasExactSynonym "altered FGF23 signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered FGF23/Klotho axis"^^xsd:string ;
  obo:id "PW:0001181"^^xsd:string ;
  rdfs:label "altered fibroblast growth factor 23 signaling pathway"^^xsd:string ;
  skos:notation "PW:0001181"^^xsd:string .

ns1:PW_0001182
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001692 ;
  ns2:treeView ns1:PW_0001692 ;
  ns1:IAO_0000115 "Phosphate is an essential element with many important roles in biology, from skeletal development and integrity to metabolism and cellular signaling. The greatest amount of phosphate is found in bone and teeth. The major regulator of phosphate homeostasis is  the kidney. Maintenance of proper phosphate levels is assured by an interplay of transport and signaling pathways. Sodium phosphate co-transporters, primarily type 2 and 3 and parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) signaling are essential components."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-02-04T10:04:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001182"^^xsd:string ;
  rdfs:label "phosphate homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0001182"^^xsd:string .

ns1:PW_0001183
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000103, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001182
  ] ;
  ns2:treeView ns1:PW_0000103, ns1:PW_0001182 ;
  ns3:part_of ns1:PW_0001182 ;
  ns1:IAO_0000115 "The pathway that assures the proper transport of phosphate in the body. Kidney plays a major role in the filtration and reabsorption of phosphate while the bone is a principal form of storage. Several types of sodium phosphate cotransporters are involved; the role of type 2 and 3 has been established. Renal phosphate transport is under the control of parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) signaling."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-02-04T10:05:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001183"^^xsd:string ;
  rdfs:label "phosphate transport pathway"^^xsd:string ;
  skos:notation "PW:0001183"^^xsd:string .

ns1:PW_0001184
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001182 ;
  ns2:treeView ns1:PW_0001182 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-02-04T10:06:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001184"^^xsd:string ;
  rdfs:label "altered phosphate homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0001184"^^xsd:string .

ns1:PW_0001185
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000316 ;
  ns2:treeView ns1:PW_0000316 ;
  ns1:IAO_0000115 "Calcium/calmodulin dependent kinase 2 (CAMK2) signaling plays important roles in excitation-contraction coupling in the heart and long-term potentiation (LPT) and memory in the brain."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-02-11T11:37:17Z"^^xsd:string ;
  obo:hasExactSynonym "CAMKII signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "CAMK2 signaling pathway"^^xsd:string ;
  obo:id "PW:0001185"^^xsd:string ;
  rdfs:label "calcium/calmodulin dependent kinase 2 signaling pathway"^^xsd:string ;
  skos:notation "PW:0001185"^^xsd:string .

ns1:PW_0001186
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000316 ;
  ns2:treeView ns1:PW_0000316 ;
  ns1:IAO_0000115 "The calcium/calmodulin dependent kinase signaling cascade require an upstream CAMK kinase (CAMKK) for activating phosphorylation."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-02-11T11:50:56Z"^^xsd:string ;
  obo:hasExactSynonym "CAMK signaling cascade"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001186"^^xsd:string ;
  rdfs:label "calcium/calmodulin dependent kinase signaling cascade"^^xsd:string ;
  skos:notation "PW:0001186"^^xsd:string .

ns1:PW_0001187
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001186 ;
  ns2:treeView ns1:PW_0001186 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-02-11T11:55:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001187"^^xsd:string ;
  rdfs:label "calcium/calmodulin dependent kinase 1 signaling pathway"^^xsd:string ;
  skos:notation "PW:0001187"^^xsd:string .

ns1:PW_0001188
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001186 ;
  ns2:treeView ns1:PW_0001186 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-02-11T11:55:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001188"^^xsd:string ;
  rdfs:label "calcium/calmodulin dependent kinase 4 signaling pathway"^^xsd:string ;
  skos:notation "PW:0001188"^^xsd:string .

ns1:PW_0001189
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000140, ns1:PW_0000429 ;
  ns2:treeView ns1:PW_0000140, ns1:PW_0000429 ;
  ns1:IAO_0000115 "A folate metabolic pathway that deviates from what its normal course should be. Impairment of folate cycle and/or folate mediated one-carbon pathways is associated with an increased risk for several conditions and developmental anomalies."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-03-11T11:53:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001189"^^xsd:string ;
  rdfs:label "altered folate metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001189"^^xsd:string .

ns1:PW_0001190
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000403, ns1:PW_0001074 ;
  ns2:treeView ns1:PW_0000403, ns1:PW_0001074 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-03-11T13:58:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001190"^^xsd:string ;
  rdfs:label "altered hydrophobic amino acid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001190"^^xsd:string .

ns1:PW_0001191
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000048, ns1:PW_0001190 ;
  ns2:treeView ns1:PW_0000048, ns1:PW_0001190 ;
  ns1:IAO_0000115 "A methionine cycle/metabolic pathway that deviates from what its normal course should be. Impaired methionine metabolism and/or altered levels of S-adenosylmethionine (AdoMet) have been associated with hepatocellular carcinoma and alcoholic liver disease."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-03-11T13:59:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001191"^^xsd:string ;
  rdfs:label "altered methionine cycle/metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001191"^^xsd:string .

ns1:PW_0001192
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000398, ns1:PW_0000402 ;
  ns2:treeView ns1:PW_0000398, ns1:PW_0000402 ;
  ns1:IAO_0000115 "A homocysteine metabolic pathway that deviates from what its normal course should be. Enzyme and/or vitamin deficiencies or defects in folate metabolism can give rise to the abnormal levels of homocysteine in homocysteinuria or  hyperhomocystenemia and the consequences related to them."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-03-12T10:18:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001192"^^xsd:string ;
  rdfs:label "altered homocysteine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001192"^^xsd:string .

ns1:PW_0001193
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000003 ;
  ns2:treeView ns1:PW_0000003 ;
  ns1:IAO_0000115 "Kinases are essential components of biological pathways. Phosphorylaton by protein kinases and dephosphorylation by protein phosphatases exert major regulatory roles. In addition, they can also initiate intracellular signaling cascades. Kinases represent a significant fraction of eukaryotic genes and prominent amongst them are the serine/threonine kinases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-03-12T10:32:24Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001193"^^xsd:string ;
  rdfs:label "kinase mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0001193"^^xsd:string .

ns1:PW_0001194
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001193 ;
  ns2:treeView ns1:PW_0001193 ;
  ns1:IAO_0000115 "Serine/threonine-specific kinase mediated signaling include essential intracellular pathways such as those involving the mitogen-activated (MAPK), Akt (also known as Pkb), protein kinase A and protein kinase C, to name a few. Serine/threonine-specific kinases represent the largest class."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-03-12T10:37:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001194"^^xsd:string ;
  rdfs:label "serine/threonine-specific kinase mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0001194"^^xsd:string .

ns1:PW_0001195
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001193 ;
  ns2:treeView ns1:PW_0001193 ;
  ns1:IAO_0000115 "The non-receptor tyrosine-specific kinases are represented by members of Src, Jak, Syk  and other families. Some, such as Jak, function as initiators of  intracellular pathways, others are components of several pathways. Tyrosine-specific kinases are also represented by receptor tyrosine kinases activated by growth factors and hormones.  These kinases are components of the pathways the specific growth factors and hormones initiate."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-03-12T10:37:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001195"^^xsd:string ;
  rdfs:label "tyrosine-specific protein kinase mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0001195"^^xsd:string .

ns1:PW_0001196
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000264, ns1:PW_0000652 ;
  ns2:treeView ns1:PW_0000264, ns1:PW_0000652 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-03-12T11:55:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001196"^^xsd:string ;
  rdfs:label "altered phosphatase mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0001196"^^xsd:string .

ns1:PW_0001197
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000653, ns1:PW_0001196 ;
  ns2:treeView ns1:PW_0000653, ns1:PW_0001196 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-03-12T11:56:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001197"^^xsd:string ;
  rdfs:label "altered serine/threonine-specific phosphatase mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0001197"^^xsd:string .

ns1:PW_0001198
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000264, ns1:PW_0001193 ;
  ns2:treeView ns1:PW_0000264, ns1:PW_0001193 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-03-12T12:09:21Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001198"^^xsd:string ;
  rdfs:label "altered kinase mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0001198"^^xsd:string .

ns1:PW_0001199
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001194, ns1:PW_0001198 ;
  ns2:treeView ns1:PW_0001194, ns1:PW_0001198 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-03-12T12:10:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001199"^^xsd:string ;
  rdfs:label "altered serine/threonine-specific kinase mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0001199"^^xsd:string .

ns1:PW_0001200
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467 ;
  ns2:treeView ns1:PW_0000467 ;
  ns1:IAO_0000115 "Thyroid-stimulating hormone (TSH) signaling stimulates the secretion of thyroid hormone. Its own secretion is dependent upon activation of thyrotropin-releasing hormone (TRH) in the hypothalamus by low levels of thyroid hormone (TH). TRH, TSH and TH signaling pathways are part of the hypothalamic-pituitary-thyroid (HPT) axis for which TH itself provides a negative regulatory loop."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-03-26T10:29:31Z"^^xsd:string ;
  obo:hasExactSynonym "TSH signaling pathway"^^xsd:string, "thyrotropin signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001200"^^xsd:string ;
  rdfs:label "thyroid-stimulating hormone signaling pathway"^^xsd:string ;
  skos:notation "PW:0001200"^^xsd:string .

ns1:PW_0001201
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467 ;
  ns2:treeView ns1:PW_0000467 ;
  ns1:IAO_0000115 "Thyrotropin-releasing hormone (TRH or TRF) signaling stimulates the production of thyroid-stimulating hormone (TSH) from the pituitary, which in turn stimulates the thyroid to produce thyroid hormone (TH). TRH, TSH and TH signaling pathways are part of the hypothalamic-pituitary-thyroid (HPT) axis for which TH itself provides a negative regulatory loop."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-03-26T10:47:07Z"^^xsd:string ;
  obo:hasExactSynonym "TRH signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "TRF signaling pathway"^^xsd:string, "thyrotropin-releasing factor signaling pathway"^^xsd:string ;
  obo:id "PW:0001201"^^xsd:string ;
  rdfs:label "thyrotropin-releasing hormone signaling pathway"^^xsd:string ;
  skos:notation "PW:0001201"^^xsd:string .

ns1:PW_0001202
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000754 ;
  ns2:treeView ns1:PW_0000754 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of compounds used for the treatment of genito-urinary system conditions or as sex hormones derivatives and analogs. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-03-26T11:29:09Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001202"^^xsd:string ;
  rdfs:label "genito-urinary system and sex hormones drug pathway"^^xsd:string ;
  skos:notation "PW:0001202"^^xsd:string .

ns1:PW_0001203
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000754 ;
  ns2:treeView ns1:PW_0000754 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of hormonal preparations that may contain natural hormones or are synthetic hormonal analogs and their derivatives. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-03-26T12:01:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001203"^^xsd:string ;
  rdfs:label "systemic hormones drug pathway"^^xsd:string ;
  skos:notation "PW:0001203"^^xsd:string .

ns1:PW_0001204
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001203 ;
  ns2:treeView ns1:PW_0001203 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of thyroid hormone analogs, many of which have tissue specific thyroid hormone action."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-03-26T12:24:40Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001204"^^xsd:string ;
  rdfs:label "thyromimetics drug pathway"^^xsd:string ;
  skos:notation "PW:0001204"^^xsd:string .

ns1:PW_0001205
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001204 ;
  ns2:treeView ns1:PW_0001204 ;
  ns1:IAO_0000115 "Sobetirome, also known as GC-1, is a one of the best characterized thyromimetics with high affinity for the beta thyroid receptor. It has been shown to reduce LDL cholesterol in animal model studies."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-03-26T12:31:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001205"^^xsd:string ;
  rdfs:label "sobetirome drug pathway"^^xsd:string ;
  skos:notation "PW:0001205"^^xsd:string .

ns1:PW_0001206
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001204 ;
  ns2:treeView ns1:PW_0001204 ;
  ns1:IAO_0000115 "Eprotirome is a thyromimetics that in addition for being selective for the beta tyrosine receptor is also highly liver-selective with minimal uptake in non-hepatic tissues. In overweight and hypercholesterolemic patients, its administration lead to lowering of total and LDL-cholesterol while stimulating bile acid biosynthesis."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-03-26T12:36:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001206"^^xsd:string ;
  rdfs:label "eprotirome drug pathway"^^xsd:string ;
  skos:notation "PW:0001206"^^xsd:string .

ns1:PW_0001207
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000140
  ] ;
  ns2:treeView ns1:PW_0000140 ;
  ns3:part_of ns1:PW_0000140 ;
  ns1:IAO_0000115 "The folate cycle metabolic pathway sums up the uptake and transport of folates, the processing and interconversion reactions of folate compounds. The folate cycle and the folate mediate one-carbon transfer pathways are part of folate metabolism."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-04-02T09:58:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001207"^^xsd:string ;
  rdfs:label "folate cycle metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001207"^^xsd:string .

ns1:PW_0001208
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001189, ns1:PW_0001207 ;
  ns2:treeView ns1:PW_0001189, ns1:PW_0001207 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-04-02T10:06:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001208"^^xsd:string ;
  rdfs:label "altered folate cycle metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001208"^^xsd:string .

ns1:PW_0001209
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000189, ns1:PW_0001189 ;
  ns2:treeView ns1:PW_0000189, ns1:PW_0001189 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-04-02T10:07:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001209"^^xsd:string ;
  rdfs:label "altered folate mediated one-carbon metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001209"^^xsd:string .

ns1:PW_0001210
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of plevitrexed, a non-polyglutamatable antifolate quinazoline derivative and thymidylate synthase inhibitor used in the treatment of cancers. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-04-05T09:15:35Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001210"^^xsd:string ;
  rdfs:label "plevitrexed drug pathway"^^xsd:string ;
  skos:notation "PW:0001210"^^xsd:string .

ns1:PW_0001211
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001210 ;
  ns2:treeView ns1:PW_0001210 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of plevitrexed, an antifolate used in the treatment of cancer. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-04-05T09:18:45Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001211"^^xsd:string ;
  rdfs:label "plevitrexed pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001211"^^xsd:string .

ns1:PW_0001212
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001210 ;
  ns2:treeView ns1:PW_0001210 ;
  ns1:IAO_0000115 "The pathway of plevitrexed-target interactions and of the biochemical or physiological responses to drug. The drug is an antifolate that targets thymidylate synthase and is used in the treatment of several cancers. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-04-05T09:19:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001212"^^xsd:string ;
  rdfs:label "plevitrexed pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001212"^^xsd:string .

ns1:PW_0001213
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of permetrexed, an antifolate originally designed as a thymidylate synthase inhibitor but which also has inhibitory effects on other enzymes involved in the folate cycle and/or folate mediated one-carbon transfer reactions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-04-05T09:21:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Alimta drug pathway"^^xsd:string ;
  obo:id "PW:0001213"^^xsd:string ;
  rdfs:label "pemetrexed drug pathway"^^xsd:string ;
  skos:notation "PW:0001213"^^xsd:string .

ns1:PW_0001214
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001213 ;
  ns2:treeView ns1:PW_0001213 ;
  ns1:IAO_0000115 "The pathway of pemetrexed-target interactions and of the biochemical or physiological responses to drug. The drug is an antifolate that targets thymidylate synthase and other enzymes of the folate cycle and folate mediated one-carbon transfer reactions and is used in the treatment of several cancers. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-04-05T09:27:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Alimta pharmacodynamics pathway"^^xsd:string ;
  obo:id "PW:0001214"^^xsd:string ;
  rdfs:label "pemetrexed pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001214"^^xsd:string .

ns1:PW_0001215
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001213 ;
  ns2:treeView ns1:PW_0001213 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of pemetrexed, an antifolate used in the treatment of cancer. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-04-05T09:27:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Alimta pharmacokinetics pathway"^^xsd:string ;
  obo:id "PW:0001215"^^xsd:string ;
  rdfs:label "pemetrexed pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001215"^^xsd:string .

ns1:PW_0001216
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of pralatrexate, a polyglutamatable antifolate used as an inhibitor of dihydrofolate reductase (DHFR) enzyme of folate cycle. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-04-05T09:34:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Folotyn drug pathway"^^xsd:string ;
  obo:id "PW:0001216"^^xsd:string ;
  rdfs:label "pralatrexate drug pathway"^^xsd:string ;
  skos:notation "PW:0001216"^^xsd:string .

ns1:PW_0001217
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001216 ;
  ns2:treeView ns1:PW_0001216 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of pralatrexed, an antifolate used in the treatment of cancer. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-04-05T09:38:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Folotyn pharmacokinetics pathway"^^xsd:string ;
  obo:id "PW:0001217"^^xsd:string ;
  rdfs:label "pralatrexate pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001217"^^xsd:string .

ns1:PW_0001218
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001216 ;
  ns2:treeView ns1:PW_0001216 ;
  ns1:IAO_0000115 "The pathway of pralatrexed-target interactions and of the biochemical or physiological responses to drug. The drug is an antifolate that targets dihydrofolate reductase (DHFR) and is used in the treatment of some cancers. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-04-05T09:39:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Folotyn pharmacodynamics pathway"^^xsd:string ;
  obo:id "PW:0001218"^^xsd:string ;
  rdfs:label "pralatrexate pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001218"^^xsd:string .

ns1:PW_0001219
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001221 ;
  ns2:treeView ns1:PW_0001221 ;
  ns1:IAO_0000115 "Hydrogen sulfide can act as a signaling molecule with roles in the heart, brain and smooth muscle."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-04-16T11:11:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "H2S signaling pathway"^^xsd:string ;
  obo:id "PW:0001219"^^xsd:string ;
  rdfs:label "hydrogen sulfide mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0001219"^^xsd:string .

ns1:PW_0001220
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000818, ns1:PW_0001221, ns1:PW_0001764 ;
  ns2:treeView ns1:PW_0000818, ns1:PW_0001221, ns1:PW_0001764 ;
  ns1:IAO_0000115 "Nitric oxide (NO) signaling, well known for its vasodilation effects, exerts multiple roles that include the immune and nervous system."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-04-16T11:14:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "NO mediated signaling pathway"^^xsd:string ;
  obo:id "PW:0001220"^^xsd:string ;
  rdfs:label "nitric oxide mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0001220"^^xsd:string .

ns1:PW_0001221
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000059, ns1:PW_0001162 ;
  ns2:treeView ns1:PW_0000059, ns1:PW_0001162 ;
  ns1:IAO_0000115 "Those signaling pathway elicited by gases such as carbon monoxide, nitric oxide or hydrogen sulfide."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-04-16T11:20:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001221"^^xsd:string ;
  rdfs:label "gasotransmitter mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0001221"^^xsd:string .

ns1:PW_0001222
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000647 ;
  ns2:treeView ns1:PW_0000647 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-02T09:37:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "FoxC signaling pathway"^^xsd:string ;
  obo:id "PW:0001222"^^xsd:string ;
  rdfs:label "forkhead class C signaling pathway"^^xsd:string ;
  skos:notation "PW:0001222"^^xsd:string .

ns1:PW_0001223
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000647 ;
  ns2:treeView ns1:PW_0000647 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-02T09:38:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "FoxP signaling pathway"^^xsd:string ;
  obo:id "PW:0001223"^^xsd:string ;
  rdfs:label "forkhead class P signaling pathway"^^xsd:string ;
  skos:notation "PW:0001223"^^xsd:string .

ns1:PW_0001224
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of irinotecan an inhibitor of DNA topoisomerase I used in the treatment of several types of cancer. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-03T10:54:39Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001224"^^xsd:string ;
  rdfs:label "irinotecan drug pathway"^^xsd:string ;
  skos:notation "PW:0001224"^^xsd:string .

ns1:PW_0001225
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001224 ;
  ns2:treeView ns1:PW_0001224 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of irinotecan, a drug used in the treatment of several types of cancer. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-03T10:58:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00600"^^xsd:string ;
  obo:id "PW:0001225"^^xsd:string ;
  rdfs:label "irinotecan pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001225"^^xsd:string .

ns1:PW_0001226
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001224 ;
  ns2:treeView ns1:PW_0001224 ;
  ns1:IAO_0000115 "The pathway of irinotecan-target interactions and of the biochemical or physiological responses to drug. Irinotecan is a DNA topoisomerase I inhibitor used in the treatment of several types of cancer. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-03T10:59:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00433"^^xsd:string ;
  obo:id "PW:0001226"^^xsd:string ;
  rdfs:label "irinotecan pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001226"^^xsd:string .

ns1:PW_0001227
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000168 ;
  ns2:treeView ns1:PW_0000168 ;
  ns1:IAO_0000115 "The Stem Cell Factor (SCF) signaling plays important roles in cell migration, proliferation and survival. SCF activates the KIT receptor tyrosine kinase which then prompts several intracellular signaling pathways. Deregulation of the pathway has been associated with several conditions including cancer."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-03T11:24:34Z"^^xsd:string ;
  obo:hasExactSynonym "SCF signaling pathway"^^xsd:string, "Steel factor signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001227"^^xsd:string ;
  rdfs:label "Stem Cell Factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0001227"^^xsd:string .

ns1:PW_0001228
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001789 ;
  ns2:treeView ns1:PW_0001789 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of drugs that target the angiotensin converting enzyme ACE. In the renin-angiotensin cascade, several bioactive peptides are derived from the precursor angiotensinogen. ACE converts angiotensin I to the potent angiotensin II. The various ACE inhibitors are grouped based on their molecular structure, the dicarboxylate-containing agents represent the largest group. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-03T11:54:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001228"^^xsd:string ;
  rdfs:label "ACE inhibitor drug pathway"^^xsd:string ;
  skos:notation "PW:0001228"^^xsd:string .

ns1:PW_0001229
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000002 ;
  ns2:treeView ns1:PW_0000002 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the uptake, modification and elimination of chemical compounds that are foreign to the biological system. This includes the biotransformation pathways organisms use to detoxify the system and the degradation of toxic pollutants by microorganisms. Many of the compounds that enter the cell are inactive and the transformation pathways aim to increase their hydrophilicity and ease the elimination.  In the process, some of the intermediates may give rise to toxic metabolites and effects. The transformation pathways are also important for the pharmacokinetics aspect of drug metabolism.  The distinction is that a drug is a foreign compound intentionally administered. In the case of the degradation pathway, microoganismal  enzymes have the ability to degrade otherwise resistant compounds."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-03T15:29:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001229"^^xsd:string ;
  rdfs:label "xenobiotic metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001229"^^xsd:string .

ns1:PW_0001230
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001228 ;
  ns2:treeView ns1:PW_0001228 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of ACE inhibitors. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-07T16:04:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001230"^^xsd:string ;
  rdfs:label "ACE inhibitor pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001230"^^xsd:string .

ns1:PW_0001231
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001228 ;
  ns2:treeView ns1:PW_0001228 ;
  ns1:IAO_0000115 "The pathway of ACE inhibitor-target interaction and of the biochemical or physiological responses to drug. The drugs are used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-07T16:05:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001231"^^xsd:string ;
  rdfs:label "ACE inhibitor pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001231"^^xsd:string .

ns1:PW_0001232
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001229 ;
  ns2:treeView ns1:PW_0001229 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-07T16:22:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001232"^^xsd:string ;
  rdfs:label "arylamine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001232"^^xsd:string .

ns1:PW_0001233
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001438 ;
  ns2:treeView ns1:PW_0001438 ;
  ns1:IAO_0000115 "Those metabolic reaction involved in handling this polycyclic aromatic hydrocarbon whose metabolites are mutagenic and carcinogenic."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-07T16:24:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001233"^^xsd:string ;
  rdfs:label "benzo(a)pyrene metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001233"^^xsd:string .

ns1:PW_0001234
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000211 ;
  ns2:treeView ns1:PW_0000211 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of biogenic amines."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T08:31:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001234"^^xsd:string ;
  rdfs:label "biogenic amine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001234"^^xsd:string .

ns1:PW_0001235
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000443, ns1:PW_0001234 ;
  ns2:treeView ns1:PW_0000443, ns1:PW_0001234 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of catecholamines. Epinephrine, norepinephrine and dopamine are among the most abundant and are produced primarily from the adrenal medulla and the postganglionic fibers of the sympathetic nervous system."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T08:33:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00012"^^xsd:string ;
  obo:id "PW:0001235"^^xsd:string ;
  rdfs:label "catecholamine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001235"^^xsd:string .

ns1:PW_0001236
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000051, ns1:PW_0000411, ns1:PW_0001238 ;
  ns2:treeView ns1:PW_0000051, ns1:PW_0000411, ns1:PW_0001238 ;
  ns1:IAO_0000115 "Histamine is derived from the amino acid histidine via a decarboxylation reaction carried out by the enzyme L-histidine decarboxylase."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T08:38:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001236"^^xsd:string ;
  rdfs:label "histamine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001236"^^xsd:string .

ns1:PW_0001237
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000410, ns1:PW_0001238 ;
  ns2:treeView ns1:PW_0000410, ns1:PW_0001238 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T08:38:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001237"^^xsd:string ;
  rdfs:label "serotonin biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001237"^^xsd:string .

ns1:PW_0001238
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000444, ns1:PW_0001234 ;
  ns2:treeView ns1:PW_0000444, ns1:PW_0001234 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T08:39:39Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001238"^^xsd:string ;
  rdfs:label "indoleamine and related compounds biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001238"^^xsd:string .

ns1:PW_0001239
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000485 ;
  ns2:treeView ns1:PW_0000485 ;
  ns1:IAO_0000115 "Those metabolic reaction involved in the synthesis of eicosanoids, molecules that play important roles in the immune and vascular systems. They are derived from either omega-3 or omega-6 fatty acids, with the route provided by the conversion of arachidonic acid, better known."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T09:54:38Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001239"^^xsd:string ;
  rdfs:label "eicosanoid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001239"^^xsd:string .

ns1:PW_0001240
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000485 ;
  ns2:treeView ns1:PW_0000485 ;
  ns1:IAO_0000115 "Prostanoids are a class of eicosanoids that contains the prostaglandins, the thromboxanes and prostacycline."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T10:04:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001240"^^xsd:string ;
  rdfs:label "prostanoid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001240"^^xsd:string .

ns1:PW_0001241
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001240 ;
  ns2:treeView ns1:PW_0001240 ;
  ns1:IAO_0000115 "Those metabolic reactions involving prostacycline - a family of prostanoid eicosanoids with important functions in the cardiovascular system."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T10:09:06Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001241"^^xsd:string ;
  rdfs:label "prostacyclin metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001241"^^xsd:string .

ns1:PW_0001242
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000464, ns1:PW_0001239 ;
  ns2:treeView ns1:PW_0000464, ns1:PW_0001239 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of leukotriene, a class of eicosanoids, molecules exerting important roles in the immune and vascular systems."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T10:16:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001242"^^xsd:string ;
  rdfs:label "leukotriene biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001242"^^xsd:string .

ns1:PW_0001243
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001239, ns1:PW_0001240 ;
  ns2:treeView ns1:PW_0001239, ns1:PW_0001240 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of prostanoids, a class of eicosanoids that includes several families and which exert important roles in the immune and vascular systems."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T10:18:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001243"^^xsd:string ;
  rdfs:label "prostanoid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001243"^^xsd:string .

ns1:PW_0001244
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002443 ;
  ns2:treeView ns1:PW_0002443 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of codeine and morphine, a class of drugs in the opiate family used as pain relievers. Both are naturally found in the poppy plant with codeine derived from the more abundant morphine, as methylated morphine. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T10:38:09Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001244"^^xsd:string ;
  rdfs:label "codeine and morphine drug pathway"^^xsd:string ;
  skos:notation "PW:0001244"^^xsd:string .

ns1:PW_0001245
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001244 ;
  ns2:treeView ns1:PW_0001244 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of codeine and morphine, a class of drug opiates used as pain relievers. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T10:42:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00621"^^xsd:string, "SMP:00622"^^xsd:string ;
  obo:id "PW:0001245"^^xsd:string ;
  rdfs:label "codeine and morphine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001245"^^xsd:string .

ns1:PW_0001246
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001244 ;
  ns2:treeView ns1:PW_0001244 ;
  ns1:IAO_0000115 "The pathway of codeine/morphine-target interaction and of the biochemical or physiological responses to drug. The drugs are potential ligands for the mu-opioid receptor, a class of opioid receptor. Opioid receptors are G-protein coupled receptors (GPCR) activated by endogenous and also exogenous opioids. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T10:42:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00405"^^xsd:string, "SMP:00406"^^xsd:string ;
  obo:id "PW:0001246"^^xsd:string ;
  rdfs:label "codeine and morphine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001246"^^xsd:string .

ns1:PW_0001247
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001894 ;
  ns2:treeView ns1:PW_0001894 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of nifedipine, a calcium channel blocker used primarily in the treatment of hypertension and angina. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T11:07:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Adalat CC drug pathway"^^xsd:string, "Procardia drug pathway"^^xsd:string ;
  obo:id "PW:0001247"^^xsd:string ;
  rdfs:label "nifedipine drug pathway"^^xsd:string ;
  skos:notation "PW:0001247"^^xsd:string .

ns1:PW_0001248
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001247 ;
  ns2:treeView ns1:PW_0001247 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of nifedipine. The drug is a calcium channel blocker used in the treatment of hypertension and angina.  Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T11:17:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001248"^^xsd:string ;
  rdfs:label "nifedipine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001248"^^xsd:string .

ns1:PW_0001249
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001247 ;
  ns2:treeView ns1:PW_0001247 ;
  ns1:IAO_0000115 "The pathway of nifedipine-target interaction and of the biochemical or physiological responses to drug. The drug is a calcium channel blocker, particularly the L-type channel.  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T11:18:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00379"^^xsd:string ;
  obo:id "PW:0001249"^^xsd:string ;
  rdfs:label "nifedipine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001249"^^xsd:string .

ns1:PW_0001250
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000103, ns1:PW_0001251 ;
  ns2:treeView ns1:PW_0000103, ns1:PW_0001251 ;
  ns1:IAO_0000115 "The pathway responsible for the transport of monoamines, biogenic amines representing various neurotransmitters. The reuptake of neurotransmitters following their release is a key element determining the duration and intensity of their signaling and is thus essential for the proper functioning of the nervous system."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T11:50:06Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "biogenic amine neurotransmitter transport pathway"^^xsd:string ;
  obo:id "PW:0001250"^^xsd:string ;
  rdfs:label "monoamine transport pathway"^^xsd:string ;
  skos:notation "PW:0001250"^^xsd:string .

ns1:PW_0001251
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000004 ;
  ns2:treeView ns1:PW_0000004 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T12:07:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001251"^^xsd:string ;
  rdfs:label "regulatory pathway pertinent to the brain"^^xsd:string ;
  skos:notation "PW:0001251"^^xsd:string .

ns1:PW_0001252
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000467 ;
  ns2:treeView ns1:PW_0000467 ;
  ns1:IAO_0000115 "Prolactin signaling pathway is important for normal reproduction. Prolactin is a peptide hormone whose signaling activates several intracellular cascades."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T12:14:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001252"^^xsd:string ;
  rdfs:label "prolactin signaling pathway"^^xsd:string ;
  skos:notation "PW:0001252"^^xsd:string .

ns1:PW_0001253
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000642 ;
  ns2:treeView ns1:PW_0000642 ;
  ns1:IAO_0000115 "The omega degradation pathway is an alternative route to the common beta degradation pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T12:38:21Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "fatty acid omega oxidation pathway"^^xsd:string ;
  obo:id "PW:0001253"^^xsd:string ;
  rdfs:label "fatty acid omega degradation pathway"^^xsd:string ;
  skos:notation "PW:0001253"^^xsd:string .

ns1:PW_0001254
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000011 ;
  ns2:treeView ns1:PW_0000011 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T12:55:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001254"^^xsd:string ;
  rdfs:label "amino acid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001254"^^xsd:string .

ns1:PW_0001255
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001075, ns1:PW_0001254 ;
  ns2:treeView ns1:PW_0001075, ns1:PW_0001254 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T12:55:35Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001255"^^xsd:string ;
  rdfs:label "hydrophilic amino acid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001255"^^xsd:string .

ns1:PW_0001256
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001074, ns1:PW_0001254 ;
  ns2:treeView ns1:PW_0001074, ns1:PW_0001254 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T12:55:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001256"^^xsd:string ;
  rdfs:label "hydrophobic amino acid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001256"^^xsd:string .

ns1:PW_0001257
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000011 ;
  ns2:treeView ns1:PW_0000011 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T12:56:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001257"^^xsd:string ;
  rdfs:label "amino acid degradation pathway"^^xsd:string ;
  skos:notation "PW:0001257"^^xsd:string .

ns1:PW_0001258
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001074, ns1:PW_0001257 ;
  ns2:treeView ns1:PW_0001074, ns1:PW_0001257 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T12:56:41Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001258"^^xsd:string ;
  rdfs:label "hydrophobic amino acid degradation pathway"^^xsd:string ;
  skos:notation "PW:0001258"^^xsd:string .

ns1:PW_0001259
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001075, ns1:PW_0001257 ;
  ns2:treeView ns1:PW_0001075, ns1:PW_0001257 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T12:57:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001259"^^xsd:string ;
  rdfs:label "hydrophilic amino acid degradation pathway"^^xsd:string ;
  skos:notation "PW:0001259"^^xsd:string .

ns1:PW_0001260
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001082, ns1:PW_0001255 ;
  ns2:treeView ns1:PW_0001082, ns1:PW_0001255 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of arginine. Although primarily a non-essential amino acid, its synthesis from citrulline may be insufficient and it is also energetically costly. Diet derived arginine can circumvent these aspects."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T13:06:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001260"^^xsd:string ;
  rdfs:label "arginine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001260"^^xsd:string .

ns1:PW_0001261
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001082, ns1:PW_0001259 ;
  ns2:treeView ns1:PW_0001082, ns1:PW_0001259 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the degradation of arginine. Higher organisms do not possess the enzymes involved in this catabolic pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T13:21:38Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001261"^^xsd:string ;
  rdfs:label "arginine degradation pathway"^^xsd:string ;
  skos:notation "PW:0001261"^^xsd:string .

ns1:PW_0001262
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000027, ns1:PW_0001255 ;
  ns2:treeView ns1:PW_0000027, ns1:PW_0001255 ;
  ns1:IAO_0000115 "Those metabolic reaction involved in the biosynthesis of glutamic acid/glutamate. Glutamate is the main excitatory neurotransmitter."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T13:30:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001262"^^xsd:string ;
  rdfs:label "glutamic acid/glutamate biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001262"^^xsd:string .

ns1:PW_0001263
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000027, ns1:PW_0001259 ;
  ns2:treeView ns1:PW_0000027, ns1:PW_0001259 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the degradation of glutamic acid/glutamate. There are several routes of glutamic acid/glutamate degradation. Some are found only in microorganisms and plants; others can be found in mammalian cells."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T13:46:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001263"^^xsd:string ;
  rdfs:label "glutamic acid/glutamate degradation pathway"^^xsd:string ;
  skos:notation "PW:0001263"^^xsd:string .

ns1:PW_0001264
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000440, ns1:PW_0001256 ;
  ns2:treeView ns1:PW_0000440, ns1:PW_0001256 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of glycine, a major inhibitory neurotransmitter."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T13:51:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001264"^^xsd:string ;
  rdfs:label "glycine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001264"^^xsd:string .

ns1:PW_0001265
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000440, ns1:PW_0001258 ;
  ns2:treeView ns1:PW_0000440, ns1:PW_0001258 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the degradation of glycine. Several routes are available of which the glycine cleavage system is the predominant one. It occurs in the mitochondria and produces 5,10-methylene tetrahydrofolate and as such, is an important component of folate cycle pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T13:54:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001265"^^xsd:string ;
  rdfs:label "glycine degradation pathway"^^xsd:string ;
  skos:notation "PW:0001265"^^xsd:string .

ns1:PW_0001266
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000051 ;
  ns2:treeView ns1:PW_0000051 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of histidine, an essential amino acid for humans. The biosynthesis of histidine has been extensively studied in E. coli and S. typhimurium."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T14:06:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001266"^^xsd:string ;
  rdfs:label "histidine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001266"^^xsd:string .

ns1:PW_0001267
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000051, ns1:PW_0001259 ;
  ns2:treeView ns1:PW_0000051, ns1:PW_0001259 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the degradation of histidine. The histidine degradation provides a source of nitrogen and is carried out in microorganisms."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T14:13:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001267"^^xsd:string ;
  rdfs:label "histidine degradation pathway"^^xsd:string ;
  skos:notation "PW:0001267"^^xsd:string .

ns1:PW_0001268
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001087, ns1:PW_0001256 ;
  ns2:treeView ns1:PW_0001087, ns1:PW_0001256 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of isoleucine, an essential amino acid for humans. Its synthesis in plants and microorganisms proceeds via several steps."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T14:24:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001268"^^xsd:string ;
  rdfs:label "isoleucine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001268"^^xsd:string .

ns1:PW_0001269
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001087, ns1:PW_0001258 ;
  ns2:treeView ns1:PW_0001087, ns1:PW_0001258 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the degradation of isoleucine."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T14:37:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001269"^^xsd:string ;
  rdfs:label "isoleucine degradation pathway"^^xsd:string ;
  skos:notation "PW:0001269"^^xsd:string .

ns1:PW_0001270
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001088, ns1:PW_0001256 ;
  ns2:treeView ns1:PW_0001088, ns1:PW_0001256 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the biosynthesis of leucine, an essential amino acid for humans. In plants and microorganisms its synthesis proceeds via a number of steps."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T14:40:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001270"^^xsd:string ;
  rdfs:label "leucine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001270"^^xsd:string .

ns1:PW_0001271
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001088, ns1:PW_0001258 ;
  ns2:treeView ns1:PW_0001088, ns1:PW_0001258 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the degradation of leucine."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-08T14:44:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001271"^^xsd:string ;
  rdfs:label "leucine degradation pathway"^^xsd:string ;
  skos:notation "PW:0001271"^^xsd:string .

ns1:PW_0001272
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000100 ;
  ns2:treeView ns1:PW_0000100 ;
  ns1:IAO_0000115 "The pathway of DNA transcription carried out by the prokaryotic and the several eukaryotic polymerases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-13T08:54:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001272"^^xsd:string ;
  rdfs:label "RNA polymerase transcription pathway"^^xsd:string ;
  skos:notation "PW:0001272"^^xsd:string .

ns1:PW_0001273
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001272 ;
  ns2:treeView ns1:PW_0001272 ;
  ns1:IAO_0000115 "The pathway of DNA transcription in prokaryotic organisms is carried out by a single polymerase. Five subunits constitute the core enzyme."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-13T08:58:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001273"^^xsd:string ;
  rdfs:label "prokaryotic RNA polymerase transcription pathway"^^xsd:string ;
  skos:notation "PW:0001273"^^xsd:string .

ns1:PW_0001274
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000127
  ] ;
  ns2:treeView ns1:PW_0000127 ;
  ns3:part_of ns1:PW_0000127 ;
  ns1:IAO_0000115 "RNA polymerase II and a set of general and specific transcription factors assemble as a large pre-initiation complex which undergoes a series of transformations before transcription proceeds. Promoter recognition and subsequent initiation of transcription are dependent upon the presence of these transcription factors. Activators and repressors impact upon transcription at these early stages."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-13T09:10:45Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001274"^^xsd:string ;
  rdfs:label "RNA polymerase II transcription initiation pathway"^^xsd:string ;
  skos:notation "PW:0001274"^^xsd:string .

ns1:PW_0001275
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001272 ;
  ns2:treeView ns1:PW_0001272 ;
  ns1:IAO_0000115 "The pathway of DNA transcription carried out by the eukaryotic polymerases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-13T09:13:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001275"^^xsd:string ;
  rdfs:label "eukaryotic RNA polymerase transcription pathway"^^xsd:string ;
  skos:notation "PW:0001275"^^xsd:string .

ns1:PW_0001276
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000219 ;
  ns2:treeView ns1:PW_0000219 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the de novo synthesis of nicotinamide adenine dinucleotide (NAD), downstream of kynurenine metabolism of tryptophan degradation."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-13T09:35:26Z"^^xsd:string ;
  obo:hasExactSynonym "de novo NAD biosynthetic pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001276"^^xsd:string ;
  rdfs:label "de novo nicotinamide adenine dinucleotide biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001276"^^xsd:string .

ns1:PW_0001277
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000134 ;
  ns2:treeView ns1:PW_0000134 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of glutathione. Glutathione is a tripeptide that exerts important functions as an antioxidant and in the conjugation of xenobiotics and drugs by phase II biotransformation enzymes."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-13T09:49:41Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001277"^^xsd:string ;
  rdfs:label "glutathione biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001277"^^xsd:string .

ns1:PW_0001278
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001085 ;
  ns2:treeView ns1:PW_0001085 ;
  ns1:IAO_0000115 "Those metabolic reaction involved in the synthesis of threonine. Threonine is an essential amino acid that human cannot synthesize. Its synthesis takes place in plants and microorganisms."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-13T10:35:40Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001278"^^xsd:string ;
  rdfs:label "threonine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001278"^^xsd:string .

ns1:PW_0001279
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001085 ;
  ns2:treeView ns1:PW_0001085 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the degradation of threonine, an essential amino acid for humans. There are several routes for the degradation of  threonine."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-13T10:48:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001279"^^xsd:string ;
  rdfs:label "threonine degradation pathway"^^xsd:string ;
  skos:notation "PW:0001279"^^xsd:string .

ns1:PW_0001280
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000054, ns1:PW_0001256, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001370
  ] ;
  ns2:treeView ns1:PW_0000054, ns1:PW_0001256, ns1:PW_0001370 ;
  ns3:part_of ns1:PW_0001370 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of tryptophan, an essential amino acid that human cannot synthesize. Its synthesis takes place in plants and microorganisms. In plants, the synthesis of aromatic amino acids is part of chorismate pathway, the end branch point of shikimate pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-13T11:10:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001280"^^xsd:string ;
  rdfs:label "tryptophan biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001280"^^xsd:string .

ns1:PW_0001281
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000054, ns1:PW_0001258 ;
  ns2:treeView ns1:PW_0000054, ns1:PW_0001258 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the degradation of tryptophan, an essential amino acid.  Tryptophan undergoes oxidative catabolism carried out by several hemeprotein enzymes. In plants, tyrosine is the precursor for several secondary metabolites."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-13T11:18:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001281"^^xsd:string ;
  rdfs:label "tryptophan degradation pathway"^^xsd:string ;
  skos:notation "PW:0001281"^^xsd:string .

ns1:PW_0001282
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001281 ;
  ns2:treeView ns1:PW_0001281 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the production of kynurenine, a product of tryptophan degradation pathway. Kynurenine and its metabolites play important roles in the nervous system and also in immunity."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-13T11:34:39Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001282"^^xsd:string ;
  rdfs:label "kynurenine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001282"^^xsd:string .

ns1:PW_0001283
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000052, ns1:PW_0001256, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001370
  ] ;
  ns2:treeView ns1:PW_0000052, ns1:PW_0001256, ns1:PW_0001370 ;
  ns3:part_of ns1:PW_0001370 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of tyrosine. In mammals, is derived from phenylalanine or from diet. In plants, is produced as part of chorismate pathway, the end branch point of shikimate pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-13T11:48:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001283"^^xsd:string ;
  rdfs:label "tyrosine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001283"^^xsd:string .

ns1:PW_0001284
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000052, ns1:PW_0001258 ;
  ns2:treeView ns1:PW_0000052, ns1:PW_0001258 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the degradation and/or conversion of tyrosine, a non- essential amino acid. Tyrosine is the precursor of several neurotransmitters and hormones. Tyrosine can also be degraded to acetoacetate and fumarate. In plants, tyrosine is the precursor of several families of secondary metabolites."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-13T12:01:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001284"^^xsd:string ;
  rdfs:label "tyrosine degradation pathway"^^xsd:string ;
  skos:notation "PW:0001284"^^xsd:string .

ns1:PW_0001285
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001080, ns1:PW_0001256 ;
  ns2:treeView ns1:PW_0001080, ns1:PW_0001256 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of valine, an essential amino acid for humans. Plants synthesize valine from pyruvic acid via a number of steps."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-13T12:36:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001285"^^xsd:string ;
  rdfs:label "valine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001285"^^xsd:string .

ns1:PW_0001286
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001080, ns1:PW_0001258 ;
  ns2:treeView ns1:PW_0001080, ns1:PW_0001258 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-13T12:40:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001286"^^xsd:string ;
  rdfs:label "valine degradation pathway"^^xsd:string ;
  skos:notation "PW:0001286"^^xsd:string .

ns1:PW_0001287
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000053, ns1:PW_0001256, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001370
  ] ;
  ns2:treeView ns1:PW_0000053, ns1:PW_0001256, ns1:PW_0001370 ;
  ns3:part_of ns1:PW_0001370 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of phenylalanine, an essential amino acid for humans. In plants, the synthesis of aromatic amino acids is part of chorismate pathway, the end branch point of shikimate pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-13T12:42:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001287"^^xsd:string ;
  rdfs:label "phenylalanine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001287"^^xsd:string .

ns1:PW_0001288
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000053, ns1:PW_0001258 ;
  ns2:treeView ns1:PW_0000053, ns1:PW_0001258 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the degradation and/or conversion of phenylalanine. Phenylalanine is the precursor of tyrosine, in turn a precursor for a number of neurotransmitters and hormones. In plants, phenylalanine serve as a precursor for a large number of functional secondary metabolites."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-13T12:42:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001288"^^xsd:string ;
  rdfs:label "phenylalanine degradation pathway"^^xsd:string ;
  skos:notation "PW:0001288"^^xsd:string .

ns1:PW_0001289
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005 ;
  ns2:treeView ns1:PW_0000005 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of carotene collectively referring to several related unsaturated hydrocarbon compounds that are synthesized by plants. Some are vitamin precursors, such as the beta-carotene precursor of vitamin A."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-13T12:52:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001289"^^xsd:string ;
  rdfs:label "carotene metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001289"^^xsd:string .

ns1:PW_0001290
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001289 ;
  ns2:treeView ns1:PW_0001289 ;
  ns1:IAO_0000115 "Those metabolic reactions involved ion the synthesis, utilization and/or degradation of lycopene - a carotene and phytochemical found in red fruits and vegetables."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-13T13:00:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001290"^^xsd:string ;
  rdfs:label "lycopene metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001290"^^xsd:string .

ns1:PW_0001291
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001290, ns1:PW_0001292 ;
  ns2:treeView ns1:PW_0001290, ns1:PW_0001292 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of lycopene, a carotene and phytochemical found in red fruits and vegetables. Plants and bacteria have the ability to synthesize lycopene."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-13T13:03:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001291"^^xsd:string ;
  rdfs:label "lycopene biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001291"^^xsd:string .

ns1:PW_0001292
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001289 ;
  ns2:treeView ns1:PW_0001289 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-13T13:07:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001292"^^xsd:string ;
  rdfs:label "carotene biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001292"^^xsd:string .

ns1:PW_0001293
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001289 ;
  ns2:treeView ns1:PW_0001289 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-13T13:07:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001293"^^xsd:string ;
  rdfs:label "carotene degradation pathway"^^xsd:string ;
  skos:notation "PW:0001293"^^xsd:string .

ns1:PW_0001294
  a owl:Class ;
  ns1:IAO_0000115 "Eicosanoids, derived from omega-3 or omega-6 fatty acids, are represented by the leukotriene and prostanoid classes of which the latter is represented by several families. Some can act as endogenous ligands for members of the peroxisomal proliferator-activated nuclear receptors (PPARs). Once activated, PPARs heterodimerize with the retinoid X receptor (RXR) and modulate the expression of target genes."^^xsd:string ;
  ns1:IAO_0000231 ns1:IAO_0000227 ;
  ns1:IAO_0100001 ns1:PW_0000565 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-13T13:46:40Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001294"^^xsd:string ;
  rdfs:label "eicosanoid signaling pathway"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0001294"^^xsd:string .

ns1:PW_0001295
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000565 ;
  ns2:treeView ns1:PW_0000565 ;
  ns1:IAO_0000115 "Leukotriene are eicosanoids derived from omega-3 or omega-6 fatty acids. One such source is the arachidonic metabolism via the 5-lipoxygenase mediated route."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-14T11:35:27Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001295"^^xsd:string ;
  rdfs:label "leukotriene signaling pathway"^^xsd:string ;
  skos:notation "PW:0001295"^^xsd:string .

ns1:PW_0001296
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000565 ;
  ns2:treeView ns1:PW_0000565 ;
  ns1:IAO_0000115 "Prostanoids are eicosanoids derived from omega-3 or omega-6 fatty acids and represented by several families. One such source is the arachidonic acid metabolism via the cyclooxygenase mediated route. Several categories of prostanoids can be generated and signaling via several receptor types elicits a range of physiological responses. Historically, they are viewed as mediators of inflammation."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-14T12:36:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001296"^^xsd:string ;
  rdfs:label "prostanoid signaling pathway"^^xsd:string ;
  skos:notation "PW:0001296"^^xsd:string .

ns1:PW_0001297
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001296 ;
  ns2:treeView ns1:PW_0001296 ;
  ns1:IAO_0000115 "Prostaglandins are one of several families of prostanoids, eicosanoids derived from omega-3 or omega-6 fatty acids. Of the several prostaglandins, prostaglandin E2 signaling via four distinct receptors mediates a broad range of  physiological effects. Others include prostaglandin D2 with various central nervous system (CNS) activities and prostaglandin I2 or prostacyclin with important vascular functions."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-14T12:40:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001297"^^xsd:string ;
  rdfs:label "prostaglandin signaling pathway"^^xsd:string ;
  skos:notation "PW:0001297"^^xsd:string .

ns1:PW_0001298
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005 ;
  ns2:treeView ns1:PW_0000005 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of trehalose - a disaccharide synthesized by bacteria, fungi, plants and invertebrates. It has important roles in plant development and it represents the energy storage that insects use for flight. It is believed to be involved in the ability of plants and animals to withstand long periods of desiccation or anhydrobiosis."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-14T12:52:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "mycose metabolic pathway"^^xsd:string, "tremalose metabolic pathway"^^xsd:string ;
  obo:id "PW:0001298"^^xsd:string ;
  rdfs:label "trehalose metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001298"^^xsd:string .

ns1:PW_0001299
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001298 ;
  ns2:treeView ns1:PW_0001298 ;
  ns1:IAO_0000115 "Those metabolic reactions involved on the synthesis of trehalose, a disaccharide found in bacteria, fungi, plants and invertebrates."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-14T13:14:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "mycose biosynthetic pathway"^^xsd:string, "tremalose biosynthetic pathway"^^xsd:string ;
  obo:id "PW:0001299"^^xsd:string ;
  rdfs:label "trehalose biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001299"^^xsd:string .

ns1:PW_0001300
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001298 ;
  ns2:treeView ns1:PW_0001298 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the degradation of trehalose. While the synthesis of trehalose does not take place in vertebrates, the catabolic route of its metabolism does occur."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-14T13:20:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00467"^^xsd:string, "mycose degradation pathway"^^xsd:string, "tremalose degradation pathway"^^xsd:string ;
  obo:id "PW:0001300"^^xsd:string ;
  rdfs:label "trehalose degradation pathway"^^xsd:string ;
  skos:notation "PW:0001300"^^xsd:string .

ns1:PW_0001301
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000048 ;
  ns2:treeView ns1:PW_0000048 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of methionine. As an essential amino acid, methionine can not be synthesized by humans. Its synthesis takes place in plants and microorganisms."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-14T13:45:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001301"^^xsd:string ;
  rdfs:label "methionine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001301"^^xsd:string .

ns1:PW_0001302
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000048 ;
  ns2:treeView ns1:PW_0000048 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the degradation of methionine. In higher organisms methionine is either recycled via the remethylation pathways or is converted to cysteine via the transsulfuration pathway of homocysteine metabolism. In fungi, plants and bacteria, methionine can be processed to compounds such as methionol and/or 2-oxobutanoate."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-14T13:56:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001302"^^xsd:string ;
  rdfs:label "methionine degradation pathway"^^xsd:string ;
  skos:notation "PW:0001302"^^xsd:string .

ns1:PW_0001303
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000248 ;
  ns2:treeView ns1:PW_0000248 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of steroids."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-14T14:10:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001303"^^xsd:string ;
  rdfs:label "steroid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001303"^^xsd:string .

ns1:PW_0001304
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001303 ;
  ns2:treeView ns1:PW_0001303 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of cholesterol, an essential component of cell membranes and lipid rafts and the precursor for the synthesis of steroid hormones and bile acids."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-14T14:11:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001304"^^xsd:string ;
  rdfs:label "cholesterol metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001304"^^xsd:string .

ns1:PW_0001305
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001303 ;
  ns2:treeView ns1:PW_0001303 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of steroid hormones."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-14T14:14:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001305"^^xsd:string ;
  rdfs:label "steroid hormone metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001305"^^xsd:string .

ns1:PW_0001306
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000751, ns1:PW_0001152 ;
  ns2:treeView ns1:PW_0000751, ns1:PW_0001152 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-14T14:34:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001306"^^xsd:string ;
  rdfs:label "altered steroid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001306"^^xsd:string .

ns1:PW_0001307
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000354 ;
  ns2:treeView ns1:PW_0000354 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of phosphatidylcholine, an essential component of the membrane."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-14T15:31:03Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001307"^^xsd:string ;
  rdfs:label "phosphatidylcholine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001307"^^xsd:string .

ns1:PW_0001308
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000013 ;
  ns2:treeView ns1:PW_0000013 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-14T15:42:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001308"^^xsd:string ;
  rdfs:label "respiratory system disease pathway"^^xsd:string ;
  skos:notation "PW:0001308"^^xsd:string .

ns1:PW_0001309
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000248 ;
  ns2:treeView ns1:PW_0000248 ;
  ns1:IAO_0000115 "Abscisic acid is a plant isoprenoid hormone important for development and stress responses."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-20T11:34:20Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001309"^^xsd:string ;
  rdfs:label "abscisic acid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001309"^^xsd:string .

ns1:PW_0001310
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001309 ;
  ns2:treeView ns1:PW_0001309 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of abscisic acid, an important plant isoprenoid hormone."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-20T11:45:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001310"^^xsd:string ;
  rdfs:label "abscisic acid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001310"^^xsd:string .

ns1:PW_0001311
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000037 ;
  ns2:treeView ns1:PW_0000037 ;
  ns1:IAO_0000115 "Sulfur, mostly found as inorganic sulfate can be taken up by plants, microorganisms and algae. Upon reduction to sulfide, is then incorporated into bioinorganic compounds. The underlying reactions and interactions constitute the sulfate assimilation pathway, best characterized in plants."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-20T12:47:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001311"^^xsd:string ;
  rdfs:label "sulfate assimilation pathway"^^xsd:string ;
  skos:notation "PW:0001311"^^xsd:string .

ns1:PW_0001312
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000329, ns1:PW_0000650 ;
  ns2:treeView ns1:PW_0000329, ns1:PW_0000650 ;
  ns1:IAO_0000115 "Nodal signaling pathway belongs to the transforming growth factor-beta superfamily and plays important roles during vertebrate embryogenesis where is involved in pattern formation and differentiation."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-20T14:12:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001312"^^xsd:string ;
  rdfs:label "Nodal signaling pathway"^^xsd:string ;
  skos:notation "PW:0001312"^^xsd:string .

ns1:PW_0001313
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000100 ;
  ns2:treeView ns1:PW_0000100 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-21T12:51:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001313"^^xsd:string ;
  rdfs:label "transcription pathway via transcription factor mediated signaling"^^xsd:string ;
  skos:notation "PW:0001313"^^xsd:string .

ns1:PW_0001314
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000807, ns1:PW_0001313 ;
  ns2:treeView ns1:PW_0000807, ns1:PW_0001313 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-21T12:54:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001314"^^xsd:string ;
  rdfs:label "altered transcription pathway via transcription factor mediated signaling"^^xsd:string ;
  skos:notation "PW:0001314"^^xsd:string .

ns1:PW_0001315
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000733 ;
  ns2:treeView ns1:PW_0000733 ;
  ns1:IAO_0000115 "Those metabolic reactions involving ascaroside, a glycolipid containing the sugar ascarylose, found in nematodes."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-21T13:47:21Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001315"^^xsd:string ;
  rdfs:label "ascaroside metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001315"^^xsd:string .

ns1:PW_0001316
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001315 ;
  ns2:treeView ns1:PW_0001315 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of ascaroside - a glycolipid containing the sugar ascarylose found in nematodes."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-21T13:48:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001316"^^xsd:string ;
  rdfs:label "ascaroside biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001316"^^xsd:string .

ns1:PW_0001317
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000085 ;
  ns2:treeView ns1:PW_0000085 ;
  ns1:IAO_0000115 "The series of events, collectively known as the cell cycle, that underlie the replication of the genome and the segregation of chromosomes into daughter cells. The mitotic cell cycle pathway underlies the generation of new cells. The meiotic cell cycle pathway is a special type of cell division that takes place in germ cells."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-22T09:56:40Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001317"^^xsd:string ;
  rdfs:label "cell cycle pathway"^^xsd:string ;
  skos:notation "PW:0001317"^^xsd:string .

ns1:PW_0001318
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001317 ;
  ns2:treeView ns1:PW_0001317 ;
  ns1:IAO_0000115 "The series of events that take place in the germ cells resulting in the production of four non-identical haploid cells from each diploid cell that enters the cycle. Meiosis involves chromosomal pairing and exchange of DNA segments or recombination."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-22T10:19:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001318"^^xsd:string ;
  rdfs:label "cell cycle pathway, meiotic"^^xsd:string ;
  skos:notation "PW:0001318"^^xsd:string .

ns1:PW_0001319
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001365 ;
  ns2:treeView ns1:PW_0001365 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of toxic secondary metabolite, known as mycotoxins, produced by some fungi, such as Fusarium. The mycotoxins they produce in cereal crops, such as species of fumonisins and trichothecenes, can affect humans and animals if present in food."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-22T11:17:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "mycotoxin biosynthetic pathway"^^xsd:string ;
  obo:id "PW:0001319"^^xsd:string ;
  rdfs:label "toxic secondary metabolite biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001319"^^xsd:string .

ns1:PW_0001320
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001319, ns1:PW_0001367 ;
  ns2:treeView ns1:PW_0001319, ns1:PW_0001367 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of fumonisin mycotoxins by members of Fusarium fungi."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-22T11:30:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001320"^^xsd:string ;
  rdfs:label "fumonisin biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001320"^^xsd:string .

ns1:PW_0001321
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001319, ns1:PW_0001368 ;
  ns2:treeView ns1:PW_0001319, ns1:PW_0001368 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of trichothecene mycotoxins by members of Fusarium fungi."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-22T11:31:27Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001321"^^xsd:string ;
  rdfs:label "trichothecene biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001321"^^xsd:string .

ns1:PW_0001322
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001321 ;
  ns2:treeView ns1:PW_0001321 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of deoxynivalenol, a type B trichothecene produced by members of Fusarium fungi."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-22T11:36:22Z"^^xsd:string ;
  obo:hasExactSynonym "DON biosynthetic pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "vomitoxin biosynthetic pathway"^^xsd:string ;
  obo:id "PW:0001322"^^xsd:string ;
  rdfs:label "deoxynivalenol biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001322"^^xsd:string .

ns1:PW_0001323
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000101, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001959
  ] ;
  ns2:treeView ns1:PW_0000101, ns1:PW_0001959 ;
  ns3:part_of ns1:PW_0001959 ;
  ns1:IAO_0000115 "The translation pathway that takes place in the mitochondrion. The mitochondrial translation pathway utilizes 22 tRNAs which are encoded in the mitochondrial genome. The mitochondrial genome also encodes 2 ribosomal genes. A small set of mitochondrially encoded proteins is translated in the mitochondrion. Most others are nuclear genes, synthesized on cytosolic ribosomes and then targeted to the organelle."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-22T13:11:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001323"^^xsd:string ;
  rdfs:label "mitochondrial translation pathway"^^xsd:string ;
  skos:notation "PW:0001323"^^xsd:string .

ns1:PW_0001324
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001323
  ] ;
  ns2:treeView ns1:PW_0001323 ;
  ns3:part_of ns1:PW_0001323 ;
  ns1:IAO_0000115 "Aminoacyl-tRNA, or transfer RNA (tRNA) carries amino acids to ribosomes and is part of the translation pathway. tRNAs are specific for the amino acids with which they are associated. Their synthesis involves adenylation of the amino acid followed by its transfer; both steps require ATP. there are 22 tRNA genes encoded by the mitochondrial genome. Mutations in these genes have been implicated in a number of disorders and may affect various steps of tRNA biosynthesis."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-22T13:16:35Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001324"^^xsd:string ;
  rdfs:label "mitochondrial aminoacyl-tRNA biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001324"^^xsd:string .

ns1:PW_0001325
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001323
  ] ;
  ns2:treeView ns1:PW_0001323 ;
  ns3:part_of ns1:PW_0001323 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-22T13:40:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001325"^^xsd:string ;
  rdfs:label "mitochondrial ribosome biogenesis pathway"^^xsd:string ;
  skos:notation "PW:0001325"^^xsd:string .

ns1:PW_0001326
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001068, ns1:PW_0001323, ns1:PW_0001960 ;
  ns2:treeView ns1:PW_0001068, ns1:PW_0001323, ns1:PW_0001960 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-22T13:59:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001326"^^xsd:string ;
  rdfs:label "altered mitochondrial translation pathway"^^xsd:string ;
  skos:notation "PW:0001326"^^xsd:string .

ns1:PW_0001327
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001324, ns1:PW_0001326 ;
  ns2:treeView ns1:PW_0001324, ns1:PW_0001326 ;
  ns1:IAO_0000115 "Mutations in the mitochondrial tRNA genes are associated with a number of disorders. These mutations may affect steps in the biosynthesis of tRNA."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-22T14:01:41Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001327"^^xsd:string ;
  rdfs:label "altered mitochondrial aminoacyl-tRNA biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001327"^^xsd:string .

ns1:PW_0001328
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000055 ;
  ns2:treeView ns1:PW_0000055 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of uridine diphosphate glucose, a nucleotide sugar."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-22T14:27:01Z"^^xsd:string ;
  obo:hasExactSynonym "UDP-glucose metabolic pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001328"^^xsd:string ;
  rdfs:label "uridine diphosphate glucose metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001328"^^xsd:string .

ns1:PW_0001329
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000055 ;
  ns2:treeView ns1:PW_0000055 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of  guanosine diphosphate mannose, a nucleotide sugar."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-22T14:32:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001329"^^xsd:string ;
  rdfs:label "guanosine diphosphate mannose metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001329"^^xsd:string .

ns1:PW_0001330
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000024, ns1:PW_0000819 ;
  ns2:treeView ns1:PW_0000024, ns1:PW_0000819 ;
  ns1:IAO_0000115 "The receptor for advanced glycation end-products is a multi-ligand receptor whose signaling engages several downstream cascades. In addition to its pro-inflammatory role in innate immunity, it is also involved in tissue homeostasis and repair. It has been associated with a range of pathological states."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-05-22T14:54:54Z"^^xsd:string ;
  obo:hasExactSynonym "RAGE signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001330"^^xsd:string ;
  rdfs:label "receptor for advanced glycation end-products signaling pathway"^^xsd:string ;
  skos:notation "PW:0001330"^^xsd:string .

ns1:PW_0001331
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000127
  ] ;
  ns2:treeView ns1:PW_0000127 ;
  ns3:part_of ns1:PW_0000127 ;
  ns1:IAO_0000115 "RNA polymerase II transcription elongation commences when the nascent transcript reaches about 25 residues. Some general transcription factors are release and the RNA polymerase II carries out elongation of pre-mRNA transcript and proofreading. Various regulators control early elongation, proximal promoter pausing and full elongation proceedings. Nascent mRNA processing, splicing and alternative splicing are co-occurring."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-03T09:19:50Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001331"^^xsd:string ;
  rdfs:label "RNA polymerase II transcription elongation pathway"^^xsd:string ;
  skos:notation "PW:0001331"^^xsd:string .

ns1:PW_0001332
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000127
  ] ;
  ns2:treeView ns1:PW_0000127 ;
  ns3:part_of ns1:PW_0000127 ;
  ns1:IAO_0000115 "Termination of transcription is important for partitioning the genome and maintaining adequate expression of neighboring genes."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-03T09:39:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001332"^^xsd:string ;
  rdfs:label "RNA polymerase II transcription termination pathway"^^xsd:string ;
  skos:notation "PW:0001332"^^xsd:string .

ns1:PW_0001333
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000100, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001959
  ] ;
  ns2:treeView ns1:PW_0000100, ns1:PW_0001959 ;
  ns3:part_of ns1:PW_0001959 ;
  ns1:IAO_0000115 "The transcription of mitochondrial DNA which encodes several genes involved in the oxidative phosphorylation pathway as well as the ribosomal and transfer RNA genes involved in their translation."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-03T09:44:20Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001333"^^xsd:string ;
  rdfs:label "mitochondrial transcription pathway"^^xsd:string ;
  skos:notation "PW:0001333"^^xsd:string .

ns1:PW_0001334
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000085 ;
  ns2:treeView ns1:PW_0000085 ;
  ns1:IAO_0000115 "Non-coding RNA are functional RNA molecules that are not translated into proteins. In addition to ribosomal and transfer RNA involved in protein translation many other small and long RNA are transcribed with important roles in the regulation of gene expression."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-03T10:07:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001334"^^xsd:string ;
  rdfs:label "non-coding RNA pathway"^^xsd:string ;
  skos:notation "PW:0001334"^^xsd:string .

ns1:PW_0001335
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001334 ;
  ns2:treeView ns1:PW_0001334 ;
  ns1:IAO_0000115 "Long non-coding RNA, of which there are several types, perform important regulatory roles whose function and mechanism are under investigation."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-03T10:15:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001335"^^xsd:string ;
  rdfs:label "long non-coding RNA pathway"^^xsd:string ;
  skos:notation "PW:0001335"^^xsd:string .

ns1:PW_0001336
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000878 ;
  ns2:treeView ns1:PW_0000878 ;
  ns1:IAO_0000115 "CDP-choline is one of the three distinct pathways of phosphatidylcholine biosynthesis. A second has been better studied in yeast while the third has only been identified in certain bacteria."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-03T11:26:24Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Kennedy pathway"^^xsd:string ;
  obo:id "PW:0001336"^^xsd:string ;
  rdfs:label "CDP-choline pathway of phosphatidylcholine biosynthesis"^^xsd:string ;
  skos:notation "PW:0001336"^^xsd:string .

ns1:PW_0001337
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000085, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000099
  ], [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000100
  ], [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001360
  ] ;
  ns2:treeView ns1:PW_0000085, ns1:PW_0000099, ns1:PW_0000100, ns1:PW_0001360 ;
  ns3:part_of ns1:PW_0000099, ns1:PW_0000100, ns1:PW_0001360 ;
  ns1:IAO_0000115 "Chromatin modification/remodeling plays a major role in the epigenetic control of gene expression. The dynamics of chromatin structure impacts on DNA replication, transcription and repair pathways. It includes the covalent modification of histones and DNA and the actions carried out by the ATP-dependent remodelers."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-03T13:05:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001337"^^xsd:string ;
  rdfs:label "chromatin modification/remodeling pathway"^^xsd:string ;
  skos:notation "PW:0001337"^^xsd:string .

ns1:PW_0001338
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001403, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001693
  ] ;
  ns2:treeView ns1:PW_0001403, ns1:PW_0001693 ;
  ns3:part_of ns1:PW_0001693 ;
  ns1:IAO_0000115 "The tails of histone proteins are subject to a wide array of modifications of which methylation and acetylation have been more thoroughly documented. The modified residues are recognized by particular proteins or readers, in turn acting upon their targets. The modifications are rendered reversible by the enzymes that carry out the reaction in the opposite direction, also referred to as erasers."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-03T14:06:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001338"^^xsd:string ;
  rdfs:label "histone modification pathway"^^xsd:string ;
  skos:notation "PW:0001338"^^xsd:string .

ns1:PW_0001339
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001337 ;
  ns2:treeView ns1:PW_0001337 ;
  ns1:IAO_0000115 "Chromatin remodelers are large complexes that use the energy derived from ATP hydrolysis to promote nucleosome sliding, ejection or repositioning, histone exchange. Currently, there are four different families of chromatin remodeling complexes."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-03T14:14:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001339"^^xsd:string ;
  rdfs:label "chromatin remodeling pathway"^^xsd:string ;
  skos:notation "PW:0001339"^^xsd:string .

ns1:PW_0001340
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001403, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001693
  ] ;
  ns2:treeView ns1:PW_0001403, ns1:PW_0001693 ;
  ns3:part_of ns1:PW_0001693 ;
  ns1:IAO_0000115 "DNA modification is a component of chromatin modification pathway. At least four DNA modification types are known. The modifications are recognized by specific readers and removed by eraser enzymes."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-03T14:57:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001340"^^xsd:string ;
  rdfs:label "DNA modification pathway"^^xsd:string ;
  skos:notation "PW:0001340"^^xsd:string .

ns1:PW_0001341
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000290, ns1:PW_0001337 ;
  ns2:treeView ns1:PW_0000290, ns1:PW_0001337 ;
  ns1:IAO_0000115 "A chromatin remodeling/modification pathway that deviate from what its normal course should be. Aberrant chromatin remodeling and modification has been associated with various conditions, particularly cancer."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-03T15:02:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001341"^^xsd:string ;
  rdfs:label "altered chromatin remodeling/modification pathway"^^xsd:string ;
  skos:notation "PW:0001341"^^xsd:string .

ns1:PW_0001342
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000151 ;
  ns2:treeView ns1:PW_0000151 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of sucrose. The disaccharide is synthesized by plants and cyanobacteria."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-04T11:18:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001342"^^xsd:string ;
  rdfs:label "sucrose biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001342"^^xsd:string .

ns1:PW_0001343
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000354 ;
  ns2:treeView ns1:PW_0000354 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of phosphatidylglycerol. The molecule is a glycerophospholipid found in pulmonary surfactant."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-04T11:47:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001343"^^xsd:string ;
  rdfs:label "phosphatidylglycerol metabolic process"^^xsd:string ;
  skos:notation "PW:0001343"^^xsd:string .

ns1:PW_0001344
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001343 ;
  ns2:treeView ns1:PW_0001343 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of cardiolipin. The molecule is derived from phosphatidylglycerol as an immature cardiolipin, further remodeled by phospholipases. Cardiolipin is important for a range of mitochondrial functions."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-04T12:16:45Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001344"^^xsd:string ;
  rdfs:label "cardiolipin metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001344"^^xsd:string .

ns1:PW_0001345
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001344 ;
  ns2:treeView ns1:PW_0001344 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of cardiolipin, a molecule important for mitochondrial function."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-04T12:31:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001345"^^xsd:string ;
  rdfs:label "cardiolipin biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001345"^^xsd:string .

ns1:PW_0001346
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000103 ;
  ns2:treeView ns1:PW_0000103 ;
  ns1:IAO_0000115 "The pathways involved in the absorption and efflux of cholesterol."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-04T12:45:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001346"^^xsd:string ;
  rdfs:label "cholesterol transport pathway"^^xsd:string ;
  skos:notation "PW:0001346"^^xsd:string .

ns1:PW_0001347
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000545, ns1:PW_0001346 ;
  ns2:treeView ns1:PW_0000545, ns1:PW_0001346 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-04T12:49:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001347"^^xsd:string ;
  rdfs:label "altered cholesterol transport pathway"^^xsd:string ;
  skos:notation "PW:0001347"^^xsd:string .

ns1:PW_0001348
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000103 ;
  ns2:treeView ns1:PW_0000103 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-04T12:59:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001348"^^xsd:string ;
  rdfs:label "ion transport pathway"^^xsd:string ;
  skos:notation "PW:0001348"^^xsd:string .

ns1:PW_0001349
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001348 ;
  ns2:treeView ns1:PW_0001348 ;
  ns1:IAO_0000115 "The transport pathways of elements in group 1, 14, 15, 16 and 17 of the periodic table."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-04T13:21:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001349"^^xsd:string ;
  rdfs:label "non-metal ion transport pathway"^^xsd:string ;
  skos:notation "PW:0001349"^^xsd:string .

ns1:PW_0001350
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001349 ;
  ns2:treeView ns1:PW_0001349 ;
  ns1:IAO_0000115 "The transport pathway of chloride ion as carried out by chloride channels and transporters in cell and organelles."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-04T13:30:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001350"^^xsd:string ;
  rdfs:label "chloride ion transport pathway"^^xsd:string ;
  skos:notation "PW:0001350"^^xsd:string .

ns1:PW_0001351
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001353 ;
  ns2:treeView ns1:PW_0001353 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-04T13:37:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001351"^^xsd:string ;
  rdfs:label "altered non-metal ion transport pathway"^^xsd:string ;
  skos:notation "PW:0001351"^^xsd:string .

ns1:PW_0001352
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001353 ;
  ns2:treeView ns1:PW_0001353 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-04T13:37:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001352"^^xsd:string ;
  rdfs:label "altered metal ion transport pathway"^^xsd:string ;
  skos:notation "PW:0001352"^^xsd:string .

ns1:PW_0001353
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000545, ns1:PW_0001348 ;
  ns2:treeView ns1:PW_0000545, ns1:PW_0001348 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-04T13:38:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001353"^^xsd:string ;
  rdfs:label "altered ion transport pathway"^^xsd:string ;
  skos:notation "PW:0001353"^^xsd:string .

ns1:PW_0001354
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001350, ns1:PW_0001351 ;
  ns2:treeView ns1:PW_0001350, ns1:PW_0001351 ;
  ns1:IAO_0000115 "A chloride ion transport pathway that deviates from what its normal course should be. Aberrant chloride ion transport have been implicated in diseases. For instance, mutations in the ABC type transporter that functions as both a chloride channel and as a regulator of other transport pathways, have been implicated in two genetic disorders of which one is cystic fibrosis."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-04T13:39:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001354"^^xsd:string ;
  rdfs:label "altered chloride ion transport pathway"^^xsd:string ;
  skos:notation "PW:0001354"^^xsd:string .

ns1:PW_0001355
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000716, ns1:PW_0001313 ;
  ns2:treeView ns1:PW_0000716, ns1:PW_0001313 ;
  ns1:IAO_0000115 "Peroxisome proliferator-activated receptor signaling is initiated in response to binding several compounds within classes of lipids such as the eicosanoid, leukotriene, prostagladin, among others. The receptors form heterodimers with the retinoid X receptor, bind to specific DNA elements and regulate the expression of target genes. Deregulation of the pathway has been implicated in several conditions."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-05T08:45:28Z"^^xsd:string ;
  obo:hasExactSynonym "PPAR signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001355"^^xsd:string ;
  rdfs:label "peroxisome proliferator-activated receptor signaling pathway"^^xsd:string ;
  skos:notation "PW:0001355"^^xsd:string .

ns1:PW_0001356
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000719, ns1:PW_0001314, ns1:PW_0001355 ;
  ns2:treeView ns1:PW_0000719, ns1:PW_0001314, ns1:PW_0001355 ;
  ns1:IAO_0000115 "Deregulation of peroxisome proliferator-activated receptor signaling can affect innate immunity and play a role in metabolic diseases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-05T09:29:37Z"^^xsd:string ;
  obo:hasExactSynonym "altered PPAR signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001356"^^xsd:string ;
  rdfs:label "altered peroxisome proliferator-activated receptor signaling pathway"^^xsd:string ;
  skos:notation "PW:0001356"^^xsd:string .

ns1:PW_0001357
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000167 ;
  ns2:treeView ns1:PW_0000167 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of coenzyme A, an  important for fatty acids, pyruvate and citric acid metabolic pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-06T10:13:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001357"^^xsd:string ;
  rdfs:label "coenzyme A metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001357"^^xsd:string .

ns1:PW_0001358
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001357 ;
  ns2:treeView ns1:PW_0001357 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of coenzyme A. The five step reaction pathway requires pantothenate (vitamin B5) and cysteine as precursors."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-06T10:18:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001358"^^xsd:string ;
  rdfs:label "coenzyme A biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001358"^^xsd:string .

ns1:PW_0001359
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000130, ns1:PW_0000666 ;
  ns2:treeView ns1:PW_0000130, ns1:PW_0000666 ;
  ns1:IAO_0000115 "A nucleotide excision repair pathway that deviates from what its normal course should be. Defects in this repair pathway have been associated with cancer and premature aging."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-10T09:38:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered NER pathway"^^xsd:string ;
  obo:id "PW:0001359"^^xsd:string ;
  rdfs:label "altered nucleotide excision repair pathway"^^xsd:string ;
  skos:notation "PW:0001359"^^xsd:string .

ns1:PW_0001360
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000085 ;
  ns2:treeView ns1:PW_0000085 ;
  ns1:IAO_0000115 "The response mechanism/pathways that assure the maintenance of genomic integrity. This involves detection of DNA damage, signaling and amplification of the signal leading to activation of effectors and resulting in repair of damage, cell cycle arrest or, if necessary, cell death. Such  response mechanism/pathways may operate collectively with some of their components being shared."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-11T11:03:38Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "DDR pathway"^^xsd:string ;
  obo:id "PW:0001360"^^xsd:string ;
  rdfs:label "DNA damage response pathway"^^xsd:string ;
  skos:notation "PW:0001360"^^xsd:string .

ns1:PW_0001361
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001194, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001360
  ] ;
  ns2:treeView ns1:PW_0001194, ns1:PW_0001360 ;
  ns3:part_of ns1:PW_0001360 ;
  ns1:IAO_0000115 "The ataxia telangiectasia-mutated (ATM) serine/threonine kinase mediated signaling plays a major role in the response to DNA double strand breaks (DSB). Following lesion sensing by the MRN complex, ATM gets activated. Active ATM phosphorylates itself and targets resulting in triggering of  DNA repair, cell cycle checkpoint and signaling pathways. While ATM signaling is best documented for its role in DSB responses, evidence accumulates that it functions in a range of other, DNA damage unrelated, responses."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-11T11:25:06Z"^^xsd:string ;
  obo:hasExactSynonym "ATM signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001361"^^xsd:string ;
  rdfs:label "ataxia telangiectasia-mutated (ATM) signaling pathway"^^xsd:string ;
  skos:notation "PW:0001361"^^xsd:string .

ns1:PW_0001362
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001194, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001360
  ] ;
  ns2:treeView ns1:PW_0001194, ns1:PW_0001360 ;
  ns3:part_of ns1:PW_0001360 ;
  ns1:IAO_0000115 "The ATM and Rad3-related (ATR) serine/threonine kinase mediated signaling responds to several kinds of DNA damage, of which single-stranded DNA (ssDNA) exerts a key role. ssDNAs are induced by stressed replication forks. ATR acting on its substrates prevents the cell from erroneous mitotic entry, plays a key role in interstrand cross link (ICL) repair pathway and also exerts important regulatory roles in  homologous recombination pathway of double-strand break repair."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-11T11:25:59Z"^^xsd:string ;
  obo:hasExactSynonym "ATR signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001362"^^xsd:string ;
  rdfs:label "ATM and Rad3-related (ATR) signaling pathway"^^xsd:string ;
  skos:notation "PW:0001362"^^xsd:string .

ns1:PW_0001363
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005 ;
  ns2:treeView ns1:PW_0000005 ;
  ns1:IAO_0000115 "Those metabolic reactions involving lactose, a disaccharide found in milk."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-11T13:14:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001363"^^xsd:string ;
  rdfs:label "lactose metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001363"^^xsd:string .

ns1:PW_0001364
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001363 ;
  ns2:treeView ns1:PW_0001363 ;
  ns1:IAO_0000115 "The breaking down of lactose to its constituent sugars."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-11T13:17:06Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00457"^^xsd:string ;
  obo:id "PW:0001364"^^xsd:string ;
  rdfs:label "lactose degradation pathway"^^xsd:string ;
  skos:notation "PW:0001364"^^xsd:string .

ns1:PW_0001365
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000147 ;
  ns2:treeView ns1:PW_0000147 ;
  ns1:IAO_0000115 "Toxic secondary metabolites, also known as mycotoxins, are natural toxins produced by organisms that belong to the fungi kingdom. They can contaminate crops and if ingested, they can cause sickness or death."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-11T13:37:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "mycotoxin metabolic pathway"^^xsd:string ;
  obo:id "PW:0001365"^^xsd:string ;
  rdfs:label "toxic secondary metabolite metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001365"^^xsd:string .

ns1:PW_0001366
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001365 ;
  ns2:treeView ns1:PW_0001365 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, transport and/or degradation of aflatoxins. Aflatoxins are potent toxic secondary metabolites that contaminate grain and nut crops. Of the four types, aflatoxin B1 is the most toxic one."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-11T13:46:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001366"^^xsd:string ;
  rdfs:label "aflatoxin metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001366"^^xsd:string .

ns1:PW_0001367
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001365 ;
  ns2:treeView ns1:PW_0001365 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-11T14:09:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001367"^^xsd:string ;
  rdfs:label "fumonisin metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001367"^^xsd:string .

ns1:PW_0001368
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001365 ;
  ns2:treeView ns1:PW_0001365 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-11T14:09:45Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001368"^^xsd:string ;
  rdfs:label "trichothecene metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001368"^^xsd:string .

ns1:PW_0001369
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001074 ;
  ns2:treeView ns1:PW_0001074 ;
  ns1:IAO_0000115 "The shikimate pathway is the  metabolic route for the production of aromatic amino acids in plants. Seven reactions catalyzed by six enzymes result in the production of chorismate, the major branch point metabolite. Chorismate is the precursor for the biosynthesis of phenylalanine, tryptophan and tyrosine."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-19T09:13:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001369"^^xsd:string ;
  rdfs:label "shikimate metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001369"^^xsd:string .

ns1:PW_0001370
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001369 ;
  ns2:treeView ns1:PW_0001369 ;
  ns1:IAO_0000115 "Chorismate, the major branch point metabolite of shikimate pathway is the precursor for the biosynthesis of aromatic amino acids phenylalanine, tryptophan and tyrosine in plants."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-19T09:31:50Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001370"^^xsd:string ;
  rdfs:label "chorismate metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001370"^^xsd:string .

ns1:PW_0001371
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000716, ns1:PW_0001313 ;
  ns2:treeView ns1:PW_0000716, ns1:PW_0001313 ;
  ns1:IAO_0000115 "Basic helix-loop-helix proteins represent a large superfamily of transcription factors that regulate the expression of genes involved in growth and development as well as environmental responses. Phylogenetically, they are classified into six clades of which the sixth, also referred to as clade F only contains plant genes."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-19T11:06:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001371"^^xsd:string ;
  rdfs:label "basic helix-loop-helix signaling pathway"^^xsd:string ;
  skos:notation "PW:0001371"^^xsd:string .

ns1:PW_0001372
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001371 ;
  ns2:treeView ns1:PW_0001371 ;
  ns1:IAO_0000115 "The inhibitor of DNA binding (ID) family belongs to the basic helix-loop-helix superfamily of transcription factor that regulate cell growth and differentiation. They lack the DNA binding domain and exert their gene expression regulatory function through the interaction with other transcription factors. They also appear to play a role in malignant biology; in neural cancers, deregulated activity has been associated with tumor progression."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-19T11:37:26Z"^^xsd:string ;
  obo:hasExactSynonym "ID signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001372"^^xsd:string ;
  rdfs:label "Inhibitor of DNA binding signaling pathway"^^xsd:string ;
  skos:notation "PW:0001372"^^xsd:string .

ns1:PW_0001373
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001372, ns1:PW_0001374 ;
  ns2:treeView ns1:PW_0001372, ns1:PW_0001374 ;
  ns1:IAO_0000115 "An inhibitor of DNA signaling pathway that deviates from what its normal course should be. In neural cancers, deregulated activity of the pathway has been associated with tumor progression."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-19T12:12:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001373"^^xsd:string ;
  rdfs:label "altered inhibitor of DNA binding signaling pathway"^^xsd:string ;
  skos:notation "PW:0001373"^^xsd:string .

ns1:PW_0001374
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000719, ns1:PW_0001314, ns1:PW_0001371 ;
  ns2:treeView ns1:PW_0000719, ns1:PW_0001314, ns1:PW_0001371 ;
  ns1:IAO_0000115 "A  basic helix-loop-helix signaling pathway that deviates from its normal course should be."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-19T12:21:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001374"^^xsd:string ;
  rdfs:label "altered basic helix-loop-helix signaling pathway"^^xsd:string ;
  skos:notation "PW:0001374"^^xsd:string .

ns1:PW_0001375
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000219 ;
  ns2:treeView ns1:PW_0000219 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of nicotinamide adenine dinucleotide (NAD) from precursors such as nicotinamide, nicotinic acid or nicotinamide riboside, collectively known as vitamin B3 or niacin."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-19T12:47:03Z"^^xsd:string ;
  obo:hasExactSynonym "NAD biosynthesis, the salvage pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001375"^^xsd:string ;
  rdfs:label "nicotinamide adenine dinucleotide biosynthesis, the salvage pathway"^^xsd:string ;
  skos:notation "PW:0001375"^^xsd:string .

ns1:PW_0001376
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000068 ;
  ns2:treeView ns1:PW_0000068 ;
  ns1:IAO_0000115 "Methane oxidation by metanotrophs produces formaldehyde which is assimilated to form metabolite subsequently used for the biosynthesis of multi-carbon compounds. Two pathways of formaldehyde assimilation are known. Both pathways are cyclic."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-19T12:54:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001376"^^xsd:string ;
  rdfs:label "formaldehyde assimilation pathway"^^xsd:string ;
  skos:notation "PW:0001376"^^xsd:string .

ns1:PW_0001377
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001376 ;
  ns2:treeView ns1:PW_0001376 ;
  ns1:IAO_0000115 "The serine pathway is one of two pathways of formaldehyde assimilation resulting in a three-carbon intermediate."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-19T13:00:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001377"^^xsd:string ;
  rdfs:label "serine pathway of formaldehyde assimilation"^^xsd:string ;
  skos:notation "PW:0001377"^^xsd:string .

ns1:PW_0001378
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001376 ;
  ns2:treeView ns1:PW_0001376 ;
  ns1:IAO_0000115 "The RuMP pathway, or RuMP cycle, is one of two pathways of formaldehyde assimilation resulting in a three-carbon intermediate."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-19T13:25:58Z"^^xsd:string ;
  obo:hasExactSynonym "RuMP cycle of formaldehyde assimilation"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001378"^^xsd:string ;
  rdfs:label "RuMP pathway of formaldehyde assimilation"^^xsd:string ;
  skos:notation "PW:0001378"^^xsd:string .

ns1:PW_0001379
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000033 ;
  ns2:treeView ns1:PW_0000033 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the oxidation of octane and found in some bacteria. The final product can be utilized as a source of carbon and energy."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-19T13:32:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001379"^^xsd:string ;
  rdfs:label "octane oxidation pathway"^^xsd:string ;
  skos:notation "PW:0001379"^^xsd:string .

ns1:PW_0001380
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001263 ;
  ns2:treeView ns1:PW_0001263 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the deamination pathway of glutamate degradation that is found in microorganisms and plants. It results in ammonia and the 2-oxoglutarate compound which is fed into the citric acid cycle."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-19T14:06:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001380"^^xsd:string ;
  rdfs:label "glutamate degradation pathway I"^^xsd:string ;
  skos:notation "PW:0001380"^^xsd:string .

ns1:PW_0001381
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001263 ;
  ns2:treeView ns1:PW_0001263 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the glutamate degradation pathway II found in certain bacteria."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-19T14:10:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001381"^^xsd:string ;
  rdfs:label "glutamate degradation pathway II"^^xsd:string ;
  skos:notation "PW:0001381"^^xsd:string .

ns1:PW_0001382
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001263 ;
  ns2:treeView ns1:PW_0001263 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in glutamate degradation pathway III which proceeds via 4-aminobutanoate (GABA) and is found in humans and other mammals."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-19T14:23:45Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "GABA shunt pathway"^^xsd:string ;
  obo:id "PW:0001382"^^xsd:string ;
  rdfs:label "glutamate degradation pathway III"^^xsd:string ;
  skos:notation "PW:0001382"^^xsd:string .

ns1:PW_0001383
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001263 ;
  ns2:treeView ns1:PW_0001263 ;
  ns1:IAO_0000115 "Those metabolic reaction involved in glutamate degradation pathway IV. It proceeds via 4-aminobutanoate (GABA), like degradation pathway III, but is found in plants."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-19T14:27:40Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001383"^^xsd:string ;
  rdfs:label "glutamate degradation pathway IV"^^xsd:string ;
  skos:notation "PW:0001383"^^xsd:string .

ns1:PW_0001384
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001385 ;
  ns2:treeView ns1:PW_0001385 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in glutamate degradation pathway V, a fermentation pathway of glutamate degradation. Glutamate degradation pathway V proceeds via hydroxyglutarate and is one of the major pathways of glutamate fermentation."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-19T14:35:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001384"^^xsd:string ;
  rdfs:label "glutamate degradation pathway V"^^xsd:string ;
  skos:notation "PW:0001384"^^xsd:string .

ns1:PW_0001385
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001263 ;
  ns2:treeView ns1:PW_0001263 ;
  ns1:IAO_0000115 "Certain anaerobic bacteria are capable of fermenting amino acids. While at least one fermentation pathway is known for every amino acid, several have been reported for glutamate."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-19T15:15:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001385"^^xsd:string ;
  rdfs:label "glutamate fermentation pathway"^^xsd:string ;
  skos:notation "PW:0001385"^^xsd:string .

ns1:PW_0001386
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001385 ;
  ns2:treeView ns1:PW_0001385 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in glutamate degradation pathway VII, a fermentation pathway of glutamate degradation. It is a methylaspartate pathway and a major route of glutamate fermentation, together with degradation pathway VI and VIII."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-19T15:24:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001386"^^xsd:string ;
  rdfs:label "glutamate degradation pathway VII"^^xsd:string ;
  skos:notation "PW:0001386"^^xsd:string .

ns1:PW_0001387
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001385 ;
  ns2:treeView ns1:PW_0001385 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in glutamate degradation pathway VI, a fermentation pathway of glutamate degradation. It is a methylaspartate pathway and a major route of glutamate fermentation, together with degradation pathway VII and VIII."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-19T15:24:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001387"^^xsd:string ;
  rdfs:label "glutamate degradation pathway VI"^^xsd:string ;
  skos:notation "PW:0001387"^^xsd:string .

ns1:PW_0001388
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001385 ;
  ns2:treeView ns1:PW_0001385 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in glutamate degradation pathway VIII, a fermentation pathway of glutamate degradation. It is a methylaspartate pathway and a major route of glutamate fermentation, together with degradation pathway VI and VII."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-19T15:49:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001388"^^xsd:string ;
  rdfs:label "glutamate degradation pathway VIII"^^xsd:string ;
  skos:notation "PW:0001388"^^xsd:string .

ns1:PW_0001389
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001263 ;
  ns2:treeView ns1:PW_0001263 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-19T15:55:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001389"^^xsd:string ;
  rdfs:label "glutamate degradation pathway IX"^^xsd:string ;
  skos:notation "PW:0001389"^^xsd:string .

ns1:PW_0001390
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000151, ns1:PW_0001391 ;
  ns2:treeView ns1:PW_0000151, ns1:PW_0001391 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of starch, a carbohydrate produced by all green plants as an energy store."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-20T09:20:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001390"^^xsd:string ;
  rdfs:label "starch biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001390"^^xsd:string .

ns1:PW_0001391
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005 ;
  ns2:treeView ns1:PW_0000005 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of starch and cellulose, two similar polymers produced and used by green plants. Both are made from glucose repeat units that differ in their orientation."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-20T09:24:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001391"^^xsd:string ;
  rdfs:label "starch and cellulose metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001391"^^xsd:string .

ns1:PW_0001392
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001391 ;
  ns2:treeView ns1:PW_0001391 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of cellulose, an important structural components of cell wall of green plants, many forms of algae and some fungus-like microorganisms."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-20T09:32:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001392"^^xsd:string ;
  rdfs:label "cellulose biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001392"^^xsd:string .

ns1:PW_0001393
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001391 ;
  ns2:treeView ns1:PW_0001391 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of starch and cellulose, two related polymers."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-20T09:32:56Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001393"^^xsd:string ;
  rdfs:label "starch and cellulose biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001393"^^xsd:string .

ns1:PW_0001394
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001397 ;
  ns2:treeView ns1:PW_0001397 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the biosynthesis of terpene and terpenoid, large classes of related organic compounds. Modified terpenes, via oxidation or re-arrangement of the carbon skeleton, the resulting compounds are generally referred to as terpenoids."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-20T14:12:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001394"^^xsd:string ;
  rdfs:label "terpene and terpenoid biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001394"^^xsd:string .

ns1:PW_0001395
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001394 ;
  ns2:treeView ns1:PW_0001394 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of terpene, a large class or organic compounds produced by a variety of plants and some insects."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-20T14:16:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001395"^^xsd:string ;
  rdfs:label "terpene biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001395"^^xsd:string .

ns1:PW_0001396
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001395 ;
  ns2:treeView ns1:PW_0001395 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of monoterpene, a class of terpene composed of two isoprene units."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-20T14:18:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001396"^^xsd:string ;
  rdfs:label "monoterpene biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001396"^^xsd:string .

ns1:PW_0001397
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000147 ;
  ns2:treeView ns1:PW_0000147 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of terpene and terpenoid, large classes of related organic compounds."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-20T14:21:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001397"^^xsd:string ;
  rdfs:label "terpene and terpenoid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001397"^^xsd:string .

ns1:PW_0001398
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001397 ;
  ns2:treeView ns1:PW_0001397 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-20T14:23:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001398"^^xsd:string ;
  rdfs:label "terpene and terpenoid degradation pathway"^^xsd:string ;
  skos:notation "PW:0001398"^^xsd:string .

ns1:PW_0001399
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001398 ;
  ns2:treeView ns1:PW_0001398 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-20T14:24:06Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001399"^^xsd:string ;
  rdfs:label "terpene degradation pathway"^^xsd:string ;
  skos:notation "PW:0001399"^^xsd:string .

ns1:PW_0001400
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001398 ;
  ns2:treeView ns1:PW_0001398 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-20T14:24:24Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001400"^^xsd:string ;
  rdfs:label "terpenoid degradation pathway"^^xsd:string ;
  skos:notation "PW:0001400"^^xsd:string .

ns1:PW_0001401
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001395 ;
  ns2:treeView ns1:PW_0001395 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of diterpene, a class of terpene composed of four isoprene units."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-20T14:27:06Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001401"^^xsd:string ;
  rdfs:label "diterpene biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001401"^^xsd:string .

ns1:PW_0001402
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001401 ;
  ns2:treeView ns1:PW_0001401 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of momilactone - a diterpene produced by rice. Momilactone A and B can act as potent phytoalexins and allelochemicals"^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-20T14:31:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001402"^^xsd:string ;
  rdfs:label "momilactone biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001402"^^xsd:string .

ns1:PW_0001403
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001337 ;
  ns2:treeView ns1:PW_0001337 ;
  ns1:IAO_0000115 "The pathway of chromatin - DNA  and constituent histones, modification mediated by writers and recognized by readers which in turn, act upon their effectors. The modifications are removed by erasers. Mutations in the writer, reader or eraser categories are known to be implicated in cancer."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-25T10:34:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001403"^^xsd:string ;
  rdfs:label "chromatin modification pathway"^^xsd:string ;
  skos:notation "PW:0001403"^^xsd:string .

ns1:PW_0001404
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001341, ns1:PW_0001403 ;
  ns2:treeView ns1:PW_0001341, ns1:PW_0001403 ;
  ns1:IAO_0000115 "A chromatin modification pathway that deviate from what its normal course should be. Mutations in the writer, reader or eraser categories of chromatin modification have been implicated in cancer."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-25T10:51:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001404"^^xsd:string ;
  rdfs:label "altered chromatin modification pathway"^^xsd:string ;
  skos:notation "PW:0001404"^^xsd:string .

ns1:PW_0001405
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001339, ns1:PW_0001341 ;
  ns2:treeView ns1:PW_0001339, ns1:PW_0001341 ;
  ns1:IAO_0000115 "A chromatin remodeling pathway that deviates from what its normal course should be. Mutations in members of the various chromatin remodeling families have been implicated in cancer."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-25T10:58:35Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001405"^^xsd:string ;
  rdfs:label "altered chromatin remodeling pathway"^^xsd:string ;
  skos:notation "PW:0001405"^^xsd:string .

ns1:PW_0001406
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001339 ;
  ns2:treeView ns1:PW_0001339 ;
  ns1:IAO_0000115 "The SWI/SNF (switching defective/sucrose nonfermenting) family of remodelers has initially been purified from Saccharomyces cerevisiae. In  mammals, two complexes are comprised of one of two mutually exclusive catalytic ATPase subunits along with a set of conserved core subunits and variant subunits. The SWI/SNF is involved in nucleosome sliding and ejection. Deregulation of pathway is associated with several human cancers."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-25T13:27:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001406"^^xsd:string ;
  rdfs:label "SWI/SNF family mediated chromatin remodeling pathway"^^xsd:string ;
  skos:notation "PW:0001406"^^xsd:string .

ns1:PW_0001407
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001339 ;
  ns2:treeView ns1:PW_0001339 ;
  ns1:IAO_0000115 "The ISWI (imitation switch) family of remodelers has initially been purified from Drosophila melanogaster. Eukaryotes assemble several ISWI complexes using one or two different catalytic subunits. Many complexes function to promote chromatin assembly and repression of transcription. Overall, the pathway is important for DNA replication and repair along with the regulation of transcription."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-25T13:37:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001407"^^xsd:string ;
  rdfs:label "ISWI family mediated chromatin remodeling pathway"^^xsd:string ;
  skos:notation "PW:0001407"^^xsd:string .

ns1:PW_0001408
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001339 ;
  ns2:treeView ns1:PW_0001339 ;
  ns1:IAO_0000115 "The INO80 (inositol requiring 80) family of remodelers has been initially purified from Saccharomyces cerevisiae. It promotes transcriptional activation and DNA repair."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-25T13:45:06Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001408"^^xsd:string ;
  rdfs:label "INO80 family mediated chromatin remodeling pathway"^^xsd:string ;
  skos:notation "PW:0001408"^^xsd:string .

ns1:PW_0001409
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001339 ;
  ns2:treeView ns1:PW_0001339 ;
  ns1:IAO_0000115 "The CHD (chromodomain, helicase, DNA binding) family of remodelers has initially been purified from Xenopus laevis. Some CHD remodelers are involved in sliding and ejection of nucleosome to promote transcription while others may have repressive roles."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-25T13:49:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001409"^^xsd:string ;
  rdfs:label "CHD family mediated chromatin remodeling pathway"^^xsd:string ;
  skos:notation "PW:0001409"^^xsd:string .

ns1:PW_0001410
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001340, ns1:PW_0001404 ;
  ns2:treeView ns1:PW_0001340, ns1:PW_0001404 ;
  ns1:IAO_0000115 "A DNA modification pathway that deviates from what its normal course should be. Mutations in the writer, reader or eraser categories of DNA modification have been implicated in several developmental abnormalities and human malignancies."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-25T14:06:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001410"^^xsd:string ;
  rdfs:label "altered DNA modification pathway"^^xsd:string ;
  skos:notation "PW:0001410"^^xsd:string .

ns1:PW_0001411
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001338, ns1:PW_0001404 ;
  ns2:treeView ns1:PW_0001338, ns1:PW_0001404 ;
  ns1:IAO_0000115 "A histone modification pathway that deviates from what its normal course should be. Mutations in the writer, reader or eraser categories of several types of histone modification have been implicated in various forms of cancer."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-06-25T14:09:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001411"^^xsd:string ;
  rdfs:label "altered histone modification pathway"^^xsd:string ;
  skos:notation "PW:0001411"^^xsd:string .

ns1:PW_0001412
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000013 ;
  ns2:treeView ns1:PW_0000013 ;
  ns1:IAO_0000115 "Any disease that affects the central or peripheral nervous system. It includes disorders of the brain, neurological, neurodegenerative, cerebrovascular disorders, syndromes, dystrophies, diseases of the central and peripheral nervous system, and others. However, mental or neuropsychiatric disorders are not included."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-01T09:53:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001412"^^xsd:string ;
  rdfs:label "nervous system disease pathway"^^xsd:string ;
  skos:notation "PW:0001412"^^xsd:string .

ns1:PW_0001413
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001697 ;
  ns2:treeView ns1:PW_0001697 ;
  ns1:IAO_0000115 "The congenital and acquired diseases affecting the liver."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-01T10:08:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001413"^^xsd:string ;
  rdfs:label "liver disease pathway"^^xsd:string ;
  skos:notation "PW:0001413"^^xsd:string .

ns1:PW_0001414
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001412 ;
  ns2:treeView ns1:PW_0001412 ;
  ns1:IAO_0000115 "The congenital and acquired diseases affecting the brain, including but not limited to the cerebral cortex, basal ganglia, thalamus and hypothalamus, brain stem, cerebellum."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-01T10:10:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001414"^^xsd:string ;
  rdfs:label "brain disease pathway"^^xsd:string ;
  skos:notation "PW:0001414"^^xsd:string .

ns1:PW_0001415
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000300, ns1:PW_0001413, ns1:PW_0001414 ;
  ns2:treeView ns1:PW_0000300, ns1:PW_0001413, ns1:PW_0001414 ;
  ns1:IAO_0000115 "A cerebro-hepato-renal phenotype caused by mutations in genes involved in the peroxisome biogenesis pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-01T10:12:52Z"^^xsd:string ;
  obo:hasExactSynonym "cerebrohepatorenal syndrome pathway"^^xsd:string, "congenital iron overload pathway"^^xsd:string, "peroxisome biogenesis disorder pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00316"^^xsd:string ;
  obo:id "PW:0001415"^^xsd:string ;
  rdfs:label "Zellweger syndrome pathway"^^xsd:string ;
  skos:notation "PW:0001415"^^xsd:string .

ns1:PW_0001416
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001646, ns1:PW_0001751 ;
  ns2:treeView ns1:PW_0001646, ns1:PW_0001751 ;
  ns1:IAO_0000115 "A neurometabolic disorder affecting the central nervous system, caused by defects in mitochondrial and/or nuclear genes involved in energy metabolic pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-01T10:17:22Z"^^xsd:string ;
  obo:hasExactSynonym "Infantile necrotizing encephalomyelopathy pathway"^^xsd:string, "Leigh syndrome pathway"^^xsd:string, "juvenile subacute necrotizing encephalomyelopathy pathway"^^xsd:string, "subacute necrotizing encephalomyelopathy pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00196"^^xsd:string ;
  obo:id "PW:0001416"^^xsd:string ;
  rdfs:label "Leigh disease pathway"^^xsd:string ;
  skos:notation "PW:0001416"^^xsd:string .

ns1:PW_0001417
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000014, ns1:PW_0001646 ;
  ns2:treeView ns1:PW_0000014, ns1:PW_0001646 ;
  ns1:IAO_0000115 "A rare autosomal recessive condition characterized by degeneration of the nervous system due to white matter vacuolization and demeylination. It results from defects in ASPA, aspartoacylase gene involved in several amino acid metabolic pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-01T10:30:56Z"^^xsd:string ;
  obo:hasExactSynonym "Canavan-Van Bogaert-Bertrand disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00175"^^xsd:string ;
  obo:id "PW:0001417"^^xsd:string ;
  rdfs:label "Canavan disease pathway"^^xsd:string ;
  skos:notation "PW:0001417"^^xsd:string .

ns1:PW_0001418
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002150 ;
  ns2:treeView ns1:PW_0002150 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of abciximab, an integrin receptor antagonist used as a platelet aggregation inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-01T11:09:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001418"^^xsd:string ;
  rdfs:label "abciximab drug pathway"^^xsd:string ;
  skos:notation "PW:0001418"^^xsd:string .

ns1:PW_0001419
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001418 ;
  ns2:treeView ns1:PW_0001418 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of abciximab, a platelet aggregation inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-01T11:13:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001419"^^xsd:string ;
  rdfs:label "abciximab pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001419"^^xsd:string .

ns1:PW_0001420
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001418 ;
  ns2:treeView ns1:PW_0001418 ;
  ns1:IAO_0000115 "The pathway of abciximab-target interaction and of the biochemical or physiological responses to drug. Abciximab is an antagonist of the integrin alpha2b/beta3 complex found on platelets. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-01T11:15:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00265"^^xsd:string ;
  obo:id "PW:0001420"^^xsd:string ;
  rdfs:label "abciximab pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001420"^^xsd:string .

ns1:PW_0001421
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000996 ;
  ns2:treeView ns1:PW_0000996 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of kanamycin, an aminoglycoside antibiotic that inhibits bacterial protein synthesis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-01T11:51:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001421"^^xsd:string ;
  rdfs:label "kanamycin drug pathway"^^xsd:string ;
  skos:notation "PW:0001421"^^xsd:string .

ns1:PW_0001422
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001421 ;
  ns2:treeView ns1:PW_0001421 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination of kanamycin - an antibiotic that interferes with bacterial protein synthesis. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-01T12:02:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001422"^^xsd:string ;
  rdfs:label "kanamycin pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001422"^^xsd:string .

ns1:PW_0001423
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001421 ;
  ns2:treeView ns1:PW_0001421 ;
  ns1:IAO_0000115 "The pathway of kanamycin-target interaction and of the biochemical or physiological responses to drug. Kanamycin interferes with bacterial protein synthesis and is used in the treatment of several infections caused by both Gram-negative and Gram-positive bacteria. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-01T12:04:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00255"^^xsd:string ;
  obo:id "PW:0001423"^^xsd:string ;
  rdfs:label "kanamycin pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001423"^^xsd:string .

ns1:PW_0001424
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000996 ;
  ns2:treeView ns1:PW_0000996 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of neviparine, a non-nucleoside reverse transcriptase inhibitor used in the treatment of HIV type 1. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-01T12:10:20Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001424"^^xsd:string ;
  rdfs:label "neviparine drug pathway"^^xsd:string ;
  skos:notation "PW:0001424"^^xsd:string .

ns1:PW_0001425
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001424 ;
  ns2:treeView ns1:PW_0001424 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination of neviparine, a reverse transcriptase inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-01T12:30:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00642"^^xsd:string ;
  obo:id "PW:0001425"^^xsd:string ;
  rdfs:label "neviparine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001425"^^xsd:string .

ns1:PW_0001426
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001424 ;
  ns2:treeView ns1:PW_0001424 ;
  ns1:IAO_0000115 "The pathway of neviaparine-target interaction and of the biochemical or physiological responses to drug. Neviparine is a non-nucleoside reverse transcriptase inhibitor used in combination with other antiretroviral drugs  for the treatment of HIV type. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-01T12:31:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00743"^^xsd:string ;
  obo:id "PW:0001426"^^xsd:string ;
  rdfs:label "neviparine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001426"^^xsd:string .

ns1:PW_0001427
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000996 ;
  ns2:treeView ns1:PW_0000996 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of amikacin, an aminoglycoside antibiotic that inhibits bacterial protein synthesis. It is used for the treatment of infections induced by Gram-negative bacteria. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-01T12:53:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001427"^^xsd:string ;
  rdfs:label "amikacin drug pathway"^^xsd:string ;
  skos:notation "PW:0001427"^^xsd:string .

ns1:PW_0001428
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001427 ;
  ns2:treeView ns1:PW_0001427 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination of amikacin, an antibiotic used for the treatment of infections induced by Gram-negative bacteria. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-01T12:55:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001428"^^xsd:string ;
  rdfs:label "amikacin pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001428"^^xsd:string .

ns1:PW_0001429
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001427 ;
  ns2:treeView ns1:PW_0001427 ;
  ns1:IAO_0000115 "The pathway of amikacin-target interaction and of the biochemical or physiological responses to drug. Amikacin inhibits bacterial protein synthesis and is used for the treatment of infections induced by Gram-negative bacteria. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-01T12:57:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00253"^^xsd:string ;
  obo:id "PW:0001429"^^xsd:string ;
  rdfs:label "amikacin pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001429"^^xsd:string .

ns1:PW_0001430
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000996 ;
  ns2:treeView ns1:PW_0000996 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of lamivudine, a reverse transcriptase enzyme inhibitor used for the treatment of HIV type 1 and 2 and Hepatitis B virus. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-01T13:09:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001430"^^xsd:string ;
  rdfs:label "lamivudine drug pathway"^^xsd:string ;
  skos:notation "PW:0001430"^^xsd:string .

ns1:PW_0001431
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001430 ;
  ns2:treeView ns1:PW_0001430 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination of lamivudine, a reverse transcriptase inhibitor used for the treatment of several virally induced diseases. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-01T13:12:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00649"^^xsd:string ;
  obo:id "PW:0001431"^^xsd:string ;
  rdfs:label "lamivudine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001431"^^xsd:string .

ns1:PW_0001432
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001430 ;
  ns2:treeView ns1:PW_0001430 ;
  ns1:IAO_0000115 "The pathway of lamivudine-target interaction and of the biochemical or physiological responses to drug. Lamivudine is a a reverse transcriptase enzyme inhibitor used for the treatment of HIV typ1 and 2 and Hepatitis B. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-01T13:17:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00742"^^xsd:string ;
  obo:id "PW:0001432"^^xsd:string ;
  rdfs:label "lamivudine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001432"^^xsd:string .

ns1:PW_0001433
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000996 ;
  ns2:treeView ns1:PW_0000996 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of gentamicin, an antibiotic that inhibits bacterial protein synthesis. The drug can cause inner ear and kidney problems. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-01T13:22:06Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001433"^^xsd:string ;
  rdfs:label "gentamicin drug pathway"^^xsd:string ;
  skos:notation "PW:0001433"^^xsd:string .

ns1:PW_0001434
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000124 ;
  ns2:treeView ns1:PW_0000124 ;
  ns1:IAO_0000115 "The responses triggered by exposure to a toxin or a toxicant, a poisonous substance naturally produced by an organism or made by humans, respectively. A toxicant can be a poison, such as a pesticide. It can also be a compound for use in certain applications or a drug, the exposure to which may be toxic. Inflammatory responses, various types of cell death, changes in gene and protein expression can be induced upon exposure."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-10T09:32:50Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001434"^^xsd:string ;
  rdfs:label "toxin and toxicant response pathway"^^xsd:string ;
  skos:notation "PW:0001434"^^xsd:string .

ns1:PW_0001435
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001434 ;
  ns2:treeView ns1:PW_0001434 ;
  ns1:IAO_0000115 "A pathway triggered by exposure to a nanomaterial. Nanomaterials, such as fullerenes and inorganic nanoparticles are increasingly being used in a broad range of applications. However, in a dose-dependent manner, they may exert toxic effects that affect cellular pathways and processes and elicit defense mechanisms."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-10T10:09:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001435"^^xsd:string ;
  rdfs:label "nanomaterial response pathway"^^xsd:string ;
  skos:notation "PW:0001435"^^xsd:string .

ns1:PW_0001436
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001435 ;
  ns2:treeView ns1:PW_0001435 ;
  ns1:IAO_0000115 "A pathway triggered by exposure to carbon nanotube (CNT), an allotrope of carbon of the fullerene structural family. CNTs have a very broad range of applications but can also exert toxic effects. Pulmonary toxicity possibly via reactive oxygen species, inhibition of potassium channels and DNA repair are some of the potential mechanisms of CNT genotoxicity. Various forms of cell death and inflammatory responses are triggered in response to CNT."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-10T10:33:41Z"^^xsd:string ;
  obo:hasExactSynonym "CNT response pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001436"^^xsd:string ;
  rdfs:label "carbon nanotube response pathway"^^xsd:string ;
  skos:notation "PW:0001436"^^xsd:string .

ns1:PW_0001437
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001435 ;
  ns2:treeView ns1:PW_0001435 ;
  ns1:IAO_0000115 "A pathway triggered by exposure to titanium dioxide nanoparticle (nano-TiO2). Nano-TiO2 has a broad range of applications but studies indicate that under conditions of long and high dose exposure, it can exert cytotoxic and genotoxic effects. Nano-TiO2 has been shown to induce inflammation, oxidative stress and MAP kinase activity."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-10T13:08:48Z"^^xsd:string ;
  obo:hasExactSynonym "nano-TiO2 response pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001437"^^xsd:string ;
  rdfs:label "titanium dioxide nanoparticle response pathway"^^xsd:string ;
  skos:notation "PW:0001437"^^xsd:string .

ns1:PW_0001438
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001229 ;
  ns2:treeView ns1:PW_0001229 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the uptake, modification and elimination of polycyclic aromatic hydrocarbons (PAHs), a class of compounds, members of which are potent mutagens and carcinogens. Metabolites of PAHs can form DNA adducts, considered a necessary step of their carcinogenic property."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-10T13:58:48Z"^^xsd:string ;
  obo:hasExactSynonym "PAH metabolic pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001438"^^xsd:string ;
  rdfs:label "polycyclic aromatic hydrocarbon metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001438"^^xsd:string .

ns1:PW_0001439
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001435 ;
  ns2:treeView ns1:PW_0001435 ;
  ns1:IAO_0000115 "A pathway triggered by exposure to cerium oxide nanoparticles, also known as nanoceria. Like other nanoparticles, nanoceria has a broad range of applications. A peculiar feature is the anti-oxidant property; by catalytically reacting with superoxide and hydrogen peroxide, it mimics the activities of superoxide dismutase and catalase enzymes. In addition, beneficial effects on cell differentiation and dopamine production have been shown. However, toxic effects have also been demonstrated."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-12T10:55:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001439"^^xsd:string ;
  rdfs:label "cerium oxide nanoparticle response pathway"^^xsd:string ;
  skos:notation "PW:0001439"^^xsd:string .

ns1:PW_0001440
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001018, ns1:PW_0001593 ;
  ns2:treeView ns1:PW_0001018, ns1:PW_0001593 ;
  ns1:IAO_0000115 "Arthritis collectively describes several conditions whose primary feature is represented by joint pain resulting from inflammation."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-12T11:28:49Z"^^xsd:string ;
  obo:hasExactSynonym "arthritis disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001440"^^xsd:string ;
  rdfs:label "arthritis pathway"^^xsd:string ;
  skos:notation "PW:0001440"^^xsd:string .

ns1:PW_0001441
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001440 ;
  ns2:treeView ns1:PW_0001440 ;
  ns1:IAO_0000115 "A metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of uric acid calculi. Elements of the gout pathway potentially contributory to the disease are urate excretion by renal transporters where mutations in these genes can increase the risk of gout, hepatic production of urate, urate crystal formation in joints and initiation of the inflammatory response."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-12T11:32:52Z"^^xsd:string ;
  obo:hasExactSynonym "gout disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001441"^^xsd:string ;
  rdfs:label "gout pathway"^^xsd:string ;
  skos:notation "PW:0001441"^^xsd:string .

ns1:PW_0001442
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001018 ;
  ns2:treeView ns1:PW_0001018 ;
  ns1:IAO_0000115 "The inflammatory bowel disease (IBD) results from the deregulation of the immune system to which both genetic and environmental factors contribute. Alterations in pattern recognition receptor signaling, such as Toll-like or Nod and signaling downstream of them, among others, may contribute to and/or lead to the chronic inflammation characteristic of the condition. The main forms of IBD are Crohn's and ulcerative colitis."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-07-24T11:11:48Z"^^xsd:string ;
  obo:hasExactSynonym "IBD disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:05321"^^xsd:string ;
  obo:id "PW:0001442"^^xsd:string ;
  rdfs:label "inflammatory bowel disease pathway"^^xsd:string ;
  skos:notation "PW:0001442"^^xsd:string .

ns1:PW_0001443
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000920 ;
  ns2:treeView ns1:PW_0000920 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of ezetimibe - a drug used to lower the plasma cholesterol level. Ezetimibe is a selective cholesterol absorption inhibitor used both as monotherapy and in combination with statins. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-08-26T09:32:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Zetia drug pathway"^^xsd:string ;
  obo:id "PW:0001443"^^xsd:string ;
  rdfs:label "ezetimibe drug pathway"^^xsd:string ;
  skos:notation "PW:0001443"^^xsd:string .

ns1:PW_0001444
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001443 ;
  ns2:treeView ns1:PW_0001443 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of ezetimibe, a selective inhibitor of cholesterol absorption. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-08-26T09:33:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Zetia pharmacokinetics pathway"^^xsd:string ;
  obo:id "PW:0001444"^^xsd:string ;
  rdfs:label "ezetimibe pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001444"^^xsd:string .

ns1:PW_0001445
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001443 ;
  ns2:treeView ns1:PW_0001443 ;
  ns1:IAO_0000115 "The pathway of ezetimibe-target interaction and of the biochemical or physiological responses to drug. Ezetimibe is a selective inhibitor of cholesterol absorption used both as monotherapy and in combination with statins. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-08-26T09:34:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Zetia pharmacodynamics pathway"^^xsd:string ;
  obo:id "PW:0001445"^^xsd:string ;
  rdfs:label "ezetimibe pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001445"^^xsd:string .

ns1:PW_0001446
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000920 ;
  ns2:treeView ns1:PW_0000920 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of lomitapide, a drug used to lower cholesterol levels. Lomitapide is an inhibitor of microsomal triglyceride transfer protein used both as monotherapy and in combination with statins. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-08-26T09:40:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001446"^^xsd:string ;
  rdfs:label "lomitapide drug pathway"^^xsd:string ;
  skos:notation "PW:0001446"^^xsd:string .

ns1:PW_0001447
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001446 ;
  ns2:treeView ns1:PW_0001446 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of lomitapide, an inhibitor of microsomal triglyceride transfer protein. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-08-26T09:41:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001447"^^xsd:string ;
  rdfs:label "lomitapide pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001447"^^xsd:string .

ns1:PW_0001448
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001446 ;
  ns2:treeView ns1:PW_0001446 ;
  ns1:IAO_0000115 "The pathway of lomitapide-target interaction and of the biochemical or physiological responses to drug. The drug is an inhibitor of microsomal triglyceride transport protein and used to lower cholesterol levels. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-08-26T09:41:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001448"^^xsd:string ;
  rdfs:label "lomitapide pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001448"^^xsd:string .

ns1:PW_0001449
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000721 ;
  ns2:treeView ns1:PW_0000721 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of nicotine, an agonist of nicotinic acetylcholine receptors. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-08-28T13:57:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00628"^^xsd:string ;
  obo:id "PW:0001449"^^xsd:string ;
  rdfs:label "nicotine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001449"^^xsd:string .

ns1:PW_0001450
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000721 ;
  ns2:treeView ns1:PW_0000721 ;
  ns1:IAO_0000115 "The pathway of nicotine-target interaction and of the biochemical or physiological responses to drug. Nicotine is an agonist of the nicotinic acetylcholine receptors and exerts stimulatory roles. It is also responsible for tobacco dependence.  Prolonged exposure and high levels of nicotine can have toxic effects. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-08-28T13:58:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00431"^^xsd:string ;
  obo:id "PW:0001450"^^xsd:string ;
  rdfs:label "nicotine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001450"^^xsd:string .

ns1:PW_0001451
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002295 ;
  ns2:treeView ns1:PW_0002295 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of valproic acid, a branched short-chain fatty acid derived from valeric acid used as a mood-stabilizing drug and in the treatment of epilepsy. More recently it has also been found to inhibit the proliferation of cancers. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-08-28T14:01:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "valproate drug pathway"^^xsd:string ;
  obo:id "PW:0001451"^^xsd:string ;
  rdfs:label "valproic acid drug pathway"^^xsd:string ;
  skos:notation "PW:0001451"^^xsd:string .

ns1:PW_0001452
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001451 ;
  ns2:treeView ns1:PW_0001451 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of valproic acid, a drug used as a mood-stabilizing and for the treatment of epilepsy. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-08-28T14:04:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00635"^^xsd:string, "valproate pharmacokinetics pathway"^^xsd:string ;
  obo:id "PW:0001452"^^xsd:string ;
  rdfs:label "valproic acid pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001452"^^xsd:string .

ns1:PW_0001453
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001451 ;
  ns2:treeView ns1:PW_0001451 ;
  ns1:IAO_0000115 "The pathway of valproic acid-target interaction and of the biochemical or physiological responses to drug. Valproic acid is used as a mood-stabilizing drug and in the treatment of epilepsy. More recently it has also been found to inhibit the proliferation of cancers. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-08-28T14:05:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "valproate pharmacodynamics pathway"^^xsd:string ;
  obo:id "PW:0001453"^^xsd:string ;
  rdfs:label "valproic acid pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001453"^^xsd:string .

ns1:PW_0001454
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002301 ;
  ns2:treeView ns1:PW_0002301 ;
  ns1:IAO_0000115 "Gaucher's disease is caused by defective sphingolipid metabolism and accumulation of glucosylceramide in the brain and other tissues."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-08-28T14:20:47Z"^^xsd:string ;
  obo:hasExactSynonym "Gaucher disease pathway"^^xsd:string, "acid beta-glucosidase deficiency pathway"^^xsd:string, "glocucerebrosidase deficiency pathway"^^xsd:string, "glucosylceramide beta-glucosidase deficiency pathway"^^xsd:string, "kerasin thesaurismosis pathway"^^xsd:string, "lipoid histiocytosis (kerasin type) pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00349"^^xsd:string ;
  obo:id "PW:0001454"^^xsd:string ;
  rdfs:label "Gaucher's disease pathway"^^xsd:string ;
  skos:notation "PW:0001454"^^xsd:string .

ns1:PW_0001455
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of doxorubicin, a streptomyces metabolite used as a chemotherapeutic agent used in the treatment of cancers. However, its use is limited by the serious cardiotoxic side effects. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-08-29T15:06:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001455"^^xsd:string ;
  rdfs:label "doxorubicin drug pathway"^^xsd:string ;
  skos:notation "PW:0001455"^^xsd:string .

ns1:PW_0001456
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001202 ;
  ns2:treeView ns1:PW_0001202 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of nystatin - a polyene antifungal drug used to treat yeast infections. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-09-05T17:25:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001456"^^xsd:string ;
  rdfs:label "nystatin drug pathway"^^xsd:string ;
  skos:notation "PW:0001456"^^xsd:string .

ns1:PW_0001457
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001456 ;
  ns2:treeView ns1:PW_0001456 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination -of nystatin. Nystatin is an antifungal that binds to ergosterol - a component of the fungal cell membrane, and also with cholesterol. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-09-05T17:29:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001457"^^xsd:string ;
  rdfs:label "nystatin pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001457"^^xsd:string .

ns1:PW_0001458
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001456 ;
  ns2:treeView ns1:PW_0001456 ;
  ns1:IAO_0000115 "The pathway of nystatin-target interactions and of the biochemical or physiological responses to drug. Nystatin interacts with both the fungal ergosterol and the host cholesterol but its afinity for ergosterol is higher. The interaction with cholesterol impacts on the uptake and activity of the anti-angiogenic endostatin."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-09-05T17:29:50Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001458"^^xsd:string ;
  rdfs:label "nystatin pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001458"^^xsd:string .

ns1:PW_0001459
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001202 ;
  ns2:treeView ns1:PW_0001202 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-09-05T17:30:56Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001459"^^xsd:string ;
  rdfs:label "amphotericin B drug pathway"^^xsd:string ;
  skos:notation "PW:0001459"^^xsd:string .

ns1:PW_0001460
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001459 ;
  ns2:treeView ns1:PW_0001459 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-09-05T17:31:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001460"^^xsd:string ;
  rdfs:label "amphotericin B pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001460"^^xsd:string .

ns1:PW_0001461
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001459 ;
  ns2:treeView ns1:PW_0001459 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-09-05T17:31:50Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001461"^^xsd:string ;
  rdfs:label "amphotericin B pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001461"^^xsd:string .

ns1:PW_0001462
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001789 ;
  ns2:treeView ns1:PW_0001789 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of losartan, an angiotensin II receptor type 1 antagonist used in the treatment of hypertension and heart failure. Losartan is one of several angiotensin II receptor type 1 antagonists and the first used on the market. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-09-20T15:43:56Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001462"^^xsd:string ;
  rdfs:label "losartan drug pathway"^^xsd:string ;
  skos:notation "PW:0001462"^^xsd:string .

ns1:PW_0001463
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001462 ;
  ns2:treeView ns1:PW_0001462 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of losartan. The drug is an angiotensin II receptor type 1 antagonist used in the treatment of hypertension and heart failure. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-09-20T15:47:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001463"^^xsd:string ;
  rdfs:label "losartan pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001463"^^xsd:string .

ns1:PW_0001464
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001462 ;
  ns2:treeView ns1:PW_0001462 ;
  ns1:IAO_0000115 "The pathway of losartan-target interaction and of the biochemical or physiological responses to drug. Losartan is an angiotensin II receptor type 1 antagonist used in the treatment of hypertension and heart failure. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-09-20T15:48:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00162"^^xsd:string ;
  obo:id "PW:0001464"^^xsd:string ;
  rdfs:label "losartan pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001464"^^xsd:string .

ns1:PW_0001465
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002150 ;
  ns2:treeView ns1:PW_0002150 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of clopidogrel, a platelet aggregation inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-10-25T12:06:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001465"^^xsd:string ;
  rdfs:label "clopidogrel drug pathway"^^xsd:string ;
  skos:notation "PW:0001465"^^xsd:string .

ns1:PW_0001466
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001465 ;
  ns2:treeView ns1:PW_0001465 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of clopidogrel. The drug is an inhibitor of ADP-dependent platelet activation and aggregation. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-10-25T12:07:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00610"^^xsd:string ;
  obo:id "PW:0001466"^^xsd:string ;
  rdfs:label "clopidogrel pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001466"^^xsd:string .

ns1:PW_0001467
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001465 ;
  ns2:treeView ns1:PW_0001465 ;
  ns1:IAO_0000115 "The pathway of clopidogrel-target interaction and of the biochemical or physiological responses to drug. The drug is an inhibitor of purinergic receptor P2RY12 a G-protein coupled receptor and chemoreceptor for adenosine diphosphate (ADP) receptor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-10-25T12:08:38Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00260"^^xsd:string ;
  obo:id "PW:0001467"^^xsd:string ;
  rdfs:label "clopidogrel pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001467"^^xsd:string .

ns1:PW_0001468
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000920, ns1:PW_0001170, ns1:PW_0001202, ns1:PW_0001546 ;
  ns2:treeView ns1:PW_0000920, ns1:PW_0001170, ns1:PW_0001202, ns1:PW_0001546 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of ibuprofen, a non-steroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes and is used in the treatment of inflammation and pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-10-25T12:10:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001468"^^xsd:string ;
  rdfs:label "ibuprofen drug pathway"^^xsd:string ;
  skos:notation "PW:0001468"^^xsd:string .

ns1:PW_0001469
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001468 ;
  ns2:treeView ns1:PW_0001468 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of ibuprofen. The drug is used in the treatment of pain and inflammation. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-10-25T12:11:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00590"^^xsd:string ;
  obo:id "PW:0001469"^^xsd:string ;
  rdfs:label "ibuprofen pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001469"^^xsd:string .

ns1:PW_0001470
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001468 ;
  ns2:treeView ns1:PW_0001468 ;
  ns1:IAO_0000115 "The pathway of ibuprofen-target interaction and of the biochemical or physiological responses to drug. Ibuprofen is an inhibitor of cyclooxygenase enzymes used in the treatment of pain and inflammation. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-10-25T12:12:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00086"^^xsd:string ;
  obo:id "PW:0001470"^^xsd:string ;
  rdfs:label "ibuprofen pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001470"^^xsd:string .

ns1:PW_0001471
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000344, ns1:PW_0002103 ;
  ns2:treeView ns1:PW_0000344, ns1:PW_0002103 ;
  ns1:IAO_0000115 "An X-linked inherited metabolic disorder affecting the cerebrovascular system. It is caused by alterations in sphingolipid metabolic pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-10-25T12:14:03Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001471"^^xsd:string ;
  rdfs:label "Fabry disease pathway, cerebrovascular"^^xsd:string ;
  skos:notation "PW:0001471"^^xsd:string .

ns1:PW_0001472
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001583 ;
  ns2:treeView ns1:PW_0001583 ;
  ns1:IAO_0000115 "Those diseases and disorders that are caused by deregulation of a metabolic pathway. It can be due to an inherited defect in an enzyme function and thus congenital, or acquired, when resulting from the failure or malfunctioning of an important metabolic organ."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-10-31T09:47:09Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001472"^^xsd:string ;
  rdfs:label "metabolic disease pathway"^^xsd:string ;
  skos:notation "PW:0001472"^^xsd:string .

ns1:PW_0001473
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001472 ;
  ns2:treeView ns1:PW_0001472 ;
  ns1:IAO_0000115 "Those diseases and disorders that are caused by deregulation of lipid metabolic pathways. The condition(s) can be inherited or acquired."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-10-31T09:58:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001473"^^xsd:string ;
  rdfs:label "lipid metabolism disease pathway"^^xsd:string ;
  skos:notation "PW:0001473"^^xsd:string .

ns1:PW_0001474
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001473 ;
  ns2:treeView ns1:PW_0001473 ;
  ns1:IAO_0000115 "Xanthomatosis results from deregulation of cholesterol metabolic pathways and is manifested by the formation of yellow,  cholesterol-rich deposits. It is a rare, inherited condition and can affect several tissues."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-10-31T10:04:06Z"^^xsd:string ;
  obo:hasExactSynonym "xanthelasmatosis pathway"^^xsd:string, "xanthomatosis disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001474"^^xsd:string ;
  rdfs:label "xanthomatosis pathway"^^xsd:string ;
  skos:notation "PW:0001474"^^xsd:string .

ns1:PW_0001475
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001474, ns1:PW_0001643 ;
  ns2:treeView ns1:PW_0001474, ns1:PW_0001643 ;
  ns1:IAO_0000115 "The cerebrotendinous type of xanthomatosis is caused by mutation in the CYP27A1 gene - a sterol hydrolase involved in the oxidation of side chain sterol intermediates. It affects many tissues, predominantly the brain and lungs."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-10-31T10:12:50Z"^^xsd:string ;
  obo:hasExactSynonym "cerebrotendinous xanthomatosis disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "CTX disease pathway"^^xsd:string, "SMP:00315"^^xsd:string ;
  obo:id "PW:0001475"^^xsd:string ;
  rdfs:label "cerebrotendinous xanthomatosis pathway"^^xsd:string ;
  skos:notation "PW:0001475"^^xsd:string .

ns1:PW_0001476
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000013 ;
  ns2:treeView ns1:PW_0000013 ;
  ns1:IAO_0000115 "Those diseases present at birth and also before birth, or those that develop during the first month of life. Alteration(s) in one or several pathways can contribute to the development of the condition usually manifested in structural deformities."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-10-31T10:45:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "congenital disorder pathway"^^xsd:string ;
  obo:id "PW:0001476"^^xsd:string ;
  rdfs:label "congenital disease pathway"^^xsd:string ;
  skos:notation "PW:0001476"^^xsd:string .

ns1:PW_0001477
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001476 ;
  ns2:treeView ns1:PW_0001476 ;
  ns1:IAO_0000115 "Those diseases that are caused by genetic mutations present during fetal development and that may be inherited from a parent or acquired in utero. The mutations can disrupt one or several pathways that give rise to a broad spectrum of conditions affecting many types of organs and/or tissues."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-10-31T10:54:45Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001477"^^xsd:string ;
  rdfs:label "inborn genetic disease pathway"^^xsd:string ;
  skos:notation "PW:0001477"^^xsd:string .

ns1:PW_0001478
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001477 ;
  ns2:treeView ns1:PW_0001477 ;
  ns1:IAO_0000115 "Congenital adrenal hyperplasia pathway represents a group of inherited disorders of the adrenal glands that results from defects in several enzymes involved in steroid hormone metabolic pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-10-31T10:59:39Z"^^xsd:string ;
  obo:hasExactSynonym "congenital adrenal hyperplasia disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001478"^^xsd:string ;
  rdfs:label "congenital adrenal hyperplasia pathway"^^xsd:string ;
  skos:notation "PW:0001478"^^xsd:string .

ns1:PW_0001479
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001478 ;
  ns2:treeView ns1:PW_0001478 ;
  ns1:IAO_0000115 "Lipoid congenital adrenal hyperplasia, the most severe disorder of steroid hormone biosynthesis, is caused by a defect in the conversion of cholesterol to pregnenolone, the first step in adrenal and gonadal steroidogenesis. All affected individuals are phenotypic females with a severe salt-losing syndrome that is fatal if not treated in early infancy."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-10-31T11:04:45Z"^^xsd:string ;
  obo:hasExactSynonym "CLAH pathway"^^xsd:string, "adrenal hyperplasia 1 pathway"^^xsd:string, "congenital adrenal hyperplasia pathway"^^xsd:string, "congenital lipoid adrenal hyperplasia pathway"^^xsd:string, "lipoid CAH pathway"^^xsd:string, "lipoid congenital adrenal hyperplasia disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "LCAH disease pathway"^^xsd:string, "SMP:00371"^^xsd:string ;
  obo:id "PW:0001479"^^xsd:string ;
  rdfs:label "lipoid congenital adrenal hyperplasia pathway"^^xsd:string ;
  skos:notation "PW:0001479"^^xsd:string .

ns1:PW_0001480
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000526
  ] ;
  ns2:treeView ns1:PW_0000526 ;
  ns3:part_of ns1:PW_0000526 ;
  ns1:IAO_0000115 "The active kinin peptides generated by the kallikrein-kinin cascade - bradykinin, kallidin and their C-terminal processed metabolites, signal via two G-protein coupled (GPCR) receptors. The two receptors employ similar signaling pathways but also exhibit distinct patterns. Type 1 receptor is inducible, type 2 is ubiquitous and can form heterodimers with angiotensin II receptors."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-11-05T15:22:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001480"^^xsd:string ;
  rdfs:label "kinin signaling pathway"^^xsd:string ;
  skos:notation "PW:0001480"^^xsd:string .

ns1:PW_0001481
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000798 ;
  ns2:treeView ns1:PW_0000798 ;
  ns1:IAO_0000115 "The peripheral dopaminergic system is distinct from the neuronal one. In the kidney, dopamine signaling plays an important role in the regulation of blood pressure and accounts for ~50% of total water and sodium excretion. Both type1-like and 2-like receptors are expressed in the mammalian kidney. They couple to distinct G protein alpha subunits to elicit renal dopamine responses. Type 1-like may be responsible for many of dopamine effects."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-11-08T09:04:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001481"^^xsd:string ;
  rdfs:label "peripheral dopamine signaling pathway"^^xsd:string ;
  skos:notation "PW:0001481"^^xsd:string .

ns1:PW_0001482
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001481, ns1:PW_0001483 ;
  ns2:treeView ns1:PW_0001481, ns1:PW_0001483 ;
  ns1:IAO_0000115 "A peripheral dopamine signaling pathway that deviates from what its normal course should be. Altered peripheral dopamine signaling has been associated with elevated blood pressure in rodent models and with essential hypertension in certain populations."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-11-08T09:19:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001482"^^xsd:string ;
  rdfs:label "altered peripheral dopamine signaling pathway"^^xsd:string ;
  skos:notation "PW:0001482"^^xsd:string .

ns1:PW_0001483
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000798, ns1:PW_0001484 ;
  ns2:treeView ns1:PW_0000798, ns1:PW_0001484 ;
  ns1:IAO_0000115 "A catecholamine signaling pathway that deviates from what its normal course should be."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-11-08T11:04:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001483"^^xsd:string ;
  rdfs:label "altered catecholamine signaling pathway"^^xsd:string ;
  skos:notation "PW:0001483"^^xsd:string .

ns1:PW_0001484
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000466, ns1:PW_0000509 ;
  ns2:treeView ns1:PW_0000466, ns1:PW_0000509 ;
  ns1:IAO_0000115 "An amino and amino acid-derived hormone signaling pathway that deviates from what its normal course should be."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-11-08T11:12:09Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001484"^^xsd:string ;
  rdfs:label "altered amine and amino acid-derived hormone signaling pathway"^^xsd:string ;
  skos:notation "PW:0001484"^^xsd:string .

ns1:PW_0001485
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001462 ;
  ns2:treeView ns1:PW_0001462 ;
  ns1:IAO_0000115 "The expanded network of losartan-interacting genes."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-11-22T14:43:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001485"^^xsd:string ;
  rdfs:label "losartan-gene, gene-chemical, gene-gene interaction pathway"^^xsd:string ;
  skos:notation "PW:0001485"^^xsd:string .

ns1:PW_0001486
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001434 ;
  ns2:treeView ns1:PW_0001434 ;
  ns1:IAO_0000115 "A pathway triggered by exposure to carbon tetrachloride, an organic compound used in several application. It is one oft he most potent hepatotoxins and has been banned in consumer products. In vivo studies using animal models show that exposure to carbon tetrachloride triggers the activity of several enzymes and the production of antioxidant molecules in a dose-dependent manner."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-12-03T10:45:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "CCl4 response pathway"^^xsd:string ;
  obo:id "PW:0001486"^^xsd:string ;
  rdfs:label "carbon tetrachloride response pathway"^^xsd:string ;
  skos:notation "PW:0001486"^^xsd:string .

ns1:PW_0001487
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001434 ;
  ns2:treeView ns1:PW_0001434 ;
  ns1:IAO_0000115 "A pathway triggered by exposure to ozone, a powerful oxidant with numerous industrial and consumer applications. However, it can induce tissue damage in animal and plants. Exposure to ozone induces the generation of free radicals, depletion of antioxidants and secretion of proinflammatory factors."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-12-03T11:17:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001487"^^xsd:string ;
  rdfs:label "ozone response pathway"^^xsd:string ;
  skos:notation "PW:0001487"^^xsd:string .

ns1:PW_0001488
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000723 ;
  ns2:treeView ns1:PW_0000723 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of metformin, an antihyperglycemic drug used in the treatment of type 2 diabetes mellitus. Metformin has also been shown to have a  tumor suppressor function. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-12-17T09:44:50Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001488"^^xsd:string ;
  rdfs:label "metformin drug pathway"^^xsd:string ;
  skos:notation "PW:0001488"^^xsd:string .

ns1:PW_0001489
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001488 ;
  ns2:treeView ns1:PW_0001488 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of metformin, an anti-diabetic drug used in the treatment of type 2 diabetes mellitus. Metformin is widely distributed in various tissues. Meformin is excreted unchanged and several transporters are involved in its tissue uptake and elimination. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-12-17T09:49:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001489"^^xsd:string ;
  rdfs:label "metformin pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001489"^^xsd:string .

ns1:PW_0001490
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001488 ;
  ns2:treeView ns1:PW_0001488 ;
  ns1:IAO_0000115 "The pathway of metformin-target interaction and of the biochemical or physiological responses to drug. Metformin lowers blood glucose levels by promoting the activation of AMPK signaling via molecular mechanisms that are not well understood. Mitochondria is the primary target of metformin which specifically inhibits complex I of the respiratory chain. The resulting change in AMP:ATP ratio can contribute to AMPK activation. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2013-12-17T09:49:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001490"^^xsd:string ;
  rdfs:label "metformin pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001490"^^xsd:string .

ns1:PW_0001491
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001488 ;
  ns2:treeView ns1:PW_0001488 ;
  ns1:IAO_0000115 "The expanded network of metformin-interacting genes."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-01-07T14:13:24Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001491"^^xsd:string ;
  rdfs:label "metformin-gene, gene-chemical, gene-gene interaction pathway"^^xsd:string ;
  skos:notation "PW:0001491"^^xsd:string .

ns1:PW_0001492
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000264, ns1:PW_0001008 ;
  ns2:treeView ns1:PW_0000264, ns1:PW_0001008 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-01-29T16:17:27Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001492"^^xsd:string ;
  rdfs:label "altered photosignal transduction pathway"^^xsd:string ;
  skos:notation "PW:0001492"^^xsd:string .

ns1:PW_0001493
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000264, ns1:PW_0001012 ;
  ns2:treeView ns1:PW_0000264, ns1:PW_0001012 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-01-29T16:18:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001493"^^xsd:string ;
  rdfs:label "altered vitamin and vitamin metabolites signaling pathway"^^xsd:string ;
  skos:notation "PW:0001493"^^xsd:string .

ns1:PW_0001494
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001116, ns1:PW_0001493 ;
  ns2:treeView ns1:PW_0001116, ns1:PW_0001493 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-01-29T16:19:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001494"^^xsd:string ;
  rdfs:label "altered vitamin A and metabolites signaling pathway"^^xsd:string ;
  skos:notation "PW:0001494"^^xsd:string .

ns1:PW_0001495
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000962, ns1:PW_0001492, ns1:PW_0001494 ;
  ns2:treeView ns1:PW_0000962, ns1:PW_0001492, ns1:PW_0001494 ;
  ns1:IAO_0000115 "Alterations in the visual phototransduction signaling have been linked to a number conditions such as retinits pigmentosa (RP), Bardet-Biedl syndrome (BBS), macular degeneration and others. More than 200 point mutations in rhodopsin account for ~25% of the autosomal dominant type of RP."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-01-29T16:20:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001495"^^xsd:string ;
  rdfs:label "altered visual phototransduction pathway"^^xsd:string ;
  skos:notation "PW:0001495"^^xsd:string .

ns1:PW_0001496
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001412 ;
  ns2:treeView ns1:PW_0001412 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-01-30T14:22:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001496"^^xsd:string ;
  rdfs:label "sensory system disease pathway"^^xsd:string ;
  skos:notation "PW:0001496"^^xsd:string .

ns1:PW_0001497
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001496 ;
  ns2:treeView ns1:PW_0001496 ;
  ns1:IAO_0000115 "Retinitis pigmentosa (RP) is a common form of photoreceptor degeneration with a varied pattern of inheritance that includes autosomal dominant and recessive and X-linked forms. Mutations in components of the visual phototransduction and visual cycle (retinoid) metabolic pathways have been associated with RP manifestations. Other genes and potential miRNAs also play a role. A fraction of RP patients also have Usher syndrome which in addition to vision loss, also involves hearing loss."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-01-30T14:22:53Z"^^xsd:string ;
  obo:hasExactSynonym "pericentral pigmentary retinopathy pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001497"^^xsd:string ;
  rdfs:label "retinitis pigmentosa pathway"^^xsd:string ;
  skos:notation "PW:0001497"^^xsd:string .

ns1:PW_0001498
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001005, ns1:PW_0001499 ;
  ns2:treeView ns1:PW_0001005, ns1:PW_0001499 ;
  ns1:IAO_0000115 "Alteration in the retinoic cycle, or the visual cycle have been associated with retinitis pigmentosa and a few other forms of photoreceptor degeneration."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-01-30T14:32:56Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered visual cycle metabolic pathway"^^xsd:string ;
  obo:id "PW:0001498"^^xsd:string ;
  rdfs:label "altered retinoid cycle metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001498"^^xsd:string .

ns1:PW_0001499
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000429, ns1:PW_0001003, ns1:PW_0001501 ;
  ns2:treeView ns1:PW_0000429, ns1:PW_0001003, ns1:PW_0001501 ;
  ns1:IAO_0000115 "A retinoid metabolic pathway that deviates from what its normal course should be."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-01-30T14:38:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001499"^^xsd:string ;
  rdfs:label "altered retinoid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001499"^^xsd:string .

ns1:PW_0001500
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000358, ns1:PW_0001006 ;
  ns2:treeView ns1:PW_0000358, ns1:PW_0001006 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-01-31T12:49:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001500"^^xsd:string ;
  rdfs:label "altered vitamin homeostasis"^^xsd:string ;
  skos:notation "PW:0001500"^^xsd:string .

ns1:PW_0001501
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001007, ns1:PW_0001500 ;
  ns2:treeView ns1:PW_0001007, ns1:PW_0001500 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-01-31T12:49:45Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001501"^^xsd:string ;
  rdfs:label "altered vitamin A homeostasis"^^xsd:string ;
  skos:notation "PW:0001501"^^xsd:string .

ns1:PW_0001502
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000003 ;
  ns2:treeView ns1:PW_0000003 ;
  ns1:IAO_0000115 "The mechanostransduction pathway involves the conversion of a mechanical stimulus into an electrical signal whose processing underlies proprioception, hearing, balance and touch. Auditory and cytoskeleton mechanotransduction are examples."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-02-12T15:58:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001502"^^xsd:string ;
  rdfs:label "mechanotransduction pathway"^^xsd:string ;
  skos:notation "PW:0001502"^^xsd:string .

ns1:PW_0001503
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001502, ns1:PW_0001536 ;
  ns2:treeView ns1:PW_0001502, ns1:PW_0001536 ;
  ns1:IAO_0000115 "The auditory mechanotransduction pathway converts mechanical stimuli into electrical signaling that are processed by the brain and account for the perception of sound, gravity and movement. The inner ear contains the cochlea and the vestibule responsible for sound and movement mechanotransduction, respectively. The auditory mechanotransduction primarily depicts the sound generated responses by the hair cells in the organ of Corti."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-02-12T16:05:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001503"^^xsd:string ;
  rdfs:label "auditory mechanotransduction pathway"^^xsd:string ;
  skos:notation "PW:0001503"^^xsd:string .

ns1:PW_0001504
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001503, ns1:PW_0001505 ;
  ns2:treeView ns1:PW_0001503, ns1:PW_0001505 ;
  ns1:IAO_0000115 "Alterations in the auditory mechanotransduction pathway is associated with hearing impairment and deafness."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-02-12T16:15:56Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001504"^^xsd:string ;
  rdfs:label "altered auditory mechanotransduction pathway"^^xsd:string ;
  skos:notation "PW:0001504"^^xsd:string .

ns1:PW_0001505
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000264, ns1:PW_0001502 ;
  ns2:treeView ns1:PW_0000264, ns1:PW_0001502 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-02-12T16:20:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001505"^^xsd:string ;
  rdfs:label "altered mechanotransduction pathway"^^xsd:string ;
  skos:notation "PW:0001505"^^xsd:string .

ns1:PW_0001506
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001496 ;
  ns2:treeView ns1:PW_0001496 ;
  ns1:IAO_0000115 "The Usher syndrome is characterized by both vision and hearing loss. One sixth of patients with retinitis pigmentosa also have Usher syndrome. Clinically, there are three types of Usher syndromes that vary in terms of severity and onset. The genes involved are located in inner ear hair cells and the connecting cilium of photoreceptor cells. Their associations with auditory mechanotransduction are better known but their roles in visual phototransduction and altered pathways are still to be delineated."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-02-14T10:52:27Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001506"^^xsd:string ;
  rdfs:label "Usher syndrome pathway"^^xsd:string ;
  skos:notation "PW:0001506"^^xsd:string .

ns1:PW_0001507
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "The pharmacokinetics/pharmacodynamics of platinum (Pt) containing drugs, widely used in the treatment of cancer. These drugs introduce intra- and inter-strand DNA breaks. The DNA lesion and responses it triggers is toxic to tumor cells. However, it can also exert toxic side effects. Three Pt-containing drugs are being used and they vary in their efficacy and toxicity. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2014-02-26T10:07:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001507"^^xsd:string ;
  rdfs:label "platinum (Pt) containing drug pathway"^^xsd:string ;
  skos:notation "PW:0001507"^^xsd:string .

ns1:PW_0001508
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001507 ;
  ns2:treeView ns1:PW_0001507 ;
  ns1:IAO_0000115 "The pharmacokinetics/pharmacodynamics of cisplatin, a platinum (Pt) containing drug widely used in the treatment of solid tumors. Cisplatin is the most potent of such drugs, it si also the one with the strongest toxic side effects. Nephorotoxicity and ototoxicity are among the primary toxic side effects. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2014-02-26T10:16:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001508"^^xsd:string ;
  rdfs:label "cisplatin drug pathway"^^xsd:string ;
  skos:notation "PW:0001508"^^xsd:string .

ns1:PW_0001509
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001434 ;
  ns2:treeView ns1:PW_0001434 ;
  ns1:IAO_0000115 "A pathway triggered by exposure to platinum (Pt) containing drugs used in the treatment of solid tumors. The DNA lesion they introduce is toxic to the tumor cells. However, they also exert powerful toxic side effects. Cisplatin, the most potent drug is also the most toxic followed by the less potent carboplatin."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2014-02-26T10:23:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001509"^^xsd:string ;
  rdfs:label "platinum (Pt) containing drug response pathway"^^xsd:string ;
  skos:notation "PW:0001509"^^xsd:string .

ns1:PW_0001510
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001509 ;
  ns2:treeView ns1:PW_0001509 ;
  ns1:IAO_0000115 "A pathway triggered by exposure to cisplatin, a widely used and very potent anti-cancer platinum containing drug. It is also the one with the most toxic side effects.  Nephorotoxicity and ototoxicity are among the primary toxic side effects."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2014-02-26T10:28:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001510"^^xsd:string ;
  rdfs:label "cisplatin response pathway"^^xsd:string ;
  skos:notation "PW:0001510"^^xsd:string .

ns1:PW_0001511
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001434 ;
  ns2:treeView ns1:PW_0001434 ;
  ns1:IAO_0000115 "A pathway triggered by exposure to bisphenol A - a synthetic compound used  in the production of plastics and certain resins. It mimics estrogen and has negative health effects with the early developmental stages being the more sensitive to its effects. It may be implicated in the etiology of several chronic diseases."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2014-02-26T10:36:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "BPA response pathway"^^xsd:string ;
  obo:id "PW:0001511"^^xsd:string ;
  rdfs:label "bisphenol A response pathway"^^xsd:string ;
  skos:notation "PW:0001511"^^xsd:string .

ns1:PW_0001512
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001507 ;
  ns2:treeView ns1:PW_0001507 ;
  ns1:IAO_0000115 "The pharmacokinetics/pharmacodynamics of oxaliplatin, a platinum (Pt) containing drug widely used in the treatment of solid tumors. While less potent than cisplatin - the most potent of the platinum containing drugs, oxaliplatin is also less toxic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2014-02-26T11:28:09Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001512"^^xsd:string ;
  rdfs:label "oxaliplatin drug pathway"^^xsd:string ;
  skos:notation "PW:0001512"^^xsd:string .

ns1:PW_0001513
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001507 ;
  ns2:treeView ns1:PW_0001507 ;
  ns1:IAO_0000115 "The pharmacokinetics/pharmacodynamics of carboplatin, a platinum (Pt) containing drug used in the treatment of solid tumors. It is not as effective as cisplatin and while exerting less severe side affects, it can lead to myelosuppression and thrombocytopenia. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2014-02-26T12:00:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001513"^^xsd:string ;
  rdfs:label "carboplatin drug pathway"^^xsd:string ;
  skos:notation "PW:0001513"^^xsd:string .

ns1:PW_0001514
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001509 ;
  ns2:treeView ns1:PW_0001509 ;
  ns1:IAO_0000115 "A pathway triggered by exposure to carboplatin, a platinum containing drug used in the treatment of solid tumor. It is less potent than cisplatin but it can have serious toxic side effects such as myelosuppression and thrombocytopenia."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2014-02-26T12:14:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001514"^^xsd:string ;
  rdfs:label "carboplatin response pathway"^^xsd:string ;
  skos:notation "PW:0001514"^^xsd:string .

ns1:PW_0001515
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000650, ns1:PW_0001194 ;
  ns2:treeView ns1:PW_0000650, ns1:PW_0001194 ;
  ns1:IAO_0000115 "Hippo signaling pathway plays important roles in organ development and growth and tumor suppression. The pathway consists of a core of four kinases  which once activate by upstream regulators promote the cytoplasmic sequestration of YAP/TAZ transcriptional regulators. Dysregulation of the pathway has been implicated in tumor metastasis."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-03-19T11:27:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001515"^^xsd:string ;
  rdfs:label "Hippo signaling pathway"^^xsd:string ;
  skos:notation "PW:0001515"^^xsd:string .

ns1:PW_0001516
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001434 ;
  ns2:treeView ns1:PW_0001434 ;
  ns1:IAO_0000115 "Organophosphates (OPs) represent one of the main classes of pesticides. However, they exert serious adverse effects, primarily affecting the cholinergic nervous system. OPs inhibit acetylcholinesterase, the enzyme that hydrolyzes acetylcholine, a major neurotransmitter in the nervous system and periphery."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-03-19T11:40:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001516"^^xsd:string ;
  rdfs:label "organophosphate response pathway"^^xsd:string ;
  skos:notation "PW:0001516"^^xsd:string .

ns1:PW_0001517
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000673, ns1:PW_0001199, ns1:PW_0001515 ;
  ns2:treeView ns1:PW_0000673, ns1:PW_0001199, ns1:PW_0001515 ;
  ns1:IAO_0000115 "A Hippo signaling pathway that deviates from what its normal course should be. Deregulated Hippo signaling has been implicated in tumor metastasis."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-03-19T11:53:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001517"^^xsd:string ;
  rdfs:label "altered Hippo signaling pathway"^^xsd:string ;
  skos:notation "PW:0001517"^^xsd:string .

ns1:PW_0001518
  a owl:Class ;
  ns1:IAO_0000231 ns1:IAO_0000227 ;
  ns1:IAO_0100001 ns1:PW_0001520 ;
  owl:deprecated true ;
  skos:notation "PW:0001518"^^xsd:string .

ns1:PW_0001519
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000555 ;
  ns2:treeView ns1:PW_0000555 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-03-20T09:04:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001519"^^xsd:string ;
  rdfs:label "glucose reduction pathway"^^xsd:string ;
  skos:notation "PW:0001519"^^xsd:string .

ns1:PW_0001520
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005, ns1:PW_0001519 ;
  ns2:treeView ns1:PW_0000005, ns1:PW_0001519 ;
  ns1:IAO_0000115 "The polyol pathway is triggered by excess glucose which is reduced to sorbitol in the first step which requires NADPH as a cofactor. Sorbitol is eventually converted to fructose. Sorbitol, which is membrane impermeable and metabolites of fructose which can lead to the production of AGEs (advance glycation endproduct), along with other pathways affected by a hyperglycemic state are thought to be associated with the pathophysiology of diabetic retinopathy. The intermediate sorbitol in the pathway is a sugar alcohol; sugar alcohols are a class of polyols - alcohol molecules with multiple hydroxyl groups."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-03-20T09:06:03Z"^^xsd:string ;
  obo:hasAlternativeId "PW:0001518"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "sorbitol-aldose reductase pathway"^^xsd:string ;
  obo:id "PW:0001520"^^xsd:string ;
  rdfs:label "polyol pathway"^^xsd:string ;
  skos:notation "PW:0001520"^^xsd:string .

ns1:PW_0001521
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000005 ;
  ns2:treeView ns1:PW_0000005 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of sugar alcohols. Sugar alcohols represent a class of polyols - alcohol molecules with multiple hydroxyl groups. They are used in place of table sugar and in combination with artificial sweeteners and while they can occur naturally, many are commercially produced."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-03-20T12:30:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001521"^^xsd:string ;
  rdfs:label "sugar alcohol metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001521"^^xsd:string .

ns1:PW_0001522
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000157 ;
  ns2:treeView ns1:PW_0000157 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the biosynthesis of dermatan sulfate - a mucopolysaccharide found primarily in skin but also in tendons, lungs, heart valves and blood vessels."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-03-20T13:05:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001522"^^xsd:string ;
  rdfs:label "dermatan sulfate biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001522"^^xsd:string .

ns1:PW_0001523
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001434 ;
  ns2:treeView ns1:PW_0001434 ;
  ns1:IAO_0000115 "A pathway triggered by exposure to nicotine, the alkaloid found in tobacco and other plants. Nicotine can act as a stimulant and is an agonist of the ionotropic acetylcholine receptors, also known as nicotinic. Sustained exposure however has an inhibitory effect resulting in muscular paralysis, seizures, hypotension and respiratory failure. Some of the symptoms are reminiscent of organophosphate poisoning; organophosphates inhibit the enzyme acetylcholinesterase leading to uncensored stimulation of both the  nicotinic and the metabotropic muscarinic acetylcholine receptors."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-03-28T10:56:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001523"^^xsd:string ;
  rdfs:label "nicotine response pathway"^^xsd:string ;
  skos:notation "PW:0001523"^^xsd:string .

ns1:PW_0001524
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001546 ;
  ns2:treeView ns1:PW_0001546 ;
  ns1:IAO_0000115 "The pharmacokinetics/pharmacodynamics of paracetamol, a widely used analgesic, known as acetaminophen (APAP). The analgesic effect is believed to be due to the inhibition of prostaglandins biosynthesis. Paracetamol overdose is associated with hepatic toxicity and a leading cause of liver failure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-04-17T11:01:04Z"^^xsd:string ;
  obo:hasExactSynonym "acetaminophen drug pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00710"^^xsd:string ;
  obo:id "PW:0001524"^^xsd:string ;
  rdfs:label "paracetamol drug pathway"^^xsd:string ;
  skos:notation "PW:0001524"^^xsd:string .

ns1:PW_0001525
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001524 ;
  ns2:treeView ns1:PW_0001524 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of paracetamol, a widely used analgesic known as acetaminophen. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-04-17T11:18:42Z"^^xsd:string ;
  obo:hasExactSynonym "acetaminophen pharmacokinetics pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00640"^^xsd:string ;
  obo:id "PW:0001525"^^xsd:string ;
  rdfs:label "paracetamol pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001525"^^xsd:string .

ns1:PW_0001526
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001434 ;
  ns2:treeView ns1:PW_0001434 ;
  ns1:IAO_0000115 "A pathway triggered by exposure to paracetamol, a widely used analgesic also known as acetaminophen. Paracetamol overdose is associated with hepatic toxicity and a leading cause of liver failure."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-04-17T11:46:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "acetaminophen response pathway"^^xsd:string ;
  obo:id "PW:0001526"^^xsd:string ;
  rdfs:label "paracetamol response pathway"^^xsd:string ;
  skos:notation "PW:0001526"^^xsd:string .

ns1:PW_0001527
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001296 ;
  ns2:treeView ns1:PW_0001296 ;
  ns1:IAO_0000115 "Thromboxane is one of several families of prostanoids, eicosanoids derived from omega-3 or omega-6 fatty acids. Of the two thromboxane molecules, only A2 has activity. Thromboxane A2 signaling exerts vasoconstrictor and platelet aggregation roles. Its actions oppose those of prostaglandin I2, the other important prostanoid for the cardiovascular system homeostasis."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-04-18T11:05:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001527"^^xsd:string ;
  rdfs:label "thromboxane A2 signaling pathway"^^xsd:string ;
  skos:notation "PW:0001527"^^xsd:string .

ns1:PW_0001528
  a owl:Class ;
  ns1:IAO_0000115 "Prostacyclin is one of several families of prostanoids, eicosanoids derived from omega-3 or omega-6 fatty acids. Prostacyclin, also known as prostaglandin I2 signaling engages one receptor to mediate a vasodilator effect and modulate immune responses."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-04-18T11:27:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001528"^^xsd:string ;
  rdfs:label "prostacyclin signaling pathway"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0001528"^^xsd:string .

ns1:PW_0001529
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001297 ;
  ns2:treeView ns1:PW_0001297 ;
  ns1:IAO_0000115 "Prostagladin E2 is the most abundant product of prostaglandin biosynthesis via the cyclooxygenase mediated metabolism of arachidonic acid. It exerts a plethora of functions by activating four receptors of the G-protein coupled (GPCRs) family."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-04-22T16:58:24Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001529"^^xsd:string ;
  rdfs:label "prostaglandin E2 signaling pathway"^^xsd:string ;
  skos:notation "PW:0001529"^^xsd:string .

ns1:PW_0001530
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001297 ;
  ns2:treeView ns1:PW_0001297 ;
  ns1:IAO_0000115 "Prostaglandin D2 signaling exerts important functions in the central nervous system (CNS) that among others, include the regulation of sleep and the perception of pain. The two D2 receptors are G-protein coupled receptors (GPCR)."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-04-22T16:58:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00343"^^xsd:string ;
  obo:id "PW:0001530"^^xsd:string ;
  rdfs:label "prostaglandin D2 signaling pathway"^^xsd:string ;
  skos:notation "PW:0001530"^^xsd:string .

ns1:PW_0001531
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001297 ;
  ns2:treeView ns1:PW_0001297 ;
  ns1:IAO_0000115 "Prostaglandin I2 signaling exerts potent vasodilator and anti-thrombic effects. Its actions oppose those of thromboxane A2, the other prostanoid important for the cardiovascular system homeostasis."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-04-22T16:59:22Z"^^xsd:string ;
  obo:hasExactSynonym "prostacyclin signaling pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00354"^^xsd:string ;
  obo:id "PW:0001531"^^xsd:string ;
  rdfs:label "prostaglandin I2 signaling pathway"^^xsd:string ;
  skos:notation "PW:0001531"^^xsd:string .

ns1:PW_0001532
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000156, ns1:PW_0001243 ;
  ns2:treeView ns1:PW_0000156, ns1:PW_0001243 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of prostaglandins - a class of eicosanoid prostanoids with several members and exerting a range of important functions in the immune and cardiovascular systems."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-04-22T17:17:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001532"^^xsd:string ;
  rdfs:label "prostaglandin biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001532"^^xsd:string .

ns1:PW_0001533
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000732, ns1:PW_0001243 ;
  ns2:treeView ns1:PW_0000732, ns1:PW_0001243 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of thromboxane - eicosanoid prostanoids essential for the homeostasis of the cardiovascular system."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-04-22T17:20:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001533"^^xsd:string ;
  rdfs:label "thromboxane biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001533"^^xsd:string .

ns1:PW_0001534
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001241, ns1:PW_0001243 ;
  ns2:treeView ns1:PW_0001241, ns1:PW_0001243 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the biosynthesis of prostacyclin, also known as prostaglandin I2. Prostacyclin and thromboxane play essential roles in cardiovascular system homeostasis."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-04-22T17:21:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001534"^^xsd:string ;
  rdfs:label "prostacyclin biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001534"^^xsd:string .

ns1:PW_0001535
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001297 ;
  ns2:treeView ns1:PW_0001297 ;
  ns1:IAO_0000115 "Prostaglandin F2alpha signaling engages one receptor and plays important roles in mammalian reproduction."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-04-24T13:14:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001535"^^xsd:string ;
  rdfs:label "prostaglandin F2alpha signaling pathway"^^xsd:string ;
  skos:notation "PW:0001535"^^xsd:string .

ns1:PW_0001536
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000059 ;
  ns2:treeView ns1:PW_0000059 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-05-13T09:23:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001536"^^xsd:string ;
  rdfs:label "sensory system signaling pathway"^^xsd:string ;
  skos:notation "PW:0001536"^^xsd:string .

ns1:PW_0001537
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001195, ns1:PW_0001198 ;
  ns2:treeView ns1:PW_0001195, ns1:PW_0001198 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-05-13T10:53:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001537"^^xsd:string ;
  rdfs:label "altered tyrosine-specific protein kinase mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0001537"^^xsd:string .

ns1:PW_0001538
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000358, ns1:PW_0000476 ;
  ns2:treeView ns1:PW_0000358, ns1:PW_0000476 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-05-13T14:25:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001538"^^xsd:string ;
  rdfs:label "altered cardiovascular system homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0001538"^^xsd:string .

ns1:PW_0001539
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000125 ;
  ns2:treeView ns1:PW_0000125 ;
  ns1:IAO_0000115 "The heterotrimer G proteins are transducers of G proteins coupled receptors (GPCRs). Many types of signals are received by the members of the large GPCR superfamily which then activate distinct G-proteins that route the signal to many and distinct intracellular signaling pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-05-13T15:02:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001539"^^xsd:string ;
  rdfs:label "heterotrimeric G protein mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0001539"^^xsd:string .

ns1:PW_0001540
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000158, ns1:PW_0000391 ;
  ns2:treeView ns1:PW_0000158, ns1:PW_0000391 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-05-13T15:07:35Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001540"^^xsd:string ;
  rdfs:label "altered Ras family mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0001540"^^xsd:string .

ns1:PW_0001541
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000125, ns1:PW_0000264 ;
  ns2:treeView ns1:PW_0000125, ns1:PW_0000264 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-05-13T15:11:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001541"^^xsd:string ;
  rdfs:label "altered G protein mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0001541"^^xsd:string .

ns1:PW_0001542
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000651 ;
  ns2:treeView ns1:PW_0000651 ;
  ns1:IAO_0000115 "Organismal aging represents the sum of impaired functions and pathways. It is associated with changes in homeostatic responses and circadian rhythm, mitochondrial  stress and dysfunction."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-05-14T10:51:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001542"^^xsd:string ;
  rdfs:label "organismal aging pathway"^^xsd:string ;
  skos:notation "PW:0001542"^^xsd:string .

ns1:PW_0001543
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000264, ns1:PW_0000818 ;
  ns2:treeView ns1:PW_0000264, ns1:PW_0000818 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-05-14T13:32:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001543"^^xsd:string ;
  rdfs:label "altered signaling pathway pertinent to immunity"^^xsd:string ;
  skos:notation "PW:0001543"^^xsd:string .

ns1:PW_0001544
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001539, ns1:PW_0001541 ;
  ns2:treeView ns1:PW_0001539, ns1:PW_0001541 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-05-14T13:44:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001544"^^xsd:string ;
  rdfs:label "altered heterotrimeric G protein mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0001544"^^xsd:string .

ns1:PW_0001545
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000237, ns1:PW_0000263 ;
  ns2:treeView ns1:PW_0000237, ns1:PW_0000263 ;
  ns1:IAO_0000115 "Alterations in the pathways and processes elicited in  response to various cues/insults the organism perceives as threatening."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-05-14T13:50:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001545"^^xsd:string ;
  rdfs:label "altered stress response pathway"^^xsd:string ;
  skos:notation "PW:0001545"^^xsd:string .

ns1:PW_0001546
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000923 ;
  ns2:treeView ns1:PW_0000923 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of compounds used to alleviate pain and/or reduce fever. Examples include the nonsteroidal anti-inflammatory drugs such as aspirin or ibuprofen and the widely used paracetamol, known as acetaminophen, among others."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-05-14T15:55:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001546"^^xsd:string ;
  rdfs:label "analgesic and/or antipyretic drug pathway"^^xsd:string ;
  skos:notation "PW:0001546"^^xsd:string .

ns1:PW_0001547
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000013 ;
  ns2:treeView ns1:PW_0000013 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-05-15T11:35:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001547"^^xsd:string ;
  rdfs:label "endocrine system disease pathway"^^xsd:string ;
  skos:notation "PW:0001547"^^xsd:string .

ns1:PW_0001548
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000176 ;
  ns2:treeView ns1:PW_0000176 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-05-15T11:42:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001548"^^xsd:string ;
  rdfs:label "diabetes complication pathway"^^xsd:string ;
  skos:notation "PW:0001548"^^xsd:string .

ns1:PW_0001549
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001548 ;
  ns2:treeView ns1:PW_0001548 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-05-15T11:48:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001549"^^xsd:string ;
  rdfs:label "diabetic angiopathy pathway"^^xsd:string ;
  skos:notation "PW:0001549"^^xsd:string .

ns1:PW_0001550
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000605 ;
  ns2:treeView ns1:PW_0000605 ;
  ns1:IAO_0000115 "A general term grouping neoplastic pathways of the brain, spinal cord or central nervous system and of nerve tissue such as neuroepithelial or neurectodermal."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-05-15T14:15:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "nervous system and nerve tissue neoplasm pathway"^^xsd:string ;
  obo:id "PW:0001550"^^xsd:string ;
  rdfs:label "nervous system and nerve tissue cancer pathway"^^xsd:string ;
  skos:notation "PW:0001550"^^xsd:string .

ns1:PW_0001551
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000290, ns1:PW_0001317 ;
  ns2:treeView ns1:PW_0000290, ns1:PW_0001317 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-07-23T13:23:38Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001551"^^xsd:string ;
  rdfs:label "altered cell cycle pathway"^^xsd:string ;
  skos:notation "PW:0001551"^^xsd:string .

ns1:PW_0001552
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000086, ns1:PW_0001551 ;
  ns2:treeView ns1:PW_0000086, ns1:PW_0001551 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-07-23T13:24:21Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001552"^^xsd:string ;
  rdfs:label "altered cell cycle pathway, mitotic"^^xsd:string ;
  skos:notation "PW:0001552"^^xsd:string .

ns1:PW_0001553
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000088, ns1:PW_0001552 ;
  ns2:treeView ns1:PW_0000088, ns1:PW_0001552 ;
  ns1:IAO_0000115 "The G1/S transition pathway defines the point when the decision to complete the cell cycle is made. Deregulation of G1/S transition is observed in many human cancers and involves important players/regulators of the pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-07-23T13:25:45Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001553"^^xsd:string ;
  rdfs:label "altered G1/S transition pathway"^^xsd:string ;
  skos:notation "PW:0001553"^^xsd:string .

ns1:PW_0001554
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001405, ns1:PW_0001406 ;
  ns2:treeView ns1:PW_0001405, ns1:PW_0001406 ;
  ns1:IAO_0000115 "Alterations in the SWI/SNF family mediated pathway of chromatin remodeling are implicated in a number of human cancers that include ovarian, pancreatic and renal, among others. Many mutations are found in Smarca4, one of the two mutually exclusive, ATP-dependent, enzymatic subunits or Arid1a subunit."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-07-23T15:25:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001554"^^xsd:string ;
  rdfs:label "altered SWI/SNF family mediated chromatin remodeling pathway"^^xsd:string ;
  skos:notation "PW:0001554"^^xsd:string .

ns1:PW_0001555
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000202, ns1:PW_0000667 ;
  ns2:treeView ns1:PW_0000202, ns1:PW_0000667 ;
  ns1:IAO_0000115 "Defective repair pathway(s) of double-strand breaks can lead to chromosomal rearrangements, genomic instability and oncogenic activation. Mutations in several components of the homologous recombination (HR) pathway have been implicated in several conditions in both an autosomal dominant and recessive fashion."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-07-29T15:45:06Z"^^xsd:string ;
  obo:hasExactSynonym "altered HR pathway of double-strand break repair"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001555"^^xsd:string ;
  rdfs:label "altered homologous recombination pathway of double-strand break repair"^^xsd:string ;
  skos:notation "PW:0001555"^^xsd:string .

ns1:PW_0001556
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000203, ns1:PW_0000667 ;
  ns2:treeView ns1:PW_0000203, ns1:PW_0000667 ;
  ns1:IAO_0000115 "Defective repair pathway(s) of double-strand breaks can lead to chromosomal rearrangements, genomic instability and oncogenic activation. Mutations in several components of the non-homologous end joining (NHEJ) pathway have been implicated in several conditions."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-07-29T15:51:22Z"^^xsd:string ;
  obo:hasExactSynonym "altered NHEJ pathway of double-strand break repair"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001556"^^xsd:string ;
  rdfs:label "altered non-homologous end joining pathway of double-strand break repair"^^xsd:string ;
  skos:notation "PW:0001556"^^xsd:string .

ns1:PW_0001557
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000275 ;
  ns2:treeView ns1:PW_0000275 ;
  ns1:IAO_0000115 "Programmed cell death pathways group together several types that can be described as apoptotic or non-apoptotic, based on morphological characteristics.  The common feature is their highly regulated nature, as opposed to accidental, non-programmed cell death."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-09-11T15:31:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001557"^^xsd:string ;
  rdfs:label "programmed cell death pathway"^^xsd:string ;
  skos:notation "PW:0001557"^^xsd:string .

ns1:PW_0001558
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000275 ;
  ns2:treeView ns1:PW_0000275 ;
  ns1:IAO_0000115 "Cell death pathways that are not the result of a regulated process and may be the result of injury or trauma, such as necrosis."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-09-11T15:49:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001558"^^xsd:string ;
  rdfs:label "non-programmed cell death pathway"^^xsd:string ;
  skos:notation "PW:0001558"^^xsd:string .

ns1:PW_0001559
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000289, ns1:PW_0001557 ;
  ns2:treeView ns1:PW_0000289, ns1:PW_0001557 ;
  ns1:IAO_0000115 "A programmed cell death pathway that deviates from what its normal course should be."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-09-11T16:09:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001559"^^xsd:string ;
  rdfs:label "altered programmed cell death pathway"^^xsd:string ;
  skos:notation "PW:0001559"^^xsd:string .

ns1:PW_0001560
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000009, ns1:PW_0000276 ;
  ns2:treeView ns1:PW_0000009, ns1:PW_0000276 ;
  ns1:IAO_0000115 "Pyroptosis pathway is a form of programmed cell death triggered by microbial infection and release of cytokines. It can also occur independently of microbial virulence. Pyroptosis can have either apoptotic or necrotic morphological features."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-09-11T16:31:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001560"^^xsd:string ;
  rdfs:label "pyroptosis pathway"^^xsd:string ;
  skos:notation "PW:0001560"^^xsd:string .

ns1:PW_0001561
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000276 ;
  ns2:treeView ns1:PW_0000276 ;
  ns1:IAO_0000115 "Necroptosis, is a programmed, or regulated form of necrosis generally triggered by DNA damage and leading to cell swelling and lysis."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-09-12T09:32:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "programmed necrosis pathway"^^xsd:string ;
  obo:id "PW:0001561"^^xsd:string ;
  rdfs:label "necroptosis pathway"^^xsd:string ;
  skos:notation "PW:0001561"^^xsd:string .

ns1:PW_0001562
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000278, ns1:PW_0001563, ns1:PW_0002403 ;
  ns2:treeView ns1:PW_0000278, ns1:PW_0001563, ns1:PW_0002403 ;
  ns1:IAO_0000115 "An autophagy pathway that deviates from what its normal course should be. Altered autophagy has been implicated in a variety of conditions, including neurodegenerative diseases, cancer and atherosclerosis, among others."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-09-12T09:44:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001562"^^xsd:string ;
  rdfs:label "altered autophagy pathway"^^xsd:string ;
  skos:notation "PW:0001562"^^xsd:string .

ns1:PW_0001563
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000276, ns1:PW_0001559 ;
  ns2:treeView ns1:PW_0000276, ns1:PW_0001559 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-09-12T09:46:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001563"^^xsd:string ;
  rdfs:label "altered non-apoptotic cell death pathway"^^xsd:string ;
  skos:notation "PW:0001563"^^xsd:string .

ns1:PW_0001564
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000009 ;
  ns2:treeView ns1:PW_0000009 ;
  ns1:IAO_0000115 "Anoikis is a form of apoptotic programmed cell death triggered by the absence of cell-matrix interactions."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-09-12T09:54:41Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001564"^^xsd:string ;
  rdfs:label "anoikis pathway"^^xsd:string ;
  skos:notation "PW:0001564"^^xsd:string .

ns1:PW_0001565
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001455 ;
  ns2:treeView ns1:PW_0001455 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of doxorubicin. Doxorubicin is used as a chemotherapeutic agent for the treatment of various cancers. Its use is limited by the serious cardiotoxic side effects it exerts. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-11-07T13:23:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00650"^^xsd:string ;
  obo:id "PW:0001565"^^xsd:string ;
  rdfs:label "doxorubicin pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001565"^^xsd:string .

ns1:PW_0001566
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001455 ;
  ns2:treeView ns1:PW_0001455 ;
  ns1:IAO_0000115 "The pathway of doxorubicin-target interaction and of the biochemical or physiological responses to drug. Doxorubicin is used as a chemotherapeutic agent for the treatment of many cancers. Its use is restricted by the serious cardiotoxic effects it exerts. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-11-07T13:28:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001566"^^xsd:string ;
  rdfs:label "doxorubicin pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001566"^^xsd:string .

ns1:PW_0001567
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000085 ;
  ns2:treeView ns1:PW_0000085 ;
  ns1:IAO_0000115 "The various pathways whereby initial RNA transcripts are processed into their mature, functional form and those involved in removing excess or erroneous RNA."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-11-07T13:56:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001567"^^xsd:string ;
  rdfs:label "RNA processing pathway"^^xsd:string ;
  skos:notation "PW:0001567"^^xsd:string .

ns1:PW_0001568
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001567 ;
  ns2:treeView ns1:PW_0001567 ;
  ns1:IAO_0000115 "Those reactions involved in producing the mature forms of RNAs: mRNA, tRNA and rRNA."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-11-07T14:43:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001568"^^xsd:string ;
  rdfs:label "RNA maturation pathway"^^xsd:string ;
  skos:notation "PW:0001568"^^xsd:string .

ns1:PW_0001569
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001568, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000127
  ] ;
  ns2:treeView ns1:PW_0000127, ns1:PW_0001568 ;
  ns3:part_of ns1:PW_0000127 ;
  ns1:IAO_0000115 "mRNA maturation involves 5'-capping and 3' processing of pre-mRNA,  splicing and alternative splicing to produce the mature mRNA molecule(s)."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-11-07T15:00:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001569"^^xsd:string ;
  rdfs:label "mRNA maturation pathway"^^xsd:string ;
  skos:notation "PW:0001569"^^xsd:string .

ns1:PW_0001570
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000126
  ] ;
  ns2:treeView ns1:PW_0000126 ;
  ns3:part_of ns1:PW_0000126 ;
  ns1:IAO_0000115 "Initiation of transcription from the bipartite rDNA repeats requires the assembly of Pol I preinitiation complex (PIC) and subsequent recruitment of the polymerase."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-11-07T15:19:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001570"^^xsd:string ;
  rdfs:label "RNA polymerase I transcription initiation pathway"^^xsd:string ;
  skos:notation "PW:0001570"^^xsd:string .

ns1:PW_0001571
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000126
  ] ;
  ns2:treeView ns1:PW_0000126 ;
  ns3:part_of ns1:PW_0000126 ;
  ns1:IAO_0000115 "Subunits of Pol I have elongation and hydrolysis capabilities. However, additional trans-acting factors are involved in pol I elongation steps."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-11-07T15:27:41Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001571"^^xsd:string ;
  rdfs:label "RNA polymerase I transcription elongation pathway"^^xsd:string ;
  skos:notation "PW:0001571"^^xsd:string .

ns1:PW_0001572
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000126
  ] ;
  ns2:treeView ns1:PW_0000126 ;
  ns3:part_of ns1:PW_0000126 ;
  ns1:IAO_0000115 "Termination of transcription by the polymerase I system requires the recruitment of specific factors to particular DNA elements."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-11-07T15:39:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001572"^^xsd:string ;
  rdfs:label "RNA polymerase I transcription termination pathway"^^xsd:string ;
  skos:notation "PW:0001572"^^xsd:string .

ns1:PW_0001573
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001568, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000128
  ] ;
  ns2:treeView ns1:PW_0000128, ns1:PW_0001568 ;
  ns3:part_of ns1:PW_0000128 ;
  ns1:IAO_0000115 "Processing of  the initial tRNA transcript, including splicing of intron-containing pre-tRNAs and multiple modifications to produce the mature tRNA molecule that is exported to the cytoplasm."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-11-07T15:44:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001573"^^xsd:string ;
  rdfs:label "tRNA maturation pathway"^^xsd:string ;
  skos:notation "PW:0001573"^^xsd:string .

ns1:PW_0001574
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001568, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000126
  ] ;
  ns2:treeView ns1:PW_0000126, ns1:PW_0001568 ;
  ns3:part_of ns1:PW_0000126 ;
  ns1:IAO_0000115 "The reactions involved in processing the primary pol I transcribed rRNA and the 5S pre-rRNA transcribed by pol III. The large pol I transcribed pre-rRNA contains the mature 18S, 5.8S and 25S/28S rRNAs separated by internal (ITS) and flanked by external transcribed spacers (ETS). The nascent pre-rRNA associates co-transcriptionally with various factors, folds and is modified, while endo- and exo-nucleolytic cleavages sequentially  remove the spacers. Cleavage at site ITS1 separates the initial 90S pre-ribosome into pre-40S and pre-60S particles whose nucleocytoplasmic processing will follow independent routes."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-11-07T15:59:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001574"^^xsd:string ;
  rdfs:label "rRNA maturation pathway"^^xsd:string ;
  skos:notation "PW:0001574"^^xsd:string .

ns1:PW_0001575
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000128
  ] ;
  ns2:treeView ns1:PW_0000128 ;
  ns3:part_of ns1:PW_0000128 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-11-07T16:04:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001575"^^xsd:string ;
  rdfs:label "RNA polymerase III transcription initiation pathway"^^xsd:string ;
  skos:notation "PW:0001575"^^xsd:string .

ns1:PW_0001576
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000128
  ] ;
  ns2:treeView ns1:PW_0000128 ;
  ns3:part_of ns1:PW_0000128 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-11-07T16:04:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001576"^^xsd:string ;
  rdfs:label "RNA polymerase III transcription elongation pathway"^^xsd:string ;
  skos:notation "PW:0001576"^^xsd:string .

ns1:PW_0001577
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000128
  ] ;
  ns2:treeView ns1:PW_0000128 ;
  ns3:part_of ns1:PW_0000128 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-11-07T16:05:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001577"^^xsd:string ;
  rdfs:label "RNA polymerase III transcription termination pathway"^^xsd:string ;
  skos:notation "PW:0001577"^^xsd:string .

ns1:PW_0001578
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001569 ;
  ns2:treeView ns1:PW_0001569 ;
  ns1:IAO_0000115 "5'-end capping occurs earlier in transcription and, along with phosphorylation of pol II, promotes productive elongation."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-12-01T15:58:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001578"^^xsd:string ;
  rdfs:label "5'-end pre-mRNA capping pathway"^^xsd:string ;
  skos:notation "PW:0001578"^^xsd:string .

ns1:PW_0001579
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001569 ;
  ns2:treeView ns1:PW_0001569 ;
  ns1:IAO_0000115 "The 3'-end processing of pre-mRNA is intimately coupled to pol II transcription termination, splicing, mRNA transport and translation."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-12-01T16:01:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001579"^^xsd:string ;
  rdfs:label "3'-end pre-mRNA processing pathway"^^xsd:string ;
  skos:notation "PW:0001579"^^xsd:string .

ns1:PW_0001580
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001568, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000127
  ] ;
  ns2:treeView ns1:PW_0000127, ns1:PW_0001568 ;
  ns3:part_of ns1:PW_0000127 ;
  ns1:IAO_0000115 "Long non-coding RNA transcripts are subject to processing in a manner analogous to mRNA thereby they are capped and polyadenylated, and also frequently spliced."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-12-04T09:22:35Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001580"^^xsd:string ;
  rdfs:label "lncRNA maturation pathway"^^xsd:string ;
  skos:notation "PW:0001580"^^xsd:string .

ns1:PW_0001581
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001580 ;
  ns2:treeView ns1:PW_0001580 ;
  ns1:IAO_0000115 "Long non-coding RNA transcripts are subject to processing in a manner analogous to mRNA thereby they are capped and polyadenylated, and also frequently spliced."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-12-04T09:40:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001581"^^xsd:string ;
  rdfs:label "lncRNA capping pathway"^^xsd:string ;
  skos:notation "PW:0001581"^^xsd:string .

ns1:PW_0001582
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001580 ;
  ns2:treeView ns1:PW_0001580 ;
  ns1:IAO_0000115 "Long non-coding RNA transcripts are subject to processing in a manner analogous to mRNA thereby they are capped and polyadenylated, and also frequently spliced."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2014-12-04T09:41:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001582"^^xsd:string ;
  rdfs:label "lncRNA polyadenylation pathway"^^xsd:string ;
  skos:notation "PW:0001582"^^xsd:string .

ns1:PW_0001583
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000013 ;
  ns2:treeView ns1:PW_0000013 ;
  ns1:IAO_0000115 "Those disorders and diseases resulting from nutritional imbalances and by alterations in various aspects of metabolism."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-01-23T08:54:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001583"^^xsd:string ;
  rdfs:label "nutritional and metabolic disease pathway"^^xsd:string ;
  skos:notation "PW:0001583"^^xsd:string .

ns1:PW_0001584
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001601 ;
  ns2:treeView ns1:PW_0001601 ;
  ns1:IAO_0000115 "Those conditions caused by inadequate levels of one or more essential vitamins due to defects in their metabolism."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-01-23T09:01:31Z"^^xsd:string ;
  obo:hasExactSynonym "avitaminosis disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001584"^^xsd:string ;
  rdfs:label "avitaminosis pathway"^^xsd:string ;
  skos:notation "PW:0001584"^^xsd:string .

ns1:PW_0001585
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001584 ;
  ns2:treeView ns1:PW_0001584 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-01-23T09:29:49Z"^^xsd:string ;
  obo:hasExactSynonym "deficiency of vitamin A pathway"^^xsd:string, "hypovitaminosis A pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00336"^^xsd:string ;
  obo:id "PW:0001585"^^xsd:string ;
  rdfs:label "vitamin A deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001585"^^xsd:string .

ns1:PW_0001586
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002347 ;
  ns2:treeView ns1:PW_0002347 ;
  ns1:IAO_0000115 "A severe form of lipid storage disease in infants caused by deficiency of acid lipase."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-01-23T09:52:30Z"^^xsd:string ;
  obo:hasExactSynonym "Acid esterase deficiency pathway"^^xsd:string, "Acid lipase deficiency pathway"^^xsd:string, "Wolman xanthomatosis pathway"^^xsd:string, "Wolman's disease pathway"^^xsd:string, "Wolman's or triglyceride storage type III disease pathway"^^xsd:string, "Xanthomatosis, familial pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00319"^^xsd:string, "SMP:00511"^^xsd:string, "lysosomal acid lipase deficiency pathway (Wolman type)"^^xsd:string ;
  obo:id "PW:0001586"^^xsd:string ;
  rdfs:label "Wolman disease pathway"^^xsd:string ;
  skos:notation "PW:0001586"^^xsd:string .

ns1:PW_0001587
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001160 ;
  ns2:treeView ns1:PW_0001160 ;
  ns1:IAO_0000115 "The pathway thereby processed, mature mRNA is exported to the cytoplasm. Two distinct export pathways are mediated by specific transport receptors. The NXF1-NXT1 heterodimer exports the bulk of mRNA whereas a subset of mRNA is exported by the CRM1 system."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-02-09T14:52:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001587"^^xsd:string ;
  rdfs:label "mRNA nuclear export pathway"^^xsd:string ;
  skos:notation "PW:0001587"^^xsd:string .

ns1:PW_0001588
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001160 ;
  ns2:treeView ns1:PW_0001160 ;
  ns1:IAO_0000115 "The pathway thereby processed, mature tRNA is exported to the cytoplasm. It is dependent upon export receptors and Ran GTPases of the small G protein of the Ras superfamily."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-02-09T14:55:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001588"^^xsd:string ;
  rdfs:label "tRNA nuclear export pathway"^^xsd:string ;
  skos:notation "PW:0001588"^^xsd:string .

ns1:PW_0001589
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001472, ns1:PW_0001477 ;
  ns2:treeView ns1:PW_0001472, ns1:PW_0001477 ;
  ns1:IAO_0000115 "Those diseases resulting from alterations in metabolic pathways that are caused by genetic mutations present during fetal development and that may be inherited from a parent or acquired in utero. The mutations can disrupt one or several pathways, giving rise to a broad spectrum of conditions affecting many types of organs and/or tissues."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-02-09T15:21:46Z"^^xsd:string ;
  obo:hasExactSynonym "inborn error of metabolism disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001589"^^xsd:string ;
  rdfs:label "inborn error of metabolism pathway"^^xsd:string ;
  skos:notation "PW:0001589"^^xsd:string .

ns1:PW_0001590
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001776 ;
  ns2:treeView ns1:PW_0001776 ;
  ns1:IAO_0000115 "Xanthinuria is a rare genetic disorder due to alterations in the purine metabolic pathway causing accumulation of xanthine and resulting in a range of symptoms. There are two types of disorders with similar clinical manifestations."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-02-09T15:30:42Z"^^xsd:string ;
  obo:hasExactSynonym "xanthine dehydrogenase deficiency pathway"^^xsd:string, "xanthinuria disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00220"^^xsd:string, "xanthine oxidase deficiency"^^xsd:string ;
  obo:id "PW:0001590"^^xsd:string ;
  rdfs:label "xanthinuria pathway"^^xsd:string ;
  skos:notation "PW:0001590"^^xsd:string .

ns1:PW_0001591
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001590 ;
  ns2:treeView ns1:PW_0001590 ;
  ns1:IAO_0000115 "Xanthinuria is a rare genetic disorder due to alterations in the purine metabolic pathway causing accumulation of xanthine and resulting in a range of symptoms. Of the two types of clinically related disorders, type I is caused by genetic defects in the xanthine dehydrogenase enzyme."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-02-09T15:45:44Z"^^xsd:string ;
  obo:hasExactSynonym "xanthinuria disease pathway, type I"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00512"^^xsd:string ;
  obo:id "PW:0001591"^^xsd:string ;
  rdfs:label "xanthinuria  type I pathway"^^xsd:string ;
  skos:notation "PW:0001591"^^xsd:string .

ns1:PW_0001592
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001590 ;
  ns2:treeView ns1:PW_0001590 ;
  ns1:IAO_0000115 "Xanthinuria is a rare genetic disorder due to alterations in the purine metabolic pathway causing accumulation of xanthine and resulting in a range of symptoms.  Of the two types of clinically related disorders, type II is caused by genetic defects in the xanthine dehydrogenase and aldehyde dehydrogenase enzymes."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-02-09T15:46:28Z"^^xsd:string ;
  obo:hasExactSynonym "xanthinuria disease pathway, type II"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00513"^^xsd:string ;
  obo:id "PW:0001592"^^xsd:string ;
  rdfs:label "xanthinuria type II pathway"^^xsd:string ;
  skos:notation "PW:0001592"^^xsd:string .

ns1:PW_0001593
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000013 ;
  ns2:treeView ns1:PW_0000013 ;
  ns1:IAO_0000115 "Those conditions affecting the muscular and skeletal systems and elements associated with them, arising from deregulation in a number of pathways."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-10T12:34:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001593"^^xsd:string ;
  rdfs:label "musculoskeletal disease pathway"^^xsd:string ;
  skos:notation "PW:0001593"^^xsd:string .

ns1:PW_0001594
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001593, ns1:PW_0001643 ;
  ns2:treeView ns1:PW_0001593, ns1:PW_0001643 ;
  ns1:IAO_0000115 "VLCAD deficiency is due to alterations in fatty acid beta oxidation pathway. It is an inherited metabolic disease due to mutations in the ACADVL gene. It appears in infancy or early childhood and is manifested  as lack of energy and muscle weakness."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-10T12:37:35Z"^^xsd:string ;
  obo:hasExactSynonym "VLCAD deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00540"^^xsd:string ;
  obo:id "PW:0001594"^^xsd:string ;
  rdfs:label "very long-chain acyl-CoA dehydrogenase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001594"^^xsd:string .

ns1:PW_0001595
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000996 ;
  ns2:treeView ns1:PW_0000996 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of abacavir, an anti-viral drug used for the treatment of HIV infection. It belongs to the family of nucleoside analog reverse transcriptase inhibitors. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-10T13:29:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001595"^^xsd:string ;
  rdfs:label "abacavir drug pathway"^^xsd:string ;
  skos:notation "PW:0001595"^^xsd:string .

ns1:PW_0001596
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001595 ;
  ns2:treeView ns1:PW_0001595 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of abacavir, a drug used for the treatment of HIV. Genetic variations can result in changes in the availability of the drug. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-10T13:39:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001596"^^xsd:string ;
  rdfs:label "abacavir pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001596"^^xsd:string .

ns1:PW_0001597
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001595 ;
  ns2:treeView ns1:PW_0001595 ;
  ns1:IAO_0000115 "The pathway of abacavir-target interaction and of the biochemical or physiological responses to them. Abacavir is a drug used for the treatment of HIV infection. Abacavir inhibits HIV-1 reverse transcriptase activity by competing with the natural substrate dGTP and by its incorporation into viral DNA whose growth is then terminated. Genetic variations can cause differences in the response of the organism to the drug. A small percentage of individuals receiving the drug develop immune-mediated hypersensitivity reactions (HSR), those carrying a variant in the human leukocyte antigen B (HLA-B) gene."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-10T13:39:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00737"^^xsd:string ;
  obo:id "PW:0001597"^^xsd:string ;
  rdfs:label "abacavir pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001597"^^xsd:string .

ns1:PW_0001598
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002325 ;
  ns2:treeView ns1:PW_0002325 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of acenocoumarol. Acenocoumarol  is used as anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-10T16:06:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001598"^^xsd:string ;
  rdfs:label "acenocoumarol drug pathway"^^xsd:string ;
  skos:notation "PW:0001598"^^xsd:string .

ns1:PW_0001599
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001598 ;
  ns2:treeView ns1:PW_0001598 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of acenocoumarol. Acenocoumarol is used as anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-10T16:08:41Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001599"^^xsd:string ;
  rdfs:label "acenocoumarol pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001599"^^xsd:string .

ns1:PW_0001600
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001598 ;
  ns2:treeView ns1:PW_0001598 ;
  ns1:IAO_0000115 "The pathway of acenocoumarol-target interaction and of the biochemical or physiological responses to drug. Acenocoumarol is used as anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-10T16:09:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00269"^^xsd:string ;
  obo:id "PW:0001600"^^xsd:string ;
  rdfs:label "acenocoumarol pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001600"^^xsd:string .

ns1:PW_0001601
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001583 ;
  ns2:treeView ns1:PW_0001583 ;
  ns1:IAO_0000115 "Those disorders caused by nutritional imbalance."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-12T09:11:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001601"^^xsd:string ;
  rdfs:label "nutritional disorder pathway"^^xsd:string ;
  skos:notation "PW:0001601"^^xsd:string .

ns1:PW_0001602
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001472 ;
  ns2:treeView ns1:PW_0001472 ;
  ns1:IAO_0000115 "Those diseases and disorders that are caused by deregulation of glucose metabolic pathways. The condition(s) can be inherited or acquired."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-12T09:47:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001602"^^xsd:string ;
  rdfs:label "glucose metabolism disease pathway"^^xsd:string ;
  skos:notation "PW:0001602"^^xsd:string .

ns1:PW_0001603
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001414, ns1:PW_0001589, ns1:PW_0001611 ;
  ns2:treeView ns1:PW_0001414, ns1:PW_0001589, ns1:PW_0001611 ;
  ns1:IAO_0000115 "A rare, autosomal recessive inborn metabolic disease caused by alterations in pyrimidine metabolic pathway."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-12T10:19:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00172"^^xsd:string, "ureidopropionase deficiency pathway"^^xsd:string ;
  obo:id "PW:0001603"^^xsd:string ;
  rdfs:label "beta-ureidopropionase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001603"^^xsd:string .

ns1:PW_0001604
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001776 ;
  ns2:treeView ns1:PW_0001776 ;
  ns1:IAO_0000115 "Alterations in the pyrimidine biosynthetic pathway resulting in excessive excretion of orotic acid. The inborn metabolic condition is primarily due to deficiency in the bifunctional uridine monophosphate (UMP) synthetase enzyme.  Orotic aciduria is also due to ornithine transcarbamylase (OTC) deficiency and its hyperammonemia."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-12T10:34:32Z"^^xsd:string ;
  obo:hasExactSynonym "orotic aciduria disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001604"^^xsd:string ;
  rdfs:label "orotic aciduria pathway"^^xsd:string ;
  skos:notation "PW:0001604"^^xsd:string .

ns1:PW_0001605
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001604 ;
  ns2:treeView ns1:PW_0001604 ;
  ns1:IAO_0000115 "The most common form of the orotic acid inborn error metabolic disease pathway is due to deficiency in the uridine monophosphate (UMP) synthase enzyme."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-12T10:43:47Z"^^xsd:string ;
  obo:hasExactSynonym "orotic aciduria 1 disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00219"^^xsd:string, "UMP synthase deficiency pathway"^^xsd:string ;
  obo:id "PW:0001605"^^xsd:string ;
  rdfs:label "orotic aciduria 1 pathway"^^xsd:string ;
  skos:notation "PW:0001605"^^xsd:string .

ns1:PW_0001606
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001604 ;
  ns2:treeView ns1:PW_0001604 ;
  ns1:IAO_0000115 "A secondary form of the orotic acid inborn error metabolic disease pathway due to deficiency in orotidine-5-monophosphate decarboxylase (C-terminal activity of uridine monophosphate synthetase)."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-12T10:50:39Z"^^xsd:string ;
  obo:hasExactSynonym "OMP decarboxylase deficiency pathway"^^xsd:string, "hereditary orotic aciduria type 2 pathway"^^xsd:string, "hereditary orotic aciduria type II pathway"^^xsd:string, "orotic aciduria II disease pathway"^^xsd:string, "orotic aciduria II pathway"^^xsd:string, "orotidine-5-phosphate decarboxylase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "OMPDC deficiency pathway"^^xsd:string ;
  obo:id "PW:0001606"^^xsd:string ;
  rdfs:label "orotic aciduria 2 pathway"^^xsd:string ;
  skos:notation "PW:0001606"^^xsd:string .

ns1:PW_0001607
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645, ns1:PW_0001646 ;
  ns2:treeView ns1:PW_0001645, ns1:PW_0001646 ;
  ns1:IAO_0000115 "A group of disorders due to inborn errors of the tyrosine metabolic pathway. The three types of tyrosinemia are caused by deficiencies in distinct enzymes of the tyrosine degradation pathway and exhibit specific phenotypes."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-12T11:13:29Z"^^xsd:string ;
  obo:hasExactSynonym "tyrosinemia disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001607"^^xsd:string ;
  rdfs:label "tyrosinemia pathway"^^xsd:string ;
  skos:notation "PW:0001607"^^xsd:string .

ns1:PW_0001608
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001607 ;
  ns2:treeView ns1:PW_0001607 ;
  ns1:IAO_0000115 "Type I tyrosinemia results from defects in the fumarylacetoacetate hydrolase (FAH) enzyme that catalyzes the last step in the tyrosine degradation pathway."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-12T11:24:18Z"^^xsd:string ;
  obo:hasExactSynonym "hepatorenal tyrosinemia pathway"^^xsd:string, "tyrosinemia type I disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00218"^^xsd:string ;
  obo:id "PW:0001608"^^xsd:string ;
  rdfs:label "tyrosinemia type I pathway"^^xsd:string ;
  skos:notation "PW:0001608"^^xsd:string .

ns1:PW_0001609
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001607 ;
  ns2:treeView ns1:PW_0001607 ;
  ns1:IAO_0000115 "Type II tyrosinemia results from defects in the tyrosine aminotransferase (TAT) enzyme that catalyzes the conversion of tyrosine to 4-hydroxyphenylpyruvate in the tyrosine degradation pathway."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-12T11:24:39Z"^^xsd:string ;
  obo:hasExactSynonym "oculocutaneous tyrosinemia pathway"^^xsd:string, "tyrosinemia type II disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Richner-Hanhart syndrome pathway"^^xsd:string, "SMP:00369"^^xsd:string ;
  obo:id "PW:0001609"^^xsd:string ;
  rdfs:label "tyrosinemia type II pathway"^^xsd:string ;
  skos:notation "PW:0001609"^^xsd:string .

ns1:PW_0001610
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001607 ;
  ns2:treeView ns1:PW_0001607 ;
  ns1:IAO_0000115 "Type III tyrosinemia results from defects in the 4-hydroxyohenylpyruvate dioxygenase (HPD) enzyme that catalyzes the second step in the tyrosine degradation pathway."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-12T11:24:59Z"^^xsd:string ;
  obo:hasExactSynonym "tyrosinemia type III disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00370"^^xsd:string, "SMP:00434"^^xsd:string ;
  obo:id "PW:0001610"^^xsd:string ;
  rdfs:label "tyrosinemia type III pathway"^^xsd:string ;
  skos:notation "PW:0001610"^^xsd:string .

ns1:PW_0001611
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001412 ;
  ns2:treeView ns1:PW_0001412 ;
  ns1:IAO_0000115 "Abnormal and involuntary movement due degenerative, post-traumatic, inflammatory, hereditary or medication-induced conditions."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-12T12:59:09Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001611"^^xsd:string ;
  rdfs:label "movement disorder pathway"^^xsd:string ;
  skos:notation "PW:0001611"^^xsd:string .

ns1:PW_0001612
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001611 ;
  ns2:treeView ns1:PW_0001611 ;
  ns1:IAO_0000115 "A movement disorder caused by defects in the tyrosine hydroxylase enzyme that converts tyrosine to L-DOPA, the precursor of dopamine in the dopamine biosynthetic pathway of the other two catecholamines downstream of it, norepinephrine and epinephrine."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-12T13:10:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00490"^^xsd:string, "dopamine-responsive dystonia pathway"^^xsd:string, "tyrosine hydroxylase deficiency pathway"^^xsd:string ;
  obo:id "PW:0001612"^^xsd:string ;
  rdfs:label "Segawa syndrome pathway"^^xsd:string ;
  skos:notation "PW:0001612"^^xsd:string .

ns1:PW_0001613
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000921, ns1:PW_0001546, ns1:PW_0002150 ;
  ns2:treeView ns1:PW_0000921, ns1:PW_0001546, ns1:PW_0002150 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of acetylasalicylic acid, known as aspirin. It is a non-steroidal anti-inflammatory drug (NSAID) used as analgesic, antipyretic and antitrombic agent. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-12T13:47:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "aspirin drug pathway"^^xsd:string ;
  obo:id "PW:0001613"^^xsd:string ;
  rdfs:label "acetylsalicylic acid drug pathway"^^xsd:string ;
  skos:notation "PW:0001613"^^xsd:string .

ns1:PW_0001614
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001613 ;
  ns2:treeView ns1:PW_0001613 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of acetylsalicylic acid, known as aspirin. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-12T14:15:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "aspirin pharmacokinetics pathway"^^xsd:string ;
  obo:id "PW:0001614"^^xsd:string ;
  rdfs:label "acetylsalicylic acid pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001614"^^xsd:string .

ns1:PW_0001615
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001613 ;
  ns2:treeView ns1:PW_0001613 ;
  ns1:IAO_0000115 "The actual targets of acetylsalicylic acid known as aspirin were discovered after the drug was marketed. It was believed that it acts upon the central nervous system, but its true mode of action is to  irreversibly inhibit  cuclooxygenase enzyme COX-1 and to a lesser extent COX-2, thus suppressing the downstream production of prostaglandins and thromboxanes. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-12T14:15:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00083"^^xsd:string, "aspirin pharmacodynamics pathway"^^xsd:string ;
  obo:id "PW:0001615"^^xsd:string ;
  rdfs:label "acetylsalicylic acid pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001615"^^xsd:string .

ns1:PW_0001616
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000996 ;
  ns2:treeView ns1:PW_0000996 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of adefovir, an anti-viral drug used for the treatment of hepatitis B. It is administered as adefovir dipivoxil prodrug. Once metabolized, it acts as a nucleotide analog reverse transcriptase inhibitor."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-12T14:35:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001616"^^xsd:string ;
  rdfs:label "adefovir drug pathway"^^xsd:string ;
  skos:notation "PW:0001616"^^xsd:string .

ns1:PW_0001617
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001616 ;
  ns2:treeView ns1:PW_0001616 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of adefovir. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-12T14:44:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00629"^^xsd:string ;
  obo:id "PW:0001617"^^xsd:string ;
  rdfs:label "adefovir pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001617"^^xsd:string .

ns1:PW_0001618
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001616 ;
  ns2:treeView ns1:PW_0001616 ;
  ns1:IAO_0000115 "Adefovir is an anti-viral drug used for the treatment of chronic hepatitis B."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-12T14:45:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00418"^^xsd:string ;
  obo:id "PW:0001618"^^xsd:string ;
  rdfs:label "adefovir pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001618"^^xsd:string .

ns1:PW_0001619
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001160 ;
  ns2:treeView ns1:PW_0001160 ;
  ns1:IAO_0000115 "The pathway whereby the pre- ribosomal particles, pre-40S and pre-60S containing three of the four rRNA genes, are exported to the cytoplasm. The two particles follow independent transport routes, embedded within ribosome biogenesis. The 5S rRNA transcribed by RNA polymerase III is independently transported to be delivered to the ribosome immediately or from a cytoplasmic pool."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-12T15:36:24Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001619"^^xsd:string ;
  rdfs:label "rRNA nuclear export pathway"^^xsd:string ;
  skos:notation "PW:0001619"^^xsd:string .

ns1:PW_0001620
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001170 ;
  ns2:treeView ns1:PW_0001170 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of bisphoshonate drugs that help prevent the loss of bone mass and are used in the treatment of osteoporosis. The two classes - non-nitrogenous and nitrogen-containing drugs, employ different mechanisms to affect osteoclast activity. Bisphosphonates are preferentially taken up by osteoclast cells. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-16T10:18:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001620"^^xsd:string ;
  rdfs:label "bisphosphonate drug pathway"^^xsd:string ;
  skos:notation "PW:0001620"^^xsd:string .

ns1:PW_0001621
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001620 ;
  ns2:treeView ns1:PW_0001620 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of nitrogenous bisphosphate drugs, inhibitors of farnesyl diphosphate synthase. The disruption of geranyl and farnesyl pyrophosphate production affects the cell membrane localization of proteins that depend on this lipid modification for proper placement. They include the members of the small G proteins and the impact on Ras, Rho and Rac G proteins is thought to underlie the effect of drugs."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-16T10:25:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001621"^^xsd:string ;
  rdfs:label "nitrogenous bisphosphonate drug pathway"^^xsd:string ;
  skos:notation "PW:0001621"^^xsd:string .

ns1:PW_0001622
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001620 ;
  ns2:treeView ns1:PW_0001620 ;
  ns1:IAO_0000115 "Non-nitrogenous bisphosphonate drugs are metabolized to compounds that render the ATP molecule non-functional, thus promoting cell death."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-16T10:26:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001622"^^xsd:string ;
  rdfs:label "non-nitrogenous bisphosphonate drug pathway"^^xsd:string ;
  skos:notation "PW:0001622"^^xsd:string .

ns1:PW_0001623
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001621 ;
  ns2:treeView ns1:PW_0001621 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of nitrogenous bisphosphonates such as alendronate, ibandronate, pamidronate or risedronate. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-16T11:05:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001623"^^xsd:string ;
  rdfs:label "nitrogenous bisphosphanate pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001623"^^xsd:string .

ns1:PW_0001624
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001621 ;
  ns2:treeView ns1:PW_0001621 ;
  ns1:IAO_0000115 "The pathway of nitrogenous bisphosphonate-target interaction and of the biochemical or physiological responses to them. They include alendronate, ibandronate, pamidronate or risedronate. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-02-16T11:06:45Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00079"^^xsd:string, "SMP:00095"^^xsd:string, "SMP:00112"^^xsd:string, "SMP:00117"^^xsd:string ;
  obo:id "PW:0001624"^^xsd:string ;
  rdfs:label "nitrogenous bisphosphonate pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001624"^^xsd:string .

ns1:PW_0001625
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001587 ;
  ns2:treeView ns1:PW_0001587 ;
  ns1:IAO_0000115 "The NXF1-NXT export pathway is involved in the trafficking of bulk mRNA. It is dependent upon the TREX/THO complex for receptor recruitment to the cargo."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-02-19T13:40:09Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001625"^^xsd:string ;
  rdfs:label "NXF1-NXT1 export pathway"^^xsd:string ;
  skos:notation "PW:0001625"^^xsd:string .

ns1:PW_0001626
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001587 ;
  ns2:treeView ns1:PW_0001587 ;
  ns1:IAO_0000115 "CRM1 export pathway is involved in trafficking a subset of mRNA as well as other RNA particles. Depending on the adaptor proteins that recruit CRM1 to cargo, there are several routes of export."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-02-19T13:40:41Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "XPO1 export pathway"^^xsd:string ;
  obo:id "PW:0001626"^^xsd:string ;
  rdfs:label "CRM1 export pathway"^^xsd:string ;
  skos:notation "PW:0001626"^^xsd:string .

ns1:PW_0001627
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001643 ;
  ns2:treeView ns1:PW_0001643 ;
  ns1:IAO_0000115 "Trifunctional protein deficiency is caused by alteration in the fatty acid beta degradation pathway. Specifically, mutations in the alpha and beta subunits of the mitochondrial enzyme that catalyzes the last three steps, have been linked to this inherited metabolic condition."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-02-19T14:03:09Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00545"^^xsd:string ;
  obo:id "PW:0001627"^^xsd:string ;
  rdfs:label "trifunctional protein deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001627"^^xsd:string .

ns1:PW_0001628
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001644 ;
  ns2:treeView ns1:PW_0001644 ;
  ns1:IAO_0000115 "The rare autosomal recessive condition is caused by mutations in the triosephosphate isomerase enzyme involved in glycolysis/gluconeogenesis metabolic pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-02-19T14:43:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00563"^^xsd:string, "triose phosphate-isomerase deficiency pathway"^^xsd:string ;
  obo:id "PW:0001628"^^xsd:string ;
  rdfs:label "triosephosphate isomerase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001628"^^xsd:string .

ns1:PW_0001629
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001644 ;
  ns2:treeView ns1:PW_0001644 ;
  ns1:IAO_0000115 "Transaldolase deficiency results from alteration in the pentose phosphate metabolic pathway, an alternative route of glucose oxidation that produces reducing equivalents. The condition affects many systems."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-02-19T15:02:57Z"^^xsd:string ;
  obo:hasExactSynonym "Eyaid syndrome pathway"^^xsd:string, "TALDO deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00520"^^xsd:string ;
  obo:id "PW:0001629"^^xsd:string ;
  rdfs:label "transaldolase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001629"^^xsd:string .

ns1:PW_0001630
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001589 ;
  ns2:treeView ns1:PW_0001589 ;
  ns1:IAO_0000115 "Lysosomal storage disease represents a group of rare genetic conditions resulting from deficiencies in particular lysosomal enzymes."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-02-25T16:09:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "lysosomal storage disorders"^^xsd:string ;
  obo:id "PW:0001630"^^xsd:string ;
  rdfs:label "lysosomal storage disease pathway"^^xsd:string ;
  skos:notation "PW:0001630"^^xsd:string .

ns1:PW_0001631
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001414, ns1:PW_0002300 ;
  ns2:treeView ns1:PW_0001414, ns1:PW_0002300 ;
  ns1:IAO_0000115 "There are several forms of Tay-Sachs disease resulting from mutations in the lysosomal hexosaminidase A enzyme. The accumulation of gangliosides in nerve cells leads to loss of mental and physical abilities, neurodegeneration and eventually death."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-02-25T16:12:55Z"^^xsd:string ;
  obo:hasExactSynonym "hexosaminidase A deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00390"^^xsd:string ;
  obo:id "PW:0001631"^^xsd:string ;
  rdfs:label "Tay-Sachs disease pathway"^^xsd:string ;
  skos:notation "PW:0001631"^^xsd:string .

ns1:PW_0001632
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002443 ;
  ns2:treeView ns1:PW_0002443 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of alfentanil - a synthetic opioid used for anesthesia in surgery. The drug is short-acting but potent and classified as restricted. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-02-26T12:43:39Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001632"^^xsd:string ;
  rdfs:label "alfentanil drug pathway"^^xsd:string ;
  skos:notation "PW:0001632"^^xsd:string .

ns1:PW_0001633
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001632 ;
  ns2:treeView ns1:PW_0001632 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of alfentanil. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-02-26T12:51:27Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001633"^^xsd:string ;
  rdfs:label "alfentanil pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001633"^^xsd:string .

ns1:PW_0001634
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001632 ;
  ns2:treeView ns1:PW_0001632 ;
  ns1:IAO_0000115 "The pathway of alfentanil-target interaction and of the biochemical or physiological responses to drug. The drug is an agonist for mu opioid receptors, is classified as a restrictive drug and is almost exclusively used for anesthesia in surgery. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-02-26T12:52:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00413"^^xsd:string ;
  obo:id "PW:0001634"^^xsd:string ;
  rdfs:label "alfentanil pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001634"^^xsd:string .

ns1:PW_0001635
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002152 ;
  ns2:treeView ns1:PW_0002152 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of alteplase - one of several recombinant tissue plasminogen activators. Plasminogen is a key player in the fibrinolytic cascade pathway of blood clots breakdown. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-02-26T13:08:24Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001635"^^xsd:string ;
  rdfs:label "alteplase drug pathway"^^xsd:string ;
  skos:notation "PW:0001635"^^xsd:string .

ns1:PW_0001636
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001635 ;
  ns2:treeView ns1:PW_0001635 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of alteplase, one of several recombinant tissue plasminogen activators. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-02-26T13:16:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001636"^^xsd:string ;
  rdfs:label "alteplase pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001636"^^xsd:string .

ns1:PW_0001637
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001635 ;
  ns2:treeView ns1:PW_0001635 ;
  ns1:IAO_0000115 "The pathway of alteplase-target interaction and of the biochemical or physiological responses to drug. Alteplase is one of several recombinant tissue plasminogen activators. Alteplase is used for treatment of myocardial infarction and ischemic stroke, among others. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-02-26T13:16:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00280"^^xsd:string ;
  obo:id "PW:0001637"^^xsd:string ;
  rdfs:label "alteplase pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001637"^^xsd:string .

ns1:PW_0001638
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002121 ;
  ns2:treeView ns1:PW_0002121 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of amiloride - a blocker of epithelial sodium channels used for the treatment of hypertension and congestive heart failure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-02-26T15:23:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001638"^^xsd:string ;
  rdfs:label "amiloride drug pathway"^^xsd:string ;
  skos:notation "PW:0001638"^^xsd:string .

ns1:PW_0001639
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001638 ;
  ns2:treeView ns1:PW_0001638 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of amiloride. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-02-26T15:23:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001639"^^xsd:string ;
  rdfs:label "amiloride pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001639"^^xsd:string .

ns1:PW_0001640
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001638 ;
  ns2:treeView ns1:PW_0001638 ;
  ns1:IAO_0000115 "The pathway of amiloride-target interaction and of the biochemical or physiological responses to drug. The drug blocks the epithelial sodium channels and is used in the treatment of hypertension and congestive heart failure. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-02-26T15:23:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00133"^^xsd:string ;
  obo:id "PW:0001640"^^xsd:string ;
  rdfs:label "amiloride pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001640"^^xsd:string .

ns1:PW_0001641
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001161 ;
  ns2:treeView ns1:PW_0001161 ;
  ns1:IAO_0000115 "The pathways of rRNA quality control whereby non-functional rRNAs, both at the level of transcript and of mature ribosome components, are subject to degradation. Bulk ribosomes can also be degraded via autophagy."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-03T09:01:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001641"^^xsd:string ;
  rdfs:label "rRNA decay pathway"^^xsd:string ;
  skos:notation "PW:0001641"^^xsd:string .

ns1:PW_0001642
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001161 ;
  ns2:treeView ns1:PW_0001161 ;
  ns1:IAO_0000115 "The pathways of tRNA quality control thereby erroneous tRNA is degraded or normal tRNA is cleaved under stress conditions."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-03T09:07:45Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001642"^^xsd:string ;
  rdfs:label "tRNA decay pathway"^^xsd:string ;
  skos:notation "PW:0001642"^^xsd:string .

ns1:PW_0001643
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001473, ns1:PW_0001589 ;
  ns2:treeView ns1:PW_0001473, ns1:PW_0001589 ;
  ns1:IAO_0000115 "Those diseases that are caused by inborn errors of lipid metabolism. The mutations can disrupt one or several pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-04T12:51:18Z"^^xsd:string ;
  obo:hasExactSynonym "inborn error of lipid metabolism disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001643"^^xsd:string ;
  rdfs:label "inborn error of lipid metabolism pathway"^^xsd:string ;
  skos:notation "PW:0001643"^^xsd:string .

ns1:PW_0001644
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001589 ;
  ns2:treeView ns1:PW_0001589 ;
  ns1:IAO_0000115 "Those diseases that are caused by inborn errors of carbohydrate metabolism. The mutations can disrupt one or several pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-04T13:16:23Z"^^xsd:string ;
  obo:hasExactSynonym "inborn error of carbohydrate metabolism disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001644"^^xsd:string ;
  rdfs:label "inborn error of carbohydrate metabolism pathway"^^xsd:string ;
  skos:notation "PW:0001644"^^xsd:string .

ns1:PW_0001645
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001589 ;
  ns2:treeView ns1:PW_0001589 ;
  ns1:IAO_0000115 "Those diseases that are caused by inborn errors of amino acid metabolism. The mutations can disrupt one or several pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-04T13:23:59Z"^^xsd:string ;
  obo:hasExactSynonym "inborn error of amino acid metabolism disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001645"^^xsd:string ;
  rdfs:label "inborn error of amino acid metabolism pathway"^^xsd:string ;
  skos:notation "PW:0001645"^^xsd:string .

ns1:PW_0001646
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001414, ns1:PW_0001589 ;
  ns2:treeView ns1:PW_0001414, ns1:PW_0001589 ;
  ns1:IAO_0000115 "Those brain diseases that are caused by inborn metabolic errors. The mutations can disrupt one or several pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-04T13:26:26Z"^^xsd:string ;
  obo:hasExactSynonym "inborn error of brain metabolic disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001646"^^xsd:string ;
  rdfs:label "inborn error of brain metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001646"^^xsd:string .

ns1:PW_0001647
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "An autosomal recessive inherited condition resulting from alteration in sulfur metabolism. It exhibits severe neurological symptoms in the neonatal period and is possibly fatal."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-04T13:41:42Z"^^xsd:string ;
  obo:hasExactSynonym "isolated sulfite oxidase deficiency pathway"^^xsd:string, "sulfocysteinuria pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00532"^^xsd:string ;
  obo:id "PW:0001647"^^xsd:string ;
  rdfs:label "sulfite oxidase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001647"^^xsd:string .

ns1:PW_0001648
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001644 ;
  ns2:treeView ns1:PW_0001644 ;
  ns1:IAO_0000115 "A congenital disorder of sucrose metabolism resulting from mutations in the enzyme involved in the hydrolysis of dietary sugars."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-04T13:47:13Z"^^xsd:string ;
  obo:hasExactSynonym "Sucrase-isomaltase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SI deficiency pathway"^^xsd:string, "SMP:00557"^^xsd:string, "congenital sucrose intolerance pathway"^^xsd:string, "congenital sucrose-isomaltose malabsorption pathway"^^xsd:string, "disaccharide intolerance I pathway"^^xsd:string ;
  obo:id "PW:0001648"^^xsd:string ;
  rdfs:label "congenital sucrase-isomaltase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001648"^^xsd:string .

ns1:PW_0001649
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "A rare autosomal recessive condition resulting from mutations in the enzyme involved in the metabolism of the neurotransmitter 4-aminobutyric acid (GABA)."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-04T14:42:55Z"^^xsd:string ;
  obo:hasExactSynonym "4-hydroxybutyric aciduria pathway"^^xsd:string, "SSADH pathway"^^xsd:string, "gamma-hydroxybutyric aciduria pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00243"^^xsd:string, "SMP:00567"^^xsd:string ;
  obo:id "PW:0001649"^^xsd:string ;
  rdfs:label "succinic semialdehyde dehydrogenase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001649"^^xsd:string .

ns1:PW_0001650
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001643, ns1:PW_0002102 ;
  ns2:treeView ns1:PW_0001643, ns1:PW_0002102 ;
  ns1:IAO_0000115 "An autosomal recessive disorder due to altered cholesterol metabolism."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-04T14:51:28Z"^^xsd:string ;
  obo:hasExactSynonym "Rutledge lethal multiple congenital anomaly syndrome pathway"^^xsd:string, "Smith-Opitz-Inborn syndrome pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00389"^^xsd:string ;
  obo:id "PW:0001650"^^xsd:string ;
  rdfs:label "Smith-Lemli-Opitz Syndrome pathway"^^xsd:string ;
  skos:notation "PW:0001650"^^xsd:string .

ns1:PW_0001651
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000922 ;
  ns2:treeView ns1:PW_0000922 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of drugs that reduce or prevent the formation of blood clots.  They are further classified depending on the blood clotting processes they affect. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-04T15:12:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "anticoagulant drug pathway"^^xsd:string ;
  obo:id "PW:0001651"^^xsd:string ;
  rdfs:label "antithrombotic drug pathway"^^xsd:string ;
  skos:notation "PW:0001651"^^xsd:string .

ns1:PW_0001652
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000922 ;
  ns2:treeView ns1:PW_0000922 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of drugs that reduce or prevent bleeding. It is to be noted here that genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-04T15:26:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "hemostatic drug pathway"^^xsd:string ;
  obo:id "PW:0001652"^^xsd:string ;
  rdfs:label "antihemorrhagic drug pathway"^^xsd:string ;
  skos:notation "PW:0001652"^^xsd:string .

ns1:PW_0001653
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001652 ;
  ns2:treeView ns1:PW_0001652 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of aminocaproic acid, an inhibitor of enzymes involved in fibrinolysis and as such, effective in the treatment of certain bleeding disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-04T15:28:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "6-aminohexanoic acid drug pathway"^^xsd:string ;
  obo:id "PW:0001653"^^xsd:string ;
  rdfs:label "aminocaproic acid drug pathway"^^xsd:string ;
  skos:notation "PW:0001653"^^xsd:string .

ns1:PW_0001654
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001653 ;
  ns2:treeView ns1:PW_0001653 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of aminocaproic acid. The drug is used in the treatment of certain bleeding disorders. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-04T15:34:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001654"^^xsd:string ;
  rdfs:label "aminocaproic acid pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001654"^^xsd:string .

ns1:PW_0001655
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001653 ;
  ns2:treeView ns1:PW_0001653 ;
  ns1:IAO_0000115 "The pathway of aminocaproic acid-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-04T15:37:06Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00286"^^xsd:string ;
  obo:id "PW:0001655"^^xsd:string ;
  rdfs:label "aminocaproic acid pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001655"^^xsd:string .

ns1:PW_0001656
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002336 ;
  ns2:treeView ns1:PW_0002336 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of amiodarone, a drug used in the treatment of arrhythmia. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-04T15:44:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001656"^^xsd:string ;
  rdfs:label "amiodarone drug pathway"^^xsd:string ;
  skos:notation "PW:0001656"^^xsd:string .

ns1:PW_0001657
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001656 ;
  ns2:treeView ns1:PW_0001656 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of amiodarone. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-05T12:07:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001657"^^xsd:string ;
  rdfs:label "amiodarone pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001657"^^xsd:string .

ns1:PW_0001658
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001656 ;
  ns2:treeView ns1:PW_0001656 ;
  ns1:IAO_0000115 "The pathway of amiodarone-target interaction and of the biochemical or physiological responses to drug. Amiodarone has beta blocker-like and calcium channel blocker-like actions. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-05T12:07:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00665"^^xsd:string ;
  obo:id "PW:0001658"^^xsd:string ;
  rdfs:label "amiodarone pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001658"^^xsd:string .

ns1:PW_0001659
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001894 ;
  ns2:treeView ns1:PW_0001894 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of amlodipine, a calcium channel blocker used to lower blood pressure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-09T15:06:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001659"^^xsd:string ;
  rdfs:label "amlodipine drug pathway"^^xsd:string ;
  skos:notation "PW:0001659"^^xsd:string .

ns1:PW_0001660
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001659 ;
  ns2:treeView ns1:PW_0001659 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of amlodipine, a calcium channel blocker. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-09T15:11:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001660"^^xsd:string ;
  rdfs:label "amlodipine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001660"^^xsd:string .

ns1:PW_0001661
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001659 ;
  ns2:treeView ns1:PW_0001659 ;
  ns1:IAO_0000115 "The pathway of amlodipine-target interaction and of the biochemical or  physiological responses to drug. Amlodipine, a calcium channel blocker is used to lower blood pressure. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-09T15:14:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00376"^^xsd:string ;
  obo:id "PW:0001661"^^xsd:string ;
  rdfs:label "amlodipine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001661"^^xsd:string .

ns1:PW_0001662
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002152 ;
  ns2:treeView ns1:PW_0002152 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of anistreplase, an antithrombic drug that converts plasminogen to the active plasmin which degrades fibrin (blood clots). Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-09T15:22:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001662"^^xsd:string ;
  rdfs:label "anistreplase drug pathway"^^xsd:string ;
  skos:notation "PW:0001662"^^xsd:string .

ns1:PW_0001663
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001662 ;
  ns2:treeView ns1:PW_0001662 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of anistreplase. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-09T15:42:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001663"^^xsd:string ;
  rdfs:label "anistreplase pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001663"^^xsd:string .

ns1:PW_0001664
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001662 ;
  ns2:treeView ns1:PW_0001662 ;
  ns1:IAO_0000115 "The pathway of anistreplase-target interaction and of the biochemical or physiological responses to drug. An anithrombic drug, anistreplase cleaves a bond in plasminogen to form plasmin. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-09T15:43:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00281"^^xsd:string ;
  obo:id "PW:0001664"^^xsd:string ;
  rdfs:label "anistreplase pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001664"^^xsd:string .

ns1:PW_0001665
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001546 ;
  ns2:treeView ns1:PW_0001546 ;
  ns1:IAO_0000115 "The pharmacokinetics/pharmacodynamics of anitpyrine, an analgesic and antipyretic drug used to relieve pain and fever.  It is thought to inhibit prostaglandin biosynthesis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-09T15:53:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00692"^^xsd:string ;
  obo:id "PW:0001665"^^xsd:string ;
  rdfs:label "antipyrine drug pathway"^^xsd:string ;
  skos:notation "PW:0001665"^^xsd:string .

ns1:PW_0001666
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001665 ;
  ns2:treeView ns1:PW_0001665 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of antipyrine, a drug used to relieve pain and fever. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-09T16:10:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001666"^^xsd:string ;
  rdfs:label "antipyrine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001666"^^xsd:string .

ns1:PW_0001667
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001643 ;
  ns2:treeView ns1:PW_0001643 ;
  ns1:IAO_0000115 "An autosomal recessive metabolic disease due to alteration in the fatty acid beta oxidation pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-10T12:51:10Z"^^xsd:string ;
  obo:hasExactSynonym "ACADS deficiency pathway"^^xsd:string, "SCADH deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SCAD deficiency pathway"^^xsd:string, "SMP:00235"^^xsd:string ;
  obo:id "PW:0001667"^^xsd:string ;
  rdfs:label "short-chain acyl-CoA dehydrogenase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001667"^^xsd:string .

ns1:PW_0001668
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001589 ;
  ns2:treeView ns1:PW_0001589 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-10T12:56:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00568"^^xsd:string ;
  obo:id "PW:0001668"^^xsd:string ;
  rdfs:label "3-hydroxyacyl-CoA dehydrogenase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001668"^^xsd:string .

ns1:PW_0001669
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001472 ;
  ns2:treeView ns1:PW_0001472 ;
  ns1:IAO_0000115 "Those conditions resulting from impaired mitochondrial function and alterations in mitochondrial pathways and due to acquired or inherited mutations."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-10T15:10:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001669"^^xsd:string ;
  rdfs:label "mitochondrial disease pathway"^^xsd:string ;
  skos:notation "PW:0001669"^^xsd:string .

ns1:PW_0001670
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645, ns1:PW_0001669 ;
  ns2:treeView ns1:PW_0001645, ns1:PW_0001669 ;
  ns1:IAO_0000115 "A rare autosomal recessive metabolic disorder due to mutations in sarcosine dehydrogenase resulting in alterations of sarcosine metabolism."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-03-10T15:15:08Z"^^xsd:string ;
  obo:hasExactSynonym "SARCOS pathway"^^xsd:string, "SARD deficiency pathway"^^xsd:string, "SARDH deficiency pathway"^^xsd:string, "SARDHD pathway"^^xsd:string, "hypersarcosinemia pathway"^^xsd:string, "sarcosine dehydrogenase complex deficiency pathway"^^xsd:string, "sarcosinemia disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00244"^^xsd:string ;
  obo:id "PW:0001670"^^xsd:string ;
  rdfs:label "sarcosinemia pathway"^^xsd:string ;
  skos:notation "PW:0001670"^^xsd:string .

ns1:PW_0001671
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000546 ;
  ns2:treeView ns1:PW_0000546 ;
  ns1:IAO_0000115 "The no-go mRNA decay pathway degrades mRNA that causes ribosomes to stall during the elongation phase of translation. It can be due to the presence of pseudoknots, stem loop structures, rare codons, other features."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-05-08T08:46:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "NGD pathway"^^xsd:string ;
  obo:id "PW:0001671"^^xsd:string ;
  rdfs:label "no-go mRNA decay pathway"^^xsd:string ;
  skos:notation "PW:0001671"^^xsd:string .

ns1:PW_0001672
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "Vinca alkaloids are anti-mitotic and anti-microtubule agents originally derived from plants and also produced as semisynthetic compounds. They have a hypoglycemic and cytotoxic effects and are widely used as cancer drugs."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-05-08T09:10:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001672"^^xsd:string ;
  rdfs:label "vinca alkaloid drug pathway"^^xsd:string ;
  skos:notation "PW:0001672"^^xsd:string .

ns1:PW_0001673
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001672 ;
  ns2:treeView ns1:PW_0001672 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of vinblastine - a vinca alkaloid used as anticancer agent. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-05-08T09:20:40Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "VBL drug pathway"^^xsd:string ;
  obo:id "PW:0001673"^^xsd:string ;
  rdfs:label "vinblastine drug pathway"^^xsd:string ;
  skos:notation "PW:0001673"^^xsd:string .

ns1:PW_0001674
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001672 ;
  ns2:treeView ns1:PW_0001672 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of vinorelbine - a vinca alkaloid used as anticancer agent. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-05-08T09:23:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "VRL drug pathway"^^xsd:string ;
  obo:id "PW:0001674"^^xsd:string ;
  rdfs:label "vinorelbine drug pathway"^^xsd:string ;
  skos:notation "PW:0001674"^^xsd:string .

ns1:PW_0001675
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001672 ;
  ns2:treeView ns1:PW_0001672 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of vincristine - a vinca alkaloid used as anticancer agent. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-05-08T09:24:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "VCR drug pathway"^^xsd:string ;
  obo:id "PW:0001675"^^xsd:string ;
  rdfs:label "vincristine drug pathway"^^xsd:string ;
  skos:notation "PW:0001675"^^xsd:string .

ns1:PW_0001676
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001672 ;
  ns2:treeView ns1:PW_0001672 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of vindesine - a vinca alkaloid used as anticancer agent. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-05-08T09:26:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "VDS drug pathway"^^xsd:string ;
  obo:id "PW:0001676"^^xsd:string ;
  rdfs:label "vindesine drug pathway"^^xsd:string ;
  skos:notation "PW:0001676"^^xsd:string .

ns1:PW_0001677
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001673 ;
  ns2:treeView ns1:PW_0001673 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of vinblastine, an anti-mitotic, anticancer agent. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-05-08T09:35:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "VBL pharmacokinetics pathway"^^xsd:string ;
  obo:id "PW:0001677"^^xsd:string ;
  rdfs:label "vinblastine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001677"^^xsd:string .

ns1:PW_0001678
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001673 ;
  ns2:treeView ns1:PW_0001673 ;
  ns1:IAO_0000115 "The pathway of vinblastine-target interaction and of the biochemical or physiological responses to drug. The drug interacts with tubulin and disrupts microtubules function, particularly those at the mitotic spindle. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-05-08T09:35:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00436"^^xsd:string, "VBL pharmacodynamics pathway"^^xsd:string ;
  obo:id "PW:0001678"^^xsd:string ;
  rdfs:label "vinblastine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001678"^^xsd:string .

ns1:PW_0001679
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001675 ;
  ns2:treeView ns1:PW_0001675 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of vincristine, an anti-mitotic, anticancer agent. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-05-08T09:35:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "VCR pharmacokinetics pathway"^^xsd:string ;
  obo:id "PW:0001679"^^xsd:string ;
  rdfs:label "vincristine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001679"^^xsd:string .

ns1:PW_0001680
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001675 ;
  ns2:treeView ns1:PW_0001675 ;
  ns1:IAO_0000115 "The pathway of vincristne-target interaction and of the biochemical or physiological responses to drug. The drug interacts with tubulin and disrupts microtubules function, particularly those at the mitotic spindle. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-05-08T09:36:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00437"^^xsd:string, "VCR pharmacodynamics pathway"^^xsd:string ;
  obo:id "PW:0001680"^^xsd:string ;
  rdfs:label "vincristine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001680"^^xsd:string .

ns1:PW_0001681
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001676 ;
  ns2:treeView ns1:PW_0001676 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of vindesine, an anti-mitotic, anticancer agent. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-05-08T09:36:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "VDS pharmacokientics pathway"^^xsd:string ;
  obo:id "PW:0001681"^^xsd:string ;
  rdfs:label "vindesine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001681"^^xsd:string .

ns1:PW_0001682
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001676 ;
  ns2:treeView ns1:PW_0001676 ;
  ns1:IAO_0000115 "The pathway of vindesine-target interaction and of the biochemical or physiological responses to drug. The drug interacts with tubulin and disrupts microtubules function, particularly those at the mitotic spindle. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-05-08T09:37:09Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00438"^^xsd:string, "VDS pharmacodynamics pathway"^^xsd:string ;
  obo:id "PW:0001682"^^xsd:string ;
  rdfs:label "vindesine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001682"^^xsd:string .

ns1:PW_0001683
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001674 ;
  ns2:treeView ns1:PW_0001674 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of vinorelbine, an anti-mitotic, anticancer agent. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-05-08T09:38:24Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "VRL pharmacokinetics pathway"^^xsd:string ;
  obo:id "PW:0001683"^^xsd:string ;
  rdfs:label "vinorelbine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001683"^^xsd:string .

ns1:PW_0001684
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001674 ;
  ns2:treeView ns1:PW_0001674 ;
  ns1:IAO_0000115 "The pathway of vinorelbine-target interaction and of the biochemical or physiological responses to drug. The drug interacts with tubulin and disrupts microtubules function, particularly those at the mitotic spindle. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-05-08T09:39:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00439"^^xsd:string, "VRL pharmacodynamics pathway"^^xsd:string ;
  obo:id "PW:0001684"^^xsd:string ;
  rdfs:label "vinorelbine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001684"^^xsd:string .

ns1:PW_0001685
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001893 ;
  ns2:treeView ns1:PW_0001893 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of verapamil - an L-type calcium channel blocker of the phenylalkylamine class. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-05-08T10:39:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001685"^^xsd:string ;
  rdfs:label "verapamil drug pathway"^^xsd:string ;
  skos:notation "PW:0001685"^^xsd:string .

ns1:PW_0001686
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001685 ;
  ns2:treeView ns1:PW_0001685 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of verapamil, an L-type calcium channel blocker used for the treatment of cardiovascular conditions. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-05-08T10:42:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001686"^^xsd:string ;
  rdfs:label "verapamil pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001686"^^xsd:string .

ns1:PW_0001687
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001685 ;
  ns2:treeView ns1:PW_0001685 ;
  ns1:IAO_0000115 "The pathway of verapamil-target interaction and of the biochemical or physiological responses to drug. The drug is an L-type calcium channel blocker used in the treatment of hypertension and other cardiovascular conditions. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-05-08T10:43:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00375"^^xsd:string ;
  obo:id "PW:0001687"^^xsd:string ;
  rdfs:label "verapamil pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001687"^^xsd:string .

ns1:PW_0001688
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001789 ;
  ns2:treeView ns1:PW_0001789 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of valsartan, an angiotensin II receptor type 1 antagonist used in the treatment of high blood pressure and congestive heart failure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-05-08T10:49:35Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001688"^^xsd:string ;
  rdfs:label "valsartan drug pathway"^^xsd:string ;
  skos:notation "PW:0001688"^^xsd:string .

ns1:PW_0001689
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001688 ;
  ns2:treeView ns1:PW_0001688 ;
  ns1:IAO_0000115 "The pathway of valsartan-target interaction and of the biochemical or physiological responses to drug. The drug is an antagonist of the angiotensin II receptor type 1. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-05-08T10:50:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00165"^^xsd:string ;
  obo:id "PW:0001689"^^xsd:string ;
  rdfs:label "valsartan pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001689"^^xsd:string .

ns1:PW_0001690
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001688 ;
  ns2:treeView ns1:PW_0001688 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of valsartan. The drug is an antagonist of angiotensin II receptor type 1. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-05-08T10:50:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001690"^^xsd:string ;
  rdfs:label "valsartan pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001690"^^xsd:string .

ns1:PW_0001691
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000355 ;
  ns2:treeView ns1:PW_0000355 ;
  ns1:IAO_0000115 "Those pathways involved in the proper balance of organic chemical levels, uptake and transport, utilization and storage, as demanded by the needs of cells tissues and organs. Disruption of organic chemical homeostasis can have harmful consequences. Collectively they represent a broad class of substances containing carbon."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-05-21T10:10:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001691"^^xsd:string ;
  rdfs:label "organic chemical homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0001691"^^xsd:string .

ns1:PW_0001692
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000355 ;
  ns2:treeView ns1:PW_0000355 ;
  ns1:IAO_0000115 "Those pathways involved in the proper balance of inorganic chemical levels, uptake and transport, utilization and storage, as demanded by the needs of cells tissues and organs. Disruption of inorganic chemical homeostasis can have harmful consequences. Collectively they represent a broad class of substances that do not  contain carbon. Chemical elements are also included."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-05-21T10:15:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001692"^^xsd:string ;
  rdfs:label "inorganic chemical homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0001692"^^xsd:string .

ns1:PW_0001693
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001691 ;
  ns2:treeView ns1:PW_0001691 ;
  ns1:IAO_0000115 "Those pathways that involve the balanced generation and utilization of S-adenosylmethionine (AdoMet or SAM). SAM is a universal methyl donor and at the cross roads of metabolism, gene expression regulation and cellular signaling."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-05-21T10:22:56Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "AdoMet homeostasis pathway"^^xsd:string, "SAM homeostasis pathway"^^xsd:string ;
  obo:id "PW:0001693"^^xsd:string ;
  rdfs:label "S-adenosylmethionine homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0001693"^^xsd:string .

ns1:PW_0001694
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001170 ;
  ns2:treeView ns1:PW_0001170 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of valdecoxib, a non-steroidal anti-inflammatory drug used in the treatment of osteoarthritis, rheumatoid arthritis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-02T14:19:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001694"^^xsd:string ;
  rdfs:label "valdecoxib drug pathway"^^xsd:string ;
  skos:notation "PW:0001694"^^xsd:string .

ns1:PW_0001695
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001694 ;
  ns2:treeView ns1:PW_0001694 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination of valdecoxib, an antirheumatic drug. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-02T14:22:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001695"^^xsd:string ;
  rdfs:label "valdecoxib pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001695"^^xsd:string .

ns1:PW_0001696
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001694 ;
  ns2:treeView ns1:PW_0001694 ;
  ns1:IAO_0000115 "The pathway of valdecoxib-target interaction and of the biochemical or physiological responses to drug. The drug is a selective cyclooxygenase-2 inhibitor. Currently, the prodrug parecoxib is being used as valdecoxib has been removed from the market because its side effects risks."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-02T14:23:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00116"^^xsd:string ;
  obo:id "PW:0001696"^^xsd:string ;
  rdfs:label "valdecoxib pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001696"^^xsd:string .

ns1:PW_0001697
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000013 ;
  ns2:treeView ns1:PW_0000013 ;
  ns1:IAO_0000115 "The congenital and acquired diseases affecting the digestive system."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-02T14:57:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001697"^^xsd:string ;
  rdfs:label "digestive system disease pathway"^^xsd:string ;
  skos:notation "PW:0001697"^^xsd:string .

ns1:PW_0001698
  a owl:Class ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-02T15:02:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001698"^^xsd:string ;
  rdfs:label "liver disease pathway"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0001698"^^xsd:string .

ns1:PW_0001699
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000013 ;
  ns2:treeView ns1:PW_0000013 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-02T15:14:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001699"^^xsd:string ;
  rdfs:label "urogenital disease pathway"^^xsd:string ;
  skos:notation "PW:0001699"^^xsd:string .

ns1:PW_0001700
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001699 ;
  ns2:treeView ns1:PW_0001699 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-02T15:15:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001700"^^xsd:string ;
  rdfs:label "urologic disease pathway"^^xsd:string ;
  skos:notation "PW:0001700"^^xsd:string .

ns1:PW_0001701
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000013 ;
  ns2:treeView ns1:PW_0000013 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-02T15:22:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001701"^^xsd:string ;
  rdfs:label "skin and connective tissue disease pathway"^^xsd:string ;
  skos:notation "PW:0001701"^^xsd:string .

ns1:PW_0001702
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002381 ;
  ns2:treeView ns1:PW_0002381 ;
  ns1:IAO_0000115 "Alterations in the biosynthetic pathway of sialic acid (N-acetylneuraminic acid) lead to its excessive accumulation in the urine, resulting in several phenotypes."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-04T14:21:31Z"^^xsd:string ;
  obo:hasExactSynonym "french type sialuria disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00216"^^xsd:string, "SMP:00217"^^xsd:string ;
  obo:id "PW:0001702"^^xsd:string ;
  rdfs:label "french type sialuria pathway"^^xsd:string ;
  skos:notation "PW:0001702"^^xsd:string .

ns1:PW_0001703
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001936 ;
  ns2:treeView ns1:PW_0001936 ;
  ns1:IAO_0000115 "Saccharopinuria, also known as hyperlysinemia type II, is an autosomal recessive condition due to alteration in metabolic pathways of lysine and its derivatives."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-04T14:47:14Z"^^xsd:string ;
  obo:hasExactSynonym "alpha-aminoadipic semialdehyde synthase deficiency pathway"^^xsd:string, "hyperlysinemia type II pathway"^^xsd:string, "saccharopine dehydrogenase deficiency pathway"^^xsd:string, "saccharopinuria disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00239"^^xsd:string, "SMP:00528"^^xsd:string, "hyperlysinemia type II disease pathway"^^xsd:string ;
  obo:id "PW:0001703"^^xsd:string ;
  rdfs:label "saccharopinuria pathway"^^xsd:string ;
  skos:notation "PW:0001703"^^xsd:string .

ns1:PW_0001704
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001644 ;
  ns2:treeView ns1:PW_0001644 ;
  ns1:IAO_0000115 "A disorder due to alteration in the pentose phosphate metabolic pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-04T14:55:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00519"^^xsd:string ;
  obo:id "PW:0001704"^^xsd:string ;
  rdfs:label "ribose 5-phosphate isomerase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001704"^^xsd:string .

ns1:PW_0001705
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001646 ;
  ns2:treeView ns1:PW_0001646 ;
  ns1:IAO_0000115 "An autosomal recessive disorder due to alterations in peroxisomal metabolic pathways manifesting in hearing loss and impaired vision."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-04T15:06:28Z"^^xsd:string ;
  obo:hasExactSynonym "HMSN type IV pathway"^^xsd:string, "HSMN IV pathway"^^xsd:string, "Heredopathia atactica polyneuritiformis pathway"^^xsd:string, "Refsum's disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00451"^^xsd:string ;
  obo:id "PW:0001705"^^xsd:string ;
  rdfs:label "Refsum disease pathway"^^xsd:string ;
  skos:notation "PW:0001705"^^xsd:string .

ns1:PW_0001706
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001751 ;
  ns2:treeView ns1:PW_0001751 ;
  ns1:IAO_0000115 "An inherited disorder affecting the red blood cells, resulting from alteration in the pyruvate metabolic pathway and manifesting in hemolytic anemia."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-04T15:13:31Z"^^xsd:string ;
  obo:hasExactSynonym "PK deficiency pathway"^^xsd:string, "hemolytic anemia due to red cell pyruvate kinase deficiency pathway"^^xsd:string, "pyruvate kinase deficiency of erythrocyte pathway"^^xsd:string, "pyruvate kinase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00559"^^xsd:string ;
  obo:id "PW:0001706"^^xsd:string ;
  rdfs:label "pyruvate kinase deficiency of red cells pathway"^^xsd:string ;
  skos:notation "PW:0001706"^^xsd:string .

ns1:PW_0001707
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001228 ;
  ns2:treeView ns1:PW_0001228 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of enalapril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-05T11:07:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001707"^^xsd:string ;
  rdfs:label "enalapril drug pathway"^^xsd:string ;
  skos:notation "PW:0001707"^^xsd:string .

ns1:PW_0001708
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001230, ns1:PW_0001707 ;
  ns2:treeView ns1:PW_0001230, ns1:PW_0001707 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of enalapril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-05T11:08:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00593"^^xsd:string ;
  obo:id "PW:0001708"^^xsd:string ;
  rdfs:label "enalapril pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001708"^^xsd:string .

ns1:PW_0001709
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001231, ns1:PW_0001707 ;
  ns2:treeView ns1:PW_0001231, ns1:PW_0001707 ;
  ns1:IAO_0000115 "The pathway of enalapril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-05T11:08:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00148"^^xsd:string ;
  obo:id "PW:0001709"^^xsd:string ;
  rdfs:label "enalapril pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001709"^^xsd:string .

ns1:PW_0001710
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001228 ;
  ns2:treeView ns1:PW_0001228 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of ramipril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-05T11:32:35Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001710"^^xsd:string ;
  rdfs:label "ramipril drug pathway"^^xsd:string ;
  skos:notation "PW:0001710"^^xsd:string .

ns1:PW_0001711
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001230, ns1:PW_0001710 ;
  ns2:treeView ns1:PW_0001230, ns1:PW_0001710 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of ramipril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-05T11:35:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00597"^^xsd:string ;
  obo:id "PW:0001711"^^xsd:string ;
  rdfs:label "ramipril pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001711"^^xsd:string .

ns1:PW_0001712
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001231, ns1:PW_0001710 ;
  ns2:treeView ns1:PW_0001231, ns1:PW_0001710 ;
  ns1:IAO_0000115 "The pathway of ramipril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-05T11:35:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00154"^^xsd:string ;
  obo:id "PW:0001712"^^xsd:string ;
  rdfs:label "ramipril pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001712"^^xsd:string .

ns1:PW_0001713
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001228 ;
  ns2:treeView ns1:PW_0001228 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of quinapril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-05T11:42:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001713"^^xsd:string ;
  rdfs:label "quinapril drug pathway"^^xsd:string ;
  skos:notation "PW:0001713"^^xsd:string .

ns1:PW_0001714
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001230, ns1:PW_0001713 ;
  ns2:treeView ns1:PW_0001230, ns1:PW_0001713 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of quinapril, an ACE inhibitor. Quinapril is a prodrug that is converted to its active  metabolite, quinaprilat, in the liver. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-05T11:42:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00596"^^xsd:string ;
  obo:id "PW:0001714"^^xsd:string ;
  rdfs:label "quinapril pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001714"^^xsd:string .

ns1:PW_0001715
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001231, ns1:PW_0001713 ;
  ns2:treeView ns1:PW_0001231, ns1:PW_0001713 ;
  ns1:IAO_0000115 "The pathway of quinapril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-05T11:43:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00153"^^xsd:string ;
  obo:id "PW:0001715"^^xsd:string ;
  rdfs:label "quinapril pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001715"^^xsd:string .

ns1:PW_0001716
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001228 ;
  ns2:treeView ns1:PW_0001228 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of perindopril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-05T13:06:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001716"^^xsd:string ;
  rdfs:label "perindopril drug pathway"^^xsd:string ;
  skos:notation "PW:0001716"^^xsd:string .

ns1:PW_0001717
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001230, ns1:PW_0001716 ;
  ns2:treeView ns1:PW_0001230, ns1:PW_0001716 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of perindopril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-05T13:07:06Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001717"^^xsd:string ;
  rdfs:label "perindopril pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001717"^^xsd:string .

ns1:PW_0001718
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001231, ns1:PW_0001716 ;
  ns2:treeView ns1:PW_0001231, ns1:PW_0001716 ;
  ns1:IAO_0000115 "The pathway of perindopril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-05T13:07:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00152"^^xsd:string ;
  obo:id "PW:0001718"^^xsd:string ;
  rdfs:label "perindopril pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001718"^^xsd:string .

ns1:PW_0001719
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001228 ;
  ns2:treeView ns1:PW_0001228 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of lisinopril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-05T13:12:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001719"^^xsd:string ;
  rdfs:label "lisinopril drug pathway"^^xsd:string ;
  skos:notation "PW:0001719"^^xsd:string .

ns1:PW_0001720
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001231, ns1:PW_0001719 ;
  ns2:treeView ns1:PW_0001231, ns1:PW_0001719 ;
  ns1:IAO_0000115 "The pathway of lisinopril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-05T13:13:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00150"^^xsd:string ;
  obo:id "PW:0001720"^^xsd:string ;
  rdfs:label "lisinopril pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001720"^^xsd:string .

ns1:PW_0001721
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001230, ns1:PW_0001719 ;
  ns2:treeView ns1:PW_0001230, ns1:PW_0001719 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of lisinopril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-05T13:14:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001721"^^xsd:string ;
  rdfs:label "lisinopril pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001721"^^xsd:string .

ns1:PW_0001722
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001228 ;
  ns2:treeView ns1:PW_0001228 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of benazepril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-05T13:16:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001722"^^xsd:string ;
  rdfs:label "benazepril drug pathway"^^xsd:string ;
  skos:notation "PW:0001722"^^xsd:string .

ns1:PW_0001723
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001230, ns1:PW_0001722 ;
  ns2:treeView ns1:PW_0001230, ns1:PW_0001722 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of benazepril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-05T13:17:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00591"^^xsd:string ;
  obo:id "PW:0001723"^^xsd:string ;
  rdfs:label "benazepril pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001723"^^xsd:string .

ns1:PW_0001724
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001231, ns1:PW_0001722 ;
  ns2:treeView ns1:PW_0001231, ns1:PW_0001722 ;
  ns1:IAO_0000115 "The pathway of benazepril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-05T13:18:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00145"^^xsd:string ;
  obo:id "PW:0001724"^^xsd:string ;
  rdfs:label "benazepril pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001724"^^xsd:string .

ns1:PW_0001725
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001228 ;
  ns2:treeView ns1:PW_0001228 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of trandolapril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-05T13:22:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001725"^^xsd:string ;
  rdfs:label "trandolapril drug pathway"^^xsd:string ;
  skos:notation "PW:0001725"^^xsd:string .

ns1:PW_0001726
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001230, ns1:PW_0001725 ;
  ns2:treeView ns1:PW_0001230, ns1:PW_0001725 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of trandolapril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-05T13:23:39Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00599"^^xsd:string ;
  obo:id "PW:0001726"^^xsd:string ;
  rdfs:label "trandolapril pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001726"^^xsd:string .

ns1:PW_0001727
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001231, ns1:PW_0001725 ;
  ns2:treeView ns1:PW_0001231, ns1:PW_0001725 ;
  ns1:IAO_0000115 "The pathway of trandolapril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-05T13:24:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00157"^^xsd:string ;
  obo:id "PW:0001727"^^xsd:string ;
  rdfs:label "trandolapril pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001727"^^xsd:string .

ns1:PW_0001728
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001228 ;
  ns2:treeView ns1:PW_0001228 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of cilazapril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-05T13:29:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001728"^^xsd:string ;
  rdfs:label "cilazapril drug pathway"^^xsd:string ;
  skos:notation "PW:0001728"^^xsd:string .

ns1:PW_0001729
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001230, ns1:PW_0001728 ;
  ns2:treeView ns1:PW_0001230, ns1:PW_0001728 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of cilazapril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-05T13:30:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00592"^^xsd:string ;
  obo:id "PW:0001729"^^xsd:string ;
  rdfs:label "cilazapril pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001729"^^xsd:string .

ns1:PW_0001730
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001231, ns1:PW_0001728 ;
  ns2:treeView ns1:PW_0001231, ns1:PW_0001728 ;
  ns1:IAO_0000115 "The pathway of cilazapril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-06-05T13:31:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00147"^^xsd:string ;
  obo:id "PW:0001730"^^xsd:string ;
  rdfs:label "cilazapril pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001730"^^xsd:string .

ns1:PW_0001731
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002150 ;
  ns2:treeView ns1:PW_0002150 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of ticlopidine, a platelet aggregation inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-09T15:59:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001731"^^xsd:string ;
  rdfs:label "ticlopidine drug pathway"^^xsd:string ;
  skos:notation "PW:0001731"^^xsd:string .

ns1:PW_0001732
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001731 ;
  ns2:treeView ns1:PW_0001731 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of ticlopidine, a platelet aggregation inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-09T16:01:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00611"^^xsd:string ;
  obo:id "PW:0001732"^^xsd:string ;
  rdfs:label "ticlopidine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001732"^^xsd:string .

ns1:PW_0001733
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001731 ;
  ns2:treeView ns1:PW_0001731 ;
  ns1:IAO_0000115 "The pathway of ticlopidine-interaction and of the biochemical or physiological responses to drug. The drug can irreversibly block the adenosine diphosphate (ADP) receptor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-09T16:02:09Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00261"^^xsd:string ;
  obo:id "PW:0001733"^^xsd:string ;
  rdfs:label "ticlopidine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001733"^^xsd:string .

ns1:PW_0001734
  a owl:Class ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of adrenergic beta receptors drugs - beta-agonists. Adrenergic beta receptors, in response to epinephrine or norepinephrine couple to the Gs alpha subunit of heterotrimeric G protein to elicit several responses. Beta-agonists are used to stimulate these responses. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-12T09:29:27Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001734"^^xsd:string ;
  rdfs:label "adrenergic beta receptor drug pathway - beta agonist"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0001734"^^xsd:string .

ns1:PW_0001735
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000920 ;
  ns2:treeView ns1:PW_0000920 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of adrenergic beta receptors blockers. Adrenergic beta receptors, in response to epinephrine or norepinephrine couple to the Gs alpha subunit of heterotrimeric G protein to elicit several responses. Beta receptor antagonists are used to inhibit these responses and they are either selective or non-selective. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-12T09:46:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001735"^^xsd:string ;
  rdfs:label "adrenergic beta receptor antagonist drug pathway"^^xsd:string ;
  skos:notation "PW:0001735"^^xsd:string .

ns1:PW_0001736
  a owl:Class ;
  ns1:IAO_0000231 ns1:IAO_0000227 ;
  ns1:IAO_0100001 ns1:PW_0002498 ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-12T09:47:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001736"^^xsd:string ;
  rdfs:label "adrenergic beta receptor agonist drug pathway"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0001736"^^xsd:string .

ns1:PW_0001737
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001735 ;
  ns2:treeView ns1:PW_0001735 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of selective adrenergic beta receptors blockers. Adrenergic beta receptors, in response to epinephrine or norepinephrine couple to the Gs alpha subunit of heterotrimeric G protein to elicit several responses. Beta-1 receptor antagonists are used to inhibit these responses. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-12T09:58:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001737"^^xsd:string ;
  rdfs:label "adrenergic beta receptor selective antagonist drug pathway"^^xsd:string ;
  skos:notation "PW:0001737"^^xsd:string .

ns1:PW_0001738
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001735 ;
  ns2:treeView ns1:PW_0001735 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of non-selective adrenergic beta receptors blockers. Adrenergic beta receptors, in response to epinephrine or norepinephrine couple to the Gs alpha subunit of heterotrimeric G protein to elicit several responses. Beta receptor antagonists are used to inhibit these responses. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-12T09:59:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001738"^^xsd:string ;
  rdfs:label "adrenergic beta receptor non-selective antagonist drug pathway"^^xsd:string ;
  skos:notation "PW:0001738"^^xsd:string .

ns1:PW_0001739
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001738 ;
  ns2:treeView ns1:PW_0001738 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of timolol - a non-selective adrenergic beta receptor blocker. It binds and inhibits the beta 1 receptor and is used in for the treatment of hypertension and other cardiovascular conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-12T10:07:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001739"^^xsd:string ;
  rdfs:label "timolol drug pathway"^^xsd:string ;
  skos:notation "PW:0001739"^^xsd:string .

ns1:PW_0001740
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001739 ;
  ns2:treeView ns1:PW_0001739 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of timolol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-12T10:09:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001740"^^xsd:string ;
  rdfs:label "timolol pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001740"^^xsd:string .

ns1:PW_0001741
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001739 ;
  ns2:treeView ns1:PW_0001739 ;
  ns1:IAO_0000115 "The pathway of timolol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta 1. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-12T10:09:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00659"^^xsd:string ;
  obo:id "PW:0001741"^^xsd:string ;
  rdfs:label "timolol pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001741"^^xsd:string .

ns1:PW_0001742
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002150 ;
  ns2:treeView ns1:PW_0002150 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of tirofiban, a platelet aggregation inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-12T10:22:21Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001742"^^xsd:string ;
  rdfs:label "tirofiban drug pathway"^^xsd:string ;
  skos:notation "PW:0001742"^^xsd:string .

ns1:PW_0001743
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001742 ;
  ns2:treeView ns1:PW_0001742 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of tirofiban, a platelet aggregation inhibitor.  Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-12T10:22:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001743"^^xsd:string ;
  rdfs:label "tirofiban pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001743"^^xsd:string .

ns1:PW_0001744
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001742 ;
  ns2:treeView ns1:PW_0001742 ;
  ns1:IAO_0000115 "The pathway of tirofiban-interaction and of the biochemical or physiological responses to drug. Tirofiban is a reversible inhibitor of glycoprotein IIb/IIIa. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-12T10:23:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00267"^^xsd:string ;
  obo:id "PW:0001744"^^xsd:string ;
  rdfs:label "tirofiban pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001744"^^xsd:string .

ns1:PW_0001745
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000996 ;
  ns2:treeView ns1:PW_0000996 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of tobramycine - an anti-bacterial antibiotic, used primarily for the treatment of Gram-negative infections. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-12T10:30:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001745"^^xsd:string ;
  rdfs:label "tobramycin drug pathway"^^xsd:string ;
  skos:notation "PW:0001745"^^xsd:string .

ns1:PW_0001746
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001745 ;
  ns2:treeView ns1:PW_0001745 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination of tobramycin - an antibiotic that interferes with bacterial protein synthesis. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-12T10:30:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001746"^^xsd:string ;
  rdfs:label "tobramycin pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001746"^^xsd:string .

ns1:PW_0001747
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001745 ;
  ns2:treeView ns1:PW_0001745 ;
  ns1:IAO_0000115 "The pathway of tobramycin-target interaction and of the biochemical or physiological responses to drug. Kanamycin interferes with bacterial protein synthesis and is used in the treatment of Gram-negative infections. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-12T10:30:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00711"^^xsd:string ;
  obo:id "PW:0001747"^^xsd:string ;
  rdfs:label "tobramycin pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001747"^^xsd:string .

ns1:PW_0001748
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001170 ;
  ns2:treeView ns1:PW_0001170 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of tolmetin, a non-steroidal anti-inflammatory drug used in the treatment of osteoarthritis, rheumatoid arthritis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-12T10:46:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001748"^^xsd:string ;
  rdfs:label "tolmetin drug pathway"^^xsd:string ;
  skos:notation "PW:0001748"^^xsd:string .

ns1:PW_0001749
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001748 ;
  ns2:treeView ns1:PW_0001748 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination of tolmetin, an antirheumatic drug. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-12T10:47:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001749"^^xsd:string ;
  rdfs:label "tolmetin pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001749"^^xsd:string .

ns1:PW_0001750
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001748 ;
  ns2:treeView ns1:PW_0001748 ;
  ns1:IAO_0000115 "The pathway of tolmetin-target interaction and of the biochemical or physiological responses to drug. Tolmetin is thought to inhibit cyclooxygenases and thus block prostaglandin synthesis. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-12T10:47:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00704"^^xsd:string ;
  obo:id "PW:0001750"^^xsd:string ;
  rdfs:label "tolmetin pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001750"^^xsd:string .

ns1:PW_0001751
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001644 ;
  ns2:treeView ns1:PW_0001644 ;
  ns1:IAO_0000115 "Those diseases that are caused by inborn errors of pyruvate metabolism. The pyruvate metabolic pathway is at the intersection of pathways important for glucose and energy homeostasis. Alterations involve several and important components."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-12T11:11:45Z"^^xsd:string ;
  obo:hasExactSynonym "inborn error of pyruvate metabolism disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001751"^^xsd:string ;
  rdfs:label "inborn error of pyruvate metabolism pathway"^^xsd:string ;
  skos:notation "PW:0001751"^^xsd:string .

ns1:PW_0001752
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001751 ;
  ns2:treeView ns1:PW_0001751 ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-12T11:15:48Z"^^xsd:string ;
  obo:hasExactSynonym "pyruvate dehydrogenase complex deficiency pathway"^^xsd:string, "pyruvate dehydrogenase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00212"^^xsd:string ;
  obo:id "PW:0001752"^^xsd:string ;
  rdfs:label "pyruvate decarboxylase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001752"^^xsd:string .

ns1:PW_0001753
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001752 ;
  ns2:treeView ns1:PW_0001752 ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-12T11:17:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00334"^^xsd:string ;
  obo:id "PW:0001753"^^xsd:string ;
  rdfs:label "pyruvate dehydrogenase E1 deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001753"^^xsd:string .

ns1:PW_0001754
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001752 ;
  ns2:treeView ns1:PW_0001752 ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-12T11:18:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00551"^^xsd:string ;
  obo:id "PW:0001754"^^xsd:string ;
  rdfs:label "pyruvate dehydrogenase E2 deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001754"^^xsd:string .

ns1:PW_0001755
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001752 ;
  ns2:treeView ns1:PW_0001752 ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-06-12T11:19:20Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00550"^^xsd:string ;
  obo:id "PW:0001755"^^xsd:string ;
  rdfs:label "pyruvate dehydrogenase E3 deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001755"^^xsd:string .

ns1:PW_0001756
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000002 ;
  ns2:treeView ns1:PW_0000002 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, folding and/or degradation of peptides and proteins, including the synthesis of protein/peptide/amino-acid based hormones."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-07-14T08:11:09Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001756"^^xsd:string ;
  rdfs:label "peptide and protein metabolic process"^^xsd:string ;
  skos:notation "PW:0001756"^^xsd:string .

ns1:PW_0001757
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001756 ;
  ns2:treeView ns1:PW_0001756 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, folding and/or degradation of peptide and protein hormones, and those derived from them."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-07-14T08:15:56Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001757"^^xsd:string ;
  rdfs:label "peptide and protein hormone metabolic process"^^xsd:string ;
  skos:notation "PW:0001757"^^xsd:string .

ns1:PW_0001758
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001757 ;
  ns2:treeView ns1:PW_0001757 ;
  ns1:IAO_0000115 "The insulin precursor, preproinsulin is subject to a several processing steps in the endoplasmic reticulum and the Golgi apparatus before ending as the mature zinc-insulin hexamer stored in secretory granules. The expression of insulin si confined to the beta cells of the pancreatic islets of Langerhans."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-07-14T08:27:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "preproinsulin processing pathway"^^xsd:string ;
  obo:id "PW:0001758"^^xsd:string ;
  rdfs:label "insulin biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001758"^^xsd:string .

ns1:PW_0001759
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001757 ;
  ns2:treeView ns1:PW_0001757 ;
  ns1:IAO_0000115 "The preproglucagon processing pathway gives rise to several peptide hormones in a tissue and cell specific manner. A subset, including glucagon, glucagon-like peptide-1 and peptide-2, and oxyntomodulin, are better characterized. The function of other preproglucagon derived peptides, remains to be established."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-07-14T08:47:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001759"^^xsd:string ;
  rdfs:label "preproglucagon processing pathway"^^xsd:string ;
  skos:notation "PW:0001759"^^xsd:string .

ns1:PW_0001760
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001759 ;
  ns2:treeView ns1:PW_0001759 ;
  ns1:IAO_0000115 "The processing of preproglucagon precursor that gives to the glucagon hormone in the alpha cells of the pancreatic islets of Langerhans."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-07-14T08:49:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001760"^^xsd:string ;
  rdfs:label "glucagon biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001760"^^xsd:string .

ns1:PW_0001761
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001759 ;
  ns2:treeView ns1:PW_0001759 ;
  ns1:IAO_0000115 "The processing of the preproglucagon precursor that gives rise to glucagon-like peptide-1 (GLP-1) in the intestinal L cells and discrete sets of neurons."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-07-14T08:52:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "GLP-1 biosynthetic pathway"^^xsd:string ;
  obo:id "PW:0001761"^^xsd:string ;
  rdfs:label "glucagon-like peptide-1 biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001761"^^xsd:string .

ns1:PW_0001762
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001759 ;
  ns2:treeView ns1:PW_0001759 ;
  ns1:IAO_0000115 "The processing of the preproglucagon precursor that gives rise to glucagon-like peptide-2 (GLP-2) in the intestinal L cell and discrete sets of neurons."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-07-14T08:55:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "GLP-2 biosynthetic pathway"^^xsd:string ;
  obo:id "PW:0001762"^^xsd:string ;
  rdfs:label "glucagon-like peptide-2 biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001762"^^xsd:string .

ns1:PW_0001763
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001759 ;
  ns2:treeView ns1:PW_0001759 ;
  ns1:IAO_0000115 "The processing of the preproglucagon precursor that gives rise to oxyntomodulin in the intestinal L cells and discrete sets of neurons."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-07-14T09:07:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001763"^^xsd:string ;
  rdfs:label "oxyntomodulin biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001763"^^xsd:string .

ns1:PW_0001764
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001162 ;
  ns2:treeView ns1:PW_0001162 ;
  ns1:IAO_0000115 "The signaling pathway initiated by a radical. The reactivity of free radicals renders them potentially hazardous but it can also positively contribute to many biological processes. The generation, utilization and neutralization of radicals is tightly regulated. Disturbance in the levels and regulation of radicals leads to pathological states including cardiovascular diseases, diabetes, cancer and aging."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-07-29T09:05:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001764"^^xsd:string ;
  rdfs:label "radical mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0001764"^^xsd:string .

ns1:PW_0001765
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001764 ;
  ns2:treeView ns1:PW_0001764 ;
  ns1:IAO_0000115 "Superoxide and the radicals for which it is a precursor participate in several reactions and processes important in immunity and epigenetics."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-07-29T09:21:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001765"^^xsd:string ;
  rdfs:label "superoxide mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0001765"^^xsd:string .

ns1:PW_0001766
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001567, ns1:PW_0001767 ;
  ns2:treeView ns1:PW_0001567, ns1:PW_0001767 ;
  ns1:IAO_0000115 "RNA molecules such as ribosomal and transfer RNA, rRNA and tRNA respectively, undergo many modifications to achieve functionality. Among the many modifications, there are those introduced by iron-sulfur (Fe/S) cluster-containing enzymes. Most have radical S-adenosylmethionine (SAM) domains that use SAM to produce 5-adenosyl radical; the intermediate allows them to mediate a vast range of chemical transformations."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-07-29T10:12:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001766"^^xsd:string ;
  rdfs:label "radical SAM enzyme mediated RNA processing pathway"^^xsd:string ;
  skos:notation "PW:0001766"^^xsd:string .

ns1:PW_0001767
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000135, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001693
  ] ;
  ns2:treeView ns1:PW_0000135, ns1:PW_0001693 ;
  ns3:part_of ns1:PW_0001693 ;
  ns1:IAO_0000115 "The radical SAM enzymes use their iron-sulfur (Fe/S) cluster(s) generate a radical using the S-adenosylmethionine (SAM) as the substrate. The intermediate radical allows these enzymes to mediate a vast range of chemical transformations important for co-factor and lipid metabolism, peptide and RNA modification."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-07-29T10:33:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001767"^^xsd:string ;
  rdfs:label "radical SAM enzyme mediated metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001767"^^xsd:string .

ns1:PW_0001768
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of docetaxel - an antineoplastiic agent. It is an anti-mitotic drug whose cytotoxicity affects tumor cells but can also extend to other dividing cells. In some cases, the drug could cause severe side effects and deaths due to its toxicity have been reported. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-03T15:18:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001768"^^xsd:string ;
  rdfs:label "docetaxel drug pathway"^^xsd:string ;
  skos:notation "PW:0001768"^^xsd:string .

ns1:PW_0001769
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001768 ;
  ns2:treeView ns1:PW_0001768 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of docetaxel. Docetaxel is used as a chemotherapeutic agent for the treatment of various cancers. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-03T15:25:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001769"^^xsd:string ;
  rdfs:label "docetaxel pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001769"^^xsd:string .

ns1:PW_0001770
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001768 ;
  ns2:treeView ns1:PW_0001768 ;
  ns1:IAO_0000115 "The pathway of docetaxel-target interaction and of the biochemical or physiological responses to drug. Docetaxel  is used as a chemotherapeutic agent for the treatment of various cancers. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-03T15:25:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00435"^^xsd:string ;
  obo:id "PW:0001770"^^xsd:string ;
  rdfs:label "docetaxel pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001770"^^xsd:string .

ns1:PW_0001771
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000996 ;
  ns2:treeView ns1:PW_0000996 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of tenofovir, an antirfetroviral drug used for the treatment of HIV infection and hepatitis B. It is a nucleoside analog reverse transcriptase inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-03T15:46:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001771"^^xsd:string ;
  rdfs:label "tenofovir drug pathway"^^xsd:string ;
  skos:notation "PW:0001771"^^xsd:string .

ns1:PW_0001772
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001771 ;
  ns2:treeView ns1:PW_0001771 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination of tenofovir - a nucleotide analogue reverse transcriptase inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-03T15:46:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00630"^^xsd:string ;
  obo:id "PW:0001772"^^xsd:string ;
  rdfs:label "tenofovir pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001772"^^xsd:string .

ns1:PW_0001773
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001771 ;
  ns2:treeView ns1:PW_0001771 ;
  ns1:IAO_0000115 "The pathway of tenofovir-target interaction and of the biochemical or physiological responses to drug. Tenofovir is a nucleotide analogue reverse transcriptase inhibitor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-03T15:46:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00419"^^xsd:string ;
  obo:id "PW:0001773"^^xsd:string ;
  rdfs:label "tenofovir pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001773"^^xsd:string .

ns1:PW_0001774
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001434 ;
  ns2:treeView ns1:PW_0001434 ;
  ns1:IAO_0000115 "A pathway triggered by administration of docetaxel, a chemotherapeutic drug. Docetaxel inhibits mitotic cell division and its cytotoxicity extends to all dividing cells, not just tumor cells. Severe side effects and even death cases have been reported."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-07T13:42:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001774"^^xsd:string ;
  rdfs:label "docetaxel response pathway"^^xsd:string ;
  skos:notation "PW:0001774"^^xsd:string .

ns1:PW_0001775
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001751 ;
  ns2:treeView ns1:PW_0001751 ;
  ns1:IAO_0000115 "An autosomal recessive metabolic disorder resulting from impaired pyruvate metabolism. An absent or decreased activity of pyruvate carboxylase results in an altered pyruvate pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-07T14:14:22Z"^^xsd:string ;
  obo:hasExactSynonym "pyruvate carboxylase deficiency disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00350"^^xsd:string ;
  obo:id "PW:0001775"^^xsd:string ;
  rdfs:label "pyruvate carboxylase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001775"^^xsd:string .

ns1:PW_0001776
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001589 ;
  ns2:treeView ns1:PW_0001589 ;
  ns1:IAO_0000115 "Those diseases that are caused by inborn errors of purine and/or pyrimidine metabolism. The mutations can disrupt one or several pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-07T14:20:56Z"^^xsd:string ;
  obo:hasExactSynonym "inborn error of purine-pyrimidine metabolism disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001776"^^xsd:string ;
  rdfs:label "inborn error of purine-pyrimidine metabolism pathway"^^xsd:string ;
  skos:notation "PW:0001776"^^xsd:string .

ns1:PW_0001777
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001776 ;
  ns2:treeView ns1:PW_0001776 ;
  ns1:IAO_0000115 "A rather rare autosomal recessive immunodeficiency resulting from decreased T-cell function. Disruption of purine nucleoside phosphorylase results in an altered purine salvage pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-07T14:23:48Z"^^xsd:string ;
  obo:hasExactSynonym "PNP deficiency pathway"^^xsd:string, "deficiency of inosine phosphorylase pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00210"^^xsd:string ;
  obo:id "PW:0001777"^^xsd:string ;
  rdfs:label "purine nucleoside phosphorylase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001777"^^xsd:string .

ns1:PW_0001778
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "An autosomal recessive metabolic disorder due to mutations in propionyl CoA carboxylase genes resulting in alteration of amino acid metabolic pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-07T14:37:35Z"^^xsd:string ;
  obo:hasExactSynonym "ketotic glycinemia pathway"^^xsd:string, "ketotic hyperglycinemia pathway"^^xsd:string, "propionic acidemia disease pathway"^^xsd:string, "propionic aciduria pathway"^^xsd:string, "propionyl-CoA carboxylase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00236"^^xsd:string ;
  obo:id "PW:0001778"^^xsd:string ;
  rdfs:label "propionic acidemia pathway"^^xsd:string ;
  skos:notation "PW:0001778"^^xsd:string .

ns1:PW_0001779
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001776 ;
  ns2:treeView ns1:PW_0001776 ;
  ns1:IAO_0000115 "A rare recessive metabolic disorder arising from alteration in the purine metabolic pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-07T14:45:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00537"^^xsd:string, "myo"^^xsd:string, "myoadenylate deaminase deficiency"^^xsd:string ;
  obo:id "PW:0001779"^^xsd:string ;
  rdfs:label "adenosine monophosphate deaminase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001779"^^xsd:string .

ns1:PW_0001780
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000300 ;
  ns2:treeView ns1:PW_0000300 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-07T15:52:54Z"^^xsd:string ;
  obo:hasExactSynonym "hyperoxaluria disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001780"^^xsd:string ;
  rdfs:label "hyperoxaluria pathway"^^xsd:string ;
  skos:notation "PW:0001780"^^xsd:string .

ns1:PW_0001781
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001644, ns1:PW_0001780 ;
  ns2:treeView ns1:PW_0001644, ns1:PW_0001780 ;
  ns1:IAO_0000115 "A genetic disorder characterized by the excretion of large amounts of oxalate and present in several forms depending on the alteration of the glyoxalate metabolic pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-07T15:53:23Z"^^xsd:string ;
  obo:hasExactSynonym "primary hyperoxaluria disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001781"^^xsd:string ;
  rdfs:label "primary hyperoxaluria pathway"^^xsd:string ;
  skos:notation "PW:0001781"^^xsd:string .

ns1:PW_0001782
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001781 ;
  ns2:treeView ns1:PW_0001781 ;
  ns1:IAO_0000115 "Hyperoxaluria results from alteration in the glyoxylate metabolic pathway. Type 1 is due to mutations in the alanine-glyoxylate aminotransferase (AGXT) enzyme."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-07T15:58:55Z"^^xsd:string ;
  obo:hasExactSynonym "primary hyperoxaluria type 1 disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00352"^^xsd:string ;
  obo:id "PW:0001782"^^xsd:string ;
  rdfs:label "primary hyperoxaluria type 1 pathway"^^xsd:string ;
  skos:notation "PW:0001782"^^xsd:string .

ns1:PW_0001783
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001781 ;
  ns2:treeView ns1:PW_0001781 ;
  ns1:IAO_0000115 "Hyperoxaluria results from alteration in the glyoxylate metabolic pathway. Type 2 is due to mutations in the glyoxylate reductase/hydroxypyruvate reductase (GRHPR) enzyme."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-07T16:03:23Z"^^xsd:string ;
  obo:hasExactSynonym "primary hyperoxaluria type 2 disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00558"^^xsd:string ;
  obo:id "PW:0001783"^^xsd:string ;
  rdfs:label "primary hyperoxaluria type 2 pathway"^^xsd:string ;
  skos:notation "PW:0001783"^^xsd:string .

ns1:PW_0001784
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001589 ;
  ns2:treeView ns1:PW_0001589 ;
  ns1:IAO_0000115 "A group of metabolic conditions due to alterations in the heme biosynthetic pathway in bone marrow, the liver or both. They are further classified depending on the enzymes that are deficient or the site."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-07T16:23:02Z"^^xsd:string ;
  obo:hasExactSynonym "porphyria disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001784"^^xsd:string ;
  rdfs:label "porphyria pathway"^^xsd:string ;
  skos:notation "PW:0001784"^^xsd:string .

ns1:PW_0001785
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001980 ;
  ns2:treeView ns1:PW_0001980 ;
  ns1:IAO_0000115 "One of several liver porphyrias, all resulting from alterations in the heme biosynthetic pathway. Here, the deficient enzyme is protoporphyrinogen oxidase."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-10T12:58:26Z"^^xsd:string ;
  obo:hasExactSynonym "porphyria variegata disease pathway"^^xsd:string, "protocoproporphyria pathway"^^xsd:string, "protoporphyrinogen oxidase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00346"^^xsd:string ;
  obo:id "PW:0001785"^^xsd:string ;
  rdfs:label "variegate porphyria pathway"^^xsd:string ;
  skos:notation "PW:0001785"^^xsd:string .

ns1:PW_0001786
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001652 ;
  ns2:treeView ns1:PW_0001652 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of tranexamic acid, an inhibitor of enzymes involved in fibrinolysis and as such, effective in the treatment of certain bleeding disorders It is also used in surgery to prevent excessive bleeding. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-10T13:41:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001786"^^xsd:string ;
  rdfs:label "tranexamic acid drug pathway"^^xsd:string ;
  skos:notation "PW:0001786"^^xsd:string .

ns1:PW_0001787
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001786 ;
  ns2:treeView ns1:PW_0001786 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of tranexamic acid. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-10T13:43:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001787"^^xsd:string ;
  rdfs:label "tranexamic acid pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001787"^^xsd:string .

ns1:PW_0001788
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001786 ;
  ns2:treeView ns1:PW_0001786 ;
  ns1:IAO_0000115 "The pathway of tranexamic acid-target interaction and of the biochemical or physiological responses to drug. It is an inhibitor of plasminogen and used to treat bleeding conditions and in surgery to prevent excessive bleeding  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-10T13:43:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00287"^^xsd:string ;
  obo:id "PW:0001788"^^xsd:string ;
  rdfs:label "tranexamic acid pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001788"^^xsd:string .

ns1:PW_0001789
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000920 ;
  ns2:treeView ns1:PW_0000920 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of drugs that target the renin-angiotensin system, such as ACE inhibitors and angiotensin II antagonists."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-10T14:22:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001789"^^xsd:string ;
  rdfs:label "renin-angiotensin system drug pathway"^^xsd:string ;
  skos:notation "PW:0001789"^^xsd:string .

ns1:PW_0001790
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000920 ;
  ns2:treeView ns1:PW_0000920 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of triamterene, a sodium channel blocker used to lower blood pressure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-10T14:37:45Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001790"^^xsd:string ;
  rdfs:label "triamterene drug pathway"^^xsd:string ;
  skos:notation "PW:0001790"^^xsd:string .

ns1:PW_0001791
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001790 ;
  ns2:treeView ns1:PW_0001790 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of triamterene. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-10T14:39:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001791"^^xsd:string ;
  rdfs:label "triamterene pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001791"^^xsd:string .

ns1:PW_0001792
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001790 ;
  ns2:treeView ns1:PW_0001790 ;
  ns1:IAO_0000115 "The pathway of triamterene-target interaction and of the biochemical or physiological responses to drug. The drug blocks the epithelial sodium channels and is used in the treatment of hypertension. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-10T14:39:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00132"^^xsd:string ;
  obo:id "PW:0001792"^^xsd:string ;
  rdfs:label "triamterene pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001792"^^xsd:string .

ns1:PW_0001793
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001170 ;
  ns2:treeView ns1:PW_0001170 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of tenoxicam, a non-steroidal anti-inflammatory drug used in the treatment of osteoarthritis, rheumatoid arthritis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-10T14:58:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001793"^^xsd:string ;
  rdfs:label "tenoxicam drug pathway"^^xsd:string ;
  skos:notation "PW:0001793"^^xsd:string .

ns1:PW_0001794
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001793 ;
  ns2:treeView ns1:PW_0001793 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination of tenoxicam, an antirheumatic drug. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-10T14:58:38Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001794"^^xsd:string ;
  rdfs:label "tenoxicam pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001794"^^xsd:string .

ns1:PW_0001795
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001793 ;
  ns2:treeView ns1:PW_0001793 ;
  ns1:IAO_0000115 "The pathway of tenoxicam-target interaction and of the biochemical or physiological responses to drug. Tenoxicam is thought to inhibit cyclooxygenases and thus block prostaglandin synthesis. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-10T14:59:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00706"^^xsd:string ;
  obo:id "PW:0001795"^^xsd:string ;
  rdfs:label "tenoxicam pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001795"^^xsd:string .

ns1:PW_0001796
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001789 ;
  ns2:treeView ns1:PW_0001789 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of telmisartan, an angiotensin II receptor type 1 antagonist used in the treatment of essential hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-10T15:06:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001796"^^xsd:string ;
  rdfs:label "telmisartan drug pathway"^^xsd:string ;
  skos:notation "PW:0001796"^^xsd:string .

ns1:PW_0001797
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001796 ;
  ns2:treeView ns1:PW_0001796 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of telmisartan. The drug is an antagonist of angiotensin II receptor type 1. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-10T15:06:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001797"^^xsd:string ;
  rdfs:label "telmisartan pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001797"^^xsd:string .

ns1:PW_0001798
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001796 ;
  ns2:treeView ns1:PW_0001796 ;
  ns1:IAO_0000115 "The pathway of telmisartan-target interaction and of the biochemical or physiological responses to drug. The drug is an antagonist of the angiotensin II receptor type 1. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-10T15:07:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00164"^^xsd:string ;
  obo:id "PW:0001798"^^xsd:string ;
  rdfs:label "telmisartan pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001798"^^xsd:string .

ns1:PW_0001799
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001170 ;
  ns2:treeView ns1:PW_0001170 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of sulindac, a non-steroidal anti-inflammatory drug used in the treatment of acute or chronic inflammatory conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-10T15:18:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001799"^^xsd:string ;
  rdfs:label "sulindac drug pathway"^^xsd:string ;
  skos:notation "PW:0001799"^^xsd:string .

ns1:PW_0001800
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001799 ;
  ns2:treeView ns1:PW_0001799 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination of sulindac, an anti-inflammatory drug. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-10T15:18:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001800"^^xsd:string ;
  rdfs:label "sulindac pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001800"^^xsd:string .

ns1:PW_0001801
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001799 ;
  ns2:treeView ns1:PW_0001799 ;
  ns1:IAO_0000115 "The pathway of sulindac-target interaction and of the biochemical or physiological responses to drug. Sulindac is thought to interfere with prostaglandin synthesis."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-10T15:19:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00094"^^xsd:string ;
  obo:id "PW:0001801"^^xsd:string ;
  rdfs:label "sulindac pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001801"^^xsd:string .

ns1:PW_0001802
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001434 ;
  ns2:treeView ns1:PW_0001434 ;
  ns1:IAO_0000115 "A pathway triggered by administration of doxorubicin, a widely used chemotherapeutic agent. The cytotoxicity of doxorubicin is primarily manifested in its cardiotoxic effect that can lead to heart failure, Possible causes are reactive oxygen species (ROS), impaired iron homeostasis and mitochondrial dysfunction."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-18T13:42:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001802"^^xsd:string ;
  rdfs:label "doxorubicin response pathway"^^xsd:string ;
  skos:notation "PW:0001802"^^xsd:string .

ns1:PW_0001803
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000996 ;
  ns2:treeView ns1:PW_0000996 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of streptomycin, a bactericidal antibiotic that inhibits bacterial protein synthesis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-19T15:13:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001803"^^xsd:string ;
  rdfs:label "streptomycin drug pathway"^^xsd:string ;
  skos:notation "PW:0001803"^^xsd:string .

ns1:PW_0001804
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001803 ;
  ns2:treeView ns1:PW_0001803 ;
  ns1:IAO_0000115 "Streptomycin inhibits bacterial protein synthesis in both Gram-positive and Gram-negative bacteria and as such is a broad-spectrum antibiotic."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-19T15:17:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00259"^^xsd:string ;
  obo:id "PW:0001804"^^xsd:string ;
  rdfs:label "streptomycin pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001804"^^xsd:string .

ns1:PW_0001805
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645, ns1:PW_0001646 ;
  ns2:treeView ns1:PW_0001645, ns1:PW_0001646 ;
  ns1:IAO_0000115 "A group of autosomal recessive disorders resulting from alterations in amino acid metabolism, mostly due to deficiency of hepatic phenylalanine hydroxylase. The enzyme catalyzes the hydroxylation of phenylalanine to tyrosine."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-19T15:26:47Z"^^xsd:string ;
  obo:hasExactSynonym "Flling's disease pathway"^^xsd:string, "PKU pathway"^^xsd:string, "phenylalaninemia pathway"^^xsd:string, "phenylketonuria disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00206"^^xsd:string ;
  obo:id "PW:0001805"^^xsd:string ;
  rdfs:label "phenylketonuria pathway"^^xsd:string ;
  skos:notation "PW:0001805"^^xsd:string .

ns1:PW_0001806
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "An inherited disorder resulting from alteration in the urea cycle metabolic pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T08:14:07Z"^^xsd:string ;
  obo:hasExactSynonym "deficiency of citrulline phosphorylase pathway"^^xsd:string, "ornithine carbamoyltransferase deficiency disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00205"^^xsd:string, "ornithine transcarbamylase deficiency pathway"^^xsd:string ;
  obo:id "PW:0001806"^^xsd:string ;
  rdfs:label "ornithine carbamoyltransferase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001806"^^xsd:string .

ns1:PW_0001807
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001496 ;
  ns2:treeView ns1:PW_0001496 ;
  ns1:IAO_0000115 "A progressive atrophy of the choroid and retina resulting from alterations in amino acid metabolic pathways involving ornithine aminotransferase enzyme."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T08:19:38Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00363"^^xsd:string, "ornithine aminotransferase deficiency pathway"^^xsd:string ;
  obo:id "PW:0001807"^^xsd:string ;
  rdfs:label "gyrate atrophy pathway"^^xsd:string ;
  skos:notation "PW:0001807"^^xsd:string .

ns1:PW_0001808
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645, ns1:PW_0001646 ;
  ns2:treeView ns1:PW_0001645, ns1:PW_0001646 ;
  ns1:IAO_0000115 "An autosomal recessive disorder resulting from alterations in the glycine metabolic pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T08:25:59Z"^^xsd:string ;
  obo:hasAlternativeId "PW:0001934"^^xsd:string ;
  obo:hasExactSynonym "non-ketotic hyperglycinemia pathway"^^xsd:string, "nonketotic hyperglycinemia disease pathway"^^xsd:string, "nonketotic hyperglycinemia pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00223"^^xsd:string, "SMP:00485"^^xsd:string ;
  obo:id "PW:0001808"^^xsd:string ;
  rdfs:label "nonketotic hyperglycinemia pathway"^^xsd:string ;
  skos:notation "PW:0001808"^^xsd:string .

ns1:PW_0001809
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645, ns1:PW_0001776 ;
  ns2:treeView ns1:PW_0001645, ns1:PW_0001776 ;
  ns1:IAO_0000115 "A rare autosomal recessive disorder resulting from alterations purine-pyrimidine and/or amino acid metabolic pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T08:35:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "MMSDH deficiency pathway"^^xsd:string, "SMP:00384"^^xsd:string ;
  obo:id "PW:0001809"^^xsd:string ;
  rdfs:label "methylmalonate semialdehyde dehydrogenase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001809"^^xsd:string .

ns1:PW_0001810
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "An inherited condition resulting from alterations in the metabolic pathway whereby methylmalonyl-coenzyme A (CoA) is converted into succinyl-CoA."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T08:42:09Z"^^xsd:string ;
  obo:hasExactSynonym "methylmalonic acidemia disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00200"^^xsd:string, "methylmalonic aciduria disease pathway"^^xsd:string ;
  obo:id "PW:0001810"^^xsd:string ;
  rdfs:label "methylmalonic acidemia pathway"^^xsd:string ;
  skos:notation "PW:0001810"^^xsd:string .

ns1:PW_0001811
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001810 ;
  ns2:treeView ns1:PW_0001810 ;
  ns1:IAO_0000115 "A form of methylmalonic aciduria disease pathway involving cobalamin (vitamin B12) in the methionine and homocysteine metabolic pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T08:50:16Z"^^xsd:string ;
  obo:hasExactSynonym "methylmalonic aciduria, cobalamin-related disease pathway"^^xsd:string, "methylmalonic aciduria, cobalamin-related, disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00201"^^xsd:string ;
  obo:id "PW:0001811"^^xsd:string ;
  rdfs:label "methylmalonic aciduria, cobalamin-related pathway"^^xsd:string ;
  skos:notation "PW:0001811"^^xsd:string .

ns1:PW_0001812
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001646 ;
  ns2:treeView ns1:PW_0001646 ;
  ns1:IAO_0000115 "An autosomal recessive disorder resulting from defects in mevalonate kinase, one of the two kinases sequentially phosphorylating mevalonate to isopentenyl pyrophosphate in the isoprenoid and cholesterol biosynthetic pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T09:03:28Z"^^xsd:string ;
  obo:hasExactSynonym "mevalonate kinase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00509"^^xsd:string, "SMP:00510"^^xsd:string, "hyper-IgD syndrome pathway"^^xsd:string, "hyperimmunoglobulinemia D disease pathway"^^xsd:string, "mevalonic aciduria disease pathway"^^xsd:string ;
  obo:id "PW:0001812"^^xsd:string ;
  rdfs:label "mevalonic aciduria pathway"^^xsd:string ;
  skos:notation "PW:0001812"^^xsd:string .

ns1:PW_0001813
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001669 ;
  ns2:treeView ns1:PW_0001669 ;
  ns1:IAO_0000115 "A condition resulting from alterations in the electron transport chain metabolic pathway involving the NADH ubiquinone oxidoreductase complex I."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T09:20:06Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001813"^^xsd:string ;
  rdfs:label "mitochondrial complex I deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001813"^^xsd:string .

ns1:PW_0001814
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001669 ;
  ns2:treeView ns1:PW_0001669 ;
  ns1:IAO_0000115 "A condition resulting from alterations in the electron transport chain metabolic pathway involving the succinate dehydrogenase complex II."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T09:20:28Z"^^xsd:string ;
  obo:hasExactSynonym "isolated mitochondrial respiratory chain complex II deficiency pathway"^^xsd:string, "isolated succinate-CoQ reductase deficiency pathway"^^xsd:string, "isolated succinate-coenzyme Q reductase deficiency pathway"^^xsd:string, "isolated succinate-ubiquinone reductase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00548"^^xsd:string ;
  obo:id "PW:0001814"^^xsd:string ;
  rdfs:label "mitochondrial complex II deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001814"^^xsd:string .

ns1:PW_0001815
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001669 ;
  ns2:treeView ns1:PW_0001669 ;
  ns1:IAO_0000115 "A condition resulting from alterations in the electron transport chain metabolic pathway involving complex III."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T09:21:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001815"^^xsd:string ;
  rdfs:label "mitochondrial complex III deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001815"^^xsd:string .

ns1:PW_0001816
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001589 ;
  ns2:treeView ns1:PW_0001589 ;
  ns1:IAO_0000115 "Those diseases that are caused by inborn errors of metal metabolism. The mutations can disrupt one or several pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T09:35:09Z"^^xsd:string ;
  obo:hasExactSynonym "inborn error of metal metabolism disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001816"^^xsd:string ;
  rdfs:label "inborn error of metal metabolism pathway"^^xsd:string ;
  skos:notation "PW:0001816"^^xsd:string .

ns1:PW_0001817
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001816 ;
  ns2:treeView ns1:PW_0001816 ;
  ns1:IAO_0000115 "A disorder resulting from alterations in the molybdenum biosynthetic pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T09:36:31Z"^^xsd:string ;
  obo:hasExactSynonym "MOCOD pathway"^^xsd:string, "combined deficiency of sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00203"^^xsd:string ;
  obo:id "PW:0001817"^^xsd:string ;
  rdfs:label "molybdenum cofactor deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001817"^^xsd:string .

ns1:PW_0001818
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001630, ns1:PW_0001644 ;
  ns2:treeView ns1:PW_0001630, ns1:PW_0001644 ;
  ns1:IAO_0000115 "A group of lysosomal storage diseases resulting from alterations in the glycosaminoglycans degradation pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T09:52:01Z"^^xsd:string ;
  obo:hasExactSynonym "mucopolysaccharidoses disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001818"^^xsd:string ;
  rdfs:label "mucopolysaccharidoses pathway"^^xsd:string ;
  skos:notation "PW:0001818"^^xsd:string .

ns1:PW_0001819
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000996 ;
  ns2:treeView ns1:PW_0000996 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of stavudine, an anti-viral drug used for the treatment of HIV infection. It belongs to the family of nucleoside analog reverse transcriptase inhibitors. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T10:07:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001819"^^xsd:string ;
  rdfs:label "stavudine drug pathway"^^xsd:string ;
  skos:notation "PW:0001819"^^xsd:string .

ns1:PW_0001820
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001819 ;
  ns2:treeView ns1:PW_0001819 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of stavudine, a drug used for the treatment of HIV. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T10:09:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001820"^^xsd:string ;
  rdfs:label "stavudine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001820"^^xsd:string .

ns1:PW_0001821
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001819 ;
  ns2:treeView ns1:PW_0001819 ;
  ns1:IAO_0000115 "The pathway of stavudine-target interaction and of the biochemical or physiological responses to drug. Stavudine is a drug used for the treatment of HIV infection. Stavudine, in its active triphosphate form, inhibits HIV-1 reverse transcriptase activity. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T10:09:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00745"^^xsd:string ;
  obo:id "PW:0001821"^^xsd:string ;
  rdfs:label "stavudine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001821"^^xsd:string .

ns1:PW_0001822
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002121 ;
  ns2:treeView ns1:PW_0002121 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of spironolactone - a drug used in the treatment of hypertension and heart failure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T10:29:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001822"^^xsd:string ;
  rdfs:label "spironolactone drug pathway"^^xsd:string ;
  skos:notation "PW:0001822"^^xsd:string .

ns1:PW_0001823
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001822 ;
  ns2:treeView ns1:PW_0001822 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of spironolactone. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T10:29:27Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001823"^^xsd:string ;
  rdfs:label "spironolactone pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001823"^^xsd:string .

ns1:PW_0001824
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001822 ;
  ns2:treeView ns1:PW_0001822 ;
  ns1:IAO_0000115 "The pathway of spironolactone-target interaction and of the biochemical or physiological responses to drug. The drug inhibits the effects of aldosterone by competing with its receptor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T10:29:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00134"^^xsd:string ;
  obo:id "PW:0001824"^^xsd:string ;
  rdfs:label "spironolactone pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001824"^^xsd:string .

ns1:PW_0001825
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001228 ;
  ns2:treeView ns1:PW_0001228 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of spirapril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T10:49:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001825"^^xsd:string ;
  rdfs:label "spirapril drug pathway"^^xsd:string ;
  skos:notation "PW:0001825"^^xsd:string .

ns1:PW_0001826
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001230, ns1:PW_0001825 ;
  ns2:treeView ns1:PW_0001230, ns1:PW_0001825 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of spirapril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T10:50:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00598"^^xsd:string ;
  obo:id "PW:0001826"^^xsd:string ;
  rdfs:label "spirapril pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001826"^^xsd:string .

ns1:PW_0001827
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001231, ns1:PW_0001825 ;
  ns2:treeView ns1:PW_0001231, ns1:PW_0001825 ;
  ns1:IAO_0000115 "The pathway of spirapril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T10:50:24Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00156"^^xsd:string ;
  obo:id "PW:0001827"^^xsd:string ;
  rdfs:label "spirapril pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001827"^^xsd:string .

ns1:PW_0001828
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001738 ;
  ns2:treeView ns1:PW_0001738 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of sotalol - a non-selective adrenergic beta receptor blocker. It binds and inhibits the beta 1 and beta 2 receptors and is used for the treatment of hypertension and other cardiovascular conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T11:09:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001828"^^xsd:string ;
  rdfs:label "sotalol drug pathway"^^xsd:string ;
  skos:notation "PW:0001828"^^xsd:string .

ns1:PW_0001829
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001828 ;
  ns2:treeView ns1:PW_0001828 ;
  ns1:IAO_0000115 "The pathway of sotalol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta 1 and beta 2. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T11:10:35Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00660"^^xsd:string ;
  obo:id "PW:0001829"^^xsd:string ;
  rdfs:label "sotalol pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001829"^^xsd:string .

ns1:PW_0001830
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001828 ;
  ns2:treeView ns1:PW_0001828 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of sotalol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-20T11:11:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001830"^^xsd:string ;
  rdfs:label "sotalol pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001830"^^xsd:string .

ns1:PW_0001831
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000590, ns1:PW_0001832 ;
  ns2:treeView ns1:PW_0000590, ns1:PW_0001832 ;
  ns1:IAO_0000115 "An iron homeostasis pathway that deviates from what its normal course should be. Either iron deficiency or iron overload contributes to the development of numerous conditions, from anemia to inflammation, cancer, cardiovascular, infection and neurodegenerative diseases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-21T08:55:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001831"^^xsd:string ;
  rdfs:label "altered iron homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0001831"^^xsd:string .

ns1:PW_0001832
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000589, ns1:PW_0001833 ;
  ns2:treeView ns1:PW_0000589, ns1:PW_0001833 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-21T08:57:45Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001832"^^xsd:string ;
  rdfs:label "altered metal homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0001832"^^xsd:string .

ns1:PW_0001833
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000358, ns1:PW_0001692 ;
  ns2:treeView ns1:PW_0000358, ns1:PW_0001692 ;
  ns1:IAO_0000115 "An inorganic chemical homeostasis pathway that deviates from what its normal course should be."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-21T08:58:09Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001833"^^xsd:string ;
  rdfs:label "altered inorganic chemical homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0001833"^^xsd:string .

ns1:PW_0001834
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000921 ;
  ns2:treeView ns1:PW_0000921 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of roxatidine acetate - a histamine H2 specific receptor antagonist used in the treatment of acid disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-24T15:00:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001834"^^xsd:string ;
  rdfs:label "roxatidine acetate drug pathway"^^xsd:string ;
  skos:notation "PW:0001834"^^xsd:string .

ns1:PW_0001835
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001834 ;
  ns2:treeView ns1:PW_0001834 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of roxatidine. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-24T15:03:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001835"^^xsd:string ;
  rdfs:label "roxatidine acetate pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001835"^^xsd:string .

ns1:PW_0001836
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001834 ;
  ns2:treeView ns1:PW_0001834 ;
  ns1:IAO_0000115 "The pathway of roxatidine-target interaction and of the biochemical or physiological responses to drug. The drug is a specific antagonist H2 receptor and it is used for the treatment of various acid disorders. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-24T15:03:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00734"^^xsd:string ;
  obo:id "PW:0001836"^^xsd:string ;
  rdfs:label "roxatidine acetate pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001836"^^xsd:string .

ns1:PW_0001837
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001621 ;
  ns2:treeView ns1:PW_0001621 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of risedronate - a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-24T15:20:24Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001837"^^xsd:string ;
  rdfs:label "risedronate drug pathway"^^xsd:string ;
  skos:notation "PW:0001837"^^xsd:string .

ns1:PW_0001838
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001624, ns1:PW_0001837 ;
  ns2:treeView ns1:PW_0001624, ns1:PW_0001837 ;
  ns1:IAO_0000115 "The pathway of risedronate-target interaction and of the biochemical or physiological responses to drug. Risedronate is a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-24T15:25:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00112"^^xsd:string ;
  obo:id "PW:0001838"^^xsd:string ;
  rdfs:label "risedronate pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001838"^^xsd:string .

ns1:PW_0001839
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001623, ns1:PW_0001837 ;
  ns2:treeView ns1:PW_0001623, ns1:PW_0001837 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of risedronate, a nitrogenous bisphosphonate drug. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-24T15:25:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001839"^^xsd:string ;
  rdfs:label "risedronate pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001839"^^xsd:string .

ns1:PW_0001840
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "A condition of elevated levels of homocysteine usually due to alteration in folate metabolic pathways. Homocysteine is an intermediate in the methionine metabolic cycle. It can be remethylated to methionine or it can follow the transsulfuration pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-24T16:01:46Z"^^xsd:string ;
  obo:hasExactSynonym "hyperhomocysteinemia disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001840"^^xsd:string ;
  rdfs:label "hyperhomocysteinemia pathway"^^xsd:string ;
  skos:notation "PW:0001840"^^xsd:string .

ns1:PW_0001841
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001840 ;
  ns2:treeView ns1:PW_0001840 ;
  ns1:IAO_0000115 "An autosomal recessive condition downstream of homocysteine and involving alterations in the transsulfuration pathway. Usually, it is due to defects in the first enzyme of the transsulfuration pathway, cystathione beta synthase."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-24T16:06:13Z"^^xsd:string ;
  obo:hasExactSynonym "CBS deficiency pathway"^^xsd:string, "cystathionine synthase deficiency pathway"^^xsd:string, "homocystinuria disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00177"^^xsd:string, "SMP:00515"^^xsd:string, "cystathionine beta-synthase deficiency pathway"^^xsd:string ;
  obo:id "PW:0001841"^^xsd:string ;
  rdfs:label "homocystinuria pathway"^^xsd:string ;
  skos:notation "PW:0001841"^^xsd:string .

ns1:PW_0001842
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002402, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001959
  ] ;
  ns2:treeView ns1:PW_0001959, ns1:PW_0002402 ;
  ns3:part_of ns1:PW_0001959 ;
  ns1:IAO_0000115 "Damage to mitochondria will promote mitophagy, the mitochondrial autophagy pathway. It exhibits features common to macroautophagy or the regular autophagy, and also features that are distinct. Under more sustained stress, the cell will promote apoptosis. Translocation of cardiolipin, the signature phospholipid of mitochondrial inner membrane, to the outer membrane, provides a signal of mitochondrial dysfunction."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-26T13:40:45Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "mitophagy pathway"^^xsd:string ;
  obo:id "PW:0001842"^^xsd:string ;
  rdfs:label "mitochondrial autophagy pathway"^^xsd:string ;
  skos:notation "PW:0001842"^^xsd:string .

ns1:PW_0001843
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000921 ;
  ns2:treeView ns1:PW_0000921 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of ranitidine acetate - a histamine H2 specific receptor antagonist used in the treatment of acid disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-28T10:10:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001843"^^xsd:string ;
  rdfs:label "ranitidine drug pathway"^^xsd:string ;
  skos:notation "PW:0001843"^^xsd:string .

ns1:PW_0001844
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001843 ;
  ns2:treeView ns1:PW_0001843 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of ranitidine. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-28T10:12:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001844"^^xsd:string ;
  rdfs:label "ranitidine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001844"^^xsd:string .

ns1:PW_0001845
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001843 ;
  ns2:treeView ns1:PW_0001843 ;
  ns1:IAO_0000115 "The pathway of ranitidine-target interaction and of the biochemical or physiological responses to drug. The drug is a specific antagonist H2 receptor and it is used for the treatment of various acid disorders. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-28T10:12:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00230"^^xsd:string ;
  obo:id "PW:0001845"^^xsd:string ;
  rdfs:label "ranitidine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001845"^^xsd:string .

ns1:PW_0001846
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000918 ;
  ns2:treeView ns1:PW_0000918 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of rabeprazole, a proton pump inhibitor. It is administered for the treatment of acid-related disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-28T10:19:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001846"^^xsd:string ;
  rdfs:label "rabeprazole drug pathway"^^xsd:string ;
  skos:notation "PW:0001846"^^xsd:string .

ns1:PW_0001847
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001846 ;
  ns2:treeView ns1:PW_0001846 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of rabeprazole, a compound in the class of proton pump inhibitors. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-28T10:22:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00616"^^xsd:string ;
  obo:id "PW:0001847"^^xsd:string ;
  rdfs:label "rabeprazole pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001847"^^xsd:string .

ns1:PW_0001848
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001846 ;
  ns2:treeView ns1:PW_0001846 ;
  ns1:IAO_0000115 "The pathway of rabeprazole-target interaction and of the biochemical or physiological responses to drug. Rabeprazole is a compound in the class of proton pump inhibitors used in the treatment of acid-related disorders. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-28T10:22:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00229"^^xsd:string ;
  obo:id "PW:0001848"^^xsd:string ;
  rdfs:label "rabeprazole pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001848"^^xsd:string .

ns1:PW_0001849
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002336 ;
  ns2:treeView ns1:PW_0002336 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of quinidine, a class I antiarrhythmic agent that can increase cardiac action potential. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-28T12:49:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001849"^^xsd:string ;
  rdfs:label "quinidine drug pathway"^^xsd:string ;
  skos:notation "PW:0001849"^^xsd:string .

ns1:PW_0001850
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001849 ;
  ns2:treeView ns1:PW_0001849 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of quinidine, a class I antiarrhythmic agent. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-28T13:01:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001850"^^xsd:string ;
  rdfs:label "quinidine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001850"^^xsd:string .

ns1:PW_0001851
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001849 ;
  ns2:treeView ns1:PW_0001849 ;
  ns1:IAO_0000115 "The pathway of quinidine-target interaction and of the biochemical or physiological responses to drug. Its primary action is blocking the fast inward sodium current. However, it can impact on other currents and channels, such as the slow inward calcium, the rapid and slow components of the delayed potassium, and the inward potassium rectifier currents, and the ATP-sensitive potassium channel. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-08-28T13:02:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00323"^^xsd:string ;
  obo:id "PW:0001851"^^xsd:string ;
  rdfs:label "quinidine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001851"^^xsd:string .

ns1:PW_0001852
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001738 ;
  ns2:treeView ns1:PW_0001738 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of propanolol - a non-selective adrenergic beta receptor blocker, used for the treatment of hypertension and other cardiovascular conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T10:17:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001852"^^xsd:string ;
  rdfs:label "propranolol drug pathway"^^xsd:string ;
  skos:notation "PW:0001852"^^xsd:string .

ns1:PW_0001853
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001852 ;
  ns2:treeView ns1:PW_0001852 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of propanolol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T10:17:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001853"^^xsd:string ;
  rdfs:label "propranolol pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001853"^^xsd:string .

ns1:PW_0001854
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001852 ;
  ns2:treeView ns1:PW_0001852 ;
  ns1:IAO_0000115 "The pathway of propanolol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T10:18:20Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00307"^^xsd:string ;
  obo:id "PW:0001854"^^xsd:string ;
  rdfs:label "propranolol pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001854"^^xsd:string .

ns1:PW_0001855
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002243 ;
  ns2:treeView ns1:PW_0002243 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of procaine, a drug used as a local anesthetic. It also has anti--inflammatory and mood enhancing effects. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T10:27:50Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "novocaine drug pathway"^^xsd:string ;
  obo:id "PW:0001855"^^xsd:string ;
  rdfs:label "procaine drug pathway"^^xsd:string ;
  skos:notation "PW:0001855"^^xsd:string .

ns1:PW_0001856
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001855 ;
  ns2:treeView ns1:PW_0001855 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of procaine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T10:31:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "novocaine pharmacokinetics pathway"^^xsd:string ;
  obo:id "PW:0001856"^^xsd:string ;
  rdfs:label "procaine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001856"^^xsd:string .

ns1:PW_0001857
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001855 ;
  ns2:treeView ns1:PW_0001855 ;
  ns1:IAO_0000115 "The pathway of procaine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T10:32:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00402"^^xsd:string, "novocaine pharmacodynamics pathway"^^xsd:string ;
  obo:id "PW:0001857"^^xsd:string ;
  rdfs:label "procaine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001857"^^xsd:string .

ns1:PW_0001858
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002336 ;
  ns2:treeView ns1:PW_0002336 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of procainamide, a class Ia antiarrhythmic drug. There are many adverse side effects and the cytotoxicity of the drug is documented. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T10:40:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001858"^^xsd:string ;
  rdfs:label "procainamide drug pathway"^^xsd:string ;
  skos:notation "PW:0001858"^^xsd:string .

ns1:PW_0001859
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001858 ;
  ns2:treeView ns1:PW_0001858 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of procainamide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T10:47:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001859"^^xsd:string ;
  rdfs:label "procainamide pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001859"^^xsd:string .

ns1:PW_0001860
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001858 ;
  ns2:treeView ns1:PW_0001858 ;
  ns1:IAO_0000115 "The pathway of procainamide-target interaction and of the biochemical or physiological responses to drug. The drug is a class Ia antiarrhythmic drug that can also elicit serious cytotoxic effects.  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T10:47:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00324"^^xsd:string ;
  obo:id "PW:0001860"^^xsd:string ;
  rdfs:label "procainamide pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001860"^^xsd:string .

ns1:PW_0001861
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001434 ;
  ns2:treeView ns1:PW_0001434 ;
  ns1:IAO_0000115 "A pathway triggered by administration of procainamide, a class Ia antiarrhythmic drug. The cytotoxic effects impact on lymphocytes and interfere with pacemaker, among others. Many of the toxic effects may result from acetylation of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T10:48:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001861"^^xsd:string ;
  rdfs:label "procainamide response pathway"^^xsd:string ;
  skos:notation "PW:0001861"^^xsd:string .

ns1:PW_0001862
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000921, ns1:PW_0001203, ns1:PW_0002369 ;
  ns2:treeView ns1:PW_0000921, ns1:PW_0001203, ns1:PW_0002369 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of prednisone - a synthetic glucocorticoid that is particularly effective as a immunosuppressant drug. Both short- and long-term effects can occur. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T11:08:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001862"^^xsd:string ;
  rdfs:label "prednisone drug pathway"^^xsd:string ;
  skos:notation "PW:0001862"^^xsd:string .

ns1:PW_0001863
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001862 ;
  ns2:treeView ns1:PW_0001862 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of prednisone, a synthetic glucocorticoid. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T11:11:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00631"^^xsd:string ;
  obo:id "PW:0001863"^^xsd:string ;
  rdfs:label "prednisone pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001863"^^xsd:string .

ns1:PW_0001864
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001862 ;
  ns2:treeView ns1:PW_0001862 ;
  ns1:IAO_0000115 "The pathway of prednisone-target interaction and of the biochemical or physiological responses to drug. The drug is particularly effective as an immunosuppressant. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T11:12:03Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00440"^^xsd:string ;
  obo:id "PW:0001864"^^xsd:string ;
  rdfs:label "prednisone pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001864"^^xsd:string .

ns1:PW_0001865
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001170 ;
  ns2:treeView ns1:PW_0001170 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of piroxicam, a non-steroidal anti-inflammatory drug used in the treatment of inflammatory conditions and to relieve pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T12:07:27Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001865"^^xsd:string ;
  rdfs:label "piroxicam drug pathway"^^xsd:string ;
  skos:notation "PW:0001865"^^xsd:string .

ns1:PW_0001866
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001865 ;
  ns2:treeView ns1:PW_0001865 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of piroxicam, an anti-inflammatory drug. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T12:08:24Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001866"^^xsd:string ;
  rdfs:label "piroxicam pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001866"^^xsd:string .

ns1:PW_0001867
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001865 ;
  ns2:treeView ns1:PW_0001865 ;
  ns1:IAO_0000115 "The pathway of piroxicam-target interaction and of the biochemical or physiological responses to drug. The drug is a non-selective cyclooxygenase (COX) inhibitor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T12:09:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00077"^^xsd:string ;
  obo:id "PW:0001867"^^xsd:string ;
  rdfs:label "piroxicam pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001867"^^xsd:string .

ns1:PW_0001868
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "An inborn metabolic disorder resulting from alterations in the methionine cycle/metabolic pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T13:13:56Z"^^xsd:string ;
  obo:hasExactSynonym "MAT I/III deficiency pathway"^^xsd:string, "MAT deficiency pathway"^^xsd:string, "isolated persistent hypermethioninemia pathway"^^xsd:string, "methionine adenosyltransferase I/III deficiency pathway"^^xsd:string, "methionine adenosyltransferase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00221"^^xsd:string ;
  obo:id "PW:0001868"^^xsd:string ;
  rdfs:label "hypermethioninemia pathway"^^xsd:string ;
  skos:notation "PW:0001868"^^xsd:string .

ns1:PW_0001869
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001643 ;
  ns2:treeView ns1:PW_0001643 ;
  ns1:IAO_0000115 "An inherited condition resulting from impaired lipid metabolic pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T13:18:45Z"^^xsd:string ;
  obo:hasExactSynonym "ACADM deficiency pathway"^^xsd:string, "MCADH deficiency pathway"^^xsd:string, "medium-chain acyl-CoA dehydrogenase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "MCAD deficiency pathway"^^xsd:string, "SMP:00542"^^xsd:string ;
  obo:id "PW:0001869"^^xsd:string ;
  rdfs:label "medium chain acyl-CoA dehydrogenase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001869"^^xsd:string .

ns1:PW_0001870
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645, ns1:PW_0001646 ;
  ns2:treeView ns1:PW_0001645, ns1:PW_0001646 ;
  ns1:IAO_0000115 "An autosomal recessive condition resulting from alterations in branched-chain amino acid metabolic pathways. It has several forms and a range of phenotypes."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T13:26:10Z"^^xsd:string ;
  obo:hasExactSynonym "branched chain ketoaciduria pathway"^^xsd:string, "dihydrolipoamide dehydrogenase deficiency pathway"^^xsd:string, "ketoacidemia pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00199"^^xsd:string ;
  obo:id "PW:0001870"^^xsd:string ;
  rdfs:label "maple syrup urine disease pathway"^^xsd:string ;
  skos:notation "PW:0001870"^^xsd:string .

ns1:PW_0001871
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "A disorder resulting from an impaired transport pathway of positively charged amino acids."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T14:04:21Z"^^xsd:string ;
  obo:hasExactSynonym "LPI pathway"^^xsd:string, "dibasic amino aciduria II pathway"^^xsd:string, "hyperdibasic aminoaciduria pathway"^^xsd:string, "lysinuric protein intolerance disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00197"^^xsd:string, "SMP:00585"^^xsd:string ;
  obo:id "PW:0001871"^^xsd:string ;
  rdfs:label "lysinuric protein intolerance pathway"^^xsd:string ;
  skos:notation "PW:0001871"^^xsd:string .

ns1:PW_0001872
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001477 ;
  ns2:treeView ns1:PW_0001477 ;
  ns1:IAO_0000115 "Those conditions resulting from alterations in pathways involving genes on the X-chromosome in humans or in other species."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T14:25:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001872"^^xsd:string ;
  rdfs:label "X-linked genetic disease pathway"^^xsd:string ;
  skos:notation "PW:0001872"^^xsd:string .

ns1:PW_0001873
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001477 ;
  ns2:treeView ns1:PW_0001477 ;
  ns1:IAO_0000115 "Those conditions resulting from alterations in pathways involving genes on the Y-chromosome in humans or in other species."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T14:27:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001873"^^xsd:string ;
  rdfs:label "Y-linked genetic disease pathway"^^xsd:string ;
  skos:notation "PW:0001873"^^xsd:string .

ns1:PW_0001874
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "A rare autosomal condition resulting from an impaired amino acid metabolism."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T14:54:06Z"^^xsd:string ;
  obo:hasExactSynonym "isovaleric acid CoA dehydrogenase deficiency pathway"^^xsd:string, "isovaleric acidemia disease pathway"^^xsd:string, "isovaleric aciduria pathway"^^xsd:string, "isovaleryl-CoA dehydrogenase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00238"^^xsd:string, "SMP:00524"^^xsd:string, "isovaleric aciduria disease pathway"^^xsd:string ;
  obo:id "PW:0001874"^^xsd:string ;
  rdfs:label "isovaleric acidemia pathway"^^xsd:string ;
  skos:notation "PW:0001874"^^xsd:string .

ns1:PW_0001875
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "A condition resulting from impaired amino acid metabolism."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T15:01:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00523"^^xsd:string ;
  obo:id "PW:0001875"^^xsd:string ;
  rdfs:label "isobutyryl-CoA dehydrogenase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0001875"^^xsd:string .

ns1:PW_0001876
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000354 ;
  ns2:treeView ns1:PW_0000354 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of plasmalogen, a type of ether phospholipid found in many tissues, particularly in the cardiovascular, immune and nervous system."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T15:50:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00479"^^xsd:string ;
  obo:id "PW:0001876"^^xsd:string ;
  rdfs:label "plasmalogen metabolic pathway"^^xsd:string ;
  skos:notation "PW:0001876"^^xsd:string .

ns1:PW_0001877
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001876 ;
  ns2:treeView ns1:PW_0001876 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of plasmalogen."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-01T15:54:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00479"^^xsd:string ;
  obo:id "PW:0001877"^^xsd:string ;
  rdfs:label "plasmalogen biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0001877"^^xsd:string .

ns1:PW_0001878
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001872 ;
  ns2:treeView ns1:PW_0001872 ;
  ns1:IAO_0000115 "Genetic disorders involving intellectual disabilty resulting from alterations in pathways whose component genes are located on the X chromosome."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-02T13:15:41Z"^^xsd:string ;
  obo:hasExactSynonym "X-linked mental retardation disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001878"^^xsd:string ;
  rdfs:label "X-linked intellectual disability pathway"^^xsd:string ;
  skos:notation "PW:0001878"^^xsd:string .

ns1:PW_0001879
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001646, ns1:PW_0001776, ns1:PW_0001878 ;
  ns2:treeView ns1:PW_0001646, ns1:PW_0001776, ns1:PW_0001878 ;
  ns1:IAO_0000115 "An inherited disorder with several psychomotor phenotypes resulting from altered purine metabolism, particularly the salvage pathway, due to defects in the hypoxanthine phosphoribosyltransferase 1 (HPRT1) gene, located on the X chromosome."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-02T13:22:28Z"^^xsd:string ;
  obo:hasExactSynonym "HG-PRT deficiency pathway"^^xsd:string, "X-linked hyperuricemia pathway"^^xsd:string, "complete hypoxanthine-guanine phosphoribosyltransferase deficiency pathway"^^xsd:string, "deficiency of IMP pyrophosphorylase pathway"^^xsd:string, "hypoxanthine guanine phosphoribosyltransferase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00364"^^xsd:string ;
  obo:id "PW:0001879"^^xsd:string ;
  rdfs:label "Lesch-Nyhan syndrome pathway"^^xsd:string ;
  skos:notation "PW:0001879"^^xsd:string .

ns1:PW_0001880
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000300 ;
  ns2:treeView ns1:PW_0000300 ;
  ns1:IAO_0000115 "A condition associated with impaired renal tubular transport."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-02T13:37:10Z"^^xsd:string ;
  obo:hasExactSynonym "iminoglycinuria disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00193"^^xsd:string ;
  obo:id "PW:0001880"^^xsd:string ;
  rdfs:label "iminoglycinuria pathway"^^xsd:string ;
  skos:notation "PW:0001880"^^xsd:string .

ns1:PW_0001881
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001816 ;
  ns2:treeView ns1:PW_0001816 ;
  ns1:IAO_0000115 "A genetic metabolic disorder due to impaired bone alkaline phosphatase activity and manifesting in a range of phenotypes."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-02T13:40:54Z"^^xsd:string ;
  obo:hasExactSynonym "hypophosphatasia disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00503"^^xsd:string ;
  obo:id "PW:0001881"^^xsd:string ;
  rdfs:label "hypophosphatasia pathway"^^xsd:string ;
  skos:notation "PW:0001881"^^xsd:string .

ns1:PW_0001882
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000921 ;
  ns2:treeView ns1:PW_0000921 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of pirenzepine, a muscarinic receptor antagonist used in the treatment of peptic ulcers. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-02T13:55:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001882"^^xsd:string ;
  rdfs:label "pirenzepine drug pathway"^^xsd:string ;
  skos:notation "PW:0001882"^^xsd:string .

ns1:PW_0001883
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001882 ;
  ns2:treeView ns1:PW_0001882 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of pirenzepine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-02T14:09:38Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001883"^^xsd:string ;
  rdfs:label "pirenzepine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001883"^^xsd:string .

ns1:PW_0001884
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001882 ;
  ns2:treeView ns1:PW_0001882 ;
  ns1:IAO_0000115 "The pathway of pirenzepine-target interaction and of the biochemical or physiological responses to drug.  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-02T14:10:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00246"^^xsd:string ;
  obo:id "PW:0001884"^^xsd:string ;
  rdfs:label "pirenzepine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001884"^^xsd:string .

ns1:PW_0001885
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002443 ;
  ns2:treeView ns1:PW_0002443 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of pentazocine, an opioid analgesic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-02T14:34:35Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001885"^^xsd:string ;
  rdfs:label "pentazocine drug pathway"^^xsd:string ;
  skos:notation "PW:0001885"^^xsd:string .

ns1:PW_0001886
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001885 ;
  ns2:treeView ns1:PW_0001885 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of pentazocine, an opioid analgesic. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-02T14:38:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001886"^^xsd:string ;
  rdfs:label "pentazocine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001886"^^xsd:string .

ns1:PW_0001887
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001885 ;
  ns2:treeView ns1:PW_0001885 ;
  ns1:IAO_0000115 "The pathway of pentazocine-target interaction and of the biochemical or physiological responses to drug. Pentazocine is an opioid analgesic used to treat moderate to more severe pain. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-02T14:38:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00686"^^xsd:string ;
  obo:id "PW:0001887"^^xsd:string ;
  rdfs:label "pentazocine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001887"^^xsd:string .

ns1:PW_0001888
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000918 ;
  ns2:treeView ns1:PW_0000918 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of pantoprazole, a proton pump inhibitor. It is administered for the treatment of acid-related disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-02T15:07:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001888"^^xsd:string ;
  rdfs:label "pantoprazole drug pathway"^^xsd:string ;
  skos:notation "PW:0001888"^^xsd:string .

ns1:PW_0001889
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001888 ;
  ns2:treeView ns1:PW_0001888 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of pantoprazole, a compound in the class of proton pump inhibitors. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-02T15:08:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00615"^^xsd:string ;
  obo:id "PW:0001889"^^xsd:string ;
  rdfs:label "pantoprazole pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001889"^^xsd:string .

ns1:PW_0001890
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001888 ;
  ns2:treeView ns1:PW_0001888 ;
  ns1:IAO_0000115 "The pathway of pantoprazole-target interaction and of the biochemical or physiological responses to drug. Pantoprazole is a compound in the class of proton pump inhibitors used in the treatment of acid-related disorders. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-02T15:09:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00228"^^xsd:string ;
  obo:id "PW:0001890"^^xsd:string ;
  rdfs:label "pantoprazole pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001890"^^xsd:string .

ns1:PW_0001891
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001803 ;
  ns2:treeView ns1:PW_0001803 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination of streptomycin - an antibiotic that interferes with bacterial protein synthesis. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-02T15:31:20Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001891"^^xsd:string ;
  rdfs:label "streptomycin pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001891"^^xsd:string .

ns1:PW_0001892
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000920 ;
  ns2:treeView ns1:PW_0000920 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of calcium channel blockers - agents used as antihypertensive drugs. They are further classified as dihydropyridine and non-dihydropyridine drugs, and both classes are rather selective. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T10:14:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001892"^^xsd:string ;
  rdfs:label "calcium channel blocker drug pathway"^^xsd:string ;
  skos:notation "PW:0001892"^^xsd:string .

ns1:PW_0001893
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001892 ;
  ns2:treeView ns1:PW_0001892 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of non-dihydropyridine calcium channel blockers - agents often used to treat angina and relatively selective for myocardium. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T10:31:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001893"^^xsd:string ;
  rdfs:label "non-dihydropyridine calcium channel blocker drug pathway"^^xsd:string ;
  skos:notation "PW:0001893"^^xsd:string .

ns1:PW_0001894
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001892 ;
  ns2:treeView ns1:PW_0001892 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of dihydropyridine calcium channel blockers - agents derived from dihydropyridine and used to reduce arterial pressure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T10:31:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001894"^^xsd:string ;
  rdfs:label "dihydropyridine calcium channel blocker drug pathway"^^xsd:string ;
  skos:notation "PW:0001894"^^xsd:string .

ns1:PW_0001895
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001894 ;
  ns2:treeView ns1:PW_0001894 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of nimodipine, a calcium channel blocker developed for the treatment of hypertension but now used to prevent vasospasm. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T10:48:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001895"^^xsd:string ;
  rdfs:label "nimodipine drug pathway"^^xsd:string ;
  skos:notation "PW:0001895"^^xsd:string .

ns1:PW_0001896
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001894 ;
  ns2:treeView ns1:PW_0001894 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of nifedipine, a calcium channel blocker used in the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T10:50:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001896"^^xsd:string ;
  rdfs:label "nisoldipine drug pathway"^^xsd:string ;
  skos:notation "PW:0001896"^^xsd:string .

ns1:PW_0001897
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001894 ;
  ns2:treeView ns1:PW_0001894 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of nitrendipine, a calcium channel blocker used in the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T10:51:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001897"^^xsd:string ;
  rdfs:label "nitrendipine drug pathway"^^xsd:string ;
  skos:notation "PW:0001897"^^xsd:string .

ns1:PW_0001898
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001895 ;
  ns2:treeView ns1:PW_0001895 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of nimodipine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T10:54:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001898"^^xsd:string ;
  rdfs:label "nimodipine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001898"^^xsd:string .

ns1:PW_0001899
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001896 ;
  ns2:treeView ns1:PW_0001896 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of nisoldipine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T10:54:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001899"^^xsd:string ;
  rdfs:label "nisoldipine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001899"^^xsd:string .

ns1:PW_0001900
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001897 ;
  ns2:treeView ns1:PW_0001897 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of nitrendipine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T10:54:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001900"^^xsd:string ;
  rdfs:label "nitrendipine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001900"^^xsd:string .

ns1:PW_0001901
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001895 ;
  ns2:treeView ns1:PW_0001895 ;
  ns1:IAO_0000115 "The pathway of nimodipine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T10:55:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00380"^^xsd:string ;
  obo:id "PW:0001901"^^xsd:string ;
  rdfs:label "nimodipine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001901"^^xsd:string .

ns1:PW_0001902
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001896 ;
  ns2:treeView ns1:PW_0001896 ;
  ns1:IAO_0000115 "The pathway of nisoldipine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T10:55:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00381"^^xsd:string ;
  obo:id "PW:0001902"^^xsd:string ;
  rdfs:label "nisoldipine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001902"^^xsd:string .

ns1:PW_0001903
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001897 ;
  ns2:treeView ns1:PW_0001897 ;
  ns1:IAO_0000115 "The pathway of nitrendipine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T10:55:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00382"^^xsd:string ;
  obo:id "PW:0001903"^^xsd:string ;
  rdfs:label "nitrendipine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001903"^^xsd:string .

ns1:PW_0001904
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000921 ;
  ns2:treeView ns1:PW_0000921 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of nizatidine - a histamine H2 specific receptor antagonist used in the treatment of acid disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T11:32:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001904"^^xsd:string ;
  rdfs:label "nizatidine drug pathway"^^xsd:string ;
  skos:notation "PW:0001904"^^xsd:string .

ns1:PW_0001905
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001904 ;
  ns2:treeView ns1:PW_0001904 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of nizatidine. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T11:33:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001905"^^xsd:string ;
  rdfs:label "nizatidine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001905"^^xsd:string .

ns1:PW_0001906
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001904 ;
  ns2:treeView ns1:PW_0001904 ;
  ns1:IAO_0000115 "The pathway of nizatidine-target interaction and of the biochemical or physiological responses to drug. The drug is a histamine H2 receptor specific antagonist used for the treatment of various acid disorders. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T11:34:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00233"^^xsd:string ;
  obo:id "PW:0001906"^^xsd:string ;
  rdfs:label "nizatidine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001906"^^xsd:string .

ns1:PW_0001907
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001789 ;
  ns2:treeView ns1:PW_0001789 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of olmesartan, an angiotensin II receptor type 1 antagonist used in the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T11:42:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001907"^^xsd:string ;
  rdfs:label "olmesartan drug pathway"^^xsd:string ;
  skos:notation "PW:0001907"^^xsd:string .

ns1:PW_0001908
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001907 ;
  ns2:treeView ns1:PW_0001907 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of olmesartan. The drug is an antagonist of angiotensin II receptor type 1. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T11:42:20Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001908"^^xsd:string ;
  rdfs:label "olmesartan pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001908"^^xsd:string .

ns1:PW_0001909
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001907 ;
  ns2:treeView ns1:PW_0001907 ;
  ns1:IAO_0000115 "The pathway of olmesartan-target interaction and of the biochemical or physiological responses to drug. The drug is an antagonist of the angiotensin II receptor type 1. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T11:42:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00163"^^xsd:string ;
  obo:id "PW:0001909"^^xsd:string ;
  rdfs:label "olmesartan pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001909"^^xsd:string .

ns1:PW_0001910
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001737 ;
  ns2:treeView ns1:PW_0001737 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of nebivolol, a selective beta adrenergic type 1 receptor antagonist used in the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T12:21:35Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001910"^^xsd:string ;
  rdfs:label "nebivolol drug pathway"^^xsd:string ;
  skos:notation "PW:0001910"^^xsd:string .

ns1:PW_0001911
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001910 ;
  ns2:treeView ns1:PW_0001910 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of nebivolol. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T12:22:06Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001911"^^xsd:string ;
  rdfs:label "nebivolol pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001911"^^xsd:string .

ns1:PW_0001912
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001910 ;
  ns2:treeView ns1:PW_0001910 ;
  ns1:IAO_0000115 "The pathway of nebivolol-target interaction and of the biochemical or physiological responses to drug. The drug is a selective antagonist of beta adrenergic type 1 receptor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T12:22:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00366"^^xsd:string ;
  obo:id "PW:0001912"^^xsd:string ;
  rdfs:label "nebivolol pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001912"^^xsd:string .

ns1:PW_0001913
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001202, ns1:PW_0001546 ;
  ns2:treeView ns1:PW_0001202, ns1:PW_0001546 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of naproxen, a non-steroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes and is used in the treatment of inflammation and pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T12:33:24Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001913"^^xsd:string ;
  rdfs:label "naproxen drug pathway"^^xsd:string ;
  skos:notation "PW:0001913"^^xsd:string .

ns1:PW_0001914
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001913 ;
  ns2:treeView ns1:PW_0001913 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of naproxen. The drug is used in the treatment of pain and inflammation. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T12:33:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001914"^^xsd:string ;
  rdfs:label "naproxen pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001914"^^xsd:string .

ns1:PW_0001915
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001913 ;
  ns2:treeView ns1:PW_0001913 ;
  ns1:IAO_0000115 "The pathway of naproxen-target interaction and of the biochemical or physiological responses to drug. Naproxen is an inhibitor of cyclooxygenase enzymes used in the treatment of pain and inflammation. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T12:34:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00120"^^xsd:string ;
  obo:id "PW:0001915"^^xsd:string ;
  rdfs:label "naproxen pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001915"^^xsd:string .

ns1:PW_0001916
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002443 ;
  ns2:treeView ns1:PW_0002443 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of naltrexone, an antagonist of opioid receptors used in the treatment of substance dependence. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T12:42:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001916"^^xsd:string ;
  rdfs:label "naltrexone drug pathway"^^xsd:string ;
  skos:notation "PW:0001916"^^xsd:string .

ns1:PW_0001917
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001916 ;
  ns2:treeView ns1:PW_0001916 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of naltrexone, an antagonist of opioid receptors. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T12:43:21Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001917"^^xsd:string ;
  rdfs:label "naltrexone pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001917"^^xsd:string .

ns1:PW_0001918
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001916 ;
  ns2:treeView ns1:PW_0001916 ;
  ns1:IAO_0000115 "The pathway of naltrexone-target interaction and of the biochemical or physiological responses to drug. The drug is an antagonist of mu opioid receptor and to a lesser and much lesser extent, the kappa and delta opioid receptors, respectively. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T12:43:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00687"^^xsd:string ;
  obo:id "PW:0001918"^^xsd:string ;
  rdfs:label "naltrexone pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001918"^^xsd:string .

ns1:PW_0001919
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002443 ;
  ns2:treeView ns1:PW_0002443 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of nalbuphine, a semi-synthetic opioid used an analgesic for the relief of moderate to severe pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T13:11:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001919"^^xsd:string ;
  rdfs:label "nalbuphine drug pathway"^^xsd:string ;
  skos:notation "PW:0001919"^^xsd:string .

ns1:PW_0001920
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001919 ;
  ns2:treeView ns1:PW_0001919 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of nalbuphine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T13:29:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001920"^^xsd:string ;
  rdfs:label "nalbuphine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001920"^^xsd:string .

ns1:PW_0001921
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001919 ;
  ns2:treeView ns1:PW_0001919 ;
  ns1:IAO_0000115 "The pathway of nalbuphine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T13:29:06Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00691"^^xsd:string ;
  obo:id "PW:0001921"^^xsd:string ;
  rdfs:label "nalbuphine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001921"^^xsd:string .

ns1:PW_0001922
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001170 ;
  ns2:treeView ns1:PW_0001170 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of nabumetone, a non-steroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes, preferentially COX-2 type. The drug is used in the treatment of inflammation and pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T13:44:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001922"^^xsd:string ;
  rdfs:label "nabumetone drug pathway"^^xsd:string ;
  skos:notation "PW:0001922"^^xsd:string .

ns1:PW_0001923
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001922 ;
  ns2:treeView ns1:PW_0001922 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of nabumetone. The drug is rapidly metabolized in the liver to 6-methoxy-2-naphthyl, its major active metabolite. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T13:44:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001923"^^xsd:string ;
  rdfs:label "nabumetone pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001923"^^xsd:string .

ns1:PW_0001924
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001922 ;
  ns2:treeView ns1:PW_0001922 ;
  ns1:IAO_0000115 "The pathway of nabumetone-target interaction and of the biochemical or physiological responses to drug. Nabumetone is an inhibitor of COX-2 enzyme used in the treatment of pain and inflammation. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T13:45:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00114"^^xsd:string ;
  obo:id "PW:0001924"^^xsd:string ;
  rdfs:label "nabumetone pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001924"^^xsd:string .

ns1:PW_0001925
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002121 ;
  ns2:treeView ns1:PW_0002121 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of metolazone - a blocker of sodium -chloride symporter in the distal convoluted tubule of the nephron. The drug is used for the treatment of hypertension and congestive heart failure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T14:03:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001925"^^xsd:string ;
  rdfs:label "metolazone drug pathway"^^xsd:string ;
  skos:notation "PW:0001925"^^xsd:string .

ns1:PW_0001926
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001925 ;
  ns2:treeView ns1:PW_0001925 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of metolazone. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T14:03:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001926"^^xsd:string ;
  rdfs:label "metolazone pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001926"^^xsd:string .

ns1:PW_0001927
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001925 ;
  ns2:treeView ns1:PW_0001925 ;
  ns1:IAO_0000115 "The pathway of metolazone-target interaction and of the biochemical or physiological responses to drug. The drug blocks the sodium-chloride symporter and is used in the treatment of hypertension and congestive heart failure. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T14:04:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00105"^^xsd:string ;
  obo:id "PW:0001927"^^xsd:string ;
  rdfs:label "metolazone pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001927"^^xsd:string .

ns1:PW_0001928
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001737 ;
  ns2:treeView ns1:PW_0001737 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of metoprolol, a selective beta adrenergic type 1 receptor antagonist used in the treatment of hypertension and several other conditions involving a faster than normal heart rate. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T14:34:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001928"^^xsd:string ;
  rdfs:label "metoprolol drug pathway"^^xsd:string ;
  skos:notation "PW:0001928"^^xsd:string .

ns1:PW_0001929
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001928 ;
  ns2:treeView ns1:PW_0001928 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of metoprolol. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T14:35:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001929"^^xsd:string ;
  rdfs:label "metoprolol pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001929"^^xsd:string .

ns1:PW_0001930
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001928 ;
  ns2:treeView ns1:PW_0001928 ;
  ns1:IAO_0000115 "The pathway of metoprolol-target interaction and of the biochemical or physiological responses to drug. The drug is a selective antagonist of beta adrenergic type 1 receptor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T14:35:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00302"^^xsd:string ;
  obo:id "PW:0001930"^^xsd:string ;
  rdfs:label "metoprolol pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001930"^^xsd:string .

ns1:PW_0001931
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "A condition resulting from alterations in the proline amino acid metabolic pathway and involving the enzyme proline oxidase."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T15:21:03Z"^^xsd:string ;
  obo:hasExactSynonym "hyperprolinemia disease pathway"^^xsd:string, "hyperprolinemia pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00361"^^xsd:string, "hyperprolinemia type I disease pathway"^^xsd:string ;
  obo:id "PW:0001931"^^xsd:string ;
  rdfs:label "hyperprolinemia type I pathway"^^xsd:string ;
  skos:notation "PW:0001931"^^xsd:string .

ns1:PW_0001932
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "A rare condition resulting from alterations in the proline amino acid metabolic pathway leading to high levels of proline and the related compound pyrroline-5-carboxylase in the circulation."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-17T15:25:18Z"^^xsd:string ;
  obo:hasExactSynonym "1-pyrroline-5-carboxylate dehydrogenase deficiency pathway"^^xsd:string, "hyperprolinemia type II disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00360"^^xsd:string ;
  obo:id "PW:0001932"^^xsd:string ;
  rdfs:label "hyperprolinemia type II pathway"^^xsd:string ;
  skos:notation "PW:0001932"^^xsd:string .

ns1:PW_0001933
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001473 ;
  ns2:treeView ns1:PW_0001473 ;
  ns1:IAO_0000115 "A condition resulting from alterations in the various aspects of cholesterol metabolism or transport along with environmental or other diseases related aspects and manifesting in high levels of circulating cholesterol."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-18T09:19:58Z"^^xsd:string ;
  obo:hasExactSynonym "hypercholesterolemia disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00209"^^xsd:string ;
  obo:id "PW:0001933"^^xsd:string ;
  rdfs:label "hypercholesterolemia pathway"^^xsd:string ;
  skos:notation "PW:0001933"^^xsd:string .

ns1:PW_0001934
  a owl:Class ;
  ns1:IAO_0000231 ns1:IAO_0000227 ;
  ns1:IAO_0100001 ns1:PW_0001808 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-18T09:26:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00485"^^xsd:string ;
  obo:id "PW:0001934"^^xsd:string ;
  rdfs:label "Nonketotic hyperglycinemia disease pathway"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0001934"^^xsd:string .

ns1:PW_0001935
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001602 ;
  ns2:treeView ns1:PW_0001602 ;
  ns1:IAO_0000115 "A condition spanning a spectrum of manifestations that may also cause hypoglycemia resulting from alterations in glucose homeostasis and insulin related pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-18T09:39:35Z"^^xsd:string ;
  obo:hasExactSynonym "hyperinsulinism disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001935"^^xsd:string ;
  rdfs:label "hyperinsulinism pathway"^^xsd:string ;
  skos:notation "PW:0001935"^^xsd:string .

ns1:PW_0001936
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645, ns1:PW_0001646 ;
  ns2:treeView ns1:PW_0001645, ns1:PW_0001646 ;
  ns1:IAO_0000115 "A group of inherited disorders resulting from alterations in the lysine metabolic pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-18T09:46:36Z"^^xsd:string ;
  obo:hasExactSynonym "hyperlysinemia disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00527"^^xsd:string, "familial hyperlysinemia disease pathway"^^xsd:string, "type I lysinemia disease pathway"^^xsd:string ;
  obo:id "PW:0001936"^^xsd:string ;
  rdfs:label "hyperlysinemia pathway"^^xsd:string ;
  skos:notation "PW:0001936"^^xsd:string .

ns1:PW_0001937
  a owl:Class ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-18T10:06:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001937"^^xsd:string ;
  rdfs:label "<new term>"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0001937"^^xsd:string .

ns1:PW_0001938
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001441 ;
  ns2:treeView ns1:PW_0001441 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-18T10:10:54Z"^^xsd:string ;
  obo:hasExactSynonym "HPRT deficiency pathway"^^xsd:string, "partial hypoxanthine guanine phosphoribosyltransferase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "HPRT-related gout disease pathway"^^xsd:string, "SMP:00365"^^xsd:string ;
  obo:id "PW:0001938"^^xsd:string ;
  rdfs:label "Kelley-Seegmiller syndrome pathway"^^xsd:string ;
  skos:notation "PW:0001938"^^xsd:string .

ns1:PW_0001939
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002443 ;
  ns2:treeView ns1:PW_0002443 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of methadone, an acyclic analog of morphine and heroin acting on the same opioid receptors and used in the management of severe, chronic pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-22T14:15:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001939"^^xsd:string ;
  rdfs:label "methadone drug pathway"^^xsd:string ;
  skos:notation "PW:0001939"^^xsd:string .

ns1:PW_0001940
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001939 ;
  ns2:treeView ns1:PW_0001939 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of methadone. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-22T14:17:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00624"^^xsd:string ;
  obo:id "PW:0001940"^^xsd:string ;
  rdfs:label "methadone pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001940"^^xsd:string .

ns1:PW_0001941
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001939 ;
  ns2:treeView ns1:PW_0001939 ;
  ns1:IAO_0000115 "The pathway of methadone-target interaction and of the biochemical or physiological responses to drug. Methadone binds the mu-opioid receptor of sensory neurons triggering downstream cascades that activate potassium channels while inactivating calcium channels. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-22T14:18:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00408"^^xsd:string ;
  obo:id "PW:0001941"^^xsd:string ;
  rdfs:label "methadone pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001941"^^xsd:string .

ns1:PW_0001942
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367, ns1:PW_0002369 ;
  ns2:treeView ns1:PW_0002367, ns1:PW_0002369 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of mercaptopurine, an immunosuppressive drug used in the treatment of leukemia, Crohn's disease and colitis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-22T14:28:40Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001942"^^xsd:string ;
  rdfs:label "mercaptopurine drug pathway"^^xsd:string ;
  skos:notation "PW:0001942"^^xsd:string .

ns1:PW_0001943
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001942 ;
  ns2:treeView ns1:PW_0001942 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of mercaptopurine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-22T14:30:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00609"^^xsd:string ;
  obo:id "PW:0001943"^^xsd:string ;
  rdfs:label "mercaptopurine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001943"^^xsd:string .

ns1:PW_0001944
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001942 ;
  ns2:treeView ns1:PW_0001942 ;
  ns1:IAO_0000115 "The pathway of mercaptopurine-target interaction and of the biochemical or physiological responses to drug. The drug is used as an immunosuppressive and its cytotoxic effects result from its interference with nucleic acids synthesis and function. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-22T14:30:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00428"^^xsd:string ;
  obo:id "PW:0001944"^^xsd:string ;
  rdfs:label "mercaptopurine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001944"^^xsd:string .

ns1:PW_0001945
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002243 ;
  ns2:treeView ns1:PW_0002243 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of mepivacaine, a drug used as a local anesthetic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-22T14:49:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001945"^^xsd:string ;
  rdfs:label "mepivacaine drug pathway"^^xsd:string ;
  skos:notation "PW:0001945"^^xsd:string .

ns1:PW_0001946
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001945 ;
  ns2:treeView ns1:PW_0001945 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of mepivacaine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-22T14:50:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001946"^^xsd:string ;
  rdfs:label "mepivacaine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001946"^^xsd:string .

ns1:PW_0001947
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001945 ;
  ns2:treeView ns1:PW_0001945 ;
  ns1:IAO_0000115 "The pathway of mepivacaine-target interaction and of the biochemical or physiological responses to drug. It acts mainly as a blocker of voltage-gated sodium channels. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-22T14:51:24Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00399"^^xsd:string ;
  obo:id "PW:0001947"^^xsd:string ;
  rdfs:label "mepivacaine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001947"^^xsd:string .

ns1:PW_0001948
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001170 ;
  ns2:treeView ns1:PW_0001170 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of meloxicam, a non-steroidal anti-inflammatory drug used to relieve pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-22T15:10:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001948"^^xsd:string ;
  rdfs:label "meloxicam drug pathway"^^xsd:string ;
  skos:notation "PW:0001948"^^xsd:string .

ns1:PW_0001949
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001948 ;
  ns2:treeView ns1:PW_0001948 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of piroxicam. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-22T15:11:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001949"^^xsd:string ;
  rdfs:label "meloxicam pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001949"^^xsd:string .

ns1:PW_0001950
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001948 ;
  ns2:treeView ns1:PW_0001948 ;
  ns1:IAO_0000115 "The pathway of meloxicam-target interaction and of the biochemical or physiological responses to drug. The drug is a non-selective cyclooxygenase (COX) inhibitor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-22T15:11:35Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00106"^^xsd:string ;
  obo:id "PW:0001950"^^xsd:string ;
  rdfs:label "meloxicam pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001950"^^xsd:string .

ns1:PW_0001951
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001170 ;
  ns2:treeView ns1:PW_0001170 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of mefenamic acid, a non-steroidal anti-inflammatory drug used to treat mild to moderate pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-22T15:17:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001951"^^xsd:string ;
  rdfs:label "mefenamic acid drug pathway"^^xsd:string ;
  skos:notation "PW:0001951"^^xsd:string .

ns1:PW_0001952
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001951 ;
  ns2:treeView ns1:PW_0001951 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of mefenamic acid. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-22T15:18:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001952"^^xsd:string ;
  rdfs:label "mefenamic acid pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001952"^^xsd:string .

ns1:PW_0001953
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001951 ;
  ns2:treeView ns1:PW_0001951 ;
  ns1:IAO_0000115 "The pathway of mefenamic acid-target interaction and of the biochemical or physiological responses to drug. The drug is a non-selective cyclooxygenase (COX) inhibitor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-22T15:18:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00109"^^xsd:string ;
  obo:id "PW:0001953"^^xsd:string ;
  rdfs:label "mefenamic acid pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001953"^^xsd:string .

ns1:PW_0001954
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000098 ;
  ns2:treeView ns1:PW_0000098 ;
  ns1:IAO_0000115 "Nuclear eukaryotic DNA replication takes place in the context of the cell cycle during the S-phase. The fast and accurate replication of DNA requires the presence and the coordinated function of a complex of proteins known as the replisome. The exact composition of the replisome in higher organisms still has to be fully determined. Mitochondria contain their own DNA. Human mtDNA is a small, circular molecule that resides in the matrix and, depending on cell type, can exist as a few to several thousands copies. mtDNA has its own replicative machinery."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-24T12:48:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001954"^^xsd:string ;
  rdfs:label "eukaryotic DNA replication pathway"^^xsd:string ;
  skos:notation "PW:0001954"^^xsd:string .

ns1:PW_0001955
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000098 ;
  ns2:treeView ns1:PW_0000098 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-24T12:49:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001955"^^xsd:string ;
  rdfs:label "bacterial DNA replication pathway"^^xsd:string ;
  skos:notation "PW:0001955"^^xsd:string .

ns1:PW_0001956
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001954, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000089
  ] ;
  ns2:treeView ns1:PW_0000089, ns1:PW_0001954 ;
  ns3:part_of ns1:PW_0000089 ;
  ns1:IAO_0000115 "Nuclear eukaryotic DNA replication takes place in the context of the cell cycle during the S-phase. The fast and accurate replication of DNA requires the presence and the coordinated function of a complex of proteins known as the replisome. The exact composition of the replisome in higher organisms still has to be fully determined."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-24T13:01:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001956"^^xsd:string ;
  rdfs:label "nuclear DNA replication pathway"^^xsd:string ;
  skos:notation "PW:0001956"^^xsd:string .

ns1:PW_0001957
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001954, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001959
  ] ;
  ns2:treeView ns1:PW_0001954, ns1:PW_0001959 ;
  ns3:part_of ns1:PW_0001959 ;
  ns1:IAO_0000115 "Mitochondria contain their own DNA. Human mtDNA is a small, circular molecule that resides in the matrix and, depending on cell type, can exist as a few to several thousands copies. mtDNA has its own replicative machinery."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-24T13:02:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "mtDNA replication pathway"^^xsd:string ;
  obo:id "PW:0001957"^^xsd:string ;
  rdfs:label "mitochondrial DNA replication pathway"^^xsd:string ;
  skos:notation "PW:0001957"^^xsd:string .

ns1:PW_0001958
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001563, ns1:PW_0001842, ns1:PW_0001960, ns1:PW_0002403 ;
  ns2:treeView ns1:PW_0001563, ns1:PW_0001842, ns1:PW_0001960, ns1:PW_0002403 ;
  ns1:IAO_0000115 "A mitophagy pathway that deviates from what its normal course should be. Mitochondrial damage and altered mitophagy pathway have been implicated in neurodegenerative diseases associated with aging, such as Parkinson, Huntington and Alzheimer diseases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-24T13:15:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered mitophagy pathway"^^xsd:string ;
  obo:id "PW:0001958"^^xsd:string ;
  rdfs:label "altered mitochondrial autophagy pathway"^^xsd:string ;
  skos:notation "PW:0001958"^^xsd:string .

ns1:PW_0001959
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000355 ;
  ns2:treeView ns1:PW_0000355 ;
  ns1:IAO_0000115 "The various pathways and mechanisms that assure the proper function and abundance of mitochondria within cells. In addition to being the powerhouse of the cell as the place of oxidative phosphorylation, mitochondria are also the site of other important metabolic pathways and play essential roles in calcium storage and signaling and apoptosis, among others."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-24T13:29:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001959"^^xsd:string ;
  rdfs:label "mitochondria homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0001959"^^xsd:string .

ns1:PW_0001960
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000358, ns1:PW_0001959 ;
  ns2:treeView ns1:PW_0000358, ns1:PW_0001959 ;
  ns1:IAO_0000115 "Disruption of mitochondrial homeostasis is associated with neurodegenerative diseases, cancer and aging."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-24T13:39:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001960"^^xsd:string ;
  rdfs:label "altered mitochondria homeostasis pathway"^^xsd:string ;
  skos:notation "PW:0001960"^^xsd:string .

ns1:PW_0001961
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001959
  ] ;
  ns2:treeView ns1:PW_0001959 ;
  ns3:part_of ns1:PW_0001959 ;
  ns1:IAO_0000115 "The interplay of mitochondria fission and fusion and mitochondria trafficking to properly respond to cellular needs. Mitochondria tend to form reticular networks, regulated through the coordination of fission, fusion and redistribution."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-24T13:45:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001961"^^xsd:string ;
  rdfs:label "mitochondria dynamics pathway"^^xsd:string ;
  skos:notation "PW:0001961"^^xsd:string .

ns1:PW_0001962
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000535, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001959
  ] ;
  ns2:treeView ns1:PW_0000535, ns1:PW_0001959 ;
  ns3:part_of ns1:PW_0001959 ;
  ns1:IAO_0000115 "Mitochondria are essential organelles that provide most of the ATP fuel for the cell, are the site of several important metabolic pathways and play essential roles in calcium storage, signaling and apoptosis. Of the many proteins involved, only 13 are encoded in the mammalian mitochondrial DNA. The remaining ~99% of mitochondrial proteins are translocated from the cytosol via a complex, multicomponent pathway system. Mitochondria-encoded proteins are translocated from the mitochondrial matrix into the inner mitochondrial membrane by a single system."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-24T14:05:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001962"^^xsd:string ;
  rdfs:label "mitochondrial protein import pathway"^^xsd:string ;
  skos:notation "PW:0001962"^^xsd:string .

ns1:PW_0001963
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000918 ;
  ns2:treeView ns1:PW_0000918 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of lansoprazole, a proton pump inhibitor. It is administered for the treatment of acid-related disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-24T14:41:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001963"^^xsd:string ;
  rdfs:label "lansoprazole drug pathway"^^xsd:string ;
  skos:notation "PW:0001963"^^xsd:string .

ns1:PW_0001964
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001963 ;
  ns2:treeView ns1:PW_0001963 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of lansoprazole, a compound in the class of proton pump inhibitors pharmacologically related to omeprazole. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-24T14:42:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00614"^^xsd:string ;
  obo:id "PW:0001964"^^xsd:string ;
  rdfs:label "lansoprazole pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001964"^^xsd:string .

ns1:PW_0001965
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001963 ;
  ns2:treeView ns1:PW_0001963 ;
  ns1:IAO_0000115 "The pathway of lansoprazole-target interaction and of the biochemical or physiological responses to drug. Lansoprazole is a compound in the class of proton pump inhibitors pharmacologically related to omperazole, used in the treatment of acid-related disorders. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-24T14:43:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00227"^^xsd:string ;
  obo:id "PW:0001965"^^xsd:string ;
  rdfs:label "lansoprazole pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001965"^^xsd:string .

ns1:PW_0001966
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001170 ;
  ns2:treeView ns1:PW_0001170 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of ketorolac, a non-steroidal anti-inflammatory drug used to treat moderate to severe pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-24T15:07:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001966"^^xsd:string ;
  rdfs:label "ketorolac drug pathway"^^xsd:string ;
  skos:notation "PW:0001966"^^xsd:string .

ns1:PW_0001967
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001966 ;
  ns2:treeView ns1:PW_0001966 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of ketorolac. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-24T15:11:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001967"^^xsd:string ;
  rdfs:label "ketorolac pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001967"^^xsd:string .

ns1:PW_0001968
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001966 ;
  ns2:treeView ns1:PW_0001966 ;
  ns1:IAO_0000115 "The pathway of ketorolac-target interaction and of the biochemical or physiological responses to drug. The drug is a non-selective cyclooxygenase (COX) inhibitor used for short-term management of moderate to severe pain. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-24T15:11:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00098"^^xsd:string ;
  obo:id "PW:0001968"^^xsd:string ;
  rdfs:label "ketorolac pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001968"^^xsd:string .

ns1:PW_0001969
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001170, ns1:PW_0001546 ;
  ns2:treeView ns1:PW_0001170, ns1:PW_0001546 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of ketoprofen, a non-steroidal anti-inflammatory drug that also has analgesic and antipyretic effects. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-24T15:23:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001969"^^xsd:string ;
  rdfs:label "ketoprofen drug pathway"^^xsd:string ;
  skos:notation "PW:0001969"^^xsd:string .

ns1:PW_0001970
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001969 ;
  ns2:treeView ns1:PW_0001969 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of ketoprofen. The drug is used in the treatment of inflammation and pain. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-24T15:27:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001970"^^xsd:string ;
  rdfs:label "ketoprofen pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001970"^^xsd:string .

ns1:PW_0001971
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001969 ;
  ns2:treeView ns1:PW_0001969 ;
  ns1:IAO_0000115 "The pathway of ketoprofen-target interaction and of the biochemical or physiological responses to drug. Ketoprofen is an inhibitor of cyclooxygenase enzymes used in the treatment of inflammation and pain. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-24T15:27:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00085"^^xsd:string ;
  obo:id "PW:0001971"^^xsd:string ;
  rdfs:label "ketoprofen pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001971"^^xsd:string .

ns1:PW_0001972
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001894 ;
  ns2:treeView ns1:PW_0001894 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of isradipine, a calcium channel blocker used for the treatment of high blood pressure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-24T15:45:27Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001972"^^xsd:string ;
  rdfs:label "isradipine drug pathway"^^xsd:string ;
  skos:notation "PW:0001972"^^xsd:string .

ns1:PW_0001973
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001972 ;
  ns2:treeView ns1:PW_0001972 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of isradipine. The drug is a calcium channel blocker used in the treatment of high blood pressure.  Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-24T15:46:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001973"^^xsd:string ;
  rdfs:label "isradipine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001973"^^xsd:string .

ns1:PW_0001974
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001972 ;
  ns2:treeView ns1:PW_0001972 ;
  ns1:IAO_0000115 "The pathway of isradipine-target interaction and of the biochemical or physiological responses to drug. The drug is a calcium channel blocker, particularly the L-type channel, used for the treatment of high blood pressure.  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-24T15:46:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00378"^^xsd:string ;
  obo:id "PW:0001974"^^xsd:string ;
  rdfs:label "isradipine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001974"^^xsd:string .

ns1:PW_0001975
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000237, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001959
  ] ;
  ns2:treeView ns1:PW_0000237, ns1:PW_0001959 ;
  ns3:part_of ns1:PW_0001959 ;
  ns1:IAO_0000115 "A stress response pathway to mitochondrial DNA depletion or accumulation of misfolded protein in the matrix or intermembrane space. Mitochondrial-to-nucleus signaling results in the increased expression of genes important for mitochondrial protein homeostasis. UPRmt can promote increased lifespan but the mechanisms are not well understood. Mitchondrial dysfunction contributes to normal aging. Yet, mild distress can extent life span by almost 50% in organisms ranging from yeast to worms, flies, and mice."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-25T09:07:21Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "UPRmt pathway"^^xsd:string ;
  obo:id "PW:0001975"^^xsd:string ;
  rdfs:label "mitochondrial unfolded protein response pathway"^^xsd:string ;
  skos:notation "PW:0001975"^^xsd:string .

ns1:PW_0001976
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001589 ;
  ns2:treeView ns1:PW_0001589 ;
  ns1:IAO_0000115 "Disorders caused by alterations in the amino acid transport pathways across cell membranes."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-25T10:11:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001976"^^xsd:string ;
  rdfs:label "inborn error amino acid transport disorder pathway"^^xsd:string ;
  skos:notation "PW:0001976"^^xsd:string .

ns1:PW_0001977
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000300, ns1:PW_0001646, ns1:PW_0001976 ;
  ns2:treeView ns1:PW_0000300, ns1:PW_0001646, ns1:PW_0001976 ;
  ns1:IAO_0000115 "An autosomal recessive disorder caused by alterations in the transport of neutral amino acids in the intestine and proximal renal tubules. The condition is associated with psychosis and mental retardation."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-25T10:14:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00189"^^xsd:string ;
  obo:id "PW:0001977"^^xsd:string ;
  rdfs:label "Hartnup disease pathway"^^xsd:string ;
  skos:notation "PW:0001977"^^xsd:string .

ns1:PW_0001978
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "An autosomal recessive condition resulting from alterations in the histidine metabolic pathway and characterized by increased levels of histidine in blood, cerebrospinal fluid and urine."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-25T10:49:47Z"^^xsd:string ;
  obo:hasExactSynonym "histidinemia disease pathway"^^xsd:string, "histidinuria pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00191"^^xsd:string ;
  obo:id "PW:0001978"^^xsd:string ;
  rdfs:label "histidinemia pathway"^^xsd:string ;
  skos:notation "PW:0001978"^^xsd:string .

ns1:PW_0001979
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645, ns1:PW_0001646 ;
  ns2:treeView ns1:PW_0001645, ns1:PW_0001646 ;
  ns1:IAO_0000115 "The pathway involved in a progressive neurologic disorder resulting from a deficiency of homocarnosinase."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-25T10:57:34Z"^^xsd:string ;
  obo:hasAlternativeId "OMIM:236130"^^xsd:string ;
  obo:hasExactSynonym "HOMOCARNOSINASE DEFICIENCY PATHWAY"^^xsd:string, "homocarnosinosis disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00385"^^xsd:string ;
  obo:id "PW:0001979"^^xsd:string ;
  rdfs:label "homocarnosinosis pathway"^^xsd:string ;
  skos:notation "PW:0001979"^^xsd:string .

ns1:PW_0001980
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001413, ns1:PW_0001784 ;
  ns2:treeView ns1:PW_0001413, ns1:PW_0001784 ;
  ns1:IAO_0000115 "A group of metabolic conditions due to alterations in the heme biosynthetic pathway in the liver. They are further classified depending on the enzymes that are deficient or the site."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-25T11:04:44Z"^^xsd:string ;
  obo:hasExactSynonym "hepatic porphyria disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001980"^^xsd:string ;
  rdfs:label "hepatic porphyria pathway"^^xsd:string ;
  skos:notation "PW:0001980"^^xsd:string .

ns1:PW_0001981
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001980 ;
  ns2:treeView ns1:PW_0001980 ;
  ns1:IAO_0000115 "An autosomal dominant liver porphyria due to deficiency in the coproporphyrinogen oxidase gene."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-25T11:10:32Z"^^xsd:string ;
  obo:hasExactSynonym "coproporphyrinogen oxidase deficiency pathway"^^xsd:string, "hereditary coproporphyria disease pathway"^^xsd:string, "hereditary coproporphyria porphyria pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00342"^^xsd:string ;
  obo:id "PW:0001981"^^xsd:string ;
  rdfs:label "hereditary coproporphyria pathway"^^xsd:string ;
  skos:notation "PW:0001981"^^xsd:string .

ns1:PW_0001982
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001789 ;
  ns2:treeView ns1:PW_0001789 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of irbesartan, an angiotensin II receptor type 1 antagonist used in the treatment of hypertension. Irbesartan is one of several angiotensin II receptor antagonists.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-28T15:08:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001982"^^xsd:string ;
  rdfs:label "irbesartan drug pathway"^^xsd:string ;
  skos:notation "PW:0001982"^^xsd:string .

ns1:PW_0001983
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001982 ;
  ns2:treeView ns1:PW_0001982 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of irbesartan. The drug is an antagonist of angiotensin II receptor type 1. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-28T15:11:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001983"^^xsd:string ;
  rdfs:label "irbesartan pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001983"^^xsd:string .

ns1:PW_0001984
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001982 ;
  ns2:treeView ns1:PW_0001982 ;
  ns1:IAO_0000115 "The pathway of irbesartan-target interaction and of the biochemical or physiological responses to drug. The drug is an antagonist of the angiotensin II receptor type 1. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-28T15:11:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00161"^^xsd:string ;
  obo:id "PW:0001984"^^xsd:string ;
  rdfs:label "irbesartan pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001984"^^xsd:string .

ns1:PW_0001985
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002113 ;
  ns2:treeView ns1:PW_0002113 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of imipramine, an antidepressant used in the treatment of major depression. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-28T15:24:56Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001985"^^xsd:string ;
  rdfs:label "imipramine drug pathway"^^xsd:string ;
  skos:notation "PW:0001985"^^xsd:string .

ns1:PW_0001986
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001985 ;
  ns2:treeView ns1:PW_0001985 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of imipramine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-28T15:27:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00625"^^xsd:string ;
  obo:id "PW:0001986"^^xsd:string ;
  rdfs:label "imipramine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001986"^^xsd:string .

ns1:PW_0001987
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001985 ;
  ns2:treeView ns1:PW_0001985 ;
  ns1:IAO_0000115 "The pathway of imipramine-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of major depression and its effect results from inhibition of serotonin and norepinephrine neurotransmitter reuptake. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-28T15:28:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00422"^^xsd:string ;
  obo:id "PW:0001987"^^xsd:string ;
  rdfs:label "imipramine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001987"^^xsd:string .

ns1:PW_0001988
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002336 ;
  ns2:treeView ns1:PW_0002336 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of ibutilide, an antiarrhythmic agent. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-28T15:52:56Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001988"^^xsd:string ;
  rdfs:label "ibutilide drug pathway"^^xsd:string ;
  skos:notation "PW:0001988"^^xsd:string .

ns1:PW_0001989
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001988 ;
  ns2:treeView ns1:PW_0001988 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of ibutilide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-28T15:54:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001989"^^xsd:string ;
  rdfs:label "ibutilide pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0001989"^^xsd:string .

ns1:PW_0001990
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001988 ;
  ns2:treeView ns1:PW_0001988 ;
  ns1:IAO_0000115 "The pathway of ibutilide-target interaction and of the biochemical or physiological responses to drug. The drug is an antiarrhythmic agent. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-28T15:55:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00332"^^xsd:string ;
  obo:id "PW:0001990"^^xsd:string ;
  rdfs:label "ibutilide pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0001990"^^xsd:string .

ns1:PW_0001991
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001644 ;
  ns2:treeView ns1:PW_0001644 ;
  ns1:IAO_0000115 "A group of inherited metabolic disorders resulting from alterations in the glycogen metabolic pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-29T15:05:20Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001991"^^xsd:string ;
  rdfs:label "glycogen storage disease pathway"^^xsd:string ;
  skos:notation "PW:0001991"^^xsd:string .

ns1:PW_0001992
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001991 ;
  ns2:treeView ns1:PW_0001991 ;
  ns1:IAO_0000115 "One of the two forms of the type I glycogen storage disease pathway involving glucose-6-phosphate, here due to mutations in glucose-6-phosphatase. It is characterized by the accumulation of glycogen in particular organs and tissues."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-29T15:12:57Z"^^xsd:string ;
  obo:hasExactSynonym "glycogen storage disease pathway, type IA"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00374"^^xsd:string, "SMP:00581"^^xsd:string, "Von Gierke disease pathway"^^xsd:string, "glucose-6-phosphatase deficiency pathway"^^xsd:string, "hepatorenal glycogen storage disease pathway"^^xsd:string ;
  obo:id "PW:0001992"^^xsd:string ;
  rdfs:label "glycogen storage disease  type Ia pathway"^^xsd:string ;
  skos:notation "PW:0001992"^^xsd:string .

ns1:PW_0001993
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001991 ;
  ns2:treeView ns1:PW_0001991 ;
  ns1:IAO_0000115 "One of the two forms of the type I glycogen storage disease pathway involving glucose-6-phosphate, here due to mutations affecting the glucose-6-phosphate transporter. It is characterized by the accumulation of glycogen in particular organs and tissues."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-29T15:19:58Z"^^xsd:string ;
  obo:hasExactSynonym "glucose-6-phosphate transport defect pathway"^^xsd:string, "glycogen storage disease pathway, type IB"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00573"^^xsd:string ;
  obo:id "PW:0001993"^^xsd:string ;
  rdfs:label "glycogen storage disease type Ib pathway"^^xsd:string ;
  skos:notation "PW:0001993"^^xsd:string .

ns1:PW_0001994
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001991 ;
  ns2:treeView ns1:PW_0001991 ;
  ns1:IAO_0000115 "A type of glycogen disease pathway that involves the glycogen debranching enzyme. There are further subdivisions, to delineate the clinical manifestations."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-29T15:37:11Z"^^xsd:string ;
  obo:hasExactSynonym "amylo 1,6 glucosidase deficiency pathway"^^xsd:string, "deficiency of debranching enzyme pathway"^^xsd:string, "deficiency of dextrin pathway"^^xsd:string, "glycogen storage disease pathway, type III"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Cori disease pathway"^^xsd:string, "SMP:00553"^^xsd:string ;
  obo:id "PW:0001994"^^xsd:string ;
  rdfs:label "glycogen storage disease type III pathway"^^xsd:string ;
  skos:notation "PW:0001994"^^xsd:string .

ns1:PW_0001995
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001991 ;
  ns2:treeView ns1:PW_0001991 ;
  ns1:IAO_0000115 "A type of glycogen storage disease pathway involving glycogen branching enzyme 1."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-29T15:47:11Z"^^xsd:string ;
  obo:hasExactSynonym "Branching-transferase deficiency glycogenosis pathway"^^xsd:string, "amylopectinosis pathway"^^xsd:string, "brancher deficiency glycogenosis pathway"^^xsd:string, "deficiency of 1,4-alpha-glucan branching enzyme pathway"^^xsd:string, "glycogen storage disease pathway, type IV."^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Andersen disease pathway"^^xsd:string, "SMP:00554"^^xsd:string ;
  obo:id "PW:0001995"^^xsd:string ;
  rdfs:label "glycogen storage disease type IV pathway"^^xsd:string ;
  skos:notation "PW:0001995"^^xsd:string .

ns1:PW_0001996
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001991 ;
  ns2:treeView ns1:PW_0001991 ;
  ns1:IAO_0000115 "A type of glycogen storage disease pathway involving the liver phosphorylase."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-29T15:50:38Z"^^xsd:string ;
  obo:hasExactSynonym "glycogen storage disease pathway, type VI"^^xsd:string, "hepatic glycogen phosphorylase deficiency pathway"^^xsd:string, "hepatophosphorylase deficiency glycogenosis pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Hers disease pathway"^^xsd:string, "SMP:00555"^^xsd:string ;
  obo:id "PW:0001996"^^xsd:string ;
  rdfs:label "glycogen storage disease type VI pathway"^^xsd:string ;
  skos:notation "PW:0001996"^^xsd:string .

ns1:PW_0001997
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001991 ;
  ns2:treeView ns1:PW_0001991 ;
  ns1:IAO_0000115 "A type of glycogen storage disease pathway involving muscle phosphofructokinase."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-09-29T15:55:27Z"^^xsd:string ;
  obo:hasExactSynonym "glycogen storage disease pathway, type VII"^^xsd:string, "muscle phosphofructokinase deficiency pathway"^^xsd:string, "phosphofructokinase myopathy pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00531"^^xsd:string, "Tarui disease pathway"^^xsd:string ;
  obo:id "PW:0001997"^^xsd:string ;
  rdfs:label "glycogen storage disease type VII pathway"^^xsd:string ;
  skos:notation "PW:0001997"^^xsd:string .

ns1:PW_0001998
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001961
  ] ;
  ns2:treeView ns1:PW_0001961 ;
  ns3:part_of ns1:PW_0001961 ;
  ns1:IAO_0000115 "The events leading to fission of mitochondria. Fission allows mitochondria to divide and grow and also to isolate and remove defective organelles."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-01T14:42:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001998"^^xsd:string ;
  rdfs:label "mitochondria fission pathway"^^xsd:string ;
  skos:notation "PW:0001998"^^xsd:string .

ns1:PW_0001999
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001961
  ] ;
  ns2:treeView ns1:PW_0001961 ;
  ns3:part_of ns1:PW_0001961 ;
  ns1:IAO_0000115 "The events leading to fusion of mitochondria."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-01T14:43:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0001999"^^xsd:string ;
  rdfs:label "mitochondria fusion pathway"^^xsd:string ;
  skos:notation "PW:0001999"^^xsd:string .

ns1:PW_0002000
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001621 ;
  ns2:treeView ns1:PW_0001621 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of ibandronate - a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-01T14:58:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002000"^^xsd:string ;
  rdfs:label "ibandronate drug pathway"^^xsd:string ;
  skos:notation "PW:0002000"^^xsd:string .

ns1:PW_0002001
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001623, ns1:PW_0001624, ns1:PW_0002000 ;
  ns2:treeView ns1:PW_0001623, ns1:PW_0001624, ns1:PW_0002000 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of ibandronate, a nitrogenous bisphosphonate drug. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-01T15:00:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002001"^^xsd:string ;
  rdfs:label "ibandronate pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002001"^^xsd:string .

ns1:PW_0002002
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002000 ;
  ns2:treeView ns1:PW_0002000 ;
  ns1:IAO_0000115 "The pathway of ibandronate-target interaction and of the biochemical or physiological responses to drug. Ibandronate is a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-01T15:01:20Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00079"^^xsd:string ;
  obo:id "PW:0002002"^^xsd:string ;
  rdfs:label "ibandronate pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002002"^^xsd:string .

ns1:PW_0002003
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002121 ;
  ns2:treeView ns1:PW_0002121 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of hydrochlorothiazide, a drug used in the treatment of high blood pressure.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-01T15:18:39Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002003"^^xsd:string ;
  rdfs:label "hydrochlorothiazide drug pathway"^^xsd:string ;
  skos:notation "PW:0002003"^^xsd:string .

ns1:PW_0002004
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002003 ;
  ns2:treeView ns1:PW_0002003 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of hydrochlorothiazide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-01T15:25:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002004"^^xsd:string ;
  rdfs:label "hydrochlorothiazide pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002004"^^xsd:string .

ns1:PW_0002005
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002003 ;
  ns2:treeView ns1:PW_0002003 ;
  ns1:IAO_0000115 "The pathway of hydrochlorothiazide-target interaction and of the biochemical or physiological responses to drug. The drug reduces sodium reabsorption in the distal convoluted tubule of kidney nephron. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-01T15:25:40Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00100"^^xsd:string ;
  obo:id "PW:0002005"^^xsd:string ;
  rdfs:label "hydrochlorothiazide pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002005"^^xsd:string .

ns1:PW_0002006
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000723 ;
  ns2:treeView ns1:PW_0000723 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of gliclazide, a second generation sulfonylurea anti-diabetic drug used in the treatment of type 2 diabetes mellitus. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-01T15:51:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002006"^^xsd:string ;
  rdfs:label "gliclazide drug pathway"^^xsd:string ;
  skos:notation "PW:0002006"^^xsd:string .

ns1:PW_0002007
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002006 ;
  ns2:treeView ns1:PW_0002006 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of gliclazide, an anti-diabetic drug used in the treatment of type 2 diabetes mellitus. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-01T15:51:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002007"^^xsd:string ;
  rdfs:label "gliclazide pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002007"^^xsd:string .

ns1:PW_0002008
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002006 ;
  ns2:treeView ns1:PW_0002006 ;
  ns1:IAO_0000115 "The pathway of gliclazide-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of type 2 diabetes mellitus. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-01T15:52:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00461"^^xsd:string ;
  obo:id "PW:0002008"^^xsd:string ;
  rdfs:label "gliclazide pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002008"^^xsd:string .

ns1:PW_0002009
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000723 ;
  ns2:treeView ns1:PW_0000723 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of glyburide, a second generation sulfonylurea anti-diabetic drug used in the treatment of type 2 diabetes mellitus. The drug is also known as glibenclamide. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-02T12:51:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "glibenclamide drug pathway"^^xsd:string ;
  obo:id "PW:0002009"^^xsd:string ;
  rdfs:label "glyburide drug pathway"^^xsd:string ;
  skos:notation "PW:0002009"^^xsd:string .

ns1:PW_0002010
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002009 ;
  ns2:treeView ns1:PW_0002009 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of glyburide, an anti-diabetic drug used in the treatment of type 2 diabetes mellitus. The drug is also known is glibenclamide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-02T12:53:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "glibenclamide pharmacokinetics pathway"^^xsd:string ;
  obo:id "PW:0002010"^^xsd:string ;
  rdfs:label "glyburide pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002010"^^xsd:string .

ns1:PW_0002011
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002009 ;
  ns2:treeView ns1:PW_0002009 ;
  ns1:IAO_0000115 "The pathway of glyburide-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of type 2 diabetes mellitus. Glyburide is also known as glibenclamide. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-02T12:54:21Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00460"^^xsd:string, "glibenclamide pharmacodynamics pathway"^^xsd:string ;
  obo:id "PW:0002011"^^xsd:string ;
  rdfs:label "glyburide pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002011"^^xsd:string .

ns1:PW_0002012
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001433 ;
  ns2:treeView ns1:PW_0001433 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination of gentamicin - an antibiotic that interferes with bacterial protein synthesis. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-02T13:01:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002012"^^xsd:string ;
  rdfs:label "gentamicin pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002012"^^xsd:string .

ns1:PW_0002013
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001433 ;
  ns2:treeView ns1:PW_0001433 ;
  ns1:IAO_0000115 "The pathway of gentamicin-target interaction and of the biochemical or physiological responses to drug. Gentamicin interferes with bacterial protein synthesis and is used in the treatment of several infections caused by both Gram-negative and Gram-positive bacteria. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-02T13:01:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00254"^^xsd:string ;
  obo:id "PW:0002013"^^xsd:string ;
  rdfs:label "gentamicin pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002013"^^xsd:string .

ns1:PW_0002014
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002121 ;
  ns2:treeView ns1:PW_0002121 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of furosemide - a blocker of luminal sodium-potassium-chloride symporter used for the treatment of hypertension and edema. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-02T13:13:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002014"^^xsd:string ;
  rdfs:label "furosemide drug pathway"^^xsd:string ;
  skos:notation "PW:0002014"^^xsd:string .

ns1:PW_0002015
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002014 ;
  ns2:treeView ns1:PW_0002014 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of furosemide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-02T13:13:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002015"^^xsd:string ;
  rdfs:label "furosemide pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002015"^^xsd:string .

ns1:PW_0002016
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002014 ;
  ns2:treeView ns1:PW_0002014 ;
  ns1:IAO_0000115 "The pathway of furosemide-target interaction and of the biochemical or physiological responses to drug. The drug blocks the luminal sodium-potassium-chloride symporter in the thick ascending limb of the loop of Henle. Furosemide is used in the treatment of hypertension and edema.  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-02T13:13:35Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00115"^^xsd:string ;
  obo:id "PW:0002016"^^xsd:string ;
  rdfs:label "furosemide pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002016"^^xsd:string .

ns1:PW_0002017
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001980 ;
  ns2:treeView ns1:PW_0001980 ;
  ns1:IAO_0000115 "A rather common autosomal dominant porphyria resulting from defects in hydroxymethybilane synthase in the heme biosynthetic pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-02T13:27:53Z"^^xsd:string ;
  obo:hasExactSynonym "acute intermittent porphyria disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00344"^^xsd:string ;
  obo:id "PW:0002017"^^xsd:string ;
  rdfs:label "acute intermittent porphyria pathway"^^xsd:string ;
  skos:notation "PW:0002017"^^xsd:string .

ns1:PW_0002018
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001644 ;
  ns2:treeView ns1:PW_0001644 ;
  ns1:IAO_0000115 "A rare metabolic disease due to alterations in the glycerol metabolic pathway resulting from defects in the glycerol kinase enzyme."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-02T13:36:38Z"^^xsd:string ;
  obo:hasExactSynonym "GK deficiency pathway"^^xsd:string, "GKD pathway"^^xsd:string, "hyperglycerolemia disease pathway"^^xsd:string, "hyperglycerolemia pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00187"^^xsd:string, "glycerol kinase deficiency pathway"^^xsd:string ;
  obo:id "PW:0002018"^^xsd:string ;
  rdfs:label "glycerol kinase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002018"^^xsd:string .

ns1:PW_0002019
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "A condition resulting from alterations in the glutathione biosynthesis pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-02T13:41:53Z"^^xsd:string ;
  obo:hasExactSynonym "pyroglutamic aciduria pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "5-oxoprolinemia disease pathway"^^xsd:string, "5-oxoprolinuria disease pathway"^^xsd:string, "SMP:00143"^^xsd:string, "SMP:00337"^^xsd:string ;
  obo:id "PW:0002019"^^xsd:string ;
  rdfs:label "glutathione synthase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002019"^^xsd:string .

ns1:PW_0002020
  a owl:Class ;
  ns1:IAO_0000115 "The lysosomal storage disease pathways affecting the nervous system."^^xsd:string ;
  ns1:IAO_0000231 ns1:IAO_0000227 ;
  ns1:IAO_0100001 ns1:PW_0002300 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-02T13:53:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002020"^^xsd:string ;
  rdfs:label "nervous system lysosomal storage disease pathway"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0002020"^^xsd:string .

ns1:PW_0002021
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002300 ;
  ns2:treeView ns1:PW_0002300 ;
  ns1:IAO_0000115 "An autosomal recessive metabolic disorder caused by a deficiency of galactosylceramidase leading to intralysosomal accumulation of galactolipids such as galactosylceramides and psychosine."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-02T13:56:44Z"^^xsd:string ;
  obo:hasExactSynonym "Krabbe's disease pathway"^^xsd:string, "Krabbe's leukodystrophy pathway"^^xsd:string, "beta galactocerebrosidase deficiency pathway"^^xsd:string, "diffuse globoid body sclerosis pathway"^^xsd:string, "galactosylceramide beta-galactosidase deficiency pathway"^^xsd:string, "globoid cell leukodystrophy disease pathway"^^xsd:string, "globoid cell leukodystrophy pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00348"^^xsd:string ;
  obo:id "PW:0002021"^^xsd:string ;
  rdfs:label "Krabbe disease pathway"^^xsd:string ;
  skos:notation "PW:0002021"^^xsd:string .

ns1:PW_0002022
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001228 ;
  ns2:treeView ns1:PW_0001228 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of fosinopril - an angiotensin converting enzyme (ACE) inhibitor used for the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-10-07T15:23:24Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002022"^^xsd:string ;
  rdfs:label "fosinopril drug pathway"^^xsd:string ;
  skos:notation "PW:0002022"^^xsd:string .

ns1:PW_0002023
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002022 ;
  ns2:treeView ns1:PW_0002022 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of fosinopril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-10-07T15:23:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00594"^^xsd:string ;
  obo:id "PW:0002023"^^xsd:string ;
  rdfs:label "fosinopril pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002023"^^xsd:string .

ns1:PW_0002024
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001231, ns1:PW_0002022 ;
  ns2:treeView ns1:PW_0001231, ns1:PW_0002022 ;
  ns1:IAO_0000115 "The pathway of fosinopril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-10-07T15:24:20Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00149"^^xsd:string ;
  obo:id "PW:0002024"^^xsd:string ;
  rdfs:label "fosinopril pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002024"^^xsd:string .

ns1:PW_0002025
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001789 ;
  ns2:treeView ns1:PW_0001789 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of forasartan, an angiotensin II receptor type 1 antagonist used in the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-10-07T15:29:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002025"^^xsd:string ;
  rdfs:label "forasartan drug pathway"^^xsd:string ;
  skos:notation "PW:0002025"^^xsd:string .

ns1:PW_0002026
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002025 ;
  ns2:treeView ns1:PW_0002025 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of forasartan. The drug is an antagonist of angiotensin II receptor type 1. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-10-07T15:30:27Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002026"^^xsd:string ;
  rdfs:label "forasartan pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002026"^^xsd:string .

ns1:PW_0002027
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002025 ;
  ns2:treeView ns1:PW_0002025 ;
  ns1:IAO_0000115 "The pathway of forasartan-target interaction and of the biochemical or physiological responses to drug. The drug is an antagonist of the angiotensin II receptor type 1. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-10-07T15:30:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00160"^^xsd:string ;
  obo:id "PW:0002027"^^xsd:string ;
  rdfs:label "forasartsn pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002027"^^xsd:string .

ns1:PW_0002028
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002115 ;
  ns2:treeView ns1:PW_0002115 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of fluoxetine, an antidepressant used in the treatment of major depressive disorders. The drug is a selective serotonin reuptake inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-10-07T15:41:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002028"^^xsd:string ;
  rdfs:label "fluoxetine drug pathway"^^xsd:string ;
  skos:notation "PW:0002028"^^xsd:string .

ns1:PW_0002029
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002028 ;
  ns2:treeView ns1:PW_0002028 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of fluoxetine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-10-07T15:43:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00646"^^xsd:string ;
  obo:id "PW:0002029"^^xsd:string ;
  rdfs:label "fluoxetine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002029"^^xsd:string .

ns1:PW_0002030
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002028 ;
  ns2:treeView ns1:PW_0002028 ;
  ns1:IAO_0000115 "The pathway of fluoxetine-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of major depressive disorders and its effect results from selective inhibition of serotonin reuptake. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2015-10-07T15:43:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00426"^^xsd:string ;
  obo:id "PW:0002030"^^xsd:string ;
  rdfs:label "fluoxetine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002030"^^xsd:string .

ns1:PW_0002031
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002336 ;
  ns2:treeView ns1:PW_0002336 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of flecainide, a drug used in the treatment of cardiac arrhythmias. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-08T14:41:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002031"^^xsd:string ;
  rdfs:label "flecainide drug pathway"^^xsd:string ;
  skos:notation "PW:0002031"^^xsd:string .

ns1:PW_0002032
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002031 ;
  ns2:treeView ns1:PW_0002031 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of flecainide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-08T14:42:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002032"^^xsd:string ;
  rdfs:label "flecainide pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002032"^^xsd:string .

ns1:PW_0002033
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002031 ;
  ns2:treeView ns1:PW_0002031 ;
  ns1:IAO_0000115 "The pathway of flecainide-target interaction and of the biochemical or physiological responses to drug. The drug is an antiarrhythmic agent that acts by blocking sodium and possibly other channels in cardiomyocytes. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-08T14:42:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00331"^^xsd:string ;
  obo:id "PW:0002033"^^xsd:string ;
  rdfs:label "flecainde pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002033"^^xsd:string .

ns1:PW_0002034
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002443 ;
  ns2:treeView ns1:PW_0002443 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of fentanyl, a potent opioid analgesic used to treat sudden, severe pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-08T14:55:41Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002034"^^xsd:string ;
  rdfs:label "fentanyl drug pathway"^^xsd:string ;
  skos:notation "PW:0002034"^^xsd:string .

ns1:PW_0002035
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002034 ;
  ns2:treeView ns1:PW_0002034 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of fentanyl, a potent opioid analgesic. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-08T14:56:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002035"^^xsd:string ;
  rdfs:label "fentanyl pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002035"^^xsd:string .

ns1:PW_0002036
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002034 ;
  ns2:treeView ns1:PW_0002034 ;
  ns1:IAO_0000115 "The pathway of fentonyl-target interaction and of the biochemical or physiological responses to drug. The drug is a synthetic opioid analgesic acting as a strong inhibitor of mu receptors. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-08T14:56:56Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00415"^^xsd:string ;
  obo:id "PW:0002036"^^xsd:string ;
  rdfs:label "fentanyl pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002036"^^xsd:string .

ns1:PW_0002037
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000921 ;
  ns2:treeView ns1:PW_0000921 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of famotidine - a histamine H2 receptor antagonist used in the treatment of acid disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-08T15:28:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002037"^^xsd:string ;
  rdfs:label "famotidine drug pathway"^^xsd:string ;
  skos:notation "PW:0002037"^^xsd:string .

ns1:PW_0002038
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002037 ;
  ns2:treeView ns1:PW_0002037 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of famotidine. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-08T15:29:39Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002038"^^xsd:string ;
  rdfs:label "famotidine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002038"^^xsd:string .

ns1:PW_0002039
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002037 ;
  ns2:treeView ns1:PW_0002037 ;
  ns1:IAO_0000115 "The pathway of famotidine-target interaction and of the biochemical or physiological responses to drug. The drug is a histamine H2 receptor antagonist used in the treatment of acid disorders. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-08T15:30:03Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00231"^^xsd:string ;
  obo:id "PW:0002039"^^xsd:string ;
  rdfs:label "famotidine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002039"^^xsd:string .

ns1:PW_0002040
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001170 ;
  ns2:treeView ns1:PW_0001170 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of etodolac, a non-steroidal anti-inflammatory drug used in the treatment of mild to moderate pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-08T15:37:06Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002040"^^xsd:string ;
  rdfs:label "etodolac drug pathway"^^xsd:string ;
  skos:notation "PW:0002040"^^xsd:string .

ns1:PW_0002041
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002040 ;
  ns2:treeView ns1:PW_0002040 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of etodolac. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-08T15:37:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002041"^^xsd:string ;
  rdfs:label "etodolac pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002041"^^xsd:string .

ns1:PW_0002042
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002040 ;
  ns2:treeView ns1:PW_0002040 ;
  ns1:IAO_0000115 "The pathway of etodolac-target interaction and of the biochemical or physiological responses to drug. The drug is a cyclooxygenase (COX) inhibitor with a preference for COX-2 enzyme. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-08T15:38:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00084"^^xsd:string ;
  obo:id "PW:0002042"^^xsd:string ;
  rdfs:label "etodolac pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002042"^^xsd:string .

ns1:PW_0002043
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002121 ;
  ns2:treeView ns1:PW_0002121 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of etacrinic acid, a loop diuretic used  in the treatment of high blood pressure.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-09T12:53:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002043"^^xsd:string ;
  rdfs:label "etacryninc acid drug pathway"^^xsd:string ;
  skos:notation "PW:0002043"^^xsd:string .

ns1:PW_0002044
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002043 ;
  ns2:treeView ns1:PW_0002043 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of etacrynic acid. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-09T12:54:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002044"^^xsd:string ;
  rdfs:label "etacrynic acid pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002044"^^xsd:string .

ns1:PW_0002045
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002043 ;
  ns2:treeView ns1:PW_0002043 ;
  ns1:IAO_0000115 "The pathway of etacrynic acid-target interaction and of the biochemical or physiological responses to drug. The drug acts by inhibiting sodium-potassium-chloride contransport in the ascending loop of Henle. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-09T12:54:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00097"^^xsd:string ;
  obo:id "PW:0002045"^^xsd:string ;
  rdfs:label "etacrynic acid pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002045"^^xsd:string .

ns1:PW_0002046
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001737 ;
  ns2:treeView ns1:PW_0001737 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of esmolol, a selective beta adrenergic type 1 receptor antagonist used in the treatment of hypertension and several other conditions involving a faster than normal heart rate. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-09T13:02:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002046"^^xsd:string ;
  rdfs:label "esmolol drug pathway"^^xsd:string ;
  skos:notation "PW:0002046"^^xsd:string .

ns1:PW_0002047
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002046 ;
  ns2:treeView ns1:PW_0002046 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of esmolol. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-09T13:03:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002047"^^xsd:string ;
  rdfs:label "esmolol pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002047"^^xsd:string .

ns1:PW_0002048
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002046 ;
  ns2:treeView ns1:PW_0002046 ;
  ns1:IAO_0000115 "The pathway of esmolol-target interaction and of the biochemical or physiological responses to drug. The drug is a selective antagonist of beta adrenergic type 1 receptor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-09T13:04:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00301"^^xsd:string ;
  obo:id "PW:0002048"^^xsd:string ;
  rdfs:label "esmolol pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002048"^^xsd:string .

ns1:PW_0002049
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002115 ;
  ns2:treeView ns1:PW_0002115 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of escitalopram, an antidepressant used in the treatment of major depressive disorders. The drug is a selective serotonin reuptake inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-09T13:35:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002049"^^xsd:string ;
  rdfs:label "escitalopram drug pathway"^^xsd:string ;
  skos:notation "PW:0002049"^^xsd:string .

ns1:PW_0002050
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002049 ;
  ns2:treeView ns1:PW_0002049 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of escitalopram. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-09T13:36:39Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002050"^^xsd:string ;
  rdfs:label "escitalopram pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002050"^^xsd:string .

ns1:PW_0002051
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002049 ;
  ns2:treeView ns1:PW_0002049 ;
  ns1:IAO_0000115 "The pathway of escitalopram-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of major depressive disorders and its effect results from selective inhibition of serotonin reuptake. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-09T13:37:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00425"^^xsd:string ;
  obo:id "PW:0002051"^^xsd:string ;
  rdfs:label "escitalopram pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002051"^^xsd:string .

ns1:PW_0002052
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000996 ;
  ns2:treeView ns1:PW_0000996 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of erythromycin, an antibiotic that inhibits bacterial growth and used for the treatment of several bacterial infections. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-09T13:41:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002052"^^xsd:string ;
  rdfs:label "erythromycin drug pathway"^^xsd:string ;
  skos:notation "PW:0002052"^^xsd:string .

ns1:PW_0002053
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002052 ;
  ns2:treeView ns1:PW_0002052 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination of erythromycin - an antibiotic that interferes with bacterial growth. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-09T13:41:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002053"^^xsd:string ;
  rdfs:label "erythromycin pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002053"^^xsd:string .

ns1:PW_0002054
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002052 ;
  ns2:treeView ns1:PW_0002052 ;
  ns1:IAO_0000115 "The pathway of ertthromycin-target interaction and of the biochemical or physiological responses to drug. The drug interferes with bacterial growth via incompletely understood mechanisms. It is used for the treatment of several bacterial infections. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-09T13:43:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00250"^^xsd:string ;
  obo:id "PW:0002054"^^xsd:string ;
  rdfs:label "erythromycin pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002054"^^xsd:string .

ns1:PW_0002055
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002150 ;
  ns2:treeView ns1:PW_0002150 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of eptifibatide, a platelet aggregation inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-09T14:39:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002055"^^xsd:string ;
  rdfs:label "eptifibatide drug pathway"^^xsd:string ;
  skos:notation "PW:0002055"^^xsd:string .

ns1:PW_0002056
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002055 ;
  ns2:treeView ns1:PW_0002055 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of eptifibatide, a platelet aggregation inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-09T14:39:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002056"^^xsd:string ;
  rdfs:label "eptifibatide pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002056"^^xsd:string .

ns1:PW_0002057
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002055 ;
  ns2:treeView ns1:PW_0002055 ;
  ns1:IAO_0000115 "The pathway of eftifibatide-interaction and of the biochemical or physiological responses to drug. The platelet aggregation inhibitor belongs to glycoprotein IIb/IIIa inhibitor class. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-09T14:40:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00266"^^xsd:string ;
  obo:id "PW:0002057"^^xsd:string ;
  rdfs:label "eptifibatide pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002057"^^xsd:string .

ns1:PW_0002058
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001789 ;
  ns2:treeView ns1:PW_0001789 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of eprosartan, an angiotensin II receptor type 1 antagonist used in the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-09T14:51:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002058"^^xsd:string ;
  rdfs:label "eprosartan drug pathway"^^xsd:string ;
  skos:notation "PW:0002058"^^xsd:string .

ns1:PW_0002059
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002058 ;
  ns2:treeView ns1:PW_0002058 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of eprosartan. The drug is an antagonist of angiotensin II receptor type 1. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-09T14:51:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002059"^^xsd:string ;
  rdfs:label "eprosartan pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002059"^^xsd:string .

ns1:PW_0002060
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002058 ;
  ns2:treeView ns1:PW_0002058 ;
  ns1:IAO_0000115 "The pathway of eprosartan-target interaction and of the biochemical or physiological responses to drug. The drug is an antagonist of the angiotensin II receptor type 1. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-09T14:52:03Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00159"^^xsd:string ;
  obo:id "PW:0002060"^^xsd:string ;
  rdfs:label "eprosartan pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002060"^^xsd:string .

ns1:PW_0002061
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000103, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0001961
  ] ;
  ns2:treeView ns1:PW_0000103, ns1:PW_0001961 ;
  ns3:part_of ns1:PW_0001961 ;
  ns1:IAO_0000115 "The transport of mitochondria to sites of high energy demand, such as neurons and cardiomyocytes. Mitochondrial distribution at synaptic terminals and active growth cones is crucial for the proper function of neurons. Impaired transport and other aspects of mitochondrial dysfunction are involved in the pathology of major neurodegenerative disorders."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-13T13:04:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "mitochondria trafficking pathway"^^xsd:string ;
  obo:id "PW:0002061"^^xsd:string ;
  rdfs:label "mitochondria transport pathway"^^xsd:string ;
  skos:notation "PW:0002061"^^xsd:string .

ns1:PW_0002062
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001960, ns1:PW_0001961 ;
  ns2:treeView ns1:PW_0001960, ns1:PW_0001961 ;
  ns1:IAO_0000115 "Defects in mitochondrial dynamics are associated with the pathology of major neurodegenerative disorders."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-13T13:55:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002062"^^xsd:string ;
  rdfs:label "altered mitochondria dynamics pathway"^^xsd:string ;
  skos:notation "PW:0002062"^^xsd:string .

ns1:PW_0002063
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000923 ;
  ns2:treeView ns1:PW_0000923 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of disulfiram, a drug used in the treatment of chronic alcoholism and also cocaine dependence. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-13T14:16:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002063"^^xsd:string ;
  rdfs:label "disulfiram drug pathway"^^xsd:string ;
  skos:notation "PW:0002063"^^xsd:string .

ns1:PW_0002064
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002063 ;
  ns2:treeView ns1:PW_0002063 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of disulfiram. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-13T14:16:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002064"^^xsd:string ;
  rdfs:label "disulfiram pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002064"^^xsd:string .

ns1:PW_0002065
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002063 ;
  ns2:treeView ns1:PW_0002063 ;
  ns1:IAO_0000115 "The pathway of disulfiram-target interaction and of the biochemical or physiological responses to drug. The drug inhibits the enzyme acetaldehyde dehydrogenase and also appears to prevent the breakdown of dopamine. Disulfiram is used in the treatment of chronic alcoholism and also cocaine dependence. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-13T14:17:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00429"^^xsd:string ;
  obo:id "PW:0002065"^^xsd:string ;
  rdfs:label "disulfiram pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002065"^^xsd:string .

ns1:PW_0002066
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002336 ;
  ns2:treeView ns1:PW_0002336 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of disopyramide, a drug used in the treatment of arrhythmia. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-13T14:51:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002066"^^xsd:string ;
  rdfs:label "disopyramide drug pathway"^^xsd:string ;
  skos:notation "PW:0002066"^^xsd:string .

ns1:PW_0002067
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002066 ;
  ns2:treeView ns1:PW_0002066 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of disopyramide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-13T14:53:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002067"^^xsd:string ;
  rdfs:label "disopyramide pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002067"^^xsd:string .

ns1:PW_0002068
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002066 ;
  ns2:treeView ns1:PW_0002066 ;
  ns1:IAO_0000115 "The pathway of disopyramide-target interaction and of the biochemical or physiological responses to drug. The drug is a sodium channel blocker used in the treatment of arrhythmia. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-13T14:54:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00325"^^xsd:string ;
  obo:id "PW:0002068"^^xsd:string ;
  rdfs:label "disopyramide pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002068"^^xsd:string .

ns1:PW_0002069
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002150 ;
  ns2:treeView ns1:PW_0002150 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of dipyridamole, a drug that inhibits the formation of blood clots via inhibition of platelet aggregation. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-13T15:01:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002069"^^xsd:string ;
  rdfs:label "dipyridamole drug pathway"^^xsd:string ;
  skos:notation "PW:0002069"^^xsd:string .

ns1:PW_0002070
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002069 ;
  ns2:treeView ns1:PW_0002069 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of dipyridamole. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-13T15:02:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002070"^^xsd:string ;
  rdfs:label "dipyridamole pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002070"^^xsd:string .

ns1:PW_0002071
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002069 ;
  ns2:treeView ns1:PW_0002069 ;
  ns1:IAO_0000115 "The pathway of dipyridamole-target nteraction and of the biochemical or physiological responses to drug. Dipyridamole inhibits he formation of blood clots via inhibition of platelet aggregation. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-13T15:02:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00264"^^xsd:string ;
  obo:id "PW:0002071"^^xsd:string ;
  rdfs:label "dipyridamole pharmacodyamics pathway"^^xsd:string ;
  skos:notation "PW:0002071"^^xsd:string .

ns1:PW_0002072
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001363 ;
  ns2:treeView ns1:PW_0001363 ;
  ns1:IAO_0000115 "Those reaction involved in the synthesis of lactose, the major sugar in milk."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-15T09:55:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00444"^^xsd:string ;
  obo:id "PW:0002072"^^xsd:string ;
  rdfs:label "lactose biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0002072"^^xsd:string .

ns1:PW_0002073
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002061, ns1:PW_0002062 ;
  ns2:treeView ns1:PW_0002061, ns1:PW_0002062 ;
  ns1:IAO_0000115 "A mitochondria transport pathway that deviates from what its normal could should be. Impaired transport and other aspects of mitochondrial dysfunction are involved in the pathology of major neurodegenerative disorders."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-15T10:16:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002073"^^xsd:string ;
  rdfs:label "altered mitochondria transport pathway"^^xsd:string ;
  skos:notation "PW:0002073"^^xsd:string .

ns1:PW_0002074
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001999, ns1:PW_0002062 ;
  ns2:treeView ns1:PW_0001999, ns1:PW_0002062 ;
  ns1:IAO_0000115 "A mitochondria fusion pathway that deviates from what its normal could should be."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-15T10:29:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002074"^^xsd:string ;
  rdfs:label "altered mitochondria fusion pathway"^^xsd:string ;
  skos:notation "PW:0002074"^^xsd:string .

ns1:PW_0002075
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001998, ns1:PW_0002062 ;
  ns2:treeView ns1:PW_0001998, ns1:PW_0002062 ;
  ns1:IAO_0000115 "A mitochondria fission pathway that deviates from what its normal could should be."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-15T10:29:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002075"^^xsd:string ;
  rdfs:label "altered mitochondria fission pathway"^^xsd:string ;
  skos:notation "PW:0002075"^^xsd:string .

ns1:PW_0002076
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001893 ;
  ns2:treeView ns1:PW_0001893 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of diltiazem- a benzothiazepine L-type calcium channel blocker used in the treatment of hypertension and other cardiovascular conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T08:40:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002076"^^xsd:string ;
  rdfs:label "diltiazem drug pathway"^^xsd:string ;
  skos:notation "PW:0002076"^^xsd:string .

ns1:PW_0002077
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002076 ;
  ns2:treeView ns1:PW_0002076 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of diltiazem, an L-type calcium channel blocker used for the treatment of cardiovascular conditions. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T08:44:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002077"^^xsd:string ;
  rdfs:label "diltiazem pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002077"^^xsd:string .

ns1:PW_0002078
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002076 ;
  ns2:treeView ns1:PW_0002076 ;
  ns1:IAO_0000115 "The pathway of diltiazem-target interaction and of the biochemical or physiological responses to drug. The drug is an L-type calcium channel blocker used in the treatment of hypertension and other cardiovascular conditions. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T08:45:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00359"^^xsd:string ;
  obo:id "PW:0002078"^^xsd:string ;
  rdfs:label "diltiazem pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002078"^^xsd:string .

ns1:PW_0002079
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001546 ;
  ns2:treeView ns1:PW_0001546 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of diflunisal,  a non-steroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes and is used in the treatment of inflammation and pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T08:51:21Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002079"^^xsd:string ;
  rdfs:label "diflunisal drug pathway"^^xsd:string ;
  skos:notation "PW:0002079"^^xsd:string .

ns1:PW_0002080
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002079 ;
  ns2:treeView ns1:PW_0002079 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of diflunisal. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T08:53:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002080"^^xsd:string ;
  rdfs:label "diflunisal pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002080"^^xsd:string .

ns1:PW_0002081
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002079 ;
  ns2:treeView ns1:PW_0002079 ;
  ns1:IAO_0000115 "The pathway of diflunisal-target interaction and of the biochemical or physiological responses to drug. Diflunisal is an inhibitor of cyclooxygenase enzymes used in the treatment of pain and inflammation. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T08:53:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00289"^^xsd:string ;
  obo:id "PW:0002081"^^xsd:string ;
  rdfs:label "diflunisal pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002081"^^xsd:string .

ns1:PW_0002082
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000996 ;
  ns2:treeView ns1:PW_0000996 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of didanosine - an antiretroviral drug used in the treatment of HIV infection. It is a reverse transcriptase inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T09:07:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002082"^^xsd:string ;
  rdfs:label "didanosine drug pathway"^^xsd:string ;
  skos:notation "PW:0002082"^^xsd:string .

ns1:PW_0002083
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002082 ;
  ns2:treeView ns1:PW_0002082 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of didanosine, a drug used for the treatment of HIV. Didanosine triphosphate is the active form of the drug which is intracellularly metabolized. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T09:11:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002083"^^xsd:string ;
  rdfs:label "didanosine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002083"^^xsd:string .

ns1:PW_0002084
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002082 ;
  ns2:treeView ns1:PW_0002082 ;
  ns1:IAO_0000115 "The pathway of didanosine-target interaction and of the biochemical or physiological responses to drug. Didanosine is a drug used for the treatment of HIV infection. Didanosine, in its active triphosphate form, inhibits HIV-1 reverse transcriptase activity. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T09:12:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00739"^^xsd:string ;
  obo:id "PW:0002084"^^xsd:string ;
  rdfs:label "didanosine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002084"^^xsd:string .

ns1:PW_0002085
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001170 ;
  ns2:treeView ns1:PW_0001170 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of diclofenac, a non-steroidal anti-inflammatory drug used to treat arthritis and other joint diseases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T09:33:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002085"^^xsd:string ;
  rdfs:label "diclofenac drug pathway"^^xsd:string ;
  skos:notation "PW:0002085"^^xsd:string .

ns1:PW_0002086
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002085 ;
  ns2:treeView ns1:PW_0002085 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of diclofenac. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T09:37:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002086"^^xsd:string ;
  rdfs:label "diclofenac pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002086"^^xsd:string .

ns1:PW_0002087
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002085 ;
  ns2:treeView ns1:PW_0002085 ;
  ns1:IAO_0000115 "The pathway of diclofenac-target interaction and of the biochemical or physiological responses to drug. The drug is used for the treatment of various joint diseases and in pain management. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T09:37:41Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00093"^^xsd:string ;
  obo:id "PW:0002087"^^xsd:string ;
  rdfs:label "diclofenac pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002087"^^xsd:string .

ns1:PW_0002088
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002113 ;
  ns2:treeView ns1:PW_0002113 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of desipramine, an antidepressant used in the treatment of depression and attention deficit disorder. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T09:52:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002088"^^xsd:string ;
  rdfs:label "desipramine drug pathway"^^xsd:string ;
  skos:notation "PW:0002088"^^xsd:string .

ns1:PW_0002089
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002088 ;
  ns2:treeView ns1:PW_0002088 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of desipramine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T10:01:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00626"^^xsd:string ;
  obo:id "PW:0002089"^^xsd:string ;
  rdfs:label "desipramine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002089"^^xsd:string .

ns1:PW_0002090
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002088 ;
  ns2:treeView ns1:PW_0002088 ;
  ns1:IAO_0000115 "The pathway of desipramine-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of major depression and its effect results from inhibition of norepinephrine and to a lesser extent serotonin neurotransmitter reuptake. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T10:01:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00423"^^xsd:string ;
  obo:id "PW:0002090"^^xsd:string ;
  rdfs:label "desipramine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002090"^^xsd:string .

ns1:PW_0002091
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001644, ns1:PW_0001646 ;
  ns2:treeView ns1:PW_0001644, ns1:PW_0001646 ;
  ns1:IAO_0000115 "A group of inherited enzyme deficiencies that affect galactose metabolism and manifest as elevated galactose levels in the blood."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T10:18:44Z"^^xsd:string ;
  obo:hasExactSynonym "galactosemias disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002091"^^xsd:string ;
  rdfs:label "galactosemias pathway"^^xsd:string ;
  skos:notation "PW:0002091"^^xsd:string .

ns1:PW_0002092
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002091 ;
  ns2:treeView ns1:PW_0002091 ;
  ns1:IAO_0000115 "A galactosemia resulting from defects in the galactose-1-phosphate uridylyltransferase enzyme GALT."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T10:22:32Z"^^xsd:string ;
  obo:hasExactSynonym "GALT deficiency pathway"^^xsd:string, "classic galactosemia pathway"^^xsd:string, "galactose-1-phosphate uridylyl transferase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00182"^^xsd:string ;
  obo:id "PW:0002092"^^xsd:string ;
  rdfs:label "galactosemia pathway"^^xsd:string ;
  skos:notation "PW:0002092"^^xsd:string .

ns1:PW_0002093
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002091 ;
  ns2:treeView ns1:PW_0002091 ;
  ns1:IAO_0000115 "A galactosemia resulting from defects in the UDP-galactose-4-epimerase enzyme GALE."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T10:23:26Z"^^xsd:string ;
  obo:hasExactSynonym "UDP-galactose-4-epimerase deficiency pathway"^^xsd:string, "galactose epimerase deficiency pathway"^^xsd:string, "galactosemia III pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00496"^^xsd:string ;
  obo:id "PW:0002093"^^xsd:string ;
  rdfs:label "GALE deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002093"^^xsd:string .

ns1:PW_0002094
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002091 ;
  ns2:treeView ns1:PW_0002091 ;
  ns1:IAO_0000115 "A galactosemia resulting from defects in the galactokinase enzyme GALK1."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T10:23:54Z"^^xsd:string ;
  obo:hasExactSynonym "GALK deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00495"^^xsd:string ;
  obo:id "PW:0002094"^^xsd:string ;
  rdfs:label "galactokinase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002094"^^xsd:string .

ns1:PW_0002095
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "A condition caused by alterations in gamma aminobutyric acid metabolism due to defects in the 4-aminobutyrate aminotransferase enzyme."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T10:54:18Z"^^xsd:string ;
  obo:hasExactSynonym "gamma aminobutyric acid transaminase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "GABA transaminase deficiency pathway"^^xsd:string, "SMP:00351"^^xsd:string ;
  obo:id "PW:0002095"^^xsd:string ;
  rdfs:label "GABA aminotransferase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002095"^^xsd:string .

ns1:PW_0002096
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000178 ;
  ns2:treeView ns1:PW_0000178 ;
  ns1:IAO_0000115 "Those symptoms associated with conditions affecting the muscles, neuromuscular junctions or peripheral nerves."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T11:09:16Z"^^xsd:string ;
  obo:hasExactSynonym "neuromuscular manifestation disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002096"^^xsd:string ;
  rdfs:label "neuromuscular manifestation of disease pathway"^^xsd:string ;
  skos:notation "PW:0002096"^^xsd:string .

ns1:PW_0002097
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002096 ;
  ns2:treeView ns1:PW_0002096 ;
  ns1:IAO_0000115 "A disorder manifested by a diminished skeletal muscle tone."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T11:12:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002097"^^xsd:string ;
  rdfs:label "muscle hypotonia disorder pathway"^^xsd:string ;
  skos:notation "PW:0002097"^^xsd:string .

ns1:PW_0002098
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001589, ns1:PW_0002097 ;
  ns2:treeView ns1:PW_0001589, ns1:PW_0002097 ;
  ns1:IAO_0000115 "A severe autosomal recessive metabolic disorder resulting from defects in the fumarate hydratase enzyme and manifesting in early-onset hypotonia, psychomotor and brain abnormalities."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T11:14:36Z"^^xsd:string ;
  obo:hasExactSynonym "fumaric aciduria disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00547"^^xsd:string, "fumarase deficiency pathway"^^xsd:string ;
  obo:id "PW:0002098"^^xsd:string ;
  rdfs:label "fumaric aciduria pathway"^^xsd:string ;
  skos:notation "PW:0002098"^^xsd:string .

ns1:PW_0002099
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001644 ;
  ns2:treeView ns1:PW_0001644 ;
  ns1:IAO_0000115 "Those diseases that are caused by inborn errors of fructose metabolism."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T11:27:44Z"^^xsd:string ;
  obo:hasExactSynonym "inborn error of fructose metabolism disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002099"^^xsd:string ;
  rdfs:label "inborn error of fructose metabolism pathway"^^xsd:string ;
  skos:notation "PW:0002099"^^xsd:string .

ns1:PW_0002100
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002099 ;
  ns2:treeView ns1:PW_0002099 ;
  ns1:IAO_0000115 "An autosomal recessive condition resulting from alterations in fructose metabolism due to defects in the enzyme fructose-1,6-bisphosphatase."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T11:29:17Z"^^xsd:string ;
  obo:hasExactSynonym "fructose-1,6-diphosphatase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00562"^^xsd:string ;
  obo:id "PW:0002100"^^xsd:string ;
  rdfs:label "fructose-1,6-bisphosphatase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002100"^^xsd:string .

ns1:PW_0002101
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002099 ;
  ns2:treeView ns1:PW_0002099 ;
  ns1:IAO_0000115 "An autosomal recessive disorder resulting from alterations in fructose metabolism and due to defects in the fructose-1-phosphate aldolase enzyme."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T11:32:59Z"^^xsd:string ;
  obo:hasExactSynonym "fructose intolerance pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00725"^^xsd:string ;
  obo:id "PW:0002101"^^xsd:string ;
  rdfs:label "hereditary fructose intolerance syndrome pathway"^^xsd:string ;
  skos:notation "PW:0002101"^^xsd:string .

ns1:PW_0002102
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001589 ;
  ns2:treeView ns1:PW_0001589 ;
  ns1:IAO_0000115 "Those disorders resulting from alterations in steroid metabolic pathways due to inborn genetic mutations."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T12:53:22Z"^^xsd:string ;
  obo:hasExactSynonym "inborn error of steroid metabolism disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002102"^^xsd:string ;
  rdfs:label "inborn error of steroid metabolism pathway"^^xsd:string ;
  skos:notation "PW:0002102"^^xsd:string .

ns1:PW_0002103
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001872, ns1:PW_0002301 ;
  ns2:treeView ns1:PW_0001872, ns1:PW_0002301 ;
  ns1:IAO_0000115 "An X-linked inherited metabolic disorder resulting from alterations in lipid metabolic pathways. It is due to defects in alpha-galactosidase leading to accumulation of glycosphingolipids in blood vessels."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T12:58:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00525"^^xsd:string ;
  obo:id "PW:0002103"^^xsd:string ;
  rdfs:label "Fabry disease pathway"^^xsd:string ;
  skos:notation "PW:0002103"^^xsd:string .

ns1:PW_0002104
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001611 ;
  ns2:treeView ns1:PW_0001611 ;
  ns1:IAO_0000115 "Movement disorders classified by patterns of inheritance and age of onset."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-21T13:09:09Z"^^xsd:string ;
  obo:hasExactSynonym "dystonia disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002104"^^xsd:string ;
  rdfs:label "dystonia pathway"^^xsd:string ;
  skos:notation "PW:0002104"^^xsd:string .

ns1:PW_0002105
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002104 ;
  ns2:treeView ns1:PW_0002104 ;
  ns1:IAO_0000115 "A condition resulting from alterations in the metabolism of tetrahydrobiopterin (BH4), an essential cofactor for the activity of many enzymes. Diet and supplements, such as administration of L-Dopa, may diminish the outcomes of the condition."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-22T12:42:09Z"^^xsd:string ;
  obo:hasExactSynonym "dopa responsive dystonia disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00486"^^xsd:string ;
  obo:id "PW:0002105"^^xsd:string ;
  rdfs:label "dopa responsive dystonia pathway"^^xsd:string ;
  skos:notation "PW:0002105"^^xsd:string .

ns1:PW_0002106
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001643 ;
  ns2:treeView ns1:PW_0001643 ;
  ns1:IAO_0000115 "A rare autosomal recessive disorder likely resulting from alteration in cholesterol metabolism. Desmosterol, a precursor of cholesterol, is present in elevated amounts."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-22T12:54:48Z"^^xsd:string ;
  obo:hasExactSynonym "desmosterolosis disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00386"^^xsd:string ;
  obo:id "PW:0002106"^^xsd:string ;
  rdfs:label "desmosterolosis pathway"^^xsd:string ;
  skos:notation "PW:0002106"^^xsd:string .

ns1:PW_0002107
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of  cyclophosphamide, an alkylating agent used in the treatment of certain cancer types. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-27T14:31:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002107"^^xsd:string ;
  rdfs:label "cyclophosphamide drug pathway"^^xsd:string ;
  skos:notation "PW:0002107"^^xsd:string .

ns1:PW_0002108
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002107 ;
  ns2:treeView ns1:PW_0002107 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of cyclophosphamide. It is a prodrug that has to be converted to its metabolite - 4-hydroxy cyclophosphamide, to exhibit chemotherapeutic activity. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-27T14:31:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00604"^^xsd:string ;
  obo:id "PW:0002108"^^xsd:string ;
  rdfs:label "cyclophosphamide pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002108"^^xsd:string .

ns1:PW_0002109
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002107 ;
  ns2:treeView ns1:PW_0002107 ;
  ns1:IAO_0000115 "The pathway of cyclophosphamide-target interaction and of the biochemical or physiological responses to drug. The alkylating drug is used for the treatment of several cancer types but its toxicity can have severe adverse effects. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-27T14:33:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00447"^^xsd:string ;
  obo:id "PW:0002109"^^xsd:string ;
  rdfs:label "cyclophosphamide pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002109"^^xsd:string .

ns1:PW_0002110
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000921 ;
  ns2:treeView ns1:PW_0000921 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of cimetidine - a histamine H2 receptor antagonist used in the treatment of acid disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-27T14:42:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002110"^^xsd:string ;
  rdfs:label "cimetidine drug pathway"^^xsd:string ;
  skos:notation "PW:0002110"^^xsd:string .

ns1:PW_0002111
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002110 ;
  ns2:treeView ns1:PW_0002110 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of cimetidine. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-27T14:42:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00617"^^xsd:string ;
  obo:id "PW:0002111"^^xsd:string ;
  rdfs:label "cimetidine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002111"^^xsd:string .

ns1:PW_0002112
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002110 ;
  ns2:treeView ns1:PW_0002110 ;
  ns1:IAO_0000115 "The pathway of cimetidine-target interaction and of the biochemical or physiological responses to drug. The drug is a histamine H2 receptor antagonist used for the treatment of various acid disorders. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-27T14:43:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00232"^^xsd:string ;
  obo:id "PW:0002112"^^xsd:string ;
  rdfs:label "cimetidine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002112"^^xsd:string .

ns1:PW_0002113
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002114 ;
  ns2:treeView ns1:PW_0002114 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of non- selective monoamine reuptake inhibitor drugs."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-27T14:51:09Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002113"^^xsd:string ;
  rdfs:label "non-selective monoamine reuptake inhibitor drug pathway"^^xsd:string ;
  skos:notation "PW:0002113"^^xsd:string .

ns1:PW_0002114
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000923 ;
  ns2:treeView ns1:PW_0000923 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of compounds used to treat various forms of depression. Some are non-selective monoamine reuptake inhibitors, others are selective serotonin reuptake inhibitors. The category also includes monoamine oxidase inhibitors and drug classified as others."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-27T14:52:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002114"^^xsd:string ;
  rdfs:label "antidepressant drug pathway"^^xsd:string ;
  skos:notation "PW:0002114"^^xsd:string .

ns1:PW_0002115
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002114 ;
  ns2:treeView ns1:PW_0002114 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of selective serotonin uptake  inhibitor drugs."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-27T15:02:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002115"^^xsd:string ;
  rdfs:label "selective serotonin uptake inhibitor drug pathway"^^xsd:string ;
  skos:notation "PW:0002115"^^xsd:string .

ns1:PW_0002116
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002115 ;
  ns2:treeView ns1:PW_0002115 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of citalopram, an antidepressant used in the treatment of major depressive disorders. The drug is a selective serotonin reuptake inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-27T15:06:39Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002116"^^xsd:string ;
  rdfs:label "citalopram drug pathway"^^xsd:string ;
  skos:notation "PW:0002116"^^xsd:string .

ns1:PW_0002117
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002116 ;
  ns2:treeView ns1:PW_0002116 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of citalopram. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-27T15:07:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00627"^^xsd:string ;
  obo:id "PW:0002117"^^xsd:string ;
  rdfs:label "citalopram pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002117"^^xsd:string .

ns1:PW_0002118
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002116 ;
  ns2:treeView ns1:PW_0002116 ;
  ns1:IAO_0000115 "The pathway of citalopram-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of major depressive disorders and its effect results from selective inhibition of serotonin reuptake. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-27T15:07:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00424"^^xsd:string ;
  obo:id "PW:0002118"^^xsd:string ;
  rdfs:label "citalopram pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002118"^^xsd:string .

ns1:PW_0002119
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000818, ns1:PW_0002120 ;
  ns2:treeView ns1:PW_0000818, ns1:PW_0002120 ;
  ns1:IAO_0000115 "Histamine signaling is important for the central and to some extent the peripheral nervous systems and is also involved in the immune responses. Histamine signaling engages four G-protein coupled receptors (GPCR). In the immune system/inflammatory it involves receptors H2 and H4. H2 couples to Galphas."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-28T14:35:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00335"^^xsd:string ;
  obo:id "PW:0002119"^^xsd:string ;
  rdfs:label "histamine signaling pathway, immunological"^^xsd:string ;
  skos:notation "PW:0002119"^^xsd:string .

ns1:PW_0002120
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000466, ns1:PW_0001162 ;
  ns2:treeView ns1:PW_0000466, ns1:PW_0001162 ;
  ns1:IAO_0000115 "Histamine is a nitrogenous compound derived from histidine whose signaling plays important roles in the nervous and immune systems."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-28T14:41:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002120"^^xsd:string ;
  rdfs:label "histamine signaling pathway"^^xsd:string ;
  skos:notation "PW:0002120"^^xsd:string .

ns1:PW_0002121
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000920 ;
  ns2:treeView ns1:PW_0000920 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of drugs that increase water excretion and are used in the treatment of hypertension, heart failure and certain kidney disorders. They are further categorized by type. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-29T11:30:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002121"^^xsd:string ;
  rdfs:label "diuretic drug pathway"^^xsd:string ;
  skos:notation "PW:0002121"^^xsd:string .

ns1:PW_0002122
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002121 ;
  ns2:treeView ns1:PW_0002121 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of chlorothalidone - a blocker of sodium -chloride symporter in the distal convoluted tubule of the nephron. The drug is used for the treatment of hypertension and also as an adjuvant drug for treating edema. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-29T11:40:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002122"^^xsd:string ;
  rdfs:label "chlorthalidone drug pathway"^^xsd:string ;
  skos:notation "PW:0002122"^^xsd:string .

ns1:PW_0002123
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002122 ;
  ns2:treeView ns1:PW_0002122 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of chlorthalidone. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-29T12:28:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002123"^^xsd:string ;
  rdfs:label "chlorthalidone pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002123"^^xsd:string .

ns1:PW_0002124
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002122 ;
  ns2:treeView ns1:PW_0002122 ;
  ns1:IAO_0000115 "The pathway of chlorthalidone-target interaction and of the biochemical or physiological responses to drug. The drug blocks the sodium-chloride symporter and is used in the treatment of hypertension and as an adjuvant for treating edema. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-29T12:29:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00122"^^xsd:string ;
  obo:id "PW:0002124"^^xsd:string ;
  rdfs:label "chlorthalidone pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002124"^^xsd:string .

ns1:PW_0002125
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001228 ;
  ns2:treeView ns1:PW_0001228 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of captopril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-29T13:08:06Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002125"^^xsd:string ;
  rdfs:label "captopril drug pathway"^^xsd:string ;
  skos:notation "PW:0002125"^^xsd:string .

ns1:PW_0002126
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001230, ns1:PW_0002125 ;
  ns2:treeView ns1:PW_0001230, ns1:PW_0002125 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of captopril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-29T13:08:35Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002126"^^xsd:string ;
  rdfs:label "captopril pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002126"^^xsd:string .

ns1:PW_0002127
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001231, ns1:PW_0002125 ;
  ns2:treeView ns1:PW_0001231, ns1:PW_0002125 ;
  ns1:IAO_0000115 "The pathway of captopril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-29T13:09:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00146"^^xsd:string ;
  obo:id "PW:0002127"^^xsd:string ;
  rdfs:label "captopril pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002127"^^xsd:string .

ns1:PW_0002128
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001789 ;
  ns2:treeView ns1:PW_0001789 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of candsartan, an angiotensin II receptor type 1 antagonist used in the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-29T13:42:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002128"^^xsd:string ;
  rdfs:label "candesartan drug pathway"^^xsd:string ;
  skos:notation "PW:0002128"^^xsd:string .

ns1:PW_0002129
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002128 ;
  ns2:treeView ns1:PW_0002128 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of candesartan. The drug is an antagonist of angiotensin II receptor type 1. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-29T13:43:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002129"^^xsd:string ;
  rdfs:label "candesartan pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002129"^^xsd:string .

ns1:PW_0002130
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002128 ;
  ns2:treeView ns1:PW_0002128 ;
  ns1:IAO_0000115 "The pathway of candesartan-target interaction and of the biochemical or physiological responses to drug. The drug is an antagonist of the angiotensin II receptor type 1. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-29T13:43:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00158"^^xsd:string ;
  obo:id "PW:0002130"^^xsd:string ;
  rdfs:label "candesartan pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002130"^^xsd:string .

ns1:PW_0002131
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of capecitabine, an agent used in the treatment of several cancers. Capecitabine is a prodrug that is enzymatically converted to 5-fluorouracil which inhibits the activity of thymidylate synthase necessary for the de novo DNA synthesis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-29T14:00:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002131"^^xsd:string ;
  rdfs:label "capecitabine drug pathway"^^xsd:string ;
  skos:notation "PW:0002131"^^xsd:string .

ns1:PW_0002132
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002131 ;
  ns2:treeView ns1:PW_0002131 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of capecitabine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-29T14:02:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00607"^^xsd:string ;
  obo:id "PW:0002132"^^xsd:string ;
  rdfs:label "capecitabine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002132"^^xsd:string .

ns1:PW_0002133
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002131 ;
  ns2:treeView ns1:PW_0002131 ;
  ns1:IAO_0000115 "The pathway of capecitabine-target interaction and of the biochemical or physiological responses to drug. Capecitabine  is used in the treatment of numerous cancers. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-29T14:03:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00469"^^xsd:string ;
  obo:id "PW:0002133"^^xsd:string ;
  rdfs:label "capecitabine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002133"^^xsd:string .

ns1:PW_0002134
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001738 ;
  ns2:treeView ns1:PW_0001738 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of buoranolol - a non-selective adrenergic beta receptor blocker, used for the treatment of hypertension and other cardiovascular conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-29T14:16:38Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00670"^^xsd:string ;
  obo:id "PW:0002134"^^xsd:string ;
  rdfs:label "bupranolol drug pathway"^^xsd:string ;
  skos:notation "PW:0002134"^^xsd:string .

ns1:PW_0002135
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002134 ;
  ns2:treeView ns1:PW_0002134 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of bupranolol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-29T14:17:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002135"^^xsd:string ;
  rdfs:label "bupranolol pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002135"^^xsd:string .

ns1:PW_0002136
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002134 ;
  ns2:treeView ns1:PW_0002134 ;
  ns1:IAO_0000115 "The pathway of buopranolol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-29T14:17:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00670"^^xsd:string ;
  obo:id "PW:0002136"^^xsd:string ;
  rdfs:label "bupranolol pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002136"^^xsd:string .

ns1:PW_0002137
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001962 ;
  ns2:treeView ns1:PW_0001962 ;
  ns1:IAO_0000115 "A classical pathway of mitochondrial protein import that delivers matrix resident and some of the inner membrane proteins. The precursor proteins are synthesized with an amino terminal peptide extension - the presequence. Translocase complexes, chaperones and processing enzymes cooperate in the process."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-30T09:05:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002137"^^xsd:string ;
  rdfs:label "presequence pathway of mitochondrial protein import"^^xsd:string ;
  skos:notation "PW:0002137"^^xsd:string .

ns1:PW_0002138
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001962 ;
  ns2:treeView ns1:PW_0001962 ;
  ns1:IAO_0000115 "The carrier pathway delivers many of the inner mitochondrial membrane proteins. These proteins are synthesized without a  presequence."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-30T09:41:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002138"^^xsd:string ;
  rdfs:label "carrier pathway of mitochondrial protein import."^^xsd:string ;
  skos:notation "PW:0002138"^^xsd:string .

ns1:PW_0002139
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001962 ;
  ns2:treeView ns1:PW_0001962 ;
  ns1:IAO_0000115 "The mitochondrial intermembrane space assembly pathway (MIA) delivers the resident proteins of this mitochondrial localization."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-30T09:51:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002139"^^xsd:string ;
  rdfs:label "intermembrane space assembly pathway of mitochondrial protein import"^^xsd:string ;
  skos:notation "PW:0002139"^^xsd:string .

ns1:PW_0002140
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001962 ;
  ns2:treeView ns1:PW_0001962 ;
  ns1:IAO_0000115 "The mitochondrial protein import thereby beta-barrel proteins of the outer mitochondrial membrane are sorted and assembled."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-30T10:06:56Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002140"^^xsd:string ;
  rdfs:label "beta-barrel pathway of mitochondrial protein import"^^xsd:string ;
  skos:notation "PW:0002140"^^xsd:string .

ns1:PW_0002141
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001962 ;
  ns2:treeView ns1:PW_0001962 ;
  ns1:IAO_0000115 "The mitochondrial protein import thereby alpha-helical proteins of the outer mitochondrial membrane are sorted and assembled."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-10-30T10:07:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002141"^^xsd:string ;
  rdfs:label "alpha-helical insertion pathway of mitochondrial protein import"^^xsd:string ;
  skos:notation "PW:0002141"^^xsd:string .

ns1:PW_0002142
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645, ns1:PW_0001646 ;
  ns2:treeView ns1:PW_0001645, ns1:PW_0001646 ;
  ns1:IAO_0000115 "A rare congenital disorder resulting from alterations in the urea cycle pathway. The neonatal form exhibits several phenotypes and can result in death."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-02T08:59:19Z"^^xsd:string ;
  obo:hasAlternativeId "PW:0002219"^^xsd:string ;
  obo:hasExactSynonym "inborn error of urea cycle disease pathway"^^xsd:string, "urea cycle disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002142"^^xsd:string ;
  rdfs:label "inborn error of urea cycle pathway"^^xsd:string ;
  skos:notation "PW:0002142"^^xsd:string .

ns1:PW_0002143
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002142 ;
  ns2:treeView ns1:PW_0002142 ;
  ns1:IAO_0000115 "The condition represents a group of disorders due to argininosuccinate synthase deficiency. The enzyme is a component of the urea cycle pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-02T09:04:28Z"^^xsd:string ;
  obo:hasExactSynonym "citrullinemia disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00001"^^xsd:string, "citrullinemia type I disease pathway"^^xsd:string ;
  obo:id "PW:0002143"^^xsd:string ;
  rdfs:label "citrullinemia pathway"^^xsd:string ;
  skos:notation "PW:0002143"^^xsd:string .

ns1:PW_0002144
  a owl:Class ;
  ns1:IAO_0000115 "An autosomal recessive disorder resulting from alterations in the urea cycle pathway and due to defects in the hepatic mitochondrial enzyme carbamoyl phosphate synthetase 1."^^xsd:string ;
  ns1:IAO_0000231 ns1:IAO_0000227 ;
  ns1:IAO_0100001 ns1:PW_0002220 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-02T09:11:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002144"^^xsd:string ;
  rdfs:label "carbamoyl phosphate synthase I deficiency pathway"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0002144"^^xsd:string .

ns1:PW_0002145
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002142 ;
  ns2:treeView ns1:PW_0002142 ;
  ns1:IAO_0000115 "A rare autosomal recessive disorder resulting from alterations in the urea cycle pathway and due to defects in the argininosuccinate lyase enzyme."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-02T09:16:25Z"^^xsd:string ;
  obo:hasExactSynonym "argininosuccinic aciduria disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00003"^^xsd:string ;
  obo:id "PW:0002145"^^xsd:string ;
  rdfs:label "argininosuccinic aciduria pathway"^^xsd:string ;
  skos:notation "PW:0002145"^^xsd:string .

ns1:PW_0002146
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002151 ;
  ns2:treeView ns1:PW_0002151 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of drugs that reduce or prevent the formation of blood clots by directly inhibiting thrombin. Thrombin is a serine protease involved in coagulation-related reactions. The drugs are further classified depending on how they interact with thrombin. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-02T11:47:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002146"^^xsd:string ;
  rdfs:label "direct thrombin inhibitor drug pathway"^^xsd:string ;
  skos:notation "PW:0002146"^^xsd:string .

ns1:PW_0002147
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002146 ;
  ns2:treeView ns1:PW_0002146 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of bivalirudin, a direct thrombin inhibitor. Bivalirudin binds to both the catalytic site and anion-binding exosite of thrombin and as classified as a bivalent inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-02T11:55:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002147"^^xsd:string ;
  rdfs:label "bivalirudin drug pathway"^^xsd:string ;
  skos:notation "PW:0002147"^^xsd:string .

ns1:PW_0002148
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002147 ;
  ns2:treeView ns1:PW_0002147 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of bivalirudin, a bivalent direct thrombin inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-02T11:55:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002148"^^xsd:string ;
  rdfs:label "bivalirudin pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002148"^^xsd:string .

ns1:PW_0002149
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002147 ;
  ns2:treeView ns1:PW_0002147 ;
  ns1:IAO_0000115 "The pathway of bivalirudin-target interaction and of the biochemical or physiological responses to drug. The drug is a bivalent direct thrombin inhibitor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-02T11:56:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00277"^^xsd:string ;
  obo:id "PW:0002149"^^xsd:string ;
  rdfs:label "bivalirudin pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002149"^^xsd:string .

ns1:PW_0002150
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001651 ;
  ns2:treeView ns1:PW_0001651 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of drugs that decrease platelet aggregation and inhibit blood clot formation. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-02T14:59:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002150"^^xsd:string ;
  rdfs:label "antiplatelet drug pathway"^^xsd:string ;
  skos:notation "PW:0002150"^^xsd:string .

ns1:PW_0002151
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001651 ;
  ns2:treeView ns1:PW_0001651 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of drugs that prevent the coagulation of blood. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-02T15:04:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002151"^^xsd:string ;
  rdfs:label "anticoagulant drug pathway"^^xsd:string ;
  skos:notation "PW:0002151"^^xsd:string .

ns1:PW_0002152
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001651 ;
  ns2:treeView ns1:PW_0001651 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of drugs that can dissolve blood clots. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-02T15:07:56Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002152"^^xsd:string ;
  rdfs:label "thrombolytic drug pathway"^^xsd:string ;
  skos:notation "PW:0002152"^^xsd:string .

ns1:PW_0002153
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002121 ;
  ns2:treeView ns1:PW_0002121 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of bumetanide - a blocker of luminal sodium-potassium-chloride symporter used for the treatment of heart failure.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-02T15:18:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002153"^^xsd:string ;
  rdfs:label "bumetanide drug pathway"^^xsd:string ;
  skos:notation "PW:0002153"^^xsd:string .

ns1:PW_0002154
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002153 ;
  ns2:treeView ns1:PW_0002153 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of bumetanide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-02T15:22:40Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002154"^^xsd:string ;
  rdfs:label "bumetanide pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002154"^^xsd:string .

ns1:PW_0002155
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002153 ;
  ns2:treeView ns1:PW_0002153 ;
  ns1:IAO_0000115 "The pathway of bumetanide-target interaction and of the biochemical or physiological responses to drug. The drug blocks the luminal sodium-potassium-chloride symporter in the thick ascending limb of the loop of Henle. Bumetanide is used in the treatment of heart failure.  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-02T15:23:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00088"^^xsd:string ;
  obo:id "PW:0002155"^^xsd:string ;
  rdfs:label "bumetanide pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002155"^^xsd:string .

ns1:PW_0002156
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001737 ;
  ns2:treeView ns1:PW_0001737 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of bisoprolol, a selective beta adrenergic type 1 receptor antagonist used in the treatment of hypertension and several other conditions involving a faster than normal heart rate. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-02T15:38:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002156"^^xsd:string ;
  rdfs:label "bisoprolol drug pathway"^^xsd:string ;
  skos:notation "PW:0002156"^^xsd:string .

ns1:PW_0002157
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002156 ;
  ns2:treeView ns1:PW_0002156 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of bisoprolol. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-02T15:39:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002157"^^xsd:string ;
  rdfs:label "bisoprolol pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002157"^^xsd:string .

ns1:PW_0002158
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002156 ;
  ns2:treeView ns1:PW_0002156 ;
  ns1:IAO_0000115 "The pathway of bisoprolol-target interaction and of the biochemical or physiological responses to drug. The drug is a selective antagonist of beta adrenergic type 1 receptor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-02T15:39:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00300"^^xsd:string ;
  obo:id "PW:0002158"^^xsd:string ;
  rdfs:label "bisoprolol pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002158"^^xsd:string .

ns1:PW_0002159
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000754 ;
  ns2:treeView ns1:PW_0000754 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of compounds used in the treatment of conditions affecting the sensory organs. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-02T15:53:41Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002159"^^xsd:string ;
  rdfs:label "sensory organ drug pathway"^^xsd:string ;
  skos:notation "PW:0002159"^^xsd:string .

ns1:PW_0002160
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001737, ns1:PW_0002159 ;
  ns2:treeView ns1:PW_0001737, ns1:PW_0002159 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of betaxolol, a selective beta adrenergic type 1 receptor antagonist used in the treatment of hypertension and glaucoma. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-02T15:58:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002160"^^xsd:string ;
  rdfs:label "betaxolol drug pathway"^^xsd:string ;
  skos:notation "PW:0002160"^^xsd:string .

ns1:PW_0002161
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002160 ;
  ns2:treeView ns1:PW_0002160 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of betaxolol. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-02T15:58:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002161"^^xsd:string ;
  rdfs:label "betaxolol pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002161"^^xsd:string .

ns1:PW_0002162
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002160 ;
  ns2:treeView ns1:PW_0002160 ;
  ns1:IAO_0000115 "The pathway of betaxolol-target interaction and of the biochemical or physiological responses to drug. The drug is a selective antagonist of beta adrenergic type 1 receptor used in the treatment of hypertension and glaucoma. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-02T15:59:06Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00299"^^xsd:string ;
  obo:id "PW:0002162"^^xsd:string ;
  rdfs:label "betaxolol pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002162"^^xsd:string .

ns1:PW_0002163
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001228 ;
  ns2:treeView ns1:PW_0001228 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of moexipril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-03T08:54:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002163"^^xsd:string ;
  rdfs:label "moexipril drug pathway"^^xsd:string ;
  skos:notation "PW:0002163"^^xsd:string .

ns1:PW_0002164
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001230, ns1:PW_0002163 ;
  ns2:treeView ns1:PW_0001230, ns1:PW_0002163 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of moexipril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-03T08:54:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00595"^^xsd:string ;
  obo:id "PW:0002164"^^xsd:string ;
  rdfs:label "moexipril pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002164"^^xsd:string .

ns1:PW_0002165
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001231, ns1:PW_0002163 ;
  ns2:treeView ns1:PW_0001231, ns1:PW_0002163 ;
  ns1:IAO_0000115 "The pathway of moexipril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and congestive heart failure. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-03T08:59:40Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00151"^^xsd:string ;
  obo:id "PW:0002165"^^xsd:string ;
  rdfs:label "moexipril pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002165"^^xsd:string .

ns1:PW_0002166
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001478 ;
  ns2:treeView ns1:PW_0001478 ;
  ns1:IAO_0000115 "A form of congenital hyperplasia resulting from defects in the CYP17A1 gene."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-04T15:18:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00372"^^xsd:string ;
  obo:id "PW:0002166"^^xsd:string ;
  rdfs:label "17-alpha-hydroxylase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002166"^^xsd:string .

ns1:PW_0002167
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001478 ;
  ns2:treeView ns1:PW_0001478 ;
  ns1:IAO_0000115 "A form of congenital hyperplasia resulting from defects in the CYP21A2 gene."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-04T15:18:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00373"^^xsd:string ;
  obo:id "PW:0002167"^^xsd:string ;
  rdfs:label "21-alpha-hydroxylase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002167"^^xsd:string .

ns1:PW_0002168
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001478 ;
  ns2:treeView ns1:PW_0001478 ;
  ns1:IAO_0000115 "A form of congenital hyperplasia resulting from defects in the CYP11B1 gene."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-04T15:26:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00575"^^xsd:string ;
  obo:id "PW:0002168"^^xsd:string ;
  rdfs:label "11-beta-hydroxylase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002168"^^xsd:string .

ns1:PW_0002169
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001737 ;
  ns2:treeView ns1:PW_0001737 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of acebutolol, a selective beta adrenergic type 1 receptor antagonist used in the treatment of hypertension and arrhythmias. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-05T14:15:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002169"^^xsd:string ;
  rdfs:label "acebutolol drug pathway"^^xsd:string ;
  skos:notation "PW:0002169"^^xsd:string .

ns1:PW_0002170
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002169 ;
  ns2:treeView ns1:PW_0002169 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of acebutolol. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-05T14:16:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002170"^^xsd:string ;
  rdfs:label "acebutolol pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002170"^^xsd:string .

ns1:PW_0002171
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002169 ;
  ns2:treeView ns1:PW_0002169 ;
  ns1:IAO_0000115 "The pathway of acebutolol-target interaction and of the biochemical or physiological responses to drug. The drug is a selective antagonist of beta adrenergic type 1 receptor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-05T14:16:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00296"^^xsd:string ;
  obo:id "PW:0002171"^^xsd:string ;
  rdfs:label "acebutolol pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002171"^^xsd:string .

ns1:PW_0002172
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001621 ;
  ns2:treeView ns1:PW_0001621 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of alendronate - a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-05T14:21:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002172"^^xsd:string ;
  rdfs:label "alendronate drug pathway"^^xsd:string ;
  skos:notation "PW:0002172"^^xsd:string .

ns1:PW_0002173
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001623, ns1:PW_0002172 ;
  ns2:treeView ns1:PW_0001623, ns1:PW_0002172 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of alendronate, a nitrogenous bisphosphonate drug. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-05T14:23:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002173"^^xsd:string ;
  rdfs:label "alendronate pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002173"^^xsd:string .

ns1:PW_0002174
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001624, ns1:PW_0002172 ;
  ns2:treeView ns1:PW_0001624, ns1:PW_0002172 ;
  ns1:IAO_0000115 "The pathway of alendronate-target interaction and of the biochemical or physiological responses to drug. Alendronate is a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-05T14:24:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00095"^^xsd:string ;
  obo:id "PW:0002174"^^xsd:string ;
  rdfs:label "alendronate pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002174"^^xsd:string .

ns1:PW_0002175
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001621 ;
  ns2:treeView ns1:PW_0001621 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of pamidronate - a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-05T14:27:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002175"^^xsd:string ;
  rdfs:label "pamidronate drug pathway"^^xsd:string ;
  skos:notation "PW:0002175"^^xsd:string .

ns1:PW_0002176
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001623, ns1:PW_0002175 ;
  ns2:treeView ns1:PW_0001623, ns1:PW_0002175 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of pamidronate, a nitrogenous bisphosphonate drug. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-05T14:28:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002176"^^xsd:string ;
  rdfs:label "pamidronate pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002176"^^xsd:string .

ns1:PW_0002177
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001624, ns1:PW_0002175 ;
  ns2:treeView ns1:PW_0001624, ns1:PW_0002175 ;
  ns1:IAO_0000115 "The pathway of pamidronate-target interaction and of the biochemical or physiological responses to drug. Pamidronate is a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-05T14:28:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00117"^^xsd:string ;
  obo:id "PW:0002177"^^xsd:string ;
  rdfs:label "pamidronate pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002177"^^xsd:string .

ns1:PW_0002178
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001701 ;
  ns2:treeView ns1:PW_0001701 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-05T15:04:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002178"^^xsd:string ;
  rdfs:label "skin disease pathway"^^xsd:string ;
  skos:notation "PW:0002178"^^xsd:string .

ns1:PW_0002179
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001701 ;
  ns2:treeView ns1:PW_0001701 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-05T15:04:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002179"^^xsd:string ;
  rdfs:label "connective tissue disease pathway"^^xsd:string ;
  skos:notation "PW:0002179"^^xsd:string .

ns1:PW_0002180
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002178 ;
  ns2:treeView ns1:PW_0002178 ;
  ns1:IAO_0000115 "Those skin diseases that contain a genetic component, usually resulting from inborn error of metabolism."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-05T15:05:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002180"^^xsd:string ;
  rdfs:label "genetic skin disease pathway"^^xsd:string ;
  skos:notation "PW:0002180"^^xsd:string .

ns1:PW_0002181
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645, ns1:PW_0002180 ;
  ns2:treeView ns1:PW_0001645, ns1:PW_0002180 ;
  ns1:IAO_0000115 "A rare autosomal recessive disorder resulting from alterations in collagen metabolism and due to defects in the prolidase PEPD gene. The condition is manifested in skin ulcers and mental retardation."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-05T15:09:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00207"^^xsd:string ;
  obo:id "PW:0002181"^^xsd:string ;
  rdfs:label "prolidase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002181"^^xsd:string .

ns1:PW_0002182
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000918 ;
  ns2:treeView ns1:PW_0000918 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of esomeprazole, a proton pump inhibitor. It is administered for the treatment of acid-related disorders. The drug inhibits the hydrogen potassium ATPase in the parietal cells of the stomach. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-05T15:16:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002182"^^xsd:string ;
  rdfs:label "esomeprazole drug pathway"^^xsd:string ;
  skos:notation "PW:0002182"^^xsd:string .

ns1:PW_0002183
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002182 ;
  ns2:treeView ns1:PW_0002182 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of esomeprazole, a compound in the class of proton pump inhibitors used in the treatment of acid-related disorders. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-05T15:17:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00612"^^xsd:string ;
  obo:id "PW:0002183"^^xsd:string ;
  rdfs:label "esomeprazole pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002183"^^xsd:string .

ns1:PW_0002184
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002182 ;
  ns2:treeView ns1:PW_0002182 ;
  ns1:IAO_0000115 "The pathway of esomeprazole-target interaction and of the biochemical or physiological responses to drug. Esomeprazole is a compound in the class of proton pump inhibitors used in the treatment of acid-related disorders. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-05T15:18:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00225"^^xsd:string ;
  obo:id "PW:0002184"^^xsd:string ;
  rdfs:label "esomeprazole pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002184"^^xsd:string .

ns1:PW_0002185
  a owl:Class ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of lysine, an essential amino acid."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-06T08:49:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002185"^^xsd:string ;
  rdfs:label "lysine metabolic pathway"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0002185"^^xsd:string .

ns1:PW_0002186
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002121 ;
  ns2:treeView ns1:PW_0002121 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of chlorothiazide, a drug used in the treatment of high blood pressure.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-09T08:33:21Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002186"^^xsd:string ;
  rdfs:label "chlorothiazide drug pathway"^^xsd:string ;
  skos:notation "PW:0002186"^^xsd:string .

ns1:PW_0002187
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002186 ;
  ns2:treeView ns1:PW_0002186 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of chlorothiazide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-09T08:34:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002187"^^xsd:string ;
  rdfs:label "chlorothiazide pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002187"^^xsd:string .

ns1:PW_0002188
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002186 ;
  ns2:treeView ns1:PW_0002186 ;
  ns1:IAO_0000115 "The pathway of chlorothiazide-target interaction and of the biochemical or physiological responses to drug. The drug reduces sodium reabsorption in the distal convoluted tubule of kidney nephron. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-09T08:34:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00078"^^xsd:string ;
  obo:id "PW:0002188"^^xsd:string ;
  rdfs:label "chlorothiazide pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002188"^^xsd:string .

ns1:PW_0002189
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002443 ;
  ns2:treeView ns1:PW_0002443 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of buprenorphine, a semi-synthetic opioid and a mixed partial agonist opioid receptor modulator used to treat opioid addiction and to control moderate to acute pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-09T08:43:27Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002189"^^xsd:string ;
  rdfs:label "buprenorphine drug pathway"^^xsd:string ;
  skos:notation "PW:0002189"^^xsd:string .

ns1:PW_0002190
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002189 ;
  ns2:treeView ns1:PW_0002189 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of buprenorphine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-09T08:44:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002190"^^xsd:string ;
  rdfs:label "buprenorphine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002190"^^xsd:string .

ns1:PW_0002191
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002189 ;
  ns2:treeView ns1:PW_0002189 ;
  ns1:IAO_0000115 "The pathway of buprenorphine-target interaction and of the biochemical or physiological responses to drug. The drug is a non-selective, mixed agonist-antagonist opioid receptor modulator. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-09T08:44:27Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00684"^^xsd:string ;
  obo:id "PW:0002191"^^xsd:string ;
  rdfs:label "buprenorphine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002191"^^xsd:string .

ns1:PW_0002192
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002243 ;
  ns2:treeView ns1:PW_0002243 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of bupivacaine, a drug used as a local anesthetic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-09T09:07:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002192"^^xsd:string ;
  rdfs:label "bupivacaine drug pathway"^^xsd:string ;
  skos:notation "PW:0002192"^^xsd:string .

ns1:PW_0002193
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002192 ;
  ns2:treeView ns1:PW_0002192 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of bupivacaine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-09T09:09:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002193"^^xsd:string ;
  rdfs:label "bupivacaine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002193"^^xsd:string .

ns1:PW_0002194
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002192 ;
  ns2:treeView ns1:PW_0002192 ;
  ns1:IAO_0000115 "The pathway of bupivacaine-target interaction and of the biochemical or physiological responses to drug. It acts mainly as a voltage-gated sodium channel blocker. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-09T09:09:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00393"^^xsd:string ;
  obo:id "PW:0002194"^^xsd:string ;
  rdfs:label "bupivacaine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002194"^^xsd:string .

ns1:PW_0002195
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002121 ;
  ns2:treeView ns1:PW_0002121 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of bendroflumethiazide, a drug used in the treatment of high blood pressure.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-09T09:30:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002195"^^xsd:string ;
  rdfs:label "bendroflumethiazide drug pathway"^^xsd:string ;
  skos:notation "PW:0002195"^^xsd:string .

ns1:PW_0002196
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002195 ;
  ns2:treeView ns1:PW_0002195 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of bendroflumethiazide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-09T09:30:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002196"^^xsd:string ;
  rdfs:label "bendroflumethiazide pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002196"^^xsd:string .

ns1:PW_0002197
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002195 ;
  ns2:treeView ns1:PW_0002195 ;
  ns1:IAO_0000115 "The pathway of bendroflumethiazide-target interaction and of the biochemical or physiological responses to drug. The drug reduces sodium reabsorption in the distal convoluted tubule of kidney nephron. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-09T09:30:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00090"^^xsd:string ;
  obo:id "PW:0002197"^^xsd:string ;
  rdfs:label "bendroflumethiazide pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002197"^^xsd:string .

ns1:PW_0002198
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000996 ;
  ns2:treeView ns1:PW_0000996 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of azithromycin, an antibiotic that inhibits bacterial growth and used for the treatment of several bacterial infections and a number of sexually transmitted infections. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-09T09:40:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002198"^^xsd:string ;
  rdfs:label "azithromycin drug pathway"^^xsd:string ;
  skos:notation "PW:0002198"^^xsd:string .

ns1:PW_0002199
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002198 ;
  ns2:treeView ns1:PW_0002198 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination of azithromycin - an antibiotic that interferes with bacterial growth. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-09T09:40:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002199"^^xsd:string ;
  rdfs:label "azithromycin pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002199"^^xsd:string .

ns1:PW_0002200
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002198 ;
  ns2:treeView ns1:PW_0002198 ;
  ns1:IAO_0000115 "The pathway of azithromycin-target interaction and of the biochemical or physiological responses to drug. The drug interferes with bacterial growth and is used for the treatment of several bacterial infections and a number of sexually transmitted infections. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-09T09:41:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00247"^^xsd:string ;
  obo:id "PW:0002200"^^xsd:string ;
  rdfs:label "azithromycin pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002200"^^xsd:string .

ns1:PW_0002201
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002369 ;
  ns2:treeView ns1:PW_0002369 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of azathioprine, an immunosupressive drug used in organ transplantation and autoimmune diseases. It is a prodrug for mercaptopurine, thus inhibiting DNA synthesis.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-09T09:50:24Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002201"^^xsd:string ;
  rdfs:label "azathioprine drug pathway"^^xsd:string ;
  skos:notation "PW:0002201"^^xsd:string .

ns1:PW_0002202
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002201 ;
  ns2:treeView ns1:PW_0002201 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of azathioprine, a meracptopurine prodrug. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-09T09:50:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002202"^^xsd:string ;
  rdfs:label "azathioprine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002202"^^xsd:string .

ns1:PW_0002203
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002201 ;
  ns2:treeView ns1:PW_0002201 ;
  ns1:IAO_0000115 "The pathway of azathioprine-target interaction and of the biochemical or physiological responses to drug. It is an immunosupressive drug that inhibits DNA synthesis. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-09T09:51:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00427"^^xsd:string ;
  obo:id "PW:0002203"^^xsd:string ;
  rdfs:label "azathioprine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002203"^^xsd:string .

ns1:PW_0002204
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "An inherited condition resulting from alterations in lysine metabolism. Mutations in the DHTKD1 gene, encoding an enzyme involved in the lysine degradation pathway, have been associated with the condition."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-10T08:53:07Z"^^xsd:string ;
  obo:hasExactSynonym "2-aminoadipic 2-oxoadipic aciduria disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00719"^^xsd:string ;
  obo:id "PW:0002204"^^xsd:string ;
  rdfs:label "2-aminoadipic 2-oxoadipic aciduria pathway"^^xsd:string ;
  skos:notation "PW:0002204"^^xsd:string .

ns1:PW_0002205
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001646 ;
  ns2:treeView ns1:PW_0001646 ;
  ns1:IAO_0000115 "An autosomal recessive neurometabolic disorder with several phenotypes and due to mutations in the L2HGDH gene (the L-type), D2HGDH and IDH2 genes (the D-type). A combined L- and D-type has also been observed and has been attributed to mutations in the SLC25A1 gene."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-10T09:02:17Z"^^xsd:string ;
  obo:hasExactSynonym "2-hydroxyglutaricaciduria disease pathway"^^xsd:string, "2-hydroxyglutaricaciduria pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00136"^^xsd:string ;
  obo:id "PW:0002205"^^xsd:string ;
  rdfs:label "2-hydroxyglutaric aciduria pathway"^^xsd:string ;
  skos:notation "PW:0002205"^^xsd:string .

ns1:PW_0002206
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001646 ;
  ns2:treeView ns1:PW_0001646 ;
  ns1:IAO_0000115 "An autosomal recessive metabolic disorder affecting the brain and peripheral vessels and manifested in infancy. Genetic studies identify defects in the ETHE1 gene, a mitochondrial resident gene product, thus pointing to implications in many aspects of mitochondrial metabolism and homeostasis."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-10T09:38:05Z"^^xsd:string ;
  obo:hasExactSynonym "ethylmalonic encephalopathy disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00181"^^xsd:string ;
  obo:id "PW:0002206"^^xsd:string ;
  rdfs:label "ethylmalonic encephalopathy pathway"^^xsd:string ;
  skos:notation "PW:0002206"^^xsd:string .

ns1:PW_0002207
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001412 ;
  ns2:treeView ns1:PW_0001412 ;
  ns1:IAO_0000115 "Conditions of the parasympathetic and sympathetic divisions of the autonomic nervous system."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-10T09:55:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002207"^^xsd:string ;
  rdfs:label "autonomic nervous system disease pathway"^^xsd:string ;
  skos:notation "PW:0002207"^^xsd:string .

ns1:PW_0002208
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002207 ;
  ns2:treeView ns1:PW_0002207 ;
  ns1:IAO_0000115 "A condition resulting from alterations in the pathways of norepinephrine and epinephrine biosynthesis due to defects in the dopamine beta-hydroxylase gene (DBH). DBH catalyzes the conversion of dopamine to norepinephrine, in turn the precursor to epinephrine."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-10T09:57:28Z"^^xsd:string ;
  obo:hasExactSynonym "dopamine beta hydroxylase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00498"^^xsd:string ;
  obo:id "PW:0002208"^^xsd:string ;
  rdfs:label "dopamine beta-hydroxylase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002208"^^xsd:string .

ns1:PW_0002209
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "An autosomal recessive disorder resulting in alterations in glycine, choline and folate metabolism and due to mutations in DMGDH gene."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-10T10:08:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00242"^^xsd:string, "SMP:00484"^^xsd:string ;
  obo:id "PW:0002209"^^xsd:string ;
  rdfs:label "dimethylglycine dehydrogenase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002209"^^xsd:string .

ns1:PW_0002210
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001776 ;
  ns2:treeView ns1:PW_0001776 ;
  ns1:IAO_0000115 "An autosomal recessive disorder resulting from alterations in pyrimidine degradation pathway due to mutations in dihydropyrimidine gene (DPYD). DPYD catalyzes the initial and rate-limiting step in pyrimidine bases (uracil and thymine) catabolism."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-10T10:22:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00179"^^xsd:string ;
  obo:id "PW:0002210"^^xsd:string ;
  rdfs:label "dihydropyrimidine dehydrogenase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002210"^^xsd:string .

ns1:PW_0002211
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001776 ;
  ns2:treeView ns1:PW_0001776 ;
  ns1:IAO_0000115 "An autosomal recessive disorder resulting from alterations in pyrimidine degradation pathway due to mutations in dihydropyrimidinase gene (DPYS). DPYS catalyzes the second step in pyrimidine bases (uracil and thymine) catabolism."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-10T10:29:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00178"^^xsd:string ;
  obo:id "PW:0002211"^^xsd:string ;
  rdfs:label "dihydropyrimidinase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002211"^^xsd:string .

ns1:PW_0002212
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001644 ;
  ns2:treeView ns1:PW_0001644 ;
  ns1:IAO_0000115 "A very rare autosomal recessive condition resulting from alterations in glycerolipid metabolism due to defects in the glycerate kinase (GLYCTK) gene."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-10T10:41:14Z"^^xsd:string ;
  obo:hasExactSynonym "D-glycericacidemia disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "D-glyceric aciduria disease pathway"^^xsd:string, "SMP:00529"^^xsd:string ;
  obo:id "PW:0002212"^^xsd:string ;
  rdfs:label "D-glycericacidemia pathway"^^xsd:string ;
  skos:notation "PW:0002212"^^xsd:string .

ns1:PW_0002213
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000300, ns1:PW_0001589 ;
  ns2:treeView ns1:PW_0000300, ns1:PW_0001589 ;
  ns1:IAO_0000115 "Conditions resulting from genetic defects in the selective or non-selective transport pathways of kidney tubules."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-11T15:21:59Z"^^xsd:string ;
  obo:hasExactSynonym "inborn error of renal tubular transport disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002213"^^xsd:string ;
  rdfs:label "inborn error of renal tubular transport pathway"^^xsd:string ;
  skos:notation "PW:0002213"^^xsd:string .

ns1:PW_0002214
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002213 ;
  ns2:treeView ns1:PW_0002213 ;
  ns1:IAO_0000115 "An autosomal condition resulting from impaired epithelial transport of cystine and dibasic amino acids in the proximal renal tubule. It is further classified based on differences in the genetic basis of the disorder."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-11T15:22:06Z"^^xsd:string ;
  obo:hasExactSynonym "cystinuria disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00723"^^xsd:string ;
  obo:id "PW:0002214"^^xsd:string ;
  rdfs:label "cystinuria pathway"^^xsd:string ;
  skos:notation "PW:0002214"^^xsd:string .

ns1:PW_0002215
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001611 ;
  ns2:treeView ns1:PW_0001611 ;
  ns1:IAO_0000115 "An autosomal recessive condition resulting from alterations in creatine metabolism due to mutations in the GAMT gene."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-11T15:42:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "GAMT deficiency pathway"^^xsd:string, "SMP:00188"^^xsd:string, "SMP:00504"^^xsd:string, "creatine deficiency syndrome pathway due to GMAT deficiency"^^xsd:string ;
  obo:id "PW:0002215"^^xsd:string ;
  rdfs:label "guanidinoacetate methyltransferase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002215"^^xsd:string .

ns1:PW_0002216
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001784 ;
  ns2:treeView ns1:PW_0001784 ;
  ns1:IAO_0000115 "An autosomal recessive condition due to defects in the uroporphyrinogen III synthase gene."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-11T15:48:23Z"^^xsd:string ;
  obo:hasExactSynonym "erythropoietic porphyria disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Gunther disease pathway"^^xsd:string, "SMP:00345"^^xsd:string ;
  obo:id "PW:0002216"^^xsd:string ;
  rdfs:label "erythropoietic porphyria pathway"^^xsd:string ;
  skos:notation "PW:0002216"^^xsd:string .

ns1:PW_0002217
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001630 ;
  ns2:treeView ns1:PW_0001630 ;
  ns1:IAO_0000115 "A condition resulting from alterations in the transport of cystine across the lysosomal membrane due to defects in the lysosomal cystine transporter, cystinosin (CTNS)."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-12T08:12:25Z"^^xsd:string ;
  obo:hasExactSynonym "cystinosis disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002217"^^xsd:string ;
  rdfs:label "cystinosis pathway"^^xsd:string ;
  skos:notation "PW:0002217"^^xsd:string .

ns1:PW_0002218
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002217 ;
  ns2:treeView ns1:PW_0002217 ;
  ns1:IAO_0000115 "A variant of the classic nephropathic cystinosis type."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-12T08:18:06Z"^^xsd:string ;
  obo:hasExactSynonym "ocular non-nephropathic cystinosis pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00722"^^xsd:string ;
  obo:id "PW:0002218"^^xsd:string ;
  rdfs:label "ocular nonnephropathic cystinosis pathway"^^xsd:string ;
  skos:notation "PW:0002218"^^xsd:string .

ns1:PW_0002219
  a owl:Class ;
  ns1:IAO_0000115 "Conditions resulting from alterations in the urea cycle pathway."^^xsd:string ;
  ns1:IAO_0000231 ns1:IAO_0000227 ;
  ns1:IAO_0100001 ns1:PW_0002142 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-12T09:15:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002219"^^xsd:string ;
  rdfs:label "urea cycle disease pathway"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0002219"^^xsd:string .

ns1:PW_0002220
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001669, ns1:PW_0002142 ;
  ns2:treeView ns1:PW_0001669, ns1:PW_0002142 ;
  ns1:IAO_0000115 "An autosomal recessive disorder resulting from alterations in the urea cycle pathway and due to defects in the hepatic mitochondrial enzyme carbamoyl phosphate synthetase 1."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-12T09:18:07Z"^^xsd:string ;
  obo:hasAlternativeId "PW:0002144"^^xsd:string ;
  obo:hasExactSynonym "carbamoyl phosphate synthase I deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00002"^^xsd:string, "carbamoyl synthetase deficiency pathway"^^xsd:string ;
  obo:id "PW:0002220"^^xsd:string ;
  rdfs:label "carbamoyl phosphate synthetase I deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002220"^^xsd:string .

ns1:PW_0002221
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001652 ;
  ns2:treeView ns1:PW_0001652 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of aprotinin, an antifibrinolytic inhibitor of trypsin and other serine proteases, used to reduce bleeding during surgery. Once withdrawn from the market, it has been reintroduced. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-12T09:49:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002221"^^xsd:string ;
  rdfs:label "aprotinin drug pathway"^^xsd:string ;
  skos:notation "PW:0002221"^^xsd:string .

ns1:PW_0002222
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002221 ;
  ns2:treeView ns1:PW_0002221 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of aprotinin. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-12T09:49:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002222"^^xsd:string ;
  rdfs:label "aprotinin pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002222"^^xsd:string .

ns1:PW_0002223
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002221 ;
  ns2:treeView ns1:PW_0002221 ;
  ns1:IAO_0000115 "The pathway of aprotinin-target interaction and of the biochemical or physiological responses to drug. Aprotinin is a serine protease inhibitor of trypsin, chymotrypsin and others. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-12T09:49:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00288"^^xsd:string ;
  obo:id "PW:0002223"^^xsd:string ;
  rdfs:label "aprotinin pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002223"^^xsd:string .

ns1:PW_0002224
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000996 ;
  ns2:treeView ns1:PW_0000996 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of arbekacin, an antibiotic used for the treatment of infections caused by multi-resistant bacteria. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-12T10:06:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002224"^^xsd:string ;
  rdfs:label "arbekacin drug pathway"^^xsd:string ;
  skos:notation "PW:0002224"^^xsd:string .

ns1:PW_0002225
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002224 ;
  ns2:treeView ns1:PW_0002224 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of arbekacin. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-12T10:07:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002225"^^xsd:string ;
  rdfs:label "arbekacin pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002225"^^xsd:string .

ns1:PW_0002226
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002224 ;
  ns2:treeView ns1:PW_0002224 ;
  ns1:IAO_0000115 "The pathway of arbekacin-target interaction and of the biochemical or physiological responses to drug. Arbekacin inhibits protein synthesis by irreversibly binding to bacterial 30S ribosomal subunit. The drug is used for the treatment of infections caused by multi-resistant bacteria. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-12T10:08:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00713"^^xsd:string ;
  obo:id "PW:0002226"^^xsd:string ;
  rdfs:label "arbekacin pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002226"^^xsd:string .

ns1:PW_0002227
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002146 ;
  ns2:treeView ns1:PW_0002146 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of argatroban, a direct thrombin inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-12T10:29:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002227"^^xsd:string ;
  rdfs:label "argatrobran drug pathway"^^xsd:string ;
  skos:notation "PW:0002227"^^xsd:string .

ns1:PW_0002228
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002227 ;
  ns2:treeView ns1:PW_0002227 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of argatroban, a direct thrombin inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-12T10:30:50Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002228"^^xsd:string ;
  rdfs:label "argatrobran pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002228"^^xsd:string .

ns1:PW_0002229
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002227 ;
  ns2:treeView ns1:PW_0002227 ;
  ns1:IAO_0000115 "The pathway of argatroban-target interaction and of the biochemical or physiological responses to drug. The drug is a direct thrombin inhibitor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-12T10:31:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00276"^^xsd:string ;
  obo:id "PW:0002229"^^xsd:string ;
  rdfs:label "argatroban pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002229"^^xsd:string .

ns1:PW_0002230
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001737 ;
  ns2:treeView ns1:PW_0001737 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of atenotolol, a selective beta adrenergic type 1 receptor antagonist used in the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-12T10:40:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002230"^^xsd:string ;
  rdfs:label "atenolol drug pathway"^^xsd:string ;
  skos:notation "PW:0002230"^^xsd:string .

ns1:PW_0002231
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002230 ;
  ns2:treeView ns1:PW_0002230 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of atenolol. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-12T10:41:27Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002231"^^xsd:string ;
  rdfs:label "atenolol pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002231"^^xsd:string .

ns1:PW_0002232
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002230 ;
  ns2:treeView ns1:PW_0002230 ;
  ns1:IAO_0000115 "The pathway of atenolol-target interaction and of the biochemical or physiological responses to drug. The drug is a selective antagonist of beta adrenergic type 1 receptor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-12T10:41:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00298"^^xsd:string ;
  obo:id "PW:0002232"^^xsd:string ;
  rdfs:label "atenolol pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002232"^^xsd:string .

ns1:PW_0002233
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001697 ;
  ns2:treeView ns1:PW_0001697 ;
  ns1:IAO_0000115 "The various conditions affecting any segment of the gastrointestinal tract resulting from alterations in one or several pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-17T08:19:56Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002233"^^xsd:string ;
  rdfs:label "gastrointestinal disease pathway"^^xsd:string ;
  skos:notation "PW:0002233"^^xsd:string .

ns1:PW_0002234
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001584 ;
  ns2:treeView ns1:PW_0001584 ;
  ns1:IAO_0000115 "A condition resulting from inadequate levels of folic acid in the diet and manifested as various forms of anemia. In certain tissues, the condition is indistinguishable from vitamin B deficiency."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-17T08:23:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002234"^^xsd:string ;
  rdfs:label "folic acid deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002234"^^xsd:string .

ns1:PW_0002235
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001472, ns1:PW_0002366 ;
  ns2:treeView ns1:PW_0001472, ns1:PW_0002366 ;
  ns1:IAO_0000115 "The group of syndromes resulting from failure of normal intestinal absorption of nutrients."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-17T08:26:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002235"^^xsd:string ;
  rdfs:label "malabsorption syndrome pathway"^^xsd:string ;
  skos:notation "PW:0002235"^^xsd:string .

ns1:PW_0002236
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002234, ns1:PW_0002235 ;
  ns2:treeView ns1:PW_0002234, ns1:PW_0002235 ;
  ns1:IAO_0000115 "An autosomal recessive condition likely due to alterations in folate transport and exhibiting the symptoms of folate deficiency."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-17T08:30:57Z"^^xsd:string ;
  obo:hasExactSynonym "hereditary folate malabsorption disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00724"^^xsd:string ;
  obo:id "PW:0002236"^^xsd:string ;
  rdfs:label "hereditary folate malabsorption pathway"^^xsd:string ;
  skos:notation "PW:0002236"^^xsd:string .

ns1:PW_0002237
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001738 ;
  ns2:treeView ns1:PW_0001738 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of penbutolol - a non-selective adrenergic beta receptor blocker, used in the treatment of high blood pressure. Penbutolol is a sympathomimetic drug. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-17T09:12:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002237"^^xsd:string ;
  rdfs:label "penbutolol drug pathway"^^xsd:string ;
  skos:notation "PW:0002237"^^xsd:string .

ns1:PW_0002238
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002237 ;
  ns2:treeView ns1:PW_0002237 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of penbutolol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-17T09:13:41Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002238"^^xsd:string ;
  rdfs:label "penbutolol pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002238"^^xsd:string .

ns1:PW_0002239
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002237 ;
  ns2:treeView ns1:PW_0002237 ;
  ns1:IAO_0000115 "The pathway of penbutolol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-17T09:14:09Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00305"^^xsd:string ;
  obo:id "PW:0002239"^^xsd:string ;
  rdfs:label "penbutolol pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002239"^^xsd:string .

ns1:PW_0002240
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001738 ;
  ns2:treeView ns1:PW_0001738 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of oxeprenolol - a non-selective adrenergic beta receptor blocker, used for the treatment of angina, high blood pressure and abnormal heart rhythms. The drug has some intrinsic sympathomimetic properties. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-17T09:17:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002240"^^xsd:string ;
  rdfs:label "oxeprenolol drug pathway"^^xsd:string ;
  skos:notation "PW:0002240"^^xsd:string .

ns1:PW_0002241
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002240 ;
  ns2:treeView ns1:PW_0002240 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of oxeprenolol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-17T09:22:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002241"^^xsd:string ;
  rdfs:label "oxeprenolol pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002241"^^xsd:string .

ns1:PW_0002242
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002240 ;
  ns2:treeView ns1:PW_0002240 ;
  ns1:IAO_0000115 "The pathway of oxeprenolol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-17T09:22:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00304"^^xsd:string ;
  obo:id "PW:0002242"^^xsd:string ;
  rdfs:label "oxeprenolol pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002242"^^xsd:string .

ns1:PW_0002243
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000923 ;
  ns2:treeView ns1:PW_0000923 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of compounds used to cause reversible loss of sensation and generally administered to facilitate surgery."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-18T15:14:45Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002243"^^xsd:string ;
  rdfs:label "anesthetic drug pathway"^^xsd:string ;
  skos:notation "PW:0002243"^^xsd:string .

ns1:PW_0002244
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002243 ;
  ns2:treeView ns1:PW_0002243 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of prilocaine, a drug used as a local anesthetic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-18T15:30:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002244"^^xsd:string ;
  rdfs:label "prilocaine drug pathway"^^xsd:string ;
  skos:notation "PW:0002244"^^xsd:string .

ns1:PW_0002245
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002244 ;
  ns2:treeView ns1:PW_0002244 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of prilocaine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-18T15:30:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002245"^^xsd:string ;
  rdfs:label "prilocaine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002245"^^xsd:string .

ns1:PW_0002246
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002244 ;
  ns2:treeView ns1:PW_0002244 ;
  ns1:IAO_0000115 "The pathway of prilocaine-target interaction and of the biochemical or physiological responses to drug. The drug exerts its effects by blocking the voltage-gated sodium channels. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-18T15:31:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00401"^^xsd:string ;
  obo:id "PW:0002246"^^xsd:string ;
  rdfs:label "prilocaine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002246"^^xsd:string .

ns1:PW_0002247
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002243 ;
  ns2:treeView ns1:PW_0002243 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of ropivacaine, a drug used as a local anesthetic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-18T15:37:03Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002247"^^xsd:string ;
  rdfs:label "ropivacaine drug pathway"^^xsd:string ;
  skos:notation "PW:0002247"^^xsd:string .

ns1:PW_0002248
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002247 ;
  ns2:treeView ns1:PW_0002247 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of ropivacaine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-18T15:37:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002248"^^xsd:string ;
  rdfs:label "ropivacaine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002248"^^xsd:string .

ns1:PW_0002249
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002247 ;
  ns2:treeView ns1:PW_0002247 ;
  ns1:IAO_0000115 "The pathway of ropivacaine-target interaction and of the biochemical or physiological responses to drug. The drug exerts its effects by blocking the voltage-gated sodium channels. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-18T15:38:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00404"^^xsd:string ;
  obo:id "PW:0002249"^^xsd:string ;
  rdfs:label "ropivacaine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002249"^^xsd:string .

ns1:PW_0002250
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002121 ;
  ns2:treeView ns1:PW_0002121 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of torasemide, a diuretic drug mainly used in the management of edema associated with congestive heart failure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-20T09:50:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "torsemide drug pathway"^^xsd:string ;
  obo:id "PW:0002250"^^xsd:string ;
  rdfs:label "torasemide drug pathway"^^xsd:string ;
  skos:notation "PW:0002250"^^xsd:string .

ns1:PW_0002251
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002250 ;
  ns2:treeView ns1:PW_0002250 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of torasemide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-20T09:52:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "torsemide pharmacokinetics pathway"^^xsd:string ;
  obo:id "PW:0002251"^^xsd:string ;
  rdfs:label "torasemide pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002251"^^xsd:string .

ns1:PW_0002252
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002250 ;
  ns2:treeView ns1:PW_0002250 ;
  ns1:IAO_0000115 "The pathway of torasemide-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-20T09:52:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00118"^^xsd:string, "torsemide pharmacodynamics pathway"^^xsd:string ;
  obo:id "PW:0002252"^^xsd:string ;
  rdfs:label "torasemide pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002252"^^xsd:string .

ns1:PW_0002253
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001644, ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001644, ns1:PW_0001645 ;
  ns1:IAO_0000115 "Autosomal recessive conditions resulting from alterations in biotin metabolism."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-20T10:05:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002253"^^xsd:string ;
  rdfs:label "multiple carboxylase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002253"^^xsd:string .

ns1:PW_0002254
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002253 ;
  ns2:treeView ns1:PW_0002253 ;
  ns1:IAO_0000115 "A late onset form of multiple carboxylase deficiency due to defects in the biotin recycling biotinidase enzyme."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-20T10:16:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00174"^^xsd:string ;
  obo:id "PW:0002254"^^xsd:string ;
  rdfs:label "biotinidase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002254"^^xsd:string .

ns1:PW_0002255
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002253 ;
  ns2:treeView ns1:PW_0002253 ;
  ns1:IAO_0000115 "The neonatal form of multiple carboxylase deficiency due to defects in holocarboxylase synthetase, the enzyme catalyzing the covalent attachment of biotin to biotin-dependent carboxylases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-20T10:23:25Z"^^xsd:string ;
  obo:hasExactSynonym "Biotin-(propionyl-CoA-carboxylase) ligase deficiency pathway"^^xsd:string, "multiple carboxylase deficiency (neonatal onset) pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00564"^^xsd:string ;
  obo:id "PW:0002255"^^xsd:string ;
  rdfs:label "holocarboxylase synthetase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002255"^^xsd:string .

ns1:PW_0002256
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002152 ;
  ns2:treeView ns1:PW_0002152 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of reteplase - one of several recombinant tissue plasminogen activators. Plasminogen is a key player in the fibrinolytic cascade pathway of blood clots breakdown. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-20T10:47:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002256"^^xsd:string ;
  rdfs:label "reteplase drug pathway"^^xsd:string ;
  skos:notation "PW:0002256"^^xsd:string .

ns1:PW_0002257
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002256 ;
  ns2:treeView ns1:PW_0002256 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of reteplase, one of several recombinant tissue plasminogen activators. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-20T10:47:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002257"^^xsd:string ;
  rdfs:label "reteplase pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002257"^^xsd:string .

ns1:PW_0002258
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002256 ;
  ns2:treeView ns1:PW_0002256 ;
  ns1:IAO_0000115 "The pathway of reteplase-target interaction and of the biochemical or physiological responses to drug. Reteplase is one of several recombinant tissue plasminogen activators. Reteplase is used to treat heart attack. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-20T10:47:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00285"^^xsd:string ;
  obo:id "PW:0002258"^^xsd:string ;
  rdfs:label "reteplase pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002258"^^xsd:string .

ns1:PW_0002259
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001738 ;
  ns2:treeView ns1:PW_0001738 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of nadolol - a non-selective adrenergic beta receptor blocker, used in the treatment of high blood pressure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-20T10:56:45Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002259"^^xsd:string ;
  rdfs:label "nadolol drug pathway"^^xsd:string ;
  skos:notation "PW:0002259"^^xsd:string .

ns1:PW_0002260
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002259 ;
  ns2:treeView ns1:PW_0002259 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of nadolol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-20T10:57:38Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002260"^^xsd:string ;
  rdfs:label "nadolol pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002260"^^xsd:string .

ns1:PW_0002261
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002259 ;
  ns2:treeView ns1:PW_0002259 ;
  ns1:IAO_0000115 "The pathway of nadolol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-20T10:58:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00303"^^xsd:string ;
  obo:id "PW:0002261"^^xsd:string ;
  rdfs:label "nadolol pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002261"^^xsd:string .

ns1:PW_0002262
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001738 ;
  ns2:treeView ns1:PW_0001738 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of pindolol - a non-selective adrenergic beta receptor blocker, used in the treatment of high blood pressure. Pindolol is a sympathomimetic drug. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-20T11:03:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002262"^^xsd:string ;
  rdfs:label "pindolol drug pathway"^^xsd:string ;
  skos:notation "PW:0002262"^^xsd:string .

ns1:PW_0002263
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002262 ;
  ns2:treeView ns1:PW_0002262 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of pindolol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-20T11:08:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002263"^^xsd:string ;
  rdfs:label "pindolol pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002263"^^xsd:string .

ns1:PW_0002264
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002262 ;
  ns2:treeView ns1:PW_0002262 ;
  ns1:IAO_0000115 "The pathway of pindolol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-20T11:08:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00306"^^xsd:string ;
  obo:id "PW:0002264"^^xsd:string ;
  rdfs:label "pindolol pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002264"^^xsd:string .

ns1:PW_0002265
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of teniposide, a drug used to treat childhood leukemia. The drug inhibits DNA synthesis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-20T11:41:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002265"^^xsd:string ;
  rdfs:label "teniposide drug pathway"^^xsd:string ;
  skos:notation "PW:0002265"^^xsd:string .

ns1:PW_0002266
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002265 ;
  ns2:treeView ns1:PW_0002265 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of teniposide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-20T11:46:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00602"^^xsd:string ;
  obo:id "PW:0002266"^^xsd:string ;
  rdfs:label "teniposide pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002266"^^xsd:string .

ns1:PW_0002267
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002265 ;
  ns2:treeView ns1:PW_0002265 ;
  ns1:IAO_0000115 "The pathway of teniposide-target interactions and of the biochemical or physiological responses to drug. The drug is used in the treatment of certain cancers and its mode of action is believed to be inhibition of DNA synthesis. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-20T11:47:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00443"^^xsd:string ;
  obo:id "PW:0002267"^^xsd:string ;
  rdfs:label "teniposide pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002267"^^xsd:string .

ns1:PW_0002268
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001621 ;
  ns2:treeView ns1:PW_0001621 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of zoledronate - a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T08:18:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002268"^^xsd:string ;
  rdfs:label "zoledronate drug pathway"^^xsd:string ;
  skos:notation "PW:0002268"^^xsd:string .

ns1:PW_0002269
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002268 ;
  ns2:treeView ns1:PW_0002268 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of zoledronate, a nitrogenous bisphosphonate drug. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T08:20:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002269"^^xsd:string ;
  rdfs:label "zoledronate pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002269"^^xsd:string .

ns1:PW_0002270
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002268 ;
  ns2:treeView ns1:PW_0002268 ;
  ns1:IAO_0000115 "The pathway of zoledronate-target interaction and of the biochemical or physiological responses to drug. Zoledronate is a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T08:21:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00107"^^xsd:string ;
  obo:id "PW:0002270"^^xsd:string ;
  rdfs:label "zoledronate pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002270"^^xsd:string .

ns1:PW_0002271
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002121 ;
  ns2:treeView ns1:PW_0002121 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of eplrenone, a drug used as an adjunct in the management of chronic heart failure. enetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T08:31:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002271"^^xsd:string ;
  rdfs:label "eplerenone drug pathway"^^xsd:string ;
  skos:notation "PW:0002271"^^xsd:string .

ns1:PW_0002272
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002271 ;
  ns2:treeView ns1:PW_0002271 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of eplerenone. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T08:31:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002272"^^xsd:string ;
  rdfs:label "eplerenone pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002272"^^xsd:string .

ns1:PW_0002273
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002271 ;
  ns2:treeView ns1:PW_0002271 ;
  ns1:IAO_0000115 "The pathway of eplerenone-target interaction and of the biochemical or physiological responses to drug. Eplerenone is an antagonist of the mineralocorticoid receptor and indicated for the reduction of cardiovascular death risk in people with heart failure.  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T08:31:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00135"^^xsd:string ;
  obo:id "PW:0002273"^^xsd:string ;
  rdfs:label "eplerenone pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002273"^^xsd:string .

ns1:PW_0002274
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001589 ;
  ns2:treeView ns1:PW_0001589 ;
  ns1:IAO_0000115 "A rare autosomal recessive condition resulting from alterations in leucine metabolism."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T08:42:36Z"^^xsd:string ;
  obo:hasExactSynonym "3-methylglutaconyl-CoA hydratase deficiency pathway"^^xsd:string, "3MG-CoA hydratase deficiency pathway"^^xsd:string, "MGA type I pathway"^^xsd:string, "MGA1 pathway"^^xsd:string, "type I 3-Methylglutaconic aciduria disease pathway"^^xsd:string, "type I 3-Methylglutaconic aciduria pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00139"^^xsd:string ;
  obo:id "PW:0002274"^^xsd:string ;
  rdfs:label "3-methylglutaconic aciduria type 1 pathway"^^xsd:string ;
  skos:notation "PW:0002274"^^xsd:string .

ns1:PW_0002275
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000178, ns1:PW_0001589, ns1:PW_0001611 ;
  ns2:treeView ns1:PW_0000178, ns1:PW_0001589, ns1:PW_0001611 ;
  ns1:IAO_0000115 "A syndrome consisting of early-onset bilateral optic atrophy associated with later-onset spasticity and cognitive deficit."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T08:46:19Z"^^xsd:string ;
  obo:hasExactSynonym "3-methylglutaconic aciduria type III pathway"^^xsd:string, "Costeff optic atrophy syndrome pathway"^^xsd:string, "Costeff syndrome pathway"^^xsd:string, "Iraqi-Jewish optic atrophy plus pathway"^^xsd:string, "MGA3 pathway"^^xsd:string, "autosomal recessive optic atrophy plus syndrome pathway"^^xsd:string, "autosomal recessive optic atrophy type 3 pathway"^^xsd:string, "infantile optic atrophy with chorea and spastic paraplegia pathway"^^xsd:string, "type III 3-Methylglutaconic aciduria disease pathway"^^xsd:string, "type III 3-Methylglutaconic aciduria pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Costeff syndrome disease pathway"^^xsd:string, "SMP:00140"^^xsd:string ;
  obo:id "PW:0002275"^^xsd:string ;
  rdfs:label "3-methylglutaconic aciduria type 3 pathway"^^xsd:string ;
  skos:notation "PW:0002275"^^xsd:string .

ns1:PW_0002276
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001776 ;
  ns2:treeView ns1:PW_0001776 ;
  ns1:IAO_0000115 "An autosomal recessive condition resulting from alteration in the de novo purine biosynthetic pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T08:58:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00167"^^xsd:string ;
  obo:id "PW:0002276"^^xsd:string ;
  rdfs:label "adenylosuccinate lyase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002276"^^xsd:string .

ns1:PW_0002277
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "An autosomal recessive condition resulting from alterations in the metabolism of phenylalanine and tyrosine."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T09:03:16Z"^^xsd:string ;
  obo:hasExactSynonym "alkaptonuria disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00169"^^xsd:string ;
  obo:id "PW:0002277"^^xsd:string ;
  rdfs:label "alkaptonuria pathway"^^xsd:string ;
  skos:notation "PW:0002277"^^xsd:string .

ns1:PW_0002278
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001170 ;
  ns2:treeView ns1:PW_0001170 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of fenoprofen, a non-steroidal anti-inflammatory drug used  in the treatment of rheumatoid arthritis and mild pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T10:30:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002278"^^xsd:string ;
  rdfs:label "fenoprofen drug pathway"^^xsd:string ;
  skos:notation "PW:0002278"^^xsd:string .

ns1:PW_0002279
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002278 ;
  ns2:treeView ns1:PW_0002278 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of fenoprofen. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T10:44:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002279"^^xsd:string ;
  rdfs:label "fenoprofen pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002279"^^xsd:string .

ns1:PW_0002280
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002278 ;
  ns2:treeView ns1:PW_0002278 ;
  ns1:IAO_0000115 "The pathway of fenoprofen-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of rheumatoid arthritis and mild pain.  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T10:44:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00696"^^xsd:string ;
  obo:id "PW:0002280"^^xsd:string ;
  rdfs:label "fenoprofen pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002280"^^xsd:string .

ns1:PW_0002281
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000754 ;
  ns2:treeView ns1:PW_0000754 ;
  ns1:IAO_0000115 "One of the subgroups of the Therapeutic Chemical  Classification System developed by WHO for grouping drugs acting as antidotes, chelators, detoxifying agents, and others. The pharmacokinetics and pharmacodynamics of such agents. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T10:58:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002281"^^xsd:string ;
  rdfs:label "various drug pathway"^^xsd:string ;
  skos:notation "PW:0002281"^^xsd:string .

ns1:PW_0002282
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002281 ;
  ns2:treeView ns1:PW_0002281 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of naloxone, a medication used to reverse the effects opioids overdose. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T11:03:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002282"^^xsd:string ;
  rdfs:label "naloxone drug pathway"^^xsd:string ;
  skos:notation "PW:0002282"^^xsd:string .

ns1:PW_0002283
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002282 ;
  ns2:treeView ns1:PW_0002282 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of naloxone. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T11:04:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002283"^^xsd:string ;
  rdfs:label "naloxone pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002283"^^xsd:string .

ns1:PW_0002284
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002282 ;
  ns2:treeView ns1:PW_0002282 ;
  ns1:IAO_0000115 "The pathway of naloxone-target interaction and of the biochemical or physiological responses to drug. Naloxone is a mu-opioid receptor competitive antagonist. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T11:05:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00688"^^xsd:string ;
  obo:id "PW:0002284"^^xsd:string ;
  rdfs:label "naloxone pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002284"^^xsd:string .

ns1:PW_0002285
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000190 ;
  ns2:treeView ns1:PW_0000190 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of porphyrin. Porphyrins represent a group of heterocyclic macrocycle organic compounds. Many are naturally occurring and one best example is the red blood cell heme pigment."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T11:36:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00024"^^xsd:string ;
  obo:id "PW:0002285"^^xsd:string ;
  rdfs:label "porphyrin metabolic pathway"^^xsd:string ;
  skos:notation "PW:0002285"^^xsd:string .

ns1:PW_0002286
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002150 ;
  ns2:treeView ns1:PW_0002150 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of cilostazol, a platelet aggregation inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T14:28:24Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002286"^^xsd:string ;
  rdfs:label "cilostazol drug pathway"^^xsd:string ;
  skos:notation "PW:0002286"^^xsd:string .

ns1:PW_0002287
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002286 ;
  ns2:treeView ns1:PW_0002286 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of cilostazol, a platelet aggregation inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T14:29:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002287"^^xsd:string ;
  rdfs:label "cilostazol pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002287"^^xsd:string .

ns1:PW_0002288
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002286 ;
  ns2:treeView ns1:PW_0002286 ;
  ns1:IAO_0000115 "The pathway of cilostazol-interaction and of the biochemical or physiological responses to drug. The drug is a selective inhibitor of phosphodiesterase type 3. The increase in cyclic AMP (cAMP) and subsequent increase in active protein kinase A (PKA) leads to inhibition of platelet aggregation. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T14:30:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00263"^^xsd:string ;
  obo:id "PW:0002288"^^xsd:string ;
  rdfs:label "cilostazol pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002288"^^xsd:string .

ns1:PW_0002289
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001589 ;
  ns2:treeView ns1:PW_0001589 ;
  ns1:IAO_0000115 "A rare inherited metabolic condition due to alterations in the activity of malonyl-CoA decarboxylase."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T15:11:20Z"^^xsd:string ;
  obo:hasAlternativeId "PW:0002550"^^xsd:string ;
  obo:hasExactSynonym "malonic aciduria disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00198"^^xsd:string, "SMP:00502"^^xsd:string, "malonyl-CoA decarboxylase deficiency pathway"^^xsd:string ;
  obo:id "PW:0002289"^^xsd:string ;
  rdfs:label "malonic aciduria pathway"^^xsd:string ;
  skos:notation "PW:0002289"^^xsd:string .

ns1:PW_0002290
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002142 ;
  ns2:treeView ns1:PW_0002142 ;
  ns1:IAO_0000115 "A rare autosomal condition resulting from alterations in the urea cycle pathway and due to defects in the arginase enzyme."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T15:23:30Z"^^xsd:string ;
  obo:hasExactSynonym "deficiency of canavanase pathway"^^xsd:string, "hyperargininemia disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00357"^^xsd:string, "arginase deficiency pathway"^^xsd:string, "argininemia disease pathway"^^xsd:string ;
  obo:id "PW:0002290"^^xsd:string ;
  rdfs:label "hyperargininemia pathway"^^xsd:string ;
  skos:notation "PW:0002290"^^xsd:string .

ns1:PW_0002291
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000132 ;
  ns2:treeView ns1:PW_0000132 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of carnitine. Carnitine is derived from lysine and methionine and is important for fatty acids transport into the mitochondrial matrix."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T15:38:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002291"^^xsd:string ;
  rdfs:label "carnitine metabolic pathway"^^xsd:string ;
  skos:notation "PW:0002291"^^xsd:string .

ns1:PW_0002292
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002291 ;
  ns2:treeView ns1:PW_0002291 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of carnitine. It involves the amino acids lysine and methionine and it largely occurs in the kidney and liver."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T15:40:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00465"^^xsd:string ;
  obo:id "PW:0002292"^^xsd:string ;
  rdfs:label "carnitine biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0002292"^^xsd:string .

ns1:PW_0002293
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002291 ;
  ns2:treeView ns1:PW_0002291 ;
  ns1:IAO_0000115 "Those metabolic reactions resulting in the breakdown of carnitine."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-23T15:42:39Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002293"^^xsd:string ;
  rdfs:label "carnitine degradation pathway"^^xsd:string ;
  skos:notation "PW:0002293"^^xsd:string .

ns1:PW_0002294
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001496, ns1:PW_0001589 ;
  ns2:treeView ns1:PW_0001496, ns1:PW_0001589 ;
  ns1:IAO_0000115 "A condition resulting from alterations in the de novo purine biosynthetic pathway and due to defects in the enzyme catalyzing the final steps."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-24T08:45:20Z"^^xsd:string ;
  obo:hasExactSynonym "AICAR Transformylase Inosine Monophosphate Cyclohydrolase Deficiency Pathway"^^xsd:string, "AICAR Transformylase/IMP Cyclohydrloase Deficiency Pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00168"^^xsd:string ;
  obo:id "PW:0002294"^^xsd:string ;
  rdfs:label "AICA-ribosuria pathway"^^xsd:string ;
  skos:notation "PW:0002294"^^xsd:string .

ns1:PW_0002295
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000923 ;
  ns2:treeView ns1:PW_0000923 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of compounds used in the treatment of epilepsy or seizure. Some can also act as mood stabilizers."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-24T09:53:06Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002295"^^xsd:string ;
  rdfs:label "antiepileptic drug pathway"^^xsd:string ;
  skos:notation "PW:0002295"^^xsd:string .

ns1:PW_0002296
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002295 ;
  ns2:treeView ns1:PW_0002295 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of fosphenytoin, a drug used in the treatment of acute convulsive epileptic seizure. Fosphenytoin is a water-soluble phenytoin prodrug. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-24T09:56:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002296"^^xsd:string ;
  rdfs:label "fosphenytoin drug pathway"^^xsd:string ;
  skos:notation "PW:0002296"^^xsd:string .

ns1:PW_0002297
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002296 ;
  ns2:treeView ns1:PW_0002296 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of fosphenytoin, a prodrug used for the treatment of epilepsy. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-24T09:57:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00618"^^xsd:string ;
  obo:id "PW:0002297"^^xsd:string ;
  rdfs:label "fosphenytoin pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002297"^^xsd:string .

ns1:PW_0002298
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002296 ;
  ns2:treeView ns1:PW_0002296 ;
  ns1:IAO_0000115 "The pathway of fosphenytoin-target interaction and of the biochemical or physiological responses to drug. Fosphenytoin is a water-soluble phenytoin prodrug used for the treatment of epilepsy. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-24T09:57:45Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00326"^^xsd:string ;
  obo:id "PW:0002298"^^xsd:string ;
  rdfs:label "fosphenytoin pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002298"^^xsd:string .

ns1:PW_0002299
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "A condition due to defects in glycine N-methyltransferase (GNMT). As a component of methionine, homocysteine and folate metabolism among others, the defective enzyme potentially disrupts many metabolic pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-24T10:44:24Z"^^xsd:string ;
  obo:hasExactSynonym "hypermethioninemia due to GNMT deficiency pathway"^^xsd:string, "hypermethioninemia due to glycine N-methyltransferase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00222"^^xsd:string ;
  obo:id "PW:0002299"^^xsd:string ;
  rdfs:label "glycine N-methyltransferase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002299"^^xsd:string .

ns1:PW_0002300
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001630, ns1:PW_0001646 ;
  ns2:treeView ns1:PW_0001630, ns1:PW_0001646 ;
  ns1:IAO_0000115 "The lysosomal storage disease pathways affecting the nervous system."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-24T13:55:10Z"^^xsd:string ;
  obo:hasAlternativeId "PW:0002020"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002300"^^xsd:string ;
  rdfs:label "nervous system lysosomal storage disease pathway"^^xsd:string ;
  skos:notation "PW:0002300"^^xsd:string .

ns1:PW_0002301
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001643, ns1:PW_0002300 ;
  ns2:treeView ns1:PW_0001643, ns1:PW_0002300 ;
  ns1:IAO_0000115 "A group of inherited metabolic disorders resulting in abnormal accumulation of sphingolipids in the central nervous system and also visceral organs due to defects in their degradation pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-24T14:00:39Z"^^xsd:string ;
  obo:hasExactSynonym "sphingolipidoses disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002301"^^xsd:string ;
  rdfs:label "sphingolipidosis pathway"^^xsd:string ;
  skos:notation "PW:0002301"^^xsd:string .

ns1:PW_0002302
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002102 ;
  ns2:treeView ns1:PW_0002102 ;
  ns1:IAO_0000115 "A condition characterized by elevated serum bile acid concentration that can be due to defects in any of several genes."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-11-24T14:37:58Z"^^xsd:string ;
  obo:hasExactSynonym "familial hypercholanemia disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "FHCA disease pathway"^^xsd:string, "SMP:00317"^^xsd:string ;
  obo:id "PW:0002302"^^xsd:string ;
  rdfs:label "familial hypercholanemia pathway"^^xsd:string ;
  skos:notation "PW:0002302"^^xsd:string .

ns1:PW_0002303
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001170, ns1:PW_0001546 ;
  ns2:treeView ns1:PW_0001170, ns1:PW_0001546 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of indometacin, a non-steroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes and is used in the treatment of inflammation and pain and to reduce fever. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-02T14:30:20Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002303"^^xsd:string ;
  rdfs:label "indometacin drug pathway"^^xsd:string ;
  skos:notation "PW:0002303"^^xsd:string .

ns1:PW_0002304
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002303 ;
  ns2:treeView ns1:PW_0002303 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of indometacin. The drug is used in the treatment of pain and inflammation and to reduce fever. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-02T14:35:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002304"^^xsd:string ;
  rdfs:label "indometacin pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002304"^^xsd:string .

ns1:PW_0002305
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002303 ;
  ns2:treeView ns1:PW_0002303 ;
  ns1:IAO_0000115 "The pathway of indometacin-target interaction and of the biochemical or physiological responses to drug. Indometcin is an inhibitor of cyclooxygenase enzymes used in the treatment of pain and inflammation and to reduce fever. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-02T14:35:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00104"^^xsd:string ;
  obo:id "PW:0002305"^^xsd:string ;
  rdfs:label "indometacin pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002305"^^xsd:string .

ns1:PW_0002306
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001414, ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001414, ns1:PW_0001645 ;
  ns1:IAO_0000115 "An autosomal recessive condition resulting from alterations in several metabolic pathways due to defects in the GCDH gene."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-02T14:50:47Z"^^xsd:string ;
  obo:hasExactSynonym "glutaric acidemia I pathway"^^xsd:string, "glutaric aciduria I pathway"^^xsd:string, "glutaric aciduria type I disease pathway"^^xsd:string, "glutaryl-CoA dehydrogenase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00185"^^xsd:string, "SMP:00186"^^xsd:string ;
  obo:id "PW:0002306"^^xsd:string ;
  rdfs:label "glutaric aciduria type I pathway"^^xsd:string ;
  skos:notation "PW:0002306"^^xsd:string .

ns1:PW_0002307
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001738, ns1:PW_0002159 ;
  ns2:treeView ns1:PW_0001738, ns1:PW_0002159 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of levobunolol, a non-selective beta adrenergic receptor antagonist used in the treatment of glaucoma. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-03T09:47:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002307"^^xsd:string ;
  rdfs:label "levobunolol drug pathway"^^xsd:string ;
  skos:notation "PW:0002307"^^xsd:string .

ns1:PW_0002308
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002307 ;
  ns2:treeView ns1:PW_0002307 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of levobunolol. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-03T09:49:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002308"^^xsd:string ;
  rdfs:label "levobunolol pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002308"^^xsd:string .

ns1:PW_0002309
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002307 ;
  ns2:treeView ns1:PW_0002307 ;
  ns1:IAO_0000115 "The pathway of levobunolol-target interaction and of the biochemical or physiological responses to drug. The drug is a non-selective antagonist of beta adrenergic used in the treatment of glaucoma. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-03T09:49:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00666"^^xsd:string ;
  obo:id "PW:0002309"^^xsd:string ;
  rdfs:label "levobunolol pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002309"^^xsd:string .

ns1:PW_0002310
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002113 ;
  ns2:treeView ns1:PW_0002113 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of desipramine, an antidepressant used in the treatment of depression, anxiety disorders, insomnia. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-03T10:07:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002310"^^xsd:string ;
  rdfs:label "doxepin drug pathway"^^xsd:string ;
  skos:notation "PW:0002310"^^xsd:string .

ns1:PW_0002311
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002310 ;
  ns2:treeView ns1:PW_0002310 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of doxepin. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-03T10:07:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00641"^^xsd:string ;
  obo:id "PW:0002311"^^xsd:string ;
  rdfs:label "doxepin pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002311"^^xsd:string .

ns1:PW_0002312
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002310 ;
  ns2:treeView ns1:PW_0002310 ;
  ns1:IAO_0000115 "The pathway of doxepin-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of depression, anxiety disorders, insomnia. Its effects result from inhibition of serotonin and norepinephrine neurotransmitter reuptake. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-03T10:08:21Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002312"^^xsd:string ;
  rdfs:label "doxepin pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002312"^^xsd:string .

ns1:PW_0002313
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001170 ;
  ns2:treeView ns1:PW_0001170 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of indometacin, a non-steroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes. It is commonly used to reduce fever, pain and swelling in wide range of conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-04T08:50:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "indomethacin drug pathway"^^xsd:string ;
  obo:id "PW:0002313"^^xsd:string ;
  rdfs:label "indometacin drug pathway"^^xsd:string ;
  skos:notation "PW:0002313"^^xsd:string .

ns1:PW_0002314
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002313 ;
  ns2:treeView ns1:PW_0002313 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of indometacin. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-04T08:50:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "indomethacin pharmacokinetics pathway"^^xsd:string ;
  obo:id "PW:0002314"^^xsd:string ;
  rdfs:label "indometacin pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002314"^^xsd:string .

ns1:PW_0002315
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002313 ;
  ns2:treeView ns1:PW_0002313 ;
  ns1:IAO_0000115 "The pathway of indometacin-target interaction and of the biochemical or physiological responses to drug. Indometacin is an inhibitor of cyclooxygenase enzymes and commonly used to reduce fever, pain and swelling in a wide range of conditions. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-04T08:51:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00104"^^xsd:string, "indomethacin pharmacodynamics pathway"^^xsd:string ;
  obo:id "PW:0002315"^^xsd:string ;
  rdfs:label "indometacin pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002315"^^xsd:string .

ns1:PW_0002316
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000923 ;
  ns2:treeView ns1:PW_0000923 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of psychoactive drugs that can induce an improvement in the  mental or physical activity. While such drugs are used as prescription medicine they can also be abused and some substances in this category are illicit."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-07T08:26:41Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002316"^^xsd:string ;
  rdfs:label "psychostimulant drug pathway"^^xsd:string ;
  skos:notation "PW:0002316"^^xsd:string .

ns1:PW_0002317
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002316 ;
  ns2:treeView ns1:PW_0002316 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of caffeine, a psychostimulant of the methylxanthine class. It can confer some protective effects against some conditions. It is largely considered safe but the pure powdered caffeine, available as dietary supplement, can be lethal in higher amounts. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-07T08:35:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002317"^^xsd:string ;
  rdfs:label "caffeine drug pathway"^^xsd:string ;
  skos:notation "PW:0002317"^^xsd:string .

ns1:PW_0002318
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002317 ;
  ns2:treeView ns1:PW_0002317 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of caffeine, a widely used stimulant of the central nervous system. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-07T08:36:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00028"^^xsd:string ;
  obo:id "PW:0002318"^^xsd:string ;
  rdfs:label "caffeine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002318"^^xsd:string .

ns1:PW_0002319
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002317 ;
  ns2:treeView ns1:PW_0002317 ;
  ns1:IAO_0000115 "The pathway of caffeine-target interaction and of the biochemical or physiological responses to drug. Caffeine is an antagonist of adenosine receptors of all types. As such, it stimulates vasomotor and respiratory centers and also promotes neurotransmitter release. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-07T08:36:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002319"^^xsd:string ;
  rdfs:label "caffeine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002319"^^xsd:string .

ns1:PW_0002320
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002121 ;
  ns2:treeView ns1:PW_0002121 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of trichlormethiazide, a drug used in the treatment of high blood pressure.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-07T08:58:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002320"^^xsd:string ;
  rdfs:label "trichlormethiazide drug pathway"^^xsd:string ;
  skos:notation "PW:0002320"^^xsd:string .

ns1:PW_0002321
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002320 ;
  ns2:treeView ns1:PW_0002320 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of trichlormethiazide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-07T08:58:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002321"^^xsd:string ;
  rdfs:label "trichlormethiazide pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002321"^^xsd:string .

ns1:PW_0002322
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002320 ;
  ns2:treeView ns1:PW_0002320 ;
  ns1:IAO_0000115 "The pathway of trichlormethiazide-target interaction and of the biochemical or physiological responses to drug. The drug is thought to block reabsorption of chloride and possibly sodium in the ascending loop of Henle. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-07T08:59:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00121"^^xsd:string ;
  obo:id "PW:0002322"^^xsd:string ;
  rdfs:label "trichlormethiazide pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002322"^^xsd:string .

ns1:PW_0002323
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "A rare autosomal condition resulting from alterations in several metabolic pathways and due to defects in the HMGCL gene."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-07T09:04:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00138"^^xsd:string ;
  obo:id "PW:0002323"^^xsd:string ;
  rdfs:label "3-hydroxy-3-methylglutaryl-CoA lyase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002323"^^xsd:string .

ns1:PW_0002324
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "An autosomal recessive condition resulting from alterations in neurotransmitter metabolism and due to defects in the AADC gene."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-07T09:10:03Z"^^xsd:string ;
  obo:hasExactSynonym "aromatic amino acid decarboxylase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Dopa decarboxylase deficiency pathway"^^xsd:string, "SMP:00170"^^xsd:string ;
  obo:id "PW:0002324"^^xsd:string ;
  rdfs:label "aromatic L-amino acid decarboxylase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002324"^^xsd:string .

ns1:PW_0002325
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002151 ;
  ns2:treeView ns1:PW_0002151 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of drugs that prevent the coagulation of blood acting as vitamin K inhibitors . Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-07T09:44:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002325"^^xsd:string ;
  rdfs:label "vitamin K antagonist drug pathway"^^xsd:string ;
  skos:notation "PW:0002325"^^xsd:string .

ns1:PW_0002326
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002151 ;
  ns2:treeView ns1:PW_0002151 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of heparin group drugs that reduce or prevent the formation of blood clots by activating the antithrombin III (AT) thrombin inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-07T09:52:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002326"^^xsd:string ;
  rdfs:label "heparin group drug pathway"^^xsd:string ;
  skos:notation "PW:0002326"^^xsd:string .

ns1:PW_0002327
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002326 ;
  ns2:treeView ns1:PW_0002326 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of heparin, a naturally occurring anticoagulant produced by basophils and mast cells. Heparin, and its low molecular weight derivative, bind to and activates the thrombin enzyme inhibitor antithrombin III. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-07T09:55:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002327"^^xsd:string ;
  rdfs:label "heparin drug pathway"^^xsd:string ;
  skos:notation "PW:0002327"^^xsd:string .

ns1:PW_0002328
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002327 ;
  ns2:treeView ns1:PW_0002327 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of heparin. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-07T09:56:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002328"^^xsd:string ;
  rdfs:label "heparin pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002328"^^xsd:string .

ns1:PW_0002329
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002327 ;
  ns2:treeView ns1:PW_0002327 ;
  ns1:IAO_0000115 "The pathway of heparin-target interaction and of the biochemical or physiological responses to drug. Heparin is a naturally occurring anticoagulant that binds to and activates the thrombin inhibitor antithrombin III (AT). Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-07T09:56:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00274"^^xsd:string ;
  obo:id "PW:0002329"^^xsd:string ;
  rdfs:label "heparin pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002329"^^xsd:string .

ns1:PW_0002330
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002326 ;
  ns2:treeView ns1:PW_0002326 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of enoxaparin, a low molecular weight heparin derivative. The drug is an anticoagulant that activates the thrombin inhibitor antithrombin III (AT). Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-07T09:57:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002330"^^xsd:string ;
  rdfs:label "enoxaparin drug pathway"^^xsd:string ;
  skos:notation "PW:0002330"^^xsd:string .

ns1:PW_0002331
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002330 ;
  ns2:treeView ns1:PW_0002330 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of enoxaparin. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-07T09:58:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002331"^^xsd:string ;
  rdfs:label "enoxaparin pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002331"^^xsd:string .

ns1:PW_0002332
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002330 ;
  ns2:treeView ns1:PW_0002330 ;
  ns1:IAO_0000115 "The pathway of enoxaparin-target interaction and of the biochemical or physiological responses to drug. Enoxaparin is a low molecular weight heparin derivative anticoagulant that binds to and activates the thrombin inhibitor antithrombin III (AT). Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-07T09:58:21Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00272"^^xsd:string ;
  obo:id "PW:0002332"^^xsd:string ;
  rdfs:label "enoxaparin pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002332"^^xsd:string .

ns1:PW_0002333
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002295, ns1:PW_0002336 ;
  ns2:treeView ns1:PW_0002295, ns1:PW_0002336 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of fosphenytoin, an anti-seizure medication also used for certain heart arrhythmias. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-08T14:31:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002333"^^xsd:string ;
  rdfs:label "phenytoin drug pathway"^^xsd:string ;
  skos:notation "PW:0002333"^^xsd:string .

ns1:PW_0002334
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002333 ;
  ns2:treeView ns1:PW_0002333 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of phenytoin. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-08T14:31:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002334"^^xsd:string ;
  rdfs:label "phenytoin pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002334"^^xsd:string .

ns1:PW_0002335
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002333 ;
  ns2:treeView ns1:PW_0002333 ;
  ns1:IAO_0000115 "The pathway of phenytoin-target interaction and of the biochemical or physiological responses to drug. The drug is used as an anti-seizure medication and also for certain heart arrhythmias. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-08T14:32:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00327"^^xsd:string ;
  obo:id "PW:0002335"^^xsd:string ;
  rdfs:label "phenytoin pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002335"^^xsd:string .

ns1:PW_0002336
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000920 ;
  ns2:treeView ns1:PW_0000920 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of drugs used in the treatment of arrythmias.  Some beta receptor and channel blockers may also act as antiarrhythmic agents. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-08T14:42:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002336"^^xsd:string ;
  rdfs:label "antiarrhythmic drug pathway"^^xsd:string ;
  skos:notation "PW:0002336"^^xsd:string .

ns1:PW_0002337
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002336 ;
  ns2:treeView ns1:PW_0002336 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of mexiletine, a drug used in the treatment of cardiac arrhythmias. Mexiletine is a non-selective voltage-gated sodium channel blocker of the Class IB antiarrhythimc drugs. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-08T14:55:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002337"^^xsd:string ;
  rdfs:label "mexiletine drug pathway"^^xsd:string ;
  skos:notation "PW:0002337"^^xsd:string .

ns1:PW_0002338
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002337 ;
  ns2:treeView ns1:PW_0002337 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of mexiletine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-08T14:56:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002338"^^xsd:string ;
  rdfs:label "mexiletine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002338"^^xsd:string .

ns1:PW_0002339
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002337 ;
  ns2:treeView ns1:PW_0002337 ;
  ns1:IAO_0000115 "The pathway of mexiletine-target interaction and of the biochemical or physiological responses to drug. The drug is a non-selective voltage-gated sodium channel blocker  antiarrhythmic agent. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-08T14:57:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00329"^^xsd:string ;
  obo:id "PW:0002339"^^xsd:string ;
  rdfs:label "mexiletine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002339"^^xsd:string .

ns1:PW_0002340
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001593 ;
  ns2:treeView ns1:PW_0001593 ;
  ns1:IAO_0000115 "Those conditions, acquired, familial or congenital, affecting the skeletal muscle and/or smooth muscle."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-09T14:33:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002340"^^xsd:string ;
  rdfs:label "muscular disease pathway"^^xsd:string ;
  skos:notation "PW:0002340"^^xsd:string .

ns1:PW_0002341
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002096 ;
  ns2:treeView ns1:PW_0002096 ;
  ns1:IAO_0000115 "A disorder manifested by abnormal increase in skeletal or smooth muscle tone."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-09T14:40:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002341"^^xsd:string ;
  rdfs:label "muscle hypertonia disorder pathway"^^xsd:string ;
  skos:notation "PW:0002341"^^xsd:string .

ns1:PW_0002342
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002340, ns1:PW_0002341 ;
  ns2:treeView ns1:PW_0002340, ns1:PW_0002341 ;
  ns1:IAO_0000115 "A form of muscle hypertonia associated with upper motor neuron dysfunction."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-09T14:42:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002342"^^xsd:string ;
  rdfs:label "muscle spasticity disorder pathway"^^xsd:string ;
  skos:notation "PW:0002342"^^xsd:string .

ns1:PW_0002343
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001841, ns1:PW_0002342 ;
  ns2:treeView ns1:PW_0001841, ns1:PW_0002342 ;
  ns1:IAO_0000115 "A rather common condition resulting from alterations in folate metabolism and due to defects in methylenetetrahydrofolate reductase (MTHFR) gene."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-09T14:55:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00340"^^xsd:string ;
  obo:id "PW:0002343"^^xsd:string ;
  rdfs:label "methylenetetrahydrofolate reductase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002343"^^xsd:string .

ns1:PW_0002344
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of etoposide, a cytotoxic anticancer drug in the topoisomerase inhibitor class. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-09T15:29:06Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002344"^^xsd:string ;
  rdfs:label "etoposide drug pathway"^^xsd:string ;
  skos:notation "PW:0002344"^^xsd:string .

ns1:PW_0002345
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002344 ;
  ns2:treeView ns1:PW_0002344 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of etoposide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-09T15:30:50Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00601"^^xsd:string ;
  obo:id "PW:0002345"^^xsd:string ;
  rdfs:label "etoposide pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002345"^^xsd:string .

ns1:PW_0002346
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002344 ;
  ns2:treeView ns1:PW_0002344 ;
  ns1:IAO_0000115 "The pathway of etoposide-target interactions and of the biochemical or physiological responses to drug. Etoposide is a cytotoxic anticancer drug in the topoisomerase inhibitor class. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-09T15:31:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00442"^^xsd:string ;
  obo:id "PW:0002346"^^xsd:string ;
  rdfs:label "etoposide pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002346"^^xsd:string .

ns1:PW_0002347
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001630, ns1:PW_0001643 ;
  ns2:treeView ns1:PW_0001630, ns1:PW_0001643 ;
  ns1:IAO_0000115 "An autosomal recessive condition due to defects in the acid lipase gene."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-10T13:50:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00508"^^xsd:string ;
  obo:id "PW:0002347"^^xsd:string ;
  rdfs:label "cholesterol ester storage disease pathway"^^xsd:string ;
  skos:notation "PW:0002347"^^xsd:string .

ns1:PW_0002348
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001170, ns1:PW_0001546 ;
  ns2:treeView ns1:PW_0001170, ns1:PW_0001546 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of lornoxicam, a non-steroidal anti-inflammatory drug with analgesic, anti-inflammatory and antipyretic properties Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-15T08:39:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002348"^^xsd:string ;
  rdfs:label "lornoxicam drug pathway"^^xsd:string ;
  skos:notation "PW:0002348"^^xsd:string .

ns1:PW_0002349
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002348 ;
  ns2:treeView ns1:PW_0002348 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of lornoxicam. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-15T08:40:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002349"^^xsd:string ;
  rdfs:label "lornoxicam pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002349"^^xsd:string .

ns1:PW_0002350
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002348 ;
  ns2:treeView ns1:PW_0002348 ;
  ns1:IAO_0000115 "The pathway of lornoxicam-target interaction and of the biochemical or physiological responses to drug. The drug is used to relieve various types of pain. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-15T08:40:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00700"^^xsd:string ;
  obo:id "PW:0002350"^^xsd:string ;
  rdfs:label "lornoxicam pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002350"^^xsd:string .

ns1:PW_0002351
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002370 ;
  ns2:treeView ns1:PW_0002370 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of trastuzumab, a monoclonal antibody that interferes with the epidermal growth factor receptor 2, overexpressed in certain cancer types. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-15T09:22:35Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002351"^^xsd:string ;
  rdfs:label "trastuzumab drug pathway"^^xsd:string ;
  skos:notation "PW:0002351"^^xsd:string .

ns1:PW_0002352
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002351 ;
  ns2:treeView ns1:PW_0002351 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of trastuzumab. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-15T09:23:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002352"^^xsd:string ;
  rdfs:label "trastuzumab pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002352"^^xsd:string .

ns1:PW_0002353
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002351 ;
  ns2:treeView ns1:PW_0002351 ;
  ns1:IAO_0000115 "The pathway of trastuzumab-target interaction and of the biochemical or physiological responses to drug. The drug interferes with the epidermal growth factor receptor 2, overexpressed in certain cancer types. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-15T09:23:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00476"^^xsd:string ;
  obo:id "PW:0002353"^^xsd:string ;
  rdfs:label "trastuzumab pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002353"^^xsd:string .

ns1:PW_0002354
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000754 ;
  ns2:treeView ns1:PW_0000754 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of compounds used as antiparasitic agents. Genetic variations can result in changes in drug availability."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-15T09:52:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002354"^^xsd:string ;
  rdfs:label "antiparasitic drug pathway"^^xsd:string ;
  skos:notation "PW:0002354"^^xsd:string .

ns1:PW_0002355
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002354 ;
  ns2:treeView ns1:PW_0002354 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of artemether, an antimalarial agent. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-15T09:56:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002355"^^xsd:string ;
  rdfs:label "artemether drug pathway"^^xsd:string ;
  skos:notation "PW:0002355"^^xsd:string .

ns1:PW_0002356
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002355 ;
  ns2:treeView ns1:PW_0002355 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of artemether. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-15T09:56:40Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00651"^^xsd:string ;
  obo:id "PW:0002356"^^xsd:string ;
  rdfs:label "artemether pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002356"^^xsd:string .

ns1:PW_0002357
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002355 ;
  ns2:treeView ns1:PW_0002355 ;
  ns1:IAO_0000115 "The pathway of artemether-target interactions and of the biochemical or physiological responses to drug. Artemether is used to treat malaria.  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-15T09:57:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002357"^^xsd:string ;
  rdfs:label "artemether pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002357"^^xsd:string .

ns1:PW_0002358
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000240 ;
  ns2:treeView ns1:PW_0000240 ;
  ns1:IAO_0000115 "A group of mental disorders whose onset is in the developmental period."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-15T14:21:38Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002358"^^xsd:string ;
  rdfs:label "neurodevelopmental disorder pathway"^^xsd:string ;
  skos:notation "PW:0002358"^^xsd:string .

ns1:PW_0002359
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645, ns1:PW_0002358 ;
  ns2:treeView ns1:PW_0001645, ns1:PW_0002358 ;
  ns1:IAO_0000115 "An autosomal recessive condition characterized by developmental delay and mental retardation due to defects in the GATM gene."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-15T14:23:55Z"^^xsd:string ;
  obo:hasExactSynonym "arginine:glycine amidinotransferase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00362"^^xsd:string, "SMP:00507"^^xsd:string ;
  obo:id "PW:0002359"^^xsd:string ;
  rdfs:label "AGAT deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002359"^^xsd:string .

ns1:PW_0002360
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002213 ;
  ns2:treeView ns1:PW_0002213 ;
  ns1:IAO_0000115 "Condition resulting from genetic defects in the selective or non-selective transport functions of the kidney tubules."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-15T14:36:19Z"^^xsd:string ;
  obo:hasExactSynonym "fanconi syndrome pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "Fanconi-Bickel syndrome pathway"^^xsd:string, "SMP:00572"^^xsd:string ;
  obo:id "PW:0002360"^^xsd:string ;
  rdfs:label "Fanconi syndrome pathway"^^xsd:string ;
  skos:notation "PW:0002360"^^xsd:string .

ns1:PW_0002361
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002243, ns1:PW_0002443 ;
  ns2:treeView ns1:PW_0002243, ns1:PW_0002443 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of remifentanil, a synthetic opioid analgesic used in general anesthesia.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-17T08:00:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002361"^^xsd:string ;
  rdfs:label "remifentanil drug pathway"^^xsd:string ;
  skos:notation "PW:0002361"^^xsd:string .

ns1:PW_0002362
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002361 ;
  ns2:treeView ns1:PW_0002361 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of remifentanil. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-17T08:01:50Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002362"^^xsd:string ;
  rdfs:label "remifentanil pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002362"^^xsd:string .

ns1:PW_0002363
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002361 ;
  ns2:treeView ns1:PW_0002361 ;
  ns1:IAO_0000115 "The pathway of remifentanil-target interaction and of the biochemical or physiological responses to drug. The drug is a synthetic opioid analgesic used in general anesthesia. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-17T08:02:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00416"^^xsd:string ;
  obo:id "PW:0002363"^^xsd:string ;
  rdfs:label "remifentanil pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002363"^^xsd:string .

ns1:PW_0002364
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001669 ;
  ns2:treeView ns1:PW_0001669 ;
  ns1:IAO_0000115 "A heterogeneous group of disorders triggered  by alterations in mitochondria metabolism and resulting in dysfunction in muscle and nervous system."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-17T08:13:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002364"^^xsd:string ;
  rdfs:label "mitochondrial encephalomyopathy pathway"^^xsd:string ;
  skos:notation "PW:0002364"^^xsd:string .

ns1:PW_0002365
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002364, ns1:PW_0002366 ;
  ns2:treeView ns1:PW_0002364, ns1:PW_0002366 ;
  ns1:IAO_0000115 "A severe autosomal recessive disorder due to defects in the p53-inducible ribonucleotide reductase RRM2B."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-17T08:21:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "MNGIE syndrome pathway"^^xsd:string, "SMP:00202"^^xsd:string ;
  obo:id "PW:0002365"^^xsd:string ;
  rdfs:label "mitochondrial neurogastrointestinal encephalopathy syndrome pathway"^^xsd:string ;
  skos:notation "PW:0002365"^^xsd:string .

ns1:PW_0002366
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002233 ;
  ns2:treeView ns1:PW_0002233 ;
  ns1:IAO_0000115 "Conditions affecting any segment of the intestine."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-17T08:33:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002366"^^xsd:string ;
  rdfs:label "intestinal disease pathway"^^xsd:string ;
  skos:notation "PW:0002366"^^xsd:string .

ns1:PW_0002367
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000919 ;
  ns2:treeView ns1:PW_0000919 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of drugs used in the treatment of various cancers. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-17T09:05:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002367"^^xsd:string ;
  rdfs:label "antineoplastic drug pathway"^^xsd:string ;
  skos:notation "PW:0002367"^^xsd:string .

ns1:PW_0002368
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000919 ;
  ns2:treeView ns1:PW_0000919 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of drugs used as immunostimulants. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-17T09:05:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002368"^^xsd:string ;
  rdfs:label "immunostimulant drug pathway"^^xsd:string ;
  skos:notation "PW:0002368"^^xsd:string .

ns1:PW_0002369
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000919 ;
  ns2:treeView ns1:PW_0000919 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of drugs used as immunosupressants. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-17T09:06:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002369"^^xsd:string ;
  rdfs:label "immunosuppressant drug pathway"^^xsd:string ;
  skos:notation "PW:0002369"^^xsd:string .

ns1:PW_0002370
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of monoclonal antibodies used in the treatment of various types of cancer.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-17T09:16:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002370"^^xsd:string ;
  rdfs:label "monoclonal antibody drug pathway"^^xsd:string ;
  skos:notation "PW:0002370"^^xsd:string .

ns1:PW_0002371
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002370 ;
  ns2:treeView ns1:PW_0002370 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of cetuximab, a chimeric (mouse/human) monoclonal antibody that interferes with the epidermal growth factor receptor (EGFR) and used for the treatment of certain cancer types. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-17T09:38:50Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002371"^^xsd:string ;
  rdfs:label "cetuximab drug pathway"^^xsd:string ;
  skos:notation "PW:0002371"^^xsd:string .

ns1:PW_0002372
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002371 ;
  ns2:treeView ns1:PW_0002371 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of cetuximab. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-17T09:39:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002372"^^xsd:string ;
  rdfs:label "cetuximab pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002372"^^xsd:string .

ns1:PW_0002373
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002371 ;
  ns2:treeView ns1:PW_0002371 ;
  ns1:IAO_0000115 "The pathway of cetuxiumab-target interaction and of the biochemical or physiological responses to drug. The drug interferes with the epidermal growth factor receptor (EGFR) and is used for the treatment of certain cancer types. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-17T09:39:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00474"^^xsd:string ;
  obo:id "PW:0002373"^^xsd:string ;
  rdfs:label "cetuximab pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002373"^^xsd:string .

ns1:PW_0002374
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002370 ;
  ns2:treeView ns1:PW_0002370 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of panitumumab, a human monoclonal antibody that interferes with the epidermal growth factor receptor (EGFR) and used for the treatment of certain cancer types. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-17T09:45:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002374"^^xsd:string ;
  rdfs:label "panitumumab drug pathway"^^xsd:string ;
  skos:notation "PW:0002374"^^xsd:string .

ns1:PW_0002375
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002374 ;
  ns2:treeView ns1:PW_0002374 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of panitumumab. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-17T09:46:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002375"^^xsd:string ;
  rdfs:label "panitumumab pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002375"^^xsd:string .

ns1:PW_0002376
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002374 ;
  ns2:treeView ns1:PW_0002374 ;
  ns1:IAO_0000115 "The pathway of panitumumab-target interaction and of the biochemical or physiological responses to drug. The drug interferes with the epidermal growth factor receptor (EGFR) and is used for the treatment of certain cancer types. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-17T09:47:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00475"^^xsd:string ;
  obo:id "PW:0002376"^^xsd:string ;
  rdfs:label "panitumumab pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002376"^^xsd:string .

ns1:PW_0002377
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002121 ;
  ns2:treeView ns1:PW_0002121 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of hydroflumethiazide, a drug used in the treatment of high blood pressure.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-21T08:49:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002377"^^xsd:string ;
  rdfs:label "hydroflumethiazide drug pathway"^^xsd:string ;
  skos:notation "PW:0002377"^^xsd:string .

ns1:PW_0002378
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002377 ;
  ns2:treeView ns1:PW_0002377 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of hydroflumethiazide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-21T08:51:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002378"^^xsd:string ;
  rdfs:label "hydroflumethiazide pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002378"^^xsd:string .

ns1:PW_0002379
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002377 ;
  ns2:treeView ns1:PW_0002377 ;
  ns1:IAO_0000115 "The pathway of hydroflumethiazide-target interaction and of the biochemical or physiological responses to drug. The drug reduces sodium reabsorption in the distal convoluted tubule of kidney nephron. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-21T08:52:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00108"^^xsd:string ;
  obo:id "PW:0002379"^^xsd:string ;
  rdfs:label "hydroflumethiazide pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002379"^^xsd:string .

ns1:PW_0002380
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "An autosomal dominant condition resulting from alterations in amino acid metabolism due to defects in the 4-hydroxyphenylpyruvate dioxygenase (HPD) gene."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-21T08:57:39Z"^^xsd:string ;
  obo:hasExactSynonym "hawkinsinuria disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00190"^^xsd:string ;
  obo:id "PW:0002380"^^xsd:string ;
  rdfs:label "hawkinsinuria pathway"^^xsd:string ;
  skos:notation "PW:0002380"^^xsd:string .

ns1:PW_0002381
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002300 ;
  ns2:treeView ns1:PW_0002300 ;
  ns1:IAO_0000115 "Autosomal recessive neurodegenrative disorder resulting from alterations in lysosomal membrane transport due to defects in the SLC17A5 gene."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-21T09:13:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00240"^^xsd:string, "Salla disease pathway"^^xsd:string, "infantile sialic acid storage disease pathway"^^xsd:string ;
  obo:id "PW:0002381"^^xsd:string ;
  rdfs:label "sialic acid storage disease pathway"^^xsd:string ;
  skos:notation "PW:0002381"^^xsd:string .

ns1:PW_0002382
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000920 ;
  ns2:treeView ns1:PW_0000920 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of dobutamine, a drug used in the treatment of heart failure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-21T09:41:20Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002382"^^xsd:string ;
  rdfs:label "dobutamine drug pathway"^^xsd:string ;
  skos:notation "PW:0002382"^^xsd:string .

ns1:PW_0002383
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002382 ;
  ns2:treeView ns1:PW_0002382 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of dobutamine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-21T09:41:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002383"^^xsd:string ;
  rdfs:label "dobutamine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002383"^^xsd:string .

ns1:PW_0002384
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002382 ;
  ns2:treeView ns1:PW_0002382 ;
  ns1:IAO_0000115 "The pathway of dobutamine-target interaction and of the biochemical or physiological responses to drug. The drug is an agonist of beta 1 adrenergic receptor used in the treatment of heart failure. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-21T09:42:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00662"^^xsd:string ;
  obo:id "PW:0002384"^^xsd:string ;
  rdfs:label "dobutamine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002384"^^xsd:string .

ns1:PW_0002385
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002113 ;
  ns2:treeView ns1:PW_0002113 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of clomipramine, an antidepressant used in the treatment of obsessive compulsive disorder, panic disorder, major depressive disorder. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-21T10:00:09Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002385"^^xsd:string ;
  rdfs:label "clomipramine drug pathway"^^xsd:string ;
  skos:notation "PW:0002385"^^xsd:string .

ns1:PW_0002386
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002385 ;
  ns2:treeView ns1:PW_0002385 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of clomipramine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-21T10:00:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00639"^^xsd:string ;
  obo:id "PW:0002386"^^xsd:string ;
  rdfs:label "clomipramine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002386"^^xsd:string .

ns1:PW_0002387
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002385 ;
  ns2:treeView ns1:PW_0002385 ;
  ns1:IAO_0000115 "The pathway of clomipramine-target interaction and of the biochemical or physiological responses to drug. The drug is categorized as a non-selective monoamine reuptake inhibitor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-21T10:01:06Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002387"^^xsd:string ;
  rdfs:label "clomipramine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002387"^^xsd:string .

ns1:PW_0002388
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002099 ;
  ns2:treeView ns1:PW_0002099 ;
  ns1:IAO_0000115 "An autosomal recessive condition resulting from alterations in fructose metabolism and associated with defects in the ketohexokinase (KHK) gene."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-21T15:13:10Z"^^xsd:string ;
  obo:hasExactSynonym "fructosuria disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00561"^^xsd:string ;
  obo:id "PW:0002388"^^xsd:string ;
  rdfs:label "fructosuria pathway"^^xsd:string ;
  skos:notation "PW:0002388"^^xsd:string .

ns1:PW_0002389
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002295 ;
  ns2:treeView ns1:PW_0002295 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of felbamate - an anticonvulsant used in the treatment of epilepsy. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-21T15:20:39Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002389"^^xsd:string ;
  rdfs:label "felbamate drug pathway"^^xsd:string ;
  skos:notation "PW:0002389"^^xsd:string .

ns1:PW_0002390
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002389 ;
  ns2:treeView ns1:PW_0002389 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of felbamate. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-21T15:22:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00633"^^xsd:string ;
  obo:id "PW:0002390"^^xsd:string ;
  rdfs:label "felbamate pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002390"^^xsd:string .

ns1:PW_0002391
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002389 ;
  ns2:treeView ns1:PW_0002389 ;
  ns1:IAO_0000115 "The pathway of felbamate-target interaction and of the biochemical or physiological responses to drug. It is used for the treatment of severe epilepsy due to its adverse effects, particularly hepatic failure. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-21T15:22:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002391"^^xsd:string ;
  rdfs:label "felbamate pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002391"^^xsd:string .

ns1:PW_0002392
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of tioguanine, a drug used to treat several leukemia types, ulcerative colitis and some autoimmune diseases. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-29T12:59:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "thioguanine drug pathway"^^xsd:string ;
  obo:id "PW:0002392"^^xsd:string ;
  rdfs:label "tioguanine drug pathway"^^xsd:string ;
  skos:notation "PW:0002392"^^xsd:string .

ns1:PW_0002393
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002392 ;
  ns2:treeView ns1:PW_0002392 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of tioguanine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-29T12:59:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00647"^^xsd:string, "thioguanine pharmacokinetics pathway"^^xsd:string ;
  obo:id "PW:0002393"^^xsd:string ;
  rdfs:label "tioguanine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002393"^^xsd:string .

ns1:PW_0002394
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002392 ;
  ns2:treeView ns1:PW_0002392 ;
  ns1:IAO_0000115 "The pathway of teniposide-target interactions and of the biochemical or physiological responses to drug. The drug is used in the treatment of several leukemia types, ulcerative colitis and some autoimmune diseases. Derivatives of tioguanine exert several cytotoxic effects. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2015-12-29T13:00:41Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00430"^^xsd:string, "thioguanine pharmacodynamics pathway"^^xsd:string ;
  obo:id "PW:0002394"^^xsd:string ;
  rdfs:label "tioguanine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002394"^^xsd:string .

ns1:PW_0002395
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000004 ;
  ns2:treeView ns1:PW_0000004 ;
  ns1:IAO_0000115 "The endocytosis and the exocytosis pathway that deliver, uptake and recycle cellular material. Efficient coupling between exocytosis and endocytosis pathways is essential for synaptic transmission."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-06T10:48:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002395"^^xsd:string ;
  rdfs:label "cellular trafficking cycle pathway"^^xsd:string ;
  skos:notation "PW:0002395"^^xsd:string .

ns1:PW_0002396
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002395 ;
  ns2:treeView ns1:PW_0002395 ;
  ns1:IAO_0000115 "The exocytosis pathway thereby cellular material is delivered in the extracellular space our outside the cell. There two main types of exocytosis: calcium-triggered, regulated and constitutive. They are also represented in the more specific protein exocytosis pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-06T10:58:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002396"^^xsd:string ;
  rdfs:label "exocytosis pathway"^^xsd:string ;
  skos:notation "PW:0002396"^^xsd:string .

ns1:PW_0002397
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002396 ;
  ns2:treeView ns1:PW_0002396 ;
  ns1:IAO_0000115 "A signal-independent exocytic pathway employed by all cell types."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-06T11:17:50Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002397"^^xsd:string ;
  rdfs:label "constitutive exocytosis pathway"^^xsd:string ;
  skos:notation "PW:0002397"^^xsd:string .

ns1:PW_0002398
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002396 ;
  ns2:treeView ns1:PW_0002396 ;
  ns1:IAO_0000115 "A signal-dependent exocytic pathway employed by particular cell types. For instance, the release of hormones and neurotransmitters by neuroendocrine cells is mediated by regulated exocytosis."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-06T11:19:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002398"^^xsd:string ;
  rdfs:label "regulated exocytosis pathway"^^xsd:string ;
  skos:notation "PW:0002398"^^xsd:string .

ns1:PW_0002399
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0002414
  ] ;
  ns2:treeView ns1:PW_0002414 ;
  ns3:part_of ns1:PW_0002414 ;
  ns1:IAO_0000115 "The endosomal system is at the cross roads of endocytosis and secretory pathways. As the endosome goes through the maturation process various trafficking events are initiated. Material internalized from the plasma membrane or synthesized is sorted along two routes: a degradative pathway to lysosome or an export pathway. Cargo delivery to plasma membrane is via the recycling export pathway while delivery to the trans Golgi network (TGN) is via the retrograde export pathway. An important system for the selective cargo sorting is the retromer."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-12T14:39:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002399"^^xsd:string ;
  rdfs:label "endosomal sorting pathway"^^xsd:string ;
  skos:notation "PW:0002399"^^xsd:string .

ns1:PW_0002400
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002399 ;
  ns2:treeView ns1:PW_0002399 ;
  ns1:IAO_0000115 "The lysosome is the final destination of endosomal degradative and autophagy pathways. Fusion of late endosomes and mature autophagosome with the lysosome form the endolysosome or autolysosome, respectively, where cargo is actively degraded."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-12T15:06:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002400"^^xsd:string ;
  rdfs:label "degradative endosome sorting pathway"^^xsd:string ;
  skos:notation "PW:0002400"^^xsd:string .

ns1:PW_0002401
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002402 ;
  ns2:treeView ns1:PW_0002402 ;
  ns1:IAO_0000115 "Chaperone-mediated autophagy is a specific and selective pathway whereby chaperone complexes recognize substrates bearing a recognition sequence forming a chaperone/substrate complex recognized by translocators."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-12T15:11:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002401"^^xsd:string ;
  rdfs:label "chaperone mediated autophagy pathway"^^xsd:string ;
  skos:notation "PW:0002401"^^xsd:string .

ns1:PW_0002402
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000276 ;
  ns2:treeView ns1:PW_0000276 ;
  ns1:IAO_0000115 "Cellular autophagy involves the mechanisms thereby dysfunctional components, proteins or organelles, are targeted to the lysosomes for destruction. Three main pathways are known: macroautophagy generally referred to as autophagy, microautophagy and chaperone-mediated autophagy. A fourth is the autophagy pathway for the removal of damaged mitochondria whose features are both shared with the regular autophagy and distinct."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-12T15:12:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002402"^^xsd:string ;
  rdfs:label "cellular autophagy pathway"^^xsd:string ;
  skos:notation "PW:0002402"^^xsd:string .

ns1:PW_0002403
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002402 ;
  ns2:treeView ns1:PW_0002402 ;
  ns1:IAO_0000115 "A cellular autophagy pathway that deviates from what its normal course should be. Altered cellular autophagy has been associated with a range of human conditions and disorders."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-12T15:16:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002403"^^xsd:string ;
  rdfs:label "altered cellular autophagy"^^xsd:string ;
  skos:notation "PW:0002403"^^xsd:string .

ns1:PW_0002404
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002401, ns1:PW_0002403 ;
  ns2:treeView ns1:PW_0002401, ns1:PW_0002403 ;
  ns1:IAO_0000115 "Chaperone mediated autophagy declines with aging and can also be due to alterations in protein stability and gene structure. Altered chaperone mediated autophagy has been associated with conditions such as neurodegenerative diseases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-12T15:27:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002404"^^xsd:string ;
  rdfs:label "altered chaperone mediated autophagy"^^xsd:string ;
  skos:notation "PW:0002404"^^xsd:string .

ns1:PW_0002405
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002402 ;
  ns2:treeView ns1:PW_0002402 ;
  ns1:IAO_0000115 "A form of autophagy thereby the cytoplasmic material is directly engulfed in the lysosome."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-12T15:33:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002405"^^xsd:string ;
  rdfs:label "microautophagy pathway"^^xsd:string ;
  skos:notation "PW:0002405"^^xsd:string .

ns1:PW_0002406
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002399 ;
  ns2:treeView ns1:PW_0002399 ;
  ns1:IAO_0000115 "The endosome export pathway delivers cargo to the trans Golgi network (TGN) or the plasma membrane via the retrograde and recycling pathways, respectively. An important cargo sorting system for the export pathway, primarily via the retrograde, but also the recycling pathways, is the retromer complex."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-12T15:35:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002406"^^xsd:string ;
  rdfs:label "endosome export pathway"^^xsd:string ;
  skos:notation "PW:0002406"^^xsd:string .

ns1:PW_0002407
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002406 ;
  ns2:treeView ns1:PW_0002406 ;
  ns1:IAO_0000115 "The retrograde export pathway is major route to recycle components of the secretory apparatus and to diverge from lysosomal degradation components derived from endocytosis."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-12T15:39:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002407"^^xsd:string ;
  rdfs:label "retrograde export pathway"^^xsd:string ;
  skos:notation "PW:0002407"^^xsd:string .

ns1:PW_0002408
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002406 ;
  ns2:treeView ns1:PW_0002406 ;
  ns1:IAO_0000115 "The recycling export pathway routes receptors and other proteins back to the plasma membrane."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-12T15:40:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002408"^^xsd:string ;
  rdfs:label "recycling export pathway"^^xsd:string ;
  skos:notation "PW:0002408"^^xsd:string .

ns1:PW_0002409
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0002414
  ] ;
  ns2:treeView ns1:PW_0002414 ;
  ns3:part_of ns1:PW_0002414 ;
  ns1:IAO_0000115 "Early to late endosome maturation pathway is a state of flux associated with changes in component composition, such as particular Rab proteins and lipids such as phosphoinositides, increase in the number of intraluminal vesicles, luminal acidification and movement along microtubules. Along this continuum, sorting and trafficking of cargo takes place."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-13T09:48:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002409"^^xsd:string ;
  rdfs:label "endosome maturation pathway"^^xsd:string ;
  skos:notation "PW:0002409"^^xsd:string .

ns1:PW_0002410
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000263, ns1:PW_0002395 ;
  ns2:treeView ns1:PW_0000263, ns1:PW_0002395 ;
  ns1:IAO_0000115 "Any alteration in the proceedings of endocytosis or exocytosis."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-13T10:40:41Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002410"^^xsd:string ;
  rdfs:label "altered cellular trafficking cycle pathway"^^xsd:string ;
  skos:notation "PW:0002410"^^xsd:string .

ns1:PW_0002411
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000281, ns1:PW_0002410 ;
  ns2:treeView ns1:PW_0000281, ns1:PW_0002410 ;
  ns1:IAO_0000115 "Any alteration of an aspect pertinent to endocytosis pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-13T10:50:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002411"^^xsd:string ;
  rdfs:label "altered endocytosis pathway"^^xsd:string ;
  skos:notation "PW:0002411"^^xsd:string .

ns1:PW_0002412
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002399, ns1:PW_0002415 ;
  ns2:treeView ns1:PW_0002399, ns1:PW_0002415 ;
  ns1:IAO_0000115 "Alterations in the endosomal sorting pathway can dramatically impact on the proper delivery of cargo. Defects in retromer function have been linked to human conditions such as the neurodegenerative Alzheimer's and Parkinson's diseases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-13T10:58:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002412"^^xsd:string ;
  rdfs:label "altered endosomal sorting pathway"^^xsd:string ;
  skos:notation "PW:0002412"^^xsd:string .

ns1:PW_0002413
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002406, ns1:PW_0002412 ;
  ns2:treeView ns1:PW_0002406, ns1:PW_0002412 ;
  ns1:IAO_0000115 "Alterations in the endosome export pathway can dramatically impact on cellular fate. Defects in retromer function have been linked to human conditions such as the neurodegenerative Alzheimer's and Parkinson's diseases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-13T11:54:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002413"^^xsd:string ;
  rdfs:label "altered endosome export pathway"^^xsd:string ;
  skos:notation "PW:0002413"^^xsd:string .

ns1:PW_0002414
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000281
  ] ;
  ns2:treeView ns1:PW_0000281 ;
  ns3:part_of ns1:PW_0000281 ;
  ns1:IAO_0000115 "In the endosomal pathway, endosomal maturation couples to sorting of material and its appropriate delivery or degradation, promoted by specific transport along and dynamics of cytoskeleton and associated molecular motors."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-13T13:23:41Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002414"^^xsd:string ;
  rdfs:label "endosomal pathway"^^xsd:string ;
  skos:notation "PW:0002414"^^xsd:string .

ns1:PW_0002415
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002411, ns1:PW_0002414 ;
  ns2:treeView ns1:PW_0002411, ns1:PW_0002414 ;
  ns1:IAO_0000115 "Any alteration of an aspect pertinent to endosomal pathway. Defects in endosomal sorting and export have been associated with human conditions such as neurodegenerative diseases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-13T13:44:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002415"^^xsd:string ;
  rdfs:label "altered endosomal pathway"^^xsd:string ;
  skos:notation "PW:0002415"^^xsd:string .

ns1:PW_0002416
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000354 ;
  ns2:treeView ns1:PW_0000354 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of phosphatidylserine, an essential component of the membrane, and also with roles in signaling."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-13T14:01:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002416"^^xsd:string ;
  rdfs:label "phosphatidylserine metabolic process"^^xsd:string ;
  skos:notation "PW:0002416"^^xsd:string .

ns1:PW_0002417
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000354 ;
  ns2:treeView ns1:PW_0000354 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis, utilization and/or degradation of phosphatidylinositol (PtdIns). Phosphorylation of PtdIns can occur at the 3, 4, and/or 4 position of the inositol ring using one or multiple phosphate groups. These phosphorylated forms of PtdIns are known as phosphoinositides."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-13T14:16:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002417"^^xsd:string ;
  rdfs:label "phosphatidylinositol metabolic pathway"^^xsd:string ;
  skos:notation "PW:0002417"^^xsd:string .

ns1:PW_0002418
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002417 ;
  ns2:treeView ns1:PW_0002417 ;
  ns1:IAO_0000115 "Reversible phosphorylation of phosphatidylinositol at the 3, 4, and/or 5 position of the inositol ring with one or more phosphate groups by the action of phosphatidylinositol kinases and phosphatases gives rise to several different phosphoinositides (PIs) whose various distribution is important to cellular membrane identity. PIs are involved in various transport and trafficking, signaling and metabolic pathways. As such, alteration of PIs metabolism is implicated in a wide range of human diseases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-13T15:02:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00463"^^xsd:string, "phosphatidylinositol phosphate metabolic pathway"^^xsd:string ;
  obo:id "PW:0002418"^^xsd:string ;
  rdfs:label "phosphoinositide metabolic pathway"^^xsd:string ;
  skos:notation "PW:0002418"^^xsd:string .

ns1:PW_0002419
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000354, ns1:PW_0000483 ;
  ns2:treeView ns1:PW_0000354, ns1:PW_0000483 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-13T15:23:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002419"^^xsd:string ;
  rdfs:label "altered glycerophospholipid metabolic pathway"^^xsd:string ;
  skos:notation "PW:0002419"^^xsd:string .

ns1:PW_0002420
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002417, ns1:PW_0002419 ;
  ns2:treeView ns1:PW_0002417, ns1:PW_0002419 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-13T15:24:14Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002420"^^xsd:string ;
  rdfs:label "altered phosphatidylinositol metabolic pathway"^^xsd:string ;
  skos:notation "PW:0002420"^^xsd:string .

ns1:PW_0002421
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002418, ns1:PW_0002420 ;
  ns2:treeView ns1:PW_0002418, ns1:PW_0002420 ;
  ns1:IAO_0000115 "Phosphoinositides are involved in a wide range of biological processes and alterations in their metabolism have been associated with a spectrum of human conditions."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-13T15:25:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002421"^^xsd:string ;
  rdfs:label "altered phosphoinositide metabolic pathway"^^xsd:string ;
  skos:notation "PW:0002421"^^xsd:string .

ns1:PW_0002422
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001251 ;
  ns2:treeView ns1:PW_0001251 ;
  ns1:IAO_0000115 "Chemical synapses require the induction and assembly of pre- and postsynaptic structures."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-14T11:04:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002422"^^xsd:string ;
  rdfs:label "synaptic differentiation pathway"^^xsd:string ;
  skos:notation "PW:0002422"^^xsd:string .

ns1:PW_0002423
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001251, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000274
  ] ;
  ns2:treeView ns1:PW_0000274, ns1:PW_0001251 ;
  ns3:part_of ns1:PW_0000274 ;
  ns1:IAO_0000115 "The cycle of synaptic vesicle exocytosis and neurotransmitter release and the subsequent endocytosis and recycling of synaptic vesicles at nerve terminals."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-14T11:34:57Z"^^xsd:string ;
  obo:hasAlternativeId "PW:0001072"^^xsd:string ;
  obo:hasExactSynonym "synaptic vesicle cycle pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "KEGG:04721"^^xsd:string ;
  obo:id "PW:0002423"^^xsd:string ;
  rdfs:label "synaptic vesicle cycle pathway"^^xsd:string ;
  skos:notation "PW:0002423"^^xsd:string .

ns1:PW_0002424
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002423 ;
  ns2:treeView ns1:PW_0002423 ;
  ns1:IAO_0000115 "The endocytosis of synaptic vesicles, their recycle and refill for another round of exocytosis. Two recycling pathways are documented: a fast endocytosis, also referred to as 'kiss-and-run' which is thought to be clathrin-independent, and a slower route, that is clathrin-dependent."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-14T11:48:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002424"^^xsd:string ;
  rdfs:label "synaptic vesicle endocytosis pathway"^^xsd:string ;
  skos:notation "PW:0002424"^^xsd:string .

ns1:PW_0002425
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002423 ;
  ns2:treeView ns1:PW_0002423 ;
  ns1:IAO_0000115 "The release pathway of neurotransmitter filled synaptic vesicles."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-14T11:49:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002425"^^xsd:string ;
  rdfs:label "synaptic vesicle exocytosis pathway"^^xsd:string ;
  skos:notation "PW:0002425"^^xsd:string .

ns1:PW_0002426
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000263, ns1:PW_0001251 ;
  ns2:treeView ns1:PW_0000263, ns1:PW_0001251 ;
  ns1:IAO_0000115 "Any alteration in the proceedings regulatory pathways important for brain function."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-14T12:04:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002426"^^xsd:string ;
  rdfs:label "altered regulatory pathway pertinent to the brain"^^xsd:string ;
  skos:notation "PW:0002426"^^xsd:string .

ns1:PW_0002427
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002423, ns1:PW_0002426 ;
  ns2:treeView ns1:PW_0002423, ns1:PW_0002426 ;
  ns1:IAO_0000115 "Alterations in any of the various aspects pertinent to the release, endocytosis or trafficking/recycling of synaptic vesicles."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-14T12:05:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002427"^^xsd:string ;
  rdfs:label "altered synaptic vesicle cycle pathway"^^xsd:string ;
  skos:notation "PW:0002427"^^xsd:string .

ns1:PW_0002428
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002424, ns1:PW_0002427 ;
  ns2:treeView ns1:PW_0002424, ns1:PW_0002427 ;
  ns1:IAO_0000115 "Alterations in any of the mechanisms underlying the endocytosis of synaptic vesicles."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-14T12:07:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002428"^^xsd:string ;
  rdfs:label "altered synaptic vesicle endocytosis pathway"^^xsd:string ;
  skos:notation "PW:0002428"^^xsd:string .

ns1:PW_0002429
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002423 ;
  ns2:treeView ns1:PW_0002423 ;
  ns1:IAO_0000115 "Prior to exocytosis and following endocytosis, synaptic vesicles go through several trafficking steps that prepare them for neurotransmitter release."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-14T12:43:27Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002429"^^xsd:string ;
  rdfs:label "synaptic vesicle trafficking pathway"^^xsd:string ;
  skos:notation "PW:0002429"^^xsd:string .

ns1:PW_0002430
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002399, [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0002406
  ] ;
  ns2:treeView ns1:PW_0002399, ns1:PW_0002406 ;
  ns3:part_of ns1:PW_0002406 ;
  ns1:IAO_0000115 "The retromer complex is an important system for the selective cargo sorting for the endosome export pathways, primarily via the retrograde, but also the recycling pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-14T14:45:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002430"^^xsd:string ;
  rdfs:label "retromer-mediated pathway"^^xsd:string ;
  skos:notation "PW:0002430"^^xsd:string .

ns1:PW_0002431
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002413, ns1:PW_0002430 ;
  ns2:treeView ns1:PW_0002413, ns1:PW_0002430 ;
  ns1:IAO_0000115 "Alterations in retromer-mediated pathway can affect both the sorting and the export pathways subsequent to sorting. Defects in retromer function have been linked to human conditions such as the neurodegenerative Alzheimer's and Parkinson's diseases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-14T14:56:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002431"^^xsd:string ;
  rdfs:label "altered retromer-mediated pathway"^^xsd:string ;
  skos:notation "PW:0002431"^^xsd:string .

ns1:PW_0002432
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002424 ;
  ns2:treeView ns1:PW_0002424 ;
  ns1:IAO_0000115 "Clathrin-dependent endocytosis is a major route for synaptic vesicle endocytosis."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-15T08:37:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002432"^^xsd:string ;
  rdfs:label "clathrin-dependent synaptic vesicle endocytosis"^^xsd:string ;
  skos:notation "PW:0002432"^^xsd:string .

ns1:PW_0002433
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002428, ns1:PW_0002432 ;
  ns2:treeView ns1:PW_0002428, ns1:PW_0002432 ;
  ns1:IAO_0000115 "Alterations in any of the mechanisms underlying the clathrin-dependent endocytosis of synaptic vesicles."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-15T08:41:20Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002433"^^xsd:string ;
  rdfs:label "altered clathrin-dependent synaptic vesicle endocytosis"^^xsd:string ;
  skos:notation "PW:0002433"^^xsd:string .

ns1:PW_0002434
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001651 ;
  ns2:treeView ns1:PW_0001651 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of drugs that reduce or prevent the formation of blood clots.  They are further classified depending on the blood clotting processes they affect. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-25T14:43:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002434"^^xsd:string ;
  rdfs:label "other antithrombotic drug pathway"^^xsd:string ;
  skos:notation "PW:0002434"^^xsd:string .

ns1:PW_0002435
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002434 ;
  ns2:treeView ns1:PW_0002434 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of fondaparinux, a synthetic pentasaccharide factor Xa inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-25T14:48:41Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002435"^^xsd:string ;
  rdfs:label "fondaparinux drug pathway"^^xsd:string ;
  skos:notation "PW:0002435"^^xsd:string .

ns1:PW_0002436
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002435 ;
  ns2:treeView ns1:PW_0002435 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of fondaparinux. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-25T14:50:39Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002436"^^xsd:string ;
  rdfs:label "fondaparinux pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002436"^^xsd:string .

ns1:PW_0002437
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002435 ;
  ns2:treeView ns1:PW_0002435 ;
  ns1:IAO_0000115 "The pathway of fondaparinux-target interaction and of the biochemical or physiological responses to drug. Fondaparinux is a synthetic pentasaccharide factor Xa inhibitor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-25T14:51:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00273"^^xsd:string ;
  obo:id "PW:0002437"^^xsd:string ;
  rdfs:label "fondaparinux pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002437"^^xsd:string .

ns1:PW_0002438
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001593 ;
  ns2:treeView ns1:PW_0001593 ;
  ns1:IAO_0000115 "Congenital structural deformities caused by alterations in a number of pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-25T15:15:01Z"^^xsd:string ;
  obo:hasExactSynonym "congenital limb deformities disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002438"^^xsd:string ;
  rdfs:label "congenital limb deformities pathway"^^xsd:string ;
  skos:notation "PW:0002438"^^xsd:string .

ns1:PW_0002439
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001872, ns1:PW_0002438 ;
  ns2:treeView ns1:PW_0001872, ns1:PW_0002438 ;
  ns1:IAO_0000115 "An X-linked dominant disorder with a range of phenotypes and reduced activities of several enzymes in a number of metabolic pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-25T15:18:57Z"^^xsd:string ;
  obo:hasExactSynonym "congenital hemidysplasia with ichthyosiform erythroderma and limb defects disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "CHILD syndrome pathway"^^xsd:string, "SMP:00387"^^xsd:string ;
  obo:id "PW:0002439"^^xsd:string ;
  rdfs:label "congenital hemidysplasia with ichthyosiform erythroderma and limb defects pathway"^^xsd:string ;
  skos:notation "PW:0002439"^^xsd:string .

ns1:PW_0002440
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002243 ;
  ns2:treeView ns1:PW_0002243 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of levobupivacaine, a drug used as a local anesthetic. It is the S-enantiomer of bupivacaine compared to which, it has a longer duration of action and is associated with less vasodilation. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-25T15:24:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002440"^^xsd:string ;
  rdfs:label "levobupivacaine drug pathway"^^xsd:string ;
  skos:notation "PW:0002440"^^xsd:string .

ns1:PW_0002441
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002440 ;
  ns2:treeView ns1:PW_0002440 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of levobupivacaine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-25T15:25:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002441"^^xsd:string ;
  rdfs:label "levobupivacaine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002441"^^xsd:string .

ns1:PW_0002442
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002440 ;
  ns2:treeView ns1:PW_0002440 ;
  ns1:IAO_0000115 "The pathway of levobupivacaine-target interaction and of the biochemical or physiological responses to drug.  It is the S-enantiomer of bupivacaine compared to which, it has a longer duration of action and is associated with less vasodilation. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-25T15:25:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00397"^^xsd:string ;
  obo:id "PW:0002442"^^xsd:string ;
  rdfs:label "levobupivacaine phgarmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002442"^^xsd:string .

ns1:PW_0002443
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001546 ;
  ns2:treeView ns1:PW_0001546 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of compounds used to alleviate pain and which act on the nervous system in a way similar to opiate. They can be natural opiates, like morphine or codeine, endogenous opioid peptide, like endorphins, semi- or fully synthetic opioids, or drugs that chemically are not of the opioid class but act as agonists of opioid receptors. Others can act as antagonists or mixed agonists/antagonists. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-26T09:21:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002443"^^xsd:string ;
  rdfs:label "opioid drug pathway"^^xsd:string ;
  skos:notation "PW:0002443"^^xsd:string .

ns1:PW_0002444
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002443 ;
  ns2:treeView ns1:PW_0002443 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of oxycodone, a semi-synthetic opioid and a narcotic analgesic indicated for relief of moderate to severe pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-26T09:38:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002444"^^xsd:string ;
  rdfs:label "oxycodone drug pathway"^^xsd:string ;
  skos:notation "PW:0002444"^^xsd:string .

ns1:PW_0002445
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002444 ;
  ns2:treeView ns1:PW_0002444 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of oxycodone. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-26T09:39:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002445"^^xsd:string ;
  rdfs:label "oxycodone pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002445"^^xsd:string .

ns1:PW_0002446
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002444 ;
  ns2:treeView ns1:PW_0002444 ;
  ns1:IAO_0000115 "The pathway of oxycodone-target interaction and of the biochemical or physiological responses to drug. It is thought to act on different opioid receptors in different situations. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-26T09:39:50Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00409"^^xsd:string ;
  obo:id "PW:0002446"^^xsd:string ;
  rdfs:label "oxycodone pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002446"^^xsd:string .

ns1:PW_0002447
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002443 ;
  ns2:treeView ns1:PW_0002443 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of hydromorphone, a derivative of the morphine family and a potent analgesic opioid drug and a narcotic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-26T09:49:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002447"^^xsd:string ;
  rdfs:label "hydromorphone drug pathway"^^xsd:string ;
  skos:notation "PW:0002447"^^xsd:string .

ns1:PW_0002448
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002447 ;
  ns2:treeView ns1:PW_0002447 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of hydromorphone. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-26T09:49:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002448"^^xsd:string ;
  rdfs:label "hydromorphone pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002448"^^xsd:string .

ns1:PW_0002449
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002447 ;
  ns2:treeView ns1:PW_0002447 ;
  ns1:IAO_0000115 "The pathway of hydromorphone-target interaction and of the biochemical or physiological responses to drug. The drug is a mu-receptor agonist whose major effects are on the central nervous system and gastrointestinal tract. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-26T09:50:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00410"^^xsd:string ;
  obo:id "PW:0002449"^^xsd:string ;
  rdfs:label "hydromorphone pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002449"^^xsd:string .

ns1:PW_0002450
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002443 ;
  ns2:treeView ns1:PW_0002443 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of hydrocodone, a narcotic analgesic synthesized from codeine and used for relief of moderate to severe pain. It is also used as an antitussive to treat cough. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-26T10:01:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002450"^^xsd:string ;
  rdfs:label "hydrocodone drug pathway"^^xsd:string ;
  skos:notation "PW:0002450"^^xsd:string .

ns1:PW_0002451
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002450 ;
  ns2:treeView ns1:PW_0002450 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of hydrocodone. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-26T10:01:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002451"^^xsd:string ;
  rdfs:label "hydrocodone pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002451"^^xsd:string .

ns1:PW_0002452
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002450 ;
  ns2:treeView ns1:PW_0002450 ;
  ns1:IAO_0000115 "The pathway of hydrocodone-target interaction and of the biochemical or physiological responses to drug. It primarily acts on the mu-opioid receptor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-26T10:02:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00411"^^xsd:string ;
  obo:id "PW:0002452"^^xsd:string ;
  rdfs:label "hydrocodone pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002452"^^xsd:string .

ns1:PW_0002453
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002443 ;
  ns2:treeView ns1:PW_0002443 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of oxymorphone, a semi-synthetic opioid analgesic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-26T10:08:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002453"^^xsd:string ;
  rdfs:label "oxymorphone drug pathway"^^xsd:string ;
  skos:notation "PW:0002453"^^xsd:string .

ns1:PW_0002454
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002453 ;
  ns2:treeView ns1:PW_0002453 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of oxymorphone. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-26T10:08:39Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002454"^^xsd:string ;
  rdfs:label "oxymorphone pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002454"^^xsd:string .

ns1:PW_0002455
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002453 ;
  ns2:treeView ns1:PW_0002453 ;
  ns1:IAO_0000115 "The pathway of oxymorphone-target interaction and of the biochemical or physiological responses to drug. It acts on the mu-opioid receptor and to a lesser extent, the delta receptor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-26T10:09:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00412"^^xsd:string ;
  obo:id "PW:0002455"^^xsd:string ;
  rdfs:label "oxymorphone pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002455"^^xsd:string .

ns1:PW_0002456
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001546, ns1:PW_0002150, ns1:PW_0002159, ns1:PW_0002459 ;
  ns2:treeView ns1:PW_0001546, ns1:PW_0002150, ns1:PW_0002159, ns1:PW_0002459 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of salicylic acid derived from salicin, an anti-inflammatory agent produced in willow bark. It is best known for its use in anti-acne products. As a drug, it is used in the treatment of pain and inflammation and to reduce fever. Its salts and esters are known as salicylates. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-27T10:17:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002456"^^xsd:string ;
  rdfs:label "salicylic acid drug pathway"^^xsd:string ;
  skos:notation "PW:0002456"^^xsd:string .

ns1:PW_0002457
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002456 ;
  ns2:treeView ns1:PW_0002456 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of salicylic acid. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-27T10:18:52Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002457"^^xsd:string ;
  rdfs:label "salicylic acid pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002457"^^xsd:string .

ns1:PW_0002458
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002456 ;
  ns2:treeView ns1:PW_0002456 ;
  ns1:IAO_0000115 "The pathway of salicylic acid-target interaction and of the biochemical or physiological responses to drug. Salicylic acid is used in the treatment of pain and inflammation and to reduce fever. Salts and esters of salicylic acid are known as salicylates. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-27T10:19:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00709"^^xsd:string ;
  obo:id "PW:0002458"^^xsd:string ;
  rdfs:label "salicylic acid pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002458"^^xsd:string .

ns1:PW_0002459
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000754 ;
  ns2:treeView ns1:PW_0000754 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of compounds used for the treatment of conditions related to skin, hair and nails. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-27T10:35:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002459"^^xsd:string ;
  rdfs:label "dermatological drug pathway"^^xsd:string ;
  skos:notation "PW:0002459"^^xsd:string .

ns1:PW_0002460
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001546 ;
  ns2:treeView ns1:PW_0001546 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of sodium salicylate, a sodium salt of salicylic acid, used as an analgesic and antipyretic drug. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-27T10:45:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002460"^^xsd:string ;
  rdfs:label "sodium salicylate drug pathway"^^xsd:string ;
  skos:notation "PW:0002460"^^xsd:string .

ns1:PW_0002461
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002460 ;
  ns2:treeView ns1:PW_0002460 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of sodium salicylate. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-27T10:45:51Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002461"^^xsd:string ;
  rdfs:label "sodium salicylate pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002461"^^xsd:string .

ns1:PW_0002462
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002460 ;
  ns2:treeView ns1:PW_0002460 ;
  ns1:IAO_0000115 "The pathway of salicylic acid-target interaction and of the biochemical or physiological responses to drug. Sodium salicylate is used as an analgesic and antipyretic. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-27T10:46:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00708"^^xsd:string ;
  obo:id "PW:0002462"^^xsd:string ;
  rdfs:label "sodium salicylate pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002462"^^xsd:string .

ns1:PW_0002463
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002295 ;
  ns2:treeView ns1:PW_0002295 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of carbamazepine, a drug used in the treatment of epilepsy and neuropathic pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-29T08:38:19Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002463"^^xsd:string ;
  rdfs:label "carbamazepine drug pathway"^^xsd:string ;
  skos:notation "PW:0002463"^^xsd:string .

ns1:PW_0002464
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002463 ;
  ns2:treeView ns1:PW_0002463 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of carbamazepine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-29T08:40:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00634"^^xsd:string ;
  obo:id "PW:0002464"^^xsd:string ;
  rdfs:label "carbamazepine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002464"^^xsd:string .

ns1:PW_0002465
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002463 ;
  ns2:treeView ns1:PW_0002463 ;
  ns1:IAO_0000115 "The pathway of carbamazepine-target interaction and of the biochemical or physiological responses to drug. Carbamazepine is used in the treatment of epilepsy and neuropathic pain. The drug stabilizes the inactivated state of voltage-gated sodium channels and can also act as a GABA receptor agonist. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-29T08:41:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002465"^^xsd:string ;
  rdfs:label "carbamazepine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002465"^^xsd:string .

ns1:PW_0002466
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002102 ;
  ns2:treeView ns1:PW_0002102 ;
  ns1:IAO_0000115 "An autosomal recessive condition resulting from alterations in steroid metabolism due to defects in HSD11B2 gene."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-29T09:12:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00717"^^xsd:string ;
  obo:id "PW:0002466"^^xsd:string ;
  rdfs:label "apparent mineralocorticoid excess syndrome pathway"^^xsd:string ;
  skos:notation "PW:0002466"^^xsd:string .

ns1:PW_0002467
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001644 ;
  ns2:treeView ns1:PW_0001644 ;
  ns1:IAO_0000115 "A hereditary, usually autosomal dominant condition, resulting from alterations in glucose transport, affecting the nervous system and exhibiting a wide phenotypic variability."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-29T09:19:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00580"^^xsd:string ;
  obo:id "PW:0002467"^^xsd:string ;
  rdfs:label "Glut1 deficiency syndrome pathway"^^xsd:string ;
  skos:notation "PW:0002467"^^xsd:string .

ns1:PW_0002468
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001894 ;
  ns2:treeView ns1:PW_0001894 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of felodipine, a calcium channel blocker used for the treatment of high blood pressure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-29T09:37:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002468"^^xsd:string ;
  rdfs:label "felodipine drug pathway"^^xsd:string ;
  skos:notation "PW:0002468"^^xsd:string .

ns1:PW_0002469
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002468 ;
  ns2:treeView ns1:PW_0002468 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of felodipine. The drug is a calcium channel blocker used in the treatment of high blood pressure.  Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-29T09:37:50Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00619"^^xsd:string ;
  obo:id "PW:0002469"^^xsd:string ;
  rdfs:label "felodipine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002469"^^xsd:string .

ns1:PW_0002470
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002468 ;
  ns2:treeView ns1:PW_0002468 ;
  ns1:IAO_0000115 "The pathway of felodipine-target interaction and of the biochemical or physiological responses to drug. The drug is a calcium channel blocker used for the treatment of high blood pressure.  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-01-29T09:38:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002470"^^xsd:string ;
  rdfs:label "felodipine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002470"^^xsd:string .

ns1:PW_0002471
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "A condition resulting from alterations in the methionine cycle/metabolism."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-02T11:18:05Z"^^xsd:string ;
  obo:hasExactSynonym "hypermethioninemia disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00341"^^xsd:string ;
  obo:id "PW:0002471"^^xsd:string ;
  rdfs:label "hypermethioninemia pathway"^^xsd:string ;
  skos:notation "PW:0002471"^^xsd:string .

ns1:PW_0002472
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002114 ;
  ns2:treeView ns1:PW_0002114 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of compounds used to treat various forms of depression."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-02T11:56:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002472"^^xsd:string ;
  rdfs:label "other antidepressant drug pathway"^^xsd:string ;
  skos:notation "PW:0002472"^^xsd:string .

ns1:PW_0002473
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002472 ;
  ns2:treeView ns1:PW_0002472 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of venlafaxine, a drug used in the treatment of major depressive, anxiety and panic disorders. The drug inhibits the reuptake of key neurotransmitters such as serotonin, epinephrine and dopamine. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-02T11:58:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002473"^^xsd:string ;
  rdfs:label "venlafaxine drug pathway"^^xsd:string ;
  skos:notation "PW:0002473"^^xsd:string .

ns1:PW_0002474
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002473 ;
  ns2:treeView ns1:PW_0002473 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of venlafaxine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-02T11:58:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00636"^^xsd:string ;
  obo:id "PW:0002474"^^xsd:string ;
  rdfs:label "venlafaxine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002474"^^xsd:string .

ns1:PW_0002475
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002473 ;
  ns2:treeView ns1:PW_0002473 ;
  ns1:IAO_0000115 "The pathway of venlafaxiine-target interaction and of the biochemical or physiological responses to drug. The drug inhibits the reuptake of key neurotransmitters such as serotonin, epinephrine and dopamine. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-02T11:59:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002475"^^xsd:string ;
  rdfs:label "venlafaxine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002475"^^xsd:string .

ns1:PW_0002476
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000723 ;
  ns2:treeView ns1:PW_0000723 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of rosiglitazone, an anti-diabetic drug. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug. In several countries the drug was withdrawn from the market due to its side effects."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-02T12:09:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002476"^^xsd:string ;
  rdfs:label "rosiglitazone drug pathway"^^xsd:string ;
  skos:notation "PW:0002476"^^xsd:string .

ns1:PW_0002477
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002476 ;
  ns2:treeView ns1:PW_0002476 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of rosiglitazone, an anti-diabetic drug. Genetic variations can result in changes in the availability of the drug. In several countries the drug was withdrawn from the market due to its side effects."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-02T12:10:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00653"^^xsd:string ;
  obo:id "PW:0002477"^^xsd:string ;
  rdfs:label "rosiglitazone pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002477"^^xsd:string .

ns1:PW_0002478
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002476 ;
  ns2:treeView ns1:PW_0002476 ;
  ns1:IAO_0000115 "The pathway of rosiglitazone-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug.  In several countries rosiglitazone was withdrawn from the market due to its side effects."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-02T12:11:39Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002478"^^xsd:string ;
  rdfs:label "rosiglitazone pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002478"^^xsd:string .

ns1:PW_0002479
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001697 ;
  ns2:treeView ns1:PW_0001697 ;
  ns1:IAO_0000115 "The various conditions affecting any part of the biliary tract including the bile ducts,  resulting from alterations in one or several pathways."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-03T15:17:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002479"^^xsd:string ;
  rdfs:label "biliary tract disease pathway"^^xsd:string ;
  skos:notation "PW:0002479"^^xsd:string .

ns1:PW_0002480
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002479 ;
  ns2:treeView ns1:PW_0002479 ;
  ns1:IAO_0000115 "A condition where bile cannot flow from the liver to the duodenum which can be mechanical in nature as in blockage of the duct system or metabolic, resulting from alterations in bile formation due to genetic or environmental factors."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-03T15:22:30Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002480"^^xsd:string ;
  rdfs:label "cholestasis pathway"^^xsd:string ;
  skos:notation "PW:0002480"^^xsd:string .

ns1:PW_0002481
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002102, ns1:PW_0002480 ;
  ns2:treeView ns1:PW_0002102, ns1:PW_0002480 ;
  ns1:IAO_0000115 "Autosomal recessive disorders resulting from alterations in bile acid synthesis due to defects in one or several enzymes. Type 1 is due to mutations in the HSD3B7 gene, type 2 is due to mutations in the AKR1D1 gene, type 3 is due to mutations in the CYP7B1 gene."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-03T15:27:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00314"^^xsd:string, "SMP:00318"^^xsd:string ;
  obo:id "PW:0002481"^^xsd:string ;
  rdfs:label "congenital bile acid synthesis defect pathway"^^xsd:string ;
  skos:notation "PW:0002481"^^xsd:string .

ns1:PW_0002482
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002243 ;
  ns2:treeView ns1:PW_0002243 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of chloroprocaine, a drug used as a local anesthetic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-04T14:08:03Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002482"^^xsd:string ;
  rdfs:label "chloroprocaine drug pathway"^^xsd:string ;
  skos:notation "PW:0002482"^^xsd:string .

ns1:PW_0002483
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002482 ;
  ns2:treeView ns1:PW_0002482 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of chloroprocaine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-04T14:08:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002483"^^xsd:string ;
  rdfs:label "chloroprocaine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002483"^^xsd:string .

ns1:PW_0002484
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002482 ;
  ns2:treeView ns1:PW_0002482 ;
  ns1:IAO_0000115 "The pathway of chloroprocaine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-04T14:09:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00394"^^xsd:string ;
  obo:id "PW:0002484"^^xsd:string ;
  rdfs:label "chloroprocaine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002484"^^xsd:string .

ns1:PW_0002485
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000921, ns1:PW_0000924, ns1:PW_0001203, ns1:PW_0002159, ns1:PW_0002459 ;
  ns2:treeView ns1:PW_0000921, ns1:PW_0000924, ns1:PW_0001203, ns1:PW_0002159, ns1:PW_0002459 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of prednisolone - a synthetic glucocorticoid used to treat a wide range of inflammatory and autoimmune conditions, and also allergic reactions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-04T14:20:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002485"^^xsd:string ;
  rdfs:label "prednisolone drug pathway"^^xsd:string ;
  skos:notation "PW:0002485"^^xsd:string .

ns1:PW_0002486
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002485 ;
  ns2:treeView ns1:PW_0002485 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of prednisolone, a synthetic glucocorticoid. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-04T14:21:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00632"^^xsd:string ;
  obo:id "PW:0002486"^^xsd:string ;
  rdfs:label "prednisolone pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002486"^^xsd:string .

ns1:PW_0002487
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002485 ;
  ns2:treeView ns1:PW_0002485 ;
  ns1:IAO_0000115 "The pathway of prednisolone-target interaction and of the biochemical or physiological responses to drug. used to treat a wide range of inflammatory and autoimmune conditions, and also allergic reactions. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-04T14:21:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00441"^^xsd:string ;
  obo:id "PW:0002487"^^xsd:string ;
  rdfs:label "prednisolone pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002487"^^xsd:string .

ns1:PW_0002488
  a owl:Class ;
  ns1:IAO_0000231 ns1:IAO_0000227 ;
  ns1:IAO_0100001 ns1:PW_0000920 ;
  owl:deprecated true ;
  skos:notation "PW:0002488"^^xsd:string .

ns1:PW_0002489
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000059, ns1:PW_0000466, ns1:PW_0001162 ;
  ns2:treeView ns1:PW_0000059, ns1:PW_0000466, ns1:PW_0001162 ;
  ns1:IAO_0000115 "Melatonin, in human and other organisms derived from tryptophan, is a monoamine with antioxidant properties and involved in the synchronization of the circadian rhythms. Melatonin signals through three receptors types of which two are present in humans and other mammals. They are G protein coupled receptors (GPCR)."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-05T12:33:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002489"^^xsd:string ;
  rdfs:label "melatonin signaling pathway"^^xsd:string ;
  skos:notation "PW:0002489"^^xsd:string .

ns1:PW_0002490
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000456 ;
  ns2:treeView ns1:PW_0000456 ;
  ns1:IAO_0000115 "Glycine signaling is primarily inhibitory. The glycine receptor is ligand-gated ion channel that exerts its effects via chloride currents."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-05T13:27:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002490"^^xsd:string ;
  rdfs:label "glycine signaling pathway"^^xsd:string ;
  skos:notation "PW:0002490"^^xsd:string .

ns1:PW_0002491
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001589 ;
  ns2:treeView ns1:PW_0001589 ;
  ns1:IAO_0000115 "An autosomal recessive condition resulting from alteration in leukotriene C4 synthesis due to defects in the LTC4 synthase gene."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-09T11:43:14Z"^^xsd:string ;
  obo:hasExactSynonym "LTC4 synthase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00353"^^xsd:string ;
  obo:id "PW:0002491"^^xsd:string ;
  rdfs:label "leukotriene C4 synthase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002491"^^xsd:string .

ns1:PW_0002492
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002325 ;
  ns2:treeView ns1:PW_0002325 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of phenindione. The drug is used as anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-09T11:48:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002492"^^xsd:string ;
  rdfs:label "phenindione drug pathway"^^xsd:string ;
  skos:notation "PW:0002492"^^xsd:string .

ns1:PW_0002493
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002492 ;
  ns2:treeView ns1:PW_0002492 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of phenindione.  Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-09T11:49:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002493"^^xsd:string ;
  rdfs:label "phenindione pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002493"^^xsd:string .

ns1:PW_0002494
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002492 ;
  ns2:treeView ns1:PW_0002492 ;
  ns1:IAO_0000115 "The pathway of phenindione-target interaction and of the biochemical or physiological responses to drug. Phenindione is used as anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-09T11:49:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00655"^^xsd:string ;
  obo:id "PW:0002494"^^xsd:string ;
  rdfs:label "phenindione pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002494"^^xsd:string .

ns1:PW_0002495
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002325 ;
  ns2:treeView ns1:PW_0002325 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of dicoumarol. Dicoumarol is a naturally occurring anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-09T11:55:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "dicumarol drug pathway"^^xsd:string ;
  obo:id "PW:0002495"^^xsd:string ;
  rdfs:label "dicoumarol drug pathway"^^xsd:string ;
  skos:notation "PW:0002495"^^xsd:string .

ns1:PW_0002496
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002495 ;
  ns2:treeView ns1:PW_0002495 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of dicoumarol.  Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-09T11:55:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "dicumarol pharmacokinetics pathway"^^xsd:string ;
  obo:id "PW:0002496"^^xsd:string ;
  rdfs:label "dicoumarol pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002496"^^xsd:string .

ns1:PW_0002497
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002495 ;
  ns2:treeView ns1:PW_0002495 ;
  ns1:IAO_0000115 "The pathway of dicoumarol-target interaction and of the biochemical or physiological responses to drug.  Dicoumarol is a naturally occurring anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-09T11:56:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00270"^^xsd:string, "SMP:00656"^^xsd:string, "dicumarol pharmacodynamics pathway"^^xsd:string ;
  obo:id "PW:0002497"^^xsd:string ;
  rdfs:label "dicoumarol pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002497"^^xsd:string .

ns1:PW_0002498
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000920 ;
  ns2:treeView ns1:PW_0000920 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of adrenergic beta receptors agonists. The drugs can be either selective or non-selective. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-10T10:19:22Z"^^xsd:string ;
  obo:hasAlternativeId "PW:0001736"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002498"^^xsd:string ;
  rdfs:label "adrenergic beta receptor agonist drug pathway"^^xsd:string ;
  skos:notation "PW:0002498"^^xsd:string .

ns1:PW_0002499
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002498 ;
  ns2:treeView ns1:PW_0002498 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of selective adrenergic beta receptors agonists. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-10T10:22:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002499"^^xsd:string ;
  rdfs:label "adrenergic beta receptor selective agonist drug pathway"^^xsd:string ;
  skos:notation "PW:0002499"^^xsd:string .

ns1:PW_0002500
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002498 ;
  ns2:treeView ns1:PW_0002498 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of non-selective adrenergic beta receptors agonists. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-10T10:23:09Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002500"^^xsd:string ;
  rdfs:label "adrenergic beta receptor non-selective agonist drug pathway"^^xsd:string ;
  skos:notation "PW:0002500"^^xsd:string .

ns1:PW_0002501
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002500 ;
  ns2:treeView ns1:PW_0002500 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of isoprenaline, a non-selective beta adrenergic agonist used for the treatment of heart block and slow heart rate. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-10T10:36:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002501"^^xsd:string ;
  rdfs:label "isoprenaline drug pathway"^^xsd:string ;
  skos:notation "PW:0002501"^^xsd:string .

ns1:PW_0002502
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002501 ;
  ns2:treeView ns1:PW_0002501 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of isoprenaline. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-10T10:39:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002502"^^xsd:string ;
  rdfs:label "isoprenaline pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002502"^^xsd:string .

ns1:PW_0002503
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002501 ;
  ns2:treeView ns1:PW_0002501 ;
  ns1:IAO_0000115 "The pathway of isoprenaline-target interaction and of the biochemical or physiological responses to drug. The drug is a non-selective beta adrenergic agonist used for the treatment of heart block and slow heart rate.  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-10T10:40:01Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00663"^^xsd:string ;
  obo:id "PW:0002503"^^xsd:string ;
  rdfs:label "isoprenaline pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002503"^^xsd:string .

ns1:PW_0002504
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001547 ;
  ns2:treeView ns1:PW_0001547 ;
  ns1:IAO_0000115 "Those conditions resulting from alterations in one or several pathways and affecting the adrenal glands. The adrenal glands are the site of synthesis for a variety of hormones."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-10T10:56:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002504"^^xsd:string ;
  rdfs:label "adrenal gland disease pathway"^^xsd:string ;
  skos:notation "PW:0002504"^^xsd:string .

ns1:PW_0002505
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001646, ns1:PW_0001878, ns1:PW_0002504 ;
  ns2:treeView ns1:PW_0001646, ns1:PW_0001878, ns1:PW_0002504 ;
  ns1:IAO_0000115 "An X-linked disorder resulting from disturbances in the metabolism of very long chain fatty acids due to defects in the ABCD1 gene."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-10T10:59:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00516"^^xsd:string ;
  obo:id "PW:0002505"^^xsd:string ;
  rdfs:label "adrenoleukodystrophy pathway"^^xsd:string ;
  skos:notation "PW:0002505"^^xsd:string .

ns1:PW_0002506
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001643 ;
  ns2:treeView ns1:PW_0001643 ;
  ns1:IAO_0000115 "A rare autosomal recessive condition resulting from alteration in long-fatty acid oxidation and due to defects in the SLC25A20 gene."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-12T08:39:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00517"^^xsd:string ;
  obo:id "PW:0002506"^^xsd:string ;
  rdfs:label "carnitine-acylcarnitine translocase deficiency"^^xsd:string ;
  skos:notation "PW:0002506"^^xsd:string .

ns1:PW_0002507
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002369 ;
  ns2:treeView ns1:PW_0002369 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of mycophenolic acid - an immunosuppressant drug used to prevent rejection in organ transplantation. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-12T08:51:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002507"^^xsd:string ;
  rdfs:label "mycophenolic acid drug pathway"^^xsd:string ;
  skos:notation "PW:0002507"^^xsd:string .

ns1:PW_0002508
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002507 ;
  ns2:treeView ns1:PW_0002507 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of mycophenolic acid. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-12T08:52:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00652"^^xsd:string ;
  obo:id "PW:0002508"^^xsd:string ;
  rdfs:label "mycophenolic acid pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002508"^^xsd:string .

ns1:PW_0002509
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002507 ;
  ns2:treeView ns1:PW_0002507 ;
  ns1:IAO_0000115 "The pathway of mycophenolic acid-target interaction and of the biochemical or physiological responses to drug. Mycophenolic acid is used as an immunosuppressant to prevent organ rejection in transplantation. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-12T08:53:23Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002509"^^xsd:string ;
  rdfs:label "mycophenolic acid pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002509"^^xsd:string .

ns1:PW_0002510
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000443 ;
  ns2:treeView ns1:PW_0000443 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the degradation of catecholamines. Epinephrine, norepinephrine and dopamine are among the most abundant."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-16T11:08:22Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002510"^^xsd:string ;
  rdfs:label "catecholamine degradation pathway"^^xsd:string ;
  skos:notation "PW:0002510"^^xsd:string .

ns1:PW_0002511
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000409, ns1:PW_0002510 ;
  ns2:treeView ns1:PW_0000409, ns1:PW_0002510 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the degradation of dopamine. Dopamine degradation can be initiated by two enzymes. Dopamine can spontaneously oxidize and in the process, radicals are being produced. Storage of newly synthesized dopamine or degradation of excess cytosolic dopamine prevent oxidation of dopamine."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-16T11:10:38Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002511"^^xsd:string ;
  rdfs:label "dopamine degradation pathway"^^xsd:string ;
  skos:notation "PW:0002511"^^xsd:string .

ns1:PW_0002512
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000441, ns1:PW_0002510 ;
  ns2:treeView ns1:PW_0000441, ns1:PW_0002510 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the degradation of epinephrine."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-16T11:10:56Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002512"^^xsd:string ;
  rdfs:label "epinephrine degradation pathway"^^xsd:string ;
  skos:notation "PW:0002512"^^xsd:string .

ns1:PW_0002513
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000442, ns1:PW_0002510 ;
  ns2:treeView ns1:PW_0000442, ns1:PW_0002510 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the degradation of norepinephrine."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-16T11:11:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002513"^^xsd:string ;
  rdfs:label "norepinephrine degradation pathway"^^xsd:string ;
  skos:notation "PW:0002513"^^xsd:string .

ns1:PW_0002514
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001170 ;
  ns2:treeView ns1:PW_0001170 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of tiaprofenic acid, a non-steroidal anti-inflammatory drug used  to treat pain, especially arthritic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-16T12:29:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002514"^^xsd:string ;
  rdfs:label "tiaprofenic acid drug pathway"^^xsd:string ;
  skos:notation "PW:0002514"^^xsd:string .

ns1:PW_0002515
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002514 ;
  ns2:treeView ns1:PW_0002514 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-16T12:32:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002515"^^xsd:string ;
  rdfs:label "tiaprofenic acid pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002515"^^xsd:string .

ns1:PW_0002516
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002514 ;
  ns2:treeView ns1:PW_0002514 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-16T12:34:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00705"^^xsd:string ;
  obo:id "PW:0002516"^^xsd:string ;
  rdfs:label "tiaprofenic acid pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002516"^^xsd:string .

ns1:PW_0002517
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001757 ;
  ns2:treeView ns1:PW_0001757 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of thyroid-stimulating hormone (TSH). TSH is a pituitary hormone that stimulates the thyroid gland to produce thyroxine (T4) and then triiodothyronine (T3). T3 is the active thyroid hormone that stimulates cellular metabolism."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-19T09:00:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "TSH biosynthetic pathway"^^xsd:string, "thyrotropin biosynthetic pathway"^^xsd:string ;
  obo:id "PW:0002517"^^xsd:string ;
  rdfs:label "thyroid-stimulating hormone biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0002517"^^xsd:string .

ns1:PW_0002518
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001757 ;
  ns2:treeView ns1:PW_0001757 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis of thyrotropin-releasing hormone (TRH). TRH is a tripeptidal hormone produced in the hypothalamus that stimulates the release of thyroid-stimulating hormone and prolactin from the anterior pituitary."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-19T09:00:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "TRH biosynthetic pathway"^^xsd:string, "thyroliberin biosynthetic pathway"^^xsd:string, "thyrotropin-releasing factor biosynthetic pathway"^^xsd:string ;
  obo:id "PW:0002518"^^xsd:string ;
  rdfs:label "thyrotropin-releasing hormone biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0002518"^^xsd:string .

ns1:PW_0002519
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001757 ;
  ns2:treeView ns1:PW_0001757 ;
  ns1:IAO_0000115 "Somatostatin, known as growth hormone-inhibiting hormone, is a peptide hormone that regulates cell proliferation, neurotransmission and the endocrine system."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-19T09:22:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002519"^^xsd:string ;
  rdfs:label "somatostatin biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0002519"^^xsd:string .

ns1:PW_0002520
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001757 ;
  ns2:treeView ns1:PW_0001757 ;
  ns1:IAO_0000115 "Thyroglobulin, produced by the follicular cells of thyroid gland is used to produce the thyroid hormones via a number of steps. Thyroglobulin contains some 100-120 tyrosine residues, of which only a small fraction is used to produce thyroid hormones. Usually there are 5 to 6 molecules of either thyroxine (T4) and triiodothyronine (T3) derived from each molecule of thyroglobulin."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-19T09:39:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002520"^^xsd:string ;
  rdfs:label "thyroglobulin processing pathway"^^xsd:string ;
  skos:notation "PW:0002520"^^xsd:string .

ns1:PW_0002521
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0002520
  ] ;
  ns2:treeView ns1:PW_0002520 ;
  ns3:part_of ns1:PW_0002520 ;
  ns1:IAO_0000115 "The major thyroid hormones thyroxine (T4) or tetraidothyronine and triiodothyronine (T3) are the major thyroid hormones produced via processing of thyroglobulin precursor. T3 is the active hormone and is derived from T4 by the action of deiodinases."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-19T09:46:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00716"^^xsd:string ;
  obo:id "PW:0002521"^^xsd:string ;
  rdfs:label "thyroid hormone biosynthetic pathway"^^xsd:string ;
  skos:notation "PW:0002521"^^xsd:string .

ns1:PW_0002522
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001170, ns1:PW_0002159 ;
  ns2:treeView ns1:PW_0001170, ns1:PW_0002159 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of flurbiprofen, a non-steroidal anti-inflammatory drug used  in the treatment of arthritis and dental pain and also as a pre-operative solution. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-22T15:27:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002522"^^xsd:string ;
  rdfs:label "flurbiprofen drug pathway"^^xsd:string ;
  skos:notation "PW:0002522"^^xsd:string .

ns1:PW_0002523
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002522 ;
  ns2:treeView ns1:PW_0002522 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of flurbiprofen. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-22T15:30:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002523"^^xsd:string ;
  rdfs:label "flurbiprofen pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002523"^^xsd:string .

ns1:PW_0002524
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002522 ;
  ns2:treeView ns1:PW_0002522 ;
  ns1:IAO_0000115 "The pathway of flurbiprofen-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of arthritis and dental pain and also as a pre-operative solution.  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-22T15:30:45Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00697"^^xsd:string ;
  obo:id "PW:0002524"^^xsd:string ;
  rdfs:label "flurbiprofen pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002524"^^xsd:string .

ns1:PW_0002525
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000924, ns1:PW_0002159, ns1:PW_0002443 ;
  ns2:treeView ns1:PW_0000924, ns1:PW_0002159, ns1:PW_0002443 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of ethylmorphine, an opiate narcotic analgesic mostly used to treat dry cough and as an ophtalmologic agent. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-22T15:38:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002525"^^xsd:string ;
  rdfs:label "ethylmorphine drug pathway"^^xsd:string ;
  skos:notation "PW:0002525"^^xsd:string .

ns1:PW_0002526
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002525 ;
  ns2:treeView ns1:PW_0002525 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of ethylmorphine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-22T15:43:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002526"^^xsd:string ;
  rdfs:label "ethylmorphine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002526"^^xsd:string .

ns1:PW_0002527
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002525 ;
  ns2:treeView ns1:PW_0002525 ;
  ns1:IAO_0000115 "The pathway of ethylmorphine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-22T15:44:28Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00681"^^xsd:string ;
  obo:id "PW:0002527"^^xsd:string ;
  rdfs:label "ethylmorphine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002527"^^xsd:string .

ns1:PW_0002528
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001546 ;
  ns2:treeView ns1:PW_0001546 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of magnesium salicylate, used as an analgesic and antipyretic drug. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-23T15:51:27Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002528"^^xsd:string ;
  rdfs:label "magnesium salicylate drug pathway"^^xsd:string ;
  skos:notation "PW:0002528"^^xsd:string .

ns1:PW_0002529
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002528 ;
  ns2:treeView ns1:PW_0002528 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-23T15:55:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002529"^^xsd:string ;
  rdfs:label "magnesium salicylate pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002529"^^xsd:string .

ns1:PW_0002530
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002528 ;
  ns2:treeView ns1:PW_0002528 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-23T15:56:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00698"^^xsd:string ;
  obo:id "PW:0002530"^^xsd:string ;
  rdfs:label "magnesium salicylate pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002530"^^xsd:string .

ns1:PW_0002531
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001646 ;
  ns2:treeView ns1:PW_0001646 ;
  ns1:IAO_0000115 "Inherited conditions characterized by a loss of myelin in the central nervous system."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-24T09:57:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002531"^^xsd:string ;
  rdfs:label "hereditary central nervous system demyelinating disease pathway"^^xsd:string ;
  skos:notation "PW:0002531"^^xsd:string .

ns1:PW_0002532
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002301, ns1:PW_0002531 ;
  ns2:treeView ns1:PW_0002301, ns1:PW_0002531 ;
  ns1:IAO_0000115 "An autosomal recessive condition resulting from alterations in cerebroside metabolism due to defects in the cerebroside sulfatase enzyme."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-24T09:59:33Z"^^xsd:string ;
  obo:hasExactSynonym "Scholz cerebral sclerosis pathway"^^xsd:string, "arylsulfatase A deficiency pathway"^^xsd:string, "deficiency of cerebroside-sulfatase pathway"^^xsd:string, "metachromatic leukodystrophy disease pathway"^^xsd:string, "sulfatide lipoidosis pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "MLD pathway"^^xsd:string, "SMP:00347"^^xsd:string ;
  obo:id "PW:0002532"^^xsd:string ;
  rdfs:label "metachromatic leukodystrophy pathway"^^xsd:string ;
  skos:notation "PW:0002532"^^xsd:string .

ns1:PW_0002533
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002243 ;
  ns2:treeView ns1:PW_0002243 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of cocaine, a drug of few medical uses, mostly as a local anesthetic during surgery. Cocaine is highly addictive due to its effects on the reward system in the brain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-24T10:09:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002533"^^xsd:string ;
  rdfs:label "cocaine drug pathway"^^xsd:string ;
  skos:notation "PW:0002533"^^xsd:string .

ns1:PW_0002534
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002533 ;
  ns2:treeView ns1:PW_0002533 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of cocaine, a drug of limited medical uses. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-24T10:10:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002534"^^xsd:string ;
  rdfs:label "cocaine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002534"^^xsd:string .

ns1:PW_0002535
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002533 ;
  ns2:treeView ns1:PW_0002533 ;
  ns1:IAO_0000115 "The pathway of cocaine-target interaction and of the biochemical or physiological responses to drug. Cocaine has few medical uses, mostly as local anesthetic during surgery. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-24T10:10:35Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00395"^^xsd:string ;
  obo:id "PW:0002535"^^xsd:string ;
  rdfs:label "cocaine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002535"^^xsd:string .

ns1:PW_0002536
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002243, ns1:PW_0002336 ;
  ns2:treeView ns1:PW_0002243, ns1:PW_0002336 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of lidocaine, an important class 1b antiarrhythmic drug also used as a local anesthetic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-24T10:24:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002536"^^xsd:string ;
  rdfs:label "lidocaine drug pathway"^^xsd:string ;
  skos:notation "PW:0002536"^^xsd:string .

ns1:PW_0002537
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002536 ;
  ns2:treeView ns1:PW_0002536 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of lidocaine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-24T10:26:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00620"^^xsd:string ;
  obo:id "PW:0002537"^^xsd:string ;
  rdfs:label "lidocaine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002537"^^xsd:string .

ns1:PW_0002538
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002536 ;
  ns2:treeView ns1:PW_0002536 ;
  ns1:IAO_0000115 "The pathway of lidocaine-target interaction and of the biochemical or physiological responses to drug. Lidocaine is an important class 1b antiarrhythmic drug also used as a local anesthetic. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-24T10:26:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00328"^^xsd:string, "SMP:00398"^^xsd:string ;
  obo:id "PW:0002538"^^xsd:string ;
  rdfs:label "lidocaine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002538"^^xsd:string .

ns1:PW_0002539
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002159, ns1:PW_0002243 ;
  ns2:treeView ns1:PW_0002159, ns1:PW_0002243 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of oxybuprocaine, a drug used as a local anesthetic, particularly in ophtalmology and otolaryngology. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-25T08:41:40Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002539"^^xsd:string ;
  rdfs:label "oxybuprocaine drug pathway"^^xsd:string ;
  skos:notation "PW:0002539"^^xsd:string .

ns1:PW_0002540
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002539 ;
  ns2:treeView ns1:PW_0002539 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of oxybuprocaine. Genetic variations can result in changes in the availability of the drug.  Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-25T08:42:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002540"^^xsd:string ;
  rdfs:label "oxybuprocaine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002540"^^xsd:string .

ns1:PW_0002541
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002539 ;
  ns2:treeView ns1:PW_0002539 ;
  ns1:IAO_0000115 "The pathway of oxybuprocaine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-25T08:43:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00400"^^xsd:string ;
  obo:id "PW:0002541"^^xsd:string ;
  rdfs:label "oxybuprocaine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002541"^^xsd:string .

ns1:PW_0002542
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002443 ;
  ns2:treeView ns1:PW_0002443 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of dihydromorphine, a semi-synthetic opioid used for the management of moderate to severe pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-25T08:55:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002542"^^xsd:string ;
  rdfs:label "dihydromorphine drug pathway"^^xsd:string ;
  skos:notation "PW:0002542"^^xsd:string .

ns1:PW_0002543
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002542 ;
  ns2:treeView ns1:PW_0002542 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of dihydrolmorphine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-25T08:56:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002543"^^xsd:string ;
  rdfs:label "dihydromorphine pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002543"^^xsd:string .

ns1:PW_0002544
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002542 ;
  ns2:treeView ns1:PW_0002542 ;
  ns1:IAO_0000115 "The pathway of dihydromorphine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-25T08:56:41Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00689"^^xsd:string ;
  obo:id "PW:0002544"^^xsd:string ;
  rdfs:label "dihydromorphine pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002544"^^xsd:string .

ns1:PW_0002545
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001472 ;
  ns2:treeView ns1:PW_0001472 ;
  ns1:IAO_0000115 "A disturbance that leads to changes in the body's normal balance of acids and bases resulting in deviation from the normal  pH range. The imbalance is due to changes in renal or ventilation function. The changes can lead to an excess of acid, acidosis or acidaemia, or to an excess of vases, alkalosis or alkalemia."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-26T09:11:42Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002545"^^xsd:string ;
  rdfs:label "acid-base imbalance pathway"^^xsd:string ;
  skos:notation "PW:0002545"^^xsd:string .

ns1:PW_0002546
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002545 ;
  ns2:treeView ns1:PW_0002545 ;
  ns1:IAO_0000115 "Those metabolic changes resulting in an excess of acids in the system causing a decrease in the normal pH range."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-26T09:28:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002546"^^xsd:string ;
  rdfs:label "acidosis pathway"^^xsd:string ;
  skos:notation "PW:0002546"^^xsd:string .

ns1:PW_0002547
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002545 ;
  ns2:treeView ns1:PW_0002545 ;
  ns1:IAO_0000115 "Those metabolic changes resulting in an excess of bases in the system causing an increase in the normal pH range."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-26T09:28:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002547"^^xsd:string ;
  rdfs:label "alkalosis pathway"^^xsd:string ;
  skos:notation "PW:0002547"^^xsd:string .

ns1:PW_0002548
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002546 ;
  ns2:treeView ns1:PW_0002546 ;
  ns1:IAO_0000115 "An acidosis caused by alteration in lactic acid metabolism."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-26T09:33:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00313"^^xsd:string ;
  obo:id "PW:0002548"^^xsd:string ;
  rdfs:label "lactic acidosis pathway"^^xsd:string ;
  skos:notation "PW:0002548"^^xsd:string .

ns1:PW_0002549
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002546 ;
  ns2:treeView ns1:PW_0002546 ;
  ns1:IAO_0000115 "An acidosis caused by alteration in the ketone bodies metabolic pathway due to defects in the 3-oxoacid CoA transferase 1 enzyme."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-26T09:35:50Z"^^xsd:string ;
  obo:hasExactSynonym "SCOT deficiency pathway"^^xsd:string, "ketoacidosis due to SCOT deficiency pathway"^^xsd:string, "succinyl-CoA:acetoacetate transferase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00569"^^xsd:string, "succinyl-CoA:3-ketoacid CoA transferase deficiency pathway"^^xsd:string ;
  obo:id "PW:0002549"^^xsd:string ;
  rdfs:label "succinyl-CoA:3-oxoacid transferase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002549"^^xsd:string .

ns1:PW_0002550
  a owl:Class ;
  ns1:IAO_0000115 "A rare acidosis resulting from defects in malonyl-CoA decarboxylase enzyme."^^xsd:string ;
  ns1:IAO_0000231 ns1:IAO_0000227 ;
  ns1:IAO_0100001 ns1:PW_0002289 ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-02-26T09:45:10Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00502"^^xsd:string, "malonyl-CoA decarboxylase deficiency pathway"^^xsd:string ;
  obo:id "PW:0002550"^^xsd:string ;
  rdfs:label "malonic aciduria pathway"^^xsd:string ;
  owl:deprecated true ;
  skos:notation "PW:0002550"^^xsd:string .

ns1:PW_0002551
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002443 ;
  ns2:treeView ns1:PW_0002443 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of levacetylmethadol, a synthetic opioid, similar in structure to methadone, used for the treatment and management of opioid dependence.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-03-02T08:31:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "<new synonym>"^^xsd:string, "levomethadyl acetate drug pathway"^^xsd:string ;
  obo:id "PW:0002551"^^xsd:string ;
  rdfs:label "levacetylmethadol drug pathway"^^xsd:string ;
  skos:notation "PW:0002551"^^xsd:string .

ns1:PW_0002552
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002551 ;
  ns2:treeView ns1:PW_0002551 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of levacetylmethadol. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-03-02T08:33:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "levomethadyl acetate pharmacokinetics pathway"^^xsd:string ;
  obo:id "PW:0002552"^^xsd:string ;
  rdfs:label "levacetylmethadol pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002552"^^xsd:string .

ns1:PW_0002553
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002551 ;
  ns2:treeView ns1:PW_0002551 ;
  ns1:IAO_0000115 "The pathway of levacetylmethadol-target interaction and of the biochemical or physiological responses to drug. The drug acts as a mu-receptor agonist. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-03-02T08:34:15Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00677"^^xsd:string, "levomethadyl acetate pharmacodynamics pathway"^^xsd:string ;
  obo:id "PW:0002553"^^xsd:string ;
  rdfs:label "levacetylmethadol pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002553"^^xsd:string .

ns1:PW_0002554
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002443 ;
  ns2:treeView ns1:PW_0002443 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of levorphanol, an opioid used for the treatment of moderate to severe pain. Primarily an agonist of the mu opioid receptor, levorphanol acts as an agonist or antagonist for several other receptors. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-03-02T08:45:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002554"^^xsd:string ;
  rdfs:label "levorphanol drug pathway"^^xsd:string ;
  skos:notation "PW:0002554"^^xsd:string .

ns1:PW_0002555
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002554 ;
  ns2:treeView ns1:PW_0002554 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of levorphanol. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-03-02T08:46:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002555"^^xsd:string ;
  rdfs:label "levorphanol pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002555"^^xsd:string .

ns1:PW_0002556
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002554 ;
  ns2:treeView ns1:PW_0002554 ;
  ns1:IAO_0000115 "The pathway of levorphanol-target interaction and of the biochemical or physiological responses to drug. The drug acts primarily as a mu-receptor agonist, but it can be an agonist or antagonist for several other receptors. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-03-02T08:46:58Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00673"^^xsd:string ;
  obo:id "PW:0002556"^^xsd:string ;
  rdfs:label "levorphanol pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002556"^^xsd:string .

ns1:PW_0002557
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001643 ;
  ns2:treeView ns1:PW_0001643 ;
  ns1:IAO_0000115 "An inherited condition resulting from alteration in lipid metabolism due to defects in lipase or apolipoprotein functions."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-03-02T09:00:27Z"^^xsd:string ;
  obo:hasExactSynonym "Fredrickson type I hyperlipoproteinemia pathway"^^xsd:string, "Fredrickson type I lipemia pathway"^^xsd:string, "familial LPL deficiency pathway"^^xsd:string, "familial chylomiconemia syndrome pathway"^^xsd:string, "familial hyperlipoproteinemia type I pathway"^^xsd:string, "hypercholesterinemic xanthomatosis pathway"^^xsd:string, "hyperchylomicronemia pathway"^^xsd:string, "hyperlipoproteinemia type I disease pathway"^^xsd:string, "hyperlipoproteinemia type I pathway"^^xsd:string, "mixed hyperglyceridemia pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00530"^^xsd:string ;
  obo:id "PW:0002557"^^xsd:string ;
  rdfs:label "familial lipoprotein lipase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002557"^^xsd:string .

ns1:PW_0002558
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002443 ;
  ns2:treeView ns1:PW_0002443 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of heroin, an opioid painkiller and a narcotic. Chemically is 3,6-diacetyl ester of morphine. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-03-02T09:09:20Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002558"^^xsd:string ;
  rdfs:label "heroin drug pathway"^^xsd:string ;
  skos:notation "PW:0002558"^^xsd:string .

ns1:PW_0002559
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002558 ;
  ns2:treeView ns1:PW_0002558 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of heroin. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-03-02T09:09:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00623"^^xsd:string ;
  obo:id "PW:0002559"^^xsd:string ;
  rdfs:label "heroin pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002559"^^xsd:string .

ns1:PW_0002560
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002558 ;
  ns2:treeView ns1:PW_0002558 ;
  ns1:IAO_0000115 "The pathway of heroin-target interaction and of the biochemical or physiological responses to drug. Heroin is an opioid painkiller and a narcotic. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-03-02T09:10:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00407"^^xsd:string ;
  obo:id "PW:0002560"^^xsd:string ;
  rdfs:label "heroin pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002560"^^xsd:string .

ns1:PW_0002561
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001840 ;
  ns2:treeView ns1:PW_0001840 ;
  ns1:IAO_0000115 "An autosomal recessive condition resulting from alterations in the transsulfuration pathway of homocysteine metabolism."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-03-07T10:24:56Z"^^xsd:string ;
  obo:hasExactSynonym "cystathionase deficiency pathway"^^xsd:string, "cystathione gamma-lyase deficiency syndrome pathway"^^xsd:string, "gamma-cystathionase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00514"^^xsd:string ;
  obo:id "PW:0002561"^^xsd:string ;
  rdfs:label "cystathioninuria pathway"^^xsd:string ;
  skos:notation "PW:0002561"^^xsd:string .

ns1:PW_0002562
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "An inherited condition resulting from alterations in glutathione metabolism."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-03-07T10:33:20Z"^^xsd:string ;
  obo:hasExactSynonym "gamma-glutamyltransferase deficiency pathway"^^xsd:string, "gamma-glutamyltranspeptidase deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00501"^^xsd:string ;
  obo:id "PW:0002562"^^xsd:string ;
  rdfs:label "glutathionuria disease pathway"^^xsd:string ;
  skos:notation "PW:0002562"^^xsd:string .

ns1:PW_0002563
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002142 ;
  ns2:treeView ns1:PW_0002142 ;
  ns1:IAO_0000115 "An inherited condition resulting from alterations in the urea cycle pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-03-07T10:40:11Z"^^xsd:string ;
  obo:hasExactSynonym "hyperornithinemia-hyperammonemia-homocitrullinemia syndrome pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "HHH syndrome pathway"^^xsd:string, "SMP:00506"^^xsd:string ;
  obo:id "PW:0002563"^^xsd:string ;
  rdfs:label "ornithine translocase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002563"^^xsd:string .

ns1:PW_0002564
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000739 ;
  ns2:treeView ns1:PW_0000739 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the oxidation of phytanic acid, a branched chain fatty acid. Phytanic acid alpha-oxidation in the peroxisome results in pristanic acid, which can then follow a beta degradation pathway."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-03-07T10:52:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00450"^^xsd:string ;
  obo:id "PW:0002564"^^xsd:string ;
  rdfs:label "phytanic acid degradation pathway"^^xsd:string ;
  skos:notation "PW:0002564"^^xsd:string .

ns1:PW_0002565
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645, ns1:PW_0001646 ;
  ns2:treeView ns1:PW_0001645, ns1:PW_0001646 ;
  ns1:IAO_0000115 "An inherited condition resulting from alterations in carnosine metabolism due to defects in the enzyme carnosinase and manifested in neurological disorders."^^xsd:string ;
  obo:created_by "VPetri"^^xsd:string ;
  obo:creation_date "2016-03-07T11:05:38Z"^^xsd:string ;
  obo:hasExactSynonym "aminoacyl-histidine dipeptidase deficiency pathway"^^xsd:string, "carnosinase deficiency pathway"^^xsd:string, "carnosinemia disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00493"^^xsd:string ;
  obo:id "PW:0002565"^^xsd:string ;
  rdfs:label "carnosinemia pathway"^^xsd:string ;
  skos:notation "PW:0002565"^^xsd:string .

ns1:PW_0002566
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001589, ns1:PW_0002567 ;
  ns2:treeView ns1:PW_0001589, ns1:PW_0002567 ;
  ns1:IAO_0000115 "An autosomal recessive disorder leading to the formation of urinary stones."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-03-10T08:24:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00535"^^xsd:string ;
  obo:id "PW:0002566"^^xsd:string ;
  rdfs:label "adenine phoshoribosyltransferase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002566"^^xsd:string .

ns1:PW_0002567
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001700 ;
  ns2:treeView ns1:PW_0001700 ;
  ns1:IAO_0000115 "Conditions leading to the formation of stones in any part of the urinary tract."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-03-10T08:29:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002567"^^xsd:string ;
  rdfs:label "urolithiasis pathway"^^xsd:string ;
  skos:notation "PW:0002567"^^xsd:string .

ns1:PW_0002568
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "An autosomal condition resulting from alterations in cysteine metabolism due to defects in the enzyme mercaptopyruvate sulfurtransferase."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-03-10T08:36:18Z"^^xsd:string ;
  obo:hasExactSynonym "mixed disulfiduria pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00499"^^xsd:string ;
  obo:id "PW:0002568"^^xsd:string ;
  rdfs:label "mercaptolactate-cysteine disulfiduria pathway"^^xsd:string ;
  skos:notation "PW:0002568"^^xsd:string .

ns1:PW_0002569
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001645 ;
  ns2:treeView ns1:PW_0001645 ;
  ns1:IAO_0000115 "A rare condition resulting from possible alterations in amino acid metabolism for which the causative genes are a matter of debate."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-03-10T08:46:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00521"^^xsd:string, "SMP:00522"^^xsd:string ;
  obo:id "PW:0002569"^^xsd:string ;
  rdfs:label "3-hydroxyisobutyric aciduria pathway"^^xsd:string ;
  skos:notation "PW:0002569"^^xsd:string .

ns1:PW_0002570
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000921 ;
  ns2:treeView ns1:PW_0000921 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics of diphenoxylate, a drug of the phenulpiperidine sries used for the treatment of diarrhea. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-03-28T09:11:54Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002570"^^xsd:string ;
  rdfs:label "diphenoxylate drug pathway"^^xsd:string ;
  skos:notation "PW:0002570"^^xsd:string .

ns1:PW_0002571
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002570 ;
  ns2:treeView ns1:PW_0002570 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of diphenoxylate. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-03-28T09:13:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002571"^^xsd:string ;
  rdfs:label "diphenoxylate pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002571"^^xsd:string .

ns1:PW_0002572
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002570 ;
  ns2:treeView ns1:PW_0002570 ;
  ns1:IAO_0000115 "The pathway of diphenoxylate-target interaction and of the biochemical or physiological responses to drug. Diphenoxylate is used for the treatment of diarrhea. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-03-28T09:13:43Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00675"^^xsd:string ;
  obo:id "PW:0002572"^^xsd:string ;
  rdfs:label "diphenoxylate pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002572"^^xsd:string .

ns1:PW_0002573
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001602 ;
  ns2:treeView ns1:PW_0001602 ;
  ns1:IAO_0000115 "A condition resulting from alterations in glucose metabolism and homeostasis leading to abnormally low blood glucose levels."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-03-28T09:22:01Z"^^xsd:string ;
  obo:hasExactSynonym "hypoglycemia disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002573"^^xsd:string ;
  rdfs:label "hypoglycemia pathway"^^xsd:string ;
  skos:notation "PW:0002573"^^xsd:string .

ns1:PW_0002574
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001643, ns1:PW_0002573 ;
  ns2:treeView ns1:PW_0001643, ns1:PW_0002573 ;
  ns1:IAO_0000115 "An autosomal recessive disorder resulting from alterations in long chain fatty acid oxidation due to defects in the carnitine palmitoyltransferase 1A (CPT1A) enzyme."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-03-28T09:23:52Z"^^xsd:string ;
  obo:hasExactSynonym "carnitine palmitoyl transferase deficiency type I pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00538"^^xsd:string ;
  obo:id "PW:0002574"^^xsd:string ;
  rdfs:label "carnitine palmitoyltransferase I deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002574"^^xsd:string .

ns1:PW_0002575
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000409 ;
  ns2:treeView ns1:PW_0000409 ;
  ns1:IAO_0000115 "The reactions thereby dopamine can spontaneously oxidize under aerobic conditions. In the process, radicals are being formed that can potentially exert noxious effects. Oxidation of dopamine gives rise to three quinone species that can form adducts with proteins or be precursor to the neuromelanin pigment (NM). NM, which accumulates with age, but is diminished in Parkinson disease patients may confer protective roles, particularly as a metal chelator."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-03-29T11:14:20Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002575"^^xsd:string ;
  rdfs:label "dopamine oxidation pathway"^^xsd:string ;
  skos:notation "PW:0002575"^^xsd:string .

ns1:PW_0002576
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002142 ;
  ns2:treeView ns1:PW_0002142 ;
  ns1:IAO_0000115 "An inheritied condition resulting from alterations in the degradation of branched-chain amino acid due to defects in the alpha subunit of methylcrotonyl CoA carboxylase (MCCC1). MCCC is a biotin-requiring enzyme in the mitochondria."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-03-31T15:17:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "3-methylcrotonyl CoA carboxylase type I deficiency pathway"^^xsd:string, "SMP:00237"^^xsd:string ;
  obo:id "PW:0002576"^^xsd:string ;
  rdfs:label "3-methylcrotonyl CoA carboxylase 1 deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002576"^^xsd:string .

ns1:PW_0002577
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002142 ;
  ns2:treeView ns1:PW_0002142 ;
  ns1:IAO_0000115 "An inheritied condition resulting from alterations in the degradation of branched-chain amino acid due to defects in the beta subunit of methylcrotonyl CoA carboxylase (MCCC2). MCCC is a biotin-requiring enzyme in the mitochondria."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-03-31T15:29:38Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "3-methylcrotonyl CoA carboxylase type II deficiency pathway"^^xsd:string ;
  obo:id "PW:0002577"^^xsd:string ;
  rdfs:label "3-methylcrotonyl CoA carboxylase 2 deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002577"^^xsd:string .

ns1:PW_0002578
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000389, ns1:PW_0000571 ;
  ns2:treeView ns1:PW_0000389, ns1:PW_0000571 ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-04-01T13:15:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002578"^^xsd:string ;
  rdfs:label "altered neurotrophic factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0002578"^^xsd:string .

ns1:PW_0002579
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000572, ns1:PW_0002578 ;
  ns2:treeView ns1:PW_0000572, ns1:PW_0002578 ;
  ns1:IAO_0000115 "A brain-derived neurotrophic factor (BDNF) signaling pathway that deviates from what it normal course should be. Impaired BDNF signaling contributes to the pathogenesis of conditions such as Huntington Disease (HD) and depression."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-04-01T13:16:24Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered BDNF signaling pathway"^^xsd:string ;
  obo:id "PW:0002579"^^xsd:string ;
  rdfs:label "altered brain-derived neurotrophic factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0002579"^^xsd:string .

ns1:PW_0002580
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000135 ;
  ns2:treeView ns1:PW_0000135 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the synthesis and utilization of nicotinamide adenine dinucleotide (NAD). There are several routes leading to NAD biosynthesis from various sources. NAD, in addition to its well known role as a cofactor in redox reactions, also serves as a substrate for several classes of enzymes."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-01T13:58:17Z"^^xsd:string ;
  obo:hasExactSynonym "NAD metabolic pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00124"^^xsd:string, "SMP:00129"^^xsd:string ;
  obo:id "PW:0002580"^^xsd:string ;
  rdfs:label "nicotinamide adenine dinucleotide metabolic pathway"^^xsd:string ;
  skos:notation "PW:0002580"^^xsd:string .

ns1:PW_0002581
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002580 ;
  ns2:treeView ns1:PW_0002580 ;
  ns1:IAO_0000115 "Those metabolic reactions involved in the utilization of nicotinamide adenine dinucleotide (NAD). NAD, in addition to its well known role as a cofactor in redox reactions, also serves as a substrate for several classes of enzymes. These include the sirtuin deacetylases, the adenosine diphosphate (ADP)-ribose transferases/poly(ADP-ribose) polymerases, and the cyclic ADP-ribose (cADPR) synthases."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-01T14:17:00Z"^^xsd:string ;
  obo:hasExactSynonym "NAD utilization pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002581"^^xsd:string ;
  rdfs:label "nicotinamide adenine nucleotide utilization pathway"^^xsd:string ;
  skos:notation "PW:0002581"^^xsd:string .

ns1:PW_0002582
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002581 ;
  ns2:treeView ns1:PW_0002581 ;
  ns1:IAO_0000115 "Mono- and poly-ADP-ribosylation of proteins is carried out by members of the PARP family. Proteins with particular domains or modules are involved in the recognition of modified proteins while others reverse the modification. Protein ADP-ribosylation plays important roles in DNA damage repair, cell-cycle, transcription and cell death pathways."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-02T15:13:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002582"^^xsd:string ;
  rdfs:label "ADP-ribosylation pathway, mono and poly-ribosylation"^^xsd:string ;
  skos:notation "PW:0002582"^^xsd:string .

ns1:PW_0002583
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002581 ;
  ns2:treeView ns1:PW_0002581 ;
  ns1:IAO_0000115 "Cyclic ADP-ribosylation leads to the formation of second messengers with important roles in calcium signaling."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-02T15:16:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002583"^^xsd:string ;
  rdfs:label "ADP-ribosylation pathway, cyclic ribosylation"^^xsd:string ;
  skos:notation "PW:0002583"^^xsd:string .

ns1:PW_0002584
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002581 ;
  ns2:treeView ns1:PW_0002581 ;
  ns1:IAO_0000115 "Sirtuins belong to the class III deacetylases that carry out NAD-dependent deacetylation and other activities. They are sensors of NAD/NAM ratio and play important roles in cellular homeostasis."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-02T15:20:46Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002584"^^xsd:string ;
  rdfs:label "Sirtuin mediated pathway"^^xsd:string ;
  skos:notation "PW:0002584"^^xsd:string .

ns1:PW_0002585
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001738 ;
  ns2:treeView ns1:PW_0001738 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of carvedilol - a non-selective adrenergic beta receptor blocker, used in the treatment of mild to severe congestive heart failure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-06T15:41:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002585"^^xsd:string ;
  rdfs:label "carvedilol drug pathway"^^xsd:string ;
  skos:notation "PW:0002585"^^xsd:string .

ns1:PW_0002586
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002585 ;
  ns2:treeView ns1:PW_0002585 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of carvedilol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-06T15:42:27Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002586"^^xsd:string ;
  rdfs:label "carvedilol pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002586"^^xsd:string .

ns1:PW_0002587
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002585 ;
  ns2:treeView ns1:PW_0002585 ;
  ns1:IAO_0000115 "The pathway of carvedilol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta belonging to the third generation of blockers. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-06T15:43:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00367"^^xsd:string ;
  obo:id "PW:0002587"^^xsd:string ;
  rdfs:label "carvedilol pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002587"^^xsd:string .

ns1:PW_0002588
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001593 ;
  ns2:treeView ns1:PW_0001593 ;
  ns1:IAO_0000115 "Those conditions affecting the skeletal system and elements associated with it, arising from deregulation in a number of pathways."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-09T08:50:25Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002588"^^xsd:string ;
  rdfs:label "bone disease pathway"^^xsd:string ;
  skos:notation "PW:0002588"^^xsd:string .

ns1:PW_0002589
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002590 ;
  ns2:treeView ns1:PW_0002590 ;
  ns1:IAO_0000115 "A heterogeneous group of conditions with recessive, dominant, and X-linked forms."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-09T08:55:12Z"^^xsd:string ;
  obo:hasExactSynonym "chondrodysplasia punctata disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002589"^^xsd:string ;
  rdfs:label "chondrodysplasia punctata pathway"^^xsd:string ;
  skos:notation "PW:0002589"^^xsd:string .

ns1:PW_0002590
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001477, ns1:PW_0002588 ;
  ns2:treeView ns1:PW_0001477, ns1:PW_0002588 ;
  ns1:IAO_0000115 "Those conditions resulting from the abnormal development of cartilage and bone."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-09T08:59:39Z"^^xsd:string ;
  obo:hasExactSynonym "osteochondrodysplasia disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002590"^^xsd:string ;
  rdfs:label "osteochondrodysplasia pathway"^^xsd:string ;
  skos:notation "PW:0002590"^^xsd:string .

ns1:PW_0002591
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001872, ns1:PW_0002589 ;
  ns2:treeView ns1:PW_0001872, ns1:PW_0002589 ;
  ns1:IAO_0000115 "The better characterized form of chondrodysplasia punctata due to defects in the Ebp gene involved in the cholesterol biosynthetic pathway."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-09T09:18:28Z"^^xsd:string ;
  obo:hasExactSynonym "CDPXD pathway"^^xsd:string, "CONRADI-HUNERMANN SYNDROME pathway"^^xsd:string, "CONRADI-HUNERMANN-HAPPLE SYNDROME pathway"^^xsd:string, "CPXD pathway"^^xsd:string, "HAPPLE SYNDROME pathway"^^xsd:string, "X-linked dominant chondrodysplasia punctata 2 disease pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00388"^^xsd:string ;
  obo:id "PW:0002591"^^xsd:string ;
  rdfs:label "X-linked dominant chondrodysplasia punctata 2 pathway"^^xsd:string ;
  skos:notation "PW:0002591"^^xsd:string .

ns1:PW_0002592
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001016 ;
  ns2:treeView ns1:PW_0001016 ;
  ns1:IAO_0000115 "The vitamin K cycle is an essential aspect of its metabolism. The carboxylation of glutamate residues in vitamin K-dependent (VKD) proteins, necessary for their function, requires a reduced form of vitamin K as a cofactor. The resulting oxidized compound is converted back to the reduced form via a two-step reduction reaction. Natural and synthetic antagonists block the cycle and thus, the VKD protein modification. VKD proteins include coagulation factors; antagonists are used as anti-coagulation, anti-thrombotic agents."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-23T13:03:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002592"^^xsd:string ;
  rdfs:label "vitamin K cycle pathway"^^xsd:string ;
  skos:notation "PW:0002592"^^xsd:string .

ns1:PW_0002593
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002146 ;
  ns2:treeView ns1:PW_0002146 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of dabigatran, a direct thrombin inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-23T13:42:24Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002593"^^xsd:string ;
  rdfs:label "dabigatran drug pathway"^^xsd:string ;
  skos:notation "PW:0002593"^^xsd:string .

ns1:PW_0002594
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002593 ;
  ns2:treeView ns1:PW_0002593 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of dabigatran, a direct thrombin inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-23T13:44:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002594"^^xsd:string ;
  rdfs:label "dabigatran pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002594"^^xsd:string .

ns1:PW_0002595
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002593 ;
  ns2:treeView ns1:PW_0002593 ;
  ns1:IAO_0000115 "The pathway of dabigatran-target interaction and of the biochemical or physiological responses to drug. The drug is a direct thrombin inhibitor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-23T13:45:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002595"^^xsd:string ;
  rdfs:label "dabigatran pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002595"^^xsd:string .

ns1:PW_0002596
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002151 ;
  ns2:treeView ns1:PW_0002151 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of drugs that reduce or prevent the formation of blood clots by directly inhibiting activated factor X (Xa). Factor X is a serine protease and essential component of coagulation cascade. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-23T13:48:18Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002596"^^xsd:string ;
  rdfs:label "direct factors Xa inhibitor drug pathway"^^xsd:string ;
  skos:notation "PW:0002596"^^xsd:string .

ns1:PW_0002597
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002596 ;
  ns2:treeView ns1:PW_0002596 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of apixaban, a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-23T13:53:21Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002597"^^xsd:string ;
  rdfs:label "apixaban drug pathway"^^xsd:string ;
  skos:notation "PW:0002597"^^xsd:string .

ns1:PW_0002598
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002596 ;
  ns2:treeView ns1:PW_0002596 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of edoxaban, a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-23T13:54:21Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002598"^^xsd:string ;
  rdfs:label "edoxaban drug pathway"^^xsd:string ;
  skos:notation "PW:0002598"^^xsd:string .

ns1:PW_0002599
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002596 ;
  ns2:treeView ns1:PW_0002596 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of rivaroxaban, a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-23T13:54:49Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002599"^^xsd:string ;
  rdfs:label "rivaroxaban drug pathway"^^xsd:string ;
  skos:notation "PW:0002599"^^xsd:string .

ns1:PW_0002600
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002597 ;
  ns2:treeView ns1:PW_0002597 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of apixaban, a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-23T13:55:12Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002600"^^xsd:string ;
  rdfs:label "apixaban pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002600"^^xsd:string .

ns1:PW_0002601
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002597 ;
  ns2:treeView ns1:PW_0002597 ;
  ns1:IAO_0000115 "The pathway of apixaban-target interaction and of the biochemical or physiological responses to drug. The drug is a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-23T13:55:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002601"^^xsd:string ;
  rdfs:label "apixaban pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002601"^^xsd:string .

ns1:PW_0002602
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002598 ;
  ns2:treeView ns1:PW_0002598 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of edoxaban, a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-23T13:56:05Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002602"^^xsd:string ;
  rdfs:label "edoxaban pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002602"^^xsd:string .

ns1:PW_0002603
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002598 ;
  ns2:treeView ns1:PW_0002598 ;
  ns1:IAO_0000115 "The pathway of edoxaban-target interaction and of the biochemical or physiological responses to drug. The drug is a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-23T13:56:29Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002603"^^xsd:string ;
  rdfs:label "edoxaban pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002603"^^xsd:string .

ns1:PW_0002604
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002599 ;
  ns2:treeView ns1:PW_0002599 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of rivaroxaban, a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-23T13:57:09Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002604"^^xsd:string ;
  rdfs:label "rivaroxaban pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002604"^^xsd:string .

ns1:PW_0002605
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002599 ;
  ns2:treeView ns1:PW_0002599 ;
  ns1:IAO_0000115 "The pathway of rivaroxaban-target interaction and of the biochemical or physiological responses to drug. The drug is a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-06-23T13:57:36Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002605"^^xsd:string ;
  rdfs:label "rivaroxaban pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002605"^^xsd:string .

ns1:PW_0002606
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000003 ;
  ns2:treeView ns1:PW_0000003 ;
  ns1:IAO_0000115 "Proteases, the vitamin K-dependent coagulation proteases in particular, can activate a specific class of G protein-coupled receptors harboring an internally tethered ligand. The four protease-activated receptors (PARs) are involved in numerous physiologically relevant processes and can also play a role in disease-related aspects. PARs can be cleaved at different sites by different proteases to elicit distinct signaling responses, referred to as biased signaling."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-07-01T10:00:11Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002606"^^xsd:string ;
  rdfs:label "protease mediated signaling pathway"^^xsd:string ;
  skos:notation "PW:0002606"^^xsd:string .

ns1:PW_0002607
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002606 ;
  ns2:treeView ns1:PW_0002606 ;
  ns1:IAO_0000115 "Protease-activated receptor 1 (PAR1/F2R) is primarily a target of coagulation factor 2, thrombin, but other proteases can prompt or disarm it. PAR1 signaling plays many roles in the immune, cardiovascular and nervous system."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-07-01T10:39:21Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "protease mediated signaling via F2R"^^xsd:string, "protease mediated signaling via PAR1"^^xsd:string ;
  obo:id "PW:0002607"^^xsd:string ;
  rdfs:label "protease mediated signaling via protease-activated receptor 1"^^xsd:string ;
  skos:notation "PW:0002607"^^xsd:string .

ns1:PW_0002608
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002606 ;
  ns2:treeView ns1:PW_0002606 ;
  ns1:IAO_0000115 "Protease-activated receptor 2 (PAR2/F2RL1) is primarily a target of coagulation factor 10, but other proteases can prompt or disarm it. PAR2  signaling plays important roles in the cardiovascular and immune systems."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-07-01T10:45:55Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "protease mediated signaling via F2RL1"^^xsd:string, "protease mediated signaling via PAR2"^^xsd:string ;
  obo:id "PW:0002608"^^xsd:string ;
  rdfs:label "protease mediated signaling via protease-activated receptor 2"^^xsd:string ;
  skos:notation "PW:0002608"^^xsd:string .

ns1:PW_0002609
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002606 ;
  ns2:treeView ns1:PW_0002606 ;
  ns1:IAO_0000115 "Protease-activated receptor 4 (PAR4/F2RL3) is primarily a target of coagulation factor 2, thrombin, but other proteases can prompt or disarm it. PAR4 signaling plays important roles in the inflammatory response."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-07-01T10:52:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "protease mediated signaling via F2RL3"^^xsd:string, "protease mediated signaling via PAR4"^^xsd:string ;
  obo:id "PW:0002609"^^xsd:string ;
  rdfs:label "protease mediated signaling via protease-activated receptor 4"^^xsd:string ;
  skos:notation "PW:0002609"^^xsd:string .

ns1:PW_0002610
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002606 ;
  ns2:treeView ns1:PW_0002606 ;
  ns1:IAO_0000115 "Protease-activated receptor 3 (PAR3/F2RL2) is primarily a target of coagulation factor 2, thrombin, but other proteases can prompt or disarm it. PAR3 is thought to not signal autonomously and require heterodimerization with other PARs."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-07-01T10:59:48Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "protease mediated signaling via F2RL2"^^xsd:string, "protease mediated signaling via PAR3"^^xsd:string ;
  obo:id "PW:0002610"^^xsd:string ;
  rdfs:label "protease mediated signaling via protease-activated receptor 3"^^xsd:string ;
  skos:notation "PW:0002610"^^xsd:string .

ns1:PW_0002611
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000475, ns1:PW_0001538 ;
  ns2:treeView ns1:PW_0000475, ns1:PW_0001538 ;
  ns1:IAO_0000115 "Alterations in the hemostatic system can result in a series of pathological conditions. They are caused by alterations in the coagulation cascade and/or anticoagulant pathways that regulate it."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-07-14T15:33:07Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002611"^^xsd:string ;
  rdfs:label "altered hemostasis pathway"^^xsd:string ;
  skos:notation "PW:0002611"^^xsd:string .

ns1:PW_0002612
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000477, ns1:PW_0001538 ;
  ns2:treeView ns1:PW_0000477, ns1:PW_0001538 ;
  ns1:IAO_0000115 "Alterations in the anticoagulant system are associated with various conditions."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-07-14T15:38:34Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002612"^^xsd:string ;
  rdfs:label "altered natural anticoagulant pathway"^^xsd:string ;
  skos:notation "PW:0002612"^^xsd:string .

ns1:PW_0002613
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000474, ns1:PW_0002611 ;
  ns2:treeView ns1:PW_0000474, ns1:PW_0002611 ;
  ns1:IAO_0000115 "Alterations in the coagulation cascade have been associated with several conditions. Deficiencies in factors F5 and F8, the essential cofactors of the intrinsic tenase and thrombinase complexes, lead to parahemophilia and hemophilia A, respectively."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-07-14T15:40:03Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002613"^^xsd:string ;
  rdfs:label "altered coagulation cascade pathway"^^xsd:string ;
  skos:notation "PW:0002613"^^xsd:string .

ns1:PW_0002614
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000480, ns1:PW_0002612 ;
  ns2:treeView ns1:PW_0000480, ns1:PW_0002612 ;
  ns1:IAO_0000115 "Mutations in protein C (Proc) and its cofactor, protein S (Pros1) are associated with several deficiencies."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-07-14T15:44:32Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002614"^^xsd:string ;
  rdfs:label "altered protein C anticoagulant pathway"^^xsd:string ;
  skos:notation "PW:0002614"^^xsd:string .

ns1:PW_0002615
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000063 ;
  ns2:treeView ns1:PW_0000063 ;
  ns1:IAO_0000115 "The glyoxalase pathway is the main detoxifying  route to protect against the harmful effects of methylglyoxal (MG). The highly reactive dicarbonyl compound is primarily a by-product of glycolysis, but  it can also result as a by-product of fatty acid and protein metabolism. MG is also known as pyruvaldehyde or 2-oxopropanol."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-08-08T09:55:16Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "2-oxo propanol degradation pathway"^^xsd:string, "SMP:00459"^^xsd:string, "methylglyoxal degradation pathway"^^xsd:string, "pyruvaldehyde degradation pathway"^^xsd:string ;
  obo:id "PW:0002615"^^xsd:string ;
  rdfs:label "glyoxalase metabolic pathway"^^xsd:string ;
  skos:notation "PW:0002615"^^xsd:string .

ns1:PW_0002616
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000481, ns1:PW_0001538 ;
  ns2:treeView ns1:PW_0000481, ns1:PW_0001538 ;
  ns1:IAO_0000115 "A fibrinolysis pathway that deviates from what its normal course should be. Several congenital and acquired disorders of fibrinolysis are reported."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-08-17T13:50:09Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002616"^^xsd:string ;
  rdfs:label "altered fibrinolysis pathway"^^xsd:string ;
  skos:notation "PW:0002616"^^xsd:string .

ns1:PW_0002617
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001413, ns1:PW_0001644 ;
  ns2:treeView ns1:PW_0001413, ns1:PW_0001644 ;
  ns1:IAO_0000115 "A condition resulting from alterations in the gluconeogenesis pathway due to defects in the cytosolic PCK1 gene."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-08-17T14:03:09Z"^^xsd:string ;
  obo:hasExactSynonym "PCK deficiency pathway"^^xsd:string, "PCK1 deficiency pathway"^^xsd:string, "PEPCK deficiency pathway"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "SMP:00560"^^xsd:string, "phosphoenolpyruvate carboxykinase deficiency 1 pathway"^^xsd:string ;
  obo:id "PW:0002617"^^xsd:string ;
  rdfs:label "phosphoenolpyruvate carboxykinase deficiency pathway"^^xsd:string ;
  skos:notation "PW:0002617"^^xsd:string .

ns1:PW_0002618
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000297, ns1:PW_0000298, ns1:PW_0000673 ;
  ns2:treeView ns1:PW_0000297, ns1:PW_0000298, ns1:PW_0000673 ;
  ns1:IAO_0000115 "Alterations in platelet-derived growth factor signaling are implicated in cancer development."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-08-19T08:48:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:hasRelatedSynonym "altered PDGF signaling pathway"^^xsd:string ;
  obo:id "PW:0002618"^^xsd:string ;
  rdfs:label "altered platelet-derived growth factor signaling pathway"^^xsd:string ;
  skos:notation "PW:0002618"^^xsd:string .

ns1:PW_0002619
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000378, ns1:PW_0001545 ;
  ns2:treeView ns1:PW_0000378, ns1:PW_0001545 ;
  ns1:IAO_0000115 "An oxidative stress response pathway that deviates from what its normal course should be. Alterations in stress response pathway are associated with cardiovascular and neurodegenerative diseases and various forms of cancer."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-09-06T09:17:00Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002619"^^xsd:string ;
  rdfs:label "altered oxidative stress response pathway"^^xsd:string ;
  skos:notation "PW:0002619"^^xsd:string .

ns1:PW_0002620
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000124, ns1:PW_0000263 ;
  ns2:treeView ns1:PW_0000124, ns1:PW_0000263 ;
  ns1:IAO_0000115 "A cellular detoxification pathway that deviates from what its normal course should be."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-09-08T08:24:13Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002620"^^xsd:string ;
  rdfs:label "altered cellular detoxification pathway"^^xsd:string ;
  skos:notation "PW:0002620"^^xsd:string .

ns1:PW_0002621
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000369, ns1:PW_0002620 ;
  ns2:treeView ns1:PW_0000369, ns1:PW_0002620 ;
  ns1:IAO_0000115 "Deregulation of nuclear factor, erythroid 2 like 2 (Nfe2l2, also known as Nrf2) signaling pathway has been associated with several conditions, including neurodegeneration and cancer."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-09-08T08:27:47Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002621"^^xsd:string ;
  rdfs:label "altered nuclear factor, erythroid 2 like 2 signaling pathway"^^xsd:string ;
  skos:notation "PW:0002621"^^xsd:string .

ns1:PW_0002622
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000124 ;
  ns2:treeView ns1:PW_0000124 ;
  ns1:IAO_0000115 "Several endogenous small proteins are involved in the antioxidant response. Subsequently they need to be reduced back for another round of response, The reductase enzymes catalyze the reaction in an NADPH-dependent manner. The expression of these and of NADPH-producing enzymes is under the control of nuclear factor, erythroid 2 like 2 signaling pathway."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-09-08T08:38:56Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002622"^^xsd:string ;
  rdfs:label "endogenous antioxidant pathway"^^xsd:string ;
  skos:notation "PW:0002622"^^xsd:string .

ns1:PW_0002623
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002622 ;
  ns2:treeView ns1:PW_0002622 ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-09-08T09:00:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002623"^^xsd:string ;
  rdfs:label "glutathione antioxidant pathway"^^xsd:string ;
  skos:notation "PW:0002623"^^xsd:string .

ns1:PW_0002624
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002622 ;
  ns2:treeView ns1:PW_0002622 ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-09-08T09:03:33Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002624"^^xsd:string ;
  rdfs:label "thioredoxin antioxidant pathway"^^xsd:string ;
  skos:notation "PW:0002624"^^xsd:string .

ns1:PW_0002625
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002622 ;
  ns2:treeView ns1:PW_0002622 ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-09-08T09:04:03Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002625"^^xsd:string ;
  rdfs:label "peroxiredoxin antioxidant pathway"^^xsd:string ;
  skos:notation "PW:0002625"^^xsd:string .

ns1:PW_0002626
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000276 ;
  ns2:treeView ns1:PW_0000276 ;
  ns1:IAO_0000115 "Ferroptosis is a non-apoptotic form of programmed cell death that is triggered by conditions or molecules that inhibit the Gpx4 function. Loss of function of glutathione peroxidase GPX4 results in accumulation of lipid-based reactive oxygen species (ROS)."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-09-29T13:20:59Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002626"^^xsd:string ;
  rdfs:label "ferroptosis pathway"^^xsd:string ;
  skos:notation "PW:0002626"^^xsd:string .

ns1:PW_0002627
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002367 ;
  ns2:treeView ns1:PW_0002367 ;
  ns1:IAO_0000115 "The pharmacokinetics and pharmacodynamics pathway of bortezomib, a proteasome inhibitor used in the treatment of several cancer types. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-09-29T13:30:17Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002627"^^xsd:string ;
  rdfs:label "bortezomib drug pathway"^^xsd:string ;
  skos:notation "PW:0002627"^^xsd:string .

ns1:PW_0002628
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002627 ;
  ns2:treeView ns1:PW_0002627 ;
  ns1:IAO_0000115 "The pathway of processing - absorption, distribution, metabolism or elimination - of bortezomib. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-09-29T13:32:31Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002628"^^xsd:string ;
  rdfs:label "bortezomib pharmacokinetics pathway"^^xsd:string ;
  skos:notation "PW:0002628"^^xsd:string .

ns1:PW_0002629
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002627 ;
  ns2:treeView ns1:PW_0002627 ;
  ns1:IAO_0000115 "The pathway of bortezomib-target interaction and of the biochemical or physiological responses to drug. Bortezomib  is used in the treatment of several cancer types. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-09-29T13:33:02Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002629"^^xsd:string ;
  rdfs:label "bortezomib pharmacodynamics pathway"^^xsd:string ;
  skos:notation "PW:0002629"^^xsd:string .

ns1:PW_0002630
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001434 ;
  ns2:treeView ns1:PW_0001434 ;
  ns1:IAO_0000115 "Paraquat, a chemical used as a herbicide and a powerful oxidant, is highly toxic to the mammalian system. Toxicity depends on delivery routes: the highest is via inhalation, followed by the oral route, with the dermal route being moderately toxic. It has been shown that there is a connection between paraquat use and Parkinson disease (PD) in farm workers."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-09-29T13:46:37Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002630"^^xsd:string ;
  rdfs:label "paraquat response pathway"^^xsd:string ;
  skos:notation "PW:0002630"^^xsd:string .

ns1:PW_0002631
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000591 ;
  ns2:treeView ns1:PW_0000591 ;
  ns1:IAO_0000115 "Several systems are involved in the uptake of iron. They require the action of ferric reductases as the form of iron crossing the membrane is the ferrous Fe(II)."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-10-06T14:27:38Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002631"^^xsd:string ;
  rdfs:label "iron uptake pathway"^^xsd:string ;
  skos:notation "PW:0002631"^^xsd:string .

ns1:PW_0002632
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000591 ;
  ns2:treeView ns1:PW_0000591 ;
  ns1:IAO_0000115 "A single system is involved in the efflux of iron from many cell types. As the iron crossing the membrane is the ferrous Fe(II), several oxidases carry out the formation of ferric Fe(III) which can be bound by the transferrin carrier."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-10-06T14:30:53Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002632"^^xsd:string ;
  rdfs:label "iron efflux pathway"^^xsd:string ;
  skos:notation "PW:0002632"^^xsd:string .

ns1:PW_0002633
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0000590
  ] ;
  ns2:treeView ns1:PW_0000590 ;
  ns3:part_of ns1:PW_0000590 ;
  ns1:IAO_0000115 "Heme and iron-sulfur cluster (ISC) biosynthetic pathways are the major routes of iron utilization."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-10-13T14:58:57Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002633"^^xsd:string ;
  rdfs:label "iron utilization pathway"^^xsd:string ;
  skos:notation "PW:0002633"^^xsd:string .

ns1:PW_0002634
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000135, ns1:PW_0002633 ;
  ns2:treeView ns1:PW_0000135, ns1:PW_0002633 ;
  ns1:IAO_0000115 "The steps involved in the assembly and delivery of iron-sulfur (Fe-S) clusters (ISC) to Fe-S proteins. The mitochondrial ISC and the connected cytosolic assembly (CIA) pathways provide for the biogenesis of all Fe-S proteins. The Fe-S proteins participate in a broad range of important cellular processes."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-10-13T15:53:44Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002634"^^xsd:string ;
  rdfs:label "iron-sulfur cluster protein biogenesis pathway"^^xsd:string ;
  skos:notation "PW:0002634"^^xsd:string .

ns1:PW_0002635
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002634 ;
  ns2:treeView ns1:PW_0002634 ;
  ns1:IAO_0000115 "The mitochondrial pathway consists of the synthesis of [2Fe-2S] cluster on scaffold proteins, cluster transfer and formation of mitochondrial [2Fe-2S] proteins, and the synthesis of 4Fe-4S] cluster and the formation of [4Fe-4S] proteins. The first two steps are required for the mitochondrial export and the biogenesis of cytosolic and nuclear Fe-S proteins. This arm of the pathway is usually referred as the 'core'."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-10-14T11:25:35Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002635"^^xsd:string ;
  rdfs:label "mitochondrial iron-sulfur cluster protein biogenesis pathway"^^xsd:string ;
  skos:notation "PW:0002635"^^xsd:string .

ns1:PW_0002636
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002634 ;
  ns2:treeView ns1:PW_0002634 ;
  ns1:IAO_0000115 "The cytosolic iron-sulfur cluster protein assembly pathway is dependent upon the core mitochondrial assembly and export pathways. The pathway is structurally distinct from the mitochondrial system."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-10-14T11:41:08Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002636"^^xsd:string ;
  rdfs:label "cytosolic iron-sulfur cluster protein assembly pathway"^^xsd:string ;
  skos:notation "PW:0002636"^^xsd:string .

ns1:PW_0002637
  a owl:Class ;
  rdfs:subClassOf [
    a owl:Restriction ;
    owl:onProperty ns4:part_of ;
    owl:someValuesFrom ns1:PW_0002634
  ] ;
  ns2:treeView ns1:PW_0002634 ;
  ns3:part_of ns1:PW_0002634 ;
  ns1:IAO_0000115 "The core mitochondrial iron-sulfur assembly and export pathways are crucial for the assembly of cytosolic and nuclear Fe-S proteins. Despite knowledge of the export system, the  species that is actually transported remains to be determined. The exported molecule is usually termed X-S."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-10-14T11:54:27Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002637"^^xsd:string ;
  rdfs:label "mitochondrial iron-sulfur cluster export pathway"^^xsd:string ;
  skos:notation "PW:0002637"^^xsd:string .

ns1:PW_0002638
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0000103 ;
  ns2:treeView ns1:PW_0000103 ;
  ns1:IAO_0000115 "The molecular aspects of transport and intracellular trafficking of cofactors and prosthetic groups."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-10-20T10:43:26Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002638"^^xsd:string ;
  rdfs:label "cofactor transport pathway"^^xsd:string ;
  skos:notation "PW:0002638"^^xsd:string .

ns1:PW_0002639
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0002638 ;
  ns2:treeView ns1:PW_0002638 ;
  ns1:IAO_0000115 "Heme is a prosthetic group found in proteins important for many and diverse metabolic pathways. Import and export of heme into and from cells are important for proper heme homeostasis."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-10-20T10:49:06Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002639"^^xsd:string ;
  rdfs:label "heme transport pathway"^^xsd:string ;
  skos:notation "PW:0002639"^^xsd:string .

ns1:PW_0002640
  a owl:Class ;
  rdfs:subClassOf ns1:PW_0001434 ;
  ns2:treeView ns1:PW_0001434 ;
  ns1:IAO_0000115 "Acrolein is a reactive unsaturated aldehyde that is a dietary and environmental pollutant and can also be metabolically generated. It exerts severe toxic effects through production of DNA and protein adducts and disruption of important cellular pathways. Acrolein is thought to play a role in cardiovascular and neurodegenerative diseases, diabetes and immune disorders."^^xsd:string ;
  obo:created_by "vpetri"^^xsd:string ;
  obo:creation_date "2016-10-20T13:11:04Z"^^xsd:string ;
  obo:hasOBONamespace "pathway"^^xsd:string ;
  obo:id "PW:0002640"^^xsd:string ;
  rdfs:label "acrolein response pathway"^^xsd:string ;
  skos:notation "PW:0002640"^^xsd:string .

<http://bioportal.bioontology.org/ontologies/versionSubject> owl:versionInfo "7.52"^^xsd:string .
ns1:pw.owl
  obo:auto-generated-by "--RGD OBO FILE GENERATOR -- build 2019-10-18 --"^^xsd:string ;
  obo:date "19:10:2019 20:13"^^xsd:string ;
  obo:hasOBOFormatVersion "1.2"^^xsd:string ;
  obo:saved-by "gthayman"^^xsd:string ;
  obo:default-namespace "pathway"^^xsd:string .

[]
  a owl:Ontology ;
  obo:auto-generated-by "--RGD OBO FILE GENERATOR -- build 2019-10-18 --"^^xsd:string ;
  obo:date "19:10:2019 20:13"^^xsd:string ;
  obo:default-namespace "pathway"^^xsd:string ;
  obo:hasOBOFormatVersion "1.2"^^xsd:string ;
  obo:saved-by "gthayman"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000002 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The various, enzyme controlled, series of reactions allowing for the conversion of materials, energy availability and biodegradation of xenobiotics."^^xsd:string ;
  obo:hasDbXref "OneLook:http://www.onelook.com/"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000003 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathways where a signal - hormone, neurotransmitter, growth factor, peptide, any molecule - triggers one or multiple cascades of events. This involves a number of molecules, including receptors, proteins, ligands, messengers, any participating molecule. A signaling pathway may be upstream or downstream of other signaling pathways. Signaling pathways control a very broad spectrum of processes as well as pathways."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000004 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathways that control the processes by which a cell or organism develops, adjusts, behaves, responds to conditions or changes in these conditions, or in any manner helps promote and maintain its efficient functioning."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000005 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions and pathways involved in the oxidation, breakdown and synthesis of carbohydrates in the tissue. The breakdown can be utilized by the body for energy production. The converse synthesis is used for energy storage."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000006 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The Ras superfamily consists of a diverse group of small, monomeric G proteins that function as molecular switches alternating between the GDP-inactive and the GTP-active bound state. The GTP-bound form can interact with many downstream effectors. Ras superfamily controls a broad spectrum of processes; deregulation of Ras cascades has been linked to several forms of cancer. The superfamily is structurally classified in five families."^^xsd:string ;
  obo:hasDbXref "GO:0007265"^^xsd:string, "PMID:11027944"^^xsd:string, "PMID:11152757"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000007 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The mitogen -activated protein kinase pathway groups several serine/threonine protein kinases mediated cascades in response to a number of extracellular stimuli.  A characteristic feature of these cascades is the presence of at least three kinases in series leading to the activation of a multifunctional MAP kinase."^^xsd:string ;
  obo:hasDbXref "GO:0000165"^^xsd:string, "KEGG:map04010"^^xsd:string, "PMID:14570565"^^xsd:string, "PMID:14976517"^^xsd:string, "PMID:17229475"^^xsd:string, "PMID:17306385"^^xsd:string, "Reactome:REACT_634.5"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000008 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The secreted glycoproteins of the Wnt family regulate a wide spectrum of developmental processes and they are also playing important roles in the adult organism. Deregulation of Wnt cascades has oncogenic effects and is responsible for tumorigenesis in adults."^^xsd:string ;
  obo:hasDbXref "PMID:12573432"^^xsd:string, "PMID:15001769"^^xsd:string, "PMID:15041171"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000009 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Apoptosis is a programmed cell death pathway that is characterized by particular morphological features such as membrane blebbing and DNA fragmentation. It can be intrinsic or extrinsic and involves the activation of caspases."^^xsd:string ;
  obo:hasDbXref "GO:0006915"^^xsd:string, "KEGG:map04210"^^xsd:string, "PMID:12196263"^^xsd:string, "PMID:18414491"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000010 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The metabolic reactions involved in the oxidation, utilization and/or synthesis of lipids in the tissues."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000011 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of the primary or standard 20 amino acids found in proteins. Amino acids are described as non-essential or essential depending on whether humans can or can not synthesize them, respectively. Chemically, they are classified based on the polarity of their side chain or R group, as non-polar and hydrophobic and hydrophilic and charged or polar uncharged. Amino acid metabolic pathways are also listed with their KEGG entries."^^xsd:string ;
  obo:hasDbXref "KEGG:http://www.genome.jp/kegg/"^^xsd:string, "MCW library:Handbooks of Biochemistry"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000012 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of nucleotides. Nucleotides, which are the units of DNA and RNA, can also play important roles in cellular energy, enzyme regulation as well as serve as signaling molecules."^^xsd:string ;
  obo:hasDbXref "PMID:20561600"^^xsd:string, "PMID:21222015"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000013 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Complex human diseases encompass a spectrum of genetic and environmental attributes that together affect the normal functioning of several molecular and cellular pathways. Their combined and accumulated effect is manifested in the anomalous phenotype of the complex condition."^^xsd:string ;
  obo:hasDbXref "InHouse:InHouse PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000014 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Neurodegenerative diseases group together a number of conditions of various and many times poorly understood origins that are characterized by the progressive loss of particular neurons, the formation of particular structures such as plaques and fibrils, and protein aggregates. Proteosomal degradation, programmed cell death and oxidative stress are among a number of pathways thought to be disrupted."^^xsd:string ;
  obo:hasDbXref "inHouse:InHouse PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000015 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A mostly sporadic, late-onset condition affecting the central nervous system, that is the most prevalent neurodegenerative disease and the most common form of dementia. It is characterized by the presence of amyloid plaques and fibril tangles. Possible pathways affected range from protein mis-folding and aggregation, to oxidative stress and impaired metal homeostasis."^^xsd:string ;
  obo:hasDbXref "InHouse:InHouse PW dictionary"^^xsd:string, "KEGG:map05010"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000016 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A late onset, mostly sporadic neurodegenerative disease characterized by the loss of motor neurons in the brain stem and spinal cord. Various pathways are thought to be deregulated and contribute to the condition; among them calcium and/or zinc homeostasis, apoptosis, Cdk5 and calcineurin dependent processes, and in the case of the more rare, genetically inherited form of the disease, mutations in the cytosolic Cu, Zn superoxide dismutase (SOD1) and the subsequent changes in the processes that involve SOD1."^^xsd:string ;
  obo:hasDbXref "InHouse:In House PW dictionary"^^xsd:string, "KEGG:map05014"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000017 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal dominant neurodegenerative disease manifesting in movement, cognitive and psychiatric disorders caused by the abnormal expansion of a polyglutamine (polyQ) stretch in the Huntingtin (HTT) protein. It mostly affects the caudate-putamen striatal neurons. Other areas are also affected and undergo a size reduction. HTT is thought to be involved in several cellular pathways. Its functions are overcome by the mutant protein mHTT."^^xsd:string ;
  obo:hasDbXref "PMID:26938440"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000018 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "One of the most common neurodegenerative diseases that is characterized by the loss of dopaminergic neurons in the substantia nigra and the presence of cytoplasmic inclusions called Lewy bodies in surrounding neurons. Several pathways are thought to be deregulated; for instance, imbalance of iron homeostasis is believed to contribute to the pathogenesis of the condition."^^xsd:string ;
  obo:hasDbXref "KEGG:map05012"^^xsd:string, "PMID:18052765"^^xsd:string, "PMID:19422283"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000019 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Prion disease - any of a group of fatal, transmissible neurodegenerative diseases caused by abnormalities of prion protein metabolism, which may result from mutations in the prion protein gene or from infection with pathogenic isoforms of the protein.  Characteristics include neuronal loss, gliosis, and extensive vacuolization of the cerebral cortex. Prion diseases may be sporadic, inherited as an autosomal dominant trait, or acquired. Human diseases include Creutzfeldt-Jakob disease, Gerstmann-Strussler syndrome, fatal familial insomnia, and kuru"^^xsd:string ;
  obo:hasDbXref "KEGG:map05020"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000020 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Cardiovascular diseases represent a very broad spectrum of conditions that can also combine with diabetes and renal failure."^^xsd:string ;
  obo:hasDbXref "InHouse:InHouse PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000021 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Hypertension, high arterial blood pressure: various criteria for its threshold have been suggested, ranging from 140 mm Hg systolic and 90 mm Hg diastolic to as high as 200 mm Hg systolic and 110 mm Hg diastolic. Hypertension may have no known cause (essential or idiopathic h.) or be associated with other primary diseases (secondary h.)."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000022 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Cardiomyopathy - a general diagnostic term designating primary noninflammatory disease of the heart muscle, often of obscure or unknown etiology and not the result of ischemic, hypertensive, congenital, valvular, or pericardial disease. It is usually subdivided into dilated, hypertrophic, and restrictive cardiomyopathy (1). Cardiomyopathy is the deterioration of the cardiac muscle of the heart wall."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000023 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The Immune response pathways mediate the defense of host cells against infection and injury. The first line of defense is provided by the phylogenetically older innate immune response. The later, more versatile response is provided by the pathways of adaptive immunity: the B cell mediated humoral and the T cell mediated cellular or cell-mediated responses."^^xsd:string ;
  obo:hasDbXref "GO:0006955"^^xsd:string, "MCW library:Handbook of cellular and molecular immunology"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000024 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Inflammation is the cellular response of the innate immune system to infection or injury. Sensing of infection by pattern recognition receptors triggers signaling cascades leading to the expression of mediator genes such as the pro-inflammatory cytokines."^^xsd:string ;
  obo:hasDbXref "GO:0006954"^^xsd:string, "MCW library:Cellular and molecular immunology, by Abbas, Abul K"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string, "PMID:15364056"^^xsd:string, "PMID:16226680"^^xsd:string, "PMID:16281932"^^xsd:string, "PMID:20303867"^^xsd:string, "PMID:20303872"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000025 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the energy-yielding conversion of glucose to pyruvate or in the formation of glucose from non-carbohydrate precursors such as pyruvate, lactate, citric acid cycle intermediates, the carbon skeleton of many amino acids. While many enzymes are shared by the two pathways, a few steps are carried out by pathway-specific enzymes. The two pathways are independently regulated."^^xsd:string ;
  obo:hasDbXref "KEGG:map00010"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000026 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The series of chemical reactions that are central to all aerobic cells and constitute the citric acid cycle. Also known as the tricarboxylic acid cycle (TCA) or Krebs cycle, it is the center of convergence for all molecular fuels."^^xsd:string ;
  obo:hasDbXref "GO:0006099"^^xsd:string, "KEGG:map00020"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string, "Reactome:REACT_1046.3"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000027 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation glutamic acid/glutamate. Glutamate is the major excitatory neurotransmitter."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000028 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of alanine, aspartate and glutamate."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000029 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Acetyl-CoA, the starting material for fatty acid biosynthesis, can be derived from amino acid and lipid degradation or the oxidative decarboxylation of pyruvate. Fatty acid biosynthesis involves the condensation of C2 units; it requires seven enzymatic reactions which are carried out by the multifunctional enzyme fatty acid synthase."^^xsd:string ;
  obo:hasDbXref "PMID:11248039"^^xsd:string, "PMID:8001737"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000031 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of purines. Purines consist of a pyrimidine ring fused to an imidazole ring. The nucleobases adenine and guanine in DNA are purines."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000032 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of pyrimidines. Cytosine, thymine and uracil - the nucleobases found in nucleic acids, are pyrimidine derivatives."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000033 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions and pathways whose role is to release or provide energy."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000034 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions thereby the electrons derived from the oxidation of glucose and lipids or the degradation of amino acids, are passed to oxygen via a series of series of spatially separated complexes. The energy derived generates an electrochemical gradient that drives the synthesis of ATP. The coupling between the electron transport chain, also known as the respiratory chain and the ATP biosynthetic pathway is known as oxidative phosphorylation. Under certain circumstances the two may be uncoupled."^^xsd:string ;
  obo:hasDbXref "GO:0022904"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string, "PMID:19760284"^^xsd:string, "PMID:21625217"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000035 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of adenosine triphosphate (ATP). ATP synthesis is coupled to the electron transfer or respiratory chain pathway which generates an electrochemical gradient that drives the phosphorylation of ADP. The coupling of the two pathways is called oxidative phosphorylation. Under certain circumstances however, the two may be uncoupled."^^xsd:string ;
  obo:hasDbXref "GO:0006754"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string, "PMID:19760284"^^xsd:string, "PMID:21625217"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000036 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions in the nitrogen cycle carried out by various microorganisms."^^xsd:string ;
  obo:hasDbXref "KEGG:map00910"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000037 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving sulfur - a component of methionine and cysteine amino acids and of co-enzymes and vitamins. It also serves as electron donor in anaerobic respiration. Microorganisms and plants can incorporate inorganic sulfate into bioinorganic compounds; higher organisms derive them from diet."^^xsd:string ;
  obo:hasDbXref "KEGG:map00920"^^xsd:string, "PMID:16143557"^^xsd:string, "Wikipedia:http://en.wikipedia.org/wiki/Sulfur_metabolism"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000038 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "OBSOLETE. Originally found at KEGG, the term has since been deleted."^^xsd:string ;
  obo:hasDbXref "PW dictionary:InHouse dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000039 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the biosynthesis of bile acid - any of the steroid carboxylic acids derived from cholesterol. Cholic and chenodeoxycholic acids are the primary bile acids and are formed in the liver. Secondary bile acids - deoxycholic and lithocholic - are formed from the primary bile acids through the action of intestinal bacteria. Bile acid also acts as a signal molecule via several nuclear receptors."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string, "PMID:22414897"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000040 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of steroid hormones. All steroid hormones are derived from cholesterol. Steroid hormone metabolism is extremely complex and its molecular details are incompletely understood. De novo steroid biosynthesis is confined to very few tissues, primarily the adrenals, the gonads and the placenta."^^xsd:string ;
  obo:hasDbXref "KEGG:map00140"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string, "PMID:17926129"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000041 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of fructose and mannose, as depicted in the KEGG diagram."^^xsd:string ;
  obo:hasDbXref "KEGG:map00051"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000042 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of galactose - an aldohexose epimeric with glucose at the 4 carbon. Galactose is a component of lactose and other oligosaccharides, cerebrosides and gangliosides, and of various glycolipids and glycoproteins."^^xsd:string ;
  obo:hasDbXref "GO:0006012"^^xsd:string, "KEGG:map00052"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000043 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of pyruvate - a salt, ester, or anionic form of pyruvic acid. Pyruvate, which is the end-product of glycolysis can be converted to lactate under anaerobic conditions, can be further oxidized via the Krebs or citrate cycle or can be converted back to glucose via gluconeogenesis."^^xsd:string ;
  obo:hasDbXref "GO:0006090"^^xsd:string, "KEGG:00620"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string, "Reactome:REACT_2071.3"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000044 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "OBSOLETE. Duplicated term. Use PW:0000027."^^xsd:string ;
  obo:hasDbXref "PW dictionary:InHouse dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000045 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the generation of reducing equivalents and five carbon (pentose) sugars. The oxidative phase is irreversible; the non-oxidative is reversible."^^xsd:string ;
  obo:hasDbXref "GO:0006098"^^xsd:string, "KEGG:map00030"^^xsd:string, "OneLook:www.oneloook.com"^^xsd:string, "Reactome:REACT_1859.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000046 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of inositol, a cyclic sugar alcohol occurring in a number of stereoisomers of which the myo-inositol is the most prominent form. myo-inositol provides a structural basis for compounds such as inositol phosphates and phosphatidylinositols  which are secondary messengers in several signaling pathways."^^xsd:string ;
  obo:hasDbXref "GO:0006020"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000047 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of glycine, serine and threonine and which are intimately connected with serine being synthesized from glycine and threonine."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000048 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis (remethylation), utilization and/or degradation of methionine, an essential amino acid for humans. The cycle produces S-adenosylmethionine (AdoMet),  the major methyl donor for proteins, nucleic acids, lipids and other small molecules. The cycle also produces homocysteine (Hcy) which either regenerates methionine via the  remethylation pathway or leads to the synthesis of cysteine and derivatives via the transsulfuration pathway. Homocysteine and folate metabolic pathways are intimately related to the methionine cycle."^^xsd:string ;
  obo:hasDbXref "MCW library book:Homocysteine in Health and Disease"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000049 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of cysteine, a non-essential amino acid that could be essential in certain cases. Its side chain contains a sulfhydryl group that is readily oxidized to form the cystine dimer covalently linked by a disulfide bond."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000050 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of arginine - an essential amino acid - and proline - an amino acid that can play important roles in protein secondary structure."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000051 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of histidine, an essential amino acid which can act as either a proton donor or a proton acceptor. While the synthesis and degradation pathways of histidine are present in microorganisms, histidine can be acted upon by eukaryotic enzymes. Histidine is the precursor of histamine, involved in immune responses and also acting as a neurotransmitter."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000052 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of tyrosine - a non-essential amino acid produced from phenylalanine and precursor of thyroid hormones, catecholamines and melanin. Along with phenylalanine and tryptophan is one of the three aromatic amino acids."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Tyrosine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000053 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of phenylalanine, an essential amino acid. Along with tyrosine and tryptophan is one of the three aromatic amino acids."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000054 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions that are involved in the synthesis, utilization and/or degradation of tryptophan - a dietary essential amino acid and precursor for several important compounds. Along with phenylalanine and tyrosine is one of the three aromatic amino acids."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Tryptophan"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000055 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of nucleotide sugars. Nucleotide sugars are glycosyl donors usually classified depending on the type of the nucleoside forming them. Several are used in animals and many others can be found in plants and bacteria."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string, "KEGG:map00520"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000056 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A chemical combination caused by the action of light; specifically the formation of carbohydrates (with release of molecular oxygen) from carbon dioxide and water in the chlorophyll tissue of plants and blue-green algae under the influence of light. In bacteria, photosynthesis employs hydrogen sulfide, molecular hydrogen, and other reduced compounds in place of water, so that molecular oxygen is not released."^^xsd:string ;
  obo:hasDbXref "GO:0015979"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000057 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway thereby photosynthetic organisms such as plants and cyanobacteria convert inorganic carbon (usually carbon dioxide) into organic compounds (usually carbohydrates)."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000058 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of fatty acids - any long-chain monobasic organic acid."^^xsd:string ;
  obo:hasDbXref "GO:0006631"^^xsd:string, "KEGG:map00071"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000060 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Long-term potentiation (LTP) is a strengthening of the synapse that can last from hours to days and months.  It is thought to underlie information storage and constitute the cellular basis of learning and memory.  LTP engages numerous cascades of events on either side of the synapse and is accompanied by changes in gene expression."^^xsd:string ;
  obo:hasDbXref "Dorland's:www.onelook.com"^^xsd:string, "GO:0060291"^^xsd:string, "KEGG:map04720"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000061 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Long term depression is a weakening of a synapse that lasts hours to days. It results from either strong synaptic stimulation (as in the cerebellum) or to weak synaptic stimulation (as in the hippocampus), and engages several cascades."^^xsd:string ;
  obo:hasDbXref "GO:0060292"^^xsd:string, "KEGG:map04730"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000062 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of ascorbate and aldarate, as depicted in the KEGG diagram."^^xsd:string ;
  obo:hasDbXref "KEGG:map00053"^^xsd:string, "OneLook:www,onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000063 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of glyoxylate and dicarboxylate, as depicted in the KEGG diagram."^^xsd:string ;
  obo:hasDbXref "KEGG:map00630"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000064 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of propanoate - any salt or ester of propanoic or propionic acid. Several propanoates are used in the food industry."^^xsd:string ;
  obo:hasDbXref "KEGG:map00640"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string, "Web:http://dl.clackamas.cc.or.us/ch106-04/nomencla1.htm"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000065 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those reactions involved in the synthesis, utilization and/or degradation of butanoate - an ester or salt of  n-Butyric acid. Various butanoates are used as ingredients in flavoring and perfumery."^^xsd:string ;
  obo:hasDbXref "KEGG:map00650"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000067 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those reactions involved in carbon dioxide fixation - the reductive carboxylate cycle (CO2 fixation) - the conversion of atmospheric carbon dioxide to organic carbon compounds, as in photosynthesis."^^xsd:string ;
  obo:hasDbXref "KEGG:map00720"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000068 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways used by methanotrophs and the methanogens that metabolize methane as the sole carbon source or as byproduct."^^xsd:string ;
  obo:hasDbXref "GO:0015947"^^xsd:string, "KEGG:map00680"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000069 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization or degradation of ketone bodies. The chemicals acetoacetate, acetone and beta-hydroxybutyrate are collectively known as ketone bodies, although only the first two are ketones. They provide fuel for heart and skeletal muscle and for the brain during starvation. Excessive accumulation of these acidic chemicals leads to dangerous diabetic conditions known as ketoacidosis."^^xsd:string ;
  obo:hasDbXref "GO:0046950"^^xsd:string, "KEGG:map00072"^^xsd:string, "MCW Libraries:QU4 V876f 2008"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string, "Reactome:REACT_1861.3"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000070 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of C21-steroid hormones. Pregnenolone, the first C21 steroid derived from cholesterol, and progesterone, to which pregnenolone can be converted, provide the starting material for the biosynthesis of C21, C19 and C18 steroid hormones. The C21 class includes glucocorticoids such as cortisol and mineralocorticoids such as aldosterone. Glucocorticoids and mineralocorticoids are collectively referred to as corticosteroids."^^xsd:string ;
  obo:hasDbXref "KEGG:map00140"^^xsd:string, "PMID:17926129"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000071 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the degradation of valine, leucine and isoleucine - the three, dietary essential, branched amino acids."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000072 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic pathways involved in the synthesis of valine, leucine and isoleucine - the three, dietary essential, branched amino acids."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000073 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the degradation of lysine. In mammals, lysine is metabolized to acetyl-CoA. A derivative of lysine, allysine, is used in the production of elastin and collagen."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Lysine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000074 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the biosynthesis of lysine - an essential amino acid. In plants and bacteria it is synthesized from aspartate."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Lysine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000075 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of phenylalanine, tyrosine and tryptophan and which are intimately related. Although the body can not manufacture phenylalanine on its own, phenylalanine is the precursor of tyrosine. Phenylalanine together with tryptophan governs the release of an intestinal hormone - cholecystokinin."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000076 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The series of metabolic reactions, occurring in the liver, by which the ammonia derived from the breakdown of amino acids combines with carbon dioxide to form urea."^^xsd:string ;
  obo:hasDbXref "PMID:12055339"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000077 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of beta-alanine. Beta-alanine is an amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Beta-alanine is not used in the synthesis of proteins but is a component of natural peptides, vitamins such as vitamin B5 and of coenzyme. A rare genetic disorder, hyper-beta-alaninemia, has been reported."^^xsd:string ;
  obo:hasDbXref "GO:0019482"^^xsd:string, "KEGG:map00410"^^xsd:string, "Onelook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000078 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving cyanoamino acid, amino acid derivatives that contain a cyanide group."^^xsd:string ;
  obo:hasDbXref "GO:0033052"^^xsd:string, "KEGG:map00460"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000079 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "OBSOLETE. Duplicated term. Use PW:0000133"^^xsd:string ;
  obo:hasDbXref "PW dictionary:InHouse dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000080 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "OBSOLETE. Duplicated term. Use PW:0000133"^^xsd:string ;
  obo:hasDbXref "PW dictionary:InHouse dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000081 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving D-glutamine and D-glutamate as depicted in the KEGG diagram. D-glutamic acid is naturally found primarily in the cell wall of certain bacteria."^^xsd:string ;
  obo:hasDbXref "Human Metabolome Database:HMDB03339"^^xsd:string, "KEGG:map00471"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000082 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving D-arginine and D-ornithine as depicted in the KEGG diagram."^^xsd:string ;
  obo:hasDbXref "KEGG:map00472"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000083 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving D-alanine, the D-enantiomer of alanine. D-alanine can be found in bacterial cell wall and in some peptide antibiotics."^^xsd:string ;
  obo:hasDbXref "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000084 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "OBSOLETE. Duplicated term. Use PW:0000134"^^xsd:string ;
  obo:hasDbXref "PW dictionary:InHouse dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000085 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways involved in and/or controlling DNA replication, cell cycle, DNA repair and maintenance of genomic integrity, RNA and protein biosynthesis."^^xsd:string ;
  obo:hasDbXref "Handbook:Handbook of Biochemistry"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000086 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The series of events, collectively known as the cell cycle, that underlie the replication of the genome and the segregation of chromosomes into daughter cells. The cycle begins with a diploid cell and produces two identical diploid cells."^^xsd:string ;
  obo:hasDbXref "GO:0000278"^^xsd:string, "Handbook:Essential Cell Biology"^^xsd:string, "KEGG:map04110"^^xsd:string, "Reactome:REACT_152.3"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000087 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The series of events underlying the progression of early cell cycle into the G phase and under the control of D-type cyclins together with Cdk4 and Cdk6. The formation of the pre-initiation replication complex takes place during this phase."^^xsd:string ;
  obo:hasDbXref "Reactome:REACT_1590.1"^^xsd:string, "Reactomee:www.reactome.org"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000088 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The series of events underlying the transition from G1 into S phase and under the control of Cyclin E/A - Cdk2 and cyclin D-Cdk4/Cdk6 complexes and their regulators. Genetic alterations of this important transition point are frequent in human cancers."^^xsd:string ;
  obo:hasDbXref "PMID:10919634"^^xsd:string, "PMID:12200872"^^xsd:string, "PMID:16236519"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000089 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The series of events underlying duplication of the hereditary material of the cell, formation of two copies of the chromosome."^^xsd:string ;
  obo:hasDbXref "Reactome:REACT_899.3"^^xsd:string, "Reactome:www.reactome.org"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000090 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The series of events underlying the second 'gap' phase of the mitotic cell cycle - an interval between the completion of DNA synthesis and the beginning of mitosis and during which protein synthesis occurs."^^xsd:string ;
  obo:hasDbXref "Reactome:REACT_1915.2"^^xsd:string, "Reactome:www.reactome.org"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000091 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The series of events underlying the transition from the G2 phase into mitosis."^^xsd:string ;
  obo:hasDbXref "Reactome:REACT_2203.2"^^xsd:string, "Reactome:www.reactome.org"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000092 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The series of events underlying mitosis (M-phase), in turn comprised of several phases, involving nuclear division and cytokinesis and resulting in the formation of two daughter cells."^^xsd:string ;
  obo:hasDbXref "Reactome:REACT_910.1"^^xsd:string, "Reactome:www.reactome.org"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000093 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The series of events underlying progression out of mitosis and division into two daughter cells. It requires the inactivation of cyclinB-cdc2 by the ubiquitin-dependent proteolysis."^^xsd:string ;
  obo:hasDbXref "Reactome:REACT_1725.1"^^xsd:string, "Reactome:www.reactome.org"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000094 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways involved in the control of cell cycle progression as well as its precision and fidelity."^^xsd:string ;
  obo:hasDbXref "GO:0000075"^^xsd:string, "PMID:14644189"^^xsd:string, "Reactome:REACT_1538.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000095 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways of DNA damage response that occur during the G1 phase."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string, "Reactome:REACT_1538.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000096 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways that assure the genome is replicated only once per cell cycle. The checkpoints control for damaged and un-replicated DNA."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string, "Reactome:REACT_828.2"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000097 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway prevents cells with mis-aligned chromosomes from dividing. Defects of kinetochore function activate checkpoint proteins to initiate a cascade of events that eventually prevent separation of sister chromatid."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string, "Reactome:REACT_2137.2"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000099 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathways involved in the repair of damaged DNA. The damage can involve mismatched or damaged bases, distortion of the helix or breaks in the DNA double strand. Repair of DNA lesions along with the upstream lesion  detection and signaling its presence are collectively known as the DNA damage response."^^xsd:string ;
  obo:hasDbXref "GO:0006281"^^xsd:string, "PMID:19847258"^^xsd:string, "Reactome:REACT_216.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000100 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathways governing and/or regulating DNA transcription and gene expression. DNA transcription into coding and non-coding RNA is accomplished by one prokaryotic and several eukaryotic RNA polymerases. Transcription-coupled repair handles DNA lesions that interfere with the progression of RNA polymerases. Splicing of nascent RNA is thought to be predominantly co-transcriptional. Signaling pathways mediated by various transcription factors are involved in the regulation of gene expression."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Transcription"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000101 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The series of events governing the processes thereby mRNA is translated into a polypeptide chain. Post-translational modifications often accompany the formation of the final, mature protein. Translation involves initiation, elongation and termination steps and is dependent upon the availability of aminoacyl-tRNA and mature ribosomes."^^xsd:string ;
  obo:hasDbXref "GO:0006412"^^xsd:string, "PMID:23209153"^^xsd:string, "PMID:23677826"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000102 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The Raf/Mek/Erk signaling pathway - a Ras activated protein kinase cascade - regulates diverse processes such as cell growth, proliferation and differentiation, in response to cytokines, hormones, growth factors."^^xsd:string ;
  obo:hasDbXref "GO:0070371"^^xsd:string, "KEGG:map04010"^^xsd:string, "PMID:15035987"^^xsd:string, "PMID:17112607"^^xsd:string, "PMID:17229475"^^xsd:string, "PMID:17306385"^^xsd:string, "Reactome:REACT_1482.4"^^xsd:string, "Reactome:REACT_962.4"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000104 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The apoptotic pathway involving organelles, primarily the mitochondrion and endoplasmic reticulum (ER), and involving the pro and anti-apoptotic members of the Bcl family of proteins, cytochrome c, formation of the apoptosome and activation of caspases."^^xsd:string ;
  obo:hasDbXref "KEGG:map04210"^^xsd:string, "PMID:14744432"^^xsd:string, "Reactome:REACT_964.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000105 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Members of the Ras related Rho family of proteins control diverse processes such as actin cytoskeletal rearrangements, morphogenesis of dendritic spines, gene expression. Of note is the fact that cytoskeletal rearrangements, primarily actin remodeling have a role to play in vesicular trafficking, a process regulated by Rab proteins."^^xsd:string ;
  obo:hasDbXref "PMID:11075828"^^xsd:string, "PMID:11152757"^^xsd:string, "PMID:18171430"^^xsd:string, "PMID:8973630"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000106 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The apoptotic pathway involving the death receptors mediated route of caspase activation. Members of tumor necrosis superfamily such as the better known Tnf-alpha (Tnf), Fas ligand or Trail elicit apoptosis via receptor associated adapters."^^xsd:string ;
  obo:hasDbXref "KEGG:map04210"^^xsd:string, "PMID:14744432"^^xsd:string, "Reactome:REACT_1059.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000107 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those reactions involved in the breaking down of toxic chemical compounds such as oil spills, solvents, pesticides and other pollutants. These chemicals are generally resistant to degradation, but microorganisms possess enzymes that are capable of breaking them down."^^xsd:string ;
  obo:hasDbXref "KEGG:http://www.genome.jp/kegg/pathway.html#xenobiotics"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000108 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the degradation of caprolactam - a cyclic amide of caproic acid used to produce a type of nylon."^^xsd:string ;
  obo:hasDbXref "GO:0019384"^^xsd:string, "KEGG:map00930"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000109 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the degradation of bisphenol A, known as BPA, an important compound in the production of plastics. However, it is believed to be hazardous to humans and reports have linked several health effects to levels of BPA exposure."^^xsd:string ;
  obo:hasDbXref "GO:0043636"^^xsd:string, "KEGG:map00363"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000110 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the degradation of toluene and xylene. Toluene is used as organic solvent in rubber, paint, cement. Xylene represents any of three benzene derivatives used as solvent in printing, rubber, also as a cleaning agent."^^xsd:string ;
  obo:hasDbXref "KEGG:map00622"^^xsd:string, "Onelook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000111 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the degradation of gamma-hexachlorocyclohexane,  also known as lindane, used as an insecticide and suspected to be carcinogenic."^^xsd:string ;
  obo:hasDbXref "KEGG:map00361"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000112 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the degradation of 3-chloroacrylic acid."^^xsd:string ;
  obo:hasDbXref "KEGG:map00641"^^xsd:string, "Online:Various sources"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000113 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the degradation of atrazine - a herbicide used to kill weeds."^^xsd:string ;
  obo:hasDbXref "GO:0019381"^^xsd:string, "KEGG:map00791"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000114 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the aerobic pathway of benzoate degradation."^^xsd:string ;
  obo:hasDbXref "GO:0043640"^^xsd:string, "KEGG:map00362"^^xsd:string, "Online:Appl. Env. Microbiology, 2004, v.70(9), p4861-70."^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000115 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the anaerobic pathway of benzoate degradation."^^xsd:string ;
  obo:hasDbXref "GO:0010128"^^xsd:string, "KEGG:map00632"^^xsd:string, "Online:http://umbbd.ahc.umn.edu/benz/benz_map.html"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000116 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the degradation of carbazole - a crystalline, slightly basic cyclic compound found in anthracene. It reacts with carbohydrates and is used for assay and analysis of carbohydrates and in making dyes."^^xsd:string ;
  obo:hasDbXref "GO:0046232"^^xsd:string, "KEGG:map00629"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000117 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the degradation of fluorene - a colorless, crystalline hydrocarbon. It is obtained from coal tar and used in making dyes."^^xsd:string ;
  obo:hasDbXref "GO:0019429"^^xsd:string, "KEGG:map00628"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000118 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the degradation of ethylbenzene - a liquid hydrocarbon used in the manufacture of styrene and as a solvent and diluent for dyes and paints."^^xsd:string ;
  obo:hasDbXref "KEGG:map00642"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000119 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the degradation of nitrobenzene - an organic compound that occurs either as yellow crystals or yellow liquid used in the manufacture of aniline. It is a poisonous derivative of benzene."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000120 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the degradation of styrene - an aromatic hydrocarbon that is colorless and oily. It is used in the manufacture of rubber, resins, plastics. It is a toxic, possibly carcinogenic substance."^^xsd:string ;
  obo:hasDbXref "GO:0042207"^^xsd:string, "KEGG:map00643"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000121 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the degradation of tetrachloroethene - (acetylene tetrachloride) used as solvent for fats, waxes, resins and intermediate in the synthesis of chlorinated hydrocarbons."^^xsd:string ;
  obo:hasDbXref "KEGG:map00625"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000122 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The Hedgehog signaling pathway (Hh) plays important roles in vertebrate embryogenesis, particularly in the differentiation of the neural tube, in vasculogenesis and angiogenesis. Post-embryonically it is believed to play a homeostatic role in the maintenance of stem cells. Alteration of the pathway has been implicated in a number of human cancers."^^xsd:string ;
  obo:hasDbXref "GO:0007224"^^xsd:string, "KEGG:map04340"^^xsd:string, "PMID:12495844"^^xsd:string, "PMID:15205520"^^xsd:string, "PMID:15596107"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000123 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of synaptic vesicle endocytosis and neurotransmitter refill following exocytosis."^^xsd:string ;
  obo:hasDbXref "PMID:15217342"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000124 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A pathway triggered by exogenous or endogenous elements, compounds or molecules that can be harmful to the system. The phase I (oxidative) and phase II (conjugative) metabolizing enzyme and the phase III transport systems and other pathways are involved in the response mechanisms resulting in processing and subsequent elimination of such elements. Others induce downstream effects such as antioxidant, cell death or inflammatory response pathways."^^xsd:string ;
  obo:hasDbXref "PMID:15252150"^^xsd:string, "PMID:17482904"^^xsd:string, "PMID:26122708"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000125 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "G-proteins act as signal transducers between activated receptors or other incoming signals and downstream effectors.  They comprise the heterotrimeric G proteins downstream of G protein coupled receptors (GPCRs) and the Ras superfamily of small, monomeric G proteins. They function as molecular switches alternating between the GDP-inactive and GTP-active bound state."^^xsd:string ;
  obo:hasDbXref "GO:0007186"^^xsd:string, "PubMed:11152757"^^xsd:string, "PubMed:12040175"^^xsd:string, "Reactome:REACT_14797.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000126 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The series of events governing the synthesis of the large ribosomal RNA (rRNA) precursor in the nucleolus."^^xsd:string ;
  obo:hasDbXref "GO:0006360"^^xsd:string, "PMID:22365827"^^xsd:string, "Reactome:REACT_1309.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000127 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The series of events governing the synthesis of protein-coding messenger RNA (mRNA) precursor and of many classes of non-coding genes."^^xsd:string ;
  obo:hasDbXref "GO:0006366"^^xsd:string, "PMID:22365827"^^xsd:string, "PMID:23827673"^^xsd:string, "Reactome:REACT_1366.1"^^xsd:string, "Wikipedia:http://en.wikipedia.org/wiki/Transcription_%28genetics%29"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000128 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The series of events governing the synthesis of transport/transfer RNA (tRNA) precursor, the small ribosomal rRNA and other small RNAs."^^xsd:string ;
  obo:hasDbXref "GO:0006383"^^xsd:string, "PMID:22365827"^^xsd:string, "Reactome:REACT_1371.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000129 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Base excision repair pathway involves the identification and removal of the damaged base followed by its replacement with the correct nucleotide and ligation of the break in the strand."^^xsd:string ;
  obo:hasDbXref "GO:0006284"^^xsd:string, "KEGG:map03410"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string, "Reactome:REACT_1104.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000130 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Nucleotide excision repair pathway is an important mechanism for the detection of helix distorting base alterations. Unlike the base excision repair pathway that only removes the damaged bases, the NER pathway removes an entire lesion containing segment. The single-strand gap thus introduced is filled in by DNA polymerase using the undamaged strand as a template. The pathway can be subdivided into two sub-pathways: the transcription-coupled and the global genome repair. They only differ in the lesion recognition step while the core repair component is common."^^xsd:string ;
  obo:hasDbXref "GO:0006289"^^xsd:string, "KEGG:map03420"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string, "PMID:23046879"^^xsd:string, "PMID:23085398"^^xsd:string, "Reactome:REACT_1826.2"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000132 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of amino acids other than the common 20 amino acids found in protein. Some of these amino acids like carnitine or homocysteine derive from primary amino acids."^^xsd:string ;
  obo:hasDbXref "InHouse:PW InHouse dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000133 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of selenoamino acid - an amino acid in which a selenium atom replaces a sulfur atom. Examples include selenocysteine, selenohomocysteine and selenomethionine."^^xsd:string ;
  obo:hasDbXref "KEGG:map00450"^^xsd:string, "SMPDB:http://pathman.smpdb.ca/pathways/SMP00029/pathway"^^xsd:string, "Technical glossary:http://morelife.org/glossary/"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000134 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of glutathione - a tripeptide that acts as an antioxidant and provides protection against reactive oxygen species. It is also used in the conjugation of xenobiotics and drugs by the phase II biotransformation enzymes."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Glutathione"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000135 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those reactions involved in the synthesis, utilization and/or degradation of cofactors, vitamins and other nutrients. Cofactors are necessary for the proper function of certain proteins and enzymes; they can be inorganic such as the metals ions or the iron-sulfur cluster or organic. Organic compounds that are tightly bound to proteins are also referred to as prosthetic groups. Often, they are or are made from vitamins, compounds that are vital but in small amounts and which are insufficiently synthesized by the organism. Some of these molecules can also perform signaling functions."^^xsd:string ;
  obo:hasDbXref "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000136 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving thiamine, a water-soluble vitamin of the B complex. It is synthesized in bacteria, fungi and plants while animals obtain thiamine from food. Thiamine insufficiency results in a condition called beriberi."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Thiamine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000137 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving riboflavin, also known as vitamin B2 - a water-soluble vitamin. B2 occurs in several products and is a precursor for flavin coenzymes."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Riboflavin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000138 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving vitamin B6 - a water-soluble vitamin that exists in several forms. Vitamin B6 is required for many enzymatic reactions as the active pyridoxal 5'-phosphate (PLP) form. A number of organisms can carry out de novo synthesis of vitamin B6; humans derive it from diet."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Vitamin_B6"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000139 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of biotin, also known as vitamin B7 or H, a water-soluble vitamin. Biotin assists in various metabolic reactions and processes."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Biotin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000140 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Folate metabolism represents the various aspects of folate cycle and the folate mediate transfer reactions essential for several biosynthetic pathways. The folate cycle and the folate mediated one-carbon pathways are part of folate metabolism. Folate compounds are water-soluble forms of vitamin B9."^^xsd:string ;
  obo:hasDbXref "PMID:11001804"^^xsd:string, "PMID:15166809"^^xsd:string, "PMID:15298442"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000141 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those reactions involving retinol, a fat-soluble vitamin that is the dietary form of vitamin A and is important for bone growth and in vision. Precursors of retinol such as carotenoid or retinyl esters are derived from diet and are converted to retinal and retinol, respectively."^^xsd:string ;
  obo:hasDbXref "GO:0042572"^^xsd:string, "KEGG:map00830"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string, "PMID:21586336"^^xsd:string, "PMID:21718801"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000142 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the biosynthesis of ubiquinone, also known as coenzyme Q. Ubiquinone is a member of the mitochondrial respiratory chain and plays important roles in cellular metabolism."^^xsd:string ;
  obo:hasDbXref "PMID:14757233"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000143 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Insulin, the peptide hormone, secreted by the pancreatic beta cells, plays essential roles in glucose and energy homeostasis. Insulin signaling activates two main intracellular pathways to regulate carbohydrate and fat metabolism and to prompt glucose absorption in insulin sensitive tissues such as skeletal muscle and adipocytes. Deregulation of the pathway has been associated with a number of conditions, primarily diabetes."^^xsd:string ;
  obo:hasDbXref "GO:0008286"^^xsd:string, "KEGG:map4910"^^xsd:string, "PMID:12169433"^^xsd:string, "Reactome:REACT_498.5"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000144 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway for the ATP-dependent non-lysosomal proteolysis catalyzed by the 26S proteasome and for which ubiquitylation, the post-translational covalent conjugation of ubiquitin to target proteins is a key signal."^^xsd:string ;
  obo:hasDbXref "GO:0006511"^^xsd:string, "KEGG:ko04120"^^xsd:string, "PubMed:2001, v.27, 171-179."^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000145 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "OBSOLETE. Originally found at KEGG, the term has since been deleted"^^xsd:string ;
  obo:hasDbXref "PW dictionary:InHouse dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000146 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of glycans. Glycans are a class of compounds that include oligo- and polysaccharides, simple sugars or polymeric structures of mono- or di-saccharides, respectively. The term also refers to the carbohydrate moiety of glycoproteins, proteoglycans and glycolipids."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000147 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those reactions involved in the synthesis, utilization and/or degradation of secondary metabolites - products of cellular metabolism that are not essential for, or not directly involved in the normal growth, development or reproduction of an organism. Many of the chemicals that plants or microorganisms produce are secondary metabolites."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000151 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of starch and sucrose, as depicted in the KEGG diagram. Starch is a polysaccharide produced by all green plants and is an important carbohydrate in the human diet. Sucrose, or the table sugar is a disaccharide of glucose and fructose that is produced by plants and cyanobacteria."^^xsd:string ;
  obo:hasDbXref "KEGG:map00500"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000152 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of amino sugars. An amino sugar has an amino group substituent in place of a hydroxyl group. Amino sugars are important constituents of a variety of polysaccharides and glycoproteins."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Amino_sugar"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000153 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of triacylglycerols - esters of glycerols with three fatty acid molecules. Triglycerides are the common form of transport and storage of fatty acids. Esters with one or two fatty acid molecules are metabolic intermediates present in small amounts."^^xsd:string ;
  obo:hasDbXref "GO:0006641"^^xsd:string, "KEGG:map00561"^^xsd:string, "MCW library:QU4 M235b 2009"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000154 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of inositol phosphate which represents all of the possible phosphorylated states of inositol. Inositol phosphates have many important cellular functions."^^xsd:string ;
  obo:hasDbXref "GO:0043647"^^xsd:string, "KEGG:map00562"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000155 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of phospholipids - lipids containing phosphorus, including those with a glycerol backbone or a backbone of sphingosine or related substances. Phospholipids are the major form of lipid in the cell membrane."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000156 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving prostaglandins - a family of prostanoid eicosanoids with many regulatory functions."^^xsd:string ;
  obo:hasDbXref "MCW library:QU4 M235b 2009"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000157 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or  degradation of glycosaminoglycans - any of several high molecular weight linear polysaccharides of repeating disaccharide units. In many cases, the unit consists of an amino sugar and a uronic acid.  When aggregating with proteins, they form proteoglycans."^^xsd:string ;
  obo:hasDbXref "GO:0030203"^^xsd:string, "MCW Libraries:QU4 V876f 2008"^^xsd:string, "wikipedia:http://en.wikipedia.org/wiki/Glycosaminoglycan"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000158 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The Ras family mediated signaling pathways are primarily involved in the regulation of gene expression."^^xsd:string ;
  obo:hasDbXref "PMID:11152757"^^xsd:string, "PMID:11467446"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000159 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Rab family mediated signaling pathways are involved in the regulation of intracellular vesicle trafficking. More than 60 Rab members bind to specific effectors to regulate all aspects of vesicular trafficking - from formation and transport of vesicles, to tethering and fusion with target membranes. Of note is that cytoskeletal rearrangements such as actin remodeling, a process regulated by Rho family, have a role to play in vesicular trafficking."^^xsd:string ;
  obo:hasDbXref "GO:0032482"^^xsd:string, "PMID:11152757"^^xsd:string, "PMID:16882731"^^xsd:string, "PMID:18171430"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000160 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Ran family mediated signaling pathways are involved in nucleocytoplasmic trafficking."^^xsd:string ;
  obo:hasDbXref "GO:0031291"^^xsd:string, "PMID:11152757"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000161 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of glycosylphosphatidylinositol (GPI) anchor. The GPI anchor allows for the attachment of cell surface proteins to the cell membrane."^^xsd:string ;
  obo:hasDbXref "GO:0006506"^^xsd:string, "InHouse:InHouse PW dictionary"^^xsd:string, "KEGG:map00563"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000164 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of ganglioside - any of a group of glycosphingolipids in which the polar head group on ceramide is a sialic acid. Their names include letters and numbers where the letters M, D and T indicate the number of sialic acid residues in the molecule - one, two or three, respectively."^^xsd:string ;
  obo:hasDbXref "GO:0001573"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000165 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of taurine and hypotaurine."^^xsd:string ;
  obo:hasDbXref "InHouse:PW InHouse dictionary"^^xsd:string, "KEGG:map00430"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000167 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving pantothenic acid or panthotenate, also known as vitamin B5 - a water-soluble vitamin. Vitamin B5 is the precursor to coenzyme A (CoA) which in turn, plays an essential role in fatty acids and pyruvate metabolism."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Pantothenic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000168 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways that are triggered through the binding of a growth factor to its particular receptor. Growth factors carry out mitogenic signaling via their largely tyrosine kinase receptors."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string, "PMID:16632420"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000169 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Nerve growth factor (NGF) signaling pathways control a variety of processes such as neuronal cell differentiation, axon growth. Members of the NGF family are best known for their anti-apoptotic role as mediators of neuronal cell survival."^^xsd:string ;
  obo:hasDbXref "GO:0048011"^^xsd:string, "PubMed:Neuron, 2004, v42, p897-912; Cellular Signaling, 2004, v16, p127-36."^^xsd:string, "Reactome:REACT_11061.4"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000170 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Members of the EGF/neuregulin superfamily are important regulators of tissue development and repair. A characteristic feature is the presence of the EGF module, a 36-40 amino acid sequence with a disulfide-bonded three loop structure necessary for receptor binding."^^xsd:string ;
  obo:hasDbXref "GO:0007173"^^xsd:string, "KEGG:map04012"^^xsd:string, "MCW e-journal:J. Mol. Evolo.2000, v50, p397-412"^^xsd:string, "PubMed:12814936"^^xsd:string, "Reactome:REACT_9417.3"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000171 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Inherited neurodegenerative diseases that are caused by the expansion of a polyglutamine (polyQ) tract in several, unrelated proteins. The diseases are manifested as distinct neuropathies and multiple pathways are perturbed."^^xsd:string ;
  obo:hasDbXref "PMID:25309920"^^xsd:string, "PMID:25771431"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000172 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An inherited neurodegenerative disease caused by an expanded polyglutamine (polyQ) tract. Various pathways are disrupted and contribute to the manifestation of the condition."^^xsd:string ;
  obo:hasDbXref "PMID:24816443"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000173 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An inherited form of neurodegenerative disease caused by an expanded polyglutamine (polyQ) tract. Several types are grouped under SCA, types 1-3, 6, 7 and 17. Various pathways are disrupted and contribute to the manifestation of the condition."^^xsd:string ;
  obo:hasDbXref "PMID:24816443"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000174 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The metabolic syndrome is a multiphenotypic condition with concurrent features of several diseases and metabolic abnormalities. Insulin resistance, obesity and hypertension are considered risk factors. Alterations in lipid, glucose and cholesterol metabolic pathways, among others, can contribute to the multifactorial metabolic syndrome and the conditions associated with it."^^xsd:string ;
  obo:hasDbXref "PMID:16932765"^^xsd:string, "PubMed:2004, v. 17, 38047"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000175 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A possible subset of the metabolic syndrome, characterized  by features such as hypertriglyceridemia, age-dependent changes in plasma total cholesterol, overproduction of triglyceride-rich lipoproteins. Several metabolic and possibly other pathways deviate from their normal functioning."^^xsd:string ;
  obo:hasDbXref "PubMed:2004, v.17, 38-47."^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000176 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A range of conditions with various manifestations associated with disruptions of several pathways, primarily those revolving around glucose homeostasis and insulin signaling. Organs and tissues affected include the kidney, eye, cardiovascular system and nerve tissue."^^xsd:string ;
  obo:hasDbXref "MeSH:D048909"^^xsd:string, "Reactome:REACT_15380.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000177 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A common complication of diabetes and a leading cause of end stage renal diseases affecting a number of pathways, particularly the thiol and anti-oxidant pathways."^^xsd:string ;
  obo:hasDbXref "InPress:Manuscript"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000178 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Neurological disorders are a group of disorders that involve the central nervous system (brain, brainstem and cerebellum), the peripheral nervous system (including cranial nerves), and the autonomic nervous system (parts of which are located in both the central and peripheral nervous systems). Major branches are headache, stupor and coma, dementia, seizure, sleep disorders, trauma, infections, neoplasms, neuro-ophthalmologic diseases, movement disorders, demyelinating diseases, spinal cord disorders, and disorders of peripheral nerves, muscle and neuromuscular junctions. Many mental illnesses are believed to be neurological disorders of the central nervous system, but they are classified separately. They are not traditionally listed as neurological diseases because their causes are not definitely determined as biological, although there are good reasons to suspect that bipolar disorder and schizophrenia have neuro-chemical causes."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000179 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal dominant condition that often leads to seizure and other neurological symptoms and that may be linked to deregulations in the mTOR signaling pathway."^^xsd:string ;
  obo:hasDbXref "PubMed:2004, v.29(1), 32-38."^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000180 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "mTOR signaling pathway regulates cellular processes such as translation, ribosome biogenesis, cell growth and autophagy and is regulated or responds to growth factors, energy metabolites and/or levels of nutrients."^^xsd:string ;
  obo:hasDbXref "KEGG:map04150"^^xsd:string, "PubMed:TIBS, 2004, v. 29(1), 32-38."^^xsd:string, "Reactome:REACT_6838.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000181 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways that are involved in or mediate how protein fold or are maintained in a particular folding state, are sorted for translocation or degradation, are modified to regulate their function or to target them for degradation and finally, are degraded."^^xsd:string ;
  obo:hasDbXref "InHouse:InHouse PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000182 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A protein degradation pathway that involves proteases residing in lysosomes and exhibiting optimal activity at an acidic pH (e.g., cathepsins)."^^xsd:string ;
  obo:hasDbXref "PubMed:2003, v. 285, f1-f8."^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000183 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A protein degradation pathway that involves calcium-dependent proteases  (e.g., calpains) ,"^^xsd:string ;
  obo:hasDbXref "PubMed:2003, v. 285, f1-f8."^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000184 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of terpenoids. The terpenoids, sometimes referred to as isoprenoids, are a class of naturally occurring chemicals. Terpenoids are derived from five-carbon isoprene units and are assembled and modified in manifold ways. They are classified according to the number of isoprene units. The mevalonate pathway and the non-mevalonate MEP/DOXP pathway are the two biosynthetic routes. The first can branch into non-sterol and sterol-producing compounds. The second is only found in plants."^^xsd:string ;
  obo:hasDbXref "GO:0016114"^^xsd:string, "KEGG:map00900"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000185 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the degradation of limonene -  an essential oil, a monocyclic terpene, found in the peel of oranges and lemons, and pinene - a terpene found in turpentine and many essential oils, used as a solvent and in the manufacture of camphor, insecticides, and synthetic pine oil."^^xsd:string ;
  obo:hasDbXref "KEGG:map00903"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000186 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of streptomycin - the first of the aminoglycoside antibiotics to be isolated, derived from Streptomyces griseus; it is effective against a wide variety of aerobic gram-negative bacilli and some gram-positive bacteria, including mycobacteria. Its use is now limited because of the emergence of resistant strains."^^xsd:string ;
  obo:hasDbXref "GO:0019872"^^xsd:string, "KEGG:map00521"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000187 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of erythromycin -   an intermediate spectrum macrolide (a chemical compound characterized by a large lactone ring containing multiple keto and hydroxyl groups) antibiotic, produced by Streptomyces erythreus, effective against most gram-positive and certain gram-negative bacteria, such as Neisseria species and Haemophilus influenzae, and against spirochetes, some rickettsias, and Entamoeba; it is also highly effective against Mycoplasma pneumoniae. It is used especially in patients allergic to penicillin and in those with penicillin-resistant infections and legionnaires' disease; administered orally or topically."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000188 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The series or metabolic reactions involved in the interconversions of the monosaccharide pentose and glucuronate, the salts or esters of glucuronic acid, as depicted in the KEGG diagram."^^xsd:string ;
  obo:hasDbXref "KEGG:http://www.genome.ad.jp/kegg/pathway/map/map00040.html"^^xsd:string, "KEGG:map00040"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000189 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Folate mediated one-carbon metabolism represents the one-carbon transfer reactions important for de novo purine and thymidylate biosynthesis and for the remethylation of methionine in the methionine cycle and homocysteine metabolism. The methionine cycle also produces the major methyl donor for proteins, nucleic acids, lipids and other small molecules. The folate mediated one-carbon transfer and the folate cycle pathways are part of folate metabolism."^^xsd:string ;
  obo:hasDbXref "PMID:11001804"^^xsd:string, "PMID:15166809"^^xsd:string, "PMID:15298442"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000190 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those reactions involved in the synthesis, utilization and/or degradation of porphyrin - any of a group of compounds containing the porphyrin structure, four pyrrole rings connected by methine bridges in a cyclic configuration, to which a variety of side chains may be attached - and chlorophyll - any of a group of green magnesium-containing porphyrin derivatives occurring in all photosynthetic organisms."^^xsd:string ;
  obo:hasDbXref "KEGG:map00860"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000191 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the biosynthesis of keratan sulfate - a glycosaminoglycan found in the cornea, in cartilage, and in the nucleus pulposus and also as the accumulation product in Morquio's syndrome. It consists of repeating disaccharide units in specific linkage, each composed of a sulfated N-acetylglucosamine residue linked to one of galactose, which is usually sulfated. There are two forms, keratan sulfate I and keratan sulfate II, which differ in carbohydrate content and localization; the former occurs in the cornea and the latter in skeletal tissues."^^xsd:string ;
  obo:hasDbXref "GO:0018146"^^xsd:string, "KEGG:map00533"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000192 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of N-linked glycans. A 14 residue sugar is first built on a dolichol carrier and then attached to the amide group of an asparagine of a nascent polypeptide chain. The asparagine is in a specific amino acid sequence. Subsequent processing involves removal as well as addition of various sugars and produces a wide range of N-glycan structures."^^xsd:string ;
  obo:hasDbXref "KEGG:map00510"^^xsd:string, "MCW Libraries:QU4 V876f 2008"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000193 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the degradation of N-Glycans. N-Glycans are found attached to the R-group nitrogen of asparagine."^^xsd:string ;
  obo:hasDbXref "XPW InHouse Dictionary:InHouse Dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000194 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of O-linked glycans. Sugars are serially added to a fully synthesized polypeptide chain. The initial step involves the transfer of N-acetylgalactosamine to the carboxy group of a serine or threonine. The location of the residue appears to be dictated by structure rather than amino acid signature."^^xsd:string ;
  obo:hasDbXref "KEGG:map00512"^^xsd:string, "MCW Libraries:QU4 V876f"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000195 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the biosynthesis of chondroitin. Chondroitin is a mucopolysaccharide occurring in sulfated form in various animal tissues (as cartilage)."^^xsd:string ;
  obo:hasDbXref "GO:0030206"^^xsd:string, "KEGG:map00532"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000196 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of globoside - a glycosphingolipid containing acetylated amino sugars and simple hexoses."^^xsd:string ;
  obo:hasDbXref "GO:0001575"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000197 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of sphingolipids - important components of animal and plant membranes. They contain a long chain amino alcohol and a ceramide core. Ceramides are also the precursors of glycolipids, also referred to as glycosphingolipids, which have attached sugar(s)."^^xsd:string ;
  obo:hasDbXref "GO:0006665"^^xsd:string, "MCW library:QU4 M235b 2009"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string, "PMID:17976918"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000198 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A SAPK MAPK pathway that plays an important role in inflammation and may be involved in several forms of cancer."^^xsd:string ;
  obo:hasDbXref "GO:0051403"^^xsd:string, "KEGG:map04010"^^xsd:string, "PMID:14570565"^^xsd:string, "PMID:15102355"^^xsd:string, "Reactome:REACT_12065.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000199 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A Wnt mediated pathway that is involved in the regulation of cell-cell adhesion and motility."^^xsd:string ;
  obo:hasDbXref "GO:0007223"^^xsd:string, "KEGG:map04310"^^xsd:string, "PMID:10858654"^^xsd:string, "PMID:12573432"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000200 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The planar cell polarity (PCP) Wnt signaling pathway plays an essential role in morphogenesis through the regulation of tissues patterning."^^xsd:string ;
  obo:hasDbXref "GO:006071"^^xsd:string, "KEGG:map04310"^^xsd:string, "PMID:12573432"^^xsd:string, "PMID:16765615"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000201 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Wnt signaling pathway is involved in many developmental processes. In the conventional or canonical Wnt pathway,  beta-catenin is a central component required for the  transcriptional control of Wnt signaling target genes."^^xsd:string ;
  obo:hasDbXref "GO:0060070"^^xsd:string, "KEGG:map04310"^^xsd:string, "PMID:12573432"^^xsd:string, "PMID:15001769"^^xsd:string, "PMID:18432252"^^xsd:string, "Reactome:REACT_11045.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000202 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A specific pathway for repair of double-strand breaks. It is involved in repair of breaks induced by damaging agents or  generated during meiotic recombination."^^xsd:string ;
  obo:hasDbXref "PMID:24326623"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000203 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A specific pathway for repair of double-strand breaks. Possibly constitutive, it is the most important pathway in mammalian cells and plays an important role in mitotically replicating cells."^^xsd:string ;
  obo:hasDbXref "PMID:12947387"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000204 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Notch signaling pathway regulates processes involved in early embryonic development. It plays an important role in cell fate determination. Target genes of Notch have been implicated in angiogenesis, somitogenesis, gliogenesis. Deregulation of the Notch signaling pathway underlies a broad spectrum of diseases and clinical conditions."^^xsd:string ;
  obo:hasDbXref "GO:0007219"^^xsd:string, "KEGG:map04330"^^xsd:string, "PubMed:Several articles in PubMed"^^xsd:string, "Reactome:REACT_299.2"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000205 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Dentatorubral-pallidoluysian atrophy (DRPLA) is caused by an expanded trinucleotide repeat in the atrophin-1 (ATN1) gene. A rather rare condition, it can be juvenile-, early adult- or late adult-onset."^^xsd:string ;
  obo:hasDbXref "PMID:21577324"^^xsd:string, "PMID:21827919"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000206 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Transforming growth factor-beta (TGF-beta) signaling pathway regulates numerous cellular processes such as proliferation, differentiation, migration and cell death. The SMAD dependent pathway represents the core signaling cascade mediated by the TGF-beta superfamily. Mutations in TGF - beta family are responsible for a number of human diseases."^^xsd:string ;
  obo:hasDbXref "GO:0007179"^^xsd:string, "PMID:15130563"^^xsd:string, "PMID:16678165"^^xsd:string, "PubMed:TIBS, 2004, v29 (5), p265-273"^^xsd:string, "Reactome:REACT_6844.5"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000208 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Diabetes mellitus is characterized by abnormally high levels of glucose in the blood. Hereditary and environmental factors are likely contributors but the exact mechanisms are not well understood. Type 2 diabetes mellitus, characterized by insulin resistance, involves alterations in insulin secretion and signaling and impaired glucose homeostasis pathways."^^xsd:string ;
  obo:hasDbXref "KEGG:map04930"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000209 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The Jak-Stat pathway is a main intracellular cascade initiated primarily in response to cytokine and also other ligand signaling. Four Janus kinases (Jak) and seven signal transducers and activators of transcription (Stat) families of proteins mediate the action of almost 40 cytokine receptors, including the receptor for leptin. Combinations between four Jak(s) and seven Stat(s) shape the outcome of ligand triggered signaling through the various receptors."^^xsd:string ;
  obo:hasDbXref "GO:0007259"^^xsd:string, "KEGG:map04630"^^xsd:string, "MCW library:Handbook of cellular and molecular immunology"^^xsd:string, "PMID:12039028"^^xsd:string, "PMID:14668806"^^xsd:string, "PMID:14737178"^^xsd:string, "PMID:17312100"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000210 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The core intracellular  signaling cascade mediated  by the TGF-beta superfamily. SMAD proteins function by carrying signals from the cell surface to the nucleus. There are eight vertebrate SMAD proteins and they are activated  by two types of  TGF-beta receptors in response to TGF cytokines binding.There are two known SMAD-dependent TGF-beta signaling pathways. SMAP pathways can also be activated via NGF signalign pathways"^^xsd:string ;
  obo:hasDbXref "PMID:14534577"^^xsd:string, "PMID:15009204"^^xsd:string, "PubMed:Science, 2002, v296, p1564-7"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000211 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of biogenic amines and polyamines. Important biogenic amines are histamine, serotonin and the catecholamines.  Spermidine and spermine are examples of important polyamines."^^xsd:string ;
  obo:hasDbXref "GO:0006595"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string, "PMID:12641342"^^xsd:string, "Reactome:REACT_14820.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000212 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Choline metabolism is important for the synthesis of phosphatidylcholine in mammalian cells. Its oxidation results in the production of betaine, an important methyl donor. In the brain, it is converted to the powerful neurotransmitter acetylcholine."^^xsd:string ;
  obo:hasDbXref "PMID:18204095"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000213 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "RNA polymerase IV transcription pathway is found in plants and is involved in the synthesis of small interfering RNA (siRNA)."^^xsd:string ;
  obo:hasDbXref "PMID:15692015"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000214 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Polyamines play important roles in cell growth, proliferation and survival. They can be derived from diet as well as via cellular and intestinal flora mediated biosynthesis."^^xsd:string ;
  obo:hasDbXref "PMID:19603518"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000215 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "RNA polymerase V transcription pathway operates in plants and plays a role in heterochromatin formation."^^xsd:string ;
  obo:hasDbXref "PMID:19377477"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000216 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Polyamine metabolism plays important roles in a number of cellular processes. Spermidine and spermine are formed in two consecutive reactions carried out by distinct enzymes that employ the decarboxylated form of AdoMet as an aminopropyl donor."^^xsd:string ;
  obo:hasDbXref "GO:0008215"^^xsd:string, "PMID:19603518"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000217 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Tetrahydrobiopterin is a cofactor for amino acid hydroxylases involved in the synthesis of several neurotransmitters. It can be synthesized de novo from guanosine triphosphate (GTP) or recycled via a regeneration pathway."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Tetrahydrobiopterin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000218 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the biosynthesis of heme - an iron-containing compound where the iron is complexed within a porphyrin heterocyclic ring. There are several kinds of heme depending on the composition of their side chain. Heme serves as a prosthetic group for several classes of proteins that include hemoglobin and myoglobin, cytochromes, peroxidases, catalases and others."^^xsd:string ;
  obo:hasDbXref "PMID:26785297"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000219 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of nicotinamide adenine dinucleotide (NAD). NAD can be synthesized de novo downstream of kynurenine metabolism of tryptophan degradation, or from precursors such as nicotinamide, nicotinic acid or nicotinamide riboside, collectively known as vitamin B3 or niacin."^^xsd:string ;
  obo:hasDbXref "PMID:18020963"^^xsd:string, "PMID:20007326"^^xsd:string, "PMID:26785480"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000221 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of heme - an iron-containing compound where the iron is complexed within a porphyrin heterocyclic ring."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Heme"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000224 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions leading to the decomposition of N-acetylglucosamine - an acetylated amino sugar that is an important moiety of glycoproteins, N-acetylmannosamine - the acetylated derivative of mannosamine, and N-acetylneuraminic acid - the most common form of sialic acid in mammals."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000225 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving citrulline. Citrulline, not a DNA coded amino acid, is a product in the urea cycle."^^xsd:string ;
  obo:hasDbXref "GO:0019241"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000226 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Putrescine, spermidine and spermine are the only polyamines synthesized in mammalian cells. Putrescine, derived from L-ornithine, an important component of the urea cycle, is the substrate for the formation of spermidine, in turn the substrate for spermine."^^xsd:string ;
  obo:hasDbXref "GO:0009445"^^xsd:string, "PMID:19603518"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000227 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Based on sequence similarity, the Galpha genes have been grouped into four classes. Exchange of GDP to GTP promoted through binding to receptors dissociates the heterotrimeric Galpa/beta/gamma complex. GTP-bound Galpha can then interact with downstream effectors. Lipid modification of Galpha regulates membrane localization and interactions with specific effectors."^^xsd:string ;
  obo:hasDbXref "PMID:12040175"^^xsd:string, "PMID:15747061"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000228 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Based on sequence similarity, the Galpha genes have been grouped into four classes. Exchange of GDP to GTP promoted through binding to receptors dissociates the heterotrimeric Galpha/beta/gamma complex. GTP-bound Galpha can then interact with downstream effectors. Lipid modification of Galpha regulates membrane localization and interactions with specific effectors."^^xsd:string ;
  obo:hasDbXref "PMID:12040175"^^xsd:string, "PMID:15747061"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000229 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Based on sequence similarity, the Galpha genes have been grouped into four classes. Exchange of GDP to GTP promoted through binding to receptors dissociates the heterotrimeric Galpha/beta/gamma complex. GTP-bound Galpha can then interact with downstream effectors. Lipid modification of Galpha regulates membrane localization and interactions with specific effectors."^^xsd:string ;
  obo:hasDbXref "PMID:12040175"^^xsd:string, "PMID:15747061"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000230 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Based on sequence similarity, the Galpha genes have been grouped into four classes. Exchange of GDP to GTP promoted through binding to receptors dissociates the heterotrimeric Galpa/beta/gamma complex. GTP-bound Galpha can then interact with downstream effectors. Lipid modification of Galpha regulates membrane localization and interactions with specific effectors."^^xsd:string ;
  obo:hasDbXref "PMID:12040175"^^xsd:string, "PMID:15747061"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000231 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A very close relative of Ras, Rap1 mediated pathway  appears to control diverse processes such as modulation of growth and differentiation, secretion, integrin linked cell adhesion, morphogenesis."^^xsd:string ;
  obo:hasDbXref "PubMed:Nature Reviews, Mol. Cell Biology, 2001, v2, p369-77."^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000232 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Phosphatidylinositol 3-kinase-Akt signaling pathway involving PI3K class I enzymes, particularly class IA, controls various processes such as cell growth, proliferation and survival. Class IA enzymes couples to receptor tyrosine kinases or their adaptors; class IB couples to G-protein coupled receptor mainly via Galphai. The Akt family of protein kinases are activated downstream of class I PI3Ks and collectively (Akt1, 2, and 3) phosphorylate more than 70 cytoplasmic and nuclear substrates. Deregulation of the pathway has been linked to various forms of cancer."^^xsd:string ;
  obo:hasDbXref "PMID:14737178"^^xsd:string, "PMID:15023437"^^xsd:string, "PMID:15143962"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000233 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Tumor necrosis factor (Tnf) signaling plays pivotal roles in immunity, cell proliferation, differentiation and apoptosis by activating several pathways. NF-kB is a major pathway activated by Tnf; others include JNK and P38 MAPK. Through receptor associated adapters Tnf elicits apoptosis via the extrinsic pathway. Deregulation of Tnf signaling has been implicated in a great number of human diseases - cerebral malaria, cancer, multiple sclerosis, are a few examples."^^xsd:string ;
  obo:hasDbXref "GO:0033209"^^xsd:string, "PMID:12040173"^^xsd:string, "PMID:12655295"^^xsd:string, "PMID:20303867"^^xsd:string, "Reactome:REACT_1432.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000234 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The innate immune response - a universal and ancient form of host defense against infection - is a first line of response to various pathogens and also to damaged cells. It plays a role in stimulating adaptive immunity; molecules generated during innate responses act as second signals that can impact on both the magnitude and the nature of the adaptive response."^^xsd:string ;
  obo:hasDbXref "GO:0045087"^^xsd:string, "PMID:11861602"^^xsd:string, "PMID:20303867"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000235 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The adaptive immune response is an evolutionarily newer mechanism that provides great specificity and diversity of antigen recognition, immunological memory and specialized responses. The two types of adaptive immune response pathways are humoral and cellular or cell-mediated."^^xsd:string ;
  obo:hasDbXref "GO:0002250"^^xsd:string, "MCW library:Handbook on cellular and molecular immunology"^^xsd:string, "PMID:11861602"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000236 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Members of TNF superfamily mediate autoimmunity and inflammation, cell proliferation, survival and/or apoptosis through a number of signaling mechanisms that involve activation of nuclear factor-kappaB, of caspases and/or of mitogen-activated protein kinases (MAPK). TNF superfamily has been implicated in a wide range of human diseases including tumorigenesis, septic shock, rheumatoid arthritis and other conditions."^^xsd:string ;
  obo:hasDbXref "PMID:11239407"^^xsd:string, "PMID:11796220"^^xsd:string, "PMID:14555214"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000237 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway(s) elicited as a physiological response to various types of insults, injuries, shocks and other situations the organism perceives as threatening."^^xsd:string ;
  obo:hasDbXref "online:http://medical-dictionary.thefreedictionary.com/stress+response"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000238 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Insulin-like growth factor signaling plays important roles in cell growth and proliferation. Produced primarily by the liver in response to stimulation by growth hormone (GH) , the proteins activate cognate receptors to prompt intracellular signaling pathways and cell growth in a variety of tissues. Deregulation of the pathway has been associated with various conditions, including cancer."^^xsd:string ;
  obo:hasDbXref "GO:0048009"^^xsd:string, "PMID:12169433"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000239 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Diabetes mellitus is characterized by abnormally high levels of glucose in the blood. Hereditary and environmental factors are likely contributors but the exact mechanisms are not well understood. The type 1 diabetes mellitus pathway involves alterations in immune response pathways resulting in destruction of the insulin-producing beta cells."^^xsd:string ;
  obo:hasDbXref "KEGG:map04940"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000240 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Neuropsychiatric diseases are mental disorders due to various defects in the working of the nervous system."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Neuropsychiatry"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000241 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Schizophrenia is a psychiatric diagnosis denoting a persistent, often chronic, mental illness variously affecting behavior, thinking, and emotion. The term schizophrenia comes from the Greek words schizo, (split or divide) and phrenos, (mind) and is best translated as 'shattered mind'."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000242 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "As categorized by the DSM-IV, bipolar disorder is a form of mood disorder characterized by a variation of mood between a phase of manic or hypomanic elation, hyperactivity and hyper imagination, and a depressive phase of inhibition, slowness to conceive ideas and move, and anxiety or sadness. Together these form what is commonly known as manic depression. Manic depression, with its two principal sub-types, bipolar disorder and major depression, was first clinically described near the end of the 19th century by psychiatrist Emil Kraepelin, who published his account of the disease in his Textbook of Psychiatry. DSM-IV is the Diagnostic and Statistical Manual of Mental Disorders, published by the American Psychiatric Association, is the handbook used most often in diagnosing mental disorders in the United States and other countries."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000243 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The VEGF family plays key roles in angiogenesis and lymphangiogenesis. Through their receptors, VEGFs can initiate a diverse and complex network of signaling cascades. Deregulation of VEGFs mediated pathways, mostly through upregulation of VEGFs expression, has been implicated in a number of conditions, primarily cancer."^^xsd:string ;
  obo:hasDbXref "GO:0048010"^^xsd:string, "KEGG:map04370"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string, "PMID:15544039"^^xsd:string, "PMID:15563310"^^xsd:string, "Reactome:REACT_12529.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000244 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Angiotensin II signaling pathways play a critical role in the control of cardiovascular and renal homeostasis. Angiotensin II pathway can also contribute to cardiovascular diseases such as hypertension, atherosclerosis and heart failure."^^xsd:string ;
  obo:hasDbXref "PMID:15638741"^^xsd:string, "PMID:15883759"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000245 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Angiotensin peptides Ang II, Ang III, Ang IV and Ang (1-7) generated from a single precursor protein - angiotensinogen - regulate an array of physiological and pathophysiological processes."^^xsd:string ;
  obo:hasDbXref "PMID:12676163"^^xsd:string, "PMID:12676165"^^xsd:string, "PMID:15638741"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000246 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The Rheb family of proteins plays an essential role in the regulation of cell growth and cell cycle. Rheb could be a mediator of the mTOR signaling pathway. The results have been shown for Drosophila but remained to be established for mammals."^^xsd:string ;
  obo:hasDbXref "PMID:15240005"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000247 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "TGF-beta can activate signaling cascades other than the Smad-mediated ones, including MAPK pathways such as Erk, p38 and JNK. The mechanisms of MAPK pathway activation by TGF-beta are not well understood."^^xsd:string ;
  obo:hasDbXref "PMID:14534577"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000248 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of isoprenoids or terpenoids - a large class of organic biomolecules. Isoprenoids are precursors of sterols such as cholesterol and its derivative and also of non-sterols molecules many of which are used in the post-translational modification of proteins. Plant isoprenoids are among the most commonly found and have a broad range of uses and applications in plants and beyond."^^xsd:string ;
  obo:hasDbXref "MCW library:QU4 M235b 2009"^^xsd:string, "PMID:20015036"^^xsd:string, "PMID:21746700"^^xsd:string, "PMID:22442388"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000249 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the biosynthesis of lipopolysaccharides, also known as lipoglycans, found in the outer membrane of Gram-negative bacteria. They are large molecules consisting of a lipid and a polysaccharide joined by a covalent bond. In host cells they act as endotoxins which are recognized by members of the Toll-like receptors to elicit strong immune responses."^^xsd:string ;
  obo:hasDbXref "GO:0009103"^^xsd:string, "KEGG:map00540"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000250 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the biosynthesis of peptidoglycan - a high molecular weight polymer that forms the tough, rigid structure of bacterial cell walls. It is made up of three parts: (1) a backbone, composed of alternating N-acetylglucosamine and N-acetylmuramic acid; (2) a set of identical tetrapeptide side-chains attached to N-acetylmuramic acid; and (3) a set of identical peptide cross-bridges. The backbone is the same in all bacterial species; however, the tetrapeptide side-chains and the peptide cross-bridges vary from species to species."^^xsd:string ;
  obo:hasDbXref "GO:0009252"^^xsd:string, "KEGG:map00550"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000251 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of diterpenoid. Terpenoids are a large class of naturally-occurring organic chemicals. They are derived from five-carbon units and are modifed in manifold ways."^^xsd:string ;
  obo:hasDbXref "GO:0016102"^^xsd:string, "KEGG:map00904"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000253 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of indole and ipecac. Indole is a heterocyclic compound, obtained from coal tar, and produced by the decomposition of tryptophan in the intestine, being partly responsible for the peculiar odor of the feces. It is also found in cultures of Vibrio cholerae and other bacteria; a color test for its production is used in classifying enteric bacteria. Ipecac is derived from the dried rhizome and roots of Cephaelis ipecacuanha or of C. acuminata. It is a mixture of alkaloids, primarily emetine and cephaelin."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000254 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the biosynthesis of penicillin and cephalosporins. The former is the best known antibiotic which blocks the cross linking reaction in peptidoglycan synthesis, thus destroying the bacterial cell wall. The latter represents a broad class of antibiotics similar to penicillin, both chemically and in mode of action."^^xsd:string ;
  obo:hasDbXref "KEGG:map00311"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000255 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways that confer to an organism resistance to the action of beta-lactams - a class of broad spectrum antibiotics that are structurally and pharmacologically related to penicillins and cephalosporins."^^xsd:string ;
  obo:hasDbXref "KEGG:map00312"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000256 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the biosynthesis of polyketides. Polyketides are a group of secondary metabolites made by microorganisms that possess a broad range of pharmacologically important activities such as antimicrobial, antifungal, antiparasitic and antitumor."^^xsd:string ;
  obo:hasDbXref "Internet:http://linux1.nii.res.in/~pksdb/polyketide.html"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000258 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of tetracycline - any of a group of biosynthetic antibiotics. Some are isolated from certain species of Streptomyces and others are produced semisynthetically."^^xsd:string ;
  obo:hasDbXref "GO:0043644"^^xsd:string, "KEGG:map00253"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000259 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the biosynthesis of clavulanic acid. Clavulanic acid is a beta-lactam antibiotic produced by a bacterium of the genus Streptomyces (S. clavuligerus) that is a beta-lactamase inhibitor and is usually used in the form of its clavulanate salt of potassium especially in combination with amoxicillin"^^xsd:string ;
  obo:hasDbXref "GO:0033050"^^xsd:string, "Internet:Google"^^xsd:string, "KEGG:map00331"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000260 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the biosynthesis of puromycin - an antibiotic produced by Streptomyces alboniger, which has been used experimentally as an antineoplastic because of its ability to inhibit protein synthesis; it also has trypanosomicidal and amebicidal activity and was formerly used in the treatment of African trypanosomiasis and amebic dysentery."^^xsd:string ;
  obo:hasDbXref "GO:0043638"^^xsd:string, "KEGG:map00231"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000261 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The unique morphology of the neuron defies the classical organization of secretory pathways. The neuronal secretory pathway represents the intracellular trafficking route for proteins involved in synaptic transmission and plasticity and for lipids necessary for growth and remodeling of neurites. Neurons possess both somatic and dendritic Golgi compartments."^^xsd:string ;
  obo:hasDbXref "PMID:15232591"^^xsd:string, "PMID:26500481"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000262 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic pathways that deviate from what their normal course should be. Aberrant metabolic pathways, alone or in combination with other pathways, underlie many conditions, disorders and/or diseases."^^xsd:string ;
  obo:hasDbXref "PW Dictionary:InHouse dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000263 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those regulatory pathways that deviate from what their normal course should be. Aberrant regulatory pathways, alone or in combination with other pathways underlie many conditions, disorders and/or diseases."^^xsd:string ;
  obo:hasDbXref "PW Dictionary:InHouse Dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000264 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those signaling pathways that deviate from what their normal course should be. Aberrant signaling pathways, alone or in combination with other pathways underlie many conditions, disorders and/or diseases."^^xsd:string ;
  obo:hasDbXref "PW Dictionary:InHouse Dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000265 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Creutzfeldt-Jakob disease -  a rare prion disease, associated with a number of different mutations of the prion protein gene, existing in sporadic, familial (as an autosomal dominant), and infectious forms, with onset usually in middle life, and having a wide variety of clinical and pathological features. The most commonly seen are varying degrees of spongiform degeneration of neurons, neuronal loss, gliosis, and amyloid plaque formation, accompanied by rapidly progressive dementia, myoclonus, motor disturbances."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000266 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Gerstmann-Strussler syndrome,   Gerstmann-Strussler-Scheinker syndrome - a group of rare prion diseases, of autosomal dominant inheritance but linked to different mutations of the prion protein gene. Common characteristics include cognitive and motor disturbances, the presence of multicentric amyloid plaques in the brain. Its manifestations include cerebellar ataxia and dementia, rigidity, tremor, memory loss and others, depending on the form of the condition."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000267 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Fatal familial insomnia - an inherited prion disease, transmitted as an autosomal dominant trait, affecting primarily the ventral and dorsomedial nuclei of the thalamus and characterized by progressive insomnia, hallucinations, stupor, and coma ending in death within 6 months to 3 years of onset; autonomic and motor disturbances are also present."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000268 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Kuru - an infectious form of prion disease with a long incubation period, found only among the Fore and neighboring peoples of New Guinea. It is thought to be associated with ritual cannibalism. Its manifestations include truncal and limb ataxia, tremor, others; ends invariably in death. Amyloid plaques are present in about two thirds of affected individuals."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000269 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those reactions and molecular interactions underlying the folding of a protein into its functional three-dimensional structure. Folding takes place in the cytoplasm and, in the case of secreted proteins, in the endoplasmic reticulum. Proteins are checked (quality control) for proper folding and misfolded proteins are targeted for degradation."^^xsd:string ;
  obo:hasDbXref "GO:0006457"^^xsd:string, "PMID:17686625"^^xsd:string, "PMID:21495850"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000270 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The major events in presynaptic terminal differentiation are the formation of the active zone and the clustering of synaptic vesicles. Cytoskeletal and membrane specializations within the presynapse are necessary to for the regulated exo- and endocytosis of synaptic vesicles."^^xsd:string ;
  obo:hasDbXref "PMID:15194107"^^xsd:string, "PMID:25654254"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000271 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The factors and components involved in, and the elements that regulate them and together shape and modulate the formation of the postsynaptic differentiation."^^xsd:string ;
  obo:hasDbXref "PMID:20832286"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000273 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A simpler pathway of neuron-to-neuron signaling involving the direct flow of ionic currents. It is a reciprocal pathway involving membrane-to-membrane apposition known as gap junction."^^xsd:string ;
  obo:hasDbXref "PMID:24955544"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000274 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A neurotransmitter-releasing pathway of neuron-to-neuron communication. It involves fusion of neurotransmitter-filled synaptic vesicles with the plasma membrane, activation of postsynaptic receptors. It also involves recycling and re-release of synaptic vesicles."^^xsd:string ;
  obo:hasDbXref "PubMed:Annu. Rev. Neursci. 2003, v26, 701-28."^^xsd:string, "Reactome:REACT_13477.2"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000275 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A cell death pathway represents the particular series of events leading to the demise of a whole cell or parts of its contents. It plays an essential role in cellular and tissues homeostasis. Biochemical and morphological characteristics are used in the classification of various form of cell death. Deregulation of cell death can contribute to the development of cancer and neurodegeneration."^^xsd:string ;
  obo:hasDbXref "PMID:12196263"^^xsd:string, "PMID:18414491"^^xsd:string, "PMID:20211164"^^xsd:string, "PMID:21760595"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000276 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Non-apoptotic cell death pathway refers collectively to those types of cell death whose functional and/or morphological features are different from the apoptotic cell death. Cellular autophagy is an example."^^xsd:string ;
  obo:hasDbXref "PMID:12196263"^^xsd:string, "PMID:18414491"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000277 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Cellular senescence, also known as replicative senescence, results from cells ceasing to divide. Generally, it is a state of steady cell cycle arrest induced by stresses such as DNA damage, toxins and/or oncogene activation."^^xsd:string ;
  obo:hasDbXref "PMID:24449267"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000278 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Autophagic pathway involves the sequestration of misfolded or long-lived proteins and of defective organelles within double membrane vesicles, delivery of the cargo to lysosomes for degradation and recycling. It is also known as the macroautophagy, or bulk autophagy."^^xsd:string ;
  obo:hasDbXref "PMID:20034776"^^xsd:string, "PMID:20089931"^^xsd:string, "PMID:20211164"^^xsd:string, "wikipedia:https://en.wikipedia.org/wiki/Autophagy"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000279 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Necrosis represents the sum of the morphological changes indicative of cell death and caused by the progressive degradative action of enzymes; it may affect groups of cells or part of a structure or an organ. There are many causes of necrosis including injury, infection, cancer, infarction, inflammation, others. There are several distinctive morphologic patterns of necrosis."^^xsd:string ;
  obo:hasDbXref "Onelook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000280 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The secretory pathway is the route by which secreted proteins travel from sites of biosynthesis and folding, modification and sorting, to their final destinations. It involves ER insertion where folding and quality control of folding take place, move to Golgi and trans-Golgi Network (TGN) where sorting and final modifications take place, exit from Golgi and vesicular transport and delivery to plasma membrane and extracellular space or the endosomal system via constitutive or regulated exocytosis."^^xsd:string ;
  obo:hasDbXref "PMID:17686625"^^xsd:string, "PMID:18216874"^^xsd:string, "PMID:18354421"^^xsd:string, "PMID:21907200"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000281 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The endocytic pathway allows for recycling of cargo delivered via the exocytic or secretory routes, uptake of nutrients, internalization of receptors and also, the engulfing of dying cells or of material foreign to the cell. Endocytosis can be subdivided into four pathways: clathrin-mediated  and caveolae-mediated endocytosis, micropinocytosis and phagocytosis. Endosomes and lysosomes are central endocytic components responsible for sorting,  recycling, or degradation of cargo, as necessary."^^xsd:string ;
  obo:hasDbXref "GO:0006897"^^xsd:string, "PMID:16882731"^^xsd:string, "PMID:16985500"^^xsd:string, "PMID:18354421"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000282 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the degradation of benzoate - a salt of benzoic acid or benzene carboxylic acid, a fungistatic compound widely used as a food preservative."^^xsd:string ;
  obo:hasDbXref "GO:0043639"^^xsd:string, "InHouse:PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000283 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic pathways involving glycan that deviate from what their normal course should be. Aberrant glycan metabolic pathways, alone or in combination with other pathways, underlie various diseases."^^xsd:string ;
  obo:hasDbXref "PMID:15459677"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000284 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic pathways involving glycosaminoglycans that deviate from what their normal course should be. Aberrant glycosaminoglycan pathways, alone or in combination with other pathways underlie various diseases."^^xsd:string ;
  obo:hasDbXref "PMID:15459677"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000285 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic pathways involving heparan sulfate (HS) that deviate from what their normal course should be. Aberrant HS pathways, alone or in combination with other pathways may be involved in diseases. An example is the potential role of HS in Alzheimer's disease."^^xsd:string ;
  obo:hasDbXref "PMID:14530380"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000286 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Integrins signal bi-directionally across the plasma membrane and provide an example of mechanotransduction. Inside-out signaling modulates their interaction with ligands to regulate cell adhesion and ECM organization. Ligand binding initiates and shapes many signaling events and links to the cytoskeleton. Via protein clustering and ECM organization integrins synergize with and/or modulate various growth factor pathways. Integrin signaling regulates multiple processes including gene expression, cell proliferation, differentiation and survival."^^xsd:string ;
  obo:hasDbXref "GO:0007229"^^xsd:string, "KEGG:map04510"^^xsd:string, "PMID:11842240"^^xsd:string, "PMID:14570568"^^xsd:string, "PMID:15009204"^^xsd:string, "PMID:15276463"^^xsd:string, "Reactome:REACT_13552.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000287 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those apoptotic pathways that deviate from what their normal course should be. Aberrant pathways of programmed cell death, alone or in combination with other pathways underlie various diseases."^^xsd:string ;
  obo:hasDbXref "PW:InHouse"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000288 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An intrinsic apoptotic pathway that deviates from what its normal course should be. Aberrant intrinsic apoptotic pathway, alone or in combination with other pathways underlies various diseases."^^xsd:string ;
  obo:hasDbXref "PW:InHouse"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000289 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways of cell death that deviate from what their normal course should be. Aberrant pathways of cell death, alone or in combination with other pathways underlie various diseases."^^xsd:string ;
  obo:hasDbXref "PW:Inhouse"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000290 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways involved in and/or controlling DNA replication, cell cycle, DNA repair and preservation of genomic integrity, RNA and protein biosynthesis that deviate from what their normal course should be. Such aberrant pathways, alone or in combination with other pathways underlie various diseases."^^xsd:string ;
  obo:hasDbXref "PW:Inhouse"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000292 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways of DNA repair that deviate from what their normal course should be. Aberrant pathways of DNA repair, alone or in combination with other pathways underlie various diseases."^^xsd:string ;
  obo:hasDbXref "PW:InHouse"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000293 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways of protein folding, sorting, modification, translocation and degradation that deviate from what their normal course should be. Aberrant protein pathways, alone or in combination with other pathways underlie various diseases."^^xsd:string ;
  obo:hasDbXref "PW:InHouse"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000294 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An ubiquitin/proteasome degradation pathway that deviates from what its normal course should be. Aberrations in the pathway have been implicated in a number of diseases. Examples include certain malignancies, disorders of the immune and inflammatory responses and neurodegeneration."^^xsd:string ;
  obo:hasDbXref "PMID:14556719"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000295 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An integrin signaling pathway that deviates from what its normal course should be. Aberrant integrin signaling pathway, alone or in combination with other pathways underlies various diseases. An example is hypertrophic cardiomyopathy that involves integrins and the synergy between integrins and growth factors. Aberrant integrin signaling has also been correlated with tumor progression in several cancers."^^xsd:string ;
  obo:hasDbXref "PMID:15276463"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000296 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Hypertrophic cardiomyopathy, or HCM, is a disease of the myocardium (the muscle of the heart) in which a portion of the myocardium is thickened. Many physiological and pathological conditions as well as many pathways underlie the hypertrophic response."^^xsd:string ;
  obo:hasDbXref "KEGG:map05410"^^xsd:string, "OneLook:www.onelook.org"^^xsd:string, "PMID:15276462"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000297 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "PDGF signaling pathway plays an important role in the regulation of cell growth and survival."^^xsd:string ;
  obo:hasDbXref "GO:0048008"^^xsd:string, "PMID:14515146"^^xsd:string, "PMID:26153649"^^xsd:string, "Reactome:REACT_16888.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000298 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those growth factor mediated signaling pathways that deviate from what their normal course should be. Aberrant growth factor mediated pathways, alone or in combination with other pathways underlie various diseases."^^xsd:string ;
  obo:hasDbXref "PW:InHouse3"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000299 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Myocardial infarction, commonly known as heart attack, is a serious, sudden heart condition characterized by varying degrees of chest pain, weakness, sweating, nausea and vomiting, sometimes causing loss of consciousness. It occurs when parts of the heart muscle die because they are not supplied with enough blood."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.org"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000300 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The congenital and acquired diseases affecting the kidney."^^xsd:string ;
  obo:hasDbXref "PW:InHouse"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000301 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Renal failure implies the loss of kidney function. It can be acute and rapidly progressing, or chronic with slow progression. Chronic renal failure may involve a number of kidney diseases and end-stage renal failure is the ultimate consequence."^^xsd:string ;
  obo:hasDbXref "Onelook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000302 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Glomerulonephritis is accompanied by inflammation of the capillary loops in the glomeruli of the kidney. It occurs in acute, subacute, and chronic forms and may be secondary to hemolytic streptococcal infection. Evidence also supports possible immune or autoimmune mechanisms."^^xsd:string ;
  obo:hasDbXref "Onelook:www.onelook.org"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000303 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The p53-dependent pathway of G1 arrest in response to damaged DNA."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string, "Reactome:REACT_85.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000304 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The p53-independent pathway of G1/S arrest in response to damaged DNA."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string, "Reactome:REACT_1208.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000305 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways of carbohydrate metabolism that deviate from what their normal course should be. Aberrant carbohydrate metabolic pathways, alone or in combination with other pathways, underlie various diseases."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000306 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways of galactose metabolism that deviate from what their normal course should be. An aberrant galactose metabolic pathways, alone or in combination with other pathways underlies various diseases. One example is the involvement of aberrant galactose catabolism in cancer."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000307 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Coagulative necrosis is typically seen in hypoxic environments. Cell outlines remain after cell death and can be observed by light microscopy (e.g. myocardial infarction, infarct of the spleen)."^^xsd:string ;
  obo:hasDbXref "Onelook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000308 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Liquefactive necrosis is associated with cellular destruction and pus formation (e.g. pneumonia)."^^xsd:string ;
  obo:hasDbXref "onelook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000309 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Caseous necrosis is a mix of coagulative necrosis and liquefactive necrosis (e.g. tuberculosis)."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000310 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Fatty necrosis results from the action of lipases on fatty tissues (e.g. acute pancreatitis)."^^xsd:string ;
  obo:hasDbXref "Onelook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000311 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Fibrinoid necrosis involves the deposition of fibrin and other plasma proteins in the walls of afferent renal arterioles in malignant hypertension, often accompanied by an inflammatory infiltrate within the walls and thrombosis of the vessel lumen. "^^xsd:string ;
  obo:hasDbXref "Onelook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000312 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "MAPK signaling pathways that are responding to stress or injury as well as inflammatory cytokines"^^xsd:string ;
  obo:hasDbXref "PMID:10209154"^^xsd:string, "PMID:14570565"^^xsd:string, "PMID:17229475"^^xsd:string, "PMID:17306385"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000313 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A stress induced MAPK pathway that regulates an array of processes such as gene expression, cell migration, cytoskeletal organization, apoptosis."^^xsd:string ;
  obo:hasDbXref "GO:0007254"^^xsd:string, "KEGG:map04010"^^xsd:string, "PMID:15102441"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000314 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those signaling pathways that are mediated through the binding of calmodulin - a multifunctional calcium transducer - to its target effectors."^^xsd:string ;
  obo:hasDbXref "PMID:10884684"^^xsd:string, "PMID:14671000"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000315 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Calcineurin - a calcium/calmodulin dependent serine/threonine phosphatase - plays important regulatory roles in cardiac muscle growth and differentiation, memory processes and apoptosis."^^xsd:string ;
  obo:hasDbXref "PMID:15232210"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000316 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The multifunctional calcium/calmodulin dependent serine/threonine kinases (CAMKs) play important regulatory roles in the cardiac, muscle, nervous and immune tissues. They are represented by CAMK2 whose Ca2+/CaM binding leads to autophosphorylation and activation and the CAMK cascades that depend on an upstream CAMK kinase (CAMKK) for phosphorylation of an 'activation loop' and subsequent activation. CAMK1 and CAMK4 are the two CAMK signaling cascades."^^xsd:string ;
  obo:hasDbXref "PMID:21529938"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000317 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Members of the NFAT family of transcription factors, once de-phosphorylated by calcineurin translocate from the cytoplasm to the nucleus where they induce the transcription of genes involved in the immune response, cell-cell interactions. NFAT signaling is believed to play important roles in the development and function of the cardiovascular system."^^xsd:string ;
  obo:hasDbXref "GO:0033173"^^xsd:string, "PMID:11983154"^^xsd:string, "PMID:12975316"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000318 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those calcium/CaM dependent pathways that deviate from what their normal course should be. Aberrant calcium/CaM dependent pathways, alone or in combination with other pathways underlie many diseases. One example is the potential role disruptions within these pathways play in cardiac hypertrophy."^^xsd:string ;
  obo:hasDbXref "PW dictionary:InHouse PW"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000319 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A calcineurin signaling pathway that deviates from what its normal course should be. Aberrant calcineurin pathway, alone or in combination with other pathways underlie various diseases. One example is the role a constitutively active calcineurin plays in cardiac hypertrophy, via the NFAT pathway."^^xsd:string ;
  obo:hasDbXref "PMID:15276472"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000320 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of novobiocin, an aminocoumarin antibiotic. It is also known as albamycin or cathomycin and is produced by an actinomycete of the order Actinobacteria."^^xsd:string ;
  obo:hasDbXref "GO:0043642"^^xsd:string, "KEGG:map00401"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000321 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A Hedgehog signaling pathway that deviates from what its normal course should be. Aberrant Hedgehog signaling pathway has been involved in a number of human cancers."^^xsd:string ;
  obo:hasDbXref "PMID:12495844"^^xsd:string, "PMID:15205520"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000322 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Ephrins and their receptors constitute a bidirectional signaling pathway transducing forward signals through the receptors and reverse signals through the ephrins that influence the behavior of both interacting cells. The Eph/ephrin axis plays important roles in cell morphology, adhesion and migration. Its disruption has been implicated in several human cancers."^^xsd:string ;
  obo:hasDbXref "GO:0048013"^^xsd:string, "PMID:15093606"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000323 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An Eph/ephrin bidirectional axis that deviates from what its normal course should be. Aberrant Eph/ephrins axis has been implicated in a number of human cancers."^^xsd:string ;
  obo:hasDbXref "PMID:15561600"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000324 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A Notch signaling pathway that deviates from what its normal course should be. Aberrant Notch signaling pathway has been implicated in a number of human cancers."^^xsd:string ;
  obo:hasDbXref "PMID:11549580"^^xsd:string, "PMID:14988924"^^xsd:string, "PMID:15288257"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000325 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways involved in the degradation of proteins."^^xsd:string ;
  obo:hasDbXref "GO:0030163"^^xsd:string, "InHouse:InHouse PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000327 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathways involved in the formation, reduction and isomerization of disulphide bonds in proteins. Disulphide bonds are essential for the stability of proteins that are secreted or are localized to organelles of the secretory pathway."^^xsd:string ;
  obo:hasDbXref "PMID:10754564"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000328 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The family of fibroblast growth factors (FGF) comprises 22 ligands classified into seven phylogenetic subfamilies and three groups by mode of action: the intracellular intracrine and the extracellular paracrine or canonical and endocrine or hormone-like groups. The paracrine subfamilies signal via the fibroblast growth factor receptors (FGFR), receptor tyrosine kinases (RTK). The endocrine subfamily is FGFR-dependent but the affinity towards the receptors is low and it relies on the Klotho family of transmembrane proteins. The intracrine subfamily is FGFR-independent. Overall, the pathway plays important roles during embryonic and postnatal development, neuromodulation, mineral metabolism and homeostasis. Deregulation of the pathway has been associated with neoplastic and metabolic diseases."^^xsd:string ;
  obo:hasDbXref "GO:0007173"^^xsd:string, "PMID:19379279"^^xsd:string, "PMID:19601767"^^xsd:string, "PMID:20940169"^^xsd:string, "PMID:22298654"^^xsd:string, "Reactome:REACT_9470.2"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000329 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The TGF-beta superfamily of growth factors regulates a broad spectrum of processes such as angiogenesis, embryonic development, cell differentiation, proliferation, wound healing. Binding to two types of serine/threonine receptors and activation of Smad proteins is a common theme. However, ligand-receptor interaction and the identity of the activated Smad protein(s) appear to be member specific."^^xsd:string ;
  obo:hasDbXref "KEGG:map04350"^^xsd:string, "PMID:15473857"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000330 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The bone morphogenetic proteins (BMP) are related to TGF-beta and activins and are members of the TGF-beta superfamily. The BMP signaling pathway plays important roles in induction and patterning of the mesoderm. BMP pathway cross-talks to other pathways such as TGF-beta, Wnt, MAPK, Notch, JAK-STAT and others."^^xsd:string ;
  obo:hasDbXref "GO:0030509"^^xsd:string, "PMID:15368350"^^xsd:string, "Reactome:REACT_12034.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000331 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Activins are members of the TGF-beta superfamily of growth factors. The pathway plays important roles in embryonic development, inflammation, reproductive biology. Deregulation of activin signaling contributes to a number of pathological conditions."^^xsd:string ;
  obo:hasDbXref "GO:0032924"^^xsd:string, "PMID:16885529"^^xsd:string, "PMID:16997617"^^xsd:string, "PMID:19273500"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000332 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Cell-cell signaling pathway conveys information between cells using cell adhesion molecules."^^xsd:string ;
  obo:hasDbXref "RGD:InHouse dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000333 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Cadherins represent a large protein superfamily with many and important roles in cell adhesion and signaling. Cadherins are characterized by the presence of the extracellular cadherin, calcium-binding repeat. The number and structural similarities of repeats across families vary."^^xsd:string ;
  obo:hasDbXref "PMID:11171368"^^xsd:string, "PMID:18848899"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000335 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those TGF-beta superfamily mediated signaling pathways that deviate from what their normal course should be. Alone or in combination with other pathways they underlie many conditions such as pulmonary hypertension and various types of cancer."^^xsd:string ;
  obo:hasDbXref "PMID:18313409"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000336 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those cell-cell signaling pathways that deviate from what their normal course should be."^^xsd:string ;
  obo:hasDbXref "PW dictionary:InHouse PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000340 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An altered Notch signaling pathway due to mutation(s) in the main players. They include receptor(s), ligand(s), and members of the CSL complex."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000341 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An altered Notch signaling pathway due to mutation(s) in the enzymes, macromolecules that act upon the main players. They include proteases, elements of the proteo- and glucosaminoglycan metabolic pathways, ubiquitin ligases, other proteins that modulate availability, sensitivity, endocytosis of ligands/receptors."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000342 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An altered Notch signaling pathway due to mutation(s) in the target gene(s). They may include members of the HES and HERP families of basic helix-loop-helix (bHLH) transcriptional repressors."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000343 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An altered Notch signaling pathway due to mutation(s) in the promoters of target gene(s)."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000346 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "CADASIL - cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy - a disease of the small cerebral arteries characterized by subcortical stroke and vascular dementia. It is associated with mutations in the Notch3 gene. More than fifty mutations are clustered within the first EGF repeats and involve the gain or loss of a cysteine."^^xsd:string ;
  obo:hasDbXref "PMID:14667809"^^xsd:string, "PMID:14986825"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000349 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Alagille syndrome is a developmental disease characterized by defects in heart, as well as liver, skeleton and eye. Abnormalities of the central nervous system are also found. The disease is associated with mutations across the entire Jag1 gene."^^xsd:string ;
  obo:hasDbXref "PMID:14986825"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000350 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A VEGF mediated pathway that deviates from what its normal course should be. Aberrant VEGF mediated pathways have been implicated in a number of human cancers. Upregulation of VEGF expression is associated with cancer and tumor growth."^^xsd:string ;
  obo:hasDbXref "PMID:15563310"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000351 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An altered VEGF signaling pathway due to mutation(s) in the main players. They include the various VEGF molecules and VEGF receptors."^^xsd:string ;
  obo:hasDbXref "InHouse:InHouse PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000352 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An altered VEGF signaling pathway due to mutation(s) in the enzymes that process VEGF, such as the plasmin and furin-like proteases."^^xsd:string ;
  obo:hasDbXref "InHouse:In House PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000353 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An altered VEGF signaling pathway due to mutation(s), any activity change in the proteins that regulate VEGF expression. They include transcription factors such as the hypoxia-inducible factor and the many proteins impacting on the stability and/or activity of these factors."^^xsd:string ;
  obo:hasDbXref "InHouse:InHouse PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000354 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of glycerophospholipids, also known as phospholipids. They are key components of membranes and some are also involved in signaling."^^xsd:string ;
  obo:hasDbXref "GO:0006650"^^xsd:string, "KEGG:map00564"^^xsd:string, "MCW library:QU4 M235b 2009"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000355 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways involved in the maintenance of the internal environment of an organism, the adequate levels of substances and nutrients, the stability of normal body states and the feedback regulatory mechanisms that control them."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000356 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathways involved in responding to changes in and maintenance of adequate oxygen levels."^^xsd:string ;
  obo:hasDbXref "GO:0032364"^^xsd:string, "PMID:11181957"^^xsd:string, "PMID:12603312"^^xsd:string, "PMID:14597660"^^xsd:string, "PMID:15031665"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000357 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways involved in the balance between energy uptake and energy expenditure. Disturbance of this equilibrium has been linked to various conditions including obesity."^^xsd:string ;
  obo:hasDbXref "PMID:11239410"^^xsd:string, "PMID:15703762"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000358 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those homeostatic pathways that deviate from what their normal course should be. Aberrant homeostatic pathways, alone or in combination with other pathways, underlie many conditions, disorders and/or diseases."^^xsd:string ;
  obo:hasDbXref "PW dictionary:PW InHouse dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000359 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways of energy homeostasis that deviate from what their normal course should be. Obesity in particular has been associated with disturbances in the control of energy balance."^^xsd:string ;
  obo:hasDbXref "PMID:11239410"^^xsd:string, "PMID:15703762"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000360 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The hypoxia inducible transcription factor is activated in response to hypoxic conditions to promote the expression of many genes that play important roles in glucose and energy metabolism, angiogenesis and erythropoiesis."^^xsd:string ;
  obo:hasDbXref "PMID:11181957"^^xsd:string, "PMID:12603312"^^xsd:string, "PMID:14597660"^^xsd:string, "PMID:15031665"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000362 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The acute hypoxic response is mediated through the activity of excitable cells via oxygen-sensing ion channels."^^xsd:string ;
  obo:hasDbXref "PMID:11181957"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000363 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Leptin acts on two populations of hypothalamic neurons that express orexigenic (feeding inducing) and anorexigenic genes, respectively. Leptin reduces the expression of genes from the former and enhances the expression of genes from the latter neurons. Leptin mediated response acts primarily via Jak-dependent activation of STAT."^^xsd:string ;
  obo:hasDbXref "GO:0033210"^^xsd:string, "PMID:11239410"^^xsd:string, "PMID:12079865"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000365 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The melanocortin dependent system is involved in a diverse number of pathways such as pigmentation, steroidogenesis, sexual function, energy homeostasis. Its implication in energy homeostasis is of particular interest as alterations of this system have been associated with obesity."^^xsd:string ;
  obo:hasDbXref "PMID:11874690"^^xsd:string, "PMID:12556347"^^xsd:string, "PMID:15189116"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000366 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A melanocortin dependent system pathway that deviates from what its normal course should be. Mutations in the prohormone gene PMOC and the modifying enzyme PC1 are linked to obesity. Mutations in MC2R receptor and its accessory protein MRAP have been associated with type 1 and 2 familial glucocorticoid deficiency, respectively."^^xsd:string ;
  obo:hasDbXref "PMID:11874690"^^xsd:string, "PMID:19028547"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000367 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Jak-Stat signaling pathways that deviate from what their normal course should be."^^xsd:string ;
  obo:hasDbXref "InHouse:PW InHouse dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000368 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways dependent on activation by JAK kinases but independent of Stat proteins."^^xsd:string ;
  obo:hasDbXref "PMID:12884916"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000369 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Nuclear factor, 2 like 2 (Nfe2l2, also known as Nrf2) signaling pathway is one of the most important regulator of antioxidant and/or electrophilic stress responses. Upon activation, Nfe2l2 induces the expression of antioxidant, xenobiotic metabolism, and cytoprotective genes, among others. Deregulation of the pathway has been associated with various conditions, including neurodegeneration and cancer."^^xsd:string ;
  obo:hasDbXref "PMID:15252150"^^xsd:string, "PMID:20486759"^^xsd:string, "PMID:20815789"^^xsd:string, "PMID:22874821"^^xsd:string, "PMID:26122708"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000370 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The aryl hydrocarbon receptor (AhR) is a transcription factor whose ligands include a variety of aromatic hydrocarbons and which regulates the expression of phase I and phase II drug- and xenobiotic-metabolizing enzymes. Phase I enzymes convert otherwise inactive hydrocarbons into active metabolites with potential carcinogenic effects, thus rendering AhR a player in tumor initiation."^^xsd:string ;
  obo:hasDbXref "PMID:15451023"^^xsd:string, "PMID:15627472"^^xsd:string, "PMID:20106901"^^xsd:string, "PMID:20868221"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000371 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The maintenance of adequate intracellular calcium levels are crucial in order to assure the availability of this important ion and, at the same time prevent against the damage its high concentration can cause. Pumps and exchangers move the calcium ions into organelles or outside the cell, channels of many types allow for its transient flow inside the cell. Calcium transport, which maintains and controls the calcium gradient, and calcium signaling, which the gradient promotes, are inextricably connected in the fabric of calcium homeostasis."^^xsd:string ;
  obo:hasDbXref "PMID:17574670"^^xsd:string, "PMID:18083096"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000372 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Dysfunction of calcium homeostasis has been implicated in several human neural, neurodegenerative and cardiac conditions."^^xsd:string ;
  obo:hasDbXref "PMID:21170867"^^xsd:string, "PMID:21698698"^^xsd:string, "PMID:22435804"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000373 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The glutathione conjugation of endogenous and exogenous electrophilic compounds represents a major pathway phase II biotransformation. The glutathione conjugates may either be excreted or undergo further processing."^^xsd:string ;
  obo:hasDbXref "MCW - book:QV 600 C335t 2001"^^xsd:string, "PMID:17482904"^^xsd:string, "Reactome:REACT_6959.3"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000374 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Pathways of glutathione conjugates processing other than the mercapturic acid pathway."^^xsd:string ;
  obo:hasDbXref "InHouse dictionary:PW InHouse dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000375 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The major phase I biotransformation pathway for the activation of endogenous and exogenous substances carried out by members of the cytochrome P450 superfamily."^^xsd:string ;
  obo:hasDbXref "Book:QV 600 C335t 2001"^^xsd:string, "PMID:17482904"^^xsd:string, "PMID:19835560"^^xsd:string, "Reactome:REACT_13705.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000376 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A minor phase I biotransformation pathway for the activation of endogenous and exogenous substances carried by flavin-containing monooxygenases."^^xsd:string ;
  obo:hasDbXref "PMID:19835560"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000377 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The mercapturic acid pathway of glutathione conjugates processing involves the sequential cleavage of glutamyl and glycine residues of glutathione followed by cysteine N-acetylation."^^xsd:string ;
  obo:hasDbXref "MCW book:QV 600 C335t 2001"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000378 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Oxidative stress occurs when the redox balance between pro- and anti-oxidants is upset due to an increase in endogenous or exogenous pro-oxidant stimuli. The response triggers the upregulation of antioxidant and detoxification systems. Oxidants can also act as second messengers to trigger a variety of cellular signaling pathways."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Oxidative_stress"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000379 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Inhibition of protein folding or its disruption by mutant proteins in the endoplasmic reticulum triggers a signal transduction response known as the unfolded protein response (UPR). UPR increases the biosynthetic capacity while decreasing the biosynthetic burden of the secretory pathway through up- and downregulation of gene expression."^^xsd:string ;
  obo:hasDbXref "GO:0030968"^^xsd:string, "PMID:15603751"^^xsd:string, "PMID:15952902"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000380 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Drugs, endogenous and/or exogenous compounds processed through the phase I and II of  bioactivation, biotransformation pathways are eliminated via phase III transport pathway carried out by several transporter families."^^xsd:string ;
  obo:hasDbXref "PMID:17220560"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000384 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The G2M checkpoint pathways assure the genome is replicated only once per cell cycle. The checkpoints control for damaged and un-replicated DNA. Various DNA damage checkpoints lead to inhibition of the cyclin- dependent kinases that regulate the next cell cycle point."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string, "Reactome:REACT_897.2"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000385 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways that assure the genome is replicated only once per cell cycle. The checkpoints control for damaged and un-replicated DNA. Un-replicated DNA signals to block the cell cycle from proceeding. The mechanism by which the cell detects un-replicated DNA is not known."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string, "Reactome:REACT_1846.2"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000386 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A very close relative of Ras, Rap1 mediated pathway  appears to control diverse processes such as modulation of growth and differentiation, secretion, integrin linked cell adhesion, morphogenesis."^^xsd:string ;
  obo:hasDbXref "PMID:11331911"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000387 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Arf family mediated signaling pathways are involved in the regulation of intracellular vesicle trafficking. In particular they appear to control early events such as vesicle budding."^^xsd:string ;
  obo:hasDbXref "GO:0032011"^^xsd:string, "PMID:11152757"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000388 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The reelin signaling pathway regulates neuronal positioning and may also play a role in synaptic plasticity. The reelin gene appears to be downregulated in schizophrenic brains but the link between the reelin pathway and the disease remains to be established."^^xsd:string ;
  obo:hasDbXref "PMID:12764038"^^xsd:string, "PMID:14715136"^^xsd:string, "PMID:14993361"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000392 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A Ras mediated signaling pathway that deviates from what its normal course should be. Aberrant Ras mediated signaling pathways have been implicated in a number of human cancers and deregulation of Ras has been reported even in the absence of mutations."^^xsd:string ;
  obo:hasDbXref "PMID:11027944"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000394 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Dopamine signaling plays important roles in processes such as motivation, learning and movement. It also plays several roles in the periphery as a modulator of renal, cardiovascular and the endocrine systems. Dopamine signals to a family of at least 5 receptors that are classified into two subfamilies that couple to distinct G proteins to elicit diverse downstream events. Deregulation of the pathway has been implicated in several neuropsychiatric and neurological disorders."^^xsd:string ;
  obo:hasDbXref "GO:0007212"^^xsd:string, "PMID:17408758"^^xsd:string, "PMID:18353279"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000396 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Polyamine metabolism plays important roles in a number of cellular processes. Spermidine and spermine are formed in two consecutive reactions carried out by distinct enzymes that employ the decarboxylated form of AdoMet as an aminopropyl donor."^^xsd:string ;
  obo:hasDbXref "GO:0008216"^^xsd:string, "PMID:19603518"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000397 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving cobalamin, known as vitamin B12 - a water-soluble vitamin. Cobalamin which important roles in a number of metabolic pathways. There are several related compounds whose synthesis occurs in bacteria but whose conversion can be carried out in higher organisms."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Vitamin_B12"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000398 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Homocysteine (Hcy) metabolism is at the intersection of two pathways: the remethylation pathway that regenerates methionine and thus the methionine cycle and the transsulfuration pathway that gives rise to cysteine and derivatives. The Hcy pathway also engages choline, folate, vitamin(s) metabolism and links to the metabolism of other amino acids and compounds."^^xsd:string ;
  obo:hasDbXref "PMID:20814827"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000399 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The predominant route of homocysteine remethylation to methionine that requires the 5-methyl tetrahydrofolate 1 carbon donor and as such, engages folate metabolism."^^xsd:string ;
  obo:hasDbXref "PMID:20814827"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000400 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The transulfuration pathway is one of the two routes of homocysteine metabolism. It allows for the transfer of sulfur from methionine to cysteine. 70% of cysteine is then converted to glutathione and the remainder ends up as either taurine or pyruvate and sulfate."^^xsd:string ;
  obo:hasDbXref "PMID:20162368"^^xsd:string, "wikipedia:https://en.wikipedia.org/wiki/Transsulfuration_pathway"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000401 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The route of homocysteine remethyation to methionine that mainly occurs in the liver and requires betaine as the methyl donor."^^xsd:string ;
  obo:hasDbXref "PMID:20814827"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000402 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic pathways of amino acids other than the common amino acids that deviate from what their normal course should be. Aberrant metabolic pathways of other amino acids, alone or in combination with other pathways, underlie various diseases."^^xsd:string ;
  obo:hasDbXref "InHouse:PW InHouse dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000403 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways of amino acid metabolism that deviate from what their normal course should be. Aberrant amino acid metabolic pathways, alone or in combination with other pathways, underlie various diseases."^^xsd:string ;
  obo:hasDbXref "InHouse:PW InHouse dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000404 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving creatine. Officially methyl guanidino-acetic acid formed from arginine and glycine and the methyl group of methionine, creatine supplies energy to muscle cells."^^xsd:string ;
  obo:hasDbXref "GO:0006600"^^xsd:string, "Onelook:www.onelook.com"^^xsd:string, "PMID:10893433"^^xsd:string, "Reactome:REACT_813.2"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000405 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Release of neurotransmitters is mediated through the exocytosis of neurotransmitter-filled synaptic vesicles. Synaptic vesicle trafficking cycle is composed of a number of steps that culminate in calcium-triggered fusion and release."^^xsd:string ;
  obo:hasDbXref "PMID:10488439"^^xsd:string, "PMID:15217342"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000408 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of acetylcholine - an ester of choline and acetic acid that acts as a neurotransmitter in both the peripheral nervous system and the central nervous system."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000409 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of dopamine that acts as a neurotransmitter and a neurohormone. Dopamine has multiple functions in the brain."^^xsd:string ;
  obo:hasDbXref "PMID:19342614"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000410 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of serotonin - an amine neurotransmitter that is believed to play important roles in a number of conditions such as depression, bipolar disorder, anxiety."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000411 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of histamine - a biogenic amine that acts as a neurotransmitter and is also involved in the local immune responses."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000412 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of gamma-aminobutyric acid (GABA)."^^xsd:string ;
  obo:hasDbXref "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000413 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the degradation of heme - an iron-containing compound where the iron is complexed within a porphyrin heterocyclic ring, There are several kinds of hemes depending on the composition of their side chain. Heme serves as a prosthetic group for a number of proteins."^^xsd:string ;
  obo:hasDbXref "PMID:24782769"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000414 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The 'core' 20S proteasome degrades oxidized and/or unfolded proteins in an ATP and ubiquitin independent manner. The association with the 19S regulatory cap yields the 26S proteasome which has substrate selectivity and ATP and ubiquitin-dependent activity."^^xsd:string ;
  obo:hasDbXref "PMID:9212076;"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000415 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A proteasome degradation pathway mediated by cullins. Cullins are components of E3 ligase complexes and substrates for Nedd8 - a ubiquitin-like molecule. Neddylation is thought to modulate the activity of cullins."^^xsd:string ;
  obo:hasDbXref "PMID:10806345"^^xsd:string, "PMID:15021886"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000416 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A pathway of protein modification via conjugation with SUMO (small ubiquitin-related modifier).  SUMOylation does not target proteins to the proteasome, rather it targets proteins to particular cellular compartments."^^xsd:string ;
  obo:hasDbXref "PMID:10806345"^^xsd:string, "PMID:15808504"^^xsd:string, "PMID:23328396"^^xsd:string, "PMID:23416108"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000417 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway for the ATP-dependent non-lysosomal proteolysis catalyzed by the 26S proteasome and for which ubiquitination, the post-translational covalent conjugation of ubiquitin, or ubiquitin-like, to target proteins is a key signal."^^xsd:string ;
  obo:hasDbXref "PMID:10993052"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000419 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathways by which water flows into and out of the cell and into and out of sub-cellular compartments for multi-cellular organisms and mediated by members of the aquaporin family of water channels (WCP). The 13 members identified in mammals are grouped into three subfamilies: aquaporins, selective for water; aquaglyceroporins,  permeable to both water and small molecules; superaquaporins, the sub-cellular aquaporins. WCPs belong to the superfamily of major intrinsic proteins (MIPs)."^^xsd:string ;
  obo:hasDbXref "GO:0006833"^^xsd:string, "PMID:19165894"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000421 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A mitogen activated protein kinase pathway that deviates from what its normal course should be. Altered MAPK pathways have been linked to a spectrum of conditions."^^xsd:string ;
  obo:hasDbXref "PW InHouse dictionary:InHouse"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000424 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A surfactant homeostatic pathway that deviates from what its normal course should be. Mutations in surfactant proteins and in ABCA3 - a member of the ABC transporters have been implicated in the altered pathway and associated with conditions such as Respiratory Distress Syndrome (RDS) in newborns and lung diseases in infants."^^xsd:string ;
  obo:hasDbXref "PMID:15985750"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000425 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "High glucose-mediated oxidative stress effects on the expression of vascular endothelial growth factor and insulin-like growth factor, triggering of polyol metabolic pathway and activation of protein kinase c (PKC) signaling are thought to play a role in the pathophysiology of diabetic retinopathy."^^xsd:string ;
  obo:hasDbXref "PMID:16026270"^^xsd:string, "PMID:24373831"^^xsd:string, "PMID:24563789"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000426 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "In the secretory pathway, protein sorting, mainly in trans-Golgi Network (TGN), but also in other compartments, underlies cargo recognition by various carriers to assure the specificity of final localization."^^xsd:string ;
  obo:hasDbXref "PMID:17686625"^^xsd:string, "PMID:18216874"^^xsd:string, "PMID:18354421"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000427 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Molybdenum cofactor is a complex between molybdopterin and an oxide of molybdenum and is required for the activity of several enzymes."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Molybdenum"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000432 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Protein modification pathway exerts a central role in the regulation of protein function and the pathways these function impinge upon. It is also used to target protein for degradation. In the more special aspect of protein modification in the secretory pathway, it involves the final modification of glycoproteins and glycosaminoglycans as well as processing of proteins to their mature forms."^^xsd:string ;
  obo:hasDbXref "InHouse:InHouse PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000433 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Conjugation of proteins with ubiquitin and ubiquitin-like molecules proceeds via a cascade-like, enzyme-driven mechanism with diverse functionality."^^xsd:string ;
  obo:hasDbXref "PMID:10806345"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000434 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A pathway of protein modification via conjugation with ubiquitin. Ubiquitination is well known for targeting proteins for degradation.  However, ubiquitination is also used as a tag that modulates the signaling outcomes of modified substrates."^^xsd:string ;
  obo:hasDbXref "PMID:10806345"^^xsd:string, "PMID:21135871"^^xsd:string, "PMID:22420778"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000435 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A pathway of protein modification via conjugation with Nedd8  - a ubiquitin-like protein. All Nedd8 targets appear to be members of the cullin family. Cullins participate in the assembly of various E3 ligase complexes. Neddylation pathway is important for embryogenesis and cell cycle control in metazoa, embryonic development in animals."^^xsd:string ;
  obo:hasDbXref "PMID:10806345"^^xsd:string, "PMID:15021886"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000436 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The prominent examples of biogenic amines are histamine, serotonin, the catecholamine and the choline derived acetylcholine, all acting as neurotransmitters involved in a wide range of processes."^^xsd:string ;
  obo:hasDbXref "Wikipedia:http://en.wikipedia.org/wiki/Biogenic_amine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000438 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of alanine. Alanine is a non-essential amino acid with roles in glucose and protein metabolism."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000439 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of aspartic acid/aspartate. Aspartic acid is a non-essential amino acid with roles in glucose, protein and nucleotide metabolism. In the brain, it can act as a neurotransmitter."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000440 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of glycine, a non-essential amino acid. Glycine has the simplest structure with a hydrogen atom as its side chain. The amino acid is the major inhibitory neurotransmitter."^^xsd:string ;
  obo:hasDbXref "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000441 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of epinephrine - a catecholamine derived from the amino acids phenylalanine and tyrosine. It acts as a hormone and a neurotransmitter."^^xsd:string ;
  obo:hasDbXref "PMID:19342614"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000442 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of norepinephrine - a catecholamine derived from the amino acid tyrosine. It acts as a hormone and a neurotransmitter."^^xsd:string ;
  obo:hasDbXref "PMID:19342614"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000443 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of catecholamines - chemical compounds derived from tyrosine. Epinephrine, norepinephrine and dopamine are among the most abundant and are produced primarily from the adrenal medulla and the postganglionic fibers of the sympathetic nervous system."^^xsd:string ;
  obo:hasDbXref "OneLook:www,onelook.com"^^xsd:string, "PMID:19342614"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000444 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Any of a number of indole derivatives containing an amine group."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000448 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of neuropeptide Y."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000449 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of enkephalin, a pentapeptide involved in the regulation of nociception."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000450 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of neurotensin."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000451 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of beta-endorphine - a peptide neurotransmitter that may play a role in depression."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000452 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of substance P - a  short-chain polypeptide that acts as a neurotransmitter and a neuromodulator."^^xsd:string ;
  obo:hasDbXref "OneLook:www,onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000453 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of an isoprenoid. Isoprenoids are precursors of both sterols and non-sterol derivatives."^^xsd:string ;
  obo:hasDbXref "MCW library:QU4 M235b 2009"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000454 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of cholesterol, an essential sterol component of mammalian cell membrane. Cholesterol is the precursor of all steroid hormones."^^xsd:string ;
  obo:hasDbXref "GO:0006695"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string, "Reactome:REACT_9405.2"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000455 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Synaptic transmission, or neurotransmission is the pathway of neuron-to-neuron signaling via the chemical synapse and mediated by neurotransmitters. Their effect can be excitatory or inhibitory and many neurotransmitters can exert either effect. The major excitatory neurotransmitter is the amino acid glutamate."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000456 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Synaptic transmission, or neurotransmission is the pathway of neuron-to-neuron signaling via the chemical synapse and mediated by neurotransmitters. Their effect can be excitatory or inhibitory and many neurotransmitters can exert either effect. The major inhibitory neurotransmitter is gamma-aminobutyric acid (GABA)."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000457 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Angiotensin III is derived from angiotensin II through the action of aminopeptidase A and in turn is cleaved by aminopeptidase N to generate angiotensin IV. Angiotensin III appears to function in a manner similar to angiotensin II. It plays a role in vasoconstriction and the control of arterial blood pressure. Angiotensin III may be the effective angiotensin peptide in the central nervous system."^^xsd:string ;
  obo:hasDbXref "PMID:10961935"^^xsd:string, "PMID:11295571"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000458 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Angiotensin IV is derived from angiotensin III through the action of aminopeptidase N. The receptor for angiotensin IV has been shown to be the insulin-regulated membrane aminopeptidase. Studies suggest that angiotensin IV signaling activates a number of intracellular second messenger systems and plays a role in vascular remodeling and memory."^^xsd:string ;
  obo:hasDbXref "PMID:12591177"^^xsd:string, "PMID:15549174"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000459 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Apelin signaling pathway plays a role in the vascular, cardiac, bone and digestive systems as well as the brain."^^xsd:string ;
  obo:hasDbXref "GO:0060183"^^xsd:string, "PMID:15601620"^^xsd:string, "PMID:15907343"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000460 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or conversion of arachidonic acid - a polyunsaturated, omega-6 fatty acid. It is a precursor in the production of eicosanoids and can also be converted to other metabolites, collectively known as the arachidonic acid cascade."^^xsd:string ;
  obo:hasDbXref "GO:0019369"^^xsd:string, "KEGG:map00590"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string, "PMID:15896353"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000461 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The cyclooxygenase pathway is one of the three major routes of arachidonic acid oxygenation."^^xsd:string ;
  obo:hasDbXref "PMID:15896353"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000462 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Lipoxygenase pathway is one of three major routes of arachidonic acid oxygenation"^^xsd:string ;
  obo:hasDbXref "PMID:15896353"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000463 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Cytochrome P450 monooxygenase pathway is one the three major routes of arachidonic acid oxygenation."^^xsd:string ;
  obo:hasDbXref "PMID:15896353"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000464 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving leukotrienes - a class of eicosanoids whose effects include vasoconstriction and bronchoconstriction."^^xsd:string ;
  obo:hasDbXref "MCW library:QU4 M235b 2009"^^xsd:string, "PMID:15896353"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000465 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Hormones are a class of molecules that are used as messengers between cells and serve as signals to the target cell. Vertebrate hormones belong to three classes: amine and amino acid derived, peptide and protein hormones, and lipid and phospholipid derived hormones."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000468 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "steroid hormones - steroids that act as hormones - can be grouped into several categories depending on the receptor to which they bind."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000469 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The main categories of lipid hormones are the eicosanoids derived from arachidonic acid metabolism and the cholesterol derived steroid hormones. The signaling they initiate plays important roles in metabolism, inflammation and immunity, in the cardiovascular, nervous, renal and reproductive systems."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000470 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The natriuretic peptide family consists of three peptide hormones of diverse roles in cardiovascular as well as neuroendocrine and renal functions."^^xsd:string ;
  obo:hasDbXref "PMID:15246247"^^xsd:string, "PMID:15758553"^^xsd:string, "PMID:15911062"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000471 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Atrial natriuretic peptide hormone pathway plays important roles in the regulation of body fluid volume and blood pressure."^^xsd:string ;
  obo:hasDbXref "PMID:15246247"^^xsd:string, "PMID:15758553"^^xsd:string, "PMID:15911062"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000472 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "brain natriuretic peptide signaling pathway appears to elicit cardiovascular, renal and endocrine functions similar to those elicited by the atrial natriuretic peptide."^^xsd:string ;
  obo:hasDbXref "PMID:1524624"^^xsd:string, "PMID:15758553"^^xsd:string, "PMID:15911062"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000473 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The role of the C-type signaling pathway is not well established. The receptor for the C-type natriuretic peptide, unlike the receptors for the other two types of peptides, is non-guanylyl cyclase receptor that appears to couple to adenylyl cyclase inhibition/phospholipase C activation via Gi family of G-protein."^^xsd:string ;
  obo:hasDbXref "PMID:15246247"^^xsd:string, "PMID:15758553"^^xsd:string, "PMID:15911062"^^xsd:string, "PMID:15911072"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000474 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The coagulation cascade is the series of events proceeding via the tissue factor (extrinsic) or the contact activation (intrinsic) pathway and converging in the formation of fibrin clots. Several anticoagulation systems are in place to modulate the pathway. The coagulation cascade and the complement pathway of  immune responses are connected in a cross talk."^^xsd:string ;
  obo:hasDbXref "PMID:26018600"^^xsd:string, "PMID:26149013"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000475 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Hemostasis is the response to blood vessel injury to prevent blood loss via platelet mediated primary homeostasis and the secondary homeostasis of coagulation. The latter is a complex cascade which is triggered by the innate immune response and inflammation."^^xsd:string ;
  obo:hasDbXref "PMID:26018600"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000477 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The endogenous routes of inhibiting the coagulation cascade, collectively known as the natural anticoagulant pathways."^^xsd:string ;
  obo:hasDbXref "PMID:23031460"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000478 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Tissue factor pathway inhibitor isoforms alpha and beta are the main anticoagulants targeting the extrinsic coagulation cascade factors F7a and F7a-dependent F10a."^^xsd:string ;
  obo:hasDbXref "PMID:24620349"^^xsd:string, "PMID:25377319"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000479 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Antithrombin (AT) affects the activity of many coagulation factors in the intrinsic and common coagulation cascade. Heparin, though not essential, is an important AT cofactor. increasing the activity of AT by ~1,000-fold."^^xsd:string ;
  obo:hasDbXref "PMID:23031460"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000480 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Activated protein C, with the aid of protein S, inhibits F8a and F5a - the important cofactors of the intrinsic tenase and thrombinase complexes, respectively, of coagulation cascade."^^xsd:string ;
  obo:hasDbXref "PMID:23809128"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000481 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The steps leading to the activation of plasminogen and the subsequent breaking down of a fibrin clot - the product of coagulation cascade."^^xsd:string ;
  obo:hasDbXref "PMID:26149056"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000482 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of lipoproteins - any of the protein-lipid complexes. In the blood lipoproteins carry fats essential for the cell. Genetic variability and environmental (nongenetic) factors contribute to alterations in the homeostasis of lipid metabolic pathways and constitute cardiovascular disease risk."^^xsd:string ;
  obo:hasDbXref "GO:0042157"^^xsd:string, "PMID:16011471"^^xsd:string, "Reactome:REACT_6823.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000483 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those lipid metabolic pathways that deviate from what their normal course should be. Aberrant lipid metabolic pathways, alone or in combination with other pathways underlie a number of diseases."^^xsd:string ;
  obo:hasDbXref "InHouse:PW InHouse dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000484 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those lipoprotein metabolic pathways that deviate from what their normal course should be. Aberrant lipoprotein metabolic pathways, alone or in combination with other pathways underlie several diseases."^^xsd:string ;
  obo:hasDbXref "In House:PW In House dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000485 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of eicosanoids. Eicosanoids are derived from omega-6 or omega-3 fatty acids and derivatives. Examples include the leukotriene and the prostanoid classes, the latter represented by several families. Eicosanoids play important roles in the immune and vascular systems."^^xsd:string ;
  obo:hasDbXref "MCW library:QU4 M235b 2009"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string, "PMID:15896353"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000486 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Peptides generated from proteolytic degradation of cytosolic proteins are translocated to the ER where they associate with class I MHC molecules. Peptide-class I MHC complexes move through the Golgi and are transported to the cell surface to be recognized by CD8+ T cells."^^xsd:string ;
  obo:hasDbXref "MCW:Handbook on cellular nad molecular immunology"^^xsd:string, "PMID:16181325"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000487 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Peptides generated from enzymatic degradation of proteins internalized in late endosomes or lysosomes bind to class II MHC molecules. Peptide-class II MHC complexes are delivered to the cell surface to be recognized by CD4+ T cells."^^xsd:string ;
  obo:hasDbXref "MCW:Handbook on cellular and molecular immunology"^^xsd:string, "PMID:16181322"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000488 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Antigen processing pathway engages the proteosomal machinery in the cytosol, ER specific proteases as well as chaperones for loading the HMC class I molecules with the 8-10 amino acid peptides"^^xsd:string ;
  obo:hasDbXref "PMID:16181325"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000489 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Angiopoietin signaling pathway is involved in the regulation of angiogenic remodeling. Recent studies suggest that the pathway may also be involved in lymphangiogenesis and possibly in the development of hematopoietic system."^^xsd:string ;
  obo:hasDbXref "PMID:16225862"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000490 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Transforming growth factor-beta (TGF-beta) signaling is one of the best characterized module of the Tgf-b superfamily pathways. Binding to the type II receptor leads to activation of the type I receptor and subsequent activation of Smad pathway. Nuclear translocation of Smad(s) and interaction with transcription factors leads to activation or repression of many genes."^^xsd:string ;
  obo:hasDbXref "PMID:16678165"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000491 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The hormone vasopressin plays central roles in cardiovascular and water homeostasis by signaling via two receptor types, G-protein coupled receptors coupling to particular G alpha subunits of heterotrimeric G proteins."^^xsd:string ;
  obo:hasDbXref "PMID:14624682"^^xsd:string, "PMID:18431594"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000492 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The renin-angiotensin cascade (RAS) generates a number of bioactive peptides with diverse physiological and pathophysiological functions. RAS exerts vasoconstriction, vasodilation or vascular remodeling, cell proliferation or anti-proliferation effects, depending on which angiotensin peptide generates the signaling. Some of these features are also shared by the kallikrein-kinin system (KKS); the two systems can interact and cross-talk."^^xsd:string ;
  obo:hasDbXref "KEGG:ko04614"^^xsd:string, "PMID:12676165"^^xsd:string, "PMID:12793984"^^xsd:string, "PMID:15638741"^^xsd:string, "PMID:15883759"^^xsd:string, "PMID:16816138"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000493 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Corticotropin-releasing hormone is secreted by the hypothalamus in response to stress or fear and signaling through its receptors stimulates secretion of corticotropic (adrenocorticotropic, ACTH) hormone by the anterior pituitary. ACTH is one of the cleavage products of pro-opiomelanocortin (POMC)."^^xsd:string ;
  obo:hasDbXref "PMID:20132811"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000494 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The peptide hormone oxytocin plays a central role in parturition, lactation and sexual behavior."^^xsd:string ;
  obo:hasDbXref "PMID:14624682"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000495 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Gas6, a vitamin K-dependent growth factor signals through the Axl subfamily of tyrosine kinase receptors. The Gas6-Axl axis appears to be involved in growth and survival of various cell types as well as in tissue remodeling and regeneration. Deregulation of the axis is involved in a number of conditions, particularly renal."^^xsd:string ;
  obo:hasDbXref "PMID:11290560"^^xsd:string, "PMID:16285961"^^xsd:string, "PMID:16362042"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000498 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Reverse cholesterol transport (RCT) is the pathway by which cholesterol from extrahepatic cells/tissue is transported to the liver for excretion. The pathway may prevent the development of atherosclerosis by reducing the accumulation of cholesterol in the wall of arteries."^^xsd:string ;
  obo:hasDbXref "GO:0043691"^^xsd:string, "PMID:16258026"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000499 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "NF-kB signaling plays an essential role in the mammalian immune system. The classical/canonical pathway, downstream but not exclusively of tumor necrosis factor/receptor 1 signaling, is regarded as a paradigm of NF-kB signaling. The classical and the non-classical pathway downstream of a subset of Tnf receptor superfamily, share similar sets of core components, albeit in distinct ways. Collectively they regulate the expression of a vast array of genes."^^xsd:string ;
  obo:hasDbXref "PMID:15371334"^^xsd:string, "PMID:17072321"^^xsd:string, "PMID:18267068"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000501 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Thyroid hormone (TH) signaling pathway plays important roles in glucose and lipid metabolism. The TH receptors are nuclear receptors that once activated act as transcription factors. Low levels of TH stimulate the release of thyrotropin-releasing hormone (TRH) from the hypothalamus, in turn stimulating the secretion of thyroid-stimulating hormone (TSH) from the pituitary whose signaling then triggers TH production. TRH, TSH and TH signaling pathways are part of the hypothalamic-pituitary-thyroid (HPT) axis for which TH itself provides a negative regulatory loop."^^xsd:string ;
  obo:hasDbXref "PMID:20015660"^^xsd:string, "PMID:20872316"^^xsd:string, "PMID:22759379"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000502 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The complement system is an important effector of innate and also of humoral adaptive immunity. It consists of three biochemical cascades that are differently initiated but share similar late steps and effector functions. The complement pathway and the coagulation cascade are connected in a cross talk."^^xsd:string ;
  obo:hasDbXref "PMID:11287977"^^xsd:string, "PMID:26149013"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000503 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The classical complement pathway is one of the three biochemical pathways of the complement system. It is activated by antigen-bound antibodies."^^xsd:string ;
  obo:hasDbXref "KEGG:map04610"^^xsd:string, "PMID:11287977"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000504 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The lectin pathway is one of the three biochemical pathways of the complement system. It is activated by microbial polysaccharides binding to circulating lectins."^^xsd:string ;
  obo:hasDbXref "GO:0001867"^^xsd:string, "KEGG:map04610"^^xsd:string, "PMID:11287977"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000505 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The alternative pathway is one of the three biochemical pathways of the complement system. Stable activation of the alternative pathway occurs on microbial cell surfaces."^^xsd:string ;
  obo:hasDbXref "GO:0006957"^^xsd:string, "KEGG:map04610"^^xsd:string, "PMID:11287977"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000506 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Endothelins represent a family of three vasoconstrictor peptides that play a role in several intracellular signaling pathways and have been associated with hypertension, heart failure and myocardial infarction."^^xsd:string ;
  obo:hasDbXref "PMID:15124920"^^xsd:string, "PMID:16269952"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000507 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Estrogens are C18 steroid hormones that constitutes the females sex hormones. Estrogen signals via the estrogen receptor which ones activated drive the expression of target genes."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string, "PMID:14993442"^^xsd:string, "PMID:19996532"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000508 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway involving the attachment of platelets to one another and leading to the formation of a thrombus. Platelets attachment can be induced by a variety of agents."^^xsd:string ;
  obo:hasDbXref "GO:0070527, PubMed"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000513 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The interleukin-10 family comprises several interleukins, including members of the interferon type III also known as interferon lambda or interferon-like type, that carry out various immunomodulatory functions."^^xsd:string ;
  obo:hasDbXref "PMID:11929132"^^xsd:string, "PMID:20454917"^^xsd:string, "PMID:21112807"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000514 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Interleukin-6 family includes several members involved in a wide range of biological processes such as immune regulation, inflammation, hematopoiesis and oncogenesis. All members share a common signal transducer, gp130 which activates Jak-Stat and Raf/Mek/Erk signaling pathways."^^xsd:string ;
  obo:hasDbXref "PMID:20410258"^^xsd:string, "PMID:21715184"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000515 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Interleukin-10 signaling is involved in various immunomodulatory functions. It promotes the release of immune mediators and antigen presentation exerting important anti-inflammatory effects that may primarily characterize this family member. Signaling by Il-10 and the other members of the family activate the intracellular Jak-Stat cascade."^^xsd:string ;
  obo:hasDbXref "PMID:20454917"^^xsd:string, "PMID:21115385"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000516 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Interleukin-6 signaling is involved in a wide range of biological processes such as immune regulation, inflammation, hematopoiesis and oncogenesis. A signal transducer common to all family members, gp130 activates Jak-Stat and Raf/Mek/Erk signaling pathways."^^xsd:string ;
  obo:hasDbXref "PMID:20303867"^^xsd:string, "PMID:20410258"^^xsd:string, "PMID:21715184"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000517 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A pathway leading to a general or specific artery occlusion."^^xsd:string ;
  obo:hasDbXref "MeSH:Medical Subject Headings"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000518 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A pathway leading to the thickening of medium and large arteries. While lipoprotein related pathways are of interest, monogenic conditions such as those linked to mutations in the laminin gene may also provide clues regarding atherosclerosis pathways."^^xsd:string ;
  obo:hasDbXref "PMID:15205220"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000519 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the degradation of DDT - a chlorinated organic insecticide and environmental pollutant. Although it is banned in the United States, it is still widely used in developing countries."^^xsd:string ;
  obo:hasDbXref "GO:0046701"^^xsd:string, "KEGG:http://umbbd.msi.umn.edu/ddt/ddt_map.html"^^xsd:string, "KEGG:map00351"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000520 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the degradation of 2,4-dichlorobenzoate - a key intermediate in the aerobic degradation of over 200 polychlorinated biphenyls."^^xsd:string ;
  obo:hasDbXref "GO:0046298"^^xsd:string, "KEGG:http://umbbd.msi.umn.edu/dcb/dcb_map.html"^^xsd:string, "KEGG:map00623"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000521 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the degradation of 1,2-dichloroethane - a moderately reactive alkylating compound."^^xsd:string ;
  obo:hasDbXref "KEGG:http://umbbd.msi.umn.edu/dce/dce_map.html"^^xsd:string, "KEGG:map00631"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000522 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the biosynthesis of flavonoids - a class of plant secondary metabolites generally known for their antioxidant activity."^^xsd:string ;
  obo:hasDbXref "GO:0009813"^^xsd:string, "KEGG:map00941"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000523 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the synthesis, utilization or degradation of linoleic acid - an unsaturated omega-6 fatty acid. Linoleic acid is an essential fatty acid that humans and other animals cannot synthesize and must obtain from diet."^^xsd:string ;
  obo:hasDbXref "GO:0043651"^^xsd:string, "KEGG:map00591"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000524 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the biosynthesis of heparan sulfate. Heparan sulfate is a glycosaminoglycan occurring in the cell membrane of most cells. It consists of repeating disaccharide units in specific linkage, each composed of a glucosamine residue linked to an uronic acid, either glucuronic acid or L-iduronic acid, which may be sulfated."^^xsd:string ;
  obo:hasDbXref "GO:0030210"^^xsd:string, "KEGG:map00534"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000526 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The kallikrein-kinin system (KKS) cascade generates several bioactive kinins with roles in vasodilation, release of inflammatory mediators and stimulation of sensory neurons. Kinins also play a role in the renal handling of sodium and water metabolism. In the latter case, the system parallels renin-angiotensin (RAS); the two systems can cross-talk."^^xsd:string ;
  obo:hasDbXref "GO:0002255"^^xsd:string, "PMID:12558525"^^xsd:string, "PMID:12676165"^^xsd:string, "PMID:12793984"^^xsd:string, "PMID:16177542"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000527 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Angiotensin II signaling through the angiotensin type 1 receptor (AT1) activates downstream signaling pathways and elicits a broad range of physiological responses. It is involved in the regulation of blood pressure and volume, water and electrolyte balance and exerts a potent vasoconstrictive effect."^^xsd:string ;
  obo:hasDbXref "PMID:10977869"^^xsd:string, "PMID:12676164"^^xsd:string, "PMID:16141358"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000528 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Angiotensin II signaling through the angiotensin type 2 receptor (AT2) is less well understood and rather controversial. It appears to counteract AT1 receptor function and promote apoptosis. Alternatively, it may complement the effects of AT1 receptor with deleterious consequences in cardiac pathologies. AT2 receptor appears to function in a G-protein dependent as well as independent manner."^^xsd:string ;
  obo:hasDbXref "PMID:10977869"^^xsd:string, "PMID:12734384"^^xsd:string, "PMID:15158138"^^xsd:string, "PMID:16286568"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000529 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Angiotensin (1-7) is derived from angiotensin II through the action of angiotensin converting enzyme 2 (ACE2) or from angiotensin I through the action of neutral endopeptidase (NEP). Angiotensin (1-7) signaling appears to have a vasodilatory effect but the exact action of this peptide in humans remains to be established."^^xsd:string ;
  obo:hasDbXref "PMID:15687842"^^xsd:string, "PMID:15962175"^^xsd:string, "PMID:16520407"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000530 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Angiotensin III, like angiotensin II, binds to the type 1 and 2 receptors and triggers downstream signaling pathways. In rats, angiotensin III signaling through the receptor type 1 (AT1) can modulate noradrenergic transmission via phospholipase C activation."^^xsd:string ;
  obo:hasDbXref "PMID:11100981"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000531 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The role of angiotensin type 2 receptor is less well understood. In rats, angiotensin III can mediate natriuresis through the activation of receptor type 2."^^xsd:string ;
  obo:hasDbXref "PMID:16380540"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000532 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions leading to the biosynthesis of glycogen, a highly branched polysaccharide. Glycogen is the storage form of glucose in the cell; it represents an energy reserve that can be mobilized when and where there is a need for glucose."^^xsd:string ;
  obo:hasDbXref "GO:00005978"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string, "Reactome:REACT_1736.2"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000533 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of glycogen, a highly branched polysaccharide that constitutes the major form of glucose storage in the cell."^^xsd:string ;
  obo:hasDbXref "InHouse:www.rgd.mcw"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000534 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the breakdown of glycogen to glucose-6-phosphate. Glucose-6-phosphate can then be dephosphorylated to glucose or it can be utilized via glycolysis for energy production; an alternative pathways of G6P utilization is the oxidative phase of the pentose phosphate shunt. A small percentage of glucose-6-phosphate can be converted to hexosamines."^^xsd:string ;
  obo:hasDbXref "GO:0005980"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string, "Reactome:REACT_1008.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000535 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway that mediates the transport of proteins to their proper destination and the trafficking of proteins between organelles. Notable examples are the nucleocytoplasmic shuttling and the mitochondrial protein import pathways."^^xsd:string ;
  obo:hasDbXref "PMID:26172624"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000536 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "In the constitutive secretory pathway, common to all cell types, newly synthesized proteins are sorted into transport vesicles and targeted to their destination in the absence of a signal."^^xsd:string ;
  obo:hasDbXref "GO:0045054"^^xsd:string, "PMID:21907200"^^xsd:string, "PMID:23182824"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000537 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "In the regulated secretory pathway, secreted proteins are sorted into secretory vesicles which are stored intracellularly and move to the final destination upon receiving a signal. It is a salient feature of endocrine and neuroendocrine cells."^^xsd:string ;
  obo:hasDbXref "GO:0045055"^^xsd:string, "PMID:21907200"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000538 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The import-export cycle that underlies the shuttling of proteins between the cytoplasm and the nucleus."^^xsd:string ;
  obo:hasDbXref "PMID:26172624"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000539 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Ghrelin is an appetite-stimulating hormone secreted primarily from the stomach in response to fasting that can downregulate energy expenditure and lead to weight increase."^^xsd:string ;
  obo:hasDbXref "PMID:16550252"^^xsd:string, "PMID:17202582"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000540 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Obesity, usually defined as 20% or more excess body weight, constitutes a major public health problem and an independent risk factor for a number of conditions such as hypertension and diabetes. Deregulation of energy homeostasis, of various metabolic and signaling pathways, genetic and environmental aspects, all can contribute to the development of an obese state."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000542 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "AMPK senses changes in cellular energy as ATP/AMP ratio. AMP binding allosterically activates AMPK; subsequent phosphorylation events lead to repression of energy consuming pathways. One target of AMPK is mTOR signaling pathway. AMPK activates the inhibitory Tsc2 while inhibiting mTorc1 complex."^^xsd:string ;
  obo:hasDbXref "PMID:15509864"^^xsd:string, "PMID:16885148"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000543 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Protein kinase A (PKA) signaling is a widely used intracellular pathway and the major route for channeling the cAMP signal. cAMP is regulated by adenylyl cyclases that produce it and phosphodiesterases that hydrolyze it. Compartmentalization of PKA signaling is mediated by the AKAP family of scaffold proteins that bring together the kinase, cAMP modulators and sometimes the targets."^^xsd:string ;
  obo:hasDbXref "GO:0010737"^^xsd:string, "PMID:14715913"^^xsd:string, "PMID:16214430"^^xsd:string, "Reactome:REACT_15530.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000544 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An impaired pathway of reverse cholesterol transport and efflux can pose a risk for the development of cardiovascular disease. This varies in severity and manifestation depending on which gene in the pathway is affected."^^xsd:string ;
  obo:hasDbXref "PMID:16258026"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000546 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathways of mRNA quality control thereby erroneous mRNA is degraded in the nucleus or cytoplasm, or normal mRNA accumulated in the nucleus is degraded."^^xsd:string ;
  obo:hasDbXref "GO:0006402"^^xsd:string, "KEGG:map03018"^^xsd:string, "PMID:15933735"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000547 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The nuclear exosome pathway degrades erroneous mRNA as well as normal mRNA that has accumulated in the nucleus. The nucleolar exosome is  involved in the processing of rRNA."^^xsd:string ;
  obo:hasDbXref "PMID:15933735"^^xsd:string, "PMID:18786828"^^xsd:string, "PMID:20097077"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000548 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The nonsense-mediated decay pathway (NMD) degrades mRNA that contains a premature translation termination codon (PTC) and is one of the best characterized systems in eukaryotes."^^xsd:string ;
  obo:hasDbXref "GO:0000184"^^xsd:string, "PMID:15933735"^^xsd:string, "PMID:17010613"^^xsd:string, "PMID:22664987"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000549 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The nonstop mRNA decay pathway degrades mRNA that lacks a translation termination codon."^^xsd:string ;
  obo:hasDbXref "GO:0070481"^^xsd:string, "PMID:15933735"^^xsd:string, "PMID:22664987"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000550 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Staufen-mediated mRNA decay pathway (SMD) is a rather novel pathway identified in mammals. Staufen (Stau1) is thought to be involved in mRNA localization and it has recently been shown to be involved in mRNA decay. It shares some of the features of the nonsense-mediated mRNA decay pathway (NMD) but does not require components essential for NMD."^^xsd:string ;
  obo:hasDbXref "PMID:15680326"^^xsd:string, "PMID:15809649"^^xsd:string, "PMID:15933735"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000551 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An mRNA decay pathway that deviates from what its normal course should be. An aberrant mRNA decay pathway would lead to the translation of erroneous mRNA with potentially serious consequences."^^xsd:string ;
  obo:hasDbXref "InHouse PW:InHouse PW"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000552 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the biosynthesis of brassinosteroids or brassins, a group of plant hormones released in response to low oxygen and sugar, or to root stresses."^^xsd:string ;
  obo:hasDbXref "GO:0016132, KEGG"^^xsd:string, "KEGG:map00905"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000553 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways involved in the balanced maintenance of  glucose levels, transport and processing as demanded by the needs of the cells, tissues and organs. Glucose is an important and the most efficient fuel source.  Disruption of glucose homeostasis underlies many complex disorders."^^xsd:string ;
  obo:hasDbXref "GO:0042593"^^xsd:string, "PMID:15466941"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000554 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Glucose diffusion into cells requires specific transporter proteins. Two families of hexose transporters facilitate glucose transport down its concentration gradient."^^xsd:string ;
  obo:hasDbXref "GO:0015758"^^xsd:string, "PMID:15449578"^^xsd:string, "PMID:15466941"^^xsd:string, "Reactome:REACT_212.3"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000555 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The various pathways thereby glucose is oxidized to produce energy, is converted to other molecules or is stored for further use."^^xsd:string ;
  obo:hasDbXref "PMID:15466941"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000556 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The various pathways thereby glucose is converted to other compounds to yield primarily ATP. The final oxidation of glucose to carbon dioxide and water produces a net of 38 molecules of ATP per molecule of glucose."^^xsd:string ;
  obo:hasDbXref "PMID:15466941"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000557 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Glycogen is the major form of glucose storage. Excess glucose is converted into glycogen - a highly branched polysaccharide. When glucose is rapidly needed, glycogen can be broken down via glycogenolysis."^^xsd:string ;
  obo:hasDbXref "PMID:15466941"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000559 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The formation of nucleotide hexosamines, primarily UDP-N-acetylglucosamine, constitutes the final step in the hexosamine biosynthetic pathway which provides substrates for the O-linked glycosylation of proteins. Glycoproteins that are either secreted from the cell or inserted into the plasma membrane undergo N-linked glycosylation. The O-linked glycosylation of nuclear and/or cytosolic proteins confers a signaling dimension to the hexosamine biosynthetic pathway."^^xsd:string ;
  obo:hasDbXref "PMID:15466941"^^xsd:string, "PMID:16885148"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000560 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The GLUT family contains 14 members in mammals which can be grouped into 3 classes based on sequence similarities. The members of group I (best characterized) and of group III transporters facilitate glucose transport."^^xsd:string ;
  obo:hasDbXref "PMID:15449578"^^xsd:string, "PMID:15466941"^^xsd:string, "PMID:17717074"^^xsd:string, "PMID:18171430"^^xsd:string, "PMID:18570632"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000561 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The sodium-glucose or the sodium-dependent glucose cotransporters are characterized by the presence of 14 transmembrane alpha-helices. The N- and C-termini are responsible for permeating sodium and sugar, respectively."^^xsd:string ;
  obo:hasDbXref "PMID:15449578"^^xsd:string, "PMID:15466941"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000562 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The growth hormone signaling pathway is an important regulator of postnatal development. However, despite many years of research, the molecular mechanism underlying its many actions are incompletely understood. It is believed that its actions involve direct and indirect routes. An example of the latter is the role the pathway plays in stimulating the production of insulin-like growth factor."^^xsd:string ;
  obo:hasDbXref "GO:0060396"^^xsd:string, "PMID:19407495"^^xsd:string, "PMID:8853443"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000563 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Adiponectin signaling, a hormone secreted by the adipose tissue, impacts on metabolic pathways such as glucose and lipid metabolism, possibly via activation of AMPK pathway. Its deregulation has been linked to obesity, cardiovascular diseases, diabetes and metabolic syndrome."^^xsd:string ;
  obo:hasDbXref "GO:0033211"^^xsd:string, "PMID:16634986"^^xsd:string, "PMID:16823476"^^xsd:string, "PMID:17140553"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000564 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Androgens are C19 steroids that constitutes the male sex hormones. They are also the precursors of female sex hormones, the estrogens. Testosterone and its more potent metabolite, dihydrotestosterone bind to androgen receptors to then translocate to the nucleus and activate the transcription of target genes. Many regulators, both activators and repressors, have been identified. Upregulation of receptor activity has been implicated in prostate cancer."^^xsd:string ;
  obo:hasDbXref "PMID:17163421"^^xsd:string, "PMID:18657355"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000565 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Eicosanoids, derived from omega-3 or omega-6 fatty acids, are represented by the leukotriene and prostanoid classes of which the latter is represented by several families. Some can act as endogenous ligands for members of the peroxisomal proliferator-activated nuclear receptors (PPARs). Once activated, PPARs heterodimerize with the retinoid X receptor (RXR) and modulate the expression of target genes."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000566 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Corticosteroids group together glucocorticoids and mineralocorticoids, C21-steroid hormones derived from cholesterol. They control a wide range of physiological and cellular responses. Synthetic drugs mimicking their effects are used in the treatment of many conditions. Side effects, long-term use and/or natural deficiencies have been associated with various disorders."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000567 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Sex steroid mediated signaling pathways have important roles in the development and/or maintenance of sex-specific characteristics or attributes."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000568 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Aldosterone signaling through the mineralocorticoid receptor plays an important role in the balance of fluids and electrolytes in the body. Its biosynthesis is primarily regulated by the renin-angiotensin system and potassium ions concentration."^^xsd:string ;
  obo:hasDbXref "PMID:16002531"^^xsd:string, "PMID:17293689"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000569 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Cortisol, also known as hydrocortison, is the most important glucocorticoid. Cortisol signaling, via binding to the glucocorticoid receptor present in almost every animal cell, is essential for many cellular and physiological functions."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000570 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of hexosamines, amino sugars created by adding an amino group to a hexose. Hexosamines, particularly N-acetylglucosamine, are used to modify proteins."^^xsd:string ;
  obo:hasDbXref "Onelook:www.onelook.com, PubMed"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000571 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Signaling pathways activated by members of the neurotrophic family of growth factors are involved in differentiation of progenitor cells, survival and differentiation of neural cells. They exert their effects by engaging specific tropomyosin-related kinase (Trk) receptors."^^xsd:string ;
  obo:hasDbXref "PMID:25221473"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000572 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Brain-derived neurotrophic factor (BDNF) signaling pathway plays important roles in the growth, differentiation and survival of neurons, particularly the striatal neurons. BDNF signals via the tropomyosin-related kinase receptor type B (TrkB) to activate PKC, PI3K-AKT and MAPK/ERK intracellular pathways. Impaired BDNF signaling contributes to the pathogenesis of conditions such as Huntington Disease (HD) and psychiatric disorders. Upregulation on the other hand, is associated with several malignancies."^^xsd:string ;
  obo:hasDbXref "PMID:23670594"^^xsd:string, "PMID:25221473"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000573 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The oxidative (linear) phase of the pentose phosphate pathway involves the oxidation and decarboxylation of glucose-6-phosphate to produce the 5 carbon sugar ribulose-5-phosphate and the generation of NADPH."^^xsd:string ;
  obo:hasDbXref "GO:0009051"^^xsd:string, "OneLook:www.oneloook.com"^^xsd:string, "PubMed:http://www.ncbi.nlm.nih.gov/sites/entrez"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000574 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The non-oxidative (circular) phase of the pentose phosphate pathway involves conversion of  ribulose-5-phosphate to ribose-5-phosphate, important in the synthesis of nucleotides and nucleic acid, or to 3 or 6 carbon sugars."^^xsd:string ;
  obo:hasDbXref "GO:0009052"^^xsd:string, "OneLook:www.oneloook.com"^^xsd:string, "PubMed:http://www.ncbi.nlm.nih.gov/sites/entrez"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000575 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways that mediate the transport of sugars across the cell membrane. Transport of glucose, one of the major energy sources in the cell, is an important aspect of sugar transport pathway."^^xsd:string ;
  obo:hasDbXref "Pubmed:http://www.ncbi.nlm.nih.gov/"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000576 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The GLUT family contains 14 members in mammals which can be grouped into 3 classes based on sequence similarities. These transporters are characterized by the presence of 12 transmembrane alpha helices. Of the 14 members of the GLUT family, 11 have been shown to be involved in sugar transport pathway."^^xsd:string ;
  obo:hasDbXref "PMID:15449578"^^xsd:string, "PMID:15466941"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000577 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Cytokines are small proteins released by the cell and acting as intercellular mediators. Chemokines are a subset of cytokine that can attract and activate leukocytes. They are characterized by a small size and the presence of four cysteines whose location is important for their structural folding. Cytokines or chemokines binding to cognate receptors triggers numerous downstream signaling cascades."^^xsd:string ;
  obo:hasDbXref "MCW library:Handbook on molecular and cellular immunology"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000578 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Scatter factor/hepatocyte signaling impacts on various biological processes such as proliferation and survival, morphogenesis and motility. SF/HGF and its receptor c-Met have also been implicated in tumor growth and angiogenesis."^^xsd:string ;
  obo:hasDbXref "GO:0048012"^^xsd:string, "PMID:16212809"^^xsd:string, "PMID:16778093"^^xsd:string, "PMID:18175071"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000579 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Somatostatin signaling through its receptors regulates processes such as proliferation, secretion and motility via inhibition of growth hormone and factor. The potential anti-tumor activity of somatostatin has led to the development and clinical use of its analogs."^^xsd:string ;
  obo:hasDbXref "PMID:15078190"^^xsd:string, "PMID:15153426"^^xsd:string, "PMID:15853632"^^xsd:string, "PMID:16625838"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000580 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Translation initiation is the first, the rate-limiting and the most regulated step of translation. It involves the formation of a scanning competent small subunit. Upon finding the initiation codon, scanning is stopped, the large 60S subunit joins and an elongation competent 80S ribosome is formed."^^xsd:string ;
  obo:hasDbXref "GO:0006413"^^xsd:string, "PMID:17680008"^^xsd:string, "PMID:22815232"^^xsd:string, "PMID:24499181"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000581 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Translation elongation involves sampling of aminoacyl-tRNAs until a cognate tRNA is found followed by peptidyl transfer and translocation reactions. The iterative step continues until a stop codon is read or other events stall the ribosome."^^xsd:string ;
  obo:hasDbXref "GO:0006414"^^xsd:string, "PMID:17680008"^^xsd:string, "PMID:23746255"^^xsd:string, "PMID:25514765"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000582 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Translation termination occurs when a stop codon is read, followed by splitting of the ribosomal subunits and their recycling. Ribosome recycling also happens in the case of aberrantly stalled ribosomes due to features of mRNA, absence of a stop codon or its premature presence. In this case mRNA surveillance mechanisms trigger appropriate mRNA decay pathways."^^xsd:string ;
  obo:hasDbXref "GO:0006415"^^xsd:string, "PMID:17680008"^^xsd:string, "PMID:22751155"^^xsd:string, "PMID:23031510"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000583 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The orexin/hypocretin signaling appears to play a role in the stimulation of food intake. Alterations of the system are associated with the narcolepsy sleep disorder."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string, "PMID:17299454"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000584 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An orexin/hypocretin signaling pathway that deviates from what its normal course should be. Alterations in orexin/hypocretin signaling pathway have been linked to narcolepsy. It may also play a role in obesity."^^xsd:string ;
  obo:hasDbXref "PMID:17299454"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000585 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Orexin/hypocretin signaling through receptor 1 couples to Galphaq class of G proteins. Orexin/hypocretin receptor 1 primarily binds orexin A. Orexin A and B are derived from prepro-orexin precursor."^^xsd:string ;
  obo:hasDbXref "PMID:17299454"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000586 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Orexin/hypocretin signaling through receptor 2 couples to Galphaq and the inhibitory Galphai classes of G proteins. Orexin/hypocretin receptor 2 binds both orexin A and B derived from the prepro-orexin precursor."^^xsd:string ;
  obo:hasDbXref "PMID:17299454"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000587 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Narcolepsy is a neurological condition characterized by excessive day sleep, an inability to maintain awake states. Dysfunction of the orexin/hypocretin signaling pathway has been linked to this condition."^^xsd:string ;
  obo:hasDbXref "PMID:17299454"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000588 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An adiponectin signaling pathway that deviates from what its normal course should be. Deregulation of adiponectin signaling have been linked to obesity, cardiovascular diseases, diabetes and metabolic syndrome."^^xsd:string ;
  obo:hasDbXref "PMID:16634986"^^xsd:string, "PMID:16823476"^^xsd:string, "PMID:17140553"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000589 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways involved in the proper balance of metal ion levels, uptake and transport, utilization and storage as demanded by the needs of cells, tissues and organs. Disruption of metal ion homeostasis can have toxic and harmful consequences."^^xsd:string ;
  obo:hasDbXref "InHouse:PW-InHouse"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000590 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways involved in the proper balance of iron levels, uptake and transport, utilization and storage as needed by cells, tissues and organs. Iron is essential for many life processes but its reactivity makes it potentially dangerous."^^xsd:string ;
  obo:hasDbXref "GO:0055072"^^xsd:string, "PMID:17014365"^^xsd:string, "PMID:17194590"^^xsd:string, "PMID:17367269"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000591 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The uptake and efflux routes of iron transport. Several systems mediate uptake of recycled and dietary iron. One system is involved in the efflux."^^xsd:string ;
  obo:hasDbXref "PMID:25661197"^^xsd:string, "PMID:26437604"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000592 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The main storage system for iron is represented by ferritin. The iron entering the cell is in its ferrous Fe(II) form. It is oxidized to the stored ferric Fe(III) by the oxidase activity of ferritin heavy chain. Neuromelanin pigment, abundant in the dopaminergic neurons of the substantia nigra, is known as a metal chelator and is the storage form of iron in these cells."^^xsd:string ;
  obo:hasDbXref "PMID:25661197"^^xsd:string, "PMID:26455458"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000593 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways that mediate the uptake and transport of metal ions. Metal ion transport pathways are important aspects of metal ion homeostasis."^^xsd:string ;
  obo:hasDbXref "InHouse:PW-InHouse"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000594 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathways involved in the balanced maintenance of glucose levels, transport and processing as demanded by the needs of the cells, tissues and organs assure the maintenance of glucose homeostasis. Disruption in these pathways alter glucose homeostasis and underlie many complex disorders - type 2 diabetes and its associated complications is one example."^^xsd:string ;
  obo:hasDbXref "PMID:15466941"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000595 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Phosphatidylinositol kinases represent a family of lipid kinases that phosphorylate the 3' position of the inositol ring in target substrates. They are grouped into three classes: class I further subdivided into subclass A and B, class II and class III. By far the best known and characterized is class I, particularly IA that signals downstream of receptor tyrosine kinases and engages the Akt family of kinases."^^xsd:string ;
  obo:hasDbXref "PMID:16847462"^^xsd:string, "PMID:17052169"^^xsd:string, "PMID:17641274"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000596 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An insulin signaling pathway that deviates from what its normal course should be. Deregulation of insulin signaling can have profound health consequences due to its potential to alter glucose and energy homeostasis."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000597 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The non-canonical Wnt signaling pathway groups the various Wnt signaling routes that are beta-catenin independent."^^xsd:string ;
  obo:hasDbXref "PMID:16019432"^^xsd:string, "PMID:18432252"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000598 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A Wnt signaling pathway that deviates from what its normal course should be. Deregulation of Wnt signaling has been implicated in several cancers as well as diseases other than cancer."^^xsd:string ;
  obo:hasDbXref "PMID:18188179"^^xsd:string, "PMID:18432252"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000599 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A canonical Wnt signaling pathway that deviates from what its normal course should be. Mutations in core components of the canonical pathway have been implicated in several types of cancer as well as diseases other than cancer."^^xsd:string ;
  obo:hasDbXref "PMID:18188179"^^xsd:string, "PMID:18432252"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000600 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A non-canonical Wnt signaling pathway that deviates from what its normal course should be. Deregulation of the beta-catenin independent pathway appears to play a role in the biology of tumors."^^xsd:string ;
  obo:hasDbXref "PMID:18271916"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000602 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A Raf/Mek/Erk signaling pathway that deviates from what its normal course should be. Aberrant Raf/Mek/Erk signaling has been implicated in many types of cancer."^^xsd:string ;
  obo:hasDbXref "PMID:17126425"^^xsd:string, "PMID:17229475"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000603 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Erk5 pathway, also known as the big MAP kinase, is activated by various stresses but not by inflammatory cytokines. In HeLa and PC12 cells, the pathway can be activated by growth factors."^^xsd:string ;
  obo:hasDbXref "GO:0070375"^^xsd:string, "KEGG:map04010"^^xsd:string, "PMID:17229475"^^xsd:string, "PMID:17306385"^^xsd:string, "Reactome:REACT_12020.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000605 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Cancer, or malignant neoplasm, represents a category of diseases characterized by uncontrolled cell growth and avoidance of apoptosis, invasion and metastasis.  Deregulation of many pathways - signaling, regulatory, metabolic and combination of them, have been implicated in susceptibility to or development of these conditions. Generally, cancer is classified according to the tissue or organ affected."^^xsd:string ;
  obo:hasDbXref "PMID:10647931"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000606 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Urogenital cancer groups those malignancies that affect the urinary system and reproductive organs. Deregulation of several pathways along with genetic damage accumulated over time can lead to the development of these conditions."^^xsd:string ;
  obo:hasDbXref "InHouse:InHouse PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000607 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Ovarian cancer is a leading cause of cancer deaths in women. Several susceptibility genes have been identified and they have a role to play in pathways involved in or regulating proliferation, DNA repair and apoptosis."^^xsd:string ;
  obo:hasDbXref "PMID:12413930"^^xsd:string, "PMID:12886939"^^xsd:string, "PMID:15111296"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000608 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Cervical cancer affects the cervical area and human papilloma virus (HPV) infection plays a major role in the pathogenesis of the condition. A number of HPV proteins interact with and affect the function of several host proteins that play a role in apoptoptic pathway and/or those involved in cell proliferation."^^xsd:string ;
  obo:hasDbXref "PMID:10471054"^^xsd:string, "PMID:11486705"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000609 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Prostate cancer is a frequent form of cancer in men over the age of fifty. It is usually asymptomatic but when in an advanced stage, it may spread to other parts of the body, causing symptoms others than those sometimes observed. Several susceptibility as well as defective genes have been identified."^^xsd:string ;
  obo:hasDbXref "KEGG:map05215"^^xsd:string, "PMID:12878745"^^xsd:string, "PMID:14752525"^^xsd:string, "PMID:15149739"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000610 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Bladder cancer groups several types of malignant tumors of the urinary bladder. It is more prevalent in men than in women and combines both risk factors such as tobacco and exposure to certain carcinogens and genetic factors. Mutations in genes involved in a number of signaling pathways have been implicated in the development of these conditions."^^xsd:string ;
  obo:hasDbXref "KEGG:map05219"^^xsd:string, "PMID:16474624"^^xsd:string, "PMID:17158541"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000611 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Endometrial cancer affects the lining of the uterus, or endometrium. Hormonal and genetic alterations play a role in the development of this carcinoma type. Mutations in genes acting in several pathways have been associated with the condition and its types."^^xsd:string ;
  obo:hasDbXref "KEGG:map05213"^^xsd:string, "PMID:12583434"^^xsd:string, "PMID:15947972"^^xsd:string, "PMID:16508724"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000612 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Colorectal cancer are malignant tumors of the colon and rectum. Both risk factors usually relating to life style such as physical exercise or use of tobacco and genetics contribute to the development of the condition. Mutations in the components of canonical Wnt and Smad-dependent TGF-beta signaling and of DNA mismatch repair pathways  have been associated with the pathogenesis of colorectal cancer pathway."^^xsd:string ;
  obo:hasDbXref "KEGG:map05210"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000613 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A trasforming growth factor-beta (TGF-beta) signaling pathway that deviates from what its normal course should be. Altered Tgf-b signaling, primarily the well characterized SMAD dependent pathway, has been implicated in numerous conditions."^^xsd:string ;
  obo:hasDbXref "PMID:16678165"^^xsd:string, "PMID:18313409"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000614 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A transfoming growth factor-beta Smad dependent signaling pathway that deviates from what its normal course should be. Altered TGF-beta Smad dependent signaling has been implicated in vascular conditions and tumorigenesis."^^xsd:string ;
  obo:hasDbXref "PMID:18313409"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000615 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A bone morphogenetic protein (BMP) signaling pathway that deviates from what its normal course should be. Altered BMP signaling has been implicated in cardiovascular condition, pulmonary hypertension, the juvenile polyposis syndrome (JPS)."^^xsd:string ;
  obo:hasDbXref "PMID:18313409"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000616 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those tumor necrosis factor superfamily mediated pathways that deviate from what their normal course should be. Altered tumor necrosis factor superfamily pathways have been implicated in a spectrum of conditions ranging from septic shock and tumorigenesis to diabetes, rheumatoid arthritis and various inflammatory diseases."^^xsd:string ;
  obo:hasDbXref "PMID:11239407"^^xsd:string, "PMID:11796220"^^xsd:string, "PMID:14555214"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000617 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A cytokine mediated signaling pathway that deviates from what its normal course should be. Aberrant cytokine signaling pathway, alone or in combination with other pathways underlie various diseases."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000618 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A tumor necrosis factor (Tnf) signaling pathway that deviates from what its normal course should be. Altered Tnf signaling has been implicated in many human diseases - cerebral malaria, cancer, multiple sclerosis - are a few examples."^^xsd:string ;
  obo:hasDbXref "PMID:12040173"^^xsd:string, "PMID:12655295"^^xsd:string, "PMID:14504472"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000619 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A nuclear factor kappa B (NF-kB) signaling pathway that deviates from what its normal course should be. Altered NF-kB signaling has been implicated in a number of conditions including immunodeficiency, inflammation and several forms of cancer."^^xsd:string ;
  obo:hasDbXref "PMID:17072330"^^xsd:string, "PMID:17072331"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000620 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those signaling pathways involving second messengers that deviate from what their normal course should be. Deregulation of these pathways can have far reaching consequences."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000622 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A phosphatidylinositol 3-kinase-Akt signaling pathway that deviates from what its normal course should be. Altered phosphatidylinositol 3-kinase-Akt signaling pathway has been implicated in several forms of cancer. The components of the pathway are attractive targets for the development of therapeutics."^^xsd:string ;
  obo:hasDbXref "PMID:17952368"^^xsd:string, "PMID:18288939"^^xsd:string, "PMID:18288941"^^xsd:string, "PMID:18473732"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000623 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A scatter factor/hepatocyte growth factor signaling pathway that deviates from what its normal course should be. Aberrant Hgf signaling via Met receptor has been implicated in numerous forms of cancer."^^xsd:string ;
  obo:hasDbXref "PMID:18175071"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000624 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Breast cancer or neoplasm is the most common cancer among women and the second worldwide after lung cancer. Deregulated pathways such estrogen or PI3K-Akt signaling have been implicated in breast cancer. In many cases, the disease is estrogen-dependent and it is possible that dysregulation of miRNA may correlate with the expression of estrogen receptor. Mutations in a number of other genes such as Brca1, 2 and 3 or p53 have also been associated with breast cancer."^^xsd:string ;
  obo:hasDbXref "OMIM:114480"^^xsd:string, "PMID:17275086"^^xsd:string, "PMID:20739888"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000625 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A general term grouping neoplastic pathways of the biliary tract, liver, pancreas and the gastrointestinal system."^^xsd:string ;
  obo:hasDbXref "MeSH:http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi"^^xsd:string, "OMIM:OMIM"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000626 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Pancreatic cancer, a malignant tumor of the pancreas, has both genetic and predisposing factors. Deregulated pathways, such as TGF-B, PI3K-Akt or RAF/MEK/ERK, have been implicated in the development of pancreatic cancer."^^xsd:string ;
  obo:hasDbXref "KEGG:map05212"^^xsd:string, "PMID:17898532"^^xsd:string, "PMID:18662538"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000627 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A general term grouping neoplastic pathways of the esophagus, gastric or stomach and intestinal system."^^xsd:string ;
  obo:hasDbXref "MeSH:MeSH"^^xsd:string, "OMIM:OMIM"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000629 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Gastric cancer is the fourth most common form of cancer worldwide and has a high death rate. Deregulated pathways, such as Wnt, PI3K-Akt or RAF/MEK/ERK, have been implicated in the development of gastric cancer."^^xsd:string ;
  obo:hasDbXref "PMID:17203201"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000631 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A general term grouping neoplastic pathways of the upper aerodigestive system. Deregulated pathways, such as TGF-B, PI3K-Akt or epidermal growth factor (EGF) signaling, have been implicated in the of head and neck cancer."^^xsd:string ;
  obo:hasDbXref "MeSH:MeSH"^^xsd:string, "OMIM:OMIM"^^xsd:string, "PMID:18662538"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000633 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A general term grouping together neoplastic pathways of the sweat and sebaceous gland or of neuroectodermal and neuroendocrine origins."^^xsd:string ;
  obo:hasDbXref "MeSH:MeSH"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000634 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A planar cell polarity Wnt signaling pathway that deviates from what its normal course should be. Altered planar cell polarity Wnt signaling has been implicated in a number of conditions including gastric and pancreatic cancer."^^xsd:string ;
  obo:hasDbXref "PMID:17203201"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000636 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The protein exocytosis pathway involves trafficking of protein-containing vesicles to their final destination. It consists of several steps: budding, transport mediated by microtubule and actin associated molecular motors, tethering/docking and fusion with target membrane. Members of the Arf and Rab family of Ras superfamily are involved in the control of exit from Golgi and exocytic route, respectively. These are two main types of protein exocytosis which also represented in the more general exocytosis thereby material is delivered outside the cell."^^xsd:string ;
  obo:hasDbXref "PMID:16882731"^^xsd:string, "PMID:21907200"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000637 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "In the secretory pathway, the protein modification pathway involves the appropriate modification of glycoproteins and proteoglycans. It also provides for processing of the pro-forms of proteins into their mature form."^^xsd:string ;
  obo:hasDbXref "PMID:18354421"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000638 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "In the endoplasmic reticulum correctly folded proteins are targeted for further export whereas misfolded proteins are retained and targeted for degradation."^^xsd:string ;
  obo:hasDbXref "GO:0030433"^^xsd:string, "PMID:18075753"^^xsd:string, "PMID:18216874"^^xsd:string, "PMID:22535891"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000639 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The GLUT family contains 14 members in mammals which can be grouped into 3 classes based on sequence similarities. The members of group I (best characterized) and of group III transporters facilitate glucose transport. Of the three members of group I, Slc2a4 (Glut4), is involved in insulin-mediated uptake of glucose in the heart, skeletal muscle and adipose tissue. The response - central to glucose homeostasis - brings together several signaling and trafficking events."^^xsd:string ;
  obo:hasDbXref "PMID:15449578"^^xsd:string, "PMID:15466941"^^xsd:string, "PMID:17717074"^^xsd:string, "PMID:18171430"^^xsd:string, "PMID:18570632"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000640 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The glycolytic pathway converts the six-carbon glucose to two three-carbon pyruvate molecules. The ten reactions of glycolysis can be subdivided into an energy consuming 'stage I' and an energy generating 'stage II'. The net energy yield is two molecules of ATP. Pyruvate can further be oxidized via the citrate cycle, converted to lactose under anaerobic conditions or back to glucose via gluconeogenesis."^^xsd:string ;
  obo:hasDbXref "PMID:15466941"^^xsd:string, "PMID:3306346"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000641 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The gluconeogenic pathway involves the synthesis of glucose from noncarbohydrate precursors. They include the glycolysis products pyruvate and lactate, citric acid cycle intermediates and the carbon skeletons of many amino acids."^^xsd:string ;
  obo:hasDbXref "PMID:15466941"^^xsd:string, "PMID:6311081"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000642 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Fatty acid degradation occurs primarily via beta oxidation in the mitochondrion. It also occurs via the alpha degradation in peroxisomes and the omega degradation which is an alternative pathway. Other pathways include the degradation of branched-chain, unsaturated and odd-chain fatty acids."^^xsd:string ;
  obo:hasDbXref "PMID:21156023"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000643 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A glycogen metabolic pathway that deviates from what its normal course should be. Aberrant glycogen metabolism has been associated with several glycogen storage diseases."^^xsd:string ;
  obo:hasDbXref "MCW libraries:Biochemistry Handbook"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000644 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A glycogen biosynthetic pathway that deviates from what its normal course should be. Aberrant glycogen metabolism has been associated with several glycogen storage diseases."^^xsd:string ;
  obo:hasDbXref "MCW libraries:Biochemistry Handbook"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000645 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A glycogen degradation pathway that deviates from what its normal course should be. Aberrant glycogen metabolism has been associated with several glycogen storage diseases."^^xsd:string ;
  obo:hasDbXref "MCW libraries:Biochemistry Handbook"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000646 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Cell-extracellular matrix signaling pathway conveys information between cells and components of the extracellular matrix using cell adhesion molecules."^^xsd:string ;
  obo:hasDbXref "RGD:InHouse dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000647 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Forkhead proteins represent a large family of transcription factors that regulate the expression of genes involved in cell growth, proliferation and survival as well as organ development and speech acquisition."^^xsd:string ;
  obo:hasDbXref "PMID:10702024"^^xsd:string, "PMID:12801727"^^xsd:string, "PMID:15492844"^^xsd:string, "PMID:15516968"^^xsd:string, "PMID:17275054"^^xsd:string, "PMID:18174472"^^xsd:string, "PMID:19274050"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000648 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Cell adhesion signaling pathway conveys information between cells or between cells and the extracellular matrix (ECM) using cell adhesion molecules (CAMs). While many CAMs appear to be specialized for either cell-cell or cell-ECM communication, integrin family of receptors mediates both types of signaling."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000651 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Aging or the overall deteriorating change of function can be at the cellular level as well as the whole organism level. Cellular aging or senescence underlies organismal aging."^^xsd:string ;
  obo:hasDbXref "PMID:24319642"^^xsd:string, "PMID:24449267"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000652 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Phosphatases are essential components of biological pathways. Phosphorylaton by protein kinases and dephosphorylation by protein phosphatases exert major regulatory roles. In addition, they can also initiate signaling cascades."^^xsd:string ;
  obo:hasDbXref "PMID:16132230"^^xsd:string, "PMID:19099538"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000653 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Serine/threonine-specific phosphatase mediated signaling presents an interesting case. If the number of tyrosine kinases and of tyrosine phosphatases is similar (~100 in mammals), serine/threonine kinases have diversified to some 400 members in the course of evolution while the serine/threonine phosphatases count to about 25. The functional versatility is conferred through the diversity of regulatory subunits with which they interact. The holoenzyme dictates the role the protein complex plays in signaling pathways."^^xsd:string ;
  obo:hasDbXref "PMID:15780597"^^xsd:string, "PMID:17079133"^^xsd:string, "PMID:19099538"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000654 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The protein tyrosine phosphatase superfamily exerts essential roles in signaling pathways. The coordinated interplay of tyrosine kinase mediated phosphorylation and tyrosine phosphatase mediated dephosphorylation of substrates shapes the functional topology of signaling networks. The PTP superfamily is composed of four families."^^xsd:string ;
  obo:hasDbXref "PMID:15186772"^^xsd:string, "PMID:15817824"^^xsd:string, "PMID:17057753"^^xsd:string, "PMID:19099538"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000655 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those signaling pathways mediated or initiated by oligosaccharide or polysaccharide linked proteins."^^xsd:string ;
  obo:hasDbXref "OneLook:www,onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000656 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways initiated or mediated by glycoproteins. Glycoproteins have oligosaccharides attached to their amino acid side chains via N- or O-glycosylation. Glycoproteins represent a large category of proteins encompassing a wide range of functionalities."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000657 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways initiated or mediated by proteoglycans - heavily glycosylated proteins that have glycosaminoglycan (GAG) chain(s) linked to their protein cores. GAGs are long unbranched polysaccharides of repeating disaccharide units. Proteoglycans are categorized by the nature of the GAG chain or by their size."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000658 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Glypicans are heparan sulfate proteoglycans represented by six families in mammals. They impact on a number of signaling pathways; the effect on signaling can be either inhibitory or stimulatory, depending on the context. They also appear to integrate directional cues important for neuronal migration, axon guidance and synapse formation."^^xsd:string ;
  obo:hasDbXref "PMID:16937008"^^xsd:string, "PMID:18505598"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000659 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Syndecan family of proteoglycans appears to be involved in cell-adhesion, particularly cell-extracellular matrix (ECM) signaling and to integrate with the integrin pathway. They also appear to integrate directional cues important for neuronal migration, axon guidance and synapse formation."^^xsd:string ;
  obo:hasDbXref "PMID:16937008"^^xsd:string, "PMID:17971838"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000660 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Hematopoiesis refers to the formation of blood cellular components. All components are derived from the hematopoietic stem cells residing in the marrow. A great amount of new blood cells needs to be produced daily to maintain steady state levels of circulation."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000661 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A DNA repair pathway responsible for removing one or several damaged nucleotides or of  nucleotide mismatched during DNA replication in one of the DNA strands. Several excision pathways are available for correcting single-strand damage."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string, "PMID:17129767"^^xsd:string, "PMID:23085398"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000662 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Mismatch repair pathway assures the maintenance of normal Watson-Crick base pairing. Bases incorrectly matched during DNA replication are removed and replaced with the correct ones."^^xsd:string ;
  obo:hasDbXref "GO:0006298"^^xsd:string, "KEGG:map03430"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000663 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A pathway dealing with repair of double-strand breaks of the DNA or of strand damage such interstrand cross links."^^xsd:string ;
  obo:hasDbXref "PMID:23085398"^^xsd:string, "PMID:24326623"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000666 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A single-strand DNA repair pathway that deviates from what its normal course should be. Aberrant single-strand repair pathways have been linked to several diseases."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000667 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Defective repair pathway(s) of double-strand breaks can lead to chromosomal rearrangements, genomic instability and oncogenic activation."^^xsd:string ;
  obo:hasDbXref "PMID:22027614"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000668 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A mismatch repair pathway that deviates from what its normal course should be. Mutations in several genes in the pathway have been implicated in cases of colorectal cancer, primarily the inherited forms. To a lesser extent they are found in other types of cancer, such as for instance type 1 endometrial."^^xsd:string ;
  obo:hasDbXref "PubMed:Several articles"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000669 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A glycoprotein signaling pathway that deviates from what its normal course should be."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000670 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A glycoconjugated protein signaling pathway that deviates from what its normal course should be."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000674 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Insulin secretion by pancreatic beta-cells is an important aspect of glucose homeostasis. A major component of glucose stimulated insulin secretion is represented by the route dependent on the ATP sensitive potassium channels. However, other contributions are also likely to promote insulin secretion."^^xsd:string ;
  obo:hasDbXref "GO:0030073"^^xsd:string, "PMID:18728221"^^xsd:string, "PMID:18774732"^^xsd:string, "Reactome:REACT_18325.2"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000675 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Glucagon is secreted by pancreatic alpha cell; the mechanisms of its release in response to low glucose levels are poorly understood."^^xsd:string ;
  obo:hasDbXref "PMID:18522828"^^xsd:string, "PMID:18600596"^^xsd:string, "PMID:18647881"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000676 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Glucagon signaling responds to low levels of circulating glucose to stimulate its release. The action of glucagon signaling is counter-regulatory to the action of insulin and it plays an essential role in glucose homeostasis."^^xsd:string ;
  obo:hasDbXref "PMID:12626323"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000677 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An insulin secretion pathway that deviates from what its normal course should be. Altered insulin secretion has been associated with type 2 diabetes mellitus. Multiple defects are thought to underle malfunctions of insulin secretion; the exact molecular mechanisms are only partially understood."^^xsd:string ;
  obo:hasDbXref "PMID:18640585"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000678 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A glucagon secretion pathway that deviates from what its normal course should be. Elevated serum glucagon has been observed in patients with type 2 diabetes. The pathway of glucagon secretion is not well understood and this complicates the understanding of how the pathway may falter."^^xsd:string ;
  obo:hasDbXref "PMID:17623014"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000679 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A glucagon signaling pathway that deviates from what its normal course should be. Glucagon signaling counteracts the signaling of insulin and the potential exists that an alteration of glucagon signaling has a role to play in diabetes type 2. Serum glucagon is elevated in patients with the disease; the mechanisms leading to and the consequences of elevated glucagon remain to be established."^^xsd:string ;
  obo:hasDbXref "PMID:17623014"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000681 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Fas ligand binding to its receptor triggers a conformational change that allows the receptor to assemble a signaling complex known as DISC, followed by recruitment of pro-caspase-8 and activation of caspase-3 and -7. It is believed that Fas mediated signaling to elicit apoptosis follows two routes."^^xsd:string ;
  obo:hasDbXref "PubMed:14744432"^^xsd:string, "Reactome:REACT_900.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000682 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Trail mediated signaling leads to apoptosis via assembly of the DISC complex (Death-Inducing Signaling Complex) downstream of its receptors."^^xsd:string ;
  obo:hasDbXref "PMID:14744432"^^xsd:string, "Reactome:REACT_402.1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000683 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A cell-cell signaling pathway mediated by integrins, a family of receptors that convey both 'outside-in' and 'inside-out' signals."^^xsd:string ;
  obo:hasDbXref "RGD:InHouse dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000684 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A cell-extracellular matrix signaling pathway mediated by integrins, a family of receptors that convey both 'outside-in' and 'inside-out' signals."^^xsd:string ;
  obo:hasDbXref "RGD:InHouse"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000685 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The metabolic pathways for generating glucose to meet the body's glucose needs. Gluconeogenesis in the liver and to some extent in kidney is the major pathway of glucose production; glycogenolysis is another route for generating glucose in these tissues."^^xsd:string ;
  obo:hasDbXref "MCW Libraries:ISBN-13 978-0470-12930-2"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000686 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A vasopressin signaling pathway that deviates from what its normal course should be. Altered vasopressin signaling manifests clinically as problems associated with water and sodium balance."^^xsd:string ;
  obo:hasDbXref "PMID:17761027"^^xsd:string, "PMID:18431594"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000687 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A sugar transport pathway that deviates from what its normal course should be. Alterations in sugar transport, particularly glucose, can potentially have very harmful consequences."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000688 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A facilitative sugar transporter mediated sugar transport pathway that deviates from what its normal course should be. Alterations in sugar transport, particularly glucose, can potentially have very harmful consequences."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000689 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A glucose transport pathway that deviates from what its normal course should be. Alterations in glucose transport can potentially have very harmful consequences."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000690 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A facilitative sugar transporter mediated glucose transport pathway that deviates from what its normal course should be. Alterations in glucose transport can potentially have very harmful consequences."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000691 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A sodium-glucose cotransporter mediated glucose transport pathway that deviates from what its normal course should be. Alterations in glucose transport can potentially have very harmful consequences."^^xsd:string ;
  obo:hasDbXref "InHouse:PW"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000692 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An insulin responsive facilitative sugar transporter mediated glucose transport pathway that deviates from what its normal course should be. Alterations in the pathway can manifest in insulin resistance, a hallmark of type 2 diabetes."^^xsd:string ;
  obo:hasDbXref "PMID:17629673"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000693 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the degradation of biphenyl, an aromatic hydrocarbon used as a starting material for the production of polychlorinated biphenyls or as an intermediate for the production of a variety of organic compounds."^^xsd:string ;
  obo:hasDbXref "KEGG:map00621"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000694 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the degradation of geraniol, a monoterpenoid and an alcohol, used in perfumes and in flavors."^^xsd:string ;
  obo:hasDbXref "KEGG:map00281"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000696 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of zeatin - a plant hormone derived from adenine. It induces plant growth and has been reported to have anti-aging effects on human skin fibroblasts."^^xsd:string ;
  obo:hasDbXref "GO:0033398"^^xsd:string, "KEGG:map00908"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000697 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of carotenoids, organic pigments found in plants and other photosynthetic organisms. Some can act as antioxidants."^^xsd:string ;
  obo:hasDbXref "GO:0016120"^^xsd:string, "KEGG:map00906"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000698 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Thyroid cancer refers to one of several types of malignant tumors of the thyroid gland of which papillary thyroid cancer is the most frequent, accounting for almost 80% of all cases. The other types include follicular, medullary and anaplastic."^^xsd:string ;
  obo:hasDbXref "KEGG:map05216"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000699 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Parathyroid cancer is a rare type of cancer whose causes are unknown. There are four parathyroid glands, each of the two lobes of the thyroid gland houses two."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000700 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A general term grouping neoplastic pathways of the adrenal gland, ovaries and pancreas, pituitary and thyroid."^^xsd:string ;
  obo:hasDbXref "MeSH:http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000701 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A general term grouping neoplastic pathways of the heart, respiratory tract and thymus."^^xsd:string ;
  obo:hasDbXref "MeSH:http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000703 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Lung cancer is one of the most common causes of cancer-related death in men but is also very common in women. The main types are represented by small cell and non-small cell lung carcinomas. The former tends to respond better to chemotherapy; the latter is at times treated surgically."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000704 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Small cell lung cancer is an aggressive type of lung cancer. Several pathways appear to be deregulated and they include the intrinsic apoptotic pathway, PI3K-Akt signaling and changes in oncogene transcription factors such as Myc and p53."^^xsd:string ;
  obo:hasDbXref "KEGG:map05222"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000705 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Non-small cell lung carcinoma groups together several non-small cell lung carcinomas. The main types are represented by squamous cell, adeno- and large-cell carcinoma. Alterations in Ras and epidermal growth factor signaling, among others, have been implicated in the condition."^^xsd:string ;
  obo:hasDbXref "KEGG:map05223"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000706 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Leukemia is a cancer of the blood or bone marrow. The term covers a broad spectrum of conditions subdivided by proliferation type - acute and chronic, and by cell type - myeloid and lymphocytic leukemia."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook..com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000707 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Myeloid leukemia affects cells of the myeloid lineage and their precursors and in turn is subdivided by proliferation type."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000708 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Lymphoid leukemia affects lymphoid tissues and there are increase numbers of circulating lymphoblasts and lymphocytes."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000709 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Acute myeloid leukemia is a common type of leukemia among adults. Abnormal cells are present inside the bone marrow that grow very vast and replace healthy blood cells. Several signaling pathways are disrupted and/or constitutively activated."^^xsd:string ;
  obo:hasDbXref "KEGG:map05221"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000710 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chronic myeloid leukemia, a slowly progressing condition, is a type of leukemia where too many white blood cells are made in the bone marrow."^^xsd:string ;
  obo:hasDbXref "KEGG:map05220"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000711 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Gliomas are tumors of the brain categorized by the type of cell they are associated with, their location and grade. Several pathways appear to be deregulated via amplifications, overexpression, mutations or loss."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000712 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Vasopressin signaling via receptor type 1 couples to Gq alpha subunit leading to stimulation of phospholipase C beta, subsequent generation of second messengers and increase in intracellular calcium resulting in vasoconstriction."^^xsd:string ;
  obo:hasDbXref "PMID:11091117"^^xsd:string, "PMID:14624682"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000713 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Vasopressin signaling via receptor type 2 plays a central role in water homeostasis by regulating the translocation of Aqp2 channel. The receptor couples to Gs alpha subunit leading to activation of adenylyl cyclase, production of cyclic AMP and triggering of protein kinase A (PKA) signaling pathway. PKA regulates both the translocation and the expression of the channel."^^xsd:string ;
  obo:hasDbXref "PMID:11091117"^^xsd:string, "PMID:14624682"^^xsd:string, "PMID:17761027"^^xsd:string, "PMID:18431594"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000714 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A vasopressin, receptor type 1 mediated signaling pathway, that deviates from what its normal course should be. Alterations in this pathway might relate to septic shock."^^xsd:string ;
  obo:hasDbXref "PMID:17133186"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000715 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A vasopressin, receptor type 2 mediated signaling pathway, that deviates from what its normal course should be. Alterations in the pathway have been associated with Nephrogenic Diabetes Insipidus (NDI) caused by mutations in the receptor or, more rarely, in aquaporin channel 2."^^xsd:string ;
  obo:hasDbXref "PMID:17761027"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000716 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Transcription factors mediated signaling are components of transcription that, by controlling the expression of target genes, impact upon a wide range of processes."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000717 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The signaling pathway mediated by the FoxO subgroup of forkhead family of transcription factors regulates cell cycle and survival via the expression of its target genes. FoxO pathway is negatively regulated by PI3K-Akt pathway downstream of insulin signaling. It is positively regulated by the Jnk pathway of stress activated MAPK cascade."^^xsd:string ;
  obo:hasDbXref "PMID:10702024"^^xsd:string, "PMID:17275054"^^xsd:string, "PMID:19274050"^^xsd:string, "PMID:23325358"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000718 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "p53 transcription factor is a tumor suppressor frequently mutated in cancer. p53 is at the hub of many signaling and regulatory pathways. In response to various stresses, it promotes apoptosis, cell cycle arrest and other defense pathways via transcription dependent as well as independent routes. A key regulator of p53 is Mdm2. Mdm2 is a transcriptional target of p53 thus providing a negative feedback loop."^^xsd:string ;
  obo:hasDbXref "PMID:18783169"^^xsd:string, "PMID:18927276"^^xsd:string, "PMID:19007744"^^xsd:string, "PMID:19407794"^^xsd:string, "PMID:19776744"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000719 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A transcription factor mediated signaling pathway that deviates from what its normal course should be. Deregulation of such pathways has been linked to cancer and various other diseases."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000720 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A p53 signaling pathway that deviates from what its normal course should be. Due to its central role at the intersection of many cellular pathways, disturbance of p53 network can have far-reaching negative consequences. The tumor suppressor Tp53 gene is frequently mutated in cancer."^^xsd:string ;
  obo:hasDbXref "PMID:19776744"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000721 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of nicotine, an alkaloid found in tobacco and other plants. It is an agonist of nicotinic acetylcholine receptors and exerts stimulatory roles. It is also responsible for tobacco dependence.  Prolonged exposure and high levels of nicotine can have toxic effects. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/pathway/PA162355621"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000722 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of warfarin. Warfarin is used as anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Warfarin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000723 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of anti-diabetic drugs such as repaglinide, nateglinide and sulfonylurea - inhibitors of ATP-dependent potassium channel. By blocking the channel they stimulate insulin secretion to lower blood glucose level. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:11259325"^^xsd:string, "PMID:12919179"^^xsd:string, "PharmGKB:http://www.pharmgkb.org/"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000724 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of statin. Statins are a class of drugs used to lower cholesterol. They act as inhibitors of HMG-CoA reductase, the enzyme that catalyzes an early rate-limiting step in cholesterol biosynthesis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000725 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of anti-diabetic drugs-target interaction and of the biochemical or physiological responses to them. Repaglinide, nateglinide and sulfonylurea are used as inhibitors of ATP-dependent potassium channel. By blocking the channel they stimulate insulin secretion to lower blood glucose level. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000726 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of repaglinide. The drug is used as an inhibitor of ATP-dependent potassium channel. By blocking the channel it stimulates insulin secretion to lower blood glucose level. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:12919179"^^xsd:string, "PharmGKB:http://www.pharmgkb.org/"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000727 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of nateglinide. The drug is used as an inhibitor of ATP-dependent potassium channel. By blocking the channel it stimulates insulin secretion to lower blood glucose level. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:11259325"^^xsd:string, "PharmGKB:http://www.pharmgkb.org/"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000728 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of statins-target interaction and of the biochemical or physiological responses to drug. Statins are a class of drugs used to lower cholesterol. They act as inhibitors of HMG-CoA reductase, the enzyme that catalyzes an early rate-limiting step in cholesterol biosynthesis. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000729 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of statin. Statins are a class of drugs used to lower cholesterol. They act as inhibitors of HMG-CoA reductase, the enzyme that catalyzes an early rate-limiting step in cholesterol biosynthesis. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000730 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of warfarin. Warfarin is used as anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Warfarin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000731 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of warfarin-target interaction and of the biochemical or physiological responses to drug. Warfarin is used as anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Warfarin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000732 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving thromboxanes - a family of prostanoid eicosanoids whose effects include vasoconstriction and platelet aggregation."^^xsd:string ;
  obo:hasDbXref "MCW library:QU4 M235b 2009"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000733 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of glycosphingolipids - glycolipids with sugar(s) attached to the ceramide core. Based on the sequences of the core carbohydrate residues, they are classified into a number of series such as lacto- and neolacto-, globo-, ganglio- or muco-series."^^xsd:string ;
  obo:hasDbXref "GO:0006687"^^xsd:string, "MCW library:QU4 M235b 2009"^^xsd:string, "PMID:15207828"^^xsd:string, "PMID:17976918"^^xsd:string, "PMID:18845618"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000734 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of cerebroside, sphingolipids in which the sugar is a monosaccharide."^^xsd:string ;
  obo:hasDbXref "MCW library:QU4 M235b 2009"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000735 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A sphingolipid metabolic pathway that deviates from what its normal course should be. Altered sphingolipid metabolism has been associated with several lysosomal storage diseases and most appear to be fatal."^^xsd:string ;
  obo:hasDbXref "MCW library:QU4 M235b 2009"^^xsd:string, "PW dictionary:InHouse dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000736 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The de novo synthesis of triacylglycerol, the common form of fatty acid transport and storage. Most triacylglycerols are synthesized in the liver and stored in the adipose tissue."^^xsd:string ;
  obo:hasDbXref "GO:0019432"^^xsd:string, "MCW library:QU4 M235b 2009"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000737 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The degradation pathway of triacylglycerols when the energy reserves are low such as in the fasting state, during exercise or in response to stress. Triacylglycerols are the common form of fatty acid transport and storage."^^xsd:string ;
  obo:hasDbXref "GO:0019433"^^xsd:string, "MCW library:QU4 M235b 2009"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000738 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Fatty acid degradation via beta oxidation, the most common fatty acid degradation pathway, occurs in four reactions resulting in the formation of acetyl-CoA and a fatty acyl-CoA two carbon shorter than the one that began the cycle. Acetyl-CoA can undergo further oxidation via the Krebs cycle or can be converted to ketone bodies."^^xsd:string ;
  obo:hasDbXref "PMID:10816122"^^xsd:string, "PMID:14728673"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000739 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The degradation of branched-chain fatty acids is carried out by the alpha oxidation pathway. In humans, this pathway occurs in peroxisomes."^^xsd:string ;
  obo:hasDbXref "MCW library:QU4 M235b 2009"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000740 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of unsaturated fatty acids requires additional enzymes."^^xsd:string ;
  obo:hasDbXref "MCW library:QU4 M235b 2009"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000741 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A ganglioside metabolic pathway that deviates from what its normal course should be. For instance, Tay-Sachs disease is caused by a deficiency in the enzyme that degrades ganglioside GM2. This and other conditions involving impaired sphingolipid metabolism are collectively known as sphingolipid storage disease."^^xsd:string ;
  obo:hasDbXref "MCW library:QU4 M235b 2009"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000742 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A glycoshingolipid metabolic pathway that deviates from what its normal course should be. Altered glycosphingolipid metabolism has been associated with several lysosomal storage diseases and most appear to be fatal."^^xsd:string ;
  obo:hasDbXref "MCW library:QU4 M235b 2009"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000743 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of galactocerebroside, a cerebroside in which the monosaccharide is galactose."^^xsd:string ;
  obo:hasDbXref "MCW library:QU4 M235b 2009"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000744 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of glucocerebroside, a cerebroside in which the monosaccharide is glucose."^^xsd:string ;
  obo:hasDbXref "MCW library:QU4 M235b 2009"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000745 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of sphingomyelin - a sphingolipid found abundantly in the myelin sheath of nerve cells."^^xsd:string ;
  obo:hasDbXref "GO:0006684"^^xsd:string, "MCW library:QU4 M235b 2009"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000746 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A sphingomyelin metabolic pathway that deviates from what its normal course should be. For instance, Niemann-Pick disease is caused by a deficiency in the enzyme that degrades sphingomyelin. This and other conditions involving impaired sphingolipid metabolism are collectively known as sphingolipid storage disease."^^xsd:string ;
  obo:hasDbXref "MCW library:QU4 M235b 2009"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000747 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A galactocerebroside metabolic pathway that deviates from what its normal course should be. For instance, Krabbe's disease is caused by a deficiency in the enzyme that degrades galactocerebroside. This and other conditions involving impaired sphingolipid metabolism are collectively known as sphingolipid storage disease."^^xsd:string ;
  obo:hasDbXref "MCW library:QU4 M235b"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000748 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A cerebroside metabolic pathway that deviates from what its normal course should be. Altered cerebroside metabolism has been associated with several lysosomal storage diseases and most appear to be fatal."^^xsd:string ;
  obo:hasDbXref "MCW library:QU4 M235b 2009"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000749 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A glucocerebroside metabolic pathway that deviates from what its normal course should be. For instance, Gaucher's disease is caused by a deficiency in the enzyme that degrades glucocerebroside. This and other conditions involving impaired sphingolipid metabolism are collectively known as sphingolipid storage disease."^^xsd:string ;
  obo:hasDbXref "MCW library:QU4 M235b 2009"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000750 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An isoprenoid metabolic pathway that deviates from what its normal course should be. Aberrant isoprenoid metabolism, as evidenced in alterations in cholesterol metabolism, has been associated with a variety of conditions."^^xsd:string ;
  obo:hasDbXref "MCW library:QU85 B615 2008"^^xsd:string, "PMID:16876788"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000751 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An isoprenoid biosynthetic pathway that deviates from what its normal course should be. Aberrant isoprenoid biosynthetic pathway, as evidenced in altered cholesterol biosynthesis has been associated with several conditions."^^xsd:string ;
  obo:hasDbXref "MCW library:QU85 B615 2008"^^xsd:string, "PMID:16876788"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000752 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A cholesterol biosynthetic pathway that deviates from what its normal course should be. Aberrant cholesterol biosynthesis involves defects in enzymes of both early and later steps leading to several disorders."^^xsd:string ;
  obo:hasDbXref "MCW library:QU 85 B615 2008"^^xsd:string, "PMID:16876788"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000753 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The sterol regulatory element-binding protein (SREBP) pathway has important roles in the control of lipid and cholesterol metabolism. SREBPs are sterol regulated transcription factors that belong to the bHLH family."^^xsd:string ;
  obo:hasDbXref "PMID:17303406"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000754 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and the pharmacodynamics pathway elicited by the administration of specific drugs. The systems involved in drug processing and responses are also those handling exogenous, xenobiotic compounds in the cellular detoxification pathway. The distinction between a random encounter with a foreign compound and the processing of a substance administered for treatment along with the importance of genetic variation for the individual responses to particular drugs warrant their separate consideration."^^xsd:string ;
  obo:hasDbXref "KEGG:http://www.genome.jp/kegg/"^^xsd:string, "PharmGKB:http://www.pharmgkb.org/"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000755 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of benzodiazepines, a class of drugs acting upon the central nervous system. The drugs are administered as sedatives and also as antiepileptics. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000756 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of benzodiazepines. Benzodiazepine represent a class of drugs used as sedatives. They act as ligands for the GABA-A receptor to stimulate its inhibitory activity. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000757 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of benzodiazepine-target interaction and of the biochemical or physiological responses to drug. Benzodiazepines are a class of drugs used as sedatives. They act as ligands for the GABA-A receptor to stimulate its inhibitory activity. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000758 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of gemcitabine, a cytidine analogue that is administered as a prodrug for the treatment of certain types of cancer. The diphosphate form is an inhibitor of ribonucleotide reductases, essential enzymes of deoxyribonucleotide synthesis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000759 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination of gemcitabine. Gemcitabine is a cytidine analogue administered as a prodrug for the treatment of certain cancers. The diphosphate form is an inhibitor of ribonucleotide reductases, essential enzymes of deoxyribonucleotide synthesis. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/do/serve?objId=PA2036"^^xsd:string, "SMPDB:http://pathman.smpdb.ca/pathways/SMP00446/pathway"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000760 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of gemcitabine-target interaction and of the biochemical or physiological responses to drug. Gemcitabine is a cytidine analogue that is administered as a prodrug for the treatment of certain types of cancer. The diphosphate form is an inhibitor of ribonucleotide reductases, essential enzymes of deoxyribonucleotide synthesis. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/do/serve?objId=PA2036"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000761 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of celecoxib, a selective cyclooxygenase 2 inhibitor used for the treatment of osteoarthritis and rheumatoid arthritis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:www.pharmgkb.org/"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000762 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination of celecoxib - a selective inhibitor of cyclooxygenase 2 used for the treatment of osteoarthritis and rheumatoid arthritis. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/do/serve?objId=PA152241951"^^xsd:string, "SMPDB:http://pathman.smpdb.ca/pathways/SMP00096/pathway"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000763 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of celecoxib-target interaction and of the biochemical or physiological responses to drug. Celecoxib is a selective inhibitor of cyclooxygenase 2 used for the treatment of osteoarthritis and rheumatoid arthritis. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/do/serve?objId=PA152241951"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000764 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of ifosfamide, am antitumor agent used in the treatment of certain cancers. It is administered as a prodrug that has to be converted to the active form. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/"^^xsd:string, "SMPDB:http://pathman.smpdb.ca/pathways/SMP00448/pathway"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000765 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination of ifosfamide, a prodrug used against solid tumors. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/do/serve?objId=PA2037"^^xsd:string, "SMPFB:http://pathman.smpdb.ca/pathways/SMP00448/pathway"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000766 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of ifosfamide-target interaction and of the biochemical or physiological responses to drug. Ifosfamide is administered as a prodrug and is widely used as an alkylating agent for the treatment of certain cancers. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/search/pathway/ifos/ifos-pd.jsp"^^xsd:string, "SMPDB:http://pathman.smpdb.ca/pathways/SMP00448/pathway"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000767 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of omeprazole, a proton pump inhibitor. Omeprazole is the representative compound of a class of such inhibitors that are administered for the treatment of acid-related disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000768 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination of omeprazole, a representative compound of a class of proton pump inhibitors. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/do/serve?objId=PA152530846"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000769 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of omeprazole-target interaction and of the biochemical or physiological responses to drug. Omeprazole is a representative compound of a class of proton pump inhibitors used in the treatment of acid-related disorders. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/search/pathway/proton-pump/proton-pump-pd.jsp"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000770 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of C19-steroid hormones. Pregnenolone, a C21 steroid derived from cholesterol, and progesterone, to which pregnenolone can be converted, provide the starting material for the C21, C19 and C18 steroid hormones. The C19 class is represented by androgens such as testosterone."^^xsd:string ;
  obo:hasDbXref "PMID:17926129"^^xsd:string, "PMID:18720009"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000771 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Mineralocorticoids are a group of C21 steroid hormones synthesized by the adrenal cortex and so named because of their effects on the concentration of sodium as well as potassium and chloride. The group is best exemplified by aldosterone."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000772 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Glucocorticoids are a group of C21 steroid hormones synthesized by the adrenal cortex and so named because of their effects on glucose metabolism. They also play a role in developmental processes and the immune system. The group is best exemplified by cortisol."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000773 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Aldosterone is a C21 mineralocorticoid produced in the outer zone, the zona glomerulosa, of the adrenal cortex from the cholesterol precursor. It plays important roles in the regulation of water and salt balance."^^xsd:string ;
  obo:hasDbXref "PMID:17926129"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000774 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Cortisol is a C21 glucocorticoid produced in the middle zone, the zona fasciculata, of the adrenal cortex from the cholesterol precursor. It plays important roles in carbohydrate and other nutrients metabolism."^^xsd:string ;
  obo:hasDbXref "PMID:17926129"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000775 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An epidermal growth factor/neuregulin signaling pathway that deviates from what its normal course should be. Deregulation of the pathway, mostly as upregulation due to the increased expression or amplification of ligands and/or receptors, or mutations leading to such increases, has been linked to numerous forms of cancer, such as pancreatic, lung, endometrial and breast."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000776 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of acetoacetate and beta-hydroxybutyrate also known as ketone bodies although only acetoacetate is a ketone. Generally, the acetyl-CoA derived from fatty acids oxidation enters the citrate cycle. In the liver, a substantial fraction of acetyl-CoA is converted to ketone bodies which are then released into the blood stream for supply to peripheral tissues."^^xsd:string ;
  obo:hasDbXref "GO:0042181"^^xsd:string, "KEGG:map00072"^^xsd:string, "MCW Libraries:QU4 V876f 2008"^^xsd:string, "Reactome:REACT_1464.3"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000777 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions that convert acetoacetate and beta-hydroxybutyrate back to acetyl-CoA which then can enter the citrate cycle for energy production. The ketone bodies are synthesized in the liver and released into to blood stream to supply fuel to peripheral tissues, heart and skeletal muscle in particular and during starvation, the brain."^^xsd:string ;
  obo:hasDbXref "GO:0046952"^^xsd:string, "KEGG:map00072"^^xsd:string, "MCW Libraries:QU4 V876f 2008"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000778 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of testosterone, a C19-steroid hormone secreted primarily in the testes and ovaries and to a lesser extend by the adrenal glands."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000779 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of dehydroepiandrosterone, a C19 steroid hormone produced in the adrenal cortex and a primary precursor of estrogens."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000780 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of C18-steroid hormones. Pregnenolone, a C21 steroid derived from cholesterol, and progesterone, to which pregnenolone can be converted, provide the starting material for the C21, C19 and C18 steroid hormones. The C18 class is represented by estrogens. The major natural estrogens are beta-estradiol - the primary estrogen, the estrone of menopause and the estriol of pregnancy."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string, "PMID:17926129"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000781 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of estradiol, the major C18 steroid hormone. The term generally refers to the 17 beta isomer, the most potent form of estrogen."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000782 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Glucocorticoids, C21-steroid hormones, initiate signaling by binding to their specific nuclear receptor to regulate metabolism, development and immune response. The major glucocorticoid is cortisol."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000783 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Mineralocorticoids, C21 steroid hormones, initiate signaling by binding to their cognate receptor to regulate water and mineral levels. The main endogenous mineralocorticoid is aldosterone."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000784 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An androgen signaling pathway that deviates from what its normal course should be. Altered androgen signaling, due to upregulation of the androgen receptor, has been implicated in prostate cancer."^^xsd:string ;
  obo:hasDbXref "PMID:17163421"^^xsd:string, "PMID:18657355"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000788 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Glucose-dependent insulinotropic peptide signaling plays an important role in promoting insulin secretion. Gip is secreted from the K intestinal cells in response to nutrient ingestion. It signals via a G-protein coupled receptor to increase calcium and cAMP and activate downstream signaling pathways."^^xsd:string ;
  obo:hasDbXref "PMID:19074620"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000789 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Glucagon-like peptide-1 signaling pathway plays an important role in promoting insulin secretion. GLp-1 is secreted from the L intestinal cells in response to nutrient ingestion. It signals via a G-protein coupled receptor to increase calcium and cAMP and activate numerous downstream signaling pathways."^^xsd:string ;
  obo:hasDbXref "PMID:19074620"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000790 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Epinephrine acts as a hormone and a neurotransmitter. It promotes various actions by signaling via various adrenergic receptors, G-protein coupled receptor type. The alpha receptor 1 and 2 couple to the Galphaq and Galphai subunits of heterotrimeric G proteins, respectively. The three beta receptors couple to the Galphas subunit."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000791 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Norepinephrine acts as a hormone and a neurotransmitter. It promotes various actions by signaling via various adrenergic receptors, G-protein coupled receptor type. The alpha receptor 1 and 2 couple to the Galphaq and Galphai subunits of heterotrimeric G proteins, respectively. The three beta receptors couple to the Galphas subunit."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000792 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Epinephrine acts as a hormone and a neurotransmitter. It promotes various actions by signaling via various adrenergic receptors, G-protein coupled receptor type. The alpha 1 receptors couple to the Galphaq subunit."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000793 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Epinephrine acts as a hormone and a neurotransmitter. It promotes various actions by signaling via various adrenergic receptors, G-protein coupled receptor type. The alpha 2 receptors couple to the Galphai subunit."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000794 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Epinephrine acts as a hormone and a neurotransmitter. It promotes various actions by signaling via various adrenergic receptors, G-protein coupled receptor type. The beta receptors couple to the Galphas subunit. Beta 2 receptor may also couple to Galphai."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000795 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Norepinephrine acts as a hormone and a neurotransmitter. It promotes various actions by signaling via various adrenergic receptors, G-protein coupled receptor type. The alpha 1 receptors couple to the Galphaq subunit."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000796 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Norepinephrine acts as a hormone and a neurotransmitter. It promotes various actions by signaling via various adrenergic receptors, G-protein coupled receptor type. The alpha 2 receptors couple to the Galphai subunit."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000797 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Norepinephrine acts as a hormone and a neurotransmitter. It promotes various actions by signaling via various adrenergic receptors, G-protein coupled receptor type. The beta receptors couple to the Galphas subunit. Beta 2 receptor may also couple to Galphai."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000798 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Catecholamines act as hormones and neurotransmitters. The major catecholamines are dopamine, epinephrine and norepinephrine. They are derived from tyrosine and are not to be confused with tyrosine-based hormones."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000799 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of adrenergic beta receptors drugs - beta-agonists and blockers. Adrenergic beta receptors, in response to epinephrine or norepinephrine couple to the Gs alpha subunit of heterotrimeric G protein to elicit several responses. Beta-agonists are used to stimulate while beta-blocker antagonists are used to inhibit these responses, as necessary. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:19874988"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000800 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of beta adrenergic receptor drugs. The beta-agonists are used to stimulate while the beta-blockers are used to inhibit the action of adrenergic beta receptors, as necessary. Adrenergic beta receptors are G-protein coupled receptors that in response to epinephrine or norepinephrine elicit various sympathetic responses important for proper cardiac function and in the case of beta2 receptor, smooth muscle relaxation and bronchodilation. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:19874988"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000801 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of beta adrenergic drug-target interactions and of the biochemical or physiological responses to drug. The beta-agonists are used to stimulate while the beta-blockers are used to inhibit the action of adrenergic beta receptors, as necessary. Adrenergic beta receptors are G-protein coupled receptors that in response to epinephrine or norepinephrine elicit various sympathetic responses important for proper cardiac function and in the case of beta2 receptor, smooth muscle relaxation and bronchodilation. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:19874988"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000802 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of dopamine."^^xsd:string ;
  obo:hasDbXref "PMID:19342614"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000803 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the biosynthesis of epinephrine. Epinephrine is primarily synthesized in adrenal chromaffin cells in response to specific stresses that activate the sympatho-adreno-medullary system."^^xsd:string ;
  obo:hasDbXref "PMID:19342614"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000804 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the biosynthesis of norepinephrine. Norepinephrine is primarily synthesized in sympathetic neurons in response to stresses such as cold or pain."^^xsd:string ;
  obo:hasDbXref "PMID:19342614"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000805 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A Trail mediated signaling pathway that deviates from what its normal course should be. Mutations with the death domain of the receptors or deletions within the region containing the receptor genes have been reported for certain types of lymphomas."^^xsd:string ;
  obo:hasDbXref "PMID:18813321"^^xsd:string, "PMID:20336667"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000806 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A FasL mediated signaling pathway that deviates from what its normal course should be."^^xsd:string ;
  obo:hasDbXref "PMID:10712254"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000808 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "MicroRNAs (miRNAs) are a large family of small RNAs involved in the post transcriptional regulation of gene expression. The biogenesis and function of miRNA is subject to complex control. Deregulation of miRNA expression has been linked to many diseases including cancer."^^xsd:string ;
  obo:hasDbXref "PMID:20471939"^^xsd:string, "PMID:20661255"^^xsd:string, "PMID:20885409"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000809 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The small non-coding RNA pathways have emerged as potent regulators of gene expression. Three major classes have been identified of which the microRNA (miRNA) system is the better understood one."^^xsd:string ;
  obo:hasDbXref "PMID:19165215"^^xsd:string, "PMID:20484662"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000811 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Piwi-RNA (piRNAs) are believed to play a role in gene silencing, particularly the silencing of transposons as many"^^xsd:string ;
  obo:hasDbXref "Cell:new article"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000812 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A small non-coding RNA pathway that deviates from what its normal course should. For instance, alterations in miRNA pathway have been associated with many diseases including various types of cancer."^^xsd:string ;
  obo:hasDbXref "PMID:19882673"^^xsd:string, "PMID:20885409"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000813 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A microRNA pathway that deviates from what its normal course should be. An altered miRNA pathway has been implicated in many diseases including various forms of cancer."^^xsd:string ;
  obo:hasDbXref "PMID:20885409"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000814 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Toll-like receptors represent a large and the better understood family of pattern recognition receptors that sense an array of exogenous structures and recent evidence shows they can also recognize defective endogenous molecules. The intracellular signaling cascades they set in motion lead to the expression of inflammatory mediators."^^xsd:string ;
  obo:hasDbXref "PMID:20303867"^^xsd:string, "PMID:20303872"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000815 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "C-type lectin receptors represent one of four classes of pattern recognition receptors. The intracellular signaling cascades they set in motion lead to the expression of inflammatory mediators."^^xsd:string ;
  obo:hasDbXref "PMID:20303867"^^xsd:string, "PMID:20303872"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000816 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "This family of pattern recognition receptors are cytoplasmic proteins that recognize exogenous cytoplasmic DNA. The signaling cascades they set in motion lead to the expression of inflammatory mediators."^^xsd:string ;
  obo:hasDbXref "PMID:20303867"^^xsd:string, "PMID:20303872"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000817 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "NOD-like receptors are cytosolic proteins that recognize components of bacterial peptidoglycans. The signaling cascades they set in motion lead to the expression of inflammatory mediators."^^xsd:string ;
  obo:hasDbXref "PMID:20303867"^^xsd:string, "PMID:20303872"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000818 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those signaling pathways that are involved in or mediate the various aspects of immune responses."^^xsd:string ;
  obo:hasDbXref "MCW library:Cellular and molecular immunology, by Abbas, Abul K"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000821 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "T cell receptor (TCR) signaling in developing thymocytes is important for the establishment of CD4 and CD8 lineages. Mature T cells express either CD4 or CD8 co-receptors which are essential for the interaction with peptide-bound class II or class I MHC complexes to elicit CD4 T helper (Th) or CD8 cytotoxic T lymphocyte responses, respectively. In either case, T cells initiated signaling activates the expression of genes whose products mediate these responses."^^xsd:string ;
  obo:hasDbXref "MCW library:Handbook of cellular and molecular immunology"^^xsd:string, "PMID:16448548"^^xsd:string, "PMID:20537906"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000822 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Antigen recognition by B cell receptors initiates signaling cascades that activate the expression of genes whose products are important for B cell functional responses."^^xsd:string ;
  obo:hasDbXref "MCW library:Handbook on cellular and molecular immunology"^^xsd:string, "PMID:19827951"^^xsd:string, "PMID:20591989"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000823 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Humoral immunity is mediated by antibodies secreted by the B cell lymphocytes. Antibodies recognize antigens of extracellular microbes and act to neutralize and eliminate them. Activation of B cells can occur in a T cell dependent or independent manner."^^xsd:string ;
  obo:hasDbXref "MCW library:Textbook on cellular and molecular immunology"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000824 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Cell-mediated immune response pathways are carried out by T cell lymphocytes. T cells receptors recognize peptides bound to a major histocompatibility complex (MHC) on the antigen presenting cell. Depending on whether the co-receptor is CD4 or CD8, the receptors will interact with MHC class II or class I to elicit distinct responses against intracellular pathogens."^^xsd:string ;
  obo:hasDbXref "MCW library:Handbook of cellular and molecular immunology"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000825 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathways of antigen processing and presentation assure the generation of peptides that have the structural attributes necessary for the association with and their placement near major histocompatibility complex (MHC) molecules. Protein antigen present in vesicular compartments generate class II peptides, those in cytosol class I."^^xsd:string ;
  obo:hasDbXref "MCW library:Handbook on cellular and molecular immunology"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000826 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "T cells that express the CD4 co-receptor, also called T helper cells, recognize class II MHC presented antigens derived from internalized microbes to initiate a signaling cascade that results in enhanced microbicidal capacity of phagocytes. T helper cells can be further subdivided into subsets of CD4+ T cells based on the distinct cytokines they produce and effector functions they perform."^^xsd:string ;
  obo:hasDbXref "MCW:Handbook on cellular and molecular immunology"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000827 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "T cells that express the CD8 co-receptor, also called cytotoxic or cytolytic T cells, recognize class I MHC presented antigens derived from cytosolic proteins to initiate a signaling cascade that results in killing of the target cell."^^xsd:string ;
  obo:hasDbXref "MCW:Handbook on cellular and molecular immunology"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000828 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Cytokine initiated signaling pathways play important roles in innate and adaptive immunity, as well as cell proliferation and apoptosis."^^xsd:string ;
  obo:hasDbXref "MCW library:Handbook on molecular and cellular immunology"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000829 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine initiated pathways play important roles in the innate and adaptive immunity. They are also involved in development and tissue maintenance. The presence and localization of four cysteines is important for structural folding and is also the basis for chemokine classification. The spacing between the first two cysteine residues divides the family members into four groups. Most mammalian chemokines belong to the CC and CXC families. Chemokines signal via G-protein coupled receptors to engage distinct G protein signaling and downstream cascades."^^xsd:string ;
  obo:hasDbXref "MCW library:Handbook on molecular and cellular immunology"^^xsd:string, "PMID:15062643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000830 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The CXC family members are characterized by the presence of two cysteine resides separated by one amino acid. CXC and CC are the two most prominent families. This family of chemokines is also subdivided into two subgroups: the one with the ELR motif - ELR (+) and the one without - ELR(-), respectively. Generally, ELR(+) and ELR(-) members bind to distinct chemokine, G-coupled protein, receptors. The effects of their signaling is for the most part angiogenic or angiostatic, respectively."^^xsd:string ;
  obo:hasDbXref "MCW:Handbook on cellular and molecular immunology"^^xsd:string, "PMID:15062643"^^xsd:string, "PMID:18579287"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000831 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The CC family members are characterized by the presence of two adjacent cysteine residues. The CC and the CXC family are the two most prominent families. Chemokines signal via G-protein coupled receptors to engage distinct G protein signaling and downstream cascades."^^xsd:string ;
  obo:hasDbXref "MCW:Handbook on cellular and molecular biology"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000832 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The C family of chemokine is small and its members have two rather than four cysteines residues. Chemokines signal via G-protein coupled receptors to engage distinct G protein signaling and downstream cascades."^^xsd:string ;
  obo:hasDbXref "MCW:Handbook on cellular and molecular immunology"^^xsd:string, "PMID:15062643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000833 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The CX3X family of chemokine is small and characterized by the presence of three residues separating the first two cysteines. Currently, only one member is known in mammals. Chemokines signal via G-protein coupled receptors to engage distinct G protein signaling and downstream cascades."^^xsd:string ;
  obo:hasDbXref "MCW:Handbook on cellular and molecular immunology"^^xsd:string, "PMID:15062643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000834 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Bile acid absorption by the intestinal epithelium and hepatic recycling collectively group the transport pathway of the important molecules of cholesterol catabolism."^^xsd:string ;
  obo:hasDbXref "PMID:17404808"^^xsd:string, "PMID:18837078"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000835 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Breast cancer is a major cause of death among Western women and many breast tumors are estrogen-dependent. Pharmacologically two major therapies have been developed: one targets the estrogen receptors via antagonists and selective modulators (SERM) and the second targets estrogen synthesis via aromatase inhibitors."^^xsd:string ;
  obo:hasDbXref "PMID:20644568"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000836 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Aromatase inhibitors block the last step of estrogen biosynthesis. They can be classified into first-, second- and third-generation drugs. Depending on whether they inactivate the aromatase complex irreversibly or reversibly, they can be further subdivided into type I and II, respectively. Currently, third generation drugs are being used."^^xsd:string ;
  obo:hasDbXref "PMID:12402060"^^xsd:string, "PMID:14513434"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000837 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of tamoxifen - one of the most widely used anti-estrogen drug that targets the estrogen receptor. The drug is a modulator than acts as an antagonist in breast cancer cells but can be an agonist in bone and the cardiovascular system. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:19629072"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000838 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of tamoxifen - a SERM anti-estrogen drug. Genetic variations can result in changes in the availability of the drug. For instance, variation in CYP2D6, an important enzyme for the production of a primary drug metabolite, impacts on the available concentration of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:19629072"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000839 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of tamoxifen-target interaction and of the biochemical or physiological responses to drug. In breast cancer cells, tamoxifen binding antagonizes estrogen binding and the subsequent conformational changes necessary for co-activators recruitment. It may also prompt the recruitment of co-repressor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:19629072"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000840 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Protein kinase C constitutes a family of serine/threonine kinases activated by diacylglycerol (DAG) and calcium whose signal transduction plays important roles in many cellular processes. Ligand activated G protein-coupled receptors, via Galphaq pathway, stimulate phospholipase C which cleaves PIP2 into DAG and IP3. IP3 promotes calcium release."^^xsd:string ;
  obo:hasDbXref "GO:0070528"^^xsd:string, "PMID:19934406"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000841 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Acetylcholine signaling plays important roles in the central and peripheral nervous system and exerts both excitatory and inhibitory effects. It is synthesized from acetyl-CoA and choline by choline O-acetyltransferase."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string, "PMID:17786266"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000842 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Activation of the pentameric ionotropic nicotinic acetylcholine receptor leads to membrane depolarization and subsequent excitatory transmission. A salient feature of presynaptic signaling is promoting the release of various neurotransmitters depending on the neuron expressing the receptors."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string, "PMID:21130117"^^xsd:string, "PMID:22925690"^^xsd:string, "PMID:23040810"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000843 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Acetylcholine signaling via the metabotropic muscarinic receptors exerts important roles in the central and peripheral nervous system, the autonomic nervous system and also in non-neuronal cells. The five G protein-coupled receptors can be classified according to the G proteins they engage. Receptors M1, M3 and M5 predominantly couple to Galphaq whereas receptors M2 and M4 predominantly couple to Galphai mediated pathways. The signaling effects can be either excitatory or inhibitory."^^xsd:string ;
  obo:hasDbXref "GO:0007213"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string, "PMID:17786266"^^xsd:string, "PMID:18082893"^^xsd:string, "PMID:23759942"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000844 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Glutamate signaling via the ionotropic AMPA or NMDA and several metabotropic receptors plays important roles in the modulation of synaptic plasticity, long term depression or potentiation, and in learning and memory."^^xsd:string ;
  obo:hasDbXref "GO:0007215"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000845 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Glutamate signaling via the ionotropic NMDA glutamate receptor plays important roles in synaptic plasticity and in learning and memory. The receptor is ligand-gated and voltage-dependent and requires glycine as a co-agonist."^^xsd:string ;
  obo:hasDbXref "GO:0035235"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000846 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Glutamate signaling via the ionotropic AMPA receptor plays important roles in long-term potentiation (LTP). The AMPA receptors are both receptors and cation channels."^^xsd:string ;
  obo:hasDbXref "GO:0035235"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000847 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Glutamate signaling via the various metabotropic, G protein-coupled receptors plays important roles in both the central and peripheral nervous systems. Based on their structure and physiological function, the receptors have been classified into three groups. Group I receptors couple to Galphaq, group II and III couple to Galphai"^^xsd:string ;
  obo:hasDbXref "GO:0007216"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000848 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Gamma-aminobutyric acid signals at inhibitory synapses via the type A receptor, which is part of a ligand-gated ion channel and the type B receptors which are metabotropic, G protein-coupled receptors."^^xsd:string ;
  obo:hasDbXref "GO:0007214"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000851 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Dopamine signaling via D1-like receptors engages the Galphas family of G proteins leading to activation of adenylyl cyclases and increase in intracellular cAMP. Dopamine receptors 1 and 5 belong to this family."^^xsd:string ;
  obo:hasDbXref "GO:0007212"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string, "PMID:17413183"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000852 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Dopamine signaling via D2-like family of receptors engages the Galphai family of G proteins leading to inhibition of adenylyl cyclases and reduction of intracellular cAMP. Dopamine receptors 2, 3 and 4 belong to this family."^^xsd:string ;
  obo:hasDbXref "GO:0007212"^^xsd:string, "OneLook:www.onelook.com"^^xsd:string, "PMID:17413183"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000853 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Histamine signaling is important for the central and to some extent the peripheral nervous systems and is also involved in the immune responses. Histamine signaling engages four G-protein coupled receptors (GPCR). In the brain, it involves receptors H1 and H3 that couple to Galphaq and Galphai, respectively."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Histamine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000854 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Serotonin signaling exerts many roles, from regulation of appetite, mood and sleep to involvement in learning and memory and in muscle contraction. Serotonin signals via several receptors known as 5-hydroxytryptamine or 5-HT receptors. With one exception, 5-HT receptors are G protein-coupled receptors engaging distinct G protein signaling to elicit distinct, both inhibitory and excitatory responses."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string, "PMID:18571247"^^xsd:string, "PMID:18676031"^^xsd:string, "PMID:20925600"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000855 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Acetylcholine signaling via receptor type M1, M3 and M5 primarily engages G alphaq protein family resulting in activation of phospholipase C and mobilization of intracellular calcium. The receptors are expressed in various areas of the brain and the cell membrane of effector tissues."^^xsd:string ;
  obo:hasDbXref "PMID:17786266"^^xsd:string, "PMID:18082893"^^xsd:string, "PMID:23759942"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000856 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Acetylcholine signaling via receptor type M2 and M4 primarily engages G alphai protein family resulting in inhibition of adenylate cyclases and reduction of intracellular cAMP. The receptors are expressed in various areas of the brain and the cell membrane of effector tissues. A special feature is their role as autoreceptors at the presynapse of cholinergic neurons."^^xsd:string ;
  obo:hasDbXref "PMID:17786266"^^xsd:string, "PMID:18082893"^^xsd:string, "PMID:23759942"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000857 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Phase I biotransformation pathway involves the conversion of exogenous substances to more polar metabolites. Members of the cytochrome P450 superfamily and to a lesser extent, flavin containing monooxygenases mediate the reactions."^^xsd:string ;
  obo:hasDbXref "PMID:19835560"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000858 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Phase II biotransformation pathway involves the conjugation of phase I products to various hydrophilic moieties that renders them more suitable for excretion. Various enzyme superfamilies are involved in carrying out the specific conjugation of metabolites."^^xsd:string ;
  obo:hasDbXref "PMID:19835560"^^xsd:string, "PMID:20668491"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000859 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Glucuronidation of phase I products by members of the UDP-glucuronosyltranferase superfamily represents the major phase II conjugation pathway."^^xsd:string ;
  obo:hasDbXref "PMID:20668491"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000860 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The sulfonation of phase I products by members of the sulfotransferase family represents a major route of phase II biotransformation, second to the glucuronidation pathway."^^xsd:string ;
  obo:hasDbXref "PMID:20668491"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000861 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the synthesis of pyrimidine nucleotides. A major route for pyrimidine synthesis is the novo pathway. However, an alternate pathway, the salvage pathway, converts nucleosides generated by DNA or RNA breakdown back to nucleotide monophosphates which can then re-enter the biosynthetic pathway."^^xsd:string ;
  obo:hasDbXref "PMID:15096496"^^xsd:string, "PMID:16098809"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000862 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "In the de novo biosynthetic pathway, pyrimidines are synthesized from simple precursors. Six reactions carried out by three genes in higher eukaryotes result in the formation of UMP, the precursor of all other pyrimidine nucleotides."^^xsd:string ;
  obo:hasDbXref "PMID:15096496"^^xsd:string, "PMID:16098809"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000863 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The salvage pathway of pyrimidine biosynthesis, mostly used in resting and differentiated cells, allows for the synthesis of pyrimidines from intermediates derived from DNA and RNA degradation pathways."^^xsd:string ;
  obo:hasDbXref "PMID:15096496"^^xsd:string, "PMID:16098809"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000864 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the degradation of pyrimidines."^^xsd:string ;
  obo:hasDbXref "PMID:16098809"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000865 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the synthesis of purine nucleotides. A major route for purine synthesis is the novo pathway. However, an alternate pathway, the salvage pathway, can also be used."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000866 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the degradation pathway of purines. Several enzymes are involved in the breakdown of adenine and guanine to uric acid. Primates, birds and other animal excrete uric acid. In other species uric acid is further metabolized to allantoin."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string, "RGD library:Lehringer Principles of Biochemistry"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000867 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "De novo purine biosynthesis requires ten enzymatic reactions to produce inosine monophosphate (IMP). Both adenine and guanine are then derived from IMP via several reactions. Purines are synthesized as nucleosides, i.e., as bases attached to ribose. Purines can also be created synthetically."^^xsd:string ;
  obo:hasDbXref "PMID:18712276"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000869 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of gefitinib. Gefitinib is the first selective inhibitor of EGFR whose mutations within the tyrosine kinase domain have been associated with hyperactive epidermal growth factor signaling in non-small cell lung cancers. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:19657272"^^xsd:string, "PMID:21196393"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000870 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of gefitinib. Gefitinib is the first selective inhibitor of EGFR whose mutations within the tyrosine kinase domain have been associated with hyperactive epidermal growth factor signaling in non-small cell lung cancers. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:15801543"^^xsd:string, "PharmGKB:http://www.pharmgkb.org/do/serve?objId=PA152325160&objCls=Pathway"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000871 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of gefitinib-target interactions and of the biochemical or physiological responses to drug. Gefitinib is the first selective inhibitor of EGFR whose mutations within the tyrosine kinase domain have been associated with hyperactive epidermal growth factor signaling in non-small cell lung cancers. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:21388312"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000872 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of erlotinib. Erlotinib is the second (after gefitinib) selective inhibitor of EGFR whose mutations within the tyrosine kinase domain have been associated with hyperactive epidermal growth factor signaling in non-small cell lung cancers. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:19657272"^^xsd:string, "PMID:20072828"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000873 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of erlotinib. Erlotinib is the second (after gefitinib) selective inhibitor of EGFR whose mutations within the tyrosine kinase domain have been associated with hyperactive epidermal growth factor signaling in non-small cell lung cancers. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:19657272"^^xsd:string, "PharmGKB:http://www.pharmgkb.org/do/serve?objId=PA154426903&objCls=Pathway"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000874 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of erlotinib-target interaction and of the biochemical or physiological responses to drug. Erlotinib is the second (after gefitinib) selective inhibitor of EGFR whose mutations within the tyrosine kinase domain have been associated with hyperactive epidermal growth factor signaling in non-small cell lung cancers. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:20072828"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000875 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Deoxyribonucleotide synthesis occurs via the de novo pathway mediated by ribonucleotide reductase or via the salvage pathway. The de novo pathway is responsible for the bulk of dNTP during the S phase of cell cycle whereas the salvage pathway mostly operates in the quiescent state of the cell. Several cytosolic and mitochondrial enzymes are responsible for the initial steps of the salvage pathway in the two compartments and for the reverse reactions that control the size of the dNTP pool."^^xsd:string ;
  obo:hasDbXref "PMID:15158709"^^xsd:string, "PMID:16756507"^^xsd:string, "PMID:17525869"^^xsd:string, "PMID:20561600"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000876 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reaction involved in the synthesis, utilization and/or degradation of polysaccharides that are components of bacterial cell wall. They may also act as virulence factors."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000877 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of cytosine monophosphate, the only nucleotide sugar in the monophosphate form."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000878 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Phosphatidylcholine is the predominant phospholipid of eukaryotic membranes. Of the three known biosynthetic pathways, two are found in eukaryotes and one, the CDP-choline, is the best characterized."^^xsd:string ;
  obo:hasDbXref "PMID:15749057"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000879 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A cortisol signaling pathway that deviates from what its normal course should be. Mutations in the glucocorticoid receptor have been associated with rare, sporadic or familial, glucocorticoid resistance."^^xsd:string ;
  obo:hasDbXref "PMID:21448414"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000882 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The interleukin-1 family mediated signaling plays important roles in innate and adaptive immune responses. The best characterized member of the family is interleukin-1 followed by interleukin-18 and the more recently identified interleukin-33. Other family members are less well characterized."^^xsd:string ;
  obo:hasDbXref "PMID:20081871"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000883 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Interleukin-1 signaling, primarily via interleukin-1beta, plays important roles in innate and adaptive immune responses. Binding of the processed cytokine to its receptor, allows for the recruitment of several accessory and adaptor proteins leading to the activation of NF-kappaB and MAPK signaling cascades. A natural receptor antagonist and a decoy receptor act as regulators of interleukin 1alpha and beta."^^xsd:string ;
  obo:hasDbXref "PMID:20081871"^^xsd:string, "PMID:20303867"^^xsd:string, "PMID:21219179"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000884 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Interleukin-18 signaling plays important roles in innate and adaptive immunity. In the central nervous system (CNS), Il-18 and its receptors have been shown to play a role in neuroinflammatory and neurodegenerative processes as well as behavior and homeostasis. In addition, Il-18 may be a mediator of inflammation in rheumatoid arthritis."^^xsd:string ;
  obo:hasDbXref "PMID:20081871"^^xsd:string, "PMID:20113500"^^xsd:string, "PMID:21864160"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000885 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Interleukin-33 is the most recently discovered member of the interleukin-1 family. Like with the other members of the family, signaling by interleukin-33 plays important roles in inflammation and immunity and may be critical for the development of inflammatory and immune diseases."^^xsd:string ;
  obo:hasDbXref "PMID:20081871"^^xsd:string, "PMID:21934731"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000888 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Interleukin-22 signaling triggers the Jak-Stat intracellular cascade resulting in the activation of various T helper (Th) cells."^^xsd:string ;
  obo:hasDbXref "PMID:11929132"^^xsd:string, "PMID:20127093"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000894 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The interferons represent a subset of cytokines whose signaling is involved in various aspects of innate and adaptive immunity. Based on the type of receptors they employ, interferons have been classified into type I and II. A third type, the lambda interferons, are members of the interleukin 10 family."^^xsd:string ;
  obo:hasDbXref "PMID:17502369"^^xsd:string, "PMID:20712454"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000895 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Type I interferon, which includes all but one of the seven known human genes, binds to distinct receptors that activate the Jak-Stat signaling pathway."^^xsd:string ;
  obo:hasDbXref "PMID:17502369"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000896 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Type II interferon, of which there is only one in humans, binds to distinct receptors that activate Jak-Stat signaling pathway. It is known as the interferon gamma signaling."^^xsd:string ;
  obo:hasDbXref "PMID:17502369"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000897 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The interleukin-17 family mediated signaling plays important roles in inflammation and the development of autoimmunity as well as in the host defense against fungal and bacterial infections."^^xsd:string ;
  obo:hasDbXref "PMID:21349428"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000898 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Interleukin-17E signaling, also known as interleukin-25, induces the production of Th2 cell cytokine leading to enhancement of Th2 cell responses."^^xsd:string ;
  obo:hasDbXref "PMID:21349428"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000899 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Of the six family members of interleukin-17 family, interleukin-17A is the founding member and the better characterized system. While interleukin-17A binds the same receptor as interleukin-17F and can also heterodimerize with it, its signaling elicits distinct and broader responses."^^xsd:string ;
  obo:hasDbXref "PMID:21349428"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000900 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Interleukin-17F binds the same receptor as interleukin-17A and can also heterodimerize with it. However, its signaling while sharing features of interleukin-17A pathway also elicits distinct responses."^^xsd:string ;
  obo:hasDbXref "PMID:21349428"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000901 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An interleukin mediated signaling pathway that deviates from what its normal course should be. Aberrant interleukin signaling pathway, alone or in combination with other pathways underlie various diseases."^^xsd:string ;
  obo:hasDbXref "InHouse:PW dictionary"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000906 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Interleukin-2 family of cytokines, also known as gamma(c) family because of the shared gamma(c) receptor, plays crucial roles in the regulation of T cells."^^xsd:string ;
  obo:hasDbXref "PMID:19543225"^^xsd:string, "PMID:21889323"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000907 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Interleukin-2 is the prototypical member of the interleukin-2 family of cytokines. The signaling pathway initiated by Il-2 and the other family members activates the Jak-Stat intracellular cascade to regulate T cell, innate and adaptive immune responses."^^xsd:string ;
  obo:hasDbXref "PMID:19543225"^^xsd:string, "PMID:21889323"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000912 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Interleukin-4 is a member of interleukin 2 family of cytokine whose signaling is important for the differentiation of naive T helper cells."^^xsd:string ;
  obo:hasDbXref "PMID:21889323"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000913 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Interleukin-12 family members of heterodimeric cytokines are produced by antigen presenting cells. The signaling they initiate triggers the Jak-Stat intracellular cascade and plays important roles in the regulation of T helper (Th) cell differentiation."^^xsd:string ;
  obo:hasDbXref "PMID:20885915"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000914 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Interleukin-12 signaling activates the Jak-Stat intracellular cascade and promotes the differentiation and proliferation of Th1 cells and the production of interferon-gamma."^^xsd:string ;
  obo:hasDbXref "PMID:20885915"^^xsd:string, "PMID:21553332"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000918 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of proton pump inhibitor (PPI), a class of compounds that block the acid secretion from parietal cells in the stomach. A representative PPI compound is omeprazole. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000919 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of compounds used as antineoplastic or as immunomodulatory agents. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "KEGG:http://www.genome.jp/kegg-bin/get_htext?br08303.keg"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000920 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of compounds used for the treatment of various cardiovascular conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "KEGG:http://www.genome.jp/kegg-bin/get_htext?br08303.keg"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000921 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of compounds used for the treatment of alimentary tract and metabolism-related conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "KEGG:http://www.genome.jp/kegg-bin/get_htext?br08303.keg"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000922 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of compounds used for the treatment of conditions associated with blood and blood forming organs. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "KEGG:http://www.genome.jp/kegg-bin/get_htext?br08303.keg"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000923 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of compounds used for the treatment of conditions associated with the nervous system. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "KEGG:http://www.genome.jp/kegg-bin/get_htext?br08303.keg"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000924 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of compounds used for the treatment of conditions associated with the respiratory system. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "KEGG:http://www.genome.jp/kegg-bin/get_htext?br08303.keg"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000925 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Pattern recognition receptors (PRR) respond to a diverse array of exogenous molecules and also several endogenous ones. PRR's 'sensing' of pathogen-associated molecular patterns (PAMP) or damage-associated (DAMP) prompts signaling cascades leading to the expression of pro-inflammatory genes."^^xsd:string ;
  obo:hasDbXref "MCW library:Cellular and molecular immunology, by Abbas, Abul K"^^xsd:string, "PMID:20303867"^^xsd:string, "PMID:20303872"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000926 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An early response of the innate immunity is the secretion of cytokines critical for the acute inflammatory response. The major pro-inflammatory cytokines are tumor necrosis factor alpha and the interleukins 1 and 6."^^xsd:string ;
  obo:hasDbXref "MCW library:Cellular and molecular immunology, by Abbas, Abul K"^^xsd:string, "PMID:20303867"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000927 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Tumor necrosis factor (TNF) inhibitors are used in the treatment of rheumatoid arthritis. The inhibitors are recombinant proteins that bind the soluble and membrane-associated TNF and inhibit the effects of this pro-inflammatory cytokine."^^xsd:string ;
  obo:hasDbXref "PMID:21039421"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000928 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Tocilizumab is a humanized anti-interleukin 6 (Il-6) receptor antibody used in the treatment of patients with rheumatoid arthritis, Castleman's disease or juvenile idiopathic arthritis. Tocilizumab binds to the soluble and membrane associated interleukin-6 receptor and competitively blocks binding of interleukin-6 to its receptor(s) and inhibits the effects of this potent cytokine."^^xsd:string ;
  obo:hasDbXref "PMID:21419125"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000929 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Anakinra is a recombinant, non-glycosylated version of the human interleukin-1 (Il-1) receptor antagonist used for the treatment of inflammation associated with rheumatoid arthritis. Like the natural antagonist, anakinra competitively inhibits binding of interleukin-1 to its receptor and the subsequent effects of this potent pro-inflammatory cytokine."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Anakinra"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000930 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of methotrexate (MTX), a polyglutamatable antifolate used in the treatment of cancers and autoimmune diseases. The impact of MTX on cancer and rheumatoid arthritis is thought to arise through distinct mechanisms and pharmacodynamics pathways. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/pathway/PA2039"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000931 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of methotrexate (MTX), a folate analogue used in the treatment of cancers and autoimmune diseases. Genetic variations can result in changes in the availability of the drug and It is believed that variability in MTX pharmacokinetics is linked to genetic variations in transporter proteins."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/pathway/PA165816349"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000932 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of methotrexate-target interaction and of the biochemical or physiological responses to drug. The impact of MTX on cancer and rheumatoid arthritis is thought to arise through distinct mechanisms and pharmacodynamics pathways. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/pathway/PA2039"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000933 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Tumor necrosis factor member 14, also known as Light, binds the lymphotoxin beta receptor and the tumor necrosis receptor member 14 known as Hvem of the tumor necrosis receptor superfamily to elicit important responses for the dendritic (DC) and T cells of the immune system."^^xsd:string ;
  obo:hasDbXref "PMID:11239407"^^xsd:string, "PMID:12787557"^^xsd:string, "PMID:2169337"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000934 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Tumor necrosis factor member 13 also known as April, binds the tumor necrosis factor receptor member 13B known as Taci and receptor member 17 known as Bcma of the tumor necrosis factor receptor superfamily to elicit important responses for the B cells of the immune system."^^xsd:string ;
  obo:hasDbXref "PMID:11239407"^^xsd:string, "PMID:12787557"^^xsd:string, "PMID:2169337"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000935 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The tumor necrosis factor member 13b known as Baff binds to three receptors of the tumor necrosis factor receptor superfamily - the receptor member 13B known as Taci and member 17 known as Bcma to which member 13 of the ligand superfamily also binds, and additionally to member 13C of the receptor superfamily to elicit important responses for the B cells of the immune system."^^xsd:string ;
  obo:hasDbXref "PMID:11239407"^^xsd:string, "PMID:12787557"^^xsd:string, "PMID:2169337"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000936 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine ligand 1 signaling engages the chemokine (C-C motif) receptor 8 (Ccr8) and together with other CC chemokines is classified as a member of the allergenic subgroup."^^xsd:string ;
  obo:hasDbXref "PMID:15062643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000937 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine ligand 1 signaling engages the chemokine (C-C motif) receptor 2 (Ccr2) and together with other CC chemokines is classified as a member of the allergenic subgroup."^^xsd:string ;
  obo:hasDbXref "PMID:15062643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000938 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine ligand 3 signaling pathway engages chemokine (C-C motif) receptors 2 and 5 (Ccr2 and Ccr5) and together with other chemokines is classified as a member of the pro-inflammatory subgroup."^^xsd:string ;
  obo:hasDbXref "PMID:15062643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000939 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine ligand 4 signaling engages the chemokine (C-C motif) receptor 5 (Ccr5) and together with other chemokines is classified as a member of the pro-inflammatory subgroup."^^xsd:string ;
  obo:hasDbXref "PMID:15062643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000940 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine ligand 5 signaling engages chemokine (C-C motif) receptors 1, 3 and 5 (Ccr1, Ccr3 and Ccr5) and together with other chemokines is classified as a member of the pro-inflammatory subgroup."^^xsd:string ;
  obo:hasDbXref "PMID:15062643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000941 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine ligand 6 signaling is known to act in rodents and does not appear to have a human equivalent. Ccl6, together with other chemokines is classified as a member of the pro-inflammatory subgroup."^^xsd:string ;
  obo:hasDbXref "PMID:15062643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000942 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine ligand 7 signaling engages chemokine (C-C) motif receptors 1, 2, and 3 (Ccr1, Ccr2, Ccr3) and together with other chemokines is classified as a member of the allergenic subgroup."^^xsd:string ;
  obo:hasDbXref "PMID:15062643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000943 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine ligand 8 signaling engages chemokine (C-C motif) receptors 3 and 5 (Ccr3 and Ccr5) and together with other chemokines is classified as a member of the allergenic subgroup."^^xsd:string ;
  obo:hasDbXref "PMID:15062643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000944 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine ligand 11 signaling engages the chemokine (C-C motif) receptor 3 (Ccr3) and together with other chemokines is classified as a member of the allergenic subgroup."^^xsd:string ;
  obo:hasDbXref "PMID:15062643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000945 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine ligand 12 signaling is known to act in rodents and does not appear to have a human equivalent. Ccl12, together with other chemokines is classified as a member of the allergenic subgroup."^^xsd:string ;
  obo:hasDbXref "PMID:15062643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000946 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine ligand 13 signaling engages chemokine (C-C motif) receptors 2 and 3 (Ccr2 and Ccr3) and together with other chemokines is classified as a member of the allergenic subgroup."^^xsd:string ;
  obo:hasDbXref "PMID:15062643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000947 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine ligand 17 signaling engages the chemokine (C-C motif) receptor 4 (Ccr4) and together with other chemokines is classified as a member of the developmental subgroup."^^xsd:string ;
  obo:hasDbXref "PMID:15062643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000948 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine ligand 22 signaling engages the chemokine (C-C motif) receptor 4 (Ccr4) and together with other chemokines is classified as member of the developmental subgroup."^^xsd:string ;
  obo:hasDbXref "PMID:15062643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000949 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine ligand 25 signaling engages the chemokine (C-C motif) receptor 9 (Ccr9) and together with other chemokines is classified as a member of the developmental subgroup."^^xsd:string ;
  obo:hasDbXref "PMID:15062643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000950 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine ligand 24 signaling engages the chemokine (C-C motif) receptor 3 (Ccr3) and together with other chemokines is classified as member of the allergenic subgroup."^^xsd:string ;
  obo:hasDbXref "PMID:15062643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000951 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine ligand 26 signaling engages the chemokine (C-C motif) receptor 3 (Ccr3) and together with other chemokines is classified as member of the allergenic subgroup."^^xsd:string ;
  obo:hasDbXref "PMID:15062643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000952 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine ligand 14 signaling engages chemokine (C-C motif) receptors 1 and 5 (Ccr1 and Ccr5) and together with other chemokines is classified as a member of the HCC (hemofiltrate CC chemokine) subgroup."^^xsd:string ;
  obo:hasDbXref "PMID:15062643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000953 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine ligand 15 signaling engages chemokine (C-C motif) receptors 1 and 3 (Ccr1 and Ccr3) and together with other chemokines is classified as a member of the HCC (hemofiltrate CC chemokine) subgroup."^^xsd:string ;
  obo:hasDbXref "PMID:15062643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000954 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine ligand 16 signaling engages chemokine (C-C motif) receptors 1 and 2 (Ccr1 and Ccr2) and together with other chemokines is classified as a member of the HCC (hemofiltrate CC chemokine) subgroup."^^xsd:string ;
  obo:hasDbXref "PMID:15062643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000955 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine ligand 23 signaling engages the chemokine (C-C motif) receptor 1 (Ccr1) and together with other chemokines is classified as a member of the HCC (hemofiltrate CC chemokine) subgroup."^^xsd:string ;
  obo:hasDbXref "PMID:15062643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000956 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine ligand 27 signaling engages chemokine (C-C motif) receptor 10 (Ccr10) and does not appear to be a member of any of the chemokines subgroups."^^xsd:string ;
  obo:hasDbXref "PMID:15062643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000957 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine (C-X-C) ligand 1belongs to the growth-related oncogene (GRO) subgroup whose signaling engages receptor 2 and promotes chemotaxis of neutrophils."^^xsd:string ;
  obo:hasDbXref "PMID:18579287"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000958 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The signaling pathway mediated by the FoxA subgroup of forkhead family of transcription factors plays important roles in development and in modulating steroid hormone signaling. Three FoxA genes carry out overlapping yet distinct functions. FOXA1 appears to modulate steroid receptor activity in breast and prostate cancer."^^xsd:string ;
  obo:hasDbXref "PMID:19274050"^^xsd:string, "PMID:20591647"^^xsd:string, "PMID:21934649"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000960 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Sphingosine 1-phosphate (S1P), a sphingolipid metabolite, can signal intracellularly as a second messenger or extracellularly as a ligand for five G protein coupled receptors. S1P pathway plays important roles in processes such as cell migration, proliferation and survival. The five receptors engage similar G proteins but their expression varies."^^xsd:string ;
  obo:hasDbXref "PMID:18552276"^^xsd:string, "PMID:22159476"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000961 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Ceramide signaling can act as a lipid second messenger or as a mediator of various cellular signaling pathways by promoting receptor clustering. The pathway plays important roles in apoptosis."^^xsd:string ;
  obo:hasDbXref "PMID:20607622"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000962 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The signaling pathway initiated by light induced isomerization of 11-cis retinal and subsequent activation of its photoreceptors in rods and cones."^^xsd:string ;
  obo:hasDbXref "PMID:18514002"^^xsd:string, "PMID:22074921"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000963 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Phosphatidylinositol kinases represent a family of lipid kinases that phosphorylate the 3' position of the inositol ring in target substrates. They are grouped into three classes: class I further subdivided into subclass A and B, class II and class III. By far the best known and characterized is class I, particularly IA that signals downstream of receptor tyrosine kinases and engages the Akt family of kinases."^^xsd:string ;
  obo:hasDbXref "PMID:16847462"^^xsd:string, "PMID:17052169"^^xsd:string, "PMID:17641274"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000965 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Phosphatidylinositol kinases represent a family of lipid kinases that phosphorylate the 3' position of the inositol ring in target substrates. They are grouped into three classes: class I further subdivided into subclass A and B, class II and class III. By far the best known and characterized is class I, particularly IA that signals downstream of receptor tyrosine kinases and engages the Akt family of kinases."^^xsd:string ;
  obo:hasDbXref "PMID:16847462"^^xsd:string, "PMID:17052169"^^xsd:string, "PMID:17641274"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000966 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Phosphatidylinositol kinases represent a family of lipid kinases that phosphorylate the 3' position of the inositol ring in target substrates. They are grouped into three classes: class I further subdivided into subclass A and B, class II and class III. By far the best known and characterized is class I, particularly IA that signals downstream of receptor tyrosine kinases and engages the Akt family of kinases."^^xsd:string ;
  obo:hasDbXref "PMID:16847462"^^xsd:string, "PMID:17052169"^^xsd:string, "PMID:17641274"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000967 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Interleukin-3, interleukin 5 and granulocyte-macrophage colony-stimulating factors family of hemopoietic cytokine mediate overlapping and distinct signals. Collectively they regulate the production and activation of hemopoietic cells."^^xsd:string ;
  obo:hasDbXref "PMID:19436055"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000968 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Interleukin-3 signaling plays important roles in the function of hematopoietic cells."^^xsd:string ;
  obo:hasDbXref "PMID:11312115"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000969 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Interleukin-5 signaling plays important roles in the function of hematopoietic cells."^^xsd:string ;
  obo:hasDbXref "PMID:11312115"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000970 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "GM-CSF signaling, like the other hemopoietic cytokines, is involved in the production and activation of hemopoietic cells. The GM-CSF pathway acts on monocytes, macrophages and granulocytes and is also involved in the regulation of T and dendritic cells functions."^^xsd:string ;
  obo:hasDbXref "PMID:19436055"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000971 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The CXC chemokine ELR(+) subgroup mediated signaling primarily engages receptor 2 to promote angiogenic effects."^^xsd:string ;
  obo:hasDbXref "PMID:18579287"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000972 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "CXC chemokine (ELR-) subgroup mediated signaling primarily engages receptor 3 to promote angiostatic effects."^^xsd:string ;
  obo:hasDbXref "PMID:18579287"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000973 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine (C-X-C) ligand 2 belongs to the growth-related oncogene (GRO) subgroup whose signaling engages receptor 2 to promote chemotaxis of neutrophils."^^xsd:string ;
  obo:hasDbXref "PMID:18579287"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000974 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine (C-X-C) ligand 3 belongs to the growth-related oncogene (GRO) subgroup whose signaling engages receptor 2 to promote chemotaxis of neutrophils."^^xsd:string ;
  obo:hasDbXref "PMID:18579287"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000975 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine (C-X-C) ligand 5 signaling engages receptor 2 to exert potent chemotactic functions in neutrophil activation."^^xsd:string ;
  obo:hasDbXref "PMID:18579287"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000976 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine (C-X-C0) ligand 6 engages receptors 1 and 2 to promote chemoattraction of neutrophils and angiogenic effects, respectively."^^xsd:string ;
  obo:hasDbXref "PMID:18579287"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000978 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine (C-X-C) ligand 8, also known as interleukin-8 (Il-8), although a chemokine, engages receptor 1 and 2 to promote angiogenic effects."^^xsd:string ;
  obo:hasDbXref "PMID:18579287"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000979 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine (C-X-C) ligand 4 signaling engages receptor 3 to promote angiostatic effects."^^xsd:string ;
  obo:hasDbXref "PMID:18579287"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000980 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine (C-X-C) ligand 9 engages receptor 3 to promote angiostatic effects."^^xsd:string ;
  obo:hasDbXref "PMID:18579287"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000981 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine (C-X-C) ligand 10 signaling engages receptor 3 to promote angiostatic effects."^^xsd:string ;
  obo:hasDbXref "PMID:18579287"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000982 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemokine (C-X-C) ligand 11 signaling engages receptor 3 to promote angiostatic effects."^^xsd:string ;
  obo:hasDbXref "PMID:18579287"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000987 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Erythropoietin (EPO) signaling is crucial for the production of blood cell or erythropoiesis and also plays important roles in wound healing and responses to neural injury. EPO is a glycoprotein hormone and also a cytokine whose receptor belongs to type I cytokine receptor. The pathway engages the Jak-Stat intracellular cascade."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string, "PMID:21307776"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000988 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Classical cadherins, such as E- or N-cadherin are single-span transmembrane proteins with five extracellular cadherin repeats and a conserved cytoplasmic tail. Their interaction with many cytoskeletal and signaling molecules underlies the calcium-dependent cell-cell adhesion and signaling. While E- and N-cadherin share some of the interacting partners, they have different localization and impact on distinct cellular events."^^xsd:string ;
  obo:hasDbXref "PMID:11171368"^^xsd:string, "PMID:21444749"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000989 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Desmosomal cadherins, which can be further subdivided into two subgroups, possess the five cadherin repeats but have distinct cytoplasmic tails."^^xsd:string ;
  obo:hasDbXref "PMID:11171368"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000990 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Protocadherin represent a very large family which can be further subdivided into two groups. The protocadherin are predominantly expressed in the nervous system. They have up to seven cadherin repeats but distinct and even divergent cytoplasmic regions."^^xsd:string ;
  obo:hasDbXref "PMID:11171368"^^xsd:string, "PMID:17936607"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000991 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The atypical, or unconventional group includes the seven transmembrane (7TM), GPCR-like cadherins with up to nine cadherin repeats along with EGF-like and laminin motifs, the large FAT and the t-Cadherin proteins."^^xsd:string ;
  obo:hasDbXref "PMID:11171368"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000992 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "E-cadherin or the epithelial cadherin encoded by the Cdh1 gene, is a member of the classical cadherin family and among the best studied cadherin pathway. Deregulation of the pathway has been associated with several forms of cancer."^^xsd:string ;
  obo:hasDbXref "PMID:11171368"^^xsd:string, "PMID:21444749"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000993 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "N-cadherin, or neuronal cadherin, is predominantly expressed in the brain. The pathway plays important roles in learning and memory."^^xsd:string ;
  obo:hasDbXref "PMID:11171368"^^xsd:string, "PMID:21444749"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000996 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of compounds used as anti-infective agents. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "KEGG:http://www.genome.jp/kegg-bin/get_htext?br08303.keg"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000998 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Adenosine signaling is involved in the regulation of several physiological processes. It uses four receptors of the GPCR family that activate the Gaphas or Galphai types of G proteins to increase or decrease the levels of cAMP. The adenosine receptors are a class of purinergic or purinoreceptors."^^xsd:string ;
  obo:hasDbXref "PMID:21185259"^^xsd:string, "PMID:21622100"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0000999 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Adenosine triphosphate (ATP) extracellular signaling activates the P2X ligand-gated ion channels that are permeable to sodium, potassium and calcium ions. There are several P2X subtypes that are involved in a range of physiological processes. ATP along with other nucleotide also engages a class of metabotropic purinergic receptors known as P2Y that couple to either the Galphaq or to G alphai subunit of heterotrimeric G proteins. ATP is the sole ligand of P2Y 11 receptor."^^xsd:string ;
  obo:hasDbXref "PMID:21586365"^^xsd:string, "PMID:22535247"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001000 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The P2Y receptors are a class of purinergic or purinoreceptors, Gprotein-coupled receptors that respond to ADP, ATP, UDP, UTP and UDP-glucose to activate either the Galphaq or the Galphai mediated signal transduction pathways."^^xsd:string ;
  obo:hasDbXref "PMID:16968944"^^xsd:string, "PMID:20594935"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001003 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving the fat-soluble vitamin A and its metabolites. Vitamin A, retinol and vitamin A activities of metabolites such as retinal and retinoic acids are essential for visual transduction as well as for neuro and immune system functions and epithelial differentiation. Plants and microorganisms can synthesize vitamin A de novo while higher organisms derive it from diet as precursors carotenoids or retinyl esters."^^xsd:string ;
  obo:hasDbXref "PMID:21554983"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001004 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The reactions involved in deriving retinoic acid (RA) from retinal and its further processing to more polar derivatives. Retinoic acid engages several retinoic acid receptors; its actions are important for the neuro and immune system functions and energy balance. Deregulation of proper RA activity has been associated with obesity and cancer."^^xsd:string ;
  obo:hasDbXref "PMID:21621639"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001005 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The series of reactions involved in the regeneration of the visual chromophore 11-cis retinal from the all-trans retinal released from the light -activated rhodopsin."^^xsd:string ;
  obo:hasDbXref "PMID:21447403"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001006 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those pathways involved in the proper balance of vitamin levels, uptake and transport, utilization and storage, as demanded by the needs of cells tissues and organs. Disruption of vitamin homeostasis can have harmful consequences. Collectively they represent a class of organic chemicals that the organism cannot synthesize or does not in adequate quantities."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Vitamin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001007 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathways involved in the balanced maintenance of vitamin A and vitamin A metabolites uptake and transport, utilization and storage, as demanded by the needs of cells, tissues and organs. 11-cis retinal is the visual chromophore while retinoic acid signaling through its nuclear receptors transcription factors exerts the rest and manifold functions of vitamin A."^^xsd:string ;
  obo:hasDbXref "PMID:21554983"^^xsd:string, "PMID:21586336"^^xsd:string, "PMID:21621639"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001009 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving ascorbic acid, known as vitamin C, a water-soluble vitamin. Vitamin C is an essential antioxidant that is derived from glucose. Unlike many animals, humans do not have the ability to produce it. Vitamin C acts as an antioxidant."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Vitamin_C"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001010 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving niacin, also known as vitamin B3 or vitamin PP - a water-soluble vitamin. Niacin represents an essential nutrient and is also a precursor of NAD through a salvage pathway. Niacin is among the few vitamins humans can synthesize."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Niacin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001011 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving vitamin D - a fat-soluble vitamin. Vitamin D represents a group of fat-soluble compounds that can be synthesized from cholesterol and exposure to sunlight. In view of the latter source, it is not considered a true vitamin. One of its metabolites, calcitriol acts in a hormone-like manner as a signaling molecule."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Vitamin_D"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001012 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Vitamin and metabolites of vitamin in addition to representing important nutrients and aid in cellular metabolism can also, in a hormone-like manner, acts as signaling molecules."^^xsd:string ;
  obo:hasDbXref "PMID:22020178"^^xsd:string, "PMID:22318625"^^xsd:string, "PMID:22614789"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001013 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The active vitamin D metabolite plays important roles in cell growth and differentiation and in immunity. Its receptor is a transcription factor nuclear receptor."^^xsd:string ;
  obo:hasDbXref "PMID:22213316"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001014 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Retinoic acid, a vitamin A-derived metabolite plays important roles in development and cell differentiation. all-trans retinoic acid (RA) binds to nuclear RA (RARs) and X (RXRs) receptor subtypes that once activated act as transcription factors."^^xsd:string ;
  obo:hasDbXref "PMID:22020178"^^xsd:string, "PMID:22318625"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001015 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving vitamin E - a fat-soluble vitamin which represents a class of chemical compounds known as tocopherols. The alpha- and gamma-tocopherols appear to be the main dietary forms. Vitamin E is best known for its antioxidant properties."^^xsd:string ;
  obo:hasDbXref "PMID:15256801"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001016 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving vitamin K - a fat-soluble vitamin which represents a group of related compounds.  K1 form is found in plants, other forms are synthesized by bacteria, including species present in the microflora of the human gut. Vitamin K is an essential cofactor in the modification reaction of vitamin K-dependent proteins."^^xsd:string ;
  obo:hasDbXref "PMID:24489112"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001017 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Renal cell cancer, although representing a small percentage of human neoplasms, has one of the highest rates of mortality amongst genitourinary cancers. Several mutated genes and associated altered pathways have been implicated in the condition but many more remain to be elucidated."^^xsd:string ;
  obo:hasDbXref "PMID:22112490"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001019 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Rheumatoid arthritis is an autoimmune condition characterized by persistent inflammation. Several pro-inflammatory cytokines and chemokines are over-activated."^^xsd:string ;
  obo:hasDbXref "PMID:22357455"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001020 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Basal cell carcinoma is the most common form of skin cancer that is mostly sporadic. Hedgehog signaling pathway via sonic hedgehog appears to be constitutively active. Mutations in Tp53 are also frequent."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001021 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Melanoma is a form of skin cancer which, despite being less common than other forms of skin malignancies, can be dangerous if not detected earlier, and accounts for the highest percentage of skin cancer related deaths. Oncogenic Nras and other mutations in downstream pathways appear to be associated with it."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001022 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Asthma, a complex condition with many phenotypic manifestations, is primarily characterized by inflammation of the airways. Environmental and genetic factors contribute to it through complex and incompletely understood interactions."^^xsd:string ;
  obo:hasDbXref "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001023 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Systemic lupus erythematosus (SLE) is an autoimmune condition that can affect many parts of the body and which, although treatable, does not have a cure. Activation of complement and deregulations of immune regulatory and signaling pathways contribute in ways that are incompletely understood."^^xsd:string ;
  obo:hasDbXref "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001024 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Autoimmune thyroid disease (AITD) groups several conditions that are generally relatively mild but that can progress to serious symptoms."^^xsd:string ;
  obo:hasDbXref "localhealth:http://www.localhealth.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001025 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Allograft or transplant rejection results from the recipient's autoimmune response to non-self antigens."^^xsd:string ;
  obo:hasDbXref "OneLook:www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001026 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Graft-versus-host disease (GVHD) is a complication following transplantation of cells, tissues or organs from a genetically non-identical donor in which the donor T cells attack the host cells. Several pro-inflammatory pathways are activated as a result of damage in the host tissue induced by the procedure. GVHD is commonly associated with stem cell or bone marrow transplant."^^xsd:string ;
  obo:hasDbXref "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001027 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Primary immunodeficiency groups disorders that result from the immune system malfunctioning that affect both cell-mediated and humoral immunity pathways."^^xsd:string ;
  obo:hasDbXref "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001028 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Infectious diseases are caused by pathogens that have gained access to the host organism and have managed to avoid the host defense mechanisms while taking over some of the host pathways."^^xsd:string ;
  obo:hasDbXref "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001030 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Prolonged use of cocaine results in cardiovascular and brain damage. Cocaine is thought to bind to the dopamine reuptake transporter thus blocking the reuptake of dopamine into nerve terminals. The resulting higher concentration of dopamine in synapses leads to overactivation of dopamine receptors such as D1 and of signaling pathways downstream of it overall believed to be critical in mediating the behavioral responses to cocaine."^^xsd:string ;
  obo:hasDbXref "KEGG:map05030"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001031 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Amphetamine is believed to promote an elevation in extracellular dopamine. Higher and high levels of the drug lead to overactivation of transcription factors and cofactors."^^xsd:string ;
  obo:hasDbXref "KEGG:map:05031"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001032 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Morphine, an effective pain killer drug, can also be extremely addictive. Activation of dopamine neurons and reduction of inhibitory synaptic transmission might be associated with the effects or morphine. Changes in neuronal responses and communication may underlie the addictive behavior."^^xsd:string ;
  obo:hasDbXref "KEGG:map05032"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001033 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Nicotine, like the other addictive substances, impacts on the dopaminergic and mesolimbic reward circuitries. Nicotine is also a ligand for the nicotinic acetylcholine receptors which are ligand-gated ion channels."^^xsd:string ;
  obo:hasDbXref "KEGG:map05033"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001034 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The mechanisms of alcohol dependence, or alcoholism, are not well understood. Like in the case of other substances of abuse, alcohol may lead to stimulation of dopamine release and overactivation of dopamine-related circuitries."^^xsd:string ;
  obo:hasDbXref "KEGG:map05034"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001035 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Arrhythmogenic right ventricular cardiomyopathy (ARVC) represents an inherited heart muscle condition leading to arrhythmia and heart failure that could results in death. Mutations in several genes and disruption of associated pathways have been implicated in the condition."^^xsd:string ;
  obo:hasDbXref "KEGG:map05412"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001036 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Dilated cardiomyopathy (DCM) is a condition in which the heart is weakened and enlarged resulting in inefficient blood pumping. Although mostly occurring in adults, it can also affect children."^^xsd:string ;
  obo:hasDbXref "KEGG:map05414"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001037 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Myocarditis is a condition associated with inflammation of the heart muscle that can have both infectious and non-infectious etiologies, with the former being the primary cause. Viral proteins, once inside the host cells, interfere with the function of host gene and they can either avoid or appropriate host pathways."^^xsd:string ;
  obo:hasDbXref "KEGG:map05416"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001038 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Maturity onset diabetes of the young (MODY) represents any of a number of hereditary, monogenic forms of diabetes caused by mutations in several genes."^^xsd:string ;
  obo:hasDbXref "KEGG:map04950"^^xsd:string, "OneLoook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001039 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Vibrio cholerae disease is an infection of the small intestine resulting in dehydration and electrolyte imbalance which in some cases can cause death. Cholera toxin, is one the main virulence factors of the Gram-negative Vibrio cholerae bacterium which, together with other virulence factors can invade the host."^^xsd:string ;
  obo:hasDbXref "KEGG:map05110"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001040 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Salmonella, a Gram-negative bacterium of which  many species exist, in humans can cause gastroenteritis or the more severe typhoid fever. Salmonella enters the host via the digestive tract; bacteria that escape the host defense machinery can survive and replicate in Salmonella-containing vacuole (SCV) whose maturation they control."^^xsd:string ;
  obo:hasDbXref "KEGG:map05132"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001041 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathogenic Escherichia coli strains EPEC and EHEC (enteropathogenic and enterohemorrhagic E. coli, respectively) can cause sever food poisoning in humans. The non-pathogenic strains are part of the gut normal flora with beneficial contributions for the host."^^xsd:string ;
  obo:hasDbXref "KEGG:map05130"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001042 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Shigella, a Gram-negative bacterium that is related to Salmonella and to Escherichia coli, is a disease causing agent in humans and primates. Shigellosis, also known as bacillary dysentery or Marlow syndrome is due to colonization of the intestinal epithelium and the subsequent evasion of the host defense machinery and use of host intracellular pathways by the bacteria."^^xsd:string ;
  obo:hasDbXref "KEGG:map05131"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001043 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The Gram-negative Bordetella pertusis Gram-negative is the causative agent of pertussis or whooping cough. One of its main virulence factors, pertussis toxin blocks the interaction of Galphai subunit of heterotrimeric G protein with its partner receptors. This results in unrestrained adenylyl cyclase activity and subsequent increased concentration of cAMP which affects normal intracellular signaling."^^xsd:string ;
  obo:hasDbXref "KEGG:map05133"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001044 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Legionella, a pathogenic Gram-negative bacterium that includes species such as legionella pneumophila, causes several respiratory infections of which Legionnaires' disease is potentially fatal. L. pneumophila can grow within lung macrophages and is known to subvert several host pathways."^^xsd:string ;
  obo:hasDbXref "KEGG:map05134"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001045 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Staphylococcus aureus, a Gram-positive bacteria of which there are many species, usually colonizes the skin and mucous membranes of humans and other organisms and are mostly harmless. However, they can also cause a range of infections of which some can be extremely severe."^^xsd:string ;
  obo:hasDbXref "KEGG:map05150"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001046 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Mycobacterium tuberculosis is the causative agent of most forms of tuberculosis. Once in the lung, the bacteria interfere with a number of intracellular pathways and processes."^^xsd:string ;
  obo:hasDbXref "KEGG:map05152"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001047 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Leishmania is a protozoan parasite and a number of its species can infect mammals, including humans. While cutaneous leishmaniasis is the most common form, others such as visceral or mucosal have also been reported. The infection results in alterations in a number of host signaling pathways."^^xsd:string ;
  obo:hasDbXref "KEGG:map5140"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001048 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Trypanosoma is a protozoan parasite of which T brucei and cruzi are responsible for causing the sleeping sickness and Chagas disease, respectively. Several host signaling and regulatory pathways are altered in the infection."^^xsd:string ;
  obo:hasDbXref "KEGG:map5142"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001049 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Trypanosoma brucei, a protozoan parasite, is the causative agent of sleeping sickness, also known as the African trypanosomiasis, as its vector is the tsetse fly common to sub-Saharan Africa. Several pro-inflammatory cytokines are overactivated. The neurological damage the infection causes is irreversible and the disease is fatal."^^xsd:string ;
  obo:hasDbXref "KEGG:map5143"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001050 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Trypanosoma cruzi is the causative agent of the Chagas disease, also known as the American trypanosomiasis, as it occurs primarily in poor areas of the Americas, mostly Central and South America. Infection interferes with a number of intracellular pathways and it appears to activate calcium signaling."^^xsd:string ;
  obo:hasDbXref "KEGG:map05142"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001051 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Several species of the protozoan parasite Plasmodium can infect humans and cause malaria. Severe malaria, which is primarily caused by Plasmodium falciparum, can lead to death and the fatalities are mostly children. Deregulated induction of cytokines appears to play a role in the infection."^^xsd:string ;
  obo:hasDbXref "KEGG:map05144"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001052 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Toxoplasma gondii, whose hosts include various warm-blooded species including humans, is the causative agent of toxoplasmosis. The infection interferes with a number of host pathways; in its most severe manifestations it can be fatal."^^xsd:string ;
  obo:hasDbXref "KEGG:map05145"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001053 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Entamoeba histolyca is a protozoan parasite that is the causative agent of amoebiasis which affects the intestinal tissue leading to severe dysentery and ulcerations. It can also infect other tissues such as the liver and to a lesser extent the brain, lungs and spleen."^^xsd:string ;
  obo:hasDbXref "KEGG:map5146"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001054 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The influenza A virus is the causative agent of seasonal epidemics and occasional pandemics of influenza which affects the respiratory system."^^xsd:string ;
  obo:hasDbXref "KEGG:map05164"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001055 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The hepatitis C virus is the causative agent of hepatitis C, a chronic liver disease in humans. The virus interferes with several signaling and regulatory pathways in the host cells."^^xsd:string ;
  obo:hasDbXref "KEGG:map05160"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001058 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The measles virus (MV) of the genus Morbillivirus is the causative agent of the condition that bears its name. The condition causes immunosuppression and several MV proteins are thought to interfere with the normal host immune responses."^^xsd:string ;
  obo:hasDbXref "KEGG:map05162"^^xsd:string, "OneLook:http://wwwonelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001059 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Oxidative phosphorylation is the coupling of the electron transport chain and the ATP biosynthetic pathways. The electron transfer chain generates an electrochemical gradient that drives the phosphorylation of ADP. Under certain circumstances the two may be uncoupled."^^xsd:string ;
  obo:hasDbXref "GO:0006119"^^xsd:string, "KEGG:map00190"^^xsd:string, "PMID:19760284"^^xsd:string, "PMID:21625217"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001060 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Primary bile acids, cholic and  chenodeoxycholic acids, are derived from cholesterol in the liver. Upon conjugation with glycine or taurine they can be secreted into the intestine."^^xsd:string ;
  obo:hasDbXref "KEGG:map00120"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001061 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Secondary bile acids, deoxycholic and lithocholic acids, are synthesized from the primary ones by intestinal bacteria. like the primary bile acids, they need to be conjugated to glycine or taurine prior to secretion."^^xsd:string ;
  obo:hasDbXref "KEGG:map00121"^^xsd:string, "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001062 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of lacto-series type of glycosphingolipids."^^xsd:string ;
  obo:hasDbXref "PMID:1 7976918"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001063 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The metabolic reactions involving lipoic acid, a compound derived from octanoic acid that contains two sulfur centers. Lipoic acid is a co-factor for the pyruvate dehydrogenase complex responsible for the irreversible decarboxylation of pyruvate to acetyl-CoA."^^xsd:string ;
  obo:hasDbXref "PMID:17052205"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001064 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving phosphonate and phosphinate, organic compounds that contain carbon-phosphorus bonds and which can be synthesized by bacteria and protists."^^xsd:string ;
  obo:hasDbXref "KEGG:mapp00440"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001065 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Interstrand cross links (ICL) of DNA can be induced by both endogenous and exogenous ligands. ICL if not repaired will lead to cell death. ICL repair pathway, also known as Fanconi anemia pathway is the cellular response to this type of DNA damage."^^xsd:string ;
  obo:hasDbXref "PMID:19061902"^^xsd:string, "PMID:20713514"^^xsd:string, "PMID:21605559"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001066 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of ribosome biogenesis starts with the transcription of rRNA precursors, involves the co-transciptional events of pre-rRNA processing and the assembly of pre-ribosomal particles. The maturation of pre-40S and pre-60S particles follows independent routes.  Once in the cytoplasm, additional steps yield the mature, translation competent, ribosome. Alterations in the pathway result in specific phenotypes collectively known as ribosomopathies."^^xsd:string ;
  obo:hasDbXref "PMID:20194897"^^xsd:string, "PMID:20875629"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001067 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Alterations in the pathway result in specific phenotypes collectively known as ribosomopathies."^^xsd:string ;
  obo:hasDbXref "PMID:20194897"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001069 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Gonadotropin-releasing hormone signaling pathway induces the synthesis and secretion of luteinizing and follicle-stimulating hormones from the pituitary."^^xsd:string ;
  obo:hasDbXref "PMID:22024993"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001070 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Lutenizing hormone signaling is important for the normal development and function of the ovaries and testes. It acts synergistically with the follicle-stimulating hormone."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Luteinizing_hormone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001071 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Follicle-stimulating hormone signaling is important for the normal development and function of the ovaries and testes. It acts synergistically with the lutenizing hormone."^^xsd:string ;
  obo:hasDbXref "PMID:21372710"^^xsd:string, "wikipedia:https://en.wikipedia.org/wiki/Follicle-stimulating_hormone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001072 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The cycle of synaptic vesicle exocytosis and neurotransmitter release and the subsequent endocytosis and recycling of synaptic vesicles at nerve terminals."^^xsd:string ;
  obo:hasDbXref "PMID:15217342"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001073 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The spliceosome is a multimegadalton ribonucleoprotein complex that removes the exons to produce the mature mRNA, including several mature mRNAs from a single RNA transcript via alternative splicing. A complex assembly/disassembly  pathway mediates the two chemical steps of a splicing event.  lncRNAs are also frequently spliced."^^xsd:string ;
  obo:hasDbXref "PMID:21441581"^^xsd:string, "PMID:22010274"^^xsd:string, "PMID:22480731"^^xsd:string, "PMID:22975042"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001074 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving hydrophobic, uncharged amino acids. Hydrophobic amino acids include alanine, valine, isoleucine, leucine and methionine with hydrocarbon side chains and the phenylalanine, tyrosine and tryptophan with bulky, aromatic side chains."^^xsd:string ;
  obo:hasDbXref "MCE library:Handbooks of biochemistry"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001075 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving hydrophilic, polar amino acids. The hydrophilic amino acids include the negatively charged (acidic) aspartic acid and glutamic acid whose salts are glutamate and aspartate, respectively, the positively charged (basic) lysine and arginine and the uncharged polar asparagine, cysteine, glutamine, serine and threonine. Histidine, whose side chain contains an imidazole can shift from positively charged to neutral."^^xsd:string ;
  obo:hasDbXref "MCW library:Handbooks of biochemistry"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001076 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving special amino acids. The special amino acids include cysteine whose side chain contains a sulfhydryl group, glycine whose side chain is a hydrogen atom and proline whose side chain bends to form a ring and hose rigidity limits the folding abilities of proteins around proline residues."^^xsd:string ;
  obo:hasDbXref "MCW library:Nahdbooks of biochemistry"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001077 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving amino acids as listed in the Kyoto Encyclopedia of Genes and Genomes (KEGG)."^^xsd:string ;
  obo:hasDbXref "KEGG:http://www.genome.jp/kegg/"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001079 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of proline, a non-essential amino acid that could be essential in certain cases. Its side chain bends to form a ring and its rigidity limits the folding abilities of proteins around proline residues."^^xsd:string ;
  obo:hasDbXref "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001080 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of valine, an essential amino acid. Valine, along with leucine and isoleucine is a branched-chain amino acid."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Valine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001081 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of lysine, an essential amino acid."^^xsd:string ;
  obo:hasDbXref "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001082 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of arginine, a non-essential amino acid that could be essential in certain cases."^^xsd:string ;
  obo:hasDbXref "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001083 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of asparagine, a non-essential amino acid."^^xsd:string ;
  obo:hasDbXref "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001084 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of serine, a non-essential amino acid that could be essential in certain cases."^^xsd:string ;
  obo:hasDbXref "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001085 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of threonine, an essential amino acid."^^xsd:string ;
  obo:hasDbXref "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001086 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of glutamine, a non-essential amino acid that could be essential in certain cases."^^xsd:string ;
  obo:hasDbXref "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001087 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of isoleucine, an essential amino acid."^^xsd:string ;
  obo:hasDbXref "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001088 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of leucine, an essential amino acid."^^xsd:string ;
  obo:hasDbXref "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001089 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Serotonin signaling via receptor family 1 and 5 primarily engages G alphai protein family resulting in inhibition of adenylate cyclases and reduction of intracellular cAMP. There are five receptors subtypes in family 1 and one in the human family 5."^^xsd:string ;
  obo:hasDbXref "PMID:20945968"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001090 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Serotonin signaling via receptor family 2 engages G alphaq protein family resulting in activation of phospholipase C, mobilization of calcium ions and production of inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG). There are three receptors subtypes in family 2."^^xsd:string ;
  obo:hasDbXref "PMID:20945968"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001091 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Serotonin signaling via receptor family 4, 6, and 7 engages G alphas protein family resulting in activation of adenylyl cyclases and increased concentration of cAMP. There are seven receptor subtypes in family 4 and only one in families 6 and 7."^^xsd:string ;
  obo:hasDbXref "PMID:20945968"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001092 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Serotonin family 3 receptor is a ligand-gated Na+/K+ channel with two receptor subtypes and their heterodimerization is believed to be necessary for their function. Serotonin signaling results in depolarization of plasma membrane."^^xsd:string ;
  obo:hasDbXref "PMID:20945968"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001093 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Bile acid binds to and activates several nuclear receptors such as the farnesoid X and liver X receptors as well as a cell surface G-protein coupled receptor."^^xsd:string ;
  obo:hasDbXref "PMID:22414897"^^xsd:string, "PMID:22521118"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001094 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Disregulated estrogen signaling is associated with the growth and development of breast cancers; estrogen mediated transcription is constitutively active in more than 50% of cases."^^xsd:string ;
  obo:hasDbXref "PMID:9608332"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001095 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of zidovudine, an anti-viral drug used for the treatment of HIV infection. It belongs to the family of nucleoside analog reverse transcriptase inhibitors. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001096 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of zidovudine, a drug used for the treatment of HIV. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001097 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of zidovudine-target interaction and of the biochemical or physiological responses to drug. Zidovudine is a drug used for the treatment of HIV infection. Zidovudine, in its active triphosphate form, inhibits HIV-1 reverse transcriptase activity. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:www.pharmgkb.org"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001098 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of tramadol, an analgesic used for the treatment of moderate to moderately severe pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "OneLook:http://www.onelook.com"^^xsd:string, "PharmGKB:http://www.pharmgkb.org"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001099 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of tramadol, an analgesic used in the treatment of pain. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001100 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of tramadol-target interaction and of the biochemical or physiological responses to drug. Tramadol is an analgesic used for the treatment of pain. The drug and its o-desmethyl metabolite are weak, but selective opiate receptor 3 (OP3) agonists. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001101 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A number of human viruses have been shown to be associated/contribute to approximately 10 to 15% of cancers. The viral particles encode oncogenes whose escape from the host defense system impacts on many cellular pathways and promotes tumor development."^^xsd:string ;
  obo:hasDbXref "OneLook:http://www.onelook.com"^^xsd:string, "PMID:20971551"^^xsd:string, "PMID:21102637"^^xsd:string, "PMID:21445966"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001102 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A hypoxia inducible pathway that deviates from what its normal course should be. Mutations in the von Hippel-Lindau (Vhl), the E3 ubiquitin ligase which targets Hif alpha for degradation under normoxic conditions, lead to a constitutively active pathway regardless the levels of oxygen. Mutations in Vhl and a number of other genes have been implicated in renal cancers."^^xsd:string ;
  obo:hasDbXref "PMID:22406000"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001103 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathways that respond to and control the levels of protons, bicarbonate and carbon dioxide and of ammonia the cells. Several sensing pathways, i.e., prompting intracellular signaling cascade, and transport have been identified as critical players. The kidneys play a major role along with the respiratory system."^^xsd:string ;
  obo:hasDbXref "PMID:22362904"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001104 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway that respond to increases or decreases in protons, or pH levels and whose signaling aim at restoring systemic acid-base balance. Several G-protein coupled receptor  (GPCRs) and ion channel mediated signaling have been reported in the literature."^^xsd:string ;
  obo:hasDbXref "PMID:20683624"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001105 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The signaling pathway elicited by changes in pH and bicarbonate levels."^^xsd:string ;
  obo:hasDbXref "PMID:20683624"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001106 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The signaling pathway elicited by increased levels of bicarbonate. Bicarbonate results from the instantaneous dissociation of carbonic acid, the end product of carbonic anhydrase hydration of exogenous or metabolically produced carbon dioxide."^^xsd:string ;
  obo:hasDbXref "PMID:20683624"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001107 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of sorafenib, a multikinase inhibitor used in the treatment of cancer, in particular for advanced renal cell carcinoma.  The drug binds to the intracytoplasmic domain of tyrosine kinase receptors blocking the downstream signaling cascade. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:21419641"^^xsd:string, "PMID:22263843"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001108 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of sorafenib. The drug was the first oral multikinase inhibitor approved for the treatment of renal cell carcinoma. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:21419641"^^xsd:string, "PharmGKB:http://www.pharmgkb.org/pathway/PA165959537"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001109 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of sorafenib-target interaction and of the biochemical or physiological responses to drug. Sorafenib is the first multikinase inhibitor approved for the treatment of renal cell carcinoma.  The drug binds to the intracytoplasmic domain of tyrosine kinase receptors blocking the downstream signaling cascade. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:21419641"^^xsd:string, "PharmGKB:http://www.pharmgkb.org/pathway/PA165959584"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001110 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of sunitinib, a multikinase inhibitor used in the treatment of cancer, in particular for advanced renal cell carcinoma. The drug binds to the intracytoplasmic domain of tyrosine kinase receptors blocking the downstream signaling cascade. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:22328304"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001113 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of sunitinib. The drug is a multikinase inhibitor approved for the treatment of renal cell carcinoma. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:22328304"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001114 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of sunitinib-target interaction and of the biochemical or physiological responses to drug. Sunitinib is a multikinase inhibitor approved for the treatment of renal cell carcinoma. The drug binds to the intracytoplasmic domain of tyrosine kinase receptors blocking the downstream signaling cascade. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:2232830"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001115 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A signaling cascade triggered by light in the visible and red spectrum whose sensor appears to be cytochrome c oxidase, the terminal enzyme of the electron transfer chain, and which relies on a retrograde mitochondrion-to-nucleus pathway that translates in the upregulation of various genes. Unlike the visual phototransduction, this pathway does not require vitamin A metabolites."^^xsd:string ;
  obo:hasDbXref "PMID:20681024"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001117 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A signaling pathway mediated by a signaling complex for which retinol or vitamin A appears to be an essential docking molecule and redox sensor. The pathway may play an important role in regulating the tricarboxylic acid cycle through the pyruvate dehydrogenase complex by mechanisms that are still to be elucidated."^^xsd:string ;
  obo:hasDbXref "PMID:21763457"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001119 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Defects in components of the citrate cycle have been shown to relate to several types of cancer. For instance, mutations in fumarate hydratase are associated with renal cancer, in succinate dehydrogenase in renal as well as paragangliomas and pheochromocytomas. Mutations in isocitrate dehydrogenase have also been implicated in several types of cancer. Defects in this central metabolic network result in unwanted activation of hypoxia inducible factor whose target genes are involved in angiogenesis, erythropoiesis, glycolysis, among others."^^xsd:string ;
  obo:hasDbXref "PMID:21764377"^^xsd:string, "PMID:23001348"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001120 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of bevacizumab, a humanized monoclonal antibody that inhibits VEGF activity. It is used for the treatment of several types of advanced cancers. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:22594892"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001121 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of bevacizumab, a VEGF inhibitor used in the treatment of several types of  tumors. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:22594892:"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001122 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of bevacizumab-target interaction and of the biochemical or physiological responses to drug. The drug is an inhibitor of VEGF and is used in the treatment of several types of cancers such as for instance renal cell carcinoma. VEGF is a target of hypoxia inducible factor pathway, which is constitutively active in the condition.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:22594892"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001123 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of axitinib, a receptor tyrosine kinase inhibitor used in the treatment of renal cell carcinoma as well as other tumors. Angiogenic factors such as vascular endothelial or platelet derived growth factors are direct and indirect targets of hypoxia inducible factor pathway, constitutively active in renal cell carcinoma. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:22170007"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001124 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of axitinib, a receptor tyrosine kinase inhibitor used in the treatment of renal cell carcinoma and other tumors. Axitinib is a selective second generation inhibitor of vascular endothelial growth factor receptors 1, 2 and 3. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:22170007"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001125 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of axitinib-target interaction and of the biochemical or physiological responses to drug. Axitinib is a receptor tyrosine kinase inhibitor used in the treatment of renal cell carcinoma as well as other tumors. Axitinib is a selective second generation inhibitor of vascular endothelial growth factor receptors 1, 2 and 3. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:22170007"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001126 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of everolimus, an inhibitor of mTOR pathway used in the treatment of several types of tumors, including renal cell carcinoma. Hypoxia inducible factor (HIF) pathway is constitutively active in the disease; mTOR regulates the translation of HIF-alpha gene. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:20456985"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001127 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of everolimus, an inhibitor of mTOR pathway used in the treatment of renal cell carcinoma and other tumors. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:20456985"^^xsd:string, "PMID:22624503"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001128 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of everolimus-target interactions and of the biochemical or physiological responses to drug. The drug is an inhibitor of mTOR pathway and is used in the treatment of renal cell carcinoma and other types of tumors. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:20456985"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001129 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of temsirolimus, an inhibitor of mTOR pathway used in the treatment of renal cell carcinoma and other types of tumors. Hypoxia inducible factor (HIF) pathway is constitutively active in renal cell carcinoma; HIF-alpha translation is under the control of mTOR pathway. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:20456985"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001130 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of temsirolimus, an inhibitor of mTOR pathway used in the treatment of renal cell carcinoma and other tumors. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:20456985"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001131 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of temsirolimus-target interaction and of the biochemical or physiological responses to drug. The drug is an inhibitor of mTOR pathway and is used in the treatment of renal cell carcinoma and other types of tumors. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:20456985"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001132 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of pazopanib, a receptor tyrosine kinase inhibitor used in the treatment of renal cell carcinoma as well as other tumors. Angiogenic factors such as vascular endothelial or platelet derived growth factors are direct and indirect targets of hypoxia inducible factor pathway, constitutively active in renal cell carcinoma. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:20456985"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001133 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "he pathway of processing - absorption, distribution, metabolism or elimination - of pazopanib. The drug is a multikinase inhibitor approved for the treatment of renal cell carcinoma. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:20456985"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001134 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of pazopanib-target interaction and of the biochemical or physiological responses to drug. Pazopanib is a selective multikinase inhibitor approved for the treatment or renal cell carcinoma. The drug binds to the intracytoplasmic domain of tyrosine kinase receptors blocking the downstream signaling cascade. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:20456985"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001135 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Parathyroid hormone (PTH) signaling is important for calcium and phosphate homeostasis in bone and kidney. It acts to increase the concentration of calcium in the blood, has both anabolic and catabolic effects in the bone and regulates calcium and phosphate reabsorption in the kidney. It also plays important roles in vitamin D metabolism."^^xsd:string ;
  obo:hasDbXref "PMID:19857544"^^xsd:string, "PMID:21777186"^^xsd:string, "PMID:23060860"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001136 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The C16 palmitate product of fatty acid biosynthetic pathway can be esterifed to triacylglycerol or converted to longer chain saturated and unsaturated fatty acid molecules by elongases and desaturases, depending on the needs of the cell. The elongation pathway takes place in the endoplasmic reticulum or in the mitochondrion. Longer chain fatty acids are present in certain specialized tissues; for instance, myelin contains large amounts of C22 and C24 molecules."^^xsd:string ;
  obo:hasDbXref "PMID:22984005"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001137 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The C16 palmitate product of fatty acid biosynthetic pathway can be esterifed to triacylglycerol or converted to longer chain saturated and unsaturated fatty acid molecules by elongases and desaturases, depending on the needs of the cell. Unsaturated fatty acids are essential membrane components."^^xsd:string ;
  obo:hasDbXref "KEGG:map01040"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001138 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving ether lipids, lipid molecules in which one or several of the carbons on glycerol has an ether linkage to an alkyl chain. Ether lipids are constituents of cell membrane; some metabolites could act as signaling second messengers or carry out antioxidant functions."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Ether_lipid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001139 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Calcium is pumped into organelles or outside the cell by pumps and exchangers to maintain the low calcium concentration necessary for cell viability. Many type of channels, some calcium-selective, others of lower selectivity or calcium-permeant, allow for the flow of calcium from external sources or internal stores into the cell to initiate many signaling events. The movement of calcium ions, which controls and maintains the calcium gradient, and calcium signaling, which the gradient promotes, are inextricably connected in the fabric of calcium homeostasis."^^xsd:string ;
  obo:hasDbXref "PMID:12838335"^^xsd:string, "PMID:18083096"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001140 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Calcium signaling impacts on a large and diverse spectrum of cellular processes such as gene expression and cell death, proliferation, muscle contraction and energy metabolism, learning, memory and synaptic plasticity. Calcium acts in signal transduction as a first as well as a second messenger. Calcium transport, which controls and maintains the calcium gradient, and calcium signaling, which the gradient promotes, are inextricably connected in the fabric of calcium homeostasis."^^xsd:string ;
  obo:hasDbXref "PMID:12838335"^^xsd:string, "PMID:17574670"^^xsd:string, "PMID:18083096"^^xsd:string, "PMID:19243429"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001141 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Calcium signaling through the calcium-sensing receptor inhibits the secretion of parathyroid hormone in the parathyroid glands and controls calcium absorption and water balance in the kidneys. Calcium is considered the main physiological agonist but other cations and various agonists can activate the receptor. The G protein coupled receptor (GPCR) is believed to engage several types of Galpha proteins and to have many other interacting partners. The pathway leads to activation of MAPK cascades, particularly the one mediated by Erk1/2. Casr signaling is cell specific; many of its molecular details are not fully understood. Many mutations, both inactivating and activating the receptor, have been identified."^^xsd:string ;
  obo:hasDbXref "PMID:20729338"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001142 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The clathrin-mediated endocytosis pathway involves clathrin-coated vesicles used for the engulfment of material."^^xsd:string ;
  obo:hasDbXref "PMID:16985500"^^xsd:string, "Wikipedia:http://en.wikipedia.org/wiki/Endocytosis"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001145 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Phagocytosis pathway is used for the removal of unwanted material such as dying cells and also of foreign material. As such is also part of the immune response. Various receptors on the surface of a phagocytic cell will recognize/bind material and induce signaling cascades."^^xsd:string ;
  obo:hasDbXref "PMID:16985500"^^xsd:string, "PMID:9039775"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001146 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The signaling cascade initiated by an activated Fc gamma receptor. Fc receptors are classified by the type of antibody they recognize; thus, Fc gamma receptors bind IgG, the most common type of antibody. Fc gamma receptors belong to the immunoglobulin superfamily."^^xsd:string ;
  obo:hasDbXref "PMID:15466916"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001148 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Hepatitis B virus (HBV) is the causative agent of hepatitis B, an inflammatory condition of the liver affecting people in parts of Asia and Africa. The virus interferes with a number of regulatory and signaling pathways in the host."^^xsd:string ;
  obo:hasDbXref "Wikipedia:http://en.wikipedia.org/wiki/Hepatitis_B"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001149 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The human T-lymphotropic virus type 1 (HTLV-1) is a pathogenic retrovirus causing a type of cancer known as adult T-cell leukemia and lymphoma and a demyelinating condition referred to as HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). A viral regulatory protein known as Tax, which is a transcriptional co-factor, interferes with a number of signaling pathways in the host."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Human_T-lymphotropic_virus"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001150 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Fc receptors mediated signaling exerts important regulatory and modulatory roles in immunity. Fc receptors are classified by the type of antibody they recognize. They are widely expressed on immune system cells and a number of other cell types. With one exception, they mediate activating signaling cascades."^^xsd:string ;
  obo:hasDbXref "PMID:17981207"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001151 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The signaling cascade initiated by an activated Fc epsilon receptor. Fc receptors are classified by the type of antibody they recognize; thus, Fc epsilon receptors bind IgE antibody."^^xsd:string ;
  obo:hasDbXref "PMID:17981207"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001152 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of steroids. Notable examples include cholesterol and steroid hormones."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Steroid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001153 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of caffeine, a xanthine alkaloid found in the seeds, leaves, and fruit of certain plants that humans use as a stimulant."^^xsd:string ;
  obo:hasDbXref "KEGG:00232"^^xsd:string, "wikipedia:http://en.wikipedia.org/wiki/Caffeine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001154 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the degradation of glycosaminoglycans."^^xsd:string ;
  obo:hasDbXref "KEGG:00531"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001155 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of butirosin and neomycin -aminoglycoside antibiotics produced by Bacillus circulans and Streptomyces fradiae, respectively."^^xsd:string ;
  obo:hasDbXref "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001156 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of glycerolipids which are composed of mono-, di-, and tri-substituted glycerols. Triacylglycerol, or triglyceride, is the best known example."^^xsd:string ;
  obo:hasDbXref "OneLook:http://www.onelook.com"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001157 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of ether lipids. On these molecules one or more of the carbon atoms of glycerol is bonded to an alkyl group via an ether linkage."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Ether_lipid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001158 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those enzymatic reactions involved in the synthesis, utilization or degradation of alpha-linoleic acid - an unsaturated omega-3 fatty acid. Alpha-linoleic acid is an essential fatty acid that humans and other animals cannot synthesize and must obtain from diet."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Alpha-Linolenic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001159 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Aminoacyl-tRNA, or transfer RNA (tRNA) carries amino acids to ribosomes and is part of the translation pathway. tRNAs are specific for the amino acids with which they are associated. Their synthesis involves adenylation of the amino acid followed by its transfer; both steps require ATP."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Aminoacyl-tRNA"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001160 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway whereby various RNA molecules synthesized in the nucleus are exported to the cytoplasm to be further processed such as protein-coding mRNA or to fulfill particular functions."^^xsd:string ;
  obo:hasDbXref "PMID:15519698"^^xsd:string, "PMID:21776079"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001161 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The turnover of RNA molecules produced by the three eukaryotic polymerases and those resulting from their processing and/or assembly. It includes the degradation of defective molecules, of excess molecules, or of defective components by the RNA surveillance or decay pathway."^^xsd:string ;
  obo:hasDbXref "PMID:19239894"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001163 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Cannabinoids are a class of rather diverse chemical compounds of which some, like endocannabinoids are naturally produced by the body in humans and other animals, while others are found in plants or are synthesized. Signaling is mediated by the cannabinoid receptors that are G protein coupled (GPCR) receptors. The endogenous cannabinoids are lipids and the signaling route is referred to as retrograde as it  travels 'backwards' from the postsynaptic to the presynaptic cell."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Cannabinoid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001164 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The signaling pathway initiated by the endogenous cannabinoids that activate the G protein coupled (GPCR) cannabinoid receptors and utilize a retrograde route from the postsynaptic to the presynaptic neuron."^^xsd:string ;
  obo:hasDbXref "PMID:21531987"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001167 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Parathyroid hormone related peptide (PTHLH) signaling exerts pleiotropic roles, unlike the related parathyroid hormone whose specific role is in calcium and phosphate homeostasis. Initially identified as a  molecule produced by certain cancers, it is now known that it is important for normal physiological functions, mostly related to development and organogenesis."^^xsd:string ;
  obo:hasDbXref "PMID:22549910"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001168 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Altered calcium signaling due to mutations in the calcium-sensing receptor has been associated with a number of conditions. To date, more than 250 mutations have been identified of which more than half reside in the extracellular part of the receptor."^^xsd:string ;
  obo:hasDbXref "Casrdb:http://www.cardb.mcgill.ca/"^^xsd:string, "PMID:19484257"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001170 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of compounds used for the treatment of conditions associated with the musculo-skeletal system. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "KEGG:http://www.genome.jp/kegg-bin/get_htext?br08303.keg"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001171 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Tuberoinfundibular peptide of 39 residues (Tip39) is encoded by the parathyroid hormone 2 gene, weakly homologous to parathyroid hormone (PTH) and parathyroid hormone-like hormone (PTHrP). Tip39 is an endogenous ligand for the parathyroid hormone receptor 2, a G protein coupled receptor (GPCR), initially considered an orphan receptor. Signaling, mostly in the brain but also in the pancreas, testis and renal tissues, appears to involve elevation in cAMP."^^xsd:string ;
  obo:hasDbXref "PMID:19857544"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001172 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Fibroblast growth factor (FGF) signaling involves more than 20 proteins involved in embryonic and postnatal development and for some members, also acting as hormones in the adult. Deregulation of the pathway has been implicated in a number of neoplastic and metabolic conditions."^^xsd:string ;
  obo:hasDbXref "PMID:20940169"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001173 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The fibroblast growth factors (FGF)  also known as FGF homologous factors belong to the phylogenetic subfamily FGF11/12/13/14. They signal intracellularly and independent of fibroblast growth factor receptors (FGFR). The pathway plays important neuromodulatory roles. Deregulation of the pathway has been associated with several neurodegenerative disorders."^^xsd:string ;
  obo:hasDbXref "PMID:20940169"^^xsd:string, "PMID:23040813"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001174 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Paracrine fibroblast growth factors (FGF) are represented by five phylogenetic subfamilies whose signaling, also referred to as canonical, is involved in the well known role of FGF in embryonic and postnatal development. Deregulation of the pathway has been associated with several conditions."^^xsd:string ;
  obo:hasDbXref "PMID:20940169"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001175 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The endocrine fibroblast growth factors (FGF) also known as hormone-like belong to the 15/19/21/23 phylogenetic subfamily, also referred to as FGF19 subfamily. They have low affinity for the fibroblast growth factor receptors (FGFR) and rely on the Klotho family members to bind the receptors under physiological conditions. In particular, FGF23 signaling via Klotho, also known as the FGF23/Klotho axis plays a central role in vitamin D metabolism and renal phosphate homeostasis. Deregulation of the pathway has been associated with several conditions."^^xsd:string ;
  obo:hasDbXref "PMID:20730630"^^xsd:string, "PMID:20940169"^^xsd:string, "PMID:22298654"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001176 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Deregulation of endocrine fibroblast growth factor signaling pathway has been associated with several paraneoplastic and metabolic diseases that include renal failure, Cushing's syndrome, type 2 diabetes and obesity, among others."^^xsd:string ;
  obo:hasDbXref "PMID:20940169"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001177 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Deregulation of the intracrine fibroblast growth factor signaling pathway has been associated with several neurodegenerative disorders and also with mental retardation."^^xsd:string ;
  obo:hasDbXref "PMID:20940169"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001178 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Deregulation of the paracrine fibroblast growth factor signaling pathway has been associated with several congenital disorders."^^xsd:string ;
  obo:hasDbXref "PMID:20940169"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001179 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Fibroblast growth factor 23 signaling, a member of the endocrine subfamily of fibroblast growth factor family plays important roles in phosphate homeostasis. It is also important in vitamin D metabolism. The pathway is also referred to as the FGF23-Klotho axis, Klotho representing the obligatory co-receptor family for this subfamily with low affinity for the FGF receptors."^^xsd:string ;
  obo:hasDbXref "PMID:20059333"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001180 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The parathyroid hormone family consists of parathyroid hormone and parathyroid hormone-like hormone that employ the same parathyroid hormone receptor type 1, a G-protein coupled receptor (GPCR) of family B of GPCRs. Despite signaling through the same receptor, the two hormones elicit distinct functions. Receptor type 2 has been considered an orphan receptor, but a specific ligand has been identified, a 39 residues peptide with weaker amino acid sequence similarity to the two hormones."^^xsd:string ;
  obo:hasDbXref "PMID:22745236"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001182 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Phosphate is an essential element with many important roles in biology, from skeletal development and integrity to metabolism and cellular signaling. The greatest amount of phosphate is found in bone and teeth. The major regulator of phosphate homeostasis is  the kidney. Maintenance of proper phosphate levels is assured by an interplay of transport and signaling pathways. Sodium phosphate co-transporters, primarily type 2 and 3 and parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) signaling are essential components."^^xsd:string ;
  obo:hasDbXref "PMID:22552885"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001183 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway that assures the proper transport of phosphate in the body. Kidney plays a major role in the filtration and reabsorption of phosphate while the bone is a principal form of storage. Several types of sodium phosphate cotransporters are involved; the role of type 2 and 3 has been established. Renal phosphate transport is under the control of parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) signaling."^^xsd:string ;
  obo:hasDbXref "PMID:21778753"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001185 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Calcium/calmodulin dependent kinase 2 (CAMK2) signaling plays important roles in excitation-contraction coupling in the heart and long-term potentiation (LPT) and memory in the brain."^^xsd:string ;
  obo:hasDbXref "PMID:21529938"^^xsd:string, "PMID:23091085"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001186 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The calcium/calmodulin dependent kinase signaling cascade require an upstream CAMK kinase (CAMKK) for activating phosphorylation."^^xsd:string ;
  obo:hasDbXref "PMID:21529938"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001189 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A folate metabolic pathway that deviates from what its normal course should be. Impairment of folate cycle and/or folate mediated one-carbon pathways is associated with an increased risk for several conditions and developmental anomalies."^^xsd:string ;
  obo:hasDbXref "PMID:15298442"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001191 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A methionine cycle/metabolic pathway that deviates from what its normal course should be. Impaired methionine metabolism and/or altered levels of S-adenosylmethionine (AdoMet) have been associated with hepatocellular carcinoma and alcoholic liver disease."^^xsd:string ;
  obo:hasDbXref "PMID:23073625"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001192 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A homocysteine metabolic pathway that deviates from what its normal course should be. Enzyme and/or vitamin deficiencies or defects in folate metabolism can give rise to the abnormal levels of homocysteine in homocysteinuria or  hyperhomocystenemia and the consequences related to them."^^xsd:string ;
  obo:hasDbXref "PMID:22418620"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001193 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Kinases are essential components of biological pathways. Phosphorylaton by protein kinases and dephosphorylation by protein phosphatases exert major regulatory roles. In addition, they can also initiate intracellular signaling cascades. Kinases represent a significant fraction of eukaryotic genes and prominent amongst them are the serine/threonine kinases."^^xsd:string ;
  obo:hasDbXref "PMID:16132230"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001194 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Serine/threonine-specific kinase mediated signaling include essential intracellular pathways such as those involving the mitogen-activated (MAPK), Akt (also known as Pkb), protein kinase A and protein kinase C, to name a few. Serine/threonine-specific kinases represent the largest class."^^xsd:string ;
  obo:hasDbXref "OneLook:http://www.onelook.com"^^xsd:string, "PMID:16132230"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001195 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The non-receptor tyrosine-specific kinases are represented by members of Src, Jak, Syk  and other families. Some, such as Jak, function as initiators of  intracellular pathways, others are components of several pathways. Tyrosine-specific kinases are also represented by receptor tyrosine kinases activated by growth factors and hormones.  These kinases are components of the pathways the specific growth factors and hormones initiate."^^xsd:string ;
  obo:hasDbXref "PMID:16132230"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001200 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Thyroid-stimulating hormone (TSH) signaling stimulates the secretion of thyroid hormone. Its own secretion is dependent upon activation of thyrotropin-releasing hormone (TRH) in the hypothalamus by low levels of thyroid hormone (TH). TRH, TSH and TH signaling pathways are part of the hypothalamic-pituitary-thyroid (HPT) axis for which TH itself provides a negative regulatory loop."^^xsd:string ;
  obo:hasDbXref "PMID:22759379"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001201 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Thyrotropin-releasing hormone (TRH or TRF) signaling stimulates the production of thyroid-stimulating hormone (TSH) from the pituitary, which in turn stimulates the thyroid to produce thyroid hormone (TH). TRH, TSH and TH signaling pathways are part of the hypothalamic-pituitary-thyroid (HPT) axis for which TH itself provides a negative regulatory loop."^^xsd:string ;
  obo:hasDbXref "PMID:22759379"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001202 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of compounds used for the treatment of genito-urinary system conditions or as sex hormones derivatives and analogs. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "KEGG:http://www.genome.jp/kegg-bin/get_htext?br08303.keg"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001203 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of hormonal preparations that may contain natural hormones or are synthetic hormonal analogs and their derivatives. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "KEGG:http://www.genome.jp/kegg-bin/get_htext?br08303.keg"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001204 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of thyroid hormone analogs, many of which have tissue specific thyroid hormone action."^^xsd:string ;
  obo:hasDbXref "PMID:21504761"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001205 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Sobetirome, also known as GC-1, is a one of the best characterized thyromimetics with high affinity for the beta thyroid receptor. It has been shown to reduce LDL cholesterol in animal model studies."^^xsd:string ;
  obo:hasDbXref "PMID:21504761"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001206 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Eprotirome is a thyromimetics that in addition for being selective for the beta tyrosine receptor is also highly liver-selective with minimal uptake in non-hepatic tissues. In overweight and hypercholesterolemic patients, its administration lead to lowering of total and LDL-cholesterol while stimulating bile acid biosynthesis."^^xsd:string ;
  obo:hasDbXref "PMID:21504761"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001207 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The folate cycle metabolic pathway sums up the uptake and transport of folates, the processing and interconversion reactions of folate compounds. The folate cycle and the folate mediate one-carbon transfer pathways are part of folate metabolism."^^xsd:string ;
  obo:hasDbXref "PMID:11001804"^^xsd:string, "PMID:15166809"^^xsd:string, "PMID:15298442"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001210 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of plevitrexed, a non-polyglutamatable antifolate quinazoline derivative and thymidylate synthase inhibitor used in the treatment of cancers. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "NCI:http://www.cancer.gov"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001211 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of plevitrexed, an antifolate used in the treatment of cancer. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "NCI:NCI"^^xsd:string, "wikipedia:www.cancer.gov"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001212 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of plevitrexed-target interactions and of the biochemical or physiological responses to drug. The drug is an antifolate that targets thymidylate synthase and is used in the treatment of several cancers. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "NCI:NCI"^^xsd:string, "wikipedia:www.cancer.gov"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001213 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of permetrexed, an antifolate originally designed as a thymidylate synthase inhibitor but which also has inhibitory effects on other enzymes involved in the folate cycle and/or folate mediated one-carbon transfer reactions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Pemetrexed"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001214 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of pemetrexed-target interactions and of the biochemical or physiological responses to drug. The drug is an antifolate that targets thymidylate synthase and other enzymes of the folate cycle and folate mediated one-carbon transfer reactions and is used in the treatment of several cancers. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Pemetrexed"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001215 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of pemetrexed, an antifolate used in the treatment of cancer. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Pemetrexed"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001216 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of pralatrexate, a polyglutamatable antifolate used as an inhibitor of dihydrofolate reductase (DHFR) enzyme of folate cycle. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "Wikipedia:http://en.wikipedia.org/wiki/Pralatrexate"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001217 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of pralatrexed, an antifolate used in the treatment of cancer. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "NCI:www.cancer.gov"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001218 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of pralatrexed-target interactions and of the biochemical or physiological responses to drug. The drug is an antifolate that targets dihydrofolate reductase (DHFR) and is used in the treatment of some cancers. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "NCI; wikipedia:www.cancer.gov"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001219 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Hydrogen sulfide can act as a signaling molecule with roles in the heart, brain and smooth muscle."^^xsd:string ;
  obo:hasDbXref "PMID:20067586"^^xsd:string, "PMID:22546339"^^xsd:string, "PMID:22781905"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001220 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Nitric oxide (NO) signaling, well known for its vasodilation effects, exerts multiple roles that include the immune and nervous system."^^xsd:string ;
  obo:hasDbXref "PMID:26028569"^^xsd:string, "PMID:26364456"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001221 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those signaling pathway elicited by gases such as carbon monoxide, nitric oxide or hydrogen sulfide."^^xsd:string ;
  obo:hasDbXref "PMID:22546339"^^xsd:string, "PMID:22781905"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001224 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of irinotecan an inhibitor of DNA topoisomerase I used in the treatment of several types of cancer. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/pathway/"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001225 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of irinotecan, a drug used in the treatment of several types of cancer. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/pathway/PA2001"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001226 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of irinotecan-target interactions and of the biochemical or physiological responses to drug. Irinotecan is a DNA topoisomerase I inhibitor used in the treatment of several types of cancer. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/pathway/PA2029"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001227 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The Stem Cell Factor (SCF) signaling plays important roles in cell migration, proliferation and survival. SCF activates the KIT receptor tyrosine kinase which then prompts several intracellular signaling pathways. Deregulation of the pathway has been associated with several conditions including cancer."^^xsd:string ;
  obo:hasDbXref "PMID:23073628"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001228 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of drugs that target the angiotensin converting enzyme ACE. In the renin-angiotensin cascade, several bioactive peptides are derived from the precursor angiotensinogen. ACE converts angiotensin I to the potent angiotensin II. The various ACE inhibitors are grouped based on their molecular structure, the dicarboxylate-containing agents represent the largest group. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/ACE_inhibitor"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001230 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of ACE inhibitors. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/ACE_inhibitor"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001231 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of ACE inhibitor-target interaction and of the biochemical or physiological responses to drug. The drugs are used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/ACE_inhibitor"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001233 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reaction involved in handling this polycyclic aromatic hydrocarbon whose metabolites are mutagenic and carcinogenic."^^xsd:string ;
  obo:hasDbXref "Wikipedia:http://en.wikipedia.org/wiki/Benzo%28a%29pyrene"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001234 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of biogenic amines."^^xsd:string ;
  obo:hasDbXref "PMID:12641342"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001235 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of catecholamines. Epinephrine, norepinephrine and dopamine are among the most abundant and are produced primarily from the adrenal medulla and the postganglionic fibers of the sympathetic nervous system."^^xsd:string ;
  obo:hasDbXref "PMID:19342614"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001236 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Histamine is derived from the amino acid histidine via a decarboxylation reaction carried out by the enzyme L-histidine decarboxylase."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Histamine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001239 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reaction involved in the synthesis of eicosanoids, molecules that play important roles in the immune and vascular systems. They are derived from either omega-3 or omega-6 fatty acids, with the route provided by the conversion of arachidonic acid, better known."^^xsd:string ;
  obo:hasDbXref "PMID:15896353"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001240 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Prostanoids are a class of eicosanoids that contains the prostaglandins, the thromboxanes and prostacycline."^^xsd:string ;
  obo:hasDbXref "PMID:15896353"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001241 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving prostacycline - a family of prostanoid eicosanoids with important functions in the cardiovascular system."^^xsd:string ;
  obo:hasDbXref "PMID:15896353"^^xsd:string, "PMID:23063076"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001242 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of leukotriene, a class of eicosanoids, molecules exerting important roles in the immune and vascular systems."^^xsd:string ;
  obo:hasDbXref "PMID:15896353"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001243 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of prostanoids, a class of eicosanoids that includes several families and which exert important roles in the immune and vascular systems."^^xsd:string ;
  obo:hasDbXref "PMID:15896353"^^xsd:string, "PMID:23063076"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001244 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of codeine and morphine, a class of drugs in the opiate family used as pain relievers. Both are naturally found in the poppy plant with codeine derived from the more abundant morphine, as methylated morphine. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/pathway/PA146123006"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001245 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of codeine and morphine, a class of drug opiates used as pain relievers. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/pathway/PA146123006"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001246 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of codeine/morphine-target interaction and of the biochemical or physiological responses to drug. The drugs are potential ligands for the mu-opioid receptor, a class of opioid receptor. Opioid receptors are G-protein coupled receptors (GPCR) activated by endogenous and also exogenous opioids. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/pathway/PA146123006"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001247 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of nifedipine, a calcium channel blocker used primarily in the treatment of hypertension and angina. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:18793108"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001248 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of nifedipine. The drug is a calcium channel blocker used in the treatment of hypertension and angina.  Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "Wikipedia:http://en.wikipedia.org/wiki/Nifedipine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001249 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of nifedipine-target interaction and of the biochemical or physiological responses to drug. The drug is a calcium channel blocker, particularly the L-type channel.  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:17307972"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001250 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway responsible for the transport of monoamines, biogenic amines representing various neurotransmitters. The reuptake of neurotransmitters following their release is a key element determining the duration and intensity of their signaling and is thus essential for the proper functioning of the nervous system."^^xsd:string ;
  obo:hasDbXref "PMID:12511858"^^xsd:string, "PMID:16024510"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001252 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Prolactin signaling pathway is important for normal reproduction. Prolactin is a peptide hormone whose signaling activates several intracellular cascades."^^xsd:string ;
  obo:hasDbXref "PMID:21664429"^^xsd:string, "PMID:22684822"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001253 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The omega degradation pathway is an alternative route to the common beta degradation pathway."^^xsd:string ;
  obo:hasDbXref "PMID:21156023"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001260 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of arginine. Although primarily a non-essential amino acid, its synthesis from citrulline may be insufficient and it is also energetically costly. Diet derived arginine can circumvent these aspects."^^xsd:string ;
  obo:hasDbXref "Wikipedia:http://en.wikipedia.org/wiki/Arginine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001261 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the degradation of arginine. Higher organisms do not possess the enzymes involved in this catabolic pathway."^^xsd:string ;
  obo:hasDbXref "MetaCyc:http://www.biocyc.org/META/NEW-IMAGE?type=PATHWAY&object=AST-PWY"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001264 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of glycine, a major inhibitory neurotransmitter."^^xsd:string ;
  obo:hasDbXref "Wikipedia:http://en.wikipedia.org/wiki/Glycine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001265 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the degradation of glycine. Several routes are available of which the glycine cleavage system is the predominant one. It occurs in the mitochondria and produces 5,10-methylene tetrahydrofolate and as such, is an important component of folate cycle pathway."^^xsd:string ;
  obo:hasDbXref "PMID:18941301"^^xsd:string, "wikipedia:http://en.wikipedia.org/wiki/Glycine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001266 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of histidine, an essential amino acid for humans. The biosynthesis of histidine has been extensively studied in E. coli and S. typhimurium."^^xsd:string ;
  obo:hasDbXref "PMID:8852895"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001267 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the degradation of histidine. The histidine degradation provides a source of nitrogen and is carried out in microorganisms."^^xsd:string ;
  obo:hasDbXref "PMID:24165547"^^xsd:string, "PMID:24728193"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001268 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of isoleucine, an essential amino acid for humans. Its synthesis in plants and microorganisms proceeds via several steps."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Isoleucine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001270 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the biosynthesis of leucine, an essential amino acid for humans. In plants and microorganisms its synthesis proceeds via a number of steps."^^xsd:string ;
  obo:hasDbXref "Wikipedia:http://en.wikipedia.org/wiki/Leucine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001271 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the degradation of leucine."^^xsd:string ;
  obo:hasDbXref "Wikipedia:http://en.wikipedia.org/wiki/Leucine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001272 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of DNA transcription carried out by the prokaryotic and the several eukaryotic polymerases."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Transcription_%28genetics%29"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001273 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of DNA transcription in prokaryotic organisms is carried out by a single polymerase. Five subunits constitute the core enzyme."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Transcription_%28genetics%29"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001274 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "RNA polymerase II and a set of general and specific transcription factors assemble as a large pre-initiation complex which undergoes a series of transformations before transcription proceeds. Promoter recognition and subsequent initiation of transcription are dependent upon the presence of these transcription factors. Activators and repressors impact upon transcription at these early stages."^^xsd:string ;
  obo:hasDbXref "PMID:23000482"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001275 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of DNA transcription carried out by the eukaryotic polymerases."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Transcription_%28genetics%29"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001276 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the de novo synthesis of nicotinamide adenine dinucleotide (NAD), downstream of kynurenine metabolism of tryptophan degradation."^^xsd:string ;
  obo:hasDbXref "PMID:18020963"^^xsd:string, "PMID:20007326"^^xsd:string, "PMID:26785480"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001277 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of glutathione. Glutathione is a tripeptide that exerts important functions as an antioxidant and in the conjugation of xenobiotics and drugs by phase II biotransformation enzymes."^^xsd:string ;
  obo:hasDbXref "PMID:22998389"^^xsd:string, "PMID:23201762"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001278 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reaction involved in the synthesis of threonine. Threonine is an essential amino acid that human cannot synthesize. Its synthesis takes place in plants and microorganisms."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Threonine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001280 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of tryptophan, an essential amino acid that human cannot synthesize. Its synthesis takes place in plants and microorganisms. In plants, the synthesis of aromatic amino acids is part of chorismate pathway, the end branch point of shikimate pathway."^^xsd:string ;
  obo:hasDbXref "PMID:20817774"^^xsd:string, "wiki[pedia:http://en.wikipedia.org/wiki/Tryptophan"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001281 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the degradation of tryptophan, an essential amino acid.  Tryptophan undergoes oxidative catabolism carried out by several hemeprotein enzymes. In plants, tyrosine is the precursor for several secondary metabolites."^^xsd:string ;
  obo:hasDbXref "PMID:20817774"^^xsd:string, "PMID:22889220"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001282 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the production of kynurenine, a product of tryptophan degradation pathway. Kynurenine and its metabolites play important roles in the nervous system and also in immunity."^^xsd:string ;
  obo:hasDbXref "PMID:21744051"^^xsd:string, "PMID:22139324"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001283 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of tyrosine. In mammals, is derived from phenylalanine or from diet. In plants, is produced as part of chorismate pathway, the end branch point of shikimate pathway."^^xsd:string ;
  obo:hasDbXref "PMID:20817774"^^xsd:string, "wikipedia:http://en.wikipedia.org/wiki/Tyrosine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001284 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the degradation and/or conversion of tyrosine, a non- essential amino acid. Tyrosine is the precursor of several neurotransmitters and hormones. Tyrosine can also be degraded to acetoacetate and fumarate. In plants, tyrosine is the precursor of several families of secondary metabolites."^^xsd:string ;
  obo:hasDbXref "PMID:20817774"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001285 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of valine, an essential amino acid for humans. Plants synthesize valine from pyruvic acid via a number of steps."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Valine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001287 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of phenylalanine, an essential amino acid for humans. In plants, the synthesis of aromatic amino acids is part of chorismate pathway, the end branch point of shikimate pathway."^^xsd:string ;
  obo:hasDbXref "PMID:20817774"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001288 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the degradation and/or conversion of phenylalanine. Phenylalanine is the precursor of tyrosine, in turn a precursor for a number of neurotransmitters and hormones. In plants, phenylalanine serve as a precursor for a large number of functional secondary metabolites."^^xsd:string ;
  obo:hasDbXref "PMID:20817774"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001289 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of carotene collectively referring to several related unsaturated hydrocarbon compounds that are synthesized by plants. Some are vitamin precursors, such as the beta-carotene precursor of vitamin A."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Carotene"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001290 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved ion the synthesis, utilization and/or degradation of lycopene - a carotene and phytochemical found in red fruits and vegetables."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Lycopene"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001291 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of lycopene, a carotene and phytochemical found in red fruits and vegetables. Plants and bacteria have the ability to synthesize lycopene."^^xsd:string ;
  obo:hasDbXref "MetaCyc:http://biocyc.org/META/NEW-IMAGE?object=Lycopene-Biosynthesis"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001294 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Eicosanoids, derived from omega-3 or omega-6 fatty acids, are represented by the leukotriene and prostanoid classes of which the latter is represented by several families. Some can act as endogenous ligands for members of the peroxisomal proliferator-activated nuclear receptors (PPARs). Once activated, PPARs heterodimerize with the retinoid X receptor (RXR) and modulate the expression of target genes."^^xsd:string ;
  obo:hasDbXref "PMID:17132851"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001295 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Leukotriene are eicosanoids derived from omega-3 or omega-6 fatty acids. One such source is the arachidonic metabolism via the 5-lipoxygenase mediated route."^^xsd:string ;
  obo:hasDbXref "PMID:12955468"^^xsd:string, "PMID:17132851"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001296 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Prostanoids are eicosanoids derived from omega-3 or omega-6 fatty acids and represented by several families. One such source is the arachidonic acid metabolism via the cyclooxygenase mediated route. Several categories of prostanoids can be generated and signaling via several receptor types elicits a range of physiological responses. Historically, they are viewed as mediators of inflammation."^^xsd:string ;
  obo:hasDbXref "PMID:12955468"^^xsd:string, "PMID:17132851"^^xsd:string, "PMID:23063076"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001297 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Prostaglandins are one of several families of prostanoids, eicosanoids derived from omega-3 or omega-6 fatty acids. Of the several prostaglandins, prostaglandin E2 signaling via four distinct receptors mediates a broad range of  physiological effects. Others include prostaglandin D2 with various central nervous system (CNS) activities and prostaglandin I2 or prostacyclin with important vascular functions."^^xsd:string ;
  obo:hasDbXref "PMID:12955468"^^xsd:string, "PMID:23063076"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001298 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of trehalose - a disaccharide synthesized by bacteria, fungi, plants and invertebrates. It has important roles in plant development and it represents the energy storage that insects use for flight. It is believed to be involved in the ability of plants and animals to withstand long periods of desiccation or anhydrobiosis."^^xsd:string ;
  obo:hasDbXref "PMID:22140246"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001299 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved on the synthesis of trehalose, a disaccharide found in bacteria, fungi, plants and invertebrates."^^xsd:string ;
  obo:hasDbXref "PMID:22140246"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001300 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the degradation of trehalose. While the synthesis of trehalose does not take place in vertebrates, the catabolic route of its metabolism does occur."^^xsd:string ;
  obo:hasDbXref "SMPDB:http://pathman.smpdb.ca/pathways/SMP00467/pathway"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001301 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of methionine. As an essential amino acid, methionine can not be synthesized by humans. Its synthesis takes place in plants and microorganisms."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Methionine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001302 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the degradation of methionine. In higher organisms methionine is either recycled via the remethylation pathways or is converted to cysteine via the transsulfuration pathway of homocysteine metabolism. In fungi, plants and bacteria, methionine can be processed to compounds such as methionol and/or 2-oxobutanoate."^^xsd:string ;
  obo:hasDbXref "MetaCyc:http://biocyc.org/META/NEW-IMAGE?object=METHIONINE-DEG"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001307 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of phosphatidylcholine, an essential component of the membrane."^^xsd:string ;
  obo:hasDbXref "PMID:15749057"^^xsd:string, "PMID:18204095"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001309 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Abscisic acid is a plant isoprenoid hormone important for development and stress responses."^^xsd:string ;
  obo:hasDbXref "PMID:22442388"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001310 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of abscisic acid, an important plant isoprenoid hormone."^^xsd:string ;
  obo:hasDbXref "PMID:22442388"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001311 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Sulfur, mostly found as inorganic sulfate can be taken up by plants, microorganisms and algae. Upon reduction to sulfide, is then incorporated into bioinorganic compounds. The underlying reactions and interactions constitute the sulfate assimilation pathway, best characterized in plants."^^xsd:string ;
  obo:hasDbXref "PMID:19876632"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001312 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Nodal signaling pathway belongs to the transforming growth factor-beta superfamily and plays important roles during vertebrate embryogenesis where is involved in pattern formation and differentiation."^^xsd:string ;
  obo:hasDbXref "PMID:16838294"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001317 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The series of events, collectively known as the cell cycle, that underlie the replication of the genome and the segregation of chromosomes into daughter cells. The mitotic cell cycle pathway underlies the generation of new cells. The meiotic cell cycle pathway is a special type of cell division that takes place in germ cells."^^xsd:string ;
  obo:hasDbXref "Handbook:Essential Cell Biology"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001318 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The series of events that take place in the germ cells resulting in the production of four non-identical haploid cells from each diploid cell that enters the cycle. Meiosis involves chromosomal pairing and exchange of DNA segments or recombination."^^xsd:string ;
  obo:hasDbXref "Handbook:Essential cell Biology"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001319 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of toxic secondary metabolite, known as mycotoxins, produced by some fungi, such as Fusarium. The mycotoxins they produce in cereal crops, such as species of fumonisins and trichothecenes, can affect humans and animals if present in food."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Mycotoxin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001320 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of fumonisin mycotoxins by members of Fusarium fungi."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Fusarium"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001321 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of trichothecene mycotoxins by members of Fusarium fungi."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Fusarium"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001322 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of deoxynivalenol, a type B trichothecene produced by members of Fusarium fungi."^^xsd:string ;
  obo:hasDbXref "KEGG:http://www.genome.jp/dbget-bin/www_bget?cpd:C09747"^^xsd:string, "wikipedia:http://en.wikipedia.org/wiki/Deoxynivalenol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001323 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The translation pathway that takes place in the mitochondrion. The mitochondrial translation pathway utilizes 22 tRNAs which are encoded in the mitochondrial genome. The mitochondrial genome also encodes 2 ribosomal genes. A small set of mitochondrially encoded proteins is translated in the mitochondrion. Most others are nuclear genes, synthesized on cytosolic ribosomes and then targeted to the organelle."^^xsd:string ;
  obo:hasDbXref "PMID:22258151"^^xsd:string, "PMID:22729854"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001324 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Aminoacyl-tRNA, or transfer RNA (tRNA) carries amino acids to ribosomes and is part of the translation pathway. tRNAs are specific for the amino acids with which they are associated. Their synthesis involves adenylation of the amino acid followed by its transfer; both steps require ATP. there are 22 tRNA genes encoded by the mitochondrial genome. Mutations in these genes have been implicated in a number of disorders and may affect various steps of tRNA biosynthesis."^^xsd:string ;
  obo:hasDbXref "PMID:22258151"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001327 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Mutations in the mitochondrial tRNA genes are associated with a number of disorders. These mutations may affect steps in the biosynthesis of tRNA."^^xsd:string ;
  obo:hasDbXref "PMID:22258151"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001328 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of uridine diphosphate glucose, a nucleotide sugar."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/UDP-glucose"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001329 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of  guanosine diphosphate mannose, a nucleotide sugar."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/GDP-mannose"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001330 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The receptor for advanced glycation end-products is a multi-ligand receptor whose signaling engages several downstream cascades. In addition to its pro-inflammatory role in innate immunity, it is also involved in tissue homeostasis and repair. It has been associated with a range of pathological states."^^xsd:string ;
  obo:hasDbXref "PMID:23103427"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001331 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "RNA polymerase II transcription elongation commences when the nascent transcript reaches about 25 residues. Some general transcription factors are release and the RNA polymerase II carries out elongation of pre-mRNA transcript and proofreading. Various regulators control early elongation, proximal promoter pausing and full elongation proceedings. Nascent mRNA processing, splicing and alternative splicing are co-occurring."^^xsd:string ;
  obo:hasDbXref "PMID:22975042"^^xsd:string, "PMID:23000482"^^xsd:string, "PMID:23046879"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001332 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Termination of transcription is important for partitioning the genome and maintaining adequate expression of neighboring genes."^^xsd:string ;
  obo:hasDbXref "PMID:21487437"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001333 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The transcription of mitochondrial DNA which encodes several genes involved in the oxidative phosphorylation pathway as well as the ribosomal and transfer RNA genes involved in their translation."^^xsd:string ;
  obo:hasDbXref "PMID:23632312"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001334 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Non-coding RNA are functional RNA molecules that are not translated into proteins. In addition to ribosomal and transfer RNA involved in protein translation many other small and long RNA are transcribed with important roles in the regulation of gene expression."^^xsd:string ;
  obo:hasDbXref "Cell March 2013:http://www.cell.com/issue?pii=S0092-8674%2813%29X0007-8"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001335 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Long non-coding RNA, of which there are several types, perform important regulatory roles whose function and mechanism are under investigation."^^xsd:string ;
  obo:hasDbXref "PMID:23463798"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001336 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "CDP-choline is one of the three distinct pathways of phosphatidylcholine biosynthesis. A second has been better studied in yeast while the third has only been identified in certain bacteria."^^xsd:string ;
  obo:hasDbXref "PMID:15749057"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001337 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chromatin modification/remodeling plays a major role in the epigenetic control of gene expression. The dynamics of chromatin structure impacts on DNA replication, transcription and repair pathways. It includes the covalent modification of histones and DNA and the actions carried out by the ATP-dependent remodelers."^^xsd:string ;
  obo:hasDbXref "PMID:21655945"^^xsd:string, "PMID:22203491"^^xsd:string, "PMID:23085398"^^xsd:string, "PMID:23524488"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001338 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The tails of histone proteins are subject to a wide array of modifications of which methylation and acetylation have been more thoroughly documented. The modified residues are recognized by particular proteins or readers, in turn acting upon their targets. The modifications are rendered reversible by the enzymes that carry out the reaction in the opposite direction, also referred to as erasers."^^xsd:string ;
  obo:hasDbXref "PMID:21655945"^^xsd:string, "PMID:22203491"^^xsd:string, "PMID:23085398"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001339 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chromatin remodelers are large complexes that use the energy derived from ATP hydrolysis to promote nucleosome sliding, ejection or repositioning, histone exchange. Currently, there are four different families of chromatin remodeling complexes."^^xsd:string ;
  obo:hasDbXref "PMID:19355820"^^xsd:string, "PMID:21655945"^^xsd:string, "PMID:22203491"^^xsd:string, "PMID:23085398"^^xsd:string, "PMID:23524488"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001340 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "DNA modification is a component of chromatin modification pathway. At least four DNA modification types are known. The modifications are recognized by specific readers and removed by eraser enzymes."^^xsd:string ;
  obo:hasDbXref "PMID:22894577"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001341 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A chromatin remodeling/modification pathway that deviate from what its normal course should be. Aberrant chromatin remodeling and modification has been associated with various conditions, particularly cancer."^^xsd:string ;
  obo:hasDbXref "PMID:23127546"^^xsd:string, "PMID:23524488"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001342 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of sucrose. The disaccharide is synthesized by plants and cyanobacteria."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Sucrose"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001343 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of phosphatidylglycerol. The molecule is a glycerophospholipid found in pulmonary surfactant."^^xsd:string ;
  obo:hasDbXref "PMID:21382416"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001344 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of cardiolipin. The molecule is derived from phosphatidylglycerol as an immature cardiolipin, further remodeled by phospholipases. Cardiolipin is important for a range of mitochondrial functions."^^xsd:string ;
  obo:hasDbXref "PMID:22014644"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001345 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of cardiolipin, a molecule important for mitochondrial function."^^xsd:string ;
  obo:hasDbXref "PMID:22014644"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001346 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathways involved in the absorption and efflux of cholesterol."^^xsd:string ;
  obo:hasDbXref "PMID:17495606"^^xsd:string, "PMID:20809793"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001349 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The transport pathways of elements in group 1, 14, 15, 16 and 17 of the periodic table."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Nonmetal"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001350 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The transport pathway of chloride ion as carried out by chloride channels and transporters in cell and organelles."^^xsd:string ;
  obo:hasDbXref "PMID:20100480"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001354 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A chloride ion transport pathway that deviates from what its normal course should be. Aberrant chloride ion transport have been implicated in diseases. For instance, mutations in the ABC type transporter that functions as both a chloride channel and as a regulator of other transport pathways, have been implicated in two genetic disorders of which one is cystic fibrosis."^^xsd:string ;
  obo:hasDbXref "PMID:20100480"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001355 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Peroxisome proliferator-activated receptor signaling is initiated in response to binding several compounds within classes of lipids such as the eicosanoid, leukotriene, prostagladin, among others. The receptors form heterodimers with the retinoid X receptor, bind to specific DNA elements and regulate the expression of target genes. Deregulation of the pathway has been implicated in several conditions."^^xsd:string ;
  obo:hasDbXref "PMID:17132851"^^xsd:string, "PMID:17317294"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001356 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Deregulation of peroxisome proliferator-activated receptor signaling can affect innate immunity and play a role in metabolic diseases."^^xsd:string ;
  obo:hasDbXref "PMID:22704720"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001357 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of coenzyme A, an  important for fatty acids, pyruvate and citric acid metabolic pathways."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Coenzyme_A"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001358 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of coenzyme A. The five step reaction pathway requires pantothenate (vitamin B5) and cysteine as precursors."^^xsd:string ;
  obo:hasDbXref "PMID:11923312"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001359 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A nucleotide excision repair pathway that deviates from what its normal course should be. Defects in this repair pathway have been associated with cancer and premature aging."^^xsd:string ;
  obo:hasDbXref "PMID:22824526"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001360 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The response mechanism/pathways that assure the maintenance of genomic integrity. This involves detection of DNA damage, signaling and amplification of the signal leading to activation of effectors and resulting in repair of damage, cell cycle arrest or, if necessary, cell death. Such  response mechanism/pathways may operate collectively with some of their components being shared."^^xsd:string ;
  obo:hasDbXref "PMID:19847258"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001361 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The ataxia telangiectasia-mutated (ATM) serine/threonine kinase mediated signaling plays a major role in the response to DNA double strand breaks (DSB). Following lesion sensing by the MRN complex, ATM gets activated. Active ATM phosphorylates itself and targets resulting in triggering of  DNA repair, cell cycle checkpoint and signaling pathways. While ATM signaling is best documented for its role in DSB responses, evidence accumulates that it functions in a range of other, DNA damage unrelated, responses."^^xsd:string ;
  obo:hasDbXref "PMID:23486281"^^xsd:string, "PMID:23532176"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001362 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The ATM and Rad3-related (ATR) serine/threonine kinase mediated signaling responds to several kinds of DNA damage, of which single-stranded DNA (ssDNA) exerts a key role. ssDNAs are induced by stressed replication forks. ATR acting on its substrates prevents the cell from erroneous mitotic entry, plays a key role in interstrand cross link (ICL) repair pathway and also exerts important regulatory roles in  homologous recombination pathway of double-strand break repair."^^xsd:string ;
  obo:hasDbXref "PMID:20947357"^^xsd:string, "PMID:21615334"^^xsd:string, "PMID:22417748"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001363 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involving lactose, a disaccharide found in milk."^^xsd:string ;
  obo:hasDbXref "Wikipedia:http://en.wikipedia.org/wiki/Lactose"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001364 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The breaking down of lactose to its constituent sugars."^^xsd:string ;
  obo:hasDbXref "Wikipedia:http://en.wikipedia.org/wiki/Lactose"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001365 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Toxic secondary metabolites, also known as mycotoxins, are natural toxins produced by organisms that belong to the fungi kingdom. They can contaminate crops and if ingested, they can cause sickness or death."^^xsd:string ;
  obo:hasDbXref "PMID:18258326"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001366 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, transport and/or degradation of aflatoxins. Aflatoxins are potent toxic secondary metabolites that contaminate grain and nut crops. Of the four types, aflatoxin B1 is the most toxic one."^^xsd:string ;
  obo:hasDbXref "PMID:19010433"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001369 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The shikimate pathway is the  metabolic route for the production of aromatic amino acids in plants. Seven reactions catalyzed by six enzymes result in the production of chorismate, the major branch point metabolite. Chorismate is the precursor for the biosynthesis of phenylalanine, tryptophan and tyrosine."^^xsd:string ;
  obo:hasDbXref "PMID:20817774"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001370 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chorismate, the major branch point metabolite of shikimate pathway is the precursor for the biosynthesis of aromatic amino acids phenylalanine, tryptophan and tyrosine in plants."^^xsd:string ;
  obo:hasDbXref "PMID:20817774"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001371 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Basic helix-loop-helix proteins represent a large superfamily of transcription factors that regulate the expression of genes involved in growth and development as well as environmental responses. Phylogenetically, they are classified into six clades of which the sixth, also referred to as clade F only contains plant genes."^^xsd:string ;
  obo:hasDbXref "PMID:20219281"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001372 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The inhibitor of DNA binding (ID) family belongs to the basic helix-loop-helix superfamily of transcription factor that regulate cell growth and differentiation. They lack the DNA binding domain and exert their gene expression regulatory function through the interaction with other transcription factors. They also appear to play a role in malignant biology; in neural cancers, deregulated activity has been associated with tumor progression."^^xsd:string ;
  obo:hasDbXref "PMID:15013218"^^xsd:string, "PMID:15530557"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001373 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An inhibitor of DNA signaling pathway that deviates from what its normal course should be. In neural cancers, deregulated activity of the pathway has been associated with tumor progression."^^xsd:string ;
  obo:hasDbXref "PMID:15013218"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001375 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of nicotinamide adenine dinucleotide (NAD) from precursors such as nicotinamide, nicotinic acid or nicotinamide riboside, collectively known as vitamin B3 or niacin."^^xsd:string ;
  obo:hasDbXref "PMID:18020963"^^xsd:string, "PMID:20007326"^^xsd:string, "PMID:26785480"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001376 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Methane oxidation by metanotrophs produces formaldehyde which is assimilated to form metabolite subsequently used for the biosynthesis of multi-carbon compounds. Two pathways of formaldehyde assimilation are known. Both pathways are cyclic."^^xsd:string ;
  obo:hasDbXref "BioCyc:http://www.biocyc.org/META/NEW-IMAGE?type=PATHWAY&object=PWY-1861"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001377 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The serine pathway is one of two pathways of formaldehyde assimilation resulting in a three-carbon intermediate."^^xsd:string ;
  obo:hasDbXref "BioCyc:http://www.biocyc.org/META/NEW-IMAGE?type=PATHWAY&object=PWY-1861"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001378 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The RuMP pathway, or RuMP cycle, is one of two pathways of formaldehyde assimilation resulting in a three-carbon intermediate."^^xsd:string ;
  obo:hasDbXref "BioCyc:http://www.biocyc.org/META/NEW-IMAGE?type=PATHWAY&object=PWY-1861"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001379 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the oxidation of octane and found in some bacteria. The final product can be utilized as a source of carbon and energy."^^xsd:string ;
  obo:hasDbXref "BioCyc:http://biocyc.org/META/NEW-IMAGE?type=PATHWAY&object=P221-PWY"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001380 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the deamination pathway of glutamate degradation that is found in microorganisms and plants. It results in ammonia and the 2-oxoglutarate compound which is fed into the citric acid cycle."^^xsd:string ;
  obo:hasDbXref "BioCyc:http://biocyc.org/META/NEW-IMAGE?type=PATHWAY&object=GLUTAMATE-DEG1-PWY"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001381 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the glutamate degradation pathway II found in certain bacteria."^^xsd:string ;
  obo:hasDbXref "BioCyc:http://biocyc.org/META/NEW-IMAGE?type=PATHWAY&object=GLUTDEG-PWY"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001382 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in glutamate degradation pathway III which proceeds via 4-aminobutanoate (GABA) and is found in humans and other mammals."^^xsd:string ;
  obo:hasDbXref "BioCyc:http://biocyc.org/META/NEW-IMAGE?type=PATHWAY&object=GLUTDEG-PWY"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001383 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reaction involved in glutamate degradation pathway IV. It proceeds via 4-aminobutanoate (GABA), like degradation pathway III, but is found in plants."^^xsd:string ;
  obo:hasDbXref "BioCyc:http://biocyc.org/META/NEW-IMAGE?type=PATHWAY&object=PWY-4321"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001384 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in glutamate degradation pathway V, a fermentation pathway of glutamate degradation. Glutamate degradation pathway V proceeds via hydroxyglutarate and is one of the major pathways of glutamate fermentation."^^xsd:string ;
  obo:hasDbXref "BioCyc:http://biocyc.org/META/NEW-IMAGE?type=PATHWAY&object=P162-PWY"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001385 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Certain anaerobic bacteria are capable of fermenting amino acids. While at least one fermentation pathway is known for every amino acid, several have been reported for glutamate."^^xsd:string ;
  obo:hasDbXref "PMID:11759672"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001386 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in glutamate degradation pathway VII, a fermentation pathway of glutamate degradation. It is a methylaspartate pathway and a major route of glutamate fermentation, together with degradation pathway VI and VIII."^^xsd:string ;
  obo:hasDbXref "BioCyc:http://biocyc.org/META/NEW-IMAGE?type=PATHWAY&object=GLUDEG-II-PWY"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001387 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in glutamate degradation pathway VI, a fermentation pathway of glutamate degradation. It is a methylaspartate pathway and a major route of glutamate fermentation, together with degradation pathway VII and VIII."^^xsd:string ;
  obo:hasDbXref "BioCyc:http://biocyc.org/META/NEW-IMAGE?type=PATHWAY&object=PWY-5087"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001388 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in glutamate degradation pathway VIII, a fermentation pathway of glutamate degradation. It is a methylaspartate pathway and a major route of glutamate fermentation, together with degradation pathway VI and VII."^^xsd:string ;
  obo:hasDbXref "BioCyc:http://biocyc.org/META/NEW-IMAGE?type=PATHWAY&object=PWY-5088"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001390 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of starch, a carbohydrate produced by all green plants as an energy store."^^xsd:string ;
  obo:hasDbXref "Wikipedia:http://en.wikipedia.org/wiki/Starch"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001391 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of starch and cellulose, two similar polymers produced and used by green plants. Both are made from glucose repeat units that differ in their orientation."^^xsd:string ;
  obo:hasDbXref "Online:http://pslc.ws/macrog/starlose.htm"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001392 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of cellulose, an important structural components of cell wall of green plants, many forms of algae and some fungus-like microorganisms."^^xsd:string ;
  obo:hasDbXref "Wikipedia:http://en.wikipedia.org/wiki/Cellulose"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001394 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the biosynthesis of terpene and terpenoid, large classes of related organic compounds. Modified terpenes, via oxidation or re-arrangement of the carbon skeleton, the resulting compounds are generally referred to as terpenoids."^^xsd:string ;
  obo:hasDbXref "Wikipedia:http://en.wikipedia.org/wiki/Terpene"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001395 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of terpene, a large class or organic compounds produced by a variety of plants and some insects."^^xsd:string ;
  obo:hasDbXref "Wikipedia:http://en.wikipedia.org/wiki/Terpene"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001396 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of monoterpene, a class of terpene composed of two isoprene units."^^xsd:string ;
  obo:hasDbXref "Wikipedia:http://en.wikipedia.org/wiki/Terpene"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001401 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of diterpene, a class of terpene composed of four isoprene units."^^xsd:string ;
  obo:hasDbXref "Wikipedia:http://en.wikipedia.org/wiki/Terpene"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001402 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of momilactone - a diterpene produced by rice. Momilactone A and B can act as potent phytoalexins and allelochemicals"^^xsd:string ;
  obo:hasDbXref "PMID:21620514"^^xsd:string, "Wikipedia:http://en.wikipedia.org/wiki/Momilactone_B"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001403 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of chromatin - DNA  and constituent histones, modification mediated by writers and recognized by readers which in turn, act upon their effectors. The modifications are removed by erasers. Mutations in the writer, reader or eraser categories are known to be implicated in cancer."^^xsd:string ;
  obo:hasDbXref "PMID:22770212"^^xsd:string, "PMID:22894577"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001404 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A chromatin modification pathway that deviate from what its normal course should be. Mutations in the writer, reader or eraser categories of chromatin modification have been implicated in cancer."^^xsd:string ;
  obo:hasDbXref "PMID:22894577"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001405 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A chromatin remodeling pathway that deviates from what its normal course should be. Mutations in members of the various chromatin remodeling families have been implicated in cancer."^^xsd:string ;
  obo:hasDbXref "PMID:22894577"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001406 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The SWI/SNF (switching defective/sucrose nonfermenting) family of remodelers has initially been purified from Saccharomyces cerevisiae. In  mammals, two complexes are comprised of one of two mutually exclusive catalytic ATPase subunits along with a set of conserved core subunits and variant subunits. The SWI/SNF is involved in nucleosome sliding and ejection. Deregulation of pathway is associated with several human cancers."^^xsd:string ;
  obo:hasDbXref "PMID:19355820"^^xsd:string, "PMID:21654818"^^xsd:string, "PMID:23355908"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001407 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The ISWI (imitation switch) family of remodelers has initially been purified from Drosophila melanogaster. Eukaryotes assemble several ISWI complexes using one or two different catalytic subunits. Many complexes function to promote chromatin assembly and repression of transcription. Overall, the pathway is important for DNA replication and repair along with the regulation of transcription."^^xsd:string ;
  obo:hasDbXref "PMID:19355820"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001408 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The INO80 (inositol requiring 80) family of remodelers has been initially purified from Saccharomyces cerevisiae. It promotes transcriptional activation and DNA repair."^^xsd:string ;
  obo:hasDbXref "PMID:19355820"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001410 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A DNA modification pathway that deviates from what its normal course should be. Mutations in the writer, reader or eraser categories of DNA modification have been implicated in several developmental abnormalities and human malignancies."^^xsd:string ;
  obo:hasDbXref "PMID:22770212"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001411 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A histone modification pathway that deviates from what its normal course should be. Mutations in the writer, reader or eraser categories of several types of histone modification have been implicated in various forms of cancer."^^xsd:string ;
  obo:hasDbXref "PMID:22770212"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001412 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Any disease that affects the central or peripheral nervous system. It includes disorders of the brain, neurological, neurodegenerative, cerebrovascular disorders, syndromes, dystrophies, diseases of the central and peripheral nervous system, and others. However, mental or neuropsychiatric disorders are not included."^^xsd:string ;
  obo:hasDbXref "MeSH:D009422"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001413 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The congenital and acquired diseases affecting the liver."^^xsd:string ;
  obo:hasDbXref "MeSH:D008107"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001414 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The congenital and acquired diseases affecting the brain, including but not limited to the cerebral cortex, basal ganglia, thalamus and hypothalamus, brain stem, cerebellum."^^xsd:string ;
  obo:hasDbXref "MeSH:MeSH descriptor"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001415 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A cerebro-hepato-renal phenotype caused by mutations in genes involved in the peroxisome biogenesis pathway."^^xsd:string ;
  obo:hasDbXref "PMID:22871920"^^xsd:string, "PMID:24607700"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001416 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A neurometabolic disorder affecting the central nervous system, caused by defects in mitochondrial and/or nuclear genes involved in energy metabolic pathways."^^xsd:string ;
  obo:hasDbXref "PMID:22273117"^^xsd:string, "PMID:23772060"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001417 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A rare autosomal recessive condition characterized by degeneration of the nervous system due to white matter vacuolization and demeylination. It results from defects in ASPA, aspartoacylase gene involved in several amino acid metabolic pathways."^^xsd:string ;
  obo:hasDbXref "PMID:16647192"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001418 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of abciximab, an integrin receptor antagonist used as a platelet aggregation inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:23580774"^^xsd:string, "wikipedia:http://en.wikipedia.org/wiki/Abciximab"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001419 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of abciximab, a platelet aggregation inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:23580774"^^xsd:string, "wikipedia:http://en.wikipedia.org/wiki/Abciximab"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001420 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of abciximab-target interaction and of the biochemical or physiological responses to drug. Abciximab is an antagonist of the integrin alpha2b/beta3 complex found on platelets. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:23580774"^^xsd:string, "wikipedia:http://en.wikipedia.org/wiki/Abciximab"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001421 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of kanamycin, an aminoglycoside antibiotic that inhibits bacterial protein synthesis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Kanamycin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001422 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination of kanamycin - an antibiotic that interferes with bacterial protein synthesis. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Kanamycin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001423 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of kanamycin-target interaction and of the biochemical or physiological responses to drug. Kanamycin interferes with bacterial protein synthesis and is used in the treatment of several infections caused by both Gram-negative and Gram-positive bacteria. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Kanamycin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001424 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of neviparine, a non-nucleoside reverse transcriptase inhibitor used in the treatment of HIV type 1. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/search/pathwaysByCategory.action#pathwayCategories:981478748"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001425 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination of neviparine, a reverse transcriptase inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/pathway/PA165950411"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001426 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of neviaparine-target interaction and of the biochemical or physiological responses to drug. Neviparine is a non-nucleoside reverse transcriptase inhibitor used in combination with other antiretroviral drugs  for the treatment of HIV type. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PgarmGKB:http://www.pharmgkb.org/pathway/PA165950411"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001427 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of amikacin, an aminoglycoside antibiotic that inhibits bacterial protein synthesis. It is used for the treatment of infections induced by Gram-negative bacteria. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "ATC/DDD Index:http://www.whocc.no/atc_ddd_index/?code=J01GB06"^^xsd:string, "wikipedia:http://en.wikipedia.org/wiki/Amikacin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001430 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of lamivudine, a reverse transcriptase enzyme inhibitor used for the treatment of HIV type 1 and 2 and Hepatitis B virus. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "ATC/DDD Index:http://www.whocc.no/atc_ddd_index/?code=J05AF05"^^xsd:string, "PharmGKB:http://www.pharmgkb.org/pathway/PA165860384"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001431 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination of lamivudine, a reverse transcriptase inhibitor used for the treatment of several virally induced diseases. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/pathway/PA165860384"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001432 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of lamivudine-target interaction and of the biochemical or physiological responses to drug. Lamivudine is a a reverse transcriptase enzyme inhibitor used for the treatment of HIV typ1 and 2 and Hepatitis B. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PharmGKB:http://www.pharmgkb.org/pathway/PA165860384"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001433 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of gentamicin, an antibiotic that inhibits bacterial protein synthesis. The drug can cause inner ear and kidney problems. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Gentamicin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001434 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The responses triggered by exposure to a toxin or a toxicant, a poisonous substance naturally produced by an organism or made by humans, respectively. A toxicant can be a poison, such as a pesticide. It can also be a compound for use in certain applications or a drug, the exposure to which may be toxic. Inflammatory responses, various types of cell death, changes in gene and protein expression can be induced upon exposure."^^xsd:string ;
  obo:hasDbXref "Wikipedia:https://en.wikipedia.org/wiki/Toxin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001435 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A pathway triggered by exposure to a nanomaterial. Nanomaterials, such as fullerenes and inorganic nanoparticles are increasingly being used in a broad range of applications. However, in a dose-dependent manner, they may exert toxic effects that affect cellular pathways and processes and elicit defense mechanisms."^^xsd:string ;
  obo:hasDbXref "Wikipedia:http://en.wikipedia.org/wiki/Nanomaterials"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001436 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A pathway triggered by exposure to carbon nanotube (CNT), an allotrope of carbon of the fullerene structural family. CNTs have a very broad range of applications but can also exert toxic effects. Pulmonary toxicity possibly via reactive oxygen species, inhibition of potassium channels and DNA repair are some of the potential mechanisms of CNT genotoxicity. Various forms of cell death and inflammatory responses are triggered in response to CNT."^^xsd:string ;
  obo:hasDbXref "PMID:22720979"^^xsd:string, "PMID:23751779"^^xsd:string, "PMID:23770455"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001437 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A pathway triggered by exposure to titanium dioxide nanoparticle (nano-TiO2). Nano-TiO2 has a broad range of applications but studies indicate that under conditions of long and high dose exposure, it can exert cytotoxic and genotoxic effects. Nano-TiO2 has been shown to induce inflammation, oxidative stress and MAP kinase activity."^^xsd:string ;
  obo:hasDbXref "PMID:23380242"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001438 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the uptake, modification and elimination of polycyclic aromatic hydrocarbons (PAHs), a class of compounds, members of which are potent mutagens and carcinogens. Metabolites of PAHs can form DNA adducts, considered a necessary step of their carcinogenic property."^^xsd:string ;
  obo:hasDbXref "PMID:15688365"^^xsd:string, "PMID:21845152"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001439 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A pathway triggered by exposure to cerium oxide nanoparticles, also known as nanoceria. Like other nanoparticles, nanoceria has a broad range of applications. A peculiar feature is the anti-oxidant property; by catalytically reacting with superoxide and hydrogen peroxide, it mimics the activities of superoxide dismutase and catalase enzymes. In addition, beneficial effects on cell differentiation and dopamine production have been shown. However, toxic effects have also been demonstrated."^^xsd:string ;
  obo:hasDbXref "PMID:19802857"^^xsd:string, "PMID:21369578"^^xsd:string, "PMID:23416263"^^xsd:string, "PMID:23661146"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001440 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Arthritis collectively describes several conditions whose primary feature is represented by joint pain resulting from inflammation."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Arthritis"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001442 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The inflammatory bowel disease (IBD) results from the deregulation of the immune system to which both genetic and environmental factors contribute. Alterations in pattern recognition receptor signaling, such as Toll-like or Nod and signaling downstream of them, among others, may contribute to and/or lead to the chronic inflammation characteristic of the condition. The main forms of IBD are Crohn's and ulcerative colitis."^^xsd:string ;
  obo:hasDbXref "PMID:20001899"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001443 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of ezetimibe - a drug used to lower the plasma cholesterol level. Ezetimibe is a selective cholesterol absorption inhibitor used both as monotherapy and in combination with statins. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:22910633"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001444 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of ezetimibe, a selective inhibitor of cholesterol absorption. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:22910633"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001445 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of ezetimibe-target interaction and of the biochemical or physiological responses to drug. Ezetimibe is a selective inhibitor of cholesterol absorption used both as monotherapy and in combination with statins. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:22910633"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001446 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of lomitapide, a drug used to lower cholesterol levels. Lomitapide is an inhibitor of microsomal triglyceride transfer protein used both as monotherapy and in combination with statins. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:21846156"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001447 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of lomitapide, an inhibitor of microsomal triglyceride transfer protein. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:21846156"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001448 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of lomitapide-target interaction and of the biochemical or physiological responses to drug. The drug is an inhibitor of microsomal triglyceride transport protein and used to lower cholesterol levels. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:21846156"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001449 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of nicotine, an agonist of nicotinic acetylcholine receptors. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PubMed:15734728"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001450 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of nicotine-target interaction and of the biochemical or physiological responses to drug. Nicotine is an agonist of the nicotinic acetylcholine receptors and exerts stimulatory roles. It is also responsible for tobacco dependence.  Prolonged exposure and high levels of nicotine can have toxic effects. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PubMed:23933385"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001451 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of valproic acid, a branched short-chain fatty acid derived from valeric acid used as a mood-stabilizing drug and in the treatment of epilepsy. More recently it has also been found to inhibit the proliferation of cancers. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:22668241"^^xsd:string, "PMID:23407051"^^xsd:string, "Wikipedia:http://en.wikipedia.org/wiki/Valproic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001452 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of valproic acid, a drug used as a mood-stabilizing and for the treatment of epilepsy. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:23407051"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001453 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of valproic acid-target interaction and of the biochemical or physiological responses to drug. Valproic acid is used as a mood-stabilizing drug and in the treatment of epilepsy. More recently it has also been found to inhibit the proliferation of cancers. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:23407051"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001454 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Gaucher's disease is caused by defective sphingolipid metabolism and accumulation of glucosylceramide in the brain and other tissues."^^xsd:string ;
  obo:hasDbXref "PMID:23563668"^^xsd:string, "PMID:25345088"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001455 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of doxorubicin, a streptomyces metabolite used as a chemotherapeutic agent used in the treatment of cancers. However, its use is limited by the serious cardiotoxic side effects. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:21048526"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001456 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of nystatin - a polyene antifungal drug used to treat yeast infections. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Nystatin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001457 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination -of nystatin. Nystatin is an antifungal that binds to ergosterol - a component of the fungal cell membrane, and also with cholesterol. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:16890501"^^xsd:string, "PMID:21482707"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001458 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of nystatin-target interactions and of the biochemical or physiological responses to drug. Nystatin interacts with both the fungal ergosterol and the host cholesterol but its afinity for ergosterol is higher. The interaction with cholesterol impacts on the uptake and activity of the anti-angiogenic endostatin."^^xsd:string ;
  obo:hasDbXref "PMID:10991881"^^xsd:string, "PMID:21482707"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001462 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of losartan, an angiotensin II receptor type 1 antagonist used in the treatment of hypertension and heart failure. Losartan is one of several angiotensin II receptor type 1 antagonists and the first used on the market. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:21417956"^^xsd:string, "PMID:23487168"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001463 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of losartan. The drug is an angiotensin II receptor type 1 antagonist used in the treatment of hypertension and heart failure. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:21417956"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001464 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of losartan-target interaction and of the biochemical or physiological responses to drug. Losartan is an angiotensin II receptor type 1 antagonist used in the treatment of hypertension and heart failure. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:23487168"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001465 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of clopidogrel, a platelet aggregation inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:15199474"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001466 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of clopidogrel. The drug is an inhibitor of ADP-dependent platelet activation and aggregation. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:15199474"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001467 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of clopidogrel-target interaction and of the biochemical or physiological responses to drug. The drug is an inhibitor of purinergic receptor P2RY12 a G-protein coupled receptor and chemoreceptor for adenosine diphosphate (ADP) receptor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:15199474"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001468 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of ibuprofen, a non-steroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes and is used in the treatment of inflammation and pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:9013378"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001469 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of ibuprofen. The drug is used in the treatment of pain and inflammation. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:23218936"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001470 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of ibuprofen-target interaction and of the biochemical or physiological responses to drug. Ibuprofen is an inhibitor of cyclooxygenase enzymes used in the treatment of pain and inflammation. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:19563267"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001471 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An X-linked inherited metabolic disorder affecting the cerebrovascular system. It is caused by alterations in sphingolipid metabolic pathway."^^xsd:string ;
  obo:hasDbXref "MeSH:C567062"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001472 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those diseases and disorders that are caused by deregulation of a metabolic pathway. It can be due to an inherited defect in an enzyme function and thus congenital, or acquired, when resulting from the failure or malfunctioning of an important metabolic organ."^^xsd:string ;
  obo:hasDbXref "MeSH:D008659"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001473 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those diseases and disorders that are caused by deregulation of lipid metabolic pathways. The condition(s) can be inherited or acquired."^^xsd:string ;
  obo:hasDbXref "MeSH:D052439"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001474 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Xanthomatosis results from deregulation of cholesterol metabolic pathways and is manifested by the formation of yellow,  cholesterol-rich deposits. It is a rare, inherited condition and can affect several tissues."^^xsd:string ;
  obo:hasDbXref "MeSH:D014973"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001475 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The cerebrotendinous type of xanthomatosis is caused by mutation in the CYP27A1 gene - a sterol hydrolase involved in the oxidation of side chain sterol intermediates. It affects many tissues, predominantly the brain and lungs."^^xsd:string ;
  obo:hasDbXref "MeSH:D019294"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001476 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those diseases present at birth and also before birth, or those that develop during the first month of life. Alteration(s) in one or several pathways can contribute to the development of the condition usually manifested in structural deformities."^^xsd:string ;
  obo:hasDbXref "MeSH:Medical Subject Headings"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001477 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those diseases that are caused by genetic mutations present during fetal development and that may be inherited from a parent or acquired in utero. The mutations can disrupt one or several pathways that give rise to a broad spectrum of conditions affecting many types of organs and/or tissues."^^xsd:string ;
  obo:hasDbXref "MeSH:D030342"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001478 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Congenital adrenal hyperplasia pathway represents a group of inherited disorders of the adrenal glands that results from defects in several enzymes involved in steroid hormone metabolic pathways."^^xsd:string ;
  obo:hasDbXref "MeSH:D000312"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001479 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Lipoid congenital adrenal hyperplasia, the most severe disorder of steroid hormone biosynthesis, is caused by a defect in the conversion of cholesterol to pregnenolone, the first step in adrenal and gonadal steroidogenesis. All affected individuals are phenotypic females with a severe salt-losing syndrome that is fatal if not treated in early infancy."^^xsd:string ;
  obo:hasDbXref "OMIM:https://www.omim.org/entry/201710"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001480 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The active kinin peptides generated by the kallikrein-kinin cascade - bradykinin, kallidin and their C-terminal processed metabolites, signal via two G-protein coupled (GPCR) receptors. The two receptors employ similar signaling pathways but also exhibit distinct patterns. Type 1 receptor is inducible, type 2 is ubiquitous and can form heterodimers with angiotensin II receptors."^^xsd:string ;
  obo:hasDbXref "PubMed:16177542"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001481 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The peripheral dopaminergic system is distinct from the neuronal one. In the kidney, dopamine signaling plays an important role in the regulation of blood pressure and accounts for ~50% of total water and sodium excretion. Both type1-like and 2-like receptors are expressed in the mammalian kidney. They couple to distinct G protein alpha subunits to elicit renal dopamine responses. Type 1-like may be responsible for many of dopamine effects."^^xsd:string ;
  obo:hasDbXref "PMID:22407378"^^xsd:string, "PMID:23733636"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001482 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A peripheral dopamine signaling pathway that deviates from what its normal course should be. Altered peripheral dopamine signaling has been associated with elevated blood pressure in rodent models and with essential hypertension in certain populations."^^xsd:string ;
  obo:hasDbXref "PMID:22407378"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001486 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A pathway triggered by exposure to carbon tetrachloride, an organic compound used in several application. It is one oft he most potent hepatotoxins and has been banned in consumer products. In vivo studies using animal models show that exposure to carbon tetrachloride triggers the activity of several enzymes and the production of antioxidant molecules in a dose-dependent manner."^^xsd:string ;
  obo:hasDbXref "PMID:10802213"^^xsd:string, "PMID:15721980"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001487 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A pathway triggered by exposure to ozone, a powerful oxidant with numerous industrial and consumer applications. However, it can induce tissue damage in animal and plants. Exposure to ozone induces the generation of free radicals, depletion of antioxidants and secretion of proinflammatory factors."^^xsd:string ;
  obo:hasDbXref "PMID:21824516"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001488 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of metformin, an antihyperglycemic drug used in the treatment of type 2 diabetes mellitus. Metformin has also been shown to have a  tumor suppressor function. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:22117616"^^xsd:string, "PMID:22722338"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001489 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of metformin, an anti-diabetic drug used in the treatment of type 2 diabetes mellitus. Metformin is widely distributed in various tissues. Meformin is excreted unchanged and several transporters are involved in its tissue uptake and elimination. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:22117616"^^xsd:string, "PMID:22722338"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001490 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of metformin-target interaction and of the biochemical or physiological responses to drug. Metformin lowers blood glucose levels by promoting the activation of AMPK signaling via molecular mechanisms that are not well understood. Mitochondria is the primary target of metformin which specifically inhibits complex I of the respiratory chain. The resulting change in AMP:ATP ratio can contribute to AMPK activation. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:22117616"^^xsd:string, "PMID:22722338"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001495 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Alterations in the visual phototransduction signaling have been linked to a number conditions such as retinits pigmentosa (RP), Bardet-Biedl syndrome (BBS), macular degeneration and others. More than 200 point mutations in rhodopsin account for ~25% of the autosomal dominant type of RP."^^xsd:string ;
  obo:hasDbXref "PMID:20212494"^^xsd:string, "PMID:23684651"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001497 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Retinitis pigmentosa (RP) is a common form of photoreceptor degeneration with a varied pattern of inheritance that includes autosomal dominant and recessive and X-linked forms. Mutations in components of the visual phototransduction and visual cycle (retinoid) metabolic pathways have been associated with RP manifestations. Other genes and potential miRNAs also play a role. A fraction of RP patients also have Usher syndrome which in addition to vision loss, also involves hearing loss."^^xsd:string ;
  obo:hasDbXref "PMID:20212494"^^xsd:string, "PMID:23684651"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001498 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Alteration in the retinoic cycle, or the visual cycle have been associated with retinitis pigmentosa and a few other forms of photoreceptor degeneration."^^xsd:string ;
  obo:hasDbXref "PMID:20212494"^^xsd:string, "PMID:23684651"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001502 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The mechanostransduction pathway involves the conversion of a mechanical stimulus into an electrical signal whose processing underlies proprioception, hearing, balance and touch. Auditory and cytoskeleton mechanotransduction are examples."^^xsd:string ;
  obo:hasDbXref "PMID:11842240"^^xsd:string, "PMID:21304548"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001503 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The auditory mechanotransduction pathway converts mechanical stimuli into electrical signaling that are processed by the brain and account for the perception of sound, gravity and movement. The inner ear contains the cochlea and the vestibule responsible for sound and movement mechanotransduction, respectively. The auditory mechanotransduction primarily depicts the sound generated responses by the hair cells in the organ of Corti."^^xsd:string ;
  obo:hasDbXref "PMID:19804752"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001504 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Alterations in the auditory mechanotransduction pathway is associated with hearing impairment and deafness."^^xsd:string ;
  obo:hasDbXref "PMID:20955936"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001506 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The Usher syndrome is characterized by both vision and hearing loss. One sixth of patients with retinitis pigmentosa also have Usher syndrome. Clinically, there are three types of Usher syndromes that vary in terms of severity and onset. The genes involved are located in inner ear hair cells and the connecting cilium of photoreceptor cells. Their associations with auditory mechanotransduction are better known but their roles in visual phototransduction and altered pathways are still to be delineated."^^xsd:string ;
  obo:hasDbXref "PMID:22311968"^^xsd:string, "PMID:23701314"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001507 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics/pharmacodynamics of platinum (Pt) containing drugs, widely used in the treatment of cancer. These drugs introduce intra- and inter-strand DNA breaks. The DNA lesion and responses it triggers is toxic to tumor cells. However, it can also exert toxic side effects. Three Pt-containing drugs are being used and they vary in their efficacy and toxicity. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:17084534"^^xsd:string, "PMID:22986709"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001508 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics/pharmacodynamics of cisplatin, a platinum (Pt) containing drug widely used in the treatment of solid tumors. Cisplatin is the most potent of such drugs, it si also the one with the strongest toxic side effects. Nephorotoxicity and ototoxicity are among the primary toxic side effects. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:17084534"^^xsd:string, "PMID:22986709"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001509 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A pathway triggered by exposure to platinum (Pt) containing drugs used in the treatment of solid tumors. The DNA lesion they introduce is toxic to the tumor cells. However, they also exert powerful toxic side effects. Cisplatin, the most potent drug is also the most toxic followed by the less potent carboplatin."^^xsd:string ;
  obo:hasDbXref "PMID:17084534"^^xsd:string, "PMID:22986709"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001510 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A pathway triggered by exposure to cisplatin, a widely used and very potent anti-cancer platinum containing drug. It is also the one with the most toxic side effects.  Nephorotoxicity and ototoxicity are among the primary toxic side effects."^^xsd:string ;
  obo:hasDbXref "PMID:17084534"^^xsd:string, "PMID:22986709"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001511 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A pathway triggered by exposure to bisphenol A - a synthetic compound used  in the production of plastics and certain resins. It mimics estrogen and has negative health effects with the early developmental stages being the more sensitive to its effects. It may be implicated in the etiology of several chronic diseases."^^xsd:string ;
  obo:hasDbXref "PMID:24382480"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001512 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics/pharmacodynamics of oxaliplatin, a platinum (Pt) containing drug widely used in the treatment of solid tumors. While less potent than cisplatin - the most potent of the platinum containing drugs, oxaliplatin is also less toxic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:22986709"^^xsd:string, "PMID:23369220"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001513 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics/pharmacodynamics of carboplatin, a platinum (Pt) containing drug used in the treatment of solid tumors. It is not as effective as cisplatin and while exerting less severe side affects, it can lead to myelosuppression and thrombocytopenia. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:17084534"^^xsd:string, "PMID:22986709"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001514 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A pathway triggered by exposure to carboplatin, a platinum containing drug used in the treatment of solid tumor. It is less potent than cisplatin but it can have serious toxic side effects such as myelosuppression and thrombocytopenia."^^xsd:string ;
  obo:hasDbXref "PMID:17084534"^^xsd:string, "PMID:22986709"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001515 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Hippo signaling pathway plays important roles in organ development and growth and tumor suppression. The pathway consists of a core of four kinases  which once activate by upstream regulators promote the cytoplasmic sequestration of YAP/TAZ transcriptional regulators. Dysregulation of the pathway has been implicated in tumor metastasis."^^xsd:string ;
  obo:hasDbXref "PMID:23312716"^^xsd:string, "PMID:23431053"^^xsd:string, "PMID:26045258"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001516 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Organophosphates (OPs) represent one of the main classes of pesticides. However, they exert serious adverse effects, primarily affecting the cholinergic nervous system. OPs inhibit acetylcholinesterase, the enzyme that hydrolyzes acetylcholine, a major neurotransmitter in the nervous system and periphery."^^xsd:string ;
  obo:hasDbXref "PMID:16337171"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001517 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A Hippo signaling pathway that deviates from what its normal course should be. Deregulated Hippo signaling has been implicated in tumor metastasis."^^xsd:string ;
  obo:hasDbXref "PMID:24336504"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001520 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The polyol pathway is triggered by excess glucose which is reduced to sorbitol in the first step which requires NADPH as a cofactor. Sorbitol is eventually converted to fructose. Sorbitol, which is membrane impermeable and metabolites of fructose which can lead to the production of AGEs (advance glycation endproduct), along with other pathways affected by a hyperglycemic state are thought to be associated with the pathophysiology of diabetic retinopathy. The intermediate sorbitol in the pathway is a sugar alcohol; sugar alcohols are a class of polyols - alcohol molecules with multiple hydroxyl groups."^^xsd:string ;
  obo:hasDbXref "PMID:24373831"^^xsd:string, "PMID:24563789"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001521 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of sugar alcohols. Sugar alcohols represent a class of polyols - alcohol molecules with multiple hydroxyl groups. They are used in place of table sugar and in combination with artificial sweeteners and while they can occur naturally, many are commercially produced."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Sugar_alcohol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001522 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the biosynthesis of dermatan sulfate - a mucopolysaccharide found primarily in skin but also in tendons, lungs, heart valves and blood vessels."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Dermatan_sulfate"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001523 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A pathway triggered by exposure to nicotine, the alkaloid found in tobacco and other plants. Nicotine can act as a stimulant and is an agonist of the ionotropic acetylcholine receptors, also known as nicotinic. Sustained exposure however has an inhibitory effect resulting in muscular paralysis, seizures, hypotension and respiratory failure. Some of the symptoms are reminiscent of organophosphate poisoning; organophosphates inhibit the enzyme acetylcholinesterase leading to uncensored stimulation of both the  nicotinic and the metabotropic muscarinic acetylcholine receptors."^^xsd:string ;
  obo:hasDbXref "PubMed:19426718"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001524 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics/pharmacodynamics of paracetamol, a widely used analgesic, known as acetaminophen (APAP). The analgesic effect is believed to be due to the inhibition of prostaglandins biosynthesis. Paracetamol overdose is associated with hepatic toxicity and a leading cause of liver failure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:23462933"^^xsd:string, "PMID:23719833"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001525 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of paracetamol, a widely used analgesic known as acetaminophen. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:23462933"^^xsd:string, "PMID:23719833"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001526 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A pathway triggered by exposure to paracetamol, a widely used analgesic also known as acetaminophen. Paracetamol overdose is associated with hepatic toxicity and a leading cause of liver failure."^^xsd:string ;
  obo:hasDbXref "PMID:21296090"^^xsd:string, "PMID:23719833"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001527 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Thromboxane is one of several families of prostanoids, eicosanoids derived from omega-3 or omega-6 fatty acids. Of the two thromboxane molecules, only A2 has activity. Thromboxane A2 signaling exerts vasoconstrictor and platelet aggregation roles. Its actions oppose those of prostaglandin I2, the other important prostanoid for the cardiovascular system homeostasis."^^xsd:string ;
  obo:hasDbXref "PMID:12955468"^^xsd:string, "PMID:23063076"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001528 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Prostacyclin is one of several families of prostanoids, eicosanoids derived from omega-3 or omega-6 fatty acids. Prostacyclin, also known as prostaglandin I2 signaling engages one receptor to mediate a vasodilator effect and modulate immune responses."^^xsd:string ;
  obo:hasDbXref "PMID:12955468"^^xsd:string, "PMID:23063076"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001529 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Prostagladin E2 is the most abundant product of prostaglandin biosynthesis via the cyclooxygenase mediated metabolism of arachidonic acid. It exerts a plethora of functions by activating four receptors of the G-protein coupled (GPCRs) family."^^xsd:string ;
  obo:hasDbXref "PMID:23063076"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001530 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Prostaglandin D2 signaling exerts important functions in the central nervous system (CNS) that among others, include the regulation of sleep and the perception of pain. The two D2 receptors are G-protein coupled receptors (GPCR)."^^xsd:string ;
  obo:hasDbXref "PMID:23063076"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001531 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Prostaglandin I2 signaling exerts potent vasodilator and anti-thrombic effects. Its actions oppose those of thromboxane A2, the other prostanoid important for the cardiovascular system homeostasis."^^xsd:string ;
  obo:hasDbXref "PMID:23063076"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001532 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of prostaglandins - a class of eicosanoid prostanoids with several members and exerting a range of important functions in the immune and cardiovascular systems."^^xsd:string ;
  obo:hasDbXref "PMID:23063076"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001533 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of thromboxane - eicosanoid prostanoids essential for the homeostasis of the cardiovascular system."^^xsd:string ;
  obo:hasDbXref "PMID:23063076"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001534 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the biosynthesis of prostacyclin, also known as prostaglandin I2. Prostacyclin and thromboxane play essential roles in cardiovascular system homeostasis."^^xsd:string ;
  obo:hasDbXref "PMID:23063076"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001535 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Prostaglandin F2alpha signaling engages one receptor and plays important roles in mammalian reproduction."^^xsd:string ;
  obo:hasDbXref "PMID:23063076"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001539 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The heterotrimer G proteins are transducers of G proteins coupled receptors (GPCRs). Many types of signals are received by the members of the large GPCR superfamily which then activate distinct G-proteins that route the signal to many and distinct intracellular signaling pathways."^^xsd:string ;
  obo:hasDbXref "PubMed:12040175"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001542 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Organismal aging represents the sum of impaired functions and pathways. It is associated with changes in homeostatic responses and circadian rhythm, mitochondrial  stress and dysfunction."^^xsd:string ;
  obo:hasDbXref "PMID:24319642"^^xsd:string, "PMID:24603155"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001546 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of compounds used to alleviate pain and/or reduce fever. Examples include the nonsteroidal anti-inflammatory drugs such as aspirin or ibuprofen and the widely used paracetamol, known as acetaminophen, among others."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Analgesic"^^xsd:string, "wikipedia:https://en.wikipedia.org/wiki/Antipyretic"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001550 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A general term grouping neoplastic pathways of the brain, spinal cord or central nervous system and of nerve tissue such as neuroepithelial or neurectodermal."^^xsd:string ;
  obo:hasDbXref "MeSH:http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?mode=&term=Neoplasms,+Nerve+Tissue&field=entry#TreeC04.557.580"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001553 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The G1/S transition pathway defines the point when the decision to complete the cell cycle is made. Deregulation of G1/S transition is observed in many human cancers and involves important players/regulators of the pathway."^^xsd:string ;
  obo:hasDbXref "PMID:10919634"^^xsd:string, "PMID:8939849"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001554 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Alterations in the SWI/SNF family mediated pathway of chromatin remodeling are implicated in a number of human cancers that include ovarian, pancreatic and renal, among others. Many mutations are found in Smarca4, one of the two mutually exclusive, ATP-dependent, enzymatic subunits or Arid1a subunit."^^xsd:string ;
  obo:hasDbXref "PMID:23355908"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001555 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Defective repair pathway(s) of double-strand breaks can lead to chromosomal rearrangements, genomic instability and oncogenic activation. Mutations in several components of the homologous recombination (HR) pathway have been implicated in several conditions in both an autosomal dominant and recessive fashion."^^xsd:string ;
  obo:hasDbXref "PMID:22027614"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001556 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Defective repair pathway(s) of double-strand breaks can lead to chromosomal rearrangements, genomic instability and oncogenic activation. Mutations in several components of the non-homologous end joining (NHEJ) pathway have been implicated in several conditions."^^xsd:string ;
  obo:hasDbXref "PMID:22027614"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001557 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Programmed cell death pathways group together several types that can be described as apoptotic or non-apoptotic, based on morphological characteristics.  The common feature is their highly regulated nature, as opposed to accidental, non-programmed cell death."^^xsd:string ;
  obo:hasDbXref "PMID:11965491"^^xsd:string, "PMID:21760595"^^xsd:string, "PMID:23030059"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001558 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Cell death pathways that are not the result of a regulated process and may be the result of injury or trauma, such as necrosis."^^xsd:string ;
  obo:hasDbXref "Wikipedia:http://en.wikipedia.org/wiki/Necrosis"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001560 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Pyroptosis pathway is a form of programmed cell death triggered by microbial infection and release of cytokines. It can also occur independently of microbial virulence. Pyroptosis can have either apoptotic or necrotic morphological features."^^xsd:string ;
  obo:hasDbXref "PMID:20201017"^^xsd:string, "PMID:21760595"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001561 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Necroptosis, is a programmed, or regulated form of necrosis generally triggered by DNA damage and leading to cell swelling and lysis."^^xsd:string ;
  obo:hasDbXref "PMID:21760595"^^xsd:string, "PMID:23030059"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001562 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autophagy pathway that deviates from what its normal course should be. Altered autophagy has been implicated in a variety of conditions, including neurodegenerative diseases, cancer and atherosclerosis, among others."^^xsd:string ;
  obo:hasDbXref "PMID:18039129"^^xsd:string, "PMID:23030059"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001564 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Anoikis is a form of apoptotic programmed cell death triggered by the absence of cell-matrix interactions."^^xsd:string ;
  obo:hasDbXref "PMID:21760595"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001565 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of doxorubicin. Doxorubicin is used as a chemotherapeutic agent for the treatment of various cancers. Its use is limited by the serious cardiotoxic side effects it exerts. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:21048526"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001566 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of doxorubicin-target interaction and of the biochemical or physiological responses to drug. Doxorubicin is used as a chemotherapeutic agent for the treatment of many cancers. Its use is restricted by the serious cardiotoxic effects it exerts. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:21048526"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001567 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The various pathways whereby initial RNA transcripts are processed into their mature, functional form and those involved in removing excess or erroneous RNA."^^xsd:string ;
  obo:hasDbXref "PMID:23545199"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001568 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those reactions involved in producing the mature forms of RNAs: mRNA, tRNA and rRNA."^^xsd:string ;
  obo:hasDbXref "PMID:23545199"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001569 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "mRNA maturation involves 5'-capping and 3' processing of pre-mRNA,  splicing and alternative splicing to produce the mature mRNA molecule(s)."^^xsd:string ;
  obo:hasDbXref "PMID:23545199"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001570 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Initiation of transcription from the bipartite rDNA repeats requires the assembly of Pol I preinitiation complex (PIC) and subsequent recruitment of the polymerase."^^xsd:string ;
  obo:hasDbXref "PMID:22960599"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001571 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Subunits of Pol I have elongation and hydrolysis capabilities. However, additional trans-acting factors are involved in pol I elongation steps."^^xsd:string ;
  obo:hasDbXref "PMID:21893173"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001572 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Termination of transcription by the polymerase I system requires the recruitment of specific factors to particular DNA elements."^^xsd:string ;
  obo:hasDbXref "PMID:23092677"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001573 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Processing of  the initial tRNA transcript, including splicing of intron-containing pre-tRNAs and multiple modifications to produce the mature tRNA molecule that is exported to the cytoplasm."^^xsd:string ;
  obo:hasDbXref "PMID:21915787"^^xsd:string, "PMID:23545199"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001574 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The reactions involved in processing the primary pol I transcribed rRNA and the 5S pre-rRNA transcribed by pol III. The large pol I transcribed pre-rRNA contains the mature 18S, 5.8S and 25S/28S rRNAs separated by internal (ITS) and flanked by external transcribed spacers (ETS). The nascent pre-rRNA associates co-transcriptionally with various factors, folds and is modified, while endo- and exo-nucleolytic cleavages sequentially  remove the spacers. Cleavage at site ITS1 separates the initial 90S pre-ribosome into pre-40S and pre-60S particles whose nucleocytoplasmic processing will follow independent routes."^^xsd:string ;
  obo:hasDbXref "PMID:17509569"^^xsd:string, "PMID:25346433"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001578 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "5'-end capping occurs earlier in transcription and, along with phosphorylation of pol II, promotes productive elongation."^^xsd:string ;
  obo:hasDbXref "PMID:12154373"^^xsd:string, "PMID:24050178"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001579 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The 3'-end processing of pre-mRNA is intimately coupled to pol II transcription termination, splicing, mRNA transport and translation."^^xsd:string ;
  obo:hasDbXref "PMID:21957020"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001580 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Long non-coding RNA transcripts are subject to processing in a manner analogous to mRNA thereby they are capped and polyadenylated, and also frequently spliced."^^xsd:string ;
  obo:hasDbXref "PMID:23827673"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001581 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Long non-coding RNA transcripts are subject to processing in a manner analogous to mRNA thereby they are capped and polyadenylated, and also frequently spliced."^^xsd:string ;
  obo:hasDbXref "PMID:23827673"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001582 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Long non-coding RNA transcripts are subject to processing in a manner analogous to mRNA thereby they are capped and polyadenylated, and also frequently spliced."^^xsd:string ;
  obo:hasDbXref "PMID:23827673"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001583 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those disorders and diseases resulting from nutritional imbalances and by alterations in various aspects of metabolism."^^xsd:string ;
  obo:hasDbXref "MeSH:D009750"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001584 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those conditions caused by inadequate levels of one or more essential vitamins due to defects in their metabolism."^^xsd:string ;
  obo:hasDbXref "MeSH:D001361"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001586 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A severe form of lipid storage disease in infants caused by deficiency of acid lipase."^^xsd:string ;
  obo:hasDbXref "PMID:12899707"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001587 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway thereby processed, mature mRNA is exported to the cytoplasm. Two distinct export pathways are mediated by specific transport receptors. The NXF1-NXT1 heterodimer exports the bulk of mRNA whereas a subset of mRNA is exported by the CRM1 system."^^xsd:string ;
  obo:hasDbXref "PMID:23583578"^^xsd:string, "PMID:25184662"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001588 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway thereby processed, mature tRNA is exported to the cytoplasm. It is dependent upon export receptors and Ran GTPases of the small G protein of the Ras superfamily."^^xsd:string ;
  obo:hasDbXref "PMID:22944664"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001589 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those diseases resulting from alterations in metabolic pathways that are caused by genetic mutations present during fetal development and that may be inherited from a parent or acquired in utero. The mutations can disrupt one or several pathways, giving rise to a broad spectrum of conditions affecting many types of organs and/or tissues."^^xsd:string ;
  obo:hasDbXref "MeSH:D008661"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001590 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Xanthinuria is a rare genetic disorder due to alterations in the purine metabolic pathway causing accumulation of xanthine and resulting in a range of symptoms. There are two types of disorders with similar clinical manifestations."^^xsd:string ;
  obo:hasDbXref "PMID:23203137"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001591 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Xanthinuria is a rare genetic disorder due to alterations in the purine metabolic pathway causing accumulation of xanthine and resulting in a range of symptoms. Of the two types of clinically related disorders, type I is caused by genetic defects in the xanthine dehydrogenase enzyme."^^xsd:string ;
  obo:hasDbXref "PMID:23203137"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001592 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Xanthinuria is a rare genetic disorder due to alterations in the purine metabolic pathway causing accumulation of xanthine and resulting in a range of symptoms.  Of the two types of clinically related disorders, type II is caused by genetic defects in the xanthine dehydrogenase and aldehyde dehydrogenase enzymes."^^xsd:string ;
  obo:hasDbXref "PMID:23203137"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001593 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those conditions affecting the muscular and skeletal systems and elements associated with them, arising from deregulation in a number of pathways."^^xsd:string ;
  obo:hasDbXref "MeSH:D009140"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001594 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "VLCAD deficiency is due to alterations in fatty acid beta oxidation pathway. It is an inherited metabolic disease due to mutations in the ACADVL gene. It appears in infancy or early childhood and is manifested  as lack of energy and muscle weakness."^^xsd:string ;
  obo:hasDbXref "PMID:23480858"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001595 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of abacavir, an anti-viral drug used for the treatment of HIV infection. It belongs to the family of nucleoside analog reverse transcriptase inhibitors. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:24754315"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001596 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of abacavir, a drug used for the treatment of HIV. Genetic variations can result in changes in the availability of the drug. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:18479171"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001597 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of abacavir-target interaction and of the biochemical or physiological responses to them. Abacavir is a drug used for the treatment of HIV infection. Abacavir inhibits HIV-1 reverse transcriptase activity by competing with the natural substrate dGTP and by its incorporation into viral DNA whose growth is then terminated. Genetic variations can cause differences in the response of the organism to the drug. A small percentage of individuals receiving the drug develop immune-mediated hypersensitivity reactions (HSR), those carrying a variant in the human leukocyte antigen B (HLA-B) gene."^^xsd:string ;
  obo:hasDbXref "PMID:23649914"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001598 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of acenocoumarol. Acenocoumarol  is used as anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:22972051"^^xsd:string, "PMID:23919835"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001599 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of acenocoumarol. Acenocoumarol is used as anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:23919835"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001600 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of acenocoumarol-target interaction and of the biochemical or physiological responses to drug. Acenocoumarol is used as anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:22972051"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001601 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those disorders caused by nutritional imbalance."^^xsd:string ;
  obo:hasDbXref "MeSH:D009748"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001602 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those diseases and disorders that are caused by deregulation of glucose metabolic pathways. The condition(s) can be inherited or acquired."^^xsd:string ;
  obo:hasDbXref "MeSH:D044882"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001603 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A rare, autosomal recessive inborn metabolic disease caused by alterations in pyrimidine metabolic pathway."^^xsd:string ;
  obo:hasDbXref "OMIM:613161"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001604 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Alterations in the pyrimidine biosynthetic pathway resulting in excessive excretion of orotic acid. The inborn metabolic condition is primarily due to deficiency in the bifunctional uridine monophosphate (UMP) synthetase enzyme.  Orotic aciduria is also due to ornithine transcarbamylase (OTC) deficiency and its hyperammonemia."^^xsd:string ;
  obo:hasDbXref "PMID:25030255"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001605 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The most common form of the orotic acid inborn error metabolic disease pathway is due to deficiency in the uridine monophosphate (UMP) synthase enzyme."^^xsd:string ;
  obo:hasDbXref "OMIM:258900"^^xsd:string, "PMID:25030255"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001606 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A secondary form of the orotic acid inborn error metabolic disease pathway due to deficiency in orotidine-5-monophosphate decarboxylase (C-terminal activity of uridine monophosphate synthetase)."^^xsd:string ;
  obo:hasDbXref "PMID:25030255"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001607 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A group of disorders due to inborn errors of the tyrosine metabolic pathway. The three types of tyrosinemia are caused by deficiencies in distinct enzymes of the tyrosine degradation pathway and exhibit specific phenotypes."^^xsd:string ;
  obo:hasDbXref "MeSH:D020176"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001608 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Type I tyrosinemia results from defects in the fumarylacetoacetate hydrolase (FAH) enzyme that catalyzes the last step in the tyrosine degradation pathway."^^xsd:string ;
  obo:hasDbXref "OMIM:276700"^^xsd:string, "PMID:9101289"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001609 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Type II tyrosinemia results from defects in the tyrosine aminotransferase (TAT) enzyme that catalyzes the conversion of tyrosine to 4-hydroxyphenylpyruvate in the tyrosine degradation pathway."^^xsd:string ;
  obo:hasDbXref "OMIM:276600"^^xsd:string, "PMID:7648039"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001610 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Type III tyrosinemia results from defects in the 4-hydroxyohenylpyruvate dioxygenase (HPD) enzyme that catalyzes the second step in the tyrosine degradation pathway."^^xsd:string ;
  obo:hasDbXref "OMIM:276710"^^xsd:string, "PMID:11916315"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001611 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Abnormal and involuntary movement due degenerative, post-traumatic, inflammatory, hereditary or medication-induced conditions."^^xsd:string ;
  obo:hasDbXref "MeSH:D009069"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001612 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A movement disorder caused by defects in the tyrosine hydroxylase enzyme that converts tyrosine to L-DOPA, the precursor of dopamine in the dopamine biosynthetic pathway of the other two catecholamines downstream of it, norepinephrine and epinephrine."^^xsd:string ;
  obo:hasDbXref "OMIM:605407"^^xsd:string, "PMID:21176768"^^xsd:string, "PMID:9732974"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001613 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of acetylasalicylic acid, known as aspirin. It is a non-steroidal anti-inflammatory drug (NSAID) used as analgesic, antipyretic and antitrombic agent. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:23435614"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001614 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of acetylsalicylic acid, known as aspirin. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:23435614"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001615 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The actual targets of acetylsalicylic acid known as aspirin were discovered after the drug was marketed. It was believed that it acts upon the central nervous system, but its true mode of action is to  irreversibly inhibit  cuclooxygenase enzyme COX-1 and to a lesser extent COX-2, thus suppressing the downstream production of prostaglandins and thromboxanes. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:22893199"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001616 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of adefovir, an anti-viral drug used for the treatment of hepatitis B. It is administered as adefovir dipivoxil prodrug. Once metabolized, it acts as a nucleotide analog reverse transcriptase inhibitor."^^xsd:string ;
  obo:hasDbXref "PMID:12606735"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001617 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of adefovir. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:12606735"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001618 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Adefovir is an anti-viral drug used for the treatment of chronic hepatitis B."^^xsd:string ;
  obo:hasDbXref "PMID:12606735"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001619 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway whereby the pre- ribosomal particles, pre-40S and pre-60S containing three of the four rRNA genes, are exported to the cytoplasm. The two particles follow independent transport routes, embedded within ribosome biogenesis. The 5S rRNA transcribed by RNA polymerase III is independently transported to be delivered to the ribosome immediately or from a cytoplasmic pool."^^xsd:string ;
  obo:hasDbXref "PMID:17509569"^^xsd:string, "PMID:21957041"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001620 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of bisphoshonate drugs that help prevent the loss of bone mass and are used in the treatment of osteoporosis. The two classes - non-nitrogenous and nitrogen-containing drugs, employ different mechanisms to affect osteoclast activity. Bisphosphonates are preferentially taken up by osteoclast cells. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:21555003"^^xsd:string, "wikipedia:http://en.wikipedia.org/wiki/Bisphosphonate"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001621 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of nitrogenous bisphosphate drugs, inhibitors of farnesyl diphosphate synthase. The disruption of geranyl and farnesyl pyrophosphate production affects the cell membrane localization of proteins that depend on this lipid modification for proper placement. They include the members of the small G proteins and the impact on Ras, Rho and Rac G proteins is thought to underlie the effect of drugs."^^xsd:string ;
  obo:hasDbXref "PMID:21555003"^^xsd:string, "wikipedia:http://en.wikipedia.org/wiki/Bisphosphonate"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001622 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Non-nitrogenous bisphosphonate drugs are metabolized to compounds that render the ATP molecule non-functional, thus promoting cell death."^^xsd:string ;
  obo:hasDbXref "PMID:21555003"^^xsd:string, "wikipedia:http://en.wikipedia.org/wiki/Bisphosphonate"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001623 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of nitrogenous bisphosphonates such as alendronate, ibandronate, pamidronate or risedronate. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:21555003"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001624 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of nitrogenous bisphosphonate-target interaction and of the biochemical or physiological responses to them. They include alendronate, ibandronate, pamidronate or risedronate. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:21555003"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001625 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The NXF1-NXT export pathway is involved in the trafficking of bulk mRNA. It is dependent upon the TREX/THO complex for receptor recruitment to the cargo."^^xsd:string ;
  obo:hasDbXref "PMID:23583578"^^xsd:string, "PMID:25184662"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001626 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "CRM1 export pathway is involved in trafficking a subset of mRNA as well as other RNA particles. Depending on the adaptor proteins that recruit CRM1 to cargo, there are several routes of export."^^xsd:string ;
  obo:hasDbXref "PMID:23583578"^^xsd:string, "PMID:25184662"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001627 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Trifunctional protein deficiency is caused by alteration in the fatty acid beta degradation pathway. Specifically, mutations in the alpha and beta subunits of the mitochondrial enzyme that catalyzes the last three steps, have been linked to this inherited metabolic condition."^^xsd:string ;
  obo:hasDbXref "OMIM:609015"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001628 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The rare autosomal recessive condition is caused by mutations in the triosephosphate isomerase enzyme involved in glycolysis/gluconeogenesis metabolic pathways."^^xsd:string ;
  obo:hasDbXref "OMIM:615512"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001629 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Transaldolase deficiency results from alteration in the pentose phosphate metabolic pathway, an alternative route of glucose oxidation that produces reducing equivalents. The condition affects many systems."^^xsd:string ;
  obo:hasDbXref "OMIM:506003"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001630 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Lysosomal storage disease represents a group of rare genetic conditions resulting from deficiencies in particular lysosomal enzymes."^^xsd:string ;
  obo:hasDbXref "PMID:25275857"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001631 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "There are several forms of Tay-Sachs disease resulting from mutations in the lysosomal hexosaminidase A enzyme. The accumulation of gangliosides in nerve cells leads to loss of mental and physical abilities, neurodegeneration and eventually death."^^xsd:string ;
  obo:hasDbXref "PMID:9090523"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001632 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of alfentanil - a synthetic opioid used for anesthesia in surgery. The drug is short-acting but potent and classified as restricted. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Alfentanil"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001633 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of alfentanil. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Alfentanil"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001634 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of alfentanil-target interaction and of the biochemical or physiological responses to drug. The drug is an agonist for mu opioid receptors, is classified as a restrictive drug and is almost exclusively used for anesthesia in surgery. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Alfentanil"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001635 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of alteplase - one of several recombinant tissue plasminogen activators. Plasminogen is a key player in the fibrinolytic cascade pathway of blood clots breakdown. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:15846799"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001636 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of alteplase, one of several recombinant tissue plasminogen activators. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:15846799"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001637 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of alteplase-target interaction and of the biochemical or physiological responses to drug. Alteplase is one of several recombinant tissue plasminogen activators. Alteplase is used for treatment of myocardial infarction and ischemic stroke, among others. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:15846799"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001638 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of amiloride - a blocker of epithelial sodium channels used for the treatment of hypertension and congestive heart failure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Amiloride"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001640 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of amiloride-target interaction and of the biochemical or physiological responses to drug. The drug blocks the epithelial sodium channels and is used in the treatment of hypertension and congestive heart failure. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:12620920"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001641 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathways of rRNA quality control whereby non-functional rRNAs, both at the level of transcript and of mature ribosome components, are subject to degradation. Bulk ribosomes can also be degraded via autophagy."^^xsd:string ;
  obo:hasDbXref "PMID:20097077"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001642 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathways of tRNA quality control thereby erroneous tRNA is degraded or normal tRNA is cleaved under stress conditions."^^xsd:string ;
  obo:hasDbXref "PMID:20810645"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001643 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those diseases that are caused by inborn errors of lipid metabolism. The mutations can disrupt one or several pathways."^^xsd:string ;
  obo:hasDbXref "MeSH:D008052"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001644 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those diseases that are caused by inborn errors of carbohydrate metabolism. The mutations can disrupt one or several pathways."^^xsd:string ;
  obo:hasDbXref "MeSH:D002239"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001645 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those diseases that are caused by inborn errors of amino acid metabolism. The mutations can disrupt one or several pathways."^^xsd:string ;
  obo:hasDbXref "MeSH:D000592"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001646 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those brain diseases that are caused by inborn metabolic errors. The mutations can disrupt one or several pathways."^^xsd:string ;
  obo:hasDbXref "MeSH:D020739"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001647 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive inherited condition resulting from alteration in sulfur metabolism. It exhibits severe neurological symptoms in the neonatal period and is possibly fatal."^^xsd:string ;
  obo:hasDbXref "OMIM:272300"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001648 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A congenital disorder of sucrose metabolism resulting from mutations in the enzyme involved in the hydrolysis of dietary sugars."^^xsd:string ;
  obo:hasDbXref "OMIM:222900"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001649 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A rare autosomal recessive condition resulting from mutations in the enzyme involved in the metabolism of the neurotransmitter 4-aminobutyric acid (GABA)."^^xsd:string ;
  obo:hasDbXref "OMIM:271980"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001650 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive disorder due to altered cholesterol metabolism."^^xsd:string ;
  obo:hasDbXref "MeSH:D019082"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001651 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of drugs that reduce or prevent the formation of blood clots.  They are further classified depending on the blood clotting processes they affect. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Antithrombotic"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001652 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of drugs that reduce or prevent bleeding. It is to be noted here that genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Antihemorrhagic"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001653 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of aminocaproic acid, an inhibitor of enzymes involved in fibrinolysis and as such, effective in the treatment of certain bleeding disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:<new dbxrefhttps://en.wikipedia.org/wiki/Aminocaproic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001654 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of aminocaproic acid. The drug is used in the treatment of certain bleeding disorders. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Aminocaproic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001655 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of aminocaproic acid-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Aminocaproic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001656 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of amiodarone, a drug used in the treatment of arrhythmia. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Amiodarone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001657 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of amiodarone. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Amiodarone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001658 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of amiodarone-target interaction and of the biochemical or physiological responses to drug. Amiodarone has beta blocker-like and calcium channel blocker-like actions. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Amiodarone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001659 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of amlodipine, a calcium channel blocker used to lower blood pressure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Amlodipine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001660 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of amlodipine, a calcium channel blocker. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Amlodipine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001661 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of amlodipine-target interaction and of the biochemical or  physiological responses to drug. Amlodipine, a calcium channel blocker is used to lower blood pressure. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Amlodipine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001662 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of anistreplase, an antithrombic drug that converts plasminogen to the active plasmin which degrades fibrin (blood clots). Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Anistreplase"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001663 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of anistreplase. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Anistreplase"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001664 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of anistreplase-target interaction and of the biochemical or physiological responses to drug. An anithrombic drug, anistreplase cleaves a bond in plasminogen to form plasmin. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Anistreplase"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001666 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of antipyrine, a drug used to relieve pain and fever. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:7340879"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001667 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive metabolic disease due to alteration in the fatty acid beta oxidation pathway."^^xsd:string ;
  obo:hasDbXref "OMIM:201470"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001670 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A rare autosomal recessive metabolic disorder due to mutations in sarcosine dehydrogenase resulting in alterations of sarcosine metabolism."^^xsd:string ;
  obo:hasDbXref "OMIM:268900"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001671 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The no-go mRNA decay pathway degrades mRNA that causes ribosomes to stall during the elongation phase of translation. It can be due to the presence of pseudoknots, stem loop structures, rare codons, other features."^^xsd:string ;
  obo:hasDbXref "PMID:22664987"^^xsd:string, "PMID:23072885"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001672 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Vinca alkaloids are anti-mitotic and anti-microtubule agents originally derived from plants and also produced as semisynthetic compounds. They have a hypoglycemic and cytotoxic effects and are widely used as cancer drugs."^^xsd:string ;
  obo:hasDbXref "PMID:24404355"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001673 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of vinblastine - a vinca alkaloid used as anticancer agent. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:24404355"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001674 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of vinorelbine - a vinca alkaloid used as anticancer agent. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:24404355"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001675 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of vincristine - a vinca alkaloid used as anticancer agent. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:24404355"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001676 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of vindesine - a vinca alkaloid used as anticancer agent. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:24404355"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001678 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of vinblastine-target interaction and of the biochemical or physiological responses to drug. The drug interacts with tubulin and disrupts microtubules function, particularly those at the mitotic spindle. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:24404355"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001682 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of vindesine-target interaction and of the biochemical or physiological responses to drug. The drug interacts with tubulin and disrupts microtubules function, particularly those at the mitotic spindle. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:24404355"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001684 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of vinorelbine-target interaction and of the biochemical or physiological responses to drug. The drug interacts with tubulin and disrupts microtubules function, particularly those at the mitotic spindle. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:24404355"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001685 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of verapamil - an L-type calcium channel blocker of the phenylalkylamine class. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Verapamil"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001694 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of valdecoxib, a non-steroidal anti-inflammatory drug used in the treatment of osteoarthritis, rheumatoid arthritis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Valdecoxib"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001703 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Saccharopinuria, also known as hyperlysinemia type II, is an autosomal recessive condition due to alteration in metabolic pathways of lysine and its derivatives."^^xsd:string ;
  obo:hasDbXref "OMIM:268700"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001704 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A disorder due to alteration in the pentose phosphate metabolic pathway."^^xsd:string ;
  obo:hasDbXref "OMIM:608611"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001705 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive disorder due to alterations in peroxisomal metabolic pathways manifesting in hearing loss and impaired vision."^^xsd:string ;
  obo:hasDbXref "MeSH:D012035"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001706 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An inherited disorder affecting the red blood cells, resulting from alteration in the pyruvate metabolic pathway and manifesting in hemolytic anemia."^^xsd:string ;
  obo:hasDbXref "OMIM:266200"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001707 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of enalapril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Enalapril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001708 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of enalapril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Enalapril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001709 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of enalapril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Enalapril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001710 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of ramipril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Ramipril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001711 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of ramipril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Ramipril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001712 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of ramipril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Ramipril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001713 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of quinapril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Quinapril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001714 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of quinapril, an ACE inhibitor. Quinapril is a prodrug that is converted to its active  metabolite, quinaprilat, in the liver. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Quinapril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001715 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of quinapril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Quinapril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001716 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of perindopril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Perindopril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001717 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of perindopril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Perindopril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001718 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of perindopril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Perindopril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001719 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of lisinopril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Lisinopril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001720 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of lisinopril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Lisinopril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001721 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of lisinopril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Lisinopril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001722 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of benazepril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Benazepril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001723 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of benazepril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Benazepril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001724 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of benazepril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Benazepril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001725 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of trandolapril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Trandolapril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001726 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of trandolapril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Trandolapril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001727 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of trandolapril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Trandolapril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001728 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of cilazapril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Cilazapril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001729 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of cilazapril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Cilazapril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001730 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of cilazapril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Cilazapril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001731 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of ticlopidine, a platelet aggregation inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:http://en.wikipedia.org/wiki/Ticlopidine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001732 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of ticlopidine, a platelet aggregation inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Ticlopidine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001733 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of ticlopidine-interaction and of the biochemical or physiological responses to drug. The drug can irreversibly block the adenosine diphosphate (ADP) receptor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Ticlopidine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001734 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of adrenergic beta receptors drugs - beta-agonists. Adrenergic beta receptors, in response to epinephrine or norepinephrine couple to the Gs alpha subunit of heterotrimeric G protein to elicit several responses. Beta-agonists are used to stimulate these responses. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:19874988"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001735 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of adrenergic beta receptors blockers. Adrenergic beta receptors, in response to epinephrine or norepinephrine couple to the Gs alpha subunit of heterotrimeric G protein to elicit several responses. Beta receptor antagonists are used to inhibit these responses and they are either selective or non-selective. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Beta_blocker"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001737 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of selective adrenergic beta receptors blockers. Adrenergic beta receptors, in response to epinephrine or norepinephrine couple to the Gs alpha subunit of heterotrimeric G protein to elicit several responses. Beta-1 receptor antagonists are used to inhibit these responses. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Beta_blocker"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001738 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of non-selective adrenergic beta receptors blockers. Adrenergic beta receptors, in response to epinephrine or norepinephrine couple to the Gs alpha subunit of heterotrimeric G protein to elicit several responses. Beta receptor antagonists are used to inhibit these responses. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Beta_blocker"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001739 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of timolol - a non-selective adrenergic beta receptor blocker. It binds and inhibits the beta 1 receptor and is used in for the treatment of hypertension and other cardiovascular conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Timolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001740 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of timolol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Timolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001741 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of timolol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta 1. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Timolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001742 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of tirofiban, a platelet aggregation inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Tirofiban"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001743 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of tirofiban, a platelet aggregation inhibitor.  Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wkkipedia:https://en.wikipedia.org/wiki/Tirofiban"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001744 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of tirofiban-interaction and of the biochemical or physiological responses to drug. Tirofiban is a reversible inhibitor of glycoprotein IIb/IIIa. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Tirofiban"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001745 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of tobramycine - an anti-bacterial antibiotic, used primarily for the treatment of Gram-negative infections. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Tobramycin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001746 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination of tobramycin - an antibiotic that interferes with bacterial protein synthesis. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Tobramycin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001747 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of tobramycin-target interaction and of the biochemical or physiological responses to drug. Kanamycin interferes with bacterial protein synthesis and is used in the treatment of Gram-negative infections. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Tobramycin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001748 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of tolmetin, a non-steroidal anti-inflammatory drug used in the treatment of osteoarthritis, rheumatoid arthritis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Tolmetin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001749 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination of tolmetin, an antirheumatic drug. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Tolmetin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001750 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of tolmetin-target interaction and of the biochemical or physiological responses to drug. Tolmetin is thought to inhibit cyclooxygenases and thus block prostaglandin synthesis. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Tolmetin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001758 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The insulin precursor, preproinsulin is subject to a several processing steps in the endoplasmic reticulum and the Golgi apparatus before ending as the mature zinc-insulin hexamer stored in secretory granules. The expression of insulin si confined to the beta cells of the pancreatic islets of Langerhans."^^xsd:string ;
  obo:hasDbXref "PMID:24843567"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001759 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The preproglucagon processing pathway gives rise to several peptide hormones in a tissue and cell specific manner. A subset, including glucagon, glucagon-like peptide-1 and peptide-2, and oxyntomodulin, are better characterized. The function of other preproglucagon derived peptides, remains to be established."^^xsd:string ;
  obo:hasDbXref "PMID:25834231"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001760 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The processing of preproglucagon precursor that gives to the glucagon hormone in the alpha cells of the pancreatic islets of Langerhans."^^xsd:string ;
  obo:hasDbXref "PMID:25834231"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001761 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The processing of the preproglucagon precursor that gives rise to glucagon-like peptide-1 (GLP-1) in the intestinal L cells and discrete sets of neurons."^^xsd:string ;
  obo:hasDbXref "PMID:25834231"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001762 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The processing of the preproglucagon precursor that gives rise to glucagon-like peptide-2 (GLP-2) in the intestinal L cell and discrete sets of neurons."^^xsd:string ;
  obo:hasDbXref "PMID:25834231"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001763 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The processing of the preproglucagon precursor that gives rise to oxyntomodulin in the intestinal L cells and discrete sets of neurons."^^xsd:string ;
  obo:hasDbXref "PMID:25834231"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001764 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The signaling pathway initiated by a radical. The reactivity of free radicals renders them potentially hazardous but it can also positively contribute to many biological processes. The generation, utilization and neutralization of radicals is tightly regulated. Disturbance in the levels and regulation of radicals leads to pathological states including cardiovascular diseases, diabetes, cancer and aging."^^xsd:string ;
  obo:hasDbXref "PMID:22396858"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001765 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Superoxide and the radicals for which it is a precursor participate in several reactions and processes important in immunity and epigenetics."^^xsd:string ;
  obo:hasDbXref "PMID:26029480"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001766 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "RNA molecules such as ribosomal and transfer RNA, rRNA and tRNA respectively, undergo many modifications to achieve functionality. Among the many modifications, there are those introduced by iron-sulfur (Fe/S) cluster-containing enzymes. Most have radical S-adenosylmethionine (SAM) domains that use SAM to produce 5-adenosyl radical; the intermediate allows them to mediate a vast range of chemical transformations."^^xsd:string ;
  obo:hasDbXref "PMID:25477525"^^xsd:string, "PMID:25533083"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001767 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The radical SAM enzymes use their iron-sulfur (Fe/S) cluster(s) generate a radical using the S-adenosylmethionine (SAM) as the substrate. The intermediate radical allows these enzymes to mediate a vast range of chemical transformations important for co-factor and lipid metabolism, peptide and RNA modification."^^xsd:string ;
  obo:hasDbXref "PMID:25477525"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001768 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of docetaxel - an antineoplastiic agent. It is an anti-mitotic drug whose cytotoxicity affects tumor cells but can also extend to other dividing cells. In some cases, the drug could cause severe side effects and deaths due to its toxicity have been reported. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Docetaxel"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001769 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of docetaxel. Docetaxel is used as a chemotherapeutic agent for the treatment of various cancers. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Docetaxel"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001770 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of docetaxel-target interaction and of the biochemical or physiological responses to drug. Docetaxel  is used as a chemotherapeutic agent for the treatment of various cancers. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Docetaxel"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001771 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of tenofovir, an antirfetroviral drug used for the treatment of HIV infection and hepatitis B. It is a nucleoside analog reverse transcriptase inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Tenofovir"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001772 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination of tenofovir - a nucleotide analogue reverse transcriptase inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Tenofovir"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001773 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of tenofovir-target interaction and of the biochemical or physiological responses to drug. Tenofovir is a nucleotide analogue reverse transcriptase inhibitor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Tenofovir"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001774 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A pathway triggered by administration of docetaxel, a chemotherapeutic drug. Docetaxel inhibits mitotic cell division and its cytotoxicity extends to all dividing cells, not just tumor cells. Severe side effects and even death cases have been reported."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Docetaxel"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001775 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive metabolic disorder resulting from impaired pyruvate metabolism. An absent or decreased activity of pyruvate carboxylase results in an altered pyruvate pathway."^^xsd:string ;
  obo:hasDbXref "PMIM:266150"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001777 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A rather rare autosomal recessive immunodeficiency resulting from decreased T-cell function. Disruption of purine nucleoside phosphorylase results in an altered purine salvage pathway."^^xsd:string ;
  obo:hasDbXref "OMIM:613179"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001778 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive metabolic disorder due to mutations in propionyl CoA carboxylase genes resulting in alteration of amino acid metabolic pathways."^^xsd:string ;
  obo:hasDbXref "OMIM:606054"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001779 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A rare recessive metabolic disorder arising from alteration in the purine metabolic pathway."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Adenosine_monophosphate_deaminase_deficiency_type_1"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001781 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A genetic disorder characterized by the excretion of large amounts of oxalate and present in several forms depending on the alteration of the glyoxalate metabolic pathway."^^xsd:string ;
  obo:hasDbXref "MeSH:D006960"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001782 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Hyperoxaluria results from alteration in the glyoxylate metabolic pathway. Type 1 is due to mutations in the alanine-glyoxylate aminotransferase (AGXT) enzyme."^^xsd:string ;
  obo:hasDbXref "OMIM:259900"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001783 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Hyperoxaluria results from alteration in the glyoxylate metabolic pathway. Type 2 is due to mutations in the glyoxylate reductase/hydroxypyruvate reductase (GRHPR) enzyme."^^xsd:string ;
  obo:hasDbXref "OMIM:260000"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001784 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A group of metabolic conditions due to alterations in the heme biosynthetic pathway in bone marrow, the liver or both. They are further classified depending on the enzymes that are deficient or the site."^^xsd:string ;
  obo:hasDbXref "MeSH:D011164"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001785 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "One of several liver porphyrias, all resulting from alterations in the heme biosynthetic pathway. Here, the deficient enzyme is protoporphyrinogen oxidase."^^xsd:string ;
  obo:hasDbXref "MeSH:D017094"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001786 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of tranexamic acid, an inhibitor of enzymes involved in fibrinolysis and as such, effective in the treatment of certain bleeding disorders It is also used in surgery to prevent excessive bleeding. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Tranexamic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001787 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of tranexamic acid. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Tranexamic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001788 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of tranexamic acid-target interaction and of the biochemical or physiological responses to drug. It is an inhibitor of plasminogen and used to treat bleeding conditions and in surgery to prevent excessive bleeding  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Tranexamic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001790 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of triamterene, a sodium channel blocker used to lower blood pressure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Triamterene"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001791 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of triamterene. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Triamterene"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001792 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of triamterene-target interaction and of the biochemical or physiological responses to drug. The drug blocks the epithelial sodium channels and is used in the treatment of hypertension. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Triamterene"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001793 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of tenoxicam, a non-steroidal anti-inflammatory drug used in the treatment of osteoarthritis, rheumatoid arthritis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Tenoxicam"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001794 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination of tenoxicam, an antirheumatic drug. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Tenoxicam"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001795 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of tenoxicam-target interaction and of the biochemical or physiological responses to drug. Tenoxicam is thought to inhibit cyclooxygenases and thus block prostaglandin synthesis. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Tenoxicam"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001796 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of telmisartan, an angiotensin II receptor type 1 antagonist used in the treatment of essential hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Telmisartan"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001797 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of telmisartan. The drug is an antagonist of angiotensin II receptor type 1. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Telmisartan"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001798 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of telmisartan-target interaction and of the biochemical or physiological responses to drug. The drug is an antagonist of the angiotensin II receptor type 1. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Telmisartan"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001799 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of sulindac, a non-steroidal anti-inflammatory drug used in the treatment of acute or chronic inflammatory conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Sulindac"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001800 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination of sulindac, an anti-inflammatory drug. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Sulindac"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001801 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of sulindac-target interaction and of the biochemical or physiological responses to drug. Sulindac is thought to interfere with prostaglandin synthesis."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Sulindac"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001802 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A pathway triggered by administration of doxorubicin, a widely used chemotherapeutic agent. The cytotoxicity of doxorubicin is primarily manifested in its cardiotoxic effect that can lead to heart failure, Possible causes are reactive oxygen species (ROS), impaired iron homeostasis and mitochondrial dysfunction."^^xsd:string ;
  obo:hasDbXref "PMID:25895646"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001803 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of streptomycin, a bactericidal antibiotic that inhibits bacterial protein synthesis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Streptomycin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001804 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Streptomycin inhibits bacterial protein synthesis in both Gram-positive and Gram-negative bacteria and as such is a broad-spectrum antibiotic."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Streptomycin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001805 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A group of autosomal recessive disorders resulting from alterations in amino acid metabolism, mostly due to deficiency of hepatic phenylalanine hydroxylase. The enzyme catalyzes the hydroxylation of phenylalanine to tyrosine."^^xsd:string ;
  obo:hasDbXref "OMIM:261600"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001806 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An inherited disorder resulting from alteration in the urea cycle metabolic pathway."^^xsd:string ;
  obo:hasDbXref "MeSH:D020163"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001807 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A progressive atrophy of the choroid and retina resulting from alterations in amino acid metabolic pathways involving ornithine aminotransferase enzyme."^^xsd:string ;
  obo:hasDbXref "OMIM:258870"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001808 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive disorder resulting from alterations in the glycine metabolic pathway."^^xsd:string ;
  obo:hasDbXref "OMIM:605899"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001809 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A rare autosomal recessive disorder resulting from alterations purine-pyrimidine and/or amino acid metabolic pathways."^^xsd:string ;
  obo:hasDbXref "OMIM:614105"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001810 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An inherited condition resulting from alterations in the metabolic pathway whereby methylmalonyl-coenzyme A (CoA) is converted into succinyl-CoA."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Methylmalonic_acidemia"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001811 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A form of methylmalonic aciduria disease pathway involving cobalamin (vitamin B12) in the methionine and homocysteine metabolic pathways."^^xsd:string ;
  obo:hasDbXref "OMIM:613646"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001812 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive disorder resulting from defects in mevalonate kinase, one of the two kinases sequentially phosphorylating mevalonate to isopentenyl pyrophosphate in the isoprenoid and cholesterol biosynthetic pathways."^^xsd:string ;
  obo:hasDbXref "OMIM:610377"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001813 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A condition resulting from alterations in the electron transport chain metabolic pathway involving the NADH ubiquinone oxidoreductase complex I."^^xsd:string ;
  obo:hasDbXref "OMIM:252010"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001814 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A condition resulting from alterations in the electron transport chain metabolic pathway involving the succinate dehydrogenase complex II."^^xsd:string ;
  obo:hasDbXref "OMIM:252011"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001815 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A condition resulting from alterations in the electron transport chain metabolic pathway involving complex III."^^xsd:string ;
  obo:hasDbXref "OMIM:124000"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001817 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A disorder resulting from alterations in the molybdenum biosynthetic pathway."^^xsd:string ;
  obo:hasDbXref "OMIM:252150"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001819 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of stavudine, an anti-viral drug used for the treatment of HIV infection. It belongs to the family of nucleoside analog reverse transcriptase inhibitors. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Stavudine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001820 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of stavudine, a drug used for the treatment of HIV. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Stavudine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001821 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of stavudine-target interaction and of the biochemical or physiological responses to drug. Stavudine is a drug used for the treatment of HIV infection. Stavudine, in its active triphosphate form, inhibits HIV-1 reverse transcriptase activity. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Stavudine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001822 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of spironolactone - a drug used in the treatment of hypertension and heart failure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Spironolactone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001823 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of spironolactone. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Spironolactone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001824 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of spironolactone-target interaction and of the biochemical or physiological responses to drug. The drug inhibits the effects of aldosterone by competing with its receptor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Spironolactone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001825 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of spirapril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Spirapril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001826 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of spirapril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Spirapril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001827 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of spirapril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Spirapril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001828 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of sotalol - a non-selective adrenergic beta receptor blocker. It binds and inhibits the beta 1 and beta 2 receptors and is used for the treatment of hypertension and other cardiovascular conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Sotalol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001829 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of sotalol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta 1 and beta 2. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Sotalol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001830 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of sotalol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Sotalol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001831 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An iron homeostasis pathway that deviates from what its normal course should be. Either iron deficiency or iron overload contributes to the development of numerous conditions, from anemia to inflammation, cancer, cardiovascular, infection and neurodegenerative diseases."^^xsd:string ;
  obo:hasDbXref "PMID:26805813"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001834 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of roxatidine acetate - a histamine H2 specific receptor antagonist used in the treatment of acid disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Roxatidine_acetate"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001835 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of roxatidine. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Roxatidine_acetate"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001836 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of roxatidine-target interaction and of the biochemical or physiological responses to drug. The drug is a specific antagonist H2 receptor and it is used for the treatment of various acid disorders. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Roxatidine_acetate"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001837 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of risedronate - a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Risedronic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001838 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of risedronate-target interaction and of the biochemical or physiological responses to drug. Risedronate is a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:15932344"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001839 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of risedronate, a nitrogenous bisphosphonate drug. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:15932344"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001840 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A condition of elevated levels of homocysteine usually due to alteration in folate metabolic pathways. Homocysteine is an intermediate in the methionine metabolic cycle. It can be remethylated to methionine or it can follow the transsulfuration pathway."^^xsd:string ;
  obo:hasDbXref "MeSH:D020138"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001841 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive condition downstream of homocysteine and involving alterations in the transsulfuration pathway. Usually, it is due to defects in the first enzyme of the transsulfuration pathway, cystathione beta synthase."^^xsd:string ;
  obo:hasDbXref "OMIM:236200"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001842 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Damage to mitochondria will promote mitophagy, the mitochondrial autophagy pathway. It exhibits features common to macroautophagy or the regular autophagy, and also features that are distinct. Under more sustained stress, the cell will promote apoptosis. Translocation of cardiolipin, the signature phospholipid of mitochondrial inner membrane, to the outer membrane, provides a signal of mitochondrial dysfunction."^^xsd:string ;
  obo:hasDbXref "PMID:22743996"^^xsd:string, "PMID:23065344"^^xsd:string, "PMID:25673287"^^xsd:string, "PMID:25840011"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001843 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of ranitidine acetate - a histamine H2 specific receptor antagonist used in the treatment of acid disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Ranitidine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001844 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of ranitidine. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Ranitidine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001845 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of ranitidine-target interaction and of the biochemical or physiological responses to drug. The drug is a specific antagonist H2 receptor and it is used for the treatment of various acid disorders. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Ranitidine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001846 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of rabeprazole, a proton pump inhibitor. It is administered for the treatment of acid-related disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Rabeprazole"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001847 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of rabeprazole, a compound in the class of proton pump inhibitors. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Rabeprazole"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001848 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of rabeprazole-target interaction and of the biochemical or physiological responses to drug. Rabeprazole is a compound in the class of proton pump inhibitors used in the treatment of acid-related disorders. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Rabeprazole"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001849 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of quinidine, a class I antiarrhythmic agent that can increase cardiac action potential. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Quinidine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001850 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of quinidine, a class I antiarrhythmic agent. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Quinidine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001851 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of quinidine-target interaction and of the biochemical or physiological responses to drug. Its primary action is blocking the fast inward sodium current. However, it can impact on other currents and channels, such as the slow inward calcium, the rapid and slow components of the delayed potassium, and the inward potassium rectifier currents, and the ATP-sensitive potassium channel. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Quinidine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001852 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of propanolol - a non-selective adrenergic beta receptor blocker, used for the treatment of hypertension and other cardiovascular conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Propranolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001853 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of propanolol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Propranolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001854 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of propanolol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Propranolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001855 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of procaine, a drug used as a local anesthetic. It also has anti--inflammatory and mood enhancing effects. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Procaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001856 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of procaine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Procaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001857 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of procaine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Procaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001858 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of procainamide, a class Ia antiarrhythmic drug. There are many adverse side effects and the cytotoxicity of the drug is documented. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Procainamide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001859 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of procainamide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Procainamide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001860 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of procainamide-target interaction and of the biochemical or physiological responses to drug. The drug is a class Ia antiarrhythmic drug that can also elicit serious cytotoxic effects.  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Procainamide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001861 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A pathway triggered by administration of procainamide, a class Ia antiarrhythmic drug. The cytotoxic effects impact on lymphocytes and interfere with pacemaker, among others. Many of the toxic effects may result from acetylation of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Procainamide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001862 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of prednisone - a synthetic glucocorticoid that is particularly effective as a immunosuppressant drug. Both short- and long-term effects can occur. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Prednisone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001863 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of prednisone, a synthetic glucocorticoid. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Prednisone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001864 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of prednisone-target interaction and of the biochemical or physiological responses to drug. The drug is particularly effective as an immunosuppressant. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Prednisone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001865 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of piroxicam, a non-steroidal anti-inflammatory drug used in the treatment of inflammatory conditions and to relieve pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Piroxicam"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001866 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of piroxicam, an anti-inflammatory drug. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Piroxicam"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001867 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of piroxicam-target interaction and of the biochemical or physiological responses to drug. The drug is a non-selective cyclooxygenase (COX) inhibitor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Piroxicam"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001868 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An inborn metabolic disorder resulting from alterations in the methionine cycle/metabolic pathway."^^xsd:string ;
  obo:hasDbXref "OMIM:250850"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001869 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An inherited condition resulting from impaired lipid metabolic pathways."^^xsd:string ;
  obo:hasDbXref "OMIM:201450"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001870 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive condition resulting from alterations in branched-chain amino acid metabolic pathways. It has several forms and a range of phenotypes."^^xsd:string ;
  obo:hasDbXref "OMIM:248600"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001871 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A disorder resulting from an impaired transport pathway of positively charged amino acids."^^xsd:string ;
  obo:hasDbXref "OMIM:222700"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001872 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those conditions resulting from alterations in pathways involving genes on the X-chromosome in humans or in other species."^^xsd:string ;
  obo:hasDbXref "MeSH:D040181"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001873 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those conditions resulting from alterations in pathways involving genes on the Y-chromosome in humans or in other species."^^xsd:string ;
  obo:hasDbXref "MeSH:D050174"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001874 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A rare autosomal condition resulting from an impaired amino acid metabolism."^^xsd:string ;
  obo:hasDbXref "OMIM:243500"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001876 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of plasmalogen, a type of ether phospholipid found in many tissues, particularly in the cardiovascular, immune and nervous system."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Plasmalogen"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001877 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of plasmalogen."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Plasmalogen"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001878 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Genetic disorders involving intellectual disabilty resulting from alterations in pathways whose component genes are located on the X chromosome."^^xsd:string ;
  obo:hasDbXref "MeSH:D038901"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001879 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An inherited disorder with several psychomotor phenotypes resulting from altered purine metabolism, particularly the salvage pathway, due to defects in the hypoxanthine phosphoribosyltransferase 1 (HPRT1) gene, located on the X chromosome."^^xsd:string ;
  obo:hasDbXref "OMIM:300322"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001880 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A condition associated with impaired renal tubular transport."^^xsd:string ;
  obo:hasDbXref "OMIM:242600"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001881 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A genetic metabolic disorder due to impaired bone alkaline phosphatase activity and manifesting in a range of phenotypes."^^xsd:string ;
  obo:hasDbXref "MeSH:D007014"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001882 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of pirenzepine, a muscarinic receptor antagonist used in the treatment of peptic ulcers. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Pirenzepine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001885 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of pentazocine, an opioid analgesic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Pentazocine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001886 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of pentazocine, an opioid analgesic. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Pentazocine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001887 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of pentazocine-target interaction and of the biochemical or physiological responses to drug. Pentazocine is an opioid analgesic used to treat moderate to more severe pain. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Pentazocine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001888 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of pantoprazole, a proton pump inhibitor. It is administered for the treatment of acid-related disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Pantoprazole"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001889 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of pantoprazole, a compound in the class of proton pump inhibitors. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Pantoprazole"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001890 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of pantoprazole-target interaction and of the biochemical or physiological responses to drug. Pantoprazole is a compound in the class of proton pump inhibitors used in the treatment of acid-related disorders. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Pantoprazole"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001891 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination of streptomycin - an antibiotic that interferes with bacterial protein synthesis. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Streptomycin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001892 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of calcium channel blockers - agents used as antihypertensive drugs. They are further classified as dihydropyridine and non-dihydropyridine drugs, and both classes are rather selective. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Calcium_channel_blocker"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001893 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of non-dihydropyridine calcium channel blockers - agents often used to treat angina and relatively selective for myocardium. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Calcium_channel_blocker"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001894 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of dihydropyridine calcium channel blockers - agents derived from dihydropyridine and used to reduce arterial pressure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Calcium_channel_blocker"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001895 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of nimodipine, a calcium channel blocker developed for the treatment of hypertension but now used to prevent vasospasm. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Nimodipine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001896 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of nifedipine, a calcium channel blocker used in the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Nisoldipine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001897 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of nitrendipine, a calcium channel blocker used in the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Nitrendipine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001898 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of nimodipine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Nimodipine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001899 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of nisoldipine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Nisoldipine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001900 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of nitrendipine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Nitrendipine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001901 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of nimodipine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Nimodipine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001902 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of nisoldipine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Nisoldipine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001903 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of nitrendipine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:<new dbxrefhttps://en.wikipedia.org/wiki/Nitrendipine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001904 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of nizatidine - a histamine H2 specific receptor antagonist used in the treatment of acid disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Nizatidine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001905 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of nizatidine. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Nizatidine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001906 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of nizatidine-target interaction and of the biochemical or physiological responses to drug. The drug is a histamine H2 receptor specific antagonist used for the treatment of various acid disorders. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Nizatidine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001907 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of olmesartan, an angiotensin II receptor type 1 antagonist used in the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Olmesartan"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001908 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of olmesartan. The drug is an antagonist of angiotensin II receptor type 1. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Olmesartan"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001909 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of olmesartan-target interaction and of the biochemical or physiological responses to drug. The drug is an antagonist of the angiotensin II receptor type 1. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Olmesartan"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001910 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of nebivolol, a selective beta adrenergic type 1 receptor antagonist used in the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Nebivolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001911 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of nebivolol. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Nebivolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001912 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of nebivolol-target interaction and of the biochemical or physiological responses to drug. The drug is a selective antagonist of beta adrenergic type 1 receptor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Nebivolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001913 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of naproxen, a non-steroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes and is used in the treatment of inflammation and pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Naproxen"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001914 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of naproxen. The drug is used in the treatment of pain and inflammation. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Naproxen"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001915 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of naproxen-target interaction and of the biochemical or physiological responses to drug. Naproxen is an inhibitor of cyclooxygenase enzymes used in the treatment of pain and inflammation. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Naproxen"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001916 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of naltrexone, an antagonist of opioid receptors used in the treatment of substance dependence. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Naltrexone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001917 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of naltrexone, an antagonist of opioid receptors. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Naltrexone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001918 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of naltrexone-target interaction and of the biochemical or physiological responses to drug. The drug is an antagonist of mu opioid receptor and to a lesser and much lesser extent, the kappa and delta opioid receptors, respectively. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "XXwikipedia:https://en.wikipedia.org/wiki/Naltrexone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001919 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of nalbuphine, a semi-synthetic opioid used an analgesic for the relief of moderate to severe pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Nalbuphine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001920 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of nalbuphine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Nalbuphine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001921 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of nalbuphine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Nalbuphine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001922 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of nabumetone, a non-steroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes, preferentially COX-2 type. The drug is used in the treatment of inflammation and pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Nabumetone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001923 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of nabumetone. The drug is rapidly metabolized in the liver to 6-methoxy-2-naphthyl, its major active metabolite. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Nabumetone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001924 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of nabumetone-target interaction and of the biochemical or physiological responses to drug. Nabumetone is an inhibitor of COX-2 enzyme used in the treatment of pain and inflammation. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Nabumetone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001925 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of metolazone - a blocker of sodium -chloride symporter in the distal convoluted tubule of the nephron. The drug is used for the treatment of hypertension and congestive heart failure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Metolazone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001926 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of metolazone. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Metolazone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001927 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of metolazone-target interaction and of the biochemical or physiological responses to drug. The drug blocks the sodium-chloride symporter and is used in the treatment of hypertension and congestive heart failure. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Metolazone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001928 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of metoprolol, a selective beta adrenergic type 1 receptor antagonist used in the treatment of hypertension and several other conditions involving a faster than normal heart rate. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Metoprolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001929 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of metoprolol. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Metoprolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001930 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of metoprolol-target interaction and of the biochemical or physiological responses to drug. The drug is a selective antagonist of beta adrenergic type 1 receptor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Metoprolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001931 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A condition resulting from alterations in the proline amino acid metabolic pathway and involving the enzyme proline oxidase."^^xsd:string ;
  obo:hasDbXref "OMIM:239510"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001932 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A rare condition resulting from alterations in the proline amino acid metabolic pathway leading to high levels of proline and the related compound pyrroline-5-carboxylase in the circulation."^^xsd:string ;
  obo:hasDbXref "OMIM:239510"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001933 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A condition resulting from alterations in the various aspects of cholesterol metabolism or transport along with environmental or other diseases related aspects and manifesting in high levels of circulating cholesterol."^^xsd:string ;
  obo:hasDbXref "MeSH:D006937"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001935 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A condition spanning a spectrum of manifestations that may also cause hypoglycemia resulting from alterations in glucose homeostasis and insulin related pathways."^^xsd:string ;
  obo:hasDbXref "MeSH:D006946"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001936 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A group of inherited disorders resulting from alterations in the lysine metabolic pathway."^^xsd:string ;
  obo:hasDbXref "OMIM:238700"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001939 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of methadone, an acyclic analog of morphine and heroin acting on the same opioid receptors and used in the management of severe, chronic pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "eikipedia:https://en.wikipedia.org/wiki/Methadone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001940 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of methadone. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Methadone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001941 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of methadone-target interaction and of the biochemical or physiological responses to drug. Methadone binds the mu-opioid receptor of sensory neurons triggering downstream cascades that activate potassium channels while inactivating calcium channels. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Methadone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001942 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of mercaptopurine, an immunosuppressive drug used in the treatment of leukemia, Crohn's disease and colitis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Mercaptopurine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001943 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of mercaptopurine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Mercaptopurine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001944 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of mercaptopurine-target interaction and of the biochemical or physiological responses to drug. The drug is used as an immunosuppressive and its cytotoxic effects result from its interference with nucleic acids synthesis and function. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Mercaptopurine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001945 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of mepivacaine, a drug used as a local anesthetic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Mepivacaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001946 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of mepivacaine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Mepivacaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001947 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of mepivacaine-target interaction and of the biochemical or physiological responses to drug. It acts mainly as a blocker of voltage-gated sodium channels. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Mepivacaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001948 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of meloxicam, a non-steroidal anti-inflammatory drug used to relieve pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Meloxicam"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001949 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of piroxicam. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Meloxicam"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001950 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of meloxicam-target interaction and of the biochemical or physiological responses to drug. The drug is a non-selective cyclooxygenase (COX) inhibitor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Meloxicam"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001951 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of mefenamic acid, a non-steroidal anti-inflammatory drug used to treat mild to moderate pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Mefenamic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001952 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of mefenamic acid. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Mefenamic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001953 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of mefenamic acid-target interaction and of the biochemical or physiological responses to drug. The drug is a non-selective cyclooxygenase (COX) inhibitor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Mefenamic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001954 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Nuclear eukaryotic DNA replication takes place in the context of the cell cycle during the S-phase. The fast and accurate replication of DNA requires the presence and the coordinated function of a complex of proteins known as the replisome. The exact composition of the replisome in higher organisms still has to be fully determined. Mitochondria contain their own DNA. Human mtDNA is a small, circular molecule that resides in the matrix and, depending on cell type, can exist as a few to several thousands copies. mtDNA has its own replicative machinery."^^xsd:string ;
  obo:hasDbXref "PMID:19665592"^^xsd:string, "wikipedia:https://en.wikipedia.org/wiki/DNA_replication"^^xsd:string, "wikipedia:https://en.wikipedia.org/wiki/Mitochondrial_DNA"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001956 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Nuclear eukaryotic DNA replication takes place in the context of the cell cycle during the S-phase. The fast and accurate replication of DNA requires the presence and the coordinated function of a complex of proteins known as the replisome. The exact composition of the replisome in higher organisms still has to be fully determined."^^xsd:string ;
  obo:hasDbXref "PMID:19665592"^^xsd:string, "wikipedia:https://en.wikipedia.org/wiki/DNA_replication"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001957 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Mitochondria contain their own DNA. Human mtDNA is a small, circular molecule that resides in the matrix and, depending on cell type, can exist as a few to several thousands copies. mtDNA has its own replicative machinery."^^xsd:string ;
  obo:hasDbXref "PMID:25499735"^^xsd:string, "wikipedia:https://en.wikipedia.org/wiki/Mitochondrial_DNA"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001958 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A mitophagy pathway that deviates from what its normal course should be. Mitochondrial damage and altered mitophagy pathway have been implicated in neurodegenerative diseases associated with aging, such as Parkinson, Huntington and Alzheimer diseases."^^xsd:string ;
  obo:hasDbXref "PMID:22743996"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001959 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The various pathways and mechanisms that assure the proper function and abundance of mitochondria within cells. In addition to being the powerhouse of the cell as the place of oxidative phosphorylation, mitochondria are also the site of other important metabolic pathways and play essential roles in calcium storage and signaling and apoptosis, among others."^^xsd:string ;
  obo:hasDbXref "PMID:21928343"^^xsd:string, "PMID:24486129"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001960 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Disruption of mitochondrial homeostasis is associated with neurodegenerative diseases, cancer and aging."^^xsd:string ;
  obo:hasDbXref "PMID:21928343"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001961 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The interplay of mitochondria fission and fusion and mitochondria trafficking to properly respond to cellular needs. Mitochondria tend to form reticular networks, regulated through the coordination of fission, fusion and redistribution."^^xsd:string ;
  obo:hasDbXref "PMID:21683788"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001962 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Mitochondria are essential organelles that provide most of the ATP fuel for the cell, are the site of several important metabolic pathways and play essential roles in calcium storage, signaling and apoptosis. Of the many proteins involved, only 13 are encoded in the mammalian mitochondrial DNA. The remaining ~99% of mitochondrial proteins are translocated from the cytosol via a complex, multicomponent pathway system. Mitochondria-encoded proteins are translocated from the mitochondrial matrix into the inner mitochondrial membrane by a single system."^^xsd:string ;
  obo:hasDbXref "PMID:22178138"^^xsd:string, "PMID:24561263"^^xsd:string, "PMID:25633533"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001963 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of lansoprazole, a proton pump inhibitor. It is administered for the treatment of acid-related disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Lansoprazole"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001964 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of lansoprazole, a compound in the class of proton pump inhibitors pharmacologically related to omeprazole. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Lansoprazole"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001965 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of lansoprazole-target interaction and of the biochemical or physiological responses to drug. Lansoprazole is a compound in the class of proton pump inhibitors pharmacologically related to omperazole, used in the treatment of acid-related disorders. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Lansoprazole"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001966 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of ketorolac, a non-steroidal anti-inflammatory drug used to treat moderate to severe pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Ketorolac"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001967 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of ketorolac. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Ketorolac"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001968 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of ketorolac-target interaction and of the biochemical or physiological responses to drug. The drug is a non-selective cyclooxygenase (COX) inhibitor used for short-term management of moderate to severe pain. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Ketorolac"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001969 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of ketoprofen, a non-steroidal anti-inflammatory drug that also has analgesic and antipyretic effects. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Ketoprofen"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001970 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of ketoprofen. The drug is used in the treatment of inflammation and pain. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Ketoprofen"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001971 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of ketoprofen-target interaction and of the biochemical or physiological responses to drug. Ketoprofen is an inhibitor of cyclooxygenase enzymes used in the treatment of inflammation and pain. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Ketoprofen"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001972 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of isradipine, a calcium channel blocker used for the treatment of high blood pressure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Isradipine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001973 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of isradipine. The drug is a calcium channel blocker used in the treatment of high blood pressure.  Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Isradipine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001974 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of isradipine-target interaction and of the biochemical or physiological responses to drug. The drug is a calcium channel blocker, particularly the L-type channel, used for the treatment of high blood pressure.  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Isradipine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001975 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A stress response pathway to mitochondrial DNA depletion or accumulation of misfolded protein in the matrix or intermembrane space. Mitochondrial-to-nucleus signaling results in the increased expression of genes important for mitochondrial protein homeostasis. UPRmt can promote increased lifespan but the mechanisms are not well understood. Mitchondrial dysfunction contributes to normal aging. Yet, mild distress can extent life span by almost 50% in organisms ranging from yeast to worms, flies, and mice."^^xsd:string ;
  obo:hasDbXref "PMID:22445420"^^xsd:string, "PMID:25857997"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001976 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Disorders caused by alterations in the amino acid transport pathways across cell membranes."^^xsd:string ;
  obo:hasDbXref "MeSH:D020157"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001977 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive disorder caused by alterations in the transport of neutral amino acids in the intestine and proximal renal tubules. The condition is associated with psychosis and mental retardation."^^xsd:string ;
  obo:hasDbXref "MeSH:D006250"^^xsd:string, "OMIM:234500"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001978 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive condition resulting from alterations in the histidine metabolic pathway and characterized by increased levels of histidine in blood, cerebrospinal fluid and urine."^^xsd:string ;
  obo:hasDbXref "OMIM:235800"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001979 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway involved in a progressive neurologic disorder resulting from a deficiency of homocarnosinase."^^xsd:string ;
  obo:hasDbXref "OMIM:212200"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001980 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A group of metabolic conditions due to alterations in the heme biosynthetic pathway in the liver. They are further classified depending on the enzymes that are deficient or the site."^^xsd:string ;
  obo:hasDbXref "MeSH:D017094"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001981 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal dominant liver porphyria due to deficiency in the coproporphyrinogen oxidase gene."^^xsd:string ;
  obo:hasDbXref "MeSH:D046349"^^xsd:string, "OMIM:121300"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001982 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of irbesartan, an angiotensin II receptor type 1 antagonist used in the treatment of hypertension. Irbesartan is one of several angiotensin II receptor antagonists.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Irbesartan"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001983 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of irbesartan. The drug is an antagonist of angiotensin II receptor type 1. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Irbesartan"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001984 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of irbesartan-target interaction and of the biochemical or physiological responses to drug. The drug is an antagonist of the angiotensin II receptor type 1. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Irbesartan"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001985 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of imipramine, an antidepressant used in the treatment of major depression. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Imipramine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001986 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of imipramine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Imipramine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001987 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of imipramine-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of major depression and its effect results from inhibition of serotonin and norepinephrine neurotransmitter reuptake. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Imipramine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001988 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of ibutilide, an antiarrhythmic agent. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Ibutilide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001989 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of ibutilide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Ibutilide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001990 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of ibutilide-target interaction and of the biochemical or physiological responses to drug. The drug is an antiarrhythmic agent. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Ibutilide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001991 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A group of inherited metabolic disorders resulting from alterations in the glycogen metabolic pathway."^^xsd:string ;
  obo:hasDbXref "MeSH:D006008"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001992 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "One of the two forms of the type I glycogen storage disease pathway involving glucose-6-phosphate, here due to mutations in glucose-6-phosphatase. It is characterized by the accumulation of glycogen in particular organs and tissues."^^xsd:string ;
  obo:hasDbXref "OMIM:232200"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001993 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "One of the two forms of the type I glycogen storage disease pathway involving glucose-6-phosphate, here due to mutations affecting the glucose-6-phosphate transporter. It is characterized by the accumulation of glycogen in particular organs and tissues."^^xsd:string ;
  obo:hasDbXref "OMIM:232220"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001994 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A type of glycogen disease pathway that involves the glycogen debranching enzyme. There are further subdivisions, to delineate the clinical manifestations."^^xsd:string ;
  obo:hasDbXref "OMIM:232400"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001995 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A type of glycogen storage disease pathway involving glycogen branching enzyme 1."^^xsd:string ;
  obo:hasDbXref "OMIM:232500"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001996 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A type of glycogen storage disease pathway involving the liver phosphorylase."^^xsd:string ;
  obo:hasDbXref "OMIM:232700"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001997 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A type of glycogen storage disease pathway involving muscle phosphofructokinase."^^xsd:string ;
  obo:hasDbXref "OMIM:232800"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001998 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The events leading to fission of mitochondria. Fission allows mitochondria to divide and grow and also to isolate and remove defective organelles."^^xsd:string ;
  obo:hasDbXref "PMID:21683788"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0001999 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The events leading to fusion of mitochondria."^^xsd:string ;
  obo:hasDbXref "PMID:21683788"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002000 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of ibandronate - a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Ibandronic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002001 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of ibandronate, a nitrogenous bisphosphonate drug. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Ibandronic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002002 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of ibandronate-target interaction and of the biochemical or physiological responses to drug. Ibandronate is a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Ibandronic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002003 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of hydrochlorothiazide, a drug used in the treatment of high blood pressure.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Hydrochlorothiazide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002004 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of hydrochlorothiazide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Hydrochlorothiazide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002005 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of hydrochlorothiazide-target interaction and of the biochemical or physiological responses to drug. The drug reduces sodium reabsorption in the distal convoluted tubule of kidney nephron. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Hydrochlorothiazide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002006 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of gliclazide, a second generation sulfonylurea anti-diabetic drug used in the treatment of type 2 diabetes mellitus. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Gliclazide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002007 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of gliclazide, an anti-diabetic drug used in the treatment of type 2 diabetes mellitus. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Gliclazide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002008 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of gliclazide-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of type 2 diabetes mellitus. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Gliclazide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002009 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of glyburide, a second generation sulfonylurea anti-diabetic drug used in the treatment of type 2 diabetes mellitus. The drug is also known as glibenclamide. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Glibenclamide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002010 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of glyburide, an anti-diabetic drug used in the treatment of type 2 diabetes mellitus. The drug is also known is glibenclamide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Glibenclamide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002011 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of glyburide-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of type 2 diabetes mellitus. Glyburide is also known as glibenclamide. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Glibenclamide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002012 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination of gentamicin - an antibiotic that interferes with bacterial protein synthesis. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Gentamicin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002013 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of gentamicin-target interaction and of the biochemical or physiological responses to drug. Gentamicin interferes with bacterial protein synthesis and is used in the treatment of several infections caused by both Gram-negative and Gram-positive bacteria. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Gentamicin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002014 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of furosemide - a blocker of luminal sodium-potassium-chloride symporter used for the treatment of hypertension and edema. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Furosemide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002015 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of furosemide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Furosemide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002016 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of furosemide-target interaction and of the biochemical or physiological responses to drug. The drug blocks the luminal sodium-potassium-chloride symporter in the thick ascending limb of the loop of Henle. Furosemide is used in the treatment of hypertension and edema.  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Furosemide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002017 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A rather common autosomal dominant porphyria resulting from defects in hydroxymethybilane synthase in the heme biosynthetic pathway."^^xsd:string ;
  obo:hasDbXref "OMIM:176000"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002018 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A rare metabolic disease due to alterations in the glycerol metabolic pathway resulting from defects in the glycerol kinase enzyme."^^xsd:string ;
  obo:hasDbXref "OMIM:307030"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002019 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A condition resulting from alterations in the glutathione biosynthesis pathway."^^xsd:string ;
  obo:hasDbXref "OMIM:266130"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002022 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of fosinopril - an angiotensin converting enzyme (ACE) inhibitor used for the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Fosinopril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002023 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of fosinopril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Fosinopril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002024 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of fosinopril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Fosinopril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002025 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of forasartan, an angiotensin II receptor type 1 antagonist used in the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Forasartan"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002026 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of forasartan. The drug is an antagonist of angiotensin II receptor type 1. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Forasartan"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002027 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of forasartan-target interaction and of the biochemical or physiological responses to drug. The drug is an antagonist of the angiotensin II receptor type 1. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Forasartan"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002028 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of fluoxetine, an antidepressant used in the treatment of major depressive disorders. The drug is a selective serotonin reuptake inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Fluoxetine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002029 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of fluoxetine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Fluoxetine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002030 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of fluoxetine-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of major depressive disorders and its effect results from selective inhibition of serotonin reuptake. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Fluoxetine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002031 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of flecainide, a drug used in the treatment of cardiac arrhythmias. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Flecainide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002032 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of flecainide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Flecainide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002033 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of flecainide-target interaction and of the biochemical or physiological responses to drug. The drug is an antiarrhythmic agent that acts by blocking sodium and possibly other channels in cardiomyocytes. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Flecainide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002034 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of fentanyl, a potent opioid analgesic used to treat sudden, severe pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Fentanyl"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002035 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of fentanyl, a potent opioid analgesic. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Fentanyl"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002036 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of fentonyl-target interaction and of the biochemical or physiological responses to drug. The drug is a synthetic opioid analgesic acting as a strong inhibitor of mu receptors. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Fentanyl"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002037 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of famotidine - a histamine H2 receptor antagonist used in the treatment of acid disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Famotidine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002038 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of famotidine. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Famotidine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002039 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of famotidine-target interaction and of the biochemical or physiological responses to drug. The drug is a histamine H2 receptor antagonist used in the treatment of acid disorders. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Famotidine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002040 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of etodolac, a non-steroidal anti-inflammatory drug used in the treatment of mild to moderate pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Etodolac"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002041 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of etodolac. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Etodolac"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002042 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of etodolac-target interaction and of the biochemical or physiological responses to drug. The drug is a cyclooxygenase (COX) inhibitor with a preference for COX-2 enzyme. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Etodolac"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002043 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of etacrinic acid, a loop diuretic used  in the treatment of high blood pressure.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Etacrynic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002044 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of etacrynic acid. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Etacrynic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002045 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of etacrynic acid-target interaction and of the biochemical or physiological responses to drug. The drug acts by inhibiting sodium-potassium-chloride contransport in the ascending loop of Henle. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Etacrynic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002046 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of esmolol, a selective beta adrenergic type 1 receptor antagonist used in the treatment of hypertension and several other conditions involving a faster than normal heart rate. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Esmolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002047 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of esmolol. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Esmolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002048 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of esmolol-target interaction and of the biochemical or physiological responses to drug. The drug is a selective antagonist of beta adrenergic type 1 receptor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Esmolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002049 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of escitalopram, an antidepressant used in the treatment of major depressive disorders. The drug is a selective serotonin reuptake inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Escitalopram"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002050 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of escitalopram. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Escitalopram"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002051 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of escitalopram-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of major depressive disorders and its effect results from selective inhibition of serotonin reuptake. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Escitalopram"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002052 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of erythromycin, an antibiotic that inhibits bacterial growth and used for the treatment of several bacterial infections. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Erythromycin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002053 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination of erythromycin - an antibiotic that interferes with bacterial growth. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Erythromycin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002054 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of ertthromycin-target interaction and of the biochemical or physiological responses to drug. The drug interferes with bacterial growth via incompletely understood mechanisms. It is used for the treatment of several bacterial infections. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Erythromycin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002055 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of eptifibatide, a platelet aggregation inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Eptifibatide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002056 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of eptifibatide, a platelet aggregation inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Eptifibatide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002057 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of eftifibatide-interaction and of the biochemical or physiological responses to drug. The platelet aggregation inhibitor belongs to glycoprotein IIb/IIIa inhibitor class. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Eptifibatide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002058 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of eprosartan, an angiotensin II receptor type 1 antagonist used in the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Eprosartan"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002059 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of eprosartan. The drug is an antagonist of angiotensin II receptor type 1. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Eprosartan"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002060 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of eprosartan-target interaction and of the biochemical or physiological responses to drug. The drug is an antagonist of the angiotensin II receptor type 1. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Eprosartan"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002061 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The transport of mitochondria to sites of high energy demand, such as neurons and cardiomyocytes. Mitochondrial distribution at synaptic terminals and active growth cones is crucial for the proper function of neurons. Impaired transport and other aspects of mitochondrial dysfunction are involved in the pathology of major neurodegenerative disorders."^^xsd:string ;
  obo:hasDbXref "PMID:21683788"^^xsd:string, "PMID:24687278"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002062 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Defects in mitochondrial dynamics are associated with the pathology of major neurodegenerative disorders."^^xsd:string ;
  obo:hasDbXref "PMID:19808793"^^xsd:string, "PMID:24687278"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002063 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of disulfiram, a drug used in the treatment of chronic alcoholism and also cocaine dependence. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Disulfiram"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002064 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of disulfiram. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Disulfiram"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002065 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of disulfiram-target interaction and of the biochemical or physiological responses to drug. The drug inhibits the enzyme acetaldehyde dehydrogenase and also appears to prevent the breakdown of dopamine. Disulfiram is used in the treatment of chronic alcoholism and also cocaine dependence. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Disulfiram"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002066 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of disopyramide, a drug used in the treatment of arrhythmia. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Disopyramide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002067 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of disopyramide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Disopyramide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002068 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of disopyramide-target interaction and of the biochemical or physiological responses to drug. The drug is a sodium channel blocker used in the treatment of arrhythmia. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Disopyramide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002069 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of dipyridamole, a drug that inhibits the formation of blood clots via inhibition of platelet aggregation. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Dipyridamole"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002070 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of dipyridamole. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Dipyridamole"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002071 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of dipyridamole-target nteraction and of the biochemical or physiological responses to drug. Dipyridamole inhibits he formation of blood clots via inhibition of platelet aggregation. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Dipyridamole"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002072 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those reaction involved in the synthesis of lactose, the major sugar in milk."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Lactose"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002073 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A mitochondria transport pathway that deviates from what its normal could should be. Impaired transport and other aspects of mitochondrial dysfunction are involved in the pathology of major neurodegenerative disorders."^^xsd:string ;
  obo:hasDbXref "PMID:24687278"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002074 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A mitochondria fusion pathway that deviates from what its normal could should be."^^xsd:string ;
  obo:hasDbXref "PMID:21683788"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002075 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A mitochondria fission pathway that deviates from what its normal could should be."^^xsd:string ;
  obo:hasDbXref "PMID:21683788"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002076 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of diltiazem- a benzothiazepine L-type calcium channel blocker used in the treatment of hypertension and other cardiovascular conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Diltiazem"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002077 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of diltiazem, an L-type calcium channel blocker used for the treatment of cardiovascular conditions. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Diltiazem"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002078 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of diltiazem-target interaction and of the biochemical or physiological responses to drug. The drug is an L-type calcium channel blocker used in the treatment of hypertension and other cardiovascular conditions. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Diltiazem"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002079 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of diflunisal,  a non-steroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes and is used in the treatment of inflammation and pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Diflunisal"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002080 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of diflunisal. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Diflunisal"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002081 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of diflunisal-target interaction and of the biochemical or physiological responses to drug. Diflunisal is an inhibitor of cyclooxygenase enzymes used in the treatment of pain and inflammation. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Diflunisal"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002082 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of didanosine - an antiretroviral drug used in the treatment of HIV infection. It is a reverse transcriptase inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Didanosine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002083 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of didanosine, a drug used for the treatment of HIV. Didanosine triphosphate is the active form of the drug which is intracellularly metabolized. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Didanosine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002084 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of didanosine-target interaction and of the biochemical or physiological responses to drug. Didanosine is a drug used for the treatment of HIV infection. Didanosine, in its active triphosphate form, inhibits HIV-1 reverse transcriptase activity. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Didanosine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002085 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of diclofenac, a non-steroidal anti-inflammatory drug used to treat arthritis and other joint diseases."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Diclofenac"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002086 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of diclofenac. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Diclofenac"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002087 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of diclofenac-target interaction and of the biochemical or physiological responses to drug. The drug is used for the treatment of various joint diseases and in pain management. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Diclofenac"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002088 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of desipramine, an antidepressant used in the treatment of depression and attention deficit disorder. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Desipramine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002089 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of desipramine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Desipramine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002090 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of desipramine-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of major depression and its effect results from inhibition of norepinephrine and to a lesser extent serotonin neurotransmitter reuptake. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Desipramine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002091 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A group of inherited enzyme deficiencies that affect galactose metabolism and manifest as elevated galactose levels in the blood."^^xsd:string ;
  obo:hasDbXref "MeSH:D005693"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002092 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A galactosemia resulting from defects in the galactose-1-phosphate uridylyltransferase enzyme GALT."^^xsd:string ;
  obo:hasDbXref "OMIM:230400"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002093 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A galactosemia resulting from defects in the UDP-galactose-4-epimerase enzyme GALE."^^xsd:string ;
  obo:hasDbXref "OMIM:230350"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002094 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A galactosemia resulting from defects in the galactokinase enzyme GALK1."^^xsd:string ;
  obo:hasDbXref "OMIM:230200"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002095 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A condition caused by alterations in gamma aminobutyric acid metabolism due to defects in the 4-aminobutyrate aminotransferase enzyme."^^xsd:string ;
  obo:hasDbXref "OMIM:613163"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002096 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those symptoms associated with conditions affecting the muscles, neuromuscular junctions or peripheral nerves."^^xsd:string ;
  obo:hasDbXref "MeSH:D020879"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002097 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A disorder manifested by a diminished skeletal muscle tone."^^xsd:string ;
  obo:hasDbXref "MeSH:D009123"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002098 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A severe autosomal recessive metabolic disorder resulting from defects in the fumarate hydratase enzyme and manifesting in early-onset hypotonia, psychomotor and brain abnormalities."^^xsd:string ;
  obo:hasDbXref "OMIM:606812"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002099 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those diseases that are caused by inborn errors of fructose metabolism."^^xsd:string ;
  obo:hasDbXref "MeSH:D015318"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002100 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive condition resulting from alterations in fructose metabolism due to defects in the enzyme fructose-1,6-bisphosphatase."^^xsd:string ;
  obo:hasDbXref "MeSH:D015319"^^xsd:string, "OMIM:229700"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002101 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive disorder resulting from alterations in fructose metabolism and due to defects in the fructose-1-phosphate aldolase enzyme."^^xsd:string ;
  obo:hasDbXref "MeSH:D005633"^^xsd:string, "OMIM:229600"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002102 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those disorders resulting from alterations in steroid metabolic pathways due to inborn genetic mutations."^^xsd:string ;
  obo:hasDbXref "MeSH:D043202"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002103 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An X-linked inherited metabolic disorder resulting from alterations in lipid metabolic pathways. It is due to defects in alpha-galactosidase leading to accumulation of glycosphingolipids in blood vessels."^^xsd:string ;
  obo:hasDbXref "MeSH:D000795"^^xsd:string, "OMIM:301500"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002104 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Movement disorders classified by patterns of inheritance and age of onset."^^xsd:string ;
  obo:hasDbXref "MeSH:D020821"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002105 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A condition resulting from alterations in the metabolism of tetrahydrobiopterin (BH4), an essential cofactor for the activity of many enzymes. Diet and supplements, such as administration of L-Dopa, may diminish the outcomes of the condition."^^xsd:string ;
  obo:hasDbXref "PMID:19234759"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002106 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A rare autosomal recessive disorder likely resulting from alteration in cholesterol metabolism. Desmosterol, a precursor of cholesterol, is present in elevated amounts."^^xsd:string ;
  obo:hasDbXref "OMIM:602398"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002107 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of  cyclophosphamide, an alkylating agent used in the treatment of certain cancer types. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Cyclophosphamide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002108 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of cyclophosphamide. It is a prodrug that has to be converted to its metabolite - 4-hydroxy cyclophosphamide, to exhibit chemotherapeutic activity. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Cyclophosphamide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002109 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of cyclophosphamide-target interaction and of the biochemical or physiological responses to drug. The alkylating drug is used for the treatment of several cancer types but its toxicity can have severe adverse effects. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Cyclophosphamide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002110 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of cimetidine - a histamine H2 receptor antagonist used in the treatment of acid disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Cimetidine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002111 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of cimetidine. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Cimetidine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002112 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of cimetidine-target interaction and of the biochemical or physiological responses to drug. The drug is a histamine H2 receptor antagonist used for the treatment of various acid disorders. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Cimetidine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002113 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of non- selective monoamine reuptake inhibitor drugs."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/ATC_code_N06#N06A_Antidepressants"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002114 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of compounds used to treat various forms of depression. Some are non-selective monoamine reuptake inhibitors, others are selective serotonin reuptake inhibitors. The category also includes monoamine oxidase inhibitors and drug classified as others."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/ATC_code_N06#N06A_Antidepressants"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002115 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of selective serotonin uptake  inhibitor drugs."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/ATC_code_N06#N06A_Antidepressants"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002116 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of citalopram, an antidepressant used in the treatment of major depressive disorders. The drug is a selective serotonin reuptake inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Citalopram"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002117 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of citalopram. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Citalopram"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002118 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of citalopram-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of major depressive disorders and its effect results from selective inhibition of serotonin reuptake. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "XXwikipedia:https://en.wikipedia.org/wiki/Citalopram"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002119 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Histamine signaling is important for the central and to some extent the peripheral nervous systems and is also involved in the immune responses. Histamine signaling engages four G-protein coupled receptors (GPCR). In the immune system/inflammatory it involves receptors H2 and H4. H2 couples to Galphas."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Histamine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002120 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Histamine is a nitrogenous compound derived from histidine whose signaling plays important roles in the nervous and immune systems."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Histamine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002121 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of drugs that increase water excretion and are used in the treatment of hypertension, heart failure and certain kidney disorders. They are further categorized by type. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Diuretic"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002122 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of chlorothalidone - a blocker of sodium -chloride symporter in the distal convoluted tubule of the nephron. The drug is used for the treatment of hypertension and also as an adjuvant drug for treating edema. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Chlortalidone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002123 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of chlorthalidone. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Chlortalidone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002124 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of chlorthalidone-target interaction and of the biochemical or physiological responses to drug. The drug blocks the sodium-chloride symporter and is used in the treatment of hypertension and as an adjuvant for treating edema. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Chlortalidone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002125 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of captopril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Captopril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002126 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of captopril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Captopril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002127 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of captopril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Captopril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002128 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of candsartan, an angiotensin II receptor type 1 antagonist used in the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Candesartan"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002129 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of candesartan. The drug is an antagonist of angiotensin II receptor type 1. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Candesartan"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002130 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of candesartan-target interaction and of the biochemical or physiological responses to drug. The drug is an antagonist of the angiotensin II receptor type 1. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Candesartan"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002131 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of capecitabine, an agent used in the treatment of several cancers. Capecitabine is a prodrug that is enzymatically converted to 5-fluorouracil which inhibits the activity of thymidylate synthase necessary for the de novo DNA synthesis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Capecitabine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002132 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of capecitabine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Capecitabine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002133 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of capecitabine-target interaction and of the biochemical or physiological responses to drug. Capecitabine  is used in the treatment of numerous cancers. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Capecitabine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002134 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of buoranolol - a non-selective adrenergic beta receptor blocker, used for the treatment of hypertension and other cardiovascular conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Bupranolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002135 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of bupranolol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Bupranolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002136 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of buopranolol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Bupranolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002137 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A classical pathway of mitochondrial protein import that delivers matrix resident and some of the inner membrane proteins. The precursor proteins are synthesized with an amino terminal peptide extension - the presequence. Translocase complexes, chaperones and processing enzymes cooperate in the process."^^xsd:string ;
  obo:hasDbXref "PMID:22178138"^^xsd:string, "PMID:24561263"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002138 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The carrier pathway delivers many of the inner mitochondrial membrane proteins. These proteins are synthesized without a  presequence."^^xsd:string ;
  obo:hasDbXref "PMID:22178138"^^xsd:string, "PMID:24561263"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002139 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The mitochondrial intermembrane space assembly pathway (MIA) delivers the resident proteins of this mitochondrial localization."^^xsd:string ;
  obo:hasDbXref "PMID:22178138"^^xsd:string, "PMID:24561263"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002140 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The mitochondrial protein import thereby beta-barrel proteins of the outer mitochondrial membrane are sorted and assembled."^^xsd:string ;
  obo:hasDbXref "PMID:22178138"^^xsd:string, "PMID:24561263"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002141 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The mitochondrial protein import thereby alpha-helical proteins of the outer mitochondrial membrane are sorted and assembled."^^xsd:string ;
  obo:hasDbXref "PMID:22178138"^^xsd:string, "PMID:24561263"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002142 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A rare congenital disorder resulting from alterations in the urea cycle pathway. The neonatal form exhibits several phenotypes and can result in death."^^xsd:string ;
  obo:hasDbXref "MeSH:D056806"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002143 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The condition represents a group of disorders due to argininosuccinate synthase deficiency. The enzyme is a component of the urea cycle pathway."^^xsd:string ;
  obo:hasDbXref "MeSH:D020159"^^xsd:string, "OMIM:215700"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002144 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive disorder resulting from alterations in the urea cycle pathway and due to defects in the hepatic mitochondrial enzyme carbamoyl phosphate synthetase 1."^^xsd:string ;
  obo:hasDbXref "MeSH:D020165"^^xsd:string, "OMIM:23730"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002145 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A rare autosomal recessive disorder resulting from alterations in the urea cycle pathway and due to defects in the argininosuccinate lyase enzyme."^^xsd:string ;
  obo:hasDbXref "MeSH:D056807"^^xsd:string, "OMIM:207900"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002146 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of drugs that reduce or prevent the formation of blood clots by directly inhibiting thrombin. Thrombin is a serine protease involved in coagulation-related reactions. The drugs are further classified depending on how they interact with thrombin. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Direct_thrombin_inhibitor"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002147 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of bivalirudin, a direct thrombin inhibitor. Bivalirudin binds to both the catalytic site and anion-binding exosite of thrombin and as classified as a bivalent inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Bivalirudin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002148 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of bivalirudin, a bivalent direct thrombin inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Bivalirudin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002149 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of bivalirudin-target interaction and of the biochemical or physiological responses to drug. The drug is a bivalent direct thrombin inhibitor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Bivalirudin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002150 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of drugs that decrease platelet aggregation and inhibit blood clot formation. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Antiplatelet_drug"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002151 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of drugs that prevent the coagulation of blood. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Anticoagulant"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002152 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of drugs that can dissolve blood clots. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Thrombolytic_drug"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002153 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of bumetanide - a blocker of luminal sodium-potassium-chloride symporter used for the treatment of heart failure.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Bumetanide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002154 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of bumetanide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Bumetanide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002155 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of bumetanide-target interaction and of the biochemical or physiological responses to drug. The drug blocks the luminal sodium-potassium-chloride symporter in the thick ascending limb of the loop of Henle. Bumetanide is used in the treatment of heart failure.  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "pathway:https://en.wikipedia.org/wiki/Bumetanide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002156 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of bisoprolol, a selective beta adrenergic type 1 receptor antagonist used in the treatment of hypertension and several other conditions involving a faster than normal heart rate. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Bisoprolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002157 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of bisoprolol. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Bisoprolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002158 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of bisoprolol-target interaction and of the biochemical or physiological responses to drug. The drug is a selective antagonist of beta adrenergic type 1 receptor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Bisoprolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002159 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of compounds used in the treatment of conditions affecting the sensory organs. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Sensory_system"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002160 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of betaxolol, a selective beta adrenergic type 1 receptor antagonist used in the treatment of hypertension and glaucoma. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Betaxolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002161 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of betaxolol. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Betaxolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002162 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of betaxolol-target interaction and of the biochemical or physiological responses to drug. The drug is a selective antagonist of beta adrenergic type 1 receptor used in the treatment of hypertension and glaucoma. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Betaxolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002163 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of moexipril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Moexipril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002164 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of moexipril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Moexipril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002165 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of moexipril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and congestive heart failure. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Moexipril"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002166 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A form of congenital hyperplasia resulting from defects in the CYP17A1 gene."^^xsd:string ;
  obo:hasDbXref "OMIM:202110"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002167 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A form of congenital hyperplasia resulting from defects in the CYP21A2 gene."^^xsd:string ;
  obo:hasDbXref "OMIM:201910"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002168 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A form of congenital hyperplasia resulting from defects in the CYP11B1 gene."^^xsd:string ;
  obo:hasDbXref "OMIM:202010"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002169 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of acebutolol, a selective beta adrenergic type 1 receptor antagonist used in the treatment of hypertension and arrhythmias. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Acebutolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002170 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of acebutolol. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Acebutolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002171 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of acebutolol-target interaction and of the biochemical or physiological responses to drug. The drug is a selective antagonist of beta adrenergic type 1 receptor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Acebutolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002172 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of alendronate - a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Alendronic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002173 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of alendronate, a nitrogenous bisphosphonate drug. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Alendronic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002174 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of alendronate-target interaction and of the biochemical or physiological responses to drug. Alendronate is a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Alendronic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002175 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of pamidronate - a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Pamidronic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002176 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of pamidronate, a nitrogenous bisphosphonate drug. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Pamidronic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002177 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of pamidronate-target interaction and of the biochemical or physiological responses to drug. Pamidronate is a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Pamidronic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002180 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those skin diseases that contain a genetic component, usually resulting from inborn error of metabolism."^^xsd:string ;
  obo:hasDbXref "MeSH:D012873"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002181 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A rare autosomal recessive disorder resulting from alterations in collagen metabolism and due to defects in the prolidase PEPD gene. The condition is manifested in skin ulcers and mental retardation."^^xsd:string ;
  obo:hasDbXref "MeSH:D056732"^^xsd:string, "OMIM:170100"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002182 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of esomeprazole, a proton pump inhibitor. It is administered for the treatment of acid-related disorders. The drug inhibits the hydrogen potassium ATPase in the parietal cells of the stomach. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Esomeprazole"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002183 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of esomeprazole, a compound in the class of proton pump inhibitors used in the treatment of acid-related disorders. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Esomeprazole"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002184 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of esomeprazole-target interaction and of the biochemical or physiological responses to drug. Esomeprazole is a compound in the class of proton pump inhibitors used in the treatment of acid-related disorders. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Esomeprazole"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002185 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of lysine, an essential amino acid."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Lysine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002186 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of chlorothiazide, a drug used in the treatment of high blood pressure.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Chlorothiazide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002187 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of chlorothiazide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Chlorothiazide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002188 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of chlorothiazide-target interaction and of the biochemical or physiological responses to drug. The drug reduces sodium reabsorption in the distal convoluted tubule of kidney nephron. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Chlorothiazide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002189 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of buprenorphine, a semi-synthetic opioid and a mixed partial agonist opioid receptor modulator used to treat opioid addiction and to control moderate to acute pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Buprenorphine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002190 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of buprenorphine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Buprenorphine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002191 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of buprenorphine-target interaction and of the biochemical or physiological responses to drug. The drug is a non-selective, mixed agonist-antagonist opioid receptor modulator. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Buprenorphine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002192 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of bupivacaine, a drug used as a local anesthetic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Bupivacaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002193 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of bupivacaine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Bupivacaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002194 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of bupivacaine-target interaction and of the biochemical or physiological responses to drug. It acts mainly as a voltage-gated sodium channel blocker. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Bupivacaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002195 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of bendroflumethiazide, a drug used in the treatment of high blood pressure.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Bendroflumethiazide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002196 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of bendroflumethiazide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Bendroflumethiazide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002197 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of bendroflumethiazide-target interaction and of the biochemical or physiological responses to drug. The drug reduces sodium reabsorption in the distal convoluted tubule of kidney nephron. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Bendroflumethiazide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002198 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of azithromycin, an antibiotic that inhibits bacterial growth and used for the treatment of several bacterial infections and a number of sexually transmitted infections. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Azithromycin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002199 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination of azithromycin - an antibiotic that interferes with bacterial growth. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Azithromycin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002200 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of azithromycin-target interaction and of the biochemical or physiological responses to drug. The drug interferes with bacterial growth and is used for the treatment of several bacterial infections and a number of sexually transmitted infections. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Azithromycinb"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002201 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of azathioprine, an immunosupressive drug used in organ transplantation and autoimmune diseases. It is a prodrug for mercaptopurine, thus inhibiting DNA synthesis.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Azathioprine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002202 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of azathioprine, a meracptopurine prodrug. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Azathioprine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002203 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of azathioprine-target interaction and of the biochemical or physiological responses to drug. It is an immunosupressive drug that inhibits DNA synthesis. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Azathioprine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002204 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An inherited condition resulting from alterations in lysine metabolism. Mutations in the DHTKD1 gene, encoding an enzyme involved in the lysine degradation pathway, have been associated with the condition."^^xsd:string ;
  obo:hasDbXref "OMIM:204750"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002205 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive neurometabolic disorder with several phenotypes and due to mutations in the L2HGDH gene (the L-type), D2HGDH and IDH2 genes (the D-type). A combined L- and D-type has also been observed and has been attributed to mutations in the SLC25A1 gene."^^xsd:string ;
  obo:hasDbXref "OMIM:236792"^^xsd:string, "OMIM:600721"^^xsd:string, "OMIM:613657"^^xsd:string, "OMIM:615182"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002206 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive metabolic disorder affecting the brain and peripheral vessels and manifested in infancy. Genetic studies identify defects in the ETHE1 gene, a mitochondrial resident gene product, thus pointing to implications in many aspects of mitochondrial metabolism and homeostasis."^^xsd:string ;
  obo:hasDbXref "OMIM:602473"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002207 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Conditions of the parasympathetic and sympathetic divisions of the autonomic nervous system."^^xsd:string ;
  obo:hasDbXref "MeSH:D001342"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002208 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A condition resulting from alterations in the pathways of norepinephrine and epinephrine biosynthesis due to defects in the dopamine beta-hydroxylase gene (DBH). DBH catalyzes the conversion of dopamine to norepinephrine, in turn the precursor to epinephrine."^^xsd:string ;
  obo:hasDbXref "OMIM:223360"^^xsd:string, "PMID:19342614"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002209 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive disorder resulting in alterations in glycine, choline and folate metabolism and due to mutations in DMGDH gene."^^xsd:string ;
  obo:hasDbXref "OMIM:605850"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002210 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive disorder resulting from alterations in pyrimidine degradation pathway due to mutations in dihydropyrimidine gene (DPYD). DPYD catalyzes the initial and rate-limiting step in pyrimidine bases (uracil and thymine) catabolism."^^xsd:string ;
  obo:hasDbXref "MeSH:D054067"^^xsd:string, "OMIM:274270"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002211 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive disorder resulting from alterations in pyrimidine degradation pathway due to mutations in dihydropyrimidinase gene (DPYS). DPYS catalyzes the second step in pyrimidine bases (uracil and thymine) catabolism."^^xsd:string ;
  obo:hasDbXref "OMIM:222748"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002212 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A very rare autosomal recessive condition resulting from alterations in glycerolipid metabolism due to defects in the glycerate kinase (GLYCTK) gene."^^xsd:string ;
  obo:hasDbXref "OMIM:220120"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002213 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Conditions resulting from genetic defects in the selective or non-selective transport pathways of kidney tubules."^^xsd:string ;
  obo:hasDbXref "MeSH:D015499"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002214 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal condition resulting from impaired epithelial transport of cystine and dibasic amino acids in the proximal renal tubule. It is further classified based on differences in the genetic basis of the disorder."^^xsd:string ;
  obo:hasDbXref "MeSH:D003555"^^xsd:string, "OMIM:220100"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002215 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive condition resulting from alterations in creatine metabolism due to mutations in the GAMT gene."^^xsd:string ;
  obo:hasDbXref "OMIM:612736"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002217 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A condition resulting from alterations in the transport of cystine across the lysosomal membrane due to defects in the lysosomal cystine transporter, cystinosin (CTNS)."^^xsd:string ;
  obo:hasDbXref "MeSH:D003554"^^xsd:string, "OMIM:219800"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002218 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A variant of the classic nephropathic cystinosis type."^^xsd:string ;
  obo:hasDbXref "OMIM:219750"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002219 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Conditions resulting from alterations in the urea cycle pathway."^^xsd:string ;
  obo:hasDbXref "MeSH:D056806"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002221 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of aprotinin, an antifibrinolytic inhibitor of trypsin and other serine proteases, used to reduce bleeding during surgery. Once withdrawn from the market, it has been reintroduced. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Aprotinin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002222 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of aprotinin. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Aprotinin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002223 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of aprotinin-target interaction and of the biochemical or physiological responses to drug. Aprotinin is a serine protease inhibitor of trypsin, chymotrypsin and others. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Aprotinin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002224 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of arbekacin, an antibiotic used for the treatment of infections caused by multi-resistant bacteria. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Arbekacin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002225 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of arbekacin. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Arbekacin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002226 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of arbekacin-target interaction and of the biochemical or physiological responses to drug. Arbekacin inhibits protein synthesis by irreversibly binding to bacterial 30S ribosomal subunit. The drug is used for the treatment of infections caused by multi-resistant bacteria. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Arbekacin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002227 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of argatroban, a direct thrombin inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Argatroban"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002228 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of argatroban, a direct thrombin inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Argatroban"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002229 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of argatroban-target interaction and of the biochemical or physiological responses to drug. The drug is a direct thrombin inhibitor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Argatroban"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002230 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of atenotolol, a selective beta adrenergic type 1 receptor antagonist used in the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Atenolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002231 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of atenolol. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Atenolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002232 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of atenolol-target interaction and of the biochemical or physiological responses to drug. The drug is a selective antagonist of beta adrenergic type 1 receptor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:<new dbxrefhttps://en.wikipedia.org/wiki/Atenolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002233 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The various conditions affecting any segment of the gastrointestinal tract resulting from alterations in one or several pathways."^^xsd:string ;
  obo:hasDbXref "MeSH:D005767"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002234 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A condition resulting from inadequate levels of folic acid in the diet and manifested as various forms of anemia. In certain tissues, the condition is indistinguishable from vitamin B deficiency."^^xsd:string ;
  obo:hasDbXref "MeSH:D005494"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002235 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The group of syndromes resulting from failure of normal intestinal absorption of nutrients."^^xsd:string ;
  obo:hasDbXref "MeSH:D008286"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002236 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive condition likely due to alterations in folate transport and exhibiting the symptoms of folate deficiency."^^xsd:string ;
  obo:hasDbXref "OMIM:229050"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002237 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of penbutolol - a non-selective adrenergic beta receptor blocker, used in the treatment of high blood pressure. Penbutolol is a sympathomimetic drug. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Penbutolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002238 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of penbutolol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Penbutolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002239 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of penbutolol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Penbutolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002240 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of oxeprenolol - a non-selective adrenergic beta receptor blocker, used for the treatment of angina, high blood pressure and abnormal heart rhythms. The drug has some intrinsic sympathomimetic properties. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Oxprenolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002241 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of oxeprenolol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Oxprenolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002242 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of oxeprenolol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Oxprenolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002243 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of compounds used to cause reversible loss of sensation and generally administered to facilitate surgery."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Anesthetic"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002244 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of prilocaine, a drug used as a local anesthetic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Prilocaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002245 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of prilocaine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Prilocaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002246 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of prilocaine-target interaction and of the biochemical or physiological responses to drug. The drug exerts its effects by blocking the voltage-gated sodium channels. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Prilocaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002247 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of ropivacaine, a drug used as a local anesthetic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Ropivacaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002248 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of ropivacaine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Ropivacaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002249 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of ropivacaine-target interaction and of the biochemical or physiological responses to drug. The drug exerts its effects by blocking the voltage-gated sodium channels. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Ropivacaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002250 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of torasemide, a diuretic drug mainly used in the management of edema associated with congestive heart failure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Torasemide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002251 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of torasemide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Torasemide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002252 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of torasemide-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Torasemide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002253 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Autosomal recessive conditions resulting from alterations in biotin metabolism."^^xsd:string ;
  obo:hasDbXref "MeSH:D009100"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002254 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A late onset form of multiple carboxylase deficiency due to defects in the biotin recycling biotinidase enzyme."^^xsd:string ;
  obo:hasDbXref "MeSH:D028921"^^xsd:string, "OMIM:253260"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002255 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The neonatal form of multiple carboxylase deficiency due to defects in holocarboxylase synthetase, the enzyme catalyzing the covalent attachment of biotin to biotin-dependent carboxylases."^^xsd:string ;
  obo:hasDbXref "MeSH:D028922"^^xsd:string, "OMIM:253270"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002256 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of reteplase - one of several recombinant tissue plasminogen activators. Plasminogen is a key player in the fibrinolytic cascade pathway of blood clots breakdown. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Reteplase"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002257 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of reteplase, one of several recombinant tissue plasminogen activators. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Reteplase"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002258 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of reteplase-target interaction and of the biochemical or physiological responses to drug. Reteplase is one of several recombinant tissue plasminogen activators. Reteplase is used to treat heart attack. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Reteplase"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002259 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of nadolol - a non-selective adrenergic beta receptor blocker, used in the treatment of high blood pressure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Nadolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002260 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of nadolol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Nadolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002261 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of nadolol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Nadolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002262 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of pindolol - a non-selective adrenergic beta receptor blocker, used in the treatment of high blood pressure. Pindolol is a sympathomimetic drug. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Pindolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002263 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of pindolol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Pindolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002264 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of pindolol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Pindolol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002265 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of teniposide, a drug used to treat childhood leukemia. The drug inhibits DNA synthesis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:19149581"^^xsd:string, "wikipedia:https://en.wikipedia.org/wiki/Teniposide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002266 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of teniposide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:19149581"^^xsd:string, "wikipedia:https://en.wikipedia.org/wiki/Teniposide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002267 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of teniposide-target interactions and of the biochemical or physiological responses to drug. The drug is used in the treatment of certain cancers and its mode of action is believed to be inhibition of DNA synthesis. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:19149581"^^xsd:string, "wikipedia:https://en.wikipedia.org/wiki/Teniposide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002268 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of zoledronate - a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Zoledronic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002269 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of zoledronate, a nitrogenous bisphosphonate drug. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Zoledronic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002270 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of zoledronate-target interaction and of the biochemical or physiological responses to drug. Zoledronate is a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Zoledronic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002271 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of eplrenone, a drug used as an adjunct in the management of chronic heart failure. enetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Eplerenone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002272 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of eplerenone. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Eplerenone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002273 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of eplerenone-target interaction and of the biochemical or physiological responses to drug. Eplerenone is an antagonist of the mineralocorticoid receptor and indicated for the reduction of cardiovascular death risk in people with heart failure.  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Eplerenone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002274 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A rare autosomal recessive condition resulting from alterations in leucine metabolism."^^xsd:string ;
  obo:hasDbXref "OMIM:250950"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002275 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A syndrome consisting of early-onset bilateral optic atrophy associated with later-onset spasticity and cognitive deficit."^^xsd:string ;
  obo:hasDbXref "OMIM:258502"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002276 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive condition resulting from alteration in the de novo purine biosynthetic pathway."^^xsd:string ;
  obo:hasDbXref "OMIM:103050"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002277 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive condition resulting from alterations in the metabolism of phenylalanine and tyrosine."^^xsd:string ;
  obo:hasDbXref "MeSH:D000474"^^xsd:string, "OMIM:203500"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002278 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of fenoprofen, a non-steroidal anti-inflammatory drug used  in the treatment of rheumatoid arthritis and mild pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Fenoprofen"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002279 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of fenoprofen. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Fenoprofen"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002280 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of fenoprofen-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of rheumatoid arthritis and mild pain.  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Fenoprofen"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002281 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "One of the subgroups of the Therapeutic Chemical  Classification System developed by WHO for grouping drugs acting as antidotes, chelators, detoxifying agents, and others. The pharmacokinetics and pharmacodynamics of such agents. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/ATC_code_V03"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002282 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of naloxone, a medication used to reverse the effects opioids overdose. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Naloxone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002283 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of naloxone. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Naloxone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002284 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of naloxone-target interaction and of the biochemical or physiological responses to drug. Naloxone is a mu-opioid receptor competitive antagonist. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Naloxone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002285 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of porphyrin. Porphyrins represent a group of heterocyclic macrocycle organic compounds. Many are naturally occurring and one best example is the red blood cell heme pigment."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Porphyrin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002286 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of cilostazol, a platelet aggregation inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Cilostazol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002287 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of cilostazol, a platelet aggregation inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Cilostazol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002288 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of cilostazol-interaction and of the biochemical or physiological responses to drug. The drug is a selective inhibitor of phosphodiesterase type 3. The increase in cyclic AMP (cAMP) and subsequent increase in active protein kinase A (PKA) leads to inhibition of platelet aggregation. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Cilostazol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002289 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A rare inherited metabolic condition due to alterations in the activity of malonyl-CoA decarboxylase."^^xsd:string ;
  obo:hasDbXref "OMIM:248360"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002290 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A rare autosomal condition resulting from alterations in the urea cycle pathway and due to defects in the arginase enzyme."^^xsd:string ;
  obo:hasDbXref "MeSH:D020162"^^xsd:string, "OMIM:207800"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002291 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of carnitine. Carnitine is derived from lysine and methionine and is important for fatty acids transport into the mitochondrial matrix."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Carnitine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002292 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of carnitine. It involves the amino acids lysine and methionine and it largely occurs in the kidney and liver."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Carnitine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002293 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions resulting in the breakdown of carnitine."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Carnitine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002294 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A condition resulting from alterations in the de novo purine biosynthetic pathway and due to defects in the enzyme catalyzing the final steps."^^xsd:string ;
  obo:hasDbXref "OMIM:608688"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002295 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of compounds used in the treatment of epilepsy or seizure. Some can also act as mood stabilizers."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/ATC_code_N03"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002296 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of fosphenytoin, a drug used in the treatment of acute convulsive epileptic seizure. Fosphenytoin is a water-soluble phenytoin prodrug. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Fosphenytoin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002297 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of fosphenytoin, a prodrug used for the treatment of epilepsy. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Fosphenytoin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002298 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of fosphenytoin-target interaction and of the biochemical or physiological responses to drug. Fosphenytoin is a water-soluble phenytoin prodrug used for the treatment of epilepsy. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Fosphenytoin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002299 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A condition due to defects in glycine N-methyltransferase (GNMT). As a component of methionine, homocysteine and folate metabolism among others, the defective enzyme potentially disrupts many metabolic pathways."^^xsd:string ;
  obo:hasDbXref "OMIM:606664"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002300 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The lysosomal storage disease pathways affecting the nervous system."^^xsd:string ;
  obo:hasDbXref "MeSH:D020140"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002301 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A group of inherited metabolic disorders resulting in abnormal accumulation of sphingolipids in the central nervous system and also visceral organs due to defects in their degradation pathway."^^xsd:string ;
  obo:hasDbXref "MeSH:D013106"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002302 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A condition characterized by elevated serum bile acid concentration that can be due to defects in any of several genes."^^xsd:string ;
  obo:hasDbXref "OMIM:607748"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002303 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of indometacin, a non-steroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes and is used in the treatment of inflammation and pain and to reduce fever. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Indometacin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002304 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of indometacin. The drug is used in the treatment of pain and inflammation and to reduce fever. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Indometacin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002305 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of indometacin-target interaction and of the biochemical or physiological responses to drug. Indometcin is an inhibitor of cyclooxygenase enzymes used in the treatment of pain and inflammation and to reduce fever. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Indometacin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002306 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive condition resulting from alterations in several metabolic pathways due to defects in the GCDH gene."^^xsd:string ;
  obo:hasDbXref "OMIM:231670"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002307 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of levobunolol, a non-selective beta adrenergic receptor antagonist used in the treatment of glaucoma. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "drugs.com:http://www.drugs.com/pro/levobunolol.html"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002308 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of levobunolol. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "drugs.com:http://www.drugs.com/pro/levobunolol.html"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002309 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of levobunolol-target interaction and of the biochemical or physiological responses to drug. The drug is a non-selective antagonist of beta adrenergic used in the treatment of glaucoma. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "drugs.com:http://www.drugs.com/pro/levobunolol.html"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002310 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of desipramine, an antidepressant used in the treatment of depression, anxiety disorders, insomnia. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Doxepin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002311 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of doxepin. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Doxepin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002312 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of doxepin-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of depression, anxiety disorders, insomnia. Its effects result from inhibition of serotonin and norepinephrine neurotransmitter reuptake. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Doxepin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002313 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of indometacin, a non-steroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes. It is commonly used to reduce fever, pain and swelling in wide range of conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Indometacin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002314 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of indometacin. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Indometacin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002315 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of indometacin-target interaction and of the biochemical or physiological responses to drug. Indometacin is an inhibitor of cyclooxygenase enzymes and commonly used to reduce fever, pain and swelling in a wide range of conditions. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Indometacin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002316 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of psychoactive drugs that can induce an improvement in the  mental or physical activity. While such drugs are used as prescription medicine they can also be abused and some substances in this category are illicit."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Psychoactive_drug"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002317 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of caffeine, a psychostimulant of the methylxanthine class. It can confer some protective effects against some conditions. It is largely considered safe but the pure powdered caffeine, available as dietary supplement, can be lethal in higher amounts. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Caffeine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002318 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of caffeine, a widely used stimulant of the central nervous system. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Caffeine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002319 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of caffeine-target interaction and of the biochemical or physiological responses to drug. Caffeine is an antagonist of adenosine receptors of all types. As such, it stimulates vasomotor and respiratory centers and also promotes neurotransmitter release. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Caffeine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002320 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of trichlormethiazide, a drug used in the treatment of high blood pressure.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Trichlormethiazide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002321 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of trichlormethiazide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Trichlormethiazide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002322 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of trichlormethiazide-target interaction and of the biochemical or physiological responses to drug. The drug is thought to block reabsorption of chloride and possibly sodium in the ascending loop of Henle. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Trichlormethiazide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002323 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A rare autosomal condition resulting from alterations in several metabolic pathways and due to defects in the HMGCL gene."^^xsd:string ;
  obo:hasDbXref "OMIM:246450"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002324 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive condition resulting from alterations in neurotransmitter metabolism and due to defects in the AADC gene."^^xsd:string ;
  obo:hasDbXref "OMIM:608643"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002325 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of drugs that prevent the coagulation of blood acting as vitamin K inhibitors . Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/ATC_code_B01#B01AA_Vitamin_K_antagonists"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002326 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of heparin group drugs that reduce or prevent the formation of blood clots by activating the antithrombin III (AT) thrombin inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Heparin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002327 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of heparin, a naturally occurring anticoagulant produced by basophils and mast cells. Heparin, and its low molecular weight derivative, bind to and activates the thrombin enzyme inhibitor antithrombin III. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Heparin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002328 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of heparin. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Heparin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002329 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of heparin-target interaction and of the biochemical or physiological responses to drug. Heparin is a naturally occurring anticoagulant that binds to and activates the thrombin inhibitor antithrombin III (AT). Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Heparin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002330 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of enoxaparin, a low molecular weight heparin derivative. The drug is an anticoagulant that activates the thrombin inhibitor antithrombin III (AT). Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Enoxaparin_sodium"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002331 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of enoxaparin. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Enoxaparin_sodium"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002332 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of enoxaparin-target interaction and of the biochemical or physiological responses to drug. Enoxaparin is a low molecular weight heparin derivative anticoagulant that binds to and activates the thrombin inhibitor antithrombin III (AT). Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Enoxaparin_sodium"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002333 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of fosphenytoin, an anti-seizure medication also used for certain heart arrhythmias. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Phenytoin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002334 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of phenytoin. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Phenytoin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002335 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of phenytoin-target interaction and of the biochemical or physiological responses to drug. The drug is used as an anti-seizure medication and also for certain heart arrhythmias. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Phenytoin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002336 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of drugs used in the treatment of arrythmias.  Some beta receptor and channel blockers may also act as antiarrhythmic agents. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Antiarrhythmic_agent"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002337 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of mexiletine, a drug used in the treatment of cardiac arrhythmias. Mexiletine is a non-selective voltage-gated sodium channel blocker of the Class IB antiarrhythimc drugs. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Mexiletine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002338 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of mexiletine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Mexiletine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002339 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of mexiletine-target interaction and of the biochemical or physiological responses to drug. The drug is a non-selective voltage-gated sodium channel blocker  antiarrhythmic agent. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Mexiletine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002340 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those conditions, acquired, familial or congenital, affecting the skeletal muscle and/or smooth muscle."^^xsd:string ;
  obo:hasDbXref "MeSH:D009135"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002341 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A disorder manifested by abnormal increase in skeletal or smooth muscle tone."^^xsd:string ;
  obo:hasDbXref "MeSH:D009122"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002342 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A form of muscle hypertonia associated with upper motor neuron dysfunction."^^xsd:string ;
  obo:hasDbXref "MeSH:D009128"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002343 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A rather common condition resulting from alterations in folate metabolism and due to defects in methylenetetrahydrofolate reductase (MTHFR) gene."^^xsd:string ;
  obo:hasDbXref "OMIM:236250"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002344 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of etoposide, a cytotoxic anticancer drug in the topoisomerase inhibitor class. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Etoposide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002345 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of etoposide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Etoposide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002346 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of etoposide-target interactions and of the biochemical or physiological responses to drug. Etoposide is a cytotoxic anticancer drug in the topoisomerase inhibitor class. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Etoposide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002347 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive condition due to defects in the acid lipase gene."^^xsd:string ;
  obo:hasDbXref "MeSH:D015217"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002348 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of lornoxicam, a non-steroidal anti-inflammatory drug with analgesic, anti-inflammatory and antipyretic properties Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Lornoxicam"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002349 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of lornoxicam. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Lornoxicam"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002350 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of lornoxicam-target interaction and of the biochemical or physiological responses to drug. The drug is used to relieve various types of pain. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Lornoxicam"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002351 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of trastuzumab, a monoclonal antibody that interferes with the epidermal growth factor receptor 2, overexpressed in certain cancer types. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Trastuzumab"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002352 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of trastuzumab. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Trastuzumab"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002353 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of trastuzumab-target interaction and of the biochemical or physiological responses to drug. The drug interferes with the epidermal growth factor receptor 2, overexpressed in certain cancer types. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Trastuzumab"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002354 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of compounds used as antiparasitic agents. Genetic variations can result in changes in drug availability."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/ATC_code_P01"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002355 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of artemether, an antimalarial agent. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Artemether"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002356 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of artemether. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Artemether"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002357 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of artemether-target interactions and of the biochemical or physiological responses to drug. Artemether is used to treat malaria.  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Artemether"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002358 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A group of mental disorders whose onset is in the developmental period."^^xsd:string ;
  obo:hasDbXref "MeSH:D065886"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002359 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive condition characterized by developmental delay and mental retardation due to defects in the GATM gene."^^xsd:string ;
  obo:hasDbXref "OMIM:612718"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002360 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Condition resulting from genetic defects in the selective or non-selective transport functions of the kidney tubules."^^xsd:string ;
  obo:hasDbXref "MeSH:D015499"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002361 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of remifentanil, a synthetic opioid analgesic used in general anesthesia.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Remifentanil"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002362 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of remifentanil. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Remifentanil"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002363 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of remifentanil-target interaction and of the biochemical or physiological responses to drug. The drug is a synthetic opioid analgesic used in general anesthesia. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Remifentanil"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002364 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A heterogeneous group of disorders triggered  by alterations in mitochondria metabolism and resulting in dysfunction in muscle and nervous system."^^xsd:string ;
  obo:hasDbXref "MeSH:D017237"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002365 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A severe autosomal recessive disorder due to defects in the p53-inducible ribonucleotide reductase RRM2B."^^xsd:string ;
  obo:hasDbXref "OMIM:612075"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002366 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Conditions affecting any segment of the intestine."^^xsd:string ;
  obo:hasDbXref "MeSH:D007410"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002368 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of drugs used as immunostimulants. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Immunostimulant"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002369 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of drugs used as immunosupressants. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/ATC_code_L04"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002370 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of monoclonal antibodies used in the treatment of various types of cancer.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Monoclonal_antibody#Cancer_treatment"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002371 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of cetuximab, a chimeric (mouse/human) monoclonal antibody that interferes with the epidermal growth factor receptor (EGFR) and used for the treatment of certain cancer types. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Cetuximab"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002372 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of cetuximab. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Cetuximab"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002373 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of cetuxiumab-target interaction and of the biochemical or physiological responses to drug. The drug interferes with the epidermal growth factor receptor (EGFR) and is used for the treatment of certain cancer types. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Cetuximab"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002374 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of panitumumab, a human monoclonal antibody that interferes with the epidermal growth factor receptor (EGFR) and used for the treatment of certain cancer types. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Panitumumab"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002375 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of panitumumab. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Panitumumab"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002376 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of panitumumab-target interaction and of the biochemical or physiological responses to drug. The drug interferes with the epidermal growth factor receptor (EGFR) and is used for the treatment of certain cancer types. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Panitumumab"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002377 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of hydroflumethiazide, a drug used in the treatment of high blood pressure.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PubChem:https://pubchem.ncbi.nlm.nih.gov/compound/hydroflumethiazide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002378 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of hydroflumethiazide. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PubChem:https://pubchem.ncbi.nlm.nih.gov/compound/hydroflumethiazide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002379 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of hydroflumethiazide-target interaction and of the biochemical or physiological responses to drug. The drug reduces sodium reabsorption in the distal convoluted tubule of kidney nephron. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PubChem:https://pubchem.ncbi.nlm.nih.gov/compound/hydroflumethiazide"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002380 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal dominant condition resulting from alterations in amino acid metabolism due to defects in the 4-hydroxyphenylpyruvate dioxygenase (HPD) gene."^^xsd:string ;
  obo:hasDbXref "OMIM:140350"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002381 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Autosomal recessive neurodegenrative disorder resulting from alterations in lysosomal membrane transport due to defects in the SLC17A5 gene."^^xsd:string ;
  obo:hasDbXref "MeSH:D029461"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002382 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of dobutamine, a drug used in the treatment of heart failure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Dobutamine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002383 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of dobutamine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Dobutamine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002384 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of dobutamine-target interaction and of the biochemical or physiological responses to drug. The drug is an agonist of beta 1 adrenergic receptor used in the treatment of heart failure. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Dobutamine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002385 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of clomipramine, an antidepressant used in the treatment of obsessive compulsive disorder, panic disorder, major depressive disorder. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Clomipramine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002386 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of clomipramine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:dbxrefhttps://en.wikipedia.org/wiki/Clomipramine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002387 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of clomipramine-target interaction and of the biochemical or physiological responses to drug. The drug is categorized as a non-selective monoamine reuptake inhibitor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Clomipramine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002388 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive condition resulting from alterations in fructose metabolism and associated with defects in the ketohexokinase (KHK) gene."^^xsd:string ;
  obo:hasDbXref "OMIM:229800"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002389 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of felbamate - an anticonvulsant used in the treatment of epilepsy. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Felbamate"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002390 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of felbamate. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Felbamate"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002391 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of felbamate-target interaction and of the biochemical or physiological responses to drug. It is used for the treatment of severe epilepsy due to its adverse effects, particularly hepatic failure. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Felbamate"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002392 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of tioguanine, a drug used to treat several leukemia types, ulcerative colitis and some autoimmune diseases. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Tioguanine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002393 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of tioguanine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Tioguanine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002394 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of teniposide-target interactions and of the biochemical or physiological responses to drug. The drug is used in the treatment of several leukemia types, ulcerative colitis and some autoimmune diseases. Derivatives of tioguanine exert several cytotoxic effects. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Tioguanine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002395 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The endocytosis and the exocytosis pathway that deliver, uptake and recycle cellular material. Efficient coupling between exocytosis and endocytosis pathways is essential for synaptic transmission."^^xsd:string ;
  obo:hasDbXref "PMID:21304549"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002396 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The exocytosis pathway thereby cellular material is delivered in the extracellular space our outside the cell. There two main types of exocytosis: calcium-triggered, regulated and constitutive. They are also represented in the more specific protein exocytosis pathway."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Exocytosis"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002397 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A signal-independent exocytic pathway employed by all cell types."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Exocytosis"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002398 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A signal-dependent exocytic pathway employed by particular cell types. For instance, the release of hormones and neurotransmitters by neuroendocrine cells is mediated by regulated exocytosis."^^xsd:string ;
  obo:hasDbXref "PMID:24062727"^^xsd:string, "wikipedia:https://en.wikipedia.org/wiki/Exocytosis"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002399 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The endosomal system is at the cross roads of endocytosis and secretory pathways. As the endosome goes through the maturation process various trafficking events are initiated. Material internalized from the plasma membrane or synthesized is sorted along two routes: a degradative pathway to lysosome or an export pathway. Cargo delivery to plasma membrane is via the recycling export pathway while delivery to the trans Golgi network (TGN) is via the retrograde export pathway. An important system for the selective cargo sorting is the retromer."^^xsd:string ;
  obo:hasDbXref "PMID:18726175"^^xsd:string, "PMID:23148298"^^xsd:string, "PMID:24492709"^^xsd:string, "PMID:25619244"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002400 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The lysosome is the final destination of endosomal degradative and autophagy pathways. Fusion of late endosomes and mature autophagosome with the lysosome form the endolysosome or autolysosome, respectively, where cargo is actively degraded."^^xsd:string ;
  obo:hasDbXref "PMID:20034776"^^xsd:string, "PMID:24492709"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002401 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chaperone-mediated autophagy is a specific and selective pathway whereby chaperone complexes recognize substrates bearing a recognition sequence forming a chaperone/substrate complex recognized by translocators."^^xsd:string ;
  obo:hasDbXref "PMID:24281265"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002402 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Cellular autophagy involves the mechanisms thereby dysfunctional components, proteins or organelles, are targeted to the lysosomes for destruction. Three main pathways are known: macroautophagy generally referred to as autophagy, microautophagy and chaperone-mediated autophagy. A fourth is the autophagy pathway for the removal of damaged mitochondria whose features are both shared with the regular autophagy and distinct."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Autophagy"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002403 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A cellular autophagy pathway that deviates from what its normal course should be. Altered cellular autophagy has been associated with a range of human conditions and disorders."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Autophagy"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002404 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chaperone mediated autophagy declines with aging and can also be due to alterations in protein stability and gene structure. Altered chaperone mediated autophagy has been associated with conditions such as neurodegenerative diseases."^^xsd:string ;
  obo:hasDbXref "PMID:24281265"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002405 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A form of autophagy thereby the cytoplasmic material is directly engulfed in the lysosome."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Autophagy"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002406 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The endosome export pathway delivers cargo to the trans Golgi network (TGN) or the plasma membrane via the retrograde and recycling pathways, respectively. An important cargo sorting system for the export pathway, primarily via the retrograde, but also the recycling pathways, is the retromer complex."^^xsd:string ;
  obo:hasDbXref "PMID:24492709"^^xsd:string, "PMID:25619244"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002407 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The retrograde export pathway is major route to recycle components of the secretory apparatus and to diverge from lysosomal degradation components derived from endocytosis."^^xsd:string ;
  obo:hasDbXref "PMID:24492709"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002408 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The recycling export pathway routes receptors and other proteins back to the plasma membrane."^^xsd:string ;
  obo:hasDbXref "PMID:24492709"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002409 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Early to late endosome maturation pathway is a state of flux associated with changes in component composition, such as particular Rab proteins and lipids such as phosphoinositides, increase in the number of intraluminal vesicles, luminal acidification and movement along microtubules. Along this continuum, sorting and trafficking of cargo takes place."^^xsd:string ;
  obo:hasDbXref "PMID:21878991"^^xsd:string, "PMID:24709024"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002410 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Any alteration in the proceedings of endocytosis or exocytosis."^^xsd:string ;
  obo:hasDbXref "PMID:21304549"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002411 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Any alteration of an aspect pertinent to endocytosis pathway."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Endocytosis"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002412 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Alterations in the endosomal sorting pathway can dramatically impact on the proper delivery of cargo. Defects in retromer function have been linked to human conditions such as the neurodegenerative Alzheimer's and Parkinson's diseases."^^xsd:string ;
  obo:hasDbXref "PMID:25619244"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002413 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Alterations in the endosome export pathway can dramatically impact on cellular fate. Defects in retromer function have been linked to human conditions such as the neurodegenerative Alzheimer's and Parkinson's diseases."^^xsd:string ;
  obo:hasDbXref "PMID:25619244"^^xsd:string, "PMID:25701813"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002414 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "In the endosomal pathway, endosomal maturation couples to sorting of material and its appropriate delivery or degradation, promoted by specific transport along and dynamics of cytoskeleton and associated molecular motors."^^xsd:string ;
  obo:hasDbXref "PMID:24709024"^^xsd:string, "PMID:24727350"^^xsd:string, "PMID:24769370"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002415 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Any alteration of an aspect pertinent to endosomal pathway. Defects in endosomal sorting and export have been associated with human conditions such as neurodegenerative diseases."^^xsd:string ;
  obo:hasDbXref "PMID:25701813"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002416 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of phosphatidylserine, an essential component of the membrane, and also with roles in signaling."^^xsd:string ;
  obo:hasDbXref "PMID:22960354"^^xsd:string, "PMID:24747366"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002417 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis, utilization and/or degradation of phosphatidylinositol (PtdIns). Phosphorylation of PtdIns can occur at the 3, 4, and/or 4 position of the inositol ring using one or multiple phosphate groups. These phosphorylated forms of PtdIns are known as phosphoinositides."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Phosphatidylinositol#Phosphoinositides"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002418 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Reversible phosphorylation of phosphatidylinositol at the 3, 4, and/or 5 position of the inositol ring with one or more phosphate groups by the action of phosphatidylinositol kinases and phosphatases gives rise to several different phosphoinositides (PIs) whose various distribution is important to cellular membrane identity. PIs are involved in various transport and trafficking, signaling and metabolic pathways. As such, alteration of PIs metabolism is implicated in a wide range of human diseases."^^xsd:string ;
  obo:hasDbXref "PMID:23899561"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002421 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Phosphoinositides are involved in a wide range of biological processes and alterations in their metabolism have been associated with a spectrum of human conditions."^^xsd:string ;
  obo:hasDbXref "PMID:23899561"^^xsd:string, "PMID:25510381"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002422 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Chemical synapses require the induction and assembly of pre- and postsynaptic structures."^^xsd:string ;
  obo:hasDbXref "PMID:15194107"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002423 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The cycle of synaptic vesicle exocytosis and neurotransmitter release and the subsequent endocytosis and recycling of synaptic vesicles at nerve terminals."^^xsd:string ;
  obo:hasDbXref "PMID:15217342"^^xsd:string, "PMID:25339369"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002424 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The endocytosis of synaptic vesicles, their recycle and refill for another round of exocytosis. Two recycling pathways are documented: a fast endocytosis, also referred to as 'kiss-and-run' which is thought to be clathrin-independent, and a slower route, that is clathrin-dependent."^^xsd:string ;
  obo:hasDbXref "PMID:15217342"^^xsd:string, "PMID:22763746"^^xsd:string, "PMID:25339369"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002425 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The release pathway of neurotransmitter filled synaptic vesicles."^^xsd:string ;
  obo:hasDbXref "PMID:15217342"^^xsd:string, "PMID:25339369"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002427 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Alterations in any of the various aspects pertinent to the release, endocytosis or trafficking/recycling of synaptic vesicles."^^xsd:string ;
  obo:hasDbXref "PMID:22763746"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002428 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Alterations in any of the mechanisms underlying the endocytosis of synaptic vesicles."^^xsd:string ;
  obo:hasDbXref "PMID:22763746"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002429 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Prior to exocytosis and following endocytosis, synaptic vesicles go through several trafficking steps that prepare them for neurotransmitter release."^^xsd:string ;
  obo:hasDbXref "PMID:25339369"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002430 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The retromer complex is an important system for the selective cargo sorting for the endosome export pathways, primarily via the retrograde, but also the recycling pathway."^^xsd:string ;
  obo:hasDbXref "PMID:24492709"^^xsd:string, "PMID:25619244"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002431 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Alterations in retromer-mediated pathway can affect both the sorting and the export pathways subsequent to sorting. Defects in retromer function have been linked to human conditions such as the neurodegenerative Alzheimer's and Parkinson's diseases."^^xsd:string ;
  obo:hasDbXref "PMID:25619244"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002432 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Clathrin-dependent endocytosis is a major route for synaptic vesicle endocytosis."^^xsd:string ;
  obo:hasDbXref "PMID:22763746"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002433 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Alterations in any of the mechanisms underlying the clathrin-dependent endocytosis of synaptic vesicles."^^xsd:string ;
  obo:hasDbXref "PMID:22763746"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002434 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of drugs that reduce or prevent the formation of blood clots.  They are further classified depending on the blood clotting processes they affect. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/ATC_code_B01#B01AX_Other_antithrombotic_agents"^^xsd:string, "wikipedia:https://en.wikipedia.org/wiki/Antithrombotic"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002435 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of fondaparinux, a synthetic pentasaccharide factor Xa inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Fondaparinux"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002436 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of fondaparinux. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Fondaparinux"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002437 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of fondaparinux-target interaction and of the biochemical or physiological responses to drug. Fondaparinux is a synthetic pentasaccharide factor Xa inhibitor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Fondaparinux"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002438 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Congenital structural deformities caused by alterations in a number of pathways."^^xsd:string ;
  obo:hasDbXref "MeSH:D017880"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002439 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An X-linked dominant disorder with a range of phenotypes and reduced activities of several enzymes in a number of metabolic pathways."^^xsd:string ;
  obo:hasDbXref "OMIM:308050"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002440 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of levobupivacaine, a drug used as a local anesthetic. It is the S-enantiomer of bupivacaine compared to which, it has a longer duration of action and is associated with less vasodilation. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Levobupivacaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002441 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of levobupivacaine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Levobupivacaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002442 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of levobupivacaine-target interaction and of the biochemical or physiological responses to drug.  It is the S-enantiomer of bupivacaine compared to which, it has a longer duration of action and is associated with less vasodilation. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Levobupivacaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002443 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of compounds used to alleviate pain and which act on the nervous system in a way similar to opiate. They can be natural opiates, like morphine or codeine, endogenous opioid peptide, like endorphins, semi- or fully synthetic opioids, or drugs that chemically are not of the opioid class but act as agonists of opioid receptors. Others can act as antagonists or mixed agonists/antagonists. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Opioid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002444 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of oxycodone, a semi-synthetic opioid and a narcotic analgesic indicated for relief of moderate to severe pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Oxycodone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002445 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of oxycodone. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Oxycodone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002446 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of oxycodone-target interaction and of the biochemical or physiological responses to drug. It is thought to act on different opioid receptors in different situations. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Oxycodone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002447 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of hydromorphone, a derivative of the morphine family and a potent analgesic opioid drug and a narcotic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Hydromorphone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002448 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of hydromorphone. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Hydromorphone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002449 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of hydromorphone-target interaction and of the biochemical or physiological responses to drug. The drug is a mu-receptor agonist whose major effects are on the central nervous system and gastrointestinal tract. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Hydromorphone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002450 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of hydrocodone, a narcotic analgesic synthesized from codeine and used for relief of moderate to severe pain. It is also used as an antitussive to treat cough. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Hydrocodone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002451 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of hydrocodone. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Hydrocodone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002452 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of hydrocodone-target interaction and of the biochemical or physiological responses to drug. It primarily acts on the mu-opioid receptor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Hydrocodone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002453 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of oxymorphone, a semi-synthetic opioid analgesic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Oxymorphone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002454 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of oxymorphone. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Oxymorphone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002455 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of oxymorphone-target interaction and of the biochemical or physiological responses to drug. It acts on the mu-opioid receptor and to a lesser extent, the delta receptor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Oxymorphone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002456 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of salicylic acid derived from salicin, an anti-inflammatory agent produced in willow bark. It is best known for its use in anti-acne products. As a drug, it is used in the treatment of pain and inflammation and to reduce fever. Its salts and esters are known as salicylates. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Salicylic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002457 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of salicylic acid. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Salicylic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002458 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of salicylic acid-target interaction and of the biochemical or physiological responses to drug. Salicylic acid is used in the treatment of pain and inflammation and to reduce fever. Salts and esters of salicylic acid are known as salicylates. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Salicylic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002459 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of compounds used for the treatment of conditions related to skin, hair and nails. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Dermatology"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002460 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of sodium salicylate, a sodium salt of salicylic acid, used as an analgesic and antipyretic drug. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Sodium_salicylate"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002461 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of sodium salicylate. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Sodium_salicylate"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002462 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of salicylic acid-target interaction and of the biochemical or physiological responses to drug. Sodium salicylate is used as an analgesic and antipyretic. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Sodium_salicylate"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002463 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of carbamazepine, a drug used in the treatment of epilepsy and neuropathic pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Carbamazepine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002464 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of carbamazepine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Carbamazepine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002465 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of carbamazepine-target interaction and of the biochemical or physiological responses to drug. Carbamazepine is used in the treatment of epilepsy and neuropathic pain. The drug stabilizes the inactivated state of voltage-gated sodium channels and can also act as a GABA receptor agonist. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Carbamazepine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002466 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive condition resulting from alterations in steroid metabolism due to defects in HSD11B2 gene."^^xsd:string ;
  obo:hasDbXref "OMIM:218030"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002467 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A hereditary, usually autosomal dominant condition, resulting from alterations in glucose transport, affecting the nervous system and exhibiting a wide phenotypic variability."^^xsd:string ;
  obo:hasDbXref "OMIM:606777"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002468 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of felodipine, a calcium channel blocker used for the treatment of high blood pressure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Felodipine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002469 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of felodipine. The drug is a calcium channel blocker used in the treatment of high blood pressure.  Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Felodipine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002470 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of felodipine-target interaction and of the biochemical or physiological responses to drug. The drug is a calcium channel blocker used for the treatment of high blood pressure.  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Felodipine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002472 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of compounds used to treat various forms of depression."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/ATC_code_N06#N06AX_Other_antidepressants"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002473 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of venlafaxine, a drug used in the treatment of major depressive, anxiety and panic disorders. The drug inhibits the reuptake of key neurotransmitters such as serotonin, epinephrine and dopamine. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Venlafaxine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002474 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of venlafaxine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Venlafaxine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002475 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of venlafaxiine-target interaction and of the biochemical or physiological responses to drug. The drug inhibits the reuptake of key neurotransmitters such as serotonin, epinephrine and dopamine. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Venlafaxine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002476 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of rosiglitazone, an anti-diabetic drug. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug. In several countries the drug was withdrawn from the market due to its side effects."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Rosiglitazone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002477 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of rosiglitazone, an anti-diabetic drug. Genetic variations can result in changes in the availability of the drug. In several countries the drug was withdrawn from the market due to its side effects."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Rosiglitazone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002478 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of rosiglitazone-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug.  In several countries rosiglitazone was withdrawn from the market due to its side effects."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Rosiglitazone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002479 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The various conditions affecting any part of the biliary tract including the bile ducts,  resulting from alterations in one or several pathways."^^xsd:string ;
  obo:hasDbXref "MeSH:D001660"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002480 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A condition where bile cannot flow from the liver to the duodenum which can be mechanical in nature as in blockage of the duct system or metabolic, resulting from alterations in bile formation due to genetic or environmental factors."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Cholestasis"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002481 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Autosomal recessive disorders resulting from alterations in bile acid synthesis due to defects in one or several enzymes. Type 1 is due to mutations in the HSD3B7 gene, type 2 is due to mutations in the AKR1D1 gene, type 3 is due to mutations in the CYP7B1 gene."^^xsd:string ;
  obo:hasDbXref "OMIM:235555"^^xsd:string, "OMIM:607765"^^xsd:string, "OMIM:613812"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002482 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of chloroprocaine, a drug used as a local anesthetic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Chloroprocaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002483 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of chloroprocaine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Chloroprocaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002484 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of chloroprocaine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Chloroprocaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002485 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of prednisolone - a synthetic glucocorticoid used to treat a wide range of inflammatory and autoimmune conditions, and also allergic reactions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Prednisolone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002486 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of prednisolone, a synthetic glucocorticoid. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Prednisolone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002487 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of prednisolone-target interaction and of the biochemical or physiological responses to drug. used to treat a wide range of inflammatory and autoimmune conditions, and also allergic reactions. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Prednisolone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002489 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Melatonin, in human and other organisms derived from tryptophan, is a monoamine with antioxidant properties and involved in the synchronization of the circadian rhythms. Melatonin signals through three receptors types of which two are present in humans and other mammals. They are G protein coupled receptors (GPCR)."^^xsd:string ;
  obo:hasDbXref "PMID:17198536"^^xsd:string, "PMID:17298593"^^xsd:string, "PMID:18766165"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002490 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Glycine signaling is primarily inhibitory. The glycine receptor is ligand-gated ion channel that exerts its effects via chloride currents."^^xsd:string ;
  obo:hasDbXref "PMID:20438799"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002491 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive condition resulting from alteration in leukotriene C4 synthesis due to defects in the LTC4 synthase gene."^^xsd:string ;
  obo:hasDbXref "OMIM:614037"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002492 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of phenindione. The drug is used as anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Phenindione"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002493 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of phenindione.  Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Phenindione"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002494 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of phenindione-target interaction and of the biochemical or physiological responses to drug. Phenindione is used as anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Phenindione"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002495 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of dicoumarol. Dicoumarol is a naturally occurring anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Dicoumarol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002496 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of dicoumarol.  Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Dicoumarol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002497 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of dicoumarol-target interaction and of the biochemical or physiological responses to drug.  Dicoumarol is a naturally occurring anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Dicoumarol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002498 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of adrenergic beta receptors agonists. The drugs can be either selective or non-selective. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Beta-adrenergic_agonist"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002499 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of selective adrenergic beta receptors agonists. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Beta-adrenergic_agonist"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002500 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of non-selective adrenergic beta receptors agonists. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Beta-adrenergic_agonist"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002501 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of isoprenaline, a non-selective beta adrenergic agonist used for the treatment of heart block and slow heart rate. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Isoprenaline"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002502 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of isoprenaline. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Isoprenaline"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002503 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of isoprenaline-target interaction and of the biochemical or physiological responses to drug. The drug is a non-selective beta adrenergic agonist used for the treatment of heart block and slow heart rate.  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Isoprenaline"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002504 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those conditions resulting from alterations in one or several pathways and affecting the adrenal glands. The adrenal glands are the site of synthesis for a variety of hormones."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Adrenal_gland"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002505 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An X-linked disorder resulting from disturbances in the metabolism of very long chain fatty acids due to defects in the ABCD1 gene."^^xsd:string ;
  obo:hasDbXref "MeSH:D000326"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002506 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A rare autosomal recessive condition resulting from alteration in long-fatty acid oxidation and due to defects in the SLC25A20 gene."^^xsd:string ;
  obo:hasDbXref "OMIM:212138"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002507 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of mycophenolic acid - an immunosuppressant drug used to prevent rejection in organ transplantation. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Mycophenolic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002508 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of mycophenolic acid. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Mycophenolic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002509 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of mycophenolic acid-target interaction and of the biochemical or physiological responses to drug. Mycophenolic acid is used as an immunosuppressant to prevent organ rejection in transplantation. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Mycophenolic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002510 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the degradation of catecholamines. Epinephrine, norepinephrine and dopamine are among the most abundant."^^xsd:string ;
  obo:hasDbXref "PMID:19342614"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002511 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the degradation of dopamine. Dopamine degradation can be initiated by two enzymes. Dopamine can spontaneously oxidize and in the process, radicals are being produced. Storage of newly synthesized dopamine or degradation of excess cytosolic dopamine prevent oxidation of dopamine."^^xsd:string ;
  obo:hasDbXref "PMID:24548101"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002512 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the degradation of epinephrine."^^xsd:string ;
  obo:hasDbXref "PMID:19342614"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002513 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the degradation of norepinephrine."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Norepinephrine#Degradation"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002514 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of tiaprofenic acid, a non-steroidal anti-inflammatory drug used  to treat pain, especially arthritic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Tiaprofenic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002517 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of thyroid-stimulating hormone (TSH). TSH is a pituitary hormone that stimulates the thyroid gland to produce thyroxine (T4) and then triiodothyronine (T3). T3 is the active thyroid hormone that stimulates cellular metabolism."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Thyroid-stimulating_hormone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002518 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis of thyrotropin-releasing hormone (TRH). TRH is a tripeptidal hormone produced in the hypothalamus that stimulates the release of thyroid-stimulating hormone and prolactin from the anterior pituitary."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Thyrotropin-releasing_hormone"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002519 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Somatostatin, known as growth hormone-inhibiting hormone, is a peptide hormone that regulates cell proliferation, neurotransmission and the endocrine system."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Somatostatin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002520 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Thyroglobulin, produced by the follicular cells of thyroid gland is used to produce the thyroid hormones via a number of steps. Thyroglobulin contains some 100-120 tyrosine residues, of which only a small fraction is used to produce thyroid hormones. Usually there are 5 to 6 molecules of either thyroxine (T4) and triiodothyronine (T3) derived from each molecule of thyroglobulin."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Thyroglobulin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002521 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The major thyroid hormones thyroxine (T4) or tetraidothyronine and triiodothyronine (T3) are the major thyroid hormones produced via processing of thyroglobulin precursor. T3 is the active hormone and is derived from T4 by the action of deiodinases."^^xsd:string ;
  obo:hasDbXref "PMID:21913492"^^xsd:string, "PMID:24251883"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002522 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of flurbiprofen, a non-steroidal anti-inflammatory drug used  in the treatment of arthritis and dental pain and also as a pre-operative solution. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Flurbiprofen"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002523 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of flurbiprofen. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Flurbiprofen"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002524 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of flurbiprofen-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of arthritis and dental pain and also as a pre-operative solution.  Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Flurbiprofen"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002525 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of ethylmorphine, an opiate narcotic analgesic mostly used to treat dry cough and as an ophtalmologic agent. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Ethylmorphine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002526 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of ethylmorphine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Ethylmorphine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002527 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of ethylmorphine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Ethylmorphine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002528 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of magnesium salicylate, used as an analgesic and antipyretic drug. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Magnesium_salicylate"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002531 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Inherited conditions characterized by a loss of myelin in the central nervous system."^^xsd:string ;
  obo:hasDbXref "MeSH:D020279"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002532 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive condition resulting from alterations in cerebroside metabolism due to defects in the cerebroside sulfatase enzyme."^^xsd:string ;
  obo:hasDbXref "MeSH:D007966"^^xsd:string, "OMIM:25010"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002533 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of cocaine, a drug of few medical uses, mostly as a local anesthetic during surgery. Cocaine is highly addictive due to its effects on the reward system in the brain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Cocaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002534 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of cocaine, a drug of limited medical uses. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Cocaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002535 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of cocaine-target interaction and of the biochemical or physiological responses to drug. Cocaine has few medical uses, mostly as local anesthetic during surgery. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Cocaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002536 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of lidocaine, an important class 1b antiarrhythmic drug also used as a local anesthetic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Lidocaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002537 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of lidocaine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Lidocaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002538 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of lidocaine-target interaction and of the biochemical or physiological responses to drug. Lidocaine is an important class 1b antiarrhythmic drug also used as a local anesthetic. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Lidocaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002539 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of oxybuprocaine, a drug used as a local anesthetic, particularly in ophtalmology and otolaryngology. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Oxybuprocaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002540 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of oxybuprocaine. Genetic variations can result in changes in the availability of the drug.  Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Oxybuprocaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002541 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of oxybuprocaine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Oxybuprocaine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002542 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of dihydromorphine, a semi-synthetic opioid used for the management of moderate to severe pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Dihydromorphine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002543 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of dihydrolmorphine. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Dihydromorphine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002544 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of dihydromorphine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Dihydromorphine"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002545 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A disturbance that leads to changes in the body's normal balance of acids and bases resulting in deviation from the normal  pH range. The imbalance is due to changes in renal or ventilation function. The changes can lead to an excess of acid, acidosis or acidaemia, or to an excess of vases, alkalosis or alkalemia."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Acid%E2%80%93base_imbalance"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002546 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic changes resulting in an excess of acids in the system causing a decrease in the normal pH range."^^xsd:string ;
  obo:hasDbXref "MeSH:D000138"^^xsd:string, "wikipedia:https://en.wikipedia.org/wiki/Acid%E2%80%93base_imbalance"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002547 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic changes resulting in an excess of bases in the system causing an increase in the normal pH range."^^xsd:string ;
  obo:hasDbXref "MeSH:D000471"^^xsd:string, "wikipedia:https://en.wikipedia.org/wiki/Acid%E2%80%93base_imbalance"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002548 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An acidosis caused by alteration in lactic acid metabolism."^^xsd:string ;
  obo:hasDbXref "MeSH:D000140"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002549 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An acidosis caused by alteration in the ketone bodies metabolic pathway due to defects in the 3-oxoacid CoA transferase 1 enzyme."^^xsd:string ;
  obo:hasDbXref "OMIM:245050"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002550 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A rare acidosis resulting from defects in malonyl-CoA decarboxylase enzyme."^^xsd:string ;
  obo:hasDbXref "OMIM:248360"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002551 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of levacetylmethadol, a synthetic opioid, similar in structure to methadone, used for the treatment and management of opioid dependence.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Levacetylmethadol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002552 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of levacetylmethadol. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Levacetylmethadol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002553 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of levacetylmethadol-target interaction and of the biochemical or physiological responses to drug. The drug acts as a mu-receptor agonist. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Levacetylmethadol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002554 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of levorphanol, an opioid used for the treatment of moderate to severe pain. Primarily an agonist of the mu opioid receptor, levorphanol acts as an agonist or antagonist for several other receptors. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Levorphanol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002555 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of levorphanol. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Levorphanol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002556 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of levorphanol-target interaction and of the biochemical or physiological responses to drug. The drug acts primarily as a mu-receptor agonist, but it can be an agonist or antagonist for several other receptors. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Levorphanol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002557 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An inherited condition resulting from alteration in lipid metabolism due to defects in lipase or apolipoprotein functions."^^xsd:string ;
  obo:hasDbXref "MeSH:D008072"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002558 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of heroin, an opioid painkiller and a narcotic. Chemically is 3,6-diacetyl ester of morphine. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Heroin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002559 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of heroin. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Heroin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002560 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of heroin-target interaction and of the biochemical or physiological responses to drug. Heroin is an opioid painkiller and a narcotic. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Heroin"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002561 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive condition resulting from alterations in the transsulfuration pathway of homocysteine metabolism."^^xsd:string ;
  obo:hasDbXref "OMIM:219500"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002562 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An inherited condition resulting from alterations in glutathione metabolism."^^xsd:string ;
  obo:hasDbXref "OMIM:231950"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002563 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An inherited condition resulting from alterations in the urea cycle pathway."^^xsd:string ;
  obo:hasDbXref "OMIM:238970"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002564 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the oxidation of phytanic acid, a branched chain fatty acid. Phytanic acid alpha-oxidation in the peroxisome results in pristanic acid, which can then follow a beta degradation pathway."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Phytanic_acid"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002565 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An inherited condition resulting from alterations in carnosine metabolism due to defects in the enzyme carnosinase and manifested in neurological disorders."^^xsd:string ;
  obo:hasDbXref "OMIM:212200"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002566 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive disorder leading to the formation of urinary stones."^^xsd:string ;
  obo:hasDbXref "OMIM:614723"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002567 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Conditions leading to the formation of stones in any part of the urinary tract."^^xsd:string ;
  obo:hasDbXref "MeSH:D052878"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002568 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal condition resulting from alterations in cysteine metabolism due to defects in the enzyme mercaptopyruvate sulfurtransferase."^^xsd:string ;
  obo:hasDbXref "PMID:16719781"^^xsd:string, "PMID:23759691"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002569 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A rare condition resulting from possible alterations in amino acid metabolism for which the causative genes are a matter of debate."^^xsd:string ;
  obo:hasDbXref "PMID:11446412"^^xsd:string, "PMID:16466957"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002570 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics of diphenoxylate, a drug of the phenulpiperidine sries used for the treatment of diarrhea. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Diphenoxylate"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002571 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of diphenoxylate. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Diphenoxylate"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002572 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of diphenoxylate-target interaction and of the biochemical or physiological responses to drug. Diphenoxylate is used for the treatment of diarrhea. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Diphenoxylate"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002573 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A condition resulting from alterations in glucose metabolism and homeostasis leading to abnormally low blood glucose levels."^^xsd:string ;
  obo:hasDbXref "MeSH:D007003"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002574 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An autosomal recessive disorder resulting from alterations in long chain fatty acid oxidation due to defects in the carnitine palmitoyltransferase 1A (CPT1A) enzyme."^^xsd:string ;
  obo:hasDbXref "OMIM:255120"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002575 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The reactions thereby dopamine can spontaneously oxidize under aerobic conditions. In the process, radicals are being formed that can potentially exert noxious effects. Oxidation of dopamine gives rise to three quinone species that can form adducts with proteins or be precursor to the neuromelanin pigment (NM). NM, which accumulates with age, but is diminished in Parkinson disease patients may confer protective roles, particularly as a metal chelator."^^xsd:string ;
  obo:hasDbXref "PMID:24548101"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002576 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An inheritied condition resulting from alterations in the degradation of branched-chain amino acid due to defects in the alpha subunit of methylcrotonyl CoA carboxylase (MCCC1). MCCC is a biotin-requiring enzyme in the mitochondria."^^xsd:string ;
  obo:hasDbXref "OMIM:210200"^^xsd:string, "wikipedia:https://en.wikipedia.org/wiki/Methylcrotonyl-CoA_carboxylase"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002577 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "An inheritied condition resulting from alterations in the degradation of branched-chain amino acid due to defects in the beta subunit of methylcrotonyl CoA carboxylase (MCCC2). MCCC is a biotin-requiring enzyme in the mitochondria."^^xsd:string ;
  obo:hasDbXref "OMIM:210210"^^xsd:string, "wikipedia:https://en.wikipedia.org/wiki/Methylcrotonyl-CoA_carboxylase"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002579 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A brain-derived neurotrophic factor (BDNF) signaling pathway that deviates from what it normal course should be. Impaired BDNF signaling contributes to the pathogenesis of conditions such as Huntington Disease (HD) and depression."^^xsd:string ;
  obo:hasDbXref "PMID:24668475"^^xsd:string, "PMID:25221473"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002580 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the synthesis and utilization of nicotinamide adenine dinucleotide (NAD). There are several routes leading to NAD biosynthesis from various sources. NAD, in addition to its well known role as a cofactor in redox reactions, also serves as a substrate for several classes of enzymes."^^xsd:string ;
  obo:hasDbXref "PMID:18020963"^^xsd:string, "PMID:20007326"^^xsd:string, "PMID:26785480"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002581 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those metabolic reactions involved in the utilization of nicotinamide adenine dinucleotide (NAD). NAD, in addition to its well known role as a cofactor in redox reactions, also serves as a substrate for several classes of enzymes. These include the sirtuin deacetylases, the adenosine diphosphate (ADP)-ribose transferases/poly(ADP-ribose) polymerases, and the cyclic ADP-ribose (cADPR) synthases."^^xsd:string ;
  obo:hasDbXref "PMID:18020963"^^xsd:string, "PMID:20007326"^^xsd:string, "PMID:26785480"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002582 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Mono- and poly-ADP-ribosylation of proteins is carried out by members of the PARP family. Proteins with particular domains or modules are involved in the recognition of modified proteins while others reverse the modification. Protein ADP-ribosylation plays important roles in DNA damage repair, cell-cycle, transcription and cell death pathways."^^xsd:string ;
  obo:hasDbXref "PMID:25828806"^^xsd:string, "PMID:26091342"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002583 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Cyclic ADP-ribosylation leads to the formation of second messengers with important roles in calcium signaling."^^xsd:string ;
  obo:hasDbXref "PMID:25828806"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002584 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Sirtuins belong to the class III deacetylases that carry out NAD-dependent deacetylation and other activities. They are sensors of NAD/NAM ratio and play important roles in cellular homeostasis."^^xsd:string ;
  obo:hasDbXref "PMID:27154583"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002585 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of carvedilol - a non-selective adrenergic beta receptor blocker, used in the treatment of mild to severe congestive heart failure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Carvedilol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002586 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of carvedilol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Carvedilol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002587 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of carvedilol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta belonging to the third generation of blockers. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Carvedilol"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002588 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those conditions affecting the skeletal system and elements associated with it, arising from deregulation in a number of pathways."^^xsd:string ;
  obo:hasDbXref "MeSH:D001847"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002589 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A heterogeneous group of conditions with recessive, dominant, and X-linked forms."^^xsd:string ;
  obo:hasDbXref "MeSH:D002806"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002590 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Those conditions resulting from the abnormal development of cartilage and bone."^^xsd:string ;
  obo:hasDbXref "MeSH:D010009"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002591 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The better characterized form of chondrodysplasia punctata due to defects in the Ebp gene involved in the cholesterol biosynthetic pathway."^^xsd:string ;
  obo:hasDbXref "OMIM:302960"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002592 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The vitamin K cycle is an essential aspect of its metabolism. The carboxylation of glutamate residues in vitamin K-dependent (VKD) proteins, necessary for their function, requires a reduced form of vitamin K as a cofactor. The resulting oxidized compound is converted back to the reduced form via a two-step reduction reaction. Natural and synthetic antagonists block the cycle and thus, the VKD protein modification. VKD proteins include coagulation factors; antagonists are used as anti-coagulation, anti-thrombotic agents."^^xsd:string ;
  obo:hasDbXref "PMID:24489112"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002593 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of dabigatran, a direct thrombin inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:26150723"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002594 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of dabigatran, a direct thrombin inhibitor. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:26150723"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002595 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of dabigatran-target interaction and of the biochemical or physiological responses to drug. The drug is a direct thrombin inhibitor. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:26150723"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002596 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of drugs that reduce or prevent the formation of blood clots by directly inhibiting activated factor X (Xa). Factor X is a serine protease and essential component of coagulation cascade. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:26150723"^^xsd:string, "wikipedia:https://en.wikipedia.org/wiki/Direct_Xa_inhibitor"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002597 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of apixaban, a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:26150723"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002598 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of edoxaban, a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:26150723"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002599 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of rivaroxaban, a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:26150723"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002600 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of apixaban, a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:26150723"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002601 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of apixaban-target interaction and of the biochemical or physiological responses to drug. The drug is a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:26150723"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002602 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of edoxaban, a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:26150723"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002603 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of edoxaban-target interaction and of the biochemical or physiological responses to drug. The drug is a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:26150723"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002604 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of rivaroxaban, a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "PMID:26150723"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002605 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of rivaroxaban-target interaction and of the biochemical or physiological responses to drug. The drug is a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "PMID:26150723"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002606 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Proteases, the vitamin K-dependent coagulation proteases in particular, can activate a specific class of G protein-coupled receptors harboring an internally tethered ligand. The four protease-activated receptors (PARs) are involved in numerous physiologically relevant processes and can also play a role in disease-related aspects. PARs can be cleaved at different sites by different proteases to elicit distinct signaling responses, referred to as biased signaling."^^xsd:string ;
  obo:hasDbXref "PMID:24860547"^^xsd:string, "PMID:24990498"^^xsd:string, "PMID:27068977"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002607 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Protease-activated receptor 1 (PAR1/F2R) is primarily a target of coagulation factor 2, thrombin, but other proteases can prompt or disarm it. PAR1 signaling plays many roles in the immune, cardiovascular and nervous system."^^xsd:string ;
  obo:hasDbXref "PMID:25986685"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002608 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Protease-activated receptor 2 (PAR2/F2RL1) is primarily a target of coagulation factor 10, but other proteases can prompt or disarm it. PAR2  signaling plays important roles in the cardiovascular and immune systems."^^xsd:string ;
  obo:hasDbXref "PMID:25120239"^^xsd:string, "PMID:27006943"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002609 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Protease-activated receptor 4 (PAR4/F2RL3) is primarily a target of coagulation factor 2, thrombin, but other proteases can prompt or disarm it. PAR4 signaling plays important roles in the inflammatory response."^^xsd:string ;
  obo:hasDbXref "PMID:25664811"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002610 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Protease-activated receptor 3 (PAR3/F2RL2) is primarily a target of coagulation factor 2, thrombin, but other proteases can prompt or disarm it. PAR3 is thought to not signal autonomously and require heterodimerization with other PARs."^^xsd:string ;
  obo:hasDbXref "PMID:18264801"^^xsd:string, "PMID:22117049"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002611 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Alterations in the hemostatic system can result in a series of pathological conditions. They are caused by alterations in the coagulation cascade and/or anticoagulant pathways that regulate it."^^xsd:string ;
  obo:hasDbXref "PMID:12787532"^^xsd:string, "PMID:26018600"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002612 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Alterations in the anticoagulant system are associated with various conditions."^^xsd:string ;
  obo:hasDbXref "PMID:23031460"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002613 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Alterations in the coagulation cascade have been associated with several conditions. Deficiencies in factors F5 and F8, the essential cofactors of the intrinsic tenase and thrombinase complexes, lead to parahemophilia and hemophilia A, respectively."^^xsd:string ;
  obo:hasDbXref "PMID:19765210"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002614 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Mutations in protein C (Proc) and its cofactor, protein S (Pros1) are associated with several deficiencies."^^xsd:string ;
  obo:hasDbXref "PMID:12787532"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002615 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The glyoxalase pathway is the main detoxifying  route to protect against the harmful effects of methylglyoxal (MG). The highly reactive dicarbonyl compound is primarily a by-product of glycolysis, but  it can also result as a by-product of fatty acid and protein metabolism. MG is also known as pyruvaldehyde or 2-oxopropanol."^^xsd:string ;
  obo:hasDbXref "PMID:23763312"^^xsd:string, "PMID:25709564"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002616 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A fibrinolysis pathway that deviates from what its normal course should be. Several congenital and acquired disorders of fibrinolysis are reported."^^xsd:string ;
  obo:hasDbXref "PMID:25294122"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002617 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A condition resulting from alterations in the gluconeogenesis pathway due to defects in the cytosolic PCK1 gene."^^xsd:string ;
  obo:hasDbXref "OMIM:261680"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002618 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Alterations in platelet-derived growth factor signaling are implicated in cancer development."^^xsd:string ;
  obo:hasDbXref "PMID:26153649"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002621 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Deregulation of nuclear factor, erythroid 2 like 2 (Nfe2l2, also known as Nrf2) signaling pathway has been associated with several conditions, including neurodegeneration and cancer."^^xsd:string ;
  obo:hasDbXref "PMID:26122708"^^xsd:string, "PMID:26419687"^^xsd:string, "PMID:27192495"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002622 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Several endogenous small proteins are involved in the antioxidant response. Subsequently they need to be reduced back for another round of response, The reductase enzymes catalyze the reaction in an NADPH-dependent manner. The expression of these and of NADPH-producing enzymes is under the control of nuclear factor, erythroid 2 like 2 signaling pathway."^^xsd:string ;
  obo:hasDbXref "PMID:23397885"^^xsd:string, "PMID:24647116"^^xsd:string, "PMID:26122708"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002626 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Ferroptosis is a non-apoptotic form of programmed cell death that is triggered by conditions or molecules that inhibit the Gpx4 function. Loss of function of glutathione peroxidase GPX4 results in accumulation of lipid-based reactive oxygen species (ROS)."^^xsd:string ;
  obo:hasDbXref "PMID:26653790"^^xsd:string, "PMID:26725301"^^xsd:string, "PMID:27048822"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002627 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pharmacokinetics and pharmacodynamics pathway of bortezomib, a proteasome inhibitor used in the treatment of several cancer types. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Bortezomib"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002628 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of processing - absorption, distribution, metabolism or elimination - of bortezomib. Genetic variations can result in changes in the availability of the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Bortezomib"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002629 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The pathway of bortezomib-target interaction and of the biochemical or physiological responses to drug. Bortezomib  is used in the treatment of several cancer types. Genetic variations can cause differences in the response of the organism to the drug."^^xsd:string ;
  obo:hasDbXref "wikipedia:https://en.wikipedia.org/wiki/Bortezomib"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002630 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Paraquat, a chemical used as a herbicide and a powerful oxidant, is highly toxic to the mammalian system. Toxicity depends on delivery routes: the highest is via inhalation, followed by the oral route, with the dermal route being moderately toxic. It has been shown that there is a connection between paraquat use and Parkinson disease (PD) in farm workers."^^xsd:string ;
  obo:hasDbXref "PMID:18161502"^^xsd:string, "PMID:22024235"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002631 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Several systems are involved in the uptake of iron. They require the action of ferric reductases as the form of iron crossing the membrane is the ferrous Fe(II)."^^xsd:string ;
  obo:hasDbXref "PMID:25661197"^^xsd:string, "PMID:26725301"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002632 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "A single system is involved in the efflux of iron from many cell types. As the iron crossing the membrane is the ferrous Fe(II), several oxidases carry out the formation of ferric Fe(III) which can be bound by the transferrin carrier."^^xsd:string ;
  obo:hasDbXref "PMID:26437604"^^xsd:string, "PMID:26596411"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002633 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Heme and iron-sulfur cluster (ISC) biosynthetic pathways are the major routes of iron utilization."^^xsd:string ;
  obo:hasDbXref "PMID:25661197"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002634 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The steps involved in the assembly and delivery of iron-sulfur (Fe-S) clusters (ISC) to Fe-S proteins. The mitochondrial ISC and the connected cytosolic assembly (CIA) pathways provide for the biogenesis of all Fe-S proteins. The Fe-S proteins participate in a broad range of important cellular processes."^^xsd:string ;
  obo:hasDbXref "PMID:25583461"^^xsd:string, "PMID:26099175"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002635 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The mitochondrial pathway consists of the synthesis of [2Fe-2S] cluster on scaffold proteins, cluster transfer and formation of mitochondrial [2Fe-2S] proteins, and the synthesis of 4Fe-4S] cluster and the formation of [4Fe-4S] proteins. The first two steps are required for the mitochondrial export and the biogenesis of cytosolic and nuclear Fe-S proteins. This arm of the pathway is usually referred as the 'core'."^^xsd:string ;
  obo:hasDbXref "PMID:25583461"^^xsd:string, "PMID:26099175"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002636 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The cytosolic iron-sulfur cluster protein assembly pathway is dependent upon the core mitochondrial assembly and export pathways. The pathway is structurally distinct from the mitochondrial system."^^xsd:string ;
  obo:hasDbXref "PMID:25583461"^^xsd:string, "PMID:26099175"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002637 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "The core mitochondrial iron-sulfur assembly and export pathways are crucial for the assembly of cytosolic and nuclear Fe-S proteins. Despite knowledge of the export system, the  species that is actually transported remains to be determined. The exported molecule is usually termed X-S."^^xsd:string ;
  obo:hasDbXref "PMID:25583461"^^xsd:string, "PMID:26099175"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002639 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Heme is a prosthetic group found in proteins important for many and diverse metabolic pathways. Import and export of heme into and from cells are important for proper heme homeostasis."^^xsd:string ;
  obo:hasDbXref "PMID:24926267"^^xsd:string, "PMID:26100009"^^xsd:string .

[]
  a owl:Axiom ;
  owl:annotatedSource ns1:PW_0002640 ;
  owl:annotatedProperty ns1:IAO_0000115 ;
  owl:annotatedTarget "Acrolein is a reactive unsaturated aldehyde that is a dietary and environmental pollutant and can also be metabolically generated. It exerts severe toxic effects through production of DNA and protein adducts and disruption of important cellular pathways. Acrolein is thought to play a role in cardiovascular and neurodegenerative diseases, diabetes and immune disorders."^^xsd:string ;
  obo:hasDbXref "PMID:25628402"^^xsd:string .

